PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kesanakurti, D; Maddirela, D; Banasavadi-Siddegowda, YK; Lai, TH; Qamri, Z; Jacob, NK; Sampath, D; Mohanam, S; Kaur, B; Puduvalli, VK				Kesanakurti, D.; Maddirela, D.; Banasavadi-Siddegowda, Y. K.; Lai, T-H; Qamri, Z.; Jacob, N. K.; Sampath, D.; Mohanam, S.; Kaur, B.; Puduvalli, V. K.			A novel interaction of PAK4 with PPAR gamma to regulate Nox1 and radiation-induced epithelial-to-mesenchymal transition in glioma	ONCOGENE			English	Article							ACTIVATED-RECEPTOR-GAMMA; OXYGEN SPECIES GENERATION; BREAST-CANCER CELLS; EXTRACELLULAR-MATRIX; DEPENDENT ACTIVATION; MALIGNANT GLIOMA; BETA-CATENIN; STEM-CELLS; KAPPA-B; INVASION	Tumor recurrence in glioblastoma (GBM) is, in part, attributed to increased epithelial-to-mesenchymal transition (EMT) and enhanced tumor cell dissemination in adjacent brain parenchyma after ionizing radiation (IR). EMT is associated with aggressive behavior, increased stem-like characteristics and treatment resistance in malignancies; however, the underlying signaling mechanisms that regulate EMT are poorly understood. We identified grade-dependent p21-activated kinases 4 (PAK4) upregulation in gliomas and further determined its role in mesenchymal transition and radioresistance. IR treatment significantly elevated expression and nuclear localization of PAK4 in correlation with induction of reactive oxygen species (ROS) and mesenchymal transition in GBM cells. Stable PAK4 overexpression promoted mesenchymal transition by elevating EMT marker expression in these cells. Of note, transcription factor-DNA-binding arrays and chromatin immunoprecipitation experiments identified the formation of a novel nuclear PAK4/PPAR gamma complex which was recruited to the promoter of Nox1, a peroxisome proliferator-activated receptor gamma (PPAR gamma) target gene. In addition, IR further elevated PAK4/PPAR gamma complex co-recruitment to Nox1 promoter, and increased Nox1 expression and ROS levels associated with mesenchymal transition in these cells. Conversely, specific PAK4 downregulation decreased PPAR gamma-mediated Nox1 expression and suppressed EMT in IR-treated cells. In vivo orthotopic tumor experiments showed inhibition of growth and suppression of IR-induced PPAR gamma and Nox1 expression by PAK4 downregulation in tumors. Our results provide the first evidence of a novel role for PAK4 in IR-induced EMT and suggest potential therapeutic efficacy of targeting PAK4 to overcome radioresistance in gliomas.	[Kesanakurti, D.; Puduvalli, V. K.] Ohio State Univ, Ctr Comprehens Canc, Dardinger Ctr Neurooncol & Neurosci, Div Neurooncol, 320W 10th Ave Starling Loving Hall Suite M410, Columbus, OH 43210 USA; [Kesanakurti, D.; Banasavadi-Siddegowda, Y. K.; Kaur, B.; Puduvalli, V. K.] Ohio State Univ, Ctr Comprehens Canc, Dardinger Ctr Neurooncol & Neurosci, Dept Neurosurg, 320W 10th Ave Starling Loving Hall Suite M410, Columbus, OH 43210 USA; [Maddirela, D.; Lai, T-H; Sampath, D.; Mohanam, S.] Ohio State Univ, Ctr Comprehens Canc, Div Hematol, 320W 10th Ave Starling Loving Hall Suite M410, Columbus, OH 43210 USA; [Maddirela, D.; Mohanam, S.] Univ Illinois, Coll Med Peoria, Dept Canc Biol & Pharmacol, Peoria, IL USA; [Qamri, Z.; Jacob, N. K.] Ohio State Univ, Ctr Comprehens Canc, Dept Radiat Oncol, 320W 10th Ave Starling Loving Hall Suite M410, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Peoria; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Kesanakurti, D (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Dardinger Ctr Neurooncol & Neurosci, Div Neurooncol, 320W 10th Ave Starling Loving Hall Suite M410, Columbus, OH 43210 USA.	Divya.Kesanakurti@osumc.edu; Vinay.Puduvalli@osumc.edu	Sampath, Deepa/T-5069-2019	/0000-0002-4730-6918; Sampath, Deepa/0000-0002-4366-8436	Ohio State University Pelotonia Fellowship; NCI [5K24CA160777]; Sanford/Rife Family Glioblastoma Research Fund; Snyder Nation Foundation; Ellen and John Hines Neuro-oncology Research Fund; NATIONAL CANCER INSTITUTE [K24CA160777, P30CA016058] Funding Source: NIH RePORTER	Ohio State University Pelotonia Fellowship; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sanford/Rife Family Glioblastoma Research Fund; Snyder Nation Foundation; Ellen and John Hines Neuro-oncology Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Jihong Xu, Krishna K Veeravalli and Bharath Chelluboina for technical help. We greatly appreciate Dr. Annie NY Cheung (University of Hong Kong, Hong Kong, China)) and Dr Audrey Minden (Rutgers University, NJ, USA) for kindly providing the PAK4-NLS-Mut and PAK4-K350M plasmids respectively, for our studies. We thank Drs Deepa Sampath and Rosa Lapalombella for manuscript review and helpful comments. This project was supported by the Ohio State University Pelotonia Fellowship (DK), NCI grant 5K24CA160777 (VKP), the Sanford/Rife Family Glioblastoma Research Fund, the Snyder Nation Foundation and the Ellen and John Hines Neuro-oncology Research Fund.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Badiga AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020614; Baldassa S, 2010, J CELL PHYSIOL, V224, P722, DOI 10.1002/jcp.22172; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Callow MG, 2005, J CELL SCI, V118, P1861, DOI 10.1242/jcs.02313; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chattopadhyay N, 2000, J NEUROSCI RES, V61, P67, DOI 10.1002/1097-4547(20000701)61:1<67::AID-JNR8>3.0.CO;2-7; Chen L, 2006, J BIOL CHEM, V281, P24575, DOI 10.1074/jbc.M604147200; Dart AE, 2015, J CELL BIOL, V211, P863, DOI 10.1083/jcb.201501072; Davison CA, 2013, CANCER RES, V73, P3704, DOI 10.1158/0008-5472.CAN-12-2482; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Han EJ, 2013, INT J RADIAT ONCOL, V85, pE239, DOI 10.1016/j.ijrobp.2012.11.040; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Jin RS, 2014, J CELL SCI, V127, P3116, DOI 10.1242/jcs.147835; Kahlert UD, 2013, CANCER LETT, V331, P131, DOI 10.1016/j.canlet.2012.12.010; Kamata T, 2009, CANCER SCI, V100, P1382, DOI 10.1111/j.1349-7006.2009.01207.x; Kesanakurti D, 2013, ONCOGENE, V32, P5144, DOI 10.1038/onc.2012.546; Kesanakurti D, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.182; Kim KY, 2006, BIOCHEM PHARMACOL, V72, P530, DOI 10.1016/j.bcp.2006.05.009; Komatsu D, 2008, ONCOGENE, V27, P4724, DOI 10.1038/onc.2008.102; Kubelt C, 2015, INT J ONCOL, V46, P2515, DOI 10.3892/ijo.2015.2944; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee JJ, 2012, ONCOGENE, V31, P3818, DOI 10.1038/onc.2011.543; Lee KS, 2006, J ALLERGY CLIN IMMUN, V118, P120, DOI 10.1016/j.jaci.2006.03.021; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li XD, 2010, INT J BIOCHEM CELL B, V42, P70, DOI 10.1016/j.biocel.2009.09.008; Li Y, 2012, BBA-MOL CELL RES, V1823, P465, DOI 10.1016/j.bbamcr.2011.11.013; Liu F, 2012, J INVEST DERMATOL, V132, P2033, DOI 10.1038/jid.2012.119; Liu YY, 2008, MOL CANCER RES, V6, P1215, DOI 10.1158/1541-7786.MCR-08-0087; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Mahabir R, 2014, NEURO-ONCOLOGY, V16, P671, DOI 10.1093/neuonc/not239; Masuda T, 2005, CLIN CANCER RES, V11, P4012, DOI 10.1158/1078-0432.CCR-05-0087; Meng J, 2014, ONCOTARGET, V5, P4683, DOI 10.18632/oncotarget.2088; Michalik L, 2004, NAT REV CANCER, V4, P61, DOI 10.1038/nrc1254; Minden Audrey, 2012, ISRN Oncol, V2012, P694201, DOI 10.5402/2012/694201; Nagano O, 2013, ONCOGENE, V32, P5191, DOI 10.1038/onc.2012.638; Paliouras GN, 2009, MOL CELL BIOL, V29, P3018, DOI 10.1128/MCB.01286-08; Park MT, 2014, CELL DEATH DIFFER, V21, P1185, DOI 10.1038/cdd.2014.34; Pestereva E, 2012, BRIT J CANCER, V106, P1702, DOI 10.1038/bjc.2012.161; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Qu J, 2001, MOL CELL BIOL, V21, P3523, DOI 10.1128/MCB.21.10.3523-3533.2001; Radu M, 2014, NAT REV CANCER, V14, P13, DOI 10.1038/nrc3645; Sawayama H, 2014, CANCER RES, V74, P575, DOI 10.1158/0008-5472.CAN-13-1836; Schaefer KL, 2005, CANCER RES, V65, P2251, DOI 10.1158/0008-5472.CAN-04-3037; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Siebzehnrubl FA, 2013, EMBO MOL MED, V5, P1196, DOI 10.1002/emmm.201302827; Siu MKY, 2010, P NATL ACAD SCI USA, V107, P18622, DOI 10.1073/pnas.0907481107; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tyagi N, 2016, CANCER LETT, V370, P260, DOI 10.1016/j.canlet.2015.10.028; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang X, 2013, ONCOGENE, V32, P5512, DOI 10.1038/onc.2013.217; Whale AD, 2013, ONCOGENE, V32, P2114, DOI 10.1038/onc.2012.233; Wu CH, 2012, J BIOL CHEM, V287, P25292, DOI 10.1074/jbc.M111.291195; Zarkoob H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064169; Zaytseva YY, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-90; Zhang HQ, 2002, J CELL BIOL, V158, P1287, DOI 10.1083/jcb.200207008; Zheng HQ, 2014, CANCER CELL, V26, P358, DOI 10.1016/j.ccr.2014.07.022	68	28	33	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 14	2017	36	37					5309	5320		10.1038/onc.2016.261	http://dx.doi.org/10.1038/onc.2016.261			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FG8HT	28534509	Green Accepted			2022-12-26	WOS:000410671700009
J	Ying, F; Cai, Y; Cai, Y; Wang, Y; Tang, EHC				Ying, Fan; Cai, Yin; Cai, Yu; Wang, Yu; Tang, Eva Hoi Ching			Prostaglandin E receptor subtype 4 regulates lipid droplet size and mitochondrial activity in murine subcutaneous white adipose tissue	FASEB JOURNAL			English	Article						CL316243; WAT remodeling; mitochondrial biogenesis; FSP27; phosphorylation AMPK	FAT-SPECIFIC PROTEIN-27; DE-NOVO LIPOGENESIS; BROWN ADIPOCYTES; EP4 RECEPTOR; METABOLISM; THERMOGENESIS; CONTRIBUTES; ACTIVATION; LIPOLYSIS; STORAGE	The purpose of this study was to investigate whether genetic ablation of prostaglandin E receptor subtype 4 (EP4) affects white adipose tissue (WAT) remodeling mediated by beta(3)-adrenergic stimulation. The selective b3-adrenergic agonist, CL316243 (1mg/kg/d, i.p.) caused a greater increase in metabolic rate in EP4-knockout mice. CL316243 fragmented the unilocular lipid droplet into multilocular lipid vacuoles and increased mitochondrial biogenesis and its activity. These changes were amplified in mice with EP4 deficiency and were selectively seen in subcutaneous WAT. The expression of fat-specific protein (FSP)-27, a protein that promotes fusion of triglycerides and formation of unilocular lipid droplets were diminished, whereas the expression of phosphorylated AMPK, the upstream regulator of FSP27, was enhanced in EP4-deficient mice. The present study showed that EP4 acts as a negative regulator of WAT remodeling, it tightly coordinates rates of triglyceride storage in lipid droplets and mitochondrial respiratory function in subcutaneous white adipocytes through the phosphorylated AMPK-FSP27 signaling axis. Thus, deletion of EP4 increases mitochondrial biogenesis and oxidative capacity in WAT, and fat mass loss ensues in mice.	[Ying, Fan; Cai, Yu; Wang, Yu; Tang, Eva Hoi Ching] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Cai, Yin] Univ Hong Kong, Dept Anesthesiol, Hong Kong, Hong Kong, Peoples R China; [Tang, Eva Hoi Ching] Univ Hong Kong, Li Ka Shing Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Tang, EHC (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, L2-26C,2-F Lab Block,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	evatang1@hku.hk		wang, yu/0000-0001-8697-2940; Cai, Yin/0000-0002-7763-0612	Research Grant Council of Hong Kong Special Administrative Region (SAR) [27101314]	Research Grant Council of Hong Kong Special Administrative Region (SAR)	The authors thank Prof. Paul M. Vanhoutte (University of Hong Kong), for language editing and proofreading the manuscript. This work was supported, in part, by grants from the Research Grant Council of Hong Kong Special Administrative Region (SAR) under the General Research Fund (27101314 to E.H.C.T.). The authors declare no conflicts of interest.	Astrup A., 2014, HDB OBESITY CLIN APP, P315; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Billot X, 2003, BIOORG MED CHEM LETT, V13, P1129, DOI 10.1016/S0960-894X(03)00042-8; Bugge A, 2014, METHOD ENZYMOL, V538, P233, DOI 10.1016/B978-0-12-800280-3.00013-X; Cai Y, 2015, CELL CYCLE, V14, P3580, DOI 10.1080/15384101.2015.1100771; Cai Y, 2015, FASEB J, V29, P4924, DOI 10.1096/fj.15-274597; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, P990, DOI 10.1101/pdb.prot5648; Contreras GA, 2014, AM J PHYSIOL-ENDOC M, V307, pE793, DOI 10.1152/ajpendo.00033.2014; Costford SR, 2006, AM J PHYSIOL-ENDOC M, V290, pE1304, DOI 10.1152/ajpendo.00401.2005; De Pauw A, 2009, AM J PATHOL, V175, P927, DOI 10.2353/ajpath.2009.081155; Dunham-Snary KJ, 2014, REDOX BIOL, V2, P656, DOI 10.1016/j.redox.2014.04.005; Facemire CS, 2011, AM J PHYSIOL-RENAL, V301, pF1035, DOI 10.1152/ajprenal.00054.2011; Gaidhu MP, 2011, J LIPID RES, V52, P1702, DOI 10.1194/jlr.M015354; Gaidhu MP, 2009, J LIPID RES, V50, P704, DOI 10.1194/jlr.M800480-JLR200; Ghorbani Masoud, 2015, Drug Des Devel Ther, V9, P669, DOI 10.2147/DDDT.S73891; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Granneman JG, 2003, AM J PHYSIOL-ENDOC M, V285, pE1230, DOI 10.1152/ajpendo.00197.2003; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Harper ME, 2004, PHARMACOTHERAPY OF OBESITY: OPTIONS AND ALTERNATIVES, P363; Herms A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8176; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Lo KA, 2013, BIOSCIENCE REP, V33, P711, DOI 10.1042/BSR20130046; Machwate M, 2001, MOL PHARMACOL, V60, P36, DOI 10.1124/mol.60.1.36; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Meyer CW, 2010, AM J PHYSIOL-REG I, V299, pR1396, DOI 10.1152/ajpregu.00021.2009; Mottillo EP, 2014, J LIPID RES, V55, P2276, DOI 10.1194/jlr.M050005; Musa CV, 2012, INT J OBESITY, V36, P207, DOI 10.1038/ijo.2011.81; Nedergaard J, 2014, CELL METAB, V20, P396, DOI 10.1016/j.cmet.2014.07.005; Nguyen MT, 1997, NATURE, V390, P78, DOI 10.1038/36342; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Riordan NH, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-29; Rosell M, 2014, AM J PHYSIOL-ENDOC M, V306, pE945, DOI 10.1152/ajpendo.00473.2013; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Tang EHC, 2015, J LIPID RES, V56, P358, DOI 10.1194/jlr.M054817; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Wu W, 2015, EURASIP J WIREL COMM, DOI 10.1186/s13638-015-0378-2; Yokoyama U, 2013, PHARMACOL REV, V65, P1010, DOI 10.1124/pr.112.007195; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zhang XD, 2014, AM J PHYSIOL-ENDOC M, V307, pE1047, DOI 10.1152/ajpendo.00125.2014	46	10	11	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4023	4036		10.1096/fj.201700191R	http://dx.doi.org/10.1096/fj.201700191R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28533326				2022-12-26	WOS:000408713300027
J	Assadian, F; Kamel, W; Laurell, G; Svensson, C; Punga, T; Akusjarvi, G				Assadian, Farzaneh; Kamel, Wael; Laurell, Goran; Svensson, Catharina; Punga, Tanel; Akusjarvi, Goran			Expression profile of Epstein-Barr virus and human adenovirus small RNAs in tonsillar B and T lymphocytes	PLOS ONE			English	Article							NONCODING RNAS; MICRORNAS; DNA; TARGETS; CELLS; VAI; IDENTIFICATION; INTERFERENCE; QUANTITATION; PREVALENCE	We have used high-throughput small RNA sequencing to characterize viral small RNA expression in purified tonsillar B and T lymphocytes isolated from patients tested positive for Epstein-Barr virus (EBV) or human adenovirus (HAdV) infections, respectively. In the small set of patients analyzed, the expression profile of EBV and HAdV miRNAs could not distinguish between patients diagnosed with tonsillar hypertrophy or chronic/recurrent tonsillitis. The EBV miR-BART expression profile among the patients diagnosed with tonsillar diseases resembles most closely the pattern seen in EBV+ tumors (Latency II/I). The miRBARTs that appear to be absent in normal EBV infected cells are essentially all detectable in the diseased tonsillar B lymphocytes. In the EBV+ B cells we detected 44 EBV miRBARTs derived from the proposed BART precursor hairpins whereof five are not annotated in miRBase v21. One previously undetected miRNA, BART16b-5p, originates from the miR-BART16 precursor hairpin as an alternative 5 A miR-BART16 located precisely upstream of the annotated miR-BART16-5p. Further, our analysis revealed an extensive sequence variation among the EBV miRNAs with isomiRs having a constant 5 A end but alternative 3 A ends. A range of small RNAs was also detected from the terminal stem of the EBER RNAs and the 3 A part of v-snoRNA1. During a lytic HAdV infection in established cell lines the terminal stem of the viral non-coding VA RNAs are processed to highly abundant viral miRNAs (mivaRNAs). In contrast, mivaRNA expression in HAdV positive tonsillar T lymphocytes was very low. The small RNA profile further showed that the 5 A mivaRNA from VA RNAI and the 3 A mivaRNA from VA RNAII were as predicted, whereas the 3 A mivaRNA from VA RNAI showed an aberrant processing upstream of the expected Dicer cleavage site.	[Assadian, Farzaneh; Kamel, Wael; Svensson, Catharina; Punga, Tanel; Akusjarvi, Goran] Uppsala Univ, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Laurell, Goran] Uppsala Univ, Dept Surg Sci Otorhinolaryngol & Head & Neck Surg, Uppsala, Sweden; [Assadian, Farzaneh] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA	Uppsala University; Uppsala University; University of Minnesota System; University of Minnesota Twin Cities	Akusjarvi, G (corresponding author), Uppsala Univ, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden.	goran.akusjarvi@imbim.uu.se	Punga, Tanel/K-9844-2019; Kamel, Wael/AAD-4645-2022	Punga, Tanel/0000-0002-0561-367X; Kamel, Wael/0000-0002-7625-2648; Akusjarvi, Goran/0000-0003-2961-5060	Swedish Cancer Society [120678, 130469]; Swedish Research Council through Uppsala RNA Research Centre [2006-5038-36531-16]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council through Uppsala RNA Research Centre	This work was supported by the Swedish Cancer Society (grant numbers 120678 and 130469, www.cancerfonden.se) and the Swedish Research Council through a grant to the Uppsala RNA Research Centre (grant number 2006-5038-36531-16, www.vr.se)	Adhikary AK, 2014, J CLIN VIROL, V61, P477, DOI 10.1016/j.jcv.2014.10.015; Alkhalaf MA, 2013, J MED VIROL, V85, P1947, DOI 10.1002/jmv.23678; Alles Julia, 2015, Non-Coding RNA, V1, P170, DOI 10.3390/ncrna1030170; Ambrosio MR, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-12; Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Assadian F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154814; Assadian F, 2015, JOVE-J VIS EXP, DOI 10.3791/53374; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Bavi P, 2011, J PATHOL, V224, P355, DOI 10.1002/path.2864; Bellutti F, 2015, J VIROL, V89, P1608, DOI 10.1128/JVI.02336-14; Berger C, 2007, J MED VIROL, V79, P1147, DOI 10.1002/jmv.20899; Cai Xuezhong, 2006, PLoS Pathogens, V2, P236, DOI 10.1371/journal.ppat.0020023; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; CLARKE PA, 1991, NUCLEIC ACIDS RES, V19, P243, DOI 10.1093/nar/19.2.243; Delecluse HJ, 2007, J CLIN PATHOL, V60, P1358, DOI 10.1136/jcp.2006.044586; Dirmeier U, 2005, ONCOGENE, V24, P1711, DOI 10.1038/sj.onc.1208367; Eliopoulos AG, 2001, SEMIN CANCER BIOL, V11, P435, DOI 10.1006/scbi.2001.0410; Furuse Y, 2013, VIROLOGY, V447, P140, DOI 10.1016/j.virol.2013.08.024; Garnett CT, 2009, J VIROL, V83, P2417, DOI 10.1128/JVI.02392-08; Garnett CT, 2002, J VIROL, V76, P10608, DOI 10.1128/JVI.76.21.10608-10616.2002; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Gu S, 2012, CELL, V151, P900, DOI 10.1016/j.cell.2012.09.042; Guo L, 2012, EUR J CLIN MICROBIOL, V31, P1051, DOI 10.1007/s10096-011-1406-8; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hage E, 2015, J GEN VIROL, V96, P2734, DOI 10.1099/vir.0.000196; Hooykaas MJG, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2978-6; Hudnall SD, 2005, MODERN PATHOL, V18, P519, DOI 10.1038/modpathol.3800369; Hutzinger R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000547; Ikeda T, 2000, J GEN VIROL, V81, P1211, DOI 10.1099/0022-1317-81-5-1211; Iwakiri D, 2016, VIRUS RES, V212, P30, DOI 10.1016/j.virusres.2015.08.007; Iwakiri D, 2009, J EXP MED, V206, P2091, DOI 10.1084/jem.20081761; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kamel W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105746; Kamel W, 2013, NUCLEIC ACIDS RES, V41, P4802, DOI 10.1093/nar/gkt172; Kang D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004979; Kincaid RP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003018; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Li ZY, 2012, COMPUT ENG APPL, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0040132; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Lu Jun, 2012, EPSTEIN BARR VIRUS E; Lu LJ, 2015, ARCH VIROL, V160, P1229, DOI 10.1007/s00705-015-2387-1; Lung RWM, 2013, INT J MOL SCI, V14, P17378, DOI 10.3390/ijms140917378; Ma YL, 1996, J VIROL, V70, P5083, DOI 10.1128/JVI.70.8.5083-5099.1996; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nachmani D, 2009, CELL HOST MICROBE, V5, P376, DOI 10.1016/j.chom.2009.03.003; Nadal D, 2002, J MED VIROL, V67, P54, DOI 10.1002/jmv.2192; Nanbo A, 2002, EMBO J, V21, P954, DOI 10.1093/emboj/21.5.954; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pimienta G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124638; Proenca-Modena JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042136; Punga T, 2013, FUTURE VIROL, V8, P343, DOI 10.2217/FVL.13.19; Qiu J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002193; Richman D. D., 2009, Clinical virology; Riley KJL, 2010, J VIROL, V84, P5148, DOI 10.1128/JVI.00110-10; Roberts ML, 1998, VIROLOGY, V240, P93, DOI 10.1006/viro.1997.8901; Robinson CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01812; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; ROSA MD, 1981, MOL CELL BIOL, V1, P785, DOI 10.1128/MCB.1.9.785; Samanta M, 2008, ONCOGENE, V27, P4150, DOI 10.1038/onc.2008.75; Sano M, 2006, FEBS LETT, V580, P1553, DOI 10.1016/j.febslet.2006.01.085; SHARP TV, 1993, NUCLEIC ACIDS RES, V21, P4483, DOI 10.1093/nar/21.19.4483; Skalsky RL, 2014, J VIROL, V88, P1617, DOI 10.1128/JVI.02071-13; Skalsky RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002484; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Tycowski KT, 2015, GENE DEV, V29, P567, DOI 10.1101/gad.259077.115; Umbach JL, 2010, J VIROL, V84, P695, DOI 10.1128/JVI.02013-09; VANDERVE.J, 1973, INFECT IMMUN, V7, P604, DOI 10.1128/IAI.7.4.604-609.1973; VENNSTROM B, 1978, NUCLEIC ACIDS RES, V5, P195, DOI 10.1093/nar/5.1.195; Wong AMG, 2012, CANCER-AM CANCER SOC, V118, P698, DOI 10.1002/cncr.26309; Wu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030988; Xia T, 2008, CANCER RES, V68, P1436, DOI 10.1158/0008-5472.CAN-07-5126; Xing L, 2007, J VIROL, V81, P9967, DOI 10.1128/JVI.02244-06; Xu N, 2007, J VIROL, V81, P10540, DOI 10.1128/JVI.00885-07; Xu N, 2009, NUCLEIC ACIDS RES, V37, P6950, DOI 10.1093/nar/gkp764; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhao HX, 2015, VIROLOGY, V478, P99, DOI 10.1016/j.virol.2015.01.033	85	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177275	10.1371/journal.pone.0177275	http://dx.doi.org/10.1371/journal.pone.0177275			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542273	gold, Green Published, Green Submitted			2022-12-26	WOS:000402062800013
J	Forde, C; Stierman, B; Ramon-Pardo, P; dos Santos, T; Singh, N				Forde, Corey; Stierman, Bryan; Ramon-Pardo, Pilar; dos Santos, Thais; Singh, Nalini			Carbapenem-resistant Klebsiella pneumoniae in Barbados: Driving change in practice at the national level	PLOS ONE			English	Article							RISK-FACTORS; PCR ASSAY; EPIDEMIOLOGY; INFECTION; IDENTIFICATION; COLONIZATION; MORTALITY; OUTBREAK; CLONES; KPC	Introduction Carbapenem-resistant Klebsiella pneumoniae (CRKP) is of growing concern globally. The risk for transmission of antimicrobial resistant organisms across several continents to the Caribbean is a real one given its tourism industry. After a cluster of cases of CRKP were detected, several studies detailed in this report were initiated to better characterize the problem. Methods A hospital-wide point prevalence study and active surveillance were performed at Queen Elizabeth Hospital (QEH) in Barbados in 2013 to assess the prevalence of CRKP infection/ colonization. Following this, a 1-year longitudinal study measured the prevalence of CRKP isolates in the hospital and across all healthcare facilities in the country. Results In 2013, eleven viable isolates of CRKP from cluster of cases were sent for molecular epidemiology studies. When sequenced, they were found to be the ST-258 clone. Identification of a cluster of cases of CRKP ST-258/512 clones indicated person-to-person transmission. In September 2013, the hospital-wide point prevalence study revealed 18% of patients (53/299) at the hospital were either colonized or infected with CRKP. The infection to colonization ratio was 1:7. Patients who were infected/colonized vs. non-colonized were older (64.7 vs. 48.7 years, p<0.0001), were hospitalized longer (42.5 days vs. 27 days, p = 0.0042), were more likely to have an invasive device (66% vs. 32%, p<0.0001), especially urinary catheters (55% vs. 24%, p<0.0001), and were more likely to have used antimicrobials within the prior 14 days (91% vs. 46%, p<0.0001). Specific antimicrobials, including fluoroquinolones and piperacillin-tazobactam, were significantly associated with infection/colonization. In 2014, the 12-month period prevalence of CRKP in Barbados was 49.6 per 100,000 population and of blood stream infections was 3.2 per 100,000 population. Conclusions This point prevalence study identified patients at-risk of acquisition of CRKP and allowed QEH to implement interventions aimed at decreasing the prevalence of CRKP. Organization of a National and regional Infection Prevention and Control Committee in 2014 aimed to strengthen antimicrobial resistance surveillance programs across the English-speaking Caribbean were established.	[Forde, Corey] Queen Elizabeth Hosp, Bridgetown, Barbados; [Stierman, Bryan; Singh, Nalini] Childrens Natl Hlth Syst, Washington, DC 20010 USA; [Ramon-Pardo, Pilar; dos Santos, Thais] Pan Amer Hlth Org, Washington, DC USA; [Singh, Nalini] George Washington Univ, Washington, DC 20052 USA	Children's National Health System; Pan American Health Organization; George Washington University	Forde, C (corresponding author), Queen Elizabeth Hosp, Bridgetown, Barbados.; Singh, N (corresponding author), Childrens Natl Hlth Syst, Washington, DC 20010 USA.; Singh, N (corresponding author), George Washington Univ, Washington, DC 20052 USA.	cfordeclinic@gmail.com; nsingh@childrensnational.org						Adler A, 2014, DIAGN MICR INFEC DIS, V78, P12, DOI 10.1016/j.diagmicrobio.2013.10.003; Ben-David D, 2010, INFECT CONT HOSP EP, V31, P620, DOI 10.1086/652528; Benenson S, 2012, J ANTIMICROB CHEMOTH, V67, P1651, DOI 10.1093/jac/dks115; BTI, TOUR PROF; CDC, 2015, FAC GUID CONTR CARB; Chroboczek T, 2013, J TRAVEL MED, V20, P283, DOI 10.1111/jtm.12047; CLSI, 2016, LAB DET REP CARB RES; Debby BD, 2012, EUR J CLIN MICROBIOL, V31, P1811, DOI 10.1007/s10096-011-1506-5; Escandon-Vargas K, 2017, EXPERT REV ANTI-INFE, V15, P277, DOI 10.1080/14787210.2017.1268918; Rueda VG, 2014, COLOMB MEDICA, V45, P54; Gomez SA, 2016, INFECT GENET EVOL, V44, P145, DOI 10.1016/j.meegid.2016.06.018; Gregory CJ, 2010, INFECT CONT HOSP EP, V31, P476, DOI 10.1086/651670; Hickey B, 2017, WHO GAP AMR NEWSLETT; Hoxha A, 2016, J HOSP INFECT, V92, P61, DOI 10.1016/j.jhin.2015.06.018; Jiao Y, 2015, PATHOG GLOB HEALTH, V109, P68, DOI 10.1179/2047773215Y.0000000004; Kochar S, 2009, INFECT CONT HOSP EP, V30, P447, DOI 10.1086/596734; Mills JP, 2016, INFECT CONT HOSP EP, V37, P55, DOI 10.1017/ice.2015.254; Robledo IE, 2010, ANTIMICROB AGENTS CH, V54, P1354, DOI 10.1128/AAC.00899-09; Saint S, 2016, NEW ENGL J MED, V374, P2111, DOI 10.1056/NEJMoa1504906; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS165, DOI 10.1016/j.ajic.2007.10.006; Singh N., 2017, CLIN MICROBIOLOGY IN; Tacconelli E, 2017, GLOBAL PRIORITY LIST; Temkin E, 2014, ANN NY ACAD SCI, V1323, P22, DOI 10.1111/nyas.12537; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Turner R., 2015, TRAVEL TOURISM EC IM; Ulu AC, 2015, MED SCI MONITOR, V21, P219, DOI 10.12659/MSM.892516; WHO, 2017, WHO PUBLISHES LIST B; Wiener-Well Y, 2010, J HOSP INFECT, V74, P344, DOI 10.1016/j.jhin.2009.07.022; World Health Organization, 2016, GUID COR COMP INF PR	29	9	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0176779	10.1371/journal.pone.0176779	http://dx.doi.org/10.1371/journal.pone.0176779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542162	Green Published, gold, Green Submitted			2022-12-26	WOS:000402062800003
J	Zhou, DY; Pan, Q; Chhipi-Shrestha, G; Li, XY; Zhang, K; Hewage, K; Sadiq, R				Zhou, Deyun; Pan, Qian; Chhipi-Shrestha, Gyan; Li, Xiaoyang; Zhang, Kun; Hewage, Kasun; Sadiq, Rehan			A new weighting factor in combining belief function	PLOS ONE			English	Article							EVIDENTIAL REASONING ALGORITHM; DECISION-ANALYSIS; WATER-QUALITY; COMBINATION; UNCERTAINTY; DISTANCE; NUMBERS; IMPACT; MODEL; TBM	Dempster-Shafer evidence theory has been widely used in various applications. However, to solve the problem of counter-intuitive outcomes by using classical Dempster-Shafer combination rule is still an open issue while fusing the conflicting evidences. Many approaches based on discounted evidence and weighted average evidence have been investigated and have made significant improvements. Nevertheless, all of these approaches have inherent flaws. In this paper, a new weighting factor is proposed to address this problem. First, a modified dissimilarity measurement is proposed which is characterized by both distance and conflict between evidences. Second, a measurement of information volume of each evidence based on Deng entropy is introduced. Then two kinds of weight derived from aforementioned measurement are combined to obtain a new weighting factor and a weighted average method based on the new weighting factor is proposed. Numerical examples are used to illustrate the validity and effectiveness of the proposed method. In the end, the new method is applied to a real-life application of river water quality monitoring, which effectively identify the major land use activities contributing to river pollution.	[Zhou, Deyun; Pan, Qian; Li, Xiaoyang; Zhang, Kun] Northwestern Polytech Univ, Sch Elect & Informat, Xian, Peoples R China; [Chhipi-Shrestha, Gyan; Hewage, Kasun; Sadiq, Rehan] Univ British Columbia Okanagan, Sch Engn, Kelowna, BC, Canada	Northwestern Polytechnical University; University of British Columbia; University of British Columbia Okanagan	Pan, Q (corresponding author), Northwestern Polytech Univ, Sch Elect & Informat, Xian, Peoples R China.	panq@mail.nwpu.edu.cn	Hewage, Kasun/AAQ-2395-2020		National Natural Science Foundation of China [61401363]; Natural Sciences and Engineering Research Council of Canada (NSERC) Collaborative Research and Development Grants [CRDPJ 446638-12]; Science and Technology on Avionics Integration Laboratory and Aeronautical Science Foundation [20155153034]; Fundamental Research Funds for the Central Universities [3102016AXXX005, 3102015BJIIJGZ009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences and Engineering Research Council of Canada (NSERC) Collaborative Research and Development Grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); Science and Technology on Avionics Integration Laboratory and Aeronautical Science Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant No. 61401363) (K.Z.); Natural Sciences and Engineering Research Council of Canada (NSERC) Collaborative Research and Development Grants (Grant No. CRDPJ 446638-12) (K.H.); Science and Technology on Avionics Integration Laboratory and Aeronautical Science Foundation (Grant No. 20155153034) (K.Z.); Fundamental Research Funds for the Central Universities (Grant No. 3102016AXXX005, 3102015BJIIJGZ009) (K.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work is partially supported by the National Natural Science Foundation of China (Grant No. 61401363), the Natural Sciences and Engineering Research Council of Canada (NSERC) Collaborative Research and Development Grants (Grant No. CRDPJ 446638-2), the Science and Technology on Avionics Integration Laboratory and Aeronautical Science Foundation (Grant No. 20155153034), the Fundamental Research Funds for the Central Universities (Grant No. 3102016AXXX005, 3102015BJIIJGZ009).	Chhipi-Shrestha GK., 2007, THESIS; Chhipi-Shrestha GK, 2007, P INT S COMM LED MAN, P163; Chhipi-Shrestha GKaP A. M. S, 2007, J SAN STRATIGRAPHICA, V6, P55; Dempster AP, 2006, INT J INTELL SYST, V21, P283, DOI 10.1002/int.20135; DEMPSTER AP, 1967, ANN MATH STAT, V38, P325, DOI 10.1214/aoms/1177698950; Deng XY, 2014, EXPERT SYST APPL, V41, P635, DOI 10.1016/j.eswa.2013.07.088; Deng Y, 2015, INT J UNCONVENTIONAL, V11; Deng Y., 2015, ARTIF INTELL, V6, P176; Deng Y, 2015, APPL INTELL, V43, P530, DOI 10.1007/s10489-015-0661-2; Deng Y, 2010, DEFENCE SCI J, V60, P525, DOI 10.14429/dsj.60.576; Dezert J, 2006, CS0610175 ARXIV; Dubois D., 1988, Computational Intelligence, V4, P244, DOI 10.1111/j.1467-8640.1988.tb00279.x; ERNST C., 2004, AM WATER WORKS ASS, V30, P1, DOI [10.1002/j.1551-8701.2004.tb01752.x, DOI 10.1002/J.1551-8701.2004.TB01752.X]; Cunha DGF, 2016, ECOL ENG, V94, P516, DOI 10.1016/j.ecoleng.2016.06.063; Fu C, 2014, KNOWL-BASED SYST, V59, P9, DOI 10.1016/j.knosys.2014.01.024; Garcia ML, 2005, VULNERABILITY ASSESS; Hamacher H., 1978, LOGISCHE AGGREGATION; Han DQ, 2012, SCI CHINA INFORM SCI, V55, P558, DOI 10.1007/s11432-011-4541-z; He Y, 2012, SCI CHINA INFORM SCI, V55, P312, DOI 10.1007/s11432-011-4346-0; Jiang W, 2015, INT J COMPUT COMMUN, V10, P333, DOI 10.15837/ijccc.2015.3.1656; Jiang W, 2016, ADV MECH ENG, V8, DOI 10.1177/1687814016641820; Jiang Wen, 2010, Systems Engineering and Electronics, V32, P562; Joussleme A.-L., 2001, Information Fusion, V2, P91, DOI 10.1016/S1566-2535(01)00026-4; Kang BY, 2012, KNOWL-BASED SYST, V35, P77, DOI 10.1016/j.knosys.2012.04.007; Kumar AY, 2009, ENVIRON MONIT ASSESS, V157, P223, DOI 10.1007/s10661-008-0530-0; Liu HC, 2013, IEEE T RELIAB, V62, P23, DOI 10.1109/TR.2013.2241251; Liu WR, 2006, ARTIF INTELL, V170, P909, DOI 10.1016/j.artint.2006.05.002; Liu Z-g, 2015, ADV APPL DSMT INFORM, VIV, P23; Liu ZG, 2011, DECIS SUPPORT SYST, V52, P133, DOI 10.1016/j.dss.2011.06.002; Martin A., 2008, INF FUS 2008 11 INT; McKleroy VS, 2006, AIDS EDUC PREV, V18, P59, DOI 10.1521/aeap.2006.18.supp.59; Murphy CK, 2000, DECIS SUPPORT SYST, V29, P1, DOI 10.1016/S0167-9236(99)00084-6; Rao SS, 2013, J MECH DESIGN, V135, DOI 10.1115/1.4024229; Ristic B, 2006, INFORM FUSION, V7, P276, DOI 10.1016/j.inffus.2005.04.004; Shafer G.A., 1976, MATH THEORY EVIDENCE; Smarandache F, 2006, ADV APPL DSM INFORM; Smets P, 2005, INT J APPROX REASON, V38, P133, DOI 10.1016/j.ijar.2004.05.003; SMETS P, 1994, ARTIF INTELL, V66, P191, DOI 10.1016/0004-3702(94)90026-4; SMETS P, 1990, IEEE T PATTERN ANAL, V12, P447, DOI 10.1109/34.55104; Smets P, 2008, STUD FUZZ SOFT COMP, V219, P633; Su XY, 2015, RISK ANAL, V35, P1296, DOI 10.1111/risa.12347; Tianlu C, 2006, J SYSTEMS ENG ELECT, V17, P279; Wang YN, 2015, INT J COMPUT INT SYS, V8, P75, DOI 10.1080/18756891.2014.964009; YAGER RR, 1987, INFORM SCIENCES, V41, P93, DOI 10.1016/0020-0255(87)90007-7; Yang JB, 2002, IEEE T SYST MAN CY A, V32, P289, DOI 10.1109/TSMCA.2002.802746; Yang JB, 2013, ARTIF INTELL, V205, P1, DOI 10.1016/j.artint.2013.09.003; Yong D., 2004, DECIS SUPPORT SYST, V38, P489, DOI DOI 10.1016/J.DSS.2004.04.015; Zadeh L.A., 1986, AI MAG, V7, P85, DOI DOI 10.1609/AIMAG.V7I2.542; Zhang MJ, 2017, EUR J OPER RES, V257, P1005, DOI 10.1016/j.ejor.2016.08.028; Zia H, 2013, COMPUT ELECTRON AGR, V96, P126, DOI 10.1016/j.compag.2013.05.001	50	5	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177695	10.1371/journal.pone.0177695	http://dx.doi.org/10.1371/journal.pone.0177695			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542549	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800023
J	Zhu, BY; Rippe, C; Hien, TT; Zeng, JW; Albinsson, S; Stenkula, KG; Uvelius, B; Sward, K				Zhu, Baoyi; Rippe, Catarina; Tran Thi Hien; Zeng, Jianwen; Albinsson, Sebastian; Stenkula, Karin G.; Uvelius, Bengt; Sward, Karl			Similar regulatory mechanisms of caveolins and cavins by myocardin family coactivators in arterial and bladder smooth muscle	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; GENE-EXPRESSION; URINARY-BLADDER; ACTIN DYNAMICS; UP-REGULATION; TRANSCRIPTION; MICE; DIFFERENTIATION; HYPERTROPHY; ADIPOCYTES	Caveolae are membrane invaginations present at high densities in muscle and fat. Recent work has demonstrated that myocardin family coactivators (MYOCD, MKL1), which are important for contractile differentiation and cell motility, increase caveolin (CAV1, CAV2, CAV3) and cavin (CAVIN1, CAVIN2, CAVIN3) transcription, but several aspects of this control mechanism remain to be investigated. Here, using promoter reporter assays we found that both MKL1/MRTF-A and MKL2/MRTF-B control caveolins and cavins via their proximal promoter sequences. Silencing of MKL1 and MKL2 in smooth muscle cells moreover reduced CAV1 and CAVIN1 mRNA levels by well over 50%, as did treatment with second generation inhibitors of MKL activity. GATA6, which modulates expression of smooth muscle-specific genes, reduced CAV1 and CAV2, whereas the cavins were unaffected or increased. Viral overexpression of MKL1 and myocardin induced caveolin and cavin expression in bladder smooth muscle cells from rats and humans and MYOCD correlated tightly with CAV1 and CAVIN1 in human bladder specimens. A recently described activator of MKL-driven transcription (ISX) failed to induce CAV1/CAVIN1 which may be due to an unusual transactivation mechanism. In all, these findings further support the view that myocardin family coactivators are important transcriptional drivers of caveolins and cavins in smooth muscle.	[Zhu, Baoyi; Rippe, Catarina; Tran Thi Hien; Albinsson, Sebastian; Stenkula, Karin G.; Sward, Karl] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Zhu, Baoyi; Zeng, Jianwen] Guangzhou Med Univ, Affiliated Hosp 6, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Uvelius, Bengt] Lund Univ, Dept Urol Clin Sci, Lund, Sweden	Lund University; Guangzhou Medical University; Lund University	Sward, K (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	karl.sward@med.lu.se	Rippe, Catarina/B-4110-2010; Albinsson, Sebastian/B-4105-2010	Rippe, Catarina/0000-0001-8621-9836; Stenkula, Karin/0000-0002-0739-1150; Uvelius, Bengt/0000-0003-0201-8928; Albinsson, Sebastian/0000-0001-6936-3967; Sward, Karl/0000-0002-7255-5510; Zhu, Baoyi/0000-0002-6727-3607	Swedish Research Council (Vetenskapsradet) [K2015-65X-22662-01-3, K2013-99X22245-01-5]; Crafoord Foundation; Royal Physiographic Society (Kungliga Fysiografiska Sallskapet); Hillevi Fries' foundation; Gosta Jonsson's foundation	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Crafoord Foundation; Royal Physiographic Society (Kungliga Fysiografiska Sallskapet); Hillevi Fries' foundation; Gosta Jonsson's foundation	This study was funded by The Swedish Research Council (Vetenskapsradet, http://www.vr.se/,K2015-65X-22662-01-3 (KS) and K2013-99X22245-01-5 (SA)), the Crafoord Foundation (ham://en.crafoord.se/,CR), the Royal Physiographic Society (Kungliga Fysiografiska Sallskapet, http://www.fyslografen.se/, CR) and Hillevi Fries' and Gosta Jonsson's foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Bell JL, 2013, BIOORG MED CHEM LETT, V23, P3826, DOI 10.1016/j.bmcl.2013.04.080; Bist A, 1997, P NATL ACAD SCI USA, V94, P10693, DOI 10.1073/pnas.94.20.10693; Boopathi E, 2011, AM J PATHOL, V178, P2236, DOI 10.1016/j.ajpath.2011.01.038; Boscher C, 2012, ADV EXP MED BIOL, V729, P29, DOI 10.1007/978-1-4614-1222-9_3; Bruno C, 1993, GENEREVIEWS, P1993; Burgermeister E, 2003, ONCOGENE, V22, P3888, DOI 10.1038/sj.onc.1206625; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Ekman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082308; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Evelyn CR, 2010, BIOORG MED CHEM LETT, V20, P665, DOI 10.1016/j.bmcl.2009.11.056; Gurbuz I, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-22; Huang JH, 2015, P NATL ACAD SCI USA, V112, P4447, DOI 10.1073/pnas.1420363112; Joshi B, 2012, J CELL BIOL, V199, P425, DOI 10.1083/jcb.201207089; Karbalaei MS, 2012, EUR J PHARMACOL, V689, P179, DOI 10.1016/j.ejphar.2012.05.023; Kovtun O, 2015, J CELL SCI, V128, P1269, DOI 10.1242/jcs.167866; Krawczyk KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133931; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; Lai HH, 2004, NEUROCHEM INT, V45, P1185, DOI 10.1016/j.neuint.2004.06.016; McDonald ME, 2015, CELL, V160, P105, DOI 10.1016/j.cell.2014.12.005; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Nassar ZD, 2015, INT REV CEL MOL BIO, V320, P235, DOI 10.1016/bs.ircmb.2015.07.009; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Regazzetti C, 2015, ENDOCRINOLOGY, V156, P789, DOI 10.1210/en.2014-1656; Sadegh MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116784; Sadegh MK, 2011, BRIT J PHARMACOL, V162, P1156, DOI 10.1111/j.1476-5381.2010.01115.x; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sward K, 2016, J PHYSIOL-LONDON, V594, P4741, DOI 10.1113/JP271913; Hien TT, 2016, J BIOL CHEM, V291, P3552, DOI 10.1074/jbc.M115.654384; van den Heuvel APJ, 2005, BIOCHEM J, V385, P795, DOI 10.1042/BJ20041449; Velasquez LS, 2013, P NATL ACAD SCI USA, V110, P16850, DOI 10.1073/pnas.1316764110; Wang Y, 2012, P NATL ACAD SCI USA, V109, P4892, DOI 10.1073/pnas.1112129109; Woodman SE, 2004, J UROLOGY, V171, P950, DOI 10.1097/01.ju.0000105102.72295.b8; Yin F, 2005, J BIOL CHEM, V280, P4745, DOI 10.1074/jbc.M411585200; Zeng JW, 2015, EUR J PHARMACOL, V762, P82, DOI 10.1016/j.ejphar.2015.05.037	37	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0176759	10.1371/journal.pone.0176759	http://dx.doi.org/10.1371/journal.pone.0176759			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542204	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800001
J	Crawford, ED; Quan, JN; Horst, JA; Ebert, D; Wu, W; DeRisi, JL				Crawford, Emily D.; Quan, Jenai; Horst, Jeremy A.; Ebert, Daniel; Wu, Wesley; DeRisi, Joseph L.			Plasmid-free CRISPR/Cas9 genome editing in Plasmodium falciparum confirms mutations conferring resistance to the dihydroisoquinolone clinical candidate SJ733	PLOS ONE			English	Article							MALARIA PARASITE; RECOMBINATION; VARIANTS; SOFTWARE; SEQUENCE; SYSTEM; PFATP4; DRUGS	Genetic manipulation of the deadly malaria parasite Plasmodium falciparum remains challenging, but the rise of CRISPR/Cas9-based genome editing tools is increasing the feasibility of altering this parasite's genome in order to study its biology. Of particular interest is the investigation of drug targets and drug resistance mechanisms, which have major implications for fighting malaria. We present a new method for introducing drug resistance mutations in P. falciparum without the use of plasmids or the need for cloning homologous recombination templates. We demonstrate this method by introducing edits into the sodium efflux channel PfATP4 by transfection of a purified CRISPR/Cas9-guide RNA ribonucleoprotein complex and a 200-nucleotide single-stranded oligodeoxynucleotide (ssODN) repair template. Analysis of whole genome sequencing data with the variant-finding program MinorityReport confirmed that only the intended edits were made, and growth inhibition assays confirmed that these mutations confer resistance to the antimalarial SJ733. The method described here is ideally suited for the introduction of mutations that confer a fitness advantage under selection conditions, and the novel finding that an ssODN can function as a repair template in P. falciparum could greatly simplify future editing attempts regardless of the nuclease used or the delivery method.	[Crawford, Emily D.; Quan, Jenai; DeRisi, Joseph L.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Crawford, Emily D.; Quan, Jenai; Horst, Jeremy A.; Ebert, Daniel; Wu, Wesley; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Crawford, Emily D.; Quan, Jenai; Ebert, Daniel; DeRisi, Joseph L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Ebert, Daniel] Touro Coll Osteopath Med, Middletown, NY USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute	DeRisi, JL (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; DeRisi, JL (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.; DeRisi, JL (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	joe@czbiohub.org	Crawford, Emily/AAA-9674-2019; Crawford, Emily/AAP-9565-2020	Crawford, Emily/0000-0003-4182-2337; Crawford, Emily/0000-0003-4182-2337; Quan, Jen Ai/0000-0002-2311-249X	Howard Hughes Medical Institute; Chan Zuckerberg Biohub; National Institutes of Health NIDCR [T32-DE007306]; Philippine California Advanced Research Institutes, project IHITM [63]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Chan Zuckerberg Biohub; National Institutes of Health NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Philippine California Advanced Research Institutes, project IHITM	This work was supported by Howard Hughes Medical Institute and the Chan Zuckerberg Biohub. JAH was funded by National Institutes of Health NIDCR grant number T32-DE007306. WW was funded by the Philippine California Advanced Research Institutes, project IHITM 63. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bansal A, 2016, MBIO, V7, DOI [10.1128/mBio.02011-16, 10.1128/mbio.02011-16]; Jimenez-Diaz MB, 2014, P NATL ACAD SCI USA, V111, pE5455, DOI 10.1073/pnas.1414221111; Caro F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-22; Corey VC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11901; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Flannery EL, 2015, ACS CHEM BIOL, V10, P413, DOI 10.1021/cb500616x; Gabryszewski SJ, 2016, MOL BIOL EVOL, V33, P1554, DOI 10.1093/molbev/msw037; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Gu W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0904-5; Horst JA, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1730-2; Huskey SEW, 2016, DRUG METAB DISPOS, V44, P672, DOI 10.1124/dmd.115.069187; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kirkman LA, 2014, NUCLEIC ACIDS RES, V42, P370, DOI 10.1093/nar/gkt881; LaMonte G, 2016, MBIO, V7, DOI 10.1128/mBio.00696-16; Lee AH, 2014, MICROBIOL MOL BIOL R, V78, P469, DOI 10.1128/MMBR.00059-13; Lim MYX, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.166, 10.1038/nmicrobiol.2016.166]; Lu JN, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1487-4; Mogollon CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168362; Ng CL, 2016, MOL MICROBIOL, V101, P381, DOI 10.1111/mmi.13397; Peng D, 2015, MICROB GENOMICS, V1, DOI 10.1099/mgen.0.000033; Ruby JG, 2013, G3-GENES GENOM GENET, P3; Sonoiki E, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01949-16, 10.1128/aac.01949-16]; Sonoiki E, 2016, ANTIMICROB AGENTS CH, V60, P4886, DOI 10.1128/AAC.00820-16; Spillman NJ, 2015, INT J PARASITOL-DRUG, V5, P149, DOI 10.1016/j.ijpddr.2015.07.001; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Straimer J, 2012, NAT METHODS, V9, P993, DOI [10.1038/NMETH.2143, 10.1038/nmeth.2143]; Veiga MI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11553; Wagner JC, 2014, NAT METHODS, V11, P915, DOI [10.1038/NMETH.3063, 10.1038/nmeth.3063]; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Wu W, 2015, ANTIMICROB AGENTS CH, V59, P356, DOI 10.1128/AAC.03342-14	34	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178163	10.1371/journal.pone.0178163	http://dx.doi.org/10.1371/journal.pone.0178163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542423	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058400065
J	Deng, ZS; Yang, F; Bai, Y; He, LJ; Li, Q; Wu, YR; Luo, L; Li, H; Ma, LM; Yang, ZQ; He, YS; Cui, LW				Deng, Zeshuai; Yang, Fang; Bai, Yao; He, Lijun; Li, Qing; Wu, Yanrui; Luo, Lan; Li, Hong; Ma, Limei; Yang, Zhaoqing; He, Yongshu; Cui, Liwang			Co-inheritance of glucose-6-phosphate dehydrogenase deficiency mutations and hemoglobin E in a Kachin population in a malaria-endemic region of Southeast Asia	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; ALPHA-THALASSEMIA; MOLECULAR CHARACTERIZATION; G6PD DEFICIENCY; PREVALENCE; THAILAND; VARIANT; CHINA; RESISTANCE; IDENTIFICATION	Glucose-6-phosphate dehydrogenase (G6PD) deficiency and hemoglobin E (HbE, beta(26) (Glu-Lys)) are two common red cell disorders in Southeast Asia. G6PD deficiency produces hemolytic anemia, which can be triggered by certain drugs or infections. HbE is asymptomatic or is manifested as microcytic, minimally hemolytic anemia. The association between G6PD deficiency and HbE is little understood. This study aimed to investigate G6PD deficiency and HbE in a Kachin ethnic group in the China-Myanmar border area. G6PD enzyme activity was measured using a quantitative G6PD assay, G6PD variants genotyped by the SNaP-shot assay, and an HbE gene mutation identified by an amplification refractory mutation system and subsequently confirmed by using a reverse dot blot hybridization assay from 100 unrelated individuals in the study area. G6PD enzyme activity ranged from 0.4 to 24.7 U/g Hb, and six males had severe G6PD deficiency (<0.12-1.2 U/g Hb), while six males and 12 females had mild G6PD deficiency (>1.2-4.5 U/g Hb). Among the 24 G6PD-deficient subjects, 22 (92%) had the Mahidol 487G> A mutation (12 male hemizygotes, one female homozygote, and nine female heterozygotes), while the G6PD genotypes in two female subjects were unknown. HbE was identified in 39 subjects (20 males and 19 females), including 15 HbEE (seven males and eight females) and 24 HbAE (13 males and 11 females). Twenty-three subjects co-inherited both G6PD deficiency and HbE (22 with HbAE and one with HbEE). Whereas mean Hb levels were not significantly different between the HbA and HbE groups, G6PD-deficient males had significantly lower Hb levels than G6PD-normal males (P < 0.05, t-test). However, it is noteworthy that two G6PD-deficient hemizygous males with HbAE were severely anemic with Hb levels below 50 g/L. This study revealed high prevalence of co-inheritance of G6PD deficiency with HbAE in the Kachin ethnicity, and a potential interaction of the G6PD Mahidol 487G> A and HbAE in males leading to severe anemia. The presence of 6% males with severe G6PD deficiency raised a major concern in the use of primaquine for radical cure of vivax malaria.	[Deng, Zeshuai; Yang, Fang; He, Lijun; Li, Qing; Wu, Yanrui; Luo, Lan; Li, Hong; He, Yongshu] Kunming Med Univ, Dept Cell Biol & Med Genet, Kunming, Yunnan Province, Peoples R China; [Bai, Yao; Yang, Zhaoqing] Kunming Med Univ, Dept Pathogen Biol & Immunol, Kunming, Yunnan Province, Peoples R China; [Ma, Limei] Kunming Med Univ, Dept Histol & Embryol, Kunming, Yunnan Province, Peoples R China; [Cui, Liwang] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	Kunming Medical University; Kunming Medical University; Kunming Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	He, YS (corresponding author), Kunming Med Univ, Dept Cell Biol & Med Genet, Kunming, Yunnan Province, Peoples R China.; Cui, LW (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	yongshuhe@hotmail.com; luc2@psu.edu	Deng, Zeshuai/ABE-6738-2020	Deng, Zeshuai/0000-0002-9570-2077	National Natural Science Foundation of China [31260264]; High Talent Introduction Project of Yunnan province [2013HA026]; National Institute of Allergy and Infectious Diseases, National Institutes of Health [NIH U19AI089672]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089672] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Talent Introduction Project of Yunnan province; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Natural Science Foundation of China (#31260264); the High Talent Introduction Project of Yunnan province (#2013HA026); and the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH U19AI089672).	Amoako N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112868; Bancone G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116063; Charoenkwan P, 2014, SE ASIAN J TROP MED, V45, P187; Chotivanich K, 2002, BLOOD, V100, P1172, DOI 10.1182/blood.V100.4.1172.h81602001172_1172_1176; Chu CS, 2016, EXPERT REV ANTI-INFE, V14, P885, DOI 10.1080/14787210.2016.1220304; FLINT J, 1993, BAILLIERE CLIN HAEM, V6, P215, DOI 10.1016/S0950-3536(05)80071-X; Glader BE, 1996, PEDIATR CLIN N AM, V43, P665, DOI 10.1016/S0031-3955(05)70427-2; He J, 2016, HEMATOLOGY, V21, P54, DOI 10.1179/1607845415Y.0000000044; Hu Y, 2016, ACTA TROP, V157, P12, DOI 10.1016/j.actatropica.2016.01.022; Khan TA, 2017, MICROB PATHOGENESIS, V102, P160, DOI 10.1016/j.micpath.2016.11.025; Li Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134593; Lithanatudom P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148079; Liu HX, 2016, AM J HUM BIOL, V28, P927, DOI 10.1002/ajhb.22868; Lopez C, 2010, GENE, V467, P1, DOI 10.1016/j.gene.2010.07.008; Louicharoen C, 2009, SCIENCE, V326, P1546, DOI 10.1126/science.1178849; Lyttleton C, 2016, SOC SCI MED, V150, P144, DOI 10.1016/j.socscimed.2015.12.033; Min-Oo G, 2005, CELL MICROBIOL, V7, P753, DOI 10.1111/j.1462-5822.2005.00524.x; Naka I, 2008, BIOCHEM GENET, V46, P708, DOI 10.1007/s10528-008-9185-3; O'Riordan S, 2010, BRIT J HAEMATOL, V150, P359, DOI 10.1111/j.1365-2141.2010.08237.x; Ohashi J, 2004, AM J HUM GENET, V74, P1198, DOI 10.1086/421330; ORKIN SH, 1982, NATURE, V300, P768, DOI 10.1038/300768a0; Pornprasert S, 2013, HEMOGLOBIN, V37, P536, DOI 10.3109/03630269.2013.819558; Sanchaisuriya K, 2003, ANN HEMATOL, V82, P612, DOI 10.1007/s00277-003-0689-y; Sarkar S, 2010, INFECT GENET EVOL, V10, P1228, DOI 10.1016/j.meegid.2010.08.003; Shannon KL, 2015, AM J TROP MED HYG, V93, P281, DOI 10.4269/ajtmh.14-0623; Suresh S, 2013, BLOOD CELL MOL DIS, V50, P93, DOI 10.1016/j.bcmd.2012.10.001; Tagarelli A, 2000, FEBS LETT, V466, P139, DOI 10.1016/S0014-5793(99)01776-7; Taylor SM, 2012, LANCET INFECT DIS, V12, P457, DOI 10.1016/S1473-3099(12)70055-5; Than AM, 2005, INT J HEMATOL, V82, P119, DOI 10.1532/IJH97.05028; Timmann C, 2012, NATURE, V489, P443, DOI 10.1038/nature11334; Tsegaye A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-438; Vizzi E, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1069-5; Wang S, 2015, COMPUT MATH METHOD M, V2015, P12, DOI DOI 10.3892/MMR.2015.4100; Yang YF, 2007, SCI CHINA SER C, V50, P479, DOI 10.1007/s11427-007-0072-7; Yanola J, 2014, SE ASIAN J TROP MED, V45, P920; Zhang L, 2015, INT J LAB HEMATOL, V37, P739, DOI 10.1111/ijlh.12405	36	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177917	10.1371/journal.pone.0177917	http://dx.doi.org/10.1371/journal.pone.0177917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531196	Green Submitted, gold, Green Published			2022-12-26	WOS:000402058400039
J	Rodrigues, MV; de Castro, SO; de Albuquerque, CZ; Mattaraia, VGD; Santoro, ML				Rodrigues, Mariana Valotta; de Castro, Simone Oliveira; de Albuquerque, Cynthia Zaccanini; de Moura Mattaraia, Vania Gomes; Santoro, Marcelo Larami			The gingival vein as a minimally traumatic site for multiple blood sampling in guinea pigs and hamsters	PLOS ONE			English	Article							SYRIAN-HAMSTER; SAPHENOUS-VEIN; COLLECTION; MODEL; PUNCTURE; SCIENCE; SAFETY; RAT	Laboratory animals are still necessary in scientific investigation and vaccine testing, but while novel methodological approaches are not available for their replacement, the search for new, humane, easy, and painless methods is necessary to diminish their stress and pain. When multiple blood samples are to be collected from hamsters and guinea pigs, the number of available venipuncture sites-which are greatly diminished in these species in comparison with other rodents due to the absence of a long tail-, harasses animal caregivers and researchers. Thus, this study aimed to evaluate if gingival vein puncture could be used as an additional route to obtain multiple blood samples from anesthetized hamsters and guinea pigs in such a way that animal behavior, well-being or hematological parameters would not be altered. Thus, twelve anesthetized Syrian golden hamsters and English guinea pigs were randomly allocated in two groups: a control group, whose blood samples were not collected, and an experimental group in which blood samples (200 microliters) were collected by gingival vein puncture at weekly intervals over six weeks. Clinical assessment, body weight gain and complete blood cell count were evaluated weekly, and control and experimental animals were euthanized at week seven, when the mentolabial region was processed to histological analyses. Multiple blood sampling from the gingival vein evoked no clinical manifestations or alteration in the behavioral repertoire, nor a statistically significant difference in weight gain in both species. Guinea pigs showed no alteration in red blood cell, leukocyte or platelet parameters over time. Hamsters developed a characteristic pattern of age-related physiological changes, which were considered normal. Histological analyses showed no difference in morphological structures in the interdental gingiva, confirming that multiple blood sampling is barely traumatic. Thus, these results evidence that blood collection from multiple gingival vein puncture is minimally invasive and traumatic to hamsters and guinea pigs, and that it can be accomplished during at least six weeks.	[Rodrigues, Mariana Valotta; de Castro, Simone Oliveira; de Albuquerque, Cynthia Zaccanini; de Moura Mattaraia, Vania Gomes] Inst Butantan, Anim Facil, Sao Paulo, SP, Brazil; [Santoro, Marcelo Larami] Inst Butantan, Lab Pathophysiol, Sao Paulo, SP, Brazil	Instituto Butantan; Instituto Butantan	Santoro, ML (corresponding author), Inst Butantan, Lab Pathophysiol, Sao Paulo, SP, Brazil.	marcelo.santoro@butantan.gov.br	Santoro, Marcelo L./K-7064-2019; Santoro, Marcelo/H-3892-2012	Santoro, Marcelo L./0000-0001-6364-3757; 	Sao Paulo Research Foundation (FAPESP) [2013/25177-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [305245/2015-5]; Fundacao Butantan	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Butantan	This work was supported by the Sao Paulo Research Foundation (FAPESP, grants # 2013/25177-0), URL: www.fapesp.br; and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grant # 305245/2015-5), URL: www.cnpq.br, and Fundacao Butantan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CR, 2014, J AM ASSOC LAB ANIM, V53, P81; [Anonymous], 2010, FARMACOPEIA BRASILEI; BAUMANS V, 1994, LAB ANIM-UK, V28, P97, DOI 10.1258/002367794780745308; Birck MM, 2014, JOVE-J VIS EXP, DOI 10.3791/51982; BULLOCK LP, 1983, LAB ANIM SCI, V33, P70; Burch R. L, 1958, PRINCIPLES HUMANE EX; CARSTAIRS KC, 1965, J PATHOL BACTERIOL, V90, P225, DOI 10.1002/path.1700900124; Casey W, 2011, PROCEDIA VACCINOL, V5, P33, DOI 10.1016/j.provac.2011.10.003; Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council, 2011, GUIDE CARE USE LAB A; Conselho Nacional de Controle de Experimentacao Animal, 2015, NORM CONC PROD MAN U; da Silva CB, 2016, ALTEX-ALTERN ANIM EX, V33, P322; Dang V, 2008, J AM ASSOC LAB ANIM, V47, P56; Desai R.G., 1968, GOLDEN HAMSTER ITS B, P185; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Donnelly Thomas M, 2004, Vet Clin North Am Exot Anim Pract, V7, P351, DOI 10.1016/j.cvex.2004.02.006; Donovan John, 2006, Curr Protoc Immunol, VChapter 1, DOI 10.1002/0471142735.im0108s73; DWYER SD, 1986, THROMB RES, V42, P139, DOI 10.1016/0049-3848(86)90290-2; Dyer Stephen M., 2008, Veterinary Clinics of North America Exotic Animal Practice, V11, P423, DOI 10.1016/j.cvex.2008.03.008; Ellen Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161941; Flecknell P., 2009, LAB ANIMAL ANAESTHES; GRACE ND, 1970, J NUTR, V100, P37, DOI 10.1093/jn/100.1.37; Haake David A, 2006, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12e02s02; Harkness JE, 2010, BIOL MED RABBITS ROD, V5th; Heimann M, 2009, LAB ANIM-UK, V43, P255, DOI 10.1258/la.2008.007073; Hem A, 1998, LAB ANIM-UK, V32, P364, DOI 10.1258/002367798780599866; HOCHMAN D, 1983, J PHARM SCI, V72, P975, DOI 10.1002/jps.2600720841; HOUSE EL, 1961, AM J PHYSIOL, V200, P1018, DOI 10.1152/ajplegacy.1961.200.5.1018; Joslin JO, 2009, J EXOT PET MED, V18, P117, DOI 10.1053/j.jepm.2009.04.002; Keino M, 2002, JPN J INFECT DIS, V55, P27; KREIENBUHL G, 1976, PFLUG ARCH EUR J PHY, V366, P167, DOI 10.1007/BF00585873; Munson E, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/504215; National Centre for the Replacement Refinement & Reduction of Animals in Research (NC, 2017, RETR; NAU R, 1993, LAB ANIM, V27, P23, DOI 10.1258/002367793781082449; Oliveira DT, 2009, SCAND J LAB ANIM SCI, V36, P109; Organization World Health., 2013, MAN QUAL CONTR DIPHT; Padilla-Carlin DJ, 2008, COMPARATIVE MED, V58, P324; Picazo MG, 2009, LAB ANIMAL, V38, P211, DOI 10.1038/laban0609-211; Raabe BM, 2011, J AM ASSOC LAB ANIM, V50, P680; SACHSER N, 1984, AGGRESSIVE BEHAV, V10, P285, DOI 10.1002/1098-2337(1984)10:4<285::AID-AB2480100402>3.0.CO;2-8; Safronetz D, 2012, ANTIVIR RES, V95, P282, DOI 10.1016/j.antiviral.2012.06.002; Santoro ML, 2004, THROMB HAEMOSTASIS, V92, P369, DOI 10.1160/TH04-02-0120; Santoro ML, 2014, ESTUDO HISTOLOGICO C; Schneider JE, 2000, AM J PHYSIOL-REG I, V278, pR476, DOI 10.1152/ajpregu.2000.278.2.R476; Scipioni RL, 1997, LAB ANIM SCI, V47, P293; STEIN KF, 1945, P SOC EXP BIOL MED, V60, P313, DOI 10.3181/00379727-60-15173; Stewart MO, 1944, J EXP MED, V80, P189, DOI 10.1084/jem.80.3.189; Struillou X, 2010, OPEN DENT J, V4, P37, DOI 10.2174/1874210601004010037; Wahl-Jensen V, 2012, VIRUSES-BASEL, V4, P3754, DOI 10.3390/v4123754; Washington IM, 2012, AM COLL LAB, P57, DOI 10.1016/B978-0-12-380920-9.00003-1; Weiss DJ, 2010, SCHALMS VET HEMATOLO; Williams WR, 2016, LAB ANIMAL, V45, P35, DOI 10.1038/laban.911; Williams WR, 2015, LAB ANIMAL, V44, P207, DOI 10.1038/laban.787; Wolfensohn S, 2003, HDB LAB ANIMAL MANAG	53	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177967	10.1371/journal.pone.0177967	http://dx.doi.org/10.1371/journal.pone.0177967			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531179	Green Submitted, Green Published, gold			2022-12-26	WOS:000402058400046
J	Ismail, B; de Kemp, RA; Croteau, E; Hadizad, T; Burns, KD; Beanlands, RS; DaSilva, JN				Ismail, Basma; de kemp, Rob A.; Croteau, Etienne; Hadizad, Tayebeh; Burns, Kevin D.; Beanlands, Rob S.; DaSilva, Jean N.			Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT(1) receptor expression as measured with PET imaging	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; BLOOD-PRESSURE CONTROL; GLOMERULAR-FILTRATION-RATE; CALCIUM-CHANNEL BLOCKERS; DIABETIC-NEPHROPATHY; ANTIHYPERTENSIVE THERAPY; ACE-INHIBITION; ALL-CAUSE; IN-VIVO; INJURY	ACE inhibitors are considered first line of treatment in patients with many forms of chronic kidney disease (CKD). Other antihypertensives such as calcium channel blockers achieve similar therapeutic effectiveness in attenuating hypertension-related renal damage progression. Our objective was to explore the value of positron emission tomography (PET) imaging of renal AT(1) receptor (AT(1)R) to guide therapy in the 5/6 subtotal-nephrectomy (Nx) rat model of CKD. Ten weeks after Nx, Sprague-Dawley rats were administered 10mg/kg/d enalapril (NxE), 30mg/kg/d diltiazem (NxD) or left untreated (Nx) for an additional 8-10 weeks. Kidney AT(1)R expression was assessed using in vivo [F-18] fluoropyridine-losartan PET and in vitro autoradiography. Compared to shams, Nx rats exhibited higher systolic blood pressure that was reduced by both enalapril and diltiazem. At 18-20 weeks, plasma creatinine and albuminuria were significantly increased in Nx, reduced to sham levels in NxE, but enhanced in NxD rats. Enalapril treatment decreased kidney angiotensin II whereas diltiazem induced significant elevations in plasma and kidney levels. Reduced PET renal AT(1)R levels in Nx were normalized by enalapril but not diltiazem, and results were supported by autoradiography. Reduction of renal blood flow in Nx was restored by enalapril, while no difference was observed in myocardial blood flow amongst groups. Enhanced left ventricle mass in Nx was not reversed by enalapril but was augmented with diltiazem. Stroke volume was diminished in untreated Nx compared to shams and restored with both therapies. [F-18] Fluoropyridine-Losartan PET allowed in vivo quantification of kidney AT(1)R changes associated with progression of CKD and with various pharmacotherapies.	[Ismail, Basma; de kemp, Rob A.; Croteau, Etienne; Hadizad, Tayebeh; Beanlands, Rob S.; DaSilva, Jean N.] Univ Ottawa, Heart Inst, Cardiac PET Ctr, Dept Med,Div Cardiol, Ottawa, ON, Canada; [Ismail, Basma; Burns, Kevin D.; Beanlands, Rob S.; DaSilva, Jean N.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Burns, Kevin D.] Univ Ottawa, Ottawa Hosp Res Inst, Kidney Res Ctr, Ottawa, ON, Canada; [DaSilva, Jean N.] Univ Montreal, Dept Radiol Radiooncol & Nucl Med, Montreal, PQ, Canada; [DaSilva, Jean N.] Univ Montreal, Hosp Res Ctr, CRCHUM, Montreal, PQ, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Universite de Montreal; Universite de Montreal	DaSilva, JN (corresponding author), Univ Ottawa, Heart Inst, Cardiac PET Ctr, Dept Med,Div Cardiol, Ottawa, ON, Canada.; DaSilva, JN (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.; DaSilva, JN (corresponding author), Univ Montreal, Dept Radiol Radiooncol & Nucl Med, Montreal, PQ, Canada.; DaSilva, JN (corresponding author), Univ Montreal, Hosp Res Ctr, CRCHUM, Montreal, PQ, Canada.	jean.dasilva@umontreal.ca	Beanlands, Rob S/M-2105-2017	Beanlands, Rob S/0000-0001-7857-8169	Ontario Preclinical Imaging Consortium (OPIC) grant [RE03-51]; Canadian Institutes of Health Research [MOP-80203, MOP-287694]; Molecular Function and Imaging Heart and Stroke Foundation of Ontario Program Grant [PRG6242]; University of Ottawa's Faculty of Medicine Endowed Funds for Cardiac Graduate Research; UOHI Foundation; Heart and Stroke Foundation of Ontario (HFSO); University of Ottawa Heart Institute (UOHI) Vered Chair in Cardiology; Tier 1 University of Ottawa Chair in Cardiovascular Research	Ontario Preclinical Imaging Consortium (OPIC) grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Molecular Function and Imaging Heart and Stroke Foundation of Ontario Program Grant; University of Ottawa's Faculty of Medicine Endowed Funds for Cardiac Graduate Research; UOHI Foundation; Heart and Stroke Foundation of Ontario (HFSO)(Heart & Stroke Foundation of Ontario); University of Ottawa Heart Institute (UOHI) Vered Chair in Cardiology; Tier 1 University of Ottawa Chair in Cardiovascular Research	This work was supported in part by, the Ontario Preclinical Imaging Consortium (OPIC) grant# RE03-51 (Ontario Research Foundation) and the Canadian Institutes of Health Research (MOP-80203 & MOP-287694) and by the Molecular Function and Imaging Heart and Stroke Foundation of Ontario Program Grant (#PRG6242). BI was a doctoral student co-supervised by JDS and RSB and supported by the PhD scholarship from the University of Ottawa's Faculty of Medicine Endowed Funds for Cardiac Graduate Research and the UOHI Foundation. RSB is a Career Investigator supported by the Heart and Stroke Foundation of Ontario (HFSO), the University of Ottawa Heart Institute (UOHI) Vered Chair in Cardiology and Tier 1 University of Ottawa Chair in Cardiovascular Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello S, 1998, KIDNEY INT, pS63; Allred AJ, 2000, AM J PHYSIOL-RENAL, V279, pF636, DOI 10.1152/ajprenal.2000.279.4.F636; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Arksey N, 2014, BIOORGAN MED CHEM, V22, P3931, DOI 10.1016/j.bmc.2014.06.011; Arora P, 2013, CAN MED ASSOC J, V185, pE417, DOI 10.1503/cmaj.120833; Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; Bader J, 2001, J MOL MED, V79, P76, DOI 10.1007/s001090100210; Bader M, 2010, ANNU REV PHARMACOL, V50, P439, DOI 10.1146/annurev.pharmtox.010909.105610; Bidani AK, 2006, NAT CLIN PRACT NEPHR, V2, P542, DOI 10.1038/ncpneph0299; Black HR, 1998, CONTROL CLIN TRIALS, V19, P370, DOI 10.1016/S0197-2456(98)00013-0; BRENNER BM, 1983, KIDNEY INT, V23, P647, DOI 10.1038/ki.1983.72; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; Bruzzi I, 1997, J NEPHROL, V10, P179; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Dilauro M, 2010, AM J PHYSIOL-RENAL, V298, pF1523, DOI 10.1152/ajprenal.00426.2009; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Ghosh SS, 2009, AM J PHYSIOL-RENAL, V296, pF1146, DOI 10.1152/ajprenal.90732.2008; Griffin KA, 1999, KIDNEY INT, V55, P1849, DOI 10.1046/j.1523-1755.1999.00434.x; GRIFFIN KA, 1995, J CLIN INVEST, V96, P793, DOI 10.1172/JCI118125; Griffin KA, 2004, AM J PHYSIOL-RENAL, V286, pF1136, DOI 10.1152/ajprenal.00401.2003; Griffin KA, 2003, HYPERTENSION, V41, P201, DOI 10.1161/01.HYP.0000049881.25304.73; Griffin KA, 2006, CLIN J AM SOC NEPHRO, V1, P1054, DOI 10.2215/CJN.02231205; Griffin Karen A, 2008, Curr Cardiol Rep, V10, P448; Hachem M, 2015, J NUCL MED IN PRESS; Hadizad T, 2011, J LABELLED COMPD RAD, V54, P754, DOI 10.1002/jlcr.1917; Hadizad T, 2009, BIOORGAN MED CHEM, V17, P7971, DOI 10.1016/j.bmc.2009.10.016; Hansson L, 2000, LANCET, V356, P359, DOI 10.1016/S0140-6736(00)02526-5; Herzog CA, 2011, KIDNEY INT, V80, P572, DOI 10.1038/ki.2011.223; Ismail B, 2016, EJNMMI RES, V6, DOI 10.1186/s13550-016-0209-4; Ismail B, 2015, NUCL MED BIOL, V42, P850, DOI 10.1016/j.nucmedbio.2015.06.012; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Joly E, 2005, CLIN EXP PHARMACOL P, V32, P241, DOI 10.1111/j.1440-1681.2005.04181.x; Kenk M, 2007, NUCL MED BIOL, V34, P71, DOI 10.1016/j.nucmedbio.2006.10.002; Klein R, 2010, J NUCL CARDIOL, V17, P555, DOI 10.1007/s12350-010-9256-9; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Kujal P, 2010, CLIN EXP PHARMACOL P, V37, P1159, DOI 10.1111/j.1440-1681.2010.05453.x; Le Corvoisier P, 2010, EUR J HEART FAIL, V12, P1171, DOI 10.1093/eurjhf/hfq146; Levin A, 2008, CAN MED ASSOC J, V179, P1154, DOI 10.1503/cmaj.080351; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LOGAN J, 1987, J NEUROCHEM, V48, P73, DOI 10.1111/j.1471-4159.1987.tb13129.x; Lopez-Novoa JM, 2010, PHARMACOL THERAPEUT, V128, P61, DOI 10.1016/j.pharmthera.2010.05.006; Lortie M, 2013, NUCL MED BIOL, V40, P252, DOI 10.1016/j.nucmedbio.2012.10.013; Macconi D, 2010, HISTOL HISTOPATHOL, V25, P655, DOI 10.14670/HH-25.655; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Moriguchi Y, BIOMED RES, V32, P83; NAKAMOTO H, 1995, HYPERTENSION, V25, P796, DOI 10.1161/01.HYP.25.4.796; Nathan S, 2005, HYPERTENSION, V46, P637, DOI 10.1161/01.HYP.0000184541.24700.c7; Noda M, 1999, KIDNEY INT, V56, P898, DOI 10.1046/j.1523-1755.1999.00614.x; Parving HH, 2001, KIDNEY INT, V60, P228, DOI 10.1046/j.1523-1755.2001.00790.x; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Podjarny E, 2004, NEPHROL DIAL TRANSPL, V19, P2223, DOI 10.1093/ndt/gfh383; PODJARNY E, 1993, NEPHROL DIAL TRANSPL, V8, P501, DOI 10.1093/ndt/8.6.501; Pohl MA, 2005, J AM SOC NEPHROL, V16, P3027, DOI 10.1681/ASN.2004110919; Rahn KH, 2005, PEDIATR NEPHROL, V20, P1208, DOI 10.1007/s00467-005-1982-x; Ruggenenti P, 1997, LANCET, V349, P1857; Segura J., 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P55, DOI 10.2174/1568016052773261; Shiba N, 2011, J CARDIOL, V57, P8, DOI 10.1016/j.jjcc.2010.09.004; Sukumaran V, 2010, HYPERTENS RES, V33, P695, DOI 10.1038/hr.2010.67; Sviglerova J, 2010, PHYSIOL RES, V59, pS81, DOI 10.33549/physiolres.932003; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Toto Robert D, 2005, J Clin Hypertens (Greenwich), V7, P15, DOI 10.1111/j.1524-6175.2004.4471.x; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Vaziri ND, 2007, J PHARMACOL EXP THER, V323, P85, DOI 10.1124/jpet.107.123638; Windt WAKM, 2006, J RENIN-ANGIO-ALDO S, V7, P217, DOI 10.3317/jraas.2006.041; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421	67	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177451	10.1371/journal.pone.0177451	http://dx.doi.org/10.1371/journal.pone.0177451			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542215	gold, Green Published, Green Submitted			2022-12-26	WOS:000401672600010
J	Shen, YJ; Li, G; Gu, CY; Chen, B; Chen, AH; Li, H; Gao, B; Liang, CC; Wu, JS; Yang, T; Jin, L; Su, Y				Shen, Yijun; Li, Gang; Gu, Chunying; Chen, Ben; Chen, Aihua; Li, Hua; Gao, Bei; Liang, Chencai; Wu, Jingsong; Yang, Tong; Jin, Li; Su, Yong			T0001, a variant of TNFR2-Fc fusion protein, exhibits improved Fc effector functions through increased binding to membrane-bound TNF alpha	PLOS ONE			English	Article							ANTITUMOR NECROSIS FACTOR; THERAPEUTIC ANTIBODIES; AGENTS; INFLIXIMAB; CELLS; RESPONSES; DISEASE; ASSAY	T0001 is a recombinant human TNFR-Fc fusion protein mutant; it exhibits higher affinity to TNF alpha than etanercept and is now being tested in a Phase 1 study in China (ClinicalTrials. gov Identifier: NCT02481180). T0001 can inhibit the binding of soluble TNF alpha(sTNF alpha) or membrane-bound TNF alpha(mTNF alpha) to TNF receptors. When bound to mTNF alpha, the Fc-bearing TNF alpha antagonists have the potential to induce Fc-mediated effects, such as antibody-dependent cellular cytotoxicity (ADCC) and complement-mediated cytotoxicity (CDC) as well as outside-to-inside signals (apoptosis mainly). Recent studies have shown that ADCC may also play an important role in Crohn's disease (CD) and ulcerative colitis (UC). In this study, T0001 presented a higher binding activity on mTNF alpha than etanercept and similar binding activity with adalimumab and infliximab. Upon the addition of sTNF alpha, adalimumab and infliximab showed significantly increased binding to Fc gamma RIIIa and C1q than T0001 and etanercept. T0001 exhibited significantly higher ADCC and CDC activity than etanercept, and the potency and the reporter response of T0001 were very close to adalimumab and infliximab in ADCC reporter gene assays. And the similar potency of T0001 was also corroborated by PMBC-based ADCC assay. T0001, but not etanercept could induce apoptosis, while adalimumab and infliximab were more effective. These results suggest that T0001 may not only exert improved efficacy in treating rheumatoid arthritis (RA) because of its high affinity to sTNF alpha but also has a therapeutic potential in CD and UC due to its increased binding to mTNF alpha with resultant Fc-associated functions (ADCC, in particular) and improved apoptosis.	[Shen, Yijun; Jin, Li] Fudan Univ, Key Lab Contemporary Anthropol, Minist Educ, Shanghai, Peoples R China; [Shen, Yijun; Li, Gang; Gu, Chunying; Chen, Ben; Chen, Aihua; Li, Hua; Gao, Bei; Liang, Chencai; Wu, Jingsong; Yang, Tong; Su, Yong] Shanghai Fudan Zhangjiang Biopharmaceut Co Ltd, R&D Dept Genet Engn, Shanghai, Peoples R China	Fudan University	Jin, L (corresponding author), Fudan Univ, Key Lab Contemporary Anthropol, Minist Educ, Shanghai, Peoples R China.; Su, Y (corresponding author), Shanghai Fudan Zhangjiang Biopharmaceut Co Ltd, R&D Dept Genet Engn, Shanghai, Peoples R China.	lijin.fudan@gmail.com; ysu@fd-zj.com	Jin, Li/C-1468-2009; Jin, Li/M-5063-2019; Shen, Yi/GRS-3602-2022	Jin, Li/0000-0002-4546-2415; 	Shanghai Fudan-Zhangjiang BioPharmaceutical Co, Ltd. (China)	Shanghai Fudan-Zhangjiang BioPharmaceutical Co, Ltd. (China)	This project was supported by internal funds of Shanghai Fudan-Zhangjiang BioPharmaceutical Co, Ltd. (China). The funder provided support in the form of salaries for authors, YShen, GL, CG, BC, AC, HL, BG, CL, JW, TY and YSu, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arora T, 2009, CYTOKINE, V45, P124, DOI 10.1016/j.cyto.2008.11.008; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Cheng ZJ, 2014, J IMMUNOL METHODS, V414, P69, DOI 10.1016/j.jim.2014.07.010; de Mattos BR, 2015, MEDIAT INFLAMM, V2015, DOI DOI 10.1155/2015/493012; Feagan BG, 2014, BIOLOGICALS, V42, P177, DOI 10.1016/j.biologicals.2014.05.005; Health Canada, 2014, SUMMARY BASIS OF DEC; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; Jiang XR, 2011, NAT REV DRUG DISCOV, V10, P101, DOI 10.1038/nrd3365; Kaymakcalan Z, 2009, CLIN IMMUNOL, V131, P308, DOI 10.1016/j.clim.2009.01.002; Kollias G, 1999, ANN RHEUM DIS, V58, P32, DOI 10.1136/ard.58.2008.i32; Levin A, 2008, BIOL-TARGETS THER, V2, P379; Lis K, 2014, ARCH MED SCI, V10, P1175, DOI 10.5114/aoms.2014.47827; Mitoma H, 2005, GASTROENTEROLOGY, V128, P376, DOI 10.1053/j.gastro.2004.11.060; Mitoma H, 2008, ARTHRITIS RHEUM-US, V58, P1248, DOI 10.1002/art.23447; Moots RJ, 2011, CLIN EXP RHEUMATOL, V29, P26; Nesbitt A, 2007, INFLAMM BOWEL DIS, V13, P1323, DOI 10.1002/ibd.20225; Parekh BS, 2012, MABS-AUSTIN, V4, P310, DOI 10.4161/mabs.19873; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; Siberil S, 2007, CRIT REV ONCOL HEMAT, V62, P26, DOI 10.1016/j.critrevonc.2006.12.003; Tilg H, 2007, EXPERT OPIN BIOL TH, V7, P1051, DOI 10.1517/14712598.7.7.1051; Van Den Brande JMH, 2003, GASTROENTEROLOGY, V124, P1774, DOI 10.1016/S0016-5085(03)00382-2; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; Yang T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000669	25	2	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177891	10.1371/journal.pone.0177891	http://dx.doi.org/10.1371/journal.pone.0177891			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542350	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672600029
J	Lai, YC; Fujikawa, T; Maemura, T; Ando, T; Kitahara, G; Endo, Y; Yamato, O; Koiwa, M; Kubota, C; Miura, N				Lai, Yu-Chang; Fujikawa, Takuro; Maemura, Tadashi; Ando, Takaaki; Kitahara, Go; Endo, Yasuyuki; Yamato, Osamu; Koiwa, Masateru; Kubota, Chikara; Miura, Naoki			Inflammation-related microRNA expression level in the bovine milk is affected by mastitis	PLOS ONE			English	Article							KAPPA-B PATHWAY; DIGITAL PCR; ESCHERICHIA-COLI; MACROPHAGES; MIRNAS; QUANTIFICATION; IDENTIFICATION; BIOMARKERS; INHIBITOR; DIAGNOSIS	MicroRNA (miRNA) in tissue and liquid samples have been shown to be associated with many diseases including inflammation. We aimed to identify inflammation-related miRNA expression level in the bovine mastitis milk. Expression level of inflammation-related miRNA in milk from mastitis-affected and normal cows was analyzed using qPCR. We found that expression level of miR-21, miR-146a, miR-155, miR-222, and miR-383 was significantly upregulated in California mastitis test positive (CMT+) milk. We further analyzed these miRNA using a chip-based QuantStudio Digital PCR System. The digital PCR results correlated with those of qPCR, demonstrating upregulation of miR-21, miR-146a, miR-155, miR222, and miR-383 in CMT+milk. In conclusion, we identified miRNA that are upregulated in CMT+milk. These miRNA exhibited sensitivity and specificity greater than 80% for differentiating between CMT+milk and normal milk. Our findings suggest that inflammation-related miRNA expression level in the bovine milk was affected by mastitis, and miRNA in milk have potential for use as biomarkers of bovine mastitis.	[Lai, Yu-Chang; Maemura, Tadashi; Miura, Naoki] Kagoshima Univ, Vet Teaching Hosp, Joint Fac Vet Med, Kagoshima, Japan; [Lai, Yu-Chang; Fujikawa, Takuro] Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi, Japan; [Fujikawa, Takuro; Ando, Takaaki; Kubota, Chikara] Kagoshima Univ, Joint Fac Vet Med, Lab Vet Theriogenol, Kagoshima, Japan; [Kitahara, Go] Univ Miyazaki, Fac Agr, Dept Vet Sci, Miyazaki, Japan; [Endo, Yasuyuki] Kagoshima Univ, Joint Fac Vet Med, Lab Small Anim Internal Med, Kagoshima, Japan; [Yamato, Osamu] Kagoshima Univ, Joint Fac Vet Med, Lab Vet Clin Pathol, Kagoshima, Japan; [Koiwa, Masateru] Rakuno Gakuen Univ, Sch Vet Med, Ebetsu, Hokkaido, Japan	Kagoshima University; Yamaguchi University; Kagoshima University; University of Miyazaki; Kagoshima University; Kagoshima University; Rakuno Gakuen University	Miura, N (corresponding author), Kagoshima Univ, Vet Teaching Hosp, Joint Fac Vet Med, Kagoshima, Japan.	k9236024@kadai.jp	Miura, Naoki/A-5734-2010; Miura, Naoki/O-6997-2016	Miura, Naoki/0000-0002-4625-5231; Miura, Naoki/0000-0002-4625-5231; Yamato, Osamu/0000-0002-4430-5645	Project of the Bio-oriented Technology Research Advancement Institution, NARO; JSPS KAKENHI [25660243]; Morinaga Houshikai Research Grant; Grants-in-Aid for Scientific Research [17H03926, 16H05845] Funding Source: KAKEN	Project of the Bio-oriented Technology Research Advancement Institution, NARO; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Morinaga Houshikai Research Grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Project of the Bio-oriented Technology Research Advancement Institution, NARO (the special scheme project on advanced research and development for next-generation technology) to CK and NM, and by the the JSPS KAKENHI-25660243 to NM, and by the the Morinaga Houshikai Research Grant to NM.	Bai WL, 2013, J DAIRY SCI, V96, P4529, DOI 10.3168/jds.2013-6603; Chen CYA, 2016, NUCLEIC ACIDS RES, V44, P3772, DOI 10.1093/nar/gkw205; Chen T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-100; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Dilda F, 2012, VET J, V192, P514, DOI 10.1016/j.tvjl.2011.08.018; Fan GW, 2016, INFLAMMATION, V39, P375, DOI 10.1007/s10753-015-0259-1; FOX LK, 1993, VET CLIN N AM-FOOD A, V9, P475, DOI 10.1016/S0749-0720(15)30615-0; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; Gu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043691; Hata T, 2010, BIOCHEM BIOPH RES CO, V396, P528, DOI 10.1016/j.bbrc.2010.04.135; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Hulsmans M, 2011, FASEB J, V25, P2515, DOI 10.1096/fj.11-181149; Izumi H, 2012, J DAIRY SCI, V95, P4831, DOI 10.3168/jds.2012-5489; Izumi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088843; Jin WW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-181; Kasimanickam V, 2016, SCI REP-UK, V6, DOI 10.1038/srep29509; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; KOBAYASHI Y, 1978, J DAIRY SCI, V61, P592, DOI 10.3168/jds.S0022-0302(78)94414-4; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Kotsinas A, 2015, CURR MED CHEM, V22, P2666, DOI 10.2174/0929867322666150716113304; Lai YC, 2017, J ANIM SCI; Lam TJGM, 2009, IRISH VET J, V62, P34, DOI 10.1186/2046-0481-62-S4-S34; Larrea E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050627; Lawless N, 2014, MICRORNA REGULATION, VG3, P4; Lawless N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057543; Li GR, 2011, INVEST OPHTH VIS SCI, V52, P2999, DOI 10.1167/iovs.10-6708; Li LH, 2015, J MOL NEUROSCI, V56, P858, DOI 10.1007/s12031-015-0526-5; Li N, 2014, J CANCER RES CLIN, V140, P145, DOI 10.1007/s00432-013-1555-5; Li R, 2015, INT J MOL SCI, V16, P4997, DOI 10.3390/ijms16034997; Ma J, 2013, BIOMARK INSIGHTS, V8, P127, DOI [10.4137/BMI.S13154, 10.4137/BMIMI.S13154]; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Mangolini A, 2015, BIOMARK RES, V3, DOI 10.1186/s40364-015-0037-0; Mi Shuangli, 2013, Microrna, V2, P63, DOI 10.2174/2211536611302010007; Na RS, 2015, GENET MOL RES, V14, P11371, DOI 10.4238/2015.September.25.4; Naeem A, 2012, J DAIRY SCI, V95, P6397, DOI 10.3168/jds.2011-5173; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Ortega FJ, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0083-3; Rivkin M, 2016, GASTROENTEROLOGY, V151, P999, DOI 10.1053/j.gastro.2016.07.031; Saikumar J, 2014, CLIN CHEM, V60, P1158, DOI 10.1373/clinchem.2013.216044; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Sharma N, 2011, ASIAN AUSTRAL J ANIM, V24, P429, DOI 10.5713/ajas.2011.10233; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; SMITH KL, 1993, VET CLIN N AM-FOOD A, V9, P489, DOI 10.1016/S0749-0720(15)30616-2; Song JL, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00056; Sun JJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2044-9; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Vikram A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12565; Wang HJ, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0704-9; Wang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038885; Wang J, 2016, J CELL PHYSIOL, V231, P25, DOI 10.1002/jcp.25056; Wang XP, 2016, MOL CELL PROBES; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Yagi Y, 2004, J VET MED SCI, V66, P381, DOI 10.1292/jvms.66.381; Yeh DW, 2016, CELL DEATH DIFFER, V23, P841, DOI 10.1038/cdd.2015.147; Zhang L, 2015, J IMMUNOL, V195, P5404, DOI 10.4049/jimmunol.1402933; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118	57	35	36	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177182	10.1371/journal.pone.0177182	http://dx.doi.org/10.1371/journal.pone.0177182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520748	Green Submitted, Green Published, gold			2022-12-26	WOS:000401487700040
J	Gonzalez, D; Contreras, O; Rebolledo, DL; Espinoza, JP; van Zundert, B; Brandan, E				Gonzalez, David; Contreras, Osvaldo; Rebolledo, Daniela L.; Pablo Espinoza, Juan; van Zundert, Brigitte; Brandan, Enrique			ALS skeletal muscle shows enhanced TGF-beta signaling, fibrosis and induction of fibro/adipogenic progenitor markers	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TISSUE GROWTH-FACTOR; DUCHENNE MUSCULAR-DYSTROPHY; MOTOR-NEURON DEGENERATION; TRIGGER MOTONEURON DEATH; FACTOR GENE-EXPRESSION; MESENCHYMAL PROGENITORS; DISEASE PROGRESSION; FIBROTIC RESPONSE; SATELLITE CELLS	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease in which upper and lower motoneurons degenerate leading to muscle wasting, paralysis and eventually death from respiratory failure. Several studies indicate that skeletal muscle contributes to disease progression; however the molecular mechanisms remain elusive. Fibrosis is a common feature in skeletal muscle under chronic damage conditions such as those caused by muscular dystrophies or denervation. However, the exact mechanisms of fibrosis induction and the cellular bases of this pathological response are unknown. We show that extracellular matrix (ECM) components are augmented in skeletal muscles of symptomatic hSOD1(G93A) mice, a widely used murine model of ALS. These mice also show increased TGF-beta 1 mRNA levels, total Smad3 protein levels and p-Smad3 positive nuclei. Furthermore, platelet-derived growth factor receptor-alpha (PDGFR alpha), Tcf4 and alpha-smooth muscle actin (alpha-SMA) levels are augmented in the skeletal muscle of symptomatic hSOD1(G93A) mice. Additionally, the fibro/adipogenic progenitors (FAPs), which are the main producers of ECM constituents, are also increased in these pathogenic conditions. Therefore, FAPs and ECM components are more abundant in symptomatic stages of the disease than in pre-symptomatic stages. We present evidence that fibrosis observed in skeletal muscle of symptomatic hSOD1(G93A) mice is accompanied with an induction of TGF-beta signaling, and also that FAPs might be involved in triggering a fibrotic response. Co-localization of p-Smad3 positive cells together with PDGFRa was observed in the interstitial cells of skeletal muscles from symptomatic hSOD1(G93A) mice. Finally, the targeting of pro-fibrotic factors such as TGF-beta, CTGF/CCN2 and platelet-derived growth factor (PDGF) signaling pathway might be a suitable therapeutic approach to improve muscle function in several degenerative diseases.	[Gonzalez, David; Contreras, Osvaldo; Rebolledo, Daniela L.; Pablo Espinoza, Juan; Brandan, Enrique] Pontificia Univ Catolica Chile, CARE Chile UC, Ctr Envejecimiento & Regenerac, Santiago, Chile; [Gonzalez, David; Contreras, Osvaldo; Rebolledo, Daniela L.; Pablo Espinoza, Juan; Brandan, Enrique] Pontificia Univ Catolica Chile, Dept Biol Celular & Mol, Fac Ciencias Biol, Santiago, Chile; [van Zundert, Brigitte] Univ Andres Bello, Ctr Invest Biomed, Fac Ciencias Biol, Santiago, Chile; [van Zundert, Brigitte] Univ Andres Bello, Fac Med, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad Andres Bello; Universidad Andres Bello	Brandan, E (corresponding author), Pontificia Univ Catolica Chile, CARE Chile UC, Ctr Envejecimiento & Regenerac, Santiago, Chile.; Brandan, E (corresponding author), Pontificia Univ Catolica Chile, Dept Biol Celular & Mol, Fac Ciencias Biol, Santiago, Chile.	ebrandan@bio.puc.cl	Rebolledo, Daniela/GXG-6724-2022; Contreras, Osvaldo/O-4518-2019; Brandan, Enrique/A-7063-2017	Rebolledo, Daniela/0000-0002-6240-6669; Contreras, Osvaldo/0000-0002-8722-9371; Brandan, Enrique/0000-0002-6820-5059	FONDECYT [1150106, 3140357, CARE-PFB-12/2007]; CONICYT [21130854]; ALS Therapy Alliance [2014-F-034]; DRI USA [2013-0030]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); ALS Therapy Alliance; DRI USA	This study received financial support from FONDECYT, grant #1150106 to E.B., a CARE-PFB-12/2007 grant, FONDECYT grant #3140357 to D.L.R., CONICYT, 21130854, PhDc David Gonzalez and CONICYT Doctoral Fellowship grants to D.G. and O.C. This work was supported by the ALS Therapy Alliance-2014-F-034, and DRI USA 2013-0030 to B.v.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandan E, 2013, FEBS J, V280, P4109, DOI 10.1111/febs.12278; Bros-Facer V, 2014, HUM MOL GENET, V23, P4187, DOI 10.1093/hmg/ddu136; Burks TN, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-19; Cabrera D, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-6; Caceres S, 2000, EUR J CELL BIOL, V79, P173, DOI 10.1078/S0171-9335(04)70020-5; Chang Z, 2014, DIS MODEL MECH, V7, P83, DOI 10.1242/dmm.013326; Chen WSV, 2004, NAT GENET, V36, P304, DOI 10.1038/ng1306; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Contreras O, 2016, CELL TISSUE RES, V364, P647, DOI 10.1007/s00441-015-2343-0; Cozzoli A, 2011, PHARMACOL RES, V64, P482, DOI 10.1016/j.phrs.2011.06.002; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; Day WA, 2005, NEUROBIOL DIS, V19, P323, DOI 10.1016/j.nbd.2005.01.010; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Dulauroy S, 2012, NAT MED, V18, P1262, DOI 10.1038/nm.2848; Endo F, 2015, CELL REP, V11, P592, DOI 10.1016/j.celrep.2015.03.053; Fritz E, 2013, J NEUROPHYSIOL, V109, P2803, DOI 10.1152/jn.00500.2012; Morales MG, 2013, HUM MOL GENET, V22, P4938, DOI 10.1093/hmg/ddt352; Morales MG, 2011, J PATHOL, V225, P490, DOI 10.1002/path.2952; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Houi K, 2002, ACTA NEUROL SCAND, V106, P299, DOI 10.1034/j.1600-0404.2002.01301.x; IGARASHI A, 1995, J INVEST DERMATOL, V105, P280, DOI 10.1111/1523-1747.ep12318465; Igarashi A, 1996, J INVEST DERMATOL, V106, P729, DOI 10.1111/1523-1747.ep12345771; Ilzecka J, 2002, CYTOKINE, V20, P239, DOI 10.1006/cyto.2002.2005; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Acuna MJ, 2014, HUM MOL GENET, V23, P1237, DOI 10.1093/hmg/ddt514; Judson RN, 2013, FEBS J, V280, P4100, DOI 10.1111/febs.12370; Katsuno M, 2011, Curr Mol Med, V11, P48, DOI 10.2174/156652411794474356; Kharraz Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/965631; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; Le M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048040; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lemos DR, 2015, NAT MED, V21, P786, DOI 10.1038/nm.3869; Lemos DR, 2012, STEM CELLS, V30, P1152, DOI 10.1002/stem.1082; Lorts A, 2012, P NATL ACAD SCI USA, V109, P10978, DOI 10.1073/pnas.1204708109; Mancuso R, 2015, PROG NEUROBIOL, V133, P1, DOI 10.1016/j.pneurobio.2015.07.004; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mathew SJ, 2011, DEVELOPMENT, V138, P371, DOI 10.1242/dev.057463; Miller TM, 2006, P NATL ACAD SCI USA, V103, P19546, DOI 10.1073/pnas.0609411103; Mueller AA, 2016, NATURE, V540, P276, DOI 10.1038/nature20160; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; Pansarasa O, 2014, MOL NEUROBIOL, V49, P984, DOI 10.1007/s12035-013-8578-4; Paradis V, 2002, LAB INVEST, V82, P767, DOI 10.1097/01.LAB.0000017365.18894.D3; Partridge TA, 2013, FEBS J, V280, P4177, DOI 10.1111/febs.12267; Pessina P, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-7; Philips Thomas, 2015, Curr Protoc Pharmacol, V69, DOI 10.1002/0471141755.ph0567s69; Quattrocelli M, 2017, BBA-MOL CELL RES, V1864, P572, DOI 10.1016/j.bbamcr.2016.12.020; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rojas F, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00203, 10.3389/fncel.2015.00203]; Rojas F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00024; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Si Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138425; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Uezumi A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00068; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Vainzof M, 2008, J MOL NEUROSCI, V34, P241, DOI 10.1007/s12031-007-9023-9; Van Dyke JM, 2016, EXP NEUROL IN PRESS; Vial C, 2008, J CELL PHYSIOL, V215, P410, DOI 10.1002/jcp.21324; Wong M, 2010, HUM MOL GENET, V19, P2284, DOI 10.1093/hmg/ddq106; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919; Zhou L, 2010, J NEUROPATH EXP NEUR, V69, P771, DOI 10.1097/NEN.0b013e3181e9a34b	69	72	73	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177649	10.1371/journal.pone.0177649	http://dx.doi.org/10.1371/journal.pone.0177649			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520806	Green Published, gold, Green Submitted			2022-12-26	WOS:000401485500052
J	Moutaoufik, MT; Morrow, G; Finet, S; Tanguay, RM				Moutaoufik, Mohamed Taha; Morrow, Genevieve; Finet, Stephanie; Tanguay, Robert M.			Effect of N-terminal region of nuclear Drosophila melanogaster small heat shock protein DmHsp27 on function and quaternary structure	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; CHAPERONE-LIKE ACTIVITY; PHOSPHOPROTEOME ANALYSIS; STRESS-PROTEIN; HSP27; SUBSTRATE; PHOSPHORYLATION; OLIGOMERIZATION; MECHANISM; DYNAMICS	The importance of the N-terminal region (NTR) in the oligomerization and chaperone-like activity of the Drosophila melanogaster small nuclear heat shock protein DmHsp27 was investigated by mutagenesis using size exclusion chromatography and native gel electrophoresis. Mutation of two sites of phosphorylation in the N-terminal region, S58 and S75, did not affect the oligomerization equilibrium or the intracellular localization of DmHsp27 when transfected into mammalian cells. Deletion or mutation of specific residues within the NTR region delineated a motif (FGFG) important for the oligomeric structure and chaperone-like activity of this sHsp. While deletion of the full N-terminal region, resulted in total loss of chaperone-like activity, removal of the (FGFG) at position 29 to 32 or single mutation of F29A/Y, G30R and G32R enhanced oligomerization and chaperoning capacity under non-heat shock conditions in the insulin assay suggesting the importance of this site for chaperone activity. Unlike mammalian sHsps DmHsp27 heat activation leads to enhanced association of oligomers to form large structures of approximately 1100 kDa. A new mechanism of thermal activation for DmHsp27 is presented.	[Moutaoufik, Mohamed Taha; Morrow, Genevieve; Tanguay, Robert M.] Univ Laval, Lab Genet Cellulaire & Dev, Dept Biol Mol Biochim Med & Pathol, IBIS, Quebec City, PQ, Canada; [Moutaoufik, Mohamed Taha; Morrow, Genevieve; Tanguay, Robert M.] Univ Laval, PROTEO, Quebec City, PQ, Canada; [Finet, Stephanie] UPMC Paris 6, CNRS, IMPMC, UMR7590, 4 Pl Jussieu, Paris, France	Laval University; Laval University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD)	Tanguay, RM (corresponding author), Univ Laval, Lab Genet Cellulaire & Dev, Dept Biol Mol Biochim Med & Pathol, IBIS, Quebec City, PQ, Canada.; Tanguay, RM (corresponding author), Univ Laval, PROTEO, Quebec City, PQ, Canada.	Robert.tanguay@fmed.ulaval.ca		Moutaoufik, Mohamed Taha/0000-0002-2013-1601	NSERC; FQRNT; PROTEO, Quebec	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); FQRNT(FQRNT); PROTEO, Quebec	This work was funded by a grant from NSERC to RMT and a FQRNT exchange studentship to RMT and SF. MTM held a studentship from PROTEO, Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigo AP, 2013, FEBS LETT, V587, P1959, DOI 10.1016/j.febslet.2013.05.011; Baranova EV, 2011, J MOL BIOL, V411, P110, DOI 10.1016/j.jmb.2011.05.024; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Basha E, 2010, J BIOL CHEM, V285, P11489, DOI 10.1074/jbc.M109.074088; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; BEAULIEU JF, 1989, J CELL SCI, V92, P29; Benesch JLP, 2010, CHEM BIOL, V17, P1008, DOI 10.1016/j.chembiol.2010.06.016; Bepperling A, 2012, P NATL ACAD SCI USA, V109, P20407, DOI 10.1073/pnas.1209565109; Bodenmiller B, 2007, MOL BIOSYST, V3, P275, DOI 10.1039/b617545g; Bourrelle-Langlois M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162233; Braun N, 2011, P NATL ACAD SCI USA, V108, P20491, DOI 10.1073/pnas.1111014108; Capponi S, 2011, J PERIPHER NERV SYST, V16, P287, DOI 10.1111/j.1529-8027.2011.00361.x; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; Cheng GL, 2008, J BIOL CHEM, V283, P26634, DOI 10.1074/jbc.M802946200; Chowdary TK, 2004, BIOCHEM J, V381, P379, DOI 10.1042/BJ20031958; CRABBE MJC, 1994, BIOCHEM J, V297, P653, DOI 10.1042/bj2970653; Crack JA, 2002, EUR J BIOCHEM, V269, P933, DOI 10.1046/j.0014-2956.2001.02726.x; DAS KP, 1995, FEBS LETT, V369, P321, DOI 10.1016/0014-5793(95)00775-5; Datta SA, 1999, J BIOL CHEM, V274, P34773, DOI 10.1074/jbc.274.49.34773; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; Delbecq SP, 2013, FEBS LETT, V587, P1073, DOI 10.1016/j.febslet.2013.01.021; den Engelsman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073489; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Feil IK, 2001, J BIOL CHEM, V276, P12024, DOI 10.1074/jbc.M010856200; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Franzmann TM, 2008, MOL CELL, V29, P207, DOI 10.1016/j.molcel.2007.11.025; Fu XM, 2006, J MOL EVOL, V62, P257, DOI 10.1007/s00239-005-0076-5; Garrido C, 2012, INT J BIOCHEM CELL B, V44, P1588, DOI 10.1016/j.biocel.2012.02.022; Ghosh JG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000498; Hanazono Y, 2013, STRUCTURE, V21, P220, DOI 10.1016/j.str.2012.11.015; Haslbeck M., 2015, BIG BOOK SMALL HEAT, P155, DOI [10.1007/978-3-319-16077-1_6, DOI 10.1007/978-3-319-16077-1_6]; Haslbeck M, 2016, BBA-GEN SUBJECTS, V1860, P149, DOI 10.1016/j.bbagen.2015.06.008; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Hayes D, 2009, J BIOL CHEM, V284, P18801, DOI 10.1074/jbc.M109.011353; Heirbaut M., 2015, BIG BOOK SMALL HEAT, P197; Heirbaut M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105892; Horwitz J, 1998, INT J BIOL MACROMOL, V22, P263, DOI 10.1016/S0141-8130(98)00024-5; Ito K, 2001, J BIOL CHEM, V276, P5346, DOI 10.1074/jbc.M009004200; Jehle S, 2011, P NATL ACAD SCI USA, V108, P6409, DOI 10.1073/pnas.1014656108; Kappe G, 2010, CELL STRESS CHAPERON, V15, P457, DOI 10.1007/s12192-009-0155-4; KATO K, 1994, J BIOL CHEM, V269, P11274; Kelley PB, 2003, MOL CELL BIOCHEM, V252, P273, DOI 10.1023/A:1025568417000; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kundu M, 2007, BIOPOLYMERS, V86, P177, DOI 10.1002/bip.20716; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Lelj-Garolla B, 2006, J BIOL CHEM, V281, P8169, DOI 10.1074/jbc.M512553200; Leroux MR, 1997, J BIOL CHEM, V272, P24646, DOI 10.1074/jbc.272.39.24646; Lund AA, 2001, J BIOL CHEM, V276, P29924, DOI 10.1074/jbc.M103373200; Maaroufi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081207; Marin R, 1996, EXP CELL RES, V223, P1, DOI 10.1006/excr.1996.0052; Mchaourab HS, 2012, BIOCHEMISTRY-US, V51, P5105, DOI 10.1021/bi300525x; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Michaud S, 2008, BBA-MOL CELL RES, V1783, P1200, DOI 10.1016/j.bbamcr.2008.01.031; Michaud Sebastien, 2002, Prog Mol Subcell Biol, V28, P79; Morrow G, 2006, CELL STRESS CHAPERON, V11, P51, DOI 10.1379/CSC-166.1; Morrow G., 2015, BIG BOOK SMALL HEAT, P579, DOI DOI 10.1007/978-3-319-16077-1_25; Moutaoufik MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112742; Moutaoufik MT, 2016, CELL STRESS CHAPERON, P1; Muranova LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126248; Pasta SY, 2003, J BIOL CHEM, V278, P51159, DOI 10.1074/jbc.M307523200; Patel S, 2014, BIOPHYS J, V106, P2644, DOI 10.1016/j.bpj.2014.04.048; Peschek J, 2013, P NATL ACAD SCI USA, V110, pE3780, DOI 10.1073/pnas.1308898110; Plater ML, 1996, J BIOL CHEM, V271, P28558, DOI 10.1074/jbc.271.45.28558; RAMAN B, 1995, FEBS LETT, V365, P133, DOI 10.1016/0014-5793(95)00440-K; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Sharma KK, 1998, J BIOL CHEM, V273, P15474, DOI 10.1074/jbc.273.25.15474; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Smith JB, 1996, EXP EYE RES, V63, P125, DOI 10.1006/exer.1996.0100; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Sun Y, 2004, J BIOL CHEM, V279, P39999, DOI 10.1074/jbc.M406999200; Theriault JR, 2004, J BIOL CHEM, V279, P23463, DOI 10.1074/jbc.M402325200; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; Weeks SD, 2014, METHODS MOL BIOL, V1200, P511, DOI 10.1007/978-1-4939-1292-6_42; Zhai B, 2008, J PROTEOME RES, V7, P1675, DOI 10.1021/pr700696a; Zhang KM, 2015, SCI REP-UK, V5, DOI 10.1038/srep08811	78	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177821	10.1371/journal.pone.0177821	http://dx.doi.org/10.1371/journal.pone.0177821			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520783	Green Published, Green Submitted, gold			2022-12-26	WOS:000401485500073
J	Ka, SO; Bang, IH; Bae, EJ; Park, BH				Ka, Sun-O; Bang, In Hyuk; Bae, Eun Ju; Park, Byung-Hyun			Hepatocyte-specific sirtuin 6 deletion predisposes to nonalcoholic steatohepatitis by up-regulation of Bach1, an Nrf2 repressor	FASEB JOURNAL			English	Article						inflammation; fibrosis; oxidative stress; liver	FATTY LIVER-DISEASE; OXIDATIVE STRESS; HEPATOCELLULAR-CARCINOMA; HEPATIC STEATOSIS; GENE-EXPRESSION; NRF2-NULL MICE; INFLAMMATION; PROGRESSION; DEACETYLATION; CIRRHOSIS	Sirtuin (Sirt)6 has been implicated in negative regulation of inflammation and lipid metabolism, although its function in the progression from simple steatosis to nonalcoholic steatohepatitis (NASH) remains to be defined. To explore the role of hepatocyte Sirt6 in NASH development, we generated hepatocyte-specific Sirt6-knockout (KO) mice that were fed a high-fat and high-fructose (HFHF) diet for 16 wk. HFHF-fed KO mice had increased hepatic steatosis and inflammation and aggravated glucose intolerance and insulin resistance compared with wild-type mice. HFHF-induced liver fibrosis and oxidative stress and related gene expression were significantly elevated in KO mice. In the livers of KO mice, nuclear factor erythroid 2-related factor 2 (Nrf2) was down-regulated; conversely, BTB domain and CNC homolog 1 (Bach1), a nuclear repressor of Nrf2, were up-regulated. We discovered that Sirt6, which interacts with Bach1 under basal condition, induces its detachment from the antioxidant response element (ARE) region of heme oxygenase 1 promoter. Furthermore, we found that Sirt6 promotes Nrf2 binding to ARE in response to oxidative stimuli, which leads to the expression of phase II/antioxidant enzymes. Finally, we showed that HFHF-induced steatosis, inflammation, and fibrosis were ameliorated by adenoviral Sirt6 overexpression. Sirt6 may be a useful therapeutic target for amelioration of NASH by curbing inflammation and oxidative stress.	[Ka, Sun-O; Bang, In Hyuk; Park, Byung-Hyun] Chonbuk Natl Univ, Dept Biochem, Sch Med, Jeonju, South Korea; [Bae, Eun Ju] Woosuk Univ, Coll Pharm, 443 Samnye Ro, Wonju 55338, Jeonbuk, South Korea	Jeonbuk National University; Woosuk University	Bae, EJ (corresponding author), Woosuk Univ, Coll Pharm, 443 Samnye Ro, Wonju 55338, Jeonbuk, South Korea.; Park, BH (corresponding author), Chonbuk Natl Univ, Sch Med, 567 Baekje Daero, Jeonju 54896, Jeonbuk, South Korea.	bhpark@jbnu.ac.kr			Basic Science Research Program through the Korean National Research Foundation (Ministry of Science, Information and Communication Technology and Future Planning) [2015R1D1A1A01058502, 2017R1A2B2005730, 2017R1A2B4008593]; Medical Research Center Program through the Korean National Research Foundation (Ministry of Science, Information and Communication Technology and Future Planning) [2008-0062279]	Basic Science Research Program through the Korean National Research Foundation (Ministry of Science, Information and Communication Technology and Future Planning); Medical Research Center Program through the Korean National Research Foundation (Ministry of Science, Information and Communication Technology and Future Planning)	This work was supported by the Basic Science Research Program (Grants 2015R1D1A1A01058502, 2017R1A2B2005730, and 2017R1A2B4008593), and by the Medical Research Center Program (Grant 2008-0062279) through the Korean National Research Foundation (Ministry of Science, Information and Communication Technology and Future Planning). The authors declare no conflicts of interest.	Anderson JG, 2015, MOL METAB, V4, P846, DOI 10.1016/j.molmet.2015.09.003; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dominy JE, 2012, MOL CELL, V48, P900, DOI 10.1016/j.molcel.2012.09.030; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Gracia-Sancho J, 2008, HEPATOLOGY, V47, P1248, DOI 10.1002/hep.22166; Hoebe KHN, 2001, AM J PHYSIOL-GASTR L, V280, pG720, DOI 10.1152/ajpgi.2001.280.4.G720; Jang HY, 2016, J ALLERGY CLIN IMMUN, V138, P1452, DOI 10.1016/j.jaci.2016.05.019; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Lappas M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/597514; Lee HS, 2013, ARTHRITIS RHEUM-US, V65, P1776, DOI 10.1002/art.37963; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Li Y, 2014, GASTROENTEROLOGY, V146, P539, DOI 10.1053/j.gastro.2013.10.059; Liu F, 2010, TOXICOL SCI, V115, P596, DOI 10.1093/toxsci/kfq075; Marquardt JU, 2013, HEPATOLOGY, V58, P1054, DOI 10.1002/hep.26413; Meakin PJ, 2014, MOL CELL BIOL, V34, P3305, DOI [10.1128/MCB.00677-14, 10.1128/MCB.00677-1]; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; Okita Y, 2013, J BIOL CHEM, V288, P20658, DOI 10.1074/jbc.M113.450478; Palekar NA, 2006, LIVER INT, V26, P151, DOI 10.1111/j.1478-3231.2005.01209.x; Pan HZ, 2016, CELL RES, V26, P190, DOI 10.1038/cr.2016.4; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Radak Z, 2013, FREE RADICAL BIO MED, V58, P87, DOI 10.1016/j.freeradbiomed.2013.01.004; Ramadori P, 2016, FREE RADICAL BIO MED, V91, P114, DOI 10.1016/j.freeradbiomed.2015.12.014; Ryan MC, 2005, DIABETES CARE, V28, P1222, DOI 10.2337/diacare.28.5.1222; Shima T, 2015, HEPATOL RES, V45, P548, DOI 10.1111/hepr.12384; Shimozono R, 2013, MOL PHARMACOL, V84, P62, DOI 10.1124/mol.112.084269; Song MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep30321; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Thandavarayan RA, 2015, EXP DERMATOL, V24, P773, DOI 10.1111/exd.12762; Wang J, 2017, HEPATOLOGY, V65, P225, DOI 10.1002/hep.28777; Xiao CY, 2012, J BIOL CHEM, V287, P41903, DOI 10.1074/jbc.M112.415182; Yin HQ, 2014, GASTROENTEROLOGY, V146, P801, DOI 10.1053/j.gastro.2013.11.008; Zhang ZG, 2014, MOL MED REP, V9, P882, DOI 10.3892/mmr.2013.1879	42	59	60	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3999	4010		10.1096/fj.201700098RR	http://dx.doi.org/10.1096/fj.201700098RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28536120				2022-12-26	WOS:000408713300025
J	van Dijk, IA; Ferrando, ML; van der Wijk, AE; Hoebe, RA; Nazmi, K; de Jonge, WJ; Krawczyk, PM; Bolscher, JGM; Veerman, ECI; Stap, J				van Dijk, Irene A.; Ferrando, Maria Laura; van der Wijk, Anne-Eva; Hoebe, Ron A.; Nazmi, Kamran; de Jonge, Wouter J.; Krawczyk, Przemek M.; Bolscher, Jan G. M.; Veerman, Enno C. I.; Stap, Jan			Human salivary peptide histatin-1 stimulates epithelial and endothelial cell adhesion and barrier function	FASEB JOURNAL			English	Article						adherens junctions; tight junctions; oral cavity	HISTIDINE-RICH POLYPEPTIDES; SMALL G-PROTEINS; E-CADHERIN; MESENCHYMAL TRANSITION; ACTIN CYTOSKELETON; STREPTOCOCCUS-SUIS; CARCINOMA-CELLS; BETA-CATENIN; INTESTINAL-MUCOSA; GENE-EXPRESSION	Histatins are multifunctional histidine-rich peptides secreted by the salivary glands and exclusively present in the saliva of higher primates, where they play a fundamental role in the protection of the oral cavity. Our previously published results demonstrated that histatin-1 (Hst1) promotes cell-substrate adhesion in various cell types and hinted that it could also be involved in cell-cell adhesion, a process of fundamental importance to epithelial and endothelial barriers. Here we explore the effects of Hst1 on cellular barrier function. We show that Hst1 improved endothelial barrier integrity, decreased its permeability for large molecules, and prevented translocation of bacteria across epithelial cell layers. These effects are mediated by the adherens junction protein E-cadherin (E-cad) and by the tight junction protein zonula occludens 1, as Hst1 increases the levels of zonula occludens 1 and of active E-cad. Hst1 may also promote epithelial differentiation as Hst1 induced transcription of the epithelial cell differentiation marker apolipoprotein A-IV (a downstream E-cad target). In addition, Hst1 counteracted the effects of epithelial-mesenchymal transition inducers on the outgrowth of oral cancer cell spheroids, suggesting that Hst1 affects processes that are implicated in cancer progression.	[van Dijk, Irene A.; Hoebe, Ron A.; Krawczyk, Przemek M.; Stap, Jan] Univ Amsterdam, Acad Med Ctr LCAM AMC, Dept Med Biol & Core Facil Cellular Imaging, Van Leeuwenhoek Ctr Adv Microscopy, Amsterdam, Netherlands; [Ferrando, Maria Laura] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands; [van der Wijk, Anne-Eva] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands; [van der Wijk, Anne-Eva] Univ Amsterdam, Acad Med Ctr, Dept Med Biol, Ocular Angiogenesis Grp, Amsterdam, Netherlands; [de Jonge, Wouter J.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands; [van Dijk, Irene A.; Nazmi, Kamran; Bolscher, Jan G. M.; Veerman, Enno C. I.] Univ Amsterdam, Dept Oral Biochem, Amsterdam, Netherlands; [van Dijk, Irene A.; Nazmi, Kamran; Bolscher, Jan G. M.; Veerman, Enno C. I.] Vrije Univ VU Amsterdam, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	van Dijk, IA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biol & Core Facil Cellular Imaging LCAM, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	i.a.vandijk@amc.uva.nl	Bolscher, Jan/ABF-6102-2021; Ferrando, Maria Laura/M-3026-2018	Bolscher, Jan/0000-0001-5669-6164; Ferrando, Maria Laura/0000-0002-1398-8244; van der Wijk, Anne-Eva/0000-0002-7436-5323	Dutch Organization for Scientific Research (NWO) [ALW2PJ/09070]; International Team for Implantology (Basel, Switzerland) (ITI) [1091_2015]; Academic Proof-of-Concept fund of the municipality of Amsterdam; University of Amsterdam	Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); International Team for Implantology (Basel, Switzerland) (ITI); Academic Proof-of-Concept fund of the municipality of Amsterdam; University of Amsterdam	The authors thank K. Kurakula [Academic Medical Center (AMC)] for help with the inhibitor studies, C. de Vries (AMC) for use of equipment and helpful discussions, A. Jansen (AMC) and W. Kamphuis (Netherlands Institute for Neuroscience) for help with qPCR, I. Klaassen (AMC) for use of equipment and designing primers for qPCR, K. Wolthers and C. Schultsz (AMC) for providing the Caco-2 cell line and S. suis strains, respectively, B. Arik-Yetkin (AMC) for providing the HUVECs for cell spreading experiments, E. Verver (AMC) for providing the EGF, and E. Reits for valuable comments on the article. This work was supported by the Dutch Organization for Scientific Research (NWO; Grant ALW2PJ/09070), the International Team for Implantology (Basel, Switzerland) (ITI; Grant 1091_2015), the Academic Proof-of-Concept fund of the municipality of Amsterdam, and a grant from the University of Amsterdam for research into the focal point of oral infections and inflammation.	Auersperg N, 1999, P NATL ACAD SCI USA, V96, P6249, DOI 10.1073/pnas.96.11.6249; Boink MA, 2016, WOUND REPAIR REGEN, V24, P100, DOI 10.1111/wrr.12380; Bolscher JGM, 2011, FASEB J, V25, P2650, DOI 10.1096/fj.11-182212; Chartier NT, 2006, J CELL SCI, V119, P31, DOI 10.1242/jcs.02698; Dardousis K, 2007, MOL THER, V15, P94, DOI 10.1038/sj.mt.6300003; DELI MA, 1995, EXP PHYSIOL, V80, P675, DOI 10.1113/expphysiol.1995.sp003877; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Ferrando ML, 2016, GUT MICROBES, V7, P154, DOI 10.1080/19490976.2016.1144008; Ferrando ML, 2015, J INFECT DIS, V212, P95, DOI 10.1093/infdis/jiu813; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hashimoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047899; Hazan RB, 1998, J BIOL CHEM, V273, P9078, DOI 10.1074/jbc.273.15.9078; HERMISTON ML, 1995, J CELL BIOL, V129, P489, DOI 10.1083/jcb.129.2.489; HILGERS AR, 1990, PHARMACEUT RES, V7, P902, DOI 10.1023/A:1015937605100; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Johnson DA, 2000, ARCH ORAL BIOL, V45, P731, DOI 10.1016/S0003-9969(00)00047-9; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kamei T, 1999, ONCOGENE, V18, P6776, DOI 10.1038/sj.onc.1203114; Klaassen I, 2009, EXP EYE RES, V89, P4, DOI 10.1016/j.exer.2009.01.006; Krisanaprakornkit S., 2012, ISRN ONCOL, DOI DOI 10.5402/2012/681469; Kudo Y, 2004, CLIN CANCER RES, V10, P5455, DOI 10.1158/1078-0432.CCR-04-0372; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; LeBeyec J, 1997, EXP CELL RES, V236, P311; Leckband D, 2006, ANNU REV BIOMED ENG, V8, P259, DOI 10.1146/annurev.bioeng.8.061505.095753; MACKAY BJ, 1984, INFECT IMMUN, V44, P695, DOI 10.1128/IAI.44.3.695-701.1984; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Muhamed I, 2016, J CELL SCI, V129, P1843, DOI 10.1242/jcs.185447; Mullin JM, 2005, DRUG DISCOV TODAY, V10, P395, DOI 10.1016/S1359-6446(05)03379-9; Nanci A., 2013, 10 CATES ORAL HISTOL, DOI DOI 10.1016/B978-0-323-07846-7.00001-X; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Oudhoff MJ, 2009, J DENT RES, V88, P846, DOI 10.1177/0022034509342951; Oudhoff MJ, 2008, FASEB J, V22, P3805, DOI 10.1096/fj.08-112003; Oudhoff MJ, 2009, FASEB J, V23, P3928, DOI 10.1096/fj.09-137588; Pal S, 2014, NEW J CHEM, V38, P3889, DOI 10.1039/c4nj00160e; Peignon G, 2006, J BIOL CHEM, V281, P3560, DOI 10.1074/jbc.M506360200; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; POLLOCK JJ, 1984, INFECT IMMUN, V44, P702, DOI 10.1128/IAI.44.3.702-707.1984; Ratheesh A, 2012, NAT REV MOL CELL BIO, V13, P673, DOI 10.1038/nrm3431; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Sako Y, 1998, J CELL BIOL, V140, P1227, DOI 10.1083/jcb.140.5.1227; Schreider C, 2002, J CELL SCI, V115, P543; Schubert W, 2001, J BIOL CHEM, V276, P48619, DOI 10.1074/jbc.C100613200; Scrace S, 2013, METHODS MOL BIOL, V1046, P295, DOI 10.1007/978-1-62703-538-5_17; Siemerink MJ, 2012, ANGIOGENESIS, V15, P151, DOI 10.1007/s10456-011-9251-z; Smith HE, 1999, INFECT IMMUN, V67, P1750; Sume SS, 2010, AM J PATHOL, V177, P208, DOI 10.2353/ajpath.2010.090952; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; van Dijk IA, 2017, J DENT RES, V96, P423, DOI 10.1177/0022034516681761; van Dijk IA, 2015, FASEB J, V29, P3124, DOI 10.1096/fj.14-266825; Vicente-Manzanares M, 2008, J CELL BIOL, V183, P543, DOI 10.1083/jcb.200806030; Vincent-Salomon A, 2003, BREAST CANCER RES, V5, P101, DOI 10.1186/bcr578; Weber GF, 2011, J CELL SCI, V124, P1183, DOI 10.1242/jcs.064618; Wells A, 2011, FRONT BIOSCI-LANDMRK, V16, P815, DOI 10.2741/3722; Wisniewska-Kruk J, 2015, EXP EYE RES, V138, P167, DOI 10.1016/j.exer.2015.07.006; Woichansky I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10834; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yaguchi T., 2012, Patent, Patent No. [WO/ 2012/ 023588, 2012023588]; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; YAN QY, 1995, BIOCHEM J, V311, P341, DOI 10.1042/bj3110341; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yin A, 2003, ARCH ORAL BIOL, V48, P361, DOI 10.1016/S0003-9969(03)00012-8; Yokoyama K, 2001, ORAL ONCOL, V37, P65, DOI 10.1016/S1368-8375(00)00059-2; Zheng XY, 2006, BIOTECHNOL PROGR, V22, P1294, DOI 10.1021/bp060121o	71	27	27	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3922	3933		10.1096/fj.201700180R	http://dx.doi.org/10.1096/fj.201700180R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28522595				2022-12-26	WOS:000408713300019
J	Agrawal, G; Shang, HH; Xia, ZJ; Subramani, S				Agrawal, Gaurav; Shang, Helen H.; Xia, Zhi-Jie; Subramani, Suresh			Functional regions of the peroxin Pex19 necessary for peroxisome biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN BOUNDARY PREDICTION; MEMBRANE-PROTEINS; ENDOPLASMIC-RETICULUM; RECEPTOR PEX19P; IMPORT RECEPTOR; PEX3P; DIVISION; DISTINCT; YEAST; FARNESYLATION	The peroxins Pex19 and Pex3 play an indispensable role in peroxisomal membrane protein (PMP) biogenesis, peroxisome division, and inheritance. Pex19 plays multiple roles in these processes, but how these functions relate to the structural organization of the Pex19 domains is unresolved. To this end, using deletion mutants, we mapped the Pex19 regions required for peroxisome biogenesis in the yeast Pichia pastoris. Surprisingly, import-competent peroxisomes still formed when Pex19 domains previously believed to be required for biogenesis were deleted, although the peroxisome size was larger than that in wild-type cells. Moreover, these mutants exhibited a delay of 14-24 h in peroxisome biogenesis. The shortest functional N-terminal (NTCs) and C-terminal constructs (CTCs) were Pex19 (aa 1-150) and Pex19 (aa 89-300), respectively. Deletions of the N-terminal Pex3-binding site disrupted the direct interactions of Pex19 with Pex3, but preserved interactions with a membrane peroxisomal targeting signal (mPTS)-containing PMP, Pex10. In contrast, deletion of the C-terminal mPTSbinding domain of Pex19 disrupted its interaction with Pex10 while leaving the Pex19-Pex3 interactions intact. However, Pex11 and Pex25 retained their interactions with both Nand C-terminal deletion mutants. NTC-CTC co-expression improved growth and reversed the larger-than-normal peroxisome size observed with the single deletions. Pex25 was critical for peroxisome formation with the CTC variants, and its overexpression enhanced their interactions with Pex3 and aided the growth of both NTC and CTC Pex19 variants. In conclusion, physical segregation of the Pex3-and PMP-binding domains of Pex19 has provided novel insights into the modular architecture of Pex19. We define the minimum region of Pex19 required for peroxisome biogenesis and a unique role for Pex25 in this process.	[Agrawal, Gaurav; Shang, Helen H.; Xia, Zhi-Jie; Subramani, Suresh] Univ Calif San Diego, Div Biol Sci, Sect Mol Biol, Rm 3326,Bonner Hall,9500 Gilman Dr, La Jolla, CA 92093 USA; [Xia, Zhi-Jie] Shandong Normal Univ, Coll Life Sci, Jinan 250014, Shandong, Peoples R China	University of California System; University of California San Diego; Shandong Normal University	Subramani, S (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Mol Biol, Rm 3326,Bonner Hall,9500 Gilman Dr, La Jolla, CA 92093 USA.	ssubramani@ucsd.edu	Xia, Zhijie/J-6987-2017	Xia, Zhijie/0000-0003-3018-1925	National Institutes of Health [RO1DK41737]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant RO1DK41737 (to S. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrawal G, 2016, BBA-MOL CELL RES, V1863, P892, DOI 10.1016/j.bbamcr.2015.09.014; Agrawal G, 2016, J CELL BIOL, V212, P335, DOI 10.1083/jcb.201506141; Agrawal G, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00286; Agrawal G, 2011, P NATL ACAD SCI USA, V108, P9113, DOI 10.1073/pnas.1018749108; Bryson K, 2007, CURR PROTEIN PEPT SC, V8, P181, DOI 10.2174/138920307780363415; Chen YX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6790; Cheng JL, 2006, DATA MIN KNOWL DISC, V13, P1, DOI 10.1007/s10618-005-0023-5; Delille HK, 2008, J BIOL CHEM, V283, P31107, DOI 10.1074/jbc.M803332200; Eickholt J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-43; ERDMANN R, 1995, J CELL BIOL, V128, P509, DOI 10.1083/jcb.128.4.509; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Fransen M, 2005, J MOL BIOL, V346, P1275, DOI 10.1016/j.jmb.2005.01.013; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1639, DOI 10.1016/j.bbamcr.2006.08.030; Giannopoulou EA, 2016, BBA-MOL CELL RES, V1863, P863, DOI 10.1016/j.bbamcr.2015.09.031; Gotte K, 1998, MOL CELL BIOL, V18, P616; Hettema EH, 2009, J CELL SCI, V122, P2331, DOI 10.1242/jcs.034363; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Huber A, 2012, TRAFFIC, V13, P157, DOI 10.1111/j.1600-0854.2011.01290.x; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Joshi S, 2012, MOL BIOL CELL, V23, P1307, DOI 10.1091/mbc.E11-09-0782; Kashiwayama Y, 2005, BBA-MOL CELL RES, V1746, P116, DOI 10.1016/j.bbamcr.2005.10.006; Klouwer FCC, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0368-9; Lam SK, 2010, P NATL ACAD SCI USA, V107, P21523, DOI 10.1073/pnas.1013397107; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Marshall PA, 1996, J CELL BIOL, V135, P123, DOI 10.1083/jcb.135.1.123; Mast FD, 2016, J BIOL CHEM, V291, P15408, DOI 10.1074/jbc.M116.728154; Matsuzaki T, 2008, J CELL BIOL, V183, P1275, DOI 10.1083/jcb.200806062; Matsuzono Y, 2006, J BIOL CHEM, V281, P36, DOI 10.1074/jbc.M509819200; Matsuzono Y, 2006, J CELL SCI, V119, P3539, DOI 10.1242/jcs.03100; Motley AM, 2007, J CELL BIOL, V178, P399, DOI 10.1083/jcb.200702167; Otzen ML, 2012, TRAFFIC, V13, P947, DOI 10.1111/j.1600-0854.2012.01364.x; Otzen M, 2006, FEMS YEAST RES, V6, P1157, DOI 10.1111/j.1567-1364.2006.00102.x; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Rottensteiner H, 2003, MOL BIOL CELL, V14, P4316, DOI 10.1091/mbc.E03-03-0153; Rucktaschel R, 2009, J BIOL CHEM, V284, P20885, DOI 10.1074/jbc.M109.016584; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Sato Y, 2008, J BIOL CHEM, V283, P6136, DOI 10.1074/jbc.M706139200; Sato Y, 2010, EMBO J, V29, P4083, DOI 10.1038/emboj.2010.293; Schmidt F, 2012, TRAFFIC, V13, P1244, DOI 10.1111/j.1600-0854.2012.01380.x; Schmidt F, 2010, J BIOL CHEM, V285, P25410, DOI 10.1074/jbc.M110.138503; Schrader M, 2008, HISTOCHEM CELL BIOL, V129, P421, DOI 10.1007/s00418-008-0396-9; Schrader M, 2006, INT REV CYTOL, V255, P237, DOI 10.1016/S0074-7696(06)55005-3; Schueller N, 2010, EMBO J, V29, P2491, DOI 10.1038/emboj.2010.115; Shibata H, 2004, J BIOL CHEM, V279, P38486, DOI 10.1074/jbc.M402204200; SIBIRNY AA, 1988, J BASIC MICROB, V28, P293, DOI 10.1002/jobm.3620280503; Snyder WB, 1999, MOL BIOL CELL, V10, P1745, DOI 10.1091/mbc.10.6.1745; Subramani S, 1998, PHYSIOL REV, V78, P171, DOI 10.1152/physrev.1998.78.1.171; Tabak HF, 2013, ANNU REV BIOCHEM, V82, P723, DOI 10.1146/annurev-biochem-081111-125123; Theodoulou FL, 2013, BIOCHEM J, V451, P345, DOI 10.1042/BJ20130078; Tower RJ, 2011, MOL BIOL CELL, V22, P1727, DOI 10.1091/mbc.E11-01-0084; van der Zand A, 2012, CELL, V149, P397, DOI 10.1016/j.cell.2012.01.054; Vastiau IMK, 2006, CELL MOL LIFE SCI, V63, P1686, DOI 10.1007/s00018-006-6110-y; VEENHUIS M, 1983, ADV MICROB PHYSIOL, V24, P1, DOI 10.1016/S0065-2911(08)60384-7; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Yagita Y, 2013, J CELL BIOL, V200, P651, DOI 10.1083/jcb.201211077	56	14	14	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11547	11560		10.1074/jbc.M116.774067	http://dx.doi.org/10.1074/jbc.M116.774067			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28526747	hybrid, Green Published			2022-12-26	WOS:000405119600034
J	Deuss, FA; Gully, BS; Rossjohn, J; Berry, R				Deuss, Felix A.; Gully, Benjamin S.; Rossjohn, Jamie; Berry, Richard			Recognition of nectin-2 by the natural killer cell receptor T cell immunoglobulin and ITIM domain (TIGIT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL IMMUNOEVASIN; PVR CD155; NK CELLS; MOLECULE; CYTOTOXICITY; ACTIVATION; SEQUENCE; ADHESION; LIGANDS; FAMILY	T cell immunoglobulin and ITIM domain (TIGIT) is an inhibitory receptor expressed on the surface of natural killer (NK) cells. TIGIT recognizes nectin and nectin-like adhesion molecules and thus plays a critical role in the innate immune response to malignant transformation. Although the TIGIT nectin-like protein-5 (necl-5) interaction is well understood, how TIGIT engages nectin-2, a receptor that is broadly over-expressed in breast and ovarian cancer, remains unknown. Here, we show that TIGIT bound to the immunoglobulin domain of nectin-2 that is most distal from the membrane with an affinity of 6 mu M, which was moderately lower than the affinity observed for the TIGIT/necl-5 interaction (3.2 mu M). The TIGIT/nectin-2 binding disrupted preassembled nectin-2 oligomers, suggesting that receptor-ligand and ligand-ligand associations are mutually exclusive events. Indeed, the crystal structure of TIGIT bound to the first immunoglobulin domain of nectin-2 indicated that the receptor and ligand dock using the same molecular surface and a conserved " lock and key" binding motifs previously observed to mediate nectin/nectin homotypic interactions as well as TIGIT/necl-5 recognition. Using a mutagenesis approach, we dissected the energetic basis for the TIGIT/nectin-2 interaction and revealed that an " aromatic key" of nectin-2 is critical for this interaction, whereas variations in the lock were tolerated. Moreover, we found that the C-C' loop of the ligand dictates the TIGIT binding hierarchy. Altogether, these findings broaden our understanding of nectin/nectin receptor interactions and have implications for better understanding the molecular basis for autoimmune disease and cancer.	[Deuss, Felix A.; Gully, Benjamin S.; Rossjohn, Jamie; Berry, Richard] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Deuss, Felix A.; Gully, Benjamin S.; Rossjohn, Jamie; Berry, Richard] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Deuss, Felix A.; Gully, Benjamin S.; Rossjohn, Jamie; Berry, Richard] Monash Univ, Australian Res Council, Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales	Monash University; Monash University; Monash University; Cardiff University	Rossjohn, J; Berry, R (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.; Rossjohn, J; Berry, R (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.; Rossjohn, J; Berry, R (corresponding author), Monash Univ, Australian Res Council, Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia.; Rossjohn, J (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales.	Jamie.rossjohn@monash.edu; Richard.berry@monash.edu	Rossjohn, Jamie/F-9032-2013	Rossjohn, Jamie/0000-0002-2020-7522; Deuss, Felix/0000-0002-0386-4336; Gully, Benjamin/0000-0002-8197-0871; berry, richard/0000-0001-7043-0469	Australian Research Council [FL160100049]; National Health and Medical Research Council of Australia [APP1109901]	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Supported by Australian Research Council Laureate Fellowship FL160100049. To whom correspondence may be addressed. Tel.: 61-3-9902-9236; Fax: 99054699; E-mail: Jamie.rossjohn@monash.edu. 3; Supported by Career Development Fellowship Grant APP1109901 from the National Health and Medical Research Council of Australia. To whom correspondence may be addressed. Tel.: 61-3-9902-9239; E-mail: Richard.berry@monash.edu.	Aguilar OA, 2017, CELL, V169, P58, DOI 10.1016/j.cell.2017.03.002; Andrews DM, 2012, NAT IMMUNOL, V13, P1171, DOI 10.1038/ni.2468; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Berry R, 2014, J BIOL CHEM, V289, P23753, DOI 10.1074/jbc.M114.584128; Berry R, 2014, IMMUNOL CELL BIOL, V92, P214, DOI 10.1038/icb.2013.100; Berry R, 2013, NAT IMMUNOL, V14, P699, DOI 10.1038/ni.2605; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Boyington JC, 2001, IMMUNOL REV, V181, P66, DOI 10.1034/j.1600-065X.2001.1810105.x; Brooks AG, 1997, J EXP MED, V185, P795, DOI 10.1084/jem.185.4.795; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Dam J, 2003, NAT IMMUNOL, V4, P1213, DOI 10.1038/ni1006; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Gromeier M, 2000, P NATL ACAD SCI USA, V97, P6803, DOI 10.1073/pnas.97.12.6803; Harrison OJ, 2012, NAT STRUCT MOL BIOL, V19, P906, DOI 10.1038/nsmb.2366; Hsu JL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004811; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Lazetic S, 1996, J IMMUNOL, V157, P4741; Liu J, 2012, J IMMUNOL, V188, P5511, DOI 10.4049/jimmunol.1200324; Liu S, 2013, CELL DEATH DIFFER, V20, P456, DOI 10.1038/cdd.2012.141; Long EO, 1997, IMMUNOL REV, V155, P135, DOI 10.1111/j.1600-065X.1997.tb00946.x; Martinet L, 2015, NAT REV IMMUNOL, V15, P243, DOI 10.1038/nri3799; Masson D, 2001, GUT, V49, P236, DOI 10.1136/gut.49.2.236; Matusali G, 2012, J VIROL, V86, P4496, DOI 10.1128/JVI.05788-11; Oshima T, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-60; Petrie EJ, 2008, J EXP MED, V205, P725, DOI 10.1084/jem.20072525; Saunders PM, 2015, IMMUNOL REV, V267, P148, DOI 10.1111/imr.12319; Seth S, 2007, BIOCHEM BIOPH RES CO, V364, P959, DOI 10.1016/j.bbrc.2007.10.102; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Stanietsky N, 2013, EUR J IMMUNOL, V43, P2138, DOI 10.1002/eji.201243072; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Stengel KF, 2012, P NATL ACAD SCI USA, V109, P5399, DOI 10.1073/pnas.1120606109; Sullivan LC, 2016, J BIOL CHEM, V291, P18740, DOI 10.1074/jbc.M116.737130; Tahara-Hanaoka S, 2004, INT IMMUNOL, V16, P533, DOI 10.1093/intimm/dxh059; Tomasec P, 2005, NAT IMMUNOL, V6, P181, DOI 10.1038/ni1156; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674	38	46	50	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11413	11422		10.1074/jbc.M117.786483	http://dx.doi.org/10.1074/jbc.M117.786483			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28515320	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000405119600024
J	Lara, P; Ojemalm, K; Reithinger, J; Holgado, A; Maojun, Y; Hammed, A; Mattle, D; Kim, H; Nilsson, I				Lara, Patricia; Ojemalm, Karin; Reithinger, Johannes; Holgado, Aurora; Maojun, You; Hammed, Abdessalem; Mattle, Daniel; Kim, Hyun; Nilsson, IngMarie			Refined topology model of the STT3/Stt3 protein subunit of the oligosaccharyltransferase complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; N-LINKED GLYCOSYLATION; TRANSMEMBRANE HELICES; BACTERIAL OLIGOSACCHARYLTRANSFERASE; TRANSLOCON COMPLEX; SEC61 TRANSLOCON; ESCHERICHIA-COLI; MOLECULAR CODE; P-GLYCOPROTEIN; STT3 SUBUNIT	The oligosaccharyltransferase complex, localized in the endoplasmic reticulum (ER) of eukaryotic cells, is responsible for the N-linked glycosylation of numerous protein substrates. The membrane protein STT3 is a highly conserved part of the oligosaccharyltransferase and likely contains the active site of the complex. However, understanding the catalytic determinants of this system has been challenging, in part because of a discrepancy in the structural topology of the bacterial versus eukaryotic proteins and incomplete information about the mechanism of membrane integration. Here, we use a glycosylation mapping approach to investigate these questions. We measured the membrane integration efficiency of the mouse STT3-A and yeast Stt3p transmembrane domains (TMDs) and report a refined topology of the N-terminal half of the mouse STT3-A. Our results show that most of the STT3 TMDs are well inserted into the ER membrane on their own or in the presence of the natural flanking residues. However, for the mouse STT3-A hydrophobic domains 4 and 6 and yeast Stt3p domains 2, 3a, 3c, and 6 we measured reduced insertion efficiency into the ER membrane. Furthermore, we mapped the first half of the STT3-A protein, finding two extra hydrophobic domains between the third and the fourthTMD. This result indicates that the eukaryotic STT3 has 13 transmembrane domains, consistent with the structure of the bacterial homolog of STT3 and setting the stage for future combined efforts to interrogate this fascinating system.	[Lara, Patricia; Ojemalm, Karin; Reithinger, Johannes; Holgado, Aurora; Maojun, You; Hammed, Abdessalem; Mattle, Daniel; Nilsson, IngMarie] Stockholm Univ, Dept Biochem & Biophys, Svante Arrhenius Vag 16C, SE-10691 Stockholm, Sweden; [Kim, Hyun] Seoul Natl Univ, Dept Biol Sci, Seoul 08826, South Korea	Stockholm University; Seoul National University (SNU)	Nilsson, I (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Svante Arrhenius Vag 16C, SE-10691 Stockholm, Sweden.	ingmarie@dbb.su.se		You, Maojun/0000-0001-6665-9068; Holgado, Aurora/0000-0001-6724-2758	Swedish Cancer Foundation [130624]; Swedish Foundation for International Cooperation in Research and Higher Education (STINT) [210/083(12), KU 2003-4674]; Swedish Strategic Foundation [A302:200, SB12-0026]; National Research Foundation of Korea [NRF-2016R1A2B2013459]; Promising-Pioneering Researcher Program through Seoul National University	Swedish Cancer Foundation; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Swedish Strategic Foundation; National Research Foundation of Korea(National Research Foundation of Korea); Promising-Pioneering Researcher Program through Seoul National University	This work was supported by grants from the Swedish Cancer Foundation (130624; to I. N. and Gunnar von Heijne), from the Swedish Foundation for International Cooperation in Research and Higher Education (STINT) (210/083(12) and KU 2003-4674; to I. N.), from the Swedish Strategic Foundation (A302:200 and SSF-Infection Biology 2012(SB12-0026); to I. N.), and from the National Research Foundation of Korea (NRF-2016R1A2B2013459) and Promising-Pioneering Researcher Program through Seoul National University (to H. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Anthony V, 2002, CURR PROTEIN PEPT SC, V3, P485, DOI 10.2174/1389203023380503; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021; Cherepanova NA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20946; Chi YH, 2010, COMP BIOCHEM PHYS B, V156, P40, DOI 10.1016/j.cbpb.2010.01.017; Cuviello F, 2015, FEBS LETT, V589, P3921, DOI 10.1016/j.febslet.2015.10.030; De Marothy MT, 2015, PROTEIN SCI, V24, P1057, DOI 10.1002/pro.2698; Devaraneni PK, 2011, CELL, V146, P134, DOI 10.1016/j.cell.2011.06.004; Enquist K, 2009, J MOL BIOL, V387, P1153, DOI 10.1016/j.jmb.2009.02.035; Gil GC, 2009, PROTEOMICS, V9, P2555, DOI 10.1002/pmic.200800775; Gilmore R, 2012, TRENDS BIOCHEM SCI, V37, P303, DOI 10.1016/j.tibs.2012.05.003; Hedin LE, 2010, J MOL BIOL, V396, P221, DOI 10.1016/j.jmb.2009.11.036; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hessa T, 2009, J MOL BIOL, V386, P1222, DOI 10.1016/j.jmb.2009.01.027; Hong GZ, 1996, GENOMICS, V31, P295, DOI 10.1006/geno.1996.0051; Igura M, 2011, J BIOL CHEM, V286, P13255, DOI 10.1074/jbc.M110.213900; Jaffee MB, 2011, BIOCHEMISTRY-US, V50, P7557, DOI 10.1021/bi201018d; JOHANSSON M, 1993, MOL GEN GENET, V239, P251, DOI 10.1007/BF00281625; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Khafizov K, 2010, BIOCHEMISTRY-US, V49, P10702, DOI 10.1021/bi101256x; Kim H, 2005, J BIOL CHEM, V280, P20261, DOI 10.1074/jbc.M412213200; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lundin C, 2008, P NATL ACAD SCI USA, V105, P15702, DOI 10.1073/pnas.0804842105; Martinez-Gil L, 2011, FEBS J, V278, P3846, DOI 10.1111/j.1742-4658.2011.08185.x; MILETICH JP, 1990, J BIOL CHEM, V265, P11397; Nilsson I, 2003, J CELL BIOL, V161, P715, DOI 10.1083/jcb.200301043; Nilsson I, 2002, FEBS LETT, V516, P106, DOI 10.1016/S0014-5793(02)02511-5; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Ojemalm K, 2012, MOL CELL, V45, P529, DOI 10.1016/j.molcel.2011.12.024; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Pitonzo D, 2006, BBA-BIOMEMBRANES, V1758, P976, DOI 10.1016/j.bbamem.2006.04.021; Pitonzo D, 2009, MOL BIOL CELL, V20, P685, DOI 10.1091/mbc.E08-09-0902; Reithinger JH, 2013, J BIOL CHEM, V288, P18058, DOI 10.1074/jbc.M113.473009; Sadlish H, 2004, J MEMBRANE BIOL, V202, P115, DOI 10.1007/s00232-004-0715-6; Sato C, 2000, J BIOCHEM-TOKYO, V127, P65, DOI 10.1093/oxfordjournals.jbchem.a022585; Sato Y, 2002, P NATL ACAD SCI USA, V99, P60, DOI 10.1073/pnas.012399799; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Stamm M, 2014, NUCLEIC ACIDS RES, V42, pW246, DOI 10.1093/nar/gku291; Stamm M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057731; Wacker M, 2006, P NATL ACAD SCI USA, V103, P7088, DOI 10.1073/pnas.0509207103; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Wanngren J, 2014, FEBS OPEN BIO, V4, P393, DOI 10.1016/j.fob.2014.04.006; Wilkinson BM, 2001, DEV CELL, V1, P401, DOI 10.1016/S1534-5807(01)00043-0; Yasuda D, 2015, FASEB J, V29, P2412, DOI 10.1096/fj.14-267096; YOSHIDA S, 1992, MOL GEN GENET, V231, P337, DOI 10.1007/BF00292700; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	49	5	5	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11349	11360		10.1074/jbc.M117.779421	http://dx.doi.org/10.1074/jbc.M117.779421			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28512128	hybrid, Green Published			2022-12-26	WOS:000405119600019
J	Niu, ZJ; Feng, Y; Mei, LY; Sun, J; Wang, XP; Wang, JC; Hu, ZM; Dong, YP; Chen, HS; He, CF; Liu, YL; Cai, XZ; Liu, XZ; Jiang, L				Niu, Zhijie; Feng, Yong; Mei, Lingyun; Sun, Jie; Wang, Xueping; Wang, Juncheng; Hu, Zhengmao; Dong, Yunpeng; Chen, Hongsheng; He, Chufeng; Liu, Yalan; Cai, Xinzhang; Liu, Xuezhong; Jiang, Lu			A novel frameshift mutation of SMPX causes a rare form of X-linked nonsyndromic hearing loss in a Chinese family	PLOS ONE			English	Article							DEAFNESS; PROTEIN	X-linked hearing impairment is the rarest form of genetic hearing loss (HL) and represents only a minor fraction of all cases. The aim of this study was to investigate the cause of X-linked inherited sensorineural HL in a four-generation Chinese family. A novel duplication variant (c. 217dupA, p. Ile73Asnfs* 5) in SMPX was identified by whole-exome sequencing. The frameshift mutation predicted to result in the premature truncation of the SMPX protein was co-segregated with the HL phenotype and was absent in 295 normal controls. Subpopulation screening of the coding exons and flanking introns of SMPX was further performed for 338 Chinese patients with nonsydromic HL by Sanger sequencing, and another two potential causative substitutions (c. 238C>A and c. 55A>G) in SMPX were identified in additional sporadic cases of congenital deafness. Collectively, this study is the first to report the role of SMPX in Chinese population and identify a novel frameshift mutation in SMPX that causes not only nonsyndromic late-onset progressive HL, but also congenital hearing impairment. Our findings extend the mutation and phenotypic spectrum of the SMPX gene.	[Niu, Zhijie; Feng, Yong; Mei, Lingyun; Sun, Jie; Wang, Xueping; Wang, Juncheng; Chen, Hongsheng; He, Chufeng; Liu, Yalan; Cai, Xinzhang; Liu, Xuezhong; Jiang, Lu] Cent South Univ, Xiangya Hosp, Dept Otolaryngol Head & Neck Surg, Changsha, Hunan, Peoples R China; [Niu, Zhijie; Feng, Yong; Mei, Lingyun; Sun, Jie; Wang, Xueping; Wang, Juncheng; Chen, Hongsheng; He, Chufeng; Liu, Yalan; Cai, Xinzhang; Jiang, Lu] Key Lab Otolaryngol Major Dis Res Hunan Prov, Changsha, Hunan, Peoples R China; [Niu, Zhijie; Dong, Yunpeng; Liu, Xuezhong] Univ Miami, Miller Sch Med, Dept Otolaryngol D 48, Miami, FL 33136 USA; [Feng, Yong; Hu, Zhengmao] Cent South Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China	Central South University; University of Miami; Central South University	Jiang, L (corresponding author), Cent South Univ, Xiangya Hosp, Dept Otolaryngol Head & Neck Surg, Changsha, Hunan, Peoples R China.; Jiang, L (corresponding author), Key Lab Otolaryngol Major Dis Res Hunan Prov, Changsha, Hunan, Peoples R China.	44496635@QQ.com	Niu, Zhijie/GRS-2684-2022; CAI, XINZHANG/GQZ-3111-2022	Feng, Yong/0000-0003-3824-3780; CAI, XINZHANG/0000-0003-3211-7521; Chen, Hongsheng/0000-0002-1373-6434	National 973 Basic Research Program of China [2014CB541702, 2014CB943003]; National Natural Science Foundation of China [81500803, 81470705, 81300833]; Science and Technology Projects in Hunan Province [13JJ4023]	National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Projects in Hunan Province	This work was supported by the National 973 Basic Research Program of China (Grant Nos. 2014CB541702 and 2014CB943003); National Natural Science Foundation of China (Grant Nos. 81500803, 81470705, and 81300833); and Science and Technology Projects in Hunan Province (Grant No. 13JJ4023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelfatah N, 2013, HUM MUTAT, V34, P66, DOI 10.1002/humu.22205; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Cediel R, 2006, EUR J NEUROSCI, V23, P587, DOI 10.1111/j.1460-9568.2005.04584.x; Dobyns WB, 2006, ACTA PAEDIATR, V95, P11, DOI 10.1080/08035320600618759; Dror AA, 2010, NEURON, V68, P293, DOI 10.1016/j.neuron.2010.10.011; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Evans AL, 2000, NAT GENET, V24, P424, DOI 10.1038/74286; Grimsley-Myers CM, 2009, J NEUROSCI, V29, P15859, DOI 10.1523/JNEUROSCI.3998-09.2009; Huebner AK, 2011, AM J HUM GENET, V88, P621, DOI 10.1016/j.ajhg.2011.04.007; Lin X, 2012, HEARING RES, V288, P67, DOI 10.1016/j.heares.2012.01.004; Palmer S, 2001, J CELL BIOL, V153, P985, DOI 10.1083/jcb.153.5.985; Patzak D, 1999, HUM GENET, V105, P506, DOI 10.1007/s004390051138; Petersen MB, 2008, CLIN GENET, V73, P14, DOI 10.1111/j.1399-0004.2007.00913.x; Richardson GP, 2011, ANNU REV PHYSIOL, V73, P311, DOI 10.1146/annurev-physiol-012110-142228; Schraders M, 2011, AM J HUM GENET, V88, P628, DOI 10.1016/j.ajhg.2011.04.012; Shearer AE, 2013, J MED GENET, V50, P627, DOI 10.1136/jmedgenet-2013-101749	16	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178384	10.1371/journal.pone.0178384	http://dx.doi.org/10.1371/journal.pone.0178384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542515	Green Submitted, Green Published, gold			2022-12-26	WOS:000402062800084
J	Masunaga, H; Sugimoto, Y; Magi, S; Itasaki, R; Okada-Hatakeyama, M; Kurata, H				Masunaga, Hiroyuki; Sugimoto, Yurie; Magi, Shigeyuki; Itasaki, Ryunosuke; Okada-Hatakeyama, Mariko; Kurata, Hiroyuki			Robustness analysis of the detailed kinetic model of an ErbB signaling network by using dynamic sensitivity	PLOS ONE			English	Article							SINGLE-MOLECULE ANALYSIS; SYSTEMS-BIOLOGY; BIOCHEMICAL NETWORKS; GROWTH; HEREGULIN; TOOLBOX; SURFACE; MATLAB	The ErbB receptor signaling pathway plays an important role in the regulation of cellular proliferation, survival and differentiation, and dysregulation of the pathway is linked to various types of human cancer. Mathematical models have been developed as a practical complementary approach to deciphering the complexity of ErbB receptor signaling and elucidating how the pathways discriminate between ligands to induce different cell fates. In this study, we developed a simulator to accurately calculate the dynamic sensitivity of extracellular-signal-regulated kinase (ERK) activity (ERK*) and Akt activity (Akt*), downstream of the ErbB receptors stimulated with epidermal growth factor (EGF) and heregulin (HRG). To demonstrate the feasibility of this simulator, we estimated how the reactions critically responsible for ERK* and Akt* change with time and in response to different doses of EGF and HRG, and predicted that only a small number of reactions determine ERK* and Akt*. ERK* increased steeply with increasing HRG dose until saturation, while showing a gently rising response to EGF. Akt* had a gradual wide-range response to HRG and a blunt response to EGF. Akt* was sensitive to perturbations of intracellular kinetics, while ERK* was more robust due to multiple, negative feedback loops. Overall, the simulator predicted reactions that were critically responsible for ERK* and Akt* in response to the dose of EGF and HRG, illustrated the response characteristics of ERK* and Akt*, and estimated mechanisms for generating robustness in the ErbB signaling network.	[Masunaga, Hiroyuki; Sugimoto, Yurie; Itasaki, Ryunosuke; Kurata, Hiroyuki] Kyushu Inst Technol, Dept Biosci & Bioinformat, Fukuoka, Japan; [Magi, Shigeyuki; Okada-Hatakeyama, Mariko] RIKEN, Ctr Integrat Med Sci IMS, Lab Integrated Cellular Syst, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Okada-Hatakeyama, Mariko] Osaka Univ, Inst Prot Res, Lab Cell Syst, Suita, Osaka, Japan; [Kurata, Hiroyuki] Kyushu Inst Technol, Biomed Informat R&D Ctr, Fukuoka, Japan	Kyushu Institute of Technology; RIKEN; Osaka University; Kyushu Institute of Technology	Kurata, H (corresponding author), Kyushu Inst Technol, Dept Biosci & Bioinformat, Fukuoka, Japan.; Kurata, H (corresponding author), Kyushu Inst Technol, Biomed Informat R&D Ctr, Fukuoka, Japan.	kurata@bio.kyutech.ac.jp			Japan Society for the Promotion of Science [25280107]; Ministry of Education, Culture, Sports, Science and Technology of Japan [26119716]; JSPS KAKENHI [15KT0084]; RIKEN Epigenome and Single Cell Project	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); RIKEN Epigenome and Single Cell Project	This work was supported by Grant-in-Aid for Scientific Research (B) (25280107) from Japan Society for the Promotion of Science and Grant-in-Aid for Scientific Research on Innovative Areas (26119716) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to HK and JSPS KAKENHI Grant No. 15KT0084 and RIKEN Epigenome and Single Cell Project Grants to MOH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Kazuhiro Maeda for trouble shooting computational problems. This work was, in part, supported by JSPS KAKENHI Grant No.15KT0084 and RIKEN Epigenome and Single Cell Project Grants to MO-H.	Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Blinov ML, 2006, BIOSYSTEMS, V83, P136, DOI 10.1016/j.biosystems.2005.06.014; Chaouiya C, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-135; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; DICKINSON RP, 1976, J COMPUT PHYS, V21, P123, DOI 10.1016/0021-9991(76)90007-3; Hatakeyama M, 2003, BIOCHEM J, V373, P451, DOI 10.1042/BJ20021824; Hendriks BS, 2003, J BIOL CHEM, V278, P23343, DOI 10.1074/jbc.M300477200; Hiroshima M, 2012, P NATL ACAD SCI USA, V109, P13984, DOI 10.1073/pnas.1200464109; Inoue K, 2014, BIOPROC BIOSYST ENG, V37, P1925, DOI 10.1007/s00449-014-1167-8; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kurata H, 2005, GENOME RES, V15, P590, DOI 10.1101/gr.3463705; Kurata H, 2006, PLOS COMPUT BIOL, V2, P663, DOI 10.1371/journal.pcbi.0020059; Maeda K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030489; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; Resat H, 2003, BIOPHYS J, V85, P730, DOI 10.1016/S0006-3495(03)74516-0; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Schmidt H, 2007, BIOINFORMATICS, V23, P646, DOI 10.1093/bioinformatics/btl668; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Shankaran H, 2006, BIOPHYS J, V90, P3993, DOI 10.1529/biophysj.105.080580; Teramura Y, 2006, EMBO J, V25, P4215, DOI 10.1038/sj.emboj.7601308; Thottassery JV, 2004, CANCER RES, V64, P4637, DOI 10.1158/0008-5472.CAN-03-2645; Wu WH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S17; Zi Z, 2011, IET SYST BIOL, V5, P336, DOI 10.1049/iet-syb.2011.0015	23	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178250	10.1371/journal.pone.0178250	http://dx.doi.org/10.1371/journal.pone.0178250			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542548	gold, Green Published, Green Submitted			2022-12-26	WOS:000402061500077
J	Peach, T; Pollock, K; van der Wardt, V; das Nair, R; Logan, P; Harwood, RH				Peach, Tamsin; Pollock, Kristian; van der Wardt, Veronika; das Nair, Roshan; Logan, Pip; Harwood, Rowan H.			Attitudes of older people with mild dementia and mild cognitive impairment and their relatives about falls risk and prevention: A qualitative study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ADULTS; EXERCISE; INTERVENTIONS; METAANALYSIS; COMMUNITY; VIEWS; AGE; CAREGIVERS; TRIAL	Objective To explore the perceptions of older people with mild dementia and mild cognitive impairment, and their family carers, about falling, falls risk and the acceptability of falls prevention interventions. Design Qualitative study involving thematic analysis of semi-structured interviews with patient and relative dyads. Participants and setting 20 patient/relative dyads recruited from Memory Assessment Services and Falls Prevention Services in the United Kingdom. Results The findings are presented under four key themes: attitudes to falls, attitudes to falls prevention interventions, barriers and facilitators, and the role of relatives. Participants' attitudes to falls interventions were varied and sometimes conflicting. Some worried about falls, but many resisted identifying themselves as potential `fallers', even despite having fallen, and rejected the idea of needing the help that structured interventions signify. Participants preferred to focus on coping in the present rather than anticipating, and preparing for, an uncertain future. Falls prevention interventions were acknowledged to be valuable in principle and if required in the future but often felt to be not necessary or appropriate at present. Conclusions This study of how persons with cognitive impairment, and their relatives, view falls risk and prevention mirror findings relating to the wider population of older persons without dementia. Participants did not generally see falls prevention interventions as currently relevant to themselves. The challenge for clinicians is how to present interventions with understanding and respect for the older person's identity. They must identify and address goals that patients and relatives value. Simplistic or paternalistic approaches will likely fail. Individualised interventions which focus on maintaining independence and preserving quality of life are more likely to be acceptable by supporting a positive self-image for patients and their relatives.	[Peach, Tamsin] Nottingham CityCare Partnership, Nottingham, England; [Pollock, Kristian] Univ Nottingham, Sch Hlth Sci, Queens Med Ctr, Nottingham, England; [van der Wardt, Veronika; Logan, Pip; Harwood, Rowan H.] Univ Nottingham, Sch Med, Div Rehabil & Ageing, Nottingham, England; [das Nair, Roshan] Univ Nottingham, Sch Med, Div Psychiat & Appl Psychol, Nottingham, England; [Harwood, Rowan H.] Nottingham Univ Hosp NHS Trust, Hlth Care Older People, Nottingham, England	University of Nottingham; University of Nottingham; University of Nottingham; Nottingham University Hospital NHS Trust	Pollock, K (corresponding author), Univ Nottingham, Sch Hlth Sci, Queens Med Ctr, Nottingham, England.	kitstian.pollock@nottingham.ac.uk	Pollock, Kristian/B-9734-2008; van der Wardt, Veronika/ABF-3836-2021	Pollock, Kristian/0000-0002-6836-8595; van der Wardt, Veronika/0000-0003-3995-7056; das Nair, Roshan/0000-0001-8143-7893; Harwood, Rowan/0000-0002-4920-6718; Logan, Philippa/0000-0002-6657-2381	National Institute for Health Research (NIHR) under its Programme Development Grant Programme [RP-DG-0611-10013]; National Institute for Health Research [RP-PG-0614-20007, RP-DG-0611-10013] Funding Source: researchfish	National Institute for Health Research (NIHR) under its Programme Development Grant Programme; National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Development Grant Programme (Reference Number RP-DG-0611-10013), https://www.nihr.ac.uk/funding-and-support/. Principal Investigator: Rowan Harwood. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005521; Bazeley P., 2013, QUALITATIVE DATA ANA, V2nd; Beuscher L, 2009, RES GERONTOL NURS, V2, P6, DOI 10.3928/19404921-20090101-04; Blankevoort CG, 2010, DEMENT GERIATR COGN, V30, P392, DOI 10.1159/000321357; Burt RS, 2005, BROKERAGE CLOSURE IN; Burton E, 2013, PREV MED, V57, P824; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Cornwell J., 1985, HARD EARNED LIVES AC; Cox KL, 2013, PREV MED, V57, P824, DOI 10.1016/j.ypmed.2013.09.010; de Witt L, 2010, J ADV NURS, V66, P1698, DOI 10.1111/j.1365-2648.2010.05295.x; Delbaere K, 2012, AM J GERIAT PSYCHIAT, V20, P845, DOI 10.1097/JGP.0b013e31824afbc4; Dickinson A, 2011, AGE AGEING, V40, P724, DOI 10.1093/ageing/afr111; Dickinson Angela, 2011, Br J Community Nurs, V16, P174; Dollard J, 2012, J CLIN NURS, V21, P2617, DOI 10.1111/j.1365-2702.2011.03990.x; Ellingson T, 2000, J Gerontol Nurs, V26, P17; Faes MC, 2010, AGING MENT HEALTH, V14, P834, DOI 10.1080/13607861003781825; Fairhall N, 2011, AGE AGEING, V40, P666, DOI 10.1093/ageing/afr077; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Harlein J, 2009, J ADV NURS, V65, P922, DOI 10.1111/j.1365-2648.2008.04950.x; Hanson HM, 2009, DISABIL HEALTH J, V2, P36, DOI 10.1016/j.dhjo.2008.11.001; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Hill AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063450; Horne M, 2014, CLIN NURS RES, V23, P94, DOI 10.1177/1054773813488938; Kearney FC, 2013, DEMENT GERIATR COGN, V36, P20, DOI 10.1159/000350031; Knapp M, 2007, DEMENTIA UK; Kuzuya M, 2006, INT J GERIATR PSYCH, V21, P740, DOI 10.1002/gps.1554; Logsdon RG, 2009, GERONTOLOGIST, V49, DOI 10.1093/geront/gnp082; Malthouse R, 2014, PHYSIOTHERAPY, V100, P169, DOI 10.1016/j.physio.2013.10.002; Matthews F, 2005, PLOS MED, V2, P753, DOI 10.1371/journal.pmed.0020193; Mcintyre A, 2012, AGEING SOC, V32, P873, DOI 10.1017/S0144686X11000699; Meyer C, 2015, GERONTOLOGIST, V55, P560, DOI 10.1093/geront/gnt127; Muir SW, 2012, AGE AGEING, V41, P299, DOI 10.1093/ageing/afs012; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; NICE,, 2013, FALLS OLD PEOPL ASS; Nicholson C, 2012, SOC SCI MED, V75, P1426, DOI 10.1016/j.socscimed.2012.06.011; Nyman SR, 2012, AGE AGEING, V41, P16, DOI 10.1093/ageing/afr103; Olsson Roy H Jr, 2005, J Gerontol Nurs, V31, P45; Robertson MC, 2001, BRIT MED J, V322, P701, DOI 10.1136/bmj.322.7288.701; Rothman AJ, 1997, PSYCHOL BULL, V121, P3, DOI 10.1037/0033-2909.121.1.3; Royal College of Physicians, 2011, REP NAT AUD FALLS BO; Shaw FE, 2007, J NEURAL TRANSM, V114, P1259, DOI 10.1007/s00702-007-0741-5; Taylor JS, 2012, J AM GERIATR SOC, V60, P413, DOI 10.1111/j.1532-5415.2011.03847.x; Teixeira PJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-78; Vogel DL, 2009, PSYCHOLOGIST, V22, P20; Walker Wendy, 2011, Nurs Older People, V23, P21; Weiss D, 2012, PSYCHOL AGING, V27, P173, DOI 10.1037/a0024819; WHO, 2007, WHO GLOB REP FALLP; Womens Royal Voluntary Service, 2012, FALLS MEAS IMP OLD P; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yardley L, 2006, HEALTH EDUC RES, V21, P508, DOI 10.1093/her/cyh077; Yardley L, 2006, GERONTOLOGIST, V46, P650, DOI 10.1093/geront/46.5.650	52	17	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177530	10.1371/journal.pone.0177530	http://dx.doi.org/10.1371/journal.pone.0177530			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PW	28542315	Green Submitted, gold, Green Published			2022-12-26	WOS:000401672600014
J	Liao, PC; Tandarich, LC; Hollenbeck, PJ				Liao, Pin-Chao; Tandarich, Lauren C.; Hollenbeck, Peter J.			ROS regulation of axonal mitochondrial transport is mediated by Ca2+ and JNK in Drosophila	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; OXIDATIVE STRESS; REACTIVE OXYGEN; SCAFFOLD PROTEIN; NOX ENZYMES; CALCIUM; MOTOR; ACTIVATION; APOPTOSIS; CHANNEL	Mitochondria perform critical functions including aerobic ATP production and calcium (Ca2+) homeostasis, but are also a major source of reactive oxygen species (ROS) production. To maintain cellular function and survival in neurons, mitochondria are transported along axons, and accumulate in regions with high demand for their functions. Oxidative stress and abnormal mitochondrial axonal transport are associated with neurodegenerative disorders. However, we know little about the connection between these two. Using the Drosophila third instar larval nervous system as the in vivo model, we found that ROS inhibited mitochondrial axonal transport more specifically, primarily due to reduced flux and velocity, but did not affect transport of other organelles. To understand the mechanisms underlying these effects, we examined Ca2+ levels and the JNK (c-Jun N-terminal Kinase) pathway, which have been shown to regulate mitochondrial transport and general fast axonal transport, respectively. We found that elevated ROS increased Ca2+ levels, and that experimental reduction of Ca2+ to physiological levels rescued ROS-induced defects in mitochondrial transport in primary neuron cell cultures. In addition, in vivo activation of the JNK pathway reduced mitochondrial flux and velocities, while JNK knockdown partially rescued ROS-induced defects in the anterograde direction. We conclude that ROS have the capacity to regulate mitochondrial traffic, and that Ca2+ and JNK signaling play roles in mediating these effects. In addition to transport defects, ROS produces imbalances in mitochondrial fission-fusion and metabolic state, indicating that mitochondrial transport, fission-fusion steady state, and metabolic state are closely interrelated in the response to ROS.	[Liao, Pin-Chao; Tandarich, Lauren C.; Hollenbeck, Peter J.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hollenbeck, PJ (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	phollenb@purdue.edu	Liao, Pin-chao/Z-2825-2019	Liao, Pin-Chao/0000-0002-1969-5565	National Institutes of Health; National Institute of Neurological Disorders and Stroke [5 R01 NS027073]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health, National Institute of Neurological Disorders and Stroke grant: 5 R01 NS027073. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva AV, 2008, FASEB J, V22, P2821, DOI 10.1096/fj.07-104224; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Barkus RV, 2008, MOL BIOL CELL, V19, P274, DOI 10.1091/mbc.E07-03-0261; Bhat AH, 2015, BIOMED PHARMACOTHER, V74, P101, DOI 10.1016/j.biopha.2015.07.025; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Chen S, 2007, MOL CELL NEUROSCI, V36, P472, DOI 10.1016/j.mcn.2007.08.004; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen YM, 2013, J CELL BIOL, V202, P351, DOI 10.1083/jcb.201302040; Court FA, 2012, TRENDS NEUROSCI, V35, P364, DOI 10.1016/j.tins.2012.04.001; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Devireddy S, 2015, J NEUROSCI, V35, P9391, DOI 10.1523/JNEUROSCI.1198-15.2015; Devireddy S, 2014, METHOD ENZYMOL, V547, P131, DOI 10.1016/B978-0-12-801415-8.00008-4; Elia AJ, 1999, FREE RADICAL BIO MED, V26, P1332, DOI 10.1016/S0891-5849(98)00333-5; Fan XY, 2010, FREE RADICAL BIO MED, V49, P1646, DOI 10.1016/j.freeradbiomed.2010.08.024; Fang C, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-29; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; Fischer LR, 2010, ACTA NEUROPATHOL, V119, P249, DOI 10.1007/s00401-009-0631-z; Frank M, 2012, BBA-MOL CELL RES, V1823, P2297, DOI 10.1016/j.bbamcr.2012.08.007; Genova ML, 2015, ANTIOXID REDOX SIGN, V23, P208, DOI 10.1089/ars.2014.6214; Gleichmann M, 2011, ANTIOXID REDOX SIGN, V14, P1261, DOI 10.1089/ars.2010.3386; Gorlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010; Grupe M, 2010, CELL CALCIUM, V48, P1, DOI 10.1016/j.ceca.2010.05.005; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hidalgo C, 2008, ANTIOXID REDOX SIGN, V10, P1275, DOI 10.1089/ars.2007.1886; Horiuchi D, 2005, CURR BIOL, V15, P2137, DOI 10.1016/j.cub.2005.10.047; Huang Y, 2014, MOL CELL BIOCHEM, V394, P1, DOI 10.1007/s11010-014-2073-8; Hudasek K, 2004, BIOCHEM BIOPH RES CO, V318, P135, DOI 10.1016/j.bbrc.2004.04.011; Jendrach M, 2008, MITOCHONDRION, V8, P293, DOI 10.1016/j.mito.2008.06.001; Kim J, 2004, TOXICOL SCI, V81, P518, DOI 10.1093/toxsci/kfh221; Kim-Han JS, 2011, J NEUROSCI, V31, P7212, DOI 10.1523/JNEUROSCI.0711-11.2011; Lambeth JD, 2014, ANNU REV PATHOL-MECH, V9, P119, DOI 10.1146/annurev-pathol-012513-104651; Lee KS, 2009, J BIOL CHEM, V284, P29454, DOI 10.1074/jbc.M109.028027; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010; Misko AL, 2012, J NEUROSCI, V32, P4145, DOI 10.1523/JNEUROSCI.6338-11.2012; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Nagao M, 1999, ONCOGENE, V18, P4425, DOI 10.1038/sj.onc.1202832; Nayernia Z, 2014, ANTIOXID REDOX SIGN, V20, P2815, DOI 10.1089/ars.2013.5703; Nguyen TT, 2014, P NATL ACAD SCI USA, V111, pE3631, DOI 10.1073/pnas.1402449111; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Sato T, 2015, CELL DEATH DIFFER, V22, P1260, DOI 10.1038/cdd.2014.207; Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Shidara Y, 2010, J NEUROSCI, V30, P11369, DOI 10.1523/JNEUROSCI.0529-10.2010; Shin JE, 2012, P NATL ACAD SCI USA, V109, pE3696, DOI 10.1073/pnas.1216204109; Son Y, 2013, METHOD ENZYMOL, V528, P27, DOI 10.1016/B978-0-12-405881-1.00002-1; Song W, 2012, NEUROBIOL DIS; Stephen TL, 2015, J NEUROSCI, V35, P15996, DOI 10.1523/JNEUROSCI.2068-15.2015; Tabet F, 2004, J CARDIOVASC PHARM, V44, P200, DOI 10.1097/00005344-200408000-00009; Taru H, 2002, J BIOL CHEM, V277, P20070, DOI 10.1074/jbc.M108372200; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Verburg J, 2008, J NEUROSCI, V28, P8306, DOI 10.1523/JNEUROSCI.2614-08.2008; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Whitmarsh AJ, 2001, GENE DEV, V15, P2421, DOI 10.1101/gad.922801; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Yu YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18981; Zhang YY, 2015, BIOCHEM BIOPH RES CO, V456, P926, DOI 10.1016/j.bbrc.2014.12.036	66	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178105	10.1371/journal.pone.0178105	http://dx.doi.org/10.1371/journal.pone.0178105			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542430	Green Submitted, Green Published, gold			2022-12-26	WOS:000401672400142
J	Lowgren, K; Baath, R; Rasmussen, A; Boele, HJ; Koekkoek, SKE; De Zeeuw, CI; Hesslow, G				Lowgren, Karolina; Baath, Rasmus; Rasmussen, Anders; Boele, Henk-Jan; Koekkoek, Sebastiaan K. E.; De Zeeuw, Chris I.; Hesslow, Germund			Performance in eyeblink conditioning is age and sex dependent	PLOS ONE			English	Article							CEREBELLAR CORTEX; CHILDREN; DELAY; TRACE; LANGUAGE; ACQUISITION; INVOLVEMENT; ONTOGENY; PARALLEL; LESIONS	A growing body of evidence suggests that the cerebellum is involved in both cognition and language. Abnormal cerebellar development may contribute to neurodevelopmental disorders such as attention deficit hyperactivity disorder (ADHD), autism, fetal alcohol syndrome, dyslexia, and specific language impairment. Performance in eyeblink conditioning, which depends on the cerebellum, can potentially be used to clarify the neural mechanisms underlying the cerebellar dysfunction in disorders like these. However, we must first understand how the performance develops in children who do not have a disorder. In this study we assessed the performance in eyeblink conditioning in 42 typically developing children between 6 and 11 years old as well as in 26 adults. Older children produced more conditioned eyeblink responses than younger children and adults produced more than children. In addition, females produced more conditioned eyeblink responses than males among both children and adults. These results highlight the importance of considering the influence of age and sex on the performance when studying eyeblink conditioning as a measure of cerebellar development.	[Lowgren, Karolina] Lund Univ, Dept Clin Sci, Lund, Sweden; [Baath, Rasmus] Lund Univ, Dept Philosophy, Cognit Sci, Lund, Sweden; [Rasmussen, Anders; Boele, Henk-Jan; Koekkoek, Sebastiaan K. E.; De Zeeuw, Chris I.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [De Zeeuw, Chris I.] Royal Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Hesslow, Germund] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University; Lund University; Erasmus University Rotterdam; Erasmus MC; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Lund University	Lowgren, K (corresponding author), Lund Univ, Dept Clin Sci, Lund, Sweden.	karolina.lowgren@med.lu.se	Boele, Henk-Jan/AAI-7261-2021; Rasmussen, Anders/D-6157-2014; Boele, Henk-Jan/AAK-3836-2021	Boele, Henk-Jan/0000-0001-8449-4391; Rasmussen, Anders/0000-0003-4477-369X; Lowgren, Karolina/0000-0002-2791-8239	Swedish Research Council [349-2007-8695, 09899, 201500276]; Soderberg; Krapperup; Ahlen foundations; European Research Council (ERC-adv); Dutch Council for Medical Research; Fundamental Research; EMBO [ALTF 88-2015]; European commission [GA-2013-609409]; Marie-Curie Actions	Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderberg; Krapperup; Ahlen foundations; European Research Council (ERC-adv); Dutch Council for Medical Research; Fundamental Research; EMBO(European Molecular Biology Organization (EMBO)); European commission(European CommissionEuropean Commission Joint Research Centre); Marie-Curie Actions(European Commission)	We gratefully acknowledge the support from the Linnaeus centre Thinking in Time: Cognition, Communication and Learning at Lund University, financed by the Swedish Research Council (grant no. 349-2007-8695) (https.//www.vr.se/). G. Hesslow was supported by grants from the Soderberg, Krapperup and Ahlen foundations, and the Swedish Research Council (09899). C. De Zeeuw was supported by grants from the European Research Council (ERC-adv), Dutch Council for Medical Research (ZonMw), and Fundamental Research (NWO-MaGW and NWO-ALW). A. Rasmussen was supported by grants from the EMBO (ALTF 88-2015), the European commission (LTFCOFUND2013, GA-2013-609409), Marie-Curie Actions, and the Swedish Research Council (201500276). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton RA, 2014, CURR BIOL, V24, P2440, DOI 10.1016/j.cub.2014.08.056; Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159; Cheng DT, 2014, HUM BRAIN MAPP, V35, P1390, DOI 10.1002/hbm.22261; Coffin JM, 2005, CORTEX, V41, P389, DOI 10.1016/S0010-9452(08)70275-2; Dalla C, 2009, PHYSIOL BEHAV, V97, P229, DOI 10.1016/j.physbeh.2009.02.035; DAUM I, 1993, BEHAV NEUROSCI, V107, P748, DOI 10.1037/0735-7044.107.5.748; Davies W, 2006, BRAIN RES, V1126, P36, DOI 10.1016/j.brainres.2006.09.105; De Smet HJ, 2007, FOLIA PHONIATR LOGO, V59, P165, DOI 10.1159/000102927; Desmond JE, 1998, TRENDS COGN SCI, V2, P355, DOI 10.1016/S1364-6613(98)01211-X; Dimitrova A, 2008, BRAIN RES, V1198, P73, DOI 10.1016/j.brainres.2008.01.034; Durston S., 2002, DEV DISABIL RES REV, V9, P184; Fatemi SH, 2013, CEREBELLUM, V12, P778, DOI 10.1007/s12311-013-0484-9; FINKBINER RG, 1991, PSYCHOL AGING, V6, P109, DOI 10.1037/0882-7974.6.1.109; Flatters I, 2014, PLOS ONE, V9, P1; Frings M, 2010, EXP BRAIN RES, V201, P167, DOI 10.1007/s00221-009-2020-1; Giedd JN, 2009, J AM ACAD CHILD PSY, V48, P465, DOI 10.1097/CHI.0b013e31819f2715; Green JT, 2002, LEARN MEMORY, V9, P304, DOI 10.1101/lm.47602; Haar S, 2014, CEREB CORTEX; Hardiman MJ, 2013, BRAIN LANG, V127, P428, DOI 10.1016/j.bandl.2013.08.001; Herbert JS, 2003, BEHAV NEUROSCI, V117, P1196, DOI 10.1037/0735-7044.117.6.1196; Hesslow Germund, 2002, P86; Highnam CL, 2011, AM J SPEECH-LANG PAT, V20, P337, DOI 10.1044/1058-0360(2011/10-0096); Hodes GE, 2005, HORM BEHAV, V48, P163, DOI 10.1016/j.yhbeh.2005.02.008; Hodge SM, 2010, J AUTISM DEV DISORD, V40, P300, DOI 10.1007/s10803-009-0872-7; Ivkovich D, 2000, DEV PSYCHOBIOL, V36, P148, DOI 10.1002/(SICI)1098-2302(200003)36:2<148::AID-DEV6>3.0.CO;2-L; Ivry R B, 1992, Curr Opin Neurobiol, V2, P212, DOI 10.1016/0959-4388(92)90015-D; Jacobson SW, 2008, ALCOHOL CLIN EXP RES, V32, P365, DOI 10.1111/j.1530-0277.2007.00585.x; Jacobson SW, 2011, ALCOHOL CLIN EXP RES, V35, P250, DOI 10.1111/j.1530-0277.2010.01341.x; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Koekkoek SKE, 2002, J NEUROPHYSIOL, V88, P2124, DOI 10.1152/jn.2002.88.4.2124; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; MCCORMICK DA, 1982, P NATL ACAD SCI-BIOL, V79, P2731, DOI 10.1073/pnas.79.8.2731; Nanova P, 2008, CLIN NEUROPHYSIOL, V119, P1992, DOI 10.1016/j.clinph.2008.05.002; Nicolson RI, 2002, EXP BRAIN RES, V143, P42, DOI 10.1007/s00221-001-0969-5; Oristaglio J, 2013, NEUROSCIENCE, V248, P708, DOI 10.1016/j.neuroscience.2013.06.007; Paquier PF, 2005, APHASIOLOGY, V19, P3, DOI 10.1080/02687030444000615; Parker KL, 2012, CEREBELLUM, V11, P946, DOI 10.1007/s12311-012-0377-3; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Radell M, 2014, COGN AFFECT BEHAV NE, V14, P1142, DOI 10.3758/s13415-014-0263-1; Ramtekkar UP, 2010, J AM ACAD CHILD PSY, V49, P217, DOI 10.1016/j.jaac.2009.11.011; Raven J., 2008, MANUAL FOR COLOURED; Reeb-Sutherland BC, 2015, J AUTISM DEV DISORD, V45, P376, DOI 10.1007/s10803-013-1905-9; Ross LA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00185; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; SEARS LL, 1994, J AUTISM DEV DISORD, V24, P737, DOI 10.1007/BF02172283; SOLOMON PR, 1989, PSYCHOL AGING, V4, P34, DOI 10.1037/0882-7974.4.1.34; Steinmetz AB, 2010, J NEURODEV DISORD, V2, P243, DOI 10.1007/s11689-010-9058-z; Steinmetz JE, 2000, BEHAV BRAIN RES, V110, P13, DOI 10.1016/S0166-4328(99)00181-3; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Stoodley CJ, 2013, CEREBELLUM, V12, P267, DOI 10.1007/s12311-012-0407-1; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Sugiyama T, 2008, INT J PSYCHOPHYSIOL, V69, P232, DOI 10.1016/j.ijpsycho.2008.05.094; Thurling M, 2015, J NEUROSCI, V35, P1228, DOI 10.1523/JNEUROSCI.2492-14.2015; Timmann D, 2005, EXP BRAIN RES, V162, P332, DOI 10.1007/s00221-004-2181-x; Wang SSH, 2014, NEURON, V83, P518, DOI 10.1016/j.neuron.2014.07.016; Werling DM, 2013, CURR OPIN NEUROL, V26, P146, DOI 10.1097/WCO.0b013e32835ee548; Wolf OT, 2009, NEUROBIOL LEARN MEM, V91, P431, DOI 10.1016/j.nlm.2008.11.002; WOODRUFFPAK DS, 1988, PSYCHOL AGING, V3, P219, DOI 10.1037/0882-7974.3.3.219; WOODRUFFPAK DS, 1988, NEUROBIOL AGING, V9, P511, DOI 10.1016/S0197-4580(88)80108-8; Wu KH, 2011, PEDIATR RES, V69, P80, DOI 10.1203/PDR.0b013e3181ff2f6c; Yeo CH, 1998, TRENDS COGN SCI, V2, P322, DOI 10.1016/S1364-6613(98)01219-4; YEO CH, 1984, BEHAV BRAIN RES, V13, P261, DOI 10.1016/0166-4328(84)90168-2	64	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177849	10.1371/journal.pone.0177849	http://dx.doi.org/10.1371/journal.pone.0177849			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542383	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400100
J	Tang, XJ; Zhao, S; Chiu, APY; Ma, HW; Xie, X; Mei, SJ; Kong, DF; Qin, YM; Chen, ZG; Wang, X; He, DH				Tang, Xiujuan; Zhao, Shi; Chiu, Alice P. Y.; Ma, Hanwu; Xie, Xu; Mei, Shujiang; Kong, Dongfeng; Qin, Yanmin; Chen, Zhigao; Wang, Xin; He, Daihai			Modelling the transmission and control strategies of varicella among school children in Shenzhen, China	PLOS ONE			English	Article							INFECTIOUS-DISEASES; BRUCELLOSIS MODEL; SOCIAL CONTACTS; EPIDEMIOLOGY; VACCINATION; DYNAMICS; SPREAD; IMPACT; POPULATION; PATTERNS	Objectives Varicella (chickenpox) is a highly transmissible childhood disease. Between 2010 and 2015, it displayed two epidemic waves annually among school populations in Shenzhen, China. However, their transmission dynamics remain unclear and there is no school-based vaccination programme in Shenzhen to-date. In this study, we developed a mathematical model to compare a school-based vaccination intervention scenario with a baseline (i.e. no intervention) scenario. Methods Data on varicella reported cases were downloaded from the Infectious Disease Reporting Information Management System. We obtained the population size, age structure of children aged 15 or under, the class and school distribution from Shenzhen Education Bureau. We developed an Agent-Based Susceptible-Exposed-Infectious-Recovered (ABM-SEIR) Model that considered within-class, class-to-class and out-of-school transmission modes. The intervention scenario was that school-wide vaccination intervention occurred when an outbreak threshold was reached within a school. We varied this threshold level from five to ten cases. We compared the reduction of disease outbreak size and estimated the key epidemiological parameters under the intervention strategy. Results Our ABM-SEIR model provided a good model fit to the two annual varicella epidemic waves from 2013 to 2015. The transmission dynamics displayed strong seasonality. Our results suggested that a school-based vaccination strategy could effectively prevent large outbreaks at different thresholds. Conclusions There was a considerable increase in reported varicella cases from 2013 to 2015 in Shenzhen. Our modelling study provided important theoretical support for disease control decision making during school outbreaks and the development of a school-based vaccination programme.	[Tang, Xiujuan; Ma, Hanwu; Xie, Xu; Mei, Shujiang; Kong, Dongfeng; Qin, Yanmin; Chen, Zhigao; Wang, Xin] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [Zhao, Shi; Chiu, Alice P. Y.; He, Daihai] Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Hong Kong, Peoples R China	Shenzhen Center for Disease Control & Prevention (SZCDC); Hong Kong Polytechnic University	Chiu, APY; He, DH (corresponding author), Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Hong Kong, Peoples R China.	alice.py.chiu@polyu.edu.hk; daihai.he@polyu.edu.hk	He, Daihai/AAT-8735-2021; He, Daihai/A-9347-2008; Zhao, Shi/AAW-6992-2021	Zhao, Shi/0000-0001-8722-6149; He, Daihai/0000-0003-3253-654X	Shenzhen Science and Technology Innovation Project 313 [JCYJ20150402102135501]	Shenzhen Science and Technology Innovation Project 313	This study was supported by Shenzhen Science and Technology Innovation Project 313 Grant (JCYJ20150402102135501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LJ, IEEE T AUTOM CONTROL, V43, P779; Brisson M, 2000, EPIDEMIOL INFECT, V125, P651, DOI 10.1017/S0950268800004714; Brisson M, 2010, VACCINE, V28, P3385, DOI 10.1016/j.vaccine.2010.02.079; Del Fava E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163636; FINE PEM, 1982, INT J EPIDEMIOL, V11, P15, DOI 10.1093/ije/11.1.15; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; Fu CX, 2010, PEDIATR INFECT DIS J, V29, P690, DOI 10.1097/INF.0b013e3181d7380e; He DH, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0156; He DH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1345; He DH, 2007, THEOR POPUL BIOL, V72, P274, DOI 10.1016/j.tpb.2007.04.004; Heininger U, 2006, LANCET, V368, P1365, DOI 10.1016/S0140-6736(06)69561-5; Iozzi F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001021; Izurieta HS, 1997, JAMA-J AM MED ASSOC, V278, P1495, DOI 10.1001/jama.278.18.1495; Jackson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099762; Lee LE, 2008, PEDIATRICS, V121, pE1548, DOI 10.1542/peds.2007-2031; Lenne X, 2006, VACCINE, V24, P6980, DOI 10.1016/j.vaccine.2006.04.051; Li MT, 2014, APPL MATH COMPUT, V237, P582, DOI 10.1016/j.amc.2014.03.094; Lin QY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151333; Marin M, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3741; Milne GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004005; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Ogunjimi B, 2009, MATH BIOSCI, V218, P80, DOI 10.1016/j.mbs.2008.12.009; Poletti P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060732; Sun GQ, 2017, COMMUN NONLINEAR SCI, V45, P235, DOI 10.1016/j.cnsns.2016.10.007; Sun GQ, 2014, APPL MATH COMPUT, V246, P336, DOI 10.1016/j.amc.2014.08.028; van Hoek AJ, 2011, VACCINE, V29, P2411, DOI 10.1016/j.vaccine.2011.01.037; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Xia ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13857; Zagheni E, 2008, AM J EPIDEMIOL, V168, P1082, DOI 10.1093/aje/kwn220; Zeng Y, 2016, LANCET, V388, P1930, DOI 10.1016/S0140-6736(16)31405-2	30	6	6	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177514	10.1371/journal.pone.0177514	http://dx.doi.org/10.1371/journal.pone.0177514			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542182	Green Submitted, Green Published, gold			2022-12-26	WOS:000401672400047
J	Walden, HDS; Slapcinsky, JD; Roff, S; Calle, JM; Goodwin, ZD; Stern, J; Corlett, R; Conway, J; McIntosh, A				Walden, Heather D. Stockdale; Slapcinsky, John D.; Roff, Shannon; Calle, Jorge Mendieta; Goodwin, Zakia Diaz; Stern, Jere; Corlett, Rachel; Conway, Julia; McIntosh, Antoinette			Geographic distribution of Angiostrongylus cantonensis in wild rats (Rattus rattus) and terrestrial snails in Florida, USA	PLOS ONE			English	Article							EOSINOPHILIC MENINGITIS; PARASTRONGYLUS-CANTONENSIS; INFECTION; MENINGOENCEPHALOMYELITIS; TRANSMISSION; NEMATODA; THAILAND; LUNGWORM; FULICA; HAWAII	The parasitic nematode Angiostrongylus cantonensis is a major cause of eosinophilic meningitis in humans, and has been documented in other incidental hosts such as birds, horses, dogs and non-human primates. It is endemic in Hawaii, and there have been sporadic reports in the southern continental United States. This parasite uses rats as definitive hosts and snails as intermediate hosts. In this study, we collected potential definitive and intermediate hosts throughout Florida to ascertain the geographic distribution in the state: Rats, environmental rat fecal samples, and snails were collected from 18 counties throughout the state. Classical diagnostics and morphological identification, along with molecular techniques were used to identify nematode species and confirm the presence of A. cantonensis. Of the 171 Rattus rattus collected, 39 (22.8%) were positive for A. cantonensis, and 6 of the 37 (16.2%) environmental rat fecal samples collected in three of the surveyed counties were also positive for this parasite by real time PCR. We examined 1,437 gastropods, which represented 32 species; 27 (1.9%) were positive for A. cantonensis from multiple sites across Florida. Three non-native gastropod species, Bradybaena similaris, Zachrysia provisoria, and Paropeas achatinaceum, and three native gastropod species, Succinea floridana, Ventridens demissus, and Zonitoides arboreus, which are newly recorded intermediate hosts for the parasite, were positive for A. cantonensis. This study indicates that A. cantonensis is established in Florida through the finding of adult and larval stages in definitive and intermediate hosts, respectively, throughout the state. The ability for this historically subtropical nematode to thrive in a more temperate climate is alarming, however as the climate changes and average temperatures rise, gastropod distributions will probably expand, leading to the spread of this parasite in more temperate areas. Through greater awareness of host species and prevalence of A. cantonensis in the United States, potential accidental infections may be avoided.	[Walden, Heather D. Stockdale; Roff, Shannon; Calle, Jorge Mendieta; Goodwin, Zakia Diaz; Stern, Jere; Corlett, Rachel; Conway, Julia; McIntosh, Antoinette] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA; [Slapcinsky, John D.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Walden, HDS (corresponding author), Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA.	hdstockdale@ufl.edu		Walden, Heather/0000-0002-5678-4938	National Center for Veterinary Parasitology (NCVP); UF [00111635]; University of Florida Open Access Publishing Fund	National Center for Veterinary Parasitology (NCVP); UF; University of Florida Open Access Publishing Fund	This work was funded by the National Center for Veterinary Parasitology (NCVP); www.ncvetp.org. HW received funding for this project in 2013, UF project #00111635. Publication of this article was funded in part by the University of Florida Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALICATA JE, 1962, CAN J ZOOLOG, V40, P5, DOI 10.1139/z62-002; ALICATA JE, 1962, CAN J ZOOLOG, V40, P755, DOI 10.1139/z62-070; Asato R, 2004, JPN J INFECT DIS, V57, P184; ASH LR, 1968, J PARASITOL, V54, P432, DOI 10.2307/3277060; Auffenberg K, 2011, EENY, V118, P1; Bergey EA, 2014, BIOL INVASIONS, V16, P1441, DOI 10.1007/s10530-013-0581-1; BHAIBULAYA M, 1975, INT J PARASITOL, V5, P7, DOI 10.1016/0020-7519(75)90091-0; Burns RE, 2014, J VET DIAGN INVEST; CAMPBELL BG, 1988, AM J TROP MED HYG, V38, P568, DOI 10.4269/ajtmh.1988.38.568; Capinera JL, 2013, CROP PROT, V52, P57, DOI 10.1016/j.cropro.2013.05.014; Chen H. T., 1935, Annales de Parasitologie Paris, V13, P312; Costa LRR, 2000, EQUINE VET EDUC, V12, P2, DOI 10.1111/j.2042-3292.2000.tb01754.x; Cowie RH, 2008, INT J PEST MANAGE, V54, P267, DOI 10.1080/09670870802403986; Cowie Robert H, 2013, Hawaii J Med Public Health, V72, P70; Cowie Robert H, 2013, Hawaii J Med Public Health, V72, P6; Cowie Robert H., 2001, Biological Invasions, V3, P119, DOI 10.1023/A:1014529019000; Cowie RH, 2009, AM MALACOL BULL, V27, P113, DOI 10.4003/006.027.0210; CROOK JR, 1971, T ROY SOC TROP MED H, V65, P602, DOI 10.1016/0035-9203(71)90043-5; Duffy MS, 2004, EMERG INFECT DIS, V10, P2207, DOI 10.3201/eid1012.040319; Emerson JA, 2013, VET QUART, V33, P191, DOI 10.1080/01652176.2013.880005; Fanai C, 2015, PEER J; Foster CE, 2016, CLIN INFECT DIS, V63, P1475, DOI 10.1093/cid/ciw606; GARDINER CH, 1990, AM J TROP MED HYG, V42, P70, DOI 10.4269/ajtmh.1990.42.70; HEYNEMAN D, 1967, SCIENCE, V158, P1057, DOI 10.1126/science.158.3804.1057; Hochberg NS, 2007, EMERG INFECT DIS, V13, P1675, DOI 10.3201/eid1311.070367; Hochberg NS, 2011, AM J TROP MED HYG, V85, P685, DOI 10.4269/ajtmh.2011.11-0322; HORIO S R, 1961, Hawaii Med J, V21, P139; HUBRICHT L, 1985, Fieldiana Zoology, P1; Iwanowicz DD, 2015, J WILDLIFE DIS, V51, P749, DOI 10.7589/2014-06-160; Kim DY, 2002, J PARASITOL, V88, P1024, DOI 10.1645/0022-3395(2002)088[1024:PACNEI]2.0.CO;2; Kim JA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085445, 10.1371/journal.pone.0091940]; Kottwitz JJ, 2014, JAVMA-J AM VET MED A, V245, P821, DOI 10.2460/javma.245.7.821; Lai CH, 2007, AM J TROP MED HYG, V76, P399, DOI 10.4269/ajtmh.2007.76.399; Lunn JA, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-70; Lv S, 2011, FRESHWATER BIOL, V56, P717, DOI 10.1111/j.1365-2427.2011.02579.x; MACKERRAS M. JOSEPHINE, 1955, AUSTRALIAN JOUR ZOOL, V3, P1, DOI 10.1071/ZO9550001; Monks DJ, 2005, J AVIAN MED SURG, V19, P289, DOI 10.1647/2004-024.1; NEW D, 1995, NEW ENGL J MED, V332, P1105, DOI 10.1056/NEJM199504203321619; Pilsbry H., 1939, ACAD NAT SCI PHILA M, V3, P1; Pilsbry H. A, 1940, ACAD NATURAL SCI MON ACAD NATURAL SCI MON, V1, P575; Pilsbry H.A., 1948, ACAD NATURAL SCI PHI, V3, P521; Pilsbry HA, 1946, ACAD NATURAL SCI PHI, V3, P1; PUNYAGUPTA S, 1970, AM J TROP MED HYG, V19, P950, DOI 10.4269/ajtmh.1970.19.950; PUNYAGUPTA S, 1975, AM J TROP MED HYG, V24, P921, DOI 10.4269/ajtmh.1975.24.921; Qvarnstrom Yvonne, 2013, Hawaii J Med Public Health, V72, P63; Qvarnstrom Y, 2010, APPL ENVIRON MICROB, V76, P5287, DOI 10.1128/AEM.00546-10; Robles MD, 2016, MEM I OSWALDO CRUZ, V111, P181, DOI 10.1590/0074-02760150371; Sawanyawisuth K, 2013, KOREAN J PARASITOL, V51, P735, DOI 10.3347/kjp.2013.51.6.735; Sinawat S, 2008, EYE, V22, P1446, DOI 10.1038/eye.2008.135; Stockdale-Walden HD, 2015, J PARASITOL, V101, P156, DOI 10.1645/14-553.1; Teem John L, 2013, Hawaii J Med Public Health, V72, P11; WALLACE G D, 1969, Malacologia, V7, P427; Wang QP, 2012, EUR J CLIN MICROBIOL, V31, P389, DOI 10.1007/s10096-011-1328-5; Wang QP, 2008, LANCET INFECT DIS, V8, P621, DOI 10.1016/S1473-3099(08)70229-9; Waugh CA, 2016, PARASITOLOGY, V143, P1211, DOI 10.1017/S0031182016000640; Waugh CA, 2005, EMERG INFECT DIS, V11, P1977, DOI 10.3201/eid1112.050217; Yeung Norine W, 2013, Hawaii J Med Public Health, V72, P83; York EM, 2015, EMERG INFECT DIS, V21, P1234, DOI 10.3201/eid2107.141980; York EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103831; Zajac A., 2012, PENSION FUND PERFORM, V8th edn, DOI DOI 10.1002/9781119208945.CH8	60	34	35	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177910	10.1371/journal.pone.0177910	http://dx.doi.org/10.1371/journal.pone.0177910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542310	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400112
J	Wang, XM; Liu, S; Liu, ZP				Wang, Xingmei; Liu, Shu; Liu, Zhipeng			Underwater sonar image detection: A combination of non-local spatial information and quantum-inspired shuffled frog leaping algorithm	PLOS ONE			English	Article							CLUSTERING-ALGORITHM; GENETIC ALGORITHM; OPTIMIZATION	This paper proposes a combination of non-local spatial information and quantum-inspired shuffled frog leaping algorithm to detect underwater objects in sonar images. Specifically, for the first time, the problem of inappropriate filtering degree parameter which commonly occurs in non-local spatial information and seriously affects the denoising performance in sonar images, was solved with the method utilizing a novel filtering degree parameter. Then, a quantum-inspired shuffled frog leaping algorithm based on new search mechanism (QSFLA-NSM) is proposed to precisely and quickly detect sonar images. Each frog individual is directly encoded by real numbers, which can greatly simplify the evolution process of the quantum-inspired shuffled frog leaping algorithm (QSFLA). Meanwhile, a fitness function combining intra-class difference with inter-class difference is adopted to evaluate frog positions more accurately. On this basis, recurring to an analysis of the quantum-behaved particle swarm optimization (QPSO) and the shuffled frog leaping algorithm (SFLA), a new search mechanism is developed to improve the searching ability and detection accuracy. At the same time, the time complexity is further reduced. Finally, the results of comparative experiments using the original sonar images, the UCI data sets and the benchmark functions demonstrate the effectiveness and adaptability of the proposed method.	[Wang, Xingmei] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Liu, Shu] Chinese Acad Sci, Inst Automat, Brainnetome Ctr, Beijing, Peoples R China; [Liu, Zhipeng] Chinese Acad Sci, Inst Comp Technol, Key Lab Intelligent Informat Proc CAS, Beijing, Peoples R China	Harbin Engineering University; Chinese Academy of Sciences; Institute of Automation, CAS; Chinese Academy of Sciences; Institute of Computing Technology, CAS	Wang, XM (corresponding author), Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China.	wangxingmei@hrbeu.edu.cn	liu, zhipeng/HCI-3638-2022; LIU, ZHIPENG/GWQ-5972-2022		National Natural Science Foundation of China [41306086]; technology innovation talent special foundation of Harbin [2014RFQXJ105]; Fundamental Research Funds for the Central Universities [HEUCF100606]; China Scholarship Council (CSC) [201506685079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); technology innovation talent special foundation of Harbin; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Scholarship Council (CSC)(China Scholarship Council)	This work was supported by the National Natural Science Foundation of China (No. 41306086) to XMW, http.//www.nsfc.gov.cn/, technology innovation talent special foundation of Harbin (No.2014RFQXJ105) to XMW, http://202.97.251.242:8033/, Fundamental Research Funds for the Central Universities (No.HEUCF100606) to XMW, http.//kyxt.hrbeu.edu.cn/irisweb. The first author was supported by China Scholarship Council (CSC) (No.201506685079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The first author was supported by China Scholarship Council (CSC) (No.201506685079).	Alireza Alfi, 2011, Acta Automatica Sinica, V37, P541, DOI 10.3724/SP.J.1004.2011.00541; Arshi SS, 2014, COMPUT PHYS COMMUN, V185, P2622, DOI 10.1016/j.cpc.2014.06.013; Bache Kevin, 2013, UCI MACHINE LEARNING; Buades A, 2008, INT J COMPUT VISION, V76, P123, DOI 10.1007/s11263-007-0052-1; Cai WL, 2007, PATTERN RECOGN, V40, P825, DOI 10.1016/j.patcog.2006.07.011; Chen SC, 2004, IEEE T SYST MAN CY B, V34, P1907, DOI 10.1109/TSMCB.2004.831165; [丁卫平 Ding Weiping], 2014, [计算机研究与发展, Journal of Computer Research and Development], V51, P743; Ding WP, 2013, J SYST ENG ELECTRON, V24, P426, DOI 10.1109/JSEE.2013.00051; Fan TH, 2012, INTELL AUTOM SOFT CO, V78, P70; Feng J, 2013, SIGNAL PROCESS, V93, P487, DOI 10.1016/j.sigpro.2012.08.024; Gao HY, 2012, INT J DIGITAL CONTEN, V6, P32; HOLLAND JH, 1992, SCI AM, V267, P66, DOI 10.1038/scientificamerican0792-66; Jau YM, 2013, APPL MATH COMPUT, V221, P282, DOI 10.1016/j.amc.2013.06.050; Krinidis S, 2010, IEEE T IMAGE PROCESS, V19, P1328, DOI 10.1109/TIP.2010.2040763; Kumar JV, 2014, APPL SOFT COMPUT, V21, P407, DOI 10.1016/j.asoc.2014.03.027; Lei DM, 2015, EXPERT SYST APPL, V42, P9333, DOI 10.1016/j.eswa.2015.08.025; [李灿飞 Li Canfei], 2012, [自动化学报, Acta Automatica Sinica], V38, P412; Ngo LT, 2015, COMPUT GEOSCI-UK, V83, P1, DOI 10.1016/j.cageo.2015.06.011; Luo JP, 2014, COMPUT IND ENG, V72, P84, DOI 10.1016/j.cie.2014.03.004; Mariani VC, 2012, APPL THERM ENG, V42, P119, DOI 10.1016/j.applthermaleng.2012.03.022; Niknam T, 2011, EXPERT SYST APPL, V38, P13301, DOI 10.1016/j.eswa.2011.04.151; Roy P, 2013, APPL SOFT COMPUT, V13, P4244, DOI 10.1016/j.asoc.2013.07.006; Sheikh Rahila H., 2008, 2008 1st International Conference on Emerging Trends in Engineering and Technology (ICETET), P314, DOI 10.1109/ICETET.2008.48; Shen Yuan-Xia, 2011, Journal of Software, V22, P695, DOI 10.3724/SP.J.1001.2011.03728; Szilagyi L, 2003, P ANN INT IEEE EMBS, V25, P724, DOI 10.1109/IEMBS.2003.1279866; Wang Lei, 2012, Journal of Huazhong University of Science and Technology (Natural Science Edition), V40, P25; Wang LG, 2013, INT CONF INSTR MEAS, P1655, DOI 10.1109/IMCCC.2013.366; Wang LG, 2013, 2013 NINTH INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION (ICNC), P369, DOI 10.1109/ICNC.2013.6818003; Wang XM, 2016, P CCDC YINCH CHIN, P2020, DOI 10.1109/CCDC.2016.7531310; Wang Z, 2002, IEEE SIGNAL PROC LET, V9, P81, DOI 10.1109/97.995823; Wu JP, 2015, INT CONF COMM SYST, P457, DOI 10.1109/CSNT.2015.224; Xiao J, 2010, EXPERT SYST APPL, V37, P4966, DOI 10.1016/j.eswa.2009.12.017; Ye XF, 2010, OCEAN ENG, V37, P891, DOI 10.1016/j.oceaneng.2010.03.003; Zhang B, 2015, INT J HEAT MASS TRAN, V85, P300, DOI 10.1016/j.ijheatmasstransfer.2015.01.140; Zhang H, 2015, J SIGNAL PROCESS SYS, V81, P45, DOI 10.1007/s11265-014-0898-8; Zhang XD, 2012, AEU-INT J ELECTRON C, V66, P448, DOI 10.1016/j.aeue.2011.10.004; [张毅 Zhang Yi], 2013, [计算机学报, Chinese Journal of Computers], V36, P1835; Zhang YD, 2016, TECHNOL HEALTH CARE, V24, pS641, DOI 10.3233/THC-161191; Zhang YD, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/931256; Zhao F, 2015, APPL SOFT COMPUT, V30, P48, DOI 10.1016/j.asoc.2015.01.039; Zhao F, 2014, EXPERT SYST APPL, V41, P4083, DOI 10.1016/j.eswa.2014.01.003	43	13	14	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							017766	10.1371/journal.pone.0177666	http://dx.doi.org/10.1371/journal.pone.0177666			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542266	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400065
J	Zhao, XK; Mao, YM; Meng, H; Song, X; Hu, SJ; Lv, S; Cheng, R; Zhang, TJ; Han, XN; Ren, JL; Qi, YJ; Wang, LD				Zhao, Xue Ke; Mao, Yi Min; Meng, Hui; Song, Xin; Hu, Shou Jia; Lv, Shuang; Cheng, Rang; Zhang, Tang Juan; Han, Xue Na; Ren, Jing Li; Qi, Yi Jun; Wang, Li Dong			Shared susceptibility loci at 2q33 region for lung and esophageal cancers in high-incidence areas of esophageal cancer in northern China	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SQUAMOUS-CELL CARCINOMA; GENETIC-VARIATION; POOLED ANALYSIS; NEVER SMOKERS; HAN CHINESE; RISK; POPULATION; VARIANTS; PLCE1	Background Cancers from lung and esophagus are the leading causes of cancer-related deaths in China and share many similarities in terms of histological type, risk factors and genetic variants. Recent genome-wide association studies (GWAS) in Chinese esophageal cancer patients have demonstrated six high-risk candidate single nucleotide polymorphisms (SNPs). Thus, the present study aimed to determine the risk of these SNPs predisposing to lung cancer in Chinese population. Methods A total of 1170 lung cancer patients and 1530 normal subjects were enrolled in this study from high-incidence areas for esophageal cancer in Henan, northern China. Five milliliters of blood were collected from all subjects for genotyping. Genotyping of 20 high-risk SNP loci identified from genome-wide association studies (GWAS) on esophageal, lung and gastric cancers was performed using TaqMan allelic discrimination assays. Polymorphisms were examined for deviation from Hardy-Weinberg equilibrium (HWE) using X-2 test. Bonferroni correction was performed to correct the statistical significance of 20 SNPs with the risk of lung cancer. The Pearson's X-2 test was used to compare the distributions of gender, TNM stage, histopathological type, smoking and family history by lung susceptibility genotypes. Kaplan-Meier and Cox regression analyses were carried out to evaluate the associations between genetic variants and overall survival. Results Four of the 20 SNPs identified as high-risk SNPs in Chinese esophageal cancer showed increased risk for Chinese lung cancer, which included rs3769823 (OR = 1.26; 95% CI = 1.107-1.509; P = 0.02), rs10931936 (OR = 1.283; 95% CI = 1.100-1.495; P = 0.04), rs2244438 (OR = 1.294; 95% CI = 1.098-1.525; P = 0.04) and rs13016963 (OR = 1.268; 95% CI = 1.089-1.447; P = 0.04). All these SNPs were located at 2q33 region harboringgenes of CASP8, ALS2CR12 and TRAK2. However, none of these susceptibility SNPs was observed to be significantly associated with gender, TNM stage, histopathological type, smoking, family history and overall survival. Conclusions The present study identified four high-risk SNPs at 2q33 locus for Chinese lung cancer and demonstrated the shared susceptibility loci at 2q33 region for Chinese lung and esophageal cancers.	[Zhao, Xue Ke; Mao, Yi Min; Meng, Hui; Song, Xin; Hu, Shou Jia; Lv, Shuang; Cheng, Rang; Zhang, Tang Juan; Han, Xue Na; Ren, Jing Li; Wang, Li Dong] Zhengzhou Univ, Henan Key Lab Esophageal Canc Res, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China; [Qi, Yi Jun] Henan Univ Sci & Technol, Coll Clin Med, Affiliated Hosp 1, Henan Key Lab Canc Epigenet,Canc Inst, Luoyang, Henan, Peoples R China	Zhengzhou University; Henan University of Science & Technology	Wang, LD (corresponding author), Zhengzhou Univ, Henan Key Lab Esophageal Canc Res, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China.	ldwang2007@126.com		Qi, Yi-Jun/0000-0003-0239-5862; HU, SHOU JIA/0000-0002-9857-0065; Wang, Li Dong/0000-0002-7933-0410	National Natural Science Foundation of China; Guangdong Provincial People's Government of the Joint Natural Science Fund [U1301227]; Major Project of Science and Technology of Henan Province [161100311300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial People's Government of the Joint Natural Science Fund; Major Project of Science and Technology of Henan Province	The study has been funded by the National Natural Science Foundation of China, and the Guangdong Provincial People's Government of the Joint Natural Science Fund (U1301227) and Major Project of Science and Technology of Henan Province (161100311300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Our study was supported by the National Natural Science Foundation of China, and the Guangdong Provincial People's Government of the Joint Natural Science Fund (U1301227) and Major Project of Science and Technology of Henan Province (161100311300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680; Chung CC, 2011, HUM GENET, V130, P59, DOI 10.1007/s00439-011-1030-9; Cote ML, 2012, EUR J CANCER, V48, P1957, DOI 10.1016/j.ejca.2012.01.038; Couch FJ, 2009, CANCER EPIDEM BIOMAR, V18, P3044, DOI 10.1158/1055-9965.EPI-09-0306; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Delahaye-Sourdeix M, 2015, PLOS ONE, V10, P3; Gavine PR, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1455-y; Grishin A, 2006, J BIOL CHEM, V281, P30104, DOI 10.1074/jbc.M602439200; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; He P, 2014, INT J MOL SCI, V15, P5446, DOI 10.3390/ijms15045446; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Hu ZB, 2011, NAT GENET, V43, P792, DOI 10.1038/ng.875; Huang XP, 2014, GENET MOL RES, V13, P2107, DOI 10.4238/2014.January.24.17; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Ichinose J, 2014, CHEST, V146, P644, DOI 10.1378/chest.14-0159; Lan Q, 2009, BLOOD, V114, P264, DOI 10.1182/blood-2009-01-198697; Li YF, 2010, LANCET ONCOL, V11, P321, DOI 10.1016/S1470-2045(10)70042-5; Liu L, 2014, CANCER EPIDEMIOL, V38, P66, DOI 10.1016/j.canep.2013.12.009; Lu Y, 2014, HUM MOL GENET, V23, P6112, DOI 10.1093/hmg/ddu312; Mechanic LE, 2007, CANCER EPIDEM BIOMAR, V16, P214, DOI 10.1158/1055-9965.EPI-06-0790; Nandy N, 2013, CURR MED RES OPIN, V29, P1055, DOI 10.1185/03007995.2013.816276; Rafnar T, 2011, CANCER RES, V71, P1356, DOI 10.1158/0008-5472.CAN-10-2852; Sato N, 2010, CLIN CANCER RES, V16, P226, DOI 10.1158/1078-0432.CCR-09-1405; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Son JW, 2006, CANCER GENET CYTOGEN, V169, P121, DOI 10.1016/j.cancergencyto.2006.04.001; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; Sun Y, 2013, ASIAN PAC J CANCER P, V14, P5171, DOI 10.7314/APJCP.2013.14.9.5171; Tan W, 2001, INT J CANCER, V95, P96, DOI 10.1002/1097-0215(20010320)95:2&lt;96::AID-IJC1017&gt;3.0.CO;2-2; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wu C, 2014, NAT GENET, V46, P1001, DOI 10.1038/ng.3064; Xue L, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-296; Zhao Y, 2010, J CELL PHYSIOL, V225, P316, DOI 10.1002/jcp.22276; Zhou LQ, 2012, GENE, V506, P295, DOI 10.1016/j.gene.2012.07.007	37	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177504	10.1371/journal.pone.0177504	http://dx.doi.org/10.1371/journal.pone.0177504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542283	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400046
J	Braem, M; Asher, L; Furrer, S; Lechner, I; Wurbel, H; Melotti, L				Braem, Maya; Asher, Lucy; Furrer, Sibylle; Lechner, Isabel; Wurbel, Hanno; Melotti, Luca			Development of the "Highly Sensitive Dog" questionnaire to evaluate the personality dimension "Sensory Processing Sensitivity" in dogs	PLOS ONE			English	Article							QUALITY-OF-LIFE; TEST-RETEST RELIABILITY; DIFFERENTIAL SUSCEPTIBILITY; GREAT TITS; INDIVIDUAL-DIFFERENCES; TRAINING METHODS; PUMPKINSEED SUNFISH; ANIMAL PERSONALITY; ATOPIC-DERMATITIS; BREED DIFFERENCES	In humans, the personality dimension 'sensory processing sensitivity (SPS)', also referred to as "high sensitivity", involves deeper processing of sensory information, which can be associated with physiological and behavioral overarousal. However, it has not been studied up to now whether this dimension also exists in other species. SPS can influence how people perceive the environment and how this affects them, thus a similar dimension in animals would be highly relevant with respect to animal welfare. We therefore explored whether SPS translates to dogs, one of the primary model species in personality research. A 32-item questionnaire to assess the "highly sensitive dog score" (HSD-s) was developed based on the "highly sensitive person" (HSP) questionnaire. A large-scale, international online survey was conducted, including the HSD questionnaire, as well as questions on fearfulness, neuroticism, "demographic" (e.g. dog sex, age, weight; age at adoption, etc.) and "human" factors (e.g. owner age, sex, profession, communication style, etc.), and the HSP questionnaire. Data were analyzed using linear mixed effect models with forward stepwise selection to test prediction of HSD-s by the above-mentioned factors, with country of residence and dog breed treated as random effects. A total of 3647 questionnaires were fully completed. HSD-, fearfulness, neuroticism and HSP-scores showed good internal consistencies, and HSD-s only moderately correlated with fearfulness and neuroticism scores, paralleling previous findings in humans. Intra- (N = 447) and inter-rater (N = 120) reliabilities were good. Demographic and human factors, including HSP score, explained only a small amount of the variance of HSD-s. A PCA analysis identified three subtraits of SPS, comparable to human findings. Overall, the measured personality dimension in dogs showed good internal consistency, partial independence from fearfulness and neuroticism, and good intra-and inter-rater reliability, indicating good construct validity of the HSD questionnaire. Human and demographic factors only marginally affected the HSD-s suggesting that, as hypothesized for human SPS, a genetic basis may underlie this dimension within the dog species.	[Braem, Maya; Furrer, Sibylle; Wurbel, Hanno; Melotti, Luca] Univ Bern, Vetsuisse Fac, Vet Publ Hlth Inst, Div Anim Welf, Bern, Switzerland; [Asher, Lucy] Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne, Tyne & Wear, England; [Lechner, Isabel] Univ Bern, Vetsuisse Fac, Vet Publ Hlth Inst, Bern, Switzerland	University of Bern; Newcastle University - UK; University of Bern	Braem, M (corresponding author), Univ Bern, Vetsuisse Fac, Vet Publ Hlth Inst, Div Anim Welf, Bern, Switzerland.	maya.braem@vetsuisse.unibe.ch		Lechner, Isabel/0000-0001-5155-9734; Asher, Lucy/0000-0001-9729-7856	Margaret und Francis Fleitmann Stiftung Luzern, Switzerland	Margaret und Francis Fleitmann Stiftung Luzern, Switzerland	This study was funded by Margaret und Francis Fleitmann Stiftung Luzern, Switzerland (MB).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo BP, 2014, BRAIN BEHAV, V4, P580, DOI 10.1002/brb3.242; Akerberg H, 2012, J VET BEHAV, V7, P327, DOI 10.1016/j.jveb.2012.01.007; Appleby DL, 2002, VET REC, V150, P434, DOI 10.1136/vr.150.14.434; Aron A, 2010, SOC COGN AFFECT NEUR, V5, P219, DOI 10.1093/scan/nsq028; Aron EN, 2012, PERS SOC PSYCHOL REV, V16, P262, DOI 10.1177/1088868311434213; Aron EN, 1997, J PERS SOC PSYCHOL, V73, P345, DOI 10.1037/0022-3514.73.2.345; Aron EN, 2005, PERS SOC PSYCHOL B, V31, P181, DOI 10.1177/0146167204271419; Aron EN, 2006, J JUNGIAN THEORY PRA, V8, P11; Aron EN, 2002, HARMONY; Arvelius P, 2014, J VET BEHAV, V9, P281, DOI 10.1016/j.jveb.2014.06.008; Asp HE, 2015, APPL ANIM BEHAV SCI, V169, P69, DOI 10.1016/j.applanim.2015.04.010; Battaglia CL, 2009, J VET BEHAV, V4, P203, DOI 10.1016/j.jveb.2009.03.003; Becuwe-Bonnet V, 2012, J VET BEHAV, V7, P194, DOI 10.1016/j.jveb.2011.07.003; Belshaw Z, 2015, VET J, V206, P203, DOI 10.1016/j.tvjl.2015.07.016; Belsky J, 1998, DEV PSYCHOPATHOL, V10, P301, DOI 10.1017/S095457949800162X; Belsky J, 2007, CURR DIR PSYCHOL SCI, V16, P300, DOI 10.1111/j.1467-8721.2007.00525.x; Benham G, 2006, PERS INDIV DIFFER, V40, P1433, DOI 10.1016/j.paid.2005.11.021; Bennett PC, 2007, APPL ANIM BEHAV SCI, V102, P65, DOI 10.1016/j.applanim.2006.03.009; BENUS RF, 1991, EXPERIENTIA, V47, P1008, DOI 10.1007/BF01923336; Berenbaum SA, 1997, PSYCHONEUROENDOCRINO, V22, P505, DOI 10.1016/S0306-4530(97)00049-8; Blackwell EJ, 2008, J VET BEHAV, V3, P207, DOI 10.1016/j.jveb.2007.10.008; Bolhuis JE, 2005, ANIM BEHAV, V69, P1085, DOI 10.1016/j.anbehav.2004.09.013; Booth C, 2015, PERS INDIV DIFFER, V87, P24, DOI 10.1016/j.paid.2015.07.020; Boterberg S, 2016, PERS INDIV DIFFER, V92, P80, DOI 10.1016/j.paid.2015.12.022; Bouissou MF, 1996, HORM BEHAV, V30, P93, DOI 10.1006/hbeh.1996.0013; Bradley RH, 2008, J CHILD PSYCHOL PSYC, V49, P124, DOI [10.1111/j-1469-7610.2007.01829.x, 10.1111/j.1469-7610.2007.01829.x]; Capitanio JP, 1999, AM J PRIMATOL, V47, P299, DOI 10.1002/(SICI)1098-2345(1999)47:4<299::AID-AJP3>3.0.CO;2-P; Carere C, 2004, PHYSIOL BEHAV, V82, P905, DOI 10.1016/j.physbeh.2004.07.009; Carere C, 2005, ANIM BEHAV, V70, P795, DOI 10.1016/j.anbehav.2005.01.003; Carere C., 2013, ANIMAL PERSONALITIES; CAREY WB, 1978, PEDIATRICS, V61, P735; Chen C, 2011, PLOS ONE, V6; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Costa PT, 2001, J PERS SOC PSYCHOL, V81, P322, DOI [10.1037/0022-3514.81.2.322, 10.1037//0022-3514.81.2.322]; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Denissen JJA, 2008, J RES PERS, V42, P1285, DOI 10.1016/j.jrp.2008.04.002; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Diverio S, 2014, J VET BEHAV, P1; DRAPER TW, 1995, J GEN PSYCHOL, V122, P241, DOI 10.1080/00221309.1995.9921236; Duffy DL, 2008, APPL ANIM BEHAV SCI, V114, P441, DOI 10.1016/j.applanim.2008.04.006; Evers A., 2008, INT J STRESS MANAG, V15, P189, DOI [10.1037/1072-5245.15.2.189, DOI 10.1037/1072-5245.15.2.189]; Fadel FR, 2016, NATURE, P1; Favrot C, 2010, VET DERMATOL, V21, P63, DOI 10.1111/j.1365-3164.2009.00781.x; Fielding WJ, 2008, ANTHROZOOS, V21, P351, DOI 10.2752/175303708X371573; Foyer P, 2015, NATURE; Fratkin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054907; Freeman HD, 2010, AM J PRIMATOL, V72, P653, DOI 10.1002/ajp.20833; Freeman LM, 2005, JAVMA-J AM VET MED A, V226, P1864, DOI 10.2460/javma.2005.226.1864; Gartner MC, 2015, PERS INDIV DIFFER, V75, P102, DOI 10.1016/j.paid.2014.10.042; Gazzano A, 2008, APPL ANIM BEHAV SCI, V110, P294, DOI 10.1016/j.applanim.2007.05.007; GODDARD ME, 1984, APPL ANIM BEHAV SCI, V12, P253, DOI 10.1016/0168-1591(84)90118-7; GOLDBERG LR, 1990, J PERS SOC PSYCHOL, V59, P1216, DOI 10.1037/0022-3514.59.6.1216; Gosling SD, 2009, CAMBRIDGE HANDBOOK OF PERSONALITY PSYCHOLOGY, P275; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gosling SD, 2003, J PERS SOC PSYCHOL, V85, P1161, DOI 10.1037/0022-3514.85.6.1161; Gosling SD, 2002, J RES PERS, V36, P607, DOI 10.1016/S0092-6566(02)00511-1; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Guardini G, 2016, APPL ANIM BEHAV SCI, V181, P137, DOI 10.1016/j.applanim.2016.05.006; Gupta RR, 2001, BRAIN RES, V888, P356, DOI 10.1016/S0006-8993(00)03116-4; Hansen SW, 1996, APPL ANIM BEHAV SCI, V49, P137, DOI 10.1016/0168-1591(96)01045-3; Harvey ND, 2016, J VET BEHAV, V16, P13, DOI 10.1016/j.jveb.2016.03.004; Harvey ND, 2016, J VET BEHAV, V11, P65, DOI 10.1016/j.jveb.2015.09.005; Haverbeke A, 2010, APPL ANIM BEHAV SCI, V123, P143, DOI 10.1016/j.applanim.2009.12.014; Herron ME, 2009, APPL ANIM BEHAV SCI, V117, P47, DOI 10.1016/j.applanim.2008.12.011; HESSING MJC, 1994, PHYSIOL BEHAV, V55, P39, DOI 10.1016/0031-9384(94)90007-8; Hodosy J, 2012, PHARMACOL BIOCHEM BE, V102, P191, DOI 10.1016/j.pbb.2012.04.005; Holton L, 2001, VET REC, V148, P525, DOI 10.1136/vr.148.17.525; Homberg JR, 2016, NEUROSCI BIOBEHAV R, V71, P472, DOI 10.1016/j.neubiorev.2016.09.029; Hournmady S, 2016, APPL ANIM BEHAV SCI, V177, P42, DOI 10.1016/j.applanim.2016.01.015; Houston AI, 2010, PHILOS T R SOC B, V365, P3969, DOI 10.1098/rstb.2010.0161; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Jagiellowicz J, 2011, SOC COGN AFFECT NEUR, V6, P38, DOI 10.1093/scan/nsq001; Jagoe A, 1996, APPL ANIM BEHAV SCI, V47, P31, DOI 10.1016/0168-1591(95)01008-4; Jones A.C., 2008, THESIS; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; Kemler DS, 2006, PERCEPT MOTOR SKILL, V102, P747, DOI 10.2466/PMS.102.3.747-759; Kim HH, 2006, VET J, V172, P154, DOI 10.1016/j.tvjl.2005.02.028; Kis A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083993; Kis A, 2012, INTERACT STUD, V13, P373, DOI 10.1075/is.13.3.03kis; Kochanska G, 2002, CHILD DEV, V73, P461, DOI 10.1111/1467-8624.00418; Kochanska G, 2007, DEV PSYCHOL, V43, P222, DOI 10.1037/0012-1649.43.1.222; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Ley J, 2008, APPL ANIM BEHAV SCI, V110, P305, DOI 10.1016/j.applanim.2007.04.016; Ley JM, 2009, APPL ANIM BEHAV SCI, V119, P85, DOI 10.1016/j.applanim.2009.02.027; Ley JM, 2009, APPL ANIM BEHAV SCI, V116, P220, DOI 10.1016/j.applanim.2008.09.009; Lindley S., 2012, UK Vet: Companion Animal, V17, P50; Linek M, 2010, VET DERMATOL, V21, P456, DOI 10.1111/j.1365-3164.2010.00899.x; Lloyd AS, 2007, APPL ANIM BEHAV SCI, V105, P205, DOI 10.1016/j.applanim.2006.05.017; Locurto C, 2007, COMP COGN BEHAV REV, V2, P67; Marshall-Pescini S, 2016, ANIM COGN; Mathews GA, 2009, HORM BEHAV, V55, P285, DOI 10.1016/j.yhbeh.2008.11.007; McDermott CM, 2012, PHYSIOL BEHAV, V105, P1168, DOI 10.1016/j.physbeh.2011.12.016; McGarrity ME, 2016, APPL ANIM BEHAV SCI, V179, P82, DOI 10.1016/j.applanim.2016.03.013; Mehrkam LR, 2014, APPL ANIM BEHAV SCI, V155, P12, DOI 10.1016/j.applanim.2014.03.005; Mezulis AH, 2006, DEV PSYCHOL, V42, P1012, DOI 10.1037/0012-1649.42.6.1012; Miklosi A, 2014, THE SOCIAL DOG BEHAV; Miller LJ, 2008, ENCYCLOPEDIA OF INFA, P127; Mirko E, 2012, APPL ANIM BEHAV SCI, V138, P88, DOI 10.1016/j.applanim.2012.02.016; Momozawa Y, 2005, APPL ANIM BEHAV SCI, V92, P77, DOI 10.1016/j.applanim.2004.11.006; Morris AS, 2002, J MARRIAGE FAM, V64, P461, DOI 10.1111/j.1741-3737.2002.00461.x; Naguib M, 2011, DEV PSYCHOBIOL, V53, P592, DOI 10.1002/dev.20533; Nettle D, 2006, AM PSYCHOL, V61, P622, DOI 10.1037/0003-066X.61.6.622; Pageat P., 1998, PATHOLOGIE COMPORTEM; Petelle MB, 2013, ANIM BEHAV, V86, P1147, DOI 10.1016/j.anbehav.2013.09.016; Pluess M., 2015, CARDIAC CYTOARCHITEC, P1; Pluess M., 2010, FAM SCI, V1, P14, DOI [10.1080/19424620903388554, DOI 10.1080/19424620903388554]; Pluess M, 2015, PERS INDIV DIFFER, V82, P40, DOI 10.1016/j.paid.2015.03.011; Pluess M, 2010, DEV PSYCHOL, V46, P379, DOI 10.1037/a0015203; Pluess M, 2009, J CHILD PSYCHOL PSYC, V50, P396, DOI 10.1111/j.1469-7610.2008.01992.x; Rayment DJ, 2015, APPL ANIM BEHAV SCI, V163, P1, DOI 10.1016/j.applanim.2014.11.020; Rooney NJ, 2011, APPL ANIM BEHAV SCI, V132, P169, DOI 10.1016/j.applanim.2011.03.007; Roshier AL, 2013, VET REC, V172, DOI 10.1136/vr.101125; Sangster MD, 2012, AN FMRI STUDY OF SEN, P136; Schroll S, 2007, VERHALTENSMEDIZIN BE; Segurson SA, 2005, JAVMA-J AM VET MED A, V227, P1755, DOI 10.2460/javma.2005.227.1755; Serpell JA, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00049; Sheppard G., 2002, INT J COMP PSYCHOL, V15, P201, DOI DOI 10.5811/WESTJEM.2011.5.6700; Shivley CB, 2016, JAVMA-J AM VET MED A, V248, P1165, DOI 10.2460/javma.248.10.1165; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sinn DL, 2008, ANIM BEHAV, V75, P433, DOI 10.1016/j.anbehav.2007.05.008; Sinn DL, 2010, APPL ANIM BEHAV SCI, V127, P51, DOI 10.1016/j.applanim.2010.08.007; Smolewska KA, 2006, PERS INDIV DIFFER, V40, P1269, DOI 10.1016/j.paid.2005.09.022; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Starling MJ, 2013, VET J, V197, P868, DOI 10.1016/j.tvjl.2013.05.019; Starling MJ, 2013, BEHAV PROCESS, V97, P53, DOI 10.1016/j.beproc.2013.04.008; Suomi SJ, 2003, NATURE NURTURE COMPL, P35; Svartberg K, 2006, APPL ANIM BEHAV SCI, V96, P293, DOI 10.1016/j.applanim.2005.06.014; Svartberg K, 2005, APPL ANIM BEHAV SCI, V91, P103, DOI 10.1016/j.applanim.2004.08.030; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P157, DOI 10.1016/S0168-1591(02)00120-X; Tiira K, 2014, APPL ANIM BEHAV SCI, V155, P82, DOI 10.1016/j.applanim.2014.03.007; Turcsan B, 2012, APPL ANIM BEHAV SCI, V140, P154, DOI 10.1016/j.applanim.2012.06.004; van Aken C, 2007, INFANT CHILD DEV, V16, P553, DOI 10.1002/icd.529; Vandenheede M, 1996, APPL ANIM BEHAV SCI, V47, P211, DOI 10.1016/0168-1591(95)00673-7; Vas J, 2007, APPL ANIM BEHAV SCI, V103, P105, DOI 10.1016/j.applanim.2006.03.017; Wan M, 2009, APPL ANIM BEHAV SCI, V121, P206, DOI 10.1016/j.applanim.2009.09.015; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; WILSON DS, 1993, J COMP PSYCHOL, V107, P250, DOI 10.1037/0735-7036.107.3.250; Wiseman-Orr ML, 2006, AM J VET RES, V67, P1826, DOI 10.2460/ajvr.67.11.1826; Wojciechowska JI, 2005, AM J VET RES, V66, P1461, DOI 10.2460/ajvr.2005.66.1461; Wolf M, 2008, P NATL ACAD SCI USA, V105, P15825, DOI 10.1073/pnas.0805473105; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Wright H.F., 2011, INT J COMP PSYCH, V24, P210, DOI DOI 10.5811/westjem.2011.5.6700; Zagron G, 2006, BEHAV BRAIN RES, V175, P323, DOI 10.1016/j.bbr.2006.09.003; Zeigler-Hill V, 2010, APPL ANIM BEHAV SCI, V124, P104, DOI 10.1016/j.applanim.2010.02.012; Ziv G., 2017, J VET BEHAV	146	6	6	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177616	10.1371/journal.pone.0177616	http://dx.doi.org/10.1371/journal.pone.0177616			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DC	28520773	Green Published, gold, Green Submitted			2022-12-26	WOS:000401485500044
J	Liao, XH; Xue, CJ; Su, FZ				Liao, Xiaohan; Xue, Cunjin; Su, Fenzhen			Tree-based approach for exploring marine spatial patterns with raster datasets	PLOS ONE			English	Article							SPATIOTEMPORAL ASSOCIATION PATTERNS; TIME-SERIES; MINING APPROACH; ENSO; FRAMEWORK; SYSTEM; SCIENCE; CLIMATE; IMAGES; RULES	From multiple raster datasets to spatial association patterns, the data-mining technique is divided into three subtasks, i.e., raster dataset pretreatment, mining algorithm design, and spatial pattern exploration from the mining results. Comparison with the former two subtasks reveals that the latter remains unresolved. Confronted with the interrelated marine environmental parameters, we propose a Tree-based Approach for eXploring Marine Spatial Patterns with multiple raster datasets called TAXMarSP, which includes two models. One is the Tree-based Cascading Organization Model (TCOM), and the other is the Spatial Neighborhood-based CAlculation Model (SNCAM). TCOM designs the "Spatial node -> Pattern node" from top to bottom layers to store the table-formatted frequent patterns. Together with TCOM, SNCAM considers the spatial neighborhood contributions to calculate the pattern-matching degree between the specified marine parameters and the table-formatted frequent patterns and then explores the marine spatial patterns. Using the prevalent quantification Apriori algorithm and a real remote sensing dataset from January 1998 to December 2014, a successful application of TAXMarSP to marine spatial patterns in the Pacific Ocean is described, and the obtained marine spatial patterns present not only the well-known but also new patterns to Earth scientists.	[Liao, Xiaohan; Su, Fenzhen] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Xue, Cunjin] Chinese Acad Sci, Key Lab Digital Earth Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China; [Xue, Cunjin] Key Lab Earth Observat, Sanya, Hainan, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS	Xue, CJ (corresponding author), Chinese Acad Sci, Key Lab Digital Earth Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China.; Xue, CJ (corresponding author), Key Lab Earth Observat, Sanya, Hainan, Peoples R China.	xuecj@radi.ac.cn		XUE, Cunjin/0000-0003-3605-6578	National Natural Science Foundation of China [41671401, 41371385]; Youth Innovation Promotion Association of Chinese Academy of Science [2013113]; National key research and development program of China [2016YFA0600304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association of Chinese Academy of Science; National key research and development program of China	This study has been funded by National Natural Science Foundation of China with No.41671401 and No. 41371385, by Youth Innovation Promotion Association of Chinese Academy of Science with No.2013113, and by National key research and development program of China with No. 2016YFA0600304. CX received all funding. There was no additional external funding received for this study.	Agrawal R., 1995, P DATA ENG, V1995, P3, DOI DOI 10.1109/ICDE.1995.380415; [Anonymous], 2010, B CHIN ACAD SCI; Bayardo Jr Roberto J., 1999, P 5 ACM SIGKDD INT C, P145, DOI DOI 10.1145/312129.312219; Bertolotto M, 2007, INT J GEOGR INF SCI, V21, P895, DOI 10.1080/13658810701349052; Compieta P, 2007, J VISUAL LANG COMPUT, V18, P255, DOI 10.1016/j.jvlc.2007.02.006; Curtis S, 2007, J HYDROMETEOROL, V8, P678, DOI 10.1175/JHM601.1; Ertek G, 2006, LECT NOTES COMPUT SC, V4263, P593; Hoffman FM, 2011, PROCEDIA COMPUT SCI, V4, P1450, DOI 10.1016/j.procs.2011.04.157; Hofmann H., 2000, Proceedings. KDD-2000. Sixth ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P227, DOI 10.1145/347090.347133; Hofmann H, 2001, COMPUTATION STAT, V16, P399, DOI 10.1007/s001800100075; Hooker SB, 2000, PROG OCEANOGR, V45, P427, DOI 10.1016/S0079-6611(00)00012-4; INSELBERG A, 1990, PROCEEDINGS OF THE FIRST IEEE CONFERENCE ON VISUALIZATION - VISUALIZATION 90, P361, DOI 10.1109/VISUAL.1990.146402; Julea A, 2011, IEEE T GEOSCI REMOTE, V49, P1417, DOI 10.1109/TGRS.2010.2081372; Korting TS, 2013, COMPUT GEOSCI-UK, V57, P133, DOI 10.1016/j.cageo.2013.02.007; Kumar V, 2010, COMPUTER SCI, P6118; Li LW, 2014, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.083615; Li X. Y., 2000, ACTA METEOROL SIN, V58, P102; Liao SH, 2012, EXPERT SYST APPL, V39, P11303, DOI 10.1016/j.eswa.2012.02.063; McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Romani LAS, 2013, IEEE T GEOSCI REMOTE, V51, P140, DOI 10.1109/TGRS.2012.2199501; Saulquin B, 2014, IEEE J-STARS, V7, P3543, DOI 10.1109/JSTARS.2014.2329921; Sekhavat Y.A., 2013, INT J INTELL SCI, V3, P34; Srikant R., 1996, P 5 INT C EXT DAT TE, P3, DOI 10.1007/BFb0014140; Su FZ, 2004, ECOL MODEL, V174, P421, DOI 10.1016/j.ecolmodel.2003.10.006; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Trenberth KE, 1997, B AM METEOROL SOC, V78, P2771, DOI 10.1175/1520-0477(1997)078<2771:TDOENO>2.0.CO;2; Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336; Wu E, 2008, THESIS; Xue CJ, 2014, INT J REMOTE SENS, V35, P4467, DOI 10.1080/01431161.2014.916436; Xue CJ, 2015, REMOTE SENS-BASEL, V7, P9149, DOI 10.3390/rs70709149; Xue CJ, 2015, INT J APPL EARTH OBS, V38, P105, DOI 10.1016/j.jag.2014.12.009; Xue CJ, 2015, COMPUT GEOSCI-UK, V76, P121, DOI 10.1016/j.cageo.2014.12.001; Yang J, 2013, NAT CLIM CHANGE, V3, P875, DOI [10.1038/nclimate1908, 10.1038/NCLIMATE1908]; Zhang JT, 2009, COMPUT GEOSCI-UK, V35, P1827, DOI 10.1016/j.cageo.2009.02.006	35	0	0	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177438	10.1371/journal.pone.0177438	http://dx.doi.org/10.1371/journal.pone.0177438			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510602	Green Published, gold, Green Submitted			2022-12-26	WOS:000401485500030
J	Prasetia, R; Sinniger, F; Hashizume, K; Harii, S				Prasetia, Rian; Sinniger, Frederic; Hashizume, Kaito; Harii, Saki			Reproductive biology of the deep brooding coral Seriatopora hystrix: Implications for shallow reef recovery	PLOS ONE			English	Article							GREAT-BARRIER-REEF; LONG-DISTANCE DISPERSAL; POCILLOPORA-DAMICORNIS; RED-SEA; STYLOPHORA-PISTILLATA; SCLERACTINIAN CORAL; SEXUAL REPRODUCTION; LUNAR PERIODICITY; CLIMATE-CHANGE; LARVAL RELEASE	Mesophotic coral ecosystems (MCEs, between 30 and 150 m depth) are hypothesized to contribute to the recovery of degraded shallow reefs through sexually produced larvae (referred to as Deep Reef Refuge Hypothesis). In Okinawa, Japan, the brooder coral Seriatopora hystrix was reported to be locally extinct in a shallow reef while it was found abundant at a MCE nearby. In this context, S. hystrix represents a key model to test the Deep Reef Refuge Hypothesis and to understand the potential contribution of mesophotic corals to shallow coral reef recovery. However, the reproductive biology of mesophotic S. hystrix and its potential to recolonize shallow reefs is currently unknown. This study reports for the first time, different temporal scales of reproductive periodicity and larval settlement of S. hystrix from an upper mesophotic reef (40 m depth) in Okinawa. We examined reproductive seasonality, lunar, and circadian periodicity (based on polyp dissection, histology, and ex situ planula release observations) and larval settlement rates in the laboratory. Mesophotic S. hystrix reproduced mainly in July and early August, with a small number of planulae being released at the end of May, June and August. Compared to shallow colonies in the same region, mesophotic S. hystrix has a 4-month shorter reproductive season, similar circadian periodicity, and smaller planula size. In addition, most of the planulae settled rapidly, limiting larval dispersal potential. The shorter reproductive season and smaller planula size may result from limited energy available for reproduction at deeper depths, while the similar circadian periodicity suggests that this reproductive aspect is not affected by environmental conditions differing with depth. Overall, contribution of mesophotic S. hystrix to shallow reef rapid recovery appears limited, although they may recruit to shallow reefs through a multi-step process over a few generations or through random extreme mixing such as typhoons.	[Prasetia, Rian; Sinniger, Frederic; Hashizume, Kaito; Harii, Saki] Univ Ryukyus, Sesoko Stn, Trop Biosphere Res Ctr, Motobu, Japan	University of the Ryukyus	Harii, S (corresponding author), Univ Ryukyus, Sesoko Stn, Trop Biosphere Res Ctr, Motobu, Japan.	sharii@lab.u-ryukyu.ac.jp	Harii, Saki/AHC-2263-2022	Harii, Saki/0000-0003-0440-7169; Prasetia, Rian/0000-0003-1492-0804	Japan Society for the Promotion of Science [16H02490]; Japan Science Society [27-749]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science Society	This work was funded by the Grant-in-Aid for Scientific Research(A) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/index.html) (No.16H02490) to SH and a Sasakawa Scientific Research Grant from the Japan Science Society (http://www.jss.or.jp/ikusei/sasakawa/) (No. 27-749) to RP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atoda K., 1951, Science Reports of the Tohoku University (4), V19, P33; ATODA K, 1947, SCI REP TOHOKU U, V18, P48; ATODA KENJI, 1947, SCI REPTS TOHOKU IMP UNIV SER 4, V18, P24; AYRE DJ, 1994, EVOLUTION, V48, P1183, DOI 10.1111/j.1558-5646.1994.tb05304.x; AYRE DJ, 1986, MAR BIOL, V90, P187, DOI 10.1007/BF00569126; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bongaerts P, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602373; Bryan DR, 2013, J APPL ICHTHYOL, V29, P108, DOI 10.1111/j.1439-0426.2012.02055.x; Cacciapaglia C, 2016, GLOBAL CHANGE BIOL, V22, P1145, DOI 10.1111/gcb.13166; Cooper TF, 2011, P ROY SOC B-BIOL SCI, V278, P1840, DOI 10.1098/rspb.2010.2321; Dai CF, 1992, P 7 INT COR REEF S G, V1, P448; de Putron SJ, 2011, B MAR SCI, V87, P75, DOI 10.5343/bms.2009.1027; Eyal-Shaham L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20964; Fan TY, 2006, MAR ECOL PROG SER, V321, P133, DOI 10.3354/meps321133; Fan TY, 2002, ZOOL STUD, V41, P288; Garcia-Sais JR, 2010, CORAL REEFS, V29, P277, DOI 10.1007/s00338-009-0582-9; GLYNN PW, 1991, MAR BIOL, V109, P355, DOI 10.1007/BF01313501; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Harii S, 2003, CORAL REEFS, V22, P188, DOI 10.1007/s00338-003-0302-9; Harii S, 2001, CORAL REEFS, V20, P19; Harriott V.J., 1983, Coral Reefs, V2, P151, DOI 10.1007/BF00336721; Harrison P.L., 1990, P133; HAYASHIBARA T, 1993, MAR ECOL PROG SER, V101, P253, DOI 10.3354/meps101253; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Holstein DM, 2016, CORAL REEFS, V35, P23, DOI 10.1007/s00338-015-1339-2; Holstein DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146068; Holstein DM, 2015, SCI REP-UK, V5, DOI 10.1038/srep12407; Hongo C, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001902; Isomura N, 2001, CORAL REEFS, V20, P309, DOI 10.1007/s003380100180; Japan Oceanographic Data Center, 2005, STAT WAT TEMP SAL 1; JOKIEL PL, 1985, MAR BIOL, V88, P167, DOI 10.1007/BF00397164; JOKIEL PL, 1978, B MAR SCI, V28, P786; Kahng SE, 2014, CURR OPIN ENV SUST, V7, P72, DOI 10.1016/j.cosust.2013.11.019; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; KOJIS BL, 1984, CORAL REEFS, V3, P165, DOI 10.1007/BF00301961; KOJIS BL, 1986, MAR BIOL, V91, P291, DOI 10.1007/BF00428623; Lin CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064584; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Loya Y, 2016, CORAL REEFS, V35, P1, DOI 10.1007/s00338-016-1410-7; Madsen A., 2014, SEX EARLY DEV AQUAT, V1, P25, DOI [10.3354/sedao00004, DOI 10.3354/SEDA000004, DOI 10.3354/SEDAO00004]; Maier E, 2005, MAR BIOL, V147, P1109, DOI 10.1007/s00227-005-0013-6; Marshall AT, 2004, CORAL REEFS, V23, P218, DOI 10.1007/s00338-004-0369-y; Marshall DJ, 2008, ADV MAR BIOL, V53, P1, DOI 10.1016/S0065-2881(07)53001-4; McGuire MP, 1998, CORAL REEFS, V17, P369, DOI 10.1007/s003380050141; MNE, 2008, MAR ECOL PROG SER, V370, P111; Nir O, 2011, CORAL REEFS, V30, P1089, DOI 10.1007/s00338-011-0801-z; Nozawa Y, 2005, MAR ECOL PROG SER, V286, P115, DOI 10.3354/meps286115; Pereira GH, 2011, BRAZ J OCEANOGR, V59, P201, DOI 10.1590/S1679-87592011000300001; Prasetia R, 2016, CORAL REEFS, V35, P53, DOI 10.1007/s00338-015-1348-1; Pratchett MS, 2001, CORAL REEFS, V20, P13, DOI 10.1007/s003380000113; Puglise KA, 2016, MESOPHOTIC CORAL ECO, P83; Putnam HM, 2008, BIOL BULL-US, V215, P135, DOI 10.2307/25470694; R Core Team, 2013, R LANG ENV STAT COMP; RICHMOND RH, 1984, B MAR SCI, V34, P280; RICHMOND RH, 1987, B MAR SCI, V41, P594; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; RINKEVICH B, 1979, MAR ECOL PROG SER, V1, P145, DOI 10.3354/meps001145; RINKEVICH B, 1989, MAR BIOL, V101, P259, DOI 10.1007/BF00391465; RINKEVICH B, 1987, BIOL BULL, V173, P335, DOI 10.2307/1541546; Serrano X, 2014, MOL ECOL, V23, P4226, DOI 10.1111/mec.12861; Serrano XM, 2016, SCI REP-UK, V6, DOI 10.1038/srep21619; Sherman CDH, 2008, HEREDITY, V100, P296, DOI 10.1038/sj.hdy.6801076; SHLESINGER Y, 1985, SCIENCE, V228, P1333, DOI 10.1126/science.228.4705.1333; Sinniger F, FRONT MAR S IN PRESS; Sinniger F., 2016, MESOPHOTIC CORAL ECO, P43; Sinniger F, 2013, CORAL REEFS, V32, P153, DOI 10.1007/s00338-012-0973-1; STIMSON JS, 1978, MAR BIOL, V48, P173, DOI 10.1007/BF00395017; STODDART JA, 1985, MAR ECOL PROG SER, V23, P153, DOI 10.3354/meps023153; SZMANTFROELICH A, 1985, B MAR SCI, V37, P880; Tanner JE, 1996, CORAL REEFS, V15, P59, DOI 10.1007/s003380050028; Underwood JN, 2007, MOL ECOL, V16, P771, DOI 10.1111/j.1365-294X.2006.03187.x; van Oppen MJH, 2011, MOL ECOL, V20, P1647, DOI 10.1111/j.1365-294X.2011.05050.x; van Oppen MJH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003401; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; VANMOORSEL GWNM, 1983, MAR ECOL PROG SER, V13, P273, DOI 10.3354/meps013273; Veron JEN, 2000, CORALS WORLD, V2, P48; Vize PD, 2006, CORAL REEFS, V25, P169, DOI 10.1007/s00338-005-0082-5; Warner PA, 2016, MOL ECOL, V25, P1398, DOI 10.1111/mec.13553; Yamazato K, 2008, J JAPANESE CORAL REE, V10, P1; Zakai D, 2006, MAR ECOL PROG SER, V311, P93, DOI 10.3354/meps311093	86	30	30	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177034	10.1371/journal.pone.0177034	http://dx.doi.org/10.1371/journal.pone.0177034			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510601	Green Submitted, gold, Green Published			2022-12-26	WOS:000401485500010
J	Wang, H; Li, SY; Teng, SZ; Liang, HS; Xin, HJ; Gao, HH; Huang, DF; Lang, ZH				Wang, Hai; Li, Shengyan; Teng, Shouzhen; Liang, Haisheng; Xin, Hongjia; Gao, Hongjiang; Huang, Dafang; Lang, Zhihong			Transcriptome profiling revealed novel transcriptional regulators in maize responses to Ostrinia furnacalis and jasmonic acid	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; FEEDING SPODOPTERA-LITTORALIS; PATHOGENESIS-RELATED GENES; DROUGHT STRESS TOLERANCE; INDUCED PLANT DEFENSES; MADS DOMAIN PROTEIN; LIMA-BEAN LEAVES; ABSCISIC-ACID; MOLECULAR ANALYSIS; NICOTIANA-ATTENUATA	Chewing insects cause severe yield losses in crop production worldwide. Crop plants counteract chewing insects by transcriptionally promoting a repertoire of defense gene products that are either toxic to, or attractive to the natural enemies of, pest insects. However, the complexity of the transcriptional reprogramming in plant defense response against chewing insects is still not well understood. In this study, the genome-wide early responses in maize seedlings to Asian corn borer (ACB, Ostrinia furnacalis) and also to jasmonic acid(JA), the pivotal phytohormone controlling plant defense response against herbivory, were transcriptionally profiled by RNA-Seq. Clustering of differentially expressed genes (DEGs) along with functional enrichment analysis revealed important biological processes regulated in response to ACB infestation and/or jasmonic acid. Moreover, DEGs with distinct expression patterns were differentially enriched with diverse families of cis-elements on their promoters. Multiple inventories of differentially expressed transcription factors (DETFs) in each DEG group were also analyzed. A transient expression assay using transfected maize protoplastswas established to examine the potential roles of DETFs in maize defense response and JA signaling, and this was used to show that ZmNAC60, an ACB- and JA-inducible DETF, represented a novel positive regulator of JA and defense pathway genes. This study provided a comprehensive transcriptional picture for the early dynamics of maize defense responses and JA signaling, and the identification of DETFs offered potential targets for further functional genomics investigation of master regulators in maize defense responses against herbivory.	[Wang, Hai; Li, Shengyan; Teng, Shouzhen; Liang, Haisheng; Xin, Hongjia; Gao, Hongjiang; Huang, Dafang; Lang, Zhihong] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Lang, ZH (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China.	langzhihong@caas.cn		Wang, Hai/0000-0002-1722-1518	National Natural Science Foundation of China [31501325, 31570272]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant 31501325 to Hai Wang and Grant 31570272 to Zhihong Lang). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ankala A, 2013, PLANT SCI, V199, P103, DOI 10.1016/j.plantsci.2012.09.017; Butron A, 2010, THEOR APPL GENET, V120, P721, DOI 10.1007/s00122-009-1192-1; Chuang WP, 2014, NEW PHYTOL, V201, P928, DOI 10.1111/nph.12581; Chung HS, 2010, PLANT J, V63, P613, DOI 10.1111/j.1365-313X.2010.04265.x; CONE KC, 1986, P NATL ACAD SCI USA, V83, P9631, DOI 10.1073/pnas.83.24.9631; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Degenhardt J, 2009, P NATL ACAD SCI USA, V106, P13213, DOI 10.1073/pnas.0906365106; Delessert C, 2005, PLANT J, V43, P745, DOI 10.1111/j.1365-313X.2005.02488.x; Eveland AL, 2013, GENOME RES; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Fescemyer HW, 2013, INSECT BIOCHEM MOLEC, V43, P280, DOI 10.1016/j.ibmb.2012.12.008; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Gatehouse JA, 2002, NEW PHYTOL, V156, P145, DOI 10.1046/j.1469-8137.2002.00519.x; Greve K, 2003, BIOCHEM J, V371, P97, DOI 10.1042/BJ20021123; Grunewald W, 2008, PLANT PHYSIOL, V148, P358, DOI 10.1104/pp.108.119131; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu P, 2013, MOL CELL, V50, P504, DOI 10.1016/j.molcel.2013.04.027; Hu W, 2006, PLANT J, V45, P399, DOI 10.1111/j.1365-313X.2005.02626.x; Kesarwani M, 2007, PLANT PHYSIOL, V144, P336, DOI 10.1104/pp.106.095299; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Knight H, 2004, PLANT PHYSIOL, V135, P1710, DOI 10.1104/pp.104.043562; Lawrence SD, 2012, PHYSIOL PLANTARUM, V144, P303, DOI 10.1111/j.1399-3054.2011.01557.x; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Lee SJ, 2009, MOL CELLS, V27, P409, DOI 10.1007/s10059-009-0058-3; Li HM, 2007, PLANT MOL BIOL, V65, P655, DOI 10.1007/s11103-007-9230-3; Lin RC, 2008, MOL PLANT, V1, P42, DOI 10.1093/mp/ssm004; Lopez L, 2007, PLANTA, V226, P517, DOI 10.1007/s00425-007-0501-7; Macel M, 2005, J CHEM ECOL, V31, P1493, DOI 10.1007/s10886-005-5793-0; Maffei ME, 2006, PLANT PHYSIOL, V140, P1022, DOI 10.1104/pp.105.071993; Manevski A, 2000, FEBS LETT, V483, P43, DOI 10.1016/S0014-5793(00)02056-1; Manzaneda AJ, 2010, NEW PHYTOL, V188, P464, DOI 10.1111/j.1469-8137.2010.03385.x; Mao JL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005760; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; Mendes MA, 2013, PLANT CELL, V25, P2560, DOI 10.1105/tpc.112.108688; Mithofer A, 2008, PLANT PHYSIOL, V146, P825, DOI 10.1104/pp.107.113118; Mithofer A, 2005, PLANT PHYSIOL, V137, P1160, DOI 10.1104/pp.104.054460; Mousavi SAR, 2013, NATURE, V500, P422, DOI 10.1038/nature12478; Mukhtar MS, 2008, PLANT J, V56, P935, DOI 10.1111/j.1365-313X.2008.03651.x; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Nesi N, 2002, PLANT CELL, V14, P2463, DOI 10.1105/tpc.004127; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Pandey SP, 2010, PLANT J, V64, P912, DOI 10.1111/j.1365-313X.2010.04387.x; PENACORTES H, 1995, P NATL ACAD SCI USA, V92, P4106, DOI 10.1073/pnas.92.10.4106; Pesch M, 2014, PLANT CELL, V26, P4067, DOI 10.1105/tpc.114.129379; Pre M, 2008, PLANT PHYSIOL, V147, P1347, DOI 10.1104/pp.108.117523; Redillas MCFR, 2012, PLANT BIOTECHNOL J, V10, P792, DOI 10.1111/j.1467-7652.2012.00697.x; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Santiago R, 2005, J ECON ENTOMOL, V98, P1349, DOI 10.1603/0022-0493-98.4.1349; Sasaki-Sekimoto Y, 2013, PLANT PHYSIOL, V163, P291, DOI 10.1104/pp.113.220129; Schafer M, 2011, PLANT PHYSIOL, V156, P1520, DOI 10.1104/pp.111.173567; Schluter U, 2010, J EXP BOT, V61, P4169, DOI 10.1093/jxb/erq166; Schmelz EA, 2012, PLANT PHYSIOL, V160, P1468, DOI 10.1104/pp.112.201061; Schmelz EA, 2009, P NATL ACAD SCI USA, V106, P653, DOI 10.1073/pnas.0811861106; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schnee C, 2006, P NATL ACAD SCI USA, V103, P1129, DOI 10.1073/pnas.0508027103; Schweizer F, 2013, PLANT CELL, V25, P3117, DOI 10.1105/tpc.113.115139; Schweizer F, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00013; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; SHEEN J, 1991, PLANT CELL, V3, P225, DOI 10.1105/tpc.3.3.225; Shen BZ, 2000, P NATL ACAD SCI USA, V97, P14807, DOI 10.1073/pnas.240284097; Song CP, 2005, PLANT CELL, V17, P2384, DOI 10.1105/tpc.105.033043; Song SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003653; Tamayo MC, 2000, PLANTA, V211, P62, DOI 10.1007/s004250000258; Tang WN, 2003, J BIOL CHEM, V278, P28154, DOI 10.1074/jbc.M212976200; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Tilly JJ, 1998, DEVELOPMENT, V125, P1647; To A, 2006, PLANT CELL, V18, P1642, DOI 10.1105/tpc.105.039925; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tremousaygue D, 1999, PLANT J, V20, P553, DOI 10.1046/j.1365-313X.1999.00627.x; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Wang L, 2008, PLANT PHYSIOL, V146, P904, DOI 10.1104/pp.107.109264; Wu JQ, 2007, PLANT CELL, V19, P1096, DOI 10.1105/tpc.106.049353; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yan YX, 2012, PLANT CELL, V24, P1420, DOI 10.1105/tpc.111.094151; Yang FS, 2015, SCI REP-UK, V5, DOI 10.1038/srep16500; Ye M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036214; Yoshii M, 2010, PLANT J, V61, P804, DOI 10.1111/j.1365-313X.2009.04107.x; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x; Zhu ZQ, 2011, P NATL ACAD SCI USA, V108, P12539, DOI 10.1073/pnas.1103959108	87	9	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177739	10.1371/journal.pone.0177739	http://dx.doi.org/10.1371/journal.pone.0177739			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520800	Green Published, gold, Green Submitted			2022-12-26	WOS:000401485500065
J	Wang, J; Zhao, SS; He, W; Wei, Y; Zhang, Y; Pegg, H; Shore, P; Roberts, SGE; Deng, WS				Wang, Juan; Zhao, Shasha; He, Wei; Wei, Yun; Zhang, Yang; Pegg, Henry; Shore, Paul; Roberts, Stefan G. E.; Deng, Wensheng			A transcription factor IIA-binding site differentially regulates RNA polymerase II-mediated transcription in a promoter context-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST TFIIA/TBP/DNA COMPLEX; CORE PROMOTER; TATA BOX; GENERAL TRANSCRIPTION; ACTIVATED TRANSCRIPTION; DNA-BINDING; IN-VITRO; QUATERNARY COMPLEX; CRYSTAL-STRUCTURE; TBP BINDING	RNA polymerase II (pol II) is required for the transcription of all protein-coding genes and as such represents a major enzyme whose activity is tightly regulated. Transcriptional initiation therefore requires numerous general transcriptional factors and cofactors that associate with pol II at the core promoter to form a pre-initiation complex. Transcription factor IIA (TFIIA) is a general cofactor that binds TFIID and stabilizes the TFIID-DNA complex during transcription initiation. Previous studies showed that TFIIA can make contact with the DNA sequence upstream or downstream of the TATA box, and that the region bound by TFIIA could overlap with the elements recognized by another factor, TFIIB, at adenovirus major late core promoter. Whether core promoters contain a DNA motif recognized by TFIIA remains unknown. Here we have identified a core promoter element upstream of the TATA box that is recognized by TFIIA. A search of the human promoter database revealed that many natural promoters contain a TFIIA recognition element (IIARE). We show that the IIARE enhances TFIIA-promoter binding and enhances the activity of TATA-containing promoters, but represses or activates promoters that lack a TATA box. Chromatin immunoprecipitation assays revealed that the IIARE activates transcription by increasing the recruitment of pol II, TFIIA, TAF4, and P300 at TATA-dependent promoters. These findings extend our understanding of the role of TFIIA in transcription, and provide new insights into the regulatory mechanism of core promoter elements in gene transcription by pol II.	[Wang, Juan; Zhao, Shasha; He, Wei; Wei, Yun; Zhang, Yang; Deng, Wensheng] Wuhan Univ Sci & Technol, Inst Biol & Med, Wuhan 430065, Hubei Province, Peoples R China; [Pegg, Henry; Shore, Paul] Univ Manchester, Sch Biol Sci, Manchester M13 9PL, Lancs, England; [Roberts, Stefan G. E.] Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England	Wuhan University of Science & Technology; University of Manchester; University of Bristol	Deng, WS (corresponding author), Wuhan Univ Sci & Technol, Inst Biol & Med, Wuhan 430065, Hubei Province, Peoples R China.; Roberts, SGE (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England.	stefan.roberts@bristol.ac.uk; dengwensheng@wust.edu.cn	Roberts, Stefan GE/R-5537-2016	Roberts, Stefan GE/0000-0002-7535-6365; Shore, Paul/0000-0002-1832-5976	National Natural Science Foundation of China [31271395, 31673157]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Project Grants 31271395 and 31673157 (to W. D.). The authors declare that they have no conflicts of interest with the contents of this article.	AUBLE DT, 1993, GENE DEV, V7, P844, DOI 10.1101/gad.7.5.844; Barbash ZS, 2013, MOL CELL BIOL, V33, P4395, DOI 10.1128/MCB.00553-13; Bleichenbacher M, 2003, J MOL BIOL, V332, P783, DOI 10.1016/S0022-2836(03)00887-8; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; Clemens KE, 1996, MOL CELL BIOL, V16, P4656; Coleman RA, 1999, MOL CELL, V4, P451, DOI 10.1016/S1097-2765(00)80453-0; COULOMBE B, 1994, J BIOL CHEM, V269, P19962; Danino YM, 2015, BBA-GENE REGUL MECH, V1849, P1116, DOI 10.1016/j.bbagrm.2015.04.003; DEJONG J, 1995, P NATL ACAD SCI USA, V92, P3313, DOI 10.1073/pnas.92.8.3313; Deng WS, 2009, MOL CELL BIOL, V29, P1389, DOI 10.1128/MCB.01346-08; Deng WS, 2005, GENE DEV, V19, P2418, DOI 10.1101/gad.342405; Dion V, 2003, J BIOL CHEM, V278, P11495, DOI 10.1074/jbc.M211938200; Dreos R, 2015, NUCLEIC ACIDS RES, V43, pD92, DOI 10.1093/nar/gku1111; Dreos R, 2017, NUCLEIC ACIDS RES, V45, pD51, DOI 10.1093/nar/gkw1069; Evans R, 2001, GENE DEV, V15, P2945, DOI 10.1101/gad.206901; Ge H, 1996, METHOD ENZYMOL, V274, P57; GE H, 1994, J BIOL CHEM, V269, P17136; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; KOBAYASHI N, 1995, MOL CELL BIOL, V15, P6465; KOKUBO T, 1993, GENE DEV, V7, P1033, DOI 10.1101/gad.7.6.1033; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Lagrange T, 1996, P NATL ACAD SCI USA, V93, P10620, DOI 10.1073/pnas.93.20.10620; Lee MP, 2005, GENOME RES, V15, P1189, DOI 10.1101/gr.3873705; MA DM, 1993, GENE DEV, V7, P2246, DOI 10.1101/gad.7.11.2246; Malecova B, 2015, TRANSCR-AUSTIN, V6, P21, DOI 10.1080/21541264.2015.1052178; Marbach-Bar N, 2016, NUCLEIC ACIDS RES, V44, P1080, DOI 10.1093/nar/gkv1032; Maston GA, 2012, ELIFE, V1, DOI 10.7554/eLife.00068; Mitsiou DJ, 2003, EMBO J, V22, P4501, DOI 10.1093/emboj/cdg419; Oelgeschlager T, 1996, NATURE, V382, P735, DOI 10.1038/382735a0; Oyama T, 2013, DEV CELL, V27, P188, DOI 10.1016/j.devcel.2013.09.025; OZER J, 1994, GENE DEV, V8, P2324, DOI 10.1101/gad.8.19.2324; Papai G, 2010, NATURE, V465, P956, DOI 10.1038/nature09080; Rabenstein MD, 1999, P NATL ACAD SCI USA, V96, P4791, DOI 10.1073/pnas.96.9.4791; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; REITER WD, 1990, P NATL ACAD SCI USA, V87, P9509, DOI 10.1073/pnas.87.24.9509; Robinson MM, 2005, MOL CELL BIOL, V25, P945, DOI 10.1128/MCB.25.3.945-957.2005; Roy AL, 2015, TRENDS BIOCHEM SCI, V40, P165, DOI 10.1016/j.tibs.2015.01.007; Schimanski B, 2005, MOL CELL BIOL, V25, P7303, DOI 10.1128/MCB.25.16.7303-7313.2005; Shao HS, 2005, MOL CELL BIOL, V25, P206, DOI 10.1128/MCB.25.1.206-219.2005; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Solow S, 2001, J BIOL CHEM, V276, P15886, DOI 10.1074/jbc.M009385200; Suzuki H, 2015, NUCLEIC ACIDS RES, V43, P6285, DOI 10.1093/nar/gkv576; Takeda S, 2015, J CLIN INVEST, V125, P1203, DOI 10.1172/JCI77075; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; VANDYKE MW, 1988, SCIENCE, V241, P1335, DOI 10.1126/science.3413495; Venters BJ, 2009, CRIT REV BIOCHEM MOL, V44, P117, DOI 10.1080/10409230902858785; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135317; Wu SY, 1998, J BIOL CHEM, V273, P12492, DOI 10.1074/jbc.273.20.12492; Xie J, 2000, EMBO J, V19, P672, DOI 10.1093/emboj/19.4.672; YOKOMORI K, 1993, GENE DEV, V7, P2235, DOI 10.1101/gad.7.11.2235; Zaborowska J, 2012, TRANSCR-AUSTIN, V3, P92, DOI 10.4161/trns.19783; Zhou HQ, 2006, MOL CELL BIOL, V26, P2728, DOI 10.1128/MCB.26.7.2728-2735.2006	56	8	8	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11873	11885		10.1074/jbc.M116.770412	http://dx.doi.org/10.1074/jbc.M116.770412			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28539359	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000405485600024
J	Albarino, CG; Guerrero, LW; Jenks, HM; Chakrabarti, AK; Ksiazek, TG; Rollin, PE; Nichol, ST				Albarino, Cesar G.; Guerrero, Lisa Wiggleton; Jenks, Harley M.; Chakrabarti, Ayan K.; Ksiazek, Thomas G.; Rollin, Pierre E.; Nichol, Stuart T.			Insights into Reston virus spillovers and adaption from virus whole genome sequences	PLOS ONE			English	Article							EBOLA-VIRUS; IMMUNE EVASION; SUBTYPE RESTON; FRUIT BATS; INFECTION; EVOLUTION; PHILIPPINES; ANTIBODIES; DISEASE	Reston virus (family Filoviridae) is unique among the viruses of the Ebolavirus genus in that it is considered non-pathogenic in humans, in contrast to the other members which are highly virulent. The virus has however, been associated with several outbreaks of highly lethal hemorrhagic fever in non-human primates (NHPs), specifically cynomolgus monkeys (Macaca fascicularis) originating in the Philippines. In addition, Reston virus has been isolated from domestic pigs in the Philippines. To better understand virus spillover events and potential adaption to new hosts, the whole genome sequences of representative Reston virus isolates were obtained using a next generation sequencing (NGS) approach and comparative genomic analysis and virus fitness analyses were performed. Nine virus genome sequences were completed for novel and previously described isolates obtained from a variety of hosts including a human case, non-human primates and pigs. Results of phylogenetic analysis of the sequence differences are consistent with multiple independent introductions of RESTV from a still unknown natural reservoir into non-human primates and swine farming operations. No consistent virus genetic markers were found specific for viruses associated with primate or pig infections, but similar to what had been seen with some Ebola viruses detected in the large Western Africa outbreak in 2014-2016, a truncated version of VP30 was identified in a subgroup of Reston viruses obtained from an outbreak in pigs 2008-2009. Finally, the genetic comparison of two closely related viruses, one isolated from a human case and one from an NHP, showed amino acid differences in the viral polymerase and detectable differences were found in competitive growth assays on human and NHP cell lines.	[Albarino, Cesar G.; Guerrero, Lisa Wiggleton; Jenks, Harley M.; Chakrabarti, Ayan K.; Rollin, Pierre E.; Nichol, Stuart T.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Ksiazek, Thomas G.] Univ Texas Med Branch, Galveston, TX 77555 USA	Centers for Disease Control & Prevention - USA; University of Texas System; University of Texas Medical Branch Galveston	Albarino, CG (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA USA.	calbarino@cdc.gov		Rollin, Pierre/0000-0002-4608-2641	Department of Health and Human Services, United States Government	Department of Health and Human Services, United States Government	The study was funded by the Department of Health and Human Services, United States Government. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarino CG, 2016, VIROLOGY, V496, P237, DOI 10.1016/j.virol.2016.06.011; Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; Basler CF, 2015, VIROLOGY, V479, P122, DOI 10.1016/j.virol.2015.03.030; Burk R, 2016, FEMS MICROBIOL REV, V40, P494, DOI 10.1093/femsre/fuw010; Cantoni D, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00322-16; Carroll SA, 2013, J VIROL, V87, P2608, DOI 10.1128/JVI.03118-12; CDC, 1989, MMWR-MORBID MORTAL W, V38, P7; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P831; Centers for Disease Control (CDC), 1990, MMWR Morb Mortal Wkly Rep, V39, P221; Cornish JP, 2017, GENOME ANNOUNCEMENTS, V5; DALGARD DW, 1992, LAB ANIM SCI, V42, P152; Feldmann H., 2013, FIELDS VIROLOGY, V1, P923; GEISBERT TW, 1990, J CLIN PATHOL, V43, P813, DOI 10.1136/jcp.43.10.813; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Groseth A, 2002, VIRUS RES, V87, P155, DOI 10.1016/S0168-1702(02)00087-4; Guito JC, 2017, VIROLOGY, V501, P147, DOI 10.1016/j.virol.2016.11.015; Ikegami T, 2001, ARCH VIROL, V146, P2021, DOI 10.1007/s007050170049; JAHRLING PB, 1990, LANCET, V335, P502, DOI 10.1016/0140-6736(90)90737-P; Jayme SI, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0331-3; Kugelman JR, 2015, EMERG INFECT DIS, V21, P1135, DOI 10.3201/eid2107.150522; Ladner JT, 2015, CELL HOST MICROBE, V18, P659, DOI 10.1016/j.chom.2015.11.008; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Maganga GD, 2014, NEW ENGL J MED, V371, P2083, DOI 10.1056/NEJMoa1411099; Messaoudi I, 2015, NAT REV MICROBIOL, V13, P663, DOI 10.1038/nrmicro3524; Miranda MEG, 2011, J INFECT DIS, V204, pS757, DOI 10.1093/infdis/jir296; Morikawa S, 2007, COMP IMMUNOL MICROB, V30, P391, DOI 10.1016/j.cimid.2007.05.005; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Ng M, 2015, ELIFE, V4, DOI 10.7554/eLife.11785; Olival KJ, 2013, EMERG INFECT DIS, V19, P270, DOI 10.3201/eid1902.120524; Pan YY, 2014, ARCH VIROL, V159, P1129, DOI 10.1007/s00705-012-1477-6; Pourrut X, 2007, J INFECT DIS, V196, pS176, DOI 10.1086/520541; Rollin PE, 1999, J INFECT DIS, V179, pS108, DOI 10.1086/514303; Rougeron V, 2015, J CLIN VIROL, V64, P111, DOI 10.1016/j.jcv.2015.01.014; Taniguchi S, 2011, EMERG INFECT DIS, V17, P1559, DOI 10.3201/eid1708.101693; Tong YG, 2015, NATURE, V524, P93, DOI 10.1038/nature14490; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Whitmer SLM, 2016, J INFECT DIS, V214, pS333, DOI 10.1093/infdis/jiw177; WHO, 1992, VIR HAEM FEV IMP MON; World Health Organisation, 2016, EB SIT REP 30 MARCH; Yuan JF, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-236; Zhang APP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002550	42	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178224	10.1371/journal.pone.0178224	http://dx.doi.org/10.1371/journal.pone.0178224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542463	Green Published, gold, Green Submitted			2022-12-26	WOS:000402062800057
J	Cameron, SJS; Lewis, KE; Huws, SA; Hegarty, MJ; Lewis, PD; Pachebat, JA; Mur, LAJ				Cameron, Simon J. S.; Lewis, Keir E.; Huws, Sharon A.; Hegarty, Matthew J.; Lewis, Paul D.; Pachebat, Justin A.; Mur, Luis A. J.			A pilot study using metagenomic sequencing of the sputum microbiome suggests potential bacterial biomarkers for lung cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; STREPTOCOCCUS-ANGINOSUS; GRANULICATELLA-ADIACENS; COMMUNITIES; INFECTION; SERVER; COPD; HEAD; DNA	Lung cancer (LC) is the most prevalent cancer worldwide, and responsible for over 1.3 million deaths each year. Currently, LC has a low five year survival rates relative to other cancers, and thus, novel methods to screen for and diagnose malignancies are necessary to improve patient outcomes. Here, we report on a pilot-sized study to evaluate the potential of the sputum microbiome as a source of non-invasive bacterial biomarkers for lung cancer status and stage. Spontaneous sputum samples were collected from ten patients referred with possible LC, of which four were eventually diagnosed with LC (LC+), and six had no LC after one year (LC-). Of the seven bacterial species found in all samples, Streptococcus viridans was significantly higher in LC+ samples. Seven further bacterial species were found only in LC-, and 16 were found only in samples from LC+. Additional taxonomic differences were identified in regards to significant fold changes between LC+ and LC- cases, with five species having significantly higher abundances in LC+, with Granulicatella adiacens showing the highest level of abundance change. Functional differences, evident through significant fold changes, included polyamine metabolism and iron siderophore receptors. G. adiacens abundance was correlated with six other bacterial species, namely Enterococcus sp. 130, Streptococcus intermedius, Escherichia coli, S. viridans, Acinetobacter junii, and Streptococcus sp. 6, in LC+ samples only, which could also be related to LC stage. Spontaneous sputum appears to be a viable source of bacterial biomarkers which may have utility as biomarkers for LC status and stage.	[Cameron, Simon J. S.; Huws, Sharon A.; Hegarty, Matthew J.; Pachebat, Justin A.; Mur, Luis A. J.] Inst Biol Environm & Rural Sci, Edward Llywd Bldg,Penglais Campus, Aberystwyth, Ceredigion, Wales; [Lewis, Keir E.] Hywel Dda Univ, Prince Phillip Hosp, Dept Resp Med, Hlth Board, Llanelli, Wales; [Lewis, Keir E.; Lewis, Paul D.] Swansea Univ, Coll Med, Swansea, W Glam, Wales	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Swansea University	Mur, LAJ (corresponding author), Inst Biol Environm & Rural Sci, Edward Llywd Bldg,Penglais Campus, Aberystwyth, Ceredigion, Wales.	lum@aber.ac.uk	Mur, Luis a. j./U-1052-2017	Mur, Luis a. j./0000-0002-0961-9817; Lewis, Keir/0000-0002-8248-6774; Pachebat, Justin/0000-0003-3369-3205; Hegarty, Matthew/0000-0001-6547-3800; Lewis, Keir/0000-0001-9756-4723; Cameron, Simon/0000-0001-9570-135X; Huws, Sharon/0000-0002-9284-2453	BBSRC (UK) [BBS/ENV/10964A01A]; Aberystwyth University; National Institute for Social Care and Health Research (NISCHR, Wales, UK); Biotechnology and Biological Sciences Research Council (BBSRC), UK; The British Council [172629373] Funding Source: researchfish	BBSRC (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Aberystwyth University; National Institute for Social Care and Health Research (NISCHR, Wales, UK); Biotechnology and Biological Sciences Research Council (BBSRC), UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); The British Council	BBSRC (UK) support (BBS/ENV/10964A01A) allowed the metagenomic sequencing to be carried out. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SJSC is grateful for studentship from Aberystwyth University. We wish to thank Dr Paul Griffiths, Consultant histopathologist, for sputum cytological assessment and Dr Chris Creevey and Dr Martin Swain for helpful discussion. This work is also partially supported through grants to KEL and PDL from National Institute for Social Care and Health Research (NISCHR, Wales, UK). IBERS receives strategic funding from Biotechnology and Biological Sciences Research Council (BBSRC), UK who provided the sequencing platform infrastructure to support this work. We would also like to thank the reviewers of this manuscript for their helpful and constructive criticisms of earlier drafts.	Bizzarro MJ, 2011, EMERG INFECT DIS, V17, P1971, DOI 10.3201/eid1710.101967; Brenner DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017479; Cameron SJS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149095; Cameron SJS, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv091; Caramori G, 2011, INT J BIOCHEM CELL B, V43, P1030, DOI 10.1016/j.biocel.2010.08.022; Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743; D'Urso V, 2013, J CELL PHYSIOL, V228, P945, DOI 10.1002/jcp.24263; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Field D, 2006, NAT BIOTECHNOL, V24, P801, DOI 10.1038/nbt0706-801; Hao F, 2013, ADV MATER RES-SWITZ, V641-642, P625, DOI 10.4028/www.scientific.net/AMR.641-642.625; Hauser PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090934; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hosgood HD, 2014, ENVIRON MOL MUTAGEN, V55, P643, DOI 10.1002/em.21878; Hubers AJ, 2013, BRIT J CANCER, V109, P530, DOI 10.1038/bjc.2013.393; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Khan AA, 2012, BBA-REV CANCER, V1826, P331, DOI 10.1016/j.bbcan.2012.05.005; Koshiol J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032106; Lewis PD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-640; Lim YW, 2013, J CYST FIBROS, V12, P154, DOI 10.1016/j.jcf.2012.07.009; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Narikiyo M, 2004, CANCER SCI, V95, P569, DOI 10.1111/j.1349-7006.2004.tb02488.x; Nowotarski SL, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.3; Ohigashi S, 2013, DIGEST DIS SCI, V58, P1717, DOI 10.1007/s10620-012-2526-4; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Perkins A, 2003, CLIN MICROBIOL INFEC, V9, P576, DOI 10.1046/j.1469-0691.2003.00646.x; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sasaki H, 1998, CANCER RES, V58, P2991; Shiga K, 2001, ONCOL REP, V8, P245; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Tateda M, 2000, INT J MOL MED, V6, P699; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347; Willner D, 2011, ISME J; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Woo PCY, 2003, J MED MICROBIOL, V52, P137, DOI 10.1099/jmm.0.04950-0; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xiong W, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0028-2; Young RP, 2010, EUR RESPIR J, V36, P1375, DOI 10.1183/09031936.00033310; Young RP, 2009, EUR RESPIR J, V34, P380, DOI 10.1183/09031936.00144208	44	83	92	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177062	10.1371/journal.pone.0177062	http://dx.doi.org/10.1371/journal.pone.0177062			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542458	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800007
J	Fang, H; Liang, JJ; Hong, Z; Sugiyama, K; Nozaki, T; Kobayashi, S; Sameshima, T; Namba, H; Asakawa, T				Fang, Huan; Liang, Jingjuan; Hong, Zhen; Sugiyama, Kenji; Nozaki, Takao; Kobayashi, Susumu; Sameshima, Tetsuro; Namba, Hiroki; Asakawa, Tetsuya			Psychometric evaluation of the Chinese version of the revised American Pain Society Patient Outcome Questionnaire concerning pain management in Chinese orthopedic patients	PLOS ONE			English	Article							QUALITY; ADULTS	The present study tested the clinical efficiency (item grouping, internal consistency of the subscales, construct validity, and clinical feasibility) of a widely used pain assessment system, the Mandarin version of the American Pain Society Patient Outcome Questionnaire (APS-POQ-R-C), in Chinese patients. We also attempted to investigate the current quality of pain management provided in orthopedic inpatient units in China and provide baseline data. First, we investigated the test-retest reliability of APS-POQ-R-C. In total, 236 orthopedic patients were evaluated. Our results showed that APS-POQ-R-C has satisfactory internal consistency and construct validity, although some items are not appropriate for orthopedic patients. Test-retest reliability outcomes indicated that APS-POQ-R-C is a satisfactory battery with acceptable validity and reliability, and is therefore recommended for pain management in future studies.	[Fang, Huan] Fudan Univ, Dept Pharm, Jinshan Hosp, Shanghai, Peoples R China; [Liang, Jingjuan] Fudan Univ, Dept Orthoped, Huashan Hosp, Shanghai, Peoples R China; [Hong, Zhen] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai, Peoples R China; [Sugiyama, Kenji; Nozaki, Takao; Kobayashi, Susumu; Sameshima, Tetsuro; Namba, Hiroki; Asakawa, Tetsuya] Hamamatsu Univ, Dept Neurosurg, Sch Med, Hamamatsu, Shizuoka, Japan	Fudan University; Fudan University; Fudan University; Hamamatsu University School of Medicine	Fang, H (corresponding author), Fudan Univ, Dept Pharm, Jinshan Hosp, Shanghai, Peoples R China.; Asakawa, T (corresponding author), Hamamatsu Univ, Dept Neurosurg, Sch Med, Hamamatsu, Shizuoka, Japan.	fanghanyu2010@163.com; asakawat1971@gmail.com	Asakawa, Tetsuya/ABE-5307-2020	Asakawa, Tetsuya/0000-0002-2300-3509	Japanese Society for the Promotion of Science [20791025, 24592157, 15k10358]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	A was supported by grants from the Japanese Society for the Promotion of Science (Grant-in-Aid for Young Scientists, Type B, No. 20791025 and Grant-in-Aid for Scientific Research C, General, No. 24592157 and 15k10358). https:// www.jsps.go.jp/english/.	Anastasi AaU, 1997, PSYCHOL TESTING; Bond MR, P 7 WORLD C PAIN; Botti M, 2015, J PAIN, V16, P727, DOI 10.1016/j.jpain.2015.03.016; Dihle A, 2006, J PAIN, V7, P272, DOI 10.1016/j.jpain.2005.11.005; Dihle A, 2008, J CLIN NURS, V17, P2070, DOI 10.1111/j.1365-2702.2007.02142.x; Dong NPT, 2017, SOMATOSENS MOT RES, P1; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; Erlenwein J, 2014, SCHMERZ, V28, P147, DOI 10.1007/s00482-014-1398-2; Evans CJ, 2004, PAIN, V112, P254, DOI 10.1016/j.pain.2004.09.005; Field A., 2009, DISCOVERING STAT USI, V3, DOI DOI 10.1080/1057610X.2016.1157408; Gilson AM, 2007, CA-CANCER J CLIN, V57, P341, DOI 10.3322/CA.57.6.341; Gordon DB, 2005, ARCH INTERN MED, V165, P1574, DOI 10.1001/archinte.165.14.1574; Gordon Debra B, 2002, Pain Manag Nurs, V3, P116, DOI 10.1053/jpmn.2002.127570; Gordon DB, 2010, J PAIN, V11, P1172, DOI 10.1016/j.jpain.2010.02.012; Hansson E, 2006, PAIN MANAG NURS, V7, P93, DOI 10.1016/j.pmn.2006.06.002; Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016; Idvall E, 2002, J ADV NURS, V37, P532, DOI 10.1046/j.1365-2648.2002.02130.x; Khan DA, 2010, J ALLERGY CLIN IMMUN, V125, pS126, DOI 10.1016/j.jaci.2009.10.028; Kwon JH, 2013, J PALLIAT MED, V16, P908, DOI 10.1089/jpm.2012.0610; Labianca R, 2012, CLIN DRUG INVEST, V32, P53, DOI 10.2165/11630080-000000000-00000; Langford RM, 2006, CLIN RHEUMATOL, V25, pS2, DOI 10.1007/s10067-006-0311-5; Lorenz KA, 2009, J AM BOARD FAM MED, V22, P291, DOI 10.3122/jabfm.2009.03.080162; Manjiani D, 2014, OCHSNER J, V14, P208; Mularski RA, 2006, J GEN INTERN MED, V21, P607, DOI 10.1111/j.1525-1497.2006.00415.x; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Shaik MM, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0509-5; Solensky R, 2010, ANN ALLERG ASTHMA IM, V105, P259, DOI 10.1016/j.anai.2010.08.002; Stockler MR, 2012, J CLIN ONCOL, V30, P1907, DOI 10.1200/JCO.2011.41.3146; Tan EC, 2008, J PAIN, V9, P849, DOI 10.1016/j.jpain.2008.04.004; Walid Mohammad Sami, 2008, Pain Pract, V8, P417, DOI 10.1111/j.1533-2500.2008.00222.x; Zoega S, 2014, PAIN MANAG NURS, V15, P143, DOI 10.1016/j.pmn.2012.08.001	31	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178268	10.1371/journal.pone.0178268	http://dx.doi.org/10.1371/journal.pone.0178268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542551	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800061
J	Takeda, H; Zhou, W; Kido, K; Suno, R; Iwasaki, T; Kobayashi, T; Sawasaki, T				Takeda, Hiroyuki; Zhou, Wei; Kido, Kohki; Suno, Ryoji; Iwasaki, Takahiro; Kobayashi, Takuya; Sawasaki, Tatsuya			CP5 system, for simple and highly efficient protein purification with a C-terminal designed mini tag	PLOS ONE			English	Article							RECOMBINANT PROTEINS; STEP PURIFICATION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; COUPLED RECEPTOR; AFFINITY TAG; ANTIBODY; IMMOBILIZATION; PEPTIDE; COMPLEX	There are many strategies to purify recombinant proteins of interest, and affinity purification utilizing monoclonal antibody that targets a linear epitope sequence is one of the essential techniques used in current biochemistry and structural biology. Here we introduce a new protein purification system using a very short CP5 tag. First, we selected anti-dopamine receptor D1 (DRD1) rabbit monoclonal antibody clone Ra62 (Ra62 antibody) as capture antibody, and identified its minimal epitope sequence as a 5-amino-acid sequence at C-terminal of DRD1 (GQHPT-COOH, D1CE sequence). We found that single amino acid substitution in D1CE sequence (GQHVT-COOH) increased dissociation rate up to 10-fold, and named the designed epitope sequence CP5 tag. Using Ra62 antibody and 2 peptides with different affinity, we developed a new affinity protein purification method, CP5 system. Ra62 antibody quickly captures CP5-tagged target protein, and captured CP5-tagged protein was eluted by competing with higher affinity D1CE peptide. By taking the difference of the affinity between D1CE and CP5, sharp elution under mild condition was achieved. Using CP5 system, we successfully purified deubiquitinase CYLD and E3 ubiquitin ligase MARCH3, and detected their catalytic activity. As to G protein-coupled receptors (GPCRs), 9 out of 12 cell-free synthesized ones were purified, demonstrating its purification capability of integral membrane proteins. CP5 tagged CHRM2 expressed by baculovirus-insect cell was also successfully purified by CP5 system. CP5 system offers several distinct advantages in addition to its specificity and elution performance. CP5 tag is easy to construct and handle because of its short length, which has less effect on protein characters. Mild elution of CP5 system is particulaly suitable for preparing delicate proteins such as enzymes and membrane proteins. Our data demonstrate that CP5 system provides a new promising option in protein sample preparation with high yield, purity and activity for downstream applications in functional and structural analysis.	[Takeda, Hiroyuki; Zhou, Wei; Kido, Kohki; Iwasaki, Takahiro; Sawasaki, Tatsuya] Ehime Univ, Proteosci Ctr, Matsuyama, Ehime, Japan; [Suno, Ryoji; Kobayashi, Takuya] Kyoto Univ, Dept Med Chem & Cell Biol, Grad Sch Med, Sakyo Ku, Kyoto, Japan; [Kobayashi, Takuya] Japan Agcy Med Res & Dev, AMED CREST, Chiyoda Ku, Tokyo, Japan	Ehime University; Kyoto University	Sawasaki, T (corresponding author), Ehime Univ, Proteosci Ctr, Matsuyama, Ehime, Japan.	sawasaki@ehime-u.ac.jp		Suno, Ryoji/0000-0003-2378-236X; Sawasaki, Tatsuya/0000-0002-7952-0556	Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan; JSPS KAKENHI [24710251, 15K08268, 25117719, 25290077, 26640130, 26750375]; Grants-in-Aid for Scientific Research [16H06579, 16H04729] Funding Source: KAKEN	Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was mainly supported by Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan (K. T. and T. S.). This work was also partially supported by JSPS KAKENHI Grant Numbers 24710251 (H. T.), 15K08268 (R.S.), 25117719 (T.S.), 25290077 (T.S.), 26640130 (T.S.), and 26750375 (H. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], IMPROVED STRATEGY EA, V55, P227; BEDOUELLE H, 1988, EUR J BIOCHEM, V171, P541, DOI 10.1111/j.1432-1033.1988.tb13823.x; Crowe J, 1994, Methods Mol Biol, V31, P371; Dalibor Milie DBV, 2015, FRONTIERS MEDIA SA, V6, P394; Einhauer A, 2001, J CHROMATOGR A, V921, P25, DOI 10.1016/S0021-9673(01)00831-7; Fujii Y, 2014, PROTEIN EXPRES PURIF, V95, P240, DOI 10.1016/j.pep.2014.01.009; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Morris J, 2016, PROTEIN EXPRES PURIF, V126, P93, DOI 10.1016/j.pep.2016.05.013; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nilsson J, 1997, PROTEIN EXPRES PURIF, V11, P1, DOI 10.1006/prep.1997.0767; PRICKETT KS, 1989, BIOTECHNIQUES, V7, P580; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Sawasaki T, 2002, FEBS LETT, V514, P102, DOI 10.1016/S0014-5793(02)02329-3; Sawasaki T, 2008, FEBS LETT, V582, P221, DOI 10.1016/j.febslet.2007.12.004; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Takeda H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11333; Wood DW, 2014, CURR OPIN STRUC BIOL, V26, P54, DOI 10.1016/j.sbi.2014.04.006; Xu XL, 2010, PROTEIN EXPRES PURIF, V72, P149, DOI 10.1016/j.pep.2010.04.009; Yano T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156716	27	5	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178246	10.1371/journal.pone.0178246	http://dx.doi.org/10.1371/journal.pone.0178246			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542437	Green Submitted, Green Published, gold			2022-12-26	WOS:000402062800060
J	Finch, JA; Guillaume, G; French, SA; Colaco, RDDR; Davies, JM; Swarbreck, SM				Finch, Jessica A.; Guillaume, Gaetan; French, Stephanie A.; Colaco, Renato D. D. R.; Davies, Julia M.; Swarbreck, Stephanie M.			Wheat root length and not branching is altered in the presence of neighbours, including blackgrass	PLOS ONE			English	Article							ARCHITECTURAL TRAITS; GRAIN-YIELD; PLANT; RECOGNITION; ADAPTATION; GROWTH; BRACHYPODIUM; PRODUCTIVITY; NUTRIENTS; RESPONSES	The effect of neighbouring plants on crop root system architecture may directly interfere with water and nutrient acquisition, yet this important and interesting aspect of competition remains poorly understood. Here, the effect of the weed blackgrass (Alopecurus myosuroides Huds.) on wheat (Triticum aestivum L.) roots was tested, since a low density of this species (25 plants m(-2)) can lead to a 10% decrease in wheat yield and herbicide resistance is problematic. We used a simplified growth system based on gelled medium, to grow wheat alongside a neighbour, either another wheat plant, a blackgrass or Brachypodium dystachion individual (a model grass). A detailed analysis of wheat seminal root system architecture showed that the presence of a neighbour principally affected the root length, rather than number or diameter under a high nutrient regime. In particular, the length of first order lateral roots decreased significantly in the presence of blackgrass and Brachypodium. However, this effect was not noted when wheat plants were grown in low nutrient conditions. This suggests that wheat may be less sensitive to the presence of blackgrass when grown in low nutrient conditions. In addition, nutrient availability to the neighbour did not modulate the neighbour effect on wheat root architecture.	[Finch, Jessica A.; Guillaume, Gaetan; French, Stephanie A.; Colaco, Renato D. D. R.; Davies, Julia M.; Swarbreck, Stephanie M.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Finch, Jessica A.] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England; [French, Stephanie A.] Univ Liverpool, Dept Mol & Clin Pharmacol, Inst Translat Med, Liverpool, Merseyside, England; [Colaco, Renato D. D. R.] Univ Cambridge, Dept Med, Cambridge, England	University of Cambridge; University of Warwick; University of Liverpool; University of Cambridge	Swarbreck, SM (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	ss2062@cam.ac.uk	French, Stephanie/GQB-0570-2022	Colaco, Renato Daniel dos Reis/0000-0002-9047-1468; Swarbreck, Stephanie M./0000-0001-8355-7354	European Union FP7 Marie Curie International Reintegration Grant; Gatsby Charitable Foundation; Broodbank Trust University of Cambridge; Newton Trust University of Cambridge	European Union FP7 Marie Curie International Reintegration Grant; Gatsby Charitable Foundation; Broodbank Trust University of Cambridge; Newton Trust University of Cambridge	This work was supported European Union FP7 Marie Curie International Reintegration Grant, the Gatsby Charitable Foundation, the Broodbank Trust University of Cambridge, the Newton Trust University of Cambridge.; We thank Dr. Krys Kelly (Department of Plant Sciences, University of Cambridge) and Dr. Tangyao Wang (Department of Pure Mathematics and Mathematical Statistics, University of Cambridge) for advice on statistical analyses. This work was supported by European Union FP7 Marie Curie International Reintegration Grant, the Gatsby Charitable Foundation, the Broodbank Trust and the Newton Trust University of Cambridge.	Andrew IKS, 2015, WEED RES, V55, P239, DOI 10.1111/wre.12137; Araus JL, 2008, CRIT REV PLANT SCI, V27, P377, DOI 10.1080/07352680802467736; Armas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027791; Badri DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046640; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bais HP, 2003, SCIENCE, V301, P1377, DOI 10.1126/science.1083245; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Bazzzaz FA, 1996, PLANT CHANGING ENV L; Belter PR, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv059; Bengough AG, 2004, PLANT SOIL, V262, P63, DOI 10.1023/B:PLSO.0000037029.82618.27; Biedrzycki Meredith L, 2010, Commun Integr Biol, V3, P28; Blair AM, 1999, 1999 BRIGHTON CONFERENCE: WEEDS, VOLS 1-3, P753; Caffaro MM, 2013, PLANT GROWTH REGUL, V70, P141, DOI 10.1007/s10725-013-9786-7; Cahill JF, 2010, SCIENCE, V328, P1657, DOI 10.1126/science.1189736; Chochois V, 2012, J EXP BOT, V63, P3467, DOI 10.1093/jxb/ers044; de Kroon H, 2007, SCIENCE, V318, P1562, DOI 10.1126/science.1150726; de Wit M, 2012, P NATL ACAD SCI USA, V109, P14705, DOI 10.1073/pnas.1205437109; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; Fang SQ, 2013, P NATL ACAD SCI USA, V110, P2670, DOI 10.1073/pnas.1222821110; Fang SQ, 2011, PLANT PHYSIOL, V155, P1277, DOI 10.1104/pp.110.167304; Foulkes MJ, 2009, FIELD CROP RES, V114, P329, DOI 10.1016/j.fcr.2009.09.005; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Fraser LH, 2015, SCIENCE, V349, P302, DOI 10.1126/science.aab3916; Gersani M, 2001, J ECOLOGY; Gewin V, 2010, NATURE, V466, P552, DOI 10.1038/466552a; Gmerek J, 2010, ALLELOPATHY J, V25, P475; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Lobet G, 2011, PLANT PHYSIOL, V157, P29, DOI 10.1104/pp.111.179895; LUTMAN PJW, 2013, ALOPECURUS MYOSUROID, V53, P299, DOI DOI 10.1111/WRE.12024; Manschadi AM, 2008, PLANT SOIL, V303, P115, DOI 10.1007/s11104-007-9492-1; Manschadi AM, 2006, FUNCT PLANT BIOL, V33, P823, DOI 10.1071/FP06055; Mommer L, 2012, FUNCT ECOL, V26, P66, DOI 10.1111/j.1365-2435.2011.01916.x; Moss SR, 2004, WEED SCI, V52, P864, DOI 10.1614/WS-04-012R1; Moss SR, 2007, WEED TECHNOL, V21, P300, DOI 10.1614/WT-06-087.1; Narayanan S, 2014, PLOS ONE, V9; Nord EA, 2012, FUNCTIONAL PLANT BIO; OYANAGI A, 1994, PLANT SOIL, V165, P323, DOI 10.1007/BF00008076; Paez-Garcia Ana, 2015, Plants-Basel, V4, P334, DOI 10.3390/plants4020334; Pinheiro J, 2016, R PACKAGE VERSION; Rewald B, 2011, PLANT CELL ENVIRON, V34, P33, DOI 10.1111/j.1365-3040.2010.02223.x; Reynolds MP, 2006, J AGR SCI-CAMBRIDGE, V144, P3, DOI 10.1017/S0021859606005867; RICHARDS RA, 1989, AUST J AGR RES, V40, P943, DOI 10.1071/AR9890943; Roy R, 2014, PLANT SCI, V221, P42, DOI 10.1016/j.plantsci.2014.01.007; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Semchenko M, 2007, NEW PHYTOL, V176, P644, DOI 10.1111/j.1469-8137.2007.02211.x; Semchenko M, 2014, NEW PHYTOL, V204, P631, DOI 10.1111/nph.12930; Sparkes DL, 2008, ANN APPL BIOL, V152, P389, DOI 10.1111/j.1744-7348.2008.00230.x; Stark G., 2011, Aspects of Applied Biology, P259; Stobart RM, 2013, 509 HGCA, P1; Storkey J, 2010, WEED SCI, V58, P39, DOI 10.1614/WS-09-096.1; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Trapeznikov VK, 2003, PLANT SOIL, V252, P207, DOI 10.1023/A:1024734310214; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2006, THEOR APPL GENET, V113, P186, DOI 10.1007/s00122-006-0285-3; Wang J, 2013, ANN BOT-LONDON, V111, P1139, DOI 10.1093/aob/mct080	55	5	5	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178176	10.1371/journal.pone.0178176	http://dx.doi.org/10.1371/journal.pone.0178176			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542446	Green Published, gold, Green Submitted			2022-12-26	WOS:000402061500070
J	Murray, MH; Fassina, S; Hopkins, JB; Whittington, J; St Clair, CC				Murray, Maureen H.; Fassina, Sarah; Hopkins, John B., III; Whittington, Jesse; St Clair, Colleen C.			Seasonal and individual variation in the use of rail-associated food attractants by grizzly bears (Ursus arctos) in a national park	PLOS ONE			English	Article							LEARNED FORAGING BEHAVIOR; STABLE-ISOTOPES; BROWN BEARS; BLACK BEARS; ROADS; DIET; MORTALITY; CONFLICT; PATTERNS; COYOTES	Similar to vehicles on roadways, trains frequently kill wildlife via collisions along railways. Despite the prevalence of this mortality worldwide, little is known about the relative importance of wildlife attractants associated with railways, including spilled agricultural products, enhanced vegetation, invertebrates, and carcasses of rail-killed ungulates. We assessed the relative importance of several railway attractants to a provincially-threatened population of grizzly bears (Ursus arctos) in Banff and Yoho National Parks, Canada, for which rail-caused mortality has increased in recent decades without known cause. We examined the relationship between the use of the railway and diet by fitting 21 grizzly bears with GPS collars in 2011-2013 and measuring the stable isotope values (delta(15) N, delta(34) S) derived from their hair. We also examined the importance of rail-associated foods to grizzly bears by analyzing 230 grizzly bear scats collected from May through October in 2012-2014, some of which could be attributed to GPS-collared bears. Among the 21 collared bears, 17 used the rail rarely (< 9% of the days they were monitored), and only four bears (which included the three smallest bears and the largest bear in our sample) used the rail frequently (> 20% of their monitored days). We found no significant relationships between delta(15) N and delta(34) S values measured from the hair of grizzlies and their frequency of rail use. Instead, delta(15) N increased with body mass, especially for male bears, suggesting large males consumed more animal protein during hair growth. All four bears that used the railway frequently produced scats containing grain. Almost half the scats (43%) collected within 150 m of the railway contained grain compared to only 7% of scats found > 150 m from the railway. Scats deposited near the rail were also more likely to contain grain in the fall (85% of scats) compared to summer (14%) and spring (17%), and those containing grain were more diverse in their contents (6.8 +/- 2.2 species vs. 4.9 +/- 1.6, P < 0.001). Lastly, scats collected near the rail were more likely to contain ungulate hair and ant remains, especially in the summer. Our results support local management knowledge that some bears in the region use the railway to forage and supplement their diets with spilled grain, but that individual use of the railway and associated foods were highly variable. We suggest that managers continue to reduce the risk of bears being killed by trains by reactively removing grain and ungulate carcasses from the railway, reducing the amount of grain spilled by trains, and target mitigation to the specific individuals and locations that attract recurrent rail-based foraging.	[Murray, Maureen H.; Fassina, Sarah; Hopkins, John B., III; St Clair, Colleen C.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Whittington, Jesse] Banff Natl Pk, Banff, AB, Canada; [Murray, Maureen H.] Univ Georgia, Warne Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Hopkins, John B., III] Unity Coll, Sch Biodivers Conservat, Unity, ME USA	University of Alberta; University System of Georgia; University of Georgia	St Clair, CC (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	cstclair@ualberta.ca	St. Clair, Colleen Cassady/A-2953-2016	St. Clair, Colleen Cassady/0000-0002-3378-795X	Joint Initiative for Grizzly Bear Conservation by Parks Canada and Canadian Pacific; Natural Sciences and Engineering Council of Canada [File CRDPJ 441928-12]; Collaborative Research and Development Program of the Natural Science and Engineering Council [File CRDPJ 441928-12]	Joint Initiative for Grizzly Bear Conservation by Parks Canada and Canadian Pacific; Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Collaborative Research and Development Program of the Natural Science and Engineering Council	We are grateful for funding to conduct this project from the Joint Initiative for Grizzly Bear Conservation by Parks Canada and Canadian Pacific and the Natural Sciences and Engineering Council of Canada, grant number File CRDPJ 441928-12, url: http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/-index_eng.asp. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript, but Parks Canada provided the hair samples used for the SIA analysis.; We are grateful for extensive logistical support and funding to conduct this project from the Joint Initiative for Grizzly Bear Conservation by Parks Canada and Canadian Pacific with matching funds from the Collaborative Research and Development Program of the Natural Science and Engineering Council (File CRDPJ 441928-12). We also thank Dan Tyers and Molly Runyun (USFS, Bozeman, MT) for their considerable help with scat analysis instruction. We also appreciated the capable and conscientious work of many individuals at Parks Canada (Brianna Burley, Anne Forshner, Blair Fyten, Dave Garrow, Don Gorrie, Simon Ham, Bill Hunt, Tom Hurd, Rick Kubian, Kris McCleary, Steve Michel, Saundi Norris, Dan Rafla), Canadian Pacific (Chris Bunce, Perry Busse, Ken Roberge, Lorne Hoffman, Joshua Pemberton), and NSERC (Theresa Anderson). Excellent field assistance was provided by Allison Banting, Kevan Cave, Ben Dorsey, Daniel Ellis, Patrick Gilhooly, Liam Harrap, Brittany Jackson, Julia Jackson, Megan Kinley, Pete Knamiller, Cole Lord-May, Breda Moriarty, Niels de Nijs, Gregor Pachmann, Sonya Pollock, Laurens Put, Meg Raymond, Camille Toscani, and John Tress.	Andersen Reidar, 1991, Alces, V27, P79; Ando Chieko, 2003, Mammal Study, V28, P135, DOI 10.3106/mammalstudy.28.135; [Anonymous], 2015, PARKS CAN ATT 2010 1; [Anonymous], 1987, BEARS BIOL MANAG; Arjo WM, 2002, J MAMMAL, V83, P754, DOI 10.1644/1545-1542(2002)083<0754:DOBWAC>2.0.CO;2; Babinska-Werka J, 2015, TRANSPORT RES D-TR E, V38, P6, DOI 10.1016/j.trd.2015.04.021; Barboza P. S., 2009, INT WILDL NUTR, P350, DOI 10. 1007/978-3-540-87885-8; BARNARD GA, 1947, BIOMETRIKA, V34, P123, DOI 10.2307/2332517; Becker Earl F., 1991, Alces, V27, P161; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Bertch B., 2010, GRIZZLY BEAR MONITOR; Boscagli G., 1987, INT C BEAR RES MANAG, P97; Cherel Y, 2007, J ANIM ECOL, V76, P826, DOI 10.1111/j.1365-2656.2007.01238.x; Clark ML, 2003, DYNAMICS WHEAT BARLE; Clevenger AP, 2001, WILDLIFE SOC B, V29, P646; Coogan SCP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097968; Dasgupta S, 2015, HUM DIMENS WILDL, V20, P81, DOI 10.1080/10871209.2014.937017; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Di Domenico G, 2012, MAMM BIOL, V77, P190, DOI 10.1016/j.mambio.2012.01.002; Dorsey B. P., 2011, THESIS; Dorsey B, 2015, HANDBOOK OF ROAD ECOLOGY, P219; Edwards MA, 2011, OECOLOGIA, V165, P877, DOI 10.1007/s00442-010-1869-9; Elfstrom M, 2013, WILDLIFE BIOL, V19, P317, DOI 10.2981/12-121; Elfstrom M, 2014, MAMMAL REV, V44, P5, DOI 10.1111/j.1365-2907.2012.00223.x; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Gangadharan A, 2017, ANIM CONSER IN PRESS; Garshelis DL, 2005, J WILDLIFE MANAGE, V69, P277, DOI 10.2193/0022-541X(2005)069<0277:GBDIAA>2.0.CO;2; Gibbs JP, 2002, CONSERV BIOL, V16, P1647, DOI 10.1046/j.1523-1739.2002.01215.x; Griffin KA, 2011, J ANIM ECOL, V80, P1246, DOI 10.1111/j.1365-2656.2011.01856.x; Hobson KA, 2000, CAN J ZOOL, V78, P1332, DOI 10.1139/cjz-78-8-1332; Hopkins JB, 2014, ISOT ENVIRON HEALT S, V50, P322, DOI 10.1080/10256016.2014.922555; Hopkins JB, 2014, FRONT ECOL ENVIRON, V12, P107, DOI 10.1890/130276; Hopkins JB, 2013, J MAMMAL, V94, P1214, DOI 10.1644/13-MAMM-A-009.1; Hopkins JB, 2012, J WILDLIFE MANAGE, V76, P703, DOI 10.1002/jwmg.318; Hopkins JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028478; Huber D, 1998, URSUS-SERIES, V10, P167; Ito TY, 2005, CONSERV BIOL, V19, P945, DOI 10.1111/j.1523-1739.2005.004364.x; Jacoby ME, 1999, J WILDLIFE MANAGE, V63, P921, DOI 10.2307/3802806; Jaren Vemund, 1991, Alces, V27, P93; Kershaw L, 1998, PLANTS ROCKY MOUNTAI, P49; Kusta T, 2014, TURK J ZOOL, V38, P479, DOI 10.3906/zoo-1308-18; Mazur R, 2008, ANIM BEHAV, V75, P1503, DOI 10.1016/j.anbehav.2007.10.027; Mizukami RN, 2005, URSUS, V16, P93, DOI 10.2192/1537-6176(2005)016[0093:EOFHBM]2.0.CO;2; Mowat G, 2006, CAN J ZOOL, V84, P473, DOI 10.1139/z06-016; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Murray Edwards M, 2015, P R SOC B, V282; Murray M, 2015, ECOGRAPHY, V38, P1235, DOI 10.1111/ecog.01128; Nelson RA, 1983, BEARS THEIR BIOL MAN, V5, P284, DOI [DOI 10.2307/3872551, 10.2307/3872551]; Newsome SD, 2010, J MAMMAL, V91, P1313, DOI 10.1644/09-MAMM-A-362.1; Nielsen SE, 2004, BIOL CONSERV, V120, P101, DOI 10.1016/j.biocon.2004.02.020; Oro D, 2013, ECOL LETT, V16, P1501, DOI 10.1111/ele.12187; Pereira LM, 2014, MAMMAL REV, V44, P44, DOI 10.1111/mam.12005; Reynolds-Hogland MJ, 2007, J MAMMAL, V88, P1050, DOI 10.1644/06-MAMM-A-072R1.1; Sawaya MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034777; Schwartz C.C., 1991, ALCES, V27, P227; Semmens BX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006187; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Singh A. K., 2001, ELEPHANT MORTALITY T; St Clair CC, 2003, CONSERV BIOL, V17, P1151; Steiner W, 2014, ACCIDENT ANAL PREV, V66, P168, DOI 10.1016/j.aap.2014.01.020; Swenson JE, 1999, CAN J ZOOL, V77, P551, DOI 10.1139/cjz-77-4-551; Tear MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068382; Train Pissot J., 2007, P 2007 INT C EC TRAN, P64; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Van Der Grift E. A., 1999, Lutra, V42, P77; Waller JS, 2005, J WILDLIFE MANAGE, V69, P985, DOI 10.2193/0022-541X(2005)069[0985:EOTIOG]2.0.CO;2; Welbes M., 2011, RAIL MODERNIZATION S; Wells P, 1999, P 3 INT C WILDL EC T, P237; Whittington J, J APPL ECOL	70	24	24	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0175658	10.1371/journal.pone.0175658	http://dx.doi.org/10.1371/journal.pone.0175658			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542218	gold, Green Published, Green Submitted			2022-12-26	WOS:000402061500002
J	Peng, JP; Zheng, H; Wang, X; Cheng, ZX				Peng, Jianping; Zheng, Hang; Wang, Xia; Cheng, Zhixiang			Upregulation of TLR4 via PKC activation contributes to impaired wound healing in high-glucose-treated kidney proximal tubular cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ISCHEMIA-REPERFUSION INJURY; ACUTE-RENAL-FAILURE; LIVER-REGENERATION; MICE; PROLIFERATION; APOPTOSIS; PATHWAY; DISEASE; REPAIR	Acute kidney injury (AKI) leads to a worse prognosis in diabetic patients compared with prognoses in non-diabetic patients, but whether and how diabetes affects kidney repair after AKI remains unknown. Here, we used scratch-wound healing and transwell migration models to examine whether and how wound healing is affected by high glucose levels in cultured kidney proximal tubular cells (RPTC). The results show that scratch-wound healing and transwell migration were significantly slower in high-glucose-treated kidney tubular cells (30 mM glucose) than in low-glucose-treated cells (5.5 mM). Toll-like receptor 4 (TLR4), MyD88, phospho-protein kinase C (PKC), phospho-p38 MAPK and monocyte chemoattractant protein-1 (MCP-1) mRNA levels were upregulated after high glucose treatments. Staurosporine, a selective PKC inhibitor, inhibited TLR4, MyD88 and p-p38 upregulation in the high-glucose-treated cells, indicating the involvement of PKC in high-glucose-induced TLR4 upregulation. The pharmacological inhibition of TLR4 or shRNA-mediated TLR4 knockdown improved wound healing and transwell migration in high-glucose-treated RPTC. In contrast, the overexpression of TLR4 in low-glucose-treated RPTC suppressed wound healing, mimicking the effects of high glucose levels. These results suggest that the upregulation of TLR4 expression via PKC activation contributes to defective wound healing in high-glucosetreated kidney tubular cells.	[Peng, Jianping; Zheng, Hang] Wuhan Univ, Zhongnan Hosp, Dept Urol, Wuhan, Peoples R China; [Wang, Xia] Wuhan Univ, Hosp Wuhan Univ, Dept Internal Med, Wuhan, Peoples R China; [Cheng, Zhixiang] Wuhan Univ, Zhongnan Hosp, Dept Gen Surg, Wuhan, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Zheng, H (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Urol, Wuhan, Peoples R China.	pengjianping@whu.edu.cn		peng, Jianping/0000-0001-8611-0718	National Nature Science Foundation of China (NSFC) [81300578]; Wuhan University Research Foundation [2042016kf1012]	National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Wuhan University Research Foundation	This study was funded by the National Nature Science Foundation of China (NSFC) to JPP (81300578), and the Wuhan University Research Foundation to JPP (2042016kf1012). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip.	Bonventre JV, 2010, CONTRIB NEPHROL, V165, P9, DOI 10.1159/000313738; Brown SL, 2007, J CLIN INVEST, V117, P258, DOI 10.1172/JCI29159; Campbell JS, 2006, J IMMUNOL, V176, P2522, DOI 10.4049/jimmunol.176.4.2522; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Chen JL, 2011, KIDNEY INT, V79, P288, DOI 10.1038/ki.2010.381; Chen L, 2013, J INVEST DERMATOL, V133, P258, DOI 10.1038/jid.2012.267; Cunningham PN, 2004, J IMMUNOL, V172, P2629, DOI 10.4049/jimmunol.172.4.2629; Dasu MR, 2008, DIABETES, V57, P3090, DOI 10.2337/db08-0564; Dasu MR, 2013, J DIABETES COMPLICAT, V27, P417, DOI 10.1016/j.jdiacomp.2013.05.002; Dasu MR, 2012, J INVEST DERMATOL, V132, P1955, DOI 10.1038/jid.2012.208; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Goor Y, 1996, DIABETOLOGIA, V39, P1036; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Kluwe J, 2009, J MOL MED, V87, P125, DOI 10.1007/s00109-008-0426-z; Lamers ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022865; Lin M, 2012, J AM SOC NEPHROL, V23, P86, DOI 10.1681/ASN.2010111210; Macedo L, 2007, AM J PATHOL, V171, P1774, DOI 10.2353/ajpath.2007.061048; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Peng JP, 2015, KIDNEY INT, V87, P137, DOI 10.1038/ki.2014.226; Peng JP, 2012, J PHARMACOL EXP THER, V340, P176, DOI 10.1124/jpet.111.187427; Seki E, 2005, HEPATOLOGY, V41, P443, DOI 10.1002/hep.20603; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sun L, 2008, J AM SOC NEPHROL, V19, P2293, DOI 10.1681/ASN.2008030336; Sun R, 2004, GASTROENTEROLOGY, V127, P1525, DOI 10.1053/j.gastro.2004.08.055; Tamura M, 2003, KIDNEY INT, V63, P722, DOI 10.1046/j.1523-1755.2003.00772.x; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Thakar CV, 2011, CLIN J AM SOC NEPHRO, V6, P2567, DOI 10.2215/CJN.01120211; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Wu HL, 2010, J AM SOC NEPHROL, V21, P1878, DOI 10.1681/ASN.2009101048; Xu KP, 2009, DIABETES, V58, P1077, DOI 10.2337/db08-0997; Xuan YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108182	34	8	9	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178147	10.1371/journal.pone.0178147	http://dx.doi.org/10.1371/journal.pone.0178147			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542370	Green Submitted, Green Published, gold			2022-12-26	WOS:000402061500064
J	Teixeira, PL; Mendenhall, JL; Heinze, S; Weiner, B; Skwark, MJ; Meiler, J				Teixeira, Pedro L.; Mendenhall, Jeff L.; Heinze, Sten; Weiner, Brian; Skwark, Marcin J.; Meiler, Jens			Membrane protein contact and structure prediction using co-evolution in conjunction with machine learning	PLOS ONE			English	Article							TRANSMEMBRANE PROTEINS; RESIDUE CONTACTS; IDENTIFICATION; SOFTWARE	De novo membrane protein structure prediction is limited to small proteins due to the conformational search space quickly expanding with length. Long-range contacts (24+ amino acid separation)-residue positions distant in sequence, but in close proximity in the structure, are arguably the most effective way to restrict this conformational space. Inverse methods for co-evolutionary analysis predict a global set of position-pair couplings that best explain the observed amino acid co-occurrences, thus distinguishing between evolutionarily explained co-variances and these arising from spurious transitive effects. Here, we show that applying machine learning approaches and custom descriptors improves evolutionary contact prediction accuracy, resulting in improvement of average precision by 6 percentage points for the top 1L non-local contacts. Further, we demonstrate that predicted contacts improve protein folding with BCL::Fold. The mean RMSD100 metric for the top 10 models folded was reduced by an average of 2 angstrom for a benchmark of 25 membrane proteins.	[Teixeira, Pedro L.; Meiler, Jens] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN 37235 USA; [Mendenhall, Jeff L.; Heinze, Sten; Weiner, Brian; Skwark, Marcin J.; Meiler, Jens] Vanderbilt Univ, Dept Chem, Ctr Struct Biol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University	Meiler, J (corresponding author), Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN 37235 USA.; Meiler, J (corresponding author), Vanderbilt Univ, Dept Chem, Ctr Struct Biol, Nashville, TN 37235 USA.	jens@meilerlab.org	Skwark, Marcin Jerzy/Y-4019-2018	Skwark, Marcin Jerzy/0000-0002-2022-6766; Teixeira, Pedro/0000-0002-3268-5556	National Institutes of Health (National Institute of General Medical Sciences) [R01 GM080403]; National Institute of General Medical Studies [T32 GM07347]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080403] Funding Source: NIH RePORTER	National Institutes of Health (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Studies(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the Meiler laboratory is supported through the National Institutes of Health (National Institute of General Medical Sciences R01 GM080403 [https://www.nigms.nih.gov/Pages/default.aspx] (JM). This work was supported by Public Health Service award T32 GM07347 [https://www.nigms.nih.gov/Pages/default.aspx)] from the National Institute of General Medical Studies for the Vanderbilt Medical-Scientist Training Program (PLT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahram Mamoun, 2006, In Silico Biology, V6, P379; Aurell E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004777; Bakheet TM, 2009, BIOINFORMATICS, V25, P451, DOI 10.1093/bioinformatics/btp002; Baldassi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092721; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Dekker JP, 2004, BIOINFORMATICS, V20, P1565, DOI 10.1093/bioinformatics/bth128; Di Lena P, 2012, BIOINFORMATICS, V28, P2449, DOI 10.1093/bioinformatics/bts475; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Engelbrecht AP, 2001, FUNDAM INFORM, V46, P219; Ezkurdia I, 2009, PROTEINS, V77, P196, DOI 10.1002/prot.22554; Feinauer C, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003847; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fischer AW, 2015, PROTEINS, V83, P1947, DOI 10.1002/prot.24801; Fuchs A, 2009, PROTEINS, V74, P857, DOI 10.1002/prot.22194; Grana O, 2005, PROTEINS, V61, P214, DOI 10.1002/prot.20739; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Izarzugaza JMG, 2007, PROTEINS, V69, P152, DOI 10.1002/prot.21637; Jones DT, 2015, BIOINFORMATICS, V31, P999, DOI 10.1093/bioinformatics/btu791; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kajan L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-85; Karakas M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049240; Karakas M, 2010, J COMPUT BIOL, V17, P153, DOI 10.1089/cmb.2009.0030; KENT JT, 1983, BIOMETRIKA, V70, P163, DOI 10.1093/biomet/70.1.163; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Leman JK, 2013, PROTEINS, V81, P1127, DOI 10.1002/prot.24258; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Monastyrskyy B, 2013, PROTEINS; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Raman P, 2006, CELL MOL LIFE SCI, V63, P36, DOI 10.1007/s00018-005-5350-6; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Seemayer S, 2014, BIOINFORMATICS, V30, P3128, DOI 10.1093/bioinformatics/btu500; Skwark MJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003889; Skwark MJ, 2013, BIOINFORMATICS, V29, P1815, DOI 10.1093/bioinformatics/btt259; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, pD275, DOI 10.1093/nar/gki002; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; Viklund H, 2008, BIOINFORMATICS, V24, P2928, DOI 10.1093/bioinformatics/btn550; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Weiner BE, 2014, PROTEINS, V82, P587, DOI 10.1002/prot.24427; Weiner BE, 2013, STRUCTURE, V21, P1107, DOI 10.1016/j.str.2013.04.022; Woetzel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049242; Zhang HL, 2016, PROTEINS, V84, P332, DOI 10.1002/prot.24979; Zurada JM, 1997, NEUROCOMPUTING, V14, P177, DOI 10.1016/S0925-2312(96)00031-8	44	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177866	10.1371/journal.pone.0177866	http://dx.doi.org/10.1371/journal.pone.0177866			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542325	gold, Green Published			2022-12-26	WOS:000402061500042
J	Li, Z; Gong, Y; Pan, ZS; Hu, GY				Li, Zhen; Gong, Yong; Pan, Zhisong; Hu, Guyu			An efficient semi-supervised community detection framework in social networks	PLOS ONE			English	Article								Community detection is an important tasks across a number of research fields including social science, biology, and physics. In the real world, topology information alone is often inadequate to accurately find out community structure due to its sparsity and noise. The potential useful prior information such as pairwise constraints which contain must-link and cannot-link constraints can be obtained from domain knowledge in many applications. Thus, combining network topology with prior information to improve the community detection accuracy is promising. Previous methods mainly utilize the must-link constraints while cannot make full use of cannot-link constraints. In this paper, we propose a semi-supervised community detection framework which can effectively incorporate two types of pairwise constraints into the detection process. Particularly, must-link and cannot-link constraints are represented as positive and negative links, and we encode them by adding different graph regularization terms to penalize closeness of the nodes. Experiments on multiple real-world data setss how that the proposed framework significantly improves the accuracy of community detection.	[Li, Zhen; Gong, Yong; Pan, Zhisong; Hu, Guyu] PLA Univ Sci & Technol, Coll Command Informat Syst, Nanjing, Jiangsu, Peoples R China	Army Engineering University of PLA	Hu, GY (corresponding author), PLA Univ Sci & Technol, Coll Command Informat Syst, Nanjing, Jiangsu, Peoples R China.	huguyu@189.cn			Natural Science Foundation of Jiangsu Province, China [BK20140073]	Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province)	This work was supported by Natural Science Foundation of Jiangsu Province, China (No. BK20140073), the website is https://www.nsfc.gov.cn/. The author Y Gong received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdyan A E, 2010, EPL, V90, P983; [Anonymous], [No title captured]; Aurelien D., 2011, PHYS REV LETT, V107, P3337; Chiang K Y, 2013, J MACHINE LEARNING R, V15, P1177; Ding C, 2010, IEEE T PATTERN ANAL, V32, P45, DOI 10.1109/TPAMI.2008.277; Ding Chris, 2006, P 12 ACM SIGKDD INT, V2006, P126; Eaton E, 2012, 26 AAAI C ART INT; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Greene D., 2013, P WEBSCI 2013, P1; Lee DD, 2001, ADV NEUR IN, V13, P556; Lu HC, 2004, NUCLEIC ACIDS RES, V32, P4804, DOI 10.1093/nar/gkh814; Ma XK, 2010, PHYSICA A, V389, P187, DOI 10.1016/j.physa.2009.09.018; Mahmoudi A, 2016, INT J FUZZY SYST, V18, P1117, DOI 10.1007/s40815-016-0173-1; Malliaros FD, 2013, PHYS REP, V533, P95, DOI 10.1016/j.physrep.2013.08.002; Mo QY, 2012, LECT NOTES COMPUT SC, V7578, P402, DOI 10.1007/978-3-642-33786-4_30; Nadakuditi RR, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.188701; Pei YL, 2015, INT C INTEL HUM MACH, DOI 10.1109/IHMSC.2015.148; Steeg GV, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/08/P08009; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Tang J, 2015, COMPUTER SCI; Tang L., 2010, COMMUNITY DETECTION, P85287; Wang F., 2008, P SIAM INT C DAT MIN, P1, DOI DOI 10.1137/1.9781611972788.1; Yang L, 2014, IEEE T CYBERNETICS, V45, P1; Zhang Z.-Y., 2013, SCI REPORTS, V3; Zhaoxian Wang, 2015, Advances in Swarm and Computational Intelligence. 6th International Conference, ICSI 2015 held in conjunction with the Second BRICS Congress, CCI 2015. Proceedings: LNCS 9141, P349, DOI 10.1007/978-3-319-20472-7_38	25	5	5	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178046	10.1371/journal.pone.0178046	http://dx.doi.org/10.1371/journal.pone.0178046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542520	gold, Green Submitted, Green Published			2022-12-26	WOS:000402058800035
J	Baeza-Yates, R; Sangal, PM; Villoslada, P				Baeza-Yates, Ricardo; Sangal, Puneet Mohan; Villoslada, Pablo			Burden of neurological diseases in the US revealed by web searches	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; BEHAVIOR; PEOPLE; EPILEPSY; TRENDS	Background Analyzing the disease-related web searches of Internet users provides insight into the interests of the general population as well as the healthcare industry, which can be used to shape health care policies. Methods We analyzed the searches related to neurological diseases and drugs used in neurology using the most popular search engines in the US, Google and Bing/Yahoo. Results We found that the most frequently searched diseases were common diseases such as dementia or Attention Deficit/Hyperactivity Disorder (ADHD), as well as medium frequency diseases with high social impact such as Parkinson's disease, MS and ALS. The most frequently searched CNS drugs were generic drugs used for pain, followed by sleep disorders, dementia, ADHD, stroke and Parkinson's disease. Regarding the interests of the healthcare industry, ADHD, Alzheimer's disease, MS, ALS, meningitis, and hypersomnia received the higher advertising bids for neurological diseases, while painkillers and drugs for neuropathic pain, drugs for dementia or insomnia, and triptans had the highest advertising bidding prices. Conclusions Web searches reflect the interest of people and the healthcare industry, and are based either on the frequency or social impact of the disease.	[Baeza-Yates, Ricardo] Univ Pompeu Fabra, Barcelona, Spain; [Sangal, Puneet Mohan] Amazon, Seattle, WA USA; [Villoslada, Pablo] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Villoslada, Pablo] Univ Barcelona, Inst Invest Biomed August Pi Sunyer IDIBAPS, Barcelona, Spain	Pompeu Fabra University; Amazon.com; University of California System; University of California San Francisco; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Villoslada, P (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.; Villoslada, P (corresponding author), Univ Barcelona, Inst Invest Biomed August Pi Sunyer IDIBAPS, Barcelona, Spain.	Pablo.VillosladaDiaz@ucsf.edu	Villoslada, Pablo/AAF-9547-2019; Villoslada, Pablo/O-1757-2019; Baeza-Yates, Ricardo/H-5692-2015	Villoslada, Pablo/0000-0002-8735-6119; Baeza-Yates, Ricardo/0000-0003-3208-9778	CERCA Program / Generalitat de Catalunya; Amazon Inc.	CERCA Program / Generalitat de Catalunya; Amazon Inc.	This study was funded by CERCA Program / Generalitat de Catalunya to PV. Funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Amazon Inc., a commercial company provided support in the form of salaries for author PS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions.	Agarwal Vibhu, 2016, AMIA Jt Summits Transl Sci Proc, V2016, P15; Brigo F, 2016, NEUROL SCI, V37, P781, DOI 10.1007/s10072-016-2501-5; Brigo F, 2015, J PUBLIC HEALTH-UK, V37, P555, DOI 10.1093/pubmed/fdu083; Brigo F, 2015, EPILEPSY BEHAV, V49, P146, DOI 10.1016/j.yebeh.2015.02.029; Brigo F, 2015, J CLIN NEUROSCI, V22, P1170, DOI 10.1016/j.jocn.2015.02.006; Brigo F, 2014, MULT SCLER RELAT DIS, V3, P440, DOI 10.1016/j.msard.2014.02.005; Brigo F, 2014, EPILEPSY BEHAV, V31, P67, DOI 10.1016/j.yebeh.2013.11.020; Cerminara C, 2014, EPILEPSY BEHAV, V41, P119, DOI 10.1016/j.yebeh.2014.09.053; Colombo C, 2014, INTERACT J MED RES, V3, P2, DOI 10.2196/ijmr.3034; De Lott LB, 2016, NEUROLOGY, V86, P1491, DOI 10.1212/WNL.0000000000002589; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Jansen Bernard J., 2008, International Journal of Electronic Business, V6, P114, DOI 10.1504/IJEB.2008.018068; Moccia M, 2016, J NEUROL NEUROSUR PS, V87, P1028, DOI 10.1136/jnnp-2016-313260; Otte WM, 2013, EPILEPSY BEHAV, V29, P571, DOI 10.1016/j.yebeh.2013.10.013; Vera C, 2012, TECH VASC INTERV RAD, V15, P153, DOI 10.1053/j.tvir.2012.02.009; White RW, 2013, J AM MED INFORM ASSN, V20, P404, DOI 10.1136/amiajnl-2012-001482; World Health Organization (OMS), 2006, NEUR DIS PUBL HLTH C	18	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178019	10.1371/journal.pone.0178019	http://dx.doi.org/10.1371/journal.pone.0178019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531237	Green Submitted, Green Published, gold			2022-12-26	WOS:000402058400050
J	Childs, LM; Prosper, OF				Childs, Lauren M.; Prosper, Olivia F.			Simulating within-vector generation of the malaria parasite diversity	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; TRANSMISSION; INFECTION; MODEL; GAMETOCYTOGENESIS; RECOMBINATION; SIGNATURE; DYNAMICS; IMPACT	Plasmodium falciparum, the most virulent human malaria parasite, undergoes asexual reproduction within the human host, but reproduces sexually within its vector host, the Anopheles mosquito. Consequently, the mosquito stage of the parasite life cycle provides an opportunity to create genetically novel parasites in multiply-infected mosquitoes, potentially increasing parasite population diversity. Despite the important implications for disease transmission and malaria control, a quantitative mapping of how parasite diversity entering a mosquito relates to diversity of the parasite exiting, has not been undertaken. To examine the role that vector biology plays in modulating parasite diversity, we develop a two-part model framework that estimates the diversity as a consequence of different bottlenecks and expansion events occurring during the vector-stage of the parasite life cycle. For the underlying framework, we develop the first stochastic model of within-vector P. falciparum parasite dynamics and go on to simulate the dynamics of two parasite subpopulations, emulating multiply infected mosquitoes. We show that incorporating stochasticity is essential to capture the extensive variation in parasite dynamics, particularly in the presence of multiple parasites. In particular, unlike deterministic models, which always predict the most fit parasites to produce the most sporozoites, we find that occasionally only parasites with lower fitness survive to the sporozoite stage. This has important implications for onward transmission. The second part of our framework includes a model of sequence diversity generation resulting from recombination and reassortment between parasites within a mosquito. Our two-part model framework shows that bottlenecks entering the oocyst stage decrease parasite diversity from what is present in the initial gametocyte population in a mosquito's blood meal. However, diversity increases with the possibility for recombination and proliferation in the formation of sporozoites. Furthermore, when we begin with two parasite subpopulations in the initial gametocyte population, the probability of transmitting more than two unique parasites from mosquito to human is over 50% for a wide range of initial gametocyte densities.	[Childs, Lauren M.] Virginia Tech, Dept Math, Blacksburg, VA 24061 USA; [Prosper, Olivia F.] Univ Kentucky, Dept Math, Lexington, KY 40506 USA	Virginia Polytechnic Institute & State University; University of Kentucky	Childs, LM (corresponding author), Virginia Tech, Dept Math, Blacksburg, VA 24061 USA.	lchilds@vt.edu		Childs, Lauren/0000-0003-3904-3895; Prosper, Olivia/0000-0002-8042-0616	National Institute of General Medical Sciences [U54GM088558]; Virginia Tech's Open Access Subvention Fun; FAS Division of Science, Research Computing Group at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Virginia Tech's Open Access Subvention Fun; FAS Division of Science, Research Computing Group at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	L.M.C. was partially supported by award number U54GM088558 from the National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. The authors also acknowledge the support of Virginia Techs Open Access Subvention Fun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank T. Bousema and W. Stone for sharing the data for replication of Figure 1 in [47]. L.M.C. was supported by award number U54GM088558 from the National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. The authors acknowledge the Odyssey cluster supported by the FAS Division of Science, Research Computing Group at Harvard University and Advanced Research Computing at Virginia Tech for providing computational resources and technical support that have contributed to the results reported within this paper.	Allen LJ., 2010, INTRO STOCHASTIC PRO; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Annan Z, 2007, P NATL ACAD SCI USA, V104, P7987, DOI 10.1073/pnas.0702715104; Bei AK, 2015, INFECT IMMUN, V83, P276, DOI 10.1128/IAI.01979-14; Branch OH, 2011, MOL BIOL EVOL, V28, P1973, DOI 10.1093/molbev/msq311; Buckee CO, 2011, P NATL ACAD SCI USA, V108, P15504, DOI 10.1073/pnas.1102445108; Carter TE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140416; Childs LM, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1379; Churcher TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00626; Collins WE, 2003, AM J TROP MED HYG, V68, P366, DOI 10.4269/ajtmh.2003.68.366; Conway DJ, 1999, P NATL ACAD SCI USA, V96, P4506, DOI 10.1073/pnas.96.8.4506; Da DF, 2015, EXP PARASITOL, V149, P74, DOI 10.1016/j.exppara.2014.12.010; Daniels R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-223; Dwivedi A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1370-y; Eckhoff P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044950; Eichner M, 2001, T ROY SOC TROP MED H, V95, P497, DOI 10.1016/S0035-9203(01)90016-1; Gerald N, 2011, EUKARYOT CELL, V10, P474, DOI 10.1128/EC.00314-10; Handel MA, 1997, MEIOSIS GAMETOGENESI; JEFFERY GM, 1955, AM J TROP MED HYG, V4, P781, DOI 10.4269/ajtmh.1955.4.781; Jiang HY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r33; Johnston GL, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003025; Juliano JJ, 2010, P NATL ACAD SCI USA, V107, P20138, DOI 10.1073/pnas.1007068107; Kappe SHI, 2010, SCIENCE, V328, P862, DOI 10.1126/science.1184785; KOELLA JC, 1991, ACTA TROP, V49, P1, DOI 10.1016/0001-706X(91)90026-G; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Maire N, 2006, AM J TROP MED HYG, V75, P19, DOI 10.4269/ajtmh.2006.75.19; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; McQueen PG, 2004, P NATL ACAD SCI USA, V101, P9161, DOI 10.1073/pnas.0308256101; Medica DL, 2005, INFECT IMMUN, V73, P4363, DOI 10.1128/IAI.73.7.4363-4369.2005; Morlais I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123777; Nassir E, 2005, INT J PARASITOL, V35, P49, DOI 10.1016/j.ijpara.2004.10.014; Nkhoma SC, 2012, P ROY SOC B-BIOL SCI, V279, P2589, DOI 10.1098/rspb.2012.0113; Nsango SE, 2012, INT J PARASITOL, V42, P589, DOI 10.1016/j.ijpara.2012.03.008; Reininger L, 2005, J BIOL CHEM, V280, P31957, DOI 10.1074/jbc.M504523200; Roitberg BD, 2005, J VECTOR ECOL, V30, P83; ROSENBERG R, 1990, T ROY SOC TROP MED H, V84, P209, DOI 10.1016/0035-9203(90)90258-G; Ross A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042496; Ross R., 1911, PREVENTION MALARIA; Sandeu MM, 2016, INFECT GENET EVOL, V45, P138, DOI 10.1016/j.meegid.2016.08.025; Sinden RE, 2015, CELL MICROBIOL, V17, P451, DOI 10.1111/cmi.12413; Sinden RE, 2009, PARASITOLOGY, V136, P1427, DOI 10.1017/S0031182009990667; SINDEN RE, 1985, ANN SOC BELG MED TR, V65, P21; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Stone WJR, 2013, SCI REP-UK, V3, DOI 10.1038/srep03418; Sutton PL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-329; Taylor LH, 1997, PARASITOLOGY, V115, P121, DOI 10.1017/S0031182097001145; Teboh-Ewungkem MI, 2009, PUBLIC HEALTH 21ST C, P177; Teboh-Ewungkem MI, 2010, J THEOR BIOL, V264, P273, DOI 10.1016/j.jtbi.2009.12.017; VAUGHAN JA, 1992, J PARASITOL, V78, P716, DOI 10.2307/3283550; WHO, 2013, WORLD MALARIA REPORT 2013, P1	50	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177941	10.1371/journal.pone.0177941	http://dx.doi.org/10.1371/journal.pone.0177941			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542484	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058400041
J	Silva, RM; Lamas, J; Silva, CC; Coello, Y; Mouta, S; Santos, JA				Silva, Rosa Mariana; Lamas, Joao; Silva, Carlos Cesar; Coello, Yann; Mouta, Sandra; Santos, Jorge Almeida			Judging time-to-passage of looming sounds: Evidence for the use of distance-based information	PLOS ONE			English	Article							IMPENDING COLLISION; RHESUS-MONKEYS; PERCEPTION; LOCALIZATION; INTEGRATION; ACCURACY; ARRIVAL; MOTION; BIAS; CUES	Perceptual judgments are an essential mechanism for our everyday interaction with other moving agents or events. For instance, estimation of the time remaining before an object contacts or passes us is essential to act upon or to avoid that object. Previous studies have demonstrated that participants use different cues to estimate the time to contact or the time to passage of approaching visual stimuli. Despite the considerable number of studies on the judgment of approaching auditory stimuli, not much is known about the cues that guide listeners' performance in an auditory Time-to-Passage (TTP) task. The present study evaluates how accurately participants judge approaching white-noise stimuli in a TTP task that included variable occlusion periods (portion of the presentation time where the stimulus is not audible). Results showed that participants were able to accurately estimate TTP and their performance, in general, was weakly affected by occlusion periods. Moreover, we looked into the psychoacoustic variables provided by the stimuli and analysed how binaural cues related with the performance obtained in the psychophysical task. The binaural temporal difference seems to be the psychoacoustic cue guiding participants' performance for lower amounts of occlusion, while the binaural loudness difference seems to be the cue guiding performance for higher amounts of occlusion. These results allowed us to explain the perceptual strategies used by participants in a TTP task (maintaining accuracy by shifting the informative cue for TTP estimation), and to demonstrate that the psychoacoustic cue guiding listeners' performance changes according to the occlusion period.	[Silva, Rosa Mariana; Lamas, Joao; Silva, Carlos Cesar; Mouta, Sandra; Santos, Jorge Almeida] Ctr Comp Graph, Guimaraes, Portugal; [Silva, Rosa Mariana; Santos, Jorge Almeida] Univ Minho, Sch Psychol, Dept Basic Psychol, Braga, Portugal; [Silva, Carlos Cesar] Univ Minho, Dept Informat, Braga, Portugal; [Silva, Carlos Cesar; Mouta, Sandra] Inst Syst & Comp Engn Technol & Sci, INESC TEC, Porto, Portugal; [Mouta, Sandra] Univ Lille, UMR CNRS 9193, SCALab, Cognit & Affect Sci Lab, Villeneuve Dascq, France; [Santos, Jorge Almeida] Univ Minho, Ctr Algoritmi, Guimaraes, Portugal	Universidade do Minho; Universidade do Minho; INESC TEC; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Lille - ISITE; Universite de Lille; Universidade do Minho	Silva, RM (corresponding author), Ctr Comp Graph, Guimaraes, Portugal.; Silva, RM (corresponding author), Univ Minho, Sch Psychol, Dept Basic Psychol, Braga, Portugal.	mariana.macedo.silva@gmail.com	Lamas, João PSA/J-3299-2017	Lamas, João PSA/0000-0002-0633-180X; Loureiro Silva, Carlos Cesar/0000-0002-4886-9405; Santos, Jorge/0000-0001-5881-8567; Silva, Rosa Mariana/0000-0002-9902-6205	Fundacao Bial [143/13]; Fundacao para a Ciencia e Tecnologia [SFRH/BPD/63393/2009, PTDC/EEA-ELC/112137/2009]; COMPETE [POCI-01-0145-FEDER-007043]; FCT-Fundacao para a Ciencia e Tecnologia [UID/CEC/00319/2013]; Bial Foundation [143/14]; FCT [PTDC/EEA-ELC/112137/2009]; Fundação para a Ciência e a Tecnologia [PTDC/EEA-ELC/112137/2009] Funding Source: FCT	Fundacao Bial(Bial Foundation); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); COMPETE; FCT-Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); Bial Foundation(Bial Foundation); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This study was supported by: Bial Foundation Grant 143/14 (https:/www.bial.com/en/bial_foundation.11/11th_symposium.219/ fellows_preliminary_results.2357fellows_ preliminary_results.a569.html); FCT PTDC/EEA-ELC/112137/2009 (https://www.fct.pt/apoios/ projectos/consultaA/vglobal_projecto?idProjecto=1121378& and COMPETE:POCI-01-0145-FEDER-007043 and FCT-Fundacao para a Ciencia e Tecnologia within the Project Scope: UID/CEC/00319/2013.; This work has been supported by Fundacao Bial (Grant 143/13), Fundacao para a Ciencia e Tecnologia (SFRH/BPD/63393/2009; PTDC/EEA-ELC/112137/2009). This work was funded by COMPETE: POCI-01-0145-FEDER-007043 and FCT-Fundacao para a Ciencia e Tecnologia within the Project Scope: UID/CEC/00319/2013.	Bach DR, 2009, INT J PSYCHOPHYSIOL, V74, P28, DOI 10.1016/j.ijpsycho.2009.06.004; Brungart DS, 1999, J ACOUST SOC AM, V106, P1956, DOI 10.1121/1.427943; Calabro FJ, 2011, VISION RES, V51, P2378, DOI 10.1016/j.visres.2011.09.016; Carlile S., 1996, VIRTUAL AUDITORY SPA, P27; Cheng CI, 2001, J AUDIO ENG SOC, V49, P231, DOI 10.1016/S0022-5096(00)00039-9; COLEMAN PD, 1963, PSYCHOL BULL, V60, P302, DOI 10.1037/h0045716; Cutting J.E., 1995, PERCEPTION SPACE MOT, P69, DOI 10.1016/B978-012240530-3/50005-5; Efron B., INTRO BOOTSTRAP; Gardner B., 1994, HRTF MEASUREMENTS OF; Ghazanfar AA, 2002, P NATL ACAD SCI USA, V99, P15755, DOI 10.1073/pnas.242469699; Gray R, 1998, VISION RES, V38, P499, DOI 10.1016/S0042-6989(97)00230-7; Gray R, 2001, PERCEPTION, V30, P1007, DOI 10.1068/p3220; Guski R., 1992, ECOL PSYCHOL, V4, P189, DOI DOI 10.1207/S15326969EC00403_4; Hancock PA, 1998, OCCUPATIONAL INJURY: RISK, PREVENTION AND INTERVENTION, P44; HEUER H, 1993, PERCEPTION, V22, P549, DOI 10.1068/p220549; Keil MS, 2012, PLOS COMPUTATIONAL B, V8, P1; KNOWLES WB, 1958, AM PSYCHOL, V13, P405; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; Lina D.P., 2015, REHABILITATING COCO, P1; Lopez-Moliner J, 2007, PERCEPT PSYCHOPHYS, V69, P887, DOI 10.3758/BF03193925; Lugtigheid AJ, 2011, J VISION, V11, DOI 10.1167/11.13.1; Maier JX, 2004, NEURON, V43, P177, DOI 10.1016/j.neuron.2004.06.027; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; Moore BCJ, 1997, J AUDIO ENG SOC, V45, P224; Mouta S, 2012, J VISION, V12, DOI 10.1167/12.2.21; Neuhoff JG, 1998, NATURE, V395, P123, DOI 10.1038/25862; Neuhoff JG, 2001, ECOL PSYCHOL, V13, P87, DOI 10.1207/S15326969ECO1302_2; Neuhoff JG, 2012, EVOL HUM BEHAV, V33, P318, DOI 10.1016/j.evolhumbehav.2011.11.001; Regan D, 2000, TRENDS COGN SCI, V4, P99, DOI 10.1016/S1364-6613(99)01442-4; ROSENBLUM LD, 1993, PERCEPTION, V22, P1467, DOI 10.1068/p221467; ROSENBLUM LD, 1987, PERCEPTION, V16, P175, DOI 10.1068/p160175; SCHIFF W, 1990, J EXP PSYCHOL HUMAN, V16, P303, DOI 10.1037/0096-1523.16.2.303; SCHIFF W, 1979, PERCEPTION, V8, P647, DOI 10.1068/p080647; Seifritz E, 2002, CURR BIOL, V12, P2147, DOI 10.1016/S0960-9822(02)01356-8; Stevens S. S., 1983, HEARING ITS PSYCHOL; Tresilian JR, 1999, P ROY SOC B-BIOL SCI, V266, P39, DOI 10.1098/rspb.1999.0601; Wada Y, 2003, INT J PSYCHOPHYSIOL, V50, P117, DOI 10.1016/S0167-8760(03)00128-4; Yan JJ, 2011, J VISION, V11, DOI 10.1167/11.12.7	38	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177734	10.1371/journal.pone.0177734	http://dx.doi.org/10.1371/journal.pone.0177734			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531210	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058400027
J	Schaebel, LK; Bonefeld-Jorgensen, EC; Vestergaard, H; Andersen, S				Schaebel, L. K.; Bonefeld-Jorgensen, E. C.; Vestergaard, H.; Andersen, S.			The influence of persistent organic pollutants in the traditional Inuit diet on markers of inflammation	PLOS ONE			English	Article							POPULATION-BASED SURVEY; CARDIOVASCULAR-DISEASE; POLYCHLORINATED-BIPHENYLS; OXIDATIVE STRESS; GREENLAND INUIT; ARCTIC SOCIETY; HEART-DISEASE; CONTAMINANTS; FOOD; TRANSITION	Concentrations of persistent organic pollutants (POPs) are high in Inuit living predominately on the traditional marine diet. Adverse effects of POPs include disruption of the immune system and cardiovascular diseases that are frequent in Greenland Inuit. We aimed to assess the association between exposure to POPs from the marine diet and inflammation, taking into account other factors such as vitamin D. We invited Inuit and non-Inuit living in settlements or the town in rural East Greenland or in the capital city Nuuk. Participants completed a food frequency questionnaire and donated a blood sample for measurement of the two markers of inflammation YKL-40 and hsCRP, 25-hydroxy-vitamin D, eleven organochlorine pesticides (OCPs), fourteen polychlorinated biphenyls (PCBs), one polybrominated biphenyl, and nine polybrominated diphenyl ethers (PBDEs) adjusted to the serum lipid content. Participants were 50 through 69 years old, living in settlements, town or city (n = 151/173/211; 95% participation rate). Sigma OCP, Sigma PCB and Sigma PBDE serum levels were higher in Inuit than in non-Inuit (p<0.001/ p<0.001/ p<0.001), in older individuals (p<0.001/ p<0.001/ p = 0.002) and in participants with the highest intake of Greenlandic food items (p<0.001/ p<0.001/ p<0.001). Both YKL-40 and hsCRP serum levels were higher in Inuit compared to non-Inuit (p<0.001/ p = 0.001), and increased with age (p<0.001/ p = 0.001) and with the intake of Greenlandic food items (p<0.001/ p = 0.002). Multivariate analysis conformed to a marked influence on both YKL-40 and hsCRP by SOCP (p<0.001/ p<0.001) and Sigma PCBs (p<0.001/ p = 0.001) after adjusting for age, BMI, vitamin D, alcohol and smoking. POP levels were associated with the intake of the traditional Inuit diet and with markers of inflammation. This supports a pro-inflammatory role of POPs to promote chronic diseases common to populations in Greenland. These data inform guidelines on 'the Arctic dilemma' and encourage follow-up on the ageing Arctic populations.	[Schaebel, L. K.; Bonefeld-Jorgensen, E. C.] Aarhus Univ, Dept Publ Hlth, Ctr Arctic Hlth, Aarhus, Denmark; [Schaebel, L. K.; Andersen, S.] Aalborg Univ, Inst Clin Med, Arctic Hlth Res Ctr, Aalborg, Denmark; [Vestergaard, H.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, Fac Hlth & Med Sci, Copenhagen, Denmark; [Andersen, S.] Aalborg Univ Hosp, Dept Geriatr & Internal Med, Aalborg, Denmark; [Andersen, S.] Univ Greenland, Inst Hlth Sci, Ilisimatusarfik, Nuuk, Greenland	Aarhus University; Aalborg University; Novo Nordisk Foundation; University of Copenhagen; Aalborg University; Aalborg University Hospital	Schaebel, LK (corresponding author), Aarhus Univ, Dept Publ Hlth, Ctr Arctic Hlth, Aarhus, Denmark.; Schaebel, LK (corresponding author), Aalborg Univ, Inst Clin Med, Arctic Hlth Res Ctr, Aalborg, Denmark.	lohos@rn.dk	Andersen, Stig/J-2636-2015	Vestergaard, Henrik/0000-0003-3090-269X; Andersen, Stig/0000-0003-3632-5213	Danish Environmental Protection Agency; Greenland Government; Aalborg City Christmas Lottery; O bel Family Foundation; Northern Jutland Research Foundation; Danish Hospital Foundation; Faroe Islands and Greenland	Danish Environmental Protection Agency; Greenland Government; Aalborg City Christmas Lottery; O bel Family Foundation; Northern Jutland Research Foundation; Danish Hospital Foundation; Faroe Islands and Greenland	This work was supported by the Danish Environmental Protection Agency; Greenland Government; Aalborg City Christmas Lottery; O bel Family Foundation; Northern Jutland Research Foundation; Danish Hospital Foundation for Medical Research, Region of Copenhagen, the Faroe Islands and Greenland.; We gratefully acknowledge Karoline Berglund for her enthusiasm and thorough interviewing of Inuit, the invaluable support from the primary health care clinic in Nuuk, from Hans Chr. Florian Sorensen and from the hospital in Tasiilaq and the nursing stations in Tiniteqilaaq, Sermiligaaq, Kuummiut and Kulusuk. Also, Danish Environmental Protection Agency is acknowledged for financial support allowing for POP analysis.	Andersen S, 2005, AM J CLIN NUTR, V81, P656; Andersen S, 2013, BRIT J NUTR, V109, P928, DOI 10.1017/S0007114512002097; Arctic Monitoring and Assessment Programme (AMAP), AN AMAP ASS 2015 HUM; Aslani BA, 2016, LIFE SCI, V146, P163, DOI 10.1016/j.lfs.2016.01.014; BANG HO, 1980, AM J CLIN NUTR, V33, P2657, DOI 10.1093/ajcn/33.12.2657; Bjerregaard P, 1996, Arctic Med Res, V55 Suppl 1, P25; Bjerregaard P., 2013, SCI TOTAL ENVIRON, V454-455, P283; Deutch B, 2007, SCI TOTAL ENVIRON, V384, P106, DOI 10.1016/j.scitotenv.2007.05.042; Deutch B, 2007, SCI TOTAL ENVIRON, V372, P486, DOI 10.1016/j.scitotenv.2006.10.043; Dietz R, 1996, SCI TOTAL ENVIRON, V186, P67, DOI 10.1016/0048-9697(96)05086-3; Fang J, 2015, ENVIRON SCI POLLUT R, V22, P8989, DOI 10.1007/s11356-015-4080-z; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Heilmann C, 2006, PLOS MED, V3, P1352, DOI 10.1371/journal.pmed.0030311; Hennig B, 2002, INT J HYG ENVIR HEAL, V205, P95, DOI 10.1078/1438-4639-00134; Hojskov CS, 2010, CLIN CHIM ACTA, V411, P114, DOI 10.1016/j.cca.2009.10.010; Hong MY, 2015, J NUTR, V145, P939, DOI 10.3945/jn.114.206607; Imbeault P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039931; Johansen P, 2004, SCI TOTAL ENVIRON, V331, P189, DOI 10.1016/j.scitotenv.2004.03.029; Jones KC, 1999, ENVIRON POLLUT, V100, P209, DOI 10.1016/S0269-7491(99)00098-6; Jorgensen ME, 2008, ATHEROSCLEROSIS, V196, P772, DOI 10.1016/j.atherosclerosis.2007.01.008; Kim Ki-Su, 2012, J Prev Med Public Health, V45, P62, DOI 10.3961/jpmph.2012.45.2.62; Kim MJ, 2012, ENVIRON HEALTH PERSP, V120, P508, DOI 10.1289/ehp.1104282; Kjaergaard M, 2009, ATHEROSCLEROSIS, V203, P599, DOI 10.1016/j.atherosclerosis.2008.07.027; Kumar J, 2014, ENVIRON HEALTH PERSP, V122, P977, DOI 10.1289/ehp.1307613; La Merrill M, 2013, ENVIRON HEALTH PERSP, V121, P162, DOI 10.1289/ehp.1205485; Lind L, 2012, J INTERN MED, V271, P537, DOI 10.1111/j.1365-2796.2012.02536.x; Long MH, 2015, SCI TOTAL ENVIRON, V529, P198, DOI 10.1016/j.scitotenv.2015.05.022; Milnerowicz H, 2015, J TRACE ELEM MED BIO, V29, P1, DOI 10.1016/j.jtemb.2014.04.008; Pars T., 2001, ARCTIC, P54; Perkins JT, 2016, ENVIRON SCI POLLUT R, V23, P2160, DOI 10.1007/s11356-015-4479-6; Rathcke CN, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-61; Schaebel LH, 2013, ATHEROSCLEROSIS, V228, P496, DOI 10.1016/j.atherosclerosis.2013.03.022; Schaebel LK, 2015, J NUTR SCI, V4, DOI 10.1017/jns.2015.33; Stockholm convention, 2014, STOCKH CONV PERS ORG	34	16	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177781	10.1371/journal.pone.0177781	http://dx.doi.org/10.1371/journal.pone.0177781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542407	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672600023
J	Abulseoud, OA; Ho, MC; Choi, DS; Stanojevic, A; Cupic, Z; Kolar-Anic, L; Vukojevic, V				Abulseoud, Osama A.; Ho, Man Choi; Choi, Doo-Sup; Stanojevic, Ana; Cupic, Zeljko; Kolar-Anic, Ljiljana; Vukojevic, Vladana			Corticosterone oscillations during mania induction in the lateral hypothalamic kindled rat-Experimental observations and mathematical modeling	PLOS ONE			English	Article							DEXAMETHASONE-SUPPRESSION TEST; CORTICOTROPIN-RELEASING HORMONE; PITUITARY-ADRENAL AXIS; HPA AXIS; BIPOLAR DISORDER; CEREBROSPINAL-FLUID; SEX-DIFFERENCES; ADRENOCORTICAL FUNCTION; CORTISOL RESPONSE; PREDICTIVE-VALUE	Changes in the hypothalamic-pituitary-adrenal (HPA) axis activity constitute a key component of bipolar mania, but the extent and nature of these alterations are not fully understood. We use here the lateral hypothalamic-kindled (LHK) rat model to deliberately induce an acute manic-like episode and measure serum corticosterone concentrations to assess changes in HPA axis activity. A mathematical model is developed to succinctly describe the entwined biochemical transformations that underlay the HPA axis and emulate by numerical simulations the considerable increase in serum corticosterone concentration induced by LHK. Synergistic combination of the LHK rat model and dynamical systems theory allows us to quantitatively characterize changes in HPA axis activity under controlled induction of acute manic-like states and provides a framework to study in silico how the dynamic integration of neurochemical transformations underlying the HPA axis is disrupted in these states.	[Abulseoud, Osama A.; Choi, Doo-Sup] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA; [Abulseoud, Osama A.] NIDA, Chem & Drug Metab, IRP, NIH, Baltimore, MD 21224 USA; [Ho, Man Choi; Choi, Doo-Sup] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Stanojevic, Ana; Kolar-Anic, Ljiljana] Univ Belgrade, Fac Phys Chem, Studentski Trg 12-16, Belgrade, Serbia; [Cupic, Zeljko; Kolar-Anic, Ljiljana] Univ Belgrade, Inst Chem Technol & Met, Dept Catalysis & Chem Engn, Njegoseva 12, Belgrade, Serbia; [Vukojevic, Vladana] Karolinska Inst, Dept Clin Neurosci, Ctr Mol Med CMM L8 01, Stockholm, Sweden	Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Mayo Clinic; University of Belgrade; University of Belgrade; Karolinska Institutet	Abulseoud, OA (corresponding author), Mayo Clin, Dept Psychiat & Psychol, Rochester, MN 55905 USA.; Abulseoud, OA (corresponding author), NIDA, Chem & Drug Metab, IRP, NIH, Baltimore, MD 21224 USA.; Vukojevic, V (corresponding author), Karolinska Inst, Dept Clin Neurosci, Ctr Mol Med CMM L8 01, Stockholm, Sweden.	osama.abulseoud@nih.gov; vladana.vukojevic@ki.se	Cupic, Zeljko/L-3192-2019; Ho, Ada Man-Choi/AGD-8869-2022; Vukojevic, Vladana B/AAY-3144-2021	Cupic, Zeljko/0000-0002-4939-6718; Vukojevic, Vladana/0000-0003-0873-5653; Ho, Man Choi/0000-0003-4989-8782; Stanojevic, Ana/0000-0002-8302-191X	KI-Mayo research; Swedish Research Council; Knut and Alice Wallenberg Foundation; Rajko and Maj DermanoviC Fund; Ministry of Education, Science and Technological Development of the Republic of Serbia [172015, 45001]; CMST COST Action CM1304 "Emergence and Evolution of Complex Chemical Systems"	KI-Mayo research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Rajko and Maj DermanoviC Fund; Ministry of Education, Science and Technological Development of the Republic of Serbia; CMST COST Action CM1304 "Emergence and Evolution of Complex Chemical Systems"	Support from the KI-Mayo research collaboration grant (OAA and VV), Swedish Research Council (VV), Knut and Alice Wallenberg Foundation (VV), Rajko and Maj DermanoviC Fund (ZC), Ministry of Education, Science and Technological Development of the Republic of Serbia (grants 172015 and 45001, LjKA, ZC, AS), CMST COST Action CM1304 "Emergence and Evolution of Complex Chemical Systems" (ZC, VV) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support from the KI-Mayo research collaboration grant (OAA and VV), Karolinska Institute Research Funds (VV), Swedish Research Council (VV), Knut and Alice Wallenberg Foundation (VV), Rajko and Maj Dermanovic Fund (ZC), Ministry of Education, Science and Technological Development of the Republic of Serbia (grants 172015 and 45001; LjK-A, ZC, AS), CMST COST Action CM1304 "Emergence and Evolution of Complex Chemical Systems" (ZC, VV) is gratefully acknowledged.	Abulseoud OA, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.30; Abulseoud OA, 2014, INT J BIPOLAR DISORD, V2, DOI 10.1186/s40345-014-0007-8; AKESODE A, 1976, PSYCHONEUROENDOCRINO, V1, P419, DOI 10.1016/0306-4530(76)90009-3; ALDENHOFF JB, 1983, SCIENCE, V221, P875, DOI 10.1126/science.6603658; AMSTERDAM JD, 1982, AM J PSYCHIAT, V139, P287; AMSTERDAM JD, 1983, ARCH GEN PSYCHIAT, V40, P515; Andersen M, 2013, MATH BIOSCI, V246, P122, DOI 10.1016/j.mbs.2013.08.010; ARANA GW, 1983, AM J PSYCHIAT, V140, P1521; Arita K, 2005, NEUROL MED-CHIR, V45, P221, DOI 10.2176/nmc.45.221; BAUMGARTNER A, 1986, PSYCHIAT RES, V18, P9, DOI 10.1016/0165-1781(86)90057-0; Ben-Zvi A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000273; Bhangle SD, 2013, RHEUMATOL INT, V33, P1923, DOI 10.1007/s00296-013-2750-z; Bisagno V, 2014, BEHAV PHARMACOL, V25, P445, DOI 10.1097/FBP.0000000000000049; BRADBURY MW, 1974, J PHYSIOL-LONDON, V239, P269, DOI 10.1113/jphysiol.1974.sp010568; BROOKSBANK BW, 1967, BRIT J PSYCHIAT, V113, P395, DOI 10.1192/bjp.113.497.395; BRYSON RW, 1954, LANCET, V2, P365; BUNNEY WE, 1965, ARCH GEN PSYCHIAT, V12, P619; CARPENTER WT, 1971, ARCH GEN PSYCHIAT, V25, P270; CARROLL BJ, 1979, ARCH GEN PSYCHIAT, V36, P870; Cassidy F, 1998, BIOL PSYCHIAT, V43, P747, DOI 10.1016/S0006-3223(97)00274-6; Chen G, 2010, MOL PSYCHIATR, V15, P883, DOI 10.1038/mp.2010.3; CHRISTIE JE, 1986, BRIT J PSYCHIAT, V148, P58, DOI 10.1192/bjp.148.1.58; Chu CP, 2012, NEUROSCI LETT, V511, P79, DOI 10.1016/j.neulet.2012.01.035; CLARKE BL, 1988, CELL BIOPHYS, V12, P237, DOI 10.1007/BF02918360; COOKSON JC, 1985, BRIT J PSYCHIAT, V146, P498, DOI 10.1192/bjp.146.5.498; COOKSON JC, 1985, J AFFECT DISORDERS, V8, P233, DOI 10.1016/0165-0327(85)90021-7; COPPEN A, 1971, J NEUROL NEUROSUR PS, V34, P432, DOI 10.1136/jnnp.34.4.432; Cupic Z, 1999, ADVANCED SCIENCE AND TECHNOLOGY OF SINTERING, P75; Cupic Z., 2011, MATH MODELLING, P111; Daban C, 2005, PSYCHIAT CLIN N AM, V28, P469, DOI 10.1016/j.psc.2005.01.005; Deshauer D, 1999, BIOL PSYCHIAT, V45, P1023, DOI 10.1016/S0006-3223(98)00334-5; Deshauer D, 2003, CAN J PSYCHIAT, V48, P462, DOI 10.1177/070674370304800706; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; EVANS DL, 1983, AM J PSYCHIAT, V140, P615; Fries GR, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu043; Fries GR, 2014, INT J NEUROPSYCHOPH, V18, P1; Gallagher P, 2007, SCHIZOPHR RES, V90, P258, DOI 10.1016/j.schres.2006.11.020; GERNER RH, 1983, AM J PSYCHIAT, V140, P92; GODWIN CD, 1984, AM J PSYCHIAT, V141, P1610; GODWIN CD, 1984, J AFFECT DISORDERS, V7, P281, DOI 10.1016/0165-0327(84)90049-1; GODWIN CD, 1984, AM J PSYCHIAT, V141, P1263; GOLD PW, 1978, LANCET, V1, P1233; GRAHAM PM, 1982, J AFFECT DISORDERS, V4, P201, DOI 10.1016/0165-0327(82)90004-0; GREDEN JF, 1982, BIOL PSYCHIAT, V17, P455; Havermans R, 2011, PSYCHONEUROENDOCRINO, V36, P258, DOI 10.1016/j.psyneuen.2010.07.016; HWU HG, 1990, BIOL PSYCHIAT, V27, P609, DOI 10.1016/0006-3223(90)90528-A; Jelic S, 2005, MATH BIOSCI, V197, P173, DOI 10.1016/j.mbs.2005.06.006; Jelic Scupic, 2008, NEW RES NEUROSECRETO, p225 ; Jelic S, 2009, INT J NONLIN SCI NUM, V10, P1451; JIMERSON DC, 1980, AM J PSYCHIAT, V137, P979; JOYCE PR, 1995, J AFFECT DISORDERS, V33, P233, DOI 10.1016/0165-0327(94)00094-P; JOYCE PR, 1987, J AFFECT DISORDERS, V12, P1, DOI 10.1016/0165-0327(87)90054-1; Kassi EN, 2013, HORM-INT J ENDOCRINO, V12, P172, DOI 10.14310/horm.2002.1402; Kellendonk C, 2002, BRAIN RES BULL, V57, P73, DOI 10.1016/S0361-9230(01)00638-4; Kessler RC, 2007, ANNU REV CLIN PSYCHO, V3, P137, DOI 10.1146/annurev.clinpsy.3.022806.091444; Kolar-Anic L, 2010, CHEM ENG SCI, V65, P3718, DOI 10.1016/j.ces.2010.03.008; Kratzer S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00091; Krishnan KRR, 2005, PSYCHOSOM MED, V67, P1, DOI 10.1097/01.psy.0000151489.36347.18; KRISHNAN RR, 1983, AM J PSYCHIAT, V140, P203; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Leszczynska-Rodziewicz A, 2012, J AFFECT DISORDERS, V138, P490, DOI 10.1016/j.jad.2012.01.025; LEVIN N, 1989, ENDOCRINOLOGY, V125, P2957, DOI 10.1210/endo-125-6-2957; Lightman S. L., 2002, Archives of Physiology and Biochemistry, V110, P90, DOI 10.1076/apab.110.1.90.899; Lightman SL, 2010, NAT REV NEUROSCI, V11, P710, DOI 10.1038/nrn2914; LINGJAERDE P, 1964, BRIT J PSYCHIAT, V110, P423, DOI 10.1192/bjp.110.466.423; LINKOWSKI P, 1994, ARCH GEN PSYCHIAT, V51, P616; Makino S, 2002, PHARMACOL BIOCHEM BE, V73, P147, DOI 10.1016/S0091-3057(02)00791-8; Manenschijn L, 2012, PSYCHONEUROENDOCRINO, V37, P1960, DOI 10.1016/j.psyneuen.2012.04.010; Markovic VM, 2011, ENDOCR J, V58, P889, DOI 10.1507/endocrj.EJ11-0037; Miller S, 2014, J AFFECT DISORDERS, V169, pS3, DOI 10.1016/S0165-0327(14)70003-5; Miller WL., 2001, ENDOCRINOLOGY METABO, P387; Muller H, 2010, J ENDOCRINOL, V204, P85, DOI 10.1677/JOE-09-0363; Naughton M, 2014, HAND CLINIC, V124, P69, DOI 10.1016/B978-0-444-59602-4.00005-8; NINK M, 1991, KLIN WOCHENSCHR, V69, P185, DOI 10.1007/BF01646939; PERINI GI, 1984, PHARMACOPSYCHIATRY, V17, P94, DOI 10.1055/s-2007-1017415; PLATMAN SR, 1968, ARCH GEN PSYCHIAT, V18, P591; Postnova S, 2013, PHARMACOPSYCHIATRY, V46, pS36, DOI 10.1055/s-0033-1333763; Rhodes ME, 1999, BRAIN RES REV, V30, P135, DOI 10.1016/S0165-0173(99)00011-9; RIZZO ND, 1954, ANN INTERN MED, V41, P798, DOI 10.7326/0003-4819-41-4-798; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Russell GM, 2015, J NEUROENDOCRINOL, V27, P378, DOI 10.1111/jne.12247; Rybakowski JK, 1999, J PSYCHIAT RES, V33, P363, DOI 10.1016/S0022-3956(99)00014-X; Sachar E J, 1975, Prog Brain Res, V42, P81; SACHAR EJ, 1972, ARCH GEN PSYCHIAT, V26, P137; Schaffer A, 2015, BIPOLAR DISORD, V17, P1, DOI 10.1111/bdi.12271; SCHLESSER MA, 1980, ARCH GEN PSYCHIAT, V37, P737; Schmider J, 1995, BIOL PSYCHIAT, V38, P797, DOI 10.1016/0006-3223(95)00064-X; Schulkin J, 1998, PSYCHONEUROENDOCRINO, V23, P219, DOI 10.1016/S0306-4530(97)00099-1; Schulz P, 2007, DIALOGUES CLIN NEURO, V9; Shaikh S., 2012, ISRN ANESTHESIOLOGY, V2012, P1, DOI 10.5402/2012/985495; Sivukhina EV, 2016, STEROIDS; Smith Sean M, 2006, Dialogues Clin Neurosci, V8, P383; SORENSEN PS, 1985, J NEUROL NEUROSUR PS, V48, P50, DOI 10.1136/jnnp.48.1.50; Spiga F, 2014, COMPR PHYSIOL, V4, P1273, DOI 10.1002/cphy.c140003; Srivastava R, 2002, J THEOR BIOL, V218, P309, DOI 10.1006/jtbi.2002.3078; Steen NE, 2014, J PSYCHIATR RES, V52, P57, DOI 10.1016/j.jpsychires.2014.01.017; Steinman MQ, 2015, PSYCHONEUROENDOCRINO, V51, P122, DOI 10.1016/j.psyneuen.2014.09.009; STOKES PE, 1984, ARCH GEN PSYCHIAT, V41, P257; SWANN AC, 1994, BIOL PSYCHIAT, V35, P803, DOI 10.1016/0006-3223(94)91143-6; SWANN AC, 1992, ACTA PSYCHIAT SCAND, V85, P270, DOI 10.1111/j.1600-0447.1992.tb01468.x; Terenius L., 2016, ADDICT BIOL, p1 ; Voyadzis JM, 2004, J NEUROSURG, V100, P212, DOI 10.3171/ped.2004.100.2.0212; Vukojevic V, 1996, J PHYS CHEM-US, V100, P17175, DOI 10.1021/jp960785o; Walker JJ, 2010, J NEUROENDOCRINOL, V22, P1226, DOI 10.1111/j.1365-2826.2010.02087.x; Waters RP, 2015, NEUROSCI BIOBEHAV R, V58, P63, DOI 10.1016/j.neubiorev.2015.07.011; Watson S, 2005, AUST NZ J PSYCHIAT, V39, P244, DOI 10.1111/j.1440-1614.2005.01560.x; Watson S, 2004, BRIT J PSYCHIAT, V184, P496, DOI 10.1192/bjp.184.6.496; Watson S, 2007, PSYCHONEUROENDOCRINO, V32, P464, DOI 10.1016/j.psyneuen.2007.02.010; WHALLEY LJ, 1989, BRIT J PSYCHIAT, V155, P455, DOI 10.1192/bjp.155.4.455; Yang J, 2005, LAB ANIM-UK, V39, P259, DOI 10.1258/0023677054307033; Zarate CA, 2008, MT SINAI J MED, V75, P226, DOI 10.1002/msj.20042; Zarzer CA, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-65; Zelena D, 2015, AMINO ACIDS, V47, P2245, DOI 10.1007/s00726-015-2026-x	114	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177551	10.1371/journal.pone.0177551	http://dx.doi.org/10.1371/journal.pone.0177551			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542167	gold, Green Published, Green Submitted			2022-12-26	WOS:000401672400053
J	Lin, JL; Wang, ZH; Chung, CC; Xu, JA; Dai, MM; Huang, JJ				Lin, Jialiu; Wang, Zhonghao; Chung, Chuchen; Xu, Jianan; Dai, Miaomiao; Huang, Jingjing			Dynamic changes of anterior segment in patients with different stages of primary angle-closure in both eyes and normal subjects	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; PHYSIOLOGICAL MYDRIASIS; CHAMBER ANGLE; IRIS CHANGES; RISK-FACTOR; GLAUCOMA; PARAMETERS; SUBTYPES; CHINESE	Purpose To compare changes in anterior segment parameters under light and dark (light-to-dark) conditions among eyes with chronic primary angle-closure glaucoma (CPACG), fellow eyes with confirmed or suspect primary angle-closure (PAC or PACS), and age-matched healthy eyes. Methods Consecutive patients with CPACG in one eye and PAC/PACS in the fellow eye, as well as age-matched healthy subjects were recruited. Anterior segment optical coherence tomography measurements were conducted under light and dark conditions, and anterior chamber, lens, and iris parameters compared. Demographic and biometric factors associated with light-to-dark change in iris area were analyzed by linear regression. Results Fifty-seven patients (mean age 59.6 +/- 8.9 years) and 30 normal subjects matched for age (60.6 +/- 9.3 years) and sex ratio were recruited. In regards to differences under light-to-dark conditions, angle opening distance at 500 mu m (AOD500 mu m) and iris area during light-to-dark transition were smaller in CPACG eyes than fellow PACS/PAC eyes and normal eyes (P < 0.017). Pupil diameter change was largest in normal eyes, and larger in PACS/PAC eyes than CPACG eyes (P < 0.017). There was an average reduction of 0.145 mm(2) in iris area for each millimeter of pupil diameter increase in CPACG eyes, 0.161 mm(2) in fellow PAC/PACS eyes, and 0.165 mm(2) in normal eyes. Larger iris curvature in the dark and diagnosis of PACG were significantly associated with less light-to-dark iris area changes. Conclusions Dynamic changes in iris parameters with light-to-dark transition differed significantly among CPACG eyes, fellow PAC/PACS eyes, and normal eyes. Greater iris curvature under dark conditions was correlated with reduced light-to-dark change in iris area and pupil diameter, which may contribute to disease progression.	[Lin, Jialiu; Wang, Zhonghao; Chung, Chuchen; Xu, Jianan; Dai, Miaomiao; Huang, Jingjing] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Huang, JJ (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.	hjjing@mail.sysu.edu.cn			Guangzhou Science Technology and Innovation Commission in China [201607010321]; Science and Technology Planning Project of Guangdong Province in China [2013B022000037]	Guangzhou Science Technology and Innovation Commission in China; Science and Technology Planning Project of Guangdong Province in China	This work is supported by the Research Grant 201607010321 from Guangzhou Science Technology and Innovation Commission in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The URLs of the funder is http://wsbs.gzsi.gov.cn/login.html. This work is also supported by Grant 2013B022000037 from Science and Technology Planning Project of Guangdong Province in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The URLs of the funder is http://pro. gdstc.gov.cn/egrantweb/.	Aung T, 2005, ARCH OPHTHALMOL-CHIC, V123, P527, DOI 10.1001/archopht.123.4.527; Cook C, 2012, CAN J OPHTHALMOL, V47, P223, DOI 10.1016/j.jcjo.2012.02.003; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Ganeshrao SB, 2012, OPTOMETRY VISION SCI, V89, P483, DOI 10.1097/OPX.0b013e31824c3731; Henzan IM, 2011, AM J OPHTHALMOL, V151, P1065, DOI 10.1016/j.ajo.2010.11.030; Hirose F, 2013, GRAEF ARCH CLIN EXP, V251, P2395, DOI 10.1007/s00417-013-2378-4; Huang JJ, 2015, J GLAUCOMA, V24, P323, DOI 10.1097/IJG.0b013e31829e55cd; KALENAK JW, 1991, AM J OPHTHALMOL, V112, P219, DOI 10.1016/S0002-9394(14)76713-3; Lee Y, 2012, INVEST OPHTH VIS SCI, V53, P693, DOI 10.1167/iovs.11-8389; Leung CKS, 2010, OPHTHALMOLOGY, V117, P1684, DOI 10.1016/j.ophtha.2010.01.026; Leung CKS, 2007, INVEST OPHTH VIS SCI, V48, P4116, DOI 10.1167/iovs.07-0010; Maslin JS, 2015, INDIAN J OPHTHALMOL, V63, P630, DOI 10.4103/0301-4738.169787; Narayanaswamy A, 2013, INVEST OPHTH VIS SCI, V54, P708, DOI 10.1167/iovs.12-10844; Nongpiur ME, 2011, OPHTHALMOLOGY, V118, P474, DOI 10.1016/j.ophtha.2010.07.025; Nongpiur ME, 2011, CURR OPIN OPHTHALMOL, V22, P96, DOI 10.1097/ICU.0b013e32834372b9; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2010, OPHTHALMOLOGY, V117, P1, DOI 10.1016/j.ophtha.2009.11.002; Quigley HA, 2009, AM J OPHTHALMOL, V148, P657, DOI 10.1016/j.ajo.2009.08.009; Quigley HA, 2009, J GLAUCOMA, V18, P173, DOI 10.1097/IJG.0b013e31818624ce; Seager FE, 2014, INVEST OPHTH VIS SCI, V55, P1672, DOI 10.1167/iovs.13-13641; Sihota R, 2005, J GLAUCOMA, V14, P387, DOI 10.1097/01.ijg.0000176934.14229.32; Wang YE, 2013, INVEST OPHTH VIS SCI, V54, P7717, DOI 10.1167/iovs.13-12850; Wang ZT, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0141807, 10.1371/journal.pone.0120843]; Zhang Y, 2016, INVEST OPHTH VIS SCI, V57, P218, DOI 10.1167/iovs.15-17651; Zhang Y, 2014, INVEST OPHTH VIS SCI, V55, P4405, DOI 10.1167/iovs.13-13782	25	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177769	10.1371/journal.pone.0177769	http://dx.doi.org/10.1371/journal.pone.0177769			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542344	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400080
J	Su, MZ; Ma, Y; Zhang, XF; Wang, Y; Zhang, YP				Su, Mingzhe; Ma, Yan; Zhang, Xiangfen; Wang, Yan; Zhang, Yuping			MBR-SIFT: A mirror reflected invariant feature descriptor using a binary representation for image matching	PLOS ONE			English	Article								The traditional scale invariant feature transform (SIFT) method can extract distinctive features for image matching. However, it is extremely time-consuming in SIFT matching because of the use of the Euclidean distance measure. Recently, many binary SIFT (BSIFT) methods have been developed to improve matching efficiency; however, none of them is invariant to mirror reflection. To address these problems, in this paper, we present a horizontal or vertical mirror reflection invariant binary descriptor named MBR-SIFT, in addition to a novel image matching approach. First, 16 cells in the local region around the SIFT keypoint are reorganized, and then the 128-dimensional vector of the SIFT descriptor is transformed into a reconstructed vector according to eight directions. Finally, the MBR-SIFT descriptor is obtained after binarization and reverse coding. To improve the matching speed and accuracy, a fast matching algorithm that includes a coarse-to-fine two-step matching strategy in addition to two similarity measures for the MBR-SIFT descriptor are proposed. Experimental results on the UKBench dataset show that the proposed method not only solves the problem of mirror reflection, but also ensures desirable matching accuracy and speed.	[Su, Mingzhe; Ma, Yan; Zhang, Xiangfen; Zhang, Yuping] Shanghai Normal Univ, Coll Informat Mech & Elect Engn, Shanghai, Peoples R China; [Wang, Yan] Univ Paul Sabatier, Math, Informat, Telecommun Toulouse, Toulouse, France	Shanghai Normal University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Ma, Y (corresponding author), Shanghai Normal Univ, Coll Informat Mech & Elect Engn, Shanghai, Peoples R China.	ma-yan@shnu.edu.cn			National Natural Science Foundation of China [61373004]; Shanghai Normal University Innovation Team Project [A700115001005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Normal University Innovation Team Project	This work is supported by the National Natural Science Foundation of China (No.61373004) and Shanghai Normal University Innovation Team Project (No.A700115001005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the National Natural Science Foundation of China(No.61373004) and Shanghai Normal University Innovation Team Project (No.A700115001005).	Alahi A, 2012, PROC CVPR IEEE, P510, DOI 10.1109/CVPR.2012.6247715; Brown M, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1218; Calonder M, 2010, LECT NOTES COMPUT SC, V6314, P778, DOI 10.1007/978-3-642-15561-1_56; Chen CC, 2015, J VIS COMMUN IMAGE R, V30, P86, DOI 10.1016/j.jvcir.2015.02.014; Ferrari V, 2004, LECT NOTES COMPUT SC, V3021, P40; Heikkila M, 2009, PATTERN RECOGN, V42, P425, DOI 10.1016/j.patcog.2008.08.014; Kahaki SMM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149710; Ke Y, 2004, PROC CVPR IEEE, P506; Lazebnik S, 2003, PROC CVPR IEEE, P319; Li CL, 2009, PATTERN RECOGN LETT, V30, P544, DOI 10.1016/j.patrec.2008.12.004; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Matas J, 2004, IMAGE VISION COMPUT, V22, P761, DOI 10.1016/j.imavis.2004.02.006; Mikolajczyk K, 2005, IEEE T PATTERN ANAL, V27, P1615, DOI 10.1109/TPAMI.2005.188; Mikolajczyk K, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P525, DOI 10.1109/ICCV.2001.937561; Ni Zhen-Sheng, 2012, 2012 4th International Conference on Digital Home (ICDH 2012), P117, DOI 10.1109/ICDH.2012.69; Nister D., 2006, P IEEE COMP SOC C CO, P2161; Pollefeys M, 2002, COMMUN ACM, V45, P50, DOI 10.1145/514236.514263; Scovanner P., 2007, P 15 ACM INT C MULT, P357, DOI DOI 10.1145/1291233.1291311; Tuytelaars T, 2004, INT J COMPUT VISION, V59, P61, DOI 10.1023/B:VISI.0000020671.28016.e8; Xiaojie Guo, 2009, Computer Vision - ACCV 2009. 9th Asian Conference on Computer Vision. Revised Selected Papers, P536; Zhou WG, 2015, IEEE T IMAGE PROCESS, V24, P967, DOI 10.1109/TIP.2015.2389624	23	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178090	10.1371/journal.pone.0178090	http://dx.doi.org/10.1371/journal.pone.0178090			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542537	gold, Green Published, Green Submitted			2022-12-26	WOS:000401672400140
J	Doxzen, KW; Doudna, JA				Doxzen, Kevin W.; Doudna, Jennifer A.			DNA recognition by an RNA-guided bacterial Argonaute	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; TARGET RECOGNITION; PROTEINS; INSIGHTS; COMPLEX	Argonaute (Ago) proteins are widespread in prokaryotes and eukaryotes and share a four-domain architecture capable of RNA-or DNA-guided nucleic acid recognition. Previous studies identified a prokaryotic Argonaute protein from the eubacterium Marinitoga piezophila (MpAgo), which binds preferentially to 50-hydroxylated guide RNAs and cleaves single-stranded RNA (ssRNA) and DNA (ssDNA) targets. Here we present a 3.2 angstrom resolution crystal structure of MpAgo bound to a 21-nucleotide RNA guide and a complementary 21-nucleotide ssDNA substrate. Comparison of this ternary complex to other target-bound Argonaute structures reveals a unique orientation of the N-terminal domain, resulting in a straight helical axis of the entire RNA-DNA heteroduplex through the central cleft of the protein. Additionally, mismatches introduced into the heteroduplex reduce MpAgo cleavage efficiency with a symmetric profile centered around the middle of the helix. This pattern differs from the canonical mismatch tolerance of other Argonautes, which display decreased cleavage efficiency for substrates bearing sequence mismatches to the 50 region of the guide strand. This structural analysis of MpAgo bound to a hybrid helix advances our understanding of the diversity of target recognition mechanisms by Argonaute proteins.	[Doxzen, Kevin W.; Doudna, Jennifer A.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	doudna@berkeley.edu		Doxzen, Kevin/0000-0002-3616-6569	Allen Distinguished Investigator Program, through The Paul G. Allen Frontiers Group; NSF	Allen Distinguished Investigator Program, through The Paul G. Allen Frontiers Group; NSF(National Science Foundation (NSF))	This research was supported by the Allen Distinguished Investigator Program, through The Paul G. Allen Frontiers Group. This research was also supported through a NSF grant to JAD.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Carmell MA, 2002, ARGONAUTE FAMILY TEN; Cheatham TE, 1997, J AM CHEM SOC, V119, P4805, DOI 10.1021/ja963641w; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enghiad B, 2017, ACS SYNTH BIOL; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jiang F, 2016, ANN REV BIOPHYS, V46; Jo MH, 2015, MOL CELL, V59, P117, DOI 10.1016/j.molcel.2015.04.027; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaya E, 2016, P NATL ACAD SCI USA, V113, P4057, DOI 10.1073/pnas.1524385113; Kunne T, 2014, TRENDS MICROBIOL, V22, P74, DOI 10.1016/j.tim.2013.12.003; Kwak PB, 2012, NAT STRUCT MOL BIOL, V19, P145, DOI 10.1038/nsmb.2232; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Makarova KS, 2009, BIOLOGY; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Murakami R, 2016, NATURE COMMUNICATION, V7, P1; Nakanishi K, 2012, NATURE, V486, P368, DOI 10.1038/nature11211; Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014; RATMEYER L, 1994, BIOCHEMISTRY-US, V33, P5298, DOI 10.1021/bi00183a037; Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Sheng G, 2014, STRUCTURE BASED CLEA; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Swarts DC, 2015, NUCLEIC ACIDS RES, V43, P5120, DOI 10.1093/nar/gkv415; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; Swarts DC, 2014, NATURE, P1; Turner DH, 1996, CURR OPIN STRUC BIOL, V6, P299, DOI 10.1016/S0959-440X(96)80047-9; Wang Y, 2008, NATURE; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Willkomm Sarah, 2015, Life-Basel, V5, P538, DOI 10.3390/life5010538; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	43	29	30	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177097	10.1371/journal.pone.0177097	http://dx.doi.org/10.1371/journal.pone.0177097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520746	gold, Green Published, Green Submitted			2022-12-26	WOS:000401487700036
J	Kim, GW; Kim, YH; Jeong, GW				Kim, Gwang-Won; Kim, Yun-Hyeon; Jeong, Gwang-Woo			Whole brain volume changes and its correlation with clinical symptom severity in patients with schizophrenia: A DARTEL-based VBM study	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; GRAY-MATTER VOLUME; ANTERIOR CINGULATE CORTEX; 1ST-EPISODE SCHIZOPHRENIA; SEX-DIFFERENCES; WHITE-MATTER; INSULAR CORTEX; LIKELIHOOD ESTIMATION; STRUCTURAL-CHANGES; PREFRONTAL CORTEX	The purpose of this study was to evaluate gray matter (GM) and white matter (WM) volume alterations in whole-brain structures in patients with schizophrenia and healthy controls using voxel-based morphometry (VBM), and further to assess the correlation between GM and WM volume variations and symptom severity in schizophrenia. A total of 22 patients with schizophrenia and 22 age-matched healthy controls participated. Magnetic resonance image data were processed using SPM8 software with diffeomorphic anatomical registration via an exponentiated Lie algebra (DARTEL) algorithm. Patients with schizophrenia exhibited significantly decreased GM volumes of the insula, superior temporal gyrus (STG), gyrus rectus, and anterior cingulate cortex (ACC) compared with healthy controls. The GM volumes of the STG and gyrus rectus were negatively correlated with the positive scales on the Positive and Negative Syndrome Scale (PANSS) and those of the STG and ACC were negatively correlated with the negative scales. The durations of illness in schizophrenia were negatively correlated with the GM volumes of the insula, STG, and ACC. Patients with schizophrenia exhibited significantly decreased WM volumes of the superior frontal gyrus, inferior temporal gyrus, and STG. The WM volumes of the STG were negatively correlated with the duration of illness. Our findings suggest that GM and WM volume abnormalities in the STG are associated with the psychopathology of schizophrenia.	[Kim, Gwang-Won; Jeong, Gwang-Woo] Chonnam Natl Univ, Med Sch, Res Inst Med Imaging, Gwangju, South Korea; [Kim, Yun-Hyeon; Jeong, Gwang-Woo] Chonnam Natl Univ, Chonnam Natl Univ Hosp, Med Sch, Dept Radiol, Gwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University Hospital	Jeong, GW (corresponding author), Chonnam Natl Univ, Med Sch, Res Inst Med Imaging, Gwangju, South Korea.; Jeong, GW (corresponding author), Chonnam Natl Univ, Chonnam Natl Univ Hosp, Med Sch, Dept Radiol, Gwangju, South Korea.	gwjeong@jnu.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2006730]; Chonnam National University	National Research Foundation of Korea (NRF) - Ministry of Education; Chonnam National University	This research was supported by the National Research Foundation of Korea (NRF) grants funded by the Ministry of Education (2014R1A1A2006730) and Chonnam National University Research Fund for JNU distinguished research emeritus professor (2017-2019).	Abel KM, 2010, INT REV PSYCHIATR, V22, P417, DOI 10.3109/09540261.2010.515205; Asami T, 2012, NEUROIMAGE, V59, P986, DOI 10.1016/j.neuroimage.2011.08.066; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bagary MS, 2003, ARCH GEN PSYCHIAT, V60, P779, DOI 10.1001/archpsyc.60.8.779; BARTA PE, 1990, AM J PSYCHIAT, V147, P1457; BENES FM, 1991, ARCH GEN PSYCHIAT, V48, P996; Benes FM, 2001, BIOL PSYCHIAT, V50, P395, DOI 10.1016/S0006-3223(01)01084-8; Borgwardt SJ, 2007, BIOL PSYCHIAT, V61, P1148, DOI 10.1016/j.biopsych.2006.08.009; Buchsbaum MS, 2006, BIOL PSYCHIAT, V60, P1181, DOI 10.1016/j.biopsych.2005.11.028; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Castellani U, 2012, J NEURAL TRANSM, V119, P395, DOI 10.1007/s00702-011-0693-7; Crespo-Facorro B, 2004, PSYCHIAT RES-NEUROIM, V132, P107, DOI 10.1016/j.pscychresns.2004.09.002; Crespo-Facorro B, 2000, SCHIZOPHR RES, V46, P35, DOI 10.1016/S0920-9964(00)00028-1; Dazzan P, 2005, NEUROPSYCHOPHARMACOL, V30, P765, DOI 10.1038/sj.npp.1300603; Egashira K, 2014, NEUROPSYCHOBIOLOGY, V70, P142, DOI 10.1159/000364827; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; Fujiwara H, 2007, NEUROIMAGE, V36, P1236, DOI 10.1016/j.neuroimage.2007.03.068; Glahn DC, 2008, BIOL PSYCHIAT, V64, P774, DOI 10.1016/j.biopsych.2008.03.031; Goldstein JM, 2002, ARCH GEN PSYCHIAT, V59, P154, DOI 10.1001/archpsyc.59.2.154; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gur RE, 2000, ARCH GEN PSYCHIAT, V57, P761, DOI 10.1001/archpsyc.57.8.761; Highley JR, 1999, BRIT J PSYCHIAT, V175, P127, DOI 10.1192/bjp.175.2.127; Hirayasu Y, 2001, CEREB CORTEX, V11, P374, DOI 10.1093/cercor/11.4.374; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Horn H, 2010, PSYCHIAT RES-NEUROIM, V182, P183, DOI 10.1016/j.pscychresns.2010.01.016; JAKOB H, 1986, J NEURAL TRANSM, V65, P303, DOI 10.1007/BF01249090; Kalayci D, 2013, KLIN PSIKOFARMAKOL B, V23, P215, DOI 10.5455/bcp.20130713094216; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kim G, 2015, NEUROREPORT IN PRESS; Kim GW, 2017, NEUROSCIENCE, V343, P449, DOI 10.1016/j.neuroscience.2016.12.010; Kim GW, 2015, NEUROREPORT, V26, P647, DOI 10.1097/WNR.0000000000000405; Kim GW, 2015, J NEUROPSYCH CLIN N, V27, pE1, DOI 10.1176/appi.neuropsych.13080177; Kim JJ, 2003, SCHIZOPHR RES, V60, P173, DOI 10.1016/S0920-9964(02)00299-2; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; McGrath J, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-13; MENON RR, 1995, SCHIZOPHR RES, V16, P127, DOI 10.1016/0920-9964(94)00067-I; NASRALLAH HA, 1990, SCHIZOPHRENIA BULL, V16, P205, DOI 10.1093/schbul/16.2.205; Nishimura J, 2014, NEUROPSYCH DIS TREAT, V10, P2315, DOI 10.2147/NDT.S72715; Noga JT, 1995, PSYCHIAT RES-NEUROIM, V61, P201, DOI 10.1016/0925-4927(95)02612-2; Nopoulos P, 1997, AM J PSYCHIAT, V154, P1648, DOI 10.1176/ajp.154.12.1648; O'Daly OG, 2007, PSYCHIAT RES-NEUROIM, V156, P15, DOI 10.1016/j.pscychresns.2007.03.001; Pennington K, 2008, SCHIZOPHR RES, V106, P164, DOI 10.1016/j.schres.2008.08.022; Pennington K, 2008, PROTEOMICS, V8, P5097, DOI 10.1002/pmic.200800415; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Slewa-Younan S, 2004, AM J PSYCHIAT, V161, P1595, DOI 10.1176/appi.ajp.161.9.1595; Sun JH, 2009, BRAIN RES REV, V61, P14, DOI 10.1016/j.brainresrev.2009.03.004; Tomelleri L, 2009, EUR NEUROPSYCHOPHARM, V19, P835, DOI 10.1016/j.euroneuro.2009.07.007; Vita A, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.116; Whitford TJ, 2007, AM J PSYCHIAT, V164, P1082, DOI 10.1176/appi.ajp.164.7.1082; Whitwell JL, 2009, J NEUROSCI, V29, P9661, DOI 10.1523/JNEUROSCI.2160-09.2009; Wible CG, 2001, PSYCHIAT RES-NEUROIM, V108, P65, DOI 10.1016/S0925-4927(01)00109-3; Wilke M, 2001, NEUROIMAGE, V13, P814, DOI 10.1006/nimg.2001.0751; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Wylie KP, 2010, SCHIZOPHR RES, V123, P93, DOI 10.1016/j.schres.2010.08.027; Yamasue H, 2004, PSYCHIAT RES-NEUROIM, V131, P195, DOI 10.1016/j.pscychresns.2004.05.004; Yao L, 2014, MAGN RESON MATER PHY, V27, P283, DOI 10.1007/s10334-013-0411-6	58	76	81	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177251	10.1371/journal.pone.0177251	http://dx.doi.org/10.1371/journal.pone.0177251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520743	Green Published, Green Submitted, gold			2022-12-26	WOS:000401487700041
J	Hanafusa, N; Isoai, A; Ishihara, T; Inoue, T; Ishitani, K; Utsugisawa, T; Yamaka, T; Ito, T; Sugiyama, H; Arakawa, A; Yamada, Y; Itano, Y; Onodera, H; Kobayashi, R; Torii, N; Numata, T; Kashiwabara, T; Matsuno, Y; Kato, M				Hanafusa, Norio; Isoai, Ayako; Ishihara, Tomoaki; Inoue, Tetsuya; Ishitani, Ken; Utsugisawa, Taiju; Yamaka, Toshihiko; Ito, Tetsuya; Sugiyama, Hiroshi; Arakawa, Atsushi; Yamada, Yosuke; Itano, Yasuo; Onodera, Hirokazu; Kobayashi, Ryosuke; Torii, Naoko; Numata, Toyoko; Kashiwabara, Taihei; Matsuno, Yoshihiro; Kato, Michio			Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance results	PLOS ONE			English	Article							MALIGNANCY-RELATED ASCITES; CANCER-PATIENTS; ALBUMIN; FLUID	We performed post-marketing surveillance to evaluate the safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART). In total, 356 CART sessions in 147 patients at 22 centers were performed. The most common primary disease was cancer (128 cases, 300 sessions). Mean amount of ascites collected was 3.7 L, and mean concentration ratio was 9.2. Mean amount of reinfused protein was 67.8 g (recovery rate, 72.0%). Performance status, dietary intake, urine volume, body weight and abdominal circumference were significantly improved after CART. Body temperature increased significantly, by 0.3 degrees C on average. Concomitant steroids and/or NSAIDs use before reinfusion was significantly and negatively associated with increases in body temperature. Most adverse events were fever and chills. This study examined a large number of patients compared with previous studies, and showed that CART is an effective and relatively safe treatment for refractory ascites, such as malignant ascites.	[Hanafusa, Norio] Tokyo Womens Med Univ, Dept Blood Purificat, Kidney Ctr, Tokyo, Japan; [Isoai, Ayako; Onodera, Hirokazu; Kobayashi, Ryosuke; Torii, Naoko; Numata, Toyoko; Matsuno, Yoshihiro] Asahi Kasei Med Co Ltd, Blood Purificat Div, Tokyo, Japan; [Ishihara, Tomoaki] Yokkaichi Digest Dis Ctr, Dept Gastroenterol & Hepatol, Yokaichi, Mie, Japan; [Inoue, Tetsuya] Hita Cent Hosp, Dept Surg, Oita, Japan; [Ishitani, Ken] Kitasato Univ, Dept Gynecol, Kitasato Inst Hosp, Tokyo, Japan; [Utsugisawa, Taiju] Tokyo Womens Med Univ, Dept Transfus Med & Cell Proc, Tokyo, Japan; [Yamaka, Toshihiko] Kanagawa Inst Technol, Dept Clin Engn, Fac Engn, Kanagawa, Japan; [Ito, Tetsuya] Japanese Red Cross Med Ctr, Dept Palliat Care, Tokyo, Japan; [Sugiyama, Hiroshi] Kizawa Mem Hosp, Dept Gastroenterol, Gifu, Japan; [Arakawa, Atsushi] Nagoya City Univ, Dept Obstet & Gynecol, Grad Sch Med Sci, Aichi, Japan; [Yamada, Yosuke] Shinshu Univ Hosp, Div Nephrol, Nagano, Japan; [Itano, Yasuo] Okayama Kyoritsu Gen Hosp, Dept Internal Med, Okayama, Japan; [Kashiwabara, Taihei] Asahi Kasei Med Co Ltd, Vigilance & Qual Assurance Div, Prod Vigilance & Qual Assurance Dept, Regulatory Affairs, Tokyo, Japan; [Kato, Michio] Kato Michio Clin Liver Dis, Med Corp, Kenseikai, Hyogo, Japan	Tokyo Women's Medical University; Kitasato University; Tokyo Women's Medical University; Kanagawa Institute Technology; Japanese Red Cross Medical Center; University of Tokyo; Nagoya City University; Shinshu University	Hanafusa, N (corresponding author), Tokyo Womens Med Univ, Dept Blood Purificat, Kidney Ctr, Tokyo, Japan.	hanafusa@twmu.ac.jp	Utsugisawa, Taiju/ABD-7059-2021	Ito, Tetsuya/0000-0002-3872-4632; Hanafusa, Norio/0000-0002-0563-3320				[Anonymous], 2014, PRACT GUID MAN TRANS, P41; BRADLEY SE, 1947, J CLIN INVEST, V26, P1010, DOI 10.1172/JCI101867; DASCOMBE MJ, 1985, PROG NEUROBIOL, V25, P327, DOI 10.1016/0301-0082(85)90019-X; Davis HA, 1939, J CLIN INVEST, V18, P219, DOI 10.1172/JCI101037; Ernest D, 1999, CRIT CARE MED, V27, P46, DOI 10.1097/00003246-199901000-00025; HALLOWELL P, 1978, ANN THORAC SURG, V25, P22, DOI 10.1016/S0003-4975(10)63481-9; Ito T, 2015, INT J CLIN ONCOL, V20, P623, DOI 10.1007/s10147-014-0750-y; Ito T, 2014, THER APHER DIAL, V18, P87, DOI 10.1111/1744-9987.12049; Light RW, 2002, NEW ENGL J MED, V346, P1971, DOI 10.1056/NEJMcp010731; Maeda O, 2014, MOL CLIN ONCOL, V2, P1103, DOI 10.3892/mco.2014.335; Maeda S, 2015, THER APHER DIAL, V19, P342, DOI 10.1111/1744-9987.12343; Matsusaki K, 2011, INT J CLIN ONCOL, V16, P395, DOI 10.1007/s10147-011-0199-1; Mullens W, 2008, J AM COLL CARDIOL, V51, P300, DOI 10.1016/j.jacc.2007.09.043; Nakajima F, 2001, J JPN SOC DIAL THER, V34, P335, DOI DOI 10.4009/jsdt.34.335; Oda T, 1974, JPN J CLIN EXP MED, V51, P343; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Orimi S, 2011, THER APHER DIAL, V15, P411, DOI 10.1111/j.1744-9987.2011.00973.x; Ronco C, 2012, J AM COLL CARDIOL, V60, P1031, DOI 10.1016/j.jacc.2012.01.077; RUNYON BA, 1992, ANN INTERN MED, V117, P215, DOI 10.7326/0003-4819-117-3-215; SCHNEDITZ D, 1992, KIDNEY INT, V42, P1425, DOI 10.1038/ki.1992.437; Takamatsu S, 2003, KAN TAN SUI, V46, P663; Ueda T, 2012, ANTICANCER RES, V32, P2353; Wang LC, 2015, J OBSTET GYNAECOL RE, V41, P1614, DOI 10.1111/jog.12763; Yamaguchi H, 2015, EJSO-EUR J SURG ONC, V41, P875, DOI 10.1016/j.ejso.2015.04.013; Zaak D, 2001, Z GASTROENTEROL, V39, P5, DOI 10.1055/s-2001-10707	25	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177303	10.1371/journal.pone.0177303	http://dx.doi.org/10.1371/journal.pone.0177303			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510606	Green Published, gold, Green Submitted			2022-12-26	WOS:000401485500022
J	Lopez-Arias, B; Turiegano, E; Monedero, I; Canal, I; Torroja, L				Lopez-Arias, Begona; Turiegano, Enrique; Monedero, Ignacio; Canal, Inmaculada; Torroja, Laura			Presynaptic A beta 40 prevents synapse addition in the adult Drosophila neuromuscular junction	PLOS ONE			English	Article							A-BETA-OLIGOMER; AMYLOID-BETA; ALZHEIMERS-DISEASE; FUNCTIONAL SENESCENCE; PLASTICITY; PROTEIN; MEMORY; MODEL; AGE; MELANOGASTER	Complexity in the processing of the Amyloid Precursor Protein, which generates a mixture of beta amyloid peptides, lies beneath the difficulty in understanding the etiology of Alzheimer's disease. Moreover, whether A beta peptides have any physiological role in neurons is an unresolved question. By expressing single, defined A beta peptides in Drosophila, specific effects can be discriminated in vivo. Here, we show that in the adult neuromuscular junction (NMJ), presynaptic expression of A beta 40 hinders the synaptic addition that normally occurs in adults, yielding NMJs with an invariable number of active zones at all ages tested. A similar trend is observed for A beta 42 at young ages, but net synaptic loss occurs at older ages in NMJs expressing this amyloid species. In contrast, A beta 42arc produces net synaptic loss at all ages tested, although age-dependent synaptic variations are maintained. Inhibition of the PI3K synaptogenic pathway may mediate some of these effects, because western analyses show that A beta peptides block activation of this pathway, and A beta species-specific synaptotoxic effects persists in NMJs overgrown by over-expression of PI3K. Finally, individual A beta effects are also observed when toxicity is examined by quantifying neurodegeneration and survival. Our results suggest a physiological effect of A beta 40 in synaptic plasticity, and imply different toxic mechanisms for each peptide species.	[Lopez-Arias, Begona; Turiegano, Enrique; Monedero, Ignacio; Canal, Inmaculada; Torroja, Laura] Univ Autonoma Madrid, Dept Biol, Madrid, Spain	Autonomous University of Madrid	Torroja, L (corresponding author), Univ Autonoma Madrid, Dept Biol, Madrid, Spain.	laura.torroja@uam.es	Cobeta, Ignacio Monedero/AAD-5777-2022; Torroja, Laura/L-2449-2013; Torroja, Laura/AAU-7896-2021; Monedero, Ignacio/G-4858-2015; Turiegano, Enrique/M-8679-2013	Cobeta, Ignacio Monedero/0000-0001-6370-0467; Torroja, Laura/0000-0001-6939-6259; Torroja, Laura/0000-0001-6939-6259; Monedero, Ignacio/0000-0001-6370-0467; Turiegano, Enrique/0000-0003-4620-7894	Fundacion Centro de Investigacion de Enfermedades; Neurologicas - Fundacion Reina Sofia [PI0006-08]; Ministerio de Ciencia y Tecnologia (ES) [BFU2008-04683-C02-02]; Ministerio de Economia y Competitividad (ES) [BFU2016-8327-P]	Fundacion Centro de Investigacion de Enfermedades; Neurologicas - Fundacion Reina Sofia; Ministerio de Ciencia y Tecnologia (ES); Ministerio de Economia y Competitividad (ES)	Support was provided by Fundacion Centro de Investigacion de Enfermedades; Neurologicas - Fundacion Reina Sofia Grant PI0006-08 to LT and IC; Ministerio de Ciencia y Tecnologia (ES) grant BFU2008-04683-C02-02 to LT; Ministerio de Economia y Competitividad (ES) grant BFU2016-8327-P to LT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Beramendi A, 2007, J COMP NEUROL, V501, P498, DOI 10.1002/cne.21253; Brorsson AC, 2010, BIOPHYS J, V98, P1677, DOI 10.1016/j.bpj.2009.12.4320; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Chiang HC, 2010, P NATL ACAD SCI USA, V107, P7060, DOI 10.1073/pnas.0909314107; Costa R, 2011, J BIOL CHEM, V286, P41647, DOI 10.1074/jbc.M111.274548; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Cuesto G, 2011, J NEUROSCI, V31, P2721, DOI 10.1523/JNEUROSCI.4477-10.2011; Devaud JM, 2003, J NEUROBIOL, V56, P13, DOI 10.1002/neu.10215; Donlea JM, 2014, SLEEP, V37, P1427, DOI 10.5665/sleep.3988; Fang LQ, 2012, NEUROSCI BULL, V28, P585, DOI 10.1007/s12264-012-1267-x; Feng JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023655; Garcia-Osta A, 2009, LEARN MEMORY, V16, P267, DOI 10.1101/lm.1310209; Grotewiel MS, 2005, AGEING RES REV, V4, P372, DOI 10.1016/j.arr.2005.04.001; Haddadi M, 2014, BEHAV BRAIN RES, V259, P60, DOI 10.1016/j.bbr.2013.10.036; Hebbar S, 2006, J NEUROBIOL, V66, P1140, DOI 10.1002/neu.20279; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Iijima-Ando K, 2010, BRAIN STRUCT FUNCT, V214, P245, DOI 10.1007/s00429-009-0234-4; Iliadi KG, 2010, ANN NY ACAD SCI, V1197, P9, DOI 10.1111/j.1749-6632.2009.05372.x; Iwanami A, 2009, GENE DEV, V23, P1699, DOI 10.1101/gad.1832909; Jimenez S, 2011, J BIOL CHEM, V286, P18414, DOI 10.1074/jbc.M110.209718; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kerr F, 2011, NEUROBIOL AGING, V32, P1977, DOI 10.1016/j.neurobiolaging.2009.10.015; Knafo S, 2012, CURR OPIN NEUROBIOL, V22, P405, DOI 10.1016/j.conb.2012.02.008; Kremer A, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00017; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lee HK, 2009, MOL BIOL CELL, V20, P1533, DOI 10.1091/mbc.E08-07-0777; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Legan SK, 2008, J BIOL CHEM, V283, P32492, DOI 10.1074/jbc.M805832200; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Llorens-Martin M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00046; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Ma T, 2012, J NEUROCHEM, V120, P140, DOI 10.1111/j.1471-4159.2011.07506.x; Martin-Pena A, 2006, J NEUROSCI, V26, P10199, DOI 10.1523/JNEUROSCI.1223-06.2006; MCDONALD MP, 1994, BEHAV NEURAL BIOL, V62, P60, DOI 10.1016/S0163-1047(05)80059-7; McGurk L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000834; McKinney RA, 2010, J PHYSIOL-LONDON, V588, P107, DOI 10.1113/jphysiol.2009.178905; Moloney A, 2010, TRENDS BIOCHEM SCI, V35, P228, DOI 10.1016/j.tibs.2009.11.004; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Norlin N, 2012, J STRUCT BIOL, V180, P174, DOI 10.1016/j.jsb.2012.06.010; Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Rivlin PK, 2004, J COMP NEUROL, V468, P596, DOI 10.1002/cne.10977; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Sofola O, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001087; Speretta E, 2012, J BIOL CHEM, V287, P20748, DOI 10.1074/jbc.M112.350124; Technau GM, 1984, J NEUROGENET, V1, P113, DOI 10.3109/01677068409107077; Thomas U, 2012, ADV EXP MED BIOL, V970, P3, DOI 10.1007/978-3-7091-0932-8_1; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wasling P, 2009, J ALZHEIMERS DIS, V16, P1, DOI 10.3233/JAD-2009-0918; Wilcox KC, 2011, CELL MOL NEUROBIOL, V31, P939, DOI 10.1007/s10571-011-9691-4; William CM, 2012, J NEUROSCI, V32, P8004, DOI 10.1523/JNEUROSCI.5369-11.2012; Zhao XL, 2010, J NEUROSCI, V30, P1512, DOI 10.1523/JNEUROSCI.3699-09.2010; Zhou XY, 2014, CELL CYCLE, V13, P3164, DOI 10.4161/15384101.2014.962954	64	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177541	10.1371/journal.pone.0177541	http://dx.doi.org/10.1371/journal.pone.0177541			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520784	Green Published, gold, Green Submitted			2022-12-26	WOS:000401485500039
J	Wang, S; Song, JY; Yang, YD; Chawla, NV; Ma, J; Wang, HJ				Wang, Shuo; Song, Jieyun; Yang, Yide; Chawla, Nitesh V.; Ma, Jun; Wang, Haijun			Rs12970134 near MC4R is associated with appetite and beverage intake in overweight and obese children: A family-based association study in Chinese population	PLOS ONE			English	Article							MELANOCORTIN-4 RECEPTOR MUTATIONS; BODY-MASS INDEX; EATING BEHAVIOR PATTERNS; COMMON GENETIC-VARIATION; GENOME-WIDE ASSOCIATION; CHILDHOOD OBESITY; FOOD-INTAKE; VARIANTS; WEIGHT; RISK	Background Recent studies indicated that eating behaviors are under genetic influence, and the melanocortin 4 receptor (MC4R) gene polymorphisms can affect the total energy intake and the consumption of fat, protein and carbohydrates. Our study aims at investigating the association of the MC4R polymorphism with appetite and food intake among Chinese children. Methods A family-based association study was conducted among 151 Chinese trios whose offsprings were overweight/obese children aged 9-15 years. The rs12970134 near MC4R was genotyped, and the Children Eating Behavior Questionnaire (CEBQ) and a self-designed questionnaire measuring food intake were performed. The FBAT and PBAT software packages were used. Results The family-based association analysis showed that there was a significant association between rs12970134 and obesity (Z = 2.449, P = 0.014). After adjusting for age, gender and standardized BMI, rs12970134 was significantly associated with food responsiveness (FR) among children (beta'(b) = 0.077, P-b = 0.028), and with satiety responsiveness (SR) in trios (P = -0.026). The polymorphism was associated with beverage intake (beta'(b) = 0.331, P-b = 0.00016 in children; P = 0.043 in trios), but not significantly associated with vegetable, fruit or meat intake (P>0.050). We further found a significant mediation effect among the rs12970134, FR and beverage intake (b = 0.177, P = 0.047). Conclusions Our study is the first to report that rs12970134 near MC4R was associated with appetite and beverage intake, and food responsiveness could mediate the effect of rs12970134 on beverage intake in overweight and obese Chinese children population. Further studies are needed to uncover the genetic basis for eating behaviors, which could lead to develop and implement effective interventional strategies early in life.	[Wang, Shuo; Song, Jieyun; Yang, Yide; Ma, Jun; Wang, Haijun] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing, Peoples R China; [Wang, Shuo; Chawla, Nitesh V.] Univ Notre Dame, Interdisciplinary Ctr Network Sci & Applicat, Notre Dame, IN 46556 USA; [Chawla, Nitesh V.] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA	Peking University; University of Notre Dame; University of Notre Dame	Ma, J; Wang, HJ (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing, Peoples R China.	majunt@bjmu.edu.cn; whjun1@bjmu.edu.cn	Wang, Haijun/AAD-1302-2021; Chawla, Nitesh/F-2690-2016	Wang, Haijun/0000-0003-0849-2903; Chawla, Nitesh/0000-0003-3932-5956; Yang, Yide/0000-0003-3297-1306; Wang, Shuo/0000-0002-3146-5818	Research Special Fund for Public Welfare of Health [201202010]; National Natural Science Foundation of China [81573170]	Research Special Fund for Public Welfare of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding for the study is provided by the Research Special Fund for Public Welfare of Health (201202010, JM, http://health1147.bjmu.edu.cn/) and the grant from National Natural Science Foundation of China (81573170, HW, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Adan RAH, 2006, BRIT J PHARMACOL, V149, P815, DOI 10.1038/sj.bjp.0706929; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bellisle F, 2009, ENCEPHALE, V35, P182, DOI 10.1016/j.encep.2008.03.009; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Cao YT, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-5; Carnell S, 2007, APPETITE, V48, P104, DOI 10.1016/j.appet.2006.07.075; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Chen WM, 2009, AM J HUM GENET, V85, P364, DOI 10.1016/j.ajhg.2009.08.003; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Dratva J, 2016, PUBLIC HEALTH NUTR, V19, P1944, DOI 10.1017/S136898001600015X; Dwivedi OP, 2013, J HUM GENET, V58, P27, DOI 10.1038/jhg.2012.129; Ewens KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016390; Faith MS, 2013, HUM HERED, V75, P80, DOI 10.1159/000353879; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fernandes AE, 2015, ENDOCRINE, V49, P653, DOI 10.1007/s12020-015-0616-8; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Garcia-Dominic O, 2012, HEALTH PROMOT PRACT, V13, P763, DOI 10.1177/1524839911405847; Gardner KR, 2015, PEDIATR OBES, V10, P476, DOI 10.1111/ijpo.12010; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hebebrand J, 2004, MOL PSYCHIATR, V9, P796, DOI 10.1038/sj.mp.4001491; Ho-Urriola J, 2014, NUTRITION, V30, P145, DOI 10.1016/j.nut.2013.05.030; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Hunsberger M, 2015, MATERN CHILD NUTR, V11, P260, DOI 10.1111/j.1740-8709.2012.00446.x; Ji CY, 2005, BIOMED ENVIRON SCI, V18, P390; Kochetova O V, 2015, Genetika, V51, P248; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Loh DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082885; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Lubrano-Berthelier C, 2006, J CLIN ENDOCR METAB, V91, P1811, DOI 10.1210/jc.2005-1411; McCaffery JM, 2017, PSYCHOSOM MED, V79, P224, DOI 10.1097/PSY.0000000000000380; Meng XR, 2014, PEDIATR RES, V76, P310, DOI 10.1038/pr.2014.88; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Monks SA, 2000, AM J HUM GENET, V66, P576, DOI 10.1086/302745; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Obregon AM, 2017, J PHYSIOL BIOCHEM, V73, P29, DOI 10.1007/s13105-016-0521-5; Qi L, 2008, HUM MOL GENET, V17, P3502, DOI 10.1093/hmg/ddn242; Rigoli L, 2010, ACTA PAEDIATR, V99, P722, DOI 10.1111/j.1651-2227.2010.01709.x; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Shugart YY, 2009, AM J MED GENET B, V150B, P886, DOI 10.1002/ajmg.b.30914; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Stutzmann F, 2009, INT J OBESITY, V33, P373, DOI 10.1038/ijo.2008.279; Stutzmann F, 2008, DIABETES, V57, P2511, DOI 10.2337/db08-0153; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Valette M, 2014, INT J OBESITY, V38, P883, DOI 10.1038/ijo.2013.190; Valette M, 2013, INT J OBESITY, V37, P1027, DOI 10.1038/ijo.2012.169; Valladares M, 2010, NUTR NEUROSCI, V13, P71, DOI 10.1179/147683010X12611460763643; Vega JA, 2016, ANN NUTR METAB, V68, P35, DOI 10.1159/000439092; Wang S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145944; Wardle J, 2001, J CHILD PSYCHOL PSYC, V42, P963, DOI 10.1111/1469-7610.00792; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Xia QH, 2013, ANN NY ACAD SCI, V1281, P178, DOI 10.1111/nyas.12020; Yoon YR, 2015, ENDOCRINOL METAB, V30, P576, DOI 10.3803/EnM.2015.30.4.576	57	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177983	10.1371/journal.pone.0177983	http://dx.doi.org/10.1371/journal.pone.0177983			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DC	28520814	Green Published, gold, Green Submitted			2022-12-26	WOS:000401485500084
J	Gericke, B; Schecker, N; Amiri, M; Naim, HY				Gericke, Birthe; Schecker, Natalie; Amiri, Mahdi; Naim, Hassan Y.			Structure-function analysis of human sucrase-isomaltase identifies key residues required for catalytic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALTASE-GLUCOAMYLASE ACTIVITY; LACTASE-PHLORHIZIN HYDROLASE; AMINO-ACID-SEQUENCE; ALPHA-GLUCOSIDASE; FAMILY 31; SUBSTRATE-SPECIFICITY; STARCH DIGESTION; EXPRESSION; TRANSPORT; DOMAIN	Sucrase-isomaltase (SI) is an intestinal membrane-associated alpha-glucosidase that breaks down di-and oligosaccharides to absorbable monosaccharides. SI has two homologous functional subunits (sucrase and isomaltase) that both belong to the glycoside hydrolase family 31 (GH31) and differ in substrate specificity. All GH31 enzymes share a consensus sequence harboring an aspartic acid residue as a catalytic nucleophile. Moreover, crystallographic structural analysis of isomaltase predicts that another aspartic acid residue functions as a proton donor in hydrolysis. Here, we mutagenized the predicted proton donor residues and the nucleophilic catalyst residues in each SI subunit. We expressed these SI variants in COS-1 cells and analyzed their structural, transport, and functional characteristics. All of the mutants revealed expression levels and maturation rates comparable with those of the wild-type species and the corresponding nonmutated subunits were functionally active. Thereby we determined rate and substrate specificity for each single subunit without influence from the other subunit. This approach provides a model for functional analysis of the single subunits within a multidomain protein, achieved without the necessity to express the individual subunits separately. Of note, we also found that glucose product inhibition regulates the activities of both SI subunits. We experimentally confirmed the catalytic function of the predicted proton donor residues, and sequence analysis suggested that these residues are located in a consensus region in many GH31 family members. In summary, these findings reveal the kinetic features specific for each human SI subunit and demonstrate that the activities of these subunits are regulated via product inhibition.	[Gericke, Birthe; Schecker, Natalie; Amiri, Mahdi; Naim, Hassan Y.] Univ Vet Med Hannover, Dept Physiol Chem, D-30559 Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Amiri, M; Naim, HY (corresponding author), Univ Vet Med Hannover, Dept Physiol Chem, D-30559 Hannover, Germany.	mahdi.amiri@tiho-hannover.de; hassan.naim@tiho-hannover.de	Amiri, Mahdi/L-6934-2019	Amiri, Mahdi/0000-0003-4775-9535; Gericke, Birthe/0000-0002-9181-4493				Amiri M, 2014, J INHERIT METAB DIS, V37, P929, DOI 10.1007/s10545-014-9725-4; Amiri M, 2012, J INHERIT METAB DIS, V35, P949, DOI 10.1007/s10545-012-9523-9; Amit-Romach E, 2006, INT J MOL MED, V18, P721; Cohen Stanley A, 2016, Mol Cell Pediatr, V3, P5, DOI 10.1186/s40348-015-0028-0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Eggert MW, 2011, APPL BIOCHEM BIOTECH, V165, P676, DOI 10.1007/s12010-011-9287-y; Ernst HA, 2006, J MOL BIOL, V358, P1106, DOI 10.1016/j.jmb.2006.02.056; FERRARIS RP, 1990, AM J PHYSIOL, V259, pG822, DOI 10.1152/ajpgi.1990.259.5.G822; Frandsen TP, 1998, PLANT MOL BIOL, V37, P1, DOI 10.1023/A:1005925819741; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GRAY GM, 1979, J BIOL CHEM, V254, P6038; HAURI HP, 1985, J CELL BIOL, V101, P838, DOI 10.1083/jcb.101.3.838; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HERMANS MMP, 1991, J BIOL CHEM, V266, P13507; HUNZIKER W, 1986, CELL, V46, P227, DOI 10.1016/0092-8674(86)90739-7; IWANAMI S, 1995, BIOSCI BIOTECH BIOCH, V59, P459, DOI 10.1271/bbb.59.459; Jacob R, 2000, J CLIN INVEST, V106, P281, DOI 10.1172/JCI9677; Jacob R, 2002, J BIOL CHEM, V277, P32141, DOI 10.1074/jbc.M204116200; Jourdan N, 1998, J VIROL, V72, P7228, DOI 10.1128/JVI.72.9.7228-7236.1998; Keiser M, 2006, J BIOL CHEM, V281, P14393, DOI 10.1074/jbc.M513631200; Lee SS, 2002, J AM CHEM SOC, V124, P4948, DOI 10.1021/ja0255610; Lee SS, 2001, BIOCHEM J, V359, P381, DOI 10.1042/0264-6021:3590381; Liu XF, 1999, J BIOL CHEM, V274, P31155, DOI 10.1074/jbc.274.44.31155; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lovering AL, 2005, J BIOL CHEM, V280, P2105, DOI 10.1074/jbc.M410468200; NAIM HY, 1988, J BIOL CHEM, V263, P7242; NAIM HY, 1987, BIOCHEM J, V241, P427, DOI 10.1042/bj2410427; NAIM HY, 1991, J BIOL CHEM, V266, P12313; Nichols BL, 2003, P NATL ACAD SCI USA, V100, P1432, DOI 10.1073/pnas.0237170100; Okuyama M, 2001, EUR J BIOCHEM, V268, P2270, DOI 10.1046/j.1432-1327.2001.02104.x; Okuyama M, 2011, BIOSCI BIOTECH BIOCH, V75, P2269, DOI 10.1271/bbb.110610; Ouwendijk J, 1996, J CLIN INVEST, V97, P633, DOI 10.1172/JCI118459; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; QUARONI A, 1976, J BIOL CHEM, V251, P3250; Quezada-Calvillo R, 2008, J NUTR, V138, P685, DOI 10.1093/jn/138.4.685; Quezada-Calvillo R, 2007, J PEDIATR GASTR NUTR, V45, P32, DOI 10.1097/MPG.0b013e31804216fc; Ren LM, 2011, PROTEIN CELL, V2, P827, DOI 10.1007/s13238-011-1105-3; Robayo-Torres CC, 2009, J PEDIATR GASTR NUTR, V48, P412, DOI 10.1097/MPG.0b013e318180cd09; Sander Petra, 2006, Hum Mutat, V27, P119, DOI 10.1002/humu.9392; Scott KGE, 2004, INFECT IMMUN, V72, P3536, DOI 10.1128/IAI.72.6.3536-3542.2004; SEMENZA G, 1965, BIOCHIM BIOPHYS ACTA, V96, P487, DOI 10.1016/0005-2787(65)90565-4; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Song KM, 2013, BIOSCI BIOTECH BIOCH, V77, P1759, DOI 10.1271/bbb.130325; Treem WR, 2012, J PEDIATR GASTR NUTR, V55, pS7, DOI 10.1097/01.mpg.0000421401.57633.90; TREEM WR, 1995, J PEDIATR GASTR NUTR, V21, P1, DOI 10.1097/00005176-199507000-00001; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; Trombetta ES, 2001, BIOCHEMISTRY-US, V40, P10717, DOI 10.1021/bi010629u; Uhrich S, 2012, J PEDIATR GASTR NUTR, V55, pS34, DOI 10.1097/01.mpg.0000421408.65257.b5; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]	51	18	18	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					11070	11078		10.1074/jbc.M117.791939	http://dx.doi.org/10.1074/jbc.M117.791939			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28522605	Green Published, hybrid			2022-12-26	WOS:000404391000027
J	Tomimatsu, N; Mukherjee, B; Harris, JL; Boffo, FL; Hardebeck, MC; Potts, PR; Khanna, KK; Burma, S				Tomimatsu, Nozomi; Mukherjee, Bipasha; Harris, Janelle Louise; Boffo, Francesca Ludovica; Hardebeck, Molly Catherine; Potts, Patrick Ryan; Khanna, Kum Kum; Burma, Sandeep			DNA-damage-induced degradation of EXO1 exonuclease limits DNA end resection to ensure accurate DNA repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-BREAK REPAIR; HOMOLOGOUS RECOMBINATION REPAIR; SINGLE-NUCLEOTIDE POLYMORPHISMS; SCF UBIQUITIN LIGASES; PATHWAY CHOICE; COLORECTAL-CANCER; REPLICATION FORKS; GENOTOXIC STRESS; CELL-CYCLE; E3 LIGASE	End resection of DNA double-strand breaks (DSBs) to generate 3'-single-stranded DNA facilitates DSB repair via error-free homologous recombination (HR) while stymieing repair by the error-prone non-homologous end joining (NHEJ) pathway. Activation of DNA end resection involves phosphorylation of the 5' to 3' exonuclease EXO1 by the phosphoinositide 3-kinase-like kinases ATM (ataxia telangiectasia-mutated) and ATR (ATM and Rad3-related) and by the cyclin-dependent kinases 1 and 2. After activation, EXO1 must also be restrained to prevent over-resection that is known to hamper optimal HR and trigger global genomic instability. However, mechanisms by which EXO1 is restrained are still unclear. Here, we report that EXO1 is rapidly degraded by the ubiquitin-proteasome system soon after DSB induction in human cells. ATR inhibition attenuated DNA-damage-induced EXO1 degradation, indicating that ATRmediated phosphorylation of EXO1 targets it for degradation. In accord with these results, EXO1 became resistant to degradation when its SQ motifs required for ATR-mediated phosphorylation were mutated. We show that upon the induction of DNA damage, EXO1 is ubiquitinated by a member of the Skp1-Cullin1-F-box (SCF) family of ubiquitin ligases in a phosphorylation-dependent manner. Importantly, expression of degradation-resistant EXO1 resulted in hyper-resection, which attenuated both NHEJ and HR and severely compromised DSB repair resulting in chromosomal instability. These findings indicate that the coupling of EXO1 activation with its eventual degradation is a timing mechanism that limits the extent of DNA end resection for accurate DNA repair.	[Tomimatsu, Nozomi; Mukherjee, Bipasha; Hardebeck, Molly Catherine; Burma, Sandeep] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Harris, Janelle Louise; Khanna, Kum Kum] QIMR Berghofer Med Res Inst, Signal Transduct Lab, Brisbane, Qld, Australia; [Boffo, Francesca Ludovica] Univ Federico II, Dept Mol Med & Med Biotechnol, I-80131 Naples, Italy; [Potts, Patrick Ryan] St Jude Childrens Res Hosp, Dept Cell & Mol Biol, Memphis, TN 38105 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; QIMR Berghofer Medical Research Institute; University of Naples Federico II; St Jude Children's Research Hospital	Burma, S (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Div Mol Radiat Biol, Dept Radiat Oncol, 2201 Inwood Rd,NC7-208, Dallas, TX 75390 USA.	sandeep.burma@utsouthwestern.edu	Potts, Patrick R/P-4707-2018	Potts, Patrick R/0000-0002-2024-8885; Boffo, Francesca Ludovica/0000-0002-9790-7148; Khanna, Kum Kum/0000-0001-8650-5381; Hancock, Janelle/0000-0001-6703-7228	National Institutes of Health [RO1CA197796, RO1CA149461, R21CA202403]; National Aeronautics and Space Administration [NNX16AD78G]; NATIONAL CANCER INSTITUTE [R01CA197796, R21CA202403, R01CA149461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1CA197796, RO1CA149461, and R21CA202403 (to S. B). This work was also supported by National Aeronautics and Space Administration Grant NNX16AD78G. The authors declare that they have no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bau DT, 2009, CHINESE J PHYSIOL, V52, P411, DOI 10.4077/CJP.2009.AMH076; Bolderson E, 2010, NUCLEIC ACIDS RES, V38, P1821, DOI 10.1093/nar/gkp1164; Bolderson E, 2009, NUCLEIC ACIDS RES, V37, P3452, DOI 10.1093/nar/gkp194; Bologna S, 2015, CELL CYCLE, V14, P2439, DOI 10.1080/15384101.2015.1060381; Brown JS, 2015, CELL REP, V11, P704, DOI 10.1016/j.celrep.2015.03.058; Buis J, 2012, NAT STRUCT MOL BIOL, V19, P246, DOI 10.1038/nsmb.2212; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Burma S, 2006, DNA REPAIR, V5, P1042, DOI 10.1016/j.dnarep.2006.05.026; Chang JS, 2008, CANCER EPIDEM BIOMAR, V17, P1368, DOI 10.1158/1055-9965.EPI-07-2830; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chen XQ, 2015, J BIOL CHEM, V290, P12300, DOI 10.1074/jbc.M115.644005; Chen XQ, 2013, NUCLEIC ACIDS RES, V41, P9325, DOI 10.1093/nar/gkt672; Costelloe T, 2012, NATURE, V489, P581, DOI 10.1038/nature11353; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; Daley JM, 2015, DNA REPAIR, V32, P66, DOI 10.1016/j.dnarep.2015.04.015; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Eid W, 2010, EMBO REP, V11, P962, DOI 10.1038/embor.2010.157; El-Shemerly M, 2008, NUCLEIC ACIDS RES, V36, P511, DOI 10.1093/nar/gkm1052; Elia AEH, 2015, MOL CELL, V59, P867, DOI 10.1016/j.molcel.2015.05.006; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Falck J, 2012, EMBO REP, V13, P561, DOI 10.1038/embor.2012.58; Fernandez-Capetillo O, 2013, CELL, V155, P979, DOI 10.1016/j.cell.2013.10.049; Ferretti LP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12628; Ferretti Lorenza P., 2013, Frontiers in Genetics, V4, P99, DOI 10.3389/fgene.2013.00099; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Goellner EM, 2015, DNA REPAIR, V32, P24, DOI 10.1016/j.dnarep.2015.04.010; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Han XZ, 2014, P NATL ACAD SCI USA, V111, P17456, DOI 10.1073/pnas.1408538111; Hannah J, 2009, DNA REPAIR, V8, P536, DOI 10.1016/j.dnarep.2009.01.011; Hao YH, 2013, CELL, V152, P1051, DOI 10.1016/j.cell.2013.01.051; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; HSIANG YH, 1989, CANCER RES, V49, P5077; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Ismail IH, 2015, NAT CELL BIOL, V17, P1446, DOI 10.1038/ncb3259; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jin GF, 2008, LUNG CANCER, V60, P340, DOI 10.1016/j.lungcan.2007.11.003; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Keijzers G, 2016, CRIT REV BIOCHEM MOL, V51, P440, DOI 10.1080/10409238.2016.1215407; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Leszczynska KB, 2016, RADIOTHER ONCOL, V121, P232, DOI 10.1016/j.radonc.2016.10.023; Liao SR, 2011, NUCLEIC ACIDS RES, V39, P5967, DOI 10.1093/nar/gkr216; Lu G, 2013, SCI WORLD J, DOI 10.1155/2013/424617; Luo KT, 2012, EMBO J, V31, P3008, DOI 10.1038/emboj.2012.158; Makharashvili N, 2014, MOL CELL, V54, P1022, DOI 10.1016/j.molcel.2014.04.011; McEllin B, 2010, CANCER RES, V70, P5457, DOI 10.1158/0008-5472.CAN-09-4295; Michailidou K, 2015, NAT GENET, V47, P373, DOI 10.1038/ng.3242; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mladenov E, 2016, SEMIN CANCER BIOL, V37-38, P51, DOI 10.1016/j.semcancer.2016.03.003; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Mukherjee B, 2008, DNA REPAIR, V7, P1717, DOI 10.1016/j.dnarep.2008.06.016; Mukherjee B, 2015, METHODS MOL BIOL, V1292, P67, DOI 10.1007/978-1-4939-2522-3_5; Mukherjee B, 2012, NEOPLASIA, V14, P34, DOI 10.1593/neo.111512; Mukherjee B, 2009, CANCER RES, V69, P4252, DOI 10.1158/0008-5472.CAN-08-4853; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Ochs F, 2016, NAT STRUCT MOL BIOL, V23, P714, DOI 10.1038/nsmb.3251; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Parameswaran B, 2015, CELL CYCLE, V14, P437, DOI 10.4161/15384101.2014.972901; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Postow L, 2013, CELL CYCLE, V12, P587, DOI 10.4161/cc.23408; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Saintigny Y, 2001, EMBO J, V20, P3861, DOI 10.1093/emboj/20.14.3861; Sarkaria JN, 1999, CANCER RES, V59, P4375; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Silverman JS, 2012, TRENDS BIOCHEM SCI, V37, P66, DOI 10.1016/j.tibs.2011.10.004; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Sun XM, 2002, CANCER RES, V62, P6026; Symington LS, 2016, CRIT REV BIOCHEM MOL, V51, P195, DOI 10.3109/10409238.2016.1172552; Symington LS, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016436; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tang XJ, 2005, METHOD ENZYMOL, V399, P433, DOI 10.1016/S0076-6879(05)99030-7; TOLEDO LI, 2013, Patent No. 1551088; Tomimatsu N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4561; Tomimatsu N, 2012, DNA REPAIR, V11, P441, DOI 10.1016/j.dnarep.2012.01.006; Tomimatsu N, 2009, EMBO REP, V10, P629, DOI 10.1038/embor.2009.60; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Tsai MH, 2009, ORAL ONCOL, V45, pE90, DOI 10.1016/j.oraloncology.2009.03.011; Ulrich HD, 2012, J CELL SCI, V125, P249, DOI 10.1242/jcs.091801; Veuger SJ, 2003, CANCER RES, V63, P6008; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang HC, 2009, ANTICANCER RES, V29, P3897; Wu Y, 2001, GASTROENTEROLOGY, V120, P1580, DOI 10.1053/gast.2001.25117; Xie J, 2015, J CLIN INVEST, V125, P1523, DOI 10.1172/JCI79325; Xu GQ, 2013, BIOTECHNOL GENET ENG, V29, P73, DOI 10.1080/02648725.2013.801232; Yamamoto H, 2005, CARCINOGENESIS, V26, P411, DOI 10.1093/carcin/bgh335; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhang F, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv939; Zhang Ya-ni, 2009, Proceedings of the 2009 Asia Communications and Photonics Conference and Exhibition (ACP 2009); Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zheng XF, 2015, DNA REPAIR, V32, P58, DOI 10.1016/j.dnarep.2015.04.014; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zong DL, 2016, NAT STRUCT MOL BIOL, V23, P699, DOI 10.1038/nsmb.3274	99	40	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10779	10790		10.1074/jbc.M116.772475	http://dx.doi.org/10.1074/jbc.M116.772475			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28515316	hybrid, Green Published			2022-12-26	WOS:000404391000003
J	Negedu-Momoh, OR; Jegede, FE; Yakubu, A; Balogun, O; Abdullahi, M; Badru, T; Oladele, EA; Agbakwuru, C; Khamofu, H; Torpey, K				Negedu-Momoh, Olubunmi Ruth; Jegede, Feyisayo Ebenezer; Yakubu, Ali; Balogun, Oluseyi; Abdullahi, Musa; Badru, Titilope; Oladele, Edward Adekola; Agbakwuru, Chinedu; Khamofu, Hadiza; Torpey, Kwasi			Performance evaluation of BD FACSPresto (TM) point of care CD4 analyzer to enumerate CD4 counts for monitoring HIV infected individuals in Nigeria	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SETTINGS; CLINICS; PIMA	Background Despite the upsurge in support and intervention of donor agencies in HIV care and treatment programing in Sub-Sahara African, antiretroviral (ART) programs are still confronted with access and coverage challenges which influence enrolment of new patients. This study investigated the validity of point of care BD FACSPresto (TM) CD4 analyzer for CD4+ cell count, overall agreement, correlation, sensitivity, and specificity in comparison to a reference standard flow cytometry method. We also assessed the feasibility of use among non-laboratorians. Methods Blood samples from 300 HIV infected individuals were analyzed for CD4+ T cell and CD4%, using finger prick capillary sample from 150 PMTCT clients and 150 ART clients at Murtala Mohammed Specialist Hospital, Kano, Nigeria. Their venous samples were compared on a flow cytometry reference method using BD FACSCount CD4+ count system. The accuracy of the BD FACSPresto machine in comparison to BD FACSCount was evaluated. Statistical analysis was carried out using STATA (version 12). Bland-Altman method and correlation analysis were used to analyze agreement between both measurements. In addition, sensitivity and specificity of both measurements were determined. Statistical significance was set at p-value <0.05. Results The mean bias and limit of agreement for CD4+ count between BD FACSPresto and BD FACS count machine were 7.49 (95% CI: 2.44 to 12.54) and -8.14 to 96.39 respectively. Further analysis revealed close agreement between BD FACSPresto and BD FACSCount with no significant difference between the two methods (p = .0.95). Using a threshold of 500 cells/mu L, sensitivity and specificity of BD FACSPresto were 95.1% and 97.1% respectively, compared to BD FACSCount. There was no statistically significant difference in the misclassification between BD FACSPresto and BD FACSCount results (p = 0.23). Furthermore, sensitivity and specificity were similar when BD FACSPresto machine was operated by a nurse or laboratory scientist, there was no substantial difference in testing variability observed between laboratory and non-laboratory operators using the BD FACSPresto analyzer. Conclusions Overall, BD FACSPresto Point of Care CD4+ count finger stick capillary blood results is a reliable method in comparison to venous sample cytometry method and no significant difference variability observed between laboratory personnel and non-laboratory operators. The BD FACSPresto is simple, more robust and easy to use equipment without significant variability in reliability by non-laboratory health care workers hence will be a valuable instrument in increasing access and coverage of CD4 estimations in developing countries. The introduction of the BD FACSPresto POC analyzer has a high potential in reducing patients waiting time and improving the overall quality of ART service and clients' satisfaction especially in rural settings.	[Negedu-Momoh, Olubunmi Ruth; Jegede, Feyisayo Ebenezer; Balogun, Oluseyi; Badru, Titilope; Oladele, Edward Adekola; Agbakwuru, Chinedu; Khamofu, Hadiza; Torpey, Kwasi] Family Hlth Int FHI360, Garki Abuja, Nigeria; [Yakubu, Ali; Abdullahi, Musa] Murtala Mohammed Specialist Hosp, Kano, Nigeria; [Torpey, Kwasi] Univ Ghana, Coll Hlth Sci, Accra, Ghana	University of Ghana	Negedu-Momoh, OR (corresponding author), Family Hlth Int FHI360, Garki Abuja, Nigeria.	onegedumomoh@ng.fhi360.org		Torpey, Kwasi/0000-0003-1628-2922; Oladele, Edward Adekola/0000-0003-4999-1397	FHI under the USAID [360]	FHI under the USAID(United States Agency for International Development (USAID))	BD Bioscience provided the BD FACSPresto machine for the pilot testing to Murtala Mohammed Specialist Hospital, Kano, one of the supported sites by FHI 360 under the USAID funding for the SIDHAS project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angira F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157939; Beckton D, 2008, BD FACSCOUNT SYTEM U, P59; Boyle DS, 2012, TRENDS BIOTECHNOL, V30, P45, DOI 10.1016/j.tibtech.2011.06.015; Bwana P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145586; Calmy A, 2007, CLIN INFECT DIS, V44, P128, DOI 10.1086/510073; Cheng XH, 2009, LAB CHIP, V9, P1357, DOI 10.1039/b818813k; Coetzee LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156266; Federal Ministry of Health Nigeria, 2016, NAT GUID HIV PREV TR; Galiwango RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088928; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034319; Mnyani CN, 2012, JAIDS-J ACQ IMM DEF, V60, P260, DOI 10.1097/QAI.0b013e318256b651; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Mwau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067612; Pribul V., 2013, SURGERY OXFORD, V31, P84; Rathunde L, 2014, INT J STD AIDS, V25, P956, DOI 10.1177/0956462414526862; Roberts T, 2016, CLIN INFECT DIS, V62, P1043, DOI 10.1093/cid/ciw001; Shubber Z, 2013, AIDS, V27, P1403, DOI 10.1097/QAD.0b013e32835f1db0; Thakar M, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-26; Wang SQ, 2010, BIOTECHNOL ADV, V28, P770, DOI 10.1016/j.biotechadv.2010.06.004; World Health Organization, 2016, CONS GUID US ANT DRU	22	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178037	10.1371/journal.pone.0178037	http://dx.doi.org/10.1371/journal.pone.0178037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542359	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800037
J	Picheny, V; Trepos, R; Casadebaig, P				Picheny, Victor; Trepos, Ronan; Casadebaig, Pierre			Optimization of black-box models with uncertain climatic inputs-Application to sunflower ideotype design	PLOS ONE			English	Article							MULTIOBJECTIVE OPTIMIZATION; CROP; PERFORMANCE; GENOTYPE; WHEAT	Accounting for the interannual climatic variations is a well-known issue for simulation-based studies of environmental systems. It often requires intensive sampling (e.g., averaging the simulation outputs over many climatic series), which hinders many sequential processes, in particular optimization algorithms. We propose here an approach based on a subset selection in a large basis of climatic series, using an ad-hoc similarity function and clustering. A non-parametric reconstruction technique is introduced to estimate accurately the distribution of the output of interest using only the subset sampling. The proposed strategy is non-intrusive and generic (i.e. transposable to most models with climatic data inputs), and can be combined to most "off-the-shelf" optimization solvers. We apply our approach to sunflower ideotype design using the crop model SUNFLO. The underlying optimization problem is formulated as a multi-objective one to account for risk-aversion. Our approach achieves good performances even for limited computational budgets, outperforming significantly standard strategies.	[Picheny, Victor; Trepos, Ronan] Univ Toulouse, INRA, MIAT, Castanet Tolosan, France; [Casadebaig, Pierre] Univ Toulouse, INRA, AGIR, Castanet Tolosan, France	INRAE; INRAE	Picheny, V (corresponding author), Univ Toulouse, INRA, MIAT, Castanet Tolosan, France.	victor.picheny@toulouse.inra.fr	Casadebaig, Pierre/AAL-6998-2020; Casadebaig, Pierre/AAL-3307-2020	Casadebaig, Pierre/0000-0001-7225-936X; 				Ailliot P, 2015, J SFDS, V156, P101; Allen R. G., 1998, FAO Irrigation and Drainage Paper; [Anonymous], 2006, WORKING DYNAMIC CROP; Bergez JE, 2013, ENVIRON MODELL SOFTW, V39, P39, DOI 10.1016/j.envsoft.2012.03.011; Beyer HG, 2007, COMPUT METHOD APPL M, V196, P3190, DOI 10.1016/j.cma.2007.03.003; Brisson N, 2003, EUR J AGRON, V18, P309, DOI 10.1016/S1161-0301(02)00110-7; Brown HE, 2014, ENVIRON MODELL SOFTW, V62, P385, DOI 10.1016/j.envsoft.2014.09.005; Casadebaig P, 2011, AGR FOREST METEOROL, V151, P163, DOI 10.1016/j.agrformet.2010.09.012; Challinor AJ, 2008, AGR FOREST METEOROL, V148, P1062, DOI 10.1016/j.agrformet.2008.02.006; Connor D.J., 1997, SUNFLOWER TECHNOLOGY, VVolume 35, P113, DOI DOI 10.2134/AGR0NM0N0GR35.C4; Cools J, 2011, ENVIRON MODELL SOFTW, V26, P44, DOI 10.1016/j.envsoft.2010.04.017; Deb K., 2016, DECISION SCI THEORY, P145; Giorgino T, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i07; Grechi I, 2012, ECOL MODEL, V246, P47, DOI 10.1016/j.ecolmodel.2012.07.023; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Holzkamper A, 2015, ENVIRON MODELL SOFTW, V66, P27, DOI 10.1016/j.envsoft.2014.12.012; Jakoby O, 2014, J APPL ECOL, V51, P483, DOI 10.1111/1365-2664.12216; Martre P, 2015, CROP PHYSIOLOGY: APPLICATIONS FOR GENETIC IMPROVEMENT AND AGRONOMY, 2ND EDITION, P349, DOI 10.1016/B978-0-12-417104-6.00014-5; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Olteanu M, 2015, NEUROCOMPUTING, V147, P15, DOI 10.1016/j.neucom.2013.11.047; PRATT JW, 1964, ECONOMETRICA, V32, P122, DOI 10.2307/1913738; Quilot-Turion B, 2012, EUR J AGRON, V42, P34, DOI 10.1016/j.eja.2011.11.008; Raquel CR, 2005, GECCO 2005: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOLS 1 AND 2, P257; Rockafellar R. T., 2000, J RISK, V2, P21, DOI 10.21314/JOR.2000.038; Ruiz-Ramos M, 2010, CLIM RES, V44, P69, DOI 10.3354/cr00933; Semenov MA, 2014, J CEREAL SCI, V59, P245, DOI 10.1016/j.jcs.2014.01.006; Semenov MA, 2013, FOOD ENERGY SECUR, V2, P185, DOI 10.1002/fes3.34; Tsoukalas I, 2014, ENV MODELLING SOFTWA; Zitzler E, 2003, IEEE T EVOLUT COMPUT, V7, P117, DOI 10.1109/TEVC.2003.810758	30	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0176815	10.1371/journal.pone.0176815	http://dx.doi.org/10.1371/journal.pone.0176815			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542198	gold, Green Published, Green Submitted			2022-12-26	WOS:000402062800004
J	Thakur, SS; Ward, MS; Popat, A; Flemming, NB; Parat, MO; Barnett, NL; Parekh, HS				Thakur, Sachin S.; Ward, Micheal S.; Popat, Amirali; Flemming, Nicole B.; Parat, Marie-Odile; Barnett, Nigel L.; Parekh, Harendra S.			Stably engineered nanobubbles and ultrasound - An effective platform for enhanced macromolecular delivery to representative cells of the retina	PLOS ONE			English	Article							INTRAVITREAL DRUG-DELIVERY; CONTRAST AGENTS; MACULAR DEGENERATION; CHOROIDAL NEOVASCULARIZATION; GENE DELIVERY; LIPOSOMES; CAVITATION; TUMORS; SIZE; MICROBUBBLES	Herein we showcase the potential of ultrasound-responsive nanobubbles in enhancing macromolecular permeation through layers of the retina, ultimately leading to significant and direct intracellular delivery; this being effectively demonstrated across three relevant and distinct retinal cell lines. Stably engineered nanobubbles of a highly homogenous and echogenic nature were fully characterised using dynamic light scattering, B-scan ultrasound and transmission electron microscopy (TEM). The nanobubbles appeared as spherical liposome-like structures under TEM, accompanied by an opaque luminal core and darkened corona around their periphery, with both features indicative of efficient gas entrapment and adsorption, respectively. A nanobubble +/- ultrasound sweeping study was conducted next, which determined the maximum tolerated dose for each cell line. Detection of underlying cellular stress was verified using the biomarker heat shock protein 70, measured before and after treatment with optimised ultrasound. Next, with safety to nanobubbles and optimised ultrasound demonstrated, each human or mouse-derived cell population was incubated with biotinylated rabbit-IgG in the presence and absence of ultrasound +/- nanobubbles. Intracellular delivery of antibody in each cell type was then quantified using Cy3-streptavidin. Nanobubbles and optimised ultrasound were found to be negligibly toxic across all cell lines tested. Macromolecular internalisation was achieved to significant, yet varying degrees in all three cell lines. The results of this study pave the way towards better understanding mechanisms underlying cellular responsiveness to ultrasound-triggered drug delivery in future ex vivo and in vivo models of the posterior eye.	[Thakur, Sachin S.; Popat, Amirali; Parat, Marie-Odile; Parekh, Harendra S.] Univ Queensland, Sch Pharm, Woolloongabba, Qld, Australia; [Ward, Micheal S.; Popat, Amirali; Flemming, Nicole B.] Univ Queensland, Mater Res Inst, Translat Res Inst, Woolloongabba, Qld, Australia; [Ward, Micheal S.] Univ Queensland, Sch Med, Herston, Qld, Australia; [Barnett, Nigel L.] Queensland Eye Inst, South Brisbane, Qld, Australia; [Barnett, Nigel L.] Univ Queensland, UQ Ctr Clin Res, Herston, Qld, Australia; [Barnett, Nigel L.] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia; [Thakur, Sachin S.] Univ Auckland, Dept Ophthalmol, Auckland, New Zealand	University of Queensland; Mater Research; University of Queensland; University of Queensland; Queensland Eye Institute; University of Queensland; Queensland University of Technology (QUT); University of Auckland	Parekh, HS (corresponding author), Univ Queensland, Sch Pharm, Woolloongabba, Qld, Australia.	h.parekh@uq.edu.au	Barnett, Nigel L/F-1226-2010; Parekh, Harendra/P-3964-2019; Parekh, Harendra S/D-6846-2011; Parat, Marie-Odile/G-4410-2010; Thakur, Sachin Sunil/AAC-4256-2019	Barnett, Nigel L/0000-0002-0704-2233; Parekh, Harendra/0000-0001-8792-4318; Parekh, Harendra S/0000-0001-8792-4318; Parat, Marie-Odile/0000-0003-4895-7381; Thakur, Sachin Sunil/0000-0003-4910-0005; Popat, Amirali/0000-0001-5401-3446; Flemming, Nicole/0000-0002-7259-443X	National Health and Medical Research Council of Australia [1023444]; Juvenile Diabetes Research Foundation International [3-2013-217]; University of Queensland School of Pharmacy Research and Maintenance Funds	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); University of Queensland School of Pharmacy Research and Maintenance Funds	This work was supported by the National Health and Medical Research Council of Australia (Grant number: 1023444); the Juvenile Diabetes Research Foundation International (Grant number: 3-2013-217); and the University of Queensland School of Pharmacy Research and Maintenance Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angius F, 2015, TOXICOL IN VITRO, V29, P314, DOI 10.1016/j.tiv.2014.11.009; APFEL RE, 1991, ULTRASOUND MED BIOL, V17, P179, DOI 10.1016/0301-5629(91)90125-G; Bai YY, 2009, J PATHOL, V219, P446, DOI 10.1002/path.2611; Birch DG, 2007, INT J NANOMED, V2, P65, DOI 10.2147/nano.2007.2.1.65; Bonilha VL, 2008, CLIN OPHTHALMOL, V2, P413; Chomas JE, 2001, J BIOMED OPT, V6, P141, DOI 10.1117/1.1352752; DEJONG N, 1991, ULTRASONICS, V29, P324, DOI 10.1016/0041-624X(91)90030-C; Deng ZT, 2014, J CONTROL RELEASE, V174, P109, DOI 10.1016/j.jconrel.2013.11.018; Endo-Takahashi Y, 2012, INT J PHARMACEUT, V422, P504, DOI 10.1016/j.ijpharm.2011.11.023; Ferrara K, 2007, ANNU REV BIOMED ENG, V9, P415, DOI 10.1146/annurev.bioeng.8.061505.095852; Gao Z, 2008, ULTRASONICS, V48, P260, DOI 10.1016/j.ultras.2007.11.002; Geers B, 2012, J CONTROL RELEASE, V164, P248, DOI 10.1016/j.jconrel.2012.08.014; Goertz DE, 2007, ULTRASOUND MED BIOL, V33, P1376, DOI 10.1016/j.ultrasmedbio.2007.03.009; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Huang SL, 2001, J PHARM SCI, V90, P1917, DOI 10.1002/jps.1142; Hundt W, 2007, ACAD RADIOL, V14, P859, DOI 10.1016/j.acra.2007.04.008; Hwang TL, 2009, J PHARM SCI-US, V98, P3735, DOI 10.1002/jps.21687; Kodama T, 2010, J ELECTRON MICROSC, V59, P187, DOI 10.1093/jmicro/dfp056; Kolb H., 1995, WEBVISION ORG RETINA; Kukizaki M, 2006, J MEMBRANE SCI, V281, P386, DOI 10.1016/j.memsci.2006.04.007; Leinenga G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2512; Li HL, 2009, GENE THER, V16, P1146, DOI 10.1038/gt.2009.84; Li T, 2010, J HUAZHONG U SCI-MED, V30, P798, DOI 10.1007/s11596-010-0661-8; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Liu J, 1998, PHARMACEUT RES, V15, P918, DOI 10.1023/A:1011984817567; Miller JW, 2013, AM J OPHTHALMOL, V155, P1, DOI 10.1016/j.ajo.2012.10.018; Missel PJ, 2002, PHARMACEUT RES, V19, P1636, DOI 10.1023/A:1020940927675; Mitragotri S, 2005, NAT REV DRUG DISCOV, V4, P255, DOI 10.1038/nrd1662; Morgan KE, 2000, IEEE T ULTRASON FERR, V47, P1494, DOI 10.1109/58.883539; Negishi Y, 2011, J DRUG TARGET, V19, P830, DOI 10.3109/1061186X.2011.585428; Pan TL, 2012, FOOD CHEM TOXICOL, V50, P3892, DOI 10.1016/j.fct.2012.07.005; Paul S, 2014, COMPUT MECH, V53, P413, DOI 10.1007/s00466-013-0962-4; Peeters L, 2008, PHARM RES-DORDR, V25, P2657, DOI 10.1007/s11095-008-9684-2; Perera RH, 2014, PHARM RES-DORDR, V31, P1407, DOI 10.1007/s11095-013-1100-x; Pitt WG, 2008, J CONTROL RELEASE, V125, P174, DOI 10.1016/j.jconrel.2007.10.004; Prentice P, 2005, NAT PHYS, V1, P107, DOI 10.1038/nphys148; Rakoczy EP, 2015, ESSENT OPHTHALMOL, P65, DOI 10.1007/978-3-662-45188-5_6; Rickman CB, 2013, INVEST OPHTH VIS SCI, V54, pORSF68, DOI 10.1167/iovs.13-12757; Samuels IS, 2015, J NEUROPHYSIOL, V113, P1085, DOI 10.1152/jn.00761.2014; Schlicher RK, 2002, J ACOUST SOC AM, V112, P2339; Schlicher RK, 2010, ULTRASOUND MED BIOL, V36, P677, DOI 10.1016/j.ultrasmedbio.2010.01.010; Schon C, 2015, EUR J PHARM BIOPHARM, V95, P343, DOI 10.1016/j.ejpb.2015.01.009; Schroeder A, 2009, J CONTROL RELEASE, V137, P63, DOI 10.1016/j.jconrel.2009.03.007; Sonoda S, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/412752; Spitzer MS, 2006, BRIT J OPHTHALMOL, V90, P1316, DOI 10.1136/bjo.2006.095190; Suzuki R, 2008, INT J PHARMACEUT, V354, P49, DOI 10.1016/j.ijpharm.2007.10.034; Suzuki R, 2010, J CONTROL RELEASE, V142, P245, DOI 10.1016/j.jconrel.2009.10.027; Thakur SS, 2014, EXPERT OPIN DRUG DEL, V11, P1575, DOI 10.1517/17425247.2014.927864; Thakur SS, 2009, METHOD PREPARING LIP; Tian JL, 2015, ACS APPL MATER INTER, V7, P26579, DOI 10.1021/acsami.5b07778; Un K, 2010, HUM GENE THER, V21, P65, DOI 10.1089/hum.2009.106; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; World Health Organization, PRIOR EYE DIS 2014; Yang S, 2014, EUR RADIOL, V24, P2739, DOI 10.1007/s00330-014-3334-3; Yin TH, 2012, INT J NANOMED, V7, P895, DOI 10.2147/IJN.S28830; Zhou XY, 2009, CHINESE MED J-PEKING, V122, P2711, DOI 10.3760/cma.j.issn.0366-6999.2009.22.007	56	16	16	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178305	10.1371/journal.pone.0178305	http://dx.doi.org/10.1371/journal.pone.0178305			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542473	Green Published, gold, Green Submitted			2022-12-26	WOS:000402062800068
J	Belviso, S; Iuliano, R; Amato, R; Perrotti, N; Menniti, M				Belviso, Stefania; Iuliano, Rodolfo; Amato, Rosario; Perrotti, Nicola; Menniti, Miranda			The human asparaginase enzyme (ASPG) inhibits growth in leukemic cells	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; GLUTAMINASE ACTIVITY; CANCER; LYSOPHOSPHOLIPASE; PROLIFERATION; APOPTOSIS; AUTOPHAGY; MIGRATION	The human protein ASPG is an enzyme with a putative antitumor activity. We generated in bacteria and then purified a recombinant GST-ASPG protein that we used to characterize the biochemical and cytotoxic properties of the human ASPG. We demonstrated that ASPG possesses asparaginase and PAF acetylhydrolase activities that depend on a critical threonine residue at position 19. Consistently, ASPG but not its T19A mutant showed cytotoxic activity in K562, NALM-6 and MOLT-4 leukemic cell lines but not in normal cells. Regarding the mechanism of action of ASPG, it was able to induce a significant apoptotic death in K562 cells. Taken together our data suggest that ASPG, combining different enzymatic activities, should be considered a promising anti-cancer agent for inhibiting the growth of leukemia cells.	[Belviso, Stefania] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [Iuliano, Rodolfo; Amato, Rosario; Perrotti, Nicola; Menniti, Miranda] Magna Graecia Univ Catanzaro, Dept Human Hlth, Catanzaro, Italy	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro	Iuliano, R; Menniti, M (corresponding author), Magna Graecia Univ Catanzaro, Dept Human Hlth, Catanzaro, Italy.	iuliano@unicz.it; mirmenniti@unicz.it		Amato, Rosario/0000-0001-7162-1099	Associazione Italiana Ricerca contro it Cancro (AIRC) [16971 IG]	Associazione Italiana Ricerca contro it Cancro (AIRC)	NP was funded by Associazione Italiana Ricerca contro it Cancro (AIRC) project code 16971 IG 2015 and MM was granted by Programma Operativo Nazionale (PON) PONO4a2_00003 STAYWELL.	Bussolati B, 2000, AM J PATHOL, V157, P1713, DOI 10.1016/S0002-9440(10)64808-0; Dupuis F, 1997, BBA-MOL CELL RES, V1359, P241, DOI 10.1016/S0167-4889(97)00106-7; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Emadi A, 2014, CANCER CHEMOTH PHARM, V73, P875, DOI 10.1007/s00280-014-2402-3; Feuerherm AJ, 2013, MOL CELL BIOCHEM, V384, P83, DOI 10.1007/s11010-013-1784-6; FOA R, 1985, CANCER RES, V45, P4483; Nguyen HA, 2016, J BIOL CHEM, V291, P17664, DOI 10.1074/jbc.M116.728485; HOFFMAN DR, 1984, BLOOD, V63, P545; Kapoor N, 2009, J BIOL CHEM, V284, P24526, DOI 10.1074/jbc.M109.037390; Karamitros CS, 2014, J BIOL CHEM, V289, P12962, DOI 10.1074/jbc.M113.545038; Kawedia JD, 2014, CL LYMPH MYELOM LEUK, V14, pS14, DOI 10.1016/j.clml.2014.06.017; Kim HA, 2011, CELL PHYSIOL BIOCHEM, V27, P55, DOI 10.1159/000325205; Liu C, 2016, J CANCER, V7, P1888, DOI 10.7150/jca.15693; Maggi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117025; Menniti M, 2010, CELL PHYSIOL BIOCHEM, V26, P587, DOI 10.1159/000322326; Moorthy V, 2010, AFR J MICROBIOL RES, V4, P1862; Park JB, 2012, NAT REV CANCER, V12, P782, DOI 10.1038/nrc3379; Parmentier JH, 2015, LEUKEMIA RES, V39, P757, DOI 10.1016/j.leukres.2015.04.008; Schalk AM, 2014, J BIOL CHEM, V289, P33175, DOI 10.1074/jbc.M114.609552; Shrivastava A, 2016, CRIT REV ONCOL HEMAT, V100, P1, DOI 10.1016/j.critrevonc.2015.01.002; Song P, 2015, ONCOTARGET, V6, P3861, DOI 10.18632/oncotarget.2869; Stafforini Diana M, 2015, Enzymes, V38, P157, DOI 10.1016/bs.enz.2015.09.005; Sugimoto H, 1998, J BIOL CHEM, V273, P12536, DOI 10.1074/jbc.273.20.12536; Talarico C, 2016, ONCOTARGET, V7, DOI 10.18632/oncotarget.7520; Theilmeier G, 2000, FASEB J, V14, P2032, DOI 10.1096/fj.99-1029com; Xu SG, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2190216; Yu MS, 2012, J CELL MOL MED, V16, P2369, DOI 10.1111/j.1582-4934.2012.01547.x	27	10	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178174	10.1371/journal.pone.0178174	http://dx.doi.org/10.1371/journal.pone.0178174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542249	gold, Green Published, Green Submitted			2022-12-26	WOS:000402061500068
J	Jurca, M; Ramette, A; Dogaru, CM; Goutaki, M; Spycher, BD; Latzin, P; Gaillard, EA; Kuehni, CE				Jurca, Maja; Ramette, Alban; Dogaru, Cristian M.; Goutaki, Myrofora; Spycher, Ben D.; Latzin, Philipp; Gaillard, Erol A.; Kuehni, Claudia E.			Prevalence of cough throughout childhood: A cohort study	PLOS ONE			English	Article							DRY NIGHT COUGH; RESPIRATORY SYMPTOMS; PRESCHOOL-CHILDREN; RECURRENT COUGH; AIR-POLLUTION; NATURAL-HISTORY; YOUNG-CHILDREN; ASTHMA; WHEEZE; HEALTH	Background Cough in children is a common reason for medical consultations and affects quality of life. There are little population-based data on the epidemiology of recurrent cough in children and how this varies by age and sex, or between children with and without wheeze. We determined the prevalence of cough throughout childhood, comparing several standardised cough questions. We did this for the entire population and separately for girls and boys, and for children with and without wheeze. Methods In a population-based prospective cohort from Leicestershire, UK, we assessed prevalence of cough with repeated questionnaires from early childhood to adolescence. We asked whether the child usually coughed more than other children, with or without colds, had night-time cough or cough triggered by various factors (triggers, related to increased breathing effort, allergic or food triggers). We calculated prevalence from age 1 to 18 years using generalised estimating equations for all children, and for children with and without wheeze. Results Of 7670 children, 10% (95% CI 10-11%) coughed more than other children, 69% (69-70%) coughed usually with a cold, 34% to 55% age-dependently coughed without colds, and 25% (25-26%) had night-time cough. Prevalence of coughing more than peers, with colds, at night, and triggered by laughter varied little throughout childhood, while cough without colds and cough triggered by exercise, house dust or pollen became more frequent with age. Cough was more common in boys than in girls in the first decade of life, differences got smaller in early teens and reversed after the age of 14 years. All symptoms were more frequent in children with wheeze. Conclusions Prevalence of cough in children varies with age, sex and with the questions used to assess it, suggesting that comparisons between studies are only valid for similar questions and age groups.	[Jurca, Maja; Ramette, Alban; Goutaki, Myrofora; Spycher, Ben D.; Kuehni, Claudia E.] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Dogaru, Cristian M.] Univ Campus Suffolk, Fac Arts Business & Appl Social Sci, Ipswich, Suffolk, England; [Latzin, Philipp] Univ Bern, Univ Childrens Hosp Bern, Bern, Switzerland; [Gaillard, Erol A.] Univ Leicester, Dept Infect Immun & Inflammat, Div Child Hlth, Leicester, Leics, England	University of Bern; University of Bern; University Hospital of Bern; University of Leicester	Kuehni, CE (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	claudia.kuehni@ispm.unibe.ch	Goutaki, Myrofora/J-2869-2019; Dogaru, Cristian/I-1861-2019; Ramette, Alban/E-9197-2016; Spycher, Ben D/B-3308-2008; Latzin, Philipp/F-2206-2017	Goutaki, Myrofora/0000-0001-8036-2092; Dogaru, Cristian/0000-0002-0722-6147; Ramette, Alban/0000-0002-3437-4639; Spycher, Ben D/0000-0002-1430-5695; Latzin, Philipp/0000-0002-5239-1571; Gaillard, Erol/0000-0003-0996-8133; Jurca, Maja/0000-0003-1118-002X	Swiss National Science Foundation [SNF PDFMP3-137033, 32003B-162820, 32003B144068, 32003B-122341, PDFMP3-123162]; Bestcilia EU; Asthma UK [07/048]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bestcilia EU; Asthma UK	All phases of this study were supported by the Swiss National Science Foundation (grants: SNF PDFMP3-137033, 32003B-162820, 32003B144068, 32003B-122341, PDFMP3-123162), Bestcilia EU and Asthma UK 07/048. URL: http://www.snf.ch, http://www.asthma.org.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bacharier LB, 2004, AM J RESP CRIT CARE, V170, P426, DOI 10.1164/rccm.200308-1178OC; Brauer M, 2007, EUR RESPIR J, V29, P879, DOI 10.1183/09031936.00083406; Brooke AM, 1996, EUR RESPIR J, V9, P65, DOI 10.1183/09031936.96.09010065; Brooke AM, 1998, PEDIATR PULM, V26, P256, DOI 10.1002/(SICI)1099-0496(199810)26:4<256::AID-PPUL4>3.0.CO;2-O; Burr ML, 1999, THORAX, V54, P27, DOI 10.1136/thx.54.1.27; Chang AB, 1997, ARCH DIS CHILD, V77, P331, DOI 10.1136/adc.77.4.331; Chang AB, 2008, PAEDIAT CHILD HLTH, V18, P333; Chang AB, 2012, CHEST, V142, P943, DOI 10.1378/chest.11-2725; Chang AB, 2011, CHEST, V140, P324, DOI 10.1378/chest.10-2507; CLIFFORD RD, 1989, ARCH DIS CHILD, V64, P1118, DOI 10.1136/adc.64.8.1118; Dales RE, 1997, EUR J EPIDEMIOL, V13, P541, DOI 10.1023/A:1007311912777; de Benedictis D, 2007, PEDIATR PULM, V42, P683, DOI 10.1002/ppul.20650; Del Giacco SR, 2015, EUR CLIN RESPIR J, V2, DOI 10.3402/ecrj.v2.27984; Doull IJM, 1996, THORAX, V51, P630, DOI 10.1136/thx.51.6.630; Escamilla R, 2014, EUR RESPIR J, V44, P1103, DOI 10.1183/09031936.00150614; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Gehring U, 2002, EUR RESPIR J, V19, P690, DOI 10.1183/09031936.02.01182001; Gehring U, 2011, PEDIAT ALLERG IMM-UK, V22, P85, DOI 10.1111/j.1399-3038.2010.01100.x; Ghezzi M, 2013, PEDIATR PULM, V48, P295, DOI 10.1002/ppul.22581; Hay AD, 2002, BRIT J GEN PRACT, V52, P401; Hermann C, 2005, AM J EPIDEMIOL, V162, P345, DOI 10.1093/aje/kwi212; Janson C, 2001, EUR RESPIR J, V18, P647, DOI 10.1183/09031936.01.00098701; Kastelik JA, 2002, AM J RESP CRIT CARE, V166, P961, DOI 10.1164/rccm.2109061; Kauffmann F, 2011, PULM PHARMACOL THER, V24, P289, DOI 10.1016/j.pupt.2010.10.012; Kuehni CE, 2001, LANCET, V357, P1821, DOI 10.1016/S0140-6736(00)04958-8; Kuehni CE, 2007, INT J EPIDEMIOL, V36, P977, DOI 10.1093/ije/dym090; Leonardi GS, 2002, EUR RESPIR J, V20, P890, DOI 10.1183/09031936.02.00260802; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; Liangas G, 2003, PEDIATR PULM, V36, P107, DOI 10.1002/ppul.10313; Linehan MF, 2005, ARCH DIS CHILD, V90, P516, DOI 10.1136/adc.2004.061879; LUYT DK, 1993, BMJ-BRIT MED J, V306, P1386, DOI 10.1136/bmj.306.6889.1386; Mallol J, 2006, PEDIATR PULM, V41, P482, DOI 10.1002/ppul.20398; Marchant JM, 2008, CHEST, V134, P303, DOI 10.1378/chest.07-2236; Marchant JM, 2006, CHEST, V129, P1132, DOI 10.1378/chest.129.5.1132; Morgenstern V, 2007, OCCUP ENVIRON MED, V64, P8, DOI 10.1136/oem.2006.028241; Morice AH, 2004, EUR RESPIR J, V24, P481, DOI 10.1183/09031936.04.00027804; NINAN TK, 1995, ARCH DIS CHILD, V73, P403, DOI 10.1136/adc.73.5.403; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Ranciere F, 2013, PEDIAT ALLERG IMM-UK, V24, P131, DOI 10.1111/pai.12045; ROBERTSON CF, 1991, BMJ-BRIT MED J, V302, P1116, DOI 10.1136/bmj.302.6785.1116; ROBERTSON CF, 1993, PEDIATR PULM, V16, P219, DOI 10.1002/ppul.1950160403; SENNHAUSER FH, 1995, PEDIATR PULM, V19, P161, DOI 10.1002/ppul.1950190304; Sheel AW, 2016, EXP PHYSIOL, V101, P213, DOI 10.1113/EP085366; Silvestri M, 1999, ANN ALLERG ASTHMA IM, V83, P335, DOI 10.1016/S1081-1206(10)62674-9; Spycher BD, 2008, EUR RESPIR J, V31, P974, DOI 10.1183/09031936.00153507; Strippoli MPF, 2007, ARCH DIS CHILD, V92, P861, DOI 10.1136/adc.2007.117978; Subbarao P, 2009, CAN MED ASSOC J, V181, pE181, DOI 10.1503/cmaj.080612; TIBBLIN G, 1990, Scandinavian Journal of Primary Health Care, V8, P9, DOI 10.3109/02813439008994923; TIMONEN KL, 1995, EUR RESPIR J, V8, P1155, DOI 10.1183/09031936.95.08071155; VONMUTIUS E, 1992, BMJ-BRIT MED J, V305, P1395, DOI 10.1136/bmj.305.6866.1395; Wright AL, 2006, PEDIATR PULM, V41, P318, DOI 10.1002/ppul.20373	52	14	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177485	10.1371/journal.pone.0177485	http://dx.doi.org/10.1371/journal.pone.0177485			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542270	gold, Green Published			2022-12-26	WOS:000402061500029
J	Lindahl, JR; Fisher, NE; Cooper, DJ; Rosen, RK; Britton, WB				Lindahl, Jared R.; Fisher, Nathan E.; Cooper, David J.; Rosen, Rochelle K.; Britton, Willoughby B.			The varieties of contemplative experience: A mixed-methods study of meditation-related challenges in Western Buddhists	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; RANDOMIZED-CONTROLLED-TRIAL; COGNITIVE THERAPY; PSYCHIATRIC-DISORDERS; CLINICAL-IMPLICATIONS; INTENSIVE MEDITATION; CAUSALITY ASSESSMENT; CURRENT STATE; FOLLOW-UP; DSM-IV	Buddhist-derived meditation practices are currently being employed as a popular form of health promotion. While meditation programs draw inspiration from Buddhist textual sources for the benefits of meditation, these sources also acknowledge a wide range of other effects beyond health-related outcomes. The Varieties of Contemplative Experience study investigates meditation-related experiences that are typically underreported, particularly experiences that are described as challenging, difficult, distressing, functionally impairing, and/or requiring additional support. A mixed-methods approach featured qualitative interviews with Western Buddhist meditation practitioners and experts in Theravada, Zen, and Tibetan traditions. Interview questions probed meditation experiences and influencing factors, including interpretations and management strategies. A follow-up survey provided quantitative assessments of causality, impairment and other demographic and practice-related variables. The content-driven thematic analysis of interviews yielded a taxonomy of 59 meditation-related experiences across 7 domains: cognitive, perceptual, affective, somatic, conative, sense of self, and social. Even in cases where the phenomenology was similar across participants, interpretations of and responses to the experiences differed considerably. The associated valence ranged from very positive to very negative, and the associated level of distress and functional impairment ranged from minimal and transient to severe and enduring. In order to determine what factors may influence the valence, impact, and response to any given experience, the study also identified 26 categories of influencing factors across 4 domains: practitioner-level factors, practice-level factors, relationships, and health behaviors. By identifying a broader range of experiences associated with meditation, along with the factors that contribute to the presence and management of experiences reported as challenging, difficult, distressing or functionally impairing, this study aims to increase our understanding of the effects of contemplative practices and to provide resources for mediators, clinicians, meditation researchers, and meditation teachers.	[Lindahl, Jared R.] Brown Univ, Cogut Ctr Humanities, Providence, RI 02912 USA; [Fisher, Nathan E.] Univ Calif Santa Barbara, Dept Religious Studies, Santa Barbara, CA 93106 USA; [Cooper, David J.; Britton, Willoughby B.] Brown Univ, Sch Med, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Rosen, Rochelle K.; Britton, Willoughby B.] Brown Univ, Dept Behav & Social Sci, Sch Publ Hlth, Providence, RI 02912 USA	Brown University; University of California System; University of California Santa Barbara; Brown University; Brown University	Britton, WB (corresponding author), Brown Univ, Sch Med, Dept Psychiat & Human Behav, Providence, RI 02912 USA.; Britton, WB (corresponding author), Brown Univ, Dept Behav & Social Sci, Sch Publ Hlth, Providence, RI 02912 USA.	willoughby_britton@brown.edu	/V-3995-2019		National Center for Complementary and Integrative Health at the National Institutes of Health [K23-AT006328-01A1]; Bial Foundation [256/12]; Varela Research Award from the Mind and Life Institute; 40 Foundation; National Center for Complementary & Integrative Health [K23AT006328] Funding Source: NIH RePORTER	National Center for Complementary and Integrative Health at the National Institutes of Health; Bial Foundation(Bial Foundation); Varela Research Award from the Mind and Life Institute; 40 Foundation; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grant number K23-AT006328-01A1 from the National Center for Complementary and Integrative Health (https://nccah.nih.gov/) at the National Institutes of Health, grant number 256/12 from the Bial Foundation (www.bial.com) (WB), the Varela Research Award from the Mind and Life Institute (ww.mindandlife.org) (NF) and the 1440 Foundation (www.1440.org) (WB, JL). The funders had no role in the study design, data collection, decision to publish or preparation of the manuscript.	Agbabiaka TB, 2008, DRUG SAFETY, V31, P21, DOI 10.2165/00002018-200831010-00003; Aitken Robert., 1982, TAKING PATH ZEN; [Anonymous], 2015, NATL HLTH STAT REPOR; APA, 1994, 300 6 DEP DIS DIAGN; APA, 2013, 300 6 DEP DER DIS DI, P302; Ataria Y, 2015, PHILOS PSYCHOL, V28, P1128, DOI 10.1080/09515089.2014.969801; Ataria Y, 2015, CONSCIOUS COGN, V37, P133, DOI 10.1016/j.concog.2015.09.002; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bent S, 2006, ANN INTERN MED, V144, P257, DOI 10.7326/0003-4819-144-4-200602210-00007; Berkovich-Ohana A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00912; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Boorstein S, 1996, TXB TRANSPERSONAL PS; Bovin M. J., 2015, PSYCHOMETRIC PROPERT; Brattstrom O, 2015, EUR J EPIDEMIOL, V30, P151, DOI 10.1007/s10654-014-9969-1; Britton WB, 2014, ANN NY ACAD SCI, V1307, P64, DOI 10.1111/nyas.12279; BROWN D, 1984, PERCEPT MOTOR SKILL, V58, P775, DOI 10.2466/pms.1984.58.3.775; Buddhaghosa B., 1991, PATH PURIFICATION; Carlson LE, 2016, PSYCHO-ONCOLOGY, V25, P750, DOI 10.1002/pon.4150; Carrington P., 1977, MISUSE MEDITATION PR; CASTILLO RJ, 1990, PSYCHIATRY, V53, P158; Census Bureau US, 2014, ED ATT US 2014 DET T; Cermolacce M, 2007, CONSCIOUS COGN, V16, P703, DOI 10.1016/j.concog.2007.05.013; Chambers R, 2009, CLIN PSYCHOL REV, V29, P560, DOI 10.1016/j.cpr.2009.06.005; Chan-Ob Tinnakorn, 1999, Journal of the Medical Association of Thailand, V82, P925; Chen Z, 2011, J SCI STUD RELIG, V50, P654, DOI 10.1111/j.1468-5906.2011.01606.x; Chiesa A, 2014, SUBST USE MISUSE, V49, P492, DOI 10.3109/10826084.2013.770027; Chiesa A, 2011, PSYCHIAT RES, V187, P441, DOI 10.1016/j.psychres.2010.08.011; Chiesa A, 2011, J ALTERN COMPLEM MED, V17, P83, DOI 10.1089/acm.2009.0546; Chiesa A, 2011, CLIN PSYCHOL REV, V31, P449, DOI 10.1016/j.cpr.2010.11.003; CRAVEN JL, 1989, CAN J PSYCHIAT, V34, P648, DOI 10.1177/070674378903400705; DeCuir-Gunby JT, 2011, FIELD METHOD, V23, P136, DOI 10.1177/1525822X10388468; DeHoff SL, 2015, PASTOR PSYCHOL, V64, P21, DOI 10.1007/s11089-013-0584-y; DEIKMAN AJ, 1966, J NERV MENT DIS, V142, P101, DOI 10.1097/00005053-196602000-00001; Dein S, 2011, TRANSCULT PSYCHIATRY, V48, P318, DOI 10.1177/1363461511402723; Disayavanish C, 1984, J PSYCHIAT ASS THAIL, V29, P1; Dobkin PL, 2012, MINDFULNESS, V3, P44, DOI 10.1007/s12671-011-0079-9; Dor-Ziderman Y, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00582; Droit-Volet S, 2015, CONSCIOUS COGN, V31, P86, DOI 10.1016/j.concog.2014.10.007; Eisendrath SJ, 2016, PSYCHOTHER PSYCHOSOM, V85, P99, DOI 10.1159/000442260; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Epstein M. D., 1981, J TRANSPERSONAL PSYC, V13, P137; Faugier J, 1997, J ADV NURS, V26, P790, DOI 10.1046/j.1365-2648.1997.00371.x; FENWICK P, 1983, BRIT MED J, V287, P1401, DOI 10.1136/bmj.287.6403.1401; Follette V., 2006, J RATION-EMOT COGN-B, V24, P45, DOI [DOI 10.1007/S10942-006-0025-2, https://doi.org/10.1007/s10942-006-0025-2]; Fonteyn ME, 2008, APPL NURS RES, V21, P165, DOI 10.1016/j.apnr.2006.08.005; Fowler FJ, 1998, PUBLIC OPIN QUART, V62, P29; Full GE, 2013, MINDFULNESS, V4, P55, DOI 10.1007/s12671-012-0173-7; Gallagher RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028096; Gallagher Sh, 2013, OXFORD HDB SELF; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Grant JA, 2014, ANN NY ACAD SCI, V1307, P55, DOI 10.1111/nyas.12282; Grant JA, 2009, PSYCHOSOM MED, V71, P106, DOI 10.1097/PSY.0b013e31818f52ee; Greenberg MT, 2012, CHILD DEV PERSPECT, V6, P161, DOI 10.1111/j.1750-8606.2011.00215.x; Gregory PN, 2001, RELIG AM CULT, V11, P233, DOI 10.1525/rac.2001.11.2.233; Guest G, 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Gyatso J, 1999, J AM ACAD RELIG, V67, P113; Hakuin, 2009, HAKUINS PRECIOUS MIR; Hanley AW, 2016, J COUNS DEV, V94, P103, DOI 10.1002/jcad.12066; HEIDE FJ, 1983, J CONSULT CLIN PSYCH, V51, P171, DOI 10.1037/0022-006X.51.2.171; Hickey WakohS., 2010, J GLOBAL BUDDHISM, V11, P1; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hill AB, 2015, J ROY SOC MED, V108, P32, DOI 10.1177/0141076814562718; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Hua H, 2003, SHURANGAMA SUTRA COM, V8; Huntington CW, 2015, J AM ACAD RELIG, V83, P624, DOI 10.1093/jaarel/lfv008; Davidson R, 2012, CHILD DEV PERSPECT, V6, P146, DOI 10.1111/j.1750-8606.2012.00240.x; Jardri R., 2013, NEUROSCIENCE HALLUCI, P43, DOI DOI 10.1007/978-1-4614-4121-2; Jaseja H, 2010, EPILEPSY BEHAV, V17, P124, DOI 10.1016/j.yebeh.2009.10.022; Jha AP, 2010, EMOTION, V10, P54, DOI 10.1037/a0018438; Jonsson U, 2014, CONTEMP CLIN TRIALS, V38, P1, DOI 10.1016/j.cct.2014.02.005; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kabat-Zinn J, 2011, CONTEMP BUDDHISM, V12, P281, DOI 10.1080/14639947.2011.564844; Kaiser-Greenland S., 2010, THE MINDFUL CHILD; Kaliman P, 2014, PSYCHONEUROENDOCRINO, V40, P96, DOI 10.1016/j.psyneuen.2013.11.004; Kerr CE, 2011, CLIN PSYCHOL PSYCHOT, V18, P80, DOI 10.1002/cpp.700; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; Kirmayer L, 2013, ADV PSYCHOSOMATIC ME, P33; Kornfield J., 1979, J TRANSPERSONAL PSY, V11, P4158; Kornfield J., 2011, BRINGING HOME DHARMA; Kriegel Uriah, 2015, VARIETIES CONSCIOUSN; Kuijpers HJH, 2007, PSYCHOPATHOLOGY, V40, P461, DOI 10.1159/000108125; KUTZ I, 1985, PSYCHOTHER PSYCHOSOM, V43, P209; Kuyken W., 2012, MINDFULNESS BASED CO; Kuyken W., 2016, JAMA PSYCHIAT; Kuyken W, 2015, LANCET, V386, P63, DOI 10.1016/S0140-6736(14)62222-4; Lindahl J, 2011, RELIGION, V41, P79, DOI 10.1080/0048721X.2011.553135; Lindahl JR, 2015, MINDFULNESS, V6, P57, DOI 10.1007/s12671-014-0380-5; Lindahl JR, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00973; Lindahl JR, 2012, PACIFIC WORLD J I BU, V3, P231; Lomas T., 2014, MINDFULNESS, V2014, P1; Lopez D.S., 2012, SCI BUDDHA HIS SHORT; Lopez Donald S., 2009, BUDDHISM SCI GUIDE P; Luhrmann TM, 2015, TOP COGN SCI, V7, P646, DOI 10.1111/tops.12158; LUKOFF D, 1995, PSYCHIAT CLIN N AM, V18, P467, DOI 10.1016/S0193-953X(18)30035-2; Lustyk M Kathleen B, 2009, Adv Mind Body Med, V24, P20; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; MacLean KA, 2010, PSYCHOL SCI, V21, P829, DOI 10.1177/0956797610371339; MacQueen K, 1998, CULTURAL ANTHR METHO, V10; Mani M, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.4328; McFarlane Alexander, 2005, Journal of Integrative Neuroscience, V4, P27, DOI 10.1142/S0219635205000689; McMahan D., 2011, HDB RELIG AUTHORITY; McMahan David L., 2008, MAKING BUDDHIST MODE; Meiklejohn J, 2012, MINDFULNESS, V3, P291, DOI 10.1007/s12671-012-0094-5; Menezes A, 2010, CURR PSYCHIAT REP, V12, P174, DOI 10.1007/s11920-010-0117-7; MILLER JJ, 1995, GEN HOSP PSYCHIAT, V17, P192, DOI 10.1016/0163-8343(95)00025-M; MILLER JJ, 1993, J TRANSPERSONAL PSY, V25, P169; Monteiro LM, 2015, MINDFULNESS, V6, P1, DOI 10.1007/s12671-014-0301-7; Nakaya M., 2010, GER J PSYCHIAT, V13, P161; Namto S., 1989, INSIGHT MEDITATION P; Naranjo C A, 1986, Drug Inf J, V20, P387; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; NARANJO CA, 1982, PROG NEURO-PSYCHOPH, V6, P651, DOI 10.1016/S0278-5846(82)80162-0; NIA, 2011, NIA ADV EV SER ADV E; NIH, 2016, ADV EV SER ADV EV GU; O'Connor S, 2010, MENT HEALTH RELIG CU, V13, P171, DOI 10.1080/13674670903277984; Office for Human Research Protections (OHRP), 2007, GUID REV REP UN PROB; Olano HA, 2015, J ALTERN COMPLEM MED, V21, P100, DOI 10.1089/acm.2014.0269; Parnas J, 2005, PSYCHOPATHOLOGY, V38, P236, DOI 10.1159/000088441; Pasick RJ, 2009, HEALTH EDUC BEHAV, V36, p11S, DOI 10.1177/1090198109338917; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Perez-De-Albeniz A., 2000, INT J PSYCHOTHER, V5, P49, DOI DOI 10.1080/13569080050020263; Robins L.N., 1991, PSYCHIAT DISORDERS A; Samuelson M, 2007, PRISON J, V87, P254, DOI 10.1177/0032885507303753; Sayadaw M., 2016, MANUAL OF INSIGHT; Sayadaw M., 1965, PROGR INSIGHT MODERN; Sethi S, 2003, AUST NZ J PSYCHIAT, V37, P382; Shapiro D H Jr, 1992, Int J Psychosom, V39, P62; SHAPIRO DH, 1982, AM J PSYCHIAT, V139, P267; Shapiro SL, 2011, TEACH COLL REC, V113, P493; Sharf R., 2014, TRANSCULT PSYCHIATRY, V52, P470; SHARF RH, 1995, NUMEN, V42, P228, DOI 10.1163/1568527952598549; Sharf Robert H., 1998, CRITICAL TERMS RELIG; Shimokawa K, 2010, J CONSULT CLIN PSYCH, V78, P298, DOI 10.1037/a0019247; Shonin E., 2014, CLIN PRACTICE, V11, P389, DOI DOI 10.2217/cpr.14.23; Shonin E, 2014, INT J MENT HEALTH AD, V12, P181, DOI 10.1007/s11469-013-9460-3; Shonin E, 2014, J RELIG HEALTH, V53, P849, DOI 10.1007/s10943-013-9679-0; Shonin E, 2014, AUST NZ J PSYCHIAT, V48, P124, DOI 10.1177/0004867413512688; Sierra M, 2001, J NERV MENT DIS, V189, P629, DOI 10.1097/00005053-200109000-00010; Simeon D, 2009, DISSOCIATION DISSOCI; Sogen O., 2001, INTRO ZEN TRAINING; Stanley E. A., 2009, JOINT FORCE Q, V55, P144; Stanley EA, 2011, COGN BEHAV PRACT, V18, P566, DOI 10.1016/j.cbpra.2010.08.002; Strauss A., 1998, BASICS QUALITATIVE R; Strauss C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096110; SUDSUANG R, 1991, PHYSIOL BEHAV, V50, P543, DOI 10.1016/0031-9384(91)90543-W; Sumter Melvina T, 2009, J Correct Health Care, V15, P47, DOI 10.1177/1078345808326621; Tate A., 1993, AUTOBIOGRAPHY FOREST; Taves A, 2009, RELIGIOUS EXPERIENCE RECONSIDERED: A BUILDING-BLOCK APPROACH TO THE STUDY OF RELIGION AND OTHER SPECIAL THINGS, P1; Taves A, 2008, RELIGION, V38, P125, DOI 10.1016/j.religion.2008.01.005; Teasdale JD, 2011, CONTEMP BUDDHISM, V12, P103, DOI 10.1080/14639947.2011.564826; Teddlie C, 2007, J MIX METHOD RES, V1, P77, DOI 10.1177/2345678906292430; Theophile H, 2010, DRUG SAFETY, V33, P1045, DOI 10.2165/11537780-000000000-00000; Turner C. F., 1992, SURVEY MEASUREMENT D, P177; TURNER RP, 1995, J NERV MENT DIS, V183, P435, DOI 10.1097/00005053-199507000-00003; Turner W M, 1984, Drug Inf J, V18, P259; VanderKooi L., 1997, J TRANSPERSONAL PSY, V29, P31; VANNUYS D, 1973, INT J CLIN EXP HYP, V21, P59, DOI 10.1080/00207147308409306; Waelde L. C., 2004, J TRAUMA DISSOCIATIO, V5, P147, DOI [10.1300/J229v05n02_08, DOI 10.1300/J229V05N02_08]; Wallace, 2006, ATTENTION REVOLUTION; Wallace B.A., 2011, STILLING MIND SHAMAT; Wallace BA, 2015, DUDJOM LINGPAS VISIO, V3; WALSH R, 1979, AM J PSYCHIAT, V136, P1085; Walsh R., 1977, J TRANSPERSONAL PSYC, V9, P151; Walsh RN, 1978, J TRANSPERSONAL PSY, V10, P1; Weissman JS, 2008, ANN INTERN MED, V149, P100, DOI 10.7326/0003-4819-149-2-200807150-00006; Wieczner J., 2016, FORTUNE, P1; Wildman Wesley J., 2011, RELIG SPIRITUAL EXPE; Williams JMG, 2014, J CONSULT CLIN PSYCH, V82, P275, DOI 10.1037/a0035036; Wilson J., 2014, MINDFUL AM MUTUAL TR; World Health Organization, 2016, US WHO UMC SYST STAN; Yorston G.A., 2001, MENTAL HLTH RELIG CU, V4, P209, DOI DOI 10.1080/713685624	175	177	178	6	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0176239	10.1371/journal.pone.0176239	http://dx.doi.org/10.1371/journal.pone.0176239			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EV8VE	28542181	Green Submitted, Green Published, gold			2022-12-26	WOS:000402061500004
J	Pecaut, MJ; Mao, XW; Bellinger, DL; Jonscher, KR; Stodieck, LS; Ferguson, VL; Bateman, TA; Mohney, RP; Gridley, DS				Pecaut, Michael J.; Mao, Xiao Wen; Bellinger, Denise L.; Jonscher, Karen R.; Stodieck, Louis S.; Ferguson, Virginia L.; Bateman, Ted A.; Mohney, Robert P.; Gridley, Daila S.			Is spaceflight-induced immune dysfunction linked to systemic changes in metabolism?	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; PERIPHERAL-BLOOD LEUKOCYTES; ACTIVATED RECEPTOR-GAMMA; SPACE-FLIGHT; PPAR-GAMMA; APPLIED PHYSIOLOGY; ENDOTHELIAL-CELLS; GENETIC MODELS; ANGIOTENSIN-II; C57BL/6 MOUSE	The Space Shuttle Atlantis launched on its final mission (STS-135) on July 8, 2011. After just under 13 days, the shuttle landed safely at Kennedy Space Center (KSC) for the last time. Female C57BL/6J mice flew as part of the Commercial Biomedical Testing Module-3 (CBTM-3) payload. Ground controls were maintained at the KSC facility. Subsets of these mice were made available to investigators as part of NASA's Bio-specimen Sharing Program (BSP). Our group characterized cell phenotype distributions and phagocytic function in the spleen, catecholamine and corticosterone levels in the adrenal glands, and transcriptomics/metabolomics in the liver. Despite decreases in most splenic leukocyte subsets, there were increases in reactive oxygen species (ROS)-related activity. Although there were increases noted in corticosterone levels in both the adrenals and liver, there were no significant changes in catecholamine levels. Furthermore, functional analysis of gene expression and metabolomic profiles suggest that the functional changes are not due to oxidative or psychological stress. Despite changes in gene expression patterns indicative of increases in phagocytic activity (e.g. endocytosis and formation of peroxisomes), there was no corresponding increase in genes related to ROS metabolism. In contrast, there were increases in expression profiles related to fatty acid oxidation with decreases in glycolysis-related profiles. Given the clear link between immune function and metabolism in many ground-based diseases, we propose a similar link may be involved in spaceflight-induced decrements in immune and metabolic function.	[Pecaut, Michael J.; Mao, Xiao Wen; Gridley, Daila S.] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Radiat Res, Loma Linda, CA 92350 USA; [Bellinger, Denise L.] Loma Linda Univ, Dept Anat, Loma Linda, CA 92350 USA; [Jonscher, Karen R.] Univ Colorado, Sch Med, Dept Anesthesiol, Anschutz Med Campus, Denver, CO USA; [Stodieck, Louis S.; Ferguson, Virginia L.] Univ Colorado, BioServe Space Technol, Boulder, CO 80309 USA; [Bateman, Ted A.] Univ North Carolina Chapel Hill, Dept Bioengn, Chapel Hill, NC USA; [Mohney, Robert P.] Metabolon Inc, Morrisville, NC USA	Loma Linda University; Loma Linda University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Boulder; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Metabolon	Pecaut, MJ (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Div Radiat Res, Loma Linda, CA 92350 USA.	mpecaut@llu.edu	Pecaut, Michael J/P-6481-2015; Gridley, Daila S/P-7711-2015	Pecaut, Michael J/0000-0002-2915-9686; mao, xiao/0000-0002-4508-8689	NASA [NNX10AJ31G]; LLUMC Department of Radiation Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); LLUMC Department of Radiation Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by NASA managed cooperative agreement NNX10AJ31G and the LLUMC Department of Radiation Medicine. Metabolon provided support in the form of salaries for RM, but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. RM played a role in the study design, data collection, analysis, and preparation of the manuscript.	Allebban Z, 1996, J APPL PHYSIOL, V81, P117, DOI 10.1152/jappl.1996.81.1.117; ALLEBBAN Z, 1994, J LEUKOCYTE BIOL, V55, P209, DOI 10.1002/jlb.55.2.209; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; BATUMAN OA, 1990, BRAIN BEHAV IMMUN, V4, P105, DOI 10.1016/0889-1591(90)90013-G; BERRY CA, 1970, AEROSPACE MED, V41, P500; Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Blanc S, 1998, NEUROCHEM INT, V33, P375, DOI 10.1016/S0197-0186(98)00042-4; Buckey JC, 2006, SPACE PHYSL; Chapes SK, 1999, ADV SPACE RES, V23, P1955, DOI 10.1016/S0273-1177(99)00456-1; Chapes SK, 1999, J APPL PHYSIOL, V86, P2065, DOI 10.1152/jappl.1999.86.6.2065; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Congdon CC, 1996, J APPL PHYSIOL, V81, P172, DOI 10.1152/jappl.1996.81.1.172; Da Silva MS, 2002, NUTRITION, V18, P805, DOI 10.1016/S0899-9007(02)00915-2; Dallman MF, 2007, CURR ALZHEIMER RES, V4, P199, DOI 10.2174/156720507780362236; Dallman MF, 2007, EXP NEUROL, V206, P179, DOI 10.1016/j.expneurol.2007.06.002; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Delerive P, 1999, CIRC RES, V85, P394, DOI 10.1161/01.RES.85.5.394; Dello SAWG, 2013, CLIN NUTR, V32, P325, DOI 10.1016/j.clnu.2012.10.008; DURNOVA GN, 1976, AVIAT SPACE ENVIR MD, V47, P588; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fagette S, 1996, AVIAT SPACE ENVIR MD, V67, P458; FAREH J, 1993, AVIAT SPACE ENVIR MD, V64, P507; Gridley DS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075097, 10.1371/annotation/e66bdc4e-2409-4582-b163-7bc182db275e]; Gridley DS, 2009, J APPL PHYSIOL, V106, P194, DOI 10.1152/japplphysiol.91126.2008; Gridley DS, 2003, J APPL PHYSIOL, V94, P2095, DOI 10.1152/japplphysiol.01053.2002; GRINDELAND RE, 1990, FASEB J, V4, P105, DOI 10.1096/fasebj.4.1.2295371; GROVE DS, 1995, EXP CELL RES, V219, P102, DOI 10.1006/excr.1995.1210; Ichiki AT, 1996, J LEUKOCYTE BIOL, V60, P37, DOI 10.1002/jlb.60.1.37; Jackson SM, 1999, ARTERIOSCL THROM VAS, V19, P2094, DOI 10.1161/01.ATV.19.9.2094; Jahns G, 1992, 43 C INT ASTR FED 19; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jonscher KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152877; Kaur I, 2005, BRAIN BEHAV IMMUN, V19, P547, DOI 10.1016/j.bbi.2004.12.006; Kaur I, 2004, BRAIN BEHAV IMMUN, V18, P443, DOI 10.1016/j.bbi.2003.10.005; Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; LEACH CS, 1975, ACTA ASTRONAUT, V2, P115, DOI 10.1016/0094-5765(75)90048-X; LEBRETHON MC, 1994, MOL CELL ENDOCRINOL, V106, P137, DOI 10.1016/0303-7207(94)90195-3; LESNYAK AT, 1993, J LEUKOCYTE BIOL, V54, P214, DOI 10.1002/jlb.54.3.214; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mao XW, 2014, FREE RADICAL RES, V48, P890, DOI 10.3109/10715762.2014.920086; Marx N, 1999, CIRCULATION, V99, P3125, DOI 10.1161/01.CIR.99.24.3125; Marx N, 1998, AM J PATHOL, V153, P17, DOI 10.1016/S0002-9440(10)65540-X; MEEHAN R, 1993, J LEUKOCYTE BIOL, V54, P236, DOI 10.1002/jlb.54.3.236; MEEHAN RT, 1992, IMMUNOLOGY, V76, P491; Mehta SK, 2000, J INFECT DIS, V182, P1761, DOI 10.1086/317624; Mehta SK, 2001, J APPL PHYSIOL, V91, P1814, DOI 10.1152/jappl.2001.91.4.1814; Mehta SK, 2014, BRAIN BEHAV IMMUNITY; MERRILL AH, 1992, J APPL PHYSIOL, V73, pS132, DOI 10.1152/jappl.1992.73.2.S132; Momoi A, 1999, FEBS LETT, V452, P301, DOI 10.1016/S0014-5793(99)00678-X; MORITA TM, 1995, ENDOCR J, V42, P475, DOI 10.1507/endocrj.42.475; Murao K, 1999, FEBS LETT, V454, P27, DOI 10.1016/S0014-5793(99)00765-6; NASH PV, 1992, EXP CELL RES, V202, P125, DOI 10.1016/0014-4827(92)90411-Z; Ortega MT, 2009, J APPL PHYSIOL, V106, P548, DOI 10.1152/japplphysiol.91138.2008; Pecaut MJ, 2003, J APPL PHYSIOL, V94, P2085, DOI 10.1152/japplphysiol.01052.2002; Pecaut MJ, 2000, AM J PHYSIOL-REG I, V279, pR2072, DOI 10.1152/ajpregu.2000.279.6.R2072; Peckett AJ, 2011, METABOLISM, V60, P1500, DOI 10.1016/j.metabol.2011.06.012; PENHOAT A, 1994, MOL CELL ENDOCRINOL, V103, pR7, DOI 10.1016/0303-7207(94)90088-4; PENHOAT A, 1989, P NATL ACAD SCI USA, V86, P4978, DOI 10.1073/pnas.86.13.4978; Pierson DL, 2005, BRAIN BEHAV IMMUN, V19, P235, DOI 10.1016/j.bbi.2004.08.001; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Russell TD, 2007, J LIPID RES, V48, P1463, DOI 10.1194/jlr.M600474-JLR200; Serova L V, 1980, Physiologist, V23, pS22; Sha W, 2010, FASEB J, V24, P2962, DOI 10.1096/fj.09-154054; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Sonnenfeld G, 1998, INT J SPORTS MED, V19, pS195, DOI 10.1055/s-2007-971992; SONNENFELD G, 1992, J APPL PHYSIOL, V73, pS191, DOI 10.1152/jappl.1992.73.2.S191; Sonnenfeld G, 1998, J APPL PHYSIOL, V85, P1429, DOI 10.1152/jappl.1998.85.4.1429; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701; STEIN TP, 1994, AM J PHYSIOL, V266, pE448, DOI 10.1152/ajpendo.1994.266.3.E448; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stowe RP, 2000, NEUROIMMUNOMODULAT, V8, P51, DOI 10.1159/000026453; Stowe RP, 1999, J LEUKOCYTE BIOL, V65, P179, DOI 10.1002/jlb.65.2.179; Stowe RP, 2001, PSYCHOSOM MED, V63, P891, DOI 10.1097/00006842-200111000-00007; Stowe RP, 2001, AVIAT SPACE ENVIR MD, V72, P884; Sung M, 2013, J MUSCULOSKEL NEURON, V13, P405; UDDEN MM, 1995, AVIAT SPACE ENVIR MD, V66, P557; Voorhees JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077935; Weiner J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040221; Wronski TJ, 1998, J APPL PHYSIOL, V85, P279, DOI 10.1152/jappl.1998.85.1.279; Zhou YC, 1999, J BIOL CHEM, V274, P2672, DOI 10.1074/jbc.274.5.2672; Zoladz PR, 2008, STRESS, V11, P259, DOI 10.1080/10253890701768613	84	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0174174	10.1371/journal.pone.0174174	http://dx.doi.org/10.1371/journal.pone.0174174			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542224	Green Published, Green Submitted, gold			2022-12-26	WOS:000402061500001
J	Burkhardt, C; Neuwirth, C; Sommacal, A; Andersen, PM; Weber, M				Burkhardt, Christian; Neuwirth, Christoph; Sommacal, Andreas; Andersen, Peter M.; Weber, Markus			Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients	PLOS ONE			English	Article							QUALITY STANDARDS SUBCOMMITTEE; NONINVASIVE VENTILATION; RESPIRATORY-FAILURE; PRACTICE PARAMETER; AMERICAN ACADEMY; FRENCH PATIENTS; DEATH; CARE; DIAGNOSIS; CRITERIA	Background Non-invasive ventilation (NIV) and percutaneous gastrostomy (PEG) are guideline-recommended interventions for symptom management in amyotrophic lateral sclerosis (ALS). Their effect on survival is controversial and the impact on causes of death is unknown. Objective To investigate the effect of NIV and PEG on survival and causes of death in ALS patients. Methods Eighty deceased ALS patients underwent a complete post mortem analysis for causes of death between 2003 and 2015. Forty-two of these patients consented for genetic testing. Effects of NIV and PEG on survival and causes of death were analyzed in a multivariable Cox proportional hazard regression. Results Six patients, who requested assisted suicide causing drug-induced hypoxia, were excluded from final analysis. Respiratory failure was the main cause of death in 72 out of 74 patients. Fifteen out of 74 died of aspiration pneumonia 23/74 of bronchopneumonia and 8/74 of a combination of aspiration pneumonia and bronchopneumonia. Twenty died of hypoxia without concomitant infection, and six patients had pulmonary embolism alone or in combination with pneumonia. NIV (p = 0.01) and PEG (p<0.01) had a significant impact on survival. In patients using NIV bronchopneumonia was significantly more frequent (p <0.04) compared to non-NIV patients. This effect was even more pronounced in limb onset patients (p<0.002). Patients with C9orf72 hexanucleotide repeat expansions showed faster disease progression and shorter survival (p = 0.01). Conclusion The use of NIV and PEG prolongs survival in ALS. This study supports current AAN and EFNS guidelines which recommend NIV and PEG as a treatment option in ALS. The risk of bronchopneumonia as cause of death may be increased by NIV.	[Burkhardt, Christian; Neuwirth, Christoph; Weber, Markus] Kantonsspital St Gallen, Neuromuscular Dis Unit, ALS Clin, St Gallen, Switzerland; [Sommacal, Andreas] Kantonsspital St Gallen, Dept Pathol, St Gallen, Switzerland; [Andersen, Peter M.] Umea Univ, Inst Pharmacol & Clin Neurosci, Umea, Sweden	Kantonsspital St. Gallen; Kantonsspital St. Gallen; Umea University	Burkhardt, C (corresponding author), Kantonsspital St Gallen, Neuromuscular Dis Unit, ALS Clin, St Gallen, Switzerland.	christian.burkhardt@kssg.ch	Weber, Markus/AAI-7138-2020; Neuwirth, Christoph/AAE-2211-2020	Burkhardt, Christian/0000-0002-8606-7905	Swiss ALS Foundation; EU Joint Programme-Neurodegenerative Disease Research (JPND) projects [SNF 31ND30_141622, 31ND30_151115]; Swedish Science Council	Swiss ALS Foundation; EU Joint Programme-Neurodegenerative Disease Research (JPND) projects; Swedish Science Council	Christian Burkhardt receives honoraria from Biogen Idec for training courses and receives research support from the Swiss ALS Foundation and the EU Joint Programme-Neurodegenerative Disease Research (JPND) projects (grant number SNF 31ND30_141622 (SOPHIA) and 31ND30_151115 (STRENGTH)). Christoph Neuwirth receives honoraria from Biogen Idec, USA, as advisory board member tasks and training courses and support from the Swiss ALS Foundation and the EU Joint Programme Neurodegenerative Disease Research (JPND) projects (grant number SNF 31ND30_141622 (SOPHIA) and 31ND30_151115 (STRENGTH)). Andreas Sommacal reports no disclosures. Peter M. Andersen receives honoraria from Biogen Idec and Neuroimmune for advisory board tasks and counselling on clinical trials. He receives numerous research grants from the Swedish Science Council and private foundations and patient organizations in Sweden and Norway. Markus Weber receives honoraria from Merz Pharma Schweiz AG, Biogen Idec, USA, as advisory board member and support from the Swiss ALS Foundation and the EU Joint Programme-Neurodegenerative Disease Research (JPND) projects (grant number SNF 31ND30_141622 (SOPHIA) and 31ND30_151115 (STRENGTH))	Akimoto C, 2014, J MED GENET, V51, P419, DOI 10.1136/jmedgenet-2014-102360; Andersen PM, 2012, EUR J NEUROL, V19, P360, DOI 10.1111/j.1468-1331.2011.03501.x; Andersen PM, 2005, EUR J NEUROL, V12, P921, DOI 10.1111/j.1468-1331.2005.01351.x; Berlowitz DJ, 2016, J NEUROL NEUROSUR PS, V87, P280, DOI 10.1136/jnnp-2014-310055; Bourke SC, 2006, LANCET NEUROL, V5, P140, DOI 10.1016/S1474-4422(05)70326-4; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Burns KEA, 2014, CAN MED ASSOC J, V186, pE112, DOI 10.1503/cmaj.130974; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Choudhuri Anirban H, 2013, Int J Crit Illn Inj Sci, V3, P169, DOI 10.4103/2229-5151.119195; Colosimo C, 2003, J NEUROL NEUROSUR PS, V74, P852, DOI 10.1136/jnnp.74.7.852; Corcia P, 2008, AMYOTROPH LATERAL SC, V9, P59, DOI 10.1080/17482960701656940; Czell D, 2013, RESP CARE, V58, P838, DOI 10.4187/respcare.02024; D'Ottavianol FG, 2013, BRAZ J OTORHINOLAR, V79, P349, DOI 10.5935/1808-8694.20130061; Gil J, 2008, EUR J NEUROL, V15, P1245, DOI 10.1111/j.1468-1331.2008.02307.x; Gladman M, 2014, NEUROLOGY, V82, P1674, DOI 10.1212/WNL.0000000000000405; Higo R, 2002, LARYNGOSCOPE, V112, P911, DOI 10.1097/00005537-200205000-00024; Katzberg HD, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004030.pub3; Kimura F, 2006, NEUROLOGY, V66, P265, DOI 10.1212/01.wnl.0000194316.91908.8a; KNIFFIN WD, 1994, ARCH INTERN MED, V154, P861, DOI 10.1001/archinte.154.8.861; Kurian KM, 2009, J NEUROL NEUROSUR PS, V80, P84, DOI 10.1136/jnnp.2008.149708; Lechtzin N, 2009, EUR J NEUROL, V16, P5, DOI 10.1111/j.1468-1331.2008.02327.x; Mehal JM, 2013, AMYOTROPH LAT SCL FR, V14, P346, DOI 10.3109/21678421.2013.787629; Miller RG, 2009, NEUROLOGY, V73, P1218, DOI 10.1212/WNL.0b013e3181bc0141; Miller RG, 1999, NEUROLOGY, V52, P1311, DOI 10.1212/WNL.52.7.1311; Nicolini A, 2016, CLIN RESPIR J, V10, P98, DOI 10.1111/crj.12184; Piao YS, 2003, BRAIN PATHOLOGY ZURI, V13, P10, DOI DOI 10.1111/J.1750-3639.2003.TB00002.X; Rajput AH, 2014, NEUROLOGY, V83, P386, DOI 10.1212/WNL.0000000000000653; RICKHAM PP, 1964, BRIT MED J, V2, P173; Sorenson EJ, 2007, AMYOTROPH LATERAL SC, V8, P87, DOI 10.1080/17482960601147461; Spataro R, 2010, ACTA NEUROL SCAND, V122, P217, DOI 10.1111/j.1600-0404.2009.01290.x; Spataro R, 2011, J NEUROL SCI, V304, P44, DOI 10.1016/j.jns.2011.02.016; VICTOROFF J, 1995, AM J PSYCHIAT, V152, P1476	32	49	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177555	10.1371/journal.pone.0177555	http://dx.doi.org/10.1371/journal.pone.0177555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542233	gold, Green Submitted, Green Published			2022-12-26	WOS:000402058800019
J	D'Auria, L; Reiter, C; Ward, E; Moyano, AL; Marshall, MS; Nguyen, D; Scesa, G; Hauck, Z; van Breemen, R; Givogri, MI; Bongarzone, ER				D'Auria, Ludovic; Reiter, Cory; Ward, Emma; Moyano, Ana Lis; Marshall, Michael S.; Duc Nguyen; Scesa, Giuseppe; Hauck, Zane; van Breemen, Richard; Givogri, Maria I.; Bongarzone, Ernesto R.			Psychosine enhances the shedding of membrane microvesicles: Implications in demyelination in Krabbe's disease	PLOS ONE			English	Article							GLOBOID-CELL LEUKODYSTROPHY; TWITCHER MOUSE; NERVOUS-SYSTEM; LIPID ORDER; RAT-BRAIN; TMA-DPH; FLUIDITY; CHOLESTEROL; PATHOGENESIS; MYELINATION	In prior studies, our laboratory showed that psychosine accumulates and disrupts lipid rafts in brain membranes of Krabbe's disease. A model of lipid raft disruption helped explaining psychosine's effects on several signaling pathways important for oligodendrocyte survival and differentiation but provided more limited insight in how this sphingolipid caused demyelination. Here, we have studied how this cationic inverted coned lipid affects the fluidity, stability and structure of myelin and plasma membranes. Using a combination of cutting-edge imaging techniques in non-myelinating (red blood cell), and myelinating (oligodendrocyte) cell models, we show that psychosine is sufficient to disrupt sphingomyelin-enriched domains, increases the rigidity of localized areas in the plasma membrane, and promotes the shedding of membranous microvesicles. The same physicochemical and structural changes were measured in myelin membranes purified from the mutant mouse Twitcher, a model for Krabbe's disease. Areas of higher rigidity were measured in Twitcher myelin and correlated with higher levels of psychosine and of myelin microvesiculation. These results expand our previous analyses and support, for the first time a pathogenic mechanism where psychosine's toxicity in Krabbe disease involves deregulation of cell signaling not only by disruption of membrane rafts, but also by direct local destabilization and fragmentation of the membrane through microvesiculation. This model of membrane disruption may be fundamental to introduce focal weak points in the myelin sheath, and consequent diffuse demyelination in this leukodystrophy, with possible commonality to other demyelinating disorders.	[D'Auria, Ludovic; Reiter, Cory; Ward, Emma; Moyano, Ana Lis; Marshall, Michael S.; Duc Nguyen; Scesa, Giuseppe; Givogri, Maria I.; Bongarzone, Ernesto R.] Univ Illinois, Coll Med, Dept Anat & Cell Biol, Chicago, IL 60607 USA; [Hauck, Zane; van Breemen, Richard] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL USA; [Bongarzone, Ernesto R.] Univ Buenos Aires, Dept Quim Biol, Fac Farm & Bioquirn, Buenos Aires, DF, Argentina	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Buenos Aires	Bongarzone, ER (corresponding author), Univ Illinois, Coll Med, Dept Anat & Cell Biol, Chicago, IL 60607 USA.; Bongarzone, ER (corresponding author), Univ Buenos Aires, Dept Quim Biol, Fac Farm & Bioquirn, Buenos Aires, DF, Argentina.	ebongarz@uic.edu	van Breemen, Richard/AAO-2875-2020; Marshall, Michael/B-9705-2015	Marshall, Michael/0000-0002-5742-2031; Moyano, Ana Lis/0000-0002-1089-8542; van Breemen, Richard/0000-0003-2016-0063; d'auria, ludovic/0000-0001-6270-7739	National Institutes of Health [R01 NS065808]; Legacy of Angels Foundation; European Leukodystrophy Association; National Multiple Sclerosis Society; Belgian American Educational Foundation; Chicago Biomedical Consortium pilot grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Legacy of Angels Foundation; European Leukodystrophy Association; National Multiple Sclerosis Society(National Multiple Sclerosis Society); Belgian American Educational Foundation; Chicago Biomedical Consortium pilot grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was partially funded with grants from the National Institutes of Health (R01 NS065808), The Legacy of Angels Foundation, and the European Leukodystrophy Association to ERB. LDA was funded by a postdoctoral fellowship of the National Multiple Sclerosis Society, a fellowship from Belgian American Educational Foundation, and a Chicago Biomedical Consortium pilot grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLT G, 1988, ACTA NEUROPATHOL, V75, P456, DOI 10.1007/BF00687132; Awojoodu AO, 2014, BLOOD, V124, P1941, DOI 10.1182/blood-2014-01-543652; Boggs JM, 2000, BIOPHYS J, V78, P874, DOI 10.1016/S0006-3495(00)76645-8; Bongarzone ER, 2016, PEDIATR ENDOCR REV P, V13, P689; Carquin M, 2016, PROG LIPID RES, V62, P1, DOI 10.1016/j.plipres.2015.12.004; Castelvetri LC, 2011, ACTA NEUROPATHOL, V122, P35, DOI 10.1007/s00401-011-0814-2; Chauhan NB, 2003, J LIPID RES, V44, P2019, DOI 10.1194/jlr.R300010-JLR200; Cheng ZJ, 2006, MOL BIOL CELL, V17, P3197, DOI 10.1091/mbc.E05-12-1101; COOPER RA, 1977, NEW ENGL J MED, V297, P371; CRAVIOTO H, 1967, J NEUROPATH EXP NEUR, V26, P157; D'Auria L, 2013, BBA-BIOMEMBRANES, V1828, P2064, DOI 10.1016/j.bbamem.2013.05.006; D'Auria L, 2016, J NEUROSCI RES, V94, P1019, DOI 10.1002/jnr.23750; D'Auria L, 2013, J LIPID RES, V54, P1066, DOI 10.1194/jlr.M034314; D'auria L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017021; de Vito G, 2017, J BIOPHOTONICS, V10, P385, DOI 10.1002/jbio.201500305; DUCHEN LW, 1980, BRAIN, V103, P695, DOI 10.1093/brain/103.3.695; Dutta R, 2011, PROG NEUROBIOL, V93, P1, DOI 10.1016/j.pneurobio.2010.09.005; FLORINECASTEEL K, 1991, FASEB J, V5, P2078, DOI 10.1096/fasebj.5.7.2010060; FONTAINE G, 1973, ACTA NEUROPATHOL, V23, P118, DOI 10.1007/BF00685766; Galbiati F, 2007, J NEUROSCI, V27, P13730, DOI 10.1523/JNEUROSCI.3379-07.2007; Galvan C, 2008, MOL BIOL CELL, V19, P509, DOI 10.1091/mbc.E07-05-0439; Givogri MI, 2002, J NEUROSCI RES, V67, P309, DOI 10.1002/jnr.10128; Golfetto O, 2013, BIOPHYS J, V104, P1238, DOI 10.1016/j.bpj.2012.12.057; GREGOIRE A, 1966, J NEUROPATH EXP NEUR, V25, P617, DOI 10.1097/00005072-196610000-00008; Grisendi G, 2015, BLOOD TRANSFUS-ITALY, V13, P274, DOI 10.2450/2014.0136-14; Hawkins-Salsbury JA, 2013, J LIPID RES, V54, P3303, DOI 10.1194/jlr.M039610; IGISU H, 1984, SCIENCE, V224, P753, DOI 10.1126/science.6719111; Jarsch IK, 2016, J CELL BIOL, V214, P375, DOI 10.1083/jcb.201604003; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; KOBAYASHI T, 1980, BRAIN RES, V202, P479, DOI 10.1016/0006-8993(80)90159-6; Koike T, 1998, BBA-MOL BASIS DIS, V1406, P327, DOI 10.1016/S0925-4439(98)00019-2; Kostova EB, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150019; KUHRY JG, 1983, CELL BIOPHYS, V5, P129, DOI 10.1007/BF02796139; KUHRY JG, 1985, BIOCHIM BIOPHYS ACTA, V845, P60, DOI 10.1016/0167-4889(85)90055-2; Leppimaki P, 2000, EUR J BIOCHEM, V267, P6385, DOI 10.1046/j.1432-1327.2000.01726.x; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; LOUIS JC, 1992, J NEUROSCI RES, V31, P193, DOI 10.1002/jnr.490310125; MARSH JB, 1966, J LIPID RES, V7, P574; McMahon HT, 2015, J CELL SCI, V128, P1065, DOI 10.1242/jcs.114454; MEIER C, 1976, ACTA NEUROPATHOL, V36, P369, DOI 10.1007/BF00699642; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; NAGARA H, 1982, BRAIN RES, V244, P289, DOI 10.1016/0006-8993(82)90087-7; Nishio M, 2004, J BIOL CHEM, V279, P33368, DOI 10.1074/jbc.M403816200; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; O'Meara RW, 2011, JOVE-J VIS EXP, DOI 10.3791/3324; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; PARNHAM MJ, 1993, CHEM PHYS LIPIDS, V64, P263, DOI 10.1016/0009-3084(93)90070-J; PELLISSIER JF, 1986, ACTA NEUROPATHOL, V72, P178, DOI 10.1007/BF00685981; Pituch KC, 2015, J BIOL CHEM, V290, P7040, DOI 10.1074/jbc.M115.636498; PRINEAS JW, 1984, ANN NY ACAD SCI, V436, P11, DOI 10.1111/j.1749-6632.1984.tb14773.x; Prinetti A, 2009, BBA-BIOMEMBRANES, V1788, P184, DOI 10.1016/j.bbamem.2008.09.001; PURPURA DP, 1978, NATURE, V276, P520, DOI 10.1038/276520a0; PURPURA DP, 1977, NATURE, V266, P552; Saldanha C, 2002, J MEMBRANE BIOL, V190, P75, DOI 10.1007/s00232-002-1025-5; Shaharabani R, 2016, J AM CHEM SOC, V138, P12159, DOI 10.1021/jacs.6b04826; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Suzuki K, 1998, NEUROCHEM RES, V23, P251, DOI 10.1023/A:1022436928925; TAKAHASHI H, 1984, ACTA NEUROPATHOL, V62, P298, DOI 10.1007/BF00687612; TANIIKE M, 1994, ACTA NEUROPATHOL, V88, P228; Thompson AG, 2016, NAT REV NEUROL, V12, P346, DOI 10.1038/nrneurol.2016.68; Turgeon CT, 2015, J INHERIT METAB DIS, V38, P923, DOI 10.1007/s10545-015-9822-z; Tyteca D, 2010, BBA-BIOMEMBRANES, V1798, P909, DOI 10.1016/j.bbamem.2010.01.021; von Einem B, 2012, INT J MOL SCI, V13, P15801, DOI 10.3390/ijms131215801; Westerlund B, 2009, BBA-BIOMEMBRANES, V1788, P194, DOI 10.1016/j.bbamem.2008.11.010; White AB, 2011, J NEUROSCI RES, V89, P352, DOI 10.1002/jnr.22564; White AB, 2009, J NEUROSCI, V29, P6068, DOI 10.1523/JNEUROSCI.5597-08.2009; Yang XG, 2014, MOL NEUROBIOL, V50, P119, DOI 10.1007/s12035-014-8652-6; YECHIEL E, 1987, J CELL BIOL, V105, P755, DOI 10.1083/jcb.105.2.755; Zhu HL, 2012, ARCH PATHOL LAB MED, V136, P709, DOI 10.5858/arpa.2011-0667-LE	69	26	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178103	10.1371/journal.pone.0178103	http://dx.doi.org/10.1371/journal.pone.0178103			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531236	Green Published, Green Submitted, gold			2022-12-26	WOS:000402058400057
J	Katayama, I; Eida, S; Fujita, S; Hotokezaka, Y; Sumi, M; Nakamura, T				Katayama, Ikuo; Eida, Sato; Fujita, Shuichi; Hotokezaka, Yuka; Sumi, Misa; Nakamura, Takashi			Perfusion MR imaging detection of carcinoma arising from preexisting salivary gland pleomorphic adenoma by computer-assisted analysis of time-signal intensity maps	PLOS ONE			English	Article							INTRAVOXEL INCOHERENT MOTION; TUMORS; DIFFERENTIATION; BENIGN; PROGRESSION; DIFFUSION; HEAD	Tumor perfusion can be evaluated by analyzing the time-signal intensity curve (TIC) after dynamic contrast-enhanced (DCE) MR imaging. Accordingly, TIC profiles are characteristic of some benign and malignant salivary gland tumors. A carcinoma ex pleomorphic adenoma (CXPA) arises from a long-standing pleomorphic adenoma (PA) and has a distinctive prognostic risk depending on the tumor growth potential such as invasion beyond the preexisting capsule. Differentiating CXPA from PA can be very challenging. In this study, we have attempted to discriminate CXPA from PA based on a two-dimensional TIC mapping algorithm. TIC mapping analysis was performed on 8 patients with CXPA and 20 patients with PA after dynamic contrast-enhanced (DCE) MR imaging using a 1.5-T MR system. The TIC profiles obtained were automatically categorized into 5 types based on the enhancement ratio, maximum time, and washout ratio (Type 1 TIC with flat profile, Type 2 TIC with slow uptake, Type 3 TIC with rapid uptake and a low washout ratio, Type 4 TIC with rapid uptake and a high washout ratio, and Type 5 TIC not otherwise specific). The percentage tumor areas with each of the 5 TIC types were compared between CXPAs and PAs. Stepwise differentiation and cluster analysis using multiple TIC cut-off thresholds distinguished CXPAs from PAs with 75% sensitivity, 95% specificity, 86% accuracy, and 86% positive and 90% negative predictive values, when tumors with <= 1.1% Type 1 and >= 15% Type 4, or those with <= 1.1% Type 1, >= 78.1% Type 2, >= 16.1% Type 3, and <15% Type 4, or those with >1.1% Type 1, >= 78.1% Type 2, and >= 16.1% Type 3 areas were diagnosed as CXPAs. The overall TIC profiles predicted some aggressive CXPA growth patterns. These results suggest that stepwise differentiation based on TIC mapping is helpful in differentiating CXPAs from PAs.	[Katayama, Ikuo; Eida, Sato; Hotokezaka, Yuka; Sumi, Misa; Nakamura, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiol & Canc Biol, Nagasaki, Japan; [Fujita, Shuichi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Pathol & Bone Metab, Nagasaki, Japan	Nagasaki University; Nagasaki University	Nakamura, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiol & Canc Biol, Nagasaki, Japan.	taku@nagasaki-u.ac.jp			Grants-in-Aid for Scientific Research [15K11078] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Antony J, 2012, HEAD NECK PATHOL, V6, P1, DOI 10.1007/s12105-011-0281-z; Bryan RN, 2016, RADIOLOGY, V281, P665, DOI 10.1148/radiol.2016162151; DONAHUE KM, 1995, MAGN RESON MED, V34, P423, DOI 10.1002/mrm.1910340320; Eida S, 2008, J MAGN RESON IMAGING, V27, P1256, DOI 10.1002/jmri.21349; Eida S, 2010, J MAGN RESON IMAGING, V31, P673, DOI 10.1002/jmri.22091; Gnepp D.R., 2005, WHO CLASSIFICATION T, P242; Iima M, 2016, RADIOLOGY, V278, P13, DOI 10.1148/radiol.2015150244; Katabi N, 2010, HUM PATHOL, V41, P927, DOI 10.1016/j.humpath.2009.12.011; Knopp MV, 1999, JMRI-J MAGN RESON IM, V10, P260, DOI 10.1002/(SICI)1522-2586(199909)10:3<260::AID-JMRI6>3.0.CO;2-7; Lewis JE, 2001, HUM PATHOL, V32, P596, DOI 10.1053/hupa.2001.25000; Nakamura T, METHODS CANC DIAGNOS, V7; Oshida K, 2005, EUR RADIOL, V15, P1353, DOI 10.1007/s00330-005-2661-9; Rito M, 2016, VIRCHOWS ARCH, V468, P297, DOI 10.1007/s00428-015-1887-4; Sasaki M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112866; Stodulski D, 2016, EUR ARCH OTO-RHINO-L, V273, P3937, DOI 10.1007/s00405-016-4048-8; Sumi M, 2014, EUR RADIOL, V24, P223, DOI 10.1007/s00330-013-3002-z; Sumi M, 2012, RADIOLOGY, V263, P770, DOI 10.1148/radiol.12111248; Sumi M, 2011, J MAGN RESON IMAGING, V33, P830, DOI 10.1002/jmri.22454; Suzuki M, 2016, ACTA OTO-LARYNGOL, V136, P1154, DOI 10.1080/00016489.2016.1191671; Wang K, 2016, CLIN CANCER RES, V22, P6061, DOI 10.1158/1078-0432.CCR-15-2568; Weiler C, 2011, HISTOPATHOLOGY, V59, P741, DOI 10.1111/j.1365-2559.2011.03937.x; Yabuuchi H, 2003, RADIOLOGY, V226, P345, DOI 10.1148/radiol.2262011486	22	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178002	10.1371/journal.pone.0178002	http://dx.doi.org/10.1371/journal.pone.0178002			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531213	gold, Green Published, Green Submitted			2022-12-26	WOS:000402058400047
J	Lee, J; Ouh, YT; Ahn, KH; Hong, SC; Oh, MJ; Kim, HJ; Cho, GJ				Lee, Joohyun; Ouh, Yung-taek; Ahn, Ki Hoon; Hong, Soon Cheol; Oh, Min-Jeong; Kim, Hai-Joong; Cho, Geum Joon			Preeclampsia: A risk factor for gestational diabetes mellitus in subsequent pregnancy	PLOS ONE			English	Article							HYPERTENSIVE DISORDERS; INSULIN-RESISTANCE; WOMEN; INTOLERANCE; PREVALENCE; MORTALITY; CARPENTER; DISEASE; HEALTH	Preeclampsia and gestational diabetes (GDM) have several mechanisms in common. The aim of this study was to determine whether women with preeclampsia have an increased risk of GDM in a subsequent pregnancy. Study data were collected from the Korea National Health Insurance Claims Database of the Health Insurance Review and Assessment Service for 2007-2012. Patients who had their first delivery in 2007 and a subsequent delivery between 2008 and 2012 in Korea were enrolled. A model of multivariate logistic regression analysis was performed with GDM as the final outcome to evaluate the risk of GDM in the second pregnancy. Among the 252,276 women who had their first delivery in 2007, 150,794 women had their second delivery between 2008 and 2012. On the multivariate regression analysis, women with preeclampsia alone in the first pregnancy had an increased risk of GDM in the second pregnancy when compared with women who had neither of these conditions in their first pregnancy (OR 1.2, 95% CI, 1.1-1.3). Women with GDM alone in the first pregnancy were at an increased risk for GDM in the second pregnancy (OR 3.3, 95% CI 3.1-3.4). The co-presence of preeclampsia and GDM in the first pregnancy further increased the risk of GDM in the second pregnancy (OR 5.9, 95% CI, 4.0-8.6). Our study showed that a history of preeclampsia may serve as an additional risk factor for GDM in a subsequent pregnancy.	[Lee, Joohyun; Ouh, Yung-taek; Ahn, Ki Hoon; Hong, Soon Cheol; Oh, Min-Jeong; Kim, Hai-Joong; Cho, Geum Joon] Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine)	Cho, GJ (corresponding author), Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	md_cho@hanmail.net	Rhim, Sonny H./W-9532-2019					Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; American College of Obstetricians and Gynecologists Committee on Practice Bulletins D Obstetrics, 2011, OBSTET GYNECOL, V98, P525; Anastasiou E, 1998, DIABETES CARE, V21, P2111, DOI 10.2337/diacare.21.12.2111; Guimares MFBD, 2014, ARCH GYNECOL OBSTET, V290, P441, DOI 10.1007/s00404-014-3220-x; Bryson CL, 2003, AM J EPIDEMIOL, V158, P1148, DOI 10.1093/aje/kwg273; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Cheng YW, 2009, OBSTET GYNECOL, V114, P326, DOI 10.1097/AOG.0b013e3181ae8d85; Cho GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136017; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Ferrara A, 2002, DIABETES CARE, V25, P1625, DOI 10.2337/diacare.25.9.1625; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Haddad B, 2010, Ann Fr Anesth Reanim, V29, pe59, DOI 10.1016/j.annfar.2010.02.019; Heitritter SM, 2005, J CLIN ENDOCR METAB, V90, P3983, DOI 10.1210/jc.2004-2494; Hogberg U, 2005, SCAND J PUBLIC HEALT, V33, P409, DOI 10.1080/14034940500217037; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Jenkins SM, 2002, AM J OBSTET GYNECOL, V186, P790, DOI 10.1067/mob.2002.122290; Kim JY, 2006, CONSTRUCTION NATL SU; King H, 2002, DIABETES RES CLIN PR, V55, P19, DOI 10.1016/S0168-8227(01)00251-0; Lee AJ, 2007, DIABETES CARE, V30, P878, DOI 10.2337/dc06-1816; Lee CH, 2013, THORAX, V68, P1105, DOI 10.1136/thoraxjnl-2012-203175; Miyakoshi K, 2004, DIABETES RES CLIN PR, V64, P201, DOI 10.1016/j.diabres.2003.11.002; Nerenberg K, 2014, CAN J CARDIOL, V30, P765, DOI 10.1016/j.cjca.2013.12.030; NISELL H, 1995, BRIT J OBSTET GYNAEC, V102, P876, DOI 10.1111/j.1471-0528.1995.tb10874.x; Ostlund I, 2004, EUR J OBSTET GYN R B, V113, P12, DOI 10.1016/j.ejogrb.2003.07.001; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Ray JG, 2005, LANCET, V366, P1797, DOI 10.1016/S0140-6736(05)67726-4; Reaven GM, 1996, NEW ENGL J MED, V334, P374, DOI 10.1056/NEJM199602083340607; Retnakaran R, 2009, CURR DIABETES REV, V5, P239, DOI 10.2174/157339909789804378; Schneider S, 2012, EARLY HUM DEV, V88, P179, DOI 10.1016/j.earlhumdev.2011.08.004; Solomon CG, 2001, HYPERTENSION, V37, P232, DOI 10.1161/01.HYP.37.2.232; Vambergue A, 2002, EUR J OBSTET GYN R B, V102, P31, DOI 10.1016/S0301-2115(01)00556-5; Vikse BE, 2006, J AM SOC NEPHROL, V17, P837, DOI 10.1681/ASN.2005050492; Wolf M, 2002, J CLIN ENDOCR METAB, V87, P1563, DOI 10.1210/jc.87.4.1563; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Zhou Y, 1997, J CLIN INVEST, V99, P2152, DOI 10.1172/JCI119388; ZHOU Y, 1993, J CLIN INVEST, V91, P950, DOI 10.1172/JCI116316	37	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178150	10.1371/journal.pone.0178150	http://dx.doi.org/10.1371/journal.pone.0178150			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542483	gold, Green Published, Green Submitted			2022-12-26	WOS:000402058400062
J	Quader, ZS; Cogswell, ME; Fang, J; King, SMC; Merritt, RK				Quader, Zerleen S.; Cogswell, Mary E.; Fang, Jing; King, Sallyann M. Coleman; Merritt, Robert K.			Changes in primary healthcare providers' attitudes and counseling behaviors related to dietary sodium reduction, DocStyles 2010 and 2015	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; PHYSICIAN ADVICE; NATIONAL-HEALTH; BLOOD-PRESSURE; ADULTS; MANAGEMENT; EXERCISE	High blood pressure is a major risk factor for cardiovascular disease. The 2013 ACC/AHA Lifestyle Management Guideline recommends counseling pre-hypertensive and hypertensive patients to reduce sodium intake. Population sodium reduction efforts have been introduced in recent years, and dietary guidelines continued to emphasize sodium reduction in 2010 and 2015. The objective of this analysis was to determine changes in primary health care providers' sodium-reduction attitudes and counseling between 2010 and 2015. Primary care internists, family/general practitioners, and nurse practitioners answered questions about sodium-related attitudes and counseling behaviors in DocStyles, a repeated cross-sectional web-based survey in the United States. Differences in responses between years were examined. In 2015, the majority (78%) of participants (n = 1,251) agreed that most of their patients should reduce sodium intake, and reported advising hypertensive (85%), and chronic kidney disease patients (71%), but not diabetic patients (48%) and African-American patients (43%) to consume less salt. Since 2010, the proportion of participants agreeing their patients should reduce sodium intake decreased while the proportion advising patients with these characteristics to consume less salt increased and the prevalence of specific types of advice declined. Changes in behaviors between surveys remained significant after adjusting for provider and practice characteristics. More providers are advising patients to consume less salt in 2015 compared to 2010; however, fewer agree their patients should reduce intake and counseling is not universally applied across patient groups at risk for hypertension. Further efforts and educational resources may be required to enable patient counseling about sodium reduction strategies.	[Quader, Zerleen S.; Cogswell, Mary E.; Fang, Jing; King, Sallyann M. Coleman; Merritt, Robert K.] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Atlanta, GA 30333 USA; [Quader, Zerleen S.] IHRC Inc, Atlanta, GA 30346 USA	Centers for Disease Control & Prevention - USA	Quader, ZS (corresponding author), Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Atlanta, GA 30333 USA.; Quader, ZS (corresponding author), IHRC Inc, Atlanta, GA 30346 USA.	zquader@cdc.gov						Adler AJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009217.pub3; Agricultural Research Service U. S. Department of Agriculture, 2011, WWEIA DAT TABL; [Anonymous], NAT AMB MED CAR SURV; Ayala C, 2012, J CLIN HYPERTENS, V14, P447, DOI 10.1111/j.1751-7176.2012.00632.x; Corsino Leonor, 2009, N C Med J, V70, P391; Donahue KE, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130157; Eckel R. H., 2014, Journal of the American College of Cardiology, V63, P2960, DOI [10.1161/01.cir.0000437740.48606.d1, 10.1016/j.jacc.2013.11.003]; Evert AB, 2013, DIABETES CARE, V36, P3821, DOI 10.2337/dc13-2042; Fang J, 2012, ARCH INTERN MED, V172, P76, DOI 10.1001/archinternmed.2011.620; Gillespie CD, 2013, MMWR-MORBID MORTAL W, V62, P144; Henderson JT, 2001, MED CARE, V39, P1281, DOI 10.1097/00005650-200112000-00004; Honda K, 2004, AM J HEALTH PROMOT, V18, P370, DOI 10.4278/0890-1171-18.5.370; Institute of Medicine [IOM], 2010, STRATEGIES REDUCE SO; Jackson SL, 2016, AM J PREV MED, V50, P30, DOI 10.1016/j.amepre.2015.04.034; Kreuter MW, 2000, ARCH FAM MED, V9, P426, DOI 10.1001/archfami.9.5.426; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Lopez L, 2009, AM J HYPERTENS, V22, P325, DOI 10.1038/ajh.2008.348; MATTES RD, 1991, J AM COLL NUTR, V10, P383; Moshfegh Alanna J., 2012, Morbidity and Mortality Weekly Report, V61, P92; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; NYC Department of Health and Mental Hygiene, SOD IN; Rees K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002128.pub4; Ritseman TS, 2014, PREV CHRONIC DIS, V11, DOI [10.5888/pcd11.130175, 10.5888/pcd11.130175Eg]; Sinclair J, 2008, CAN FAM PHYSICIAN, V54, P404; Tabenkin H, 2010, ANN FAM MED, V8, P25, DOI 10.1370/afm.1071; US Department of Agriculture U. D. o. H. a. H. S, 2015, DIET GUID AM; Valderrama AL, 2010, J CLIN HYPERTENS, V12, P784, DOI 10.1111/j.1751-7176.2010.00323.x; Viera AJ, 2008, J CLIN HYPERTENS, V10, P105, DOI 10.1111/j.1751-7176.2008.07577.x; Wexler R, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-23	29	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177693	10.1371/journal.pone.0177693	http://dx.doi.org/10.1371/journal.pone.0177693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531232	Green Published, Green Submitted, gold			2022-12-26	WOS:000402058400024
J	Peredo, CM; Pyenson, ND; Uhen, MD; Marshall, CD				Peredo, Carlos Mauricio; Pyenson, Nicholas D.; Uhen, Mark D.; Marshall, Christopher D.			Alveoli, teeth, and tooth loss: Understanding the homology of internal mandibular structures in mysticete cetaceans	PLOS ONE			English	Article							BALAENOPTERA-ACUTOROSTRATA; RORQUAL WHALES; GIANT ANTEATER; MINKE WHALE; NEW-ZEALAND; EVOLUTION; BALEEN; MASTICATION; MANDIBLES; MORPHOLOGY	The evolution of filter feeding in baleen whales (Mysticeti) facilitated a wide range of ecological diversity and extreme gigantism. The innovation of filter feeding evolved in a shift from a mineralized upper and lower dentition in stem mysticetes to keratinous baleen plates that hang only from the roof of the mouth in extant species, which are all edentulous as adults. While all extant mysticetes are born with a mandible lacking a specialized feeding structure (i.e., baleen), the bony surface retains small foramina with elongated sulci that often merge together in what has been termed the alveolar gutter. Because mysticete embryos develop tooth buds that resorb in utero, these foramina have been interpreted as homologous to tooth alveoli in other mammals. Here, we test this homology by creating 3D models of the internal mandibular morphology from terrestrial artiodactyls and fossil and extant cetaceans, including stem cetaceans, odontocetes and mysticetes. We demonstrate that dorsal foramina on the mandible communicate with the mandibular canal via smaller canals, which we explain within the context of known mechanical models of bone resorption. We suggest that these dorsal foramina represent distinct branches of the inferior alveolar nerve (or artery), rather than alveoli homologous with those of other mammals. As a functional explanation, we propose that these branches provide sensation to the dorsal margin of the mandible to facilitate placement and occlusion of the baleen plates during filer feeding.	[Peredo, Carlos Mauricio] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA; [Peredo, Carlos Mauricio; Pyenson, Nicholas D.] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; [Uhen, Mark D.] George Mason Univ, Dept Atmospher Ocean & Earth Sci, Fairfax, VA 22030 USA; [Marshall, Christopher D.] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Marshall, Christopher D.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, Galveston, TX USA	George Mason University; Smithsonian Institution; Smithsonian National Museum of Natural History; George Mason University; Texas A&M University System; Texas A&M University System	Peredo, CM (corresponding author), George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA.; Peredo, CM (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA.	CPeredo@masonlive.gmu.edu	Uhen, Mark D/AAZ-3158-2020; Marshall, Christopher/AAF-9097-2019	Uhen, Mark D/0000-0002-2689-0801; Peredo, Carlos/0000-0002-7217-9850; Pyenson, Nicholas/0000-0003-4678-5782	Smithsonian Institution; NMNH Remington Kellogg Fund; Basis Foundation	Smithsonian Institution(Smithsonian Institution); NMNH Remington Kellogg Fund; Basis Foundation	CMP and NDP were supported by the Smithsonian Institution and the NMNH Remington Kellogg Fund (http://www.mnh.si.edu), and NDP was supported by the Basis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON L C, 1991, Journal of Oral Implantology, V17, P394; Boessenecker RW, 2015, ZOOL J LINN SOC-LOND, V175, P607, DOI 10.1111/zoj.12297; Boessenecker RW, 2015, PEERJ, V3, DOI 10.7717/peerj.1129; Cade DE, 2016, CURR BIOL, V26, P2617, DOI 10.1016/j.cub.2016.07.037; CARTER RB, 1971, J ANAT, V108, P433; CAWOOD JI, 1988, INT J ORAL MAX SURG, V17, P232, DOI 10.1016/S0901-5027(88)80047-X; DENIO D, 1992, J ENDODONT, V18, P161, DOI 10.1016/S0099-2399(06)81411-1; Domning DP., 1978, U CALIFORNIA PUBLICA, V118, P1; Drake R. L., 2010, GRAYS ANATOMY STUDEN; Emry RJ, 2004, B AM MUS NAT HIST, P130; Endo H, 2007, ZOOL SCI, V24, P1005, DOI 10.2108/zsj.24.1005; Evans H.E., 2013, MILLERS ANATOMY DOG; Field DJ, 2010, ANAT REC, V293, P1240, DOI 10.1002/ar.21165; Fitzgerald EMG, 2012, BIOL LETTERS, V8, P94, DOI 10.1098/rsbl.2011.0690; FRASER F. C., 1960, BULL BRIT MUS [NAT HIST] ZOOL, V7, P1; Gingerich Philip D., 1995, Contributions from the Museum of Paleontology University of Michigan, V29, P291; Gingerich Philip D., 1995, Contributions from the Museum of Paleontology University of Michigan, V29, P331; Goldbogen JA, 2010, AM SCI, V98, P124, DOI 10.1511/2010.83.124; Hall B, 1994, HOMOLOGY HIERARCHIAL; Hall BK, 2003, BIOL REV, V78, P409, DOI 10.1017/S1464793102006097; Hassani A, 2013, TXB ADV ORAL MAXILLO; Herring SW, 2001, COMP BIOCHEM PHYS A, V131, P207, DOI 10.1016/S1095-6433(01)00472-X; HERRING SW, 1993, AM ZOOL, V33, P289; Holliday CM, 2007, J MORPHOL, V268, P457, DOI 10.1002/jmor.10524; Huang SL, 2009, MAR MAMMAL SCI, V25, P875, DOI 10.1111/j.1748-7692.2009.00288.x; ISHIKAWA H, 1995, J VET MED SCI, V57, P665, DOI 10.1292/jvms.57.665; Ishikawa H, 1999, J VET MED SCI, V61, P227, DOI 10.1292/jvms.61.227; Karlsen K., 1962, Hvalradets Skrifter, VNo. 45, P1; Kellogg R., 1968, US NATL MUSEUM B, V247, P103; Kieser J, 2005, J CRANIOFAC SURG, V16, P6, DOI 10.1097/00001665-200501000-00003; Lyson TR, 2013, EVOL DEV, V15, P317, DOI 10.1111/ede.12041; Marks SC, 1996, ANAT RECORD, V245, P374, DOI 10.1002/(SICI)1097-0185(199606)245:2<374::AID-AR18>3.0.CO;2-M; Marshall CD, 2015, MARINE MAMMAL PHYSL, P95; Marx F.G., 2016, CETACEAN PALEOBIOLOG; May NDS, 1964, ANATOMY SHEEP; Mead James G., 2009, Smithsonian Contributions to Zoology, P1; Meredith RW, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-20; Naples VL, 1999, J ZOOL, V249, P19; Norris K.S., 1980, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V28, P495; Okazaki Yoshihiko, 2012, Bulletin of the Kitakyushu Museum of Natural History and Human History Series A Natural History, P129; PACKARD EARL L., 1934, CARNEGIE INST WASHINGTON PUBL, V447, P1; Pinto SJD, 2013, J MORPHOL, V274, P947, DOI 10.1002/jmor.20154; Pyenson ND, 2013, BIOL J LINN SOC, V108, P586, DOI 10.1111/j.1095-8312.2012.02032.x; Pyenson ND, 2012, NATURE, V485, P498, DOI 10.1038/nature11135; Ridgway SH, 2009, ENCYCL NEUROSCI, V4, P1031, DOI [10.1016/B978-008045046-9.00263-1, DOI 10.1016/B978-008045046-9.00263-1]; Saint-Hilaire G., 1807, ANN MUS HIST NAT, V10, P342; Sisson S, 1953, ANATOMY DOMESTIC ANI, V3; Thewissen JGM, 2017, J ANAT, V230, P549, DOI 10.1111/joa.12579; Uhen MD., 2004, U MICHIGAN PAP PALEO, V34, P1; ULM CW, 1993, BRIT J ORAL MAX SURG, V31, P370, DOI 10.1016/0266-4356(93)90193-Z; Ulm CW, 1997, CLIN ORAL IMPLAN RES, V8, P125, DOI 10.1034/j.1600-0501.1997.080207.x; Vickaryous MK, 2006, J ANAT, V208, P263, DOI 10.1111/j.1469-7580.2006.00542.x; Werth AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150106; Yeh K, 2010, ARCH ORAL BIOL, V55, P663, DOI 10.1016/j.archoralbio.2010.05.014	54	10	11	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178243	10.1371/journal.pone.0178243	http://dx.doi.org/10.1371/journal.pone.0178243			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542468	Green Published, gold			2022-12-26	WOS:000401672600048
J	Ysasi, AB; Wagner, WL; Valenzuela, CD; Kienzle, A; Servais, AB; Bennett, RD; Tsuda, A; Ackermann, M; Mentzer, SJ				Ysasi, Alexandra B.; Wagner, Willi L.; Valenzuela, Cristian D.; Kienzle, Arne; Servais, Andrew B.; Bennett, Robert D.; Tsuda, Akira; Ackermann, Maximilian; Mentzer, Steven J.			Evidence for pleural epithelial-mesenchymal transition in murine compensatory lung growth	PLOS ONE			English	Article							SMOOTH-MUSCLE; PNEUMONECTOMY; MECHANISMS; CELLS; ANGIOGENESIS; INGRESSION; EXPRESSION; CYTOMETRY; MICE; FLOW	In many mammals, including rodents and humans, removal of one lung results in the compensatory growth of the remaining lung; however, the mechanism of compensatory lung growth is unknown. Here, we investigated the changes in morphology and phenotype of pleural cells after pneumonectomy. Between days 1 and 3 after pneumonectomy, cells expressing alpha-smooth muscle actin (SMA), a cytoplasmic marker of myofibroblasts, were significantly increased in the pleura compared to surgical controls (p < .01). Scanning electron microscopy of the pleural surface 3 days post-pneumonectomy demonstrated regions of the pleura with morphologic features consistent with epithelial-mesenchymal transition (EMT); namely, cells with disrupted intercellular junctions and an acquired mesenchymal (rounded and fusiform) morphotype. To detect the migration of the transitional pleural cells into the lung, a biotin tracer was used to label the pleural mesothelial cells at the time of surgery. By post-operative day 3, image cytometry of post-pneumonectomy subpleural alveoli demonstrated a 40-fold increase in biotin(+) cells relative to pneumonectomy-plus-plombage controls (p < .01). Suggesting a similar origin in space and time, the distribution of cells expressing biotin, SMA, or vimentin demonstrated a strong spatial autocorrelation in the subpleural lung (p < .001). We conclude that post-pneumonectomy compensatory lung growth involves EMT with the migration of transitional mesothelial cells into subpleural alveoli.	[Ysasi, Alexandra B.; Wagner, Willi L.; Valenzuela, Cristian D.; Kienzle, Arne; Servais, Andrew B.; Bennett, Robert D.; Mentzer, Steven J.] Harvard Med Sch, Brigham & Womens Hosp, Lab Adapt & Regenerat Biol, Boston, MA 02115 USA; [Wagner, Willi L.; Ackermann, Maximilian] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Funct & Clin Anat, Mainz, Germany; [Tsuda, Akira] Harvard Sch Publ Hlth, Mol & Integrat Physiol Sci, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Johannes Gutenberg University of Mainz; Harvard University; Harvard T.H. Chan School of Public Health	Mentzer, SJ (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Lab Adapt & Regenerat Biol, Boston, MA 02115 USA.	smentzer@bwh.harvard.edu	Kienzle, Arne/AAN-3260-2021; Bennett, Robert/AAW-6353-2021	Ysasi, Alexandra/0000-0002-2932-870X; Valenzuela, Cristian/0000-0002-8694-9174; Kienzle, Arne/0000-0002-4556-2993	NIH [HL94567, HL134229, HL007734, CA009535, ES000002]; German Research Foundation [SFB1066]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007734, R56HL136476] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported in part by NIH Grant HL94567, HL134229, HL007734, CA009535, ES000002 and the German Research Foundation (SFB1066). There was no additional external funding received for this study	ABDI K, 1993, ELECTROPHORESIS, V14, P73, DOI 10.1002/elps.1150140113; Ackermann M, 2014, ANGIOGENESIS, V17, P541, DOI 10.1007/s10456-013-9399-9; ANDREWS PM, 1973, ANAT RECORD, V177, P409, DOI 10.1002/ar.1091770307; Bennett RA, 2016, AM J PHYSIOL, V312, pL79; Butler JP, 2012, NEW ENGL J MED, V367, P244, DOI 10.1056/NEJMoa1203983; DEAN PN, 1990, CYTOMETRY, V11, P321, DOI 10.1002/cyto.990110302; Dickie R, 2007, J MORPHOL, V268, P1067; Ding L, 2011, METHODS MOL BIOL, V762, P91, DOI 10.1007/978-1-61779-185-7_7; Fehrenbach H, 2008, EUR RESPIR J, V31, P515, DOI 10.1183/09031936.00109407; Filipovic N, 2014, COMPUT METHOD BIOMEC, V17, P838, DOI 10.1080/10255842.2012.719606; Filipovic N, 2013, J APPL PHYSIOL, V115, P1370, DOI 10.1152/japplphysiol.00635.2013; FINK RD, 1985, DEV BIOL, V107, P66, DOI 10.1016/0012-1606(85)90376-8; Gibney BC, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-48; Gibney BC, 2012, EXP LUNG RES, V38, P396, DOI 10.3109/01902148.2012.715364; Gibney BC, 2011, EXP LUNG RES, V37, P301, DOI 10.3109/01902148.2011.561399; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hsia CCW, 2004, AM J RESP CRIT CARE, V170, P319, DOI 10.1164/rccm.200209-1062ST; Konerding MA, 2012, ANGIOGENESIS, V15, P23, DOI 10.1007/s10456-011-9236-y; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lin M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-98; Minot C-S, 1890, AM NAT, V24, P877; Mund SI, 2008, DEV DYNAM, V237, P2108, DOI 10.1002/dvdy.21633; Ravnic DJ, 2007, MICROSC RES TECHNIQ, V70, P776, DOI 10.1002/jemt.20463; Rutkowski JM, 2007, TRENDS CELL BIOL, V17, P44, DOI 10.1016/j.tcb.2006.11.007; SANTISTEBAN MS, 1992, J HISTOCHEM CYTOCHEM, V40, P1789, DOI 10.1177/40.11.1431064; Schechtman AM, 1935, P SOC EXP BIOL MED, V32, P1072; Schechtman AM, 1934, UNIPOLAR INGRESS IN; Voswinckel R, 2004, EUR RESPIR J, V24, P524, DOI 10.1183/09031936.04.10004904; WILSON TA, 1982, J APPL PHYSIOL, V52, P1064, DOI 10.1152/jappl.1982.52.4.1064; Yamada M, 2005, J HISTOCHEM CYTOCHEM, V53, P735, DOI 10.1369/jhc.4A6483.2005; Yamada T, 2002, ARCH HISTOL CYTOL, V65, P55, DOI 10.1679/aohc.65.55; Ysasi AB, 2015, AM J PHYSIOL-LUNG C, V308, pL1237, DOI 10.1152/ajplung.00042.2015; Ysasi AB, 2013, AM J PHYSIOL-LUNG C, V305, pL439, DOI 10.1152/ajplung.00134.2013	33	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177921	10.1371/journal.pone.0177921	http://dx.doi.org/10.1371/journal.pone.0177921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542402	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672600031
J	Shioda, M; Muneta, T; Tsuji, K; Mizuno, M; Komori, K; Koga, H; Sekiya, I				Shioda, Mikio; Muneta, Takeshi; Tsuji, Kunikazu; Mizuno, Mitsuru; Komori, Keiichiro; Koga, Hideyuki; Sekiya, Ichiro			TNFa promotes proliferation of human synovial MSCs while maintaining chondrogenic potential	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; NF-KAPPA-B; IN-VITRO CHONDROGENESIS; BONE-MARROW; MENISCAL REGENERATION; CARTILAGE FORMATION; CAUSES NECROSIS; ADIPOSE-TISSUE; STROMAL CELLS; SERUM FACTOR	Synovial mesenchymal stem cells (MSCs) are a candidate cell source for cartilage and meniscus regeneration. If we can proliferate synovial MSCs more effectively, we can expand clinical applications to patients with large cartilage and meniscus lesions. TNFa is a pleiotropic cytokine that can affect the growth and differentiation of cells in the body. The purpose of this study was to examine the effect of TNFa on proliferation, chondrogenesis, and other properties of human synovial MSCs. Passage 1 human synovial MSCs from 2 donors were cultured with 2.5 x 10(-12) similar to 10(-7) g/ml, 10 fold dilution series of TNFa for 14 days, then the cell number and colony number was counted. The effect of the optimum dose of TNFa on proliferation was also examined in synovial MSCs from 6 donors. Chondrogenic potential of synovial MSCs pretreated with TNFa was evaluated in 6 donors. The expressions of 12 surface antigens were also examined in 3 donors. 2.5 ng/ml and higher concentration of TNFa significantly increased cell number/dish and cell number/colony in both donors. The effect of 25 ng/ml TNFa was confirmed in all 6 donors. There was no significant difference in the weight, or amount of glycosaminoglycan and DNA of the cartilage pellets between the MSCs untreated and MSCs pretreated with 25 ng/ml TNFa. TNFa decreased expression rate of CD 105 and 140b in all 3 donors. TNFa promoted proliferation of synovial MSCs with increase of cell number/colony. Pretreatment with TNFa did not affect chondrogenesis of synovial MSCs. However, TNFa affected some properties of synovial MSCs.	[Shioda, Mikio; Muneta, Takeshi; Koga, Hideyuki] Tokyo Med & Dent Univ, Grad Sch Med, Dept Joint Surg & Sports Med, Tokyo, Japan; [Tsuji, Kunikazu] Tokyo Med & Dent Univ, Grad Sch Med, Dept Cartilage Regenerat, Tokyo, Japan; [Mizuno, Mitsuru; Komori, Keiichiro; Sekiya, Ichiro] Tokyo Med & Dent Univ, Ctr Stem Cell & Regenerat Med, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Sekiya, I (corresponding author), Tokyo Med & Dent Univ, Ctr Stem Cell & Regenerat Med, Tokyo, Japan.	sekiya.arm@tmd.ac.jp	Tsuji, Kunikazu/HDM-9242-2022; Mitsuru, Mizuno/K-3962-2017; Koga, Hideyuki/B-2448-2019	Tsuji, Kunikazu/0000-0002-1013-8359; Mitsuru, Mizuno/0000-0002-4410-3621; Koga, Hideyuki/0000-0003-4574-1796; Muneta, Takeshi/0000-0003-1018-2939	JSPS KAKENHI [JP16K20039]; Japan Agency for Medical Research and Development [122011A182]; Japan Society for the promotion of Science [15K10464]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by JSPS KAKENHI grant number JP16K20039, Japan Agency for Medical Research and Development #122011A182, and Japan Society for the promotion of Science #15K10464. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2014, RHEUMATOLOGY, V53, P165, DOI 10.1093/rheumatology/ket334; Aggarwal BB, 1996, EUR CYTOKINE NETW, V7, P93; Bargou RC, 1997, J CLIN INVEST, V100, P2961, DOI 10.1172/JCI119849; BERTOLINI DR, 1986, NATURE, V319, P516, DOI 10.1038/319516a0; Bocker WG, 2008, J MOL MED, V86, P1183, DOI 10.1007/s00109-008-0378-3; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Casnici C, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/702057; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fan WS, 2016, BIOCHEM BIOPH RES CO, V474, P338, DOI 10.1016/j.bbrc.2016.04.101; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; GREEN S, 1976, P NATL ACAD SCI USA, V73, P381, DOI 10.1073/pnas.73.2.381; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hatsushika D, 2014, OSTEOARTHR CARTILAGE, V22, P941, DOI 10.1016/j.joca.2014.04.028; Hatsushika D, 2013, J ORTHOP RES, V31, P1354, DOI 10.1002/jor.22370; Horie M, 2009, STEM CELLS, V27, P878, DOI 10.1634/stemcells.2008-0616; Ichinose S, 2010, LAB INVEST, V90, P210, DOI 10.1038/labinvest.2009.125; Jagielski M, 2014, INT J MOL SCI, V15, P15821, DOI 10.3390/ijms150915821; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Koga H, 2008, CELL TISSUE RES, V333, P207, DOI 10.1007/s00441-008-0633-5; Kondo S, 2016, J ORTHOPAEDIC RES OF; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin CS, 2010, HISTOL HISTOPATHOL, V25, P807, DOI 10.14670/HH-25.807; Nagase T, 2008, ARTHRITIS RHEUM, V58, P1389, DOI 10.1002/art.23418; Nair S, 2011, REPROD SCI, V18, P1186, DOI 10.1177/1933719111408111; Nimura A, 2008, ARTHRITIS RHEUM, V58, P501, DOI 10.1002/art.23219; Redlich K, 2002, J CLIN INVEST, V110, P1419, DOI 10.1172/JCI200215582; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Segawa Y, 2009, J ORTHOP RES, V27, P435, DOI 10.1002/jor.20786; Sekiya I, 2005, CELL TISSUE RES, V320, P269, DOI 10.1007/s00441-004-1075-3; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Sekiya I, 2001, BIOCHEM BIOPH RES CO, V284, P411, DOI 10.1006/bbrc.2001.4898; Sekiya I, 2015, CLIN ORTHOP RELAT R, V473, P2316, DOI 10.1007/s11999-015-4324-8; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Shirasawa S, 2006, J CELL BIOCHEM, V97, P84, DOI 10.1002/jcb.20546; Sousa BR, 2014, CYTOM PART A, V85A, P43, DOI 10.1002/cyto.a.22402; Suzuki S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3869; Venkatachalam K, 2009, J BIOL CHEM, V284, P14414, DOI 10.1074/jbc.M809757200; Wehling N, 2009, ARTHRITIS RHEUM-US, V60, P801, DOI 10.1002/art.24352; Widera D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-64; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z	43	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177771	10.1371/journal.pone.0177771	http://dx.doi.org/10.1371/journal.pone.0177771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542363	gold, Green Submitted, Green Published			2022-12-26	WOS:000401672400081
J	Song, Y; Wang, YBN; Mao, WF; Sui, HX; Yong, L; Yang, DJ; Jiang, DG; Zhang, L; Gong, YY				Song, Yan; Wang, Yibana; Mao, Weifeng; Sui, Haixia; Yong, Ling; Yang, Dajin; Jiang, Dingguo; Zhang, Lei; Gong, Yunyun			Dietary cadmium exposure assessment among the Chinese population	PLOS ONE			English	Article							RISK-ASSESSMENT; CANCER; ELEMENTS; FOOD	Cadmium, a toxic heavy metal, is widely present in food. It has been reported that chronic cadmium exposure is associated with kidney disease, osteoporosis, cardiovascular disease and cancer. The aim of this study was to assess the dietary cadmium exposure and potential health risk in different age-sex groups of the Chinese population (children aged 4-11 years, young people aged 12-17 years and adults aged over 18 years), and in the southern and northern population using a semi-probabilistic method. Cadmium was detected in 228,687 food samples from 32 food categrories by graphite furnace atomic absorption spectrometry. The dietary cadmium exposures were estimated by combining the cadmium concentration data with food consumption data derived from the China National Nutrient and Health Survey 2002, and evaluated against the Provisional Tolerable Monthly Intake (PTMI) of 25 mu g/kg BW/month established by the Joint FAO/WHO expert committee on food additives (JECFA). The mean dietary cadmium exposure of the general Chinese population (15.3 mu g/kg BW/month) was below the PTMI. The high consumer exposures (95(th) percentile, P95) for the general population and different sub-groups were higher than the PTMI. The dietary cadmium exposure of the southern population was apparently higher than that of the northern population. Rice was the most important contributor to cadmium exposure for Chinese people, especially those living in the southern areas of China. These findings indicated that the health risk from dietary cadmium exposure of the general Chinese people was low, but the health risk of cadmium exposure of certain sub-groups should be of concern.	[Song, Yan; Wang, Yibana; Mao, Weifeng; Sui, Haixia; Yong, Ling; Yang, Dajin; Jiang, Dingguo; Zhang, Lei] China Natl Ctr Food Safety Risk Assessment, Natl Hlth & Family Planning Commiss Peoples Repub, Key Lab Food Safety Risk Assessment, Beijing, Peoples R China; [Gong, Yunyun] Univ Leeds, Leeds, W Yorkshire, England	University of Leeds	Zhang, L (corresponding author), China Natl Ctr Food Safety Risk Assessment, Natl Hlth & Family Planning Commiss Peoples Repub, Key Lab Food Safety Risk Assessment, Beijing, Peoples R China.	zhanglei@cfsa.net.cn	Gong, Yun Yun/L-7094-2016; Gong, Yun Yun/C-8412-2018	Gong, Yun Yun/0000-0003-4927-5526; Gong, Yun Yun/0000-0003-4927-5526; Yang, Dajin/0000-0001-7032-5642; Zhang, Lei/0000-0003-0936-4356	Testing Technology of Safety and Standards of Traditional Chinese medicine [2014ZX09304307]; China Agro-scientific Research in the Public Interest [200903054-06]	Testing Technology of Safety and Standards of Traditional Chinese medicine; China Agro-scientific Research in the Public Interest	This work was partially supported by Special Fund for Testing Technology of Safety and Standards of Traditional Chinese medicine (2014ZX09304307) and China Agro-scientific Research in the Public Interest (200903054-06).	Akesson A, 2008, CANCER RES, V68, P6435, DOI 10.1158/0008-5472.CAN-08-0329; Al-Rmalli SW, 2012, J FOOD SCI, V77, pT26, DOI 10.1111/j.1750-3841.2011.02467.x; [Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.980; ATSDR (Agency for Toxic Substances and Disease Registry), 2008, TOX PROF CA IN PRESS; Bampidis V. A., 2013, Scientific Papers: Animal Science and Biotechnologies, V46, P17; Chen J, 1997, Wei Sheng Yan Jiu, V26, P199; CHEN JS, 1993, J AOAC INT, V76, P1193; Chen L, 2006, TOXICOL APPL PHARM, V215, P93, DOI 10.1016/j.taap.2006.01.013; Chunhabundit R, 2016, TOXICOL RES-GER, V32, P65, DOI 10.5487/TR.2016.32.1.065; EC, 1997, REP SCI COMM FOOD, P67; *EUR FOOD SAF AUTH, 2012, EFSA J; European Food Safety Authorities, 2005, EFSA J, V241, P1, DOI [DOI 10.2903/J.EFSA.2005.241, DOI 10.2903/J.EFSA.2004.84]; European Food Safety Authority, 2012, EFSA J, V10, DOI [10.2903/j.efsa.2012.2551, 10.2903/j.efsa.2012.2831]; FAO/ WHO, 1989, WHO TECHN REP SER, V776; FAO/ WHO, 2001, WHO TECHN REP SER, V901; FAO/WHO, 2011, WHO TECHN REP SER, V960; Gao Jun-quan, 2006, Wei Sheng Yan Jiu, V35, P750; Huang Y, 2014, BIOMED ENVIRON SCI, V27, P819, DOI 10.3967/bes2014.119; Huff J, 2007, INT J OCCUP ENV HEAL, V13, P202, DOI 10.1179/oeh.2007.13.2.202; Il'yasova D, 2005, TOXICOL APPL PHARM, V207, P179, DOI 10.1016/j.taap.2004.12.005; International Agency for Research on Cancer (IARC), 1993, IARC MON EV CARC RIS, V58; Kazantzis G, 2004, BIOMETALS, V17, P493, DOI 10.1023/B:BIOM.0000045727.76054.f3; Kellen E, 2007, CANCER DETECT PREV, V31, P77, DOI 10.1016/j.cdp.2006.12.001; Kim M, 2011, FOOD ADDIT CONTAM A, V28, P62, DOI 10.1080/19440049.2010.529620; KJELLSTROM T, 1978, ENVIRON RES, V16, P248, DOI 10.1016/0013-9351(78)90160-3; Marcussen H, 2013, ASIA PAC J CLIN NUTR, V22, P300, DOI 10.6133/apjcn.2013.22.2.06; McElroy JA, 2006, JNCI-J NATL CANCER I, V98, P869, DOI 10.1093/jnci/djj233; Moschandreas DJ, 2002, J EXPO ANAL ENV EPID, V12, P233, DOI 10.1038/sj.jea.7500230; Nasreddine L, 2010, FOOD CHEM TOXICOL, V48, P1262, DOI 10.1016/j.fct.2010.02.020; Nawrot T, 2006, LANCET ONCOL, V7, P119, DOI 10.1016/S1470-2045(06)70545-9; Nordberg G, 2002, AMBIO, V31, P478, DOI 10.1639/0044-7447(2002)031[0478:LBDARD]2.0.CO;2; Nordberg GF, 1985, EXPOSURE DOSE METABO, V1; Ohno K, 2010, WATER SCI TECHNOL, V62, P2694, DOI 10.2166/wst.2010.392; Satarug S, 2013, ENVIRON HEALTH PERSP, V121, P531, DOI 10.1289/ehp.1104769; Sioen I, 2012, ENVIRON INT, V48, P102, DOI 10.1016/j.envint.2012.07.004; Thomas LDK, 2011, J BONE MINER RES, V26, P1601, DOI 10.1002/jbmr.386; U. S. Geological Survey, 2015, MIN COMM SUMM 2015, P36; United Nations Environment Programme, 2010, FIN REV SCI INF CADM, P87; Vinceti M, 2007, SCI TOTAL ENVIRON, V373, P77, DOI 10.1016/j.scitotenv.2006.11.005; World Health Organization (WHO), 1995, WORKSH FRAM GEMS FOO; Wu HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29989; Yuan XP, 2014, J SCI FOOD AGR, V94, P373, DOI 10.1002/jsfa.6394; [詹杰 Zhan Jie], 2012, [农业环境科学学报, Journal of Agro-Environment Science], V31, P1257; Zhang L, 2016, BIOMED ENVIRON SCI, V29, P365, DOI 10.3967/bes2016.047	44	169	193	29	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177978	10.1371/journal.pone.0177978	http://dx.doi.org/10.1371/journal.pone.0177978			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542445	gold, Green Published, Green Submitted			2022-12-26	WOS:000401672400124
J	Yin, SL; Kleijn, D; Muskens, GJDM; Fouchier, RAM; Verhagen, JH; Glazov, PM; Si, YL; Prins, HHT; de Boer, WF				Yin, Shenglai; Kleijn, David; Muskens, Gerard J. D. M.; Fouchier, Ron A. M.; Verhagen, Josanne H.; Glazov, Petr M.; Si, Yali; Prins, Herbert H. T.; de Boer, Willem Frederik			No evidence that migratory geese disperse avian influenza viruses from breeding to wintering ground	PLOS ONE			English	Article							A VIRUS; BODY CONDITION; WILD BIRDS; H5N1 VIRUS; INFECTION; SURVEILLANCE; DYNAMICS; PATTERNS; SPREAD; DUCKS	Low pathogenic avian influenza virus can mutate to a highly pathogenic strain that causes severe clinical signs in birds and humans. Migratory waterfowl, especially ducks, are considered the main hosts of low pathogenic avian influenza virus, but the role of geese in dispersing the virus over long-distances is still unclear. We collected throat and cloaca samples from three goose species, Bean goose (Anser fabalis), Barnacle goose (Branta leucopsis) and Greater white-fronted goose (Anser albifrons), from their breeding grounds, spring stopover sites, and wintering grounds. We tested if the geese were infected with low pathogenic avian influenza virus outside of their wintering grounds, and analysed the spatial and temporal patterns of infection prevalence on their wintering grounds. Our results show that geese were not infected before their arrival on wintering grounds. Barnacle geese and Greater white-fronted geese had low prevalence of infection just after their arrival on wintering grounds in the Netherlands, but the prevalence increased in successive months, and peaked after December. This suggests that migratory geese are exposed to the virus after their arrival on wintering grounds, indicating that migratory geese might not disperse low pathogenic avian influenza virus during autumn migration.	[Yin, Shenglai; Si, Yali; Prins, Herbert H. T.; de Boer, Willem Frederik] Wageningen Univ & Res, Resource Ecol Grp, Wageningen, Netherlands; [Kleijn, David] Wageningen Univ & Res, Plant Ecol & Nat Conservat Grp, Wageningen, Netherlands; [Muskens, Gerard J. D. M.] Wageningen Univ & Res, Alterra, Ctr Ecosyst Studies, Wageningen, Netherlands; [Fouchier, Ron A. M.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Verhagen, Josanne H.] Linnaeus Univ, Dept Biol & Environm Sci, Kalmar, Sweden; [Glazov, Petr M.] Russian Acad Sci, Inst Geog, Lab Biogeog, Moscow, Russia; [Si, Yali] Tsinghua Univ, Minist Educ, Key Lab Earth Syst Modelling, Beijing, Peoples R China; [Si, Yali] Tsinghua Univ, Dept Earth Syst Sci, Beijing, Peoples R China	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Erasmus University Rotterdam; Erasmus MC; Linnaeus University; Institute of Geography, Russian Academy of Sciences; Russian Academy of Sciences; Tsinghua University; Tsinghua University	Yin, SL; de Boer, WF (corresponding author), Wageningen Univ & Res, Resource Ecol Grp, Wageningen, Netherlands.	shenglai.yin@wur.nl; fred.deboer@wur.nl	Yin, Shenglai/GVU-1617-2022; Si, Yali/B-3573-2012; Kleijn, David/HCH-3477-2022; Glazov, Petr/AAE-4780-2019; Fouchier, Ron A/A-1911-2014	Si, Yali/0000-0001-7107-9850; Glazov, Petr/0000-0003-3462-7031; Fouchier, Ron A/0000-0001-8095-2869; Kleijn, David/0000-0003-2500-7164; Verhagen, Josanne/0000-0003-3133-5228; Prins, Herbert/0000-0003-1131-5107	Dutch Ministry of Agriculture, Nature Conservation and Food Quality [BO-10-003-002, 2001126]; Ph.D. scholarship [201406190178]; Dutch Ministry of Economic Affairs, European Research Council project FLUPLAN [250136]; NIAID/NIH [HHSN272201400008C]	Dutch Ministry of Agriculture, Nature Conservation and Food Quality; Ph.D. scholarship; Dutch Ministry of Economic Affairs, European Research Council project FLUPLAN; NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was carried out in the framework of the projects 'Flyway conservation of migratory waterbirds', BO-10-003-002, and Vooltetting monitoring ganzen en Smienten ivm het voorkomen van vogelgriepvirussen in 2008/2009', Verpl. Nr. 2001126, funded by the Dutch Ministry of Agriculture, Nature Conservation and Food Quality. The study is supported by a Ph.D. scholarship to Shenglai Yin from the Chinese Scholarship Council (Nr. 201406190178), and by the Dutch Ministry of Economic Affairs, European Research Council project FLUPLAN [250136] and NIAID/NIH contract HHSN272201400008C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Andrea K, 2016, OIKOS, V125, P1496; AP, 2007, P R SOC, P274; Bradley CA, 2005, ECOL LETT, V8, P290, DOI 10.1111/j.1461-0248.2005.00722.x; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Burthe S, 2008, J ANIM ECOL, V77, P110, DOI 10.1111/j.1365-2656.2007.01302.x; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; de Crespigny FEC, 2006, P ROY SOC B-BIOL SCI, V273, P1455, DOI 10.1098/rspb.2006.3478; Delany S., 2009, BRIT BIRDS, V102, P639; Gaidet N, 2011, P R SOC, V279; Gilbert M, 2006, EMERG INFECT DIS, V12, P1650, DOI 10.3201/eid1211.060223; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Hornman M., 2013, WATERVOGELS NEDERLAN; Hornman M, 2015, WATERVOGELS NEDERLAN; Hoye BJ, 2011, OIKOS, V120, P748, DOI 10.1111/j.1600-0706.2010.18961.x; Jonassen CM, 2007, AVIAN DIS, V51, P425, DOI 10.1637/7555-033106R1.1; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; KIDA H, 1980, INFECT IMMUN, V30, P547; Kleijn D, 2010, P R SOC, V277; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P2347, DOI 10.1098/rspb.2009.0275; Lewis NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058534; Madsen J., 1999, GOOSE POPULATIONS W; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Munster VJ, 2009, J CLIN MICROBIOL, V47, P666, DOI 10.1128/JCM.01625-08; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pasick J, 2007, EMERG INFECT DIS, V13, P1821, DOI 10.3201/eid1312.070502; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Samuel MD, 2015, ECOL APPL, V25, P1851, DOI 10.1890/14-1820.1; Scheper J, 2014, P NATL ACAD SCI USA, V111, P17552, DOI 10.1073/pnas.1412973111; Schulte-Hostedde AI, 2001, CAN J ZOOL, V79, P1021, DOI 10.1139/cjz-79-6-1021; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Team RC, 2014, LANG ENV STAT COMP; van Dijk JGB, 2015, OIKOS, V124, P1293, DOI 10.1111/oik.01836; van Dijk JGB, 2015, ECOL EVOL, V5, P436, DOI 10.1002/ece3.1359; Verhagen JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112366; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Wang RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028873; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2013, CUM NUMB CONF HUM CA; World Health Organization, 2013, H5N1 HIGHL PATH AV I; World Organization for Animal Health, 2017, UPD HIGHL PATH AV IN	43	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177790	10.1371/journal.pone.0177790	http://dx.doi.org/10.1371/journal.pone.0177790			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542340	gold, Green Published, Green Submitted			2022-12-26	WOS:000401672400083
J	Castro, ACMCE; Barbosa, NCCP				Morales-Correa e Castro, Adriana C.; Chiarini Pena Barbosa, Nara Cristina			Recent evolutionary history of Chrysoperla externa (Hagen 1861) (Neuroptera: Chrysopidae) in Brazil	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; GENETIC-STRUCTURE; OUTGROUP SELECTION; MITOCHONDRIAL GENE; PHYLOGEOGRAPHY; INFERENCE; SOFTWARE; NEUTRALITY; SEQUENCES	This work aimed to elucidate the distribution of Chrysoperla externa haplotypes and investigate whether it exhibits structure based on genetic composition as opposed to geographic location. The genetic diversity of C. externa, analyzed by AMOVA using the COI and 16S rRNA genes as mitochondrial markers, showed significant haplotype structure arising from genetic differences that was not associated with sampling location. This was reflected in the network grouping. Bayesian inference showed that haplotype distribution may have its origins in C. externa divergence into two distinct clades, which dispersed to various locations, and their subsequent diversification. The evolutionary history of C. externa may include multiple ancestral haplotypes differentiating within the same geographic area to generate the current broad genetic diversity, so that the earlier geographical history has been erased, and now we have highlighted its more recent genetic history.	[Morales-Correa e Castro, Adriana C.; Chiarini Pena Barbosa, Nara Cristina] Univ Estadual Paulista, Inst Biociencias Letras & Ciencias Exatas, Dept Biol, Programa Posgrad Biociencias, Sao Jose Do Rio Preto, SP, Brazil; [Morales-Correa e Castro, Adriana C.] Univ Estadual Paulista, Fac Ciencias Agrarias & Veterinarias, Dept Biol Aplicada Agropecuaria, Jaboticabal, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Castro, ACMCE (corresponding author), Univ Estadual Paulista, Inst Biociencias Letras & Ciencias Exatas, Dept Biol, Programa Posgrad Biociencias, Sao Jose Do Rio Preto, SP, Brazil.; Castro, ACMCE (corresponding author), Univ Estadual Paulista, Fac Ciencias Agrarias & Veterinarias, Dept Biol Aplicada Agropecuaria, Jaboticabal, SP, Brazil.	dri_morales@fcav.unesp.br		Coletto Morales, Adriana/0000-0002-2108-427X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Programa Taxonomia [150150/2007-5]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Programa Taxonomia	ACMCC received support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Programa Taxonomia (150150/2007-5). NCCPB received support from Conselho Nacional de Desenvolvimento Cientffico e Tecnologico-(grant to master degree).	ALBUQUERQUE GS, 1994, BIOL CONTROL, V4, P8, DOI 10.1006/bcon.1994.1002; Barbosa NCCP, 2014, REV BRAS ENTOMOL, V58, P203, DOI 10.1590/S0085-56262014000200012; Brooks S.J., 1990, Bulletin of the British Museum (Natural History) Entomology, V59, P117; Brooks S.J., 1994, Bulletin of the Natural History Museum Entomology Series, V63, P137; Canestrelli D, 2014, SCI REP-UK, V4, DOI 10.1038/srep05042; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Vinas MD, 2015, J EXP MAR BIOL ECOL, V468, P97, DOI 10.1016/j.jembe.2015.03.012; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Ferreri M, 2011, AFR J BIOTECHNOL, V10, P12799; Finn DS, 2007, FRESHWATER BIOL, V52, P1881, DOI 10.1111/j.1365-2427.2007.01813.x; Fu YX, 1997, GENETICS, V147, P915; Godoy JA, 2004, MOL ECOL, V13, P371, DOI 10.1046/j.1365-294X.2003.02075.x; Grazziotin FG, 2006, MOL ECOL, V15, P3969, DOI 10.1111/j.1365-294X.2006.03057.x; Hartl D.L., 2010, PRINCIPIOS GENETICA, V4; Horn A, 2006, MOL ECOL, V15, P1603, DOI 10.1111/j.1365-294X.2006.02872.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Lavagnini TC, 2015, BRAZ J BIOL, V75, P878, DOI 10.1590/1519-6984.02014; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Luo A-Rong, 2010, Acta Entomologica Sinica, V53, P192; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Milot E, 2000, MOL ECOL, V9, P667, DOI 10.1046/j.1365-294x.2000.00897.x; Morales AC, 2013, NEOTROP ENTOMOL, V42, P32, DOI 10.1007/s13744-012-0085-1; Morales AC, 2010, BRAZ J BIOL, V70, P1115, DOI 10.1590/S1519-69842010000500030; Muwanika VB, 2003, HEREDITY, V91, P361, DOI 10.1038/sj.hdy.6800341; Oswald J.D., 2015, NEUROPTERIDA SPECIES; Pellegrino KCM, 2005, BIOL J LINN SOC, V85, P13, DOI 10.1111/j.1095-8312.2005.00472.x; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2002, TREE ANNOTATOR V1 8; Rambaut A, 2014, TRACER V1 6 SOFTWARE; Rambaut A., 2006, FIGTREE V 1 4 2 SOFT; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Technelysium Ltd, 1998, CHROM LIT VERS 2 1 1; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; Turchetto-Zolet AC, 2012, MOL PHYLOGENET EVOL, V65, P174, DOI 10.1016/j.ympev.2012.06.012; Ware JL, 2008, SYST ENTOMOL, V33, P429, DOI 10.1111/j.1365-3113.2008.00424.x; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615	48	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177414	10.1371/journal.pone.0177414	http://dx.doi.org/10.1371/journal.pone.0177414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510607	Green Published, gold, Green Submitted			2022-12-26	WOS:000401485500028
J	Norton, JN; Reynolds, RP; Chan, C; Valdivia, RH; Staats, HF				Norton, John N.; Reynolds, Randall P.; Chan, Cliburn; Valdivia, Raphael H.; Staats, Herman F.			Assessing the satisfaction and burden within an academic animal care and use program	FASEB JOURNAL			English	Article						compliance; oversight; policies; standards	HARM-BENEFIT ANALYSIS; IMPOSED REGULATORY BURDEN; SELF-ASSESSMENT SURVEY; FELASA WORKING GROUP; USE COMMITTEE; PART 1; OVERSIGHT; IACUC	Although animal research requires adherence to various regulations and standards, the manner in which compliance is maintained and the degree of additional constraints varies between institutions. Regulatory burden, particularly if institutionally imposed, has become a concern for institutions as increased regulatory expectations result in decreased resources available for research efforts. Faculty, research staff, and support staff engaged in animal research were surveyed to determine what institutional animal care and use committee (IACUC) processes were considered burdensome, the perceived value of some suggested modifications, and satisfaction with the IACUC administrative office and the animal resource unit. Although the results revealed overwhelming satisfaction with the IACUC administrative office and the animal resource unit, several IACUC processes were deemed burdensome, and therefore there would be value in modifying IACUC processes. When comparing the value of modifying IACUC processes, different groups within the animal care and use program (ACUP) tended to have different responses on many of the topics. This survey identified several perceived burdensome IACUC processes that would likely benefit individuals if modified. In today's environment of shrinking budgets for biomedical research, minimizing regulatory burden-particularly unnecessary, self-imposed burden-in the ACUP is particularly important to ensure that costs, time, and effort are appropriate to achieve animal welfare and quality of research endeavors.	[Norton, John N.; Reynolds, Randall P.] Duke Univ, Med Ctr, Div Lab Anim Resources, 103 Res Dr,DUMC 3180, Durham, NC 27710 USA; [Norton, John N.; Staats, Herman F.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Chan, Cliburn] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA; [Valdivia, Raphael H.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Norton, JN (corresponding author), Duke Univ, Med Ctr, Div Lab Anim Resources, 103 Res Dr,DUMC 3180, Durham, NC 27710 USA.	john.norton@duke.edu	Valdivia, Raphael/R-5377-2019	Valdivia, Raphael/0000-0003-0961-073X				Animal Welfare Regulations, 9 CFR AN AN PROD 1; Banks RE, 2008, ILAR J, V49, P402, DOI 10.1093/ilar.49.4.402; Bronstad A, 2016, LAB ANIM-UK, V50, P1, DOI 10.1177/0023677216642398; Collins JG, 2008, ILAR J, V49, P388, DOI 10.1093/ilar.49.4.388; Committee on Federal Research Regulations and Reporting Re-quirements, 2016, OPT NAT INV AC RES N; Cummings SR., 2013, DESIGNING CLIN RES, V4th, P223; Dale WE, 2008, ILAR J, V49, P393, DOI 10.1093/ilar.49.4.393; Decker RS, 2007, PROFILE FEDERAL GRAN; Federation of American Societies for Experimental Biology, 2013, FIND FASEB SURV ADM; Geetter J. S., 2016, 21 CENTURY CURES MOD; Graham ML, 2015, EUR J PHARMACOL, V759, P19, DOI 10.1016/j.ejphar.2015.03.040; Haywood JR, 2008, ILAR J, V49, P426, DOI 10.1093/ilar.49.4.426; Ingham KM, 2000, CONTEMP TOP LAB ANIM, V39, P28; Laber K, 2016, LAB ANIM-UK, V50, P21, DOI 10.1177/0023677216642397; Levine AS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5200; National Research Council, 2011, GUIDE CARE USE LAB A; National Science Board (NSB), 2014, NSB1418 NAT SCI FDN; Plante A, 2008, ILAR J, V49, P419, DOI 10.1093/ilar.49.4.419; Pritt S, 2016, LAB ANIMAL, V45, P297, DOI 10.1038/laban.1067; PublicHealth Service, 1986, POL HUM CAR US LAB A; Schneider Sandra, 2014, 2012 FACULTY WORKLOA; Silverman J, 2012, LAB ANIMAL, V41, P289, DOI 10.1038/laban1012-289; Silverman J, 2012, LAB ANIMAL, V41, P230, DOI 10.1038/laban0812-230; Thulin JD, 2014, FASEB J, V28, P3297, DOI 10.1096/fj.14-254094; Vanderford DA, 2015, LAB ANIMAL, V44, P395, DOI 10.1038/laban.856	25	4	4	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3913	3921		10.1096/fj.201700072RR	http://dx.doi.org/10.1096/fj.201700072RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28515151				2022-12-26	WOS:000408713300018
J	Zurawski, Z; Page, B; Chicka, MC; Brindley, RL; Wells, CA; Preininger, AM; Hyde, K; Gilbert, JA; Cruz-Rodriguez, O; Currie, KPM; Chapman, ER; Alford, S; Hamm, HE				Zurawski, Zack; Page, Brian; Chicka, Michael C.; Brindley, Rebecca L.; Wells, Christopher A.; Preininger, Anita M.; Hyde, Karren; Gilbert, James A.; Cruz-Rodriguez, Osvaldo; Currie, Kevin P. M.; Chapman, Edwin R.; Alford, Simon; Hamm, Heidi E.			G beta gamma directly modulates vesicle fusion by competing with synaptotagmin for binding to neuronal SNARE proteins embedded in membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINUS; PRESYNAPTIC INHIBITION; CA2+-DEPENDENT BINDING; CRYSTAL-STRUCTURE; CRITICAL RESIDUES; CALCIUM CURRENTS; INSULIN-RELEASE; C2B DOMAIN; TRANSMISSION; MACHINERY	G(i/o)-coupled G protein-coupled receptors can inhibit neurotransmitter release at synapses via multiple mechanisms. In addition to G beta gamma-mediated modulation of voltage-gated calcium channels (VGCC), inhibition can also be mediated through the direct interaction of G beta gamma subunits with the soluble N-ethylmaleimide attachment protein receptor (SNARE) complex of the vesicle fusion apparatus. Binding studies with soluble SNARE complexes have shown that G beta gamma binds to both ternary SNARE complexes, t-SNARE heterodimers, and monomeric SNAREs, competing with synaptotagmin 1(syt1) for binding sites on t-SNARE. However, in secretory cells, G beta gamma, SNAREs, and synaptotagmin interact in the lipid environment of a vesicle at the plasma membrane. To approximate this environment, we show that fluorescently labeled G beta gamma interacts specifically with lipid-embedded t-SNAREs consisting of full-length syntaxin 1 and SNAP-25B at the membrane, as measured by fluorescence polarization. Fluorescently labeled syt1 undergoes competition with G beta gamma for SNARE-binding sites in lipid environments. Mutant G beta gamma subunits that were previously shown to be more efficacious at inhibiting Ca2+-triggered exocytotic release than wild-type G beta gamma were also shown to bind SNAREs at a higher affinity than wild type in a lipid environment. These mutant G beta gamma subunits were unable to inhibit VGCC currents. Specific peptides corresponding to regions on G beta and G gamma shown to be important for the interaction disrupt the interaction in a concentration-dependent manner. In in vitro fusion assays using full-length t-and v-SNAREs embedded in liposomes, G beta gamma inhibited Ca2+/synaptotagmin-dependent fusion. Together, these studies demonstrate the importance of these regions for the G beta gamma-SNARE interaction and show that the target of G beta gamma, downstream of VGCC, is the membrane-embedded SNARE complex.	[Zurawski, Zack; Wells, Christopher A.; Preininger, Anita M.; Hyde, Karren; Gilbert, James A.; Currie, Kevin P. M.; Hamm, Heidi E.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Page, Brian; Alford, Simon] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Chicka, Michael C.; Chapman, Edwin R.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53705 USA; [Chicka, Michael C.; Chapman, Edwin R.] Univ Wisconsin, Dept Neurosci, Madison, WI 53705 USA; [Brindley, Rebecca L.; Currie, Kevin P. M.] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN 37232 USA; [Cruz-Rodriguez, Osvaldo] Univ Michigan, Inst Life Sci, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Cruz-Rodriguez, Osvaldo] Univ Michigan, Inst Life Sci, Dept Biol Chem, Ann Arbor, MI 48109 USA	Vanderbilt University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Vanderbilt University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hamm, HE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, 442 Robinson Res Bldg,23rd Ave South Pierce, Nashville, TN 37232 USA.	heidi.hamm@vanderbilt.edu	Currie, Kevin P/J-9561-2019	Currie, Kevin P/0000-0002-0861-423X; Alford, Simon/0000-0002-0454-4246; Brindley, Rebecca/0000-0002-4357-4413; Chapman, Edwin/0000-0001-9787-8140; Preininger, Anita/0000-0001-8011-9391	National Institutes of Health [R01NS052446, R01EY010291, R01MH101679, R01MH061876, R01MH084874]; NATIONAL EYE INSTITUTE [R01EY010291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109204] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101679, R01MH061876, R01MH084874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS052446 (NINDS), R01EY010291 (NEI), and R01MH101679, R01MH061876, and R01MH084874 (National Institute of Mental Health). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Betke KM, 2012, PROG NEUROBIOL, V96, P304, DOI 10.1016/j.pneurobio.2012.01.009; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Blackmer T, 2005, NAT NEUROSCI, V8, P421, DOI 10.1038/nn1423; Blackmer T, 2001, SCIENCE, V292, P293, DOI 10.1126/science.1058803; Brewer KD, 2015, NAT STRUCT MOL BIOL, V22, P555, DOI 10.1038/nsmb.3035; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Delaney AJ, 2007, NEURON, V56, P880, DOI 10.1016/j.neuron.2007.10.022; DUNLAP K, 1978, NATURE, V276, P837, DOI 10.1038/276837a0; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gaffaney JD, 2008, J BIOL CHEM, V283, P31763, DOI 10.1074/jbc.M803355200; Gerachshenko T, 2005, NAT NEUROSCI, V8, P597, DOI 10.1038/nn1439; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Glitsch M, 2006, J NEUROPHYSIOL, V96, P86, DOI 10.1152/jn.01282.2005; Hamid E, 2014, J NEUROSCI, V34, P260, DOI 10.1523/JNEUROSCI.3633-12.2014; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Iremonger KJ, 2009, J NEUROSCI, V29, P7349, DOI 10.1523/JNEUROSCI.0381-09.2009; Isaacson JS, 1998, J NEUROPHYSIOL, V80, P1571, DOI 10.1152/jn.1998.80.3.1571; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kozasa T., 1995, J BIOL CHEM, V12; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Liu HS, 2014, NAT NEUROSCI, V17, P670, DOI 10.1038/nn.3681; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; MANDARINO L, 1980, ENDOCRINOLOGY, V106, P430, DOI 10.1210/endo-106-2-430; MAZZONI MR, 1991, J BIOL CHEM, V266, P14072; McDavid S, 2006, J NEUROSCI, V26, P13373, DOI 10.1523/JNEUROSCI.3332-06.2006; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Rizo J, 2015, ANNU REV BIOPHYS, V44, P339, DOI 10.1146/annurev-biophys-060414-034057; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SILINSKY EM, 1984, J PHYSIOL-LONDON, V346, P243, DOI 10.1113/jphysiol.1984.sp015019; SIMONDS WF, 1991, J BIOL CHEM, V266, P5363; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Takahashi T, 1998, J NEUROSCI, V18, P3138; Takida S, 2003, J BIOL CHEM, V278, P17284, DOI 10.1074/jbc.M213239200; Van Hook MJ, 2017, J NEUROSCI, V37, P4618, DOI 10.1523/JNEUROSCI.2948-16.2017; Waldschmidt HV, 2016, J MED CHEM, V59, P3793, DOI 10.1021/acs.jmedchem.5b02000; Wang Z, 2011, J CELL BIOL, V195, P1159, DOI 10.1083/jcb.201104079; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wells CA, 2012, MOL PHARMACOL, V82, P1136, DOI 10.1124/mol.112.080507; WOLLHEIM CB, 1977, J CLIN INVEST, V60, P1165, DOI 10.1172/JCI108869; Yim YY, 2015, METHODS MOL BIOL, V1278, P307, DOI 10.1007/978-1-4939-2425-7_18; Yoon EJ, 2008, J NEUROPHYSIOL, V100, P2929, DOI 10.1152/jn.90839.2008; Yoon EJ, 2007, MOL PHARMACOL, V72, P1210, DOI 10.1124/mol.107.039446; Zamponi GW, 2013, BBA-BIOMEMBRANES, V1828, P1629, DOI 10.1016/j.bbamem.2012.10.004; Zhang X.-L., 2016, PLOS ONE, V6; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2; Zhao Y., 2010, J PHYSL; Zhou QJ, 2015, NATURE, V525, P62, DOI 10.1038/nature14975; Zurawski Z, 2016, MOL PHARMACOL, V89, P75, DOI 10.1124/mol.115.101600	60	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12165	12177		10.1074/jbc.M116.773523	http://dx.doi.org/10.1074/jbc.M116.773523			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28515322	Green Published, hybrid			2022-12-26	WOS:000406053300015
J	Senger, M; Stripp, ST; Soboh, B				Senger, Moritz; Stripp, Sven T.; Soboh, Basem			Proteolytic cleavage orchestrates cofactor insertion and protein assembly in [NiFe]-hydrogenase biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIFE HYDROGENASE MATURATION; CIRCULAR-DICHROISM SPECTRA; ESCHERICHIA-COLI K-12; ACCESSORY PROTEINS; LARGE SUBUNIT; ACTIVE-SITE; STRUCTURAL BASIS; CATALYTIC CYCLE; CARBON-MONOXIDE; IRON	Metalloenzymes catalyze complex and essential processes, such as photosynthesis, respiration, and nitrogen fixation. For example, bacteria and archaea use [NiFe]-hydrogenases to catalyze the uptake and release of molecular hydrogen (H-2). [NiFe]-hydrogenases are redox enzymes composed of a large subunit that harbors a NiFe(CN)(2)CO metallo-center and a small subunit with three iron-sulfur clusters. The large subunit is synthesized with a C-terminal extension, cleaved off by a specific endopeptidase during maturation. The exact role of the C-terminal extension has remained elusive; however, cleavage takes place exclusively after assembly of the [NiFe]-cofactor and before large and small subunits form the catalytically active heterodimer. To unravel the functional role of the C-terminal extension, we used an enzymatic in vitro maturation assay that allows synthesizing functional [NiFe]-hydrogenase-2 of Escherichia coli from purified components. The maturation process included formation and insertion of the NiFe(CN)(2)CO cofactor into the large subunit, endoproteolytic cleavage of the C-terminal extension, and dimerization with the small subunit. Biochemical and spectroscopic analysis indicated that the C-terminal extension of the large subunit is essential for recognition by the maturation machinery. Only upon completion of cofactor insertion was removal of the C-terminal extension observed. Our results indicate that endoproteolytic cleavage is a central checkpoint in the maturation process. Here, cleavage temporally orchestrates cofactor insertion and protein assembly and ensures that only cofactor-containing protein can continue along the assembly line toward functional [NiFe]-hydrogenase.	[Senger, Moritz; Stripp, Sven T.; Soboh, Basem] Free Univ Berlin, Dept Phys, Expt Mol Biophys, Arnimallee 14, D-14195 Berlin, Germany	Free University of Berlin	Soboh, B (corresponding author), Free Univ Berlin, Dept Phys, Expt Mol Biophys, Arnimallee 14, D-14195 Berlin, Germany.	basem.soboh@fu-berlin.de	Senger, Moritz/O-1086-2017; Stripp, Sven Timo/O-9051-2019	Senger, Moritz/0000-0001-9225-4910; Stripp, Sven Timo/0000-0002-8412-0258	Deutsche Forschungsgemeinschaft through the priority program "Iron-Sulfur for Life" [SO 1325/5-1]	Deutsche Forschungsgemeinschaft through the priority program "Iron-Sulfur for Life"	This work was supported by the Deutsche Forschungsgemeinschaft through the priority program "Iron-Sulfur for Life," Grant SO 1325/5-1 (to B.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Ash PA, 2017, ACS CATAL, V7, P2471, DOI 10.1021/acscatal.6b03182; BALLANTINE SP, 1985, J BACTERIOL, V163, P454, DOI 10.1128/JB.163.2.454-459.1985; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Binder U, 1996, ARCH MICROBIOL, V165, P69, DOI 10.1007/s002030050299; Blokesch M, 2004, J MOL BIOL, V344, P155, DOI 10.1016/j.jmb.2004.09.040; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Burstel I, 2016, P NATL ACAD SCI USA, V113, P14722, DOI 10.1073/pnas.1614656113; Butland G, 2006, FEBS LETT, V580, P677, DOI 10.1016/j.febslet.2005.12.063; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Currin A, 2015, CHEM SOC REV, V44, P1172, DOI 10.1039/c4cs00351a; Drapal N, 1998, BIOCHEMISTRY-US, V37, P2941, DOI 10.1021/bi9720078; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Friedrich B, 2005, BIOCHEM SOC T, V33, P97, DOI 10.1042/BST0330097; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Happe RP, 1997, NATURE, V385, P126, DOI 10.1038/385126a0; Hedderich R, 2005, J MOL MICROB BIOTECH, V10, P92, DOI 10.1159/000091557; Hube M, 2002, J BACTERIOL, V184, P3879, DOI 10.1128/JB.184.14.3879-3885.2002; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Khorasani-Motlagh M, 2017, METALLOMICS, V9, P482, DOI 10.1039/c7mt00037e; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Lacasse MJ, 2016, BIOCHEMISTRY-US, V55, P6821, DOI 10.1021/acs.biochem.6b00706; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lu Y, 2009, NATURE, V460, P855, DOI 10.1038/nature08304; Lubitz W, 2014, CHEM REV, V114, P4081, DOI 10.1021/cr4005814; Lukey MJ, 2010, J BIOL CHEM, V285, P3928, DOI 10.1074/jbc.M109.067751; MAIER T, 1995, EUR J BIOCHEM, V230, P133, DOI 10.1111/j.1432-1033.1995.tb20543.x; Massanz C, 1997, EUR J BIOCHEM, V245, P441, DOI 10.1111/j.1432-1033.1997.t01-3-00441.x; MENON NK, 1994, J BACTERIOL, V176, P4416, DOI 10.1128/jb.176.14.4416-4423.1994; MIZUNO Y, 1989, ANAL BIOCHEM, V183, P46, DOI 10.1016/0003-2697(89)90169-3; Pardo A, 2006, J BIOL INORG CHEM, V11, P286, DOI 10.1007/s00775-005-0076-3; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Petkun S, 2011, STRUCTURE, V19, P1773, DOI 10.1016/j.str.2011.09.023; Pierik AJ, 1999, J BIOL CHEM, V274, P3331, DOI 10.1074/jbc.274.6.3331; Pinske C, 2011, ARCH MICROBIOL, V193, P893, DOI 10.1007/s00203-011-0726-5; Redwood MD, 2008, FEMS MICROBIOL LETT, V278, P48, DOI 10.1111/j.1574-6968.2007.00966.x; Roseboom W, 2005, FEBS LETT, V579, P469, DOI 10.1016/j.febslet.2004.12.013; Senger M, 2016, P NATL ACAD SCI USA, V113, P8454, DOI 10.1073/pnas.1606178113; Shomura Y, 2012, J BIOL CHEM, V287, P28409, DOI 10.1074/jbc.M112.387134; Soboh B, 2002, EUR J BIOCHEM, V269, P5712, DOI 10.1046/j.1432-1033.2002.03282.x; Soboh B, 2004, MICROBIOL-SGM, V150, P2451, DOI 10.1099/mic.0.27159-0; Soboh B, 2014, BIOCHEM J, V464, P169, DOI 10.1042/BJ20140485; Soboh B, 2013, FEBS LETT, V587, P2512, DOI 10.1016/j.febslet.2013.06.055; Soboh B, 2012, FEBS LETT, V586, P3882, DOI 10.1016/j.febslet.2012.09.019; Soboh B, 2012, BIOCHEM BIOPH RES CO, V424, P158, DOI 10.1016/j.bbrc.2012.06.096; Soboh B, 2010, FEBS LETT, V584, P4109, DOI 10.1016/j.febslet.2010.08.037; SORGENFREI O, 1993, EUR J BIOCHEM, V213, P1355, DOI 10.1111/j.1432-1033.1993.tb17888.x; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Stripp ST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133118; Stripp ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107488; Stripp ST, 2013, BIOCHEMISTRY-US, V52, P3289, DOI 10.1021/bi400302v; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Thauer RK, 2010, ANNU REV BIOCHEM, V79, P507, DOI 10.1146/annurev.biochem.030508.152103; Theodoratou E, 2005, BIOCHEM SOC T, V33, P108, DOI 10.1042/BST0330108; Theodoratou E, 2000, EUR J BIOCHEM, V267, P1995, DOI 10.1046/j.1432-1327.2000.01202.x; Thomas C, 2015, J BACTERIOL, V197, P2989, DOI 10.1128/JB.00437-15; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Watanabe S, 2015, P NATL ACAD SCI USA, V112, P7701, DOI 10.1073/pnas.1503102112; Watanabe S, 2012, STRUCTURE, V20, P2124, DOI 10.1016/j.str.2012.09.018	61	19	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11670	11681		10.1074/jbc.M117.788125	http://dx.doi.org/10.1074/jbc.M117.788125			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28539366	hybrid, Green Published			2022-12-26	WOS:000405485600008
J	Tetley, GJN; Mott, HR; Cooley, RN; Owen, D				Tetley, George J. N.; Mott, Helen R.; Cooley, R. Neil; Owen, Darerca			A dock and coalesce mechanism driven by hydrophobic interactions governs Cdc42 binding with its effector protein ACK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY DISORDERED PROTEINS; NONRECEPTOR TYROSINE KINASE; ALDRICH-SYNDROME PROTEIN; GTPASE-BINDING; P21-ACTIVATED KINASE; RATE CONSTANTS; DOMAIN; ACTIVATION; MUTATIONS; AUTOINHIBITION	Cdc42 is a Rho-family small G protein that has been widely studied for its role in controlling the actin cytoskeleton and plays a part in several potentially oncogenic signaling networks. Similar to most other small G proteins, Cdc42 binds to many downstream effector proteins to elicit its cellular effects. These effector proteins all engage the same face of Cdc42, the conformation of which is governed by the activation state of the G protein. Previously, the importance of individual residues in conferring binding affinity has been explored for residues within Cdc42 for three of its Cdc42/Rac interactive binding (CRIB) effectors, activated Cdc42 kinase (ACK), p21-activated kinase (PAK), and Wiskott-Aldrich syndrome protein (WASP). Here, in a complementary study, we have used our structure of Cdc42 bound toACKvia an intrinsically disorderedACKregion to guide an analysis of the Cdc42 interface on ACK, creating a panel of mutant proteins with which we can now describe the complete energetic landscape of the Cdc42-binding site on ACK. Our data suggest that the binding affinity ofACKrelies on several conserved residues that are critical for stabilizing the quaternary structure. These residues are centered on the CRIB region, with the complete binding region anchored at each end by hydrophobic interactions. These findings suggest that ACK adopts a dock and coalesce binding mechanism with Cdc42. In contrast to other CRIB-family effectors and indeed other intrinsically disordered proteins, hydrophobic residues likely drive Cdc42-ACK binding.	[Tetley, George J. N.; Mott, Helen R.; Owen, Darerca] Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England; [Cooley, R. Neil] Isogenica Ltd, Chesterford Res Pk, Saffron Walden CB10 1XL, Essex, England; [Cooley, R. Neil] Abcam, 330 Cambridge Sci Pk, Cambridge CB4 OFL, England	University of Cambridge; Isogenica Limited	Owen, D (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	do202@cam.ac.uk	Mott, Helen/AAV-3873-2020	Mott, Helen/0000-0002-7890-7097; Tetley, George/0000-0002-7134-7066	Medical Research Council CASE Studentship [MR/K017101/1]; Medical Research Council [1366170] Funding Source: researchfish	Medical Research Council CASE Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council CASE Studentship MR/K017101/1 (to D. O., H. R. M., and R. N. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Ash J, 2003, GENETICS, V163, P9; Buck M, 2004, J MOL BIOL, V338, P271, DOI 10.1016/j.jmb.2004.02.036; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Chang CEA, 2007, P NATL ACAD SCI USA, V104, P1534, DOI 10.1073/pnas.0610494104; Dehouck Y, 2013, NUCLEIC ACIDS RES, V41, pW333, DOI 10.1093/nar/gkt450; Dogan J, 2014, PHYS CHEM CHEM PHYS, V16, P6323, DOI 10.1039/c3cp54226b; Elliot-Smith AE, 2005, BIOCHEMISTRY-US, V44, P12373, DOI 10.1021/bi0506021; Elliot-Smith AE, 2007, BIOCHEMISTRY-US, V46, P14087, DOI 10.1021/bi701539x; Gajiwala KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053994; Galisteo ML, 2006, P NATL ACAD SCI USA, V103, P9796, DOI 10.1073/pnas.0603714103; Gu Y, 2004, J BIOL CHEM, V279, P30507, DOI 10.1074/jbc.M313518200; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Lamson RE, 2002, MOL CELL BIOL, V22, P2939, DOI 10.1128/MCB.22.9.2939-2951.2002; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lin Q, 2012, BIOCHEM J, V445, P255, DOI 10.1042/BJ20111575; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Mahajan K, 2015, ONCOGENE, V34, P4162, DOI 10.1038/onc.2014.350; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Mott HR, 2015, CRIT REV BIOCHEM MOL, V50, P85, DOI 10.3109/10409238.2014.999191; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Nur-E-Kamal MSA, 1999, ONCOGENE, V18, P7787; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Pang XD, 2016, PROTEINS, V84, P674, DOI 10.1002/prot.25018; Phillips MJ, 2008, J BIOL CHEM, V283, P14153, DOI 10.1074/jbc.M706271200; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Pirone DM, 2000, J BIOL CHEM, V275, P22650, DOI 10.1074/jbc.M002832200; Prieto-Echague V, 2010, J BIOL CHEM, V285, P10605, DOI 10.1074/jbc.M109.060459; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Stengel KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037317; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Zhou HX, 2012, PHYS CHEM CHEM PHYS, V14, P10466, DOI 10.1039/c2cp41196b	39	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11361	11373		10.1074/jbc.M117.789883	http://dx.doi.org/10.1074/jbc.M117.789883			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28539360	Green Published, hybrid			2022-12-26	WOS:000405119600020
J	Nishio, M; Nakane, K; Kubo, T; Yakami, M; Emoto, Y; Nishio, M; Togashi, K				Nishio, Mizuho; Nakane, Kazuaki; Kubo, Takeshi; Yakami, Masahiro; Emoto, Yutaka; Nishio, Mari; Togashi, Kaori			Automated prediction of emphysema visual score using homology-based quantification of low-attenuation lung region	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; PULMONARY-EMPHYSEMA; PERSISTENT HOMOLOGY; CT; CANCER; MODES; CLASSIFICATION; RISK; COPD; DNA	Objective The purpose of this study was to investigate the relationship between visual score of emphysema and homology-based emphysema quantification (HEQ) and evaluate whether visual score was accurately predicted by machine learning and HEQ. Materials and methods A total of 115 anonymized computed tomography images from 39 patients were obtained from a public database. Emphysema quantification of these images was performed by measuring the percentage of low-attenuation lung area (LAA%). The following values related to HEQ were obtained: nb(0) and nb(1). LAA% and HEQ were calculated at various threshold levels ranging from -1000 HU to -700 HU. Spearman's correlation coefficients between emphysema quantification and visual score were calculated at the various threshold levels. Visual score was predicted by machine learning and emphysema quantification (LAA% or HEQ). Random Forest was used as a machine learning algorithm, and accuracy of prediction was evaluated by leave-one-patient-out cross validation. The difference in the accuracy was assessed using McNemar's test. Results The correlation coefficients between emphysema quantification and visual score were as follows: LAA% (-950 HU), 0.567; LAA% (-910 HU), 0.654; LAA% (-875 HU), 0.704; nb(0) (-950 HU), 0.552; nb(0) (-910 HU), 0.629; nb(0) (-875 HU), 0.473; nb(1) (-950 HU), 0.149; nb(1) (-910 HU), 0.519; and nb(1) (-875 HU), 0.716. The accuracy of prediction was as follows: LAA%, 55.7% and HEQ, 66.1%. The difference in accuracy was statistically significant (p = 0.0290). Conclusion LAA% and HEQ at -875 HU showed a stronger correlation with visual score than those at -910 or -950 HU. HEQ was more useful than LAA% for predicting visual score.	[Nishio, Mizuho; Kubo, Takeshi; Yakami, Masahiro; Togashi, Kaori] Kyoto Univ, Dept Diagnost Imaging & Nucl Med, Grad Sch Med, Kyoto, Kyoto, Japan; [Nishio, Mizuho; Yakami, Masahiro] Kyoto Univ Hosp, Preempt Med & Lifestyle Dis Res Ctr, Kyoto, Kyoto, Japan; [Nakane, Kazuaki] Osaka Univ, Dept Mol Pathol, Grad Sch Med & Hlth Sci, Suita, Osaka, Japan; [Emoto, Yutaka] Kyoto Coll Med Sci, Dept Med Sci, Nantan, Kyoto, Japan; [Nishio, Mari] Kobe Univ, Dept Pathol, Grad Sch Med, Kobe, Hyogo, Japan	Kyoto University; Kyoto University; Osaka University; Kobe University	Nishio, M (corresponding author), Kyoto Univ, Dept Diagnost Imaging & Nucl Med, Grad Sch Med, Kyoto, Kyoto, Japan.; Nishio, M (corresponding author), Kyoto Univ Hosp, Preempt Med & Lifestyle Dis Res Ctr, Kyoto, Kyoto, Japan.	nmizuho@kuhp.kyoto-u.ac.jp	Nishio, Mari/C-9322-2016; Nishio, Mizuho/ACC-0897-2022	Nishio, Mari/0000-0002-7413-0751; 	JSPS KAKENHI [26310209, JP16K19883]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by both JSPS KAKENHI Grant-in-Aid for Scientific Research (B) (Grant Number 26310209) and JSPS KAKENHI (Grant Number JP16K19883). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock A, 2014, COMPUT VIS IMAGE UND, V121, P36, DOI 10.1016/j.cviu.2013.10.014; Bankier AA, 1999, RADIOLOGY, V211, P851, DOI 10.1148/radiology.211.3.r99jn05851; Barr RG, 2012, COPD, V9, P151, DOI 10.3109/15412555.2012.654923; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X; Edelsbrunner H, 2008, CONTEMP MATH, V453, P257; Galban CJ, 2012, NAT MED, V18, P1711, DOI 10.1038/nm.2971; Gietema HA, 2011, ACAD RADIOL, V18, P661, DOI 10.1016/j.acra.2011.01.011; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Ishida Masayuki, 2015, Advanced Materials Research, V1102, P59, DOI 10.4028/www.scientific.net/AMR.1102.59; Kusano G, 2016, PR MACH LEARN RES, V48; Liu B, 2017, ONCOTARGET, V8, P13338, DOI 10.18632/oncotarget.14524; Liu B, 2016, BIOINFORMATICS, V32, P2411, DOI 10.1093/bioinformatics/btw186; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2015, BIOINFORMATICS, V31, P1307, DOI 10.1093/bioinformatics/btu820; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mishima M, 1999, P NATL ACAD SCI USA, V96, P8829, DOI 10.1073/pnas.96.16.8829; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; Nakane K, 2014, MATER RES INNOV, V18, P33, DOI 10.1179/1432891713Z.000000000353; Nakane K., 2013, DIAGN PATHOL S1, V8, pS27, DOI 10.1186/1746-1596-8-S1-S27; Nakane K, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0244-x; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Nishio M, ACAD RADIOL IN PRESS; Nishio M, 2016, INT J CHRONIC OBSTR, V11, P2125, DOI 10.2147/COPD.S110504; Qaiser T, 2016, PROCEDIA COMPUT SCI, V90, P119, DOI 10.1016/j.procs.2016.07.033; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Schwartz AG, 2016, CANC EPIDEMIOL BIOMA; Smith BM, 2012, LUNG CANCER, V77, P58, DOI 10.1016/j.lungcan.2012.02.019; Sorensen L, 2010, IEEE T MED IMAGING, V29, P559, DOI 10.1109/TMI.2009.2038575; Wang ZM, 2013, EUR RADIOL, V23, P975, DOI 10.1007/s00330-012-2683-z; Wille MMW, 2016, EUR RADIOL, V26, P487, DOI 10.1007/s00330-015-3826-9	31	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178217	10.1371/journal.pone.0178217	http://dx.doi.org/10.1371/journal.pone.0178217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542398	gold, Green Submitted, Green Published			2022-12-26	WOS:000402062800056
J	Niyangoda, C; Miti, T; Breydo, L; Uversky, V; Muschol, M				Niyangoda, Chamani; Miti, Tatiana; Breydo, Leonid; Uversky, Vladimir; Muschol, Martin			Carbonyl-based blue autofluorescence of proteins and amino acids	PLOS ONE			English	Article							LASER-INDUCED FLUORESCENCE; INTRINSIC FLUORESCENCE; VISIBLE FLUORESCENCE; PHOSPHORESCENCE; POLYPEPTIDES; TRANSITIONS; EXCITATION; ACETONE; STATE	Intrinsic protein fluorescence is inextricably linked to the near-UV autofluorescence of aromatic amino acids. Here we show that a novel deep-blue autofluorescence (dbAF), previously thought to emerge as a result of protein aggregation, is present at the level of monomeric proteins and even poly- and single amino acids. Just as its aggregation-related counterpart, this autofluorescence does not depend on aromatic residues, can be excited at the long wavelength edge of the UV and emits in the deep blue. Differences in dbAF excitation and emission peaks and intensities from proteins and single amino acids upon changes in solution conditions suggest dbAF's sensitivity to both the chemical identity and solution environment of amino acids. Autofluorescence comparable to dbAF is emitted by carbonyl-containing organic solvents, but not those lacking the carbonyl group. This implicates the carbonyl double bonds as the likely source for the autofluorescence in all these compounds. Using beta-lactoglobulin and proline, we have measured the molar extinction coefficients and quantum yields for dbAF in the monomeric state. To establish its potential utility in monitoring protein biophysics, we show that dbAF emission undergoes a red-shift comparable in magnitude to tryptophan upon thermal denaturation of lysozyme, and that it is sensitive to quenching by acrylamide. Carbonyl dbAF therefore provides a previously neglected intrinsic optical probe for investigating the structure and dynamics of amino acids, proteins and, by extension, DNA and RNA.	[Niyangoda, Chamani; Miti, Tatiana; Muschol, Martin] Univ S Florida, Dept Phys, Tampa, FL 33620 USA; [Breydo, Leonid; Uversky, Vladimir] USF Hlth, Dept Mol Med, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Muschol, M (corresponding author), Univ S Florida, Dept Phys, Tampa, FL 33620 USA.	mmuschol@usf.edu	Breydo, Leo/AAJ-7996-2020; Uversky, Vladimir N./F-4515-2011	Uversky, Vladimir N./0000-0002-4037-5857; Muschol, Martin/0000-0002-6488-0049	NIH [2R15GM097723]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM097723] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Portions of this work were supported by NIH grant 2R15GM097723.	Borisevich N. A., 2007, Journal of Applied Spectroscopy, V74, P245, DOI 10.1007/s10812-007-0038-3; Brackmann C, 2003, SPECTROCHIM ACTA A, V59, P3347, DOI 10.1016/S1386-1425(03)00163-X; Brancato G, 2008, CHEM PHYS LETT, V453, P202, DOI 10.1016/j.cplett.2008.01.045; Chan F.T.S., 2013, BIONANOIMAGING PROTE, P147, DOI [10.1016/B978-0-12-394431-3.00013-4, DOI 10.1016/B978-0-12-394431-3.00013-4]; Chan FTS, 2013, ANALYST, V138, P2156, DOI 10.1039/c3an36798c; Choudhary A, 2014, ORG LETT, V16, P3421, DOI 10.1021/ol5012967; DALTON JC, 1976, J AM CHEM SOC, V98, P398, DOI 10.1021/ja00418a013; del Mercato LL, 2007, P NATL ACAD SCI USA, V104, P18019, DOI 10.1073/pnas.0702843104; DOTY P, 1957, J POLYM SCI, V23, P851, DOI 10.1002/pol.1957.1202310429; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; Foley J, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4811343; Gong YY, 2013, SCI CHINA CHEM, V56, P1178, DOI 10.1007/s11426-013-4923-8; GRANT DH, 1973, J CHROMATOGR, V79, P267, DOI 10.1016/S0021-9673(01)85297-3; Guptasarma P, 2008, ARCH BIOCHEM BIOPHYS, V478, P127, DOI 10.1016/j.abb.2008.08.002; Hill SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018171; KALLMAN H, 1968, PHOTOCHEM PHOTOBIOL, V8, P65, DOI 10.1111/j.1751-1097.1968.tb05845.x; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, P446; Lapidus LJ, 2000, P NATL ACAD SCI USA, V97, P7220, DOI 10.1073/pnas.97.13.7220; Longworth JW, 1971, EXCITED STATES PROTE, P319; Ma HB, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4808442; MELHUISH WH, 1961, J PHYS CHEM-US, V65, P229, DOI 10.1021/j100820a009; Miti T, 2015, BIOMACROMOLECULES, V16, P326, DOI 10.1021/bm501521r; NAGASAWA M, 1964, J AM CHEM SOC, V86, P538, DOI 10.1021/ja01058a002; Parmar AS, 2007, BIOPHYS CHEM, V129, P224, DOI 10.1016/j.bpc.2007.06.002; Pinotsi D, 2016, J AM CHEM SOC, V138, P3046, DOI 10.1021/jacs.5b11012; Retailleau P, 1997, BIOPHYS J, V73, P2156, DOI 10.1016/S0006-3495(97)78246-8; Sauer M., 2011, HDB FLUORESCENCE SPE; Shukla A, 2004, ARCH BIOCHEM BIOPHYS, V428, P144, DOI 10.1016/j.abb.2004.05.007; Sizemore SM, 2015, BIOPHYS J, V109, P1038, DOI 10.1016/j.bpj.2015.07.023; Stehli D., 2015, INTRINSICALLY DISORD, V3, P1; TEALE FWJ, 1960, BIOCHEM J, V76, P381, DOI 10.1042/bj0760381; Thurber MC, 1998, APPL OPTICS, V37, P4963, DOI 10.1364/AO.37.004963; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008	33	42	43	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0176983	10.1371/journal.pone.0176983	http://dx.doi.org/10.1371/journal.pone.0176983			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542206	Green Submitted, gold, Green Published			2022-12-26	WOS:000402062800006
J	Song, DK; Hong, YS; Sung, YA; Lee, H				Song, Do Kyeong; Hong, Young Sun; Sung, Yeon-Ah; Lee, Hyejin			Insulin resistance according to beta-cell function in women with polycystic ovary syndrome and normal glucose tolerance	PLOS ONE			English	Article							METABOLIC SYNDROME; SENSITIVITY; PREVALENCE; PCOS	Background Polycystic ovary syndrome (PCOS) is associated with insulin resistance (IR) and compensatory hyperinsulinemia. IR is recognized as a major risk factor for the development of type 2 diabetes mellitus. However, few studies have investigated IR in women with PCOS and normal glucose tolerance. The objective of this study was to evaluate IR and beta-cell function in women with PCOS and normal glucose tolerance. Additionally, we sought to evaluate the usefulness of oral glucose tolerance test (OGTT)-derived IR indices in lean women with PCOS. Methods We recruited 100 women with PCOS and normal glucose tolerance and 100 age-and BMI-matched women as controls. IR and insulin secretory indices, including the homeostasis-model assessment (HOMA)-IR, HOMA-M-120, HOMA-F and the Stumvoll index, were calculated from an OGTT. Increased beta-cell function was defined as > 75th percentile for the HOMA-F in control women. Results Women with PCOS had higher values for post-load 2-hour glucose, fasting insulin, post-load 2-hour insulin, HOMA-IR, HOMA-M120, HOMA-F and lower values for the Stumvoll index than the controls (all Ps < 0.05). Women with PCOS and increased beta-cell function showed lower Stumvoll index values than the matched controls (P < 0.05). The HOMA-F was significantly associated with the HOMA-M120 and Stumvoll index when adjusted for age and BMI in a multiple regression analysis (all Ps < 0.05). The HOMA-M120 was positively correlated with triglycerides and free testosterone, and the Stumvoll index was negatively correlated with triglycerides and free testosterone in lean women with PCOS (all Ps < 0.05). Conclusions Women with PCOS and normal glucose tolerance showed higher IR than controls matched for age, BMI, and beta-cell function. beta-cell function was increased in women with PCOS when compared to the matched controls, but not when the lean subjects were compared to the matched controls separately. Therefore, early evaluation of IR in women with PCOS and normal glucose tolerance may be needed.	[Song, Do Kyeong; Hong, Young Sun; Sung, Yeon-Ah; Lee, Hyejin] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea	Ewha Womans University	Lee, H (corresponding author), Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea.	hyejinlee@ewha.ac.kr						Balen AH, 2003, HUM REPROD UPDATE, V9, P505, DOI 10.1093/humupd/dmg044; Carmina E, 2004, FERTIL STERIL, V82, P661, DOI 10.1016/j.fertnstert.2004.01.041; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Diamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; Dunaif A, 2006, FERTIL STERIL, V86, pS13, DOI 10.1016/j.fertnstert.2006.04.011; Ehrmann DA, 2006, J CLIN ENDOCR METAB, V91, P48, DOI 10.1210/jc.2005-1329; Escobar-Morreale HF, 2012, HUM REPROD UPDATE, V18, P146, DOI 10.1093/humupd/dmr042; Ginsberg HN, 2005, ARCH MED RES, V36, P232, DOI 10.1016/j.arcmed.2005.01.005; Hillman JK, 2014, FERTIL STERIL, V101, P530, DOI 10.1016/j.fertnstert.2013.10.055; Jensterle M, 2008, INT J GYNECOL OBSTET, V102, P137, DOI 10.1016/j.ijgo.2008.03.017; Kim JJ, 2013, OBSTET GYNECOL SCI, V56, P137, DOI DOI 10.5468/0GS.2013.56.3.137; Li WP, 2012, ENDOCR J, V59, P765, DOI 10.1507/endocrj.EJ12-0049; Manco M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092995; Morciano A, 2014, FERTIL STERIL, V102, P250, DOI 10.1016/j.fertnstert.2014.04.004; Song DY, 2014, DIABETES RES CLIN PR, V106, pS45, DOI 10.1016/S0168-8227(14)70293-1; Stepto NK, 2013, HUM REPROD, V28, P777, DOI 10.1093/humrep/des463; Sung Y-A, 2012, HANYANG MED REV, V32, P197; Tao T, 2012, INT J CLIN EXP PATHO, V5, P777; Toprak S, 2001, HORM RES, V55, P65, DOI 10.1159/000049972; Vrbikova J, 2002, DIABETES CARE, V25, P1217, DOI 10.2337/diacare.25.7.1217; Vrbikova J, 2004, J CLIN ENDOCR METAB, V89, P2942, DOI 10.1210/jc.2003-031378; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC	23	19	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178120	10.1371/journal.pone.0178120	http://dx.doi.org/10.1371/journal.pone.0178120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542421	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800045
J	Fernandez-Feijoo, CD; Carrasco, CC; Francisco, NV; Romero, JC; Lorenzo, JRF; Jimenez-Chillaron, JC; Camprubi, MC				Duran Fernandez-Feijoo, Cristina; Carrasco Carrasco, Cristina; Villalmazo Francisco, Nuria; Cebria Romero, Judit; Fernandez Lorenzo, Jose Ramon; Jimenez-Chillaron, J. C.; Camprubi Camprubi, Marta			Influence of catch up growth on spatial learning and memory in a mouse model of intrauterine growth restriction	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; DEPENDENT SYNAPTIC PLASTICITY; LONG-TERM POTENTIATION; LOW-BIRTH-WEIGHT; CHILDREN BORN; HIPPOCAMPAL-NEURONS; POSTNATAL-GROWTH; MALE-RAT; INSULIN; RECEPTOR	Background Intrauterine growth restriction (IUGR) and rapid postnatal weight gain or catch up growth (CUG) increase the susceptibility to metabolic syndrome during adult life. Longitudinal studies have also revealed a high incidence of learning difficulties in children with IUGR. The aim of the present study was to investigate the effect of nutrition and CUG on learning memory in an IUGR animal model. We hypothesized that synaptic protein expression and transcription, an essential mechanism for memory consolidation, might be affected by intrauterine undernutrition. Methods IUGR was induced by 50% maternal caloric undernutrition throughout late gestation. During the suckling period, dams were either fed ad libitum or food restricted. The pups were divided into: Normal prenatal diet-Normal postnatal diet (NN), Restricted prenatal diet-Normal postnatal diet + catch up growth (RN+), Normal prenatal diet-Restricted postnatal diet (NR) and Restricted prenatal diet-Restricted postnatal diet (RR). At 4 weeks of age, memory was assessed via a water maze test. To evaluate synaptic function, 2 specific synaptic proteins (postsynaptic density-95 [PSD95], synaptophysin) as well as insulin receptors (IR) were tested by Western Blot and quantitative polymerase chain reaction (qPCR). Brain-derived neurotrophic factor and serum insulin levels were also studied. Results and conclusions The RN+ group presented a learning curve similar to the NN animals. The RR animals without CUG showed learning disabilities. PSD95 was lower in the RR group than in the NN and RN+ mice. In contrast, synaptophysin was similar in all groups. IR showed an inverse expression pattern to that of the PSD95. In conclusion, perinatal nutrition plays an important role in learning. CUG after a period of prenatal malnutrition seems to improve learning skills. The functional alterations observed might be related to lower PSD95 activity and a possible dysfunction in the hormone regulation of synaptic plasticity.	[Duran Fernandez-Feijoo, Cristina; Fernandez Lorenzo, Jose Ramon] Pediat Serv, Hosp Alvaro Cunqueiro, Vigo, Spain; [Carrasco Carrasco, Cristina; Villalmazo Francisco, Nuria; Camprubi Camprubi, Marta] Univ Barcelona, Hosp Sant Joan de Deu, Barcelona Ctr Maternal Fetal & Neonatal Med, Neonatol Serv,BCNatal, Esplugas de Llobregat, Spain; [Carrasco Carrasco, Cristina; Villalmazo Francisco, Nuria; Camprubi Camprubi, Marta] Univ Barcelona, Hosp Clin, Esplugas de Llobregat, Spain; [Cebria Romero, Judit; Jimenez-Chillaron, J. C.] Inst Recerca Sant Joan de Deu, Endocrinol, Barcelona, Spain	University of Barcelona; University of Barcelona	Camprubi, MC (corresponding author), Univ Barcelona, Hosp Sant Joan de Deu, Barcelona Ctr Maternal Fetal & Neonatal Med, Neonatol Serv,BCNatal, Esplugas de Llobregat, Spain.; Camprubi, MC (corresponding author), Univ Barcelona, Hosp Clin, Esplugas de Llobregat, Spain.; Jimenez-Chillaron, JC (corresponding author), Inst Recerca Sant Joan de Deu, Endocrinol, Barcelona, Spain.	jjimenezc@fsjd.org; mcamprubic@hsjdbcn.org		Duran Fernandez-Feijoo, Cristina/0000-0002-0807-8393; Fernandez-Lorenzo, Jose Ramon/0000-0002-0559-6240	BebeDue, Santa Perpetua de Moguda, Barcelona, Spain; Premi Carmen Pedraz-SEN; BBDUE	BebeDue, Santa Perpetua de Moguda, Barcelona, Spain; Premi Carmen Pedraz-SEN; BBDUE	This work was supported by a private grant from BebeDue, Santa Perpetua de Moguda, Barcelona, Spain. This work was also supported by "Premi Carmen Pedraz-SEN". The authors confirm that the funder had no influence over the study design, content of the article, or selection of this journal.; Neonatology research was supported by BBDUE.	Akman C, 2004, EPILEPSY BEHAV, V5, P446, DOI 10.1016/j.yebeh.2004.03.008; Arcangeli T, 2012, ULTRASOUND OBST GYN, V40, P267, DOI 10.1002/uog.11112; AUSTIN KB, 1986, DEV BRAIN RES, V29, P267, DOI 10.1016/0165-3806(86)90102-1; Barker DJP, 1999, ANN MED, V31, P3, DOI 10.1080/07853890.1999.11904392; Bieswal F, 2006, OBESITY, V14, P1330, DOI 10.1038/oby.2006.151; Boersma B, 2002, HORM RES, V58, P57, DOI 10.1159/000064771; Bronzino JD, 1996, HIPPOCAMPUS, V6, P109, DOI 10.1002/(SICI)1098-1063(1996)6:2<109::AID-HIPO2>3.0.CO;2-K; Caldeira MV, 2007, MOL CELL NEUROSCI, V35, P208, DOI 10.1016/j.mcn.2007.02.019; Chen MJ, 2007, CELL SIGNAL, V19, P114, DOI 10.1016/j.cellsig.2006.05.028; Corbett SS, 2007, PAEDIATR PERINAT EP, V21, P57, DOI 10.1111/j.1365-3016.2007.00783.x; Daskalakis NP, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00068; Dieni S, 2003, J NEUROBIOL, V55, P41, DOI 10.1002/neu.10194; Dou JT, 2005, LEARN MEMORY, V12, P646, DOI 10.1101/lm.88005; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Fattal-Valevski A, 2009, J CHILD NEUROL, V24, P846, DOI 10.1177/0883073808331082; Geva R, 2006, BRAIN RES, V1117, P186, DOI 10.1016/j.brainres.2006.08.004; Geva R, 2006, PEDIATRICS, V118, P91, DOI 10.1542/peds.2005-2343; Ghasemi R, 2013, MOL NEUROBIOL, V47, P145, DOI 10.1007/s12035-012-8339-9; GOLDENBERG RL, 1989, AM J OBSTET GYNECOL, V161, P271, DOI 10.1016/0002-9378(89)90497-3; HOKKENKOELEGA ACS, 1995, PEDIATR RES, V38, P267, DOI 10.1203/00006450-199508000-00022; Hollo O, 2002, ARCH PEDIAT ADOL MED, V156, P179, DOI 10.1001/archpedi.156.2.179; Hughes TM, 2016, BBA-MOL BASIS DIS, V1862, P983, DOI 10.1016/j.bbadis.2015.11.013; Ibanez L, 2006, J CLIN ENDOCR METAB, V91, P2153, DOI 10.1210/jc.2005-2778; Jain V, 2012, REV ENDOCR METAB DIS, V13, P141, DOI 10.1007/s11154-012-9216-6; Jimenez-Chillaron JC, 2006, DIABETOLOGIA, V49, P1974, DOI 10.1007/s00125-006-0311-7; Jimenez-Chillaron JC, 2005, DIABETES, V54, P702, DOI 10.2337/diabetes.54.3.702; Jimenez-Chillaron Josep C, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P23, DOI 10.1097/MED.0b013e328013da8e; Jones RH, 2009, MOL CELL ENDOCRINOL, V297, P4, DOI 10.1016/j.mce.2008.06.020; Keith D, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.004.2008; Larroque B, 2001, PEDIATRICS, V108, P111, DOI 10.1542/peds.108.1.111; Latal-Hajnal B, 2003, J PEDIATR-US, V143, P163, DOI 10.1067/S0022-3476(03)00243-9; Leal G, 2015, BRAIN RES, V1621, P82, DOI 10.1016/j.brainres.2014.10.019; Leal G, 2014, NEUROPHARMACOLOGY, V76, P639, DOI 10.1016/j.neuropharm.2013.04.005; Lee CC, 2005, J BIOL CHEM, V280, P18543, DOI 10.1074/jbc.M414112200; Leitner Y, 2007, J CHILD NEUROL, V22, P580, DOI 10.1177/0883073807302605; Lister JP, 2005, HIPPOCAMPUS, V15, P393, DOI 10.1002/hipo.20065; Lundgren EM, 2001, PEDIATR RES, V50, P91, DOI 10.1203/00006450-200107000-00017; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Morley R, 2004, PEDIATRICS, V113, P515, DOI 10.1542/peds.113.3.515; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Muratli S, 2016, JAMA NEUROL, V73, P239, DOI 10.1001/jamaneurol.2015.3983; Murray E, 2015, BJOG-INT J OBSTET GY, V122, P1062, DOI 10.1111/1471-0528.13435; Ninan I, 2010, J NEUROSCI, V30, P8866, DOI 10.1523/JNEUROSCI.1405-10.2010; O'Keeffe MJ, 2003, PEDIATRICS, V112, P301, DOI 10.1542/peds.112.2.301; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Pattwell SS, 2012, J NEUROSCI, V32, P2410, DOI 10.1523/JNEUROSCI.5205-11.2012; Richards M, 2001, BRIT MED J, V322, P199, DOI 10.1136/bmj.322.7280.199; Romo Agustin, 2009, Pediatr Endocrinol Rev, V6 Suppl 3, P332; Saenger P, 2007, ENDOCR REV, V28, P219, DOI 10.1210/er.2006-0039; Singhal A, 2004, CIRCULATION, V109, P1108, DOI 10.1161/01.CIR.0000118500.23649.DF; Slipczuk L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006007; Smith MA, 1995, ANN NY ACAD SCI, V771, P234, DOI 10.1111/j.1749-6632.1995.tb44684.x; Stettler N, 2005, CIRCULATION, V111, P1897, DOI 10.1161/01.CIR.0000161797.67671.A7; Vaag A., 2006, HORMONE RES PAEDIAT, V65; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; van der Heide LP, 2005, J NEUROCHEM, V94, P1158, DOI 10.1111/j.1471-4159.2005.03269.x; Varella MH, 2015, EARLY HUM DEV, V91, P491, DOI 10.1016/j.earlhumdev.2015.06.002; Vasiliadis HM, 2010, DEPRESS ANXIETY, V27, P1066, DOI 10.1002/da.20739; Zhang Y, 2013, NEUROSCIENCE, V244, P31, DOI 10.1016/j.neuroscience.2013.03.061; Zhang YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21186; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893	65	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177468	10.1371/journal.pone.0177468	http://dx.doi.org/10.1371/journal.pone.0177468			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542302	Green Published, gold, Green Submitted			2022-12-26	WOS:000402061500027
J	Masschaele, D; De Ceuninck, L; Wauman, J; Defever, D; Stenner, F; Lievens, S; Peelman, F; Tavernier, J				Masschaele, Delphine; De Ceuninck, Leentje; Wauman, Joris; Defever, Dieter; Stenner, Frank; Lievens, Sam; Peelman, Frank; Tavernier, Jan			RNF41 interacts with the VPS52 subunit of the GARP and EARP complexes	PLOS ONE			English	Article							E3 UBIQUITIN-LIGASE; RETROGRADE PROTEIN COMPLEX; RECEPTOR TYROSINE KINASE; TETHERING COMPLEXES; LATE GOLGI; TRANSPORT; ERBB3; NRDP1; CYTOKINE; DEGRADATION	RNF41 (Ring Finger Protein 41) is an E3 ubiquitin ligase involved in the intracellular sorting and function of a diverse set of substrates. Next to BRUCE and Parkin, RNF41 can directly ubiquitinate ErbB3, IL-3, EPO and RARa receptors or downstream signaling molecules such as Myd88, TBK1 and USP8. In this way it can regulate receptor signaling and routing. To further elucidate the molecular mechanism behind the role of RNF41 in intracellular transport we performed an Array MAPPIT (Mammalian Protein-Protein Interaction Trap) screen using an extensive set of proteins derived from the human ORFeome collection. This paper describes the identification of VPS52, a subunit of the GARP (Golgi-Associated Retrograde Protein) and the EARP (Endosome-Associated Recycling Protein) complexes, as a novel interaction partner of RNF41. Through interaction via their coiled coil domains, RNF41 ubiquitinates and relocates VPS52 away from VPS53, a common subunit of the GARP and EARP complexes, towards RNF41 bodies.	[Masschaele, Delphine; De Ceuninck, Leentje; Wauman, Joris; Defever, Dieter; Lievens, Sam; Peelman, Frank; Tavernier, Jan] Univ Ghent, Fac Med & Hlth Sci, Dept Biochem, Cytokine Receptor Lab, Ghent, Belgium; [Masschaele, Delphine; De Ceuninck, Leentje; Wauman, Joris; Defever, Dieter; Lievens, Sam; Peelman, Frank; Tavernier, Jan] VIB, VIB Med Biotechnol Ctr, Ghent, Belgium; [Stenner, Frank] Univ Basel, Univ Basel Hosp, Dept Oncol, Basel, Switzerland	Ghent University; Flanders Institute for Biotechnology (VIB); University of Basel	Tavernier, J (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Biochem, Cytokine Receptor Lab, Ghent, Belgium.; Tavernier, J (corresponding author), VIB, VIB Med Biotechnol Ctr, Ghent, Belgium.	jan.tavernier@vib-ugent.be	Tavernier, Jan/AAG-3636-2019; Wauman, Joris/GZL-0902-2022	Stenner, Frank/0000-0003-4541-8817	Belgian government; Belgian government (Interuniversity Attraction Poles) [P6/28, P6/3]; Research Foundation-Flanders [G.0521.12N]; ERC advanced Grant (GYRE) [340941]	Belgian government; Belgian government (Interuniversity Attraction Poles); Research Foundation-Flanders(FWO); ERC advanced Grant (GYRE)	D.M. holds an IWT grant from the Belgian government. This work was further supported by grants from the Belgian government (Interuniversity Attraction Poles Projects P6/28 and P6/36) and the Research Foundation-Flanders (Project G.0521.12N). J.T. is a recipient of an ERC advanced Grant (GYRE, #340941).	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Bouyain S, 2007, PROTEIN SCI, V16, P654, DOI 10.1110/ps.062700307; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Cao ZW, 2007, MOL CELL BIOL, V27, P2180, DOI 10.1128/MCB.01245-06; Chia Pei Zhi Cheryl, 2014, F1000Prime Rep, V6, P74, DOI 10.12703/P6-74; Chou HT, 2016, NAT STRUCT MOL BIOL, V23, P761, DOI 10.1038/nsmb.3264; Conibear E, 2003, MOL BIOL CELL, V14, P1610, DOI 10.1091/mbc.E02-10-0654; Conibear E, 2000, MOL BIOL CELL, V11, P305, DOI 10.1091/mbc.11.1.305; De Ceuninck L, 2013, J CELL SCI, V126, P3770, DOI 10.1242/jcs.131250; Diamonti AJ, 2002, P NATL ACAD SCI USA, V99, P2866, DOI 10.1073/pnas.052709799; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Fasshauer D, 2003, BBA-MOL CELL RES, V1641, P87, DOI 10.1016/S0167-4889(03)00090-9; Frohlich F, 2015, ELIFE, V4, DOI 10.7554/eLife.08712; Fry WHD, 2011, MOL CELL BIOL, V31, P3009, DOI 10.1128/MCB.05105-11; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hirata T, 2015, MOL BIOL CELL, V26, P3071, DOI 10.1091/mbc.E14-11-1568; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Jing X, 2008, EXP HEMATOL, V36, P1110, DOI 10.1016/j.exphem.2008.04.001; Kim S, 2009, BIOL PSYCHIAT, V65, P425, DOI 10.1016/j.biopsych.2008.09.015; Kozakova L, 2015, CELL CYCLE, V14, P920, DOI 10.1080/15384101.2014.1000112; Lievens S, 2009, J PROTEOME RES, V8, P877, DOI 10.1021/pr8005167; Liewen H, 2005, EXP CELL RES, V306, P24, DOI 10.1016/j.yexcr.2005.01.022; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Perez-Victoria FJ, 2008, MOL BIOL CELL, V19, P2350, DOI 10.1091/mbc.E07-11-1189; Perez-Victoria FJ, 2009, MOL CELL BIOL, V29, P5251, DOI 10.1128/MCB.00495-09; Perez-Victoria FJ, 2010, MOL BIOL CELL, V21, P3386, DOI 10.1091/mbc.E10-05-0392; Perez-Victoria FJ, 2010, P NATL ACAD SCI USA, V107, P12860, DOI 10.1073/pnas.1004756107; Piper R. C., 2014, COLD SPRING HARB PER, V6, DOI [10.1101/cshperspect.a016808, DOI 10.1101/CSHPERSPECT.A016808]; Piper RC, 2011, TRENDS CELL BIOL, V21, P647, DOI 10.1016/j.tcb.2011.08.007; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Printsev I, 2014, J BIOL CHEM, V289, P8570, DOI 10.1074/jbc.M113.527036; Qiu XB, 2002, P NATL ACAD SCI USA, V99, P14843, DOI 10.1073/pnas.232580999; Qiu XB, 2004, EMBO J, V23, P800, DOI 10.1038/sj.emboj.7600075; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Sannerud R, 2003, CURR OPIN CELL BIOL, V15, P438, DOI 10.1016/S0955-0674(03)00077-2; Schindler C, 2015, NAT CELL BIOL, V17, P639, DOI 10.1038/ncb3129; Scott CC, 2014, SEMIN CELL DEV BIOL, V31, P2, DOI 10.1016/j.semcdb.2014.03.034; Tokarev AA, 2000, LANDES BIOSCIENCE; Uyttendaele I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044143; Vincent TL, 2013, BIOINFORMATICS, V29, P69, DOI 10.1093/bioinformatics/bts648; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wauman J, 2011, J CELL SCI, V124, P921, DOI 10.1242/jcs.078055; Whyte JRC, 2002, J CELL SCI, V115, P2627; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Zhong L, 2005, J BIOL CHEM, V280, P9425, DOI 10.1074/jbc.M408955200	51	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178132	10.1371/journal.pone.0178132	http://dx.doi.org/10.1371/journal.pone.0178132			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542518	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058400059
J	Feliciano, MAR; Uscategui, RAR; Maronezi, MC; Simoes, APR; Silva, P; Gasser, B; Pavan, L; Carvalho, CF; Canola, JC; Vicente, WRR				Rossi Feliciano, Marcus Antonio; Ramirez Uscategui, Ricardo Andres; Maronezi, Marjury Cristina; Rodrigues Simoes, Ana Paula; Silva, Priscila; Gasser, Beatriz; Pavan, Leticia; Carvalho, Cibele Figueira; Canola, Julio Carlos; Russiano Vicente, Wilter Ricardo			Ultrasonography methods for predicting malignancy in canine mammary tumors	PLOS ONE			English	Article							CONTRAST-ENHANCED ULTRASOUND; BREAST-LESIONS; POWER DOPPLER; DIFFERENTIAL-DIAGNOSIS; SPECTRAL DOPPLER; COLOR DOPPLER; B-MODE; BENIGN; ELASTOGRAPHY; TISSUE	The aim of this study was to evaluate and compare the efficacy of B-mode, Doppler, contrast- enhanced ultrasonography (CEUS), and Acoustic Radiation Force Impulse (ARFI) elastography in predicting malignancy in canine mammary masses. This was a prospective cohort study from 2014 to 2016, which included 153 bitches with one or more mammary masses. A total of 300 masses were evaluated by ultrasonography (B-mode, Doppler, CEUS, and ARFI) and subsequently classified as benign or malignant by histopathology. Each ultrasound parameters studied were compared between benign and malignant masses by Chi-square or Student tests and differences were considered significant when P < 0.01. For the variables that proved significant differences were estimated the cut-off point, sensitivity, specificity, accuracy, and area under curve (AUC) by receiver-operating characteristic curve (ROC) analysis in a logistic regression model using histopathological classification as reference, to assess and compare diagnostic performance of each technique. Out of 300 mammary masses evaluated 246 were classified as malignant and 54 as benign. B-mode measurements showed sensitivity 67.9%, and specificity 67.6% as malignancy predictors on canine mammary masses; Doppler indexes systolic (> 21.2 m/s) and diastolic velocity (> 4.8 m/s) sensitivity 79.2% and specificity 70.8%; CEUS wash-out time (< 80.5 s) sensitivity 80.2% and specificity 16.7%; and ARFI elastography shear velocity (SWV > 2.57 m/s) sensitivity 94.7% and specificity 97.2% In conclusion B-mode and Doppler ultrasound evaluations may assist in malignancy prediction of canine mammary masses with moderate sensitivity and specificity, already the SWV was an great accurate predictor. Therefore, ARFI elastography exam inclusion in veterinary clinic oncology and research is highly recommended, since it allows fast, non-invasive, and complication-free malignancy prediction of canine mammary masses.	[Rossi Feliciano, Marcus Antonio; Rodrigues Simoes, Ana Paula; Gasser, Beatriz; Pavan, Leticia; Russiano Vicente, Wilter Ricardo] Univ Estadual Paulista, UNESP, Dept Anim Reprod, Sch Agr Sci & Vet Med, Campus Jaboticabal, Jaboticabal, SP, Brazil; [Ramirez Uscategui, Ricardo Andres; Maronezi, Marjury Cristina; Silva, Priscila; Carvalho, Cibele Figueira; Canola, Julio Carlos] Univ Estadual Paulista, UNESP, Dept Vet Clin & Surg, Sch Agr Sci & Vet Med, Campus Jaboticabal, Jaboticabal, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Feliciano, MAR (corresponding author), Univ Estadual Paulista, UNESP, Dept Anim Reprod, Sch Agr Sci & Vet Med, Campus Jaboticabal, Jaboticabal, SP, Brazil.	marcusfeliciano@yahoo.com.br	Feliciano, Marcus Antonio Rossi/S-9666-2019; Carvalho, C/M-6912-2019; Maronezi, Marjury Cristina/Q-7917-2019; Maronezi, Marjury/X-3699-2018; Feliciano, Marcus Antônio Rossi MAR/S-5343-2016; Vicente, Wilter R R/J-4984-2012; Uscategui, Ricardo Andres Ramirez/K-9407-2017	Feliciano, Marcus Antonio Rossi/0000-0003-4373-6539; Maronezi, Marjury Cristina/0000-0001-9039-1751; Maronezi, Marjury/0000-0001-9039-1751; Feliciano, Marcus Antônio Rossi MAR/0000-0003-4373-6539; Vicente, Wilter R R/0000-0001-7696-0962; Uscategui, Ricardo Andres Ramirez/0000-0002-9760-8631	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/16635-2, 2013/06443-1 - MARF 2014/15117-3 - LP, 2013/06443-1, 2014/15117-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br) Research grant and young researcher award: processes 2012/16635-2; 2013/06443-1 - MARF 2014/15117-3 - LP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Fundacao de Amparo a Pesquisa do Estado de Sao Paulo hitp://www.fapesp.br for the financial support provided as well as Research grant and young researcher award: processes 2012/16635-2; 2013/06443-1 to MARF and 2014/15117-3 to LP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastan A, 2009, KAFKAS UNIV VET FAK, V15, P81; Calas Maria Julia Gregorio, 2007, Radiol Bras, V40, P1, DOI 10.1590/S0100-39842007000100003; Cassali G. D., 2014, Brazilian Journal of Veterinary Pathology, V7, P38; Choi HY, 1999, CLIN IMAG, V23, P284, DOI 10.1016/S0899-7071(99)00152-7; Davoudi Y, 2014, J MED ULTRASOUND, V22, P92, DOI 10.1016/j.jmu.2013.12.001; DOCK W, 1991, RADIOLOGY, V181, P241, DOI 10.1148/radiology.181.1.1887039; Feliciano MAR, 2014, J SMALL ANIM PRACT, V55, P504, DOI 10.1111/jsap.12256; Feliciano MAR, 2012, ARQ BRAS MED VET ZOO, V64, P1094, DOI 10.1590/S0102-09352012000500002; Feliciano MAR, 2012, J SMALL ANIM PRACT, V53, P332, DOI 10.1111/j.1748-5827.2012.01227.x; Gokhale Sudheer, 2009, Indian J Radiol Imaging, V19, P242, DOI 10.4103/0971-3026.54878; Gong JJ, 2016, INT J CLIN EXP MED, V9, P8108; Ishii Masahiro, 1993, Nippon Acta Radiologica, V53, P1141; Jensen-Jarolim E, 2015, CANCER IMMUNOL IMMUN, V64, P531, DOI 10.1007/s00262-015-1684-6; Jin ZQ, 2012, CLIN BREAST CANCER, V12, P420, DOI 10.1016/j.clbc.2012.07.007; Lee SW, 2002, J CLIN ULTRASOUND, V30, P459, DOI 10.1002/jcu.10100; Li GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076322; Liberman L, 2003, AM J ROENTGENOL, V181, P519, DOI 10.2214/ajr.181.2.1810519; Liu BX, 2016, J MED ULTRASON, V43, P47, DOI 10.1007/s10396-015-0658-9; Liu H, 2008, BREAST, V17, P532, DOI 10.1016/j.breast.2008.04.004; Masciadri N, 2011, J Ultrasound, V14, P55, DOI 10.1016/j.jus.2011.03.002; Meng W, 2011, ULTRASOUND MED BIOL, V37, P1436, DOI 10.1016/j.ultrasmedbio.2011.05.022; Misdrop W, 1999, HISTOLOGICAL CLASSIF; Murad Moazzam, 2004, J Coll Physicians Surg Pak, V14, P166; Nyman HT, 2006, AM J VET RES, V67, P985, DOI 10.2460/ajvr.67.6.985; Paulinelli RR, 2005, J ULTRAS MED, V24, P635, DOI 10.7863/jum.2005.24.5.635; PETERSENGL C, 1995, BRIT J CANCER, V71, P137, DOI 10.1038/bjc.1995.28; Raza S, 2010, J ULTRAS MED, V29, P551, DOI 10.7863/jum.2010.29.4.551; Ricci P, 2014, EUR J RADIOL, V83, P429, DOI 10.1016/j.ejrad.2013.05.007; Schmillevitch Joel, 2009, Radiol Bras, V42, P241, DOI 10.1590/S0100-39842009000400010; Schroeder RJ, 2003, EUR RADIOL, V13, P68, DOI 10.1007/s00330-002-1413-3; Soler M, 2016, RES VET SCI, V107, P141, DOI 10.1016/j.rvsc.2016.05.015; Tagawa M, 2016, J VET MED SCI, V78, P521, DOI 10.1292/jvms.15-0456; Tang L, 2015, INT J CLIN EXP MED, V8, P10920; Thomas A, 2010, ACAD RADIOL, V17, P558, DOI 10.1016/j.acra.2009.12.006; Tozaki M, 2011, EUR J RADIOL, V80, pE182, DOI 10.1016/j.ejrad.2011.05.020; Visan Simona, 2016, Clujul Med, V89, P38, DOI 10.15386/cjmed-519; Wan CF, 2012, EUR J RADIOL, V81, pE444, DOI 10.1016/j.ejrad.2011.03.094; Wang YM, 2016, EUR J RADIOL, V85, P48, DOI 10.1016/j.ejrad.2015.10.017; Wojcinski S, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-47; Xia HS, 2014, EUR RADIOL, V24, P3178, DOI 10.1007/s00330-014-3375-7; Yao MH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/142504; Zhou JQ, 2014, EUR RADIOL, V24, P1659, DOI 10.1007/s00330-014-3152-7; Zhou JQ, 2013, J ULTRAS MED, V32, P285	43	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178143	10.1371/journal.pone.0178143	http://dx.doi.org/10.1371/journal.pone.0178143			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542533	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058400060
J	Braster, R; Grewal, S; Visser, R; Einarsdottir, HK; van Egmond, M; Vidarsson, G; Bogels, M				Braster, Rens; Grewal, Simran; Visser, Remco; Einarsdottir, Helga K.; van Egmond, Marjolein; Vidarsson, Gestur; Bogels, Marijn			Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in mice	PLOS ONE			English	Article							BROWN LOCUS PROTEIN; EFFECTOR FUNCTIONS; IN-VIVO; NEISSERIA-MENINGITIDIS; CHIMERIC ANTIBODIES; CELL-SURFACE; RED-CELLS; COMPLEMENT; SUBCLASSES; RITUXIMAB	Background Current anti-cancer therapeutic antibodies that are used in the clinic are predominantly humanized or fully human immunoglobulin G1 (IgG1). These antibodies bind with high affinity to the target antigen and are efficient in activating the immune system via IgG Fc receptors and/or complement. In addition to IgG1, three more isotypes are present in humans, of which IgG3 has been found to be superior compared to human IgG1 in inducing antibody dependent cell cytotoxicity (ADCC), phagocytosis or activation of complement in some models. Nonetheless, no therapeutic human IgG3 mAbs have been developed due to the short in vivo half-life of most known IgG3 allotypes. In this manuscript, we compared the efficacy of V-gene matched IgG1 and IgG3 anti-tumour mAb (TA99) in mice, using natural variants of human IgG3 with short-or long half-life, differing only at position 435 with an arginine or histidine, respectively. Results In vitro human IgG1 and IgG3 did not show any differences in opsonisation ability of B16F10-gp75 mouse melanoma cells. IgG1, however, was superior in inducing phagocytosis of tumour cells by mouse macrophages. Similarly, in a mouse peritoneal metastasis model we did not detect an improved effect of IgG3 in preventing tumour outgrowth. Moreover, replacing the arginine at position 435 for a histidine in IgG3 to enhance half-life did not result in better suppression of tumour outgrowth compared to wild type IgG3 when injected prior to tumour cell injection. Conclusion In conclusion, human IgG3 does not have improved therapeutic efficacy compared to human IgG1 in a mouse tumour model.	[Braster, Rens; Grewal, Simran; van Egmond, Marjolein; Bogels, Marijn] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Grewal, Simran; van Egmond, Marjolein; Bogels, Marijn] Vrije Univ Amsterdam, Med Ctr, Dept Surg, Amsterdam, Netherlands; [Visser, Remco; Einarsdottir, Helga K.; Vidarsson, Gestur] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunohematol, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Vidarsson, G (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunohematol, Sanquin Res & Landsteiner Lab, Amsterdam, Netherlands.	g.vidarsson@sanquin.nl	Vidarsson, Gestur/A-9909-2009	Vidarsson, Gestur/0000-0001-5621-003X				AASE A, 1994, SCAND J IMMUNOL, V39, P581, DOI 10.1111/j.1365-3083.1994.tb03416.x; Amoroso A, 2011, FRONT BIOSCI-LANDMRK, V16, P770, DOI 10.2741/3719; BAZIN R, 1994, J IMMUNOL METHODS, V172, P209, DOI 10.1016/0022-1759(94)90108-2; Biburger M, 2014, ADV IMMUNOL, V124, P67, DOI 10.1016/B978-0-12-800147-9.00003-0; Bohlson SS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00402; Braster R, 2014, METHODS, V65, P28, DOI 10.1016/j.ymeth.2013.06.020; BROUWERS HAA, 1988, BRIT J HAEMATOL, V70, P465, DOI 10.1111/j.1365-2141.1988.tb02518.x; BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chiavenna SM, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-016-0311-y; Clynes R, 1998, P NATL ACAD SCI USA, V95, P652, DOI 10.1073/pnas.95.2.652; Diebolder CA, 2014, SCIENCE, V343, P1260, DOI 10.1126/science.1248943; Einarsdottir H, 2014, TRANSFUSION, V54, P665, DOI 10.1111/trf.12334; Goh YS, 2011, IMMUNOLOGY, V133, P74, DOI 10.1111/j.1365-2567.2011.03411.x; Gul N, 2014, J CLIN INVEST, V124, P812, DOI 10.1172/JCI66776; HARA I, 1995, J EXP MED, V182, P1609, DOI 10.1084/jem.182.5.1609; Hubert P, 2011, CANCER RES, V71, P5134, DOI 10.1158/0008-5472.CAN-10-4222; Khera R, 2009, MOL IMMUNOL, V46, P761, DOI 10.1016/j.molimm.2008.09.026; Kim JK, 1999, EUR J IMMUNOL, V29, P2819, DOI 10.1002/(SICI)1521-4141(199909)29:09<2819::AID-IMMU2819>3.0.CO;2-6; KIMURA N, 1987, EUR J IMMUNOL, V17, P1653, DOI 10.1002/eji.1830171121; Kumpel BM, 2003, CLIN EXP IMMUNOL, V132, P81, DOI 10.1046/j.1365-2249.2003.02119.x; Leoh LS, 2015, MOL IMMUNOL, V67, P407, DOI 10.1016/j.molimm.2015.07.001; Macor P, 2007, CANCER RES, V67, P10556, DOI 10.1158/0008-5472.CAN-07-1811; Melis JPM, 2015, MOL IMMUNOL, V67, P117, DOI 10.1016/j.molimm.2015.01.028; Michaelsen TE, 2009, SCAND J IMMUNOL, V70, P553, DOI 10.1111/j.1365-3083.2009.02338.x; MICHAELSEN TE, 1991, EUR J IMMUNOL, V21, P11, DOI 10.1002/eji.1830210103; Michaelsen TE, 2003, BIOCHEM SOC T, V31, P1032; Natsume A, 2008, CANCER RES, V68, P3863, DOI 10.1158/0008-5472.CAN-07-6297; Natsume A, 2009, CANCER SCI, V100, P2411, DOI 10.1111/j.1349-7006.2009.01327.x; Otten MA, 2005, J IMMUNOL, V174, P5472, DOI 10.4049/jimmunol.174.9.5472; Otten MA, 2008, J IMMUNOL, V181, P6829, DOI 10.4049/jimmunol.181.10.6829; Overdijk MB, 2012, J IMMUNOL, V189, P3430, DOI 10.4049/jimmunol.1200356; Patel D, 2008, ANTICANCER RES, V28, P2679; Perri D, 2008, TRANSFUS APHER SCI, V39, P37, DOI 10.1016/j.transci.2008.05.010; Phipps C, 2015, THER ADV HEMATOL, V6, P120, DOI 10.1177/2040620715572295; Racila E, 2008, CLIN CANCER RES, V14, P6697, DOI 10.1158/1078-0432.CCR-08-0745; Recke A, 2010, J AUTOIMMUN, V34, P435, DOI 10.1016/j.jaut.2009.11.003; Rosner T, 2013, BRIT J HAEMATOL, V161, P282, DOI 10.1111/bjh.12209; Rogers LM, 2014, IMMUNOL RES, V59, P203, DOI 10.1007/s12026-014-8542-z; ROZSNYAY Z, 1989, IMMUNOLOGY, V66, P491; Salfeld JG, 2007, NAT BIOTECHNOL, V25, P1369, DOI 10.1038/nbt1207-1369; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Sesarman A, 2010, CELL MOL LIFE SCI, V67, P2533, DOI 10.1007/s00018-010-0318-6; Stapleton NM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1608; Takechi Y, 1996, CLIN CANCER RES, V2, P1837; Te Velde AA, 1992, J IMMUNOL, V149; Tebo AE, 2002, CLIN EXP IMMUNOL, V130, P300, DOI 10.1046/j.1365-2249.2002.01972.x; van der Bij GJ, 2008, CANCER LETT, V262, P77, DOI 10.1016/j.canlet.2007.11.040; van der Bij GJ, 2010, J HEPATOL, V53, P677, DOI 10.1016/j.jhep.2010.04.023; van Spriel AB, 2003, BLOOD, V101, P253, DOI 10.1182/blood.V101.1.253; Vidarsson G, 2001, J IMMUNOL, V166, P6250, DOI 10.4049/jimmunol.166.10.6250; Vidarsson G, 2001, J IMMUNOL METHODS, V249, P245, DOI 10.1016/S0022-1759(00)00337-9; Vidarsson G, 1998, CURR OPIN INFECT DIS, V11, P271, DOI 10.1097/00001432-199806000-00002; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; VIJAYASARADHI S, 1991, EXP CELL RES, V196, P233, DOI 10.1016/0014-4827(91)90256-T; VIJAYASARADHI S, 1995, J CELL BIOL, V130, P807, DOI 10.1083/jcb.130.4.807; WIENER E, 1987, IMMUNOLOGY, V62, P401; ZHOU BK, 1993, J INVEST DERMATOL, V100, P110, DOI 10.1111/1523-1747.ep12462775	60	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177736	10.1371/journal.pone.0177736	http://dx.doi.org/10.1371/journal.pone.0177736			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542406	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672600021
J	Milczarek, A; Starzynski, RR; Stys, A; Jonczy, A; Staron, R; Grzelak, A; Lipinski, P				Milczarek, Anna; Starzynski, Rafal R.; Stys, Agnieszka; Jonczy, Aneta; Staron, Robert; Grzelak, Agnieszka; Lipinski, Pawel			A drastic superoxide-dependent oxidative stress is prerequisite for the down-regulation of IRP1: Insights from studies on SOD1-deficient mice and macrophages treated with paraquat	PLOS ONE			English	Article							CELLULAR IRON HOMEOSTASIS; PROTEIN-1 GENE-EXPRESSION; DISMUTASE; PROTECTION; ACONITASE; ERYTHROPOIESIS; OVEREXPRESSION; METABOLISM; MODULATION; ACTIVATION	Iron regulatory protein 1 (IRP1) is a cytosolic bifunctional [4Fe-4S] protein which exhibits aconitase activity or binds iron responsive elements (IREs) in untranslated regions of specific mRNA encoding proteins involved in cellular iron metabolism. Superoxide radical (O-2(.-)) converts IRP1 from a [4Fe-4S] aconitase to a [3Fe-4S] "null" form possessing neither aconitase nor trans-regulatory activity. Genetic ablation of superoxide dismutase 1 (SOD1), an antioxidant enzyme that acts to reduce O(2)(.-)concentration, revealed a new O-2(.-)-dependent regulation of IRP1 leading to the reduction of IRP1 protein level and in consequence to the diminution of IRP1 enzymatic and IRE-binding activities. Here, we attempted to establish whether developmental changes in SOD1 activity occurring in the mouse liver, impact IRP1 expression. We show no correlation between hepatic SOD1 activity and IRP1 protein level neither in pre-nor postnatal period probably because the magnitude of developmental fluctuations in SOD1 activity is relatively small. The comparison of SOD1 activity in regards to IRP1 protein level in the liver of threeSOD1 genotypes (Sod1(+/+), Sod1(+/-) and Sod1(-/-)) demonstrates that only drastic SOD1 deficiency leads to the reduction of IRP1 protein level. Importantly, we found that in the liver of fetuses lacking SOD1, IRP1 is not down-regulated. To investigate O-2(.-)-dependent regulation of IRP1 in a cellular model, we exposed murine RAW 264.7 and bone marrow-derived macrophages to paraquat, widely used as a redox cycler to stimulate O(2)(.-)production in cells. We showed that IRP1 protein level as well as aconitase and IRE-binding activities are strongly reduced in macrophages treated with paraquat. The analysis of the expression of IRP1-target genes revealed the increase in L-ferritin protein level resulting from the enhanced transcriptional regulation of the LFt gene and diminished translational repression of L-ferritin mRNA by IRP1. We propose that O-2(.-)-dependent up-regulation of this cellular protectant in paraquat-treated macrophages may counterbalance iron-related toxic effects of O-2(.-.)	[Milczarek, Anna; Starzynski, Rafal R.; Stys, Agnieszka; Jonczy, Aneta; Staron, Robert; Lipinski, Pawel] Polish Acad Sci, Inst Genet & Anim Breeding, Dept Mol Biol, Jastrzebiec, Poland; [Grzelak, Agnieszka] Univ Lodz, Dept Mol Biophys, Lodz, Poland	Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; University of Lodz	Lipinski, P (corresponding author), Polish Acad Sci, Inst Genet & Anim Breeding, Dept Mol Biol, Jastrzebiec, Poland.	p.lipinski@ighz.pl		, Rafal/0000-0002-7470-0507; Grzelak, Agnieszka/0000-0002-9695-6693; Jonczy, Aneta/0000-0002-4333-6853	National Center of Science (Narodowe Centrum Nauki) [2011/01/B/NZ3/00632]; National Center of Science [2011/01/B/NZ3/00632]	National Center of Science (Narodowe Centrum Nauki); National Center of Science(National Science Centre, Poland)	This work was supported by grant no. 2011/01/B/NZ3/00632 from the National Center of Science (Narodowe Centrum Nauki) (PL).; This work was supported by grant no. 2011/01/B/NZ3/00632 from the National Center of Science.	Anderson SA, 2013, CELL METAB, V17, P282, DOI 10.1016/j.cmet.2013.01.007; Arosio P, 2010, BBA-GEN SUBJECTS, V1800, P783, DOI 10.1016/j.bbagen.2010.02.005; BAGLEY AC, 1986, P NATL ACAD SCI USA, V83, P3189, DOI 10.1073/pnas.83.10.3189; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BINDER R, 1994, EMBO J, V13, P1969, DOI 10.1002/j.1460-2075.1994.tb06466.x; Bouton C, 1996, J BIOL CHEM, V271, P2300, DOI 10.1074/jbc.271.4.2300; Bouton C, 1997, J BIOL CHEM, V272, P19969, DOI 10.1074/jbc.272.32.19969; Bouton C, 2002, J BIOL CHEM, V277, P31220, DOI 10.1074/jbc.M203276200; Bouton Cecile, 2003, Sci STKE, V2003, ppe17, DOI 10.1126/stke.2003.182.pe17; BRITIGAN BE, 1992, BLOOD, V79, P699; Corasaniti MT, 1998, PHARMACOL TOXICOL, V83, P1, DOI 10.1111/j.1600-0773.1998.tb01434.x; Dimayuga FO, 2007, J NEUROIMMUNOL, V182, P89, DOI 10.1016/j.jneuroim.2006.10.003; Drapier JC, 1996, METHOD ENZYMOL, V269, P26; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fukushima Tetsuhito, 2002, Environ Health Prev Med, V7, P89, DOI 10.1265/ehpm.2002.89; Gajowiak A, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmo1.2015.00082; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Gardner PR, 1997, BIOSCIENCE REP, V17, P33, DOI 10.1023/A:1027383100936; Ghosh MC, 2013, CELL METAB, V17, P271, DOI 10.1016/j.cmet.2012.12.016; HASSAN HM, 1979, J BIOL CHEM, V254, P846; HENTZE MW, 1989, SCIENCE, V244, P357, DOI 10.1126/science.2711187; Hintze KJ, 2005, P NATL ACAD SCI USA, V102, P15048, DOI 10.1073/pnas.0505148102; Keithley EM, 2005, HEARING RES, V209, P76, DOI 10.1016/j.heares.2005.06.009; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Lee M, 2001, J NEUROCHEM, V78, P209, DOI 10.1046/j.1471-4159.2001.00417.x; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; Liochev SI, 1999, IUBMB LIFE, V48, P157, DOI 10.1080/152165499307161; MARTINS EAL, 1995, ARCH BIOCHEM BIOPHYS, V316, P128, DOI 10.1006/abbi.1995.1019; Matzuk MM, 1998, ENDOCRINOLOGY, V139, P4008, DOI 10.1210/en.139.9.4008; MCCORD JM, 1978, FEBS LETT, V86, P139, DOI 10.1016/0014-5793(78)80116-1; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Missirlis F, 2003, J BIOL CHEM, V278, P47365, DOI 10.1074/jbc.M307700200; Mollace V, 2003, NEUROSCI LETT, V335, P163, DOI 10.1016/S0304-3940(02)01168-0; Mueller S, 2001, J BIOL CHEM, V276, P23192, DOI 10.1074/jbc.M100654200; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; Oliveira L, 2000, P NATL ACAD SCI USA, V97, P6550, DOI 10.1073/pnas.120571797; PANTOPOULOS K, 1995, EMBO J, V14, P2917, DOI 10.1002/j.1460-2075.1995.tb07291.x; Patterson AJ, 2010, CURR MOL MED, V10, P653; PHILPOTT CC, 1994, P NATL ACAD SCI USA, V91, P7321, DOI 10.1073/pnas.91.15.7321; Pietsch EC, 2003, J BIOL CHEM, V278, P2361, DOI 10.1074/jbc.M210664200; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; Siggaard-Andersen O, 1995, ACTA ANAESTHESIOL S, P107129; Srinivasan C, 2000, J BIOL CHEM, V275, P29187, DOI 10.1074/jbc.M004239200; Starzynski RR, 2009, BIOCHEM J, V420, P383, DOI 10.1042/BJ20082137; Starzynski RR, 2006, BIOCHEM J, V400, P367, DOI 10.1042/BJ20060623; Starzynski RR, 2005, J BIOL CHEM, V280, P4207, DOI 10.1074/jbc.M411055200; Stys A, 2011, J BIOL CHEM, V286, P22846, DOI 10.1074/jbc.M111.231902; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Van Remmen H, 2004, FREE RADICAL BIO MED, V36, P1625, DOI 10.1016/j.freeradbiomed.2004.03.016; Velayutham M, 2005, ARCH BIOCHEM BIOPHYS, V435, P83, DOI 10.1016/j.abb.2004.11.028; Volz K, 2008, CURR OPIN STRUC BIOL, V18, P106, DOI 10.1016/j.sbi.2007.12.010; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Wilkinson N, 2013, BLOOD, V122, P1658, DOI 10.1182/blood-2013-03-492454	55	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0176800	10.1371/journal.pone.0176800	http://dx.doi.org/10.1371/journal.pone.0176800			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542246	gold, Green Published, Green Submitted			2022-12-26	WOS:000401672600003
J	Nakajima, I; Ban, Y; Azuma, A; Onoue, N; Moriguchi, T; Yamamoto, T; Toki, S; Endo, M				Nakajima, Ikuko; Ban, Yusuke; Azuma, Akifumi; Onoue, Noriyuki; Moriguchi, Takaya; Yamamoto, Toshiya; Toki, Seiichi; Endo, Masaki			CRISPR/Cas9-mediated targeted mutagenesis in grape	PLOS ONE			English	Article							VITIS-VINIFERA; GENETIC-TRANSFORMATION; BIOLISTIC TRANSFORMATION; SOMATIC EMBRYOGENESIS; PLANTS; SYSTEM; ESTABLISHMENT; REGENERATION; CULTIVARS; EMBRYOS	RNA-guided genome editing using the CRISPR/Cas9 CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 (CRISPR-associated protein 9) system has been applied successfully in several plant species. However, to date, there are few reports on the use of any of the current genome editing approaches in grape-an important fruit crop with a large market not only for table grapes but also for wine. Here, we report successful targeted mutagenesis in grape (Vitis vinifera L., cv. Neo Muscat) using the CRISPR/Cas9 system. When a Cas9 expression construct was transformed to embryonic calli along with a synthetic sgRNA expression construct targeting the Vitis vinifera phytoene desaturase (VvPDS) gene, regenerated plants with albino leaves were obtained. DNA sequencing confirmed that the VvPDS gene was mutated at the target site in regenerated grape plants. Interestingly, the ratio of mutated cells was higher in lower, older, leaves compared to that in newly appearing upper leaves. This result might suggest either that the proportion of targeted mutagenized cells is higher in older leaves due to the repeated induction of DNA double strand breaks (DSBs), or that the efficiency of precise DSBs repair in cells of old grape leaves is decreased.	[Nakajima, Ikuko; Ban, Yusuke; Azuma, Akifumi; Onoue, Noriyuki; Moriguchi, Takaya; Yamamoto, Toshiya] Natl Agr & Food Res Org, Inst Fruit Tree & Tea Sci, Tsukuba, Ibaraki, Japan; [Toki, Seiichi; Endo, Masaki] Natl Agr & Food Res Org, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Toki, Seiichi] Yokohama City Univ, Grad Sch Nanobiosci, Kanazawa Ku, Yokohama, Kanagawa, Japan; [Toki, Seiichi] Yokohama City Univ, Kihara Inst Biol Res, Maioka Cho, Yokohama, Kanagawa, Japan; [Ban, Yusuke] Natl Agr & Food Res Org, Western Reg Agr Res Ctr, Nishifukatsu Cho, Fukuyama, Hiroshima, Japan	National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; Yokohama City University; Yokohama City University; National Agriculture & Food Research Organization - Japan	Endo, M (corresponding author), Natl Agr & Food Res Org, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan.	mendo@affrc.go.jp	Ban, Yusuke/AAV-1326-2020; 尾上, 典之/Q-8627-2019; Toki, Seiichi/AAR-1889-2021	ONOUE, Noriyuki/0000-0001-5765-4812	Cabinet Office, Government of Japan; Cross-Ministerial Strategic Innovation Promotion Program (SIP); Bio-oriented Technology Research Advancement Institution, NARO	Cabinet Office, Government of Japan; Cross-Ministerial Strategic Innovation Promotion Program (SIP); Bio-oriented Technology Research Advancement Institution, NARO	This work was supported by the Cabinet Office, Government of Japan, Cross-Ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Bouquet A., 2011, Genetics, genomics, and breeding of grapes, P1; Bouquet A., 2008, COMPENDIUM TRANSGENI, P189, DOI DOI 10.1002/9781405181099.K0407; Boyko A, 2006, PLANT PHYSIOL, V141, P488, DOI 10.1104/pp.105.074658; Fauser F, 2014, PLANT J, V79, P348, DOI 10.1111/tpj.12554; Forner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121056; Gao YB, 2015, P NATL ACAD SCI USA, V112, P2275, DOI 10.1073/pnas.1500365112; Hoshino Y, 1998, PLANT BIOTECHNOL, V15, p29 ; Hyun Y, 2015, PLANTA, V241, P271, DOI 10.1007/s00425-014-2180-5; Iocco P, 2001, TRANSGENIC RES, V10, P105, DOI 10.1023/A:1008989610340; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; KAWALLECK P, 1993, PLANT MOL BIOL, V21, P673, DOI 10.1007/BF00014550; Kikkert JR, 1996, PLANT CELL REP, V15, P311, DOI 10.1007/BF00232362; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Malnoy M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01904; MARTINELLI L, 1994, THEOR APPL GENET, V88, P621, DOI 10.1007/BF01253963; MATSUTA N, 1989, PLANT CELL REP, V7, P684, DOI 10.1007/BF00272061; MATSUTA N, 1992, JPN J BREED, V42, P879; Mikami M, 2015, PLANT CELL REP, V34, P1807, DOI 10.1007/s00299-015-1826-5; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakajima I, 2006, J JPN SOC HORTIC SCI, V75, P188, DOI 10.2503/jjshs.75.188; Nakajima I, 2003, VITIS, V42, P53; Nakajima I, 2000, J JPN SOC HORTIC SCI, V69, P186, DOI 10.2503/jjshs.69.186; Nakano M, 1997, VITIS, V36, P141; NITSCH JP, 1969, SCIENCE, V163, P85, DOI 10.1126/science.163.3862.85; Perl A, 1996, NAT BIOTECHNOL, V14, P624, DOI 10.1038/nbt0596-624; RAJASEKARAN K, 1983, AM J ENOL VITICULT, V34, P108; Ren C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32289; SRINIVASAN C, 1980, SCI HORTIC-AMSTERDAM, V13, P245, DOI 10.1016/0304-4238(80)90062-X; Tang X, 2016, MOL PLANT, V9, P1088, DOI 10.1016/j.molp.2016.05.001; Vidal JR, 2006, PLANT CELL REP, V25, P807, DOI 10.1007/s00299-006-0132-7; Wang YM, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0233-5; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Yamamoto T, 2000, PLANT CELL REP, V19, P639, DOI 10.1007/s002999900174; Zhou Q, 2014, PLANT CELL TISS ORG, V118, P157, DOI 10.1007/s11240-014-0471-y	35	92	97	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177966	10.1371/journal.pone.0177966	http://dx.doi.org/10.1371/journal.pone.0177966			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542349	gold, Green Published, Green Submitted			2022-12-26	WOS:000401672400122
J	Zaldo, C; Serrano, MD; Han, XM; Cascales, C; Cantero, M; Montoliu, L; Arza, E; Caiolfa, VR; Zamai, M				Zaldo, Carlos; Dolores Serrano, Maria; Han, Xiumei; Cascales, Concepcion; Cantero, Marta; Montoliu, Lluis; Arza, Elvira; Caiolfa, Valeria R.; Zamai, Moreno			Efficient up-conversion in Yb:Er:NaT(XO4)(2) thermal nanoprobes. Imaging of their distribution in a perfused mouse	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; NANOPARTICLES; PHOTOLUMINESCENCE; LUMINESCENCE; CRYSTALS; MICROSCOPY; GREEN; CELL; NABI(XO4)(2); NANOCRYSTALS	Yb and Er codoped NaT(XO4)(2) (T = Y, La, Gd, Lu and X = Mo, W) disordered oxides show a green (Er3+ related) up-conversion (UC) efficiency comparable to that of Yb:Er:beta-NaYF4 compound and unless 3 times larger UC ratiometric thermal sensitivity. The similar UC efficiency of Yb:Er doped NaT(XO4)(2) and beta-NaYF4 compounds allowed testing equal subcutaneous depths of ex-vivo chicken tissue in both cases. This extraordinary behavior for NaT (XO4)(2) oxides with large cutoff phonon energy (h omega approximate to 920 cm(-1)) is ascribed to F-4(9/2) electron population recycling to higher energy (4)G(11/2) level by a phonon assisted transition. Crystalline nanoparticles of Yb:Er:NaLu(MoO4)(2) have been synthesized by sol-gel with sizes most commonly in the 50-80 nm range, showing a relatively small reduction of the UC efficiency with regards to bulk materials. Fluorescence lifetime and multiphoton imaging microscopies show that these nanoparticles can be efficiently distributed to all body organs of a perfused mouse.	[Zaldo, Carlos; Dolores Serrano, Maria; Han, Xiumei; Cascales, Concepcion] CSIC, ICMM, Madrid, Spain; [Cantero, Marta; Montoliu, Lluis] CSIC, CNB, Dept Biol Mol & Celular, Madrid, Spain; [Cantero, Marta; Montoliu, Lluis] Inst Salud Carlos III ISCIII, CIBERER, Madrid, Spain; [Arza, Elvira; Caiolfa, Valeria R.; Zamai, Moreno] CNIC, Unidad Microscope & Imagen Dinam, Madrid, Spain; [Caiolfa, Valeria R.] Osped San Raffaele, Ctr Imaging Sperimentale, Milan, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Zaldo, C (corresponding author), CSIC, ICMM, Madrid, Spain.	cezaldo@icmm.csic.es	Zaldo, Carlos/K-4321-2013; Serrano, Maria Dolores/B-9629-2013; CASCALES, Concepción/C-3930-2011; Caiolfa, Valeria R./H-2769-2015; Zamai, Moreno/H-5923-2015	Zaldo, Carlos/0000-0001-9586-7771; Serrano, Maria Dolores/0000-0001-7754-0417; CASCALES, Concepción/0000-0003-2513-5887; Arza, Elvira/0000-0001-9626-047X; Cantero Gonzalez, Marta Maria/0000-0001-6554-906X; Caiolfa, Valeria R./0000-0003-4814-6490; Zamai, Moreno/0000-0002-2222-6815	Ministry of Economy and Competitiveness; European Regional Development Fund [MAT2014-56607-R]; Spanish Ministry of Economy and Competitiveness support as a Severo Ochoa Center of Excellence [SEV-2015-0505]; Pro CNIC Foundation; Ministry of Economy, Industry and Competitiveness (MEIC)	Ministry of Economy and Competitiveness; European Regional Development Fund(European Commission); Spanish Ministry of Economy and Competitiveness support as a Severo Ochoa Center of Excellence; Pro CNIC Foundation; Ministry of Economy, Industry and Competitiveness (MEIC)	The authors thankfully acknowledge the financial support by Ministry of Economy and Competitiveness and the European Regional Development Fund grant number MAT2014-56607-R, the Spanish Ministry of Economy and Competitiveness support as a Severo Ochoa Center of Excellence, grant nunber SEV-2015-0505, and by the Pro CNIC Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been supported by the Ministry of Economy and Competitiveness (MINECO) and by the European Regional Development Fund through MAT2014-56607-R project. The CNIC is supported by the Ministry of Economy, Industry and Competitiveness (MEIC) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505). Optical microscopy was carried out at the Molecular and Functional Imaging Unit, ICTS ReDIB TRIMA@CNIC. The authors are in debt with the histology facility of CNB-CSIC for tissue section preparation and with A. M. Santos Beneit (CNIC) for his help in image analysis.	Ajithkumar G, 2013, J MATER CHEM B, V1, P1561, DOI 10.1039/c3tb00551h; Ang LY, 2011, NANOMEDICINE-UK, V6, P1273, DOI [10.2217/nnm.11.108, 10.2217/NNM.11.108]; Auzel F, 1980, RADIATIONLESS PROCES, P213; Barreiro O, 2008, J CELL BIOL, V183, P527, DOI 10.1083/jcb.200805076; Boyer JC, 2010, NANOSCALE, V2, P1417, DOI 10.1039/c0nr00253d; Chen GY, 2014, CHEM REV, V114, P5161, DOI 10.1021/cr400425h; Cheng L, 2013, NANOSCALE, V5, P23, DOI 10.1039/c2nr32311g; Colyer RA, 2008, MICROSC RES TECHNIQ, V71, P201, DOI 10.1002/jemt.20540; Cui LR, 2015, J MATER CHEM B, V3, P7046, DOI 10.1039/c5tb00709g; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Serrano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059381; Elson D, 2004, PHOTOCH PHOTOBIO SCI, V3, P795, DOI 10.1039/b316456j; Esteban-Betegon F, 2010, CHEM MATER, V22, P2315, DOI 10.1021/cm9032622; Garcia-Cortes A, 2007, IEEE J QUANTUM ELECT, V43, P157, DOI 10.1109/JQE.2006.886450; Gimenez E, 2001, GENESIS, V30, P21, DOI 10.1002/gene.1028; Grzechnik A, 2002, J SOLID STATE CHEM, V165, P159, DOI 10.1006/jssc.2001.9525; Haase M, 2011, ANGEW CHEM INT EDIT, V50, P5808, DOI 10.1002/anie.201005159; Han X, 2007, CHEM MATER, V19, P3002, DOI 10.1021/cm070237v; Han XM, 2010, PHYSCS PROC, V8, P18, DOI 10.1016/j.phpro.2010.10.005; Huang K, 2016, SMALL, V12, P836, DOI 10.1002/smll.201502722; Idris NM, 2009, BIOMATERIALS, V30, P5104, DOI 10.1016/j.biomaterials.2009.05.062; Jaque D, 2016, ADV OPT PHOTONICS, V8, P1, DOI 10.1364/AOP.8.000001; Jiang S, 2013, NANOSCALE, V5, P3127, DOI 10.1039/c3nr34005h; Jiang S, 2010, J APPL PHYS, V108, DOI 10.1063/1.3499301; Kim CS, 2013, ADV DRUG DELIVER REV, V65, P93, DOI 10.1016/j.addr.2012.08.011; Kumar KU, 2013, J NANOSCI NANOTECHNO, V13, P6841, DOI 10.1166/jnn.2013.7788; Li AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep31366; Li T, 2015, J AM CERAM SOC, V98, P2812, DOI 10.1111/jace.13698; Liao JS, 2010, MATER RES BULL, V45, P1145, DOI 10.1016/j.materresbull.2010.05.027; Liu SJ, 2014, ACS APPL MATER INTER, V6, P11013, DOI 10.1021/am5035158; Marquez G, 1998, APPL OPTICS, V37, P798, DOI 10.1364/AO.37.000798; Monici M, 2005, BIOTECHNOL ANN REV, V11, P227, DOI 10.1016/S1387-2656(05)11007-2; Nadort A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063292; Nirmal M, 1996, NATURE, V383, P802, DOI 10.1038/383802a0; Page RH, 1998, J OPT SOC AM B, V15, P996, DOI 10.1364/JOSAB.15.000996; Provenzano PP, 2009, CLIN EXP METASTAS, V26, P357, DOI 10.1007/s10585-008-9204-0; Renero-Lecuna C, 2011, CHEM; Rico M, 2002, CHEM PHYS, V279, P73, DOI 10.1016/S0301-0104(02)00486-X; Rico M, 2001, J ALLOY COMPD, V323, P806, DOI 10.1016/S0925-8388(01)01149-5; Rode E. Ya., 1971, RUSS J INORG CHEM, V16, P905; Sedlmeier A, 2012, NANOSCALE, V4, P7090, DOI 10.1039/c2nr32314a; Siegel J, 2003, APPL OPTICS, V42, P2995, DOI 10.1364/AO.42.002995; Song F, 2006, OPT COMMUN, V259, P179, DOI 10.1016/j.optcom.2005.08.049; Stringari C, 2011, P NATL ACAD SCI USA, V108, P13582, DOI 10.1073/pnas.1108161108; Vetrone F, 2010, ACS NANO, V4, P3254, DOI 10.1021/nn100244a; Volkov V, 2002, J PHYS CHEM SOLIDS, V63, P95, DOI 10.1016/S0022-3697(01)00084-1; Voron'ko YK, 2000, INORG MATER+, V36, P947, DOI 10.1007/BF02758711; Wang HJ, 2014, ACS APPL MATER INTER, V6, P3219, DOI 10.1021/am500097f; Wang H, 2016, ACS APPL MATER INTER, V8, P4416, DOI 10.1021/acsami.5b11197; Wang W, 2014, ACS APPL MATER INTER, V6, P340, DOI 10.1021/am404389g; Barrera EW, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/7/075205; Xu H, 2011, BIOMATERIALS, V32, P9364, DOI 10.1016/j.biomaterials.2011.08.053; Yang J, 2009, CHEM-EUR J, V15, P4649, DOI 10.1002/chem.200802106; Yang XX, 2015, J AM CERAM SOC, V98, P2595, DOI 10.1111/jace.13624; Zhang F, 2015, NANOSTRUCTURE SCI TE; Zheng H, 2014, J COLLOID INTERF SCI, V420, P27, DOI 10.1016/j.jcis.2013.12.059	56	6	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177596	10.1371/journal.pone.0177596	http://dx.doi.org/10.1371/journal.pone.0177596			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542327	gold, Green Published, Green Submitted			2022-12-26	WOS:000401672400055
J	Bhamla, MS; Chai, C; Alvarez-Valenzuela, MA; Tajuelo, J; Fuller, GG				Bhamla, M. Saad; Chai, Chew; Alvarez-Valenzuela, Marco A.; Tajuelo, Javier; Fuller, Gerald G.			Interfacial mechanisms for stability of surfactant-laden films	PLOS ONE			English	Article							MARGINAL REGENERATION; ASYMMETRIC DRAINAGE; THIN; MODEL; DEPOSITION; FLOW	Thin liquid films are central to everyday life. They are ubiquitous in modern technology (pharmaceuticals, coatings), consumer products (foams, emulsions) and also serve vital biological functions (tear film of the eye, pulmonary surfactants in the lung). A common feature in all these examples is the presence of surface-active molecules at the air-liquid interface. Though they form only molecular-thin layers, these surfactants produce complex surface stresses on the free surface, which have important consequences for the dynamics and stability of the underlying thin liquid film. Here we conduct simple thinning experiments to explore the fundamental mechanisms that allow the surfactant molecules to slow the gravity-driven drainage of the underlying film. We present a simple model that works for both soluble and insoluble surfactant systems in the limit of negligible adsorption-desorption dynamics. We show that surfactants with finite surface rheology influence bulk flow through viscoelastic interfacial stresses, while surfactants with inviscid surfaces achieve stability through opposing surface-tension induced Marangoni flows.	[Bhamla, M. Saad] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Chai, Chew; Fuller, Gerald G.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Alvarez-Valenzuela, Marco A.] Univ Carlos III Madrid, Dept Mech Engn, Leganes 28911, Spain; [Tajuelo, Javier] Univ Nacl Educ Distancia, Dept Fis Fundamental, Madrid 28040, Spain	Stanford University; Stanford University; Universidad Carlos III de Madrid; Universidad Nacional de Educacion a Distancia (UNED)	Bhamla, MS (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	saadbhamla@gmail.com	Bhamla, M. Saad/L-3174-2013; Bhamla, Saad/K-8398-2019	Bhamla, M. Saad/0000-0002-9788-9920; Bhamla, Saad/0000-0002-9788-9920; Tajuelo, Javier/0000-0002-4085-7610; Fuller, Gerald/0000-0002-2924-053X	UNED's Researchers Formation Program; MINECO [FIS2013-47350-C5-5-R]	UNED's Researchers Formation Program; MINECO(Spanish Government)	The authors received no specific funding for this work. However, J.T. acknowledges a personal grant from UNED's Researchers Formation Program and partial support from MINECO (Grant FIS2013-47350-C5-5-R).; The authors would like to thank Daniele Tammaro and John Frostad for useful discussions. J. T. acknowledges a grant from UNED's Researchers Formation Program and partial support from MINECO (Grant FIS2013-47350-C5-5-R).	Anton N, 2013, SOFT MATTER, V9, P10081, DOI 10.1039/c3sm51688a; Behera MR, 2014, IND ENG CHEM RES, V53, P18497, DOI 10.1021/ie503591v; Bhamla MS, 2015, J COLLOID INTERF SCI, V449, P428, DOI 10.1016/j.jcis.2015.01.002; Bhamla MS, 2014, SOFT MATTER, V10, P6917, DOI 10.1039/c3sm52934g; Bird JC, 2010, NATURE, V465, P759, DOI 10.1038/nature09069; Choi SQ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1321; Cooper A, 2010, BIOPHYS CHEM, V151, P96, DOI 10.1016/j.bpc.2010.06.006; Debregeas G, 1998, SCIENCE, V279, P1704, DOI 10.1126/science.279.5357.1704; Feng J, 2014, NAT PHYS, V10, P606, DOI 10.1038/NPHYS3003; Hermans E, 2015, SOFT MATTER, V11, P8048, DOI 10.1039/c5sm01603g; Hermans E, 2014, SOFT MATTER, V10, P175, DOI 10.1039/c3sm52091a; HUDALES JBM, 1990, J COLLOID INTERF SCI, V138, P354, DOI 10.1016/0021-9797(90)90218-D; JOYE JL, 1994, LANGMUIR, V10, P3174, DOI 10.1021/la00021a046; Joye JL, 1996, J COLLOID INTERF SCI, V177, P542, DOI 10.1006/jcis.1996.0068; Kim K, 2013, P NATL ACAD SCI USA, V110, pE3054, DOI 10.1073/pnas.1303304110; Leal L, 2007, ADV TRANSPORT PHENOM, V1st; LYKLEMA J, 1965, J PHYS CHEM-US, V69, P116, DOI 10.1021/j100885a018; MYSELS KJ, 1962, J COLL SCI IMP U TOK, V17, P136, DOI 10.1016/0095-8522(62)90004-1; Naire S, 2000, J COLLOID INTERF SCI, V230, P91, DOI 10.1006/jcis.2000.7081; Naire S, 2004, J COMPUT APPL MATH, V166, P385, DOI 10.1016/j.cam.2003.08.039; Naire S, 2001, PHYS FLUIDS, V13, P2492, DOI 10.1063/1.1388540; Nierstrasz VA, 2001, J COLLOID INTERF SCI, V234, P162, DOI 10.1006/jcis.2000.7290; Nierstrasz VA, 1999, J COLLOID INTERF SCI, V215, P28, DOI 10.1006/jcis.1999.6226; Nierstrasz VA, 1998, J COLLOID INTERF SCI, V207, P209, DOI 10.1006/jcis.1998.5646; NIKOLOV AD, 1990, PROG COLL POL SCI S, V82, P87; Patist A, 2001, COLLOID SURFACE A, V176, P3, DOI 10.1016/S0927-7757(00)00610-5; RADOEV BP, 1983, J COLLOID INTERF SCI, V95, P254, DOI 10.1016/0021-9797(83)90094-2; Ramdane OO, 1997, LANGMUIR, V13, P2911; Shen AQ, 2002, PHYS FLUIDS, V14, P4055, DOI 10.1063/1.1512287; STEBE KJ, 1991, PHYS FLUIDS A-FLUID, V3, P3, DOI 10.1063/1.857862; STEIN HN, 1991, ADV COLLOID INTERFAC, V34, P175, DOI 10.1016/0001-8686(91)80050-T; Sureshbabu N, 2009, EUR BIOPHYS J BIOPHY, V38, P355, DOI 10.1007/s00249-008-0379-8; Zell ZA, 2014, P NATL ACAD SCI USA, V111, P3677, DOI 10.1073/pnas.1315991111	33	30	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0175753	10.1371/journal.pone.0175753	http://dx.doi.org/10.1371/journal.pone.0175753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520734	Green Published, gold, Green Submitted			2022-12-26	WOS:000401487700007
J	Galan, M; Varona, S; Guadall, A; Orriols, M; Navas, M; Aguilo, S; de Diego, A; Navarro, MA; Garcia-Dorado, D; Rodriguez-Sinovas, A; Martinez-Gonzalez, J; Rodriguez, C				Galan, Maria; Varona, Saray; Guadall, Anna; Orriols, Mar; Navas, Miquel; Aguilo, Silvia; de Diego, Alicia; Navarro, Maria A.; Garcia-Dorado, David; Rodriguez-Sinovas, Antonio; Martinez-Gonzalez, Jose; Rodriguez, Cristina			Lysyl oxidase overexpression accelerates cardiac remodeling and aggravates angiotensin II-induced hypertrophy	FASEB JOURNAL			English	Article						reactive oxygen species; extracellular matrix; reactive oxygen species	COLLAGEN CROSS-LINKING; NF-KAPPA-B; HEART-FAILURE; MYOCARDIAL HYPERTROPHY; FIBROSIS; EXPRESSION; FIBROBLASTS; PATHWAYS; MICE; CELL	Lysyl oxidase (LOX) controls matrix remodeling, a key process that underlies cardiovascular diseases and heart failure; however, a lack of suitable animal models has limited our knowledge with regard to the contribution of LOX to cardiac dysfunction. Here, we assessed the impact of LOX overexpression on ventricular function and cardiac hypertrophy in a transgenic LOX (TgLOX) mouse model with a strong cardiac expression of human LOX. TgLOX mice exhibited high expression of the transgene in cardiomyocytes and cardiofibroblasts, which are associated with enhanced LOX activity and H2O2 production and with cardiofibroblast reprogramming. LOX overexpression promoted an age-associated concentric remodeling of the left ventricle and impaired diastolic function. Furthermore, LOX transgenesis aggravated angiotensin II (Ang II)-induced cardiac hypertrophy and dysfunction, which triggered a greater fibrotic response that was characterized by stronger collagen deposition and cross-linking and high expression of fibrotic markers. In addition, LOX transgenesis increased the Ang II-induced myocardial inflammatory infiltrate, exacerbated expression of proinflammatory markers, and decreased that of cardioprotective factors. Mechanistically, LOX over-expression enhanced oxidative stress and potentiated the Ang II-mediated cardiac activation of p38 MAPK while reducing AMPK activation. Our findings suggest that LOX induces an age-dependent disturbance of diastolic function and aggravates Ang II-induced hypertrophy, which provides novel insights into the role of LOX in cardiac performance.	[Galan, Maria; Varona, Saray; Guadall, Anna; Orriols, Mar; Aguilo, Silvia; Rodriguez, Cristina] Inst Catala Ciencies Cardiovasc, Barcelona, Spain; [Galan, Maria; Navas, Miquel] Hosp Santa Creu & Sant Pau, Lab Angiol Biol Vasc & Inflamac, Barcelona, Spain; [Galan, Maria; Navas, Miquel] Hosp Santa Creu & Sant Pau, Serv Cirugia Vasc, Barcelona, Spain; [Galan, Maria; Varona, Saray; Guadall, Anna; Orriols, Mar; Navas, Miquel; Aguilo, Silvia; Martinez-Gonzalez, Jose; Rodriguez, Cristina] Inst Invest Biomed IIB St Pau, Barcelona, Spain; [Galan, Maria; Varona, Saray; Orriols, Mar; Garcia-Dorado, David; Rodriguez-Sinovas, Antonio; Martinez-Gonzalez, Jose; Rodriguez, Cristina] Ctr Invest Biomed Red Enfermedades Cardiovasc, Madrid, Spain; [de Diego, Alicia] Inst Aragones Ciencias Salud, Unidad Transgenesis, Zaragoza, Spain; [Navarro, Maria A.] Univ Zaragoza, Fac Vet, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Zaragoza, Spain; [Garcia-Dorado, David; Rodriguez-Sinovas, Antonio] Univ Autonoma Barcelona, Cardiovasc Dis Res Grp, Dept Cardiol, Vall dHebron Univ Hosp, Barcelona, Spain; [Garcia-Dorado, David; Rodriguez-Sinovas, Antonio] Univ Autonoma Barcelona, Res Inst, Barcelona, Spain; [Martinez-Gonzalez, Jose] Inst Invest Biomed Barcelona, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Zaragoza; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona	Martinez-Gonzalez, J; Rodriguez, C (corresponding author), Hosp Santa Creu & Sant Pau, Pabellon Inst Catala Ciencies Cardiovasc, C Antoni Maria Claret 167, Barcelona 08025, Spain.	jose.martinez@iibb.csic.es; crodriguezs@csic-iccc.org	Guadall, Anna/I-1709-2014; Rodriguez, Cristina/D-3099-2011; Arroyo, Maria Galán/S-3173-2018; Guadall, Anna/AAG-1691-2019; Navarro, Ángeles/AAG-6089-2019; Rodriguez-Sinovas, Antonio/A-8259-2010	Guadall, Anna/0000-0002-7821-8582; Rodriguez, Cristina/0000-0002-6472-5647; Arroyo, Maria Galán/0000-0002-4758-8388; Guadall, Anna/0000-0002-7821-8582; Rodriguez-Sinovas, Antonio/0000-0003-2930-8773; Navas Madronal, Miquel/0000-0003-2984-1471; de Diego, Alicia/0000-0001-7018-4018; Martinez-Gonzalez, Jose/0000-0002-3894-7166; alvarez, saray/0000-0002-7375-313X	Spanish Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII) [PI15/01016, SAF2015-64767-R, RD12/0042/0021, RD12/0042/0053]; Fundacio La Marato de TV3 [20152330, 20153610]; Fondo Europeo de Desarrollo Regional, a way to build Europe; Miguel Servet Program (ISCIII) [CP15/00126]	Spanish Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII); Fundacio La Marato de TV3; Fondo Europeo de Desarrollo Regional, a way to build Europe; Miguel Servet Program (ISCIII)	This work was cofunded by the Spanish Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII) (Grants PI15/01016, SAF2015-64767-R, RD12/0042/0021 and RD12/0042/0053), Fundacio La Marato de TV3 (20152330 and 20153610), and the Fondo Europeo de Desarrollo Regional, a way to build Europe. Centros de Investigacion Biomedica en Red de Enfermedades Cardiovasculares is an initiative of ISCIII. M.G. was supported by the Miguel Servet Program (ISCIII; CP15/00126). The authors thank Iris Rodriguez (Institut de Recerca Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau) for technical assistance.	Adam O, 2011, J MOL CELL CARDIOL, V50, P678, DOI 10.1016/j.yjmcc.2010.12.019; Aguado A, 2013, TOXICOL APPL PHARM, V268, P188, DOI 10.1016/j.taap.2013.01.030; Badenhorst D, 2003, CARDIOVASC RES, V57, P632, DOI 10.1016/S0008-6363(02)00733-2; Baicu CF, 2003, AM J PHYSIOL-HEART C, V284, pH122, DOI 10.1152/ajpheart.00233.2002; Barry SP, 2010, INT REV CEL MOL BIO, V284, P113, DOI 10.1016/S1937-6448(10)84003-1; Bendall JK, 2002, CIRCULATION, V105, P293, DOI 10.1161/hc0302.103712; Biernacka A, 2011, AGING DIS, V2, P158; Chou DK, 2007, TOXICOL SCI, V99, P267, DOI 10.1093/toxsci/kfm158; Fischer P, 2007, BASIC RES CARDIOL, V102, P279, DOI 10.1007/s00395-007-0658-z; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Frieler RA, 2015, CIRCULATION, V131, P1019, DOI 10.1161/CIRCULATIONAHA.114.008788; Galan M, 2016, DIS MODEL MECH, V9, P541, DOI 10.1242/dmm.024513; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; HIROTA H, 1995, P NATL ACAD SCI USA, V92, P4862, DOI 10.1073/pnas.92.11.4862; Kasner M, 2011, J AM COLL CARDIOL, V57, P977, DOI 10.1016/j.jacc.2010.10.024; Kawano S, 2005, CARDIOVASC RES, V67, P689, DOI 10.1016/j.cardiores.2005.04.030; Koshy SKG, 2003, CARDIOVASC RES, V57, P594, DOI 10.1016/S0008-6363(02)00877-5; Kurdi M, 2011, HYPERTENSION, V57, P1034, DOI 10.1161/HYPERTENSIONAHA.111.172700; Lopez BA, 2013, CARDIOVASC RES, V99, P111, DOI 10.1093/cvr/cvt100; Lopez B, 2012, HYPERTENSION, V60, P677, DOI 10.1161/HYPERTENSIONAHA.112.196113; Lopez B, 2010, AM J PHYSIOL-HEART C, V299, pH1, DOI 10.1152/ajpheart.00335.2010; Luo YX, 2017, EUR HEART J, V38, P1389, DOI 10.1093/eurheartj/ehw138; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Martinez-Martinez E, 2016, J MOL CELL CARDIOL, V92, P96, DOI 10.1016/j.yjmcc.2016.01.012; Moore-Morris T, 2014, J CLIN INVEST, V124, P2921, DOI 10.1172/JCI74783; Murdoch CE, 2014, J AM COLL CARDIOL, V63, P2734, DOI 10.1016/j.jacc.2014.02.572; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Nave AH, 2014, ARTERIOSCL THROM VAS, V34, P1446, DOI 10.1161/ATVBAHA.114.303534; Orriols M, 2014, THROMB HAEMOSTASIS, V112, P812, DOI 10.1160/TH14-01-0024; Planavila A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3019; Qi D, 2015, TRENDS ENDOCRIN MET, V26, P422, DOI 10.1016/j.tem.2015.05.010; Rodriguez C, 2008, CARDIOVASC RES, V79, P7, DOI 10.1093/cvr/cvn102; Rodriguez C, 2008, DRUG NEWS PERSPECT, V21, P218, DOI 10.1358/dnp.2008.21.4.1213351; Rodriguez-Calvo R, 2013, HUM MOL GENET, V22, P1949, DOI 10.1093/hmg/ddt042; Sano M, 2001, CIRC RES, V89, P661, DOI 10.1161/hh2001.098873; Shimizu I, 2016, J MOL CELL CARDIOL, V97, P245, DOI 10.1016/j.yjmcc.2016.06.001; Tanajak P, 2015, J ENDOCRINOL, V227, pR13, DOI 10.1530/JOE-15-0289; Toyoda M, 2003, DEV CELL, V5, P85, DOI 10.1016/S1534-5807(03)00189-8; Tsutamoto T, 1998, J AM COLL CARDIOL, V31, P391, DOI 10.1016/S0735-1097(97)00494-4; Yang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13710	41	34	36	2	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3787	3799		10.1096/fj.201601157RR	http://dx.doi.org/10.1096/fj.201601157RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28522596				2022-12-26	WOS:000408713300008
J	Schoonaert, L; Rue, L; Roucourt, B; Timmers, M; Little, S; Chavez-Gutierrez, L; Dewilde, M; Joyce, P; Curnock, A; Weber, P; Haustraete, J; Hassanzadeh-Ghassabeh, G; De Strooper, B; Van den Bosch, L; Van Damme, P; Lemmens, R; Robberecht, W				Schoonaert, Lies; Rue, Laura; Roucourt, Bart; Timmers, Mieke; Little, Susan; Chavez-Gutierrez, Lucia; Dewilde, Maarten; Joyce, Peter; Curnock, Adam; Weber, Peter; Haustraete, Jurgen; Hassanzadeh-Ghassabeh, Gholamreza; De Strooper, Bart; Van den Bosch, Ludo; Van Damme, Philip; Lemmens, Robin; Robberecht, Wim			Identification and characterization of Nanobodies targeting the EphA4 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-DOMAIN ANTIBODIES; BLOOD-BRAIN-BARRIER; CORTICOSPINAL TRACT AXONS; CYCLIC PEPTIDE ANTAGONIST; SPINAL-CORD-INJURY; SMALL MOLECULES; NERVOUS-SYSTEM; EPHRIN-BINDING; FUSION PROTEIN; REGENERATION	The ephrin receptor A4 (EphA4) is one of the receptors in the ephrin system that plays a pivotal role in a variety of cell-cell interactions, mostly studied during development. In addition, EphA4 has been found to play a role in cancer biology as well as in the pathogenesis of several neurological disorders such as stroke, spinal cord injury, multiple sclerosis, amyotrophic lateral sclerosis (ALS), and Alzheimer's disease. Pharmacological blocking of EphA4 has been suggested to be a therapeutic strategy for these disorders. Therefore, the aim of our study was to generate potent and selective Nanobodies against the ligand-binding domain of the human EphA4 receptor. Weidentified two Nanobodies, Nb 39 and Nb 53, that bind EphA4 with affinities in the nanomolar range. These Nanobodies were most selective for EphA4, with residual binding to EphA7 only. Using Alphascreen technology, we found that both Nanobodies displaced all known EphA4-binding ephrins from the receptor. Furthermore, Nb39 andNb53 inhibited ephrin-induced phosphorylationoftheEphA4proteininacell-basedassay. Finally, in a cortical neuron primary culture, both Nanobodies were able to inhibit endogenous EphA4-mediated growth-cone collapse induced by ephrin-B3. Our results demonstrate the potential of Nanobodies to target the ligand-binding domain of EphA4. These Nanobodiesmaydeservefurtherevaluationaspotentialtherapeutics in disorders in which EphA4-mediated signaling plays a role.	[Schoonaert, Lies; Rue, Laura; Timmers, Mieke; Van den Bosch, Ludo; Van Damme, Philip; Lemmens, Robin; Robberecht, Wim] KU Leuven Univ Leuven, Dept Neurosci, Expt Neurol, B-3000 Leuven, Belgium; [Schoonaert, Lies; Rue, Laura; Timmers, Mieke; Chavez-Gutierrez, Lucia; Dewilde, Maarten; De Strooper, Bart; Van den Bosch, Ludo; Van Damme, Philip; Lemmens, Robin; Robberecht, Wim] Leuven Res Inst Neurosci & Dis LIND, B-3000 Leuven, Belgium; [Schoonaert, Lies; Rue, Laura; Timmers, Mieke; Chavez-Gutierrez, Lucia; Dewilde, Maarten; De Strooper, Bart; Van den Bosch, Ludo; Van Damme, Philip; Lemmens, Robin] VIB, Ctr Brain & Dis Res, Neurobiol Lab, B-3000 Leuven, Belgium; [Roucourt, Bart] KU Leuven Univ Leuven, Lab Signal Integrat Cell Fate Decis, B-3000 Leuven, Belgium; [Little, Susan; Joyce, Peter; Curnock, Adam; Weber, Peter] Vertex Pharmaceut Europe Ltd, Dept Biol, Abingdon OX14 4RW, Oxon, England; [Chavez-Gutierrez, Lucia; Dewilde, Maarten; De Strooper, Bart] Katholieke Univ Leuven, Dept Neurosci, B-3000 Leuven, Belgium; [Haustraete, Jurgen] Univ Ghent, Inflammat Res Ctr, Prot Serv Facil, VIB, B-9052 Ghent, Belgium; [Hassanzadeh-Ghassabeh, Gholamreza] Vrije Univ Brussel, Nanobody Serv Facil, V1B, B-1050 Brussels, Belgium; [De Strooper, Bart] UCL, Inst Neurol, London WC1E 6BT, England; [Van Damme, Philip; Lemmens, Robin; Robberecht, Wim] Univ Hosp Leuven, Dept Neurol, B-3000 Leuven, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Vertex Pharmaceuticals; KU Leuven; Flanders Institute for Biotechnology (VIB); Ghent University; Vrije Universiteit Brussel; University of London; University College London; KU Leuven; University Hospital Leuven	Robberecht, W (corresponding author), Katholieke Univ Leuven, Neurobiol Lab, Campus Gasthuisberg,O&N4 Herestr 49 Box 602, Leuven, Belgium.	Wim.Robberecht@kuleuven.be	de+Strooper, Bart/Z-1638-2019; Van Damme, Philip/A-6464-2009; Weber, Peter Kilian/AAP-9517-2020	Van Damme, Philip/0000-0002-4010-2357; Weber, Peter Kilian/0000-0001-6022-6050; Van Den Bosch, Ludo/0000-0003-0104-4067; Dewilde, Maarten/0000-0002-3138-281X; Rue, Laura/0000-0001-5415-5153; Lemmens, Robin/0000-0002-4948-5956	VIB; KU Leuven-University of Leuven [GOA/11/014]; Vertex Pharmaceuticals Inc.; Research Foundation Flanders (FWO-Vlaanderen) [G.0996.14N]; ALS League Belgium; Thierry Latran Foundation; Geneeskundige Stichting Koningin Elisabeth (G.S.K.E.); Laevers Fund for ALS Research; Fund "Een Hart voor ALS"; European Community [259867]; European Research Council; European's Seventh Framework Programme (FP7)/ERC [340429]; structural funding for medium-scale research infrastructure (HERCULES) [AUGE/09/040]; Agency for Innovation by Science and Technology in Flanders (IWT-Vlaanderen) [101318, IWT-VIND 135043]; Cure Alzheimer's Fund; "Opening the Future" Fund from the KU Leuven-University of Leuven; Research Fund KU Leuven; E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders, from the KU Leuven-University of Leuven; MRC [MC_PC_17116] Funding Source: UKRI; Medical Research Council [MC_PC_17116] Funding Source: researchfish	VIB; KU Leuven-University of Leuven(KU Leuven); Vertex Pharmaceuticals Inc.(Vertex Pharmaceuticals); Research Foundation Flanders (FWO-Vlaanderen)(FWO); ALS League Belgium; Thierry Latran Foundation; Geneeskundige Stichting Koningin Elisabeth (G.S.K.E.); Laevers Fund for ALS Research; Fund "Een Hart voor ALS"; European Community(European Commission); European Research Council(European Research Council (ERC)European Commission); European's Seventh Framework Programme (FP7)/ERC; structural funding for medium-scale research infrastructure (HERCULES); Agency for Innovation by Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Cure Alzheimer's Fund; "Opening the Future" Fund from the KU Leuven-University of Leuven; Research Fund KU Leuven(KU Leuven); E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders, from the KU Leuven-University of Leuven; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from VIB, the KU Leuven-University of Leuven (GOA/11/014), Vertex Pharmaceuticals Inc., Research Foundation Flanders (FWO-Vlaanderen; G.0996.14N), the ALS League Belgium, the Thierry Latran Foundation, Geneeskundige Stichting Koningin Elisabeth (G.S.K.E.), Laevers Fund for ALS Research, and the Fund "Een Hart voor ALS." This work was also supported by the European Community's Health Seventh Framework Programme (FP7/2007-2013) under Grant 259867, the European Research Council, and the European's Seventh Framework Programme (FP7/2007-2013)/ERC Grant 340429 and structural funding for medium-scale research infrastructure (HERCULES, AUGE/09/040). The authors declare that they have no conflicts of interest with the contents of this article. The views expressed are those of the authors and not necessarily those of the NHS (National Health Service), the NIHR (National Institute for Health Research), or the Department of Health.; Received funding from the Agency for Innovation by Science and Technology in Flanders (IWT-Vlaanderen; project 101318).; Supported by the Cure Alzheimer's Fund.; Received funding from the Agency for Innovation by Science and Technology in Flanders (IWT-Vlaanderen; project IWT-VIND 135043).; Supported by the "Opening the Future" Fund from the KU Leuven-University of Leuven.; Supported by Research Fund KU Leuven.; Supported by the E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders, from the KU Leuven-University of Leuven.	Abulrob A, 2005, J NEUROCHEM, V95, P1201, DOI 10.1111/j.1471-4159.2005.03463.x; Benson MD, 2005, P NATL ACAD SCI USA, V102, P10694, DOI 10.1073/pnas.0504021102; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Boado RJ, 2012, DRUG METAB DISPOS, V40, P2021, DOI 10.1124/dmd.112.046375; Bowden TA, 2009, STRUCTURE, V17, P1386, DOI 10.1016/j.str.2009.07.018; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Chapman AP, 2002, ADV DRUG DELIVER REV, V54, P531, DOI 10.1016/S0169-409X(02)00026-1; Conrath KE, 2001, J BIOL CHEM, V276, P7346, DOI 10.1074/jbc.M007734200; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; De Meyer T, 2014, TRENDS BIOTECHNOL, V32, P263, DOI 10.1016/j.tibtech.2014.03.001; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; DIXON FJ, 1953, P SOC EXP BIOL MED, V83, P287; Duffy P, 2012, P NATL ACAD SCI USA, V109, P5063, DOI 10.1073/pnas.1113953109; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; Fabes J, 2006, EUR J NEUROSCI, V23, P1721, DOI 10.1111/j.1460-9568.2006.04704.x; Fabes J, 2007, EUR J NEUROSCI, V26, P2496, DOI 10.1111/j.1460-9568.2007.05859.x; Farrington GK, 2014, FASEB J, V28, P4764, DOI 10.1096/fj.14-253369; Figueroa JD, 2006, J NEUROSCI RES, V84, P1438, DOI 10.1002/jnr.21048; Frugier T, 2012, J NEUROPATH EXP NEUR, V71, P242, DOI 10.1097/NEN.0b013e3182496149; Fu AKY, 2014, P NATL ACAD SCI USA, V111, P9959, DOI 10.1073/pnas.1405803111; Gan L. S., 2013, INT J CELL BIOL, V2013; Garbuzova-Davis S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001205; Garbuzova-Davis S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00021; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Guo FY, 2014, PROTEINS, V82, P349, DOI 10.1002/prot.24414; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Han XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080183; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Kania A, 2016, NAT REV MOL CELL BIO, V17, P240, DOI 10.1038/nrm.2015.16; Kontermann R. E., 2014, ANTIBODY ENG, V2; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Lamberto I, 2014, ACS CHEM BIOL, V9, P2787, DOI 10.1021/cb500677x; Lamberto I, 2012, BIOCHEM J, V445, P47, DOI 10.1042/BJ20120408; Lemmens R, 2013, HUM MOL GENET, V22, P2214, DOI 10.1093/hmg/ddt073; Li SL, 2010, NAT NEUROSCI, V13, P1496, DOI 10.1038/nn.2674; Li TF, 2012, FASEB J, V26, P3969, DOI 10.1096/fj.11-201384; Linneberg C, 2015, ASN NEURO, V7, DOI 10.1177/1759091415602859; Lisabeth EM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009159; Martone ME, 1997, BRAIN RES, V771, P238, DOI 10.1016/S0006-8993(97)00792-0; Miyazaki K, 2011, J NEUROSCI RES, V89, P718, DOI 10.1002/jnr.22594; Murai KK, 2003, MOL CELL NEUROSCI, V24, P1000, DOI 10.1016/j.mcn.2003.08.006; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Noberini R, 2008, J BIOL CHEM, V283, P29461, DOI 10.1074/jbc.M804103200; Noberini R, 2012, SEMIN CELL DEV BIOL, V23, P51, DOI 10.1016/j.semcdb.2011.10.023; Olson EJ, 2016, ACS MED CHEM LETT, V7, P841, DOI 10.1021/acsmedchemlett.6b00132; Overman JJ, 2012, P NATL ACAD SCI USA, V109, pE2230, DOI 10.1073/pnas.1204386109; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pitulescu ME, 2010, GENE DEV, V24, P2480, DOI 10.1101/gad.1973910; Prestoz L, 2004, NEURON GLIA BIOL, V1, P73, DOI 10.1017/s1740925x04000109; Qin HN, 2010, J BIOL CHEM, V285, P644, DOI 10.1074/jbc.M109.064824; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ren Z, 2013, NEUROSCIENCE, V241, P89, DOI 10.1016/j.neuroscience.2013.03.010; Rissiek B, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00344; Saerens D, 2004, J BIOL CHEM, V279, P51965, DOI 10.1074/jbc.M409292200; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; Sheedy C, 2007, BIOTECHNOL ADV, V25, P333, DOI 10.1016/j.biotechadv.2007.02.003; Singla N, 2010, BIOCHEM BIOPH RES CO, V399, P555, DOI 10.1016/j.bbrc.2010.07.109; Steeland S, 2015, J BIOL CHEM, V290, P4022, DOI 10.1074/jbc.M114.617787; Steyaert J, 2011, CURR OPIN STRUC BIOL, V21, P567, DOI 10.1016/j.sbi.2011.06.011; Syed YA, 2016, ACTA NEUROPATHOL, V131, P281, DOI 10.1007/s00401-015-1521-1; Tognolini M, 2014, DRUG DISCOV TODAY, V19, P661, DOI 10.1016/j.drudis.2013.11.017; Tremblay ME, 2007, J COMP NEUROL, V501, P691, DOI 10.1002/cne.21263; Truitt L, 2011, BIOCHEM CELL BIOL, V89, P115, DOI [10.1139/O10-145, 10.1139/o10-145]; Van Hoecke A, 2012, NAT MED, V18, P1418, DOI 10.1038/nm.2901; Vargas LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092309; Vearing C, 2005, CANCER RES, V65, P6745, DOI 10.1158/0008-5472.CAN-05-0758; Veronese FM, 2008, BIODRUGS, V22, P315, DOI 10.2165/00063030-200822050-00004; Wang DR, 2013, P NATL ACAD SCI USA, V110, P2999, DOI 10.1073/pnas.1222742110; Wu BN, 2013, CHEM BIOL, V20, P19, DOI 10.1016/j.chembiol.2012.10.015; Xu K, 2013, P NATL ACAD SCI USA, V110, P14634, DOI 10.1073/pnas.1311000110	75	12	12	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11452	11465		10.1074/jbc.M116.774141	http://dx.doi.org/10.1074/jbc.M116.774141			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28526745	Green Published, hybrid			2022-12-26	WOS:000405119600028
J	Park, HE; Park, HT; Jung, YH; Yoo, HS				Park, Hyun-Eui; Park, Hong-Tae; Jung, Young Hoon; Yoo, Han Sang			Establishment a real-time reverse transcription PCR based on host biomarkers for the detection of the subclinical cases of Mycobacterium avium subsp paratuberculosis	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; IMMUNE-RESPONSE; FECAL CULTURE; DIAGNOSIS; EXPRESSION; INFECTION; INNATE; HAPTOGLOBIN; CATTLE; CALVES	Bovine paratuberculosis (PTB) is a chronic enteric inflammatory disease of ruminants caused by Mycobacterium avium subsp. paratuberculosis (MAP) that causes large economic losses in the dairy industry. Spread of PTB is mainly provoked by a long subclinical stage during which MAP is shed into the environment with feces; accordingly, detection of subclinical animals is very important to its control. However, current diagnostic methods are not suitable for detection of subclinical animals. Therefore, the current study was conducted to develop a diagnostic method for analysis of the expression of genes of prognostic potential biomarker candidates in the whole blood of cattle naturally infected with MAP. Real-time PCR with nine potential biomarker candidates was developed for the diagnosis of MAP subclinical infection. Animals were divided into four groups based on fecal MAP PCR and serum ELISA. Eight genes (Timp1, Hp, Serpine1, Tfrc, Mmp9, Defb1, Defb10, and S100a8) were up-regulated in MAP-infected cattle (p < 0.05). Moreover, ROC analysis revealed that eight genes (Timp1, Hp, Serpine1, Tfrc, Mmp9, Defb1, Defb10, and S100a8) showed fair diagnostic performance (AUC >= 0.8). Four biomarkers (Timp1, S100a8, Defb1, and Defb10) showed the highest diagnostic accuracy in the PCR positive and ELISA negative group (PN group) and three biomarkers (Tfrc, Hp, and Serpine1) showed the highest diagnostic accuracy in the PCR negative and ELISA positive group (NP group). Moreover, three biomarkers (S100a8, Hp, and Defb10) were considered the most reliable for the PCR positive and ELISA positive group (PP group). Taken together, our data suggest that real-time PCR based on eight biomarkers (Timp1, Hp, Serpine1, Tfrc, Mmp9, Defb1, Defb10, and S100a8) might be useful for diagnosis of JD, including subclinical stage cases.	[Park, Hyun-Eui; Park, Hong-Tae; Yoo, Han Sang] Seoul Natl Univ, Coll Vet Med, Dept Infect Dis, Seoul, South Korea; [Jung, Young Hoon] Rural Dev Adm, Natl Inst Anim Sci, Dept Anim Resoures Devlopment, Cheonan, South Korea; [Yoo, Han Sang] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang, South Korea	Seoul National University (SNU); National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Seoul National University (SNU)	Yoo, HS (corresponding author), Seoul Natl Univ, Coll Vet Med, Dept Infect Dis, Seoul, South Korea.; Yoo, HS (corresponding author), Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang, South Korea.	yoohs@snu.ac.kr		YOO, HAN SANG/0000-0003-0548-0835	Cooperative Research Program for Agriculture Science & Technology Development [PJ00897001]; Rural Development Administration, National Research Foundation [2014R1A2A2A01007291]; BK21 PLUS; Research Institute for Veterinary Sciences, Seoul National University, Republic of Korea	Cooperative Research Program for Agriculture Science & Technology Development(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, National Research Foundation; BK21 PLUS; Research Institute for Veterinary Sciences, Seoul National University, Republic of Korea	This work was supported by the Cooperative Research Program for Agriculture Science & Technology Development (Project No.PJ00897001) to HSY, Rural Development Administration, National Research Foundation (No. 2014R1A2A2A01007291) to HSY, BK21 PLUS to HSY and the Research Institute for Veterinary Sciences, Seoul National University, Republic of Korea to HSY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achouiti A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002987; Al Hajri SM, 2007, VET MICROBIOL, V121, P384, DOI 10.1016/j.vetmic.2007.01.025; Allaker RP, 2008, T ROY SOC TROP MED H, V102, P3, DOI 10.1016/j.trstmh.2007.07.005; Bogli-Stuber K, 2005, J APPL MICROBIOL, V99, P587, DOI 10.1111/j.1365-2672.2005.02645.x; Cayatte C, 2012, CLIN TRANSL GASTROEN, V3, DOI 10.1038/ctg.2012.2; Cha SB, 2013, J MICROBIOL BIOTECHN, V23, P1167, DOI 10.4014/jmb.1302.02021; Chen YY, 2017, MOL MED REP, V15, P483, DOI 10.3892/mmr.2016.5998; Cousins DV, 1999, MOL CELL PROBE, V13, P431, DOI 10.1006/mcpr.1999.0275; David J, 2014, VET RES, V45, DOI 10.1186/s13567-014-0096-5; David J, 2014, VET IMMUNOL IMMUNOP, V160, P107, DOI 10.1016/j.vetimm.2014.04.006; De Buck J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111872; Dehnad A, 2016, TUBERCULOSIS, V101, P1, DOI 10.1016/j.tube.2016.07.008; EATON JW, 1982, SCIENCE, V215, P691, DOI 10.1126/science.7036344; Eckersall PD, 2010, VET J, V185, P23, DOI 10.1016/j.tvjl.2010.04.009; El-Deeb WM, 2016, JPN J VET RES, V64, P57; Englund S, 2002, FEMS MICROBIOL LETT, V209, P267, DOI 10.1111/j.1574-6968.2002.tb11142.x; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Goetzl EJ, 1996, J IMMUNOL, V156, P1; Goyal N., 2016, BIOMARKERS, V7, P1, DOI [10.1080/1354750X.2016.1265005, DOI 10.1080/1354750X.2016.1265005]; Johnson EE, 2012, MICROBES INFECT, V14, P207, DOI 10.1016/j.micinf.2011.10.001; Kugadas A, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00085; Leach ST, 2007, SCAND J GASTROENTERO, V42, P1321, DOI 10.1080/00365520701416709; Lim JH, 2011, BIOCHEM BIOPH RES CO, V414, P67, DOI 10.1016/j.bbrc.2011.09.023; Malvisi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164461; Meade KG, 2014, PHYSIOL GENOMICS, V46, P17, DOI 10.1152/physiolgenomics.00085.2013; Mitchell RM, 2015, VET RES, V46, DOI 10.1186/s13567-015-0188-x; Mortier RAR, 2015, PREV VET MED, V121, P189, DOI 10.1016/j.prevetmed.2015.08.011; Muller MP, 2005, CLIN INFECT DIS, V40, P1079, DOI 10.1086/428577; Nielsen SS, 2008, VET MICROBIOL, V129, P217, DOI 10.1016/j.vetmic.2007.12.011; Park HT, 2016, J VET MED SCI, V78, P1537, DOI 10.1292/jvms.15-0271; Park HE, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw022; Plain KM, 2011, INFECT IMMUN, V79, P3821, DOI 10.1128/IAI.05204-11; Rossbacher J, 1999, SCAND J IMMUNOL, V50, P399, DOI 10.1046/j.1365-3083.1999.00609.x; Saeed SA, 2007, BIOCHEM BIOPH RES CO, V353, P915, DOI 10.1016/j.bbrc.2006.12.092; Schiopu A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/828354; Seppa-Lassila L, 2015, COMP IMMUNOL MICROB, V41, P10, DOI 10.1016/j.cimid.2015.05.004; Seth M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005478; Sevilla IA, 2014, APPL ENVIRON MICROB, V80, P3757, DOI 10.1128/AEM.01026-14; Shin MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138770; Shin MK, 2015, J MICROBIOL BIOTECHN, V25, P255, DOI 10.4014/jmb.1408.08059; SOCKETT DC, 1992, CAN J VET RES, V56, P148; Stabel JR, 2000, VET MICROBIOL, V77, P465, DOI 10.1016/S0378-1135(00)00331-X; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Tiwari A, 2006, CAN VET J, V47, P874; Verschoor CP, 2010, VET IMMUNOL IMMUNOP, V137, P1, DOI 10.1016/j.vetimm.2010.03.026; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Walker SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35820; Wang J, 2016, J BACTERIOL, V198, P857, DOI 10.1128/JB.00922-15; Wang XF, 2011, ANIM BIOTECHNOL, V22, P44, DOI 10.1080/10495398.2010.536096; Wang Z, 2013, BLOOD CELL MOL DIS, V50, P196, DOI 10.1016/j.bcmd.2012.11.005; Waters WR, 2016, CLIN VACCINE IMMUNOL, V23, P168, DOI 10.1128/CVI.00637-15; Wells SJ, 2006, CLIN VACCINE IMMUNOL, V13, P1125, DOI 10.1128/CVI.00236-06; Whitlock RH, 1996, VET CLIN N AM-FOOD A, V12, P345, DOI 10.1016/S0749-0720(15)30410-2; Whittington RJ, 2013, J CLIN MICROBIOL, V51, P3993, DOI 10.1128/JCM.01373-13; You QM, 2012, VET IMMUNOL IMMUNOP, V148, P243, DOI 10.1016/j.vetimm.2012.05.002	56	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178336	10.1371/journal.pone.0178336	http://dx.doi.org/10.1371/journal.pone.0178336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542507	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800075
J	Albrecht, L; Stallard, RF; Kalko, EKV				Albrecht, Larissa; Stallard, Robert F.; Kalko, Elisabeth K. V.			Land use history and population dynamics of free-standing figs in a maturing forest	PLOS ONE			English	Article							TROPICAL FOREST; FRUIT CHARACTERISTICS; TREE MORTALITY; BARRO COLORADO; RAIN-FOREST; BATS; DROUGHT; ECOLOGY; CLIMATE; COMMUNITIES	Figs (Ficus sp.) are often considered as keystone resources which strongly influence tropical forest ecosystems. We used long-term tree-census data to track the population dynamics of two abundant free-standing fig species, Ficus insipida and F. yoponensis, on Barro Colorado Island (BCI), a 15.6-km(2) island in Lake Gatu A n, Panama. Vegetation cover on BCI consists of a mosaic of old growth (>400 years) and maturing (about 90-150 year old) secondary rainforest. Locations and conditions of fig trees have been mapped and monitored on BCI for more than 35 years (1973-2011), with a focus on the Lutz Catchment area (25 ha). The original distribution of the fig trees shortly after the construction of the Panama Canal was derived from an aerial photograph from 1927 and was compared with previous land use and forest status. The distribution of both fig species (similar to 850 trees) is restricted to secondary forest. Of the original 119 trees observed in Lutz Catchment in 1973, >70% of F. insipida and >90% of F. yoponensis had died by 2011. Observations in other areas on BCI support the trend of declining free-standing figs. We interpret the decline of these figs on BCI as a natural process within a maturing tropical lowland forest. Senescence of the fig trees appears to have been accelerated by severe droughts such as the strong El Nino event in the year 1982/83. Because figs form such an important food resource for frugivores, this shift in resource availability is likely to have cascading effects on frugivore populations.	[Albrecht, Larissa; Kalko, Elisabeth K. V.] Univ Ulm, Inst Expt Ecol, Ulm, Germany; [Stallard, Robert F.; Kalko, Elisabeth K. V.] Smithsonian Trop Res Inst, Balboa, Panama; [Stallard, Robert F.] US Geol Survey, Boulder, CO USA	Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute; United States Department of the Interior; United States Geological Survey	Albrecht, L (corresponding author), Univ Ulm, Inst Expt Ecol, Ulm, Germany.	Larissa.Albrecht@alumni.uni-ulm.de			DAAD (German Academic Exchange Service) [D/06/46336]; German Science Foundation (DFG) [KA 1241/16-1]; RFS; Smithsonian Institution	DAAD (German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); German Science Foundation (DFG)(German Research Foundation (DFG)); RFS; Smithsonian Institution(Smithsonian Institution)	This work was supported by a DAAD (German Academic Exchange Service, www.daad.de) Ph.D. fellowship (D/06/46336) to LA, and by a grant (KA 1241/16-1) of the German Science Foundation (DFG, www.dfg.de) to EKVK. The U.S. Geological Survey (www.usgs.gov) and the Smithsonian Tropical Research Institute (STRI, www.stri.si.edu) supported RFS. In its earlier years, the Smithsonian Institution supported much of the fieldwork. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot HL, 1907, PROBLEMS PANAMA CANA; Albrecht L, 2007, ACTA THERIOL, V52, P141, DOI 10.1007/BF03194209; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Bartlett A, 1973, VEGETATION VEGETATIO, P203; Bartlett AS, 1969, SCIENCE, V151, P642, DOI 10.1126/science.165.3891.389.; BONACCORSO F J, 1979, Bulletin of the Florida State Museum Biological Sciences, V24, P359; Chazdon RL, 2005, ECOLOGY, V86, P1808, DOI 10.1890/04-0572; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Condit R, 1999, PHILOS T R SOC B, V354, P1739, DOI 10.1098/rstb.1999.0517; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Dunn RR, 2004, CONSERV BIOL, V18, P302, DOI 10.1111/j.1523-1739.2004.00151.x; Enders R. K., 1935, Bulletin of the Museum of Comparative Zoology, V78, P385; Foster RB, 1982, ECOLOGY TROPICAL FOR, P67; Foster RB, 1990, 4 NEOTROPICAL RAINFO, P565; GAUTIERHION A, 1989, ECOLOGY, V70, P1826, DOI 10.2307/1938115; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; Handley Jr CO, 1991, DEMOGRAPHY NATURAL H, P511; Hao GY, 2011, ECOLOGY, V92, P2117, DOI 10.1890/11-0269.1; Harrison RD, DROUGHT CONSEQUENCES; Krause GH, 2010, FUNCT PLANT BIOL, V37, P890, DOI 10.1071/FP10034; Hodgkison R, 2004, BIOTROPICA, V36, P522, DOI 10.1646/1593; Hubbell S.P., 1990, 4 NEOTROPICAL FOREST, P522; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; Kalko EKV, 1996, J BIOGEOGR, V23, P565, DOI 10.1111/j.1365-2699.1996.tb00018.x; Kalko EKV, 2008, INTEGR COMP BIOL, V48, P60, DOI 10.1093/icb/icn030; Kalko Elisabeth K.V., 1996, P503, DOI 10.1016/B978-012178075-3/50017-9; Kenoyer LA, 1929, ECOLOGY, V10, P201, DOI 10.2307/1932295; Kissling WD, 2007, P ROY SOC B-BIOL SCI, V274, P799, DOI 10.1098/rspb.2006.0311; Korine C, 2000, OECOLOGIA, V123, P560, DOI 10.1007/PL00008861; Leigh EG, 1999, TROPICAL FOREST ECOL; Matthew GE, 1949, CHAGRES RIVER GATUN; McCullough David, 1977, PATH SEAS CREATION P, P12; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Miller F., 1927, SPECIAL MAP BARRO CO; MILTON K, 1982, ECOLOGY, V63, P752, DOI 10.2307/1936796; Milton K., 1980, FORAGING STRATEGIES; MORRISON DW, 1978, ECOLOGY, V59, P716, DOI 10.2307/1938775; Morrison DW, 1975, THESIS; Muscarella R, 2007, BIOL REV, V82, P573, DOI 10.1111/j.1469-185X.2007.00026.x; Paton S., 2002, 2001 METEOROLOGICAL; Piperno DR, 1990, ECOLOGIA BOSQUE TROP, P153; REINSCH CH, 1967, NUMER MATH, V10, P177, DOI 10.1007/BF02162161; Shanahan M, 2001, BIOL REV, V76, P529, DOI 10.1017/S1464793101005760; Svenning JC, 2004, ECOLOGY, V85, P2526, DOI 10.1890/03-0396; SWAINE MD, 1987, J TROP ECOL, V3, P359, DOI 10.1017/S0266467400002339; Terborgh J, 1997, J TROP ECOL, V13, P833, DOI 10.1017/S0266467400011020; TERBORGH J, 1986, P330; Thorington Jr RW, 1974, 1973 ENV MONITORING, P256; Weghorst JA, 2007, PRIMATES, V48, P108, DOI 10.1007/s10329-006-0025-y; Wendeln MC, 2000, BIOTROPICA, V32, P489, DOI 10.1111/j.1744-7429.2000.tb00495.x; Williamson GB, 2000, CONSERV BIOL, V14, P1538, DOI 10.1046/j.1523-1739.2000.99298.x; ZOTZ G, 1995, FLORA, V190, P265, DOI 10.1016/S0367-2530(17)30663-1	53	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177060	10.1371/journal.pone.0177060	http://dx.doi.org/10.1371/journal.pone.0177060			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542161	gold, Green Published, Green Submitted			2022-12-26	WOS:000402061500010
J	Amorim, AC; Cacciari, LP; Passaro, AC; Silveira, SRB; Amorim, CF; Loss, JF; Sacco, ICN				Amorim, Amanda C.; Cacciari, Licia P.; Passaro, Anice C.; Silveira, Simone R. B.; Amorim, Cesar F.; Loss, Jefferson F.; Sacco, Isabel C. N.			Effect of combined actions of hip adduction/abduction on the force generation and maintenance of pelvic floor muscles in healthy women	PLOS ONE			English	Article							TENDINEUS FASCIAE PELVIS; DYNAMOMETRIC MEASUREMENTS; URINARY-INCONTINENCE; CONTINENCE SOCIETY; RELIABILITY; STRENGTH; ANATOMY; TRANSMISSION; CONTRACTIONS; TERMINOLOGY	Pelvic floor muscle (PFM) force and coordination are related to urinary incontinence severity and to sexual satisfaction. Health professionals frequently combine classic PFM exercises with hip adduction/abduction contraction to treat these disorders, but the real benefits of this practice are still unknown. Based on a theoretical anatomy approach whereby the levator ani muscle is inserted into the obturator internus myofascia and in which force generated by hip movements should increase the contraction quality of PFMs, our aim was to investigate the effects of isometric hip adduction and abduction on PFM force generation. Twenty healthy, nulliparous women were evaluated using two strain-gauge dynamometers (one cylinder-like inside the vaginal cavity, and the other measuring hip adduction/abduction forces around both thighs) while performing three different tasks: (a) isolated PFM contraction; (b) PFM contraction combined with hip adduction (30% and 50% maximum hip force); and (c) PFM contraction combined with hip abduction (30% and 50% maximum hip force). Data were sampled at 100Hz and subtracted from the offset if existent. We calculated a gradient between the isolated PFM contraction and each hip condition (Delta Adduction and Delta Abduction) for all variables: Maximum force (N), instant of maximum-force occurrence (s), mean force in an 8-second window (N), and PFM force loss (N.s). We compared both conditions gradients in 30% and 50% by paired t-tests. All variables did not differ between hip conditions both in 30% and 50% of maximum hip force (p >.05). PFM contraction combined with isometric hip abduction did not increase vaginal force in healthy and nulliparous women compared to PFM contraction combined with isometric hip adduction. Therefore, so far, the use of hip adduction or abduction in PFM training and treatments are not justified for improving PFM strength and endurance.	[Amorim, Amanda C.; Cacciari, Licia P.; Passaro, Anice C.; Sacco, Isabel C. N.] Univ Sao Paulo, Sch Med, Phys Therapy Speech & Occupat Therapy, Sao Paulo, Brazil; [Silveira, Simone R. B.] Univ Sao Paulo, Univ Hosp, Sao Paulo, Brazil; [Amorim, Cesar F.] Univ City Sao Paulo UNICID, Phys Therapy Master Program, Sao Paulo, Brazil; [Loss, Jefferson F.] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Cidade de Sao Paulo; Universidade Federal do Rio Grande do Sul	Sacco, ICN (corresponding author), Univ Sao Paulo, Sch Med, Phys Therapy Speech & Occupat Therapy, Sao Paulo, Brazil.	icnsacco@usp.br	Cacciari, Licia P/F-2784-2013; Sacco, Isabel/D-7172-2011; de Campos Pássaro, Anice/C-7815-2013; Sacco, Isabel/T-2630-2019; Amorim, Amanda C/J-4577-2014	Sacco, Isabel/0000-0003-1254-0007; de Campos Pássaro, Anice/0000-0001-9345-3284; Sacco, Isabel/0000-0003-1254-0007; Ferreira Amorim, Cesar/0000-0003-0137-5659; Cacciari, Licia/0000-0003-0222-6364	National Council for Scientific and Technological Development (CNPq) [MCT/CNPq 166104/2013-2]; ACA scholarship [478332/2013-0, 2013/19610-3]; LPC scholarship [2013/13820-6]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ACA scholarship; LPC scholarship	The authors are grateful to the National Council for Scientific and Technological Development (CNPq, http://www.cnpq.br/) for funding the project (MCT/CNPq 166104/2013-2) and for ACA scholarship (478332/2013-0), to the Sao Paulo State Research Foundation (FAPESP, http://www.fapesp.br/en/) for also funding this project (process 2013/19610-3), and for LPC scholarship (process 2013/13820-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arab AM, 2011, NEUROUROL URODYNAM, V30, P117, DOI 10.1002/nau.20959; Ashton-Miller JA, 2007, ANN NY ACAD SCI, V1101, P266, DOI 10.1196/annals.1389.034; Ashton-Miller JA, 2014, CLIN BIOMECH, V29, P1146, DOI 10.1016/j.clinbiomech.2014.09.011; BO K, 1994, NEUROUROL URODYNAM, V13, P35, DOI 10.1002/nau.1930130106; Bo K, 2009, OBSTET GYNECOL, V113, P1279, DOI 10.1097/AOG.0b013e3181a66f40; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; CALDWELL LS, 1974, AM IND HYG ASSOC J, V35, P201, DOI 10.1080/0002889748507023; Delancey JOL, 2004, GASTROENTEROLOGY, V126, pS23, DOI 10.1053/j.gastro.2003.10.080; Devreese A, 2004, NEUROUROL URODYNAM, V23, P190, DOI 10.1002/nau.20018; Dietz HP, 2006, BJOG-INT J OBSTET GY, V113, P225, DOI 10.1111/j.1471-0528.2006.00819.x; Dumoulin C, 2004, NEUROUROL URODYNAM, V23, P134, DOI 10.1002/nau.10175; Dumoulin C, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005654.pub3; Dumoulin C, 2015, NEUROUROL URODYNAM, V34, P300, DOI 10.1002/nau.22700; Frawley HC, 2006, NEUROUROL URODYNAM, V25, P236, DOI 10.1002/nau.20201; Hodges PW, 2014, J ELECTROMYOGR KINES, V24, P489, DOI 10.1016/j.jelekin.2014.03.011; HOFBAUER J, 1990, Z UROL NEPHROL, V83, P249; Huijing PA, 1999, J BIOMECH, V32, P329, DOI 10.1016/S0021-9290(98)00186-9; Huijing PA, 2009, J BIOMECH, V42, P9, DOI 10.1016/j.jbiomech.2008.09.027; Kepenekci I, 2011, DIS COLON RECTUM, V54, P85, DOI 10.1007/DCR.0b013e3181fd2356; Lamin E, 2016, CURR UROL REP, V17, DOI 10.1007/s11934-015-0572-0; Laycock J., 2001, PHYSIOTHERAPY, V87, P631, DOI [10.1016/s0031-9406(05)61108-x, DOI 10.1016/S0031-9406(05)61108-X]; Madill SJ, 2006, NEUROUROL URODYNAM, V25, P722, DOI 10.1002/nau.20285; Madill SJ, 2010, J ELECTROMYOGR KINES, V20, P804, DOI 10.1016/j.jelekin.2009.10.006; Messelink B, 2005, NEUROUROL URODYNAM, V24, P374, DOI 10.1002/nau.20144; Morin M, 2007, NEUROUROL URODYNAM, V26, P397, DOI 10.1002/nau.20334; Morin M, 2004, NEUROUROL URODYNAM, V23, P668, DOI 10.1002/nau.20069; Morin M, 2004, NEUROUROL URODYNAM, V23, P336, DOI 10.1002/nau.20021; Occelli B, 2001, EUR J OBSTET GYN R B, V97, P213, DOI 10.1016/S0301-2115(00)00527-3; Peschers UM, 2001, INT UROGYNECOL J PEL, V12, P27, DOI 10.1007/s001920170090; Pit MJ, 2003, CLIN ANAT, V16, P131, DOI 10.1002/ca.10102; Sapsford RR, 2001, NEUROUROL URODYNAM, V20, P31, DOI 10.1002/1520-6777(2001)20:1<31::AID-NAU5>3.0.CO;2-P; Tan L, 2015, INT UROGYNECOL J, V26, P1667, DOI 10.1007/s00192-015-2759-9; Toozs-Hobson P, 2012, INT UROGYNECOL J, V23, P527, DOI 10.1007/s00192-012-1726-y; Vaarbakken K, 2014, CLIN BIOMECH, V29, P794, DOI 10.1016/j.clinbiomech.2014.05.011; Voorham-van der Zalm PJ, 2013, NEUROUROL URODYNAM, V32, P341, DOI 10.1002/nau.22311; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Yucesoy CA, 2003, J BIOMECH, V36, P1797, DOI 10.1016/S0021-9290(03)00230-6; Yucesoy CA, 2010, EXERC SPORT SCI REV, V38, P128, DOI 10.1097/JES.0b013e3181e372ef	38	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177575	10.1371/journal.pone.0177575	http://dx.doi.org/10.1371/journal.pone.0177575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542276	Green Published, Green Submitted, gold			2022-12-26	WOS:000402061500032
J	Sun, WY; Lan, J; Chen, L; Qiu, JJ; Luo, ZG; Li, MZ; Wang, JY; Zhao, JG; Zhang, TH; Long, X; Chai, J; Yan, ZQ; Guo, ZY; Gun, SB				Sun, Wenyang; Lan, Jing; Chen, Lei; Qiu, Jinjie; Luo, Zonggang; Li, Mingzhou; Wang, Jinyong; Zhao, Jiugang; Zhang, Tinghuan; Long, Xi; Chai, Jie; Yan, Zunqiang; Guo, Zongyi; Gun, Shuangbao			A mutation in porcine pre-miR-15b alters the biogenesis of MiR-15b\16-1 cluster and strand selection of MiR-15b	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; MICRORNA BIOGENESIS; CANCER CELLS; EXPRESSION; SEQUENCE; COMPLEX; DROSHA; MIRNA; MICROPROCESSOR; PROLIFERATION	MicroRNAs (miRNAs) are small non-coding RNAs that are involved in translational regulation of the messenger RNA molecules. Sequence variations in the genes encoding miRNAs could influence their biogenesis and function. MiR-15b plays an important role in cellular proliferation, apoptosis and the cell cycle. Here, we report the identification of a C58T mutation in porcine pre-miR-15b. Through in vitro and in vivo experiments, we determined that this mutation blocks the transition from pri-miRNA to pre-miRNA, alters the strand selection between miR-15b-5p and miR-15b-3p, and obstructs biogenesis of the downstream miR16- 1. These results serve to highlight the importance of miRNA mutations and their impacts on miRNA biogenesis.	[Sun, Wenyang; Yan, Zunqiang; Gun, Shuangbao] Gansu Agr Univ, Coll Anim Sci & Technol, Lanzhou, Peoples R China; [Sun, Wenyang; Lan, Jing; Chen, Lei; Qiu, Jinjie; Luo, Zonggang; Wang, Jinyong; Zhao, Jiugang; Zhang, Tinghuan; Long, Xi; Chai, Jie; Yan, Zunqiang; Guo, Zongyi] Chongqing Acad Anim Sci, Minist Agr, Key Lab Pig Ind Sci, Chongqing, Peoples R China; [Luo, Zonggang] Southwest Univ, Dept Anim Sci, Chongqing, Peoples R China; [Li, Mingzhou] Sichuan Agr Univ, Inst Anim Genet & Breeding, Coll Anim Sci & Technol, Chengdu, Sichuan, Peoples R China; [Gun, Shuangbao] Gansu Res Ctr Swine Prod Engn & Technol, Lanzhou, Peoples R China	Gansu Agricultural University; Ministry of Agriculture & Rural Affairs; Southwest University - China; Sichuan Agricultural University	Guo, ZY (corresponding author), Chongqing Acad Anim Sci, Minist Agr, Key Lab Pig Ind Sci, Chongqing, Peoples R China.; Gun, SB (corresponding author), Gansu Res Ctr Swine Prod Engn & Technol, Lanzhou, Peoples R China.	guozongyi@sina.com; gunsbao056@126.com			National High Technology Research and Development Program of China (863 Program) [2013AA102502]; Basic Science research Foundation Project of Chongqing [2013cstc-jbky-00105-zj]; National Natural Science Foundation of China [31601930, 31372284, 31201770]; Chongqing Fund of application and development [cstc2013yykfC80003]; Chongqing agricultural development foundation [12404, 14440]; National ''Twelfth Five-Year'' Plan for Science & Technology Support [2015BAD03B02-6]; National Biological Breeding Capacity Building and Industrialization Projects - National Development and Reform Commission [(2014)2573]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Basic Science research Foundation Project of Chongqing; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Fund of application and development; Chongqing agricultural development foundation; National ''Twelfth Five-Year'' Plan for Science & Technology Support; National Biological Breeding Capacity Building and Industrialization Projects - National Development and Reform Commission	This work was supported by grants from the National High Technology Research and Development Program of China (863 Program) (2013AA102502), the Basic Science research Foundation Project of Chongqing (2013cstc-jbky-00105-zj), the National Natural Science Foundation of China (31601930, 31372284, 31201770), the Chongqing Fund of application and development (cstc2013yykfC80003), the Chongqing agricultural development foundation (12404, 14440), the National ''Twelfth Five-Year'' Plan for Science & Technology Support (2015BAD03B02-6) and the National Biological Breeding Capacity Building and Industrialization Projects [(2014)2573] sponsored by National Development and Reform Commission. The funders had no rolein study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gottwein E, 2006, J VIROL, V80, P5321, DOI 10.1128/JVI.02734-05; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Harnprasopwat R, 2010, BIOCHEM BIOPH RES CO, V399, P117, DOI 10.1016/j.bbrc.2010.07.009; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hu HY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-413; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim S, 2008, J BIOL CHEM, V283, P18158, DOI 10.1074/jbc.M800186200; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lee JS, 2013, ANIM GENET, V44, P101, DOI 10.1111/j.1365-2052.2012.02362.x; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lehmann TP, 2013, ONCOL LETT, V5, P569, DOI 10.3892/ol.2012.1040; Li W, 2009, J MED GENET, V46, P358, DOI 10.1136/jmg.2008.063123; Lovat F, 2015, P NATL ACAD SCI USA, V112, P11636, DOI 10.1073/pnas.1514954112; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Raveche ES, 2007, BLOOD, V109, P5079, DOI 10.1182/blood-2007-02-071225; Satzger I, 2010, INT J CANCER, V126, P2553, DOI 10.1002/ijc.24960; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Singh Y, 2016, IMMUNOLOGY, V149, P74, DOI 10.1111/imm.12631; Singh Y, 2015, J IMMUNOL, V195, P5667, DOI 10.4049/jimmunol.1401875; Sun GH, 2009, RNA, V15, P1640, DOI 10.1261/rna.1560209; Nguyen TA, 2015, CELL, V161, P1374, DOI 10.1016/j.cell.2015.05.010; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Zhang YP, 2015, INT J CLIN EXP PATHO, V8, P15677; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	45	8	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178045	10.1371/journal.pone.0178045	http://dx.doi.org/10.1371/journal.pone.0178045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542522	Green Submitted, Green Published, gold			2022-12-26	WOS:000402061500056
J	Treweeke, A; Hall, J; Lambie, S; Leslie, SJ; Megson, IL; MacRury, SM				Treweeke, A.; Hall, J.; Lambie, S.; Leslie, S. J.; Megson, I. L.; MacRury, S. M.			Preliminary study of hypoxia-related cardiovascular mediator-markers in patients with end-stage renal disease with and without diabetes and the effects of haemodialysis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ACUTE CORONARY SYNDROMES; OXIDATIVE STRESS; PLATELET ACTIVATION; DIALYSIS PATIENTS; N-ACETYLCYSTEINE; NEPHROPATHY; INFLAMMATION; ANTIOXIDANT; GLUTATHIONE	Background Evidence points to activation of pro-inflammatory and pro-thrombotic stimuli during the haemodialysis process in end-stage renal disease (ESRD) with potential to predispose to cardiovascular events. Diabetes is associated with a higher incidence of cardiovascular disease in haemodialysis patients. We tested the hypothesis that a range of mediators and markers that modulate cardiovascular risk are elevated in haemodialysis patients with diabetes compared to those without. Methods Men and women with diabetes (n = 6) and without diabetes (n = 6) aged 18-90 years receiving haemodialysis were recruited. Blood samples were collected and analysed pre- and post-haemodialysis sessions for (platelet-monocyte conjugates (PMC), oxidised LDL (Ox-LDL), endothelin 1 (ET-1) and vascular endothelial growth factor (VEGF-A). Results PMC levels significantly increased after haemodialysis in both groups (diabetes p = 0.047; non-diabetes p = 0.005). Baseline VEGF-A was significantly higher in people with diabetes (p = 0.009) and post-dialysis levels were significantly reduced in both groups (P = 0.002). Ox-LDL and CRP concentrations were not significantly different between groups nor affected in either group post-dialysis. Similarly, ET-1 concentrations were comparable in all patients at baseline, with no change post-dialysis in either group. Conclusions In this pilot study, we have confirmed that circulating PMCs are increased following dialysis irrespective of diabetes status. This is likely to be a mechanistic process and offers a potential explanation for high rates of vascular events associated with haemodialysis. The higher VEGF-A concentrations between patients with and without diabetes is a previously unreported finding in diabetic ESRD. Further research is merited to establish whether VEGF-A is a marker or mediator (or both) of cardiovascular risk in haemodialysis.	[Treweeke, A.; Hall, J.; Leslie, S. J.; Megson, I. L.; MacRury, S. M.] Univ Highlands & Isl, Div Hlth Res, Inverness, Scotland; [Lambie, S.; Leslie, S. J.; MacRury, S. M.] Raigmore Hosp, Dept Med, Inverness, Scotland	UHI Millennium Institute	MacRury, SM (corresponding author), Univ Highlands & Isl, Div Hlth Res, Inverness, Scotland.; MacRury, SM (corresponding author), Raigmore Hosp, Dept Med, Inverness, Scotland.	Sandra.macrury@uhi.ac.uk	Megson, Ian/K-2195-2012	Megson, Ian/0000-0001-8287-2459; MacRury, Sandra/0000-0001-7599-1302	NHS Highland R&D endowment fund	NHS Highland R&D endowment fund	The authors received funding from NHS Highland R&D endowment fund to aid this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, US RENAL DATA SYSTEM; [Anonymous], 2010, AM J KIDNEY DIS S, V55, pS269; Aslam S, 2008, CURR OPIN NEPHROL HY, V17, P99; Avci E, 2014, RENAL FAILURE, V36, P767, DOI 10.3109/0886022X.2014.890841; Becker RC, 2005, AM HEART J, V150, P189, DOI 10.1016/j.ahj.2005.04.006; Chang JJY, 2006, SEMIN DIALYSIS, V19, P297, DOI 10.1111/j.1525-139X.2006.00176.x; Couser WG, 2011, KID INT; Davenport AP, 2016, PHARMACOL REV, V68, P357, DOI 10.1124/pr.115.011833; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Doi K, 2010, CURR VASC PHARMACOL, V8, P122, DOI 10.2174/157016110790226606; Filiopoulos V, 2009, INT J ARTIF ORGANS, V32, P872, DOI 10.1177/039139880903201206; Foley RN, 1997, DIABETOLOGIA, V40, P1307, DOI 10.1007/s001250050825; Gibson KR, 2009, J CARDIOVASC PHARM, V54, P319, DOI 10.1097/FJC.0b013e3181b6e77b; Gutierrez-Adrianzen OA, 2014, J HUM HYPERTENS, P1; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Karalliedde J, 2011, DIABETES CARE, V34, pS291, DOI 10.2337/dc11-s241; Le Brocq M, 2008, ANTIOXID REDOX SIGN, V10, P1631, DOI 10.1089/ars.2007.2013; Lim HS, 2004, DIABETES CARE, V27, P2918, DOI 10.2337/diacare.27.12.2918; MacNeil SJ, 2016, NEPHRON S1, V132, P41; Martins PD, 2004, ARTERIOSCL THROM VAS, V24, P193, DOI 10.1161/01.ATV.0000106320.40933.E5; McCullough PA, 2008, AM J KIDNEY DIS, V51, pS38, DOI 10.1053/j.ajkd.2007.12.017; Megson Ian L, 2015, J Diabetes Sci Technol, V9, P573, DOI 10.1177/1932296815570359; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Nakagawa T, 2009, DIABETES, V58, P1471, DOI 10.2337/db09-0119; Ndip A, 2010, DIABETES CARE, V33, P1811, DOI 10.2337/dc10-0255; Nitsch D, 2007, QJM-INT J MED, V100, P551, DOI 10.1093/qjmed/hcm062; Pawlak K, 2006, THROMB RES, V117, P517, DOI 10.1016/j.thromres.2005.05.001; Pernow J, 2012, LIFE SCI, V91, P507, DOI 10.1016/j.lfs.2012.03.029; Sarma J, 2002, CIRCULATION, V105, P2166, DOI 10.1161/01.CIR.0000015700.27754.6F; Shoji T, 2005, J ATHEROSCLER THROMB, V12, P344, DOI 10.5551/jat.12.344; Sirolli V, 2006, INT J IMMUNOPATH PH, V19, P461, DOI 10.1177/039463200601900302; Treweeke AT, 2012, DIABETOLOGIA, V55, P2920, DOI 10.1007/s00125-012-2685-z; Van Dijk PC, 2005, KIDNEY INT, V67, P1489, DOI DOI 10.1111/J.1523-1755.2005.00227.X; Wang JH, 2007, INT J CARDIOL, V115, P361, DOI 10.1016/j.ijcard.2006.03.019; Yuan J, 2013, ADV MATH PHYS, V2013, P1, DOI DOI 10.1093/NDT/GFT256; Zhang SZ, 2007, CLIN CARDIOL, V30, P26, DOI 10.1002/clc.2	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178171	10.1371/journal.pone.0178171	http://dx.doi.org/10.1371/journal.pone.0178171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542479	Green Submitted, gold, Green Published			2022-12-26	WOS:000402058800044
J	Ginindza, TG; Sartorius, B; Dlamini, X; Ostensson, E				Ginindza, Themba G.; Sartorius, Benn; Dlamini, Xolisile; Ostensson, Ellinor			Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland	PLOS ONE			English	Article							ECONOMIC BURDEN; HPV VACCINE; CANCER PREVENTION; HERD-IMMUNITY; PROGRAM; BENEFITS; AGE	Background Human papillomavirus (HPV) has proven to be the cause of several severe clinical conditions on the cervix, vulva, vagina, anus, oropharynx and penis. Several studies have assessed the costs of cervical lesions, cervical cancer (CC), and genital warts. However, few have been done in Africa and none in Swaziland. Cost analysis is critical in providing useful information for economic evaluations to guide policymakers concerned with the allocation of resources in order to reduce the disease burden. Materials and methods A prevalence-based cost of illness (COI) methodology was used to investigate the economic burden of HPV-related diseases. We used a top-down approach for the cost associated with hospital care and a bottom-up approach to estimate the cost associated with outpatient and primary care. The current study was conducted from a provider perspective since the state bears the majority of the costs of screening and treatment in Swaziland. All identifiable direct medical costs were considered for cervical lesions, cervical cancer and genital warts, which were primary diagnoses during 2015. A mix of bottom up micro-costing ingredients approach and top-down approaches was used to collect data on costs. All costs were computed at the price level of 2015 and converted to dollars ($). Results The total annual estimated direct medical cost associated with screening, managing and treating cervical lesions, CC and genital warts in Swaziland was $ 16 million. The largest cost in the analysis was estimated for treatment of high-grade cervical lesions and cervical cancer representing 80% of the total cost ($ 12.6 million). Costs for screening only represented 5% of the total cost ($ 0.9 million). Treatment of genital warts represented 6% of the total cost ($ 1million). Conclusion According to the cost estimations in this study, the economic burden of HPV-related cervical diseases and genital warts represents a major public health issue in Swaziland. Prevention of HPV infection with a national HPV immunization programme for pre-adolescent girls would prevent the majority of CC related deaths and associated costs.	[Ginindza, Themba G.; Sartorius, Benn] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth, Durban, South Africa; [Dlamini, Xolisile] Minist Hlth, Epidemiol Unit, Mbabane, Eswatini; [Ostensson, Ellinor] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ostensson, Ellinor] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden	University of Kwazulu Natal; Karolinska Institutet; Karolinska Institutet	Ginindza, TG (corresponding author), Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth, Durban, South Africa.	Ginindza@ukzn.ac.za	Gindza, Prof. Themba G/N-5762-2013	Ginindza, Themba G/0000-0002-0993-8308; , bennsartorius/0000-0001-6761-2325	Kingdom of Swaziland Ministry of Health; International Agency for Research on Cancer (IARC); Swedish Cancer Foundation [C8 30305153]; WHO-Swaziland local office and Ministry of Health Epidemiology Unit; Sexual and Reproductive Health Unit (SRH); The University of KwaZulu-Natal, College of Health Sciences Doctoral Research Scholarship; Health and Welfare Sector Education and Training Authority (HWSETA)	Kingdom of Swaziland Ministry of Health; International Agency for Research on Cancer (IARC)(World Health Organization); Swedish Cancer Foundation; WHO-Swaziland local office and Ministry of Health Epidemiology Unit; Sexual and Reproductive Health Unit (SRH); The University of KwaZulu-Natal, College of Health Sciences Doctoral Research Scholarship; Health and Welfare Sector Education and Training Authority (HWSETA)	The University of KwaZulu-Natal, College of Health Sciences Doctoral Research Scholarship Grant and funding was received from the Health and Welfare Sector Education and Training Authority (HWSETA), funded the study. The funder had no role in the study design, data collection and analysis and decision to publish.; We thank the Kingdom of Swaziland Ministry of Health for technical, logistic, and financial support and allowing us to implement the study, and we also received support from the International Agency for Research on Cancer (IARC), the Swedish Cancer Foundation (C8 30305153), (URL: www.cancerfonden.se), WHO-Swaziland local office and Ministry of Health Epidemiology Unit and Sexual and Reproductive Health Unit (SRH). We are grateful for the facilities support, Phalala office and to the HPV/Cervical cancer research team.	Annemans Lieven, 2008, J Med Econ, V11, P135, DOI 10.3111/13696990801961611; Armstrong EP, 2010, J MANAGE CARE PHARM, V16, P217, DOI 10.18553/jmcp.2010.16.3.217; Barnighausen T, 2012, CLIN MICROBIOL INFEC, V18, P70, DOI 10.1111/j.1469-0691.2012.03977.x; Baio G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049699; Bayas JM, 2008, GYNECOL ONCOL, V110, pS11, DOI [10.1016/j.ygyno.2008.05.011, 10.1016/j.ygyno.2008.06.029]; Borget I, 2011, VACCINE, V29, P5245, DOI 10.1016/j.vaccine.2011.05.018; Cameron RL, 2016, EMERG INFECT DIS, V22, P56, DOI 10.3201/eid2201.150736; Campos NG, 2012, INT J CANCER, V130, P2672, DOI 10.1002/ijc.26269; Centers for Disease Control and Prevention, 2015, CDC VACCINE PRICE LI; Centers for Disease Control and Prevention. Centers for Disease Control and Prevention, 2015, CENT DIS CONTR PREV; Central Statistic office, 2007, SAWZ POP HOUS CENS; Chesson HW, 2012, VACCINE, V30, P6016, DOI 10.1016/j.vaccine.2012.07.056; Cutts FT, 2007, B WORLD HEALTH ORGAN, V85, P719, DOI 10.2471/BLT.06.038414; David MP, 2009, GYNECOL ONCOL, V115, pS1, DOI 10.1016/j.ygyno.2009.01.011; Drolet M, 2015, LANCET INFECT DIS, V15, P565, DOI 10.1016/S1473-3099(14)71073-4; Drummond O B., 2005, METHODS EVALUATION H; Elfstrom KM, 2013, CURR OPIN ONCOL; Ginindza TG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170189; GlaxoSmithKline, HIGHL PRESCR INF; Goldhaber-Fiebert Jeremy D, 2006, Cost Eff Resour Alloc, V4, P13, DOI 10.1186/1478-7547-4-13; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Goldie SJ, 2008, VACCINE, V26, pM17, DOI 10.1016/j.vaccine.2008.06.018; Harper DM, 2008, VACCINE, V26, pA7, DOI 10.1016/j.vaccine.2008.01.013; Harper DM, 2010, DISCOV MED, V10, P7; Herweijer E, 2016, INT J CANCER, V138, P2867, DOI 10.1002/ijc.30035; Herweijer E, 2014, JAMA-J AM MED ASSOC, V311, P597, DOI 10.1001/jama.2014.95; Hillemanns P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-76; Hopelands Cancer Centre, 2016, CERV CANC TREATM COS; Hu D, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.03.064; Insinga RP, 2005, PHARMACOECONOMICS, V23, P1107, DOI 10.2165/00019053-200523110-00004; Jit M, 2014, LANCET GLOB HEALTH, V2, pE406, DOI 10.1016/S2214-109X(14)70237-2; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Lacey CJN, 2006, VACCINE, V24, P35, DOI 10.1016/j.vaccine.2006.06.015; Legood R, 2005, INT J CANCER, V117, P981, DOI 10.1002/ijc.21220; Levin CE, 2010, INT J CANCER, V127, P1404, DOI 10.1002/ijc.25150; Lipsy Robert J, 2008, Am J Manag Care, V14, pS177; Low JJH, 2012, ASIAN PAC J CANCER P, V13, P305, DOI 10.7314/APJCP.2012.13.1.305; Mandelblatt JS, 2002, JNCI-J NATL CANCER I, V94, P1469, DOI 10.1093/jnci/94.19.1469; Mayeaux EJ, 2008, J AM OSTEOPATH ASSOC, V108, pS2; Merck & Co, HIGHL PRESCR INF; Ostensson E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139062; Ostensson E, 2013, ACTA OBSTET GYN SCAN, V92, P830, DOI 10.1111/aogs.12143; Petrosky E, 2015, MMWR-MORBID MORTAL W, V64, P300; Phalala Fund Administration Office, 2015, ANN REP YEAR 2014 15; Quentin W, 2011, TROP MED INT HEALTH, V16, P379, DOI 10.1111/j.1365-3156.2010.02722.x; Rice D P, 1985, Health Care Financ Rev, V7, P61; Schwarz TF, 2009, VACCINE, V27, P581, DOI 10.1016/j.vaccine.2008.10.088; Shavit O, 2012, APPL HEALTH ECON HEA, V10, P87, DOI 10.2165/11594780-000000000-00000; Shi Ju-Fang, 2012, BMC Health Serv Res, V12, P123, DOI 10.1186/1472-6963-12-123; STIGMA, 2019, GUID MAN SEX TRANSM; Tabrizi SN, 2014, LANCET INFECT DIS, V14, P958, DOI 10.1016/S1473-3099(14)70841-2; The Clinic Group, PRIV HLTH CAR SERV C; The Kingdom of Swaziland, 2013, CERV CANC SCREEN GUI; The Kingdom of Swaziland, 2015, HLTH MAN INF SYST HM; The Kingdom of Swaziland, 2015, ANN NAT SEX REPR HLT; The Kingdom of Swaziland Gorvernment and UNFPA, 2007, SWAZ POP PROJ 2007 2; The Kingdom of Swaziland. Swaziland National Cancer Registry, 2016, REP CAS CANC SWAZ 20; TrADING Economics, 2016, SWAZ GDP PER CAP; UNAIDS, 2012, SWAZ COUNTR REP MON; United Nations Environment Programme (UNEP)/GRID, 2005, TOP MAPS SO AFR TOP; Vijayaraghavan A, 2009, GYNECOL ONCOL, V112, P377, DOI 10.1016/j.ygyno.2008.08.030; Weisberg E, 2009, AUST FAM PHYSICIAN, V38, P72; Wiley D, 2006, OBSTET GYNECOL SURV, V61, pS3, DOI 10.1097/01.ogx.0000221010.82943.8c; World Health Organization, 2016, WORLD HLTH REP EXC S; World Health Organization, 2014, EV BAS REC HUM PAP V	65	10	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177762	10.1371/journal.pone.0177762	http://dx.doi.org/10.1371/journal.pone.0177762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531205	Green Published, Green Submitted, gold			2022-12-26	WOS:000402058400028
J	Schaefer, S; Svenstrup, TH; Guerra, B				Schaefer, Susanne; Svenstrup, Tina H.; Guerra, Barbara			The small-molecule kinase inhibitor D11 counteracts 17-AAG-mediated up-regulation of HSP70 in brain cancer cells	PLOS ONE			English	Article							PROTEIN-KINASE; TARGETING HSP90; CK2; 17-AAG; TANESPIMYCIN; AUTOPHAGY; SITES; DEATH	Many types of cancer express high levels of heat shock proteins (HSPs) that are molecular chaperones regulating protein folding and stability ensuring protection of cells from potentially lethal stress. HSPs in cancer cells promote survival, growth and spreading even in situations of growth factors deprivation by associating with oncogenic proteins responsible for cell transformation. Hence, it is not surprising that the identification of potent inhibitors of HSPs, notably HSP90, has been the primary research focus, in recent years. Exposure of cancer cells to HSP90 inhibitors, including 17-AAG, has been shown to cause resistance to chemotherapeutic treatment mostly attributable to induction of the heat shock response and increased cellular levels of pro-survival chaperones. In this study, we show that treatment of glioblastoma cells with 17-AAG leads to HSP90 inhibition indicated by loss of stability of the EGFR client protein, and significant increase in HSP70 expression. Conversely, co-treatment with the small-molecule kinase inhibitor D11 leads to suppression of the heat shock response and inhibition of HSF1 transcriptional activity. Beside HSP70, Western blot and differential mRNA expression analysis reveal that combination treatment causes strong down-regulation of the small chaperone protein HSP27. Finally, we demonstrate that incubation of cells with both agents leads to enhanced cytotoxicity and significantly high levels of LC3-II suggesting autophagy induction. Taken together, results reported here support the notion that including D11 in future treatment regimens based on HSP90 inhibition can potentially overcome acquired resistance induced by the heat shock response in brain cancer cells.	[Schaefer, Susanne; Svenstrup, Tina H.; Guerra, Barbara] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark	University of Southern Denmark	Guerra, B (corresponding author), Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark.	bag@bmb.sdu.dk		Guerra, Barbara/0000-0003-1136-2413	Danish Council for Independent Research-Natural Sciences [1323-00212A]	Danish Council for Independent Research-Natural Sciences(Det Frie Forskningsrad (DFF))	This work was supported by the Danish Council for Independent Research-Natural Sciences (Grant 1323-00212A to B. Guerra). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan A, 2012, NEOPLASIA, V14, P670, DOI 10.1593/neo.12986; Assimakopoulou M, 1997, ANTICANCER RES, V17, P2677; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chou S- D, 2012, PLOONE PUBLIC LIB, V7; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Concannon CG, 2005, CELL STRESS CHAPERON, V10, P59, DOI 10.1379/CSC-69R.1; Dai C, 2016, TRENDS CELL BIOL, V26, P17, DOI 10.1016/j.tcb.2015.10.011; Denton D, 2012, CELL DEATH DIFFER, V19, P87, DOI 10.1038/cdd.2011.146; Dokladny K, 2013, J BIOL CHEM, V288, P14959, DOI 10.1074/jbc.M113.462408; Duncan JS, 2008, BBA-PROTEINS PROTEOM, V1784, P33, DOI 10.1016/j.bbapap.2007.08.017; Gaspar N, 2009, CANCER RES, V69, P1966, DOI 10.1158/0008-5472.CAN-08-3131; Guerra B, 2008, CURR MED CHEM, V15, P1870, DOI 10.2174/092986708785132933; Guerra B, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0234-6; Guerra B, 2015, MOL CELL BIOCHEM, V406, P151, DOI 10.1007/s11010-015-2433-z; Guerra B, 2015, CANCER LETT, V356, P751, DOI 10.1016/j.canlet.2014.10.026; Guerra B, 2014, CANCER LETT, V345, P115, DOI 10.1016/j.canlet.2013.11.008; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Guo F, 2005, CANCER RES, V65, P10536, DOI 10.1158/0008-5472.CAN-05-1799; Guo WC, 2005, CANCER RES, V65, P10006, DOI 10.1158/0008-5472.CAN-05-2029; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holmberg CI, 2000, CELL STRESS CHAPERON, V5, P219, DOI 10.1379/1466-1268(2000)005<0219:FONHGV>2.0.CO;2; Holmes JL, 2008, CANCER RES, V68, P1187, DOI 10.1158/0008-5472.CAN-07-3268; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Li D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.158; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahalingam D, 2009, BRIT J CANCER, V100, P1523, DOI 10.1038/sj.bjc.6605066; Mayer MP, 2009, NAT STRUCT MOL BIOL, V16, P2, DOI 10.1038/nsmb0109-2; Mayor-Lopez L, 2014, TRANSL ONCOL, V7, P590, DOI 10.1016/j.tranon.2014.08.001; Mercier PA, 1999, J CELL SCI, V112, P2765; Miyata Y, 2005, MOL CELL BIOCHEM, V274, P171, DOI 10.1007/s11010-005-2949-8; Modi S, 2007, J CLIN ONCOL, V25, P5410, DOI 10.1200/JCO.2007.11.7960; Naidu SD, 2016, MOL CELL BIOL, V36, P2403, DOI 10.1128/MCB.00292-16; Olsen BB, 2010, ONCOGENE, V29, P6016, DOI 10.1038/onc.2010.337; Olsen BB, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-7; Park MA, 2008, MOL PHARMACOL, V73, P1168, DOI 10.1124/mol.107.042697; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	50	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177706	10.1371/journal.pone.0177706	http://dx.doi.org/10.1371/journal.pone.0177706			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542269	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400069
J	Weber, N; Bouwes, N; Pollock, MM; Volk, C; Wheaton, JM; Wathen, G; Wirtz, J; Jordan, CE				Weber, Nicholas; Bouwes, Nicolaas; Pollock, Michael M.; Volk, Carol; Wheaton, Joseph M.; Wathen, Gus; Wirtz, Jacob; Jordan, Chris E.			Alteration of stream temperature by natural and artificial beaver dams	PLOS ONE			English	Article							ONCORHYNCHUS-MYKISS; WATER TEMPERATURE; IMPACT ASSESSMENT; EASTERN OREGON; RIVER; DISTURBANCES; ECOSYSTEMS; UPSTREAM; DYNAMICS; PATTERNS	Beaver are an integral component of hydrologic, geomorphic, and biotic processes within North American stream systems, and their propensity to build dams alters stream and riparian structure and function to the benefit of many aquatic and terrestrial species. Recognizing this, beaver relocation efforts and/or application of structures designed to mimic the function of beaver dams are increasingly being utilized as effective and cost-efficient stream and riparian restoration approaches. Despite these verities, the notion that beaver dams negatively impact stream habitat remains common, specifically the assumption that beaver dams increase stream temperatures during summer to the detriment of sensitive biota such as salmonids. In this study, we tracked beaver dam distributions and monitored water temperature throughout 34 km of stream for an eight-year period between 2007 and 2014. During this time the number of natural beaver dams within the study area increased by an order of magnitude, and an additional 4 km of stream were subject to a restoration manipulation that included installing a high-density of Beaver Dam Analog (BDA) structures designed to mimic the function of natural beaver dams. Our observations reveal several mechanisms by which beaver dam development may influence stream temperature regimes; including longitudinal buffering of diel summer temperature extrema at the reach scale due to increased surface water storage, and creation of cool-water channel scale temperature refugia through enhanced groundwater-surface water connectivity. Our results suggest that creation of natural and/or artificial beaver dams could be used to mitigate the impact of human induced thermal degradation that may threaten sensitive species.	[Weber, Nicholas; Bouwes, Nicolaas; Wathen, Gus; Wirtz, Jacob] Ecolog Res Inc, Providence, UT 84332 USA; [Bouwes, Nicolaas; Wheaton, Joseph M.] Utah State Univ, Watershed Sci Dept, Logan, UT 84322 USA; [Pollock, Michael M.; Jordan, Chris E.] Northwest Fisheries Sci Ctr, Seattle, WA USA; [Volk, Carol] South Fork Res Inc, North Bend, WA USA	Utah System of Higher Education; Utah State University	Weber, N (corresponding author), Ecolog Res Inc, Providence, UT 84332 USA.	nick.weber@ecologicalresearch.net	Wheaton, Joseph Michael/F-1965-2010	Wheaton, Joseph Michael/0000-0002-8361-8150	Bonneville Power Administration (BPA) [2003-017]; National Oceanic and Atmospheric Administration as part of the Integrated Status and Effectiveness Monitoring Program; NOAA Western Regional Office	Bonneville Power Administration (BPA); National Oceanic and Atmospheric Administration as part of the Integrated Status and Effectiveness Monitoring Program; NOAA Western Regional Office	Financial support for this project was provided by the Bonneville Power Administration (BPA Project Number: 2003-017) and the National Oceanic and Atmospheric Administration as part of the Integrated Status and Effectiveness Monitoring Program, and by the NOAA Western Regional Office. The funder provided support in the form of salaries for authors affiliated with Eco-Logical Research and South Fork Research but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allan D., 2007, STREAM ECOLOGY STRUC; [Anonymous], 2019, MIDDLE COLUMBIA RIVE, P260; Arrigoni AS, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006480; Bledzki LA, 2011, ECOHYDROLOGY, V4, P698, DOI 10.1002/eco.163; Bouwes N, 2016, SCI REP-UK, V6, DOI 10.1038/srep28581; Brewitt KS, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00036.1; Butler DR, 2005, GEOMORPHOLOGY, V71, P48, DOI 10.1016/j.geomorph.2004.08.016; Cleveland, 2009, ENCY EARTH; Collen P, 2001, REV FISH BIOL FISHER, V10, P439; Demmer R, 2008, NORTHWEST SCI, V82, P309, DOI 10.3955/0029-344X-82.4.309; Ebersole JL, 2001, ECOL FRESHW FISH, V10, P1, DOI 10.1034/j.1600-0633.2001.100101.x; Evans EC, 1997, HYDROLOG SCI J, V42, P199, DOI 10.1080/02626669709492020; Fanelli RM, 2008, GROUND WATER, V46, P671, DOI 10.1111/j.1745-6584.2008.00461.x; Feldhaus JW, 2010, ENVIRON BIOL FISH, V87, P277, DOI 10.1007/s10641-010-9580-6; Fuller MR, 2011, FRESHWATER BIOL, V56, P969, DOI 10.1111/j.1365-2427.2010.02548.x; Green K. C., 2009, BC Journal of Ecosystems and Management, V10, P68; Ham J, 2006, ENVIRON GEOL, V50, P55, DOI 10.1007/s00254-006-0186-4; Johnson SL, 2004, CAN J FISH AQUAT SCI, V61, P913, DOI [10.1139/f04-040, 10.1139/F04-040]; Johnston CA, 1987, LANDSCAPE ECOL, V1, P47, DOI 10.1007/BF02275265; Kammerer BD, 2013, ENVIRON BIOL FISH, V96, P823, DOI 10.1007/s10641-012-0078-2; Kemp PS, 2012, FISH FISH, V13, P158, DOI 10.1111/j.1467-2979.2011.00421.x; LI HW, 1994, T AM FISH SOC, V123, P627, DOI 10.1577/1548-8659(1994)123<0627:CEORDA>2.3.CO;2; Lowry M. M., 1993, THESIS OREGON STATE; MAGNUSON JJ, 1979, AM ZOOL, V19, P331; Majerova M., 2015, HYDROL EARTH SYST SC, V12, P839; Margolis BE, 2001, CAN J FISH AQUAT SCI, V58, P2271, DOI 10.1139/cjfas-58-11-2271; Mccullough DA, 2009, REV FISH SCI, V17, P90, DOI 10.1080/10641260802590152; MCRAE G, 1994, T AM FISH SOC, V123, P641, DOI 10.1577/1548-8659(1994)123<0641:TCOWHS>2.3.CO;2; NAIMAN RJ, 1988, BIOSCIENCE, V38, P753, DOI 10.2307/1310784; National Marine Fisheries Service, 2008, NMFS END SPEC ACT SE; Poff NL, 1998, CAN J FISH AQUAT SCI, V55, P201, DOI 10.1139/cjfas-55-S1-201; Pollock KM., 2012, NMFSNWFSC120 NOAA US, P47; Pollock MM, 2007, EARTH SURF PROC LAND, V32, P1174, DOI 10.1002/esp.1553; Pollock MM, 2014, BIOSCIENCE, V64, P279, DOI 10.1093/biosci/biu036; Pollock MM, 2015, BEAVER RESTORATION G; Pollock MM, 2003, AM FISHERIES SOC S, P22; Poole GC, 2001, ENVIRON MANAGE, V27, P787, DOI 10.1007/s002670010188; Reynolds SK, 2005, HYDROBIOLOGIA, V544, P69, DOI 10.1007/s10750-004-8334-x; Rodnick KJ, 2004, J FISH BIOL, V64, P310, DOI 10.1111/j.0022-1112.2004.00292.x; SHETTER DAVID S., 1955, JOUR WILDLIFE MANAGEMENT, V19, P47, DOI 10.2307/3797551; Sigourney DB, 2006, T AM FISH SOC, V135, P1068, DOI 10.1577/T05-159.1; SMITH EP, 1993, CAN J FISH AQUAT SCI, V50, P627, DOI 10.1139/f93-072; Sowder C, 2012, WATER-SUI, V4, P597, DOI 10.3390/w4030597; Stewart-Oaten A, 2001, ECOL MONOGR, V71, P305, DOI 10.1890/0012-9615(2001)071[0305:TASVIE]2.0.CO;2; Stricker HK, 2010, FOREST COUNTY POTAWA; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; Wagner R, 2005, ARCH HYDROBIOL, V163, P65, DOI 10.1127/0003-9136/2005/0163-0065; Westbrook CJ, 2011, RIVER RES APPL, V27, DOI 10.1002/rra.1359; Westbrook C.J., 2013, TREATISE GEOMORPHOLO, V12, P293; Williams J.E., 2015, REFERENCE MODULE EAR; Wright JP, 2002, OECOLOGIA, V132, P96, DOI 10.1007/s00442-002-0929-1	51	48	48	5	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176313	10.1371/journal.pone.0176313	http://dx.doi.org/10.1371/journal.pone.0176313			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520714	Green Published, gold			2022-12-26	WOS:000401487700013
J	Bhatnagar, M; Goel, I; Roy, T; Shukla, SD; Khurana, S				Bhatnagar, Maheep; Goel, Ishan; Roy, Tathagato; Shukla, Sunil Dutt; Khurana, Sukant			Complete Comparison Display (CCD) evaluation of ethanol extracts of Centella asiatica and Withania somnifera shows that they can non-synergistically ameliorate biochemical and behavioural damages in MPTP induced Parkinson's model of mice	PLOS ONE			English	Article							NEURONAL DENDRITIC ARBORIZATION; GROWTH SPURT PERIOD; L-DOPA; OXIDATIVE STRESS; DISEASE; MOTOR; NEUROPROTECTION; NEUROTOXICITY; SYSTEM; ASSAY	Parkinson's disease remains as one of the most common debilitating neurodegenerative disorders. With the hopes of finding agents that can cure or reduce the pace of progression of the disease, we studied two traditional medicinal plants: Centella asiatica and Withania somnifera that have been explored in some recent studies. In agreement with the previous work on ethanol extracts of these two plants in mice model, we saw an improvement in oxidative stress profile as well as behavioral performance in 1-methyl-4-phenyl-1,2,3,6-tetrahy-dropyridine (MPTP) induced Parkinson-like symptoms in Balb/c mice. Given the known potential of both the herbal extracts in improving Parkinson-like symptoms, we expected the combination of the two to show better results than either of the two but surprisingly there was no additivity in either oxidative stress or behavioural recovery. In fact, in some assays, the combination performed worse than either of the two individual constituents. This effect of mixtures highlights the need of testing mixtures in supplements market using enthomedicine. The necessity of comparing multiple groups in this study to get most information from the experiments motivated us to design a ladder-like visualization to show comparison with different groups that we call complete comparison display (CCD). In summary, we show the potential of Centella asiatica and Withania somnifera to ameliorate Parkinson's disorder.	[Bhatnagar, Maheep; Shukla, Sunil Dutt] Mohanlal Sukhadia Univ, Dept Zool, Udaipur, Rajasthan, India; [Goel, Ishan; Khurana, Sukant] Cent Drug Res Inst, Pharmacol Dept, Lucknow, Uttar Pradesh, India; [Roy, Tathagato; Khurana, Sukant] Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Haringhata Farm, W Bengal, India; [Shukla, Sunil Dutt] Govt Meera Girls Coll, Udaipur, Rajasthan, India	Mohanlal Sukhadia University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Indian Institute of Science Education & Research (IISER) - Kolkata	Shukla, SD (corresponding author), Mohanlal Sukhadia Univ, Dept Zool, Udaipur, Rajasthan, India.; Khurana, S (corresponding author), Cent Drug Res Inst, Pharmacol Dept, Lucknow, Uttar Pradesh, India.; Khurana, S (corresponding author), Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Haringhata Farm, W Bengal, India.; Shukla, SD (corresponding author), Govt Meera Girls Coll, Udaipur, Rajasthan, India.	sukantkhurana@gmail.com; shuklasd@gmail.com	Shukla, Sunil Dutt/M-1182-2014; Shukla, Sunil Dutt/O-1443-2019	Shukla, Sunil Dutt/0000-0002-4467-3106; Shukla, Sunil Dutt/0000-0002-4467-3106				Ahmad M, 2005, HUM EXP TOXICOL, V24, P137, DOI 10.1191/0906327105ht209oa; Ahmed D, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-243; Archana R, 1999, J ETHNOPHARMACOL, V64, P91, DOI 10.1016/S0378-8741(98)00107-X; BARBEAU A, 1969, Canadian Medical Association Journal, V101, P59; Bastide MF, 2015, PROG NEUROBIOL, V132, P96, DOI 10.1016/j.pneurobio.2015.07.002; Beal MF, 2003, ANN NY ACAD SCI, V991, P120; Blesa J, 2012, NEUROBIOL DIS, V48, P79, DOI 10.1016/j.nbd.2012.05.018; Blesa J, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00092; Brotchie JM, 2005, J NEURAL TRANSM, V112, P359, DOI 10.1007/s00702-004-0251-7; Cheng CW, 2015, J PHOTOCH PHOTOBIO B, V148, P262, DOI 10.1016/j.jphotobiol.2015.04.028; Cheng CL, 2000, LIFE SCI, V67, P2647, DOI 10.1016/S0024-3205(00)00848-1; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Datusalia AK, 2012, ACTA POL PHARM, V69, P699; Dhuley JN, 1998, J ETHNOPHARMACOL, V60, P173, DOI 10.1016/S0378-8741(97)00151-7; DONNAN GA, 1987, J NEUROL SCI, V77, P185, DOI 10.1016/0022-510X(87)90121-3; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; George M, 2010, AFR J TRAD COMPL ALT, V6; Gnanapragasam A, 2004, LIFE SCI, V76, P585, DOI 10.1016/j.lfs.2004.09.009; GODWINAUSTEN RB, 1969, LANCET, V2, P165; Haleagrahara N, 2010, J TOXICOL SCI, V35, P41, DOI 10.2131/jts.35.41; Horstink M, 2006, EUR J NEUROL, V13, P1186, DOI 10.1111/j.1468-1331.2006.01548.x; HYLAND K, 1992, CLIN CHEM, V38, P2405; Inamdar PK, 1996, J CHROMATOGR A, V742, P127, DOI 10.1016/0021-9673(96)00237-3; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Jagmag SA, 2016, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00503; James JT, 2009, MOLECULES, V14, P3922, DOI 10.3390/molecules14103922; Jana U, 2010, Nepal Med Coll J, V12, P8; Jankovic J, 2005, MOVEMENT DISORD, V20, pS11, DOI 10.1002/mds.20458; Jansen RLM, 2014, PHYTOTHER RES, V28, P1789, DOI 10.1002/ptr.5199; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; Jeon W.K., 2012, EVID-BASED COMPL ALT, V2012, P1; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; Kumar Anil, 2011, Int J Alzheimers Dis, V2011, P347569, DOI 10.4061/2011/347569; Liu XX, 2000, LIFE SCI, V66, P2277, DOI 10.1016/S0024-3205(00)00557-9; MITRA N, 1992, BRAIN RES B, V28; Mohanakumar KP, 2000, BRAIN RES, V864, P281, DOI 10.1016/S0006-8993(00)02189-2; MOHANDAS J, 1984, BIOCHEM PHARMACOL, V33, P1801, DOI 10.1016/0006-2952(84)90353-8; Muralikrishnan D, 1998, FASEB J, V12, P905, DOI 10.1096/fasebj.12.10.905; NIEHAUS WG, 1968, EUR J BIOCHEM, V6, P126, DOI 10.1111/j.1432-1033.1968.tb00428.x; Panda Sunanda, 1997, Indian Journal of Physiology and Pharmacology, V41, P424; Ponnusamy K, 2008, Med J Malaysia, V63 Suppl A, P102; Prakash J, 2014, NEUROCHEM RES, V39, P2527, DOI 10.1007/s11064-014-1443-7; Prakash J, 2013, NEUROCHEM RES, V38, P972, DOI 10.1007/s11064-013-1005-4; Rao KGM, 2006, EVID-BASED COMPL ALT, V3, P349, DOI 10.1093/ecam/nel024; Rao KGM, 2009, EVID-BASED COMPL ALT, V6, P203, DOI 10.1093/ecam/nem079; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sankar SR, 2007, CELL MOL BIOL LETT, V12, P473, DOI 10.2478/s11658-007-0015-0; Shinomol GK, 2010, PHYTOTHER RES, V24, P885, DOI 10.1002/ptr.3042; Shinomol GK, 2008, NEUROTOXICOLOGY, V29, P948, DOI 10.1016/j.neuro.2008.09.009; Shukla SD, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00112; Siddique YH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/382124; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; Tandon Neeraj, 2012, Toxicol Int, V19, P245, DOI 10.4103/0971-6580.103658; Ul Kabir A, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-31; VARASTET M, 1994, NEUROSCIENCE, V63, P47, DOI 10.1016/0306-4522(94)90006-X; WEIHMULLER FB, 1989, PHARMACOL BIOCHEM BE, V34, P113, DOI 10.1016/0091-3057(89)90362-6; WEIHMULLER FB, 1988, NEUROSCI LETT, V85, P137, DOI 10.1016/0304-3940(88)90443-0; Whishaw IQ, 2003, J NEUROSCI METH, V126, P13, DOI 10.1016/S0165-0270(03)00049-9; Wijeweeraa P, PHYTOMEDICINE; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; Wong KS, 2003, J NEUROL SCI, V216, P81, DOI 10.1016/S0022-510X(03)00217-X; Xu CL, 2013, FITOTERAPIA, V90, P112, DOI 10.1016/j.fitote.2013.07.009; Xu CL, 2012, PHARMACOL BIOCHEM BE, V100, P413, DOI 10.1016/j.pbb.2011.09.014; Zaidan M R S, 2005, Trop Biomed, V22, P165; Zheng Cheng-jian, 2007, Zhong Xi Yi Jie He Xue Bao, V5, P348	65	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177254	10.1371/journal.pone.0177254	http://dx.doi.org/10.1371/journal.pone.0177254			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510600	Green Submitted, gold, Green Published			2022-12-26	WOS:000401485500018
J	Chen, JG; Yu, XX; Bi, HX; Fu, YL				Chen, Jungang; Yu, Xinxiao; Bi, Huaxing; Fu, Yanlin			Indoor simulations reveal differences among plant species in capturing particulate matter	PLOS ONE			English	Article							ULTRAFINE PARTICLE DEPOSITION; VOLATILE ORGANIC-COMPOUNDS; URBAN STREET CANYON; DRY DEPOSITION; HEALTH IMPACTS; AEROSOL; TREE; FINE; VEGETATION; POLLUTION	A number of studies have focused on the capacity of urban trees and shrubs to serve as efficient biological filters to mitigate air pollution. In this study, five different tree species were assessed for this function. Kerria japonica, Sophora japonica, Philadelphus pekinensis, Gleditsia sinensis, and Prunus persica 'Atropurpurea' were tested in a deposition chamber using (NH4)(2)SO4 particles. We quantified and compared the capability of all tested trees to remove particles by assessing deposition velocity, a measure of the ability to remove particles. When placed in the deposition chamber, S. japonica had the greatest deposition velocity, followed by Philadelphus pekinensis, G. sinensis, Prunus persica 'Atropurpurea,' and K. japonica, in descending order. In addition, the comparison of deposition velocities among these species suggested that certain leaf geometries and surface characteristics of broad-leaf trees, such as trichomes and grooves, increased particle capture. However, these results change under a different simulation condition using ambient air, suggesting that some trees actually increase pollutant number concentrations more than reduce particle concentration. This outcome can be explained by the aerodynamic effect of trees exceeding the filtering capacity of vegetation under some conditions. This highlights the difficulty of generalizing species selection criteria for practice use. Accordingly, our results indicate that using vegetation to reduce particle pollution and improve the air quality is not a universally advisable and viable solution.	[Chen, Jungang; Yu, Xinxiao; Bi, Huaxing] Beijing Forestry Univ, Coll Soil & Water Conservat, Beijing Lab Urban & Rural Ecol Environm, Beijing, Peoples R China; [Chen, Jungang; Yu, Xinxiao; Bi, Huaxing] Beijing Collaborat Innovat Ctr Ecoenvironm Improv, Beijing, Peoples R China; [Fu, Yanlin] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Bi, HX (corresponding author), Beijing Forestry Univ, Coll Soil & Water Conservat, Beijing Lab Urban & Rural Ecol Environm, Beijing, Peoples R China.; Bi, HX (corresponding author), Beijing Collaborat Innovat Ctr Ecoenvironm Improv, Beijing, Peoples R China.	bhx@bjfu.edu.cn		Chen, Jungang/0000-0002-5429-7079	forestry public welfare project of China [201304301]; Beijing Municipal Commission of Education [BLCXY201617]	forestry public welfare project of China; Beijing Municipal Commission of Education(Beijing Municipal Commission of Education)	This study was supported by the research projects of forestry public welfare project of China (No.201304301) and Graduate Training and Development Program of Beijing Municipal Commission of Education (No.BLCXY201617) and Special Found for Beijing Common Construction Project. The authors are grateful to our partners in the program for their support and comments on the manuscript. We would like to express our gratitude to the authorities at the Beijing Olympic forest park and Beijing Forestry University for their help and giving us access to the park to conduct experiments.	[Anonymous], 2011, INT J PHYTOREMEDIAT, V13, P1037; Barima YSS, 2014, SCI TOTAL ENVIRON, V470, P975, DOI 10.1016/j.scitotenv.2013.10.082; BECKETT K.P., 2000, J ARBOR, V26, P12; Beckett KP, 2000, GLOBAL CHANGE BIOL, V6, P995, DOI 10.1046/j.1365-2486.2000.00376.x; Blanusa T, 2015, URBAN FOR URBAN GREE, V14, P1095, DOI 10.1016/j.ufug.2015.10.004; BURRI K, 2011, AEOLIAN RES, V3, P205, DOI DOI 10.1016/J.AEOLIA.2011.01.003; Ceulemans K, 2010, ATMOS ENVIRON, V44, P5434, DOI 10.1016/j.atmosenv.2010.05.001; Faiola CL, 2015, ATMOS CHEM PHYS, V15, P3629, DOI 10.5194/acp-15-3629-2015; Freer-Smith PH, 2004, WATER AIR SOIL POLL, V155, P173, DOI 10.1023/B:WATE.0000026521.99552.fd; Gens A, 2014, ATMOS ENVIRON, V84, P213, DOI 10.1016/j.atmosenv.2013.11.054; Goldstein A H, 2014, AGU FALL M, V1; Gregory PH, 1973, MICROBIOLOGY ATMOSPH; Gromke C, 2007, ATMOS ENVIRON, V41, P3287, DOI 10.1016/j.atmosenv.2006.12.043; Hao LQ, 2009, ATMOS CHEM PHYS, V9, P8121, DOI 10.5194/acp-9-8121-2009; Hofman J, 2013, ENVIRON POLLUT, V183, P123, DOI 10.1016/j.envpol.2012.09.015; Huang RJ, 2014, NATURE, V514, P218, DOI 10.1038/nature13774; Hwang HJ, 2011, ATMOS ENVIRON, V45, P6987, DOI 10.1016/j.atmosenv.2011.09.019; Inomata S, 2014, ATMOS ENVIRON, V97, P397, DOI 10.1016/j.atmosenv.2014.03.045; Keebaugh AJ, 2015, SCI TOTAL ENVIRON, V533, P69, DOI 10.1016/j.scitotenv.2015.06.048; Kesselmeier J, 1999, J ATMOS CHEM, V33, P23, DOI 10.1023/A:1006127516791; Kulmala M, 2004, J AEROSOL SCI, V35, P143, DOI 10.1016/j.jaerosci.2003.10.003; Lee H, 2014, J AEROSOL SCI, V67, P166, DOI 10.1016/j.jaerosci.2013.10.006; Lee H, 2015, ENVIRON POLLUT, V207, P43, DOI 10.1016/j.envpol.2015.08.036; Lin M, 2012, ATMOS ENVIRON, V51, P293, DOI 10.1016/j.atmosenv.2012.01.004; Lin MY, 2012, AEROSOL SCI TECH, V46, P465, DOI 10.1080/02786826.2011.638346; Litschke T, 2008, METEOROL Z, V17, P229, DOI 10.1127/0941-2948/2008/0284; McDonald AG, 2007, ATMOS ENVIRON, V41, P8455, DOI 10.1016/j.atmosenv.2007.07.025; McPherson G E, 1994, NE186 USDA; Mentel TF, 2009, ATMOS CHEM PHYS, V9, P4387, DOI 10.5194/acp-9-4387-2009; Mitchell R, 2010, ENVIRON POLLUT, V158, P1472, DOI 10.1016/j.envpol.2009.12.029; Morawska L, 1998, ENVIRON SCI TECHNOL, V32, P2033, DOI 10.1021/es970826+; Nowak David J., 2006, Urban Forestry & Urban Greening, V5, P93, DOI [10.1016/j.ufug.2006.04.002, 10.1016/j.ufug.2006.01.007]; Nowak DJ, 2002, ENVIRON POLLUT, V116, P381, DOI 10.1016/S0269-7491(01)00214-7; Ottele M, 2010, ECOL ENG, V36, P154, DOI 10.1016/j.ecoleng.2009.02.007; Ould-Dada Z, 2001, ATMOS ENVIRON, V35, P3799, DOI 10.1016/S1352-2310(01)00161-3; Pataki DE, 2011, FRONT ECOL ENVIRON, V9, P27, DOI 10.1890/090220; PETERS K, 1992, ATMOS ENVIRON A-GEN, V26, P2555, DOI 10.1016/0960-1686(92)90108-W; Petroff A, 2008, ATMOS ENVIRON, V42, P3625, DOI 10.1016/j.atmosenv.2007.09.043; Pinto DM, 2007, ATMOS ENVIRON, V41, P4877, DOI 10.1016/j.atmosenv.2007.02.006; Rasanen JV, 2013, ENVIRON POLLUT, V183, P64, DOI 10.1016/j.envpol.2013.05.015; Roldin P, 2015, ATMOS CHEM PHYS, V15, P10777, DOI 10.5194/acp-15-10777-2015; Roupsard P, 2013, J AEROSOL SCI, V55, P12, DOI 10.1016/j.jaerosci.2012.07.006; Saebo A, 2012, SCI TOTAL ENVIRON, V427, P347, DOI 10.1016/j.scitotenv.2012.03.084; Song YS, 2016, J CLEAN PROD, V112, P1312, DOI 10.1016/j.jclepro.2015.05.006; Tallis M, 2011, LANDSCAPE URBAN PLAN, V103, P129, DOI 10.1016/j.landurbplan.2011.07.003; Teper E, 2009, ENVIRON MONIT ASSESS, V154, P383, DOI 10.1007/s10661-008-0405-4; Terzaghi E, 2013, ATMOS ENVIRON, V74, P378, DOI 10.1016/j.atmosenv.2013.04.013; Tiwary A, 2009, ENVIRON POLLUT, V157, P2645, DOI 10.1016/j.envpol.2009.05.005; Twomey S., 1976, SCI TOTAL ENVIRON, V13, P275; Vos PEJ, 2013, ENVIRON POLLUT, V183, P113, DOI 10.1016/j.envpol.2012.10.021; Wania A, 2012, J ENVIRON MANAGE, V94, P91, DOI 10.1016/j.jenvman.2011.06.036; WHO, 2006, EXPOSURE ASSESSMENT; YE Y, 1991, J AEROSOL SCI, V22, P63, DOI 10.1016/0021-8502(91)90093-W; Yook SJ, 2007, J AEROSOL SCI, V38, P211, DOI 10.1016/j.jaerosci.2006.11.010; Yook SJ, 2010, J AEROSOL SCI, V41, P911, DOI 10.1016/j.jaerosci.2010.06.003; Yook SJ, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3133343; Zhao DF, 2015, ATMOS CHEM PHYS, V15, P991, DOI 10.5194/acp-15-991-2015; Zhao Y, 2015, ENVIRON SCI TECHNOL, V49, P12153, DOI 10.1021/acs.est.5b02455	58	11	12	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177539	10.1371/journal.pone.0177539	http://dx.doi.org/10.1371/journal.pone.0177539			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520744	gold, Green Published, Green Submitted			2022-12-26	WOS:000401485500038
J	Semenova, G; Stepanova, DS; Dubyk, C; Handorf, E; Deyev, SM; Lazar, AJ; Chernoff, J				Semenova, G.; Stepanova, D. S.; Dubyk, C.; Handorf, E.; Deyev, S. M.; Lazar, A. J.; Chernoff, J.			Targeting group I p21-activated kinases to control malignant peripheral nerve sheath tumor growth and metastasis	ONCOGENE			English	Article							SCHWANN-CELL TRANSFORMATION; NEUROFIBROMATOSIS TYPE-1; SIGNALING PATHWAY; PAK1 INHIBITOR; MEK INHIBITOR; BETA-CATENIN; ACTIVATION; CANCER; MAPK; TUMORIGENESIS	Malignant peripheral nerve sheath tumors (MPNSTs) are devastating sarcomas for which no effective medical therapies are available. Over 50% of MPSNTs are associated with mutations in NF1 tumor suppressor gene, resulting in activation of Ras and its effectors, including the Raf/Mek/Erk and PI3K/Akt/mTORC1 signaling cascades, and also the WNT/beta-catenin pathway. As Group I p21-activated kinases (Group I Paks, PAK1/2/3) have been shown to modulate Ras-driven oncogenesis, we asked if these enzymes might regulate signaling in MPNSTs. In this study we found a strong positive correlation between the activity of PAK1/2/3 and the stage of human MPNSTs. We determined that reducing Group I Pak activity diminished MPNST cell proliferation and motility, and that these effects were not accompanied by significant blockade of the Raf/Mek/Erk pathway, but rather by reductions in Akt and beta-catenin activity. Using the small molecule PAK1/2/3 inhibitor Frax1036 and the MEK1/2 inhibitor PD0325901, we showed that the combination of these two agents synergistically inhibited MPNST cell growth in vitro and dramatically decreased local and metastatic MPNST growth in animal models. Taken together, these data provide new insights into MPNST signaling deregulation and suggest that co-targeting of PAK1/2/3 and MEK1/2 may be effective in the treatment of patients with MPNSTs.	[Semenova, G.; Deyev, S. M.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Semenova, G.; Stepanova, D. S.; Chernoff, J.] Fox Chase Canc Ctr, Canc Biol Program, 333 Cottman Ave W451, Philadelphia, PA 19111 USA; [Stepanova, D. S.] Russian Natl Res Med Univ, Moscow, Russia; [Dubyk, C.] Fox Chase Canc Ctr, Biosample Repository, 333 Cottman Ave W451, Philadelphia, PA 19111 USA; [Handorf, E.] Fox Chase Canc Ctr, Biostat & Bioinformat, 333 Cottman Ave W451, Philadelphia, PA 19111 USA; [Deyev, S. M.] Natl Res Tomsk Polytech Univ, Tomsk, Russia; [Lazar, A. J.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Fox Chase Cancer Center; Pirogov Russian National Research Medical University; Fox Chase Cancer Center; Fox Chase Cancer Center; Tomsk Polytechnic University; University of Texas System; UTMD Anderson Cancer Center	Chernoff, J (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 333 Cottman Ave W451, Philadelphia, PA 19111 USA.	Jonathan.Chernoff@fccc.edu	Chernoff, Jonathan/I-7631-2014; Stepanova, Dina/T-3999-2019; Lazar, Alexander J/A-3416-2008; Deyev, Sergey/F-8191-2014	Chernoff, Jonathan/0000-0002-4803-7836; Lazar, Alexander J/0000-0002-6395-4499; Stepanova, Dina/0000-0001-6138-8502; Deyev, Sergey/0000-0002-3952-0631	NIH [RO1 CA142928]; Children's Tumor Foundation [2011-15-012]; NIH CORE Grant [P30 CA006927]; RSF grant [14-24-00106]; state of Pennsylvania; Russian Science Foundation [17-24-00006] Funding Source: Russian Science Foundation; NATIONAL CANCER INSTITUTE [R01CA142928, P30CA006927] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Tumor Foundation; NIH CORE Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RSF grant(Russian Science Foundation (RSF)); state of Pennsylvania; Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Timothy Cripe and Nancy Ratner for providing MPNST cell lines, Ahmet Hoke for providing immortalized HSC, Maureen Murphy for providing construct pWZL-Luc, Genentech for providing Frax1036, and Erica Golemis for commentary. This work was supported by grants from the NIH (RO1 CA142928), and the Children's Tumor Foundation (2011-15-012) to Jonathan Chernoff, NIH CORE Grant P30 CA006927 and an appropriation fromthe state of Pennsylvania to the Fox Chase Cancer Center. In vitro studies were supported by RSF grant 14-24-00106.	Arias-Romero LE, 2013, CANCER RES, V73, P3671, DOI 10.1158/0008-5472.CAN-12-4453; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barker Nick, 2008, V468, P5, DOI 10.1007/978-1-59745-249-6_1; Beeser A, 2005, J BIOL CHEM, V280, P36609, DOI 10.1074/jbc.M502306200; Brown AP, 2007, CANCER CHEMOTH PHARM, V59, P671, DOI 10.1007/s00280-006-0323-5; Carroll SL, 2008, GLIA, V56, P1590, DOI 10.1002/glia.20776; Carroll SL, 2012, ACTA NEUROPATHOL, V123, P321, DOI 10.1007/s00401-011-0928-6; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chow HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013791; Chow HY, 2015, ONCOTARGET, V6, P1981, DOI 10.18632/oncotarget.2810; Connolly DC, 2009, CURRENT PROTOC PHARM, V45, P14, DOI DOI 10.1002/0471141755.ph1412s45; Crawford AT, 2008, GLIA, V56, P1637, DOI 10.1002/glia.20716; Dasgupta B, 2005, CANCER RES, V65, P236; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Endo M, 2013, CLIN CANCER RES, V19, P450, DOI 10.1158/1078-0432.CCR-12-1067; Eswaran J, 2008, TRENDS BIOCHEM SCI, V33, P394, DOI 10.1016/j.tibs.2008.06.002; Haura EB, 2010, CLIN CANCER RES, V16, P2450, DOI 10.1158/1078-0432.CCR-09-1920; He H, 2012, CANCER LETT, V317, P65, DOI 10.1016/j.canlet.2011.11.014; Ingram DA, 2001, J EXP MED, V194, P57, DOI 10.1084/jem.194.1.57; Jessen WJ, 2013, J CLIN INVEST, V123, P340, DOI 10.1172/JCI60578; Johansson G, 2008, MOL CANCER THER, V7, P1237, DOI 10.1158/1535-7163.MCT-07-2335; Karpov AS, 2015, ACS MED CHEM LETT, V6, P776, DOI 10.1021/acsmedchemlett.5b00102; Katz D, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001227; Kolberg M, 2013, NEURO-ONCOLOGY, V15, P135, DOI 10.1093/neuonc/nos287; LoRusso PM, 2010, CLIN CANCER RES, V16, P1924, DOI 10.1158/1078-0432.CCR-09-1883; Luscan A, 2014, CLIN CANCER RES, V20, P358, DOI 10.1158/1078-0432.CCR-13-0780; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Malone CF, 2014, CANCER DISCOV, V4, P1062, DOI 10.1158/2159-8290.CD-14-0159; Mo W, 2013, CELL, V152, P1077, DOI 10.1016/j.cell.2013.01.053; Ndubaku CO, 2015, ACS MED CHEM LETT, V6, P1241, DOI 10.1021/acsmedchemlett.5b00398; Packer RJ, 2002, J CHILD NEUROL, V17, P638, DOI 10.1177/088307380201700816; Prudnikova TY, 2016, ONCOGENE, V35, P2178, DOI 10.1038/onc.2015.278; Radu M, 2014, NAT REV CANCER, V14, P13, DOI 10.1038/nrc3645; Shrestha Y, 2012, ONCOGENE, V31, P3397, DOI 10.1038/onc.2011.515; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Tang Y, 1998, P NATL ACAD SCI USA, V95, P5139, DOI 10.1073/pnas.95.9.5139; Tonsgard James H, 2006, Semin Pediatr Neurol, V13, P2, DOI 10.1016/j.spen.2006.01.005; Torres KE, 2011, CLIN CANCER RES, V17, P3943, DOI 10.1158/1078-0432.CCR-11-0193; Upadhyaya M, 2012, HUM MUTAT, V33, P763, DOI 10.1002/humu.22044; Watson AL, 2014, ONCOTARGET, V5, P1502, DOI 10.18632/oncotarget.1609; Watson AL, 2013, CANCER DISCOV, V3, P674, DOI 10.1158/2159-8290.CD-13-0081; Widemann BC, 2009, CURR ONCOL REP, V11, P322, DOI 10.1007/s11912-009-0045-z; Yang JL, 2014, EUR J CANCER, V50, P593, DOI 10.1016/j.ejca.2013.11.006; Ye Diana Zi, 2012, Cell Logist, V2, P105	45	23	23	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 21	2017	36	38					5421	5431		10.1038/onc.2017.143	http://dx.doi.org/10.1038/onc.2017.143			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FH7PJ	28534510	Green Accepted			2022-12-26	WOS:000411382100008
J	Koster, B; Sondergaard, J; Nielsen, JB; Christensen, KB; Allen, M; Olsen, A; Bentzen, J				Koster, Brian; Sondergaard, Jens; Nielsen, Jesper Bo; Christensen, Karl Bang; Allen, Martin; Olsen, Anja; Bentzen, Joan			Knowledge deficit, attitude and behavior scales association to objective measures of sun exposure and sunburn in a Danish population based sample	PLOS ONE			English	Article							SKIN-CANCER PREVENTION; ULTRAVIOLET-RADIATION; RISK-FACTORS; RECALL BIAS; PROTECTION; MELANOMA; AUSTRALIA; PREDICTORS; SUNSMART; EDUCATION	The objective of this study was to develop new scales measuring knowledge and attitude about UVR and sun related behavior, and to examine their association to sun related behavior objectively measured by personal dosimetry. During May-August 2013, 664 Danes wore a personal electronic UV-dosimeter for one week that measured their UVR exposure. Afterwards, they answered a questionnaire on sun-related items. We applied descriptive analysis, linear and logistic regression analysis to evaluate the associations between the questionnaire scales and objective UVR measures. Perceiving protection as routine and important were positively correlated with protective behavior. Knowledge deficit of UV and risk of melanoma, perceived benefits and importance of protection behavior was also correlated with use of protection. 'Knowledge deficit of UV and risk of melanoma and Perceived barrier towards sun avoidance between 12 and 15' were both associated with increased risk of sunburn. Attitude towards tan was associated to both outdoor time and exposure as well as use of protection, but not to sunburn. The results regarding Knowledge deficit of UV and risk of melanoma associated to UVR exposure and Perceived barrier towards sun avoidance between 12 and 15 emphasize the importance of awareness of melanoma risk and the priority of the skin cancer prevention advice. Shifting activities to outside the suns peak-hours could be an approach for structural and campaign preventive measures. Knowledge of items predicting exposure to UVR, use of protection and sunburn are important for planning of preventive interventions and melanoma research.	[Koster, Brian; Bentzen, Joan] Danish Canc Soc, Dept Prevent & Informat, Strandblvd 49, Copenhagen O, Denmark; [Koster, Brian; Sondergaard, Jens; Nielsen, Jesper Bo] Univ Southern Denmark, Res Unit Gen Practice, Odense, Denmark; [Christensen, Karl Bang] Univ Copenhagen, Biostat Sect, Dept Publ Hlth, Copenhagen, Denmark; [Allen, Martin] Univ Canterbury, Elect & Comp Engn, Christchurch, New Zealand; [Olsen, Anja] Danish Canc Soc, Res Ctr, Copenhagen, Denmark	Danish Cancer Society; University of Southern Denmark; University of Copenhagen; University of Canterbury; Danish Cancer Society	Koster, B (corresponding author), Danish Canc Soc, Dept Prevent & Informat, Strandblvd 49, Copenhagen O, Denmark.; Koster, B (corresponding author), Univ Southern Denmark, Res Unit Gen Practice, Odense, Denmark.	Koester_brian@yahoo.com	Christensen, Karl Bang/I-2650-2019; Søndergaard, Jens js/F-3031-2013	Christensen, Karl Bang/0000-0003-4518-5187; Søndergaard, Jens js/0000-0002-1629-1864; Koster, Brian/0000-0001-8352-3066; Allen, Martin/0000-0001-8786-6429	TrygFonden; Danish Board of Research and Innovation	TrygFonden; Danish Board of Research and Innovation	This study was supported by TrygFonden and The Danish Board of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2005, PHOTOCH PHOTOBIO SCI, V4, P429, DOI 10.1039/b418942f; ARMSTRONG BK, 1993, MELANOMA RES, V3, P395, DOI 10.1097/00008390-199311000-00002; Bogh MKB, 2011, BRIT J DERMATOL, V164, P163, DOI 10.1111/j.1365-2133.2010.10082.x; Branstrom R, 2004, PREV MED, V39, P992, DOI 10.1016/j.ypmed.2004.04.004; Branstrom R, 2001, EUR J CANCER PREV, V10, P337, DOI 10.1097/00008469-200108000-00007; Branstrom R, 2010, CANCER EPIDEM BIOMAR, V19, P2199, DOI 10.1158/1055-9965.EPI-10-0196; Bray F, 2012, INTJCANCER; Buller DB, 1998, CLIN DERMATOL, V16, P447, DOI 10.1016/S0738-081X(98)00018-2; Buller DB, 1999, HEALTH EDUC BEHAV, V26, P317, DOI 10.1177/109019819902600304; Cargill J, 2012, PHOTOCHEM PHOTOBIOL, V89, P7; Carley A, 2015, J AGROMEDICINE, V20, P85, DOI 10.1080/1059924X.2015.1010059; Diffey BL, 2009, BRIT J DERMATOL, V160, P1292, DOI 10.1111/j.1365-2133.2009.09149.x; Dobbinson S, 2006, TRENDS SUN PROTECTIO; Dobbinson SJ, 2008, AM J PREV MED, V34, P94, DOI 10.1016/j.amepre.2007.09.024; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Edwards PJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Forsea AM, 2013, J EUR ACAD DERMATOL, V27, P1317, DOI 10.1111/jdv.12060; Gandini S, 2005, EUR J CANCER, V41, P45, DOI 10.1016/j.ejca.2004.10.016; Gefeller O, 2014, INT J ENV RES PUB HE, V11, P4768, DOI 10.3390/ijerph110504768; Gefeller O, 2009, AM J EPIDEMIOL, V169, P267, DOI 10.1093/aje/kwn362; Geller AC, 2002, J AM ACAD DERMATOL, V46, P683, DOI 10.1067/mjd.2002.121034; Gilaberte Y, 2008, HEALTH PROMOT INT, V23, P209, DOI 10.1093/heapro/dan020; Godar DE, 2012, ENVIRON HEALTH PERSP, V120, P139, DOI 10.1289/ehp.1003195; Hansen L, 2016, SUN EXPOSURE GUIDE L; Hansen MR, 2014, PUBLIC HEALTH, V128, P777, DOI 10.1016/j.puhe.2014.07.002; Hobart J, 2009, IMPROVING EVALUATION; IARC, 2012, INT AGENCY RES CANC; IARC group Ww, 2008, VIT D CANC, V5, P1; Icek A, 2006, CONTRUCTING TPB QUES, P1; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jensen M.P., 2015, DANSKERNES SOLVANER; Koster B, 2016, BR J DERMATOL; Koster Brian, 2016, Prev Med Rep, V3, P367, DOI 10.1016/j.pmedr.2016.04.002; Koster B, 2015, PHOTODERMATOL PHOTO, V31, P252, DOI 10.1111/phpp.12179; Koster B, 2010, SCAND J PUBLIC HEALT, V38, P548, DOI 10.1177/1403494810371250; Lucas RM, 2008, INT J EPIDEMIOL, V37, P654, DOI 10.1093/ije/dyn017; Melia J, 2000, BRIT J DERMATOL, V143, P701, DOI 10.1046/j.1365-2133.2000.03764.x; Montague M, 2001, HEALTH EDUC BEHAV, V28, P290, DOI 10.1177/109019810102800304; Morris J, 1996, HEALTH PROMOT INT, V11, P321, DOI 10.1093/heapro/11.4.321; Parr CL, 2009, AM J EPIDEMIOL, V169, P257, DOI 10.1093/aje/kwn363; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Saiag P, 2015, J EUR ACAD DERMATOL, V29, P11, DOI 10.1111/jdv.12896; Saraiya M, 2004, AM J PREV MED, V27, P422, DOI 10.1016/j.amepre.2004.08.009; Sinclair CA, 2014, AM J PUBLIC HEALTH, V104, pE7, DOI 10.2105/AJPH.2013.301703; Skobowiat C, 2013, BRIT J DERMATOL, V168, P595, DOI 10.1111/bjd.12096; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; Stanton WR, 2004, HEALTH PROMOT INT, V19, P369, DOI 10.1093/heapro/dah310; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Thieden E, 2000, PHOTODERMATOL PHOTO, V16, P57, DOI 10.1034/j.1600-0781.2000.d01-4.x; Tripp MK, 2013, AM J PREV MED, V44, P265, DOI 10.1016/j.amepre.2012.10.027; Tripp MK, 2012, HLTH EDUCRES; Veierod MB, 2010, CANCER EPIDEM BIOMAR, V19, P111, DOI 10.1158/1055-9965.EPI-09-0567; Wright CY, 2007, PHOTOCHEM PHOTOBIOL, V83, P749, DOI 10.1562/2006-08-22-RA-1010; Youl PH, 2013, BRIT J DERMATOL, V168, P136, DOI 10.1111/j.1365-2133.2012.11064.x	55	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178190	10.1371/journal.pone.0178190	http://dx.doi.org/10.1371/journal.pone.0178190			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VR	28542543	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800050
J	Wang, YY; Li, FF; Ruan, XL; Song, J; Lv, L; Chai, LY; Yang, ZH; Luo, L				Wang, Yangyang; Li, Fangfang; Ruan, Xinling; Song, Jian; Lv, Lv; Chai, Liyuan; Yang, Zhihui; Luo, Lin			Biodegradation of di-n-butyl phthalate by bacterial consortium LV-1 enriched from river sludge	PLOS ONE			English	Article							DIBUTYL PHTHALATE; HEAVY-METALS; DI-(2-ETHYLHEXYL) PHTHALATE; ACID ESTERS; GAS-PHASE; DEGRADATION; STRAIN; GROWTH; MANGANESE; SEDIMENT	A stable bacterial consortium (LV-1) capable of degrading di-n-butyl phthalate (DBP) was enriched from river sludge. Community analysis revealed that the main families of LV-1 are Brucellaceae (62.78%) and Sinobacteraceae (14.83%), and the main genera of LV-1 are Brucella spp. (62.78%) and Sinobacter spp. (14.83%). The optimal pH and temperature for LV-1 to degrade DBP were pH 6.0 and 30 degrees C, respectively. Inoculum size influenced the degradation ratio when the incubation time was < 24 h. The initial concentration of DBP also influenced the degradation rates of DBP by LV-1, and the degradation rates ranged from 69.0 +/- 775.0 mg/l/d in the first 24 h. Degradation of DBP was best fitted by first-order kinetics when the initial concentration was < 300 mg/l. In addition, Cd2+, Cr6+, and Zn2+ inhibited DBP degradation by LV-1 at all considered concentrations, but low concentrations of Pb2+, Cu2+, and Mn2+ enhanced DBP degradation. The main intermediates (mono-ethyl phthalate [MEP], mono-butyl phthalate [MBP], and phthalic acid [PA]) were identified in the DBP degradation process, thus a new biochemical pathway of DBP degradation is proposed. Furthermore, LV-1 also degraded other phthalates with shorter ester chains (DMP, DEP, and PA).	[Wang, Yangyang; Luo, Lin] Hunan Agr Univ, Sch Resources & Environm, Changsha, Hunan, Peoples R China; [Wang, Yangyang; Ruan, Xinling] Henan Univ, Key Res Inst Yellow River Civilizat & Sustainable, Kaifeng, Peoples R China; [Wang, Yangyang; Ruan, Xinling] Henan Univ, Collaborat Innovat Ctr Yellow River Civilizat Hen, Kaifeng, Peoples R China; [Wang, Yangyang; Li, Fangfang; Ruan, Xinling; Song, Jian; Lv, Lv] Henan Univ, Inst Nat Resources & Environm, Kaifeng, Peoples R China; [Chai, Liyuan; Yang, Zhihui] Cent S Univ, Sch Met & Environm, Changsha, Hunan, Peoples R China	Hunan Agricultural University; Henan University; Henan University; Henan University; Central South University	Luo, L (corresponding author), Hunan Agr Univ, Sch Resources & Environm, Changsha, Hunan, Peoples R China.	luolinwei0@163.com	Wang, Yangyang/GXH-5679-2022		National Natural Science Foundation of China [41430637]; Program for Innovative Research Team (in Science and Technology) in University of Henan Province [161RTSTHN012]; Science and technology development project of Henan Province [152102310297]; Opening Foundation of the Chinese National Engineering Research Center for Control and Treatment of Heavy Metal Pollution, Changsha [2015CNERC-CTHMP-]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team (in Science and Technology) in University of Henan Province; Science and technology development project of Henan Province; Opening Foundation of the Chinese National Engineering Research Center for Control and Treatment of Heavy Metal Pollution, Changsha	This work was supported by a grant from the National Natural Science Foundation of China (41430637); Program for Innovative Research Team (in Science and Technology) in University of Henan Province (161RTSTHN012); Science and technology development project of Henan Province (152102310297); Opening Foundation of the Chinese National Engineering Research Center for Control and Treatment of Heavy Metal Pollution, Changsha, 410083, China (No. 2015CNERC-CTHMP-).	ADAMS LF, 1985, APPL ENVIRON MICROB, V49, P556, DOI 10.1128/AEM.49.3.556-562.1985; Amir S, 2005, PROCESS BIOCHEM, V40, P2183, DOI 10.1016/j.procbio.2004.08.012; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chen YH, 2009, J HAZARD MATER, V172, P20, DOI 10.1016/j.jhazmat.2009.06.122; Dou JF, 2009, J HAZARD MATER, V165, P325, DOI 10.1016/j.jhazmat.2008.10.002; Fang CR, 2010, INT BIODETER BIODEGR, V64, P442, DOI 10.1016/j.ibiod.2010.04.010; Fang HHP, 2007, BIORESOURCE TECHNOL, V98, P717, DOI 10.1016/j.biortech.2006.02.010; Guerfali M, 2009, J MOL CATAL B-ENZYM, V57, P242, DOI 10.1016/j.molcatb.2008.09.011; Hashizume K, 2002, BIOL PHARM BULL, V25, P209, DOI 10.1248/bpb.25.209; HATTORI H, 1992, SOIL SCI PLANT NUTR, V38, P93, DOI 10.1080/00380768.1992.10416956; He ZX, 2013, BIORESOURCE TECHNOL, V128, P526, DOI 10.1016/j.biortech.2012.10.107; Herrmann S, 2010, ENVIRON MICROBIOL, V12, P401, DOI 10.1111/j.1462-2920.2009.02077.x; Hudcova T, 2011, J HAZARD MATER, V192, P605, DOI 10.1016/j.jhazmat.2011.05.061; Lertsirisopon R, 2009, J ENVIRON SCI-CHINA, V21, P285, DOI 10.1016/S1001-0742(08)62265-2; Liang DW, 2008, APPL MICROBIOL BIOT, V80, P183, DOI 10.1007/s00253-008-1548-5; Liao CS, 2010, CHEMOSPHERE, V78, P342, DOI 10.1016/j.chemosphere.2009.10.020; Lovitt B, 2010, BIOCHEMISTRY-US, V49, P3092, DOI 10.1021/bi901726c; Mrvcic J, 2011, 7 INT C FOOD TECHN B, P20; Muthukumar N, 2003, ELECTROCHEM COMMUN, V5, P421, DOI 10.1016/S1388-2481(03)00093-6; Navacharoen A, 2011, INT BIODETER BIODEGR, V65, P818, DOI 10.1016/j.ibiod.2011.05.005; Patil NK, 2006, CURR MICROBIOL, V52, P369, DOI 10.1007/s00284-005-5258-2; Prakash O, 2010, BIOTECHNOL APPL BIOC, V57, P105, DOI 10.1042/BA20100262; RAMADAN MA, 1990, APPL ENVIRON MICROB, V56, P1392, DOI 10.1128/AEM.56.5.1392-1396.1990; Ravikumar S, 2007, J ENVIRON BIOL, V28, P109; Saratale RG, 2009, BIORESOURCE TECHNOL, V100, P2493, DOI 10.1016/j.biortech.2008.12.013; Schossler P, 2011, SCI TOTAL ENVIRON, V409, P4031, DOI 10.1016/j.scitotenv.2011.06.012; Schug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007; Sevinc N., 2011, J BIOL ENV SCI, V5, P95; Vela-Cano M., 2014, ADV MICROBIOL, V48851, DOI [10.4236/aim.2014.410070, DOI 10.4236/AIM.2014.410070]; Wang YY, 2012, PROCESS BIOCHEM, V47, P936, DOI 10.1016/j.procbio.2012.02.027; Weschler CJ, 2008, ATMOS ENVIRON, V42, P1449, DOI 10.1016/j.atmosenv.2007.11.014; Wolski EA, 2006, WATER SA, V32, P93; Wu Q, 2013, INT BIODETER BIODEGR, V76, P102, DOI 10.1016/j.ibiod.2012.06.013; Wu XL, 2010, B ENVIRON CONTAM TOX, V85, P235, DOI 10.1007/s00128-010-0080-3; Wu XL, 2011, PROCESS BIOCHEM, V46, P1090, DOI 10.1016/j.procbio.2011.01.031; Wu XL, 2010, J HAZARD MATER, V176, P262, DOI 10.1016/j.jhazmat.2009.11.022; Xiao YH, 2015, APPL MICROBIOL BIOT, V99, P10311, DOI 10.1007/s00253-015-6881-x; Xu G, 2008, SCI TOTAL ENVIRON, V393, P333, DOI 10.1016/j.scitotenv.2008.01.001; Xu XR, 2005, INT BIODETER BIODEGR, V55, P9, DOI 10.1016/j.ibiod.2004.05.005; Yu Lei, 2015, Advanced Materials Research, V1073-1076, P726, DOI 10.4028/www.scientific.net/AMR.1073-1076.726; Yuan SY, 2010, J HAZARD MATER, V184, P826, DOI 10.1016/j.jhazmat.2010.08.116; Zeng F, 2008, ENVIRON INT, V34, P372, DOI 10.1016/j.envint.2007.09.002; Zhang Fei, 2015, Environmental Science & Technology (China), V38, P44; Zhou J, 2008, J LIAONING NORMAL U, V31, P343	46	25	27	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178213	10.1371/journal.pone.0178213	http://dx.doi.org/10.1371/journal.pone.0178213			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542471	gold, Green Published, Green Submitted			2022-12-26	WOS:000402062800054
J	Galan, I; Slmon, L; Boldo, E; Ortiz, C; Fernandez-Cuenca, R; Linares, C; Medrano, MJ; Pastor-Barriuso, R				Galan, Inaki; Slmon, Lorena; Boldo, Elena; Ortiz, Cristina; Fernandez-Cuenca, Rafael; Linares, Cristina; Jose Medrano, Maria; Pastor-Barriuso, Roberto			Changes in hospitalizations for chronic respiratory diseases after two successive smoking bans in Spain	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; EMERGENCY-DEPARTMENT VISITS; FREE LEGISLATION; CHILDHOOD ASTHMA; SPANISH SMOKING; BAR WORKERS; IMPACT; IMPLEMENTATION; METAANALYSIS; HEALTH	Background Existing evidence on the effects of smoke-free policies on respiratory diseases is scarce and inconclusive. Spain enacted two consecutive smoke-free regulations: a partial ban in 2006 and a comprehensive ban in 2011. We estimated their impact on hospital admissions via emergency departments for chronic obstructive pulmonary disease (COPD) and asthma. Methods Data for COPD (ICD-9 490-492, 494-496) came from 2003-2012 hospital admission records from the fourteen largest provinces of Spain and from five provinces for asthma (ICD-9 493). We estimated changes in hospital admission rates within provinces using Poisson additive models adjusted for long-term linear trends and seasonality, day of the week, temperature, influenza, acute respiratory infections, and pollen counts (asthma models). We estimated immediate and gradual effects through segmented-linear models. The coefficients within each province were combined through random-effects multivariate meta-analytic models. Results The partial ban was associated with a strong significant pooled immediate decline in COPD-related admission rates (14.7%, 95% CI: 5.0, 23.4), sustained over time with a one-year decrease of 13.6% (95% CI: 2.9, 23.1). The association was consistent across age and sex groups but stronger in less economically developed Spanish provinces. Asthma-related admission rates decreased by 7.4% (95% CI: 0.2, 14.2) immediately after the comprehensive ban was implemented, although the one-year decrease was sustained only among men (9.9%, 95% CI: 3.9, 15.6). Conclusions The partial ban was associated with an immediate and sustained strong decline in COPD-related admissions, especially in less economically developed provinces. The comprehensive ban was related to an immediate decrease in asthma, sustained for the medium-term only among men.	[Galan, Inaki; Slmon, Lorena; Boldo, Elena; Ortiz, Cristina; Fernandez-Cuenca, Rafael; Jose Medrano, Maria; Pastor-Barriuso, Roberto] Inst Salud Carlos III, Natl Ctr Epidemiol, Madrid, Spain; [Galan, Inaki] Univ Autonoma Madrid, IdiPAZ, Sch Med, Dept Prevent Med & Publ Hlth, Madrid, Spain; [Boldo, Elena; Fernandez-Cuenca, Rafael; Pastor-Barriuso, Roberto] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Boldo, Elena] Puerta de Hierro Biomed Res Inst, Madrid, Spain; [Linares, Cristina] Inst Salud Carlos III, Natl Sch Publ Hlth, Madrid, Spain	Instituto de Salud Carlos III; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III	Galan, I (corresponding author), Inst Salud Carlos III, Natl Ctr Epidemiol, Madrid, Spain.; Galan, I (corresponding author), Univ Autonoma Madrid, IdiPAZ, Sch Med, Dept Prevent Med & Publ Hlth, Madrid, Spain.	igalan@isciii.es	Pastor-Barriuso, Roberto/AAA-6746-2019; Boldo, Elena/L-6610-2014; Galán, Ignacio/P-6451-2015	Pastor-Barriuso, Roberto/0000-0002-7325-3960; Boldo, Elena/0000-0003-0027-1989; Galán, Ignacio/0000-0003-0624-9993	Institute of Health Carlos III, Ministry of Economy and Competitiveness [FIS PI11/01276]	Institute of Health Carlos III, Ministry of Economy and Competitiveness	This work was supported by Grant FIS PI11/01276 from the Institute of Health Carlos III, Ministry of Economy and Competitiveness. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allwright S, 2005, BMJ-BRIT MED J, V331, P1117, DOI 10.1136/bmj.38636.499225.55; Burke DL, 2017, STAT MED, V36, P855, DOI 10.1002/sim.7141; Hidalgo AC, 2014, GAC SANIT, V28, P456, DOI 10.1016/j.gaceta.2014.05.006; Comhair SAA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018574; Croghan IT, 2015, BMC PULM MED, V15, DOI 10.1186/1471-2466-15-6; Dusemund F, 2015, TOB CONTROL, V24, P404, DOI 10.1136/tobaccocontrol-2013-051290; Eisner MD, 2010, AM J RESP CRIT CARE, V182, P693, DOI 10.1164/rccm.200811-1757ST; Fernandez E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004244; Flouris AD, 2011, CURR OPIN PULM MED, V17, P110, DOI 10.1097/MCP.0b013e328343165d; Frazer K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005992.pub3; Galan I, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008892; Gan WQ, 2015, TOB CONTROL, V24, P568, DOI 10.1136/tobaccocontrol-2014-051660; Gasparrini A, 2012, STAT MED, V31, P3821, DOI 10.1002/sim.5471; Gaudreau K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056102; Gershon AS, 2012, COPD, V9, P216, DOI 10.3109/15412555.2011.648030; Goldstein E, 2012, EPIDEMIOLOGY, V23, P829, DOI 10.1097/EDE.0b013e31826c2dda; Hahn EJ, 2014, AM J PUBLIC HEALTH, V104, P1059, DOI 10.2105/AJPH.2014.301887; Hartl S, 2016, EUR RESPIR J, V47, P113, DOI 10.1183/13993003.01391-2014; Head P, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120079; Herman PM, 2011, AM J PUBLIC HEALTH, V101, P491, DOI 10.2105/AJPH.2009.179572; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Humair JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090417; Hunsberger S, 2002, BIOSTATISTICS, V3, P289, DOI 10.1093/biostatistics/3.2.289; Jimenez-Ruiz CA, 2008, EUR J PUBLIC HEALTH, V18, P622, DOI 10.1093/eurpub/ckn066; Kent BD, 2012, CHEST, V142, P673, DOI 10.1378/chest.11-2757; Landers G, 2014, AM J PUBLIC HEALTH, V104, pE74, DOI 10.2105/AJPH.2013.301697; Larrauri A., 2006, Boletin Epidemiologico Semanal, V14, P85; Lopez MJ, 2013, NICOTINE TOB RES, V15, P992, DOI 10.1093/ntr/nts218; Mackay D, 2010, NEW ENGL J MED, V363, P1139, DOI 10.1056/NEJMoa1002861; Menzies D, 2006, JAMA-J AM MED ASSOC, V296, P1742, DOI 10.1001/jama.296.14.1742; Millett C, 2013, PEDIATRICS, V131, pE495, DOI 10.1542/peds.2012-2592; Moraros J, 2010, INT J ENV RES PUB HE, V7, P4169, DOI 10.3390/ijerph7124169; Naiman A, 2010, CAN MED ASSOC J, V182, P761, DOI 10.1503/cmaj.091130; Rayens MK, 2008, J ALLERGY CLIN IMMUN, V122, P537, DOI 10.1016/j.jaci.2008.06.029; Shetty KD, 2011, J POLICY ANAL MANAG, V30, P6, DOI 10.1002/pam.20548; Spanish Society of Epidemiology, ASS IMP SPAN SMOK LA; Stallings-Smith S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098617; Svanes C, 2004, THORAX, V59, P295, DOI 10.1136/thx.2003.009746; Tan CE, 2012, CIRCULATION, V126, P2177, DOI 10.1161/CIRCULATIONAHA.112.121301; US Dept of Health and Human Services, 2014, HLTH CONS SMOK 50 YE HLTH CONS SMOK 50 YE; US Surgeon General, 2006, HLTH CONS INV EXP TO; Vander W. M. W., 2012, HEALTH AFFAIR, V31, P2699, DOI DOI 10.1377/HLTHAFF.2011.0385; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374	44	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177979	10.1371/journal.pone.0177979	http://dx.doi.org/10.1371/journal.pone.0177979			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VE	28542337	gold, Green Published, Green Submitted			2022-12-26	WOS:000402061500048
J	Kao, CC; Yang, JY; Chen, L; Chao, CT; Peng, YS; Chiang, CK; Huang, JW; Hung, KY				Kao, Chih-Chin; Yang, Ju-Yeh; Chen, Likwang; Chao, Chia-Ter; Peng, Yu-Sen; Chiang, Chih-Kang; Huang, Jenq-Wen; Hung, Kuan-Yu			Factors associated with poor outcomes of continuous renal replacement therapy	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; CRITICALLY-ILL PATIENTS; PERITONEAL-DIALYSIS; REQUIRING CRRT; FAILURE; DISEASE; MORTALITY; RISK; HEMODIALYSIS; CIRRHOSIS	Continuous renal replacement therapy (CRRT) is one of the dialysis modalities for critically ill patients. Despite intensive dialysis care, a high mortality rate is found in these patients. Our objective was to investigate the factors associated with poor outcomes in these patients. We conducted a retrospective cohort study using the National Health Insurance Research Database. Records of critically ill patients who received CRRT between 2007 and 2011 were retrieved, and the patients were categorized into two groups: those with acute kidney injury (AKI) and those with history of end-stage renal disease (ESRD). Our primary and secondary outcomes were in-hospital mortality and long-term survival and non-renal recovery (long-term dialysis dependence), respectively, in the AKI group. We enrolled 15,453 patients, with 13,204 and 2249 in the AKI and ESRD groups, respectively. Overall, 66.5% patients died during hospitalization. In-hospital mortality did not differ significantly between groups (adjusted odds ratio, 0.93; 95% CI, 0.84-1.02). Age, chronic liver disease, and cancer history were identified as independent risk factors for in-hospital mortality in both groups. Hypertension was associated with higher risk of in-hospital mortality in patients with AKI. Age, coronary artery disease, and admission to the medical intensive care unit (MICU) were risk factors for long-term dialysis dependence in patients with AKI. Patients with AKI and ESRD have similarly poor outcomes after CRRT. Older age and presence of chronic liver disease and cancer were associated with higher mortality. Older age, presence of coronary artery disease, and admission to MICU were associated with lower renal recovery rate in patients with AKI.	[Kao, Chih-Chin] Taipei Med Univ Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Kao, Chih-Chin] Taipei Med Univ, Sch Med, Dept Internal Med, Coll Med, Taipei, Taiwan; [Kao, Chih-Chin] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Yang, Ju-Yeh; Peng, Yu-Sen] Far Eastern Mem Hosp, Div Nephrol, New Taipei, Taiwan; [Yang, Ju-Yeh] Far Eastern Mem Hosp, Dept Qual Management Ctr, New Taipei, Taiwan; [Yang, Ju-Yeh] Oriental Inst Technol, Dept Ind Management, New Taipei, Taiwan; [Chen, Likwang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Chao, Chia-Ter; Chiang, Chih-Kang; Huang, Jenq-Wen; Hung, Kuan-Yu] Natl Taiwan Univ Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Far Eastern Memorial Hospital; Far Eastern Memorial Hospital; Asia Eastern University of Science & Technology; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital	Huang, JW (corresponding author), Natl Taiwan Univ Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan.	jenqwen@gmail.com	peng, yu/GXW-2071-2022; Chao, Chia-Ter/H-7994-2019	Chao, Chia-Ter/0000-0003-2892-7986; Yang, Ju-Yeh/0000-0003-3034-021X; HUANG, JENQ-WEN/0000-0001-8011-2317; HUNG, KUAN-YU/0000-0003-3472-5512; CHIANG, CHIH-KANG/0000-0001-9021-4616				Allegretti AS, 2013, CRIT CARE, V17, DOI 10.1186/cc12780; Arulkumaran N, 2013, BRIT J ANAESTH, V110, P13, DOI 10.1093/bja/aes401; Bagshaw SM, 2009, CRIT CARE, V13, DOI 10.1186/cc8037; Belcher JM, 2013, HEPATOLOGY, V57, P753, DOI 10.1002/hep.25735; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Brivet FG, 1996, CRIT CARE MED, V24, P192, DOI 10.1097/00003246-199602000-00003; Campbell GA, 2014, ADV CHRONIC KIDNEY D, V21, P64, DOI 10.1053/j.ackd.2013.08.002; Case J, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/479730; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Durairaj L, 2005, CHEST, V128, P1682, DOI 10.1378/chest.128.3.1682; Duran PA, 2014, HEMODIAL INT, V18, pS1, DOI 10.1111/hdi.12216; Fagundes C, 2013, J HEPATOL, V59, P474, DOI 10.1016/j.jhep.2013.04.036; Faubel S, 2008, ADV CHRONIC KIDNEY D, V15, P284, DOI 10.1053/j.ackd.2008.04.008; Fortrie G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121482; GINES A, 1993, GASTROENTEROLOGY, V105, P229, DOI 10.1016/0016-5085(93)90031-7; Grams ME, 2012, KIDNEY INT, V81, P942, DOI 10.1038/ki.2011.241; Haider AW, 2003, ANN INTERN MED, V138, P10, DOI 10.7326/0003-4819-138-1-200301070-00006; Hobson EV, 2012, PERITON DIALYSIS INT, V32, P590, DOI 10.3747/pdi.2012.00152; Hsu CY, 2007, CURR OPIN NEPHROL HY, V16, P221, DOI 10.1097/MNH.0b013e3280895ad9; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Iwagami M, 2015, NEPHROL DIAL TRANSPL, V30, P988, DOI 10.1093/ndt/gfv069; Jung YS, 2012, HEMODIAL INT, V16, P456, DOI 10.1111/j.1542-4758.2012.00694.x; Liu JN, 2010, KIDNEY INT, V77, P141, DOI 10.1038/ki.2009.413; Oh HJ, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0454-8; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Pannu Neesh, 2005, Ther Clin Risk Manag, V1, P141, DOI 10.2147/tcrm.1.2.141.62908; Ronco C, 2001, NEPHROL DIAL TRANSPL, V16, P230, DOI 10.1093/ndt/16.2.230; Salahudeen AK, 2013, CLIN J AM SOC NEPHRO, V8, P347, DOI 10.2215/CJN.03530412; Schmitt R, 2008, AM J KIDNEY DIS, V52, P262, DOI 10.1053/j.ajkd.2008.03.005; Sligl WI, 2010, CRIT CARE MED, V38, P2126, DOI 10.1097/CCM.0b013e3181eedaeb; Srisawat N, 2010, CRIT CARE, V14, DOI 10.1186/cc8933; Strijack B, 2009, J AM SOC NEPHROL, V20, P2441, DOI 10.1681/ASN.2009040366; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Vonesh EF, 2004, KIDNEY INT, V66, P2389, DOI 10.1111/j.1523-1755.2004.66028.x; Waikar SS, 2008, CLIN J AM SOC NEPHRO, V3, P844, DOI 10.2215/CJN.05191107; Walcher A, 2011, RENAL FAILURE, V33, P935, DOI 10.3109/0886022X.2011.615964; Yang JY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12816	38	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177759	10.1371/journal.pone.0177759	http://dx.doi.org/10.1371/journal.pone.0177759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542272	Green Published, gold, Green Submitted			2022-12-26	WOS:000402061500037
J	Lera, I; Perez, T; Guerrero, C; Eguiluz, VM; Juiz, C				Lera, Isaac; Perez, Toni; Guerrero, Carlos; Eguiluz, Victor M.; Juiz, Carlos			Analysing human mobility patterns of hiking activities through complex network theory	PLOS ONE			English	Article							MOVEMENT PATTERNS; SCALING LAWS; PARK	The exploitation of high volume of geolocalized data from social sport tracking applications of outdoor activities can be useful for natural resource planning and to understand the human mobility patterns during leisure activities. This geolocalized data represents the selection of hike activities according to subjective and objective factors such as personal goals, personal abilities, trail conditions or weather conditions. In our approach, human mobility patterns are analysed from trajectories which are generated by hikers. We propose the generation of the trail network identifying special points in the overlap of trajectories. Trail crossings and trailheads define our network and shape topological features. We analyse the trail network of Balearic Islands, as a case of study, using complex weighted network theory. The analysis is divided into the four seasons of the year to observe the impact of weather conditions on the network topology. The number of visited places does not decrease despite the large difference in the number of samples of the two seasons with larger and lower activity. It is in summer season where it is produced the most significant variation in the frequency and localization of activities from inland regions to coastal areas. Finally, we compare our model with other related studies where the network possesses a different purpose. One finding of our approach is the detection of regions with relevant importance where landscape interventions can be applied in function of the communities.	[Lera, Isaac; Guerrero, Carlos; Juiz, Carlos] Univ Illes Balears, Dept Matemat & Informat, Palma de Mallorca, Spain; [Perez, Toni; Eguiluz, Victor M.] CSIC UIB, IFISC, Palma de Mallorca, Spain	Universitat de les Illes Balears; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); University of Barcelona	Lera, I (corresponding author), Univ Illes Balears, Dept Matemat & Informat, Palma de Mallorca, Spain.	isaac.lera@uib.es	Lera, Isaac ILC/E-5467-2011; Eguíluz, Víctor M./B-9655-2008; Guerrero, Carlos/E-9221-2012; Juiz, Carlos/L-4018-2014	Lera, Isaac ILC/0000-0002-2826-5970; Eguíluz, Víctor M./0000-0003-1133-1289; Guerrero, Carlos/0000-0003-2969-0597; Juiz, Carlos/0000-0001-6517-5395	Departament de Matematiques i Informatica de la Universitat de les Illes Balears; SPASIMM [FIS2016-80067-P AEI/FEDER, UE]; program Juan de la Cierva of the Spanish Ministry of Economy and Competitiveness	Departament de Matematiques i Informatica de la Universitat de les Illes Balears; SPASIMM; program Juan de la Cierva of the Spanish Ministry of Economy and Competitiveness	All authors acknowledge financial support from the Departament de Matematiques i Informatica de la Universitat de les Illes Balears. VME acknowledges financial support through project SPASIMM (FIS2016-80067-P AEI/FEDER, UE). TP acknowledges support from the program Juan de la Cierva of the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All authors acknowledge financial support from the Departament de Matematiques i Informatica de la Universitat de les Illes Balears. VME acknowledges financial support through project SPASIMM (FIS2016-80067-P AEI/FEDER, UE). TP acknowledges support from the program Juan de la Cierva of the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Arase Y., 2010, P 18 ACM INT C MULT, P133, DOI DOI 10.1145/1873951.1873971; Arrowsmith C, 2002, TOURISM MANAGE, V23, P295, DOI 10.1016/S0261-5177(01)00088-7; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Bassolas A, 2016, EPJ DATA SCI, V5, DOI 10.1140/epjds/s13688-016-0073-5; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Beeco JA, 2014, LANDSCAPE URBAN PLAN, V127, P136, DOI 10.1016/j.landurbplan.2014.04.002; Beeco JA, 2013, APPL GEOGR, V45, P147, DOI 10.1016/j.apgeog.2013.09.001; Biljecki F, 2013, INT J GEOGR INF SCI, V27, P385, DOI 10.1080/13658816.2012.692791; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brakatsoulas S., 2005, P 31 INT C VERY LARG, P853; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Chowell G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.066102; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Coombes EG, 2009, COAST MANAGE, V37, P94, DOI 10.1080/08920750802527127; Cortes R, 2014, SPORT TRACKERS BIG D; de Montjoye YA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01376; Douglas D.H., 1973, CARTOGRAPHICA INT J, V10, P112, DOI [10.3138/FM57-6770-U75U-7727, DOI 10.3138/FM57-6770-U75U-7727]; Farrell T. A., 2001, Leisure/Loisir, V26, P31, DOI 10.1080/14927713.2001.9649928; Frias-Martinez V, 2014, ENG APPL ARTIF INTEL, V35, P237, DOI 10.1016/j.engappai.2014.06.019; Friedman J. H., 1977, ACM Transactions on Mathematical Software, V3, P209, DOI 10.1145/355744.355745; Giannotti F, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P330; Giannotti F, 2011, VLDB J, V20, P695, DOI 10.1007/s00778-011-0244-8; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Hoogendoorn SP, 2005, NETW SPAT ECON, V5, P193, DOI 10.1007/s11067-005-2629-y; Huang YT, 2009, MDM: 2009 10TH INTERNATIONAL CONFERENCE ON MOBILE DATA MANAGEMENT, P379, DOI 10.1109/MDM.2009.61; Kisilevich S, 2010, P 1 INT C EXH COMP G, V10, P38, DOI DOI 10.1145/1823854.1823897; Knights AM, 2013, ECOL APPL, V23, P755, DOI 10.1890/12-1137.1; Latora V, 2002, PHYSICA A, V314, P109, DOI 10.1016/S0378-4371(02)01089-0; Lera I., 2017, DATASET HUMAN HIKING; Lera I., 2016, MATCHGPX PYTHON ALGO; Li W, 2007, PHYSICA A, V382, P693, DOI 10.1016/j.physa.2007.04.031; Meijles EW, 2014, COMPUT ENVIRON URBAN, V47, P44, DOI 10.1016/j.compenvurbsys.2013.07.005; Moreira A, 2010, LECT NOTES GEOINF CA, P61, DOI 10.1007/978-3-642-12326-9_4; Mulligann C, 2011, ANAL SPATIAL SEMANTI, P350; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Orellana D, 2012, TOURISM MANAGE, V33, P672, DOI 10.1016/j.tourman.2011.07.010; Paldino S, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0043-3; Schneider CM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0246; Shang S, 2014, VLDB J, V23, P449, DOI 10.1007/s00778-013-0331-0; Shoval N, 2010, INFORMATION AND COMMUNICATION TECHNOLOGIES IN TOURISM 2010, P171, DOI 10.1007/978-3-211-99407-8_15; Sienkiewicz J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046127; Soh H, 2010, PHYSICA A, V389, P5852, DOI 10.1016/j.physa.2010.08.015; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Szabo A G, 2004, CLUSTERING COMPLEX N, P139; Tian Z, 2016, PROCEDIA ENGINEER, V138, P537, DOI 10.1016/j.proeng.2016.01.290; Vlachos M, 2002, PROC INT CONF DATA, P673, DOI 10.1109/ICDE.2002.994784; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yuan J., 2012, P 18 ACM SIGKDD INT, P186, DOI [DOI 10.1145/2339530.2339561, 10.1145/2339530.2339561]; Zhang XL, 2016, MULTIMED TOOLS APPL, V75, P17553, DOI 10.1007/s11042-016-3376-4; Zheng YT, 2012, ACM T INTEL SYST TEC, V3, DOI 10.1145/2168752.2168770	54	11	11	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177712	10.1371/journal.pone.0177712	http://dx.doi.org/10.1371/journal.pone.0177712			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VE	28542280	Green Submitted, Green Published, gold			2022-12-26	WOS:000402061500035
J	McGuire, AL; Mulroney, KT; Carson, CF; Ram, R; Morahan, G; Chakera, A				McGuire, Amanda L.; Mulroney, Kieran T.; Carson, Christine F.; Ram, Ramesh; Morahan, Grant; Chakera, Aron			Analysis of early mesothelial cell responses to Staphylococcus epidermidis isolated from patients with peritoneal dialysis-associated peritonitis	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; INNATE IMMUNITY; MESSENGER-RNA; CYTOKINES; ENDOTHELIN-1; EXPRESSION; INFECTION; RECEPTOR; OUTCOMES	The major complication of peritoneal dialysis (PD) is the development of peritonitis, an infection within the abdominal cavity, primarily caused by bacteria. PD peritonitis is associated with significant morbidity, mortality and health care costs. Staphylococcus epidermidis is the most frequently isolated cause of PD-associated peritonitis. Mesothelial cells are integral to the host response to peritonitis, and subsequent clinical outcomes, yet the effects of infection on mesothelial cells are not well characterised. We systematically investigated the early mesothelial cell response to clinical and reference isolates of S. epidermidis using primary mesothelial cells and the mesothelial cell line Met-5A. Using an unbiased whole genome microarray, followed by a targeted panel of genes known to be involved in the human antibacterial response, we identified 38 differentially regulated genes (adj. p-value < 0.05) representing 35 canonical pathways after 1 hour exposure to S. epidermidis. The top 3 canonical pathways were TNFR2 signaling, IL-17A signaling, and TNFR1 signaling (adj. p-values of 0.0012, 0.0012 and 0.0019, respectively). Subsequent qPCR validation confirmed significant differences in gene expression in a number of genes not previously described in mesothelial cell responses to infection, with heterogeneity observed between clinical isolates of S. epidermidis, and between Met-5A and primary mesothelial cells. Heterogeneity between different S. epidermidis isolates suggests that specific virulence factors may play critical roles in influencing outcomes from peritonitis. This study provides new insights into early mesothelial cell responses to infection with S. epidermidis, and confirms the importance of validating findings in primary mesothelial cells.	[McGuire, Amanda L.; Mulroney, Kieran T.; Carson, Christine F.; Chakera, Aron] Harry Perkins Inst Med Res, Translat Renal Res Grp, Nedlands, WA, Australia; [McGuire, Amanda L.; Mulroney, Kieran T.; Carson, Christine F.; Chakera, Aron] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia; [Ram, Ramesh; Morahan, Grant] Harry Perkins Inst Med Res, Ctr Diabet Res, Nedlands, WA, Australia; [Chakera, Aron] Sir Charles Gairdner Hosp, Dept Renal Med, Nedlands, WA, Australia	Harry Perkins Institute of Medical Research; University of Western Australia; Harry Perkins Institute of Medical Research; University of Western Australia	McGuire, AL (corresponding author), Harry Perkins Inst Med Res, Translat Renal Res Grp, Nedlands, WA, Australia.; McGuire, AL (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia.	Amanda.McGuire@uwa.edu.au	Morahan, Grant/T-7501-2019; Carson, Christine F/F-1521-2013	Carson, Christine F/0000-0003-3669-1651; McGuire, Amanda/0000-0002-1261-9236; Mulroney, Kieran/0000-0001-5036-1339	Sir Charles Gairdner Osborne Park Health Care Group (SCGOPHCG)'s Research Advisory Committee (RAC) [RAC 2015-16/044]; University, State and Commonwealth Governments; Diabetes Research Foundation WA, NHMRC [1069173]; NHMRC Program [53000400, 37612600]	Sir Charles Gairdner Osborne Park Health Care Group (SCGOPHCG)'s Research Advisory Committee (RAC); University, State and Commonwealth Governments; Diabetes Research Foundation WA, NHMRC; NHMRC Program(National Health and Medical Research Council (NHMRC) of Australia)	Funding for this research was provided to AC (RAC 2015-16/044) by the Sir Charles Gairdner Osborne Park Health Care Group (SCGOPHCG)'s Research Advisory Committee (RAC), in conjunction with the Charlies Foundation for Research, http://www.scgh.health.wa.gov.au/Research/RAGFunding.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Lavinia Gordon from the Australian Genome Research Facility (AGRF), Melbourne, Australia for bioinformatics assistance with the microarray data, Professor Tim Inglis and Kate Trojer from PathWest Laboratory Medicine WA for assistance obtaining clinical and reference isolates, and Zen-Bio Inc. for providing the human primary mesothelial cells used in this study. The authors acknowledge the facilities, and the scientific and technical assistance of Cytometry Core at the Centre for Microscopy, Characterisation & Analysis, The University of Western Australia, a facility funded by the University, State and Commonwealth Governments. RR is supported by the Diabetes Research Foundation WA, NHMRC Project Grant 1069173 and by NHMRC Program Grants 53000400 and 37612600.	Anand S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072860; [Anonymous], 2014, R LANG ENV STAT COMP; ANZDATA Registry, 2015, 37 ANZDATA REG; Barretti P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-212; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birnie KA, 2015, MOL CANCER RES, V13, P1106, DOI 10.1158/1541-7786.MCR-14-0442; Brewis IA, 2010, NEPHROL DIAL TRANSPL, V25, P1749, DOI 10.1093/ndt/gfq145; BROWN AL, 1991, J HOSP INFECT, V18, P109, DOI 10.1016/0195-6701(91)90155-2; Brown MC, 2011, PERITON DIALYSIS INT, V31, P639, DOI 10.3747/pdi.2010.00185; Busnadiego O, 2015, J AM SOC NEPHROL, V26, P173, DOI 10.1681/ASN.2013070799; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Cass A, 2010, EC IMPACT END STAGE; Chaudhry V, 2016, SCI REP-UK, V6, DOI 10.1038/srep19263; Colmont CS, 2011, NEPHROL DIAL TRANSPL, V26, P4079, DOI 10.1093/ndt/gfr217; Conlan S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r64; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Davenport A, 2009, PERITON DIALYSIS INT, V29, P297; del Peso G, 2005, NEPHROL DIAL TRANSPL, V20, P1201, DOI 10.1093/ndt/gfh793; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghali JR, 2011, PERITON DIALYSIS INT, V31, P651, DOI 10.3747/pdi.2010.00131; Heath CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142773; Jin W, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.58; Jones JSP, 2001, LUNG, V179, P397, DOI 10.1007/s004080000075; JONJIC N, 1992, J EXP MED, V176, P1165, DOI 10.1084/jem.176.4.1165; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kinnaert P, 1996, ANN SURG, V224, P749, DOI 10.1097/00000658-199612000-00010; Koussounadis A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10775; Kratochvill F, 2015, CANCER RES, V75, P3054, DOI 10.1158/0008-5472.CAN-15-0205; McGuire A, 2015, PERIT DIAL INT; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Mizgerd JP, 2001, J IMMUNOL, V166, P4042, DOI 10.4049/jimmunol.166.6.4042; Mutsaers SE, 2016, TXB PLEURAL DIS, P27; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Rodrigues-Diez R, 2014, KIDNEY INT; Rodriguez-Pascual F, 2014, LIFE SCI, V118, P156, DOI 10.1016/j.lfs.2013.12.024; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shin JH, 2011, PERITON DIALYSIS INT, V31, P340, DOI 10.3747/pdi.2010.00073; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tsuji S, 2001, J BIOL CHEM, V276, P23456, DOI 10.1074/jbc.M103162200; Varano Della Vergiliana JF, 2013, PLOS ONE, V8; Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0; Wang HH, 2011, J CHIN MED ASSOC, V74, P11, DOI 10.1016/j.jcma.2011.01.002; Wesener DA, 2015, NAT STRUCT MOL BIOL, V22, P603, DOI 10.1038/nsmb.3053; WEST TE, 1986, J CLIN MICROBIOL, V23, P809, DOI 10.1128/JCM.23.5.809-812.1986; White SL, 2008, B WORLD HEALTH ORGAN, V86, P229, DOI 10.2471/BLT.07.041715; Wong YY, 2013, PERITON DIALYSIS INT, V33, P507, DOI 10.3747/pdi.2012.00281; Yao YF, 2005, INFECT IMMUN, V73, P1856, DOI 10.1128/IAI.73.3.1856-1860.2005; Zhou Q, 2016, KIDNEY INT, V90, P515, DOI 10.1016/j.kint.2016.03.040	55	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178151	10.1371/journal.pone.0178151	http://dx.doi.org/10.1371/journal.pone.0178151			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542390	Green Published, Green Submitted, gold			2022-12-26	WOS:000402061500066
J	Shen, TNY; Kanazawa, S; Kado, M; Okada, K; Luo, L; Hayashi, A; Mizuno, H; Tanaka, R				Shen, Tsubame Nishikai-Yan; Kanazawa, Shigeyuki; Kado, Makiko; Okada, Kayoko; Luo, Lin; Hayashi, Ayato; Mizuno, Hiroshi; Tanaka, Rica			Interleukin-6 stimulates Akt and p38 MAPK phosphorylation and fibroblast migration in non-diabetic but not diabetic mice	PLOS ONE			English	Article							MACROPHAGE DIFFERENTIATION; OXIDATIVE STRESS; CELL-MIGRATION; ARGINASE-II; INFLAMMATION; ACTIVATION; PHENOTYPE; RECEPTOR; KINASE; WOUNDS	Persistent inflammatory environment and abnormal macrophage activation are characteristics of chronic diabetic wounds. Here, we attempted to characterize the differences in macrophage activation and temporal variations in cytokine expression in diabetic and nondiabetic wounds, with a focus on interleukin (IL)-6 mRNA expression and the p38 MAPK and PI3K/Akt signaling pathways. Cutaneous wound closure, CD68-and arginase-1 (Arg1)-expressing macrophages, and cytokine mRNA expression were examined in non-diabetic and streptozotocin-induced type 1 diabetic mice at different time points after injury. The effect of IL-6 on p38 MAPK and Akt phosphorylation was investigated, and an in vitro scratch assay was performed to determine the role of IL-6 in primary skin fibroblast migration. Before injury, mRNA expression levels of the inflammatory markers iNOS, IL-6, and TNF-alpha were higher in diabetic mice; however, IL-6 expression was significantly lower 6 h post injury in diabetic wounds than that in non-diabetic wounds. Non-diabetic wounds exhibited increased p38 MAPK and Akt phosphorylation; however, no such increase was found in diabetic wounds. In fibroblasts from non-diabetic mice, IL-6 increased the phosphorylation of p38 MAPK and levels of its downstream factor CREB, and also significantly increased Akt phosphorylation and levels of its upstream factor P13K. These effects of IL-6 were not detected in fibroblasts derived from the diabetic mice. In scratch assays, IL-6 stimulated the migration of primary cultured skin fibroblasts from the non-diabetic mice, and the inhibition of p38 MAPK was found to markedly suppress IL-6-stimulated fibroblast migration. These findings underscore the critical differences between diabetic and non-diabetic wounds in terms of macrophage activation, cytokine mRNA expression profile, and involvement of the IL-6-stimulated p38 MAPK-Akt signaling pathway. Aberrant macrophage activation and abnormalities in the cytokine mRNA expression profile during different phases of wound healing should be addressed when designing effective therapeutic modalities for refractory diabetic wounds.	[Shen, Tsubame Nishikai-Yan; Kanazawa, Shigeyuki; Kado, Makiko; Okada, Kayoko; Luo, Lin; Hayashi, Ayato; Mizuno, Hiroshi; Tanaka, Rica] Juntendo Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo, Japan; [Kanazawa, Shigeyuki] Osaka Univ, Grad Sch Med, Dept Plast Surg, Osaka, Japan	Juntendo University; Osaka University	Tanaka, R (corresponding author), Juntendo Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo, Japan.	rtanaka@juntendo.ac.jp			JSPS KAKENHI [26713051]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research is supported by the JSPS KAKENHI (Grants-in-Aid for Scientific Research) Grant Number 26713051 and MEXT-Supported Program for the Strategic Research Foundation at Private Universities.; Cactus Communications provided fact checking; referencing and editorial support in the form of medical writing based on the authors' detailed directions and collated author comments; and copyediting. We also thank Mr. Yusuke Kakinuma at Juntendou University School of Medicine Department of Plastic and Reconstructive Surgery for helpful technical support. This research is supported by the JSPS KAKENHI (Grants-in-Aid for Scientific Research) Grant Number 26713051 and MEXT-Supported Program for the Strategic Research Foundation at Private Universities.	Arranz-Valsero I, 2014, EXP EYE RES, V125, P183, DOI 10.1016/j.exer.2014.06.012; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Chesnokova V, 2002, ENDOCRINOLOGY, V143, P1571, DOI 10.1210/en.143.5.1571; Clahsen T, 2008, J LEUKOCYTE BIOL, V84, P1521, DOI 10.1189/jlb.0308178; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Das LM, 2015, J INVEST DERMATOL, V135, P389, DOI 10.1038/jid.2014.375; Fernando MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094188; Garash R, 2016, EXP BIOL MED, V241, P1054, DOI 10.1177/1535370216649444; Guest CB, 2008, FRONT BIOSCI-LANDMRK, V13, P5187, DOI 10.2741/3074; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Herder C, 2013, DIABETES OBES METAB, V15, P39, DOI 10.1111/dom.12155; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Jin XL, 2006, HEPATOLOGY, V43, P474, DOI 10.1002/hep.21087; Joko T, 2013, EXP EYE RES, V108, P23, DOI 10.1016/j.exer.2012.11.018; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Katakura T, 2004, J IMMUNOL, V172, P1407, DOI 10.4049/jimmunol.172.3.1407; Khanna S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009539; Kim JH, 2009, J APPL PHYSL 1985, V107, P1249, DOI DOI 10.1152/JAPPLPHYSI0L.91393.2008; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Kopf M, 2010, NAT REV DRUG DISCOV, V9, P703, DOI 10.1038/nrd2805; LI G, 2016, LAB INVEST, V6, P741, DOI DOI 10.1016/J.CYTO.2014.09.005; Lin ZQ, 2003, J LEUKOCYTE BIOL, V73, P713, DOI 10.1189/jlb.0802397; Loughlin DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018676; Gavito AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157956; Mangino G, 2007, J VIROL, V81, P2777, DOI 10.1128/JVI.01640-06; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; MAUER J, 2014, NATURE IMMUNOLOGY, V8, P423, DOI DOI 10.1189/JLB.0308178; Miao MY, 2012, WOUND REPAIR REGEN, V20, P203, DOI 10.1111/j.1524-475X.2012.00772.x; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016; Mirza RE, 2015, CYTOKINE, V71, P409, DOI 10.1016/j.cyto.2014.09.005; Mirza RE, 2013, DIABETES, V62, P2579, DOI 10.2337/db12-1450; Misson P, 2004, J LEUKOCYTE BIOL, V76, P926, DOI 10.1189/jlb.0104019; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nelson AM, 2015, CELL STEM CELL, V17, P139, DOI 10.1016/j.stem.2015.07.008; O'Shea JJ, 2011, J IMMUNOL, V187, P5475, DOI 10.4049/jimmunol.1102913; Okizaki S, 2016, AM J PATHOL, V186, P1481, DOI 10.1016/j.ajpath.2016.02.014; Park CH, 2015, J MED FOOD, V18, P337, DOI 10.1089/jmf.2014.3174; Ploeger DTA, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-29; Pradhan L, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000945; Ramsey SD, 1999, DIABETES CARE, V22, P382, DOI 10.2337/diacare.22.3.382; Rathmann W, 2004, DIABETES CARE, V27, P2568, DOI 10.2337/diacare.27.10.2568; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Salazar JJ, 2016, J DIABETES COMPLICAT, V30, P746, DOI 10.1016/j.jdiacomp.2015.12.017; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Wang Z, 2006, INVEST OPHTH VIS SCI, V47, P5267, DOI 10.1167/iovs.06-0642; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Yang ZH, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00149; Yepuri G, 2012, AGING CELL, V11, P1005, DOI 10.1111/acel.12001; Yu Y, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0113-z	56	42	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178232	10.1371/journal.pone.0178232	http://dx.doi.org/10.1371/journal.pone.0178232			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542434	gold, Green Published, Green Submitted			2022-12-26	WOS:000402058800048
J	Christen, M; Del Medico, L; Christen, H; Christen, B				Christen, Matthias; Del Medico, Luca; Christen, Heinz; Christen, Beat			Genome Partitioner: A web tool for multi-level partitioning of large-scale DNA constructs for synthetic biology applications	PLOS ONE			English	Article							DESIGNER; YEAST; GENEDESIGN; STANDARDS; SEQUENCES; SOFTWARE; NETWORK	Recent advances in lower-cost DNA synthesis techniques have enabled new innovations in the field of synthetic biology. Still, efficient design and higher-order assembly of genome-scale DNA constructs remains a labor-intensive process. Given the complexity, computer assisted design tools that fragment large DNA sequences into fabricable DNA blocks are needed to pave the way towards streamlined assembly of biological systems. Here, we present the Genome Partitioner software implemented as a web-based interface that permits multi-level partitioning of genome-scale DNA designs. Without the need for specialized computing skills, biologists can submit their DNA designs to a fully automated pipeline that generates the optimal retrosynthetic route for higher-order DNA assembly. To test the algorithm, we partitioned a 783 kb Caulobacter crescentus genome design. We validated the partitioning strategy by assembling a 20 kb test segment encompassing a difficult to synthesize DNA sequence. Successful assembly from 1 kb subblocks into the 20 kb segment highlights the effectiveness of the Genome Partitioner for reducing synthesis costs and timelines for higher-order DNA assembly. The Genome Partitioner is broadly applicable to translate DNA designs into ready to order sequences that can be assembled with standardized protocols, thus offering new opportunities to harness the diversity of microbial genomes for synthetic biology applications. The Genome Partitioner web tool can be accessed at https://christenlab.ethz.ch/GenomePartitioner.	[Christen, Matthias; Del Medico, Luca; Christen, Heinz; Christen, Beat] Swiss Fed Inst Technol, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Del Medico, Luca] Life Sci Zurich PhD Program Syst Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Christen, M; Christen, B (corresponding author), Swiss Fed Inst Technol, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.	matthias.christen@imsb.biol.ethz.ch; beat.christen@imsb.biol.ethz.ch	Christen, Beat/AAC-2974-2021	Del Medico, Luca/0000-0001-8248-5299; Christen, Beat/0000-0002-9528-3685; Christen, Matthias/0000-0001-7724-4562	Eidgenossische Technische Hochschule (ETH) Zurich [ETH-08 16-1]; Swiss National Science Foundation [31003A_166476]	Eidgenossische Technische Hochschule (ETH) Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Eidgenossische Technische Hochschule (ETH) Zurich [ETH-08 16-1] to BC and grant 31003A_166476 to BC from the Swiss National Science Foundation (SNSF, www.snt.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; [Anonymous], 2015, GLOBAL REGULATORY AR, V11; [Anonymous], 2011, WEBGESTER DB TRANSCR, V39, pD129; Auslander S, 2016, ANGEW CHEM INT ED EN; Awan AR, 2016, ADV DRUG DELIVER REV, V105, P96, DOI 10.1016/j.addr.2016.04.010; Bojar D, 2016, CURR OPIN CHEM BIOL, V34, P11, DOI 10.1016/j.cbpa.2016.05.012; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Casini A, 2015, NAT REV MOL CELL BIO, V16, P568, DOI 10.1038/nrm4014; Casini A, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt915; Chandran S, 2017, METHODS MOL BIOL, V1472, P187, DOI 10.1007/978-1-4939-6343-0_14; Chin JX, 2014, BIOINFORMATICS, V30, P2210, DOI 10.1093/bioinformatics/btu192; Christen B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.58; Christen M, 2015, ACS SYNTH BIOL, V4, P927, DOI 10.1021/acssynbio.5b00087; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Eisenstein M, 2016, NATURE, V531, P401, DOI 10.1038/531401a; Ellis T, 2011, INTEGR BIOL-UK, V3, P109, DOI 10.1039/c0ib00070a; George KW, 2015, ADV BIOCHEM ENG BIOT, V148, P469, DOI 10.1007/10_2015_310; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Hillson NJ, 2012, ACS SYNTH BIOL, V1, P14, DOI 10.1021/sb2000116; Hughes RA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a023812; Kosuri S, 2014, NAT METHODS, V11, P499, DOI [10.1038/NMETH.2918, 10.1038/nmeth.2918]; Kwok R, 2010, NATURE, V463, P288, DOI 10.1038/463288a; Lee ME, 2015, ACS SYNTH BIOL, V4, P975, DOI 10.1021/sb500366v; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P3, DOI 10.1093/nar/gkt990; Marillonnet S, 2015, METHODS MOL BIOL, V1321, P269, DOI 10.1007/978-1-4939-2760-9_19; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; Oberortner E, 2016, ACS SYNTH BIOL; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Pritchard L, 2006, BIOINFORMATICS, V22, P616, DOI 10.1093/bioinformatics/btk021; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Richardson SM, 2010, NUCLEIC ACIDS RES, V38, P2603, DOI 10.1093/nar/gkq143; Richardson SM, 2006, GENOME RES, V16, P550, DOI 10.1101/gr.4431306; Rokke G, 2014, METHODS MOL BIOL, V1116, P1, DOI 10.1007/978-1-62703-764-8_1; Saxena P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11247; Schwander T, 2016, SCIENCE, V354, P900, DOI 10.1126/science.aah5237; Storch M, 2017, METHODS MOL BIOL, V1472, P79, DOI 10.1007/978-1-4939-6343-0_6; Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Ye HF, 2013, P NATL ACAD SCI USA, V110, P141, DOI 10.1073/pnas.1216801110	40	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177234	10.1371/journal.pone.0177234	http://dx.doi.org/10.1371/journal.pone.0177234			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531174	Green Published, Green Submitted, gold			2022-12-26	WOS:000402058400012
J	Zhang, D; Li, T; Chen, L; Zhang, XS; Zhao, GL; Liu, ZH				Zhang, Dai; Li, Ting; Chen, Lei; Zhang, Xiaosong; Zhao, Gengli; Liu, Zhaohui			Epidemiological investigation of the relationship between common lower genital tract infections and high-risk human papillomavirus infections among women in Beijing, China	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS INFECTION; PELVIC-INFLAMMATORY-DISEASE; BACTERIAL VAGINOSIS; CERVICAL-CANCER; NEISSERIA-GONORRHOEAE; PREGNANT-WOMEN; HPV PREVALENCE; POPULATION; ABNORMALITIES; CLASSIFICATION	Background The incidence of lower genital tract infections in China has been increasing in recent years. The link between high-risk human papillomavirus (HR-HPV) and other sexually transmitted diseases (STDs) remains unclear. Methods From March to October 2014, gynecological examinations and questionnaires were conducted on 1218 married women. Cervical secretions and vaginal swab specimens were tested for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Ureaplasma urealyticum (UU), yeast, clue cells and HR-HPV. Results Laboratory results were available for 1195 of 1218 married women. HR-HPV was detected in 7.0% of participants. Forty-seven percent of women had lower genital tract infections (LGTIs). UU was the most common infection (35.5%), followed by bacterial vaginosis (BV) (10.5%), yeast infection (3.7%), CT (2.2%), and Trichomonas vaginalis (1.7%). BV was associated with an increased risk of HR-HPV (P < 0.0001; odds ratio, 3.0 [95% CI, 1.7 - 5.4]). There was a strong correlation between abnormal cervical cytology and HR-HPV infection (P < 0.0001). Conclusions The prevalence of LGTIs in Beijing is at a high level. It is clinically important to screen for the simultaneous presence of pathogens that cause co-infections with HR-HPV.	[Zhang, Dai; Li, Ting; Zhang, Xiaosong; Zhao, Gengli; Liu, Zhaohui] Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing, Peoples R China; [Chen, Lei] Haidian Maternal & Child Hlth Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China	Peking University	Liu, ZH (corresponding author), Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing, Peoples R China.	17301255426@163.com	liu, zhao/GXV-6141-2022					Banhidy F, 2009, J MATERN-FETAL NEO M, V22, P410, DOI 10.1080/14767050902801645; CASSELL GH, 1993, CLIN MICROBIOL REV, V6, P69, DOI 10.1128/CMR.6.1.69-87.1993; DAWOOD MY, 1988, AM J MED, V84, P23, DOI 10.1016/0002-9343(88)90473-1; de Abreu ALP, 2016, AM J CANCER RES, V6, P1371; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Donders GG, 2009, BJOG-INT J OBSTET GY, V116, P1315, DOI 10.1111/j.1471-0528.2009.02237.x; Donders GGG, 2014, EXPERT OPIN PHARMACO, V15, P645, DOI 10.1517/14656566.2014.881800; Dubbink JH, 2016, J CLIN MICROBIOL, V54, P200, DOI 10.1128/JCM.02848-15; Franceschi S, 2007, SEX TRANSM DIS, V34, P563, DOI 10.1097/01.olq.0000258417.66619.0e; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; GOPLERUD C P, 1976, American Journal of Obstetrics and Gynecology, V126, P858; Goto A, 2005, J EPIDEMIOL, V15, P163, DOI 10.2188/jea.15.163; Guo YI, 2012, INT J STD AIDS, V23, P581, DOI 10.1258/ijsa.2012.011342; Huijsmans CJJ, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2961-2; Kjaer S, 2006, CANCER RES, V66, P10630, DOI 10.1158/0008-5472.CAN-06-1057; Magana-Contreras M, 2015, J MED VIROL, V87, P2098, DOI 10.1002/jmv.24278; Manavi K, 2006, BEST PRACT RES CL OB, V20, P941, DOI 10.1016/j.bpobgyn.2006.06.003; Mao C, 2003, AM J OBSTET GYNECOL, V188, P677, DOI 10.1067/mob.2003.164; Markt SC, 2012, J INFECT DIS, V205, P498, DOI 10.1093/infdis/jir746; Marrazzo JM, 1997, SEX TRANSM DIS, V24, P131, DOI 10.1097/00007435-199703000-00003; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Peipert JF, 2003, NEW ENGL J MED, V349, P2424, DOI 10.1056/NEJMcp030542; Pollock KGJ, 2014, BRIT J CANCER, V111, P1824, DOI 10.1038/bjc.2014.479; Rein DB, 2000, OBSTET GYNECOL, V95, P397, DOI 10.1016/S0029-7844(99)00551-7; Samoff E, 2005, AM J EPIDEMIOL, V162, P668, DOI 10.1093/aje/kwi262; Schwebke Jane R, 2009, Curr Infect Dis Rep, V11, P143, DOI 10.1007/s11908-009-0021-7; Sha BE, 2005, J INFECT DIS, V191, P25, DOI 10.1086/426394; Singh SM, 2015, INT J CLIN EXP PATHO, V8, P11901, DOI 10.5005/jp-journals-10005-1311; Snijders PJF, 2006, J PATHOL, V208, P152, DOI 10.1002/path.1866; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Soper DE, 2010, OBSTET GYNECOL, V116, P419, DOI 10.1097/AOG.0b013e3181e92c54; Vaccarella S, 2006, CANCER EPIDEM BIOMAR, V15, P2148, DOI 10.1158/1055-9965.EPI-06-0556; Verteramo R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-16; Waites KB, 2005, CLIN MICROBIOL REV, V18, P757, DOI 10.1128/CMR.18.4.757-789.2005; WHO, 2012, GLOB INC PREV SEL CU; Wilson L, 2014, J INFECT DIS, V210, P448, DOI 10.1093/infdis/jiu104; Wu RF, 2007, INT J CANCER, V121, P1306, DOI 10.1002/ijc.22726; Xiaolei C, 2014, EUR J GYNAECOL ONCOL, V35, P571; Xu CY, 2012, J OBSTET GYNAECOL RE, V38, P310, DOI 10.1111/j.1447-0756.2011.01624.x; Yue XA, 2015, ARCH GYNECOL OBSTET, V292, P1285, DOI 10.1007/s00404-015-3774-2; Zekan Josko, 2014, Coll Antropol, V38, P779; Zhu HY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003077	43	31	34	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178033	10.1371/journal.pone.0178033	http://dx.doi.org/10.1371/journal.pone.0178033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531212	Green Submitted, gold, Green Published			2022-12-26	WOS:000402058400051
J	Abaye, GE; Abebe, T; Worku, A; Tolessa, D; Ameni, G; Mihret, A				Abaye, Gizaw E.; Abebe, Tamrat; Worku, Adane; Tolessa, Debela; Ameni, Gobena; Mihret, Adane			Detection of Mycobacterium tuberculosis from the stool of HIV sero-positive individuals suspected of pulmonary tuberculosis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SPUTUM INDUCTION; XPERT MTB/RIF; SOUTH-AFRICA; INFECTION; DIAGNOSIS; SAMPLES; SPECIMENS; COMPLEX; EPIDEMIOLOGY	Background The impact of tuberculosis (TB) is exacerbated in Africa because of the human immunodeficiency virus (HIV) pandemic. Pulmonary tuberculosis (PTB) diagnosis is difficult in HIVinfected patients and negative sputum results are more common which leads to diagnostic delay and increases morbidity and mortality. Extra-pulmonary samples such as stool may be easier to obtain and our approach may therefore significantly improve PTB detection in people living with HIV. Objective To detect Mycobacterium tuberculosis from the stool of HIV sero-positive individuals suspected of pulmonary TB. Method A total of 117 HIV-infected individuals from three public health facilities in Addis Ababa, Ethiopia were enrolled consecutively in the study. Paired morning sputum and stool samples were simultaneously collected from anti-retroviral therapy (ART) naive individuals living with HIV and suspected for PTB. The diagnostic accuracy of the smear microscopy, culture and region of difference (RD)9-based polymerase chain reaction (PCR) in stool was compared with the accuracy of sputum testing. Chi-square test and kappa value were used to compare different method used. Results Sputum culture positivity for mycobacteria was confirmed in 33(28.2%) of the study subjects. Of 33 individuals positive for sputa culture, 10 individuals were observed to be stools culture positive. Of the 84 individuals negative for mycobacteria by sputum culture, three 3.6%) were stool culture positive and thus, the sensitivity and agreement between stool culture as compare to sputum culture were 30.3% and 0.33, respectively. Of 117 individuals, 11(9.4%) were sputum smear positive and of 11 sputum smear positive three were also stool smear positive. While of the 106 sputum smear negative individuals', only one was stool smear positive resulting in 12.1% sensitivity and 0.18 agreements against sputum culture. On the other hand, the sensitivity of RD9-based PCR directly on stool was 69.7% by considering sputum culture as a reference standard. Moreover, RD9-based PCR directly on sputum detected 7(6.0%) individuals who were sputum culture negative for M. tuberculosis. Conclusion M. tuberculosis was detected in stool of individuals living with HIV who were negative for sputum smear microscopy and culture. Hence, examination of stool samples alongside with sputum samples increases the detection of PTB in individuals living with HIV.	[Abaye, Gizaw E.] Arsi Univ, Dept Med Lab Sci, Coll Hlth Sci, Asella, Ethiopia; [Abebe, Tamrat; Mihret, Adane] Addis Ababa Univ, Dept Microbiol Immunol & Parasitol, Coll Hlth Sci, Fac Med, Addis Ababa, Ethiopia; [Worku, Adane; Ameni, Gobena] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Tolessa, Debela] Arsi Univ, Dept Biomed Sci, Coll Hlth Sci, Asella, Ethiopia; [Mihret, Adane] Armauer Hansen Res Inst, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University	Abaye, GE (corresponding author), Arsi Univ, Dept Med Lab Sci, Coll Hlth Sci, Asella, Ethiopia.	gizaweshetu@yahoo.cam	Kempker, Russell/F-5776-2017; Ameni, Gobena/AAR-4201-2020	Ameni, Gobena/0000-0003-3987-0671; Eshetu, Gizaw/0000-0001-8169-1453; Mihret, Adane/0000-0003-3183-4772	NIH/Fogarty International Center Global Infectious Diseases [D43TW009127]	NIH/Fogarty International Center Global Infectious Diseases	Tamrat Abebe is supported by a fellowship from NIH/Fogarty International Center Global Infectious Diseases grant (D43TW009127).	Banada PP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151980; BARNES PF, 1991, NEW ENGL J MED, V324, P1644, DOI 10.1056/NEJM199106063242307; BATUNGWANAYO J, 1992, AM REV RESPIR DIS, V146, P53, DOI 10.1164/ajrccm/146.1.53; BEST M, 1990, J CLIN MICROBIOL, V28, P2234, DOI 10.1128/JCM.28.10.2234-2239.1990; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; COLEBUNDERS R, 1990, ANN SOC BELG MED TR, V70, P303; Conde MB, 2003, AM J RESP CRIT CARE, V167, P723, DOI 10.1164/rccm.2111019; Cordova J, 2010, J CLIN MICROBIOL, V48, P1820, DOI 10.1128/JCM.01161-09; DiNardo AR, 2015, INT J INFECT DIS, V41, P50, DOI 10.1016/j.ijid.2015.10.022; Farid Z, 1999, J Egypt Public Health Assoc, V74, P473; Ferroni A, 2006, J CLIN MICROBIOL, V44, P2237, DOI 10.1128/JCM.00285-06; Franchi LM, 1998, LANCET, V352, P1681, DOI 10.1016/S0140-6736(05)61454-7; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Harries AD, 2001, LANCET, V357, P1519, DOI 10.1016/S0140-6736(00)04639-0; Hartung TK, 2002, SAMJ S AFR MED J, V92, P455; Hassim S, 2010, CLIN INFECT DIS, V50, P1053, DOI 10.1086/651119; Havlir DV, 2008, JAMA-J AM MED ASSOC, V300, P423, DOI 10.1001/jama.300.4.423; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Hudson CP, 2000, INT J TUBERC LUNG D, V4, P240; Khe-chine AE, 2009, MICROB, V155, P2384; Kokuto H, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv074; KUBICA GP, 1964, AM REV RESPIR DIS, V89, P284; Lawn SD, 2005, AIDS, V19, P1113, DOI 10.1097/01.aids.0000176211.08581.5a; Lawn SD, 2001, INT J TUBERC LUNG D, V5, P200; LIESENFELD O, 1995, J CLIN MICROBIOL, V33, P745, DOI 10.1128/JCM.33.3.745-747.1995; Maartens G, 2002, CURR OPIN PULM MED, V8, P173, DOI 10.1097/00063198-200205000-00004; Marcy O, 2016, CLIN INFECT DIS, V62, P1161, DOI 10.1093/cid/ciw036; Maynard-Smith L, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0709-7; Moore D, 2005, LANCET, V365, P1541, DOI 10.1016/S0140-6736(05)66453-7; Nicol MP, 2013, XPERT MTB RIF TESTIN, P57; Oberhelman RA, 2006, PEDIATRICS, V118, pE100, DOI 10.1542/peds.2005-2623; Oramasionwu GE, 2013, INT J TUBERC LUNG D, V17, P1023, DOI 10.5588/ijtld.13.0061; Pape Jean William, 2004, Top HIV Med, V12, P144; Parsons LM, 2002, J CLIN MICROBIOL, V40, P2339, DOI 10.1128/JCM.40.7.2339-2345.2002; Saranchuk P, 2007, SAMJ S AFR MED J, V97, P517; Sonnenberg P, 2007, J INFECT DIS, V19, P150; Tortoli E, 2005, INT J SYST EVOL MICR, V55, P1101, DOI 10.1099/ijs.0.63485-0; Ulmar D, 1933, J AMER MED ASSOC, V101, P835, DOI 10.1001/jama.1933.02740360015006; Wolf H, 2008, AM J TROP MED HYG, V79, P893, DOI 10.4269/ajtmh.2008.79.893; World Health Organization, 2014, WHO REPORT	42	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177529	10.1371/journal.pone.0177529	http://dx.doi.org/10.1371/journal.pone.0177529			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542255	gold, Green Published, Green Submitted			2022-12-26	WOS:000401672600013
J	Ding, BB; Zhong, Q				Ding, Binbin; Zhong, Qing			Zinc deficiency: An unexpected trigger for autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							BREAST-CANCER; DEATH	Cells respond to deprivation of certain nutrients such as glucose or nitrogen by inducing autophagy, reclaiming pieces of proteins for use in critical functions. A recent study shows that, in yeast, zinc depletion acts in a similar fashion. Depletion of this essential nutrient induces non-selective autophagy by inhibiting TORC1, leading to release and recycling of zinc from degraded proteins.	[Ding, Binbin; Zhong, Qing] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dept Internal Med, Ctr Autophagy Res, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhong, Q (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dept Internal Med, Ctr Autophagy Res, Dallas, TX 75390 USA.	qing.zhong@utsouthwestern.edu		DING, BINBIN/0000-0002-6424-005X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116908] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM116908] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam S, 2012, NUTRIENTS, V4, P875, DOI 10.3390/nu4080875; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Hung HH, 2013, CELL BIOL TOXICOL, V29, P415, DOI 10.1007/s10565-013-9261-2; Hwang JJ, 2010, BIOMETALS, V23, P997, DOI 10.1007/s10534-010-9346-9; Kawamata T, 2017, J BIOL CHEM, V292, P8520, DOI 10.1074/jbc.M116.762948; Liuzzi JP, 2013, BIOL TRACE ELEM RES, V156, P350, DOI 10.1007/s12011-013-9816-3; North M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002699; Pan R, 2015, BIOL TRACE ELEM RES, V166, P89, DOI 10.1007/s12011-015-0287-6	8	18	19	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8531	8532		10.1074/jbc.H116.762948	http://dx.doi.org/10.1074/jbc.H116.762948			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28526691	hybrid, Green Published			2022-12-26	WOS:000401788600035
J	Jensen, JL; Schjonning, P; Watts, CW; Christensen, BT; Munkholm, LJ				Jensen, Johannes Lund; Schjonning, Per; Watts, Christopher W.; Christensen, Bent T.; Munkholm, Lars J.			Soil texture analysis revisited: Removal of organic matter matters more than ever	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; WATER-CONTENT; CLAY CONTENT; CARBON; FRACTIONS; PEROXIDE; DENSITY	Exact estimates of soil clay (< 2 mu m) and silt (2-20 mu m) contents are crucial as these size fractions impact key soil functions, and as pedotransfer concepts based on clay and silt contents are becoming increasingly abundant. We examined the effect of removing soil organic matter (SOM) by H2O2 before soil dispersion and determination of clay and silt. Soil samples with gradients in SOM were retrieved from three long-term field experiments each with uniform soil mineralogy and texture. For soils with less than 2 g C 100 g(-1) minerals, clay estimates were little affected by SOM. Above this threshold, underestimation of clay increased dramatically with increasing SOM content. Silt contents were systematically overestimated when SOM was not removed; no lower SOM threshold was found for silt, but the overestimation was more pronounced for finer textured soils. When exact estimates of soil particles < 20 mu m are needed, SOM should always be removed before soil dispersion.	[Jensen, Johannes Lund; Schjonning, Per; Christensen, Bent T.; Munkholm, Lars J.] Aarhus Univ, Dept Agroecol, Tjele, Denmark; [Watts, Christopher W.] Rothamsted Res, Dept Sustainable Agr Sci, Harpenden, Herts, England	Aarhus University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Jensen, JL (corresponding author), Aarhus Univ, Dept Agroecol, Tjele, Denmark.	jlj@agro.au.dk	Watts, Chris/AAA-2409-2021; Jensen, Johannes Lund/AAC-2102-2022; Schjønning, Per/F-1417-2016; watts, chris/P-6701-2015; Munkholm, Lars Juhl/E-1278-2016	watts, chris/0000-0002-7223-1444; Munkholm, Lars Juhl/0000-0002-4506-9488; Schjonning, Per/0000-0002-9362-1003; Jensen, Johannes Lund/0000-0002-0415-6665	Green Development and Demonstration Programme (GUDP) of the Ministry of Environment and Food of Denmark through the "Cover crops for optimization of cereal based cropping systems" project [3405-11-0225]; Green Development and Demonstration Programme (GUDP) of the Ministry of Environment and Food of Denmark through Optimized soil tillage in cereal based cropping systems project [34009-12-0502]; EU 7th Research Framework Programme, Distributed Infrastructure for Experimentation in Ecosystem Research (ExpeER) through the project "Identification of soil organic carbon thresholds for sustained soil functions in agroecosystems" [262060]; UK Biotechnology and Biological Sciences Research Council [BBS/E/C/00005189]; Lawes Agricultural Trust; Biotechnology and Biological Sciences Research Council [BBS/E/C/000J0300] Funding Source: researchfish; BBSRC [BBS/E/C/000J0300] Funding Source: UKRI	Green Development and Demonstration Programme (GUDP) of the Ministry of Environment and Food of Denmark through the "Cover crops for optimization of cereal based cropping systems" project; Green Development and Demonstration Programme (GUDP) of the Ministry of Environment and Food of Denmark through Optimized soil tillage in cereal based cropping systems project; EU 7th Research Framework Programme, Distributed Infrastructure for Experimentation in Ecosystem Research (ExpeER) through the project "Identification of soil organic carbon thresholds for sustained soil functions in agroecosystems"; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lawes Agricultural Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Green Development and Demonstration Programme (GUDP) of the Ministry of Environment and Food of Denmark (http://lfst.dk/tvaergaaende/gudp/) through the "Cover crops for optimization of cereal based cropping systems" (Grant No. 3405-11-0225) and Optimized soil tillage in cereal based cropping systems (Grant No. 34009-12-0502) projects coordinated by LJM, and by the EU 7th Research Framework Programme, Distributed Infrastructure for Experimentation in Ecosystem Research (ExpeER) (www.expeeronline.eu/) through the project Identification of soil organic carbon thresholds for sustained soil functions in agroecosystems (Grant No. 262060) coordinated by LJM. The Rothamsted Long-term Experiments National Capability (LTE-NCG) is supported by the UK Biotechnology and Biological Sciences Research Council (BBS/E/C/00005189) and the Lawes Agricultural Trust (www.rothamsted.ac.uk/long-term-experiments-national-capability). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society for Testing and Materials, 1998, 2000 ANN BOOK ASTM S, P518; [Anonymous], 2002, METHODS SOIL ANAL, DOI DOI 10.2136/SSSABOOKSER5.4.C12; Arthur E, 2015, EUR J SOIL SCI, V66, P206, DOI 10.1111/ejss.12191; Avery B. W., 1995, SOILS ROTHAMSTED, P1; Baver LD, 1930, J AM SOC AGRON, V24, P703; Beale OW, 1939, SOIL SCI, V48, P475, DOI 10.1097/00010694-193912000-00004; Chen C, 2014, SOIL SCI SOC AM J, V78, P119, DOI 10.2136/sssaj2013.06.0247; CHRISTENSEN BT, 1989, J SOIL SCI, V40, P641, DOI 10.1111/j.1365-2389.1989.tb01305.x; Eden M, 2012, SOIL SCI, V177, P1, DOI 10.1097/SS.0b013e31823745a9; Getahun GT, 2016, GEODERMA, V264, P94, DOI 10.1016/j.geoderma.2015.10.002; Hermansen C, 2016, SOIL SCI SOC AM J, V80, P1486, DOI 10.2136/sssaj2016.05.0159; Jensen DK, 2015, J HYDROL, V521, P498, DOI 10.1016/j.jhydrol.2014.12.018; Jensen JL, 2017, SOIL RES; Karup D, 2016, J CONTAM HYDROL, V192, P194, DOI 10.1016/j.jconhyd.2016.08.001; Knadel M, 2017, BIOSYST ENG, V156, P157, DOI 10.1016/j.biosystemseng.2017.01.007; Leifeld J, 2001, SOIL BIOL BIOCHEM, V33, P2155, DOI 10.1016/S0038-0717(01)00127-4; LEINWEBER P, 1989, Z PFLANZ BODENKUNDE, V152, P373, DOI 10.1002/jpln.19891520406; Merante P, 2017, SOIL TILL RES, V165, P95, DOI 10.1016/j.still.2016.08.001; Mikutta R, 2005, SOIL SCI SOC AM J, V69, P120, DOI 10.2136/sssaj2005.0120; Moberg JP, 1986, BERETNING NR S 1870, V1870, P1; Nocita M, 2015, ADV AGRON, V132, P139, DOI 10.1016/bs.agron.2015.02.002; Plante AF, 2004, EUR J SOIL SCI, V55, P471, DOI 10.1111/j.1365-2389.2004.00626.x; Poeplau C, 2015, SOIL TILL RES, V145, P181, DOI 10.1016/j.still.2014.09.021; Pribyl DW, 2010, GEODERMA, V156, P75, DOI 10.1016/j.geoderma.2010.02.003; Robinson GW, 1922, J AGR SCI, V12, P287, DOI 10.1017/S0021859600005347; Schjonning P, 2017, GEODERMA, V286, P83, DOI 10.1016/j.geoderma.2016.10.020; Schjonning P, 2012, VADOSE ZONE J, V11, DOI 10.2136/vzj2011.0067; Toms JD, 2003, ECOLOGY, V84, P2034, DOI 10.1890/02-0472; Watts CW, 2000, EUR J SOIL SCI, V51, P305, DOI 10.1046/j.1365-2389.2000.00311.x; Watts CW, 1997, SOIL TILL RES, V42, P253, DOI 10.1016/S0167-1987(97)00009-3	30	37	39	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178039	10.1371/journal.pone.0178039	http://dx.doi.org/10.1371/journal.pone.0178039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542416	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400133
J	He, ZZ; Zhang, JY; Yuan, XG; Liu, ZW; Liu, BB; Tuo, SH; Liu, YJ				He, Zongzhen; Zhang, Junying; Yuan, Xiguo; Liu, Zhaowen; Liu, Baobao; Tuo, Shouheng; Liu, Yajun			Network based stratification of major cancers by integrating somatic mutation and gene expression data	PLOS ONE			English	Article							NONNEGATIVE MATRIX FACTORIZATION; MUTANT LUNG ADENOCARCINOMAS; CLASSIFICATION; PREDICTION; INHIBITOR; DISCOVERY; CETUXIMAB; DISEASE	The stratification of cancer into subtypes that are significantly associated with clinical outcomes is beneficial for targeted prognosis and treatment. In this study, we integrated somatic mutation and gene expression data to identify clusters of patients. In contrast to previous studies, we constructed cancer-type-specific significant co-expression networks (SCNs) rather than using a fixed gene network across all cancers, such as the network-based stratification (NBS) method, which ignores cancer heterogeneity. For each type of cancer, the gene expression data were used to construct the SCN network, while the gene somatic mutation data were mapped onto the network, propagated, and used for further clustering. For the clustering, we adopted an improved network-regularized non-negative matrix factorization (netNMF) (netNMF_HC) for a more precise classification. We applied our method to various datasets, including ovarian cancer (OV), lung adenocarcinoma (LUAD) and uterine corpus endometrial carcinoma (UCEC) cohorts derived from the TCGA (The Cancer Genome Atlas) project. Based on the results, we evaluated the performance of our method to identify survival-relevant subtypes and further compared it to the NBS method, which adopts priori networks and netNMF algorithm. The proposed algorithm outperformed the NBS method in identifying informative cancer subtypes that were significantly associated with clinical outcomes in most cancer types we studied. In particular, our method identified survival-associated UCEC subtypes that were not identified by the NBS method. Our analysis indicated valid subtyping of patient could be applied by mutation data with cancer-type-specific SCNs and netNMF_HC for individual cancers because of specific cancer co-expression patterns and more precise clustering.	[He, Zongzhen; Zhang, Junying; Yuan, Xiguo; Liu, Zhaowen; Liu, Baobao; Tuo, Shouheng; Liu, Yajun] Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China	Xidian University	Zhang, JY (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China.	jyzhang@mail.xidian.edu.cn	Liu, Zhaowen/AAM-6710-2021; liu, bb/GXA-2527-2022	Zhang, Junying/0000-0002-7511-0277	Natural Science Foundation of China [61571341, 61201312]; Natural Science Foundation of Shaanxi Province in China [2016JM6047, 2015JM6275]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province in China(Natural Science Foundation of Shaanxi Province)	This work was supported by the Natural Science Foundation of China under Grants 61571341, and 61201312, and the Natural Science Foundation of Shaanxi Province in China under Grants 2016JM6047 and 2015JM6275. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl AA, 2015, COMPUT BIOL CHEM, V57, P3, DOI 10.1016/j.compbiolchem.2015.02.010; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Cai D, 2008, IEEE DATA MINING, P63, DOI 10.1109/ICDM.2008.57; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Chmielecki J, 2012, J THORAC ONCOL, V7, P434, DOI 10.1097/JTO.0b013e31823c5aee; Chuang CL, 2008, BIOINFORMATICS, V24, P1183, DOI 10.1093/bioinformatics/btn098; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hofree M., 2013, NATURE METHODS, V10; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Jayaswal V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp153; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Liu Z, 2015, BMC GENOMICS, V16, P1; Liu ZQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04002; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Olivier M, 2011, CURR OPIN ONCOL, V23, P88, DOI 10.1097/CCO.0b013e3283412dfa; Park S, 2010, IETE TECH REV, V27, P167, DOI 10.4103/0256-4602.60169; Pirazzoli V, 2014, CELL REP, V7, P999, DOI 10.1016/j.celrep.2014.04.014; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Van TL, 2016, BIOINFORMATICS, V32, P445, DOI 10.1093/bioinformatics/btw434; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Xue Z, 2015, BMC GENOMICS, V16, P1; Yang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4231; Zhou DY, 2004, ADV NEUR IN, V16, P321	30	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177662	10.1371/journal.pone.0177662	http://dx.doi.org/10.1371/journal.pone.0177662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520777	Green Submitted, Green Published, gold			2022-12-26	WOS:000401485500053
J	Liao, JM; Ommerborn, MJ; Clark, CR				Liao, Joshua M.; Ommerborn, Mark J.; Clark, Cheryl R.			Association between features of patient-provider discussions and routine prostate-specific antigen testing	PLOS ONE			English	Article							SHARED DECISION-MAKING; PATTERNS	Introduction Although the US Preventive Services Task Force recommends against routine prostate cancer screening with prostate-specific antigen (PSA) testing, specialty organizations support screening via shared decision making between providers and selected patients. While discussions about advantages and disadvantages of testing are a feature of patient-centered care, it is unclear how provider recommendations and the presence of a personal doctor influence testing in the presence of such discussions. Materials and methods We used the 2013 Behavioral Risk Factor Surveillance System to identify 1,737 male respondents surveyed about their PSA testing decisions. We describe the prevalence of provider recommendations and utilize weighted multivariable logistic regression models to examine the impact of provider recommendations and presence of a personal doctor on routine testing while accounting for patient-provider discussions about advantages and disadvantages. Results The majority (70.4%) of respondents reported some form of discussion with providers about testing and most underwent screening in accordance with provider recommendations. In multivariable analyses, men whose providers had never recommended PSA test were less likely to receive screening [OR 0.03, 95% CI (0.02-0.05)], and patients who did not identify a personal doctor in their care were less likely to undergo testing [OR 0.12, 95% CI (0.04-0.32)]. Discussion Provider recommendations and having a personal doctor are associated with routine PSA testing. These findings suggest that providers and policymakers should be aware of how the content and context of communication with patients, beyond discussions of risks and benefits, can influence routine PSA testing behaviors.	[Liao, Joshua M.] Univ Penn, Sch Med, Div Gen Internal Med, Philadelphia, PA 19104 USA; [Ommerborn, Mark J.; Clark, Cheryl R.] Brigham & Womens Hosp, Ctr Community Hlth & Hlth Equ, 75 Francis St, Boston, MA 02115 USA; [Clark, Cheryl R.] Harvard Med Sch, Boston, MA USA; [Clark, Cheryl R.] Brigham & Womens Faulkner Hospitalist Program, Div Gen Internal Med & Primary Care, Boston, MA USA	University of Pennsylvania; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Liao, JM (corresponding author), Univ Penn, Sch Med, Div Gen Internal Med, Philadelphia, PA 19104 USA.	joshliao@upenn.edu						American Urological Association, EARLY DETECTION PROS; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Han PKJ, 2013, ANN FAM MED, V11, P306, DOI 10.1370/afm.1539; Jemal A, 2015, JAMA-J AM MED ASSOC, V314, P2054, DOI 10.1001/jama.2015.14905; Li J, 2015, AM J PREV MED, V49, P259, DOI 10.1016/j.amepre.2015.02.007; Sammon JD, 2015, JAMA-J AM MED ASSOC, V314, P2075, DOI 10.1001/jama.2015.7273; Taneja SS, 2015, J UROLOGY, V193, P126, DOI 10.1016/j.juro.2014.10.073; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066	8	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177687	10.1371/journal.pone.0177687	http://dx.doi.org/10.1371/journal.pone.0177687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520820	Green Published, gold, Green Submitted			2022-12-26	WOS:000401485500055
J	Rode, M; Lemoine, NP; Smith, MD				Rode, Madison; Lemoine, Nathan P.; Smith, Melinda D.			Prospective evidence for independent nitrogen and phosphorus limitation of grasshopper (Chorthippus curtipennis) growth in a tallgrass prairie	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; INSECT HERBIVORES; PLANT-QUALITY; NUTRITIONAL CONSTRAINTS; NATURAL ENEMIES; PREDATION RISK; MANDUCA-SEXTA; PERFORMANCE; ECOSYSTEM; TEMPERATURE	Insect herbivores play a pivotal role in regulating plant production and community composition, and their role in terrestrial ecosystems is partly determined by their feeding behavior and performance among plants of differing nutritional quality. Historically, nitrogen (N) has been considered the primary limiting nutrient of herbivorous insects, but N is only one of many potential nutrients important to insect performance. Of these nutrients, phosphorus (P) is perhaps the most important because somatic growth depends upon P-rich ribosomal RNA. Yet relatively few studies have assessed the strength of P-limitation for terrestrial insects and even fewer have simultaneously manipulated both N and P to assess the relative strengths of N- and P-limitation. Here, we tested for potential N and P limitation, as well as N: P co-limitation, on Chorthippis curtipennis (Orthoptera, Acrididae), an abundant member of arthropod communities of central US prairies. Our results demonstrate weak evidence for both N and P limitation of C. curtipennis growth rates in laboratory feeding assays. Importantly, P-limitation was just as strong as N-limitation, but we found no evidence for NP co-limitation in our study. Furthermore, nutrient limitation was not apparent in field studies, suggesting that insect growth rates may be predominately controlled by other factors, including temperature and predation. Our results suggest that P should be jointly considered, along with N, as a primary determinant of herbivore feeding behavior under both current and future climate conditions.	[Rode, Madison; Lemoine, Nathan P.; Smith, Melinda D.] Colorado State Univ, Dept Biol, Grad Degree Program Ecol, Ft Collins, CO 80523 USA	Colorado State University	Lemoine, NP (corresponding author), Colorado State Univ, Dept Biol, Grad Degree Program Ecol, Ft Collins, CO 80523 USA.	Nate.Lemoine@colostate.edu			United Stats Department of Agriculture - National Institute of Food and Agriculture - Agriculture and Food Research Initiative [2016-67012-25169]; Division Of Environmental Biology [1440484] Funding Source: National Science Foundation	United Stats Department of Agriculture - National Institute of Food and Agriculture - Agriculture and Food Research Initiative; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by a United Stats Department of Agriculture - National Institute of Food and Agriculture - Agriculture and Food Research Initiative postdoctoral fellowship (2016-67012-25169) to NPL (https://nifa.usda.gov/ program/afri-foundational-program). The USDA had no role in the study design, data collection, or manuscript preparation.	Ayres MP, 2000, ECOLOGY, V81, P2198, DOI 10.1890/0012-9658(2000)081[2198:NBOPFB]2.0.CO;2; Bagchi R, 2014, NATURE, V506, P85, DOI 10.1038/nature12911; Bakker ES, 2009, OIKOS, V118, P1613, DOI 10.1111/j.1600-0706.2009.17199.x; Barton BT, 2010, ECOLOGY, V91, P2811, DOI 10.1890/09-2278.1; Bentz JA, 2001, ENVIRON ENTOMOL, V30, P533, DOI 10.1603/0046-225X-30.3.533; Bigger David S., 1998, Integrative Biology, V1, P60, DOI 10.1002/(SICI)1520-6602(1998)1:2<60::AID-INBI4>3.0.CO;2-Z; Bishop JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013598; BROWN VK, 1992, VEGETATIO, V101, P3, DOI 10.1007/BF00031910; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Burkepile DE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01493; Busch JW, 1999, ECOL ENTOMOL, V24, P132, DOI 10.1046/j.1365-2311.1999.00185.x; Carson WP, 2000, ECOL MONOGR, V70, P73, DOI 10.1890/0012-9615(2000)070[0073:HAPSCC]2.0.CO;2; Carson WP, 1999, OECOLOGIA, V121, P260, DOI 10.1007/s004420050928; Cease AJ, 2016, DIETARY PHOSPHATE AF, P64; CLANCY KM, 1993, ECOLOGY, V74, P442, DOI 10.2307/1939306; Coley PD, 2006, OIKOS, V115, P219, DOI 10.1111/j.2006.0030-1299.14928.x; DAVIDSON DW, 1993, OIKOS, V68, P23, DOI 10.2307/3545305; De Bruyn L, 2002, OECOLOGIA, V130, P594, DOI 10.1007/s00442-001-0840-1; De Long JR, 2016, FUNCT ECOL, V30, P314, DOI 10.1111/1365-2435.12493; DeMalach N, 2017, ECOL LETT, V20, P60, DOI 10.1111/ele.12706; Elser JJ, 2006, FUNCT ECOL, V20, P846, DOI 10.1111/j.1365-2435.2006.01165.x; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; Elser JJ, 2000, J EVOLUTION BIOL, V13, P845; Frost PC, 2002, ECOL LETT, V5, P232, DOI 10.1046/j.1461-0248.2002.00307.x; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Hawlena D, 2012, SCIENCE, V336, P1434, DOI 10.1126/science.1220097; Hoover DL, 2014, ECOLOGY, V95, P2646, DOI 10.1890/13-2186.1; Huberty AF, 2006, OECOLOGIA, V149, P444, DOI 10.1007/s00442-006-0462-8; Joern A, 2004, ENVIRON ENTOMOL, V33, P1617, DOI 10.1603/0046-225X-33.6.1617; Joern A, 2012, ECOLOGY, V93, P1002, DOI 10.1890/11-1142.1; Johnson SN, 2013, J ANIM ECOL, V82, P1021, DOI 10.1111/1365-2656.12070; Kainulainen P, 1996, J CHEM ECOL, V22, P617, DOI 10.1007/BF02033574; KAROWE DN, 1989, J INSECT PHYSIOL, V35, P699, DOI 10.1016/0022-1910(89)90089-9; Kerslake JE, 1998, NEW PHYTOL, V140, P43, DOI 10.1046/j.1469-8137.1998.00244.x; Kingsolver JG, 1997, PHYSIOL ZOOL, V70, P631, DOI 10.1086/515872; La Pierre Kimberly J., 2015, Oikos, V124, P842, DOI 10.1111/oik.01869; La Pierre KJ, 2015, OECOLOGIA; Laws AN, 2013, OIKOS, V122, P977, DOI 10.1111/j.1600-0706.2012.20419.x; Lemoine NP, 2016, ECOLOGY, V97, P2554, DOI 10.1002/ecy.1506; Lemoine NP, 2016, PHYSIOL ENTOMOL, V41, P143, DOI 10.1111/phen.12138; Lemoine NP, 2014, OECOLOGIA, V174, P1367, DOI 10.1007/s00442-013-2860-z; Lemoine NP, 2013, OIKOS, V122, P1669, DOI 10.1111/j.1600-0706.2013.00457.x; Massey FP, 2007, OECOLOGIA, V152, P677, DOI 10.1007/s00442-007-0703-5; Massey FP, 2007, J ECOL, V95, P414, DOI 10.1111/j.1365-2745.2007.01223.x; Massey FP, 2006, J ANIM ECOL, V75, P595, DOI 10.1111/j.1365-2656.2006.01082.x; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Metcalfe DB, 2014, ECOL LETT, V17, P324, DOI 10.1111/ele.12233; Nabity PD, 2012, J ECON ENTOMOL, V105, P878, DOI 10.1603/EC11424; Parsons SMA, 2014, OECOLOGIA, V174, P379, DOI 10.1007/s00442-013-2785-6; Perkins MC, 2004, ARCH INSECT BIOCHEM, V55, P153, DOI 10.1002/arch.10133; POPP MP, 1989, ENVIRON ENTOMOL, V18, P795, DOI 10.1093/ee/18.5.795; Risch AC, 2015, ECOLOGY, V96, P3312, DOI 10.1890/15-0300.1; ROSSI AM, 1991, ENVIRON ENTOMOL, V20, P1349, DOI 10.1093/ee/20.5.1349; Rossi AM, 1996, J CHEM ECOL, V22, P653, DOI 10.1007/BF02033576; Ryalls JMW, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2016.0912; SALIM M, 1991, CROP SCI, V31, P797, DOI 10.2135/cropsci1991.0011183X003100030051x; Schade JD, 2003, ECOL LETT, V6, P96, DOI 10.1046/j.1461-0248.2003.00409.x; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Schmitz OJ, 1998, AM NAT, V151, P327, DOI 10.1086/286122; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; Tao LL, 2014, FUNCT ECOL, V28, P190, DOI 10.1111/1365-2435.12163; Tao LL, 2012, GLOBAL CHANGE BIOL, V18, P1843, DOI 10.1111/j.1365-2486.2012.02645.x; TILMAN D, 1981, LIMNOL OCEANOGR, V26, P1020, DOI 10.4319/lo.1981.26.6.1020; Visanuvimol L, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.6301; Wojewodzic MW, 2011, FUNCT ECOL, V25, P1154, DOI 10.1111/j.1365-2435.2011.01864.x	66	16	16	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177754	10.1371/journal.pone.0177754	http://dx.doi.org/10.1371/journal.pone.0177754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520785	gold, Green Published, Green Submitted			2022-12-26	WOS:000401485500066
J	Unger, C; Kramer, N; Unterleuthner, D; Scherzer, M; Burian, A; Rudisch, A; Stadler, M; Schlederer, M; Lenhardt, D; Riedl, A; Walter, S; Wernitznig, A; Kenner, L; Hengstschlger, M; Schler, J; Sommergruber, W; Dolznig, H				Unger, C.; Kramer, N.; Unterleuthner, D.; Scherzer, M.; Burian, A.; Rudisch, A.; Stadler, M.; Schlederer, M.; Lenhardt, D.; Riedl, A.; Walter, S.; Wernitznig, A.; Kenner, L.; Hengstschlger, M.; Schler, J.; Sommergruber, W.; Dolznig, H.			Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; SMOOTH MUSCLE ACTIN; FACTOR-I RECEPTOR; COLORECTAL-CANCER; TUMOR MICROENVIRONMENT; CARCINOMA-CELLS; INSULIN; EXPRESSION; MYOFIBROBLASTS; FIBROBLASTS	The insulin-like growth factor (IGF) 2/IGF1 receptor (IGF1R) signaling axis has an important role in intestinal carcinogenesis and overexpression of IGF2 is an accepted risk factor for colorectal cancer (CRC) development. Genetic amplifications and loss of imprinting contribute to the upregulation of IGF2, but insufficiently explain the extent of IGF2 expression in a subset of patients. Here, we show that IGF2 was specifically induced in the tumor stroma of CRC and identified cancer-associated fibroblasts (CAFs) as the major source. Further, we provide functional evidence that stromal IGF2, via the paracrine IGF1R/insulin receptor axis, activated pro-survival AKT signaling in CRC cell lines. In addition to its effects on malignant cells, autocrine IGF2/IGF1R signaling in CAFs induced myofibroblast differentiation in terms of alpha-smooth muscle actin expression and contractility in floating collagen gels. This was further augmented in concert with transforming growth factor-beta (TGF beta) signaling suggesting a cooperative mechanism. However, we demonstrated that IGF2 neither induced TGF beta/smooth muscle actin/mothers against decapentaplegic (SMAD) signaling nor synergized with TGF beta to hyperactivate this pathway in two dimensional and three dimensional cultures. IGF2-mediated physical matrix remodeling by CAFs, but not changes in extracellular matrix-modifying proteases or other secreted factors acting in a paracrine manner on/in cancer cells, facilitated subsequent tumor cell invasion in organotypic co-cultures. Consistently, colon cancer cells co-inoculated with CAFs expressing endogenous IGF2 in mouse xenograft models exhibited elevated invasiveness and dissemination capacity, as well as increased local tumor regrowth after primary tumor resection compared with conditions with IGF2-deficient CAFs. In line, expression of IGF2 correlated with elevated relapse rates and poor survival in CRC patients. In agreement with our results, high-level coexpression of IGF2 and TGF beta was predicting adverse outcome with higher accuracy than increased expression of the individual genes alone. Taken together, we demonstrate that stromainduced IGF2 promotes colon cancer progression in a paracrine and autocrine manner and propose IGF2 as potential target for tumor stroma cotargeting strategies.	[Unger, C.; Kramer, N.; Unterleuthner, D.; Scherzer, M.; Burian, A.; Stadler, M.; Riedl, A.; Walter, S.; Hengstschlger, M.; Dolznig, H.] Med Univ Vienna, Inst Med Genet, Waehringer Str 10, A-1090 Vienna, Austria; [Rudisch, A.; Riedl, A.; Wernitznig, A.; Sommergruber, W.] Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria; [Schlederer, M.; Kenner, L.] Med Univ Vienna, Inst Clin Pathol, Vienna, Austria; [Lenhardt, D.; Schler, J.] Oncotest GmbH, Flughafen 12, Freiburg, Germany; [Kenner, L.] Ludwig Boltzmann Inst Canc Res, Vienna, Austria; [Kenner, L.] Univ Vet Med Vienna, Inst Lab Anim Pathol, Vienna, Austria; [Scherzer, M.] Karolinska Inst, Solnavagen 1, S-17177 Solna, Sweden; [Stadler, M.] Deutsch Krebsforschungszentrum DKFZ, Neuenheimer Feld 280, D-69120 Heidelberg, Germany	Medical University of Vienna; Boehringer Ingelheim; Medical University of Vienna; Oncotest GmbH; Ludwig Boltzmann Institute; University of Veterinary Medicine Vienna; Karolinska Institutet; Helmholtz Association; German Cancer Research Center (DKFZ)	Unger, C; Dolznig, H (corresponding author), Med Univ Vienna, Inst Med Genet, Waehringer Str 10, A-1090 Vienna, Austria.	christine.unger@meduniwien.ac.at; helmut.dolznig@meduniwien.ac.at	Dolznig, Helmut/L-7005-2015	Dolznig, Helmut/0000-0002-6063-3585; Kenner, Lukas/0000-0003-2184-1338; Kramer, Nina/0000-0002-9058-8076				Albrengues J, 2014, CELL REP, V7, P1664, DOI 10.1016/j.celrep.2014.04.036; Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; Baba Y, 2010, GASTROENTEROLOGY, V139, P1855, DOI 10.1053/j.gastro.2010.07.050; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brouwer-Visser J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100165; Buck E, 2010, MOL CANCER THER, V9, P2652, DOI 10.1158/1535-7163.MCT-10-0318; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Charbonney E, 2011, MOL BIOL CELL, V22, P4472, DOI 10.1091/mbc.E11-04-0335; Chen WJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4472; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Church DN, 2012, ONCOGENE, V31, P3635, DOI 10.1038/onc.2011.526; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; DARBY I, 1990, LAB INVEST, V63, P21; De Boeck A, 2013, GUT, V62, P550, DOI 10.1136/gutjnl-2011-301393; De Groot JWB, 2007, ENDOCR-RELAT CANCER, V14, P979, DOI 10.1677/ERC-07-0161; De Wever O, 2004, FASEB J, V18, P1016, DOI 10.1096/fj.03-1110fje; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Dolznig H, 2011, AM J PATHOL, V179, P487, DOI 10.1016/j.ajpath.2011.03.015; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Friedbichler K, 2014, MOL CANCER THER, V13, P399, DOI 10.1158/1535-7163.MCT-13-0598; Fukuda I, 2006, GROWTH HORM IGF RES, V16, P211, DOI 10.1016/j.ghir.2006.05.003; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gao J, 2011, CANCER RES, V71, P1029, DOI 10.1158/0008-5472.CAN-10-2274; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Goswami CP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-970; Greenall SA, 2013, J BIOL CHEM, V288, P59, DOI 10.1074/jbc.M112.432013; Harper J, 2006, CANCER RES, V66, P1940, DOI 10.1158/0008-5472.CAN-05-2036; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hu YP, 2008, CANCER RES, V68, P8004, DOI 10.1158/0008-5472.CAN-08-0280; Hylander BL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-110; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Isella C, 2015, NAT GENET, V47, P312, DOI 10.1038/ng.3224; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kaneda A, 2005, CANCER RES, V65, P11236, DOI 10.1158/0008-5472.CAN-05-2959; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Kobayashi T, 2006, BIOCHEM BIOPH RES CO, V339, P290, DOI 10.1016/j.bbrc.2005.10.209; Lee JH, 2014, J NANOMATER, V2014, DOI 10.1155/2014/567827; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liles JS, 2011, BRIT J CANCER, V105, P523, DOI 10.1038/bjc.2011.263; Livingstone C, 2013, ENDOCR-RELAT CANCER, V20, pR321, DOI 10.1530/ERC-13-0231; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; Medico E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8002; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nishida N, 2012, CLIN CANCER RES, V18, P3054, DOI 10.1158/1078-0432.CCR-11-1078; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Park JH, 2014, ANN ONCOL, V25, P644, DOI 10.1093/annonc/mdt593; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Pollak M, 2012, CLIN CANCER RES, V18, P40, DOI 10.1158/1078-0432.CCR-11-0998; Raykha C, 2013, BBA-MOL BASIS DIS, V1832, P1511, DOI 10.1016/j.bbadis.2013.04.018; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rosner M, 2010, NAT PROTOC, V5, P1081, DOI 10.1038/nprot.2010.74; Rudisch A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124283; Rupp C, 2015, ONCOGENE, V34, P815, DOI 10.1038/onc.2014.18; Sakatani T, 2005, SCIENCE, V307, P1976, DOI 10.1126/science.1108080; SELL C, 1993, P NATL ACAD SCI USA, V90, P11217, DOI 10.1073/pnas.90.23.11217; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; SINGER C, 1995, CANCER RES, V55, P2448; Singh P, 1998, GASTROENTEROLOGY, V114, P1221, DOI 10.1016/S0016-5085(98)70428-7; Singh SK, 2008, GROWTH FACTORS, V26, P92, DOI 10.1080/08977190802057258; Small EM, 2012, J CARDIOVASC TRANSL, V5, P794, DOI 10.1007/s12265-012-9397-0; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taya S, 2001, J CELL BIOL, V155, P809, DOI 10.1083/jcb.200106139; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Tsujino T, 2007, CLIN CANCER RES, V13, P2082, DOI 10.1158/1078-0432.CCR-06-2191; Ulanet DB, 2010, P NATL ACAD SCI USA, V107, P10791, DOI 10.1073/pnas.0914076107; Valentinis B, 2001, J CLIN PATHOL-MOL PA, V54, P133, DOI 10.1136/mp.54.3.133; Wang HB, 2015, EXP CELL RES, V338, P214, DOI 10.1016/j.yexcr.2015.09.016; Zanella ER, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010445; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	87	48	49	2	15	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 21	2017	36	38					5341	5355		10.1038/onc.2017.116	http://dx.doi.org/10.1038/onc.2017.116			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FH7PJ	28534511				2022-12-26	WOS:000411382100002
J	Roy, A; Ansari, SA; Das, K; Prasad, R; Bhattacharya, A; Mallik, S; Mukherjee, A; Sen, P				Roy, Abhishek; Ansari, Shabbir A.; Das, Kaushik; Prasad, Ramesh; Bhattacharya, Anindita; Mallik, Suman; Mukherjee, Ashis; Sen, Prosenjit			Coagulation factor VIIa-mediated protease-activated receptor 2 activation leads to beta-catenin accumulation via the AKT/GSK3 beta pathway and contributes to breast cancer progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TISSUE FACTOR; CYCLIN D1; EXPRESSION; CELLS; MIGRATION; PROTEINS; INSIGHTS; BINDING	Cell migration and invasion are very characteristic features of cancer cells that promote metastasis, which is one of the most common causes of mortality among cancer patients. Emerging evidence has shown that coagulation factors can directly mediate cancer-associated complications either by enhancing thrombus formation or by initiating various signaling events leading to metastatic cancer progression. It is well established that, apart from its distinct role in blood coagulation, coagulation factor FVIIa enhances aggressive behaviors of breast cancer cells, but the underlying signaling mechanisms still remain elusive. To this end, we investigated FVIIa's role in the migration and invasiveness of the breast cancer cell line MDA-MB-231. Consistent with previous observations, we observed that FVIIa increased the migratory and invasive potential of these cells. We also provide molecular evidence that protease-activated receptor 2 activation followed by PI3K-AKT activation and GSK3 beta inactivation is involved in these processes and that beta-catenin, a well known tumor-regulatory protein, contributes to this signaling pathway. The pivotal role of beta-catenin was further indicated by the up-regulation of its downstream targets cyclin D1, c-Myc, COX-2, MMP-7, MMP-14, and Claudin-1. beta-Catenin knockdown almost completely attenuated the FVIIa-induced enhancement of breast cancer migration and invasion. These findings provide a new perspective to counteract the invasive behavior of breast cancer, indicating that blocking PI3K-AKT pathway-dependent beta-catenin accumulation may represent a potential therapeutic approach to control breast cancer.	[Roy, Abhishek; Ansari, Shabbir A.; Das, Kaushik; Prasad, Ramesh; Bhattacharya, Anindita; Mallik, Suman; Sen, Prosenjit] Indian Assoc Cultivat Sci, Dept Biol Chem, 2A & 2B Raja SC Mullick Rd, Kolkata 700032, India; [Mukherjee, Ashis] Netaji Subhash Chandra Bose Canc Res Inst, Kolkata 700016, India	Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur	Sen, P (corresponding author), Indian Assoc Cultivat Sci, Dept Biol Chem, 2A & 2B Raja SC Mullick Rd, Kolkata 700032, India.	bcps@iacs.res.in	Prasad, Ramesh/HDO-1128-2022; ansari, shabbir/HDO-7187-2022; Roy, Abhishek/AAA-7591-2021; Ansari, Shabbir/GNW-5542-2022	ansari, shabbir/0000-0002-1939-7066; 	Department of Science and Technology, Government of India [SR/SO/BB-0125/2012]; Indian Association for the Cultivation of Science, Kolkata, India	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Indian Association for the Cultivation of Science, Kolkata, India	This work was supported by Department of Science and Technology, Government of India, Project Grant SR/SO/BB-0125/2012 and a startup grant from the Indian Association for the Cultivation of Science, Kolkata, India. The authors declare that they have no conflicts of interest with the contents of this article.	Aberg M, 2013, J THROMB HAEMOST, V11, P817, DOI 10.1111/jth.12156; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bluff JE, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1871; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P6258, DOI 10.1073/pnas.93.13.6258; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Candidus S, 1996, CANCER RES, V56, P49; Carmeliet P, 1996, NATURE, V383, P73, DOI 10.1038/383073a0; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cole M, 2013, ONCOLOGIST, V18, P14, DOI 10.1634/theoncologist.2012-0322; Degen JL, 2012, THROMB RES, V129, pS1, DOI 10.1016/S0049-3848(12)70143-3; Fredersdorf S, 1997, P NATL ACAD SCI USA, V94, P6380, DOI 10.1073/pnas.94.12.6380; Hjortoe GM, 2004, BLOOD, V103, P3029, DOI 10.1182/blood-2003-10-3417; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kocaturk B, 2013, J THROMB HAEMOST, V11, P285, DOI 10.1111/jth.12222; Lima LG, 2013, BIOSCIENCE REP, V33, P701, DOI 10.1042/BSR20130057; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Mann KG, 1999, THROMB HAEMOSTASIS, V82, P165; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Morris DR, 2006, CANCER RES, V66, P307, DOI 10.1158/0008-5472.CAN-05-1735; Nakopoulou L, 2006, MODERN PATHOL, V19, P556, DOI 10.1038/modpathol.3800562; Nayak RC, 2009, BLOOD, V114, P1974, DOI 10.1182/blood-2009-03-208900; Prasad R., 2017, J BIOMOL STRUCT DYN, V35, P1, DOI [10.1080/07391102.2017.1289125, DOI 10.1080/07391102.2017.1289125]; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Rosen ED, 1997, NATURE, V390, P290, DOI 10.1038/36862; Ruf W, 2006, SEMIN THROMB HEMOST, V32, P61, DOI 10.1055/s-2006-939555; SABHARWAL AK, 1995, J BIOL CHEM, V270, P15523, DOI 10.1074/jbc.270.26.15523; Sallah S, 2001, THROMB HAEMOSTASIS, V86, P828; Schaffner F, 2008, SEMIN THROMB HEMOST, V34, P147, DOI 10.1055/s-2008-1079254; Sen P, 2012, THROMB HAEMOSTASIS, V107, P951, DOI 10.1160/TH11-09-0672; Stavik B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-357; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Su S, 2009, ONCOGENE, V28, P3047, DOI 10.1038/onc.2009.163; Tian XR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/567305; Toomey JR, 1996, BLOOD, V88, P1583; van den Berg YW, 2012, BLOOD, V119, P924, DOI 10.1182/blood-2011-06-317685; Versteeg HH, 2008, J THROMB HAEMOST, V6, P1550, DOI 10.1111/j.1538-7836.2008.03091.x; Versteeg HH, 2008, CANCER RES, V68, P7219, DOI 10.1158/0008-5472.CAN-08-0419; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Versteeg HH, 2004, MOL MED, V10, P6, DOI 10.2119/2003-00047.Versteeg; Versteeg HH, 2001, THROMB HAEMOSTASIS, V86, P1353; Yan D, 2012, J BIOL CHEM, V287, P8598, DOI 10.1074/jbc.M111.322800; Yang K, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-32; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500	48	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13688	13701		10.1074/jbc.M116.764670	http://dx.doi.org/10.1074/jbc.M116.764670			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28522609	hybrid, Green Published			2022-12-26	WOS:000407942400024
J	Ulfig, A; Frobel, J; Lausberg, F; Blummel, AS; Heide, AK; Muller, M; Freudl, R				Ulfig, Agnes; Froebel, Julia; Lausberg, Frank; Bluemmel, Anne-Sophie; Heide, Anna Katharina; Mueller, Matthias; Freudl, Roland			The h-region of twin-arginine signal peptides supports productive binding of bacterial Tat precursor proteins to the TatBC receptor complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCES; ESCHERICHIA-COLI; TARGETING DETERMINANTS; TRANSPORT-SYSTEMS; MEMBRANE-BINDING; GENETIC-ANALYSIS; FOLDED PROTEINS; EXPORT PATHWAY; SIDE-CHAIN; TRANSLOCATION	The twin-arginine translocation (Tat) pathway transports folded proteins across bacterial membranes. Tat precursor proteins possess a conserved twin-arginine (RR) motif in their signal peptides that is involved in their binding to the Tat translocase, but some facets of this interaction remain unclear. Here, we investigated the role of the hydrophobic (h-) region of the Escherichia coli trimethylamine N-oxide reductase (TorA) signal peptide in TatBC receptor binding in vivo and in vitro. We show that besides the RR motif, a minimal, functional h-region in the signal peptide is required for Tat-dependent export in Escherichia coli. Furthermore, we identified mutations in the h-region that synergistically suppressed the export defect of a TorA[KQ]-30aa-MalE Tat reporter protein in which the RR motif was replaced with a lysine-glutamine pair. Strikingly, all suppressor mutations increased the hydrophobicity of the h-region. By systematically replacing a neutral residue in the h-region with various amino acids, we detected a positive correlation between the hydrophobicity of the h-region and the translocation efficiency of the resulting reporter variants. In vitro cross-inking of residues located in the periplasmically-oriented part of the TatBC receptor to TorA[KQ]-30aa-MalE reporter variants harboring a more hydrophobic h-region in their signal peptides confirmed that unlike in TorA[KQ]-30aa-MalE with an unaltered h-region, the mutated reporters moved deep into the TatBC-binding cavity. Our results clearly indicate that, besides the Tat motif, the h-region of the Tat signal peptides is another important binding determinant that significantly contributes to the productive interaction of Tat precursor proteins with the TatBC receptor complex.	[Ulfig, Agnes; Lausberg, Frank; Heide, Anna Katharina; Freudl, Roland] Forschungszentrum Julich, Inst Bio & Geosci, IBG Biotechnol 1, Wilhelm Johnen Str, D-52425 Julich, Germany; [Froebel, Julia; Bluemmel, Anne-Sophie; Mueller, Matthias] Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany	Helmholtz Association; Research Center Julich; University of Freiburg	Freudl, R (corresponding author), Forschungszentrum Julich, Inst Bio & Geosci, IBG Biotechnol 1, Wilhelm Johnen Str, D-52425 Julich, Germany.	r.freudl@fz-juelich.de	Freudl, Roland/N-4179-2017	Freudl, Roland/0000-0003-0743-1279; Ulfig, Agnes/0000-0003-2689-6311				Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Alami M, 2002, J BIOL CHEM, V277, P20499, DOI 10.1074/jbc.M201711200; Alcock F, 2016, ELIFE, V5, DOI 10.7554/eLife.20718; ARGOS P, 1982, EUR J BIOCHEM, V128, P565; Bageshwar UK, 2009, MOL MICROBIOL, V74, P209, DOI 10.1111/j.1365-2958.2009.06862.x; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Berks BC, 2015, ANNU REV BIOCHEM, V84, P843, DOI 10.1146/annurev-biochem-060614-034251; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Blaudeck N, 2003, J BACTERIOL, V185, P2811, DOI 10.1128/JB.185.9.2811-2819.2003; Blummel AS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8234; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Buchanan G, 2001, ARCH MICROBIOL, V177, P107, DOI 10.1007/s00203-001-0366-2; Celedon JM, 2013, BBA-MOL CELL RES, V1833, P341, DOI 10.1016/j.bbamcr.2012.06.028; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2015, J BIOL CHEM, V290, P16530, DOI 10.1074/jbc.R114.626820; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; DeLisa MP, 2002, J BIOL CHEM, V277, P29825, DOI 10.1074/jbc.M201956200; Denks K, 2014, MOL MEMBR BIOL, V31, P58, DOI 10.3109/09687688.2014.907455; Eisenberg D., 1982, FARADAY S CHEM SOC, V17, P109, DOI DOI 10.1039/FS9821700109; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Fincher V, 1998, FEBS LETT, V423, P66, DOI 10.1016/S0014-5793(98)00066-0; Frobel J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2308; Frobel J, 2012, PHILOS T R SOC B, V367, P1029, DOI 10.1098/rstb.2011.0202; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gerard F, 2007, J BIOL CHEM, V282, P5263, DOI 10.1074/jbc.M610337200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Goosens VJ, 2014, BBA-MOL CELL RES, V1843, P1698, DOI 10.1016/j.bbamcr.2013.10.008; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HEITMANN P, 1968, EUR J BIOCHEM, V3, P346, DOI 10.1111/j.1432-1033.1968.tb19535.x; HENGGE R, 1983, BIOCHIM BIOPHYS ACTA, V737, P443, DOI 10.1016/0304-4157(83)90009-6; Henry R, 1997, J CELL BIOL, V136, P823, DOI 10.1083/jcb.136.4.823; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Hou B, 2006, J MOL BIOL, V355, P957, DOI 10.1016/j.jmb.2005.11.029; Hou Bo, 2011, Biomol Concepts, V2, P507, DOI 10.1515/BMC.2011.040; Huang Q, 2017, P NATL ACAD SCI USA, V114, pE1958, DOI 10.1073/pnas.1615056114; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lausberg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039867; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; McDevitt CA, 2006, FEBS J, V273, P5656, DOI 10.1111/j.1742-4658.2006.05554.x; Mendel S, 2008, J MOL BIOL, V375, P661, DOI 10.1016/j.jmb.2007.09.087; MILLER JG, 1972, SHORT COURSE BACTERI; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Moser Michael, 2007, V390, P63; Nagano N, 1999, FEBS LETT, V458, P69, DOI 10.1016/S0014-5793(99)01122-9; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Robinson C, 2011, BBA-BIOMEMBRANES, V1808, P876, DOI 10.1016/j.bbamem.2010.11.023; Rodriguez F, 2013, P NATL ACAD SCI USA, V110, pE1092, DOI 10.1073/pnas.1219486110; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shanmugham A, 2006, BIOCHEMISTRY-US, V45, P2243, DOI 10.1021/bi052188a; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Strauch EM, 2007, J MOL BIOL, V374, P283, DOI 10.1016/j.jmb.2007.09.050; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; TANAKA S, 1967, J BACTERIOL, V93, P642, DOI 10.1128/JB.93.2.642-648.1967; Taubert J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119761; van Dalen A, 1999, J BIOL CHEM, V274, P19913, DOI 10.1074/jbc.274.28.19913; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Zoufaly S, 2012, J BIOL CHEM, V287, P13430, DOI 10.1074/jbc.M112.343798	65	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10865	10882		10.1074/jbc.M117.788950	http://dx.doi.org/10.1074/jbc.M117.788950			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28515319	Green Published, hybrid			2022-12-26	WOS:000404391000011
J	Kashima, S; Inoue, K; Matsumoto, M				Kashima, Saori; Inoue, Kazuo; Matsumoto, Masatoshi			Have the tsunami and nuclear accident following the Great East Japan Earthquake affected the local distribution of hospital physicians?	PLOS ONE			English	Article							HEALTH-CARE; KATRINA	Objective The Great East Japan Earthquake occurred on 11 March 2011 near the northeast coast of the main island, 'Honshu', of Japan. It wreaked enormous damage in two main ways: a giant tsunami and an accident at the Fukushima Daiichi Nuclear Power Plant (FDNPP). This disaster may have affected the distribution of physicians in the region. Here, we evaluate the effect of the disaster on the distribution of hospital physicians in the three most severely affected prefectures (Iwate, Miyagi, and Fukushima). Methods We obtained individual information about physicians from the Physician Census in 2010 (pre-disaster) and 2012 (post-disaster). We examined geographical distributions of physicians in two ways: (1) municipality-based analysis for demographic evaluation; and (2) hospital- based analysis for geographic evaluation. In each analysis, we calculated the rate of change in physician distributions between pre-and post-disaster years at various distances from the tsunami-affected coast, and from the restricted area due to the FDNPP accident. Results The change in all, hospital, and clinic physicians were 0.2%, 0.7%, and -0.7%, respectively. In the municipality-based analysis, after taking account of the decreased population, physician numbers only decreased within the restricted area. In the hospital-based analysis, hospital physician numbers did not decrease at any distance from the tsunami-affected coast. In contrast, there was a 3.3% and 2.3% decrease in hospital physicians 0-25 km and 25-50 km from the restricted area surrounding the FDNPP, respectively. Additionally, decreases were larger and increases were smaller in areas close to the FDNPP than in areas further away. Conclusions Our results suggest that the tsunami did not affect the distribution of physicians in the affected regions. However, the FDNPP accident changed physician distribution in areas close to the power plant.	[Kashima, Saori] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan; [Inoue, Kazuo] Teikyo Univ, Sch Med, Chiba Med Ctr, Dept Community Med, Chiba, Japan; [Matsumoto, Masatoshi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Community Based Med Syst, Hiroshima, Japan	Hiroshima University; Teikyo University; Hiroshima University	Kashima, S (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan.	saori.ksm@gmail.com	Kashima, Saori/B-4524-2010	Kashima, Saori/0000-0002-3401-8191; Matsumoto, Masatoshi/0000-0002-8341-9303	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP25516015]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number JP25516015 (http://www.jsps.go.jp/english/e-grants/index.html). The founder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, SUMM STAT DYN SURV M; Cabinet Office Government of Japan, 2011, WHIT PAP DIS MAN 201; Griffies WS, 2010, PSYCHIAT SERV, V61, P70, DOI 10.1176/appi.ps.61.1.70; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Ishii M., 2012, J JAPAN MED ASS, V141, P32; Kashima S, PLOS ONE IN PRESS; Madamala K, 2007, DISASTER MED PUBLIC, V1, P21, DOI 10.1097/DMP.0b013e3180679118; Ministry of Education Culture Sports Science and Technology J, 2011, RES 4 AIRB MON SURV; Ministry of Health Labour and Welfare Japan, 2011, SURV PHYS DENT PHARM; Ministry of Health Labour and Welfare Japan, 2012, RESP GREAT E JAP EAR; Ministry of Health Labour and Welfare Japan, 2012, DAM SIT MEAS TAK GRE; Ministry of Health Labour and Welfare Japan, 2013, SURV PHYS DENT PHARM; Morioka N, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0067-6; National Police Agency of Japan, 2015, DAM SIT POL COUNT; Nikkei Medical, 2012, DISASTER MED RESULT, V6; Nikkei Medical, 2012, DISASTER MED RESULT, V5; Nikkei Medical, 2012, DISASTER MED RESULT, V7; [Nuclear Emergency Response Headquarters Cabinet Office Japan Support Team for Residents Affected by Nuclear Incidents], 2013, REV AR EV ORD; U.S. Government Accountability Office, 2006, GAO06576R; UN, SOURC EFF RISKS I 1; World Health Organization, 2011, DIS RISK MAN HLTH OV; World Nuclear Association, 2015, FUK ACC	22	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178020	10.1371/journal.pone.0178020	http://dx.doi.org/10.1371/journal.pone.0178020			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542461	Green Published, gold, Green Submitted			2022-12-26	WOS:000402062800036
J	Arnesen, R; Moll, AP; Shenoi, SV				Arnesen, Rachel; Moll, Anthony P.; Shenoi, Sheela V.			Predictors of loss to follow-up among patients on ART at a rural hospital in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY INITIATION; SCALE-UP; ADHERENCE; CARE; DETERMINANTS; MORTALITY; RISK; PUSH	Introduction Improved HIV outcomes as a result of expanded antiretroviral therapy (ART) access is threatened by increasing rates of loss to follow up (LTFU) among those on ART, largely reported in urban populations. Some reports suggest that LTFU rates are overestimated due to patient movement to other facilities and inadequate medical records. Study objective To define the proportion disengaging from HIV care as well as the characteristics of those LTFU in order to design and implement appropriate interventions to increase retention. Methods We performed a retrospective review of patients who discontinued ART at a central hospital ART clinic in rural South Africa and compared with patients receiving care at the 15 primary health clinics (PHCs) to determine the true proportion of those who were LTFU. We also compared those who discontinued ART with those who did not at the central hospital ART clinic to determine predictors of loss to follow up. Results Among 3242 patients on ART, 820 were originally marked as LTFU. Among all patients, 272 (8.4%) were found at a clinic on treatment, 56 (1.7%) were found at a clinic from which they had since discontinued treatment, and 10 (0.3%) returned to care between June and July 2016, leaving 475 (14.7%) unaccounted for and thus categorized as 'true' LTFU. Factors found to be associated with discontinuation include being male, age 18-35, having a CD4 count under 200 cells/mu L, and being on ART for under six months. Conclusions Young men with low CD4 counts early after ART initiation are at highest risk of ART disengagement in this rural South African HIV clinic. Novel interventions targeting this group are needed to improve retention in care.	[Arnesen, Rachel] Yale Univ, Jackson Inst Global Affairs, New Haven, CT USA; [Moll, Anthony P.] Church Scotland Hosp, Antiretroviral Programme, Tugela Ferry, Kwazulu Natal, South Africa; [Shenoi, Sheela V.] Yale Univ, Sect Infect Dis, AIDS Program, Sch Med, New Haven, CT 06520 USA	Yale University; Yale University	Shenoi, SV (corresponding author), Yale Univ, Sect Infect Dis, AIDS Program, Sch Med, New Haven, CT 06520 USA.	sheela.shenoi@yale.edu	Shenoi, Sheela/GRY-6103-2022; Shenoi, Sheela/Z-2641-2019	Shenoi, Sheela/0000-0001-7654-4344	Yale College, Program for Global Affairs; National Institutes of Allergy and Infectious Diseases [K23AI089260]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI089260] Funding Source: NIH RePORTER	Yale College, Program for Global Affairs; National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	RA received funding from Yale College, Program for Global Affairs, http://catalog.yale.edu/ycps/subjects-of-instruction/global-affairs/. SVS received funding from National Institutes of Allergy and Infectious Diseases, K23AI089260. The spouse of author Sheela V Shenoi works part time for Amgen Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Uria G, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.21682; [Anonymous], 2015, GLOB HLTH SECT RESP; Bezabhe WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097353; Billong SC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1991-3; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Budgell EP, 2015, JAIDS-J ACQ IMM DEF, V70, P323, DOI 10.1097/QAI.0000000000000755; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; Fox M., 2016, 21 INT AIDS C DURB; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021797; Grey A, 2015, SAMJ S AFRICAN MED J, V105; Grimsrud A, 2016, J EPIDEMIOL COMMUN H, V70, P549, DOI 10.1136/jech-2015-206629; Grimsrud A, 2016, JAIDS-J ACQ IMM DEF, V71, pE16, DOI 10.1097/QAI.0000000000000863; Kanters S, 2016, LANCET HIV; Kanters S, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21141; Karcher H, 2007, TROP MED INT HEALTH, V12, P687, DOI 10.1111/j.1365-3156.2007.01830.x; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Lecher S, 2016, MMWR-MORBID MORTAL W, V65, P1332, DOI 10.15585/mmwr.mm6547a2; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Loeliger KB, 2016, AIDS PATIENT CARE ST, V30, P385, DOI 10.1089/apc.2016.0096; Loeliger KB, 2016, AIDS CARE, V28, P982, DOI 10.1080/09540121.2016.1164292; Magadzire BP, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1164-x; Mantell JE, 2014, HEALTH EDUC RES, V29, P456, DOI 10.1093/her/cyu004; Marson KG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078900; Massyn N., 2014, DURBAN HLTH SYSTEMS; Mberi MN, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0912-2; Musumari PM, 2013, AIDS CARE, V25, P1271, DOI 10.1080/09540121.2013.764391; Osler M, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18908; Roberts T, 2016, CLIN INFECT DIS, V62, P1043, DOI 10.1093/cid/ciw001; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Rutstein SE, 2016, AIDS CARE, V28, P1, DOI 10.1080/09540121.2015.1058896; Shisana O., 2014, AFRICAN NATL HIV P; Shubber Z, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002183; Tabatabai J, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24795; Van Cutsem G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014684; Yehia BR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129376	36	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177168	10.1371/journal.pone.0177168	http://dx.doi.org/10.1371/journal.pone.0177168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VE	28542309	Green Published, gold, Green Submitted			2022-12-26	WOS:000402061500014
J	Dangles, O; Rabatel, A; Kraemer, M; Zeballos, G; Soruco, A; Jacobsen, D; Anthelme, F				Dangles, Olivier; Rabatel, Antoine; Kraemer, Martin; Zeballos, Gabriel; Soruco, Alvaro; Jacobsen, Dean; Anthelme, Fabien			Ecosystem sentinels for climate change? Evidence of wetland cover changes over the last 30 years in the tropical Andes	PLOS ONE			English	Article							HABITAT QUALITY; WATER-RESOURCES; PEATLANDS; LANDSCAPE; GLACIERS; BOLIVIA; RESPONSES; PATTERNS; ECOLOGY; IMPACTS	While the impacts of climate change on individual species and communities have been well documented there is little evidence on climate-mediated changes for entire ecosystems. Pristine alpine environments can provide unique insights into natural, physical and ecological response to climate change yet broad scale and long-term studies on these potential 'ecosystem sentinels' are scarce. We addressed this issue by examining cover changes of 1689 high-elevation wetlands (temporarily or perennial water-saturated grounds) in the Bolivian Cordillera Real, a region that has experienced significant warming and glacier melting over the last 30 years. We combined high spatial resolution satellite images from PLEIADES with the long-term images archive from LANDSAT to 1) examine environmental factors (e.g., glacier cover, wetland and watershed size) that affected wetland cover changes, and 2) identify wetlands' features that affect their vulnerability (using habitat drying as a proxy) in the face of climate change. Over the (1984-2011) period, our data showed an increasing trend in the mean wetland total area and number, mainly related to the appearance of wet grassland patches during the wetter years. Wetland cover also showed high inter-annual variability and their area for a given year was positively correlated to precipitation intensities in the three months prior to the image date. Also, round wetlands located in highly glacierized catchments were less prone to drying, while relatively small wetlands with irregularly shaped contours suffered the highest rates of drying over the last three decades. High Andean wetlands can therefore be considered as ecosystem sentinels for climate change, as they seem sensitive to glacier melting. Beyond the specific focus of this study, our work illustrates how satellite-based monitoring of ecosystem sentinels can help filling the lack of information on the ecological consequences of current and changing climate conditions, a common and crucial issue especially in less-developed countries.	[Dangles, Olivier; Kraemer, Martin] IRD, EGCE, Gif Sur Yvette, France; [Dangles, Olivier; Kraemer, Martin] Univ Paris Sud, Orsay, France; [Dangles, Olivier] Pontificia Univ Catolica Ecuador, Fac Ciencias Exactas & Nat, Quito, Ecuador; [Dangles, Olivier] Univ Mayor San Andres, Inst Ecol, Unidad Limnol, La Paz, Bolivia; [Rabatel, Antoine] Univ Grenoble Alpes, CNRS, IRD, IGE, Grenoble, France; [Zeballos, Gabriel] Escuela Mil Ingn, Carrera Ingn Geog, La Paz, Bolivia; [Zeballos, Gabriel] Ohio State Univ, Dept Geog, Byrd Polar & Climate Res Ctr, Columbus, OH 43210 USA; [Soruco, Alvaro] IGEMA, Campus Univ UMSA, La Paz, Bolivia; [Jacobsen, Dean] Univ Copenhagen, Biol Dept, Freshwater Biol Lab, Copenhagen, Denmark; [Anthelme, Fabien] Univ Montpellier, CNRS, INRA, AMAP,IRD,CIRAD, Montpellier, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; Pontificia Universidad Catolica del Ecuador; Universidad Mayor de San Andres; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Recherche pour le Developpement (IRD); University System of Ohio; Ohio State University; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); CIRAD; INRAE; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Dangles, O (corresponding author), IRD, EGCE, Gif Sur Yvette, France.; Dangles, O (corresponding author), Univ Paris Sud, Orsay, France.; Dangles, O (corresponding author), Pontificia Univ Catolica Ecuador, Fac Ciencias Exactas & Nat, Quito, Ecuador.; Dangles, O (corresponding author), Univ Mayor San Andres, Inst Ecol, Unidad Limnol, La Paz, Bolivia.	olivier.dangles@ird.fr	Rabatel, Antoine/AAA-1769-2022; Jacobsen, Dean/K-4920-2014; Rabatel, Antoine/L-5249-2015; Rabatel, Antoine/AAA-1413-2021	Rabatel, Antoine/0000-0002-5304-1055; Jacobsen, Dean/0000-0001-5137-297X; 	Fond Francais pour I'Environnement Mondial (FFEM); Fondation pour la Recherche sur la Biodiversite (FRB) (Modeling BlOdiversity and land use interactions under changing glacial water availability in Tropical High Andean Wetlands" BIOTHAW) [AAP-SCEN-2011-II]; CNES/SPOT-Image ISIS program [FC18473]; LabEx OSUG (Investissements d'avenir) [ANR10 LABX56]	Fond Francais pour I'Environnement Mondial (FFEM); Fondation pour la Recherche sur la Biodiversite (FRB) (Modeling BlOdiversity and land use interactions under changing glacial water availability in Tropical High Andean Wetlands" BIOTHAW); CNES/SPOT-Image ISIS program; LabEx OSUG (Investissements d'avenir)(French National Research Agency (ANR))	This work was funded by the Fond Francais pour I'Environnement Mondial (FFEM) and the Fondation pour la Recherche sur la Biodiversite (FRB) (Modeling BlOdiversity and land use interactions under changing glacial water availability in Tropical High Andean Wetlands" BIOTHAW, AAP-SCEN-2011-II). The work was also conducted within the framework of the International Joint Laboratory GREAT-ICE and GLACIOCLIM Observatory, initiatives of the French Institut de Recherche pour le Developpement (IRD) and universities and institutions in Bolivia and Ecuador. Special thanks to the USGS-EDC for allowing free access to Landsat images. Pleiades images were provided through the CNES/SPOT-Image ISIS program, contract #FC18473. Antoine Rabatel acknowledges the support of LabEx OSUG@2020 (Investissements d'avenir - ANR10 LABX56).r Special thanks to the USGS-EDC for allowing free access to Landsat images. Pleiades images were provided through the CNES/SPOT-Image ISIS program, contract #FC18473. We are grateful to two anonymous referees for their comments in an earlier version of the manuscript.	Anderson EP., 2011, CLIMATE CHANGE BIODI, P1, DOI DOI 10.13140/2.1.3718.4969; Anthelme F, 2014, ECOL BOL, V49, P1; Anthelme F, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00387; Anthelme F, 2012, PERSPECT PLANT ECOL, V14, P363, DOI 10.1016/j.ppees.2012.05.002; Baraer M, 2012, J GLACIOL, V58, P134, DOI 10.3189/2012JoG11J186; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Belyea LR, 2004, GLOBAL CHANGE BIOL, V10, P1043, DOI 10.1111/j.1529-8817.2003.00783.x; Benavides JC, 2013, J GEOPHYS RES-BIOGEO, V118, P1627, DOI 10.1002/2013JG002419; Bookhagen B, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P223; Bradley RS, 2006, SCIENCE, V312, P1755, DOI 10.1126/science.1128087; Bragazza L, 2016, GLOBAL CHANGE BIOL, V22, P4114, DOI 10.1111/gcb.13319; Buttolph LP, 2004, J APPL ECOL, V41, P664, DOI 10.1111/j.0021-8901.2004.00921.x; Buytaert W, 2011, GLOBAL ECOL BIOGEOGR, V20, P19, DOI 10.1111/j.1466-8238.2010.00585.x; Cannone N, 2007, FRONT ECOL ENVIRON, V5, P360, DOI 10.1890/1540-9295(2007)5[360:UIOCCO]2.0.CO;2; Cauvy-Fraunie S, 2013, HYDROL EARTH SYST SC, V17, P4803, DOI 10.5194/hess-17-4803-2013; Cochrane MA, 2002, J TROP ECOL, V18, P311, DOI 10.1017/S0266467402002237; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Cooper DJ, 2010, ARCT ANTARCT ALP RES, V42, P19, DOI 10.1657/1938-4246-42.1.19; Dangles O, 2011, ECOLOGY, V92, P733, DOI 10.1890/10-0329.1; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Declerck SAJ, 2011, ECOGRAPHY, V34, P296, DOI 10.1111/j.1600-0587.2010.06462.x; Delarue F, 2016, GLOBAL CHANGE BIOL, V22, P3253, DOI 10.1111/gcb.13433; Earle LR, 2002, Q RES, V59, P2; Erschbamer B, 2007, ARCT ANTARCT ALP RES, V39, P237, DOI 10.1657/1523-0430(2007)39[237:WALOCC]2.0.CO;2; Famiglietti JS, 2015, SCIENCE, V349, P684, DOI 10.1126/science.aac9238; Freeman LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082404; Gardner RC, 2011, WETLANDS: INTEGRATING MULTIDISCIPLINARY CONCEPTS, P189, DOI 10.1007/978-94-007-0551-7_11; Garreaud R, 2003, PALAEOGEOGR PALAEOCL, V194, P5, DOI 10.1016/S0031-0182(03)00269-4; Grabherr G, 2000, MT RES DEV, V20, P190, DOI 10.1659/0276-4741(2000)020[0190:GAGORI]2.0.CO;2; HALL DK, 1995, REMOTE SENS ENVIRON, V54, P127, DOI 10.1016/0034-4257(95)00137-P; Hannah DM, 2007, AQUAT CONSERV, V17, P636, DOI 10.1002/aqc.800; Haylock MR, 2006, J CLIMATE, V19, P1490, DOI 10.1175/JCLI3695.1; Holmgren M, 2006, FRONT ECOL ENVIRON, V4, P87, DOI 10.1890/1540-9295(2006)004[0087:ECESAA]2.0.CO;2; Jacobsen D, 2014, FRESHWATER BIOL, V59, P2038, DOI 10.1111/fwb.12405; Jones MC, 2010, P NATL ACAD SCI USA, V107, P7347, DOI 10.1073/pnas.0911387107; Kramer B, 2012, BIOL CONSERV, V152, P253, DOI 10.1016/j.biocon.2012.03.038; KUPFER JA, 1995, PROG PHYS GEOG, V19, P18, DOI 10.1177/030913339501900102; Loza Herrera Susi, 2015, Ecología en Bolivia, V50, P39; Telleria JL, 2006, ARDEOLA, V53, P271; Matthews JA., 1992, ECOLOGY RECENTLY DEG; Matthews KR, 1999, J HERPETOL, V33, P615, DOI 10.2307/1565578; Michelutti N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115338; Nagy L, 2009, BIOL ALPINE HABITATS; Otto M, 2011, HYDROL EARTH SYST SC, V15, P1713, DOI 10.5194/hess-15-1713-2011; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pekel JF, 2016, NATURE, V540, P418, DOI 10.1038/nature20584; Prigent C, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007847; Quenta E, 2016, GLOBAL CHANGE BIOL, V22, P3196, DOI 10.1111/gcb.13310; Rabatel A, 2013, CRYOSPHERE, V7, P81, DOI 10.5194/tc-7-81-2013; Rabatel A, 2012, J GLACIOL, V58, P1027, DOI 10.3189/2012JoG12J027; Reveillet M, 2015, ANN GLACIOL, V56, P89, DOI 10.3189/2015AoG70A113; Ronchail J, 2006, INT J CLIMATOL, V26, P1223, DOI 10.1002/joc.1296; Ruthsatz B, 2012, PHYTOCOENOLOGIA, V42, P133, DOI 10.1127/0340-269X/2012/0042-0535; Salazar LF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029695; Schindler DW, 1996, LIMNOL OCEANOGR, V41, P1004, DOI 10.4319/lo.1996.41.5.1004; Seiler C, 2013, J APPL METEOROL CLIM, V52, P1303, DOI 10.1175/JAMC-D-12-0224.1; Skidmore AK, 2015, NATURE, V523, P403, DOI 10.1038/523403a; Soruco A, 2015, ANN GLACIOL, V56, P147, DOI 10.3189/2015AoG70A001; Soruco A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036238; Squeo FA, 2006, REV CHIL HIST NAT, V79, P245; Thibeault JM, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012718; Uden DR, 2014, ECOL APPL, V24, P1569, DOI 10.1890/13-1755.1; Vuille M, 2003, CLIMATIC CHANGE, V59, P75, DOI 10.1023/A:1024406427519; Vuille M., 2013, IDBTN515; Vuille M, 2008, EARTH-SCI REV, V89, P79, DOI 10.1016/j.earscirev.2008.04.002; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Wang XL, 2014, METHODS ECOL EVOL, V5, P634, DOI 10.1111/2041-210X.12198; Wieder RK, 2001, ECOL APPL, V11, P327, DOI 10.2307/3060892; Williamson CE, 2014, LIMNOL OCEANOGR, V59, P840, DOI 10.4319/lo.2014.59.3.0840; Williamson CE, 2009, SCIENCE, V323, P887, DOI 10.1126/science.1169443	70	44	44	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0175814	10.1371/journal.pone.0175814	http://dx.doi.org/10.1371/journal.pone.0175814			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542172	Green Submitted, Green Published, gold			2022-12-26	WOS:000402061500003
J	Stawski, R; Walczak, K; Kosielski, P; Meissner, P; Budlewski, T; Padula, G; Nowak, D				Stawski, Robert; Walczak, Konrad; Kosielski, Piotr; Meissner, Pawel; Budlewski, Tomasz; Padula, Gianluca; Nowak, Dariusz			Repeated bouts of exhaustive exercise increase circulating cell free nuclear and mitochondrial DNA without development of tolerance in healthy men	PLOS ONE			English	Article							FREE PLASMA DNA; MENSTRUAL-CYCLE; BONE-MARROW; MARATHON; RELEASE; BLOOD; MARKERS; IMPACT	Objective Acute single strenuous exercise increases circulating cell free DNA (cf DNA). We tested whether three repeated bouts of exhaustive exercise induced the cf DNA response without development of tolerance in healthy men. Methods Eleven average-trained men (age 34.0 +/- 5.2 years, body mass index 26.2 +/- 3.1 kg/m2, maximal oxygen consumption-VO(2)max 49.6 +/- 4.5 ml/kg*min) performed three treadmill exercise tests to exhaustion at speed corresponding to 70% VO(2)max separated by 72 hours of resting. Blood was collected before and after each bout of exercise for determination of cell free nuclear and mitochondrial DNA (cf n-DNA, cf mt-DNA) by real-time PCR, selected markers of muscle damage, and blood cell count. Results Each bout induced the increase (p<0.05) in plasma cf n-DNA: from 3.4 +/- 1.4 to 38.5 +/- 27.5, from 4.1 +/- 3.3 to 48.5 +/- 26.2, and 3.1 +/- 1.6 to 53.8 +/- 39.9 ng/mL after the first, second, and third exercise, respectively. In a congruent way, cf mt-DNA rose significantly after the second (from 229 +/- 216 to 450 +/- 228*103 GE/mL) and third bout of exercise (from 173 +/- 120 to 462 +/- 314*103 GE/mL). Pre-exercise cf mt-DNA decreased (p<0.05) by 2-times (from 355 +/- 219 before the first bout to 173 +/- 120*103 GE/mL before the third bout) over the study period and were accompanied by significant increase in white blood cells, platelets, creatine kinase, creatinine and lactate after each bout. However, the exercise induced percentage increment of cf n-DNA was always many times higher than corresponding increments of the afore-mentioned markers at any occasion. Conclusions Repeated bouts of exhaustive exercise induced remarkable increase in circulating cf n-DNA without signs of tolerance development. Baseline cf mt-DNA decreased in response to series of strenuous exercise. Since percentage increments of cf n-DNA in response to exercise were many times higher than those observed for other markers, measurement of circulating cf n-DNA could be a sensitive tool for monitoring acute exercise effects in human body.	[Stawski, Robert; Nowak, Dariusz] Med Univ Lodz, Dept Clin Physiol, Lodz, Poland; [Walczak, Konrad] Med Univ Lodz, Dept Internal Med & Nephrodiabetol, Lodz, Poland; [Kosielski, Piotr; Meissner, Pawel; Padula, Gianluca] Med Univ Lodz, Acad Lab Movement & Human Phys Performance, Lodz, Poland; [Budlewski, Tomasz] Cent Hosp Vet Lodz, Dept Internal Med, Mil Med Acad, Univ Hosp, Lodz, Poland	Medical University Lodz; Medical University Lodz; Medical University Lodz	Nowak, D (corresponding author), Med Univ Lodz, Dept Clin Physiol, Lodz, Poland.	dariusz.nowak@umed.lodz.pl	Stawski, Robert/G-8585-2014	Stawski, Robert/0000-0003-4164-4817; Padula, Gianluca/0000-0002-2748-9681; Nowak, Dariusz/0000-0003-3445-6930	Medical University of Lodz [503/1-079-01/503-11-001]	Medical University of Lodz	This study was supported by a research grant from Medical University of Lodz, no. 503/1-079-01/503-11-001.	Atamaniuk J, 2004, CLIN CHEM, V50, P1668, DOI 10.1373/clinchem.2004.034553; Atamaniuk J, 2008, EUR J APPL PHYSIOL, V104, P711, DOI 10.1007/s00421-008-0827-2; Atamaniuk J, 2010, EUR J APPL PHYSIOL, V110, P695, DOI 10.1007/s00421-010-1532-5; ATHENS JW, 1961, J CLIN INVEST, V40, P989, DOI 10.1172/JCI104338; Beiter T, 2014, J APPL PHYSIOL, V117, P325, DOI 10.1152/japplphysiol.00173.2014; Beiter T, 2011, CLIN CHEM, V57, P633, DOI 10.1373/clinchem.2010.158030; Bergeron R, 1999, J APPL PHYSIOL, V87, P111, DOI 10.1152/jappl.1999.87.1.111; Bergeron R, 2001, AM J PHYSIOL-REG I, V281, pR1854, DOI 10.1152/ajpregu.2001.281.6.R1854; Bogdanis GC, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00142; Boudreau LH, 2014, BLOOD, V124, P2173, DOI 10.1182/blood-2014-05-573543; Breitbach S, 1985, J APPL PHYSIOL, V2014, P119; Breitbach S, 2012, SPORTS MED, V42, P565, DOI 10.2165/11631380-000000000-00000; Brown WMC, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0032-x; Castell LM, 1997, EUR J APPL PHYSIOL O, V75, P47; Chandrananda D, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0107-z; CHAPMAN CB, 1948, J CLIN INVEST, V27, P639, DOI 10.1172/JCI102011; Chiu TW, 2006, CLIN CHEM LAB MED, V44, P13, DOI 10.1515/CCLM.2006.003; Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001; de Jonge XAKJ, 2003, SPORTS MED, V33, P833; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Elshimali YI, 2013, INT J MOL SCI, V14, P18925, DOI 10.3390/ijms140918925; Fatouros IG, 2010, CLIN BIOCHEM, V43, P1368, DOI 10.1016/j.clinbiochem.2010.08.020; Garcia-Souza LF, 2014, INT J BIOCHEM CELL B, V50, P156, DOI 10.1016/j.biocel.2014.02.015; Gleeson Michael, 2002, J Sports Sci Med, V1, P31; Helmig S, 2015, EUR J APPL PHYSIOL, V115, P2271, DOI 10.1007/s00421-015-3207-8; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; Jiang N, 2005, J LEUKOCYTE BIOL, V77, P296, DOI 10.1189/jlb.0704411; Julian R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173951; Kohler C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-105; Kratz A, 2006, AM J CLIN PATHOL, V125, P296, DOI 10.1309/PRF5N7P2XM6E243H; Li L, 2016, SCI REP-UK, V6, DOI 10.1038/srep23992; Lippi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112892; Lo YMD, 2000, CLIN CHEM, V46, P319; Lui YNYN, 2002, CLIN CHEM, V48, P421; Nasi M, 2016, INT J SPORT PHYSIOL, V11, P116, DOI 10.1123/ijspp.2014-0461; Nieman DC, 2012, J INTERF CYTOK RES, V32, P12, DOI 10.1089/jir.2011.0038; Polcher M, 2010, ANTICANCER RES, V30, P2235; Rainer TH, 2003, CLIN CHEM, V49, P562, DOI 10.1373/49.4.562; Shockett PE, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12672; Staynov DZ, 2000, NUCLEIC ACIDS RES, V28, P3092, DOI 10.1093/nar/28.16.3092; Tak T, 2013, J LEUKOCYTE BIOL, V94, P595, DOI 10.1189/jlb.1112571; Traiperm N, 2013, MED SCI SPORT EXER, V45, P1182, DOI 10.1249/MSS.0b013e3182831a93; Tug S, 2015, EXERC IMMUNOL REV, V21, P164; Velders M, 2014, CLIN BIOCHEM, V47, P471, DOI 10.1016/j.clinbiochem.2013.12.017; Wimberger P, 2011, INT J CANCER, V128, P2572, DOI 10.1002/ijc.25602; Xia P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-454; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96	47	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178216	10.1371/journal.pone.0178216	http://dx.doi.org/10.1371/journal.pone.0178216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542490	Green Published, gold, Green Submitted			2022-12-26	WOS:000402061500074
J	Luitz, MP; Barth, A; Crevenna, AH; Bomblies, R; Lamb, DC; Zacharias, M				Luitz, Manuel P.; Barth, Anders; Crevenna, Alvaro H.; Bomblies, Rainer; Lamb, Don C.; Zacharias, Martin			Covalent dye attachment influences the dynamics and conformational properties of flexible peptides	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; PHOTOINDUCED ELECTRON-TRANSFER; RIBONUCLEASE-A; CIRCULAR-DICHROISM; AQUEOUS-SOLUTION; FORCE-FIELD; S-PROTEIN; BINDING; SIMULATION; BIOMOLECULES	Fluorescence spectroscopy techniques like Forster resonance energy transfer (FRET) and fluorescence correlation spectroscopy (FCS) have become important tools for the in vitro and in vivo investigation of conformational dynamics in biomolecules. These methods rely on the distance-dependent quenching of the fluorescence signal of a donor fluorophore either by a fluorescent acceptor fluorophore (FRET) or a non-fluorescent quencher, as used in FCS with photoinduced electron transfer (PET). The attachment of fluorophores to the molecule of interest can potentially alter the molecular properties and may affect the relevant conformational states and dynamics especially of flexible biomolecules like intrinsically disordered proteins (IDP). Using the intrinsically disordered S-peptide as a model system, we investigate the impact of terminal fluorescence labeling on the molecular properties. We perform extensive molecular dynamics simulations on the labeled and unlabeled peptide and compare the results with in vitro PET-FCS measurements. Experimental and simulated timescales of end-to-end fluctuations were found in excellent agreement. Comparison between simulations with and without labels reveal that the p-stacking interaction between the fluorophore labels traps the conformation of S-peptide in a single dominant state, while the unlabeled peptide undergoes continuous conformational rearrangements. Furthermore, we find that the open to closed transition rate of S-peptide is decreased by at least one order of magnitude by the fluorophore attachment. Our approach combining experimental and in silico methods provides a benchmark for the simulations and reveals the significant effect that fluorescence labeling can have on the conformational dynamics of small biomolecules, at least for inherently flexible short peptides. The presented protocol is not only useful for comparing PET-FCS experiments with simulation results but provides a strategy to minimize the influence on molecular properties when chosing labeling positions for fluorescence experiments.	[Luitz, Manuel P.; Bomblies, Rainer; Zacharias, Martin] Tech Univ Munich, Dept Phys, T38, D-85748 Garching, Germany; [Barth, Anders; Lamb, Don C.] Ludwig Maximilians Univ Munchen, Dept Chem, Phys Chem, D-81377 Munich, Germany; [Crevenna, Alvaro H.] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, P-2780157 Oeiras, Portugal	Technical University of Munich; University of Munich; Universidade Nova de Lisboa	Zacharias, M (corresponding author), Tech Univ Munich, Dept Phys, T38, D-85748 Garching, Germany.	mzacharias@mytum.de	Crevenna, Alvaro/Q-4476-2019; Barth, Anders/S-8301-2019; Lamb, Don C/G-9501-2014	Crevenna, Alvaro/0000-0002-5580-3711; Barth, Anders/0000-0003-3671-3072; Lamb, Don C/0000-0002-0232-1903	Deutsche Forschungsgemeinschaf [DFG/SFB1035, B02]; LRZ supercomputer center (Leibniz Rechenzentrum) [pr48po]; Ludwig-Maximilians-Universitat through the Center for NanoScience; Biolmaging Network	Deutsche Forschungsgemeinschaf(German Research Foundation (DFG)); LRZ supercomputer center (Leibniz Rechenzentrum); Ludwig-Maximilians-Universitat through the Center for NanoScience; Biolmaging Network	The authors thank the Deutsche Forschungsgemeinschaft (DFG/SFB1035 project All and B02) for financial support. This work was also supported by the LRZ supercomputer center (Leibniz Rechenzentrum) through grant pr48po. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully thank Christina Stutzer for her kind introduction into circular dichroism spectrometry and the Micro-Chemistry Core Facility of the Max Planck Institute of Biochemistry (Martinsried, Germany) for peptide synthesis. We gratefully acknowledge the support from the Ludwig-Maximilians-Universitat through the Center for NanoScience and the Biolmaging Network.	Bachmann A, 2011, P NATL ACAD SCI USA, V108, P3952, DOI 10.1073/pnas.1012668108; Bastos M, 2001, PROTEINS, V42, P523, DOI 10.1002/1097-0134(20010301)42:4<523::AID-PROT100>3.0.CO;2-B; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cole R, 2002, BIOCHEMISTRY-US, V41, P6072, DOI 10.1021/bi025655m; Crevenna AH, 2012, BIOPHYS J, V102, P907, DOI 10.1016/j.bpj.2012.01.035; Daidone I, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000645; de Silva AP, 1997, CHEM REV, V97, P1515, DOI 10.1021/cr960386p; Doose S, 2009, CHEMPHYSCHEM, V10, P1389, DOI 10.1002/cphc.200900238; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Elson EL, 2011, BIOPHYS J, V101, P2855, DOI 10.1016/j.bpj.2011.11.012; Felekyan S, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1946088; Felekyan S, 2012, CHEMPHYSCHEM, V13, P1036, DOI 10.1002/cphc.201100897; FINN FM, 1972, BIOCHEMISTRY-US, V11, P455, DOI 10.1021/bi00753a025; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Frisch M. J, GAUSSIAN 09 REVISION; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Ha T, 2001, METHODS, V25, P78, DOI 10.1006/meth.2001.1217; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Haustein E, 2007, ANNU REV BIOPH BIOM, V36, P151, DOI 10.1146/annurev.biophys.36.040306.132612; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hoefling M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019791; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kalinin S, 2012, NAT METHODS, V9, P1218, DOI [10.1038/nmeth.2222, 10.1038/NMETH.2222]; KAVARNOS GJ, 1986, CHEM REV, V86, P401, DOI 10.1021/cr00072a005; Kavarnos GJ, 1994, FUNDAMENTALS PHOTOIN, V98; Kiefhaber T, 2012, CURR OPIN STRUC BIOL, V22, P21, DOI 10.1016/j.sbi.2011.09.010; Kurtsiefer C, 2001, BREAKDOWN FLASH SILI, P2039; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Li X, 2011, J PHYS CHEM B, V115, P6265, DOI 10.1021/jp200455b; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Marshall GR, 2008, BIOPOLYMERS, V90, P259, DOI 10.1002/bip.20845; MetsU E, 1997, CHEM PHYS; Michalet X, 2003, ANNU REV BIOPH BIOM, V32, P161, DOI 10.1146/annurev.biophys.32.110601.142525; Milles S, 2012, J AM CHEM SOC, V134, P5187, DOI 10.1021/ja210587q; Moerner WE, 2003, REV SCI INSTRUM, V74, P3597, DOI 10.1063/1.1589587; Murtagh F, 2012, WIRES DATA MIN KNOWL, V2, P86, DOI 10.1002/widm.53; Nettels D, 2007, P NATL ACAD SCI USA, V104, P2655, DOI 10.1073/pnas.0611093104; Neuweiler H, 2004, CURR PHARM BIOTECHNO, V5, P285, DOI 10.2174/1389201043376896; Neuweiler H, 2009, P NATL ACAD SCI USA, V106, P18569, DOI 10.1073/pnas.0910860106; Noe F, 2011, P NATL ACAD SCI USA, V108, P4822, DOI 10.1073/pnas.1004646108; RICHARDS FM, 1959, J BIOL CHEM, V234, P1459; RICHARDS FM, 1958, P NATL ACAD SCI USA, V44, P162, DOI 10.1073/pnas.44.2.162; Sahoo H, 2011, CHEMPHYSCHEM, V12, P532, DOI 10.1002/cphc.201000776; Sauer M, 2014, METHODS MOL BIOL, V1076, P597, DOI 10.1007/978-1-62703-649-8_27; Schroder GF, 2005, BIOPHYS J, V89, P3757, DOI 10.1529/biophysj.105.069500; SIMONS ER, 1968, J BIOL CHEM, V243, P218; TAMBURRO A M, 1968, Febs Letters, V1, P298, DOI 10.1016/0014-5793(68)80137-1; Tinnefeld P, 2005, ANGEW CHEM INT EDIT, V44, P2642, DOI 10.1002/anie.200300647; Vaiana AC, 2003, J AM CHEM SOC, V125, P14564, DOI 10.1021/ja036082j; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Weiss S, 2000, NATURE STRUCTURAL BI; Weller A, 1982, Z PHYS CHEM; Zhang Y, 2013, J PHYS CHEM B, V117, P7308, DOI 10.1021/jp404466f; Zhong DP, 2001, P NATL ACAD SCI USA, V98, P11873, DOI 10.1073/pnas.211440298	60	11	11	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177139	10.1371/journal.pone.0177139	http://dx.doi.org/10.1371/journal.pone.0177139			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542243	Green Published, Green Submitted, gold			2022-12-26	WOS:000402058800009
J	Oh, EH; Oh, K; Han, M; Seo, H; Chang, K; Lee, SH; Kim, GU; Song, EM; Seo, M; Lee, HS; Hwang, SW; Park, SH; Yang, DH; Kim, KJ; Byeon, JS; Myung, SJ; Yang, SK; Ye, BD				Oh, Eun Hye; Oh, Kyunghwan; Han, Minkyu; Seo, Hyungil; Chang, Kiju; Lee, Sun-Ho; Kim, Gwang-Un; Song, Eun Mi; Seo, Myeongsook; Lee, Ho-Su; Hwang, Sung Wook; Park, Sang Hyoung; Yang, Dong-Hoon; Kim, Kyung-Jo; Byeon, Jeong-Sik; Myung, Seung-Jae; Yang, Suk-Kyun; Ye, Byong Duk			Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factors	PLOS ONE			English	Article							EARLY COMBINED IMMUNOSUPPRESSION; RANDOMIZED CONTROLLED-TRIAL; INFLAMMATORY-BOWEL-DISEASE; HOSPITAL-BASED COHORT; CONVENTIONAL MANAGEMENT; COMBINATION THERAPY; CERTOLIZUMAB PEGOL; INFLIXIMAB; AZATHIOPRINE; MAINTENANCE	Although early treatment of Crohn's disease (CD) patients with anti-tumor necrosis factor (TNF) agents or immunomodulators (IMs) may improve long-term outcomes, especially those with poor prognostic factors, their effectiveness in Asians remains unclear. In this study, Korean patients with CD naive to both intestinal surgery and intestinal complications, and with at least two risk factors for progression (diagnosis at age <40 years, systemic corticosteroid treatment <3 months after diagnosis, and perianal fistula at diagnosis) were retrospectively analyzed. Patients were classified into those who started anti-TNFs, or IMs but not anti-TNFs, within 2 years of diagnosis, and those who started anti-TNFs and/or IMs later. Their probabilities of intestinal surgery and intestinal complications were compared. A total of 670 patients were enrolled, 79 in the early anti-TNF, 286 in the early IM, and 305 in the late treatment group. Kaplan-Meier analysis with the log-rank test showed that from starting anti-TNFs/IMs, times to intestinal surgery (P < 0.001), stricturing complications (P = 0.002), and penetrating complications (P < 0.001) were significantly longer in the early anti-TNF/IM groups than in the late treatment group. Multivariate Cox regression analysis showed that, from starting anti-TNFs/IMs, late anti-TNF/IM treatment was independently associated with higher risks of intestinal surgery (adjusted hazard ratio [aHR] 2.321, 95% confidence interval [CI] 1.503-3.584, P < 0.001), behavioral progression (aHR 2.001, 95% CI 1.449-2.763, P < 0.001), stricturing complications (aHR 1.736, 95% CI 1.209-2.493, P = 0.003), and penetrating complications (aHR 3.315, 95% CI 2.094-5.249, P < 0.001) than early treatment. In conclusion, treatment of Asian CD patients having poor prognostic factors with anti-TNFs/IMs within 2 years of diagnosis is associated with better clinical outcomes than later treatment.	[Oh, Eun Hye; Oh, Kyunghwan] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea; [Han, Minkyu] Univ Ulsan, Coll Med, Dept Clin Epidemiol & Biostat, Seoul, South Korea; [Seo, Hyungil; Chang, Kiju; Lee, Sun-Ho; Kim, Gwang-Un; Song, Eun Mi; Seo, Myeongsook; Hwang, Sung Wook; Park, Sang Hyoung; Yang, Dong-Hoon; Kim, Kyung-Jo; Byeon, Jeong-Sik; Myung, Seung-Jae; Yang, Suk-Kyun; Ye, Byong Duk] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea; [Lee, Ho-Su] Univ Ulsan, Coll Med, Asan Med Ctr, Hlth Screening & Promot Ctr, Seoul, South Korea; [Hwang, Sung Wook; Park, Sang Hyoung; Kim, Kyung-Jo; Yang, Suk-Kyun; Ye, Byong Duk] Univ Ulsan, Coll Med, Asan Med Ctr, Ctr Inflammatory Bowel Dis, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Ye, BD (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea.; Ye, BD (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Ctr Inflammatory Bowel Dis, Seoul, South Korea.	bdye@amc.seoul.kr	Park, Sang Hyoung/CAH-4735-2022; Ye, Byong Duk/AAF-4955-2020; Yang, Dong-Hoon/B-3437-2015	Ye, Byong Duk/0000-0001-6647-6325; Yang, Dong-Hoon/0000-0001-7756-2704				Aberra FN, 2015, CLIN GASTROENTEROL H, V13, P1702, DOI 10.1016/j.cgh.2015.02.032; Antunes O, 2014, BEST PRACT RES CL GA, V28, P473, DOI 10.1016/j.bpg.2014.05.001; Baert F, 2010, GASTROENTEROLOGY, V138, P463, DOI 10.1053/j.gastro.2009.09.056; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Beaugerie L, 2006, GASTROENTEROLOGY, V130, P650, DOI 10.1053/j.gastro.2005.12.019; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2006.11.041; Colombel JF, 2014, CLIN GASTROENTEROL H, V12, P414, DOI 10.1016/j.cgh.2013.06.019; Cosnes J, 2002, INFLAMM BOWEL DIS, V8, P244, DOI 10.1097/00054725-200207000-00002; Cosnes J, 2013, GASTROENTEROLOGY, V145, P758, DOI 10.1053/j.gastro.2013.04.048; D'Haens G, 2008, LANCET, V371, P660, DOI 10.1016/S0140-6736(08)60304-9; Danese S, 2011, ALIMENT PHARM THER, V33, P857, DOI 10.1111/j.1365-2036.2011.04598.x; De Cruz P, 2015, LANCET, V385, P1406, DOI 10.1016/S0140-6736(14)61908-5; Franchimont DP, 1998, EUR J GASTROEN HEPAT, V10, P821, DOI 10.1097/00042737-199810000-00001; Gomollon F, 2017, J CROHNS COLITIS, V11, P3, DOI 10.1093/ecco-jcc/jjw168; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Khanna R, 2015, LANCET, V386, P1825, DOI 10.1016/S0140-6736(15)00068-9; Lakatos PL, 2012, AM J GASTROENTEROL, V107, P579, DOI 10.1038/ajg.2011.448; Lakatos PL, 2009, WORLD J GASTROENTERO, V15, P3504, DOI 10.3748/wjg.15.3504; Lichtenstein GR, 2006, AM J GASTROENTEROL, V101, P1030, DOI 10.1111/j.1572-0241.2006.00463.x; Lichtenstein GR, 2006, CLIN GASTROENTEROL H, V4, P621, DOI 10.1016/j.cgh.2006.03.002; Loly C, 2008, SCAND J GASTROENTERO, V43, P948, DOI 10.1080/00365520801957149; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Ng WK, 2016, INTEST RES, V14, P111, DOI 10.5217/ir.2016.14.2.111; Ordas I, 2011, GUT, V60, P1754, DOI 10.1136/gutjnl-2011-300934; Osterman MT, 2015, CLIN GASTROENTEROL H, V13, P1293, DOI 10.1016/j.cgh.2015.02.017; Osterman MT, 2015, CLIN GASTROENTEROL H, V13, pe1272; Ott C, 2014, INT J COLORECTAL DIS, V29, P1329, DOI 10.1007/s00384-014-2002-z; Panaccione R, 2014, GASTROENTEROLOGY, V146, P392, DOI 10.1053/j.gastro.2013.10.052; Panes J, 2013, GASTROENTEROLOGY, V145, P766, DOI 10.1053/j.gastro.2013.06.009; Park SH, 2016, DIGEST DIS SCI, V61, P2060, DOI 10.1007/s10620-016-4105-6; Park SH, 2014, INFLAMM BOWEL DIS, V20, P488, DOI 10.1097/01.MIB.0000441203.56196.46; Qiu Y, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001148; Rogler G, 2013, J CROHNS COLITIS, V7, P670, DOI [10.1016/j.crohns.2013.02.014, 10.1016/j.crohns.2012.10.012]; Rogler G, 2013, DIGEST DIS, V31, P83, DOI 10.1159/000347190; Romberg-Camps MJL, 2009, AM J GASTROENTEROL, V104, P371, DOI 10.1038/ajg.2008.38; Rubin DT, 2012, INFLAMM BOWEL DIS, V18, P2225, DOI 10.1002/ibd.22925; Rutgeerts P, 2012, GASTROENTEROLOGY, V142, P1102, DOI 10.1053/j.gastro.2012.01.035; Sandborn WJ, 2007, NEW ENGL J MED, V357, P228, DOI 10.1056/NEJMoa067594; Sandborn WJ, 2014, J CROHNS COLITIS, V8, P927, DOI 10.1016/j.crohns.2014.02.021; Schreiber S, 2007, NEW ENGL J MED, V357, P239, DOI 10.1056/NEJMoa062897; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Solberg IC, 2007, CLIN GASTROENTEROL H, V5, P1430, DOI 10.1016/j.cgh.2007.09.002; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Yang SK, 2008, INFLAMM BOWEL DIS, V14, P542, DOI 10.1002/ibd.20310; Yang SK, 2016, DIGEST DIS, V34, P165, DOI 10.1159/000443134	46	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177479	10.1371/journal.pone.0177479	http://dx.doi.org/10.1371/journal.pone.0177479			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542298	gold, Green Published, Green Submitted			2022-12-26	WOS:000402058800018
J	Shen, BZ; Zhu, CL; Gao, X; Liu, G; Song, JC; Yu, Y				Shen, Bingzheng; Zhu, Chengliang; Gao, Xiang; Liu, Gang; Song, Jinchun; Yu, Yan			Oligopeptides as full-length New Delhi metallo-beta-lactamase-1 (NDM-1) inhibitors	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; IMP-1; RESISTANCE; ERTAPENEM; BACTERIA; REVEALS	'Superbug' bacteria producing NDM-1 enzyme causing wide public concern were first detected in a patient who visited India in 2008. It's an effective approach to combining beta-lactam antibiotics with NDM-1 inhibitor for treating NDM-1 producing strain infection. In our research, we designed ten oligopeptides, tested IC50 values against NDM-1 enzyme, determined the MIC values of synergistic antibacterial effect and explored the binding model. We found that the oligopeptides 2 (Cys-Phe) and 5 (Cys-Asp) respectively presented IC50 values of 113 mu M and 68 mu M and also displayed favorable synergistic effects of the inhibitors in combination with ertapenem against genetic engineering-host E. coli BL21 (DE3)/pET30aNDM-1 and a clinical isolate of P. aeruginosa with bla(NDM-1). Flexible docking and partial charge study suggested the interaction between oligopeptide and NDM-1. Three types of action effects, hydrogen bond, electrostatic effect and pi-pi interaction, contributed to the inhibitory activities.	[Shen, Bingzheng; Liu, Gang; Song, Jinchun] Wuhan Univ, Renmin Hosp, Dept Pharm, Wuhan, Peoples R China; [Shen, Bingzheng] Wuhan Univ, State Key Lab Virol, Wuhan, Peoples R China; [Zhu, Chengliang] Wuhan Univ, Renmin Hosp, Dept Clin Lab, Wuhan, Peoples R China; [Gao, Xiang] Wuhan Univ, Renmin Hosp, Cent Lab, Wuhan, Peoples R China; [Yu, Yan] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Gastroenterol, Tongji Med Coll, Wuhan, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Wuhan University; Huazhong University of Science & Technology	Song, JC (corresponding author), Wuhan Univ, Renmin Hosp, Dept Pharm, Wuhan, Peoples R China.; Yu, Y (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Gastroenterol, Tongji Med Coll, Wuhan, Peoples R China.	jcsong@live.cn; yyu_hust@yeah.net	Song, Jin/HHS-8731-2022; Li, Hongpu/B-7707-2014	Li, Hongpu/0000-0003-2323-6107	Open Research Fund Program of State Key Laboratory of Virology of China [2016KF002]; National Natural Science Foundation of China [31100253, 81672079]	Open Research Fund Program of State Key Laboratory of Virology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Open Research Fund Program of State Key Laboratory of Virology of China (2016KF002) and the National Natural Science Foundation of China (Grant No. 31100253 and 81672079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed-Bentley J, 2013, ANTIMICROB AGENTS CH, V57, P3085, DOI 10.1128/AAC.00297-13; [Anonymous], 2009, DISC STUD VERS 2 5 U; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Chen JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062082, 10.1371/journal.pone.0069704, 10.1371/journal.pone.0066841]; Clinical and Laboratory Standards Institute, 2013, 23 CLSI; Fischer J, 2013, J ANTIMICROB CHEMOTH, V68, P2954, DOI 10.1093/jac/dkt260; Giedraitiene A, 2011, MEDICINA-LITHUANIA, V47, P137, DOI 10.3390/medicina47030019; Guenther S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00246; Gupta Kalpana, 2013, PLoS One, V8, pe53674, DOI 10.1371/journal.pone.0053674; Hammond GG, 1999, FEMS MICROBIOL LETT, V179, P289, DOI 10.1111/j.1574-6968.1999.tb08740.x; Hoesly FJ, 2011, ARCH DERMATOL, V147, P1418, DOI 10.1001/archdermatol.2011.320; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024621; King D, 2011, PROTEIN SCI, V20, P1484, DOI 10.1002/pro.697; Laraki N, 1999, ANTIMICROB AGENTS CH, V43, P902, DOI 10.1128/AAC.43.4.902; Moloughney JG, 2005, FEMS MICROBIOL LETT, V243, P65, DOI 10.1016/j.femsle.2004.11.042; Musson DG, 2003, J CHROMATOGR B, V783, P1, DOI 10.1016/S1570-0232(02)00240-4; Nix DE, 2004, J ANTIMICROB CHEMOTH, V53, P23, DOI 10.1093/jac/dkh205; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P4224, DOI 10.1128/AAC.00165-11; Samuelsen O, 2008, ANTIMICROB AGENTS CH, V52, P2905, DOI 10.1128/AAC.00166-08; Shen BZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062955; Toleman MA, 2012, ANTIMICROB AGENTS CH, V56, P2773, DOI 10.1128/AAC.06297-11; Wailan AM, 2014, EXPERT REV ANTI-INFE, V12, P91, DOI 10.1586/14787210.2014.856756; Wang YX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034225, 10.1371/journal.pone.0039525, 10.1371/journal.pone.0037152]; WICKENS H, 2005, PHARM J, V274, P501; Yong Dongeun, 2009, Antimicrob Agents Chemother, V53, P5046, DOI 10.1128/AAC.00774-09; Zhang HM, 2011, FASEB J, V25, P2574, DOI 10.1096/fj.11-184036; Zhang WJ, 2013, J ANTIMICROB CHEMOTH, V68, P1681, DOI 10.1093/jac/dkt066	30	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177293	10.1371/journal.pone.0177293	http://dx.doi.org/10.1371/journal.pone.0177293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542279	gold, Green Published, Green Submitted			2022-12-26	WOS:000402058800015
J	Gallandat, K; Lantagne, D				Gallandat, Karin; Lantagne, Daniele			Selection of a Biosafety Level 1 (BSL-1) surrogate to evaluate surface disinfection efficacy in Ebola outbreaks: Comparison of four bacteriophages	PLOS ONE			English	Article							REPLICATION CYCLE; FREE CHLORINE; VIRUS; INACTIVATION; PERSISTENCE; TRANSMISSION; ENVIRONMENT; ADENOVIRUS; FOMITES; RISK	The 2014 West African Ebola virus disease outbreak was the largest to date, and conflicting, chlorine-based surface disinfection protocols to interrupt disease transmission were recommended. We identified only one study documenting surface disinfection efficacy against the Ebola virus, showing a >6.6 log reduction after 5-minute exposure to 0.5% sodium hypochlorite (NaOCl) based on small-scale tests (Cook et al. (2015)). In preparation for future extensive, large-scale disinfection efficacy experiments, we replicated the Cook et al. experiment using four potential BSL-1 surrogates selected based on similarities to the Ebola virus: bacteriophages MS2, M13, Phi6, and PR772. Each bacteriophage was exposed to 0.1% and 0.5% NaOCl for 1, 5, and 10 minutes on stainless steel. MS2 and M13 were only reduced by 3.4 log and 3.5 log after a 10-minute exposure to 0.5% NaOCl, and would be overly conservative surrogates. Conversely, PR772 was too easily inactivated for surrogate use, as it was reduced by >4.8 log after only 1-minute exposure to 0.5% NaOCl. Phi6 was slightly more resistant than the Ebola virus, with 4.1 log reduction after a 5-minute exposure and not detected after a 10-minute exposure to 0.5% NaOCl. We therefore recommend Phi6 as a surrogate for evaluating the efficacy of chlorine-based surface disinfectants against the Ebola virus.	[Gallandat, Karin; Lantagne, Daniele] Tufts Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA	Tufts University	Gallandat, K (corresponding author), Tufts Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA.	karin.gallandat@tufts.edu		Gallandat, Karin/0000-0001-6412-1483	United States Agency for International Development's Office of U.S. Foreign Disaster Assistance (USAID/OFDA); Fulbright Foreign Student Program; P.E.O. Foundation	United States Agency for International Development's Office of U.S. Foreign Disaster Assistance (USAID/OFDA)(United States Agency for International Development (USAID)); Fulbright Foreign Student Program; P.E.O. Foundation	The study was conducted with funding from the United States Agency for International Development's Office of U.S. Foreign Disaster Assistance (USAID/OFDA, https://www.usaid.gov/who-we-are/organization/bureaus/bureau-democracy-conflict-and-humanitarian-assistance/office-us). The authors gratefully acknowledge the Fulbright Foreign Student Program (http://foreign.fulbrightonline.org/) and the P.E.O. Foundation (http://www.peointernational.org/peo-foundation) for the partial support of this effort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MH, 1959, BACTERIOPHAGES; Adcock NJ, 2009, J ENVIRON SCI HEAL A, V44, P1362, DOI 10.1080/10934520903217054; ASTM International, 2011, STAND QUANT DISK CAR; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Bibby K, 2015, ENVIRON SCI TECH LET, V2, P2, DOI 10.1021/ez5003715; Brown KS, 2008, ENCY VIROLOGY, P57; Casanova LM, 2015, ENVIRON SCI TECH LET, V2, P76, DOI 10.1021/acs.estlett.5b00029; Centers for Disease Control and Prevention (CDC), 2015, INT GUID ENV INT CON; Centers for Disease Control and Prevention (CDC), 2014, INT REC CLEAN HOUS S; Centers for Disease Control and Prevention (CDC), 2014, EB EB VIR DIS INT GU; Chepurnov AA, 2003, ACTA TROP, V87, P315, DOI 10.1016/S0001-706X(03)00120-7; Cook BWM, 2016, SCI REP-UK, V6, DOI 10.1038/srep38293; Cook BWM, 2015, VIRUSES-BASEL, V7, P1975, DOI 10.3390/v7041975; Francesconi P, 2003, EMERG INFECT DIS, V9, P1430, DOI 10.3201/eid0911.030339; Gall AM, 2016, ENVIRON SCI TECHNOL, V50, P2522, DOI 10.1021/acs.est.5b04713; Gall AM, 2015, ENVIRON SCI TECHNOL, V49, P4584, DOI 10.1021/acs.est.5b00301; Herzog AB, 2012, APPL ENVIRON MICROB, V78, P7915, DOI 10.1128/AEM.01370-12; JOHNSON KM, 1977, LANCET, V1, P569; KLENK HD, 1999, MARBURG EBOLA VIRUSE; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Lee MT, 2016, ENVIRON SCI TECH LET, V3, P210, DOI 10.1021/acs.estlett.6b00105; Lucas W., 2010, ENCYCLOPEDIA OF LIFE; MacNeil A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001546; Mesquita MMF, 2010, WATER RES, V44, P1114, DOI 10.1016/j.watres.2009.11.017; Morin T, 2015, J APPL MICROBIOL, V119, P655, DOI 10.1111/jam.12870; Piercy TJ, 2010, J APPL MICROBIOL, V109, P1531, DOI 10.1111/j.1365-2672.2010.04778.x; Poranen MM, 2015, ELS; RASCHED I, 1986, MICROBIOL REV, V50, P401, DOI 10.1128/MMBR.50.4.401-427.1986; Rossi P., 1994, ADV BIOL TRACER TECH; Sagripanti JL, 2011, ARCH VIROL, V156, P489, DOI 10.1007/s00705-010-0847-1; Sagripanti JL, 2010, ARCH VIROL, V155, P2035, DOI 10.1007/s00705-010-0791-0; Schuit M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148476; Sinclair RG, 2012, APPL ENVIRON MICROB, V78, P1969, DOI 10.1128/AEM.06582-11; Sobsey M.D., 2003, VIRUS SURVIVAL ENV S, V70, P19; Tuladhar E, 2012, APPL ENVIRON MICROB, V78, P7769, DOI 10.1128/AEM.02144-12; Vaux DL, 2012, NATURE, V492, P180, DOI 10.1038/492180a; Vetter P, 2016, J INFECT DIS, V214, pS177, DOI 10.1093/infdis/jiw254; WHO, 2015, MAN CAR MAN PAT EB C; WHO & UNICEF, 2014, EB VIR DIS EVD KEY Q; Wigginton KR, 2015, ENVIRON SCI-WAT RES, V1, P735, DOI [10.1039/c5ew00125k, 10.1039/C5EW00125K]; Wigginton KR, 2012, ENVIRON SCI TECHNOL, V46, P12069, DOI 10.1021/es3029473; World Health Organisation, 2016, EB SIT REP 30 MARCH; Ye YY, 2016, ENVIRON SCI TECHNOL, V50, P5077, DOI 10.1021/acs.est.6b00876	43	31	31	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177943	10.1371/journal.pone.0177943	http://dx.doi.org/10.1371/journal.pone.0177943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531182	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000402058400042
J	Chen, TM; Huang, YX; Liu, RC; Xie, Z; Chen, SL; Hu, GQ				Chen, Tianmu; Huang, Yuanxiu; Liu, Ruchun; Xie, Zhi; Chen, Shuilian; Hu, Guoqing			Evaluating the effects of common control measures for influenza A (H1N1) outbreak at school in China: A modeling study	PLOS ONE			English	Article							PANDEMIC INFLUENZA; INFECTION; VIRUS	Background Influenza A (H1N1) outbreaks have become common at schools in China since 2009. However, the effects of common countermeasures for school influenza outbreak have not been quantified so far, including isolation, vaccination, antivirus and school closure. We conducted a mathematically modeling study to address this unsolved issue. Methods We collected data of all small-scale school outbreaks caused by influenza A that occurred in Changsha city between January 2009 and December 2013. Two outbreaks (one was in 2009 and the other one was in 2013) were used for simulating the effects of single and combined use of common measures, including isolation (Iso), therapeutics (T), prophylactics (P), vaccinating 70% of susceptible individuals prior to the outbreak (V-P70), vaccinating 70% of susceptible individuals every day during the outbreak (V-D70) and school closure of one week (S1w). A susceptible D exposed D infectious/asymptomatic D recovered (SEIR) model was developed to implement the simulations based on the natural history of influenza A. Results When no control measures are taken, the influenza is expected to spread quickly at school for the selected outbreak in 2013; the outbreak would last 56 days, and the total attack rate (TAR) would reach up to 46.32% (95% CI: 46.12-46.52). Of all single control measures, V-P70 is most effective to control the epidemic (TAR = 8.68%), followed by V-P50, V-D70, V-D50 and Iso. The use of V-P70 with any other measure can reduce TAR to 3.37-14.04% and showed better effects than any other combination of two kinds of measures. The best two-measure combination is 'S1w+V-P70' (TAR = 3.37%, DO = 41 days). All combinations of three kinds of measures were not satisfactory when V-p70 and V-D70 were excluded. The most effective three-intervention combination was 'Iso+S1w+V-P70' (with TAR = 3.23%). When V-P70 or V-D70 is included, the combinations of four or five kinds of interventions are very effective, reducing TAR to lower than 5%. But the TAR of combination of 'T+P+Iso+S1w' is 23.20%. Similar simulation results were observed for the selected outbreak in 2009. Conclusion Vaccinating no less than 70% of individuals prior to the outbreak and isolation are recommended as single measures to control H1N1 outbreak at school. The combination of V-P70+S1w can achieve very good control for school outbreak.	[Chen, Tianmu; Huang, Yuanxiu; Liu, Ruchun; Xie, Zhi; Chen, Shuilian] Changsha Ctr Dis Control & Prevent, Off Dis Control & Emergency Response, Changsha, Hunan, Peoples R China; [Hu, Guoqing] Cent S Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China	Central South University	Hu, GQ (corresponding author), Cent S Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China.	huguoging009@gmail.com		Hu, Guoqing/0000-0002-5002-8015				Arino J, 2006, J R SOC INTERFACE, V3, P453, DOI 10.1098/rsif.2006.0112; Chen TM, 2014, TRAVEL MED INFECT DI, V12, P650, DOI 10.1016/j.tmaid.2014.10.015; [陈田木 Chen Tianmu], 2014, [中国卫生统计, Chinese Journal of Health Statistics], V31, P390; Chen TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095006; Dushoff J, 2004, PNAS, V101, P16195; Hayward AC, 2014, LANCET RESP MED, V2, P445, DOI 10.1016/S2213-2600(14)70034-7; Hsieh YH, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-80; Liu R, 2015, PLOS ONE, V10; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Lv M, 2016, VACCINE, V34, P2135, DOI 10.1016/j.vaccine.2016.02.032; National Health and Family Planning Commission of the People's Republic of China, 2011, DIAGN TREATM GUID IN; National Health and Family Planning Commission of the People's Republic of China, 2010, INFL SURV PROGR CHIN; National Health and Family Planning Commission of the People's Republic of China, 2013, CLIN ED GEN PRACTICE, V11, P123; Patrozou E, 2009, PUBLIC HEALTH REP, V124, P193, DOI 10.1177/003335490912400205; Shi Jing-hong, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P62; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; Sun Yihong, 2010, J Cardiovasc Dis Res, V1, P10, DOI 10.4103/0975-3583.59978; Tracht SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009018; Wang LG, 2014, SCI REP-UK, V4, DOI 10.1038/srep05982; Yang P, 2014, VACCINE, V32, P5285, DOI 10.1016/j.vaccine.2014.07.083; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Zhang L, 2016, PEDIAT INFECT D 1128	23	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177672	10.1371/journal.pone.0177672	http://dx.doi.org/10.1371/journal.pone.0177672			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542360	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672600019
J	Zeng, T; Wang, D; Chen, J; Tian, YY; Cai, XF; Peng, H; Zhu, LY; Huang, AL; Tang, H				Zeng, Tao; Wang, Dan; Chen, Juan; Tian, Yuanyuan; Cai, Xuefei; Peng, Hong; Zhu, Liying; Huang, Ailong; Tang, Hua			LncRNA-AF113014 promotes the expression of Egr2 by interaction with miR-20a to inhibit proliferation of hepatocellular carcinoma cells	PLOS ONE			English	Article							LONG NONCODING RNA; GROWTH-RESPONSE 2; GASTRIC-CANCER PROLIFERATION; MESENCHYMAL TRANSITION; GENE EGR2; MIRNA; BINDING; DIFFERENTIATION; TRANSCRIPTION; BIOMARKERS	Long non-coding RNAs (lncRNAs), tentatively identified as non-protein coding RNA, are transcripts more than 200nt in length and accounting for 98% of the whole genome of human being. Accumulating evidence showed aberrant expressions of lncRNAs are strongly correlated to the development of cancers. In this study, AF113014 is a new lncRNA identified from Microarray. We found AF113014 is differentially expressed between HCC cell lines and normal hepatocytes. Functionally, AF113014 inhibited proliferation of HCC cells both in vitro and in vivo, whereas the opposite effect was observed when AF113014 knockdown. Moreover, we identified that Egr2, a tumor suppressor gene, was a downstream target gene of AF113014. Furthermore, we discovered that AF113014 up-regulated Egr2 expression through interacting with miR-20a by using dual-luciferase reporter assay, qRT-PCR and Western blotting analysis. Our data provides a new insight for understanding the mechanisms of HCC.	[Zeng, Tao; Wang, Dan; Chen, Juan; Cai, Xuefei; Peng, Hong; Zhu, Liying; Huang, Ailong; Tang, Hua] Chongqing Med Univ, Dept Infect Dis, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis,Minist Educ,Inst Vira, Chongqing, Peoples R China; [Tian, Yuanyuan] Qingdao Women & Children Hosp, Qingdao, Peoples R China; [Huang, Ailong] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Chongqing Medical University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Huang, AL; Tang, H (corresponding author), Chongqing Med Univ, Dept Infect Dis, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis,Minist Educ,Inst Vira, Chongqing, Peoples R China.; Huang, AL (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.	ahuang1964@163.com; tanghua86162003@cqmu.edu.cn	WANG, DAN/U-5790-2019		Major National ST Program [2013ZX10002002]; Chongqing Science & Technology Commission [cstc2013jcyjC10002]; Natural Science Foundation [20101385359, 2010BB5359]; Nature Science Foundation of China [81471946]	Major National ST Program; Chongqing Science & Technology Commission(Natural Science Foundation Project of CQ CSTC); Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Major National S&T Program (2013ZX10002002, ALH), the major project of Chongqing Science & Technology Commission (cstc2013jcyjC10002, ALH), the Natural Science Foundation Project of CQ CSTC (20101385359, ALH), the Nature Science Foundation of China (81471946, ALH).; This work was supported by the Major National S&T Program (2013ZX10002002, ALH), the major project of Chongqing Science & Technology Commission (cstc2013jcyjC10002, ALH), the Natural Science Foundation Project of CQ CSTC (2010BB5359), the Nature Science Foundation of China (81471946).	Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Barsyte-Lovejoy D, 2006, CANCER RES, V66, P5330, DOI 10.1158/0008-5472.CAN-06-0037; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Burns FR, 2016, GENE, V578, P281, DOI 10.1016/j.gene.2015.12.041; Cai H, 2015, ONCOTARGET, V6, P19759, DOI 10.18632/oncotarget.4331; Cameron SJS, 2016, LUNG CANCER, V94, P88, DOI 10.1016/j.lungcan.2016.02.006; Cao YY, 2014, BIOCHEM J, V461, P315, DOI 10.1042/BJ20140515; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chandra A, 2013, J BIOL CHEM, V288, P20488, DOI 10.1074/jbc.M112.447250; Chang S, 2016, ONCOL REP, V35, P3577, DOI 10.3892/or.2016.4743; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Dinger ME, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000176; Doncel-Perez E, 2016, J IMMUNOL, V196, P1102, DOI 10.4049/jimmunol.1502100; Droin NM, 2003, MOL CELL BIOL, V23, P7638, DOI 10.1128/MCB.23.21.7638-7647.2003; Fang F, 2011, AM J PATHOL, V178, P2077, DOI 10.1016/j.ajpath.2011.01.035; Gabet Y, 2010, BLOOD, V116, P3964, DOI 10.1182/blood-2010-01-263830; Ge YX, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005726; Grunewald TGP, 2015, NAT GENET, V47, P1073, DOI 10.1038/ng.3363; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hatano R, 2015, J IMMUNOL, V194, P960, DOI 10.4049/jimmunol.1402143; Huang JL, 2015, ONCOTARGET, V6, P33791, DOI 10.18632/oncotarget.5667; Hunten S, 2015, MOL CELL PROTEOMICS, V14, P2609, DOI 10.1074/mcp.M115.050237; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Ca H, 2012, ANTICANCER RES, V32, P1379; Jia SQ, 2016, ANTICANCER RES, V36, P1111; Jiang YW, 2014, CANCER DISCOV, V4, P995, DOI 10.1158/2159-8290.CD-14-0743; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lewis A, 2016, J CACHEXIA SARCOPENI; Li S., 2016, PROC IEEE2ND ANN SOU, P1, DOI DOI 10.1016/J.STR.2016.01.004; Li XS, 2013, INT J MOL SCI, V14, P16226, DOI 10.3390/ijms140816226; Liang WC, 2015, ONCOTARGET, V6, P22513, DOI 10.18632/oncotarget.4154; Lin Z, 2015, NEOPLASMA, V62, P846, DOI 10.4149/neo_2015_103; Liu YW, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.150; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma CC, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0367-2; Mattick JS, 2010, DEV CELL, V19, P485, DOI 10.1016/j.devcel.2010.10.003; Nafez S, 2015, MOL CELL NEUROSCI, V64, P95, DOI 10.1016/j.mcn.2014.12.008; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Ogbe A, 2015, J BIOL CHEM, V290, P20455, DOI 10.1074/jbc.M114.634816; Paraskevopoulou MD, 2016, METHODS MOL BIOL, V1402, P271, DOI 10.1007/978-1-4939-3378-5_21; Patil VS, 2014, CRIT REV BIOCHEM MOL, V49, P16, DOI 10.3109/10409238.2013.844092; Su YJ, 2015, INT J MOL SCI, V16, P13322, DOI 10.3390/ijms160613322; Sun M, 2015, ENDOCR REV, V36, P25, DOI 10.1210/er.2014-1034; Tan JY, 2016, BIOESSAYS, V38, P295, DOI 10.1002/bies.201500148; To SQ, 2013, BREAST CANCER RES TR, V138, P193, DOI 10.1007/s10549-013-2413-5; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tycowski KT, 2015, GENE DEV, V29, P567, DOI 10.1101/gad.259077.115; Unoki M, 2003, FEBS LETT, V554, P67, DOI 10.1016/S0014-5793(03)01092-5; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Wang J, 2015, ONCOTARGET, V6, P37852, DOI 10.18632/oncotarget.5635; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wu Q, 2010, BIOCHEM BIOPH RES CO, V392, P340, DOI 10.1016/j.bbrc.2009.12.182; Xin WJ, 2015, AM J TRANSL RES, V7, P2433; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Yasumo H, 2000, BBA-GENE STRUCT EXPR, V1490, P189, DOI 10.1016/S0167-4781(99)00244-4; Yin P, 2011, FERTIL STERIL, V96, P439, DOI 10.1016/j.fertnstert.2011.05.062; Yiu AJ, 2016, ANTICANCER RES, V36, P1093; Yokota I, 2010, INT J ONCOL, V37, P1407, DOI 10.3892/ijo_00000792; Yoshimizu T, 2008, P NATL ACAD SCI USA, V105, P12417, DOI 10.1073/pnas.0801540105; Zhang L, 2013, CARCINOGENESIS, V34, P577, DOI 10.1093/carcin/bgs381; Zhang M, 2015, INFLAMMATION, V38, P972, DOI 10.1007/s10753-014-0059-z; Zhong Y, 2014, J BIOL CHEM, V289, P26021, DOI 10.1074/jbc.M114.561134; Zhou XY, 2015, DIGEST DIS SCI, V60, P3271, DOI 10.1007/s10620-015-3782-x; Zhuo WK, 2015, MOL MED REP, V12, P4989, DOI 10.3892/mmr.2015.4098	68	18	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177843	10.1371/journal.pone.0177843	http://dx.doi.org/10.1371/journal.pone.0177843			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542387	Green Submitted, gold, Green Published			2022-12-26	WOS:000401672600025
J	Artamonova, EY; Vasskog, T; Eilertsen, HC				Artamonova, E. Y.; Vasskog, T.; Eilertsen, H. C.			Lipid content and fatty acid composition of Porosira glacialis and Attheya longicornis in response to carbon dioxide (CO2) aeration	PLOS ONE			English	Article							CHLORELLA-PYRENOIDOSA; SCENEDESMUS-OBLIQUUS; MICROALGAE; BIOFIXATION; METABOLISM; DIATOMS	In the current study two novel psychrophilic diatoms Porosira glacialis and Attheya longicornis were tested for suitability to CO2 mitigation coupled with production of the physiologically requisite omega-3 fatty acids. This study is in line with the worldwide conducted research aimed at applying biorefinery concept to heavy polluting industries. Since the production of algal high value compounds, i.e. essential fatty acids, relies on utilization of residual CO2 emissions coming from industry, the costs of such production maybe substantially reduced. Besides, the ecological benefits of the biorefinery concept being implemented are obvious, since CO2 is one of the major greenhouse gases. The current research has shown that one of the tested microalgal species, the diatom P. glacialis showed good tolerance to high (20-25%) levels of CO2 and maintained growth rates comparable to controls. The total lipid content in the CO2 aerated culture increased from 8.91 to 10.57% in cell dry mass. Additionally, the content of docosahexaenoic acid (DHA) increased from 3.90 to 5.75%, while the concentration of eicosapentaenoic acid (EPA) decreased from 26.59 to 23.66%. In contrast, A. longicornis did not demonstrate any significant increase in total lipid content. Besides, its growth was hampered by high levels of CO2 aeration.	[Artamonova, E. Y.; Eilertsen, H. C.] UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Tromso, Norway; [Vasskog, T.] Norut Northern Res Inst, Tromso, Norway	UiT The Arctic University of Tromso	Artamonova, EY (corresponding author), UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Tromso, Norway.	elena.artamonova@uit.no			Forskningsrad [N208463]	Forskningsrad	The study was funded by Forskningsrad (N208463, http://www.forskringsradet.no/no/ Forsider/1173185591033). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carvalho AP, 2005, MAR BIOTECHNOL, V7, P381, DOI 10.1007/s10126-004-4047-4; Cequier-Sanchez E, 2008, J AGR FOOD CHEM, V56, P4297, DOI 10.1021/jf073471e; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Chiu SY, 2009, BIORESOURCE TECHNOL, V100, P833, DOI 10.1016/j.biortech.2008.06.061; d'Ippolito G, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0212-4; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; HOLMHANSEN O, 1978, OIKOS, V30, P438, DOI 10.2307/3543338; Huseby S., THESIS; KATES M, 1966, BIOCHIM BIOPHYS ACTA, V116, P264, DOI 10.1016/0005-2760(66)90009-9; Koller M, 2014, ALGAL RES, V6, P52, DOI 10.1016/j.algal.2014.09.002; Lam MK, 2012, INT J GREENH GAS CON, V10, P456, DOI 10.1016/j.ijggc.2012.07.010; Li SW, 2013, BIORESOURCE TECHNOL, V136, P267, DOI 10.1016/j.biortech.2013.03.025; Morais MG, 2011, Z NATURFORSCH C, V66, P313, DOI 10.5560/ZNC.2011.66c0313; Muhlroth A, 2013, MAR DRUGS, V11, P4662, DOI 10.3390/md11114662; Nakanishi A, 2014, BIORESOURCE TECHNOL, V152, P247, DOI 10.1016/j.biortech.2013.11.009; SAKAI N, 1995, ENERG CONVERS MANAGE, V36, P693, DOI 10.1016/0196-8904(95)00100-R; SILVA HJ, 1984, J GEN MICROBIOL, V130, P2833; STOFFEL W, 1959, ANAL CHEM, V31, P307, DOI 10.1021/ac60146a047; Sydney EB, 2010, BIORESOURCE TECHNOL, V101, P5892, DOI 10.1016/j.biortech.2010.02.088; Tang DH, 2011, BIORESOURCE TECHNOL, V102, P3071, DOI 10.1016/j.biortech.2010.10.047; Thomas DM, 2016, ENVIRON SCI POLLUT R, V23, P16926, DOI 10.1007/s11356-016-7158-3; Wang XW, 2014, BIORESOURCE TECHNOL, V161, P124, DOI 10.1016/j.biortech.2014.03.012; WATANABE Y, 1992, ENERG CONVERS MANAGE, V33, P545, DOI 10.1016/0196-8904(92)90054-Z; Yang Y, 2003, J APPL PHYCOL, V15, P379, DOI 10.1023/A:1026021021774; Yoo C, 2010, BIORESOURCE TECHNOL, V101, pS71, DOI 10.1016/j.biortech.2009.03.030	25	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177703	10.1371/journal.pone.0177703	http://dx.doi.org/10.1371/journal.pone.0177703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542308	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400068
J	Bonicelli, A; Xhemali, B; Kranioti, EF; Zioupos, P				Bonicelli, Andrea; Xhemali, Bledar; Kranioti, Elena F.; Zioupos, Peter			Rib biomechanical properties exhibit diagnostic potential for accurate ageing in forensic investigations	PLOS ONE			English	Article							ACID RACEMIZATION METHOD; AGE ESTIMATION; ASPARTIC-ACID; CORTICAL BONE; MECHANICAL-PROPERTIES; DEATH; MICRODAMAGE; ACCUMULATION; DENSITY; END	Age estimation remains one of the most challenging tasks in forensic practice when establishing a biological profile of unknown skeletonised remains. Morphological methods based on developmental markers of bones can provide accurate age estimates at a young age, but become highly unreliable for ages over 35 when all developmental markers disappear. This study explores the changes in the biomechanical properties of bone tissue and matrix, which continue to change with age even after skeletal maturity, and their potential value for age estimation. As a proof of concept we investigated the relationship of 28 variables at the macroscopic and microscopic level in rib autopsy samples from 24 individuals. Stepwise regression analysis produced a number of equations one of which with seven variables showed an R-2 = 0.949; a mean residual error of 2.13 yrs +/- 0.4 (SD) and a maximum residual error value of 2.88 yrs. For forensic purposes, by using only bench top machines in tests which can be carried out within 36 hrs, a set of just 3 variables produced an equation with an R-2 = 0.902 a mean residual error of 3.38 yrs +/- 2.6 (SD) and a maximum observed residual error 9.26yrs. This method outstrips all existing age-at-death methods based on ribs, thus providing a novel lab based accurate tool in the forensic investigation of human remains. The present application is optimised for fresh (uncompromised by taphonomic conditions) remains, but the potential of the principle and method is vast once the trends of the biomechanical variables are established for other environmental conditions and circumstances.	[Bonicelli, Andrea] Univ Edinburgh, Sch Hist Class & Archaeol, Edinburgh Unit Forens Anthropol, Edinburgh, Midlothian, Scotland; [Bonicelli, Andrea; Zioupos, Peter] Def Acad UK, Cranfield Forens Inst, Musculoskeletal & Medicolegal Res Grp, Shrivenham, England; [Xhemali, Bledar] Forens Inst, Dept Forens Med, Tirana, Albania; [Kranioti, Elena F.] Univ Crete, Dept Forens Sci, Fac Med, Iraklion, Crete, Greece	University of Edinburgh; University of Crete	Zioupos, P (corresponding author), Def Acad UK, Cranfield Forens Inst, Musculoskeletal & Medicolegal Res Grp, Shrivenham, England.	p.zioupos@cranfield.ac.uk	ZIOUPOS, PETER/S-4342-2019; Kranioti, Elena F./I-1923-2019; Bonicelli, Andrea/GNW-6422-2022	ZIOUPOS, PETER/0000-0002-0123-2706; Kranioti, Elena F./0000-0002-1627-5899; Bonicelli, Andrea/0000-0002-9518-584X				Abdel-Wahab AA, 2011, J MECH BEHAV BIOMED, V4, P807, DOI 10.1016/j.jmbbm.2010.10.001; Agnew A, 2014, TENSILE STRESS HUMAN, P397; Agnew AM, 2015, J MECH BEHAV BIOMED, V41, P302, DOI 10.1016/j.jmbbm.2014.09.002; Agnew AM, 2013, ANN BIOMED ENG, V41, P2501, DOI 10.1007/s10439-013-0875-6; Agnew AM, 2012, AM J PHYS ANTHROPOL, V148, P462, DOI 10.1002/ajpa.22048; Baccino E, 2006, FORENSIC ANTHROPOLOGY AND MEDICINE: COMPLEMENTARY SCIENCES FROM RECOVERY TO CAUSE OF DEATH, P259, DOI 10.1007/978-1-59745-099-7_11; Burr D, 2003, OSTEOPOROSIS INT, V14, pS67, DOI 10.1007/s00198-003-1476-2; Burr DB, 1998, J BIOMECH, V31, P337, DOI 10.1016/S0021-9290(98)00016-5; Cho H, 2002, J FORENSIC SCI, V47, P12; Cornu O, 2000, J ORTHOPAED RES, V18, P426, DOI 10.1002/jor.1100180314; Currey JD, 2003, J BONE MINER RES, V18, P591, DOI 10.1359/jbmr.2003.18.4.591; Eleazer CD, 2016, AM J PHYS ANTHROPOL, V160, P317, DOI 10.1002/ajpa.22967; Franklin D, 2010, LEGAL MED-TOKYO, V12, P1, DOI 10.1016/j.legalmed.2009.09.001; Frost HM, 1960, H FORD HOSP B, V8, P25; Garamendi PM, 2011, J FORENSIC SCI, V56, pS3, DOI 10.1111/j.1556-4029.2010.01626.x; Garcia-Donas JG, 2016, J FORENSIC LEG MED, V38, P28, DOI 10.1016/j.jflm.2015.11.012; Garvin HM, 2012, J FORENSIC SCI, V57, P427, DOI 10.1111/j.1556-4029.2011.01979.x; Griffin RC, 2008, FORENSIC SCI INT, V175, P11, DOI 10.1016/j.forsciint.2007.04.226; ISCAN MY, 1984, AM J PHYS ANTHROPOL, V65, P147, DOI 10.1002/ajpa.1330650206; Jankauskas R, 2001, HOMO, V52, P59, DOI 10.1078/0018-442X-00020; Lee TC, 2000, INT J FATIGUE, V22, P847, DOI 10.1016/S0142-1123(00)00054-2; Li Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep16511; Martin RB, 2002, BONE, V30, P8, DOI 10.1016/S8756-3282(01)00620-2; Martin-de las Heras S, 1999, INT J LEGAL MED, V112, pe222; Miculescu F, 2011, UNIV POLITEH BUCHAR, V73, P203; Norman TL, 1998, BONE, V23, P303, DOI 10.1016/S8756-3282(98)00103-3; Obert M, 2013, FORENSIC SCI INT, V228, DOI 10.1016/j.forsciint.2013.02.006; Ohtani S, 2002, J FORENSIC SCI, V47, P32; Ohtani S, 2007, ARCH ORAL BIOL, V52, P233, DOI 10.1016/j.archoralbio.2006.08.011; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; PFEIFFER H, 1995, INT J LEGAL MED, V108, P19, DOI 10.1007/BF01845611; PFEIFFER H, 1995, INT J LEGAL MED, V108, P24, DOI 10.1007/BF01845612; Pfeiffer S, 2016, AM J PHYS ANTHR; Rho JY, 2002, J BIOMECH, V35, P189, DOI 10.1016/S0021-9290(01)00199-3; Ritz S, 1996, FORENSIC SCI INT, V77, P13, DOI 10.1016/0379-0738(95)01834-4; Ritz-Timme S, 2000, INT J LEGAL MED, V113, P129, DOI 10.1007/s004140050283; Sakuma A, 2012, FORENSIC SCI INT, V223, P198, DOI 10.1016/j.forsciint.2012.08.043; Schaffler MB, 1995, BONE, V17, P521, DOI 10.1016/8756-3282(95)00370-3; Schmitt A, 2010, J FORENSIC SCI, V55, P590, DOI 10.1111/j.1556-4029.2010.01341.x; Skedros JG, 2013, AM J PHYS ANTHROPOL, V151, P230, DOI 10.1002/ajpa.22270; STOUT SD, 1994, J FORENSIC SCI, V39, P778; STOUT SD, 1992, AM J PHYS ANTHROPOL, V87, P111, DOI 10.1002/ajpa.1330870110; Thomas CDL, 2000, J ANAT, V196, P463, DOI 10.1046/j.1469-7580.2000.19630463.x; THOMPSON DD, 1983, FORENSIC SCI INT, V22, P203, DOI 10.1016/0379-0738(83)90015-4; Vashishth D, 2000, BONE, V26, P375, DOI 10.1016/S8756-3282(00)00236-2; Verzeletti A, 2010, AM J FOREN MED PATH, V31, P27, DOI 10.1097/PAF.0b013e3181c0e7a5; Villa C, 2015, RES REP FORENSIC MED, V4, P3; Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4; WILSON VL, 1987, J BIOL CHEM, V262, P9948; Xu C, 2015, SCI REP-UK, V5, DOI 10.1038/srep17788; Zioupos P, 2001, J BIOMATER APPL, V15, P187, DOI 10.1106/5JUJ-TFJ3-JVVA-3RJ0; Zioupos P, 1999, J BIOMED MATER RES, V45, P108, DOI 10.1002/(SICI)1097-4636(199905)45:2<108::AID-JBM5>3.3.CO;2-1; Zioupos P, 2014, J MECH BEHAV BIOMED, V33, P109, DOI 10.1016/j.jmbbm.2013.10.015; Zioupos P, 2001, J MICROSC-OXFORD, V201, P270, DOI 10.1046/j.1365-2818.2001.00783.x; Zioupos P, 2008, J BIOMECH, V41, P1961, DOI 10.1016/j.jbiomech.2008.03.025	55	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176785	10.1371/journal.pone.0176785	http://dx.doi.org/10.1371/journal.pone.0176785			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520764	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000401487700030
J	Papanastasiou, SA; Bali, EMD; Ioannou, CS; Papachristos, DP; Zarpas, KD; Papadopoulos, NT				Papanastasiou, Stella A.; Bali, Eleftheria-Maria D.; Ioannou, Charalampos S.; Papachristos, Dimitrios P.; Zarpas, Kostas D.; Papadopoulos, Nikos T.			Toxic and hormetic-like effects of three components of citrus essential oils on adult Mediterranean fruit flies (Ceratitis capitata)	PLOS ONE			English	Article							DIPTERA TEPHRITIDAE; INDUCED HORMESIS; TRADE-OFF; FLY; CHRYSOMELIDAE; HYMENOPTERA	Plant essential oils (EOs) and a wide range of their individual components are involved in a variety of biological interactions with insect pests including stimulatory, deterrent, toxic and even hormetic effects. Both the beneficial and toxic properties of citrus EOs on the Mediterranean fruit fly (medfly) have been experimentally evidenced over the last years. However, no information is available regarding the toxic or beneficial effects of the major components of citrus EOs via contact with the adults of the Mediterranean fruit fly. In the present study, we explored the toxicity of limonene, linalool and alpha-pinene (3 of the main compounds of citrus EOs) against adult medflies and identified the effects of sub-lethal doses of limonene on fitness traits in a relaxed [full diet (yeast and sugar)] and in a stressful (sugar only) feeding environment. Our results demonstrate that all three compounds inferred high toxicity to adult medflies regardless of the diet, with males being more sensitive than females. Sublethal doses of limonene (LD20) enhanced the lifespan of adult medflies when they were deprived of protein. Fecundity was positively affected when females were exposed to limonene sub-lethal doses. Therefore, limonene, a major constituent of citrus EOs, induces high mortality at increased doses and positive effects on life history traits of medfly adults through contact at low sub-lethal doses. A hormetic-like effect of limonene to adult medflies and its possible underlying mechanisms are discussed.	[Papanastasiou, Stella A.; Bali, Eleftheria-Maria D.; Ioannou, Charalampos S.; Zarpas, Kostas D.; Papadopoulos, Nikos T.] Univ Thessaly, Dept Agr Crop Prod & Rural Environm, Nea Ionia, Magnisia, Greece; [Papachristos, Dimitrios P.] Benaki Phytopathol Inst, Dept Entomol & Agr Zool, Athens, Greece	University of Thessaly	Papadopoulos, NT (corresponding author), Univ Thessaly, Dept Agr Crop Prod & Rural Environm, Nea Ionia, Magnisia, Greece.	nikopap@uth.gr	Papanastasiou, Stella/GRO-7360-2022; Papadopoulos, Nikos/AAJ-1721-2020; Papachristos, Dimitrios/AHC-0813-2022	Papadopoulos, Nikos/0000-0003-2480-8189; Papanastasiou, Stella/0000-0003-3975-7089; Zarpas, Kostas/0000-0003-1957-8681; Papachristos, Dimitrios/0000-0002-0524-0180				[Anonymous], 1992, FRUIT FLIES EC SIGNI; Arancibia M., 2013, J AGR FOOD TECHNOL, V3, P1; Back EA, 1915, J AGR RES, P311; Benelli G, 2013, IND CROP PROD, V50, P596, DOI 10.1016/j.indcrop.2013.08.006; Benelli G, 2012, CROP PROT, V42, P223, DOI 10.1016/j.cropro.2012.05.024; Chang CL, 2009, J ECON ENTOMOL, V102, P203, DOI 10.1603/029.102.0129; Diamantidis AD, 2008, ENTOMOL EXP APPL, V128, P389, DOI 10.1111/j.1570-7458.2008.00730.x; Escher Beate I., 2011, Integrated Environmental Assessment and Management, V7, P28, DOI 10.1002/ieam.100; Flatt T, 2007, EVOLUTION, V61, P1980, DOI 10.1111/j.1558-5646.2007.00151.x; Gerofotis CD, 2016, SCI REP-UK, V6, DOI 10.1038/srep28540; Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669; Haddi K, 2015, J ECON ENTOMOL, V108, P2815, DOI 10.1093/jee/tov255; Jager T, 2013, ECOTOXICOLOGY, V22, P263, DOI 10.1007/s10646-012-1022-0; Khorram M. Safaei, 2011, Journal of Entomology, V8, P404, DOI 10.3923/je.2011.404.416; Kurdelas RR, 2012, IND CROP PROD, V40, P261, DOI 10.1016/j.indcrop.2012.03.024; Leonov A, 2015, MOLECULES, V20, P6544, DOI 10.3390/molecules20046544; LIQUIDO NJ, 1990, J ECON ENTOMOL, V83, P1863, DOI 10.1093/jee/83.5.1863; Liquido NJ, 1991, ENTOMOL SOC AM, P1863; Lopez SB, 2011, J AGR FOOD CHEM, V59, P5286, DOI 10.1021/jf104966b; Mallqui KSV, 2014, J ECON ENTOMOL, V107, P860, DOI 10.1603/EC13526; Miguel MG, 2010, J ESSENT OIL BEAR PL, V13, P191, DOI 10.1080/0972060X.2010.10643811; Moretti M. D. L., 1998, Journal of Essential Oil Research, V10, P405; Papachristos DP, 2009, ANN APPL BIOL, V155, P381, DOI 10.1111/j.1744-7348.2009.00350.x; Papachristos DP, 2004, PEST MANAG SCI, V60, P514, DOI 10.1002/ps.798; Papadopoulos NT, 2006, 7 INT S FRUIT FLIES; PROKOPY RJ, 1984, AM SCI, V72, P41; RATHMAN RJ, 1992, J ECON ENTOMOL, V85, P15, DOI 10.1093/jee/85.1.15; Renkema JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep21432; RIVNAY E, 1950, B ENTOMOL RES, V41, P321, DOI 10.1017/S0007485300027656; ROESSLER Y, 1986, PHYTOPARASITICA, V14, P168; Salvatore A, 2004, J CHEM ECOL, V30, P323, DOI 10.1023/B:JOEC.0000017980.66124.d1; Sarakatsanou A, 2011, J APPL ENTOMOL, V135, P554, DOI 10.1111/j.1439-0418.2011.01610.x; Schoonhoven L. M., 2005, Insect-plant biology; Zou SG, 2010, J GERONTOL A-BIOL, V65, P41, DOI 10.1093/gerona/glp176; Zou SG, 2009, EXP GERONTOL, V44, P472, DOI 10.1016/j.exger.2009.02.011	36	28	30	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177837	10.1371/journal.pone.0177837	http://dx.doi.org/10.1371/journal.pone.0177837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520791	Green Published, Green Submitted, gold			2022-12-26	WOS:000401485500077
J	Sato, Y; Fujimoto, S; Konta, T; Iseki, K; Moriyama, T; Yamagata, K; Tsuruya, K; Narita, I; Kondo, M; Kasahara, M; Shibagaki, Y; Asahi, K; Watanabe, T				Sato, Yuji; Fujimoto, Shouichi; Konta, Tsuneo; Iseki, Kunitoshi; Moriyama, Toshiki; Yamagata, Kunihiro; Tsuruya, Kazuhiko; Narita, Ichiei; Kondo, Masahide; Kasahara, Masato; Shibagaki, Yugo; Asahi, Koichi; Watanabe, Tsuyoshi			Body shape index: Sex-specific differences in predictive power for all-cause mortality in the Japanese population	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; MASS INDEX; ANTHROPOMETRIC MEASURES; CARDIOVASCULAR MORTALITY; METABOLIC SYNDROME; FOLLOW-UP; ASSOCIATION; RISK; OBESITY	Background While body mass index (BMI) is the most widely used anthropometric measure, its association with all-cause mortality is generally J-shaped or U-shaped. A body shape index (ABSI) is a recently formulated anthropometric measure that shows linear relationship to all-cause mortality, especially in Caucasian cohorts. We aimed to address the relationship between ABSI and all-cause mortality in Asians and to assess the influence of sex difference and of chronic kidney disease (CKD) on this relationship. Methods This was a longitudinal cohort study assessing the association of ABSI, BMI, waist circumference (WC), and waist-to-height ratio (WHtR) with all-cause mortality in a Japanese nationwide Specific Health Checkup database. The study enrolled 160,625 participants followed-up between 2008 and 2012. We calculated the all-cause mortality risk associated with a 1-standard deviation increase (+1SD) in ABSI, BMI, WC, or WHtR in cohorts stratified by sex and the presence of CKD. Results During the 4-year follow up, 1.3% of participants died. In men, ABSI (+1SD) significantly increased the risk for all-cause mortality after adjusting for other known risk factors including CKD; hazard ratio (HR) and 95% confidence intervals (CI) of non-CKD cohort, 1.30 (1.18 to 1.43), p<0.01; HR and 95% CI of CKD cohort, 1.16 (1.01 to 1.34), p = 0.04. In women, ABSI (+1SD) did not show significant association with all-cause mortality, especially in the CKD cohort; HR and 95% CI of non-CKD cohort, 1.07 (0.99 to 1.17), p = 0.09; HR and 95% CI of CKD cohort, 0.98 (0.84 to 1.14), p = 0.78. Conversely, BMI (+1SD) was associated with significantly lower risk in men, although minimal association was found in women. WC and WHtR showed little association with all-cause mortality. On stratification per ABSI quartiles, mortality risk increased linearly and significantly with ABSI in men, but not in women with CKD. Both BMI and WC showed significant but U-shaped association with mortality in the non-CKD cohort and in men with CKD. WHtR also showed significant U-shaped association with mortality in men. Conclusions In the Japanese population, ABSI showed significant and linear correlation with mortality risk in men but not in women, especially in the presence of CKD.	[Sato, Yuji] Univ Miyazaki Hosp, Dialysis Div, Miyazaki, Japan; [Fujimoto, Shouichi] Miyazaki Univ, Dept Hemovasc Med & Artificial Organs, Fac Med, Miyazaki, Japan; [Konta, Tsuneo; Iseki, Kunitoshi; Moriyama, Toshiki; Yamagata, Kunihiro; Tsuruya, Kazuhiko; Narita, Ichiei; Kondo, Masahide; Kasahara, Masato; Shibagaki, Yugo; Asahi, Koichi; Watanabe, Tsuyoshi] Steering Comm Res Design Comprehens Hlth Care Sys, Fukushima, Japan	University of Miyazaki; University of Miyazaki	Sato, Y (corresponding author), Univ Miyazaki Hosp, Dialysis Div, Miyazaki, Japan.	ysato@med.miyazaki-u.ac.jp	Narita, Ichiei/G-5204-2017; Konta, Tsuneo/AAO-9286-2021	Narita, Ichiei/0000-0001-7692-3096; 	Ministry of Health, Labor and Welfare of Japan; Japan Agency for Medical Research and Development, AMED; Grants-in-Aid for Scientific Research [16K08860] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Health and Labor Sciences Research Grants for "Design of the Comprehensive Health Care System for Chronic Kidney Disease Based on the Individual Risk Assessment by Specific Health Check" from the Ministry of Health, Labor and Welfare of Japan and a Grant-in-Aid for "Research on Advanced Chronic Kidney Disease (REACH-J), Practical Research Project for Renal Disease" from Japan Agency for Medical Research and Development, AMED.	Abete I, 2015, EUR J NUTR, V54, P365, DOI 10.1007/s00394-014-0716-x; Afsar B, 2013, NUTRITION, V29, P1214, DOI 10.1016/j.nut.2013.03.012; Allison DB, 2002, INT J OBESITY, V26, P410, DOI 10.1038/sj.ijo.0801925; Bozorgmanesh M, 2016, EUR J NUTR, V55, P147, DOI 10.1007/s00394-015-0833-1; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chang Y, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2150-2; Cheung YB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085421; Cox BD, 1996, BRIT MED J, V313, P1487, DOI 10.1136/bmj.313.7070.1487; Dhana K, 2016, MATURITAS, V88, P96, DOI 10.1016/j.maturitas.2016.03.018; Dhana K, 2016, J EPIDEMIOL COMMUN H, V70, P90, DOI 10.1136/jech-2014-205257; Dhana K, 2015, HEART, V101, P377, DOI 10.1136/heartjnl-2014-306704; Evans M, 2005, AM J KIDNEY DIS, V46, P863, DOI 10.1053/j.ajkd.2005.07.040; Fujita M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128972; Haghighatdoost F, 2014, NUTRITION, V30, P636, DOI 10.1016/j.nut.2013.10.021; He S, 2013, PLOS ONE, V8; Huang JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126668; Iseki K, 2017, CLIN EXP NEPHROL; Kovesdy CP, 2007, AM J KIDNEY DIS, V49, P581, DOI 10.1053/j.ajkd.2007.02.277; Krakauer NY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088793; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Kwan BCH, 2007, CLIN J AM SOC NEPHRO, V2, P992, DOI 10.2215/CJN.04221206; Madero M, 2007, AM J KIDNEY DIS, V50, P404, DOI 10.1053/j.ajkd.2007.06.004; Maessen MFH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107212; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Newson RB, 2010, STATA J, V10, P339, DOI 10.1177/1536867X1001000303; Ninomiya T, 2005, KIDNEY INT, V68, P228, DOI 10.1111/j.1523-1755.2005.00397.x; Patel AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109153; Sardarinia M, 2017, NUTRITION, V33, P105, DOI 10.1016/j.nut.2016.05.004; Sasazuki S, 2011, J EPIDEMIOL, V21, P417, DOI 10.2188/jea.JE20100180; Sato Y, 2015, CLIN EXP NEPHROL, V19, P790, DOI 10.1007/s10157-014-1062-2; Sato Y, 2014, CLIN EXP NEPHROL, V18, P75, DOI 10.1007/s10157-013-0809-5; Sato Y, 2012, NEPHROL DIAL TRANSPL, V27, P3862, DOI 10.1093/ndt/gfs324; SHIMOKATA H, 1989, J GERONTOL, V44, pM66, DOI 10.1093/geronj/44.2.M66; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Song X, 2015, NUTR METAB CARDIOVAS, V25, P295, DOI 10.1016/j.numecd.2014.09.004; Song X, 2013, EUR J CLIN NUTR, V67, P1298, DOI 10.1038/ejcn.2013.203; Thomson CA, 2016, OBESITY, V24, P1061, DOI 10.1002/oby.21461; Tsugane S, 2002, INT J OBESITY, V26, P529, DOI 10.1038/sj.ijo.0801961; Weiner DE, 2008, AM J KIDNEY DIS, V51, P212, DOI 10.1053/j.ajkd.2007.10.035	40	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177779	10.1371/journal.pone.0177779	http://dx.doi.org/10.1371/journal.pone.0177779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520811	Green Submitted, gold, Green Published			2022-12-26	WOS:000401485500070
J	Li, W; Hu, M; Wang, C; Lu, H; Chen, F; Xu, J; Shang, Y; Wang, F; Qin, J; Yan, Q; Krueger, BJ; Renne, R; Gao, SJ; Lu, C				Li, W.; Hu, M.; Wang, C.; Lu, H.; Chen, F.; Xu, J.; Shang, Y.; Wang, F.; Qin, J.; Yan, Q.; Krueger, B. J.; Renne, R.; Gao, S-J; Lu, C.			A viral microRNA downregulates metastasis suppressor CD82 and induces cell invasion and angiogenesis by activating the c-Met signaling	ONCOGENE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; HEPATOCYTE GROWTH-FACTOR; PRIMARY EFFUSION LYMPHOMA; LYTIC CYCLE REPLICATION; KAPOSIS-SARCOMA; ENDOTHELIAL-CELLS; ENCODED MICRORNAS; HIV-1 NEF; PROTEIN EXPRESSION; TETRASPANIN CD82	Kaposi's sarcoma (KS) as the most common AIDS-associated malignancy is etiologically caused by KS-associated herpesvirus (KSHV). KS is a highly disseminated and vascularized tumor. KSHV encodes 12 pre-microRNAs that yield 25 mature microRNAs (miRNAs), but their roles in KSHV-induced tumor metastasis and angiogenesis remain largely unclear. KSHV-encoded miR-K12-6 (miR-K6) can generate two mature miRNAs, miR-K6-5p and miR-K6-3p. Recently, we have shown that miR-K6-3p induced cell migration and angiogenesis via directly targeting SH3 domain binding glutamate-rich protein (SH3BGR). Here, by using mass spectrometry, bioinformatics analysis and luciferase reporter assay, we showed that miR-K6-5p directly targeted the coding sequence of CD82 molecule (CD82), a metastasis suppressor. Ectopic expression of miR-K6-5p specifically inhibited the expression of endogenous CD82 and strongly promoted endothelial cells invasion and angiogenesis. Overexpression of CD82 significantly inhibited cell invasion and angiogenesis induced by miR-K6-5p. Mechanistically, CD82 directly interacted with c-Met to inhibit its activation. MiR-K6-5p directly repressed CD82, relieving its inhibition on c-Met activation and inducing cell invasion and angiogenesis. Lack of miR-K6 abrogated KSHV suppression of CD82 resulting in compromised KSHV activation of c-Met pathway, and KSHV induction of cell invasion and angiogenesis. In conclusion, our data show that by reducing CD82, KSHV miR-K6-5p expedites cell invasion and angiogenesis by activating the c-Met pathway. Our findings illustrate that KSHV miRNAs may be critical for the dissemination and angiogenesis of KSHV-induced malignant tumors.	[Li, W.; Lu, C.] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Li, W.; Lu, C.] Nanjing Med Univ, Key Lab Pathogen Biol Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Li, W.; Chen, F.; Xu, J.; Shang, Y.; Wang, F.; Qin, J.; Yan, Q.; Lu, C.] Nanjing Med Univ, Dept Microbiol, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China; [Hu, M.] Xuzhou Med Univ, Dept Pathogen Biol & Immunol, Xuzhou, Peoples R China; [Wang, C.] Nanjing Med Univ, Affiliated Hosp 1, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Lu, H.] Nanjing Med Univ, Affiliated Hosp 1, Dept Obstet, Nanjing, Jiangsu, Peoples R China; [Krueger, B. J.; Renne, R.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Gao, S-J] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA USA	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Xuzhou Medical University; Nanjing Medical University; Nanjing Medical University; State University System of Florida; University of Florida; University of Southern California	Lu, C (corresponding author), Nanjing Med Univ, Dept Microbiol, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China.	clu@njmu.edu.cn	Gao, Shou-Jiang/B-8641-2012	Gao, Shou-Jiang/0000-0001-6194-1742	National Natural Science Foundation of China [81761128003, 81371824, 81401662]; NIH [R01CA213275, R01CA177377, R01CA132637]; Natural Science Youth Foundation of Jiangsu Province [BK20140908]; NATIONAL CANCER INSTITUTE [R01CA096512, R01CA132637, R01CA124332, R01CA197153, R01CA177377, R01CA213275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017333] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Youth Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from National Natural Science Foundation of China (81761128003, 81371824 and 81401662), grants from NIH (R01CA213275, R01CA177377 and R01CA132637), and the Natural Science Youth Foundation of Jiangsu Province (BK20140908).	Abend JR, 2012, J VIROL, V86, P11663, DOI 10.1128/JVI.01147-12; Atabey N, 2001, J BIOL CHEM, V276, P14308, DOI 10.1074/jbc.M010202200; Bandyopadhyay S, 2006, NAT MED, V12, P933, DOI 10.1038/nm1444; Bari R, 2009, AM J PATHOL, V174, P647, DOI 10.2353/ajpath.2009.080685; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellare P, 2009, CELL HOST MICROBE, V6, P570, DOI 10.1016/j.chom.2009.11.008; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Blankaert D, 1998, J ACQ IMMUN DEF SYND, V18, P203, DOI 10.1097/00042560-199807010-00002; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Brulois KF, 2012, J VIROL, V86, P9708, DOI 10.1128/JVI.01019-12; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Catrina AM, 2014, PATHOL ONCOL RES, V20, P153, DOI 10.1007/s12253-013-9678-1; Cheung TW, 2004, CANCER INVEST, V22, P774, DOI 10.1081/CNV-200032788; Cullen BR, 2011, GENE DEV, V25, P1881, DOI 10.1101/gad.17352611; Dai L, 2015, BLOOD, V126, P2821, DOI 10.1182/blood-2015-07-658823; Dourmishev LA, 2003, MICROBIOL MOL BIOL R, V67, P175, DOI 10.1128/MMBR.67.2.175-212.2003; ENSOLI B, 1992, IMMUNOL REV, V127, P147, DOI 10.1111/j.1600-065X.1992.tb01412.x; Feng J, 2015, CANCER METAST REV, V34, P619, DOI 10.1007/s10555-015-9585-x; Fuse N, 2016, GASTRIC CANCER, V19, P183, DOI 10.1007/s10120-015-0471-6; Gottwein E, 2011, CELL HOST MICROBE, V10, P515, DOI 10.1016/j.chom.2011.09.012; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Guo XZ, 2005, ONCOL REP, V14, P59; Han YL, 2014, ONCOL LETT, V8, P1618, DOI 10.3892/ol.2014.2390; Hanna JA, 2009, ADV CANCER RES, V103, P1, DOI 10.1016/S0065-230X(09)03001-2; Hansen A, 2010, GENE DEV, V24, P195, DOI 10.1101/gad.553410; Hu MM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005171; Jain V, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020054; Koo BS, 2014, ANN SURG ONCOL, V21, P2310, DOI 10.1245/s10434-014-3553-5; Lei XF, 2012, J VIROL, V86, P11698, DOI 10.1128/JVI.06855-11; Leo C, 2007, GYNECOL ONCOL, V104, P181, DOI 10.1016/j.ygyno.2006.07.040; Li W, 2016, ONCOTARGET, V7, P32286, DOI 10.18632/oncotarget.8591; Li W, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005605; Li Y, 2013, INT J BIOCHEM CELL B, V45, P2349, DOI 10.1016/j.biocel.2013.08.002; Lin HR, 2011, P NATL ACAD SCI USA, V108, P5148, DOI 10.1073/pnas.1102033108; Lin XZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016224; Liu WM, 2006, CANCER LETT, V240, P183, DOI 10.1016/j.canlet.2005.08.018; Lu CC, 2010, EMBO REP, V11, P784, DOI 10.1038/embor.2010.132; Lu F, 2010, J VIROL, V84, P2697, DOI 10.1128/JVI.01997-09; Marshall V, 2007, J INFECT DIS, V195, P645, DOI 10.1086/511434; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x; Neuzillet C, 2015, HISTOPATHOLOGY, V67, P664, DOI 10.1111/his.12691; Nishioka C, 2013, INT J CANCER, V132, P2006, DOI 10.1002/ijc.27904; O'Hara AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000389; Pantanowitz L, 2006, J CUTAN PATHOL, V33, P793, DOI 10.1111/j.1600-0560.2006.00567.x; Poon M, 1997, CIRCULATION, V96, P2514, DOI 10.1161/01.CIR.96.8.2514; Qin D, 2008, CELL MICROBIOL, V10, P713, DOI 10.1111/j.1462-5822.2007.01079.x; Qin J, 2017, TRENDS MICROBIOL, V25, P648, DOI 10.1016/j.tim.2017.02.002; Qin Zhiqiang, 2012, Int J Cell Biol, V2012, P603961, DOI 10.1155/2012/603961; Qin ZQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000742; Ramalingam D, 2015, J VIROL, V89, P4249, DOI 10.1128/JVI.03687-14; Rosano L, 2003, AM J PATHOL, V163, P753, DOI 10.1016/S0002-9440(10)63702-9; Royal I, 2000, MOL BIOL CELL, V11, P1709, DOI 10.1091/mbc.11.5.1709; Ruseva Z, 2009, EXP CELL RES, V315, P1759, DOI 10.1016/j.yexcr.2009.01.007; Sadagopan S, 2009, J VIROL, V83, P3342, DOI 10.1128/JVI.02052-08; Samols MA, 2005, J VIROL, V79, P9301, DOI 10.1128/JVI.79.14.9301-9305.2005; Samols MA, 2007, PLOS PATHOG, V3, P611, DOI 10.1371/journal.ppat.0030065; Sridhar SC, 2006, ONCOGENE, V25, P2367, DOI 10.1038/sj.onc.1209269; Takahashi M, 2007, INT J CANCER, V121, P1919, DOI 10.1002/ijc.22887; Todeschini AR, 2007, J BIOL CHEM, V282, P8123, DOI 10.1074/jbc.M611407200; Tohami T, 2007, FASEB J, V21, P691, DOI 10.1096/fj.06-6610com; Tonoli H, 2005, TRENDS MOL MED, V11, P563, DOI 10.1016/j.molmed.2005.10.002; Wei Q, 2014, CIRCULATION, V130, P1493, DOI 10.1161/CIRCULATIONAHA.114.011096; Xue M, 2014, NUCLEIC ACIDS RES, V42, P9862, DOI 10.1093/nar/gku583; Yan Q, 2014, J VIROL, V88, P4987, DOI 10.1128/JVI.00025-14; Yan SC, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0296-y; Yang XH, 2001, CANCER RES, V61, P5284; Yao SH, 2015, NUCLEIC ACIDS RES, V43, P9362, DOI 10.1093/nar/gkv988; Yoshida S, 2002, J CLIN ENDOCR METAB, V87, P2376, DOI 10.1210/jc.87.5.2376; Zeng Y, 2007, J VIROL, V81, P2401, DOI 10.1128/JVI.02024-06; Zhou F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053145; Zhu X, 2014, ONCOGENE, V33, P1986, DOI 10.1038/onc.2013.136; Zismanov V, 2009, BRIT J CANCER, V101, P1402, DOI 10.1038/sj.bjc.6605291; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	74	24	24	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 21	2017	36	38					5407	5420		10.1038/onc.2017.139	http://dx.doi.org/10.1038/onc.2017.139			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FH7PJ	28534512	Green Accepted			2022-12-26	WOS:000411382100007
J	Kakuta, S; Yamaguchi, J; Suzuki, C; Sasaki, M; Kazuno, S; Uchiyama, Y				Kakuta, Soichiro; Yamaguchi, Junji; Suzuki, Chigure; Sasaki, Mitsuho; Kazuno, Saiko; Uchiyama, Yasuo			Small GTPase Rab1B is associated with ATG9A vesicles and regulates autophagosome formation	FASEB JOURNAL			English	Article						autophagy; electron microscopy; mass spectrometry	ENDOPLASMIC-RETICULUM; FORMATION SITE; RECYCLING ENDOSOMES; ISOLATION MEMBRANE; EARLY STEPS; PROTEIN; BIOGENESIS; COMPLEX; CELLS; MACROAUTOPHAGY	ATG9 is a membrane protein that is essential for autophagy and is considered to be directly involved in the early steps of autophagosome formation. Yeast Atg9 is mainly localized to small vesicles (Atg9 vesicles), whereas mammalian ATG9A is reportedly localized to the trans-Golgi network, the endosomal compartment, and other unidentified membrane structures. To dissect the ATG9A-containing membranes, we examined the subcellular localization of ATG9A and performed immunoisolation of those membranes. ATG9A-green fluorescent protein in human culture cells was observed as numerous puncta that move rapidly throughout the cytoplasm. We isolated these cytoplasmic membranes and found that they were small vesicles that resemble the yeast Atg9 vesicle. One of the proteins obtained via proteomic analyses of the mammalian ATG9A vesicle was Rab1, a small GTPase that is essential in endoplasmic reticulum-to-Golgi vesicle trafficking. Knockdown studies of Rab1B showed a suppression of autophagy. In these Rab1B-depleted cells, ATG9A accumulated in intermediate membrane structures at autophagosome formation sites. These results indicate that Rab1B is involved in regulating the proper development of autophagosomes.	[Kakuta, Soichiro; Yamaguchi, Junji; Suzuki, Chigure; Uchiyama, Yasuo] Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Neuropathol, Tokyo 1138421, Japan; [Kakuta, Soichiro] Juntendo Univ, Grad Sch Med, Lab Morphol & Image Anal, Res Support Ctr, Tokyo, Japan; [Suzuki, Chigure] Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Pharmacol, Tokyo, Japan; [Kazuno, Saiko] Juntendo Univ, Grad Sch Med, Lab Prote & Biomol Sci, Res Support Ctr, Tokyo, Japan; [Sasaki, Mitsuho] Natl Inst Biomed Innovat Hlth & Nutr, Lab Anim Models Human Dis, Osaka, Japan	Juntendo University; Juntendo University; Juntendo University; Juntendo University	Uchiyama, Y (corresponding author), Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Neuropathol, Tokyo 1138421, Japan.	y-uchi@juntendo.ac.jp			Ministry of Education, Science, Sports and Culture, Japan (MEXT); MEXT-supported Program for the Strategic Research Foundation at Private Universities;  [25860149];  [16GS0315];  [23111004];  [23110517];  [10049091]	Ministry of Education, Science, Sports and Culture, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT-supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; ; 	The authors thank Tomohisa Nanao (Tokyo University of Science) for providing a plasmid and technical assistance and members of the Laboratory of Proteomics and Biomedical Science, Research Support Center, Juntendo University Graduate School of Medicine for their help in mass spectrometric analyses. This work was supported by a Grant-in-Aid for Young Scientists (B) 25860149 (to S.K.), Grant-in-Aid for Creative Scientific Research 16GS0315 (to Y.U.), Scientific Researches on Innovative Area, Grants-in-Aids for Scientific Research (B) 23111004 and 23110517 (to Y.U.), Grant-in-Aid for challenging Exploratory Research 10049091 (to Y.U.), the Ministry of Education, Science, Sports and Culture, Japan (MEXT), and the MEXT-supported Program for the Strategic Research Foundation at Private Universities (to Y.U.). The authors declare no conflicts of interest.	Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Ao X, 2014, CELL DEATH DIFFER, V21, P348, DOI 10.1038/cdd.2013.187; Carlsson SR, 2015, J CELL SCI, V128, P193, DOI 10.1242/jcs.141036; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Ge L, 2014, CURR OPIN CELL BIOL, V29, P18, DOI 10.1016/j.ceb.2014.02.005; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Huang J, 2011, AUTOPHAGY, V7, P17, DOI 10.4161/auto.7.1.13840; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Imai K, 2016, J CELL SCI, V129, P3781, DOI 10.1242/jcs.196196; Itakura E, 2012, J CELL SCI, V125, P1488, DOI 10.1242/jcs.094110; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Kageyama S, 2011, MOL BIOL CELL, V22, P2290, DOI 10.1091/mbc.E10-11-0893; Kakuta S, 2012, J BIOL CHEM, V287, P44261, DOI 10.1074/jbc.M112.411454; Kishi-Itakura C, 2014, J CELL SCI, V127, P4089, DOI 10.1242/jcs.156034; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Lang T, 2000, J BACTERIOL, V182, P2125, DOI 10.1128/JB.182.8.2125-2133.2000; Lipatova Z, 2013, MOL BIOL CELL, V24, P3133, DOI 10.1091/mbc.E13-05-0269; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Mannack LVJC, 2015, RES REP BIOCHEM, V5, P39, DOI 10.2147/RRBC.S57405; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Zoppino FCM, 2010, TRAFFIC, V11, P1246, DOI 10.1111/j.1600-0854.2010.01086.x; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mochizuki Y, 2013, J BIOL CHEM, V288, P1009, DOI 10.1074/jbc.M112.395087; Moyer BD, 2001, TRAFFIC, V2, P268, DOI 10.1034/j.1600-0854.2001.1o007.x; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Orsi A, 2012, MOL BIOL CELL, V23, P1860, DOI 10.1091/mbc.E11-09-0746; Pozuelo-Rubio Mercedes, 2012, Cells, V1, P754, DOI 10.3390/cells1040754; Puri C, 2014, AUTOPHAGY, V10, P182, DOI 10.4161/auto.27174; Sekito T, 2009, GENES CELLS, V14, P525, DOI 10.1111/j.1365-2443.2009.01299.x; Shibutani ST, 2014, CELL RES, V24, P58, DOI 10.1038/cr.2013.159; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Suzuki K, 2010, FEBS LETT, V584, P1280, DOI 10.1016/j.febslet.2010.02.001; Takahashi Y, 2016, ONCOTARGET, V7, P20855, DOI 10.18632/oncotarget.8028; Takahashi Y, 2011, AUTOPHAGY, V7, P61, DOI 10.4161/auto.7.1.14015; Uemura T, 2014, MOL CELL BIOL, V34, P1695, DOI 10.1128/MCB.01327-13; Wang J, 2015, J CELL BIOL, V210, P273, DOI 10.1083/jcb.201408075; Wang J, 2013, P NATL ACAD SCI USA, V110, P9800, DOI 10.1073/pnas.1302337110; Weerasekara VK, 2014, MOL CELL BIOL, V34, P4379, DOI 10.1128/MCB.00740-14; Wesselborg S, 2015, CELL MOL LIFE SCI, V72, P4721, DOI 10.1007/s00018-015-2034-8; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Yamada T, 2005, J BIOL CHEM, V280, P18283, DOI 10.1074/jbc.M413957200; Yamamoto H, 2012, J CELL BIOL, V198, P219, DOI 10.1083/jcb.201202061; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172	50	32	33	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3757	3773		10.1096/fj.201601052R	http://dx.doi.org/10.1096/fj.201601052R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28522593	Bronze			2022-12-26	WOS:000408713300006
J	Chisuga, T; Miyanaga, A; Kudo, F; Eguchi, T				Chisuga, Taichi; Miyanaga, Akimasa; Kudo, Fumitaka; Eguchi, Tadashi			Structural analysis of the dual-function thioesterase SAV606 unravels the mechanism of Michael addition of glycine to an alpha,beta-unsaturated thioester	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARRIER PROTEIN DEHYDRATASE; POLYKETIDE SYNTHASE; STREPTOMYCES-AVERMITILIS; PSEUDOMONAS-AERUGINOSA; STARTER UNIT; ACTIVE-SITE; BIOSYNTHESIS; REVEALS; ENZYMES; GENOME	Thioesterases catalyze hydrolysis of acyl thioesters to release carboxylic acid or macrocyclization to produce the corresponding macrocycle in the biosynthesis of fatty acids, polyketides, or nonribosomal peptides. Recently, we reported that the thioesterase CmiS1 from Streptomyces sp. MJ635-86F5 catalyzes the Michael addition of glycine to an alpha,beta-unsaturated fatty acyl thioester followed by thioester hydrolysis in the biosynthesis of the macrolactam antibiotic cremimycin. However, the molecular mechanisms of CmiS1-catalyzed reactions are unclear. Here, we report on the functional and structural characterization of the CmiS1 homolog SAV606 from Streptomyces avermitilis MA-4680. In vitro analysis indicated that SAV606 catalyzes the Michael addition of glycine to crotonic acid thioester and subsequent hydrolysis yielding (R)-N-carboxymethyl-3-aminobutyric acid. We also determined the crystal structures of SAV606 both in ligandfree form at 2.4 angstrom resolution and in complex with (R)-N-carboxymethyl-3-aminobutyric acid at 2.0 angstrom resolution. We found that SAV606 adopts an alpha/beta hotdog fold and has an active site at the dimeric interface. Examining the complexed structure, we noted that the substrate-binding loop comprising Tyr-53-Asn-61 recognizes the glycine moiety of (R)-N-carboxymethyl-3-aminobutyric acid. Moreover, we found that SAV606 does not contain an acidic residue at the active site, which is distinct from canonical hotdog thioesterases. Site-directed mutagenesis experiments revealed that His-59 plays a crucial role in both the Michael addition and hydrolysis via a water molecule. These results allow us to propose the reaction mechanism of the SAV606-catalyzed Michael addition and thioester hydrolysis and provide new insight into the multiple functions of a thioesterase family enzyme.	[Chisuga, Taichi; Eguchi, Tadashi] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan; [Miyanaga, Akimasa; Kudo, Fumitaka; Eguchi, Tadashi] Tokyo Inst Technol, Dept Chem, Meguro Ku, Tokyo 1528551, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Eguchi, T (corresponding author), Tokyo Inst Technol, Dept Chem, Meguro Ku, Tokyo 1528551, Japan.	eguchi@chem.titech.ac.jp	Miyanaga, Akimasa/C-1472-2015; Eguchi, Tadashi/B-9339-2015	Miyanaga, Akimasa/0000-0003-2219-6051; Eguchi, Tadashi/0000-0002-7830-7104; Chisuga, Taichi/0000-0001-8584-5368	Ministry of Education, Culture, Sports, Science and Technology [16H06451]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was performed with the approval of the Photon Factory Program Advisory Committee (Proposals 2014G530 and 2016G624) and was supported in part by Ministry of Education, Culture, Sports, Science and Technology Grants-in-Aid for Scientific Research in Innovative Areas 16H06451 (to T. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Amagai K, 2013, CHEMBIOCHEM, V14, P1998, DOI 10.1002/cbic.201300370; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Cantu DC, 2011, NUCLEIC ACIDS RES, V39, pD342, DOI 10.1093/nar/gkq1072; Cantu DC, 2010, PROTEIN SCI, V19, P1281, DOI 10.1002/pro.417; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Nguyen C, 2014, NATURE, V505, P427, DOI 10.1038/nature12810; Du LC, 2010, NAT PROD REP, V27, P255, DOI 10.1039/b912037h; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finzel K, 2015, CHEMBIOCHEM, V16, P528, DOI 10.1002/cbic.201402578; Gehret JJ, 2011, J BIOL CHEM, V286, P14445, DOI 10.1074/jbc.M110.214635; He HY, 2014, J AM CHEM SOC, V136, P4488, DOI 10.1021/ja500942y; Horsman ME, 2016, NAT PROD REP, V33, P183, DOI 10.1039/c4np00148f; Hunt MC, 2012, BBA-MOL BASIS DIS, V1822, P1397, DOI 10.1016/j.bbadis.2012.03.009; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Ikeda H, 2014, J IND MICROBIOL BIOT, V41, P233, DOI 10.1007/s10295-013-1327-x; Jorgensen H, 2010, APPL ENVIRON MICROB, V76, P283, DOI 10.1128/AEM.00744-09; Jorgensen H, 2009, CHEM BIOL, V16, P1109, DOI 10.1016/j.chembiol.2009.09.014; Kimber MS, 2004, J BIOL CHEM, V279, P52593, DOI 10.1074/jbc.M408105200; Korman TP, 2010, P NATL ACAD SCI USA, V107, P6246, DOI 10.1073/pnas.0913531107; Kotaka M, 2009, J BIOL CHEM, V284, P15739, DOI 10.1074/jbc.M809669200; Kudo F, 2014, NAT PROD REP, V31, P1056, DOI 10.1039/c4np00007b; Labonte JW, 2013, CHEM REV, V113, P2182, DOI 10.1021/cr300169a; Lackner G, 2013, CHEM BIOL, V20, P1101, DOI 10.1016/j.chembiol.2013.07.009; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Lou LL, 2012, BIOCHEMISTRY-US, V51, P4, DOI 10.1021/bi2015025; Miyanaga A, 2016, CURR OPIN CHEM BIOL, V35, P58, DOI 10.1016/j.cbpa.2016.08.030; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Moynie L, 2013, J MOL BIOL, V425, P365, DOI 10.1016/j.jmb.2012.11.017; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Vagstad AL, 2012, CHEM BIOL, V19, P1525, DOI 10.1016/j.chembiol.2012.10.002; Wang F, 2007, CHEM BIOL, V14, P543, DOI 10.1016/j.chembiol.2007.04.005; Wu R, 2014, BIOCHEMISTRY-US, V53, P4788, DOI 10.1021/bi500334v; Zhu YG, 2015, CHEMBIOCHEM, V16, P2086, DOI 10.1002/cbic.201500281	35	11	11	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10926	10937		10.1074/jbc.M117.792549	http://dx.doi.org/10.1074/jbc.M117.792549			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28522606	Green Published, hybrid			2022-12-26	WOS:000404391000015
J	Bunnell, BE; Escobar, JF; Bair, KL; Sutton, MD; Crane, JK				Bunnell, Bryan E.; Escobar, Jillian F.; Bair, Kirsten L.; Sutton, Mark D.; Crane, John K.			Zinc blocks SOS-induced antibiotic resistance via inhibition of RecA in Escherichia coli	PLOS ONE			English	Article							TOXIN PRODUCTION; III SECRETION; INDUCTION; EVOLUTION; VIRULENCE; GENE; EXPRESSION; INFECTION; MUTATIONS; PHENOTYPE	Zinc inhibits the virulence of diarrheagenic E. coli by inducing the envelope stress response and inhibiting the SOS response. The SOS response is triggered by damage to bacterial DNA. In Shiga-toxigenic E. coli, the SOS response strongly induces the production of Shiga toxins (Stx) and of the bacteriophages that encode the Stx genes. In E. coli, induction of the SOS response is accompanied by a higher mutation rate, called the mutator response, caused by a shift to error-prone DNA polymerases when DNA damage is too severe to be repaired by canonical DNA polymerases. Since zinc inhibited the other aspects of the SOS response, we hypothesized that zinc would also inhibit the mutator response, also known as hypermutation. We explored various different experimental paradigms to induce hypermutation triggered by the SOS response, and found that hypermutation was induced not just by classical inducers such as mitomycin C and the quinolone antibiotics, but also by antiviral drugs such as zidovudine and anti-cancer drugs such as 5-fluorouracil, 6-mercaptopurine, and azacytidine. Zinc salts inhibited the SOS response and the hypermutator phenomenon in E. coli as well as in Klebsiella pneumoniae, and was more effective in inhibiting the SOS response than other metals. We then attempted to determine the mechanism by which zinc, applied externally in the medium, inhibits hypermutation. Our results show that zinc interferes with the actions of RecA, and protects LexA from RecA-mediated cleavage, an early step in initiation of the SOS response. The SOS response may play a role in the development of antibiotic resistance and the effect of zinc suggests ways to prevent it.	[Bunnell, Bryan E.; Escobar, Jillian F.; Bair, Kirsten L.; Crane, John K.] SUNY Buffalo, Dept Med, Div Infect Dis, Buffalo, NY 14228 USA; [Sutton, Mark D.] SUNY Buffalo, Dept Biochem, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Crane, JK (corresponding author), SUNY Buffalo, Dept Med, Div Infect Dis, Buffalo, NY 14228 USA.	jcrane@buffalo.edu	Crane, John K./H-2539-2013	Crane, John K./0000-0002-1341-5665	National Institute of Allergy and Infectious Diseases, National Institutes of Health [R21 Al 102212-01, 2T35A1089693]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI102212, T35AI089693] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by: R21 Al 102212-01, National Institute of Allergy and Infectious Diseases, National Institutes of Health; to JKC, PI; https://www.niai.nih.gov; 2T35A1089693, National Institute of Allergy and Infectious Diseases, National Institutes of Health; to Timothy F. Murphy, PI; Bryan E. Bunnell, Trainee; https://www.niai.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemi JA, 2015, COMP BIOCHEM PHYS C, V172, P7, DOI 10.1016/j.cbpc.2015.04.001; Avison MB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-243; Baym M, 2016, SCIENCE, V351, DOI 10.1126/science.aad3292; Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; Bridges BA, 2001, PHILOS T ROY SOC B, V356, P29, DOI 10.1098/rstb.2000.0745; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; Crane JK, 2007, INFECT IMMUN, V75, P5974, DOI 10.1128/IAI.00750-07; Crane JK, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-145; Crane JK, 2013, VIRULENCE, V4, P589, DOI 10.4161/viru.26504; Crane JK, 2013, INFECT IMMUN, V81, P1129, DOI 10.1128/IAI.01124-12; Crane JK, 2011, INFECT IMMUN, V79, P1696, DOI 10.1128/IAI.01099-10; Errol CF, 2006, SECOND EDITION AMERI; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Fuchs S, 1999, MICROB PATHOGENESIS, V27, P13, DOI 10.1006/mpat.1999.0279; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Grad YH, 2013, MBIO, V4, DOI 10.1128/mBio.00452-12; Griffith KL, 2002, BIOCHEM BIOPH RES CO, V290, P397, DOI 10.1006/bbrc.2001.6152; Handel N, 2015, ANTIMICROBIAL AGENTS; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; Jolivet-Gougeon A, 2011, J MED MICROBIOL, V60, P563, DOI 10.1099/jmm.0.024083-0; Kim JC, 2016, EMERG INFECT DIS, V22, P802, DOI 10.3201/eid2205.151584; Kimmitt PT, 2000, EMERG INFECT DIS, V6, P458, DOI 10.3201/eid0605.000503; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; LANDICK R, 1990, GENE DEV, V4, P1623, DOI 10.1101/gad.4.9.1623; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; Leonardi AN, 2013, NUCLEIC ACIDS RES, P1; Leverton LQ, 2005, INFECT IMMUN, V73, P1034, DOI 10.1128/IAI.73.2.1034-1043.2005; LITTLE JW, 1980, P NATL ACAD SCI-BIOL, V77, P3225, DOI 10.1073/pnas.77.6.3225; Lynn S, 1997, MUTAGENESIS, V12, P353, DOI 10.1093/mutage/12.5.353; MAMBER SW, 1990, ANTIMICROB AGENTS CH, V34, P1237, DOI 10.1128/AAC.34.6.1237; Maul RW, 2005, J BACTERIOL, V187, P7607, DOI 10.1128/JB.187.22.7607-7618.2005; MCHUGH GL, 1975, LANCET, V1, P235; McKenzie GJ, 2000, P NATL ACAD SCI USA, V97, P6646, DOI 10.1073/pnas.120161797; McKenzie GJ, 2001, MOL CELL, V7, P571, DOI 10.1016/S1097-2765(01)00204-0; Mellies JL, 2007, INFECT IMMUN, V75, P4199, DOI 10.1128/IAI.01927-06; Mellies JL, 2007, J BACTERIOL, V189, P2863, DOI 10.1128/JB.01859-06; Mellies JL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-123; Mellmann A, 2005, CLIN INFECT DIS, V41, P785, DOI 10.1086/432722; Mellmann A, 2009, GASTROENTEROLOGY, V136, P1925, DOI 10.1053/j.gastro.2008.12.072; MERSCHSUNDERMANN V, 1994, MUTAGENESIS, V9, P205, DOI 10.1093/mutage/9.3.205; Monday SR, 2001, J INFECT DIS, V184, P918, DOI 10.1086/323154; ODA Y, 1987, MUTAT RES, V183, P103, DOI 10.1016/0167-8817(87)90051-4; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Olsen CH, 2014, INFECT IMMUN, V82, P916, DOI 10.1128/IAI.00811-13; Padilla E, 2010, ANTIMICROB AGENTS CH, V54, P177, DOI 10.1128/AAC.00715-09; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; PRIESTLEY GC, 1980, ACTA DERM-VENEREOL, V60, P145; Russo TA, 1996, INFECT IMMUN, V64, P2343, DOI 10.1128/IAI.64.6.2343-2348.1996; SCOTLAND SM, 1990, J INFECT DIS, V162, P1069, DOI 10.1093/infdis/162.5.1069; SOMMER S, 1993, MOL GEN GENET, V239, P137, DOI 10.1007/BF00281612; Vareille M, 2007, P NATL ACAD SCI USA, V104, P10199, DOI 10.1073/pnas.0702589104; VUOPIOVARKILA J, 1991, J EXP MED, V174, P1167, DOI 10.1084/jem.174.5.1167; Wagner PL, 2001, INFECT IMMUN, V69, P1934, DOI 10.1128/IAI.69.3.1934-1937.2001; Wick LM, 2005, J BACTERIOL, V187, P1783, DOI 10.1128/JB.187.5.1783-1791.2005; Wigle TJ, 2009, J BIOMOL SCREEN, V14, P1092, DOI 10.1177/1087057109342126; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239; Zhang YX, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-121	57	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178303	10.1371/journal.pone.0178303	http://dx.doi.org/10.1371/journal.pone.0178303			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542496	gold, Green Published, Green Submitted			2022-12-26	WOS:000402058400078
J	Kandel, JS; Krishnan, V; Jiwan, D; Chen, XM; Skinner, DZ; See, DR				Kandel, Jinita Sthapit; Krishnan, Vandhana; Jiwan, Derick; Chen, Xianming; Skinner, Daniel Z.; See, Deven R.			Mapping genes for resistance to stripe rust in spring wheat landrace PI 480035	PLOS ONE			English	Article							F-SP TRITICI; ADULT-PLANT RESISTANCE; PUCCINIA-STRIIFORMIS; HIGH-TEMPERATURE; UNITED-STATES; BREAD WHEAT; AESTIVUM L.; LEAF RUST; RACES; MAP	Stripe rust caused by Puccinia striiformis Westend. f. sp. tritici Erikks. is an economically important disease of wheat (Triticum aestivum L.). Hexaploid spring wheat landrace PI 480035 was highly resistant to stripe rust in the field in Washington during 2011 and 2012. The objective of this research was to identify quantitative trait loci (QTL) for stripe rust resistance in PI 480035. A spring wheat, "Avocet Susceptible" (AvS), was crossed with PI 480035 to develop a biparental population of 110 recombinant inbred lines (RIL). The population was evaluated in the field in 2013 and 2014 and seedling reactions were examined against three races (PSTv-14, PSTv-37, and PSTv-40) of the pathogen under controlled conditions. The population was genotyped with genotyping-by-sequencing and microsatellite markers across the whole wheat genome. A major QTL, QYr.wrsggl1-1BS was identified on chromosome 1B. The closest flanking markers were Xgwm273, Xgwm11, and Xbarc187 1.01 cM distal to QYr.wrsggl1-1BS, Xcfd59 0.59 cM proximal and XA365 3.19 cM proximal to QYr.wrsggl1-1BS. Another QTL, QYr.wrsggl1-3B, was identified on 3B, which was significant only for PSTv-40 and was not significant in the field, indicating it confers a race-specific resistance. Comparison with markers associated with previously reported Yr genes on 1B (Yr64, Yr65, and YrH52) indicated that QYr.wrsggl1-1BS is potentially a novel stripe rust resistance gene that can be incorporated into modern breeding materials, along with other all-stage and adult-plant resistance genes to develop cultivars that can provide durable resistance.	[Kandel, Jinita Sthapit; Chen, Xianming; See, Deven R.] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Kandel, Jinita Sthapit] ARS, USDA, Crop Improvement & Protect Res Unit, Salinas, CA USA; [Krishnan, Vandhana; Jiwan, Derick; Skinner, Daniel Z.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Krishnan, Vandhana] Stanford Univ, Sch Med, Stanford Ctr Genom & Personalized Med, Palo Alto, CA 94304 USA; [Chen, Xianming; Skinner, Daniel Z.; See, Deven R.] ARS, USDA, Wheat Hlth Genet & Qual Res Unit, Pullman, WA 99164 USA	Washington State University; United States Department of Agriculture (USDA); Washington State University; Stanford University; United States Department of Agriculture (USDA)	See, DR (corresponding author), Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA.; See, DR (corresponding author), ARS, USDA, Wheat Hlth Genet & Qual Res Unit, Pullman, WA 99164 USA.	deeven_see@wsu.edu	Krishnan, Vandhana/AAP-7826-2020	Krishnan, Vandhana/0000-0002-6475-8019; Sthapit Kandel, Jinita/0000-0002-9250-7874	USD-AARS; Washington Grain Commission [2011-68002-30029]; Department of Plant Pathology, College of Agricultural, Human, and Natural Resource Sciences; Agricultural Research Center [0727]; Washington State University, Pullman, USA [WA 99164-6430]	USD-AARS(United States Department of Agriculture (USDA)); Washington Grain Commission; Department of Plant Pathology, College of Agricultural, Human, and Natural Resource Sciences; Agricultural Research Center; Washington State University, Pullman, USA	This research was funded by a USD-AARS special research initiative on stem rust, the Washington Grain Commission, and Triticeae Coordinated Agricultural Project(T-CAP). 2011-68002-30029, Department of Plant Pathology, College of Agricultural, Human, and Natural Resource Sciences, Agricultural Research Center, Project No. 0727, Washington State University, Pullman, WA 99164-6430, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by a USDA-ARS special research initiative on stem rust, the Washington Grain Commission, and Triticeae Coordinated Agricultural Project (T-CAP). 2011-68002-30029, Department of Plant Pathology, College of Agricultural, Human, and Natural Resource Sciences, Agricultural Research Center, Project No. 0727, Washington State University, Pullman, WA 99164-6430, USA.	[Anonymous], 2014, ANN WHEAT NEWSL; Banana H, 2010, EUPHYTICA, V176, P251; Bansal UK, 2010, EUPHYTICA, V171, P121, DOI 10.1007/s10681-009-0007-4; Case AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091758; Chen X. M., 1994, Phytopathology, V84, P1116; Chen X. M., 2013, American Journal of Plant Sciences, V4, P608; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; CHEN XM, 1992, PHYTOPATHOLOGY, V82, P1428, DOI 10.1094/Phyto-82-1428; CHEN XM, 1992, PHYTOPATHOLOGY, V82, P633, DOI 10.1094/Phyto-82-633; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P1362, DOI 10.1094/Phyto-85-1362; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P567, DOI 10.1094/Phyto-85-567; Cheng P, 2014, THEOR APPL GENET, V127, P2267, DOI 10.1007/s00122-014-2378-8; Jia JQ, 2011, CEREAL RES COMMUN, V39, P88, DOI 10.1556/CRC.39.2011.1.9; Khlestkina EK, 2007, EUPHYTICA, V153, P1, DOI 10.1007/s10681-006-9182-8; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Li GQ, 2006, THEOR APPL GENET, V112, P1434, DOI 10.1007/s00122-006-0245-y; Lin F, 2008, THEOR APPL GENET, V116, P797, DOI 10.1007/s00122-008-0713-7; Lin F, 2007, THEOR APPL GENET, V114, P1277, DOI 10.1007/s00122-007-0518-0; Line RF, 1991, USDA TECH B, P1968; Luo PG, 2008, CAN J PLANT PATHOL, V30, P254, DOI 10.1080/07060661.2008.10540540; MACER RCF, 1975, T BRIT MYCOL SOC, V65, P351; Mascher M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076925; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Melichar JPE, 2008, THEOR APPL GENET, V117, P391, DOI 10.1007/s00122-008-0783-6; Milus EA, 2009, PHYTOPATHOLOGY, V99, P89, DOI 10.1094/PHYTO-99-1-0089; Murphy LR, 2009, CROP SCI, V49, P1786, DOI 10.2135/cropsci2008.10.0621; Newcomb M, 2013, PLANT DIS, V97, P882, DOI 10.1094/PDIS-02-12-0200-RE; Pahalawatta V, 2005, PHYTOPATHOLOGY, V95, P427, DOI 10.1094/PHYTO-95-0427; Peng JH, 2000, GENETICA, V109, P199, DOI 10.1023/A:1017573726512; QAYOUM A, 1985, PHYTOPATHOLOGY, V75, P1121, DOI 10.1094/Phyto-75-1121; Randhawa MS, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0270-0; Singh RP, 2011, ANNU REV PHYTOPATHOL, V49, P465, DOI 10.1146/annurev-phyto-072910-095423; Singh Ravi Prakash, 2005, Turkish Journal of Agriculture and Forestry, V29, P121; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Sthapit J, 2014, CROP SCI, V54, P2131, DOI 10.2135/cropsci2013.07.0438; Sthapit J, 2012, PLANT DIS, V96, P737, DOI 10.1094/PDIS-07-11-0612; Suenaga K, 2003, PHYTOPATHOLOGY, V93, P881, DOI 10.1094/PHYTO.2003.93.7.881; Wan AM, 2014, PLANT DIS, V98, P1534, DOI 10.1094/PDIS-01-14-0071-RE; Wan AM, 2016, PLANT DIS, V100, P966, DOI 10.1094/PDIS-10-15-1122-RE; Wang C, 2008, EUPHYTICA, V159, P359, DOI 10.1007/s10681-007-9524-1; Wang LM, 2009, CEREAL RES COMMUN, V37, P209, DOI 10.1556/CRC.37.2009.2.7; Wang LF, 2002, EUPHYTICA, V124, P71, DOI 10.1023/A:1015689817857; Wang S., 2011, WINDOWS QTL CARTOGRA; Wellings CR, 2004, P 11 INT CER RUSTS P, pA1; William M, 2003, PHYTOPATHOLOGY, V93, P153, DOI 10.1094/PHYTO.2003.93.2.153; ZADOKS J. C., 1961, TIJDSCHR PLANTEZIEKTEN, V67, P69, DOI 10.1007/BF01984044	47	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177898	10.1371/journal.pone.0177898	http://dx.doi.org/10.1371/journal.pone.0177898			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542451	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672600030
J	Peng, TJ; Ma, LY; Feng, X; Tao, JM; Nan, MH; Liu, YD; Li, JK; Shen, L; Wu, XL; Yu, RL; Liu, XD; Qiu, GZ; Zeng, WM				Peng, Tangjian; Ma, Liyuan; Feng, Xue; Tao, Jiemeng; Nan, Meihua; Liu, Yuandong; Li, Jiaokun; Shen, Li; Wu, Xueling; Yu, Runlan; Liu, Xueduan; Qiu, Guanzhou; Zeng, Weimin			Genomic and transcriptomic analyses reveal adaptation mechanisms of an Acidithiobacillus ferrivorans strain YL15 to alpine acid mine drainage	PLOS ONE			English	Article							ESCHERICHIA-COLI; ACIDOPHILIC MICROORGANISMS; BIOFILM FORMATION; METAL RESISTANCE; WEB SERVER; PROTEIN; BACTERIAL; DATABASE; SHOCK; DNA	Acidithiobacillus ferrivorans is an acidophile that often occurs in low temperature acid mine drainage, e.g., that located at high altitude. Being able to inhabit the extreme environment, the bacterium must possess strategies to copy with the survival stress. Nonetheless, information on the strategies is in demand. Here, genomic and transcriptomic assays were performed to illuminate the adaptation mechanisms of an A. ferrivorans strain YL15, to the alpine acid mine drainage environment in Yulong copper mine in southwest China. Genomic analysis revealed that strain has a gene repertoire for metal-resistance, e.g., genes coding for the mer operon and a variety of transporters/efflux proteins, and for low pH adaptation, such as genes for hopanoid-synthesis and the sodium: proton antiporter. Genes for various DNA repair enzymes and synthesis of UV-absorbing mycosporine-like amino acids precursor indicated hypothetical UV radiation-resistance mechanisms in strain YL15. In addition, it has two types of the acquired immune system-type III-B and type I-F CRISPR/Cas modules against invasion of foreign genetic elements. RNA-seq based analysis uncovered that strain YL15 uses a set of mechanisms to adapt to low temperature. Genes involved in protein synthesis, transmembrane transport, energy metabolism and chemotaxis showed increased levels of RNA transcripts. Furthermore, a bacterioferritin Dps gene had higher RNA transcript counts at 6 degrees C, possibly implicated in protecting DNA against oxidative stress at low temperature. The study represents the first to comprehensively unveil the adaptation mechanisms of an acidophilic bacterium to the acid mine drainage in alpine regions.	[Peng, Tangjian; Ma, Liyuan; Feng, Xue; Tao, Jiemeng; Nan, Meihua; Liu, Yuandong; Li, Jiaokun; Shen, Li; Wu, Xueling; Yu, Runlan; Liu, Xueduan; Qiu, Guanzhou; Zeng, Weimin] Cent South Univ, Sch Minerals Proc & Bioengn, Changsha, Hunan, Peoples R China; [Liu, Yuandong; Li, Jiaokun; Shen, Li; Wu, Xueling; Yu, Runlan; Liu, Xueduan; Qiu, Guanzhou; Zeng, Weimin] Cent South Univ, Minist Educ, Key Lab Biomet, Changsha, Hunan, Peoples R China; [Li, Jiaokun] Cent South Univ, Sch Met & Environm, Changsha, Hunan, Peoples R China; [Zeng, Weimin] CSIRO Proc Sci & Engn, Clayton, Vic, Australia	Central South University; Central South University; Central South University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Zeng, WM (corresponding author), Cent South Univ, Sch Minerals Proc & Bioengn, Changsha, Hunan, Peoples R China.; Zeng, WM (corresponding author), Cent South Univ, Minist Educ, Key Lab Biomet, Changsha, Hunan, Peoples R China.; Zeng, WM (corresponding author), CSIRO Proc Sci & Engn, Clayton, Vic, Australia.	zengweimin1024@sina.com		Ma, Liyuan/0000-0001-7351-836X; Peng, Tangjian/0000-0002-5265-6592	National Natural Science Foundation of China [31470230, 51320105006, 51604308]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31470230, 51320105006, 51604308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alreshidi MM, 2015, J PROTEOMICS, V121, P44, DOI 10.1016/j.jprot.2015.03.010; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bae WH, 2000, P NATL ACAD SCI USA, V97, P7784, DOI 10.1073/pnas.97.14.7784; Baker-Austin C, 2007, TRENDS MICROBIOL, V15, P165, DOI 10.1016/j.tim.2007.02.005; Barahona S, 2014, RES MICROBIOL, V165, P782, DOI 10.1016/j.resmic.2014.07.015; Bardy SL, 2003, MICROBIOL-SGM, V149, P295, DOI 10.1099/mic.0.25948-0; Barria C, 2013, MICROBIOL-SGM, V159, P2437, DOI 10.1099/mic.0.052209-0; Bayir H, 2005, CRIT CARE MED, V33, pS498, DOI 10.1097/01.CCM.0000186787.64500.12; Berger F, 1996, J BACTERIOL, V178, P2999, DOI 10.1128/jb.178.11.2999-3007.1996; BLAIR DF, 1990, CELL, V60, P439, DOI 10.1016/0092-8674(90)90595-6; Bresolin G, 2006, J BACTERIOL, V188, P2945, DOI 10.1128/JB.188.8.2945-2958.2006; Cavicchioli R, 2016, ISME J, V10, P793, DOI 10.1038/ismej.2015.160; Chen L-x, 2014, ISME J, pe245; Chen LX, 2013, ENVIRON MICROBIOL, V15, P2431, DOI 10.1111/1462-2920.12114; Chen ZJ, 2012, ENV MICROBIOL REP, V4, P633, DOI 10.1111/j.1758-2229.2012.00389.x; Christel S, 2016, EXTREMOPHILES, V20, P903, DOI 10.1007/s00792-016-0882-2; Christel S, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw057; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dopson M, 2007, BIOTECHNOL BIOENG, V97, P1205, DOI 10.1002/bit.21312; Dopson M, 2014, APPL MICROBIOL BIOT, V98, P8133, DOI 10.1007/s00253-014-5982-2; Elberling B, 2000, J CONTAM HYDROL, V41, P225, DOI 10.1016/S0169-7722(99)00085-6; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Gabani P, 2013, APPL MICROBIOL BIOT, V97, P993, DOI 10.1007/s00253-012-4642-7; GADD GM, 1978, MICROBIAL ECOL, V4, P303, DOI 10.1007/BF02013274; Gonzalez C, 2014, RES MICROBIOL, V165, P726, DOI 10.1016/j.resmic.2014.08.005; Goodchild A, 2004, MOL MICROBIOL, V53, P309, DOI 10.1111/j.1365-2958.2004.04130.x; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Guazzaroni ME, 2013, ENVIRON MICROBIOL, V15, P1088, DOI 10.1111/1462-2920.12021; Hallberg KB, 2010, EXTREMOPHILES, V14, P9, DOI 10.1007/s00792-009-0282-y; Hua Z, 2014, ISME J; Johnson DB, 2005, SCI TOTAL ENVIRON, V338, P3, DOI 10.1016/j.scitotenv.2004.09.002; JOHNSON DB, 1995, J MICROBIOL METH, V23, P205, DOI 10.1016/0167-7012(95)00015-D; Johnson DB, 2001, ENVIRON MICROBIOL, V3, P630, DOI 10.1046/j.1462-2920.2001.00234.x; Jones DS, 2012, ISME J, V6, P158, DOI 10.1038/ismej.2011.75; Keto-Timonen R, 2016, FRONT MICROBIOL, P7; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lee I, 2016, INT J SYST EVOL MICR, V66, P1100, DOI 10.1099/ijsem.0.000760; Levin BR, 2013, PLOS GENET, V9; Liljeqvist M, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv011; Liljeqvist M, 2013, APPL ENVIRON MICROB, V79, P951, DOI 10.1128/AEM.02989-12; Liljeqvist M, 2011, J BACTERIOL, V193, P4304, DOI 10.1128/JB.05373-11; Lin YF, 2006, P NATL ACAD SCI USA, V103, P15617, DOI 10.1073/pnas.0603974103; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093289; Lourdault K, 2011, INFECT IMMUN, V79, P3711, DOI 10.1128/IAI.05168-11; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Morgante V, 2014, ENV MICROBIOL; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Phadtare S, 1999, CURR OPIN MICROBIOL, V2, P175, DOI 10.1016/S1369-5274(99)80031-9; Rastogi RP, 2010, J IND MICROBIOL BIOT, V37, P537, DOI 10.1007/s10295-010-0718-5; Rath D, 2015, BIOCHIMIE, V117, P119, DOI 10.1016/j.biochi.2015.03.025; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; SQUIRES CL, 1991, J BACTERIOL, V173, P4254, DOI 10.1128/JB.173.14.4254-4262.1991; Talla E, 2014, RES MICROBIOL, V165, P753, DOI 10.1016/j.resmic.2014.08.002; Talla E, 2013, ADV MATER RES-SWITZ, V825, P145, DOI 10.4028/www.scientific.net/AMR.825.145; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Ting L, 2010, ENVIRON MICROBIOL, V12, P2658, DOI 10.1111/j.1462-2920.2010.02235.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang YG, 2012, BIORESOURCE TECHNOL, V121, P348, DOI 10.1016/j.biortech.2012.06.114; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Williams TJ, 2010, J PROTEOME RES, V9, P640, DOI 10.1021/pr900509n; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Xiao Y, 2016, APPL MICROBIOL BIOT, P1; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200	75	23	26	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178008	10.1371/journal.pone.0178008	http://dx.doi.org/10.1371/journal.pone.0178008			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542527	gold, Green Submitted, Green Published			2022-12-26	WOS:000401672600040
J	Guo, YT; Zhang, W; Chen, X; Fu, JH; Cheng, WB; Song, DS; Qu, XL; Yang, Z; Zhao, KX				Guo, Yatu; Zhang, Wei; Chen, Xia; Fu, Junhong; Cheng, Wenbo; Song, Desheng; Qu, Xiaolei; Yang, Zhuo; Zhao, Kanxing			Timing-dependent LTP and LTD in mouse primary visual cortex following different visual deprivation models	PLOS ONE			English	Article							LONG-TERM DEPRESSION; HOMEOSTATIC SYNAPTIC PLASTICITY; PRESYNAPTIC NMDA RECEPTORS; CORTICAL MAP PLASTICITY; MONOCULAR DEPRIVATION; POSTNATAL-DEVELOPMENT; IN-VIVO; SENSORY DEPRIVATION; SUBUNIT COMPOSITION; PYRAMIDAL NEURONS	Visual deprivation during the critical period induces long-lasting changes in cortical circuitry by adaptively modifying neuro-transmission and synaptic connectivity at synapses. Spike timing-dependent plasticity (STDP) is considered a strong candidate for experience-dependent changes. However, the visual deprivation forms that affect timing-dependent long-term potentiation(LTP) and long-term depression(LTD) remain unclear. Here, we demonstrated the temporal window changes of tLTP and tLTD, elicited by coincidental pre- and post-synaptic firing, following different modes of 6-day visual deprivation. Markedly broader temporal windows were found in robust tLTP and tLTD in the V1M of the deprived visual cortex in mice after 6-day MD and DE. The underlying mechanism for the changes seen with visual deprivation in juvenile mice using 6 days of dark exposure or monocular lid suture involves an increased fraction of NR2b-containing NMDAR and the consequent prolongation of NMDAR-mediated response duration. Moreover, a decrease in NR2A protein expression at the synapse is attributable to the reduction of the NR2A/2B ratio in the deprived cortex.	[Guo, Yatu; Zhang, Wei; Chen, Xia; Fu, Junhong; Cheng, Wenbo; Song, Desheng; Zhao, Kanxing] Tianjin Eye Hosp, Tianjin Eye Inst, Tianjin Key Lab Ophthalmol & Visual Sci, Tianjin, Peoples R China; [Fu, Junhong; Cheng, Wenbo; Song, Desheng] TEDA Int Hosp, Dept Ophthalmol, Tianjin, Peoples R China; [Qu, Xiaolei] Second Peoples Hosp Jinan, Dept Ophthalmol, Jinan, Shandong, Peoples R China; [Yang, Zhuo] Nankai Univ, Coll Life Sci, Key Lab Bioact Mat, Minist Educ, Tianjin, Peoples R China; [Yang, Zhuo] Nankai Univ, Coll Med, Tianjin, Peoples R China	Tianjin Medical University; Nankai University; Nankai University	Guo, YT (corresponding author), Tianjin Eye Hosp, Tianjin Eye Inst, Tianjin Key Lab Ophthalmol & Visual Sci, Tianjin, Peoples R China.	yatu.guo@gmail.com; zkx4260@163.com			National Natural Science Foundation of China [81300791]; Natural Science Foundation of Tianjin [14JCQNJC10500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work was supported by National Natural Science Foundation of China (No. 81300791) for Yatu Guo, https://isisn.nsfc.gov.cn/egrantweb/; Natural Science Foundation of Tianjin (No. 14JCQNJC10500) for Yatu Guo, http:/www.tstc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by grants from the National Natural Science Foundation of China (No. 81300791) and the Application foundation and advanced technology research project of Tianjin (No. 14JCQNJC10500).	Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Beston Brett R, 2010, Front Synaptic Neurosci, V2, P138, DOI 10.3389/fnsyn.2010.00138; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Blais BS, 2008, J NEUROPHYSIOL, V100, P2217, DOI 10.1152/jn.90411.2008; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; CARLSON M, 1986, DEV BRAIN RES, V25, P71, DOI 10.1016/0165-3806(86)90153-7; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Chen WS, 2007, NEUROPHARMACOLOGY, V52, P200, DOI 10.1016/j.neuropharm.2006.07.003; Cooke SF, 2010, J NEUROSCI, V30, P16304, DOI 10.1523/JNEUROSCI.4333-10.2010; Corlew R, 2007, J NEUROSCI, V27, P9835, DOI 10.1523/JNEUROSCI.5494-06.2007; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Froemke RC, 2006, J NEUROPHYSIOL, V95, P1620, DOI 10.1152/jn.00910.2005; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Gabbott PL, 2012, NEUROSCIENCE, V207, P65, DOI 10.1016/j.neuroscience.2012.01.003; Gordon JA, 1996, J NEUROSCI, V16, P3274; Guo YT, 2012, J NEUROSCI, V32, P15027, DOI 10.1523/JNEUROSCI.2545-12.2012; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; He KW, 2012, J NEUROSCI, V32, P8469, DOI 10.1523/JNEUROSCI.1424-12.2012; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; Huang SY, 2015, J NEUROSCI, V35, P15916, DOI 10.1523/JNEUROSCI.1813-15.2015; Huang SY, 2013, J NEUROSCI, V33, P13171, DOI 10.1523/JNEUROSCI.5741-12.2013; Huang SY, 2012, NEURON, V73, P497, DOI 10.1016/j.neuron.2011.11.023; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; Kang E, 2013, J NEUROSCI, V33, P17789, DOI 10.1523/JNEUROSCI.1500-13.2013; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Larsen RS, 2014, NEURON, V83, P879, DOI 10.1016/j.neuron.2014.07.039; Larsen Rylan S, 2010, Front Synaptic Neurosci, V2, P9, DOI 10.3389/fnsyn.2010.00009; LAURIE DJ, 1994, EUR J PHARM-MOLEC PH, V268, P335, DOI 10.1016/0922-4106(94)90058-2; LEVENTHAL AG, 1980, J NEUROPHYSIOL, V43, P1111, DOI 10.1152/jn.1980.43.4.1111; LEVENTHAL AG, 1977, P NATL ACAD SCI USA, V74, P1272, DOI 10.1073/pnas.74.3.1272; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; Lunghi C, 2015, J PHYSIOL-LONDON, V593, P4361, DOI 10.1113/JP270950; Luz Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101109; Maffei A, 2008, J NEUROSCI, V28, P4377, DOI 10.1523/JNEUROSCI.5298-07.2008; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Mainardi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004342; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mierau SB, 2004, P NATL ACAD SCI USA, V101, P15518, DOI 10.1073/pnas.0402916101; Nahmani M, 2014, J NEUROSCI, V34, P2571, DOI 10.1523/JNEUROSCI.4600-13.2014; Nataraj K, 2011, J NEUROSCI, V31, P17932, DOI 10.1523/JNEUROSCI.4455-11.2011; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Philpot BD, 2003, J NEUROSCI, V23, P5583; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Philpot BD, 2007, NEURON, V53, P495, DOI 10.1016/j.neuron.2007.01.027; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; Rodriguez-Moreno A, 2008, NAT NEUROSCI, V11, P744, DOI 10.1038/nn.2125; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Sasaki YF, 2002, J NEUROPHYSIOL, V87, P2052, DOI 10.1152/jn.00531.2001; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Storey GP, 2011, J NEUROSCI, V31, P6311, DOI 10.1523/JNEUROSCI.5553-10.2011; Tropea D, 2010, J NEUROSCI, V30, P11086, DOI 10.1523/JNEUROSCI.1661-10.2010; Whitt JL, 2014, NEUROPHARMACOLOGY, V78, P45, DOI 10.1016/j.neuropharm.2013.02.016; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Yoneda T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053082; Zhou JW, 2015, RESTOR NEUROL NEUROS, V33, P381, DOI 10.3233/RNN-140472; Zilberter M, 2009, CEREB CORTEX, V19, P2308, DOI 10.1093/cercor/bhn247	72	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176603	10.1371/journal.pone.0176603	http://dx.doi.org/10.1371/journal.pone.0176603			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520739	gold, Green Published, Green Submitted			2022-12-26	WOS:000401487700024
J	Li, JJ; Li, TY; Lu, YY; Shen, GF; Guo, H; Wu, J; Lei, C; Du, F; Zhou, FL; Zhao, XD; Nie, YZ; Fan, DM				Li, Jinjing; Li, Tingyu; Lu, Yuanyuan; Shen, Gaofei; Guo, Hao; Wu, Jian; Lei, Chao; Du, Feng; Zhou, Fenli; Zhao, Xiaodi; Nie, Yongzhan; Fan, Daiming			MiR-2392 suppresses metastasis and epithelial- mesenchymal transition by targeting MAML3 and WHSC1 in gastric cancer	FASEB JOURNAL			English	Article						microRNA; migration; invasion; EMT	MASTERMIND-LIKE 3; E-CADHERIN; PANCREATIC-CANCER; TUMOR-GROWTH; MICRORNA; CELLS; EXPRESSION; PATHWAY; TRANSCRIPTION; CARCINOMA	MicroRNAs have emerged as essential regulators of various cellular processes. We identified the role and underlying mechanisms of miR-2392 in gastric cancer (GC) metastasis. MiR-2392 was down-regulated in GC cell lines and tissues, and overexpression of miR-2392 significantly inhibited GC invasion and metastasis in vitro and in vivo. We identified MAML3 and WHSC1 as novel targets of miR-2392, and knockdown of MAML3 and WHSC1 had the same antimetastatic effect as that of miR-2392 in GC cells. These effects were clinically relevant, as low miR-2392 expression was correlated with high MAML3 and WHSC1 expression and poor survival in patients with GC. Furthermore, forced expression of miR-2392 substantially suppressed Slug and Twist1, transcriptional repressors of E-cadherin, by targeting MAML3 and WHSC1, respectively, resulting in inhibition of the epithelial-mesenchymal transition. These findings indicate that the miR-2392-MAML3/WHSC1-Slug/Twist1 regulatory axis plays a critical role in GC metastasis. Restoration of miR-2392 may be a therapeutic approach for blocking GC metastasis.	[Li, Jinjing; Li, Tingyu; Lu, Yuanyuan; Shen, Gaofei; Guo, Hao; Wu, Jian; Lei, Chao; Du, Feng; Zhou, Fenli; Zhao, Xiaodi; Nie, Yongzhan; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian, Peoples R China	Air Force Military Medical University	Zhao, XD; Nie, YZ (corresponding author), Xijing Hosp Digest Dis, State Key Lab Canc Biol, 127 Chang Le West Rd, Xian 710032, Shaanxi, Peoples R China.	leedyzhao@fmmu.edu.cn; yongznie@fmmu.edu.cn		Wu, Jian/0000-0003-4953-8330	National Natural Science Foundation of China [81430072, 81120108005, 81602641, 81572929]; National Key Basic Research Program of China [2014CBA02002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported, in part, by the National Natural Science Foundation of China (81430072, 81120108005, 81602641, 81572929) and the National Key Basic Research Program of China (2014CBA02002).	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen JY, 2013, INT J MOL MED, V32, P557, DOI 10.3892/ijmm.2013.1424; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Ezponda T, 2013, ONCOGENE, V32, P2882, DOI 10.1038/onc.2012.297; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hudlebusch HR, 2011, CANCER RES, V71, P4226, DOI 10.1158/0008-5472.CAN-10-3810; Hudlebusch HR, 2011, CLIN CANCER RES, V17, P2919, DOI 10.1158/1078-0432.CCR-10-1302; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Jia B, 2014, CANCER LETT, V342, P104, DOI 10.1016/j.canlet.2013.08.040; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Lin QS, 2014, CANCER LETT, V345, P85, DOI 10.1016/j.canlet.2013.11.014; Min DJ, 2013, LEUKEMIA, V27, P686, DOI 10.1038/leu.2012.269; Onishi H, 2016, CANCER LETT, V371, P143, DOI 10.1016/j.canlet.2015.11.012; Oyama T, 2011, DEVELOPMENT, V138, P5235, DOI 10.1242/dev.062802; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Sonoshita M, 2011, CANCER CELL, V19, P125, DOI 10.1016/j.ccr.2010.11.008; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tian Y, 2015, MOL CELL ENDOCRINOL, V403, P30, DOI 10.1016/j.mce.2015.01.015; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Van Cutsem E, 2016, LANCET, V388, P2654, DOI 10.1016/S0140-6736(16)30354-3; Vasko V, 2007, P NATL ACAD SCI USA, V104, P2803, DOI 10.1073/pnas.0610733104; Wang XQ, 2012, INT J CANCER, V131, pE163, DOI 10.1002/ijc.27336; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Yang P, 2012, MOL CELL BIOL, V32, P3121, DOI 10.1128/MCB.00204-12; Zhao X, 2014, CELL DEATH DIFFER, V21, P1900, DOI 10.1038/cdd.2014.109; Zhao X, 2013, ONCOGENE, V32, P1363, DOI 10.1038/onc.2012.156; Zhou JN, 2015, HEPATOLOGY, V62, P801, DOI 10.1002/hep.27887; Zhou L, 2013, FASEB J, V27, P4929, DOI 10.1096/fj.13-233387; Zuo QF, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.297	38	21	24	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3774	3786		10.1096/fj.201601140RR	http://dx.doi.org/10.1096/fj.201601140RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28512191				2022-12-26	WOS:000408713300007
J	Franke, B; James, AM; Mobli, M; Colgrave, ML; Mylne, JS; Rosengren, KJ				Franke, Bastian; James, Amy M.; Mobli, Mehdi; Colgrave, Michelle L.; Mylne, Joshua S.; Rosengren, K. Johan			Two proteins for the price of one: Structural studies of the dual-destiny protein preproalbumin with sunflower trypsin inhibitor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic peptide; nuclear magnetic resonance (NMR); plant biochemistry; post-translational modification (PTM); protein processing; preproalbumin with SFTI-1 (PawS1); sunflower trypsin inhibitor-1 (SFTI-1); asparaginyl endopeptidase (AEP); seed storage albumin	SEED STORAGE ALBUMINS; ASPARAGINYL-ENDOPEPTIDASE; PEPTIDE MACROCYCLIZATION; CYCLIC-PEPTIDES; BIOSYNTHESIS; CRYSTALLOGRAPHY; STABILITY; PRECURSOR; RAPESEED; BACKBONE	Seed storage proteins are both an important source of nutrition for humans and essential for seedling establishment. Interestingly, unusual napin-type 2S seed storage albumin precursors in sunflowers contain a sequence that is released as a macrocyclic peptide during post-translational processing. The mechanism by which such peptides emerge from linear precursor proteins has received increased attention; however, the structural characterization of intact precursor proteins has been limited. Here, we report the 3D NMR structure of the Helianthus annuus PawS1 (preproalbumin with sunflower trypsin inhibitor-1) and provide new insights into the processing of this remarkable dual-destiny protein. In seeds, PawS1 is matured by asparaginyl endopeptidases (AEPs) into the cyclic peptide SFTI-1 (sunflower trypsin inhibitor-1) and a heterodimeric 2S albumin. The structure of PawS1 revealed that SFTI-1 and the albumin are independently folded into well-defined domains separated by a flexible linker. PawS1 was cleaved in vitro with recombinant sunflower HaAEP1 and in situ using a sunflower seed extract in a way that resembled the expected in vivo cleavages. Recombinant HaAEP1 cleaved PawS1 at multiple positions, and in situ, its flexible linker was removed, yielding fully mature heterodimeric albumin. Liberation and cyclization of SFTI-1, however, was inefficient, suggesting that specific seed conditions or components may be required for in vivo biosynthesis of SFTI-1. In summary, this study has revealed the 3D structure of a macrocyclic precursor protein and provided important mechanistic insights into the maturation of sunflower proalbumins into an albumin and a macrocyclic peptide.	[Franke, Bastian; Rosengren, K. Johan] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Mobli, Mehdi] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld 4072, Australia; [James, Amy M.; Mylne, Joshua S.] Univ Western Australia, Sch Mol Sci, Perth, WA 6009, Australia; [James, Amy M.; Mylne, Joshua S.] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Perth, WA 6009, Australia; [Colgrave, Michelle L.] CSIRO Agr & Food, Brisbane, Qld 4067, Australia	University of Queensland; University of Queensland; University of Western Australia; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Rosengren, KJ (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia.	j.rosengren@uq.edu.au	Mylne, Josh/GMX-4544-2022; Mylne, Joshua S/A-5581-2009; Rosengren, K. Johan/P-4450-2016; Colgrave, Michelle/A-5710-2012; Mobli, Mehdi/O-7244-2014	Mylne, Josh/0000-0003-4957-6388; Mylne, Joshua S/0000-0003-4957-6388; Rosengren, K. Johan/0000-0002-5007-8434; Colgrave, Michelle/0000-0001-8463-805X; Mobli, Mehdi/0000-0003-2420-4262; Franke, Bastian/0000-0001-8029-4069; James, Amy/0000-0001-9978-0876	Australian Research Council [DP120103369, FT110100925, FT120100013, FT130100890]	Australian Research Council(Australian Research Council)	This work was supported by Australian Research Council Grant DP120103369 (to J.S.M. and K.J.R.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Australian Research Council Future Fellowships FT110100925, FT120100013, and FT130100890, respectively.	[Anonymous], 1999, SEED PROTEINS; Bernath-Levin K, 2015, CHEM BIOL, V22, P571, DOI 10.1016/j.chembiol.2015.04.010; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; Daly NL, 2016, BIOPOLYMERS, V106, P825, DOI 10.1002/bip.22977; Elliott AG, 2014, PLANT CELL, V26, P981, DOI 10.1105/tpc.114.123620; ERICSON ML, 1986, J BIOL CHEM, V261, P4576; Franke B, 2016, J PROTEOMICS, V147, P177, DOI 10.1016/j.jprot.2016.05.004; Gruis DF, 2004, PLANT CELL, V16, P270, DOI 10.1105/tpc.016378; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Harris KS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10199; Himeno K, 2015, BIOCHEMISTRY-US, V54, P4863, DOI 10.1021/acs.biochem.5b00196; Hiraiwa N, 1997, EUR J BIOCHEM, V246, P133, DOI 10.1111/j.1432-1033.1997.00133.x; Hoch JC, 1996, NMR DATA PROCESSING; Jayasena AS, 2016, THEOR APPL GENET, V129, P613, DOI 10.1007/s00122-015-2653-3; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Klint JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063865; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Korsinczky MLJ, 2001, J MOL BIOL, V311, P579, DOI 10.1006/jmbi.2001.4887; KORTT AA, 1991, EUR J BIOCHEM, V195, P329, DOI 10.1111/j.1432-1033.1991.tb15710.x; Lehmann K, 2006, BIOCHEM J, V395, P463, DOI 10.1042/BJ20051728; Li DF, 2008, J STRUCT BIOL, V162, P50, DOI 10.1016/j.jsb.2007.12.007; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Mylne JS, 2014, FUNCT PLANT BIOL, V41, P671, DOI 10.1071/FP14035; Mylne JS, 2012, PLANT CELL, V24, P2765, DOI 10.1105/tpc.112.099085; Mylne JS, 2011, NAT CHEM BIOL, V7, P257, DOI 10.1038/nchembio.542; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Nguyen GKT, 2014, NAT CHEM BIOL, V10, P732, DOI [10.1038/NCHEMBIO.1586, 10.1038/nchembio.1586]; Otegui MS, 2006, PLANT CELL, V18, P2567, DOI 10.1105/tpc.106.040931; Pantoja-Uceda D, 2004, BIOCHEMISTRY-US, V43, P16036, DOI 10.1021/bi048069x; Pantoja-Uceda D, 2004, BIOCHEMISTRY-US, V43, P6976, DOI 10.1021/bi0496900; Pantoja-Uceda D, 2003, BIOCHEMISTRY-US, V42, P13839, DOI 10.1021/bi0352217; Rico M, 1996, BIOCHEMISTRY-US, V35, P15672, DOI 10.1021/bi961748q; Rundqvist L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046435; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shimada T, 2003, J BIOL CHEM, V278, P32292, DOI 10.1074/jbc.M305740200; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wuthrich K, 1986, NMR PROTEINS NUCL AC	42	8	9	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12398	12411		10.1074/jbc.M117.776955	http://dx.doi.org/10.1074/jbc.M117.776955			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28536266	hybrid, Green Published			2022-12-26	WOS:000406636900006
J	Martin, B; Wang, R; Cong, WN; Daimon, CM; Wu, WW; Ni, B; Becker, KG; Lehrmann, E; Wood, WH; Zhang, YQ; Etienne, H; van Gastel, J; Azmi, A; Janssens, J; Maudsley, S				Martin, Bronwen; Wang, Rui; Cong, Wei-Na; Daimon, Caitlin M.; Wu, Wells W.; Ni, Bin; Becker, Kevin G.; Lehrmann, Elin; Wood, William H., III; Zhang, Yongqing; Etienne, Harmonie; van Gastel, Jaana; Azmi, Abdelkrim; Janssens, Jonathan; Maudsley, Stuart			Altered learning, memory, and social behavior in type 1 taste receptor subunit 3 knock-out mice are associated with neuronal dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINE DENSITY; CA1 PYRAMIDAL NEURONS; RECESSIVE INTELLECTUAL DISABILITY; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; SYNAPTIC PLASTICITY; MOUSE MODEL; METABOLIC SYNDROME; CREB PHOSPHORYLATION	The type 1 taste receptor member 3 (T1R3) is a G protein-coupled receptor involved in sweet-taste perception. Besides the tongue, the T1R3 receptor is highly expressed in brain areas implicated in cognition, including the hippocampus and cortex. As cognitive decline is often preceded by significant metabolic or endocrinological dysfunctions regulated by the sweet-taste perception system, we hypothesized that a disruption of the sweet-taste perception in the brain could have a key role in the development of cognitive dysfunction. To assess the importance of the sweet-taste receptors in the brain, we conducted transcriptomic and proteomic analyses of cortical and hippocampal tissues isolated from T1R3 knock-out (T1R3KO) mice. The effect of an impaired sweet-taste perception system on cognition functions were examined by analyzing synaptic integrity and performing animal behavior on T1R3KO mice. Although T1R3KO mice did not present a metabolically disrupted phenotype, bioinformatic interpretation of the high-dimensionality data indicated a strong neurodegenerative signature associated with significant alterations in pathways involved in neuritogenesis, dendritic growth, and synaptogenesis. Furthermore, a significantly reduced dendritic spine density was observed inT1R3KO mice together with alterations in learning and memory functions as well as sociability deficits. Taken together our data suggest that the sweet-taste receptor system plays an important neurotrophic role in the extralingual central nervous tissue that underpins synaptic function, memory acquisition, and social behavior.	[Martin, Bronwen; Wang, Rui; Cong, Wei-Na; Daimon, Caitlin M.; Wu, Wells W.] NIA, Metab Unit, NIH, Baltimore, MD 21224 USA; [Ni, Bin; Maudsley, Stuart] NIA, Receptor Pharmacol Unit, NIH, Baltimore, MD 21224 USA; [Becker, Kevin G.; Lehrmann, Elin; Wood, William H., III; Zhang, Yongqing] NIA, Gene Express & Genom Unit, NIH, Baltimore, MD 21224 USA; [Etienne, Harmonie; van Gastel, Jaana; Azmi, Abdelkrim; Janssens, Jonathan; Maudsley, Stuart] Univ Antwerp VIB, Dept Mol Genet, Translat Neurobiol Grp, AN-2610 Antwerp, Belgium; [Etienne, Harmonie; van Gastel, Jaana; Azmi, Abdelkrim; Janssens, Jonathan; Maudsley, Stuart] Univ Antwerp, Dept Biomed Sci, AN-2610 Antwerp, Belgium	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Flanders Institute for Biotechnology (VIB); University of Antwerp	Maudsley, S (corresponding author), Univ Antwerp VIB, Dept Mol Genet, Univ Pl 1, B-2610 Antwerp, Belgium.	stuart.maudsley@molgen.vib-ua.be	Maudsley, Stuart/AAV-9929-2021; Maudsley, Stuart/Q-4782-2019; Wang, Rui/I-5643-2019	Maudsley, Stuart/0000-0002-1868-184X; Wang, Rui/0000-0001-7015-0272; Lehrmann, Elin/0000-0002-9869-9475; Martin, Bronwen/0000-0002-9185-6925; AZMI, ASFAR/0000-0003-1178-9505	National Institutes of Health Intramural Research Program Grants from the NIA [AG000915-01, AG000917-01]; FWO Odysseus Program; Flemish Government Inter-university VIND (Flemish Impulse Funding for Networks in Dementia Research) Initiative; NATIONAL INSTITUTE ON AGING [ZICAG000616] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program Grants from the NIA; FWO Odysseus Program; Flemish Government Inter-university VIND (Flemish Impulse Funding for Networks in Dementia Research) Initiative; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Intramural Research Program Grants AG000915-01 and AG000917-01 from the NIA. This work also was supported by the FWO Odysseus Program and the Flemish Government Inter-university VIND (Flemish Impulse Funding for Networks in Dementia Research) Initiative. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed RM, 2014, JAMA NEUROL, V71, P1540, DOI 10.1001/jamaneurol.2014.1931; Akram A, 2008, NEUROBIOL AGING, V29, P1296, DOI 10.1016/j.neurobiolaging.2007.03.007; Allen PB, 2006, NEUROSCIENCE, V140, P897, DOI 10.1016/j.neuroscience.2006.02.067; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Auffret A, 2009, J NEUROSCI, V29, P10144, DOI 10.1523/JNEUROSCI.1856-09.2009; Baroukh C, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-15; Barrios FA, 2007, NEUROREPORT, V18, P73, DOI 10.1097/WNR.0b013e3280102302; Behnke J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030612; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bittner T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015477; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boccuto L, 2013, EUR J HUM GENET, V21, P310, DOI 10.1038/ejhg.2012.175; Bohnen NI, 2013, J NEURAL TRANSM, V120, P571, DOI 10.1007/s00702-012-0956-y; Bonanomi D, 2005, J NEUROSCI, V25, P7299, DOI 10.1523/JNEUROSCI.1573-05.2005; Borroto-Escuela DO, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00037; Boughter JD, 2002, CHEM SENSES, V27, P133, DOI 10.1093/chemse/27.2.133; Butterfield DA, 2006, J ALZHEIMERS DIS, V10, P391; Cahana-Amitay D, 2015, J INT NEUROPSYCH SOC, V21, P116, DOI 10.1017/S1355617715000028; Cai H, 2014, FRONT HORM RES, V42, P134, DOI 10.1159/000358322; Cai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053388; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021660; Chadwick W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014352; Chen HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062665; Chen H, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00008; Cheung WA, 2012, GENOME MED, V4, DOI 10.1186/gm376; Choi KJ, 2014, J BIOSCIENCES, V39, P97, DOI 10.1007/s12038-013-9406-8; Cohen D, 2008, DEV NEUROSCI-BASEL, V30, P187, DOI 10.1159/000109862; COLOMBARI E, 1995, BRAIN RES, V677, P110, DOI 10.1016/0006-8993(95)00131-9; Cong WN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070257; Cong WN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047240; Copland D., 2015, FRONT HUM NEUR C ABS, DOI [10.3389/conf.fnhum.2015.217.00165, DOI 10.3389/CONF.FNHUM.2015.217.00165]; Countryman RA, 2007, LEARN MEMORY, V14, P350, DOI 10.1101/lm.524907; Counts SE, 2014, NEUROPHARMACOLOGY, V79, P172, DOI 10.1016/j.neuropharm.2013.10.018; Daimon CM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00324; Dang YH, 2015, NEUROSCI LETT, V607, P40, DOI 10.1016/j.neulet.2015.08.026; Darcy MJ, 2014, HIPPOCAMPUS, V24, P315, DOI 10.1002/hipo.22225; Davis EK, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-32; Davis SA, 2017, NEUROBIOL DIS, V103, P154, DOI 10.1016/j.nbd.2017.04.012; Decker JM, 2010, NEUROSCIENCE, V169, P8, DOI 10.1016/j.neuroscience.2010.04.064; del Valle J, 2012, J ALZHEIMERS DIS, V32, P233, DOI 10.3233/JAD-2012-120718; Depoortere I, 2014, GUT, V63, P179, DOI 10.1136/gutjnl-2013-305112; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Ehninger D, 2011, BEHAV GENET, V41, P357, DOI 10.1007/s10519-010-9398-1; Elizalde N, 2010, J NEUROCHEM, V114, P1302, DOI 10.1111/j.1471-4159.2010.06854.x; Euskirchen P, 2014, J NEUROL SCI, V345, P278, DOI 10.1016/j.jns.2014.07.054; Exalto LG, 2015, J NEUROL SCI, V351, P18, DOI 10.1016/j.jns.2015.02.004; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Fernandez-Medarde A, 2007, NEUROSCIENCE, V146, P272, DOI 10.1016/j.neuroscience.2007.01.022; Fivaz M, 2005, J CELL BIOL, V170, P429, DOI 10.1083/jcb.200409157; Fukai R, 2014, AM J MED GENET A, V164, P1021, DOI 10.1002/ajmg.a.36377; Gabriel AS, 2009, BIOCHEM BIOPH RES CO, V378, P414, DOI 10.1016/j.bbrc.2008.11.060; Glendinning JI, 2002, CHEM SENSES, V27, P461, DOI 10.1093/chemse/27.5.461; Goeldner C, 2013, NEUROPHARMACOLOGY, V64, P337, DOI 10.1016/j.neuropharm.2012.08.001; Green E, 2015, BRAIN RES, V1620, P57, DOI 10.1016/j.brainres.2015.03.034; Hamr SC, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0604-7; Heese K, 2004, J CELL BIOCHEM, V91, P1030, DOI 10.1002/jcb.20010; Heyanka DJ, 2014, APPL NEUROPSYCH-ADUL, V21, P176, DOI 10.1080/09084282.2013.782031; Hotokezaka Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.90; Huey ED, 2006, NEUROLOGY, V66, P17, DOI 10.1212/01.wnl.0000191304.55196.4d; Iqbal Z, 2015, AM J HUM GENET, V96, P386, DOI 10.1016/j.ajhg.2015.01.010; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Jacova C, 2013, NEUROLOGY, V81, P1322, DOI 10.1212/WNL.0b013e3182a8237e; James BD, 2016, BRAIN, V139, P2983, DOI 10.1093/brain/aww224; Janssens J, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0246-7; Jaramillo TC, 2014, AUTISM RES, V7, P264, DOI 10.1002/aur.1362; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kim YN, 2014, FREE RADICAL BIO MED, V69, P181, DOI 10.1016/j.freeradbiomed.2014.01.006; Kinnamon SC, 2012, ACTA PHYSIOL, V204, P158, DOI 10.1111/j.1748-1716.2011.02308.x; Knecht S, 2004, ANN NEUROL, V56, P20, DOI 10.1002/ana.20125; Kojima I, 2014, ENDOCRINOL METAB, V29, P12, DOI 10.3803/EnM.2014.29.1.12; Kumar D, 2015, AGE, V37, DOI 10.1007/s11357-015-9752-6; Lai JK, 2016, J COMP NEUROL, V524, P807, DOI 10.1002/cne.23868; Lauvin M-A, 2012, Diagn Interv Imaging, V93, P139, DOI 10.1016/j.diii.2012.01.007; Laws SM, 2007, AM J PSYCHIAT, V164, P1577, DOI 10.1176/appi.ajp.2007.06091456; Lee Sarah, 2013, J Alzheimers Dis Parkinsonism, V3, P128; Lee TH, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001906; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Lin N, 2014, BEHAV BRAIN RES, V258, P8, DOI 10.1016/j.bbr.2013.10.010; Lynch VJ, 2015, CELL REP, V10, P551, DOI 10.1016/j.celrep.2014.12.052; Martin B, 2016, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00191; Martin B, 2012, J BIOL CHEM, V287, P31766, DOI 10.1074/jbc.M112.387316; Martin B, 2010, DIABETES, V59, P1143, DOI 10.2337/db09-0807; Martin B, 2009, TRENDS ENDOCRIN MET, V20, P163, DOI 10.1016/j.tem.2009.01.006; Martin B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002750; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Maudsley S, 2006, NAT MED, V12, P392, DOI 10.1038/nm0406-392; Maudsley S, 2016, METHODS, V92, P51, DOI 10.1016/j.ymeth.2015.05.013; McNay EC, 2004, DIABETES, V53, P418, DOI 10.2337/diabetes.53.2.418; Melachroinou K, 2013, NEUROBIOL AGING, V34, P2853, DOI 10.1016/j.neurobiolaging.2013.06.006; Menard C, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00182; Meng CB, 2013, J NEUROSCI, V33, P13505, DOI 10.1523/JNEUROSCI.0918-13.2013; Meyer-Gerspach AC, 2014, FRONT HORM RES, V42, P123, DOI 10.1159/000358321; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Miura Y, 2012, BBA-GEN SUBJECTS, V1820, P1678, DOI 10.1016/j.bbagen.2012.06.013; Mizuno M, 2002, BEHAV BRAIN RES, V133, P135, DOI 10.1016/S0166-4328(01)00470-3; Mohajeri MH, 2009, NEUROCHEM RES, V34, P717, DOI 10.1007/s11064-009-9919-6; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Morris KA, 2013, EXP GERONTOL, V48, P115, DOI 10.1016/j.exger.2012.11.010; Morris KA, 2010, NEUROBIOL AGING, V31, P2136, DOI 10.1016/j.neurobiolaging.2008.12.003; Murmu RP, 2015, J NEUROSCI, V35, P287, DOI 10.1523/JNEUROSCI.0244-14.2015; Nagaoka S, 1995, PROG NEURO-PSYCHOPH, V19, P1251, DOI 10.1016/0278-5846(95)00264-2; Nakagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005106; Nelson TM, 2003, CHEM SENSES, V28, P695, DOI 10.1093/chemse/bjg062; Nie DY, 2015, J NEUROSCI, V35, P10762, DOI 10.1523/JNEUROSCI.4796-14.2015; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Overk CR, 2014, BIOCHEM PHARMACOL, V88, P508, DOI 10.1016/j.bcp.2014.01.015; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Pedros I, 2015, J NUTR HEALTH AGING, V19, P403, DOI 10.1007/s12603-014-0574-5; Perez-Cruz C, 2011, J NEUROSCI, V31, P3926, DOI 10.1523/JNEUROSCI.6142-10.2011; Piguet O, 2011, ANN NEUROL, V69, P312, DOI 10.1002/ana.22244; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Potkin SG, 2009, MOL PSYCHIATR, V14, P416, DOI 10.1038/mp.2008.127; Prasad S, 2008, BIOCHEM BIOPH RES CO, V376, P347, DOI 10.1016/j.bbrc.2008.08.155; Ransome MI, 2008, HIPPOCAMPUS, V18, P1034, DOI 10.1002/hipo.20463; Ren XY, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.012.2009; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Richards P, 2011, CELL DEATH DIFFER, V18, P191, DOI 10.1038/cdd.2010.127; Riise J, 2015, J NEURAL TRANSM, V122, P1303, DOI 10.1007/s00702-015-1375-7; Rinne JO, 2002, NEUROLOGY, V58, P1489, DOI 10.1212/WNL.58.10.1489; Rodriguez GA, 2013, LEARN MEMORY, V20, P256, DOI 10.1101/lm.030031.112; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sabater L, 2005, J NEUROIMMUNOL, V170, P186, DOI 10.1016/j.jneuroim.2005.08.011; Seltman RE, 2012, CNS DRUGS, V26, P841, DOI 10.2165/11640070-000000000-00000; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Shin YK, 2008, J NEUROCHEM, V106, P455, DOI 10.1111/j.1471-4159.2008.05397.x; Shin YK, 2012, J GERONTOL A-BIOL, V67, P336, DOI 10.1093/gerona/glr192; Shin YK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012729; Siervo M, 2014, J ALZHEIMERS DIS, V41, P151, DOI 10.3233/JAD-132279; Snowden JS, 2001, J NEUROL NEUROSUR PS, V70, P323, DOI 10.1136/jnnp.70.3.323; Song JM, 2016, J ALZHEIMERS DIS, V51, P591, DOI 10.3233/JAD-150717; Sperfeld AD, 1999, ANN NEUROL, V46, P708, DOI 10.1002/1531-8249(199911)46:5<708::AID-ANA5>3.0.CO;2-K; Spreckley Eleanor, 2015, Front Nutr, V2, P23, DOI 10.3389/fnut.2015.00023; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Stranahan AM, 2009, HIPPOCAMPUS, V19, P951, DOI 10.1002/hipo.20577; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Talevi A, 2012, BIOORG MED CHEM LETT, V22, P4072, DOI 10.1016/j.bmcl.2012.04.076; Teich AF, 2015, NEUROTHERAPEUTICS, V12, P29, DOI 10.1007/s13311-014-0327-5; Temussi PA, 2002, FEBS LETT, V526, P1, DOI 10.1016/S0014-5793(02)03155-1; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Terwel D, 2005, J BIOL CHEM, V280, P3963, DOI 10.1074/jbc.M409876200; Tomasevic G, 2012, J NEUROSURG, V116, P1368, DOI 10.3171/2012.2.JNS11888; Tordoff MG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00496; Tordoff MG, 2008, PHYSIOL GENOMICS, V34, P338, DOI 10.1152/physiolgenomics.90200.2008; Tran PV, 2015, AM J PHYSIOL-REG I, V308, pR276, DOI 10.1152/ajpregu.00429.2014; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; Varadarajulu J, 2011, BEHAV BRAIN RES, V220, P305, DOI 10.1016/j.bbr.2011.02.012; Verfaillie SCJ, 2015, EUR RADIOL, V25, P3050, DOI 10.1007/s00330-015-3696-1; von Bohlen und Halbach O, 2011, CELL TISSUE RES, V345, P1, DOI 10.1007/s00441-011-1196-4; Wagner MJ, 2017, NATURE, V544, P96, DOI 10.1038/nature21726; Waltl S, 2015, CLIN GENET, V88, P136, DOI 10.1111/cge.12610; Wang R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00231; Warmus BA, 2014, J NEUROSCI, V34, P16482, DOI 10.1523/JNEUROSCI.3418-14.2014; Wauson EM, 2013, MOL ENDOCRINOL, V27, P1188, DOI 10.1210/me.2013-1100; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Winocur G, 1998, NEUROBIOL AGING, V19, P233, DOI 10.1016/S0197-4580(98)00057-8; Woolley JD, 2007, NEUROLOGY, V69, P1424, DOI 10.1212/01.wnl.0000277461.06713.23; Wu K, 2012, NEUROBIOL LEARN MEM, V97, P69, DOI 10.1016/j.nlm.2011.09.006; Wu WW, 2012, J PROTEOMICS, V75, P2480, DOI 10.1016/j.jprot.2012.02.027; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001; Yamashita N, 2016, J CELL SCI, V129, P1802, DOI 10.1242/jcs.184580; Yang L, 2016, BRAIN BEHAV IMMUN, V56, P352, DOI 10.1016/j.bbi.2016.03.001; Yang M, 2007, INT J DEV NEUROSCI, V25, P515, DOI 10.1016/j.ijdevneu.2007.09.008; Yasuda R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005611; Yuki D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07130; Yun K, 2004, DEVELOPMENT, V131, P5441, DOI 10.1242/dev.01430; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	173	11	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11508	11530		10.1074/jbc.M116.773820	http://dx.doi.org/10.1074/jbc.M116.773820			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28522608	hybrid, Green Published			2022-12-26	WOS:000405119600032
J	Barha, CK; Salvante, KG; Hanna, CW; Wilson, SL; Robinson, WP; Altman, RM; Nepomnaschy, PA				Barha, Cindy K.; Salvante, Katrina G.; Hanna, Courtney W.; Wilson, Samantha L.; Robinson, Wendy P.; Altman, Rachel M.; Nepomnaschy, Pablo A.			Child mortality, hypothalamic-pituitaryadrenal axis activity and cellular aging in mothers	PLOS ONE			English	Article							LEUKOCYTE TELOMERE LENGTH; OXIDATIVE STRESS; CORTISOL-LEVELS; PSYCHOLOGICAL STRESS; ENDOCRINE; URINARY; WOMEN; EVOLUTIONARY; CREATININE; PREGNANCY	Psychological challenges, including traumatic events, have been hypothesized to increase the age-related pace of biological aging. Here we test the hypothesis that psychological challenges can affect the pace of telomere attrition, a marker of cellular aging, using data from an ongoing longitudinal-cohort study of Kaqchikel Mayan women living in a population with a high frequency of child mortality, a traumatic life event. Specifically, we evaluate the associations between child mortality, maternal telomere length and the mothers' hypothalamic-pituitary-adrenal axis (HPAA), or stress axis, activity. Child mortality data were collected in 2000 and 2013. HPAA activity was assessed by quantifying cortisol levels in first morning urinary specimens collected every other day for seven weeks in 2013. Telomere length (TL) was quantified using qPCR in 55 women from buccal specimens collected in 2013. Results: Shorter TL with increasing age was only observed in women who experienced child mortality (p = 0.015). Women with higher average basal cortisol (p = 0.007) and greater within-individual variation (standard deviation) in basal cortisol (p = 0.053) presented shorter TL. Non-parametric bootstrapping to estimate mediation effects suggests that HPAA activity mediates the effect of child mortality on TL. Our results are, thus, consistent with the hypothesis that traumatic events can influence cellular aging and that HPAA activity may play a mediatory role. Future large-scale longitudinal studies are necessary to confirm our results and further explore the role of the HPAA in cellular aging, as well as to advance our understanding of the underlying mechanisms involved.	[Barha, Cindy K.; Salvante, Katrina G.; Nepomnaschy, Pablo A.] Simon Fraser Univ, Maternal & Child Hlth Lab, Fac Hlth Sci, Burnaby, BC, Canada; [Salvante, Katrina G.; Nepomnaschy, Pablo A.] Simon Fraser Univ, Human Evolutionary Studies Program, Burnaby, BC, Canada; [Hanna, Courtney W.; Wilson, Samantha L.; Robinson, Wendy P.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Hanna, Courtney W.; Wilson, Samantha L.; Robinson, Wendy P.; Nepomnaschy, Pablo A.] Child & Family Res Inst, Vancouver, BC, Canada; [Altman, Rachel M.] Simon Fraser Univ, Stat & Actuarial Sci, Burnaby, BC, Canada; [Barha, Cindy K.] Univ British Columbia, Dept Phys Therapy, Fac Med, Vancouver, BC, Canada; [Hanna, Courtney W.] Babraham Inst, Babraham Res Campus, Cambridge, England	Simon Fraser University; Simon Fraser University; University of British Columbia; Child & Family Research Institute; Simon Fraser University; University of British Columbia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Nepomnaschy, PA (corresponding author), Simon Fraser Univ, Maternal & Child Hlth Lab, Fac Hlth Sci, Burnaby, BC, Canada.; Nepomnaschy, PA (corresponding author), Simon Fraser Univ, Human Evolutionary Studies Program, Burnaby, BC, Canada.; Nepomnaschy, PA (corresponding author), Child & Family Res Inst, Vancouver, BC, Canada.	pan2@sfu.ca	Robinson, Wendy P/I-9590-2014; Robinson, Wendy/AAB-6420-2020	Robinson, Wendy P/0000-0002-2010-6174; Robinson, Wendy/0000-0002-2010-6174; Hanna, Courtney/0000-0002-4063-5575; Salvante, Katrina/0000-0002-8608-8001; Wilson, Samantha/0000-0003-4346-9696; Barha, Cindy/0000-0003-3149-5539; Nepomnaschy, Pablo/0000-0002-8989-7381	Canadian Institutes of Health Research Post-Doctoral Fellowship; Canadian Institutes of Health Research Training Grant; Child and Family Research Institute Graduate Studentship; Child and Family Research Institute; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research (Institute for Gender and Health) Operating Grant [106705]; Simon Fraser University Presidents Start-up Grant; Simon Fraser University Community Trust Endowment Fund Grant through Simon Fraser Universitys Human Evolutionary Studies Program; Michael Smith Foundation for Health Research Career Investigator Scholar Award	Canadian Institutes of Health Research Post-Doctoral Fellowship(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Training Grant(Canadian Institutes of Health Research (CIHR)); Child and Family Research Institute Graduate Studentship; Child and Family Research Institute; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research (Institute for Gender and Health) Operating Grant(Canadian Institutes of Health Research (CIHR)); Simon Fraser University Presidents Start-up Grant; Simon Fraser University Community Trust Endowment Fund Grant through Simon Fraser Universitys Human Evolutionary Studies Program; Michael Smith Foundation for Health Research Career Investigator Scholar Award	This project was funded by a Canadian Institutes of Health Research Post-Doctoral Fellowship to CKB (http://www.cihr-irsc.gc.ca/e/193.html); a Canadian Institutes of Health Research Training Grant to CWH (http://www.cihr-irsc.gc.ca/e/193.html); a Child and Family Research Institute Graduate Studentship to SLW (http://www.cfri.ca/); a Child and Family Research Institute salary award to WPR (http://www.cfri.ca/); a Natural Sciences and Engineering Research Council of Canada Discovery Grant to RMA (http://www.nserc-crsng.gc.ca/index_eng.asp); a Canadian Institutes of Health Research (Institute for Gender and Health) Operating Grant #106705 (http://www.cihr-irsc.gc.ca/e/193.html), a Simon Fraser University Presidents Start-up Grant (https://www.sfu.ca/vpacademic/FinBdgt_Mgmnt/prsg.html), a Simon Fraser University Community Trust Endowment Fund Grant through Simon Fraser Universitys Human Evolutionary Studies Program (https://www.sfu.ca/vpresearch/ctef.html), and a Michael Smith Foundation for Health Research Career Investigator Scholar Award (http://www.msfhr.org/) to PAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anacker C, 2013, NEUROPSYCHOPHARMACOL, V38, P872, DOI 10.1038/npp.2012.253; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Aubert G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002696; Aubert G, 2012, MUTAT RES-FUND MOL M, V730, P59, DOI 10.1016/j.mrfmmm.2011.04.003; Aulinas A, 2013, CLIN ENDOCRINOL, V79, P751, DOI 10.1111/cen.12310; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Barha CK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146424; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barrett ELB, 2011, AGING CELL, V10, P913, DOI 10.1111/j.1474-9726.2011.00741.x; BEHL C, 1995, BIOCHEM BIOPH RES CO, V216, P473, DOI 10.1006/bbrc.1995.2647; Benetos A, 2013, AGING CELL, V12, P615, DOI 10.1111/acel.12086; Bernabe DG, 2011, BRAIN BEHAV IMMUN, V25, P574, DOI 10.1016/j.bbi.2010.12.012; Carrero JJ, 2008, J INTERN MED, V263, P302, DOI 10.1111/j.1365-2796.2007.01890.x; Carroll JE, 2016, SLEEP, V39, P559, DOI 10.5665/sleep.5526; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; Cohen S, 2013, BRAIN BEHAV IMMUN, V34, P31, DOI 10.1016/j.bbi.2013.06.009; Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249; Daubenmier J, 2012, PSYCHONEUROENDOCRINO, V37, P917, DOI 10.1016/j.psyneuen.2011.10.008; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Eisenberg DTA, 2011, AM J HUM BIOL, V23, P149, DOI 10.1002/ajhb.21127; Ellison PT, 2003, FERTIL STERIL, V80, P1279, DOI 10.1016/S0015-0282(03)02158-7; Epel ES, 2014, J GERONTOL A-BIOL, V69, pS10, DOI 10.1093/gerona/glu055; Epel ES, 2010, BRAIN BEHAV IMMUN, V24, P531, DOI 10.1016/j.bbi.2009.11.018; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Epel ES, 2006, PSYCHONEUROENDOCRINO, V31, P277, DOI 10.1016/j.psyneuen.2005.08.011; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; FIBIGER W, 1984, NEUROSCI BIOBEHAV R, V8, P523, DOI 10.1016/0149-7634(84)90009-5; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Hanna CW, 2009, HUM REPROD, V24, P1206, DOI 10.1093/humrep/dep007; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; Humphreys J, 2012, BIOL RES NURS, V14, P115, DOI 10.1177/1099800411398479; Itagaki T, 2005, GUT, V54, P1782, DOI 10.1136/gut.2005.053278; Jasienska G, 2001, FOUND HUM B, P59; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; KIRSCHBAUM C, 1995, PSYCHOSOM MED, V57, P468, DOI 10.1097/00006842-199509000-00009; Kroenke CH, 2011, PSYCHOSOM MED, V73, P533, DOI 10.1097/PSY.0b013e318229acfc; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Kyo S, 1999, CANCER RES, V59, P5917; Lopes LM, 2015, DETERMINATION NIGHTT; MACKINNON DP, 1993, EVALUATION REV, V17, P144, DOI 10.1177/0193841X9301700202; Malan S, 2011, DEPRESS ANXIETY, V28, P1081, DOI 10.1002/da.20903; Martin-Ruiz CM, 2015, INT J EPIDEMIOL, V44, P1673, DOI 10.1093/ije/dyu191; Michaeli TF, 2015, FERTIL STERIL, V103, P1125, DOI 10.1016/j.fertnstert.2015.02.034; Miller DB, 2002, METABOLISM, V51, P5, DOI 10.1053/meta.2002.33184; Miller MW, 2014, MOL PSYCHIATR, V19, P1156, DOI 10.1038/mp.2014.111; Miller RC, 2004, CLIN CHEM, V50, P924, DOI 10.1373/clinchem.2004.032292; Muezzinler A, 2013, AGEING RES REV, V12, P509, DOI 10.1016/j.arr.2013.01.003; Nepomnaschy PA, 2006, P NATL ACAD SCI USA, V103, P3938, DOI 10.1073/pnas.0511183103; Nepomnaschy PA, 2004, AM J HUM BIOL, V16, P523, DOI 10.1002/ajhb.20057; Nepomnaschy PA, 2012, AM J HUM BIOL, V24, P515, DOI 10.1002/ajhb.22259; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Pardon MC, 2008, NEUROSCI BIOBEHAV R, V32, P1103, DOI 10.1016/j.neubiorev.2008.03.005; Parks CG, 2009, CANCER EPIDEM BIOMAR, V18, P551, DOI 10.1158/1055-9965.EPI-08-0614; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Abrao ALP, 2014, REV BRAS GINECOL OBS, V36, P72, DOI [10.1590/S0100-72032014000100005, 10.1590/S0100-72032014000200005]; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Puterman E, 2015, MOL PSYCHIATR, V20, P529, DOI 10.1038/mp.2014.70; Puterman E, 2012, SOC PERSONAL PSYCHOL, V6, P807, DOI 10.1111/j.1751-9004.2012.00465.x; Raymond AR, 2015, AM J HYPERTENS, V28, P623, DOI 10.1093/ajh/hpu212; Revesz D, 2014, NEUROBIOL AGING, V35, P1422, DOI 10.1016/j.neurobiolaging.2013.12.027; Salvante KG, 2012, AM J HUM BIOL, V24, P81, DOI 10.1002/ajhb.21229; Sarkar PL, 2013, AM J HUM BIOL, V25, P351, DOI 10.1002/ajhb.22376; Savolainen K, 2015, PSYCHONEUROENDOCRINO, V53, P179, DOI 10.1016/j.psyneuen.2014.12.020; Shalev C, 2013, PSYCHONEUROENDOCRINO, V38, P1835, DOI 10.1016/j.psyneuen.2013.03.010; Shalev I, 2013, MOL PSYCHIATR, V18, P576, DOI 10.1038/mp.2012.32; SMITH R, 1987, HORM METAB RES, V19, P41, DOI 10.1055/s-2007-1011733; Stearns S.C., 1992, pi; Tomiyama AJ, 2012, PHYSIOL BEHAV, V106, P40, DOI 10.1016/j.physbeh.2011.11.016; Uhart M, 2006, PSYCHONEUROENDOCRINO, V31, P642, DOI 10.1016/j.psyneuen.2006.02.003; van der Pompe G, 2001, INT J SPORTS MED, V22, P447; Verhoeven J. E., 2015, PSYCHOSOM MED; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; White BC, 2010, AM J PRIMATOL, V72, P1082, DOI 10.1002/ajp.20867; Williams TD, 2008, PHILOS T R SOC B, V363, P1687, DOI 10.1098/rstb.2007.0003	82	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177869	10.1371/journal.pone.0177869	http://dx.doi.org/10.1371/journal.pone.0177869			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542264	Green Published, gold, Green Submitted			2022-12-26	WOS:000402062800027
J	Gastal, GDA; Hamilton, A; Alves, BG; de Tarso, SGS; Feugang, JM; Banz, WJ; Apgar, GA; Nielsen, CK; Gastal, EL				Gastal, G. D. A.; Hamilton, A.; Alves, B. G.; de Tarso, S. G. S.; Feugang, J. M.; Banz, W. J.; Apgar, G. A.; Nielsen, C. K.; Gastal, E. L.			Ovarian features in white-tailed deer (Odocoileus virginianus) fawns and does	PLOS ONE			English	Article							PREANTRAL FOLLICLE POPULATION; EPIDERMAL-GROWTH-FACTOR; FERTILITY PRESERVATION; IN-SITU; TISSUE; VIABILITY; SURVIVAL; EXPRESSION; MANAGEMENT; APOPTOSIS	The knowledge about ovarian reserve is essential to determine the reproductive potential and to improve the methods of fertility control for overpopulated species, such as whitetailed deer (Odocoileus virginianus). The goal of this study was to evaluate the effect of age on the female reproductive tract of white-tailed deer, focusing on ovarian features. Genital tracts from 8 prepubertal and 10 pubertal females were used to characterize the preantral follicle population and density, morphology, distribution of follicular classes; stromal cell density; and apoptosis in the ovary. In addition, uterus and ovary weights and dimensions were recorded; and the number and the size of antral follicles and corpus luteum in the ovary were quantified. Overall, fawns had a greater (P < 0.05) preantral follicle population, percentage of normal follicles, and preantral follicle density than does. The mean stromal cell density in ovaries of fawns and does differed among animals but not between age groups. The apoptotic signaling did not differ (P > 0.05) between the ovaries of fawns and does. However, apoptotic ovarian cells negatively (P < 0.001) affected the preantral follicle morphology and density, and conversely, a positive correlation was observed with stromal cell density. As expected, the uteri and ovaries were larger (P < 0.002) and heavier (P < 0.001) in does than in fawns. In conclusion, this study has shown, for the first time, the preantral follicle population and distribution of classes, rate of morphologically normal follicles, and density of preantral follicles and stromal cells in white-tailed deer. Therefore, the findings herein described lead to a better understanding of the white-tailed deer ovarian biology, facilitating the development of new methods of fertility control.	[Gastal, G. D. A.; Hamilton, A.; Alves, B. G.; de Tarso, S. G. S.; Banz, W. J.; Apgar, G. A.; Gastal, E. L.] Southern Illinois Univ, Dept Anim Sci Food & Nutr, Carbondale, IL 62901 USA; [Feugang, J. M.] Mississippi State Univ, Dept Anim & Dairy Sci, Mississippi State, MS 39762 USA; [Nielsen, C. K.] Southern Illinois Univ, Dept Forestry, Cooperat Wildlife Res Lab, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University; Mississippi State University; Southern Illinois University System; Southern Illinois University	Gastal, EL (corresponding author), Southern Illinois Univ, Dept Anim Sci Food & Nutr, Carbondale, IL 62901 USA.	egastal@siu.edu	Gastal, Gustavo Desire Antunes/K-7424-2013; Alves, Benner/D-3599-2014; Gastal, Eduardo Leite/O-8359-2019; Gastal, Eduardo Leite/Q-9854-2017	Gastal, Gustavo Desire Antunes/0000-0002-5317-2207; Alves, Benner/0000-0001-9465-8054; Gastal, Eduardo Leite/0000-0002-8855-6980; Gastal, Eduardo Leite/0000-0002-8855-6980	CNPq, Brazil [246741/2012-0]; i2i Program at College of Agricultural Sciences, Southern Illinois University; USDA-ARSgrant [58-6402-3-018]	CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); i2i Program at College of Agricultural Sciences, Southern Illinois University; USDA-ARSgrant	G.D.A. Gastal was a recipient of a PhD scholarship from CNPq (grant #246741/2012-0), Brazil. Research supported by i2i Program at College of Agricultural Sciences, Southern Illinois University, and USDA-ARSgrant #58-6402-3-018 (to J. M. Feugang)	Alves KA, 2016, REPROD FERTIL DEV; Alves KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149693; Asher GW, 2011, ANIM REPROD SCI, V124, P170, DOI 10.1016/j.anireprosci.2010.08.026; Block E., 1952, CELLS TISSUES ORGANS, V14, P108; Bodensteiner KJ, 2004, TOXICOL SCI, V80, P83, DOI 10.1093/toxsci/kfh135; Chambers EL, 2010, HUM REPROD, V25, P2559, DOI 10.1093/humrep/deq192; Comizzoli P, 2015, ASIAN J ANDROL, V17, P640, DOI 10.4103/1008-682X.153849; Comizzoli P, 2014, REPROD FERT DEVELOP, V26, P91, DOI 10.1071/RD13259; Commin L, 2012, REPROD FERT DEVELOP, V24, P461, DOI 10.1071/RD11166; DRIANCOURT MA, 1985, J REPROD FERTIL, V73, P93, DOI 10.1530/jrf.0.0730093; Fabbri R, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/910698; Faddy MJ, 2000, MOL CELL ENDOCRINOL, V163, P43, DOI 10.1016/S0303-7207(99)00238-5; Findlay JK, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.133652; Fortin NL, 2015, WILDLIFE SOC B, V39, P56, DOI 10.1002/wsb.498; Fransolet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091073; Fujihara M, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115089; Gaytan F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144099; GOSDEN RG, 1987, J ZOOL, V211, P169, DOI 10.1111/j.1469-7998.1987.tb07460.x; GOUGEON A, 1987, J REPROD FERTIL, V81, P433; Haag KT, 2013, THERIOGENOLOGY, V79, P599, DOI 10.1016/j.theriogenology.2012.11.012; Hedgeland MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146611; HULSHOF SCJ, 1994, VET QUART, V16, P78, DOI 10.1080/01652176.1994.9694423; Albamonte MI, 2013, HUM REPROD, V28, P698, DOI 10.1093/humrep/des453; Kieser DC, 2014, BIO-MED MATER ENG, V24, P1693, DOI 10.3233/BME-140981; Kirkpatrick JF, 1997, REPROD FERT DEVELOP, V9, P105, DOI 10.1071/R96052; KOERING MJ, 1983, AM J ANAT, V166, P429, DOI 10.1002/aja.1001660405; Kristensen SG, 2011, HUM REPROD, V26, P157, DOI 10.1093/humrep/deq318; Lima GL, 2013, ANAT HISTOL EMBRYOL, V42, P304, DOI 10.1111/ahe.12021; Liu GM, 2010, CHINESE MED J-PEKING, V123, P2379, DOI 10.3760/cma.j.issn.0366-6999.2010.17.018; Lucci CM, 1999, ANIM REPROD SCI, V56, P223, DOI 10.1016/S0378-4320(99)00045-7; Malcolm KD, 2010, ANIM REPROD SCI, V117, P261, DOI 10.1016/j.anireprosci.2009.05.003; McCabe Thomas R., 1997, P11; McClellan KA, 2003, DEV BIOL, V258, P334, DOI 10.1016/S0012-1606(03)00132-5; Nichols SM, 2005, HUM REPROD, V20, P79, DOI 10.1093/humrep/deh576; Nielsen CK, 2011, WILDLIFE SOC B, V35, P124, DOI 10.1002/wsb.54; Paulini F, 2016, REPROD BIOMED ONLINE, V33, P425, DOI 10.1016/j.rbmo.2016.05.003; Pavlik EJ, 2000, GYNECOL ONCOL, V77, P410, DOI 10.1006/gyno.2000.5783; Powers JG, 2014, WILDLIFE SOC B, V38, P650, DOI 10.1002/wsb.434; Praxedes ECG, 2015, REPROD FERT DEVELOP, V29, P594; Qu JP, 2000, FERTIL STERIL, V74, P113, DOI 10.1016/S0015-0282(00)00549-5; Schmidt KLT, 2003, HUM REPROD, V18, P2654, DOI 10.1093/humrep/deg500; SEVERINGHAUS CW, 1949, J WILDLIFE MANAGE, V13, P195, DOI 10.2307/3796089; Silva-Santos KC, 2011, THERIOGENOLOGY, V76, P1051, DOI 10.1016/j.theriogenology.2011.05.008; Smith P, 2014, J ENDOCRINOL, V221, pR145, DOI 10.1530/JOE-14-0062; Soares M, 2015, HUM REPROD, V30, P1589, DOI 10.1093/humrep/dev101; Spencer TE, 2012, MOL CELL ENDOCRINOL, V354, P34, DOI 10.1016/j.mce.2011.09.035; Stansfield FJ, 2011, ANIM REPROD SCI, V129, P96, DOI 10.1016/j.anireprosci.2011.10.009; Turner JW, 2008, WILDLIFE RES, V35, P555, DOI 10.1071/WR07159; Vaskivuo TE, 2001, J CLIN ENDOCR METAB, V86, P3421, DOI 10.1210/jc.86.7.3421; VerCauteren KC, 2006, WILDLIFE SOC B, V34, P191, DOI 10.2193/0091-7648(2006)34[191:FADMAR]2.0.CO;2; Walker ML, 2009, REPRODUCTION, V138, P793, DOI 10.1530/REP-08-0449; Wallace WH, 2004, HUM REPROD, V19, P1612, DOI 10.1093/humrep/deh285; Wang Y, 2015, INT J MORPHOL, V33, P105, DOI 10.4067/S0717-95022015000100018; Wasinpongwanich K., 2014, J SPINE, V3, P187; Wright R, 1993, RENEWABLE RESOURCES, V11, P18	55	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177357	10.1371/journal.pone.0177357	http://dx.doi.org/10.1371/journal.pone.0177357			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542265	gold, Green Published, Green Submitted			2022-12-26	WOS:000402062800015
J	Gray, H; Pearce, B; Thiele, A; Rowe, C				Gray, Helen; Pearce, Bradley; Thiele, Alexander; Rowe, Candy			The use of preferred social stimuli as rewards for rhesus macaques in behavioural neuroscience	PLOS ONE			English	Article							BONNET MACAQUES; RESPONSE PATTERNS; FLUID CONTROL; VIDEO REWARD; MONKEYS; FOOD; REINFORCEMENT; ANIMALS; HUMANS; PELLET	Macaques are often motivated to perform in neuroscientific experiments by implementing fluid restriction protocols. Daily access to water is controlled and the monkeys are rewarded with droplets of fluid for performing correct trials in the laboratory. Although these protocols are widely used and highly effective, it is important from a 3Rs perspective to investigate refinements that may help to lessen the severity of the fluid restriction applied. We assessed the use of social stimuli (images of conspecifics) as rewards for four rhesus macaques performing simple cognitive tasks. We found that individual preferences for images of male faces, female perinea and control stimuli could be identified in each monkey. However, using preferred images did not translate into effective motivators on a trial-by-trial basis: animals preferred fluid rewards, even when fluid restriction was relaxed. There was no difference in the monkeys' performance of a task when using greyscale versus colour images. Based on our findings, we cannot recommend the use of social stimuli, in this form, as a refinement to current fluid restriction protocols. We discuss the potential alternatives and possibilities for future research.	[Gray, Helen; Pearce, Bradley; Thiele, Alexander; Rowe, Candy] Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne, Tyne & Wear, England; [Gray, Helen] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England	Newcastle University - UK; University of Leeds	Gray, H (corresponding author), Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne, Tyne & Wear, England.; Gray, H (corresponding author), Univ Leeds, Sch Biol, Leeds, W Yorkshire, England.	h.e.gray@leeds.ac.uk		Gray, Helen/0000-0001-8335-7432; Rowe, Candy/0000-0001-5379-843X; Thiele, Alexander/0000-0003-4894-0213	National Centre for the Replacement Refinement and Reduction of Animals in Research [NC/K500410/1]; Wellcome Trust [093104]; National Centre for the Replacement [NC/K500410/1] Funding Source: researchfish	National Centre for the Replacement Refinement and Reduction of Animals in Research; Wellcome Trust(Wellcome TrustEuropean Commission); National Centre for the Replacement	This work was supported by the National Centre for the Replacement Refinement and Reduction of Animals in Research, NC/K500410/1, https://www.nc3rs.org.uk/; and The Wellcome Trust, 093104, https://wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 1998, BEHAV PROCESS, V42, P159, DOI 10.1016/S0376-6357(97)00074-0; Andrews MW, 2002, AM J PRIMATOL, V57, P213, DOI 10.1002/ajp.10044; ANDREWS MW, 1995, LEARN MOTIV, V26, P370, DOI 10.1016/S0023-9690(05)80002-5; Andrews MW, 2001, LEARN MOTIV, V32, P401, DOI 10.1006/lmot.2001.1092; ANDREWS MW, 1993, PERCEPT MOTOR SKILL, V77, P755, DOI 10.2466/pms.1993.77.3.755; BUTLER RA, 1954, J EXP PSYCHOL, V48, P19, DOI 10.1037/h0063578; CHAMOVE A S, 1989, Animal Technology, V40, P155; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; DEMARIA C, 1988, PRIMATES, V29, P237, DOI 10.1007/BF02381125; Dobkins KR, 2000, J OPT SOC AM A, V17, P545, DOI 10.1364/JOSAA.17.000545; FUJITA K, 1986, PRIMATES, V27, P283, DOI 10.1007/BF02382072; Gray H, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0195-16.2016; HAUDE RH, 1976, PERCEPT MOTOR SKILL, V43, P231, DOI 10.2466/pms.1976.43.1.231; Higham JP, 2010, BEHAV ECOL, V21, P739, DOI 10.1093/beheco/arq047; Klein JT, 2008, CURR BIOL, V18, P419, DOI 10.1016/j.cub.2008.02.047; Lindburg D. G., 1977, P223; NC3Rs, 2006, NC3RS GUID PRIM ACC; Ogura T, 2012, J APPL ANIM WELF SCI, V15, P101, DOI 10.1080/10888705.2012.624887; Ogura T, 2011, ANIM COGN, V14, P427, DOI 10.1007/s10071-010-0377-y; Orlans F Barbara, 1991, Ilar News, V33, P48; Platt DM, 1997, APPL ANIM BEHAV SCI, V52, P139, DOI 10.1016/S0168-1591(96)01093-3; Prescott MJ, 2010, J NEUROSCI METH, V193, P167, DOI 10.1016/j.jneumeth.2010.09.003; Ramirez-Cardenas A, 2015, CURR BIOL, P1285; SACKETT GP, 1965, PERCEPT MOTOR SKILL, V20, P1027, DOI 10.2466/pms.1965.20.3c.1027; Sanayei M, 2015, EUR J NEUROSCI, V41, P947, DOI 10.1111/ejn.12857; Southwick C.H., 1965, PRIMATES BEHAV FIELD, P111, DOI DOI 10.1016/J.JHEALECO.2003.08.004; SWARTZ KB, 1980, ANIM LEARN BEHAV, V8, P311, DOI 10.3758/BF03199611; Thiele A, 2006, J NEUROSCI METH, V158, P207, DOI 10.1016/j.jneumeth.2006.05.032; Waitt C, 2003, P ROY SOC B-BIOL SCI, V270, pS144, DOI 10.1098/rsbl.2003.0065; Washburn DA, 1997, LEARN MOTIV, V28, P510, DOI 10.1006/lmot.1997.0981; WASHBURN DA, 1994, PERCEPT MOTOR SKILL, V78, P48, DOI 10.2466/pms.1994.78.1.48; Watson KK, 2012, ANIM COGN, V15, P401, DOI 10.1007/s10071-011-0467-5; Westlund K, 2012, J NEUROSCI METH, V204, P202, DOI 10.1016/j.jneumeth.2011.03.021; Willems RA, 2009, LAB ANIMAL, V38, P325, DOI 10.1038/laban1009-325	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178048	10.1371/journal.pone.0178048	http://dx.doi.org/10.1371/journal.pone.0178048			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542356	Green Published, gold			2022-12-26	WOS:000402062800039
J	Shi, K; Gu, JY; Guo, HJ; Zhao, LS; Xie, YD; Xiong, HC; Li, JH; Zhao, SR; Song, XY; Liu, LX				Shi, Kui; Gu, Jiayu; Guo, Huijun; Zhao, Linshu; Xie, Yongdun; Xiong, Hongchun; Li, Junhui; Zhao, Shirong; Song, Xiyun; Liu, Luxiang			Transcriptome and proteomic analyses reveal multiple differences associated with chloroplast development in the spaceflight-induced wheat albino mutant mta	PLOS ONE			English	Article							RNA-SEQ DATA; PROTEIN EXTRACTION; DNA METHYLATION; CHLOROPHYLL; BIOGENESIS; DIVISION; GENES; LOCUS; PIF3	Chloroplast development is an integral part of plant survival and growth, and occurs in parallel with chlorophyll biosynthesis. However, little is known about the mechanisms underlying chloroplast development in hexaploid wheat. Here, we obtained a spaceflight-induced wheat albino mutant mta. Chloroplast ultra-structural observation showed that chloroplasts of mta exhibit abnormal morphology and distribution compared to wild type. Photosynthetic pigments content was also significantly decreased in mta. Transcriptome and chloroplast proteome profiling of mta and wild type were done to identify differentially expressed genes (DEGs) and proteins (DEPs), respectively. In total 4,588 DEGs including 1,980 up-and 2,608 down-regulated, and 48 chloroplast DEPs including 15 up-and 33 down-regulated were identified in mta. Classification of DEGs revealed that most were involved in chloroplast development, chlorophyll biosynthesis, or photosynthesis. Besides, transcription factors such as PIF3, GLK and MYB which might participate in those pathways were also identified. The correlation analysis between DEGs and DEPs revealed that the transcript-toprotein in abundance was functioned into photosynthesis and chloroplast relevant groups. Real time qPCR analysis validated that the expression level of genes encoding photosynthetic proteins was significantly decreased in mta. Together, our results suggest that the molecular mechanism for albino leaf color formation in mta is a thoroughly regulated and complicated process. The combined analysis of transcriptome and proteome afford comprehensive information for further research on chloroplast development mechanism in wheat. And spaceflight provides a potential means for mutagenesis in crop breeding.	[Shi, Kui; Song, Xiyun; Liu, Luxiang] Qingdao Agr Univ, Sch Life Sci, Qingdao, Shandong, Peoples R China; [Shi, Kui; Gu, Jiayu; Guo, Huijun; Zhao, Linshu; Xie, Yongdun; Xiong, Hongchun; Li, Junhui; Zhao, Shirong; Liu, Luxiang] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China	Qingdao Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Song, XY; Liu, LX (corresponding author), Qingdao Agr Univ, Sch Life Sci, Qingdao, Shandong, Peoples R China.; Liu, LX (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China.	songxy@qau.edu.cn; liuluxiang@caas.cn			National Key Research and Development Program of China [2016YFD0102101]; National 973 Program [2014C6138101]; Core Research Budget of the Non-profit Governmental Research Institutions	National Key Research and Development Program of China; National 973 Program(National Basic Research Program of China); Core Research Budget of the Non-profit Governmental Research Institutions	This work was supported by the National Key Research and Development Program of China: grant no. 2016YFD0102101, the National 973 Program: grant no. 2014C6138101, and Core Research Budget of the Non-profit Governmental Research Institutions (ICS, CMS).	Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bao WK., 2005, CHIN J APP ENV BIOL, V11, P235, DOI DOI 10.3321/J.ISSN:1006-687X.2005.02.026; Barry CS, 2012, PLANT PHYSIOL, V159, P1086, DOI 10.1104/pp.112.197483; Beale SI, 2005, TRENDS PLANT SCI, V10, P309, DOI 10.1016/j.tplants.2005.05.005; Chan KX, 2016, ANNU REV PLANT BIOL, V67, P25, DOI 10.1146/annurev-arplant-043015-111854; Chiang YH, 2012, PLANT PHYSIOL, V160, P332, DOI 10.1104/pp.112.198705; de Luna-Valdez LA, 2014, J PROTEOMICS, V111, P148, DOI 10.1016/j.jprot.2014.07.003; Deng XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099564; Eckstein A, 2016, PHYSIOL PLANTARUM, V156, P351, DOI 10.1111/ppl.12396; Fan PX, 2009, ELECTROPHORESIS, V30, P3024, DOI 10.1002/elps.200900172; Fitter DW, 2002, PLANT J, V31, P713, DOI 10.1046/j.1365-313X.2002.01390.x; Gabruk M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116990; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu JY, 2014, PLANT GENET RESOUR-C, V12, pS99, DOI 10.1017/S1479262114000367; Guo HJ, 2012, J INTEGR AGR, V11, P888, DOI 10.1016/S2095-3119(12)60079-3; Hellinger R, 2015, J PROTEOME RES, V14, P4851, DOI 10.1021/acs.jproteome.5b00681; Hou DY, 2009, BMB REPORTS; Jung SH, 2014, BIOMETRICAL J, V56, P129, DOI 10.1002/bimj.201300048; Kamal AM, 2013, J PROTEOMICS, V93, P326, DOI 10.1016/j.jprot.2013.03.009; Kumar D, 2016, PROTEOMICS, V16, P226, DOI 10.1002/pmic.201500263; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin YP, 2014, PLANT J, V80, P14, DOI 10.1111/tpj.12611; Ma CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep33369; Maple J, 2007, ANN BOT-LONDON, V99, P565, DOI 10.1093/aob/mcl249; Masuda T, 2008, PHOTOCH PHOTOBIO SCI, V7, P1131, DOI 10.1039/b807210h; Monte E, 2004, P NATL ACAD SCI USA, V101, P16091, DOI 10.1073/pnas.0407107101; Osteryoung KW, 2003, SCIENCE, V302, P1698, DOI 10.1126/science.1082192; Ou XF, 2009, MUTAT RES-FUND MOL M, V662, P44, DOI 10.1016/j.mrfmmm.2008.12.004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pogson BJ, 2015, BBA-BIOENERGETICS, V1847, P1017, DOI 10.1016/j.bbabio.2015.02.003; Pogson BJ, 2008, TRENDS PLANT SCI, V13, P602, DOI 10.1016/j.tplants.2008.08.008; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Rossini L, 2001, PLANT CELL, V13, P1231, DOI 10.1105/tpc.13.5.1231; Sakuraba Y, 2013, PLANT J, V74, P122, DOI 10.1111/tpj.12110; Sanchez C, 2014, FOOD CHEM, V163, P37, DOI 10.1016/j.foodchem.2014.04.041; Sandhu D, 2016, PLANT SCI, V252, P76, DOI 10.1016/j.plantsci.2016.07.006; Shi DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080107; Stephenson PG, 2009, P NATL ACAD SCI USA, V106, P7654, DOI 10.1073/pnas.0811684106; Uimari A, 1997, PLANT J, V12, P1273, DOI 10.1046/j.1365-313x.1997.12061273.x; Vanyushin BF, 2011, BBA-GENE REGUL MECH, V1809, P360, DOI 10.1016/j.bbagrm.2011.04.006; Vazquez A-O, 2014, PLANT CELL, V26, P2524; Vincent A, 2011, CLIN CANCER RES, V17, P4341, DOI 10.1158/1078-0432.CCR-10-3431; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang XC, 2007, ELECTROPHORESIS, V28, P3976, DOI 10.1002/elps.200600805; Waters MT, 2008, PLANT J, V56, P432, DOI 10.1111/j.1365-313X.2008.03616.x; Waters MT, 2009, EMBO J, V28, P2861, DOI 10.1038/emboj.2009.264; Yang J, 2012, GENET MOL RES, V11, P3379, DOI 10.4238/2012.September.25.6; Yang YX, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00139; Yasumura Y, 2005, PLANT CELL, V17, P1894, DOI 10.1105/tpc.105.033191; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhao YX, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-18; Zhou KN, 2013, PLANTA, V237, P279, DOI 10.1007/s00425-012-1756-1; Zienkiewicz A, 2014, METHODS MOL BIOL, V1072, P85, DOI 10.1007/978-1-62703-631-3_7	54	16	17	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177992	10.1371/journal.pone.0177992	http://dx.doi.org/10.1371/journal.pone.0177992			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542341	Green Submitted, Green Published, gold			2022-12-26	WOS:000402061500051
J	Park, J; Lee, SH; Han, S; Jee, HS; Lee, SK; Choi, GS; Kim, GS				Park, Jungchan; Lee, Seung Hwa; Han, Sangbin; Jee, Hyun Sook; Lee, Suk-Koo; Choi, Gyu-Seong; Kim, Gaab Soo			Preoperative cardiac troponin level is associated with all-cause mortality of liver transplantation recipients	PLOS ONE			English	Article							NONCARDIAC SURGERY; MYOCARDIAL INJURY; ELEVATION; SURVIVAL	This study was aimed to evaluate the association between preoperative high-sensitivity cardiac troponin I (hs-cTnI) level and mortality in patients undergoing liver transplantation (LT). From January 2011 to May 2016, preoperative hs-cTnI level was measured in consecutive 487 patients scheduled for LT. Patients with elevated preoperative hs-cTnI were compared with those who had normal level. The primary outcome was all-cause death in follow-up period of 30 days to 1 year after operation. Of the 487 patients, 58 (11.9%) had elevated preoperative hs-cTnI and 429 (88.1%) had normal preoperative hs-cTnI. In multivariate analysis, the rate of 1-year mortality and 30-day mortality were higher in elevated preoperative hs-cTnI group (hazard ratio [HR], 3.69; confidence interval [CI] 95%, 1.83-7.42; p < 0.001, HR, 6.61; CI, 1.91-22.82; p = 0.003, respectively). After adjustment with inverse probability weighting (IPW), the incidence of 1-year mortality and 30-day mortality were higher in elevated group (HR, 4.66; CI, 3.56-6.1; p < 0.001, HR, 10.31; CI, 6.39-16.66; p < 0.001, respectively). In conclusion, this study showed that in patients who underwent LT, elevation of preoperative hs-cTnI level was associated with 1-year mortality and 30-day mortality.	[Park, Jungchan; Han, Sangbin; Jee, Hyun Sook; Kim, Gaab Soo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Lee, Seung Hwa] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Heart Vasc Stroke Inst, Seoul, South Korea; [Lee, Suk-Koo; Choi, Gyu-Seong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, GS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea.	gskim@skku.edu		Lee, Seung Hwa/0000-0001-5508-7519				Agewall S, 2011, EUR HEART J, V32, P404, DOI 10.1093/eurheartj/ehq456; Apple FS, 2002, CIRCULATION, V106, P2941, DOI 10.1161/01.CIR.0000041254.30637.34; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Beckman JA, 2013, CIRCULATION, V127, P2253, DOI 10.1161/CIRCULATIONAHA.113.003195; Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937; Caselli C, 2016, CLIN CHIM ACTA, V458, P68, DOI 10.1016/j.cca.2016.04.029; Coss E, 2011, LIVER TRANSPLANT, V17, P23, DOI 10.1002/lt.22140; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; Devereaux PJ, 2011, ANN INTERN MED, V154, P523, DOI 10.7326/0003-4819-154-8-201104190-00003; Giannitsis E, 2000, CIRCULATION, V102, P211, DOI 10.1161/01.CIR.102.2.211; Gijsberts CM, 2016, NETH HEART J, V24, P188, DOI 10.1007/s12471-015-0798-y; Gorgun E, 2016, ANN SURG, V264, P605, DOI 10.1097/SLA.0000000000001854; Levy M, 2011, ANESTHESIOLOGY, V114, P796, DOI 10.1097/ALN.0b013e31820ad503; Mahajan VS, 2011, CIRCULATION, V124, P2350, DOI 10.1161/CIRCULATIONAHA.111.023697; Maile MD, 2016, ANESTH ANALG, V123, P135, DOI 10.1213/ANE.0000000000001309; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Moini M, 2011, CLIN TRANSPLANT, V25, P638, DOI 10.1111/j.1399-0012.2010.01350.x; Nishio Y, 2007, CIRC J, V71, P631, DOI 10.1253/circj.71.631; Parekh NK, 2007, HEPATOLOGY, V45, P1489, DOI 10.1002/hep.21640; Safadi A, 2009, CIRCULATION, V120, P1189, DOI 10.1161/CIRCULATIONAHA.108.847178; Snipelisky D, 2013, J TRANSPLANT, V2013, DOI 10.1155/2013/252838; van Waes JAR, 2013, CIRCULATION, V127, P2264, DOI 10.1161/CIRCULATIONAHA.113.002128; Watt KDS, 2010, LIVER TRANSPLANT, V16, P990, DOI 10.1002/lt.22102; Zanchin T, 2016, CIRC-CARDIOVASC INTE, P9	24	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177838	10.1371/journal.pone.0177838	http://dx.doi.org/10.1371/journal.pone.0177838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542299	Green Submitted, gold, Green Published			2022-12-26	WOS:000402058800028
J	Zhang, Y; Dai, XB; Yang, S; Zhang, C; Han, M; Huang, HF; Fan, JX				Zhang, Yong; Dai, Xiaobei; Yang, Shuai; Zhang, Chen; Han, Mi; Huang, He-Feng; Fan, Jianxia			Maternal low thyroxin levels are associated with adverse pregnancy outcomes in a Chinese population	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; 5-MONOPHOSPHATE-ACTIVATED PROTEIN-KINASE; SUBCLINICAL THYROID-DISEASE; TANDEM MASS-SPECTROMETRY; TPO-ANTIBODY POSITIVITY; INCREASED RISK; CARDIOVASCULAR-SYSTEM; GENERATION R; HORMONE; DYSFUNCTION	Although thyroid dysfunction in early pregnancy may have adverse effects on pregnancy outcomes, few studies have examined the relationship between maternal low free thyroxin (FT4) levels in both first and third trimesters of pregnancy and the incidence of adverse pregnancy outcomes. We hypothesized that low FT4 levels in either first or third trimesters of pregnancy may have different effects on pregnancy outcomes. The study included 6,031 mothers who provided both first and third pregnancy serum samples for analyses of thyroid function. Adverse pregnancy outcomes, such as gestational diabetes mellitus (GDM), pregnancy-induced hypertension and preeclampsia, were diagnosed using the oral glucose tolerance test, blood pressure and urine protein test. Serum metabolites like adenosine and its analogues were identified using hydrophilic interaction liquid chromatography (HILIC)-tandem mass spectrometry (MS/MS). The incidence of hypothyroidism in pregnant women tended to increase with age and pre-pregnancy body mass index (BMI). The incidence of GDM was negatively correlated with maternal FT4 levels during early pregnancy while the incidence of preeclampsia was negatively correlated with maternal FT4 levels during late pregnancy. The incidence of pregnancy-induced hypertension was not significantly correlated with maternal FT4 levels. The women who had isolated maternal hypothyroxemia (IMH) in the third trimester of pregnancy had an increased risk of developing preeclampsia. Some metabolites like adenosine and its analogues in the serum were significantly changed in pregnant mothers with IMH. In conclusion, low FT4 levels during pregnancy are a risk factor for GDM and preeclampsia. Adenosine and its analogues may be important bridges between IMH and preeclampsia.	[Zhang, Yong; Dai, Xiaobei; Yang, Shuai; Zhang, Chen; Han, Mi; Huang, He-Feng; Fan, Jianxia] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai, Peoples R China; [Zhang, Yong; Huang, He-Feng] Shanghai Jiao Tong Univ, Sch Med, Inst Embryo Fetal Original Adult Dis, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Huang, HF; Fan, JX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Shanghai, Peoples R China.; Huang, HF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Embryo Fetal Original Adult Dis, Shanghai, Peoples R China.	huanghefg@hotmail.com; fanjianxia122@126.com	Huang, Hefeng/AAR-7184-2021; Huang, He-Feng/AAN-7985-2020; Huang, Hefeng/ABF-1117-2020	Huang, He-Feng/0000-0003-4344-8019; Fan, Jianxia/0000-0003-3338-877X	National Natural Science Foundation of China [81471516, 81501274]; Shanghai Pujiang Program [15PJ1408900]; Shanghai Municipal Commission of Health and Family Planning [15GWZK0701]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai Municipal Commission of Health and Family Planning	This work was supported by grants from the National Natural Science Foundation of China (81471516) to JF, National Natural Science Foundation of China (81501274) to YZ, Shanghai Pujiang Program (15PJ1408900) to YZ and the Shanghai Municipal Commission of Health and Family Planning (No. 15GWZK0701) to JF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarawal N, 2014, GYNECOL OBSTET INVES, V77, P94, DOI 10.1159/000357615; Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Breathnach FM, 2013, AUST NZ J OBSTET GYN, V53, P553, DOI 10.1111/ajo.12131; Casey BM, 2005, OBSTET GYNECOL, V105, P239, DOI 10.1097/01.AOG.0000152345.99421.22; Casey BM, 2007, OBSTET GYNECOL, V109, P1129, DOI 10.1097/01.AOG.0000262054.03531.24; Chan S, 2015, CLIN ENDOCRINOL, V82, P313, DOI 10.1111/cen.12605; Cleary-Goldman J, 2008, OBSTET GYNECOL, V112, P85, DOI 10.1097/AOG.0b013e3181788dd7; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; Dutta D, 2016, JOURNAL OF POSTGRADU; Fazio S, 2004, RECENT PROG HORM RES, V59, P31, DOI 10.1210/rp.59.1.31; Guzman-Gutierrez E, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00136; Guzman-Gutierrez E, 2014, MICROCIRCULATION, V21, P26, DOI 10.1111/micc.12077; Hamm MP, 2009, J OBSTET GYNAECOL CA, V31, P1015, DOI 10.1016/S1701-2163(16)34345-6; Karakosta P, 2012, J CLIN ENDOCR METAB, V97, P4464, DOI 10.1210/jc.2012-2540; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Korevaar TIM, 2013, J CLIN ENDOCR METAB, V98, P4382, DOI 10.1210/jc.2013-2855; Kumru P, 2015, ARCH GYNECOL OBSTET, V291, P1047, DOI 10.1007/s00404-014-3533-9; Mannisto T, 2013, J CLIN ENDOCR METAB, V98, P2725, DOI 10.1210/jc.2012-4233; Mannisto T, 2010, J CLIN ENDOCR METAB, V95, P1084, DOI 10.1210/jc.2009-1904; Matsumoto T, 2015, BRIT J PHARMACOL, V172, P3980, DOI 10.1111/bph.13205; Medici M, 2014, J CLIN ENDOCR METAB, V99, pE2591, DOI 10.1210/jc.2014-1505; Napoli R, 2001, CIRCULATION, V104, P3076, DOI 10.1161/hc5001.100621; Olivieri A, 2000, EUR J ENDOCRINOL, V143, P741, DOI 10.1530/eje.0.1430741; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Qian W, 2013, GYNECOL ENDOCRINOL, V29, P1059, DOI 10.3109/09513590.2013.829448; Saki F, 2015, ENDOCR RES, V40, P139, DOI 10.3109/07435800.2014.966384; Salomon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040578; Scalbert A, 2009, METABOLOMICS, V5, P435, DOI 10.1007/s11306-009-0168-0; Smallridge RC, 2001, J CLIN ENDOCR METAB, V86, P2349, DOI 10.1210/jc.86.6.2349; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Tudela CM, 2012, OBSTET GYNECOL, V119, P983, DOI 10.1097/AOG.0b013e318250aeeb; Vargas R, 2013, J BIOL REG HOMEOS AG, V27, P989; Vargas R, 2017, IMMUNOL LETT, V184, P92, DOI 10.1016/j.imlet.2017.01.007; Velkoska NV, 2010, SEC BIOL SCI MASA, V31, P51; Warth B, 2015, J CHROMATOGR A, V1423, P183, DOI 10.1016/j.chroma.2015.10.070; Westermeier F, 2011, DIABETES, V60, P1677, DOI 10.2337/db11-0155; Wilson KL, 2012, OBSTET GYNECOL, V119, P315, DOI 10.1097/AOG.0b013e318240de6a; Xian H, 2017, GENE; Yamauchi M, 2008, MOL ENDOCRINOL, V22, P893, DOI 10.1210/me.2007-0249; Yang S, 2016, J CLIN ENDOCR METAB, V101, P4237, DOI 10.1210/jc.2016-1506; Ying H, 2016, ENDOCRINE, V54, P742, DOI 10.1007/s12020-016-1022-6; Zhang GD, 2014, J CHROMATOGR A, V1325, P129, DOI 10.1016/j.chroma.2013.12.017; Zhu L, 2016, ADVANCES IN COMMUNICATIONS-BASED TRAIN CONTROL SYSTEMS, P1	43	32	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178100	10.1371/journal.pone.0178100	http://dx.doi.org/10.1371/journal.pone.0178100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542464	Green Submitted, Green Published, gold			2022-12-26	WOS:000402058800039
J	Nicholls, SB; Devos, SL; Commins, C; Nobuhara, C; Bennett, RE; Corjuc, DL; Maury, E; Eftekharzadeh, B; Akingbade, O; Fan, ZY; Roe, AD; Takeda, S; Wegmann, S; Hyman, BT				Nicholls, Samantha B.; DeVos, Sarah L.; Commins, Caitlin; Nobuhara, Chloe; Bennett, Rachel E.; Corjuc, Diana L.; Maury, Eduardo; Eftekharzadeh, Bahareh; Akingbade, Ololade; Fan, Zhanyun; Roe, Allyson D.; Takeda, Shuko; Wegmann, Susanne; Hyman, Bradley T.			Characterization of TauC3 antibody and demonstration of its potential to block tau propagation	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; MOUSE MODEL; PROTEIN; TAUOPATHY; SEQUENCE; CLEAVAGE	The spread of neurofibrillary tangle (NFT) pathology through the human brain is a hallmark of Alzheimer's disease (AD), which is thought to be caused by the propagation of "seeding" competent soluble misfolded tau. "TauC3", a C-terminally truncated form of tau that is generated by caspase-3 cleavage at D421, has previously been observed in NFTs and has been implicated in tau toxicity. Here we show that TauC3 is found in the seeding competent high molecular weight (HMW) protein fraction of human AD brain. Using a specific TauC3 antibody, we were able to substantially block the HMW tau seeding activity of human AD brain extracts in an in vitro tau seeding FRET assay. We propose that TauC3 could contribute to the templated tau misfolding that leads to NFT spread in AD brains.	[Nicholls, Samantha B.; DeVos, Sarah L.; Commins, Caitlin; Nobuhara, Chloe; Bennett, Rachel E.; Corjuc, Diana L.; Maury, Eduardo; Eftekharzadeh, Bahareh; Akingbade, Ololade; Fan, Zhanyun; Roe, Allyson D.; Takeda, Shuko; Wegmann, Susanne; Hyman, Bradley T.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Hyman, BT (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA.	bhyman@mgh.harvard.edu	Bennett, Rachel/AAU-6949-2020	Bennett, Rachel/0000-0001-9640-0575; Nicholls, Samantha/0000-0002-6001-7256	Intellect Neurosciences INC; NATIONAL INSTITUTE ON AGING [P50AG005134] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [17H05080] Funding Source: KAKEN	Intellect Neurosciences INC; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a sponsored research agreement from Intellect Neurosciences INC (http://www.intellectns.com/). Intellect Neurosciences also provided the anti-TauC3 antibody. Intellect Neurosciences had no role in study design, data collection and analysis, or preparation of the manuscript. They did approve the manuscript to be published. The Massachusetts Alzheimer Disease Research Center Brain Bank provided tissue samples (P50AG005134).; This work was supported by a sponsored research agreement from Intellect Neurosciences INC. Intellect Neurosciences also provided the anti-TauC3 antibody. Thanks to Dr. Kelly Arnett and the HMS Center for Macromolecular Interactions for training and helpful discussions on Biacore experiments. The Massachusetts Alzheimer Disease Research Center Brain Bank provided tissue samples (P50AG005134).	Barghorn Stefan, 2004, V299, P35; Barthelemy NR, 2016, J PROTEOME RES, V15, P667, DOI 10.1021/acs.jproteome.5b01001; Chung CW, 2001, NEUROBIOL DIS, V8, P162, DOI 10.1006/nbdi.2000.0335; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Halfmann R., 2008, J VIS EXP, P838; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Kim Y, 2016, NEUROBIOL DIS, V87, P19, DOI 10.1016/j.nbd.2015.12.006; Kopeikina KJ, 2011, AM J PATHOL, V179, P2071, DOI 10.1016/j.ajpath.2011.07.004; Mondragon-Rodriguez S, 2014, NEUROPATH APPL NEURO, V40, P121, DOI 10.1111/nan.12084; Nobuhara CK, 2017, AM J PATHOL, V1; Ozcelik S., 2016, MOL PSYCHIAT; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Stoothoff W, 2009, J NEUROCHEM, V111, P417, DOI 10.1111/j.1471-4159.2009.06316.x; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takeda S, 2016, ANN NEUROL, V80, P355, DOI 10.1002/ana.24716; Takeda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9490; Taniguchi-Watanabe S, 2016, ACTA NEUROPATHOL, V131, P267, DOI 10.1007/s00401-015-1503-3; Wang YP, 2010, BIOCHEM SOC T, V38, P955, DOI 10.1042/BST0380955; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011	21	20	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177914	10.1371/journal.pone.0177914	http://dx.doi.org/10.1371/journal.pone.0177914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531180	Green Published, Green Submitted, gold			2022-12-26	WOS:000402058400038
J	Yang, YD; Song, JY; Wang, S; Liu, FH; Zhang, YN; Shang, XR; Wang, HJ; Ma, J				Yang, Yi-De; Song, Jie-Yun; Wang, Shuo; Liu, Fang-Hong; Zhang, Yi-Ning; Shang, Xiao-Rui; Wang, Hai-Jun; Ma, Jun			Genetic variations in sterol regulatory element binding protein cleavage-activating protein (SCAP) are associated with blood pressure in overweight/obese Chinese children	PLOS ONE			English	Article							BODY-MASS INDEX; LIPID-LOWERING RESPONSE; CARDIOVASCULAR-DISEASE; HYPERTENSION; OBESITY; VARIANTS; SREBP-2; RISK; POLYMORPHISM; METAANALYSIS	Objective Previous studies demonstrated a role of variations in sterol regulatory element binding protein (SREBP) cleavage-activating protein (SCAP) in obesity and blood lipids. But the associations between SCAP polymorphisms and blood pressure (BP) are not clear. This study aimed to investigate the relationship between genetic variations in SCAP and BP phenotypes in a Chinese pediatric population. Methods A case-control study on 702 high blood pressure (HBP) children and 1319 controls was conducted to explore the correlation between single nucleotide polymorphism markers (rs12487736 and rs12490383) of SCAP and BP phenotypes. The associations with continuous and categorical variables were examined by linear regression and logistic regression models under a dominant genetic model for the minor rs12487736 A allele and rs12490383 T allele. Results The rs12487736 polymorphism was significantly associated with systolic BP (SBP) (beta = 1.66, P = 0.003) and diastolic BP (DBP) (beta = 1.35, P = 0.024) with age, age-squared, sex, study population and body mass index (BMI) adjusted under the dominant genetic model. The rs12490383 polymorphism was significantly associated with SBP (beta = 1.71, P = 0.004) and SHBP (OR = 1.39, 95% CI: 1.04-1.86, P = 0.027). When analyzed by BMI categories, in the normal-weight children, no significant association between the SCAP polymorphisms and BP phenotypes was observed (all P > 0.05). However, in the overweight/obese children, rs12487736 was significantly associated with SBP (beta = 1.6, P = 0.019) and SHBP (OR = 1.36, 95% CI: 1.02-1.82; P = 0.037), rs12490383 was associated with SBP (beta = 2.04, P = 0.004) and SHBP (OR = 1.50, 95% CI: 1.10-2.05; P = 0.01). Conclusions This study demonstrated that SCAP rs12487736 and rs12490383 were significantly associated with SBP and SHBP in overweight/obese Chinese children. It provided the evidence for association of SCAP with SBP.	[Yang, Yi-De; Song, Jie-Yun; Wang, Shuo; Liu, Fang-Hong; Zhang, Yi-Ning; Shang, Xiao-Rui; Wang, Hai-Jun; Ma, Jun] Peking Univ, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing, Peoples R China	Peking University	Wang, HJ; Ma, J (corresponding author), Peking Univ, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing, Peoples R China.	majunt@bjmu.edu.cn; whjun1@bjmu.edu.cn	Wang, Haijun/AAD-1302-2021	Wang, Haijun/0000-0003-0849-2903; Yang, Yide/0000-0003-3297-1306	National Natural Science Foundation of China [81573170]; Major State Basic Research and Development Program of China (973 Program) [2012CB517501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research and Development Program of China (973 Program)(National Basic Research Program of China)	This study was supported by Grants from National Natural Science Foundation of China (81573170, HJW, http//www.nsfc.gov.cn/) and the Major State Basic Research and Development Program of China (973 Program) (2012CB517501, JM, http/www.973.gov.cn/Default_3.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, WS T 456 2014; [Anonymous], CHIN J EVID BASED PE; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Chen Z, 2011, MOL BIOL REP, V38, P2895, DOI 10.1007/s11033-010-9951-2; Commodore-Mensah Y, 2014, J HYPERTENS, V32, P464, DOI 10.1097/HJH.0000000000000061; Daniels SR, 2011, CIRCULATION, V124, P1673, DOI 10.1161/CIRCULATIONAHA.110.016170; Dong B, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009050; Dong B, 2013, BIOMED ENVIRON SCI, V26, P437, DOI 10.3967/0895-3988.2013.06.004; Durst R, 2006, ATHEROSCLEROSIS, V189, P443, DOI 10.1016/j.atherosclerosis.2006.01.001; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Fan YM, 2008, THROMB J, V6, DOI 10.1186/1477-9560-6-17; Fiegenbaum M, 2005, PHARMACOGENOMICS J, V5, P359, DOI 10.1038/sj.tpj.6500334; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Friedlander Y, 2008, ATHEROSCLEROSIS, V196, P896, DOI 10.1016/j.atherosclerosis.2007.02.006; Galbete C, 2013, OBESITY, V21, P1486, DOI 10.1002/oby.20150; Haffner SM, 1996, ARCH INTERN MED, V156, P1994, DOI 10.1001/archinte.156.17.1994; Halperin RO, 2006, HYPERTENSION, V47, P45, DOI 10.1161/01.HYP.0000196306.42418.0e; Iwaki K, 1999, J HUM GENET, V44, P421, DOI 10.1007/s100380050193; Ji CY, 2005, BIOMED ENVIRON SCI, V18, P390; Lagos J, 2014, MOL DIAGN THER, V18, P435, DOI 10.1007/s40291-014-0094-3; Le Hellard S, 2009, MOL PSYCHIATR, V14, P308, DOI 10.1038/sj.mp.4002133; Liu FH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/538564; Liu XL, 2010, ATHEROSCLEROSIS, V208, P421, DOI 10.1016/j.atherosclerosis.2009.08.011; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Rafeeq MM, 2016, PHARMACOGENOMICS, V17, P2015, DOI 10.2217/pgs.16.30; Riggio S, 2010, EUR J CLIN INVEST, V40, P250, DOI 10.1111/j.1365-2362.2010.02260.x; Salek L, 2002, J MOL MED-JMM, V80, P737, DOI 10.1007/s00109-002-0381-z; SELBY JV, 1991, JAMA-J AM MED ASSOC, V265, P2079, DOI 10.1001/jama.265.16.2079; Snieder H, 2003, HYPERTENSION, V41, P1196, DOI 10.1161/01.HYP.0000072269.19820.0D; Sorof J, 2002, HYPERTENSION, V40, P441, DOI 10.1161/01.HYP.0000032940.33466.12; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang D, 2010, OBESITY, V18, P573, DOI 10.1038/oby.2009.268	33	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177973	10.1371/journal.pone.0177973	http://dx.doi.org/10.1371/journal.pone.0177973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542467	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672600037
J	Ingram, WS; Yang, JZ; Beadle, BM; Wendt, R; Rao, A; Wang, XA; Court, LE				Ingram, W. Scott; Yang, Jinzhong; Beadle, Beth M.; Wendt, Richard, III; Rao, Arvind; Wang, Xin A.; Court, Laurence E.			The feasibility of endoscopy-CT image registration in the head and neck without prospective endoscope tracking	PLOS ONE			English	Article							3-DIMENSIONAL MOTION TRACKING; SURGERY; VIDEO; BRONCHOSCOPE; ACCURACY; SYSTEM	Purpose Endoscopic examinations are frequently-used procedures for patients with head and neck cancer undergoing radiotherapy, but radiation treatment plans are created on computed tomography (CT) scans. Image registration between endoscopic video and CT could be used to improve treatment planning and analysis of radiation-related normal tissue toxicity. The purpose of this study was to explore the feasibility of endoscopy-CT image registration without prospective physical tracking of the endoscope during the examination. Methods A novel registration technique called Location Search was developed. This technique uses physical constraints on the endoscope's view direction to search for the virtual endoscope coordinates that maximize the similarity between the endoscopic video frame and the virtual endoscopic image. Its performance was tested on phantom and patient images and compared to an established registration technique, Frame-To-Frame Tracking. Results In phantoms, Location Search had average registration errors of 0.55 +/- 0.60 cm for point measurements and 0.29 +/- 0.15 cm for object surface measurements. Frame-To-Frame Tracking achieved similar results on some frames, but it failed on others due to the virtual endoscope becoming lost. This weakness was more pronounced in patients, where Frame-To-Frame tracking could not make it through the nasal cavity. On successful patient video frames, Location Search was able to find endoscope positions with an average distance of 0.98 +/- 0.53 cm away from the ground truth positions. However, it failed on many frames due to false similarity matches caused by anatomical structural differences between the endoscopic video and the virtual endoscopic images. Conclusions Endoscopy-CT image registration without prospective physical tracking of the endoscope is possible, but more development is required to achieve an accuracy suitable for clinical translation.	[Ingram, W. Scott; Yang, Jinzhong; Wang, Xin A.; Court, Laurence E.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; [Ingram, W. Scott; Yang, Jinzhong; Wendt, Richard, III; Rao, Arvind; Wang, Xin A.; Court, Laurence E.] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77204 USA; [Beadle, Beth M.] Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA; [Wendt, Richard, III] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA; [Rao, Arvind] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ingram, WS (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA.; Ingram, WS (corresponding author), Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77204 USA.	scottingram312@gmail.com		Beadle, Beth/0000-0001-5497-2831; Court, Laurence/0000-0002-3241-6145	National Institutes of Health through the Cancer Center [P30CA01672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health through the Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are grateful for the support of Mr. and Mrs. William D. Rollnick and The University of Texas MD Anderson Center for Radiation Oncology Research. This work was supported in part by the National Institutes of Health through the Cancer Center Support Grant P30CA01672 for The University of Texas MD Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anayama T, 2015, ANN THORAC SURG, V99, P224, DOI 10.1016/j.athoracsur.2014.07.050; Bradski G., 2008, LEARNING OPENCV COMP; Burschka D, 2005, MED IMAGE ANAL, V9, P413, DOI 10.1016/j.media.2005.05.005; Deligianni F, 2003, LECT NOTES COMPUT SC, V2878, P311; Fried MP, 1997, LARYNGOSCOPE, V107, P594, DOI 10.1097/00005537-199705000-00008; Hartley R., 2003, MULTIPLE VIEW GEOMET, Vsecond; Luo XB, 2014, PROC CVPR IEEE, P1250, DOI 10.1109/CVPR.2014.163; Luo XB, 2014, IEEE T MED IMAGING, V33, P1248, DOI 10.1109/TMI.2014.2307052; Mirota DJ, 2013, IEEE T MED IMAGING, V32, P1215, DOI 10.1109/TMI.2013.2243464; Mori K, 2002, MED IMAGE ANAL, V6, P321, DOI 10.1016/S1361-8415(02)00089-0; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Pluim JPW, 2000, LECT NOTES COMPUT SC, V1935, P452; Qiu J, 2012, PHYS MED BIOL, V57, P6601, DOI 10.1088/0031-9155/57/20/6601; Schroeder W., 2006, VISUALIZATION TOOLKI, V4th; Weersink RA, 2011, MED PHYS, V38, P6458, DOI 10.1118/1.3658569	15	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177886	10.1371/journal.pone.0177886	http://dx.doi.org/10.1371/journal.pone.0177886			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542331	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400107
J	Tan, XB; Dai, QY				Tan, Xiaobing; Dai, Qingyuan			Characterization of microRNAs expression profiles in human dental-derived pluripotent stem cells	PLOS ONE			English	Article							SELF-RENEWAL; IDENTIFICATION; TARGET	Induced pluripotent stem cells (iPSCs) technology provides a powerful means to generate and regenerate unlimited pluripotent stem cells directly from body tissue cells. Stem cells from apical papilla (SCAP) and Dental pulp stem cells (DPSCs) are present in 'cell-rich zones' within the dental pulp region, which are capable of regenerating pulp and dentin tissues in vivo. In this study, we investigated the difference of miRNAs expression in SCAPs and DPSCs before and after the reprogramming. Using miRNA microarray, 134 and 265 differentially expressed miRNAs in DPSCs-and SCAP-iPSCs were up-regulated compared to these before reprogramming. 117 specific miRNAs with enhanced more than 2-fold were identified in both DPSCs-and SCAP-iPSCs. Among the co-regulated miRNAs, miR-19a-3p, miR-92b-3p and miR-130b-3p showed the maximum difference, which had involvement in the cell cycle, TGF beta signaling pathway and epithelial mesenchymal transition. Using qRT-PCR analysis, the expression of miR-19a-3p, miR-92b-3p and miR-130b-3p indicated substantial increases in DPSCs-iPSCs and SCAP-iPSCs. The findings suggest that miRNAs play a part in the difference between DPSCs-iPSCs and DPSCs, as well as between SCAP-iPSCs and SCAP. The variation of miRNA expression in reprogrammed dental-derived pluripotent stem cells revealed different characteristics induced by iPSC generation.	[Tan, Xiaobing] First Peoples Hosp Yunnan Prov, Dept Cariol & Endodont, Kunming, Peoples R China; [Tan, Xiaobing] Kunming Univ Sci & Technol, Affiliated Hosp, Dept Cariol & Endodont, Kunming, Peoples R China; [Dai, Qingyuan] Kunming Med Univ, Dept Cardiol, Affiliated Hosp 1, Kunming, Peoples R China	Kunming University of Science & Technology; Kunming Medical University	Dai, QY (corresponding author), Kunming Med Univ, Dept Cardiol, Affiliated Hosp 1, Kunming, Peoples R China.	dqy_km@163.com			National Natural Science Foundation of China [81360161]; Yunnan Provincial Department of Education Science Foundation of China [2015Y153]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Department of Education Science Foundation of China	This study was supported by National Natural Science Foundation of China (81360161) and Yunnan Provincial Department of Education Science Foundation of China (2015Y153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by National Natural Science Foundation of China (81360161) and Yunnan Provincial Department of Education Science Foundation of China (2015Y153).	Balaga O, 2012, NUCLEIC ACIDS RES, V40, P9404, DOI 10.1093/nar/gks759; Barrett JR, 2004, ENVIRON HEALTH PERSP, V112, pA944; Blauwkamp TA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2064; Busch S, 2015, J IMMUNOL, V194, P1646, DOI 10.4049/jimmunol.1402163; Choi J, 2015, NAT BIOTECHNOL, V33, P1173, DOI 10.1038/nbt.3388; Galvin-Burgess KE, 2013, STEM CELLS, V31, P48, DOI 10.1002/stem.1252; Hausser J, 2014, NAT REV GENET, V15, P599, DOI 10.1038/nrg3765; He XL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086982, 10.1371/journal.pone.0104323, 10.1371/journal.pone.0105373]; Hu KJ, 2014, STEM CELLS DEV, V23, P1285, DOI 10.1089/scd.2013.0620; Jonsson ME, 2015, DEVELOPMENT, V142, P3166, DOI 10.1242/dev.122747; La Noce M, 2014, J DENT, V42, P761, DOI 10.1016/j.jdent.2014.02.018; Li S., 2016, PLOS ONE, V11; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Papapetrou EP, 2011, NAT PROTOC, V6, P1251, DOI 10.1038/nprot.2011.374; Sharma Amit, 2013, Methods Mol Biol, V936, P247; Skreka K, 2012, NUCLEIC ACIDS RES, V40, P6001, DOI 10.1093/nar/gks311; Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tirino Virginia, 2012, Methods Mol Biol, V879, P443, DOI 10.1007/978-1-61779-815-3_26; Tokudome T, 2015, ONCOL LETT, V10, P2269, DOI 10.3892/ol.2015.3594; Vasanthan P, 2015, J CELL MOL MED, V19, P566, DOI 10.1111/jcmm.12381; Walter W, 2015, BIOINFORMATICS, V31, P2912, DOI 10.1093/bioinformatics/btv300; Wang Z., 2015, PLOS ONE, V10; Wend P, 2010, SEMIN CELL DEV BIOL, V25, P254; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zou XY, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt134	27	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177832	10.1371/journal.pone.0177832	http://dx.doi.org/10.1371/journal.pone.0177832			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542487	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400095
J	Baez, PA; Lopez, MC; Duque-Jaramillo, A; Pelaez, D; Molina, F; Navas, MC				Baez, Paula A.; Lopez, Maria Camila; Duque-Jaramillo, Alejandra; Pelaez, Dioselina; Molina, Francisco; Navas, Maria-Cristina			First evidence of the Hepatitis E virus in environmental waters in Colombia	PLOS ONE			English	Article							NON-B-HEPATITIS; ENTERIC VIRUSES; HEV ANTIBODIES; FOOD-BORNE; GENOTYPE 3; A VIRUS; SEWAGE; INFECTION; SAMPLES; SWINE	Hepatitis E virus (HEV) is one of the main causes of acute viral hepatitis of enteric transmission. HEV has been detected in environmental samples in several countries from Europe and Asia, constituting a risk factor for waterborne infection. In Colombia, HEV has been identified in samples obtained from patients as well as from swine, but no environmental studies have been carried out. To determine if HEV is present in environmental waters, samples from the main source of drinking water plant and of wastewater system of eight municipalities and two villages of Antioquia state (North West Colombia), were collected between December 2012 and April 2014. The HEV genome was detected by RT-PCR in 23.3% (7/30) of the samples from the main source of drinking water plants and in 16.7% (5/30) from sewage. Viral concentrates obtained from three positive sewage samples were used to inoculate HepG2 cell cultures that were followed for one month; however, the viral genome was not detected in any cell culture. This study demonstrates the circulation of HEV in both source of drinking water plants and wastewater in Antioquia state, Colombia. The presence of HEV in environmental waters could be a risk for waterborne transmission in this population. The findings of the present study, together with the evidence of HEV circulation in human and swine in Colombia, should be consider by public health authorities for the development of surveillance programs and the inclusion of HEV infection diagnosis in the guidelines of viral hepatitis in the country. This is the first report of HEV in environmental samples in Colombia and the second one in Latin America.	[Baez, Paula A.; Lopez, Maria Camila; Duque-Jaramillo, Alejandra; Navas, Maria-Cristina] Univ Antioquia, Fac Med, Grp Gastrohepatol, Medellin, Colombia; [Pelaez, Dioselina] Inst Nacl Salud, Lab Virol, Bogota, Colombia; [Molina, Francisco] Univ Antioquia, Grp Invest Gest & Modelac Ambiental GAIA, Medellin, Colombia	Universidad de Antioquia; Instituto Nacional de Salud (Colombia); Universidad de Antioquia	Navas, MC (corresponding author), Univ Antioquia, Fac Med, Grp Gastrohepatol, Medellin, Colombia.	maria.navas@udea.edu.co	Navas, Maria Cristina/AAE-2528-2022; Jaramillo-Duque, Álvaro/AAU-9284-2021	Jaramillo-Duque, Álvaro/0000-0001-5281-7336; Molina, Francisco/0000-0002-3491-4586; Duque Jaramillo, Alejandra/0000-0002-7821-9737	Departamento Nacional de Ciencia, Innovacion y Tecnologia, Colciencias [111554531673]; Vicerrectoria de Investigacion, Universidad de Antioquia	Departamento Nacional de Ciencia, Innovacion y Tecnologia, Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Vicerrectoria de Investigacion, Universidad de Antioquia	The study was funded by Departamento Nacional de Ciencia, Innovacion y Tecnologia, Colciencias (Grant 111554531673) and Vicerrectoria de Investigacion, Universidad de Antioquia (Proyecto de Sosteni bilidad).	Baez PA, 2016, BIOMEDICA, V36, P135, DOI 10.7705/biomedica.v36i0.2979; Barnaud E, 2012, APPL ENVIRON MICROB, V78, P5153, DOI 10.1128/AEM.00436-12; Beji-Hamza A, 2015, ARCH VIROL, V160, P183, DOI 10.1007/s00705-014-2251-8; Betancur Carlos Alberto, 2013, Acta Med Colomb, V38, P68; Brassard J, 2012, APPL ENVIRON MICROB, V78, P3763, DOI 10.1128/AEM.00251-12; Calgua B, 2008, J VIROL METHODS, V153, P79, DOI 10.1016/j.jviromet.2008.08.003; Calgua B, 2013, J VIROL METHODS, V187, P215, DOI 10.1016/j.jviromet.2012.10.012; Gutierrez-Vergara CC, 2015, IATREIA, V28, P248, DOI 10.17533/udea.iatreia.v28n3a03; Clemente-Casares P, 2003, EMERG INFECT DIS, V9, P448; Cook N, 2015, FOOD ENVIRON VIROL, V7, P189, DOI 10.1007/s12560-015-9196-2; Dell'Amico MC, 2011, EMERG INFECT DIS, V17, P1488, DOI 10.3201/eid1708.100769; Direccion Seccional de Salud de Antioquia, 2000, CAS INC HEP SUBR MUN; Echevarria JM, 2013, J MED VIROL, V85, P1037, DOI 10.1002/jmv.23526; Fajardo S., 2012, PLAN DESARROLLO ANTI, P17; Fierro NA, 2016, WORLD J GASTROENTERO, V22, P2271, DOI 10.3748/wjg.v22.i7.2271; Forero J, 2013, HECHOS MICROBIOLO A, V4; Forero J. E, 2014, Rev. Med. Vet. Zoot., V61, P221, DOI 10.15446/rfmvz.v61n3.46868; Girones R, 2014, J WATER HEALTH, V12, P436, DOI 10.2166/wh.2014.027; González María M, 2006, Rev. salud pública, V8, P13; Greening GE, 2002, J APPL MICROBIOL, V93, P745, DOI 10.1046/j.1365-2672.2002.01741.x; Guerrero-Latorre L, 2016, INT J HYG ENV HLTH; Garcia CG, 2012, J MED VIROL, V84, P1025, DOI 10.1002/jmv.23277; Gutierrez Vergara CC, 2014, CES MED VET ZOOTECN, V9, P158; Gutierrez-Vergara C, 2015, GENET MOL RES, V14, P2890, DOI 10.4238/2015.March.31.20; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hoofnagle JH, 2012, NEW ENGL J MED, V367, P1237, DOI 10.1056/NEJMra1204512; Iaconelli M, 2015, FOOD ENVIRON VIROL, V7, P316, DOI 10.1007/s12560-015-9207-3; Inoue J, 2006, J VIROL METHODS, V137, P325, DOI 10.1016/j.jviromet.2006.07.004; Ippagunta SK, 2007, J MED VIROL, V79, P1827, DOI 10.1002/jmv.21017; Kamar N, 2014, CLIN MICROBIOL REV, V27, P116, DOI 10.1128/CMR.00057-13; Kase JA, 2008, INT J ENVIRON HEAL R, V18, P165, DOI 10.1080/09603120701498311; Khuroo MS, 2011, VIRUS RES, V161, P3, DOI 10.1016/j.virusres.2011.02.007; Kitajima M, 2009, T ROY SOC TROP MED H, V103, P955, DOI 10.1016/j.trstmh.2009.04.004; Kokkinos P, 2012, FOOD ENVIRON VIROL, V4, P179, DOI 10.1007/s12560-012-9087-8; Li TC, 2014, AM J TROP MED HYG, V90, P764, DOI 10.4269/ajtmh.13-0562; dos Santos DRL, 2010, J CLIN VIROL, V47, P276, DOI 10.1016/j.jcv.2009.12.021; Lopes dos Santos DR, 2009, VET J LOND ENGL, V1997, P182; Lorenzo FR, 2008, VIRUS RES, V137, P86, DOI 10.1016/j.virusres.2008.06.005; Wassaf MGM, 2014, J CLIN VIROL, V61, P334, DOI 10.1016/j.jcv.2014.08.016; Masclaux FG, 2013, WATER RES, V47, P5101, DOI 10.1016/j.watres.2013.05.050; Mirazo S, 2014, EMERG INFECT DIS, V20, P171, DOI 10.3201/eid2001.131471; Mirazo S, 2013, VIRUS RES, V173, P364, DOI 10.1016/j.virusres.2013.01.005; Villalba MDM, 2013, INFECT GENET EVOL, V14, P335, DOI 10.1016/j.meegid.2012.12.022; Villallba MDM, 2008, EMERG INFECT DIS, V14, P1320, DOI 10.3201/eid1408.080049; Munne MS, 2006, J MED VIROL, V78, P1579, DOI 10.1002/jmv.20741; Myrmel M, 2015, FOOD ENVIRON VIROL, V7, P213, DOI 10.1007/s12560-015-9200-x; National Department of Statistics DANE, 2003, FICH TECN CENS ACT P; Okamoto H, 2013, J GASTROENTEROL, V48, P147, DOI 10.1007/s00535-012-0682-0; Okamoto H, 2011, VIRUS RES, V161, P65, DOI 10.1016/j.virusres.2011.01.015; Pelaez D, 2014, BIOMEDICA, V34, P354, DOI [10.7705/biomedica.v34i3.2236, 10.1590/S0120-41572014000300006]; Pelaez D, 2010, BIOMEDICA, V30, P276, DOI 10.7705/biomedica.v30i2.191; Pina S, 1998, APPL ENVIRON MICROB, V64, P4485; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Rein DB, 2012, HEPATOLOGY, V55, P988, DOI 10.1002/hep.25505; Rendon J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148417; Rodriguez-Frias F, 2012, ENFERM INFEC MICR CL, V30, P624, DOI 10.1016/j.eimc.2012.01.014; Rusinol M, 2014, WATER RES, V59, P119, DOI 10.1016/j.watres.2014.04.013; Rutjes SA, 2009, EMERG INFECT DIS, V15, P381, DOI 10.3201/eid1503.071472; Smith DB, 2016, J MED VIROL, V88, P915, DOI 10.1002/jmv.24403; SOBSEY MD, 1985, APPL ENVIRON MICROB, V50, P1457, DOI 10.1128/AEM.50.6.1457-1463.1985; Takahashi M, 2010, J CLIN MICROBIOL, V48, P1112, DOI 10.1128/JCM.02002-09; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka T, 2007, J GEN VIROL, V88, P903, DOI 10.1099/vir.0.82535-0; Tobon F, 2011, REV MVZ CORDOBA, V16, P2605, DOI 10.21897/rmvz.1035; Tobon-Marulanda FA, 2012, REV SALUD PUBLICA, V12, P300, DOI DOI 10.1590/S0124-00642010000200013; Van der Poel WHM, 2014, CURR OPIN VIROL, V4, P91, DOI 10.1016/j.coviro.2014.01.006; VELAZQUEZ O, 1990, JAMA-J AM MED ASSOC, V263, P3281, DOI 10.1001/jama.263.24.3281; World Health Organization, 2012, PREV CONTR VIR HEP I; World Health Organization (WHO), 2015, HEP E FACT SHEET 280; Yazaki Y, 2003, J GEN VIROL, V84, P2351, DOI 10.1099/vir.0.19242-0; Yugo DM, 2013, INT J ENV RES PUB HE, V10, P4507, DOI 10.3390/ijerph10104507	71	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177525	10.1371/journal.pone.0177525	http://dx.doi.org/10.1371/journal.pone.0177525			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520759	Green Published, gold, Green Submitted			2022-12-26	WOS:000401485500036
J	Hajrah, NH; Obaid, AY; Atef, A; Ramadan, AM; Arasappan, D; Nelson, CA; Edris, S; Mutwakil, MZ; Alhebshi, A; Gadalla, NO; Makki, RM; Al-Kordy, MA; El-Domyati, FM; Sabir, JSM; Khiyami, MA; Hall, N; Bahieldin, A; Jansen, RK				Hajrah, Nahid H.; Obaid, Abdullah Y.; Atef, Ahmed; Ramadan, Ahmed M.; Arasappan, Dhivya; Nelson, Charllotte A.; Edris, Sherif; Mutwakil, Mohammed Z.; Alhebshi, Alawia; Gadalla, Nour O.; Makki, Rania M.; Al-Kordy, Madgy A.; El-Domyati, Fotouh M.; Sabir, Jamal S. M.; Khiyami, Mohammad A.; Hall, Neil; Bahieldin, Ahmed; Jansen, Robert K.			Transcriptomic analysis of salt stress responsive genes in Rhazya stricta	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; GENOME-WIDE ANALYSIS; ABIOTIC STRESS; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; RNA; BIOSYNTHESIS; CHLOROPLASTS; METABOLISM; MITOCHONDRIA	Rhazya stricta is an evergreen shrub that is widely distributed across Western and South Asia, and like many other members of the Apocynaceae produces monoterpene indole alkaloids that have anti-cancer properties. This species is adapted to very harsh desert conditions making it an excellent system for studying tolerance to high temperatures and salinity. RNA-Seq analysis was performed on R. stricta exposed to severe salt stress (500 mM NaCl) across four time intervals (0, 2, 12 and 24 h) to examine mechanisms of salt tolerance. A large number of transcripts including genes encoding tetrapyrroles and pentatricopeptide repeat (PPR) proteins were regulated only after 12 h of stress of seedlings grown in controlled greenhouse conditions. Mechanisms of salt tolerance in R. stricta may involve the upregulation of genes encoding chaperone protein Dnaj6, UDP-glucosyl transferase 85a2, protein transparent testa 12 and respiratory burst oxidase homolog protein b. Many of the highly-expressed genes act on protecting protein folding during salt stress and the production of flavonoids, key secondary metabolites in stress tolerance. Other regulated genes encode enzymes in the porphyrin and chlorophyll metabolic pathway with important roles during plant growth, photosynthesis, hormone signaling and abiotic responses. Heme biosynthesis in R. stricta leaves might add to the level of salt stress tolerance by maintaining appropriate levels of photosynthesis and normal plant growth as well as by the participation in reactive oxygen species (ROS) production under stress. We speculate that the high expression levels of PPR genes may be dependent on expression levels of their targeted editing genes. Although the results of PPR gene family indicated regulation of a large number of transcripts under salt stress, PPR actions were independent of the salt stress because their RNA editing patterns were unchanged.	[Hajrah, Nahid H.; Atef, Ahmed; Ramadan, Ahmed M.; Edris, Sherif; Mutwakil, Mohammed Z.; Alhebshi, Alawia; Makki, Rania M.; Sabir, Jamal S. M.; Hall, Neil; Bahieldin, Ahmed; Jansen, Robert K.] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Biotechnol Res Grp, Jeddah, Saudi Arabia; [Obaid, Abdullah Y.] King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia; [Ramadan, Ahmed M.] ARC, AGERI, Giza, Egypt; [Arasappan, Dhivya; Jansen, Robert K.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Nelson, Charllotte A.] Inst Integrat Biol, Ctr Genom Res, Crown St, Liverpool, Merseyside, England; [Edris, Sherif; El-Domyati, Fotouh M.; Bahieldin, Ahmed] Ain Shams Univ, Fac Agr, Dept Genet, Cairo, Egypt; [Edris, Sherif] King Abdulaziz Univ, Fac Med, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah, Saudi Arabia; [Gadalla, Nour O.] King Abdulaziz Univ, Fac Meteorol Environm & Arid Land Agr, Dept Arid Land Agr, Jeddah, Saudi Arabia; [Gadalla, Nour O.; Al-Kordy, Madgy A.] Natl Res Ctr, Genet Engn & Biotechnol Div, Genet & Cytol Dept, Dokki, Egypt; [Khiyami, Mohammad A.] KACST, Riyadh, Saudi Arabia; [Hall, Neil] Earlham Inst, Norwich Res Pk, Norwich, Norfolk, England	King Abdulaziz University; King Abdulaziz University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; University of Texas System; University of Texas Austin; Egyptian Knowledge Bank (EKB); Ain Shams University; King Abdulaziz University; King Abdulaziz University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); King Abdulaziz City for Science & Technology; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Earlham Institute	Jansen, RK (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Biotechnol Res Grp, Jeddah, Saudi Arabia.; Jansen, RK (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	jansen@austin.utexas.edu	Alhebshi, Alawiah M/AAD-4587-2019; bahieldin, ahmed/I-9186-2012; Edris, Sherif/I-8070-2012; Edris, Sherif/GXZ-9995-2022; Hajrah, Nahid/AAT-2659-2021; Sabir, Jamal S M/C-8102-2014; atef, ahmed/B-7842-2013; Hajrah, Nahid/AAY-3196-2020; Ramadan, Ahmed/I-8241-2012	Edris, Sherif/0000-0002-2810-3736; Edris, Sherif/0000-0002-2810-3736; Hajrah, Nahid/0000-0001-6404-1627; Ramadan, Ahmed/0000-0002-2502-9921; Hall, Neil/0000-0003-2808-0009; Alhebshi, Alawiah/0000-0002-1751-8944; Atef, Ahmed/0000-0001-7530-2060	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [I-008-31]	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah	This project was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant no.I-008-31.r This project was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant no. I-008-31. The authors, therefore, acknowledge with thanks DSR technical and financial support. The authors also gratefully acknowledge the support from President of King Abdulaziz University. Prof. Dr. Abdulrahman O. Alyoubi.	Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arenas A, 2014, MITOCHONDRION, V19, P126, DOI 10.1016/j.mito.2014.08.006; Bahieldin A, 2015, CR BIOL, V338, P285, DOI 10.1016/j.crvi.2015.03.010; Blanco-Herrera F, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0525-2; Brehme N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140680; Brown JA, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100043; Cao ZL, 2011, J INTEGR PLANT BIOL, V53, P258, DOI 10.1111/j.1744-7909.2011.01030.x; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Cheng CX, 2013, INT J MOL SCI, V14, P24169, DOI 10.3390/ijms141224169; Cornah JE, 2003, TRENDS PLANT SCI, V8, P224, DOI 10.1016/S1360-1385(03)00064-5; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Fini A, 2011, PLANT SIGNAL BEHAV, V6, P709, DOI 10.4161/psb.6.5.15069; FREYER R, 1993, PLANT J, V4, P621, DOI 10.1046/j.1365-313X.1993.04040621.x; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Goyal E, 2016, SCI REP-UK, V6, DOI 10.1038/srep27752; Grimm B, 1998, CURR OPIN PLANT BIOL, V1, P245, DOI 10.1016/S1369-5266(98)80112-X; Hammani K, 2011, J BIOL CHEM, V286, P21361, DOI 10.1074/jbc.M111.230516; Hammani K, 2011, PLANT CELL, V23, P730, DOI 10.1105/tpc.110.081638; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Hasan SS, 2013, P NATL ACAD SCI USA, V110, P4297, DOI 10.1073/pnas.1222248110; HIROSE T, 1994, PLANT MOL BIOL, V26, P509, DOI 10.1007/BF00039562; Jiang SC, 2015, PLANT MOL BIOL, V88, P369, DOI 10.1007/s11103-015-0327-9; Juhanningmeier U, 1984, J BIOL CHEM, V259, P13541; Karpova OV, 1999, PLANT J, V17, P511, DOI 10.1046/j.1365-313X.1999.00401.x; Khan N.A., 2014, J PLANT BIOCH PHYSL, V2, DOI [DOI 10.4172/2329-9029.1000120, 10.4172/2329-9029.1000120]; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Laluk K, 2011, PLANT PHYSIOL, V156, P2053, DOI 10.1104/pp.111.177501; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Liu Y, 2010, J BUS RES, V63, P3, DOI 10.1016/j.jbusres.2009.01.005; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Lv HX, 2014, J PLANT BIOL, V57, P291, DOI 10.1007/s12374-014-0041-1; Martin M, 2009, BBA-BIOENERGETICS, V1787, P920, DOI 10.1016/j.bbabio.2009.03.001; Meierhoff K, 2003, PLANT CELL, V15, P1480, DOI 10.1105/tpc.010397; Miyamoto T, 2002, MOL CELL BIOL, V22, P6726, DOI 10.1128/MCB.22.19.6726-6734.2002; Murayama M, 2012, J EXP BOT, V63, P5301, DOI 10.1093/jxb/ers188; Obaid AY, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0938-6; Papenbrock J, 2001, PLANTA, V213, P667, DOI 10.1007/s004250100593; Rivals E, 2006, PLANT PHYSIOL, V141, P825, DOI 10.1104/pp.106.077826; Rosa M, 2009, PLANT SIGNAL BEHAV, V4, P388, DOI 10.4161/psb.4.5.8294; Rumeau D, 2005, PLANT CELL, V17, P219, DOI 10.1105/tpc.104.028282; Sabir JSM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33782; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Sjogren LLE, 2006, PLANT CELL, V18, P2635, DOI 10.1105/tpc.106.044594; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Takenaka M, 2008, MITOCHONDRION, V8, P35, DOI 10.1016/j.mito.2007.09.004; Takenaka M, 2013, ANNU REV GENET, V47, P335, DOI 10.1146/annurev-genet-111212-133519; Turan S, 2015, PHYSIOL PLANTARUM, V153, P477, DOI 10.1111/ppl.12250; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Vierstra RD, 1996, PLANT MOL BIOL, V32, P275, DOI 10.1007/BF00039386; Wahid A, 2006, J PLANT PHYSIOL, V163, P723, DOI 10.1016/j.jplph.2005.07.007; Williams PM, 2003, PLANT J, V36, P675, DOI 10.1046/j.1365-313X.2003.01915.x; Wu DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056624, 10.1371/journal.pone.0053932, 10.1371/journal.pone.0055431]; Xiong LM, 2001, PHYSIOL PLANTARUM, V112, P152, DOI 10.1034/j.1399-3054.2001.1120202.x; Yuan H, 2012, PLANT J, V70, P432, DOI 10.1111/j.1365-313X.2011.04883.x; Zhang J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-228; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu Q, 2014, MOL PLANT, V7, P290, DOI 10.1093/mp/sst102; Zsigmond L, 2008, PLANT PHYSIOL, V146, P1721, DOI 10.1104/pp.107.111260	63	17	19	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177589	10.1371/journal.pone.0177589	http://dx.doi.org/10.1371/journal.pone.0177589			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520766	Green Published, Green Submitted, gold			2022-12-26	WOS:000401485500041
J	Zhang, MX; Li, P; Wang, W				Zhang, Mingxi; Li, Pohan; Wang, Wei			An index-based algorithm for fast on-line query processing of latent semantic analysis	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; JACOBI SVD ALGORITHM; SIMILARITY SEARCH; RECOMMENDER; NETWORK	Latent Semantic Analysis (LSA) is widely used for finding the documents whose semantic is similar to the query of keywords. Although LSA yield promising similar results, the existing LSA algorithms involve lots of unnecessary operations in similarity computation and candidate check during on-line query processing, which is expensive in terms of time cost and cannot efficiently response the query request especially when the dataset becomes large. In this paper, we study the efficiency problem of on-line query processing for LSA towards efficiently searching the similar documents to a given query. We rewrite the similarity equation of LSA combined with an intermediate value called partial similarity that is stored in a designed index called partial index. For reducing the searching space, we give an approximate form of similarity equation, and then develop an efficient algorithm for building partial index, which skips the partial similarities lower than a given threshold.. Based on partial index, we develop an efficient algorithm called ILSA for supporting fast on-line query processing. The given query is transformed into a pseudo document vector, and the similarities between query and candidate documents are computed by accumulating the partial similarities obtained from the index nodes corresponds to non-zero entries in the pseudo document vector. Compared to the LSA algorithm, ILSA reduces the time cost of on-line query processing by pruning the candidate documents that are not promising and skipping the operations that make little contribution to similarity scores. Extensive experiments through comparison with LSA have been done, which demonstrate the efficiency and effectiveness of our proposed algorithm.	[Zhang, Mingxi] Univ Shanghai Sci & Technol, Coll Commun & Art Design, Shanghai, Peoples R China; [Zhang, Mingxi; Li, Pohan; Wang, Wei] Fudan Univ, Sch Comp Sci, Shanghai, Peoples R China	University of Shanghai for Science & Technology; Fudan University	Zhang, MX (corresponding author), Univ Shanghai Sci & Technol, Coll Commun & Art Design, Shanghai, Peoples R China.; Zhang, MX (corresponding author), Fudan Univ, Sch Comp Sci, Shanghai, Peoples R China.	mingxizhang10@fudan.edu.cn			Natural Science Foundation of Shanghai grant [16ZR14228]; Innovation Program of Shanghai Municipal Education Commission [15ZZ073, 15ZZ074]; Training Project of University of Shanghai for Science and Technology grant [16HJPY-QN04]; Natural Science Foundation of Shanghai [16ZR14228]	Natural Science Foundation of Shanghai grant; Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Training Project of University of Shanghai for Science and Technology grant; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This work was supported by Natural Science Foundation of Shanghai grant 16ZR14228, http://www.stsm.gov.cn/; Innovation Program of Shanghai Municipal Education Commission grants 15ZZ073 and 15ZZ074, http://www.shmec.gov.cn/; and Training Project of University of Shanghai for Science and Technology grant 16HJPY-QN04, http://www.usst.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Natural Science Foundation of Shanghai grant 16ZR14228, http:// www.stcsm.gov.cn/: Innovation Program of Shanghai Municipal Education Commission grants 15ZZ073 and 15ZZ074, http://www.shmec.gov.cn/; and Training Project of University of Shanghai for Science and Technology grant 16HJPY-QN04, http://www.usst.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Haddou R, 2016, COMPUT AIDED GEOM D, V42, P23, DOI 10.1016/j.cagd.2015.12.003; Allioua S, 2012, NETWORKED DIGITAL TE, P297; An X, 2013, SCI WORLD J, DOI 10.1155/2013/213603; Anandkumar A, 2015, ALGORITHMICA, V72, P193, DOI 10.1007/s00453-014-9909-1; Balouchestani M, 2016, SIGNAL IMAGE VIDEO P, V10, P113, DOI 10.1007/s11760-014-0709-5; Balzano L, 2013, CORR; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Boulares M, 2016, ARTIF INTELL REV, V46, P145, DOI 10.1007/s10462-016-9460-3; Bradford R. B., 2008, P 17 ACM C INF KNOWL, P153, DOI [10.1145/1458082.1458105, DOI 10.1145/1458082.1458105]; Brand M, 2003, SIAM PROC S, P37; Brand M, 2002, LECT NOTES COMPUT SC, V2350, P707; Celikkanat H, 2016, IEEE T COGN DEV SYST, V8, P42, DOI 10.1109/TAMD.2015.2476374; Chen JF, 2016, PROC VLDB ENDOW, V9, P744, DOI 10.14778/2977797.2977801; Chen KW, 2016, EXPERT SYST APPL, V66, P245, DOI 10.1016/j.eswa.2016.09.009; Dang A, 2016, COLING 2016; Domeniconi G, 2015, DATA 2015; Drinea E, 2001, PANH C INF PCI; Drmac Z, 2007, SIAM J MATRIX ANAL A, V29, P1322, DOI 10.1137/050639193; Drmac Z, 2007, SIAM J MATRIX ANAL A, V29, P1343, DOI 10.1137/05063920X; El Ghali B, 2017, KNOWL INF SYST, V50, P751, DOI 10.1007/s10115-016-0952-x; Elghazel H, 2016, EXPERT SYST APPL, V57, P1, DOI 10.1016/j.eswa.2016.03.041; Franceschini A, 2016, BIOINFORMATICS, V32, P1085, DOI 10.1093/bioinformatics/btv696; Ghoshdastidar D, 2015, AAAI CONF ARTIF INTE, P2610; Gonzalez J, 2016, J BIOINF COMPUT BIOL, V14, P1; Guan X, 2016, LECT NOTES ARTIF INT, V9652, P503, DOI 10.1007/978-3-319-31750-2_40; Hofmann T, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P50, DOI 10.1145/312624.312649; Hofmann Thomas, 2013, CORR; Holmes M. P., 2008, ADV NEURAL INFORM PR, P673; Iwen MA, 2016, CORR; Jarvelin K, 2002, ACM T INFORM SYST, V20, P422, DOI 10.1145/582415.582418; Joachims T, 1997, 14 INT C MACH LEARN, P143; Kagie M, 2009, AI COMMUN, V22, P249, DOI 10.3233/AIC-2009-0467; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Layfield C., 2017, SEMANTIC KEYWORD BAS, V10151, P25, DOI [DOI 10.1007/978-3-319-53640-83, 10.1007/978-3-319-53640-83]; Lee M, 2014, IEEE T IMAGE PROCESS, V23, P4255, DOI 10.1109/TIP.2014.2346012; Levy A, 2000, IEEE T IMAGE PROCESS, V9, P1371, DOI 10.1109/83.855432; Li C, 2010, EDBT, P465, DOI DOI 10.1145/1739041.1739098; Luo X, 2016, IEEE T NEUR NET LEAR, V27, P524, DOI 10.1109/TNNLS.2015.2412037; Menon V, 2016, IEEE GEOSCI REMOTE S, V13, P1275, DOI 10.1109/LGRS.2016.2581172; Mingqing Zhang, 2014, Journal of Software, V9, P429, DOI 10.4304/jsw.9.2.429-436; Mirzal Andri, 2016, International Journal of Information and Decision Sciences, V8, P53; Nath C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153749; Ntalianis KS, 2015, VISAPP 2015, V2; Nugumanova A, 2013, COMM COM INF SC, V394, P92; Park J, 2016, 38 ANN INT C IEEE EN; Qin PD, 2016, NEUROCOMPUTING, V177, P257, DOI 10.1016/j.neucom.2015.11.028; Roy S, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1223-2; Sammut C, 2010, ENCY MACHINE LEARNIN, P571; Strobach P, 2008, SIGNAL PROCESS, V88, P2651, DOI 10.1016/j.sigpro.2008.05.004; Tang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096944; Wang CCN, 2016, IEEE INT C BIOINF BI, P363, DOI 10.1109/BIBE.2016.71; Wu X, 2016, COMPUT MATH METHOD M, V2016; Yan M, 2016, INFORM SOFTWARE TECH, V73, P37, DOI 10.1016/j.infsof.2016.01.005; Ye Y, 2013, FRONT COMPUT SCI-CHI, V7, P526, DOI 10.1007/s11704-013-2360-7; Yuxia Huang, 2016, Annals of GIS, V22, P113, DOI 10.1080/19475683.2016.1144648; Zeng XX, 2016, IEEE INT C BIOINFORM, P682, DOI 10.1109/BIBM.2016.7822600; Zeng XX, 2016, BRIEF BIOINFORM, V17, P193, DOI 10.1093/bib/bbv033; Zhang MX, 2015, EXPERT SYST APPL, V42, P8868, DOI 10.1016/j.eswa.2015.07.042; Zhang MX, 2015, EXPERT SYST APPL, V42, P699, DOI 10.1016/j.eswa.2014.08.039; Zhang W, 2016, MATH PROBL ENG, V2016, P1, DOI DOI 10.7554/ELIFE.11324; Zhang W, 2008, IEEE SYS MAN CYBERN, P108, DOI 10.1109/ICSMC.2008.4811259; Zhang Y, 2014, INFORM SCIENCES, V281, P687, DOI 10.1016/j.ins.2014.04.047; Zhou LF, 2016, IEEE ACCESS, V4, P869, DOI 10.1109/ACCESS.2016.2535103; Zou Q, 2016, BRIEF FUNCT GENOMICS, V15, P55, DOI 10.1093/bfgp/elv024	65	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177523	10.1371/journal.pone.0177523	http://dx.doi.org/10.1371/journal.pone.0177523			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520747	Green Published, gold, Green Submitted			2022-12-26	WOS:000401485500035
J	Zhu, C; Chrifi, I; Mustafa, D; van der Weiden, M; Leenen, PJM; Duncker, DJ; Kros, JM; Cheng, C				Zhu, C.; Chrifi, I.; Mustafa, D.; van der Weiden, M.; Leenen, P. J. M.; Duncker, D. J.; Kros, J. M.; Cheng, C.			CECR1-mediated cross talk between macrophages and vascular mural cells promotes neovascularization in malignant glioma	ONCOGENE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; ANTIANGIOGENIC THERAPY; VESSEL FORMATION; STROMAL CELLS; ANGIOGENESIS; GLIOBLASTOMA; PERICYTES; PERIOSTIN; MICROGLIA; GROWTH	Glioblastomas (glioblastoma multiforme, GBM) are most malignant brain tumors characterized by profound vascularization. The activation of macrophages strongly contributes to tumor angiogenesis during GBM development. Previously, we showed that extracellular adenosine deaminase protein Cat Eye Syndrome Critical Region Protein 1 (CECR1) is highly expressed by M2-like macrophages in GBM where it defines macrophage M2 polarization and contributes to tumor expansion. In this study, the effect of CECR1 in macrophages on tumor angiogenesis was investigated. Immunohistochemical evaluation of GBM tissue samples showed that the expression of CECR1 correlates with microvascular density in the tumors, confirming data from the TCGA set. In a threedimensional co-culture system consisting of human pericytes, human umbilical vein endothelial cells and THP1-derived macrophages, CECR1 knockdown by siRNA and CECR1 stimulation of macrophages inhibited and promoted new vessel formation, respectively. Loss and gain of function studies demonstrated that PDGFB mRNA and protein levels in macrophages are modulated by CECR1. The proangiogenic properties of CECR1 in macrophages were partially mediated via paracrine activation of pericytes by PDGFB-PDGFR beta signaling. CECR1-PDGFB-PDGFR beta cross-activation between macrophages and pericytes promoted pericyte migration, shown by transwell migration assay, and enhanced expression and deposition of periostin, a matrix component with proangiogenic properties. CECR1 function in (M2-like) macrophages mediates cross talk between macrophages and pericytes in GBM via paracrine PDGFB-PDGFR beta signaling, promoting pericyte recruitment and migration, and tumor angiogenesis. Therefore, CECR1 offers a new portent target for anti-angiogenic therapy in GBM via immune modulation.	[Zhu, C.; Mustafa, D.; van der Weiden, M.; Kros, J. M.] Erasmus MC, Dept Pathol, Room Be 230c,Wytemaweg 80,POB 2040,3015 CN, NL-3000 CA Rotterdam, Netherlands; [Zhu, C.] Shanghai Jiao Tong Univ, Shanghai Xinhua Hosp, Sch Med, Dept Pediat Neurosurg, Shanghai, Peoples R China; [Chrifi, I.; Duncker, D. J.; Cheng, C.] Erasmus MC, Thoraxctr, Div Expt Cardiol, Dept Cardiol, Rotterdam, Netherlands; [Leenen, P. J. M.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Cheng, C.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, DIGD, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Shanghai Jiao Tong University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center	Kros, JM (corresponding author), Erasmus MC, Dept Pathol, Room Be 230c,Wytemaweg 80,POB 2040,3015 CN, NL-3000 CA Rotterdam, Netherlands.	j.m.kros@erasmusmc.nl	Leenen, Pieter JM/I-5839-2013; Mustafa, Dana/AAQ-6530-2021	Leenen, Pieter JM/0000-0001-9860-2920; Mustafa, Dana/0000-0003-0644-078X	Chinese Scholar Council [201206230102]; Netherlands Foundation for Cardiovascular Excellence; Netherlands Cardiovascular Research Initiative; Dutch Heart Foundation [CVON2014-11 RECONNECT]; VIDI grant [91714302]; Erasmus MC fellowship; RM fellowship grant of the UMC Utrecht	Chinese Scholar Council; Netherlands Foundation for Cardiovascular Excellence; Netherlands Cardiovascular Research Initiative; Dutch Heart Foundation(Netherlands Heart Foundation); VIDI grant; Erasmus MC fellowship; RM fellowship grant of the UMC Utrecht	CZ was supported by the Chinese Scholar Council (201206230102). CC was supported by the Netherlands Foundation for Cardiovascular Excellence and by The Netherlands Cardiovascular Research Initiative: an initiative with support of the Dutch Heart Foundation, (CVON2014-11 RECONNECT), VIDI grant 91714302, the Erasmus MC fellowship grant and the RM fellowship grant of the UMC Utrecht. We thank CardioGenx B.V. for providing the recombinant CECR1.	Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bowman RL, 2016, CELL REP, V17, P2445, DOI 10.1016/j.celrep.2016.10.052; Brandenburg S, 2016, ACTA NEUROPATHOL, V131, P365, DOI 10.1007/s00401-015-1529-6; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chen XB, 2014, CANCER RES, V74, P7285, DOI 10.1158/0008-5472.CAN-14-1240; Das S, 2013, NEW ENGL J MED, V369, P1561, DOI 10.1056/NEJMcibr1309402; Elkan PN, 2014, NEW ENGL J MED, V370, P921, DOI 10.1056/NEJMoa1307362; Erkan M, 2007, GASTROENTEROLOGY, V132, P1447, DOI 10.1053/j.gastro.2007.01.031; Ferrara N, 2010, CYTOKINE GROWTH F R, V21, P21, DOI 10.1016/j.cytogfr.2009.11.003; Gabrusiewicz K, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85841; Garcia-Quintans N, 2016, ANGIOGENESIS, V19, P217, DOI 10.1007/s10456-016-9502-0; Gilbert MR, 2016, J CLIN ONCOL, V34, P1567, DOI 10.1200/JCO.2016.66.5364; Hambardzumyan D, 2016, NAT NEUROSCI, V19, P20, DOI 10.1038/nn.4185; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Li W, 2012, NEURO-ONCOLOGY, V14, P958, DOI 10.1093/neuonc/nos116; Lin L, 2015, ONCOTARGET, V6, P34758, DOI 10.18632/oncotarget.5325; Liu AY, 2014, MATRIX BIOL, V37, P150, DOI 10.1016/j.matbio.2014.04.007; Lu-Emerson C, 2013, NEURO-ONCOLOGY, V15, P1079, DOI 10.1093/neuonc/not082; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Nakamura R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8847; Nijaguna MB, 2015, J BIOL CHEM, V290, P23401, DOI 10.1074/jbc.M115.664037; Ochs K, 2013, J NEUROIMMUNOL, V265, P106, DOI 10.1016/j.jneuroim.2013.09.011; Park SY, 2016, MOL CANCER THER, V15, P2187, DOI 10.1158/1535-7163.MCT-15-0427; Pong WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077571; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Prosniak M, 2013, CLIN CANCER RES, V19, P3776, DOI 10.1158/1078-0432.CCR-12-1940; Riabov V, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00075; Roma-Lavisse C, 2015, DIABETES VASC DIS RE, V12, P279, DOI 10.1177/1479164115582351; Squadrito ML, 2015, NAT CELL BIOL, V17, P107, DOI 10.1038/ncb3095; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; Sun HQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114246; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Takano S, 2012, BRAIN TUMOR PATHOL, V29, P73, DOI 10.1007/s10014-011-0077-6; VIGNAUD JM, 1994, CANCER RES, V54, P5455; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xue Y, 2012, NAT MED, V18, P100, DOI 10.1038/nm.2575; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang YL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11385; Zheng PP, 2014, J CELL PHYSIOL, V229, P967, DOI 10.1002/jcp.24538; Zhong XL, 2016, ONCOTARGET, V7, P44365, DOI 10.18632/oncotarget.9744; Zhou Q, 2014, NEW ENGL J MED, V370, P911, DOI 10.1056/NEJMoa1307361; ZHU CB, 2015, CANCER RES S15, V75; Zhu CB, 2017, NEURO-ONCOLOGY, V19, P648, DOI 10.1093/neuonc/now251; Zhu CB, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-016-0405-5	48	38	38	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 21	2017	36	38					5356	5368		10.1038/onc.2017.145	http://dx.doi.org/10.1038/onc.2017.145			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FH7PJ	28534507	Green Published, hybrid			2022-12-26	WOS:000411382100003
J	Meng, GM; Tang, XY; Yang, ZL; Benesch, MGK; Marshall, A; Murray, D; Hemmings, DG; Wuest, F; McMullen, TPW; Brindley, DN				Meng, Guanmin; Tang, Xiaoyun; Yang, Zelei; Benesch, Matthew G. K.; Marshall, Alison; Murray, David; Hemmings, Denise G.; Wuest, Frank; McMullen, Todd P. W.; Brindley, David N.			Implications for breast cancer treatment from increased autotaxin production in adipose tissue after radiotherapy	FASEB JOURNAL			English	Article						lysophosphatidate signaling; wound healing; inflammatory mediators; NF-kappa B; radioresistance	NF-KAPPA-B; LYSOPHOSPHATIDIC ACID; TNF-ALPHA; LYSOPHOSPHOLIPASE-D; LUNG FIBROSIS; TUMOR-GROWTH; DNA-DAMAGE; ACTIVATION; EXPRESSION; RADIATION	We have previously established that adipose tissue adjacent to breast tumors becomes inflamed by tumor-derived cytokines. This stimulates autotaxin (ATX) secretion from adipocytes, whereas breast cancer cells produce insignificant ATX. Lysophosphatidate produced by ATX promotes inflammatory cytokine secretion in a vicious inflammatory cycle, which increases tumor growth and metastasis and decreases response to chemotherapy. We hypothesized that damage to adipose tissue during radiotherapy for breast cancer should promote lysophosphatidic acid (LPA) signaling and further inflammatory signaling, which could potentially protect cancer cells from subsequent fractions of radiation therapy. To test this hypothesis, we exposed rat and human adipose tissue to radiation doses (0.25-5 Gy) that were expected during radiotherapy. This exposure increased mRNA levels for ATX, cyclooxygenase-2, IL-1 beta, IL-6, IL-10, TNF-alpha, and LPA(1) and LPA(2) receptors by 1.8- to 5.1-fold after 4 to 48 h. There were also 1.5- to 2.5-fold increases in the secretion of ATX and 14 inflammatory mediators after irradiating at 1 Gy. Inhibition of the radiation-induced activation of NF-kappa B, cyclooxygenase-2, poly (ADP-ribose) polymerase-1, or ataxia telangiectasia and Rad3-related protein blocked inflammatory responses to gamma-radiation. Consequently, collateral damage to adipose tissue during radiotherapy could establish a comprehensive wound-healing response that involves increased signaling by LPA, cyclooxygenase-2, and other inflammatory mediators that could decrease the efficacy of further radiotherapy or chemotherapy.	[Meng, Guanmin; Tang, Xiaoyun; Yang, Zelei; Benesch, Matthew G. K.; Brindley, David N.] Univ Alberta, Signal Transduct Res Grp, Dept Biochem, Edmonton, AB, Canada; [Marshall, Alison; Murray, David; Wuest, Frank] Univ Alberta, Cross Canc Inst, Dept Oncol, Edmonton, AB, Canada; [Hemmings, Denise G.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Hemmings, Denise G.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [McMullen, Todd P. W.] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Meng, Guanmin] Tongde Hosp Zhejiang Prov, Dept Clin Lab, Hangzhou, Zhejiang, Peoples R China	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Brindley, DN (corresponding author), Univ Alberta, Dept Biochem, Heritage Med Res Ctr 357, Edmonton, AB T6G 2S2, Canada.	david.brindley@ualberta.ca	Benesch, Matthew/GRF-0677-2022	Meng, Guanmin/0000-0002-6701-8980	Canadian Cancer Society Research Institute; Canadian Breast Cancer Foundation (CBCF); Tongde Hospital of Zhejiang Province; National Natural Science Foundation of China [81602822]; 75th Anniversary Graduate Studentship from the University of Alberta; Canadian Breast Cancer Foundation; Government of Canada; Canadian Institutes of Health Research; Alberta Innovates-Health Solutions; Killam Trust Award; CBCF	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Breast Cancer Foundation (CBCF); Tongde Hospital of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 75th Anniversary Graduate Studentship from the University of Alberta; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Government of Canada(CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; Killam Trust Award; CBCF	This work was supported by grants from the Canadian Cancer Society Research Institute and the Canadian Breast Cancer Foundation (CBCF). G.M. received financial supports from Tongde Hospital of Zhejiang Province and the National Natural Science Foundation of China (Grant 81602822). Z.Y. received a 75th Anniversary Graduate Studentship from the University of Alberta and a salary through a grant from the Canadian Breast Cancer Foundation. M.G.K.B. received a Vanier Canada Graduate Scholarship (Government of Canada), a Canadian Institutes of Health Research M.D./Ph.D. Studentship, an M.D./Ph.D. Studentship from Alberta Innovates-Health Solutions, and a Killam Trust Award. X.T. held a research fellowship from CBCF. The authors thank Drs. M. Hendzel and M. Weinfeld (both from the Cross Cancer Institute, University of Alberta) for excellent advice.	Bai ZB, 2013, J IMMUNOL, V190, P2036, DOI 10.4049/jimmunol.1202025; Balogh A, 2015, CELL SIGNAL, V27, P1751, DOI 10.1016/j.cellsig.2015.05.015; Bekele RT, 2016, SCI REP-UK, V6, DOI 10.1038/srep21164; Benesch MGK, 2015, FASEB J, V29, P3990, DOI 10.1096/fj.15-274480; Benesch MGK, 2015, J LIPID RES, V56, P1134, DOI 10.1194/jlr.M057661; Benesch MGK, 2014, FEBS LETT, V588, P2712, DOI 10.1016/j.febslet.2014.02.009; Benesch MGK, 2014, FASEB J, V28, P2655, DOI 10.1096/fj.13-248641; Bhave SR, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00236; Bower JE, 2009, CLIN CANCER RES, V15, P5534, DOI 10.1158/1078-0432.CCR-08-2584; Brindley D.N., 2015, AUTOTAXIN ENZYMATIC; Brindley DN, 2013, BBA-MOL CELL BIOL L, V1831, P74, DOI 10.1016/j.bbalip.2012.08.015; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Budd DC, 2013, FUTURE MED CHEM, V5, P1935, DOI [10.4155/FMC.13.154, 10.4155/fmc.13.154]; Carswell KA, 2012, METHODS MOL BIOL, V806, P203, DOI 10.1007/978-1-61779-367-7_14; Castelino FV, 2016, ARTHRITIS RHEUMATOL, V68, P2964, DOI 10.1002/art.39797; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Dusaulcy R, 2011, J LIPID RES, V52, P1247, DOI 10.1194/jlr.M014985; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Esquivel-Velazquez M, 2015, J INTERF CYTOK RES, V35, P1, DOI 10.1089/jir.2014.0026; Euer N, 2002, ANTICANCER RES, V22, P733; FISHER B, 1995, NEW ENGL J MED, V333, P1456, DOI 10.1056/NEJM199511303332203; Fotopoulou S, 2010, DEV BIOL, V339, P451, DOI 10.1016/j.ydbio.2010.01.007; Funakoshi-Tago M, 2008, BIOCHEM PHARMACOL, V76, P662, DOI 10.1016/j.bcp.2008.06.015; Gaetano CG, 2009, MOL CARCINOGEN, V48, P801, DOI 10.1002/mc.20524; Gamper AM, 2013, NUCLEIC ACIDS RES, V41, P10334, DOI 10.1093/nar/gkt833; Gan L, 2011, BIOCHEM BIOPH RES CO, V409, P7, DOI 10.1016/j.bbrc.2011.04.084; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harbort CJ, 2015, BLOOD, V126, P2842, DOI 10.1182/blood-2015-05-645424; Harris Jay R, 2014, Am Soc Clin Oncol Educ Book, P21, DOI 10.14694/EdBook_AM.2014.34.21; Jayakumar S, 2015, MUTAT RES-FUND MOL M, V779, P33, DOI 10.1016/j.mrfmmm.2015.06.007; Koike S, 2010, BIOCHEM BIOPH RES CO, V400, P66, DOI 10.1016/j.bbrc.2010.08.008; Koike S, 2009, J BIOL CHEM, V284, P33561, DOI 10.1074/jbc.M109.012716; Lauw FN, 2000, J IMMUNOL, V165, P2783, DOI 10.4049/jimmunol.165.5.2783; Lin FT, 2007, J BIOL CHEM, V282, P37759, DOI 10.1074/jbc.M705025200; Little D, 2007, J VET INTERN MED, V21, P367, DOI 10.1892/0891-6640(2007)21[367:CCIATI]2.0.CO;2; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Mazereeuw-Hautier J, 2005, J INVEST DERMATOL, V125, P421, DOI 10.1111/j.0022-202X.2005.23855.x; McDonald JT, 2010, CANCER RES, V70, P8886, DOI 10.1158/0008-5472.CAN-10-0171; Mitchell MD, 2004, J CLIN ENDOCR METAB, V89, P4149, DOI 10.1210/jc.2004-0373; Nakasaki T, 2008, AM J PATHOL, V173, P1566, DOI 10.2353/ajpath.2008.071153; Nochi H, 2008, J IMMUNOL, V181, P5111, DOI 10.4049/jimmunol.181.7.5111; Perez CER, 2011, AM J PHYSIOL-GASTR L, V300, pG637, DOI 10.1152/ajpgi.00381.2010; Popnikolov NK, 2012, TUMOR BIOL, V33, P2237, DOI 10.1007/s13277-012-0485-1; Rancoule C, 2011, EXPERT OPIN INV DRUG, V20, P657, DOI 10.1517/13543784.2011.566864; Ray R, 2017, BLOOD, V129, P1177, DOI 10.1182/blood-2016-10-743757; Rocha S, 2005, EMBO J, V24, P1157, DOI 10.1038/sj.emboj.7600608; Samadi N, 2009, ONCOGENE, V28, P1028, DOI 10.1038/onc.2008.442; Samadi N, 2011, BIOCHIMIE, V93, P61, DOI 10.1016/j.biochi.2010.08.002; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schaue D, 2015, SEMIN RADIAT ONCOL, V25, P4, DOI 10.1016/j.semradonc.2014.07.007; Schaue D, 2012, RADIAT RES, V178, P505, DOI 10.1667/RR3031.1; Schleicher SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022182; Sekhar KR, 2015, FREE RADICAL BIO MED, V88, P268, DOI 10.1016/j.freeradbiomed.2015.04.035; Shishodia S, 2004, J IMMUNOL, V173, P2011, DOI 10.4049/jimmunol.173.3.2011; Sloan EK, 2010, CANCER RES, V70, P7042, DOI 10.1158/0008-5472.CAN-10-0522; So J, 2005, GYNECOL ONCOL, V97, P870, DOI 10.1016/j.ygyno.2005.03.004; St-Coeur PD, 2013, ARCH PHARM, V346, P91, DOI 10.1002/ardp.201200395; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Swaney JS, 2010, BRIT J PHARMACOL, V160, P1699, DOI 10.1111/j.1476-5381.2010.00828.x; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tang XY, 2014, J LIPID RES, V55, P2389, DOI 10.1194/jlr.M053462; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Venkatraman G, 2015, FASEB J, V29, P772, DOI 10.1096/fj.14-262659; Veuger SJ, 2009, ONCOGENE, V28, P832, DOI 10.1038/onc.2008.439; Vidot S, 2010, CELL SIGNAL, V22, P926, DOI 10.1016/j.cellsig.2010.01.017; Wang Y, 2004, CANCER RES, V64, P6240, DOI 10.1158/0008-5472.CAN-04-0591; Wu JM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-71; Yoo J, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-90; Zhang YF, 2012, J IMMUNOL, V189, P3914, DOI 10.4049/jimmunol.1201604; Zhao YT, 2005, BIOCHEM J, V385, P493, DOI 10.1042/BJ20041160; Zhou SN, 2013, CRIT REV ONCOL HEMAT, V88, P706, DOI 10.1016/j.critrevonc.2013.09.001	74	30	30	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4064	4077		10.1096/fj.201700159R	http://dx.doi.org/10.1096/fj.201700159R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28539367				2022-12-26	WOS:000408713300030
J	McDaniel, K; Huang, L; Sato, K; Wu, N; Annable, T; Zhou, TH; Ramos-Lorenzo, S; Wan, Y; Huang, QB; Francis, H; Glaser, S; Tsukamoto, H; Alpini, G; Meng, FY				McDaniel, Kelly; Huang, Li; Sato, Keisaku; Wu, Nan; Annable, Tami; Zhou, Tianhao; Ramos-Lorenzo, Sugeily; Wan, Ying; Huang, Qiaobing; Francis, Heather; Glaser, Shannon; Tsukamoto, Hidekazu; Alpini, Gianfranco; Meng, Fanyin			The let-7/Lin28 axis regulates activation of hepatic stellate cells in alcoholic liver injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; LET-7; FIBROSIS; LIN28; OVEREXPRESSION; MECHANISMS; MICRORNAS	The let-7/Lin28 axis is associated with the regulation of key cellular regulatory genes known as microRNAs in various human disorders and cancer development. This study evaluated the role of the let-7/Lin28 axis in regulating a mesenchymal phenotype of hepatic stellate cells in alcoholic liver injury. Weidentified that ethanol feeding significantly down-regulated several members of the let-7 family in mouse liver, including let-7a and let-7b. Similarly, the treatment of human hepatic stellate cells (HSCs) with lipopolysaccharide (LPS) and transforming growth factor-beta (TGF-beta) significantly decreased the expressions of let-7a and let-7b. Conversely, overexpression of let-7a and let-7b suppressed the myofibroblastic activation of cultured human HSCs induced by LPS and TGF-beta, as evidenced by repressed ACTA2 (alpha-actin 2), COL1A1 (collagen 1A1), TIMP1 (TIMP metallopeptidase inhibitor 1), and FN1 (fibronectin 1); this supports the notion that HSC activation is controlled by let-7. A combination of bioinformatics, dual-luciferase reporter assay, and Western blot analysis revealed that Lin28B and highmobility group AT-hook (HMGA2) were the direct targets of let-7a and let-7b. Furthermore, Lin28B deficiency increased the expression of let-7a/let-7b as well as reduced HSC activation and liver fibrosis in mice with alcoholic liver injury. This feedback regulation of let-7 by Lin28B is verified in hepatic stellate cells isolated by laser capture microdissection from the model. The identification of the let-7/Lin28 axis as an important regulator of HSC activation as well as its upstream modulators and down-stream targets will provide insights into the involvement of altered microRNA expression in contributing to the pathogenesis of alcoholic liver fibrosis and novel therapeutic approaches for human alcoholic liver diseases.	[McDaniel, Kelly; Zhou, Tianhao; Francis, Heather; Glaser, Shannon; Alpini, Gianfranco; Meng, Fanyin] Cent Texas Vet Hlth Care Syst, Div Res, Temple, TX 76504 USA; [McDaniel, Kelly; Sato, Keisaku; Wu, Nan; Zhou, Tianhao; Wan, Ying; Francis, Heather; Glaser, Shannon; Alpini, Gianfranco; Meng, Fanyin] Texas A&M Hlth Sci Ctr, Baylor Scott & White Digest Dis Res Ctr, Dept Med, Digest Dis Res Ctr, Temple, TX 76504 USA; [McDaniel, Kelly; Sato, Keisaku; Wu, Nan; Zhou, Tianhao; Wan, Ying; Francis, Heather; Glaser, Shannon; Alpini, Gianfranco; Meng, Fanyin] Baylor Scott & White Hosp, Temple, TX 76504 USA; [McDaniel, Kelly; Annable, Tami; Ramos-Lorenzo, Sugeily; Wan, Ying; Francis, Heather; Meng, Fanyin] Baylor Scott & White Hlth, Res Inst, Temple, TX 76504 USA; [Huang, Li] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Guangzhou 510080, Guangdong, Peoples R China; [Annable, Tami] Temple Biosci Dist, Temple, TX 76504 USA; [Wan, Ying; Huang, Qiaobing] Southern Med Univ, Dept Pathophysiol, Key Lab Shock & Microcirculat Res Guangdong Prov, Guangzhou 510515, Guangdong, Peoples R China; [Tsukamoto, Hidekazu] Univ Southern Calif, Keck Sch Med, Southern Calif Res Ctr Alcohol Liver & Pancreat D, Los Angeles, CA 90089 USA; [Tsukamoto, Hidekazu] Dept Vet Affairs Greater Los Angeles Healthcare S, Los Angeles, CA 90089 USA	Baylor Health Care System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor Health Care System; Baylor Health Care System; Sun Yat Sen University; Southern Medical University - China; University of Southern California	Alpini, G; Meng, FY (corresponding author), Baylor Scott & White Hlth, Cent Texas Vet Hlth Care Syst, Dept Med, 1901 S 1st St,Bldg 205,Rm 1R60, Temple, TX 76504 USA.; Alpini, G; Meng, FY (corresponding author), Baylor Scott & White Hlth, Cent Texas Vet Hlth Care Syst, Baylor Scott & White Digest Dis Res Ctr DDRC, Div Res, 1901 S 1st St,Bldg 205,Rm 1R60, Temple, TX 76504 USA.; Alpini, G; Meng, FY (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, 1901 S 1st St,Bldg 205,Rm 1R60, Temple, TX 76504 USA.	galpini@tamu.edu; fmeng@tamu.edu	Zhou, Tianhao/AAO-3542-2021	Zhou, Tianhao/0000-0002-5722-6954	National Institutes of Health [P50AA011999]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054811, P30DK048522, R01DK108959, R01DK076898, R01DK107310, R01DK058411, R01DK062975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA018663, P50AA011999] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001991, I01BX000574, I01BX003031, I01BX001724, I01BX002192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	We express our deepest appreciation for the animal core and its tissue sharing program of the Southern California Research Center for ALPD and Cirrhosis (National Institutes of Health Grant P50AA011999) for assistance with the animal studies for this project. We also acknowledge Adam C. Stephens in the Publication Department of Baylor Scott & White Health for editing assistance. This material is the result of work supported by resources at the Central Texas Veterans Health Care System.	Bansal MB, 2016, HEPATOL INT, V10, P902, DOI 10.1007/s12072-016-9758-x; Chen YM, 2016, TOXICOLOGY, V368, P80, DOI 10.1016/j.tox.2016.08.005; Cheng SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080053; Choi SS, 2009, HEPATOLOGY, V50, P2007, DOI 10.1002/hep.23196; Francis H, 2014, J BIOL CHEM, V289, P27526, DOI 10.1074/jbc.M114.602383; Glaser S, 2014, GASTROENTEROLOGY, V146, P1795, DOI 10.1053/j.gastro.2014.02.030; Han YY, 2016, J HEPATOL, V64, P1295, DOI 10.1016/j.jhep.2016.02.024; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Hurteau GJ, 2009, CELL CYCLE, V8, P2064, DOI 10.4161/cc.8.13.8883; Karin D, 2016, DIFFERENTIATION, V92, P84, DOI 10.1016/j.diff.2016.07.001; Lazaro R, 2015, HEPATOLOGY, V61, P129, DOI 10.1002/hep.27383; Lee SH, 2014, BBA-GENE REGUL MECH, V1839, P374, DOI 10.1016/j.bbagrm.2014.02.017; Lee SJ, 2014, WORLD J HEPATOL, V6, P207, DOI 10.4254/wjh.v6.i4.207; Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35; Mathews S, 2014, AM J PHYSIOL-GASTR L, V306, pG819, DOI 10.1152/ajpgi.00041.2014; Mavila N, 2014, HEPATOLOGY, V60, P941, DOI 10.1002/hep.27203; McDaniel K, 2016, AM J PHYSIOL-GASTR L, V310, pG757, DOI 10.1152/ajpgi.00080.2016; McDaniel K, 2014, J CELL MOL MED, V18, P197, DOI 10.1111/jcmm.12223; Meng FY, 2012, AM J PATHOL, V181, P804, DOI 10.1016/j.ajpath.2012.06.010; Omar R, 2016, REV PHYSIOL BIOCH P, V172, P1, DOI 10.1007/112_2016_6; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Senoo H, 2007, VITAM HORM, V75, P131, DOI 10.1016/S0083-6729(06)75006-3; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Taura K, 2016, J CLIN MED, V5, DOI 10.3390/jcm5010009; Van Wynsberghe PM, 2011, NAT STRUCT MOL BIOL, V18, P302, DOI 10.1038/nsmb.1986; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang YP, 2013, HEPATOLOGY, V58, P1349, DOI 10.1002/hep.26467; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang J, 2013, MOL CELL ENDOCRINOL, V375, P53, DOI 10.1016/j.mce.2013.04.022	31	37	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11336	11347		10.1074/jbc.M116.773291	http://dx.doi.org/10.1074/jbc.M116.773291			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28536261	Green Published, hybrid			2022-12-26	WOS:000405119600017
J	Franco-Hermida, JJ; Quintero, MF; Cabrera, RI; Guzman, JM				Jairo Franco-Hermida, John; Fernanda Quintero, Maria; Iskander Cabrera, Raul; Miguel Guzman, Jose			Determination of diagnostic standards on saturated soil extracts for cut roses grown in greenhouses	PLOS ONE			English	Article							NUTRITIONAL DIAGNOSIS; DRIS NORMS; CALCIUM; ACCUMULATION; RESPONSES; INDEXES; BALANCE; PLANTS; YIELD; PH	This work comprises the theoretical determination and validation of diagnostic standards for the analysis of saturated soil extracts for cut rose flower crops (Rosa spp.) growing in the Bogota Plateau, Colombia. The data included 684 plant tissue analyses and 684 corresponding analyses of saturated soil extracts, all collected between January 2009 and June 2013. The tissue and soil samples were selected from 13 rose farms, and from cultivars grafted on the 'Natal Briar' rootstock. These concurrent samples of soil and plant tissues represented 251 production units (locations) of approximately 10,000 m(2) distributed across the study area. The standards were conceived as a tool to improve the nutritional balance in the leaf tissue of rose plants and thereby define the norms for expressing optimum productive potential relative to nutritional conditions in the soil. To this end, previously determined diagnostic standard for rose leaf tissues were employed to obtain rates of foliar nutritional balance at each analyzed location and as criteria for determining the diagnostic norms for saturated soil extracts. Implementing this methodology to foliar analysis, showed a higher significant correlation for diagnostic indices. A similar behavior was observed in saturated soil extracts analysis, becoming a powerful tool for integrated nutritional diagnosis. Leaf analyses determine the most limiting nutrients for high yield and analyses of saturated soil extracts facilitate the possibility of correcting the fertigation formulations applied to soils or substrates. Recommendations are proposed to improve the balance in soil-plant system with which the possibility of yield increase becomes more probable. The main recommendations to increase and improve rose crop flower yields would be: continuously check pH values of SSE, reduce the amounts of P, Fe, Zn and Cu in fertigation solutions and carefully analyze the situation of Mn in the soil-plant system.	[Jairo Franco-Hermida, John] GR Chia SA, Tech Dept, Ctr Empresarial Chia, Chia, Colombia; [Fernanda Quintero, Maria] San Luis Potosi Autonomous Univ, Fac Agron, Dept Controlled Prod Syst, San Luis Potosi, Mexico; [Iskander Cabrera, Raul] Rutgers State Univ, Dept Plant Biol, Bridgeton, NJ USA; [Miguel Guzman, Jose] Cei A3 CIEMBITAL Almeria Univ, Dept Agron, Almeria, Spain	Rutgers State University New Brunswick	Quintero, MF (corresponding author), San Luis Potosi Autonomous Univ, Fac Agron, Dept Controlled Prod Syst, San Luis Potosi, Mexico.; Guzman, JM (corresponding author), Cei A3 CIEMBITAL Almeria Univ, Dept Agron, Almeria, Spain.	maria.quintero@uaslp.mx; mguzman@ual.es	Guzmán, Miguel/H-6111-2011; Quintero Castellanos, Maria Fernanda/A-9572-2015	Guzmán, Miguel/0000-0002-5648-7554; Quintero Castellanos, Maria Fernanda/0000-0002-9130-0679; Cabrera, Raul I/0000-0003-0011-6778	GR Chia, Cundinamarca, Colombia	GR Chia, Cundinamarca, Colombia	This study was financially supported by GR Chia, Cundinamarca, Colombia under contract. John J. Franco-Hermida (JJF-H) is employed by GR Chia. GR Chia provided support in the form of salary for this author (JJF-H), but did not have any additional role in the design of the study, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Arboleda V. C., 1988, Agronomia Colombiana, V5, P17; Bar-Tal A, 2001, AGRONOMIE, V21, P393, DOI 10.1051/agro:2001132; Barber S.A., 1995, SOIL NUTR BIOAVAILAB; Beaufils E., 1973, DIAGNOSIS RECOMMENDA, V1st; Beaufils E. R., 1973, Bulletin, Department of Soil Science and Agro-Meteorology, Natal University; Cabrera RI, 2009, HORTSCIENCE, V44, P2000, DOI 10.21273/HORTSCI.44.7.2000; Cabrera RI, 2003, HORTSCIENCE, V38, P533, DOI 10.21273/HORTSCI.38.4.533; Cabrera RI, 2003, SCI HORTIC-AMSTERDAM, V97, P297, DOI 10.1016/S0304-4238(02)00151-6; Cabrera RI, 2003, ENCY ROSE SCI, P573; Cadahia C., 2005, FERTIRRIGACION CULTI; Da Silva GGC, 2005, REV BRASILEIRA CIENC, P755; de Hoog Jr J., 2001, APPL PLANT RES; GANMORENEUMANN R, 1993, PLANT SOIL, V155, P151, DOI 10.1007/BF00025006; Gonzalez-Lazaro AJ, WORLD C AGR INF IT I, P381; Grattan SR, 1999, SCI HORTIC-AMSTERDAM, V78, P127, DOI 10.1016/S0304-4238(98)00192-7; Guzman M, 2006, AVANCES FERTIRRIEGO, P145; IGAC, 2000, EST GEN SUEL ZON TIE, P1; Jackson BE, 2009, HORTSCIENCE, V44, P1983, DOI 10.21273/HORTSCI.44.7.1983; Hermida JJF, 2013, HORTSCIENCE, V48, P1403, DOI 10.21273/HORTSCI.48.11.1403; JOHANSSON J, 1978, ACTA AGR SCAND, V28, P363, DOI 10.1080/00015127809435194; JONES CA, 1981, COMMUN SOIL SCI PLAN, V12, P785, DOI 10.1080/00103628109367194; KHASAWNEH FE, 1971, SOIL SCI SOC AM PRO, V35, P426, DOI 10.2136/sssaj1971.03615995003500030029x; Khiari L, 2001, AGRON J, V93, P802, DOI 10.2134/agronj2001.934802x; LINDSAY WL, 2001, CHEM EQUILIBRIA SOIL; Lopez J, 2002, J PLANT NUTR, V25, P1585, DOI 10.1081/PLN-120005409; Lucena JJ, 1997, ACTA HORTIC, P179, DOI 10.17660/ActaHortic.1997.448.28; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Modesto V. C., 2014, American Journal of Plant Sciences, V5, P497, DOI 10.4236/ajps.2014.54064; Montes RM, 2016, REV BRAS CIENC SOLO, V40; Mourao FDA, 2004, SCI AGRIC, V61, P550, DOI 10.1590/S0103-90162004000500015; Parent L. E., 2013, American Journal of Plant Sciences, V4, P1508; PARENT LE, 1992, J AM SOC HORTIC SCI, V117, P239, DOI 10.21273/JASHS.117.2.239; Parent LE, 1997, CAN J SOIL SCI, V77, P571, DOI 10.4141/S96-073; PARENT LE, 1993, HORTSCIENCE, V28, P1041, DOI 10.21273/HORTSCI.28.10.1041; Parent LE, 2011, REV BRAS FRUTIC, V33, P321, DOI 10.1590/S0100-29452011000100041; Parent S. E., 2012, SOIL FERTILITY, V83, P114; Parent SE, 2013, P 5 INT WORKSH COMP, P131; Parent SE, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00039, 10.3389/fpls.2013.00449]; Ramos-Miras JJ, 2011, J GEOCHEM EXPLOR, V110, P186, DOI 10.1016/j.gexplo.2011.05.009; Reis RD, 2003, PESQUI AGROPECU BRAS, V38, P379, DOI 10.1590/S0100-204X2003000300007; Richards LA, 1954, SOIL SCI SOC AM J, V18, P348; Rodriguez O, 1997, COMMUN SOIL SCI PLAN, V28, P1461, DOI 10.1080/00103629709369887; Wadt PGS, 2010, PESQUI AGROPECU BRAS, V45, P1180, DOI 10.1590/S0100-204X2010001000018; Schlotter D, 2012, J PLANT NUTR SOIL SC, V175, P236, DOI 10.1002/jpln.201000399; Silva Mojica Francisco, METODOS ANALITICOS L; Sparnaaij LD, 1996, EUPHYTICA, V90, P183, DOI 10.1007/BF00023857; Starkey KR, 1997, J AM SOC HORTIC SCI, V122, P863, DOI 10.21273/JASHS.122.6.863; SUMNER ME, 1977, PLANT SOIL, V46, P359, DOI 10.1007/BF00010092; Torre S, 1999, PHYSIOL PLANTARUM, V107, P214, DOI 10.1034/j.1399-3054.1999.100209.x; VOLPIN H, 1991, PHYTOPATHOLOGY, V81, P1390, DOI 10.1094/Phyto-81-1390; Wadt P. G. S., 1998, Revista Brasileira de Ciencia do Solo, V22, P661, DOI 10.1590/S0100-06831998000400011; Wadt PGS, 1996, MATH CHANCE METHODS; WALWORTH JL, 1986, SOIL SCI SOC AM J, V50, P123, DOI 10.2136/sssaj1986.03615995005000010024x; Walworth JL, 1987, ADV SOIL SCI; White J., 1987, FERTILIZATION ROSES, P87; ZIESLIN N, 1989, SCI HORTIC-AMSTERDAM, V37, P339, DOI 10.1016/0304-4238(89)90145-3	57	6	6	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178500	10.1371/journal.pone.0178500	http://dx.doi.org/10.1371/journal.pone.0178500			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542547	Green Submitted, Green Published, gold			2022-12-26	WOS:000402062800098
J	Chalacheva, P; Khaleel, M; Sunwoo, J; Shah, P; Detterich, JA; Kato, RM; Thuptimdang, W; Meiselman, HJ; Sposto, R; Tsao, J; Wood, JC; Zeltzer, L; Coates, TD; Khoo, MCK				Chalacheva, Patjanaporn; Khaleel, Maha; Sunwoo, John; Shah, Payal; Detterich, Jon A.; Kato, Roberta M.; Thuptimdang, Wanwara; Meiselman, Herbert J.; Sposto, Richard; Tsao, Jennie; Wood, John C.; Zeltzer, Lonnie; Coates, Thomas D.; Khoo, Michael C. K.			Biophysical markers of the peripheral vasoconstriction response to pain in sickle cell disease	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; ENDOTHELIAL DYSFUNCTION; CLINICAL SEVERITY; NITRIC-OXIDE; CONSTRICTION; ANEMIA; SYSTEM; DEEP	Painful vaso-occlusive crisis (VOC), a complication of sickle cell disease (SCD), occurs when sickled red blood cells obstruct flow in the microvasculature. We postulated that exaggerated sympathetically mediated vasoconstriction, endothelial dysfunction and the synergistic interaction between these two factors act together to reduce microvascular flow, promoting regional vaso-occlusions, setting the stage for VOC. We previously found that SCD subjects had stronger vasoconstriction response to pulses of heat-induced pain compared to controls but the relative degrees to which autonomic dysregulation, peripheral vascular dysfunction and their interaction are present in SCD remain unknown. In the present study, we employed a mathematical model to decompose the total vasoconstriction response to pain into: 1) the neurogenic component, 2) the vascular response to blood pressure, 3) respiratory coupling and 4) neurogenic-vascular interaction. The model allowed us to quantify the contribution of each component to the total vasoconstriction response. The most salient features of the components were extracted to represent biophysical markers of autonomic and vascular impairment in SCD and controls. These markers provide a means of phenotyping severity of disease in sickle-cell anemia that is based more on underlying physiology than on genotype. The marker of the vascular component (BMv) showed stronger contribution to vasoconstriction in SCD than controls (p = 0.0409), suggesting a dominant myogenic response in the SCD subjects as a consequence of endothelial dysfunction. The marker of neurogenic-vascular interaction (BMn-v) revealed that the interaction reinforced vasoconstriction in SCD but produced vasodilatory response in controls (p = 0.0167). This marked difference in BMn-v suggests that it is the most sensitive marker for quantifying combined alterations in autonomic and vascular function in SCD in response to heatinduced pain.	[Chalacheva, Patjanaporn; Sunwoo, John; Thuptimdang, Wanwara; Wood, John C.; Khoo, Michael C. K.] Univ Southern Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Khaleel, Maha; Shah, Payal; Coates, Thomas D.] Childrens Hosp Los Angeles, Childrens Ctr Canc & Blood Dis, Div Hematol Oncol & Blood & Marrow Transplantat, Los Angeles, CA 90027 USA; [Detterich, Jon A.; Wood, John C.] Childrens Hosp Los Angeles, Div Cardiol, Los Angeles, CA 90027 USA; [Detterich, Jon A.; Kato, Roberta M.; Coates, Thomas D.] Univ Southern Calif, Dept Pediat, Keck Sch Med, Los Angeles, CA 90089 USA; [Kato, Roberta M.] Childrens Hosp Los Angeles, Div Pulmonol, Los Angeles, CA 90027 USA; [Meiselman, Herbert J.] Univ Southern Calif, Dept Physiol & Biophys, Keck Sch Med, Los Angeles, CA 90089 USA; [Sposto, Richard] Univ Southern Calif, Dept Preventat Med, Keck Sch Med, Los Angeles, CA USA; [Tsao, Jennie; Zeltzer, Lonnie] Univ Calif Los Angeles, David Geffen Sch Med, Pediat Pain Program, Los Angeles, CA 90095 USA	University of Southern California; Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chalacheva, P (corresponding author), Univ Southern Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA.	chalache@usc.edu	Coates, Thomas/AAN-3556-2020	Coates, Thomas/0000-0001-9878-6029; Sunwoo, John/0000-0003-4314-7232	National Institutes of Health National Heart, Lung, and Blood Institute [U01 HL117718]; National Institute of Biomedical Imaging and Bioengineering [P41 EB001978]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL119627, U01HL117718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001978] Funding Source: NIH RePORTER	National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institutes of Health National Heart, Lung, and Blood Institute grant U01 HL117718 (http://www.nhlbi.nih.gov) and National Institute of Biomedical Imaging and Bioengineering grant P41 EB001978 (https://www.nibib.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Institutes of Health National Heart, Lung, and Blood Institute grant U01 HL117718 and National Institute of Biomedical Imaging and Bioengineering grant P41 EB001978.	Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; Amiya Eisuke, 2014, Ann Vasc Dis, V7, P109, DOI 10.3400/avd.ra.14-00048; Belhassen L, 2001, BLOOD, V97, P1584, DOI 10.1182/blood.V97.6.1584; Blum A, 2005, J THROMB THROMBOLYS, V19, P83, DOI 10.1007/s11239-005-1377-7; Bolton B, 1936, J PHYSIOL-LONDON, V86, P83, DOI 10.1113/jphysiol.1936.sp003345; Bruno RM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00284; Bruno RM, 2011, HYPERTENSION, V57, P79, DOI 10.1161/HYPERTENSIONAHA.110.163584; Burton AR, 2009, J PHYSIOL-LONDON, V587, P183, DOI 10.1113/jphysiol.2008.162230; Camm AJ, 1996, EUR HEART J, V17, P354; Chalacheva P, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12463; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Detterich JA, 2015, BLOOD, V126, P703, DOI 10.1182/blood-2014-12-614370; EATON WA, 1976, BLOOD, V47, P621; Elgendi M, 2012, CURR CARDIOL REV, V8, P14, DOI 10.2174/157340312801215782; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; FALCONE JC, 1991, AM J PHYSIOL, V260, pH130, DOI 10.1152/ajpheart.1991.260.1.H130; Gulati A, 1997, AM J PHYSIOL-HEART C, V273, pH1177, DOI 10.1152/ajpheart.1997.273.3.H1177; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hijmering ML, 2002, J AM COLL CARDIOL, V39, P683, DOI 10.1016/S0735-1097(01)01786-7; HUANG A, 1993, HYPERTENSION, V22, P913, DOI 10.1161/01.HYP.22.6.913; Khaleel M, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.67.67; Khoo MC, 2007, CARDIOVASC ENG; Khoo MCK, 2016, SLEEP MED CLIN, V11, P489, DOI 10.1016/j.jsmc.2016.07.003; L'Esperance VS, 2013, EXP PHYSIOL, V98, P49, DOI 10.1113/expphysiol.2011.064055; Malpas SC, 2001, IEEE ENG MED BIOL, V20, P17, DOI 10.1109/51.917720; Mestre JCR, 1997, CLIN AUTON RES, V7, P121, DOI 10.1007/BF02308838; Metivier F, 2000, NEPHROL DIAL TRANSPL, V15, P14, DOI 10.1093/oxfordjournals.ndt.a027970; Nakamura K, 1999, J CARDIOVASC PHARM, V33, P876, DOI 10.1097/00005344-199906000-00007; Nordin M, 1995, J PHYSIOL-LONDON, V489, P885, DOI 10.1113/jphysiol.1995.sp021101; Patel KP, 2001, EXP BIOL MED, V226, P814, DOI 10.1177/153537020122600902; Pearson SR, 2005, CLIN AUTON RES, V15, P400, DOI 10.1007/s10286-005-0300-9; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; SACKNER MA, 1989, J APPL PHYSIOL, V66, P410, DOI 10.1152/jappl.1989.66.1.410; SAKUMA I, 1992, CIRC RES, V70, P607, DOI 10.1161/01.RES.70.3.607; Sangkatumvong S, 2011, AM J RESP CRIT CARE, V184, P474, DOI 10.1164/rccm.201103-0537OC; Schobel HP, 1996, PAIN, V66, P117, DOI 10.1016/0304-3959(96)03079-5; SEALS DR, 1993, CIRC RES, V72, P440, DOI 10.1161/01.RES.72.2.440; Secomb T, 2008, MICROCIRCULATION, V15, P765, DOI 10.1080/10739680802350112; Sverrisdottir YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009257	39	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178353	10.1371/journal.pone.0178353	http://dx.doi.org/10.1371/journal.pone.0178353			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542469	Green Published, Green Submitted, gold			2022-12-26	WOS:000402061500082
J	Laiseca, JE; Ladelfa, MF; Cotignola, J; Peche, LY; Pascucci, FA; Castano, BA; Galigniana, MD; Schneider, C; Monte, M				Laiseca, Julieta E.; Ladelfa, Maria F.; Cotignola, Javier; Peche, Leticia Y.; Pascucci, Franco A.; Castano, Bryan A.; Galigniana, Mario D.; Schneider, Claudio; Monte, Martin			Functional interaction between co-expressed MAGE-A proteins	PLOS ONE			English	Article							ANDROGEN RECEPTOR; CANCER/TESTIS ANTIGENS; UBIQUITIN LIGASE; CANCER GENOMICS; P53 FUNCTION; METHYLATION; MELANOMA; HYPOMETHYLATION; EXPRESSION; COMPLEXES	MAGE-A (Melanoma Antigen Genes-A) are tumor-associated proteins with expression in a broad spectrum of human tumors and normal germ cells. MAGE-A gene expression and function are being increasingly investigated to better understand the mechanisms by which MAGE proteins collaborate in tumorigenesis and whether their detection could be useful for disease prognosis purposes. Alterations in epigenetic mechanisms involved in MAGE gene silencing cause their frequent co-expression in tumor cells. Here, we have analyzed the effect of MAGE-A gene co-expression and our results suggest that MageA6 can potentiate the androgen receptor (AR) co-activation function of MageA11. Database search confirmed that MageA11 and MageA6 are co-expressed in human prostate cancer samples. We demonstrate that MageA6 and MageA11 form a protein complex resulting in the stabilization of MageA11 and consequently the enhancement of AR activity. The mechanism involves association of the Mage A6-MHD domain to MageA11, prevention of MageA11 ubiquitinylation on lysines 240 and 245 and decreased proteasome-dependent degradation. We experimentally demonstrate here for the first time that two MAGE-A proteins can act together in a non-redundant way to potentiate a specific oncogenic function. Overall, our results highlight the complexity of the MAGE gene networking in regulating cancer cell behavior.	[Laiseca, Julieta E.; Ladelfa, Maria F.; Pascucci, Franco A.; Castano, Bryan A.; Monte, Martin] Univ Buenos Aires, Dept Quim Biol, Lab Oncol Mol, Buenos Aires, DF, Argentina; [Laiseca, Julieta E.; Ladelfa, Maria F.; Pascucci, Franco A.; Castano, Bryan A.; Monte, Martin] Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET, IQUIBICEN UBA, Buenos Aires, DF, Argentina; [Cotignola, Javier] Univ Buenos Aires, Dept Quim Biol, Lab Inflamac & Canc, Buenos Aires, DF, Argentina; [Cotignola, Javier] Univ Buenos Aires, Fac Ciencias Exactas & Nat, IQUIBICEN UBA, CONICET, Buenos Aires, DF, Argentina; [Peche, Leticia Y.; Schneider, Claudio] Lab Nazl Consorzio Interuniv Biotecnol, Area Sci Pk, Trieste, Italy; [Galigniana, Mario D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab Biol Mol & Celular, Buenos Aires, DF, Argentina; [Galigniana, Mario D.] Consejo Nacl Invest Cient & Tecn, IBYME, Lab Receptores Nucl, Buenos Aires, DF, Argentina; [Schneider, Claudio] Univ Udine, Dipartimento Sci & Tecnol Biomed, Ple Kolbe 4, Udine, Italy	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Udine	Monte, M (corresponding author), Univ Buenos Aires, Dept Quim Biol, Lab Oncol Mol, Buenos Aires, DF, Argentina.; Monte, M (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET, IQUIBICEN UBA, Buenos Aires, DF, Argentina.	mmonte@qb.fcen.uba.ar	Cotignola, Javier/H-3343-2019; castano, bryan/AIC-7343-2022	Cotignola, Javier/0000-0003-4473-9854; Monte, Martin/0000-0002-5068-563X; Peche, Leticia Yamila/0000-0002-1666-9433	Fundacion Rene Baron; Ministry of Science and Technology-ANPCyT [PICT12/0866]; University of Buenos Aires [UBACyT13/0013BA]; National Council for Science and Technology-CONICET [PIP13/0411]; CONICET; ANPCyT;  [UBACyT14/0318BA]	Fundacion Rene Baron; Ministry of Science and Technology-ANPCyT; University of Buenos Aires(University of Buenos Aires); National Council for Science and Technology-CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT(ANPCyT); 	This work was supported by Fundacion Rene Baron and UBACyT14/0318BA to M. Galigniana and the Ministry of Science and Technology-ANPCyT (PICT12/0866), the University of Buenos Aires (UBACyT13/0013BA), and the National Council for Science and Technology-CONICET (PIP13/0411) to M. Monte. JEL and FAP are recipients of PhD fellowships from CONICET and ANPCyT, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Fundacion Rene Baron and UBACyT14/0318BA to M.Galigniana and the Ministry of Science and Technology-ANPCyT (PICT12/0866), the University of Buenos Aires (UBACyT13/0013BA), and the National Council for Science and Technology-CONICET (PIP13/0411) to M. Monte JEL and FAP are recipients of PhD fellowships from CONICET and ANPCyT, respectively.	Askew EB, 2010, J BIOL CHEM, V285, P21824, DOI 10.1074/jbc.M110.120600; Ayyoub M, 2014, J IMMUNOTHER, V37, P73, DOI 10.1097/CJI.0000000000000013; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; De Smet C, 2004, MOL CELL BIOL, V24, P4781, DOI 10.1128/MCB.24.11.4781-4790.2004; De Smet C, 1999, MOL CELL BIOL, V19, P7327; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Ladelfa MF, 2012, CANCER LETT, V325, P11, DOI 10.1016/j.canlet.2012.05.031; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Hao JQ, 2015, ONCOTARGET, V6, P42028, DOI 10.18632/oncotarget.5973; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; Laduron S, 2004, NUCLEIC ACIDS RES, V32, P4340, DOI 10.1093/nar/gkh735; Marcar L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127713; Marcar L, 2010, CANCER RES, V70, P10362, DOI 10.1158/0008-5472.CAN-10-1341; Meek DW, 2012, CANCER LETT, V324, P126, DOI 10.1016/j.canlet.2012.05.011; Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103; Newman JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148762; Peche LY, 2012, CELL DEATH DIFFER, V19, P926, DOI 10.1038/cdd.2011.173; Peche LY, 2015, J BIOL CHEM, V290, P29652, DOI 10.1074/jbc.M115.671982; Pineda CT, 2015, CELL, V160, P715, DOI 10.1016/j.cell.2015.01.034; Rao M, 2011, CANCER RES, V71, P4192, DOI 10.1158/0008-5472.CAN-10-2442; RENNIE PS, 1988, AM J CLIN ONCOL-CANC, V11, pS13, DOI 10.1097/00000421-198801102-00004; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Su SF, 2013, J BIOL CHEM, V288, P24809, DOI 10.1074/jbc.M113.468579; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Xu YZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12104; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478	33	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178370	10.1371/journal.pone.0178370	http://dx.doi.org/10.1371/journal.pone.0178370			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542476	gold, Green Published, Green Submitted			2022-12-26	WOS:000402061500084
J	Stidham, T; Patnaik, R; Krishan, K; Singh, B; Ghosh, A; Singla, A; Kotla, SS				Stidham, Thomas; Patnaik, Rajeev; Krishan, Kewal; Singh, Bahadur; Ghosh, Abhik; Singla, Ankita; Kotla, Simran S.			The first darter (Aves: Anhingidae) fossils from India (late Pliocene)	PLOS ONE			English	Article							BIRDS	New fossils from the latest Pliocene portion of the Tatrot Formation exposed in the Siwalik Hills of northern India represent the first fossil record of a darter (Anhingidae) from India. The darter fossils possibly represent a new species, but the limited information on the fossil record of this group restricts their taxonomic allocation. The Pliocene darter has a deep pit on the distal face of metatarsal trochlea IV not reported in other anhingids, it has an open groove for the m. flexor perforatus et perforans digiti II tendon on the hypotarsus unlike New World anhingid taxa, and these darter specimens are the youngest of the handful of Neogene records of the group from Asia. These fossil specimens begin to fill in a significant geographic and temporal gap in the fossil record of this group that is largely known from other continents and other time periods. The presence of a darter and pelican (along with crabs, fish, turtles, and crocodilians) in the same fossil-bearing horizon strongly indicates the past presence of a substantial water body (large pond, lake, or river) in the interior of northern India in the foothills of the Himalayan Mountains.	[Stidham, Thomas] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Patnaik, Rajeev; Singla, Ankita; Kotla, Simran S.] Panjab Univ, Dept Geol, Chandigarh, India; [Krishan, Kewal; Singh, Bahadur; Ghosh, Abhik] Panjab Univ, Dept Anthropol, Chandigarh, India	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Panjab University; Panjab University	Stidham, T (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China.	presbyornis@gmail.com	Singh, Bahadur/H-5783-2019; Krishan, Kewal/I-3285-2014; Ghosh, Abhik/AAH-1277-2020	Singh, Bahadur/0000-0002-5370-6029; Krishan, Kewal/0000-0001-5321-0958; Ghosh, Abhik/0000-0003-1161-6364; Kotla, Simran Singh/0000-0001-9360-066X	National Natural Science Foundation of China [NSFC41472025]; Strategic Priority Research Program of the Chinese Academy of Sciences (CAS) [XDB03020501]; Ministry of Earth Science project [MoES/P.O. (Geoscience)/46/2015]; Council of Scientific and Industrial Research (CSIR) Fellowship; Promotion of University Research and Scientific Excellence (PURSE) grant; University Grants Commission (UGC) Center for Advanced Study (CAS) grant	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences (CAS); Ministry of Earth Science project; Council of Scientific and Industrial Research (CSIR) Fellowship; Promotion of University Research and Scientific Excellence (PURSE) grant; University Grants Commission (UGC) Center for Advanced Study (CAS) grant	TAS is funded by the National Natural Science Foundation of China (NSFC41472025) http://www.nsfc.gov.cn/ and the Strategic Priority Research Program of the Chinese Academy of Sciences (CAS, XDB03020501) http://english.cas.cn/. RP is supported by Ministry of Earth Science project (MoES/P.O. (Geoscience)/46/2015) http://www.moes.gov.in/, and SSK is supported by a Council of Scientific and Industrial Research (CSIR) Fellowship http://www.csirhrdg.res.in/jrfsrfra2.htm. BS, KK, and AG are funded by a Promotion of University Research and Scientific Excellence (PURSE) grant http://www.fist-dst.org/html-flies/purse.htm and the University Grants Commission (UGC) Center for Advanced Study (CAS) grant awarded to the Department of Anthropology, Panjab University, Chandigarh, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarenga HMF, 2003, J VERTEBR PALEONTOL, V23, P614, DOI 10.1671/1890; Ballmann Peter, 1987, P113; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; Brisson M.J., 1760, ORNITHOLOGIE METHOD, V1; BRODKORB P, 1982, Geobios (Villeurbanne), V15, P505, DOI 10.1016/S0016-6995(82)80071-5; Cheneval J., 1991, Journal of Southeast Asian Earth Sciences, V6, P117, DOI 10.1016/0743-9547(91)90103-5; Christidis L, 2008, SYSTEMATICS TAXONOMY; Davies W., 1880, GEOL MAG, V7, P18, DOI [10.1017/S0016756800146904, DOI 10.1017/S0016756800146904]; Dorst J., 1979, CHECK LIST BIRDS WOR, P155; Dyke GJ, 2008, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2008)3610[1:NROFWF]2.0.CO;2; Grimmett R, 2011, BIRDS INDIAN SUBCONT; Harris John M., 2003, P161; Harrison C.J.O., 1982, Tertiary Research, V4, P53; HARRISON CJO, 1978, EMU, V78, P230, DOI 10.1071/MU9780230; Hasegawa Y., 1977, B MIZUNAMI FOSSIL MU, V4, P169; Jonhsgard PA, 1993, CORMORANTS DARTERS P; Jukar AM, 2016, J VERT PALEO, V2016, P163; Klein S, FRESHWATER CRAB PLIO; Lambrecht K., 1916, MITTEILUNGEN JB KONI, V24, P1; Lesson RP., 1831, TRAITE ORNITHOLOGIE; Louchart A, 2005, ACTA PALAEONTOL POL, V50, P549; Louchart Antoine, 2008, Oryctos, V7, P147; Louchart A, 2008, J HUM EVOL, V55, P513, DOI 10.1016/j.jhevol.2008.06.002; Mackness B, 1995, EMU, V95, P265, DOI 10.1071/MU9950265; Mayr G, 2016, ACTA ZOOL-STOCKHOLM, V97, P196, DOI 10.1111/azo.12117; Mayr G, 2010, J VERTEBR PALEONTOL, V30, P467, DOI 10.1080/02724631003617357; Meijer HJM, 2014, PEERJ, V2, DOI 10.7717/peerj.295; MILLER AH, 1966, CONDOR, V68, P315, DOI 10.2307/1365447; Milne-Edwards A., 1867, RECHERCHES ANATOMIQU; Noriega Jorge I., 2002, P41; Patnaik Rajeev, 1994, Journal of the Palaeontological Society of India, V39, P77; Patnaik R, 2016, CR PALEVOL, V15, P889, DOI 10.1016/j.crpv.2015.11.004; Rich P.V., 1972, NOTES SERVICE GEOLOG, V35, P29; RICH PV, 1986, GEOBIOS-LYON, V19, P755, DOI 10.1016/S0016-6995(86)80106-1; SAIFF EI, 1978, ZOOL J LINN SOC-LOND, V63, P315, DOI 10.1111/j.1096-3642.1978.tb02099.x; Sharpe R.B., 1891, P 2 INT ORN C, V1891, P1; Stewart J.R., 2006, HIST BIOL, V18, P103; Stidham TA, 2016, PALAEONTOL ELECTRON, V19; Stidham TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111210; Worthy TH, 2012, AUK, V129, P96, DOI 10.1525/auk.2012.11204; Worthy TH, 2011, ZOOL J LINN SOC-LOND, V163, P277, DOI 10.1111/j.1096-3642.2011.00693.x; [No title captured]	42	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177129	10.1371/journal.pone.0177129	http://dx.doi.org/10.1371/journal.pone.0177129			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542291	Green Published, Green Submitted, gold			2022-12-26	WOS:000402061500013
J	Kim, J; Lee, W; Won, JU; Yoon, JH; Seok, H; Kim, YK; Lee, S; Roh, J				Kim, Jihyun; Lee, Wanhyung; Won, Jong-Uk; Yoon, Jin-Ha; Seok, Hongdeok; Kim, Yeong-Kwang; Lee, Seunghyun; Roh, Jaehoon			The relationship between occupational noise and vibration exposure and headache/eyestrain, based on the fourth Korean Working Condition Survey (KWCS)	PLOS ONE			English	Article							ASSESSMENT MIDAS SCORE; CHRONIC HEADACHES; TRAFFIC NOISE; MIGRAINE; SENSITIVITY; POPULATION; PREVALENCE; SYMPTOMS; VALIDITY; RELIABILITY	Introduction The individual and combined effect of occupational noise and vibration exposures, on workers' health has not been thoroughly investigated. In order to find better ways to prevent and manage workers' headache, this study aimed to investigate the effects of occupational noise and vibration exposure on headache/eyestrain. Methods We used data from the fourth Korean Working Condition Survey (2014). After applying inclusion and exclusion criteria, 25,751 workers were included. Occupational noise and vibration exposure and the prevalence of headache/eyestrain were investigated by self-reported survey. Chi-square tests were used to compare differences in baseline characteristics between the group with headache/eyestrain and the group without. Odds ratios and 95% confidence intervals were estimated using a logistic regression model adjusted for several covariates. Area under the receiver operating characteristics curve (AUROC) analysis was used to evaluate the effect of occupational noise and/or vibration exposure. Results Among the 25,751 study subjects, 4,903 had experienced headache/eyestrain in the preceding year. There were significant differences in age, education level, household income, occupational classification, shift work, occupational vibration exposure, and occupational noise exposure between the two groups (all p<0.05). The odds ratios between each exposure and headache/eyestrain increased proportionally with the level of exposure, increasing from 1.08 to 1.26 with increasing vibration exposure, and from 1.25 to 1.41 with increasing noise exposure. According to the AUROC analysis, the predictive power of each exposure was significant, and increased when the two exposures were considered in combination. Discussion The findings of this study show that both occupational noise and vibration exposures are associated with headache/eyestrain; noise exposure more strongly so. However, when the two exposures are considered in combination, the explanatory power for headache/eyestrain is increased. Therefore, efforts aimed at reducing and managing occupational noise and vibration exposure are crucial to maintaining workers' health.	[Kim, Jihyun; Lee, Wanhyung; Won, Jong-Uk; Yoon, Jin-Ha; Seok, Hongdeok; Kim, Yeong-Kwang; Roh, Jaehoon] Yonsei Univ, Univ Coll Med, Inst Occupat Hlth, Seoul, South Korea; [Kim, Jihyun; Lee, Wanhyung; Won, Jong-Uk; Yoon, Jin-Ha; Seok, Hongdeok; Kim, Yeong-Kwang; Roh, Jaehoon] Yonsei Univ, Grad Sch Publ Hlth, Coll Med, Seoul, South Korea; [Kim, Jihyun; Lee, Wanhyung; Won, Jong-Uk; Yoon, Jin-Ha; Seok, Hongdeok; Kim, Yeong-Kwang; Roh, Jaehoon] Incheon Workers Hlth Ctr, Incheon, South Korea; [Won, Jong-Uk; Yoon, Jin-Ha; Roh, Jaehoon] Yonsei Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Lee, Seunghyun] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Kitakyushu, Fukuoka, Japan	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of Occupational & Environmental Health - Japan	Roh, J (corresponding author), Yonsei Univ, Univ Coll Med, Inst Occupat Hlth, Seoul, South Korea.; Roh, J (corresponding author), Yonsei Univ, Grad Sch Publ Hlth, Coll Med, Seoul, South Korea.; Roh, J (corresponding author), Incheon Workers Hlth Ctr, Incheon, South Korea.; Roh, J (corresponding author), Yonsei Univ, Dept Prevent Med, Coll Med, Seoul, South Korea.	jhroh@yuhs.ac		Yoon, Jin-Ha/0000-0003-4198-2955; Won, Jong-Uk/0000-0002-9200-3297				Aaseth K, 2008, CEPHALALGIA, V28, P705, DOI 10.1111/j.1468-2982.2008.01577.x; Ahmed HO, 2004, INT J HYG ENVIR HEAL, V207, P227, DOI 10.1078/1438-4639-00291; Bussone G, 2004, NEUROL SCI, V25, pS239, DOI 10.1007/s10072-004-0295-3; Carruthers Alastair, 1999, Headache, V39, P662, DOI 10.1046/j.1526-4610.1999.3909662.x; Chakravarty A, 2010, MED HYPOTHESES, V74, P225, DOI 10.1016/j.mehy.2009.08.034; Erdogan E, 2009, AFR J AGR RES, V4, P1015; Granet DB, 2005, STRABISMUS, V13, P163, DOI 10.1080/09273970500455436; Griffin MJ, 1997, OCCUP ENVIRON MED, V54, P73, DOI 10.1136/oem.54.2.73; Harada N, 1994, AUTONOMIC NERVOUS FU; Jiao K, 2004, INT ARCH OCC ENV HEA, V77, P205, DOI 10.1007/s00420-003-0493-y; Jungsun P, 2009, IND HLTH, V47, P50; Justice AC, 1999, J ACQ IMMUN DEF SYND, V21, P126; Kim YS, 2013, SAF HEALTH WORK, V4, P111, DOI 10.1016/j.shaw.2013.05.001; LANG T, 1992, INT ARCH OCC ENV HEA, V63, P369, DOI 10.1007/BF00386929; Lanteri-Minet M, 2013, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-013-0385-0; Lee HS, 2000, J INTEL MAT SYST STR, V11, P80, DOI 10.1106/412A-2GMA-BTUL-MALT; MARCHESI C, 1989, J AFFECT DISORDERS, V16, P33, DOI 10.1016/0165-0327(89)90052-9; Martin PR, 2006, HEADACHE, V46, P962, DOI 10.1111/j.1526-4610.2006.00468.x; Martin PR, 2005, HEADACHE, V45, P1353, DOI 10.1111/j.1526-4610.2005.00268.x; MATOBA T, 1977, TOHOKU J EXP MED, V123, P57, DOI 10.1620/tjem.123.57; Olesen J, 2011, NEW PLANS HEADACHE C; Olesen J, 2009, FUTURE HEADACHE CLAS; Paiva T, 1997, ARCH INTERN MED, V157, P1701, DOI 10.1001/archinte.157.15.1701; Palmer KT, 2000, OCCUP ENVIRON MED, V57, P237, DOI 10.1136/oem.57.4.237; Rylander R, 2004, J SOUND VIB, V277, P471, DOI 10.1016/j.jsv.2004.03.008; Sadri G, 2015, IRAN J MED SCI, V27, P39; Seong JC, 2011, ENVIRON INT, V37, P1336, DOI 10.1016/j.envint.2011.05.019; Sheedy JE, 2003, OPTOMETRY VISION SCI, V80, P732, DOI 10.1097/00006324-200311000-00008; Spierings ELH, 1998, HEADACHE, V38, P191, DOI 10.1046/j.1526-4610.1998.3803191.x; Spierings ELH, 2001, HEADACHE, V41, P554, DOI 10.1046/j.1526-4610.2001.041006554.x; Stewart WF, 1999, NEUROLOGY, V53, P988, DOI 10.1212/WNL.53.5.988; Stewart WF, 2000, PAIN, V88, P41, DOI 10.1016/S0304-3959(00)00305-5; Stewart WF, 2001, NEUROLOGY, V56, pS20, DOI 10.1212/WNL.56.suppl_1.S20; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; TAKEUCHI T, 1986, SCAND J WORK ENV HEA, V12, P280, DOI 10.5271/sjweh.2140; Tian LG, 1996, INT J IND ERGONOM, V18, P221; VINCENT AJP, 1989, HEADACHE, V29, P523, DOI 10.1111/j.1526-4610.1989.hed2908523.x; Vingen JV, 1998, CEPHALALGIA, V18, P243, DOI 10.1046/j.1468-2982.1998.1805243.x; VIROKANNAS H, 1992, INT ARCH OCC ENV HEA, V64, P377, DOI 10.1007/BF00379549; Vukovic V, 2009, MIGRAINE PATHOPHYSIO, P33; Wada K, 2013, IND HEALTH, V51, P482, DOI 10.2486/indhealth.2013-0016; Wilkins K, 1998, Health Rep, V10, P47; WOODHOUSE A, 1993, CEPHALALGIA, V13, P417, DOI 10.1046/j.1468-2982.1993.1306417.x	43	6	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177846	10.1371/journal.pone.0177846	http://dx.doi.org/10.1371/journal.pone.0177846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542287	gold, Green Submitted, Green Published			2022-12-26	WOS:000402058800029
J	Lyda, TA; Wagner, EL; Bourg, AX; Peng, C; Tomaraei, GN; Dean, D; Kennedy, MS; Marcotte, WR				Lyda, Todd A.; Wagner, Elizabeth L.; Bourg, Andre X.; Peng, Congyue; Tomaraei, Golnaz Najaf; Dean, Delphine; Kennedy, Marian S.; Marcotte, William R., Jr.			A Leishmania secretion system for the expression of major ampullate spidroin mimics	PLOS ONE			English	Article							SPIDER DRAGLINE SILK; LUTZOMYIA-LONGIPALPIS; ESCHERICHIA-COLI; NEPHILA-CLAVIPES; PICHIA-PASTORIS; PROTEIN; FIBER; GENES; PROTEOPHOSPHOGLYCANS; PROMASTIGOTES	Spider major ampullate silk fibers have been shown to display a unique combination of relatively high fracture strength and toughness compared to other fibers and show potential for tissue engineering scaffolds. While it is not possible to mass produce native spider silks, the potential ability to produce fibers from recombinant spider silk fibers could allow for an increased innovation rate within tissue engineering and regenerative medicine. In this pilot study, we improved upon a prior fabrication route by both changing the expression host and additives to the fiber pulling precursor solution to improve the performance of fibers. The new expression host for producing spidroin protein mimics, protozoan parasite Leishmania tarentolae, has numerous advantages including a relatively low cost of culture, rapid growth rate and a tractable secretion pathway. Tensile testing of hand pulled fibers produced from these spidroin-like proteins demonstrated that additives could significantly modify the fiber's mechanical and/or antimicrobial properties. Cross-linking the proteins with glutaraldehyde before fiber pulling resulted in a relative increase in tensile strength and decrease in ductility. The addition of ampicillin into the spinning solution resulted in the fibers being able to inhibit bacterial growth.	[Lyda, Todd A.; Wagner, Elizabeth L.; Bourg, Andre X.; Peng, Congyue; Marcotte, William R., Jr.] Clemson Univ, Dept Genet & Biochem, Clemson, SC 29634 USA; [Tomaraei, Golnaz Najaf; Kennedy, Marian S.] Clemson Univ, Dept Mat Sci & Engn, Clemson, SC USA; [Dean, Delphine] Clemson Univ, Dept Bioengn, Clemson, SC USA; [Lyda, Todd A.] High Point Univ, Dept Biol, High Point, NC USA	Clemson University; Clemson University; Clemson University	Marcotte, WR (corresponding author), Clemson Univ, Dept Genet & Biochem, Clemson, SC 29634 USA.	marcotw@clemson.edu	Marcotte, William/AAD-8354-2019; Dean, Delphine/AAZ-7907-2021; Kennedy, Marian S/F-7283-2010; Peng, Congyue/AAK-3850-2020	Marcotte, William/0000-0003-4580-1939; Dean, Delphine/0000-0002-8631-2640; Kennedy, Marian S/0000-0003-4395-3154; Peng, Congyue/0000-0002-9992-5737	National Science Foundation [DMR-1105307]; Div Of Chem, Bioeng, Env, & Transp Sys [1254609] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The authors received funding for this work from the National Science Foundation (Award No. DMR-1105307 to WRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, PROTOCOL 0013 ELECTR, P1; Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133; Arcidiacono Steven, 2013, Methods Mol Biol, V996, P43, DOI 10.1007/978-1-62703-354-1_3; Barr LA, 2004, MOL BREEDING, V13, P345, DOI 10.1023/B:MOLB.0000034089.92263.ff; Charest H, 1996, J BIOL CHEM, V271, P17081, DOI 10.1074/jbc.271.29.17081; Clayton C, 1998, MOL BIOCHEM PARASIT, V97, P221, DOI 10.1016/S0166-6851(98)00115-7; do Vale VF, 2007, J INSECT PHYSIOL, V53, P1151, DOI 10.1016/j.jinsphys.2007.06.005; ELWASILA M, 1988, PARASITOL RES, V74, P591, DOI 10.1007/BF00531640; Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884; Fritsche C, 2007, J BASIC MICROB, V47, P384, DOI 10.1002/jobm.200710111; Gaines WA, 2008, INSECT MOL BIOL, V17, P465, DOI 10.1111/j.1365-2583.2008.00828.x; Gaines WA, 2010, J BIOL CHEM, V285, P40745, DOI 10.1074/jbc.M110.163121; Ghedin E, 1998, J BIOL CHEM, V273, P22997, DOI 10.1074/jbc.273.36.22997; GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9; Gosline JM, 1999, J EXP BIOL, V202, P3295; Hauptmann V, 2013, BIOTECHNOL J, V8, P1183, DOI 10.1002/biot.201300204; Heidebrecht A, 2015, ADV MATER, V27, P2189, DOI 10.1002/adma.201404234; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5; Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q; Ittah S, 2010, BIOPOLYMERS, V93, P458, DOI 10.1002/bip.21362; Jacobson RL, 2007, FOLIA PARASIT, V54, P301, DOI 10.14411/fp.2007.039; Lai JY, 2014, RSC ADV, V4, P18871, DOI 10.1039/c4ra01930j; Lai JY, 2010, MAT SCI ENG C-MATER, V30, P677, DOI 10.1016/j.msec.2010.02.024; Lucas F., 1968, Comprehensive Biochem, V26, P475; LUCAS FRED, 1964, DISCOVERY, V25, P20; Lyda TA, 2015, MOL CELL BIOCHEM, V404, P53, DOI 10.1007/s11010-015-2366-6; McConville MJ, 2007, TRENDS PARASITOL, V23, P368, DOI 10.1016/j.pt.2007.06.009; Meier C, 2011, BIOMACROMOLECULES, V12, P3453, DOI 10.1021/bm2005752; Peng CA, 2016, TRANSGENIC RES; Reddy N, 2015, TRENDS BIOTECHNOL, V33, P362, DOI 10.1016/j.tibtech.2015.03.008; Rogers ME, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00223; Rogers ME, 2010, MICROBES INFECT, V12, P875, DOI 10.1016/j.micinf.2010.05.014; Sallach RE, 2009, BIOTECHNOL PROGR, V25, P1810, DOI 10.1002/btpr.208; Sambook J., 1989, MOL CLONING LAB MANU, P743; Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335; STIERHOF YD, 1994, J CELL BIOL, V125, P321, DOI 10.1083/jcb.125.2.321; Stierhof YD, 1999, EUR J CELL BIOL, V78, P675, DOI 10.1016/S0171-9335(99)80036-3; Teule F, 2007, J MATER SCI, V42, P8974, DOI 10.1007/s10853-007-1642-6; Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250; UNICEF/UNDP/WorldBank/World Health Organization, 2010, CONTR LEISHM REP M W; Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2; Wen HX, 2010, MOL BIOL REP, V37, P1815, DOI 10.1007/s11033-009-9615-2; Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107; Xu GQ, 2014, SOFT MATTER, V10, P2116, DOI 10.1039/c3sm52845f; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Zama M, 1997, Nucleic Acids Symp Ser, P179; Zama M, 1999, Nucleic Acids Symp Ser, P81; Zhang YS, 2008, MOL BIOL REP, V35, P329, DOI 10.1007/s11033-007-9090-6; Zhou SB, 2008, J PHYS CHEM B, V112, P11209, DOI 10.1021/jp800913k; ZUREK W, 1981, FIBRE SCI TECHNOL, V15, P223, DOI 10.1016/0015-0568(81)90006-3	51	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178201	10.1371/journal.pone.0178201	http://dx.doi.org/10.1371/journal.pone.0178201			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542539	Green Submitted, gold, Green Published			2022-12-26	WOS:000402058800046
J	Wei, TS; Liu, PT; Chang, LW; Liu, SY				Wei, Ta-Sen; Liu, Peng-Ta; Chang, Liang-Wey; Liu, Sen-Yung			Gait asymmetry, ankle spasticity, and depression as independent predictors of falls in ambulatory stroke patients	PLOS ONE			English	Article							RISK-FACTORS; INPATIENT REHABILITATION; ATTENTION DEFICITS; TIME-COURSE; BALANCE; COMMUNITY; PEOPLE; PREVALENCE; CHILDREN; IDENTIFY	Background Falls are the leading cause of injury in stroke patients. However, the cause of a fall is complicated, and several types of risk factors are involved. Therefore, a comprehensive model to predict falls with high sensitivity and specificity is needed. Methods This study was a prospective study of 112 inpatients in a rehabilitation ward with follow-up interviews in patients' homes. Evaluations were performed 1 month after stroke and included the following factors: (1) status of cognition, depression, fear of fall and limb spasticity; (2) functional assessments [walking velocity and the Functional Independence Measure (FIM)]; and (3) objective, computerized gait and balance analyses. The outcome variable was the number of accidental falls during the 6-month follow-up period after baseline measurements. Results The non-faller group exhibited significantly better walking velocity and FIM scale compared to the faller group (P < .001). The faller group exhibited higher levels of spasticity in the affected limbs, asymmetry of gait parameters in single support (P < .001), double support (P = .027), and step time (P = .003), and lower stability of center of gravity in the medial-lateral direction (P = .008). Psychological assessments revealed that the faller group exhibited more severe depression and lower confidence without falling. A multivariate logistic regression model identified three independent predictors of falls with high sensitivity (82.6%) and specificity (86.5%): the asymmetry ratio of single support [adjusted odds ratio, aOR = 2.2, 95% CI (1.2-3.8)], the level of spasticity in the gastrocnemius [aOR = 3.2 (1.4-7.3)], and the degree of depression [aOR = 1.4 (1.2-1.8)]. Conclusions This study revealed depression, in additional to gait asymmetry and spasticity, as another independent factor for predicting falls. These results suggest that appropriate gait training, reduction of ankle spasticity, and aggressive management of depression may be critical to prevent falls in stroke patients.	[Wei, Ta-Sen; Chang, Liang-Wey] Natl Taiwan Univ, Coll Engn, Inst Biomed Engn, Taipei, Taiwan; [Wei, Ta-Sen; Chang, Liang-Wey] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Wei, Ta-Sen; Liu, Peng-Ta; Liu, Sen-Yung] Changhua Christian Hosp, Dept Phys Med & Rehabil, Changhua, Taiwan; [Wei, Ta-Sen; Liu, Peng-Ta; Liu, Sen-Yung] Changhua Christian Hosp, Fall Prevent Ctr, Changhua, Taiwan	National Taiwan University; National Taiwan University; Changhua Christian Hospital; Changhua Christian Hospital	Chang, LW (corresponding author), Natl Taiwan Univ, Coll Engn, Inst Biomed Engn, Taipei, Taiwan.; Chang, LW (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.	bmechlw@ntu.edu.tw						Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Alzahrani MA, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/470648; Ashburn A, 2008, AGE AGEING, V37, P270, DOI 10.1093/ageing/afn066; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Chan ACM, 1996, J AGING HEALTH, V8, P238, DOI 10.1177/089826439600800205; Crone C, 2003, BRAIN, V126, P495, DOI 10.1093/brain/awg036; Dusing SC, 2007, GAIT POSTURE, V25, P135, DOI 10.1016/j.gaitpost.2006.06.003; FELLOWS SJ, 1993, J NEUROL NEUROSUR PS, V56, P531, DOI 10.1136/jnnp.56.5.531; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Garland SJ, 2007, ARCH PHYS MED REHAB, V88, P218, DOI 10.1016/j.apmr.2006.11.023; Graafmans WC, 1996, AM J EPIDEMIOL, V143, P1129; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Harris JE, 2005, PHYS THER, V85, P150, DOI 10.1093/ptj/85.2.150; Hill KD, 1996, ARCH PHYS MED REHAB, V77, P1025, DOI 10.1016/S0003-9993(96)90063-5; Hosmer DW, 2005, APPL LOGISTIC REGRES, P143, DOI DOI 10.1002/0471722146; Hsu AL, 2003, ARCH PHYS MED REHAB, V84, P1185, DOI 10.1016/S0003-9993(03)00030-3; Hyndman D, 2003, DISABIL REHABIL, V25, P817, DOI 10.1080/0963828031000122221; Hyndman D, 2002, ARCH PHYS MED REHAB, V83, P165, DOI 10.1053/apmr.2002.28030; Jalayondeja C, 2014, GERIATR GERONTOL INT, V14, P778, DOI 10.1111/ggi.12164; Johnson CA, 2004, ARCH PHYS MED REHAB, V85, P902, DOI 10.1016/j.apmr.2003.08.081; Jorgensen L, 2002, STROKE, V33, P542, DOI 10.1161/hs0202.102375; Ju MS, 2000, J ELECTROMYOGR KINES, V10, P1, DOI 10.1016/S1050-6411(99)00018-8; Kerse N, 2008, STROKE, V39, P1890, DOI 10.1161/STROKEAHA.107.509885; Kim CM, 2003, GAIT POSTURE, V18, P23, DOI 10.1016/S0966-6362(02)00122-4; Kouwenhoven SE, 2011, DISABIL REHABIL, V33, P539, DOI 10.3109/09638288.2010.505997; Lamb SE, 2003, STROKE, V34, P494, DOI 10.1161/01.STR.0000053444.00582.B7; Lee JE, 2008, AM J PHYS MED REHAB, V87, P341, DOI 10.1097/PHM.0b013e31816ddc01; Maeda N, 2009, J INT MED RES, V37, P697, DOI 10.1177/147323000903700313; Mansfield A, PHYSIOTHERAPY; ODwyer NJ, 1996, BRAIN, V119, P1737, DOI 10.1093/brain/119.5.1737; Paolucci Stefano, 2008, Neuropsychiatr Dis Treat, V4, P145; Patterson KK, 2008, ARCH PHYS MED REHAB, V89, P304, DOI 10.1016/j.apmr.2007.08.142; Patterson KK, 2010, NEUROREHABIL NEURAL; Persson CU, 2011, J REHABIL MED, V43, P348, DOI 10.2340/16501977-0677; Petitpierre NJ, 2010, AGE AGEING, V39, P326, DOI 10.1093/ageing/afq010; Piirtola M, 2006, GERONTOLOGY, V52, P1, DOI 10.1159/000089820; Ring H, 1997, ARCH PHYS MED REHAB, V78, P630, DOI 10.1016/S0003-9993(97)90429-9; Saverino A, 2006, Eura Medicophys, V42, P179; Schwesig R, 2013, CLIN REHABIL, V27, P183, DOI 10.1177/0269215512452880; Soyuer F, 2007, DISABIL REHABIL, V29, P679, DOI 10.1080/09638280600925860; Stapleton T, 2001, CLIN REHABIL, V15, P437, DOI 10.1191/026921501678310243; Suzuki T, 2005, EXP AGING RES, V31, P457, DOI 10.1080/03610730500206881; Swanenburg J, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-162; Teasell R, 2002, ARCH PHYS MED REHAB, V83, P329, DOI 10.1053/apmr.2002.29623; THILMANN AF, 1991, BRAIN, V114, P233; Thorbahn LDB, 1996, PHYS THER, V76, P576, DOI 10.1093/ptj/76.6.576; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; van de Port IG, 2008, J REHABIL MED, V40, P23, DOI 10.2340/16501977-0114; Watkins CL, 2002, CLIN REHABIL, V16, P515, DOI 10.1191/0269215502cr512oa; Weerdesteyn V, 2008, DIFFERENCES, V33, P36; Wei TS, 2001, OSTEOPOROSIS INT, V12, P1050, DOI 10.1007/PL00004184; Wong AMK, 2004, AM J PHYS MED REHAB, V83, P284, DOI 10.1097/01.PHM.0000118038.02326.CA	53	47	54	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177136	10.1371/journal.pone.0177136	http://dx.doi.org/10.1371/journal.pone.0177136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542281	Green Submitted, Green Published, gold			2022-12-26	WOS:000402058800008
J	Bettecken, K; Bernhard, F; Sartor, J; Hobert, MA; Hofmann, M; Gladow, T; van Uem, JMT; Liepelt-Scarfone, I; Maetzler, W				Bettecken, Kristina; Bernhard, Felix; Sartor, Jennifer; Hobert, Markus A.; Hofmann, Marc; Gladow, Till; van Uem, Janet M. T.; Liepelt-Scarfone, Inga; Maetzler, Walter			No relevant association of kinematic gait parameters with Health-related Quality of Life in Parkinson ' s disease	PLOS ONE			English	Article							MOTOR IMPAIRMENT; DETERMINANTS; DISABILITY; DEPRESSION; SYMPTOMS; DOMAINS; PEOPLE; ICF	Background Health-related Quality of Life (HrQoL) is probably the most important outcome parameter for the evaluation and management of chronic diseases. As this parameter is subjective and prone to bias, there is an urgent need to identify objective surrogate markers. Gait velocity has been shown to be associated with HrQoL in numerous chronic diseases, such as Parkinson's disease (PD). With the development and wide availability of simple-to-use wearable sensors and sophisticated gait algorithms, kinematic gait parameters may soon be implemented in clinical routine management. However, the association of such kinematic gait parameters with HrQoL in PD has not been assessed to date. Methods Kinematic gait parameters from a 20-meter walk from 43 PD patients were extracted using a validated wearable sensor system. They were compared with the Visual Analogue Scale of the Euro-Qol-5D (EQ-5D VAS) by performing a multiple regression analysis, with the International Classification of Functioning, Disability and Health (ICF) model as a framework. Results Use of assistive gait equipment, but no kinematic gait parameter, was significantly associated with HrQoL. Conclusion The widely accepted concept of a positive association between gait velocity and HrQoL may, at least in PD, be driven by relatively independent parameters, such as assistive gait equipment.	[Bettecken, Kristina; Bernhard, Felix; Sartor, Jennifer; Hobert, Markus A.; van Uem, Janet M. T.; Liepelt-Scarfone, Inga; Maetzler, Walter] Univ Tubingen, Ctr Neurol, Dept Neurodegenerat, Tubingen, Germany; [Bettecken, Kristina; Bernhard, Felix; Sartor, Jennifer; Hobert, Markus A.; van Uem, Janet M. T.; Liepelt-Scarfone, Inga; Maetzler, Walter] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat, Tubingen, Germany; [Bettecken, Kristina; Bernhard, Felix; Sartor, Jennifer; Hobert, Markus A.; van Uem, Janet M. T.; Liepelt-Scarfone, Inga; Maetzler, Walter] DZNE, German Ctr Neurodegenerat Dis, Tubingen, Germany; [Hofmann, Marc; Gladow, Till] Hasomed, Magdeburg, Germany; [Gladow, Till] Jena Univ Hosp, Inst Physiotherapy, Dept Clin Res, Jena, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Friedrich Schiller University of Jena	van Uem, JMT (corresponding author), Univ Tubingen, Ctr Neurol, Dept Neurodegenerat, Tubingen, Germany.; van Uem, JMT (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat, Tubingen, Germany.; van Uem, JMT (corresponding author), DZNE, German Ctr Neurodegenerat Dis, Tubingen, Germany.	janet.uem@uni-tuebingen.de	Maetzler, Walter/AAE-5831-2020; Hobert, Markus A./AAR-3234-2020; Maetzler, Walter/A-6796-2011	Maetzler, Walter/0000-0002-5945-4694; Hobert, Markus A./0000-0002-7558-8107; Maetzler, Walter/0000-0002-5945-4694	Hasomed	Hasomed	The authors received no specific funding for this work. Hasomed provided support in the form of salaries for authors MH and TG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bryant MS, 2012, DISABIL REHABIL-ASSI, V7, P149, DOI 10.3109/17483107.2011.602461; Buck PO, 2011, J PARKINSON DIS, V1, P253, DOI 10.3233/JPD-2011-11035; Carod-Artal FJ, 2008, PARKINSONISM RELAT D, V14, P102, DOI 10.1016/j.parkreldis.2007.06.011; Clarke CE, 2016, JAMA NEUROL, P1; Cubo E, 2003, PARKINSONISM RELAT D, V10, P9, DOI 10.1016/S1353-8020(03)00060-9; Cubo E, 2012, NEUROEPIDEMIOLOGY, V38, P48, DOI 10.1159/000334314; Debi R, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-127; Delbaere K, 2010, BMJ-BRIT MED J, V341, P4165, DOI DOI 10.1136/BMJ.C4165; Derlien S, 2010, MAN MED, V48, P254, DOI 10.1007/s00337-010-0766-y; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Donath L, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0115-z; Drapier S, 2016, J NEUROL; Ellis T, 2011, PARKINSONISM RELAT D, V17, P693, DOI 10.1016/j.parkreldis.2011.07.004; Espay AJ, 2016, MOV DISORD; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gobbens RJJ, 2012, GERONTOLOGIST, V52, P619, DOI 10.1093/geront/gnr135; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Greene T, 2007, J AM GERIATR SOC, V55, P1888, DOI 10.1111/j.1532-5415.2007.01384.x; Hammerla N.Y., 2015, PD DIS STATE ASSESSM; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kostanjsek N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S4-S3; Kotagal V, 2014, MODIFIABLE CARDIOVAS; LACHS MS, 1990, ANN INTERN MED, V112, P699, DOI 10.7326/0003-4819-112-9-699; Levy G, 2000, NEUROLOGY, V55, P539, DOI 10.1212/WNL.55.4.539; Li HJ, 2010, MOVEMENT DISORD, V25, P2740, DOI 10.1002/mds.23368; Lord S, 2013, J GERONTOL A-BIOL, V68, P820, DOI 10.1093/gerona/gls255; Maetzler W, 2016, MOV DISORD; Maetzler W, 2013, MOVEMENT DISORD, V28, P1628, DOI 10.1002/mds.25628; Maetzler W, 2012, MOVEMENT DISORD, V27, P627, DOI 10.1002/mds.24973; Marras C, 2008, MOVEMENT DISORD, V23, P653, DOI 10.1002/mds.21853; Martinez-Martin P, 2014, EUR J NEUROL, V21, P519, DOI 10.1111/ene.12349; Martinez-Martin P, 2004, MOVEMENT DISORD, V19, P312, DOI 10.1002/mds.10656; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; Mayer L, INT J MS CARE, V17, P35; Muslimovic D, 2008, NEUROLOGY, V70, P2241, DOI 10.1212/01.wnl.0000313835.33830.80; Park K, 2016, CLIN BIOMECH, V33, P92, DOI 10.1016/j.clinbiomech.2016.02.012; Plotnik M, 2007, EXP BRAIN RES, V181, P561, DOI 10.1007/s00221-007-0955-7; Richard Irene Hegeman, 2007, Neuropsychiatr Dis Treat, V3, P903; Schmid A, 2007, STROKE, V38, P2096, DOI 10.1161/STROKEAHA.106.475921; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P67, DOI 10.1136/jnnp.69.1.67; Schuepbach WMM, 2013, NEW ENGL J MED, V368, P610, DOI 10.1056/NEJMoa1205158; Shearer J, 2012, J NEUROL, V259, P462, DOI 10.1007/s00415-011-6202-y; Slawek J, 2005, PARKINSONISM RELAT D, V11, P465, DOI 10.1016/j.parkreldis.2005.04.006; Soh SE, 2013, QUAL LIFE RES, V22, P1543, DOI 10.1007/s11136-012-0289-1; Toosizadeh N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124763; van Uem J, 2016, J PARKINSONS DIS; Van Uem JMT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151997; van Uem JMT, 2016, NEUROSCI BIOBEHAV R, V61, P26, DOI 10.1016/j.neubiorev.2015.11.014; Ward CD, 2000, J NEUROL NEUROSUR PS, V69, P289; Winter Y, 2011, PARKINSONISM RELAT D, V17, P265, DOI 10.1016/j.parkreldis.2011.01.003; Wood-Dauphinee S, 1999, J CLIN EPIDEMIOL, V52, P355, DOI 10.1016/S0895-4356(98)00179-6; Yoo Wonsuk, 2014, Int J Appl Sci Technol, V4, P9	55	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0176816	10.1371/journal.pone.0176816	http://dx.doi.org/10.1371/journal.pone.0176816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8UA	28531171	Green Submitted, Green Published, gold			2022-12-26	WOS:000402058400008
J	Song, J; Hu, YJ; Li, JQ; Zheng, HW; Wang, JJ; Guo, L; Ning, RT; Li, HZ; Yang, ZN; Fan, HT; Liu, LD				Song, Jie; Hu, Yajie; Li, Jiaqi; Zheng, Huiwen; Wang, Jingjing; Guo, Lei; Ning, Ruotong; Li, Hongzhe; Yang, Zening; Fan, Haitao; Liu, Longding			Different microRNA profiles reveal the diverse outcomes induced by EV71 and CA16 infection in human umbilical vein endothelial cells using high-throughput sequencing	PLOS ONE			English	Article							INACTIVATED ENTEROVIRUS 71; EPIDEMIOLOGY; VACCINE; EXPRESSION; IMMUNITY; THERAPEUTICS; BIOGENESIS; MIR-1246; DISEASES	Enterovirus 71 (EV71) and Coxsackievirus A16 (CA16) remain the predominant pathogens in hand, foot, and mouth disease (HFMD), but the factors underlying the pathogenesis of EV71 and CA16 infections have not been elucidated. Recently, the functions of microRNAs (miRNAs) in pathogen-host interactions have been highlighted. In the present study, we performed comprehensive miRNA profiling in EV71- and CA16-infected human umbilical vein endothelial cells (HUVECs) at multiple time points using high-throughput sequencing. The results showed that 135 known miRNAs exhibited remarkable differences in expression. Of these, 30 differentially expressed miRNAs presented opposite trends in EV71- and CA16-infected samples. Subsequently, we mainly focused on the 30 key differentially expressed miRNAs through further screening to predict targets. Gene ontology (GO) and pathway analysis of the predicted targets showed the enrichment of 14 biological processes, 9 molecular functions, 8 cellular components, and 85 pathways. The regulatory networks of these miRNAs with predicted targets, GOs, pathways, and co-expression genes were determined, suggesting that miRNAs display intricate regulatory mechanisms during the infection phase. Consequently, we specifically analyzed the hierarchical GO categories of the predicted targets involved in biological adhesion. The results indicated that the distinct changes induced by EV71 and CA16 infection may be partly linked to the function of the blood-brain barrier. Taken together, this is the first report describing miRNA expression profiles in HUVECs with EV71 and CA16 infections using high-throughput sequencing. Our data provide useful insights that may help to elucidate the different host-pathogen interactions following EV71 and CA16 infection and offer novel therapeutic targets for these infections.	[Liu, Longding] Chinese Acad Med Sci, Inst Med Biol, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Peoples R China; Peking Union Med Coll, Kunming, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, LD (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Peoples R China.	longdingl@gmail.com	Guo, Lei/AEU-0178-2022; wang, jing/GRS-7509-2022; Song, Jie/AAV-3499-2020; WANG, JINGYI/GSJ-1241-2022	Guo, Lei/0000-0003-1733-1802	CAMS Innovation Fund for Medical Sciences [2016-I2M-1-014, 2016-I2M-1-019]; National Natural Sciences Foundations of China [81373142]	CAMS Innovation Fund for Medical Sciences; National Natural Sciences Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported CAMS Innovation Fund for Medical Sciences (2016-12M1-014 and 2016-12M-1-019) (http://www.ac. cn/) and National Natural Sciences Foundations of China (81373142) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported CAMS Innovation Fund for Medical Sciences (2016-I2M-1-014 and 2016-I2M-1-019) and National Natural Sciences Foundations of China (81373142). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Auvinen E, 2017, MOL DIAGN THER, V21, P45, DOI 10.1007/s40291-016-0236-x; Bakre A, 2012, J GEN VIROL, V93, P2346, DOI 10.1099/vir.0.044255-0; Blanchette M, 2015, MECH DEVELOP, V138, P8, DOI 10.1016/j.mod.2015.07.007; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Cai YC, 2014, VACCINE, V32, P2406, DOI 10.1016/j.vaccine.2014.03.012; Chai S, 2016, HEPATOLOGY, V64, P2062, DOI 10.1002/hep.28821; Chang C-Y, 2015, GLIA; Chen G, 2011, SCI CHINA LIFE SCI, V54, P1121, DOI 10.1007/s11427-011-4255-x; Chen Xiaojing, 2016, Zhejiang Da Xue Xue Bao Yi Xue Ban, V45, P342; Cui LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027071; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hu YJ, 2017, VIRUS RES, V228, P90, DOI 10.1016/j.virusres.2016.11.024; Hui YJ, 2016, INT J BIOCHEM CELL B, V81, P20, DOI 10.1016/j.biocel.2016.10.011; Koh WM, 2016, PEDIATR INFECT DIS J, V35, pE285, DOI 10.1097/INF.0000000000001242; Lee JJ, 2011, J PROTEOMICS, V74, P2018, DOI 10.1016/j.jprot.2011.05.022; Li JX, 2014, EXPERT REV VACCINES, V13, P609, DOI 10.1586/14760584.2014.897617; Li RC, 2014, NEW ENGL J MED, V370, P829, DOI 10.1056/NEJMoa1303224; Louten J, 2015, BIOMARK INSIGHTS, V10, P25, DOI 10.4137/BMI.S29512; Lugo D, 2016, CURR OPIN PEDIATR, V28, P107, DOI 10.1097/MOP.0000000000000303; Lui YLE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102997; Mao QY, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.73; Mao QY, 2014, HUM VACC IMMUNOTHER, V10, P360, DOI 10.4161/hv.27087; Meliopoulos VA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037169; Monastyrskaya K, 2013, AM J PATHOL, V182, P431, DOI 10.1016/j.ajpath.2012.10.020; Ng QY, 2015, VIRUSES-BASEL, V7, P6441, DOI 10.3390/v7122949; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Ong KC, 2015, BRAIN PATHOL, V25, P614, DOI 10.1111/bpa.12279; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pathinayake PS, 2015, VIRUSES-BASEL, V7, P6613, DOI 10.3390/v7122961; Piva R, 2013, INT J ONCOL, V43, P985, DOI 10.3892/ijo.2013.2059; Pons-Salort M, 2015, CURR OPIN INFECT DIS, V28, P479, DOI 10.1097/QCO.0000000000000187; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Roe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102598; Sakha S, 2016, SCI REP-UK, V6, DOI 10.1038/srep38750; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Tahamtan A, 2016, REV MED VIROL, V26, P389, DOI 10.1002/rmv.1894; Trobaugh DW, 2017, TRENDS MOL MED, V23, P80, DOI 10.1016/j.molmed.2016.11.003; Velandia-Romero ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157786; Wang CY, 2015, J GEN VIROL, V96, P3010, DOI 10.1099/jgv.0.000235; Wang JJ, 2017, VIROLOGY, V500, P198, DOI 10.1016/j.virol.2016.10.031; Wang RYL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24149; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Xu F, 2014, CLIN TRANSL ONCOL, V16, P980, DOI 10.1007/s12094-014-1183-9; Xu LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095272; Xun M, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0288-2; Yuan DX, 2016, ONCOTARGET, V7, P32707, DOI 10.18632/oncotarget.9017; Zhang WC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11702; Zhu Z, 2016, BIOMED RES INT, V2016	51	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177657	10.1371/journal.pone.0177657	http://dx.doi.org/10.1371/journal.pone.0177657			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531227	Green Published, Green Submitted, gold			2022-12-26	WOS:000402058400021
J	Kitterer, D; Biegger, D; Segerer, S; Braun, N; Alscher, MD; Latus, J				Kitterer, Daniel; Biegger, Dagmar; Segerer, Stephan; Braun, Niko; Alscher, M. Dominik; Latus, Joerg			Alteration of membrane complement regulators is associated with transporter status in patients on peritoneal dialysis	PLOS ONE			English	Article							SOLUTE TRANSPORT; MESOTHELIAL CELLS; ULTRAFILTRATION FAILURE; INTERLEUKIN-6 SYSTEM; WATER PERMEABILITY; ENDOTHELIAL-CELLS; GENE-EXPRESSION; NUCLEAR-FACTOR; CAPD PATIENTS; ACTIVATION	Introduction A growing body of evidence from animal models and cell culture studies indicate an important role of a local regulatory complement system (CS) in peritoneal injury during peritoneal dialysis (PD). We investigated the expression of the local regulatory CS (reflected by CD46, CD55, CD59) in the peritoneal tissue of patients with different membrane function characteristics. Patients and methods Biopsies from the parietal peritoneum were taken from 24 patients on PD, 22 uremic patients prior to PD. PD patients were grouped according to the dialysate-to-plasma ratio of creatinine (D/P Cre) and ratio of dialysate glucose at 4 hours versus dialysate glucose at time zero (D/D0 glucose) into low or low-average peritoneal transport status (L/LA) and high-average or high-transport status (HA/H) groups. CD46, CD55, and CD59 RNA expression were analyzed by real-time polymerase chain reaction (RT-PCR). Further localization of membrane complement regulators (CRegs) and semiquantitatively analysis was done by immunohistochemistry (IHC). Results CD46 and CD59 expression were similar in all groups. CD55 expression was significantly decreased in the HA/H group compared to the L/LA group and to uremic controls (p < 0.05 and p = 0.05, respectively). No statistically significant differences in CD46, CD55, and CD55 expression were detected when considering the history of peritonitis. There was no statistically significant correlation between PD duration and the expressions of CD46, CD55, and CD59. IHC revealed strong CD46, CD55, and CD59 expression in mesothelial cells. CD55 and CD59 were additionally detected in the vasculature. Using IHC, CD46 was lower in PD patients compared to uremic controls (p> 0.05), but there was no difference between the L/LA compared to the H/HA group. Moreover IHC confirmed decreased expression of CD55 in the HA/H group compared to the L/LA group and uremic controls (p<0.0001 and p = 0.0001, respectively). Conclusion CD55 expression is decreased in patients with fast transporter membrane function, whereas peritonitis and PD duration do not appear to alter CReg expression.	[Kitterer, Daniel; Alscher, M. Dominik; Latus, Joerg] Robert Bosch Krankenhaus, Div Nephrol, Dept Internal Med, Stuttgart, Germany; [Biegger, Dagmar] Univ Tubingen, Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Segerer, Stephan] Kantonsspital Aarau, Div Nephrol Dialysis & Transplantat, Aarau, Switzerland; [Braun, Niko] Nephrol Ctr Stuttgart, Stuttgart, Germany	Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Kantonsspital Aarau AG (KSA)	Kitterer, D (corresponding author), Robert Bosch Krankenhaus, Div Nephrol, Dept Internal Med, Stuttgart, Germany.	Daniel.kitterer@gmail.com			Else Kroner-Fresenius Stiftung; Fundacao Pesquisa e Desenvolvimento Humanitario; Robert Bosch Foundation	Else Kroner-Fresenius Stiftung; Fundacao Pesquisa e Desenvolvimento Humanitario; Robert Bosch Foundation	This work was supported by Else Kroner-Fresenius Stiftung, Fundacao Pesquisa e Desenvolvimento Humanitario, Robert Bosch Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbano G, 1999, ADV PERIT D, V15, P253; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Braun N, 2011, NEPHROL DIAL TRANSPL, V26, P1033, DOI 10.1093/ndt/gfq488; Brimble KS, 2006, J AM SOC NEPHROL, V17, P2591, DOI 10.1681/ASN.2006030194; Churchill DN, 1998, J AM SOC NEPHROL, V9, P1285; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; Combet S, 2000, J AM SOC NEPHROL, V11, P717, DOI 10.1681/ASN.V114717; Cueto-Manzano AM, 2009, PERITON DIALYSIS INT, V29, pS90; Davies SJ, 1998, KIDNEY INT, V54, P2207, DOI 10.1046/j.1523-1755.1998.00180.x; Davies SJ, 1996, NEPHROL DIAL TRANSPL, V11, P498; Devuyst O, 2013, KIDNEY INT; Diaz-Buxo JA, 1999, ADV PERIT D, V15, P96; DIMITRIADIS A, 1990, ADV PERIT D, V6, P155; Flessner MF, 2007, J AM SOC NEPHROL, V18, P2294, DOI 10.1681/ASN.2006121417; Hasler U, 2011, CELL CYCLE, V10, P364, DOI 10.4161/cc.10.3.14520; HEIMBURGER O, 1990, KIDNEY INT, V38, P495, DOI 10.1038/ki.1990.231; Higuchi C, 2006, THER APHER DIAL, V10, P372, DOI 10.1111/j.1744-9987.2006.00391.x; Honda K, 1996, NEPHRON, V72, P171, DOI 10.1159/000188837; Honda K, 2008, CLIN J AM SOC NEPHRO, V3, P720, DOI 10.2215/CJN.03630807; Johnson DW, 2004, PERITON DIALYSIS INT, V24, P460; Kinashi H, 2013, J AM SOC NEPHROL, V24, P1627, DOI 10.1681/ASN.2012030226; Kitterer D, 2015, AM J PHYSIOL-RENAL, V308, pF1247, DOI 10.1152/ajprenal.00617.2014; Krediet RT, 2013, NAT REV NEPHROL, V9, P419, DOI 10.1038/nrneph.2013.99; Kuper C, 2012, CRIT CARE MED, V40, P1887, DOI 10.1097/CCM.0b013e31824e1186; Lambie M, 2013, J AM SOC NEPHROL, V24, P2071, DOI 10.1681/ASN.2013030314; Lanaspa MA, 2010, J BIOL CHEM, V285, P31694, DOI 10.1074/jbc.M109.093690; Mizuno M, 2012, AM J PHYSIOL-RENAL, V302, pF1245, DOI 10.1152/ajprenal.00652.2011; Mizuno M, 2009, J IMMUNOL, V183, P1403, DOI 10.4049/jimmunol.0804245; Mizuno T, 2013, AM J PHYSIOL-RENAL, V305, pF1603, DOI 10.1152/ajprenal.00681.2012; Mizuno T, 2011, NEPHROL DIAL TRANSPL, V26, P1821, DOI 10.1093/ndt/gfq683; Morelle J, 2016, PERITON DIALYSIS INT, V36, P227, DOI 10.3747/pdi.2015.00188; Neusser MA, 2010, KIDNEY INT, V77, P801, DOI 10.1038/ki.2010.6; Ni J, 2006, KIDNEY INT, V69, P1518, DOI 10.1038/sj.ki.5000285; Noris M, 2013, SEMIN NEPHROL, V33, P479, DOI 10.1016/j.semnephrol.2013.08.001; Numata M, 2003, PERITON DIALYSIS INT, V23, P116; Oh KH, 2010, NEPHROL DIAL TRANSPL, V25, P1639, DOI 10.1093/ndt/gfp670; Okada M, 1998, ARTERIOSCL THROM VAS, V18, P894, DOI 10.1161/01.ATV.18.6.894; Parikova A, 2006, KIDNEY INT, V70, P1988, DOI 10.1038/sj.ki.5001861; Pecoits R, 2006, PERITON DIALYSIS INT, V26, P53; REDDINGIUS RE, 1995, PERITON DIALYSIS INT, V15, P49; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rumpsfeld M, 2006, J AM SOC NEPHROL, V17, P271, DOI 10.1681/ASN.2005050566; Sei Y, 2015, MOL IMMUNOL, V65, P302, DOI 10.1016/j.molimm.2015.02.005; STRUIJK DG, 1994, KIDNEY INT, V45, P1739, DOI 10.1038/ki.1994.226; Tang S, 2004, CLIN EXP IMMUNOL, V136, P85, DOI 10.1111/j.1365-2249.2004.02407.x; TWARDOWSKI ZJ, 1987, PERITON DIALYSIS INT, V7, P138; VERGER C, 1983, KIDNEY INT, V23, P823, DOI 10.1038/ki.1983.101; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yang BX, 1999, AM J PHYSIOL-CELL PH, V276, pC76, DOI 10.1152/ajpcell.1999.276.1.C76; Yool AJ, 2013, J AM SOC NEPHROL, V24, P1045, DOI 10.1681/ASN.2012080869; YOUNG GA, 1993, NEPHROL DIAL TRANSPL, V8, P1372; Yu ZZ, 2014, CLIN J AM SOC NEPHRO, V9, P326, DOI 10.2215/CJN.04420413; Zhai YH, 2012, PEDIATR NEPHROL, V27, P1165, DOI 10.1007/s00467-012-2120-1; Zhang W, 2016, MATH PROBL ENG, V2016, P1, DOI DOI 10.7554/ELIFE.11324	55	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177487	10.1371/journal.pone.0177487	http://dx.doi.org/10.1371/journal.pone.0177487			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542228	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672600011
J	Tondolo, JSM; Loreto, ES; Ledur, PC; Jesus, FPK; Silva, TM; Kommers, GD; Alves, SH; Santurio, JM				Tondolo, Juliana S. M.; Loreto, Erico S.; Ledur, Pauline C.; Jesus, Francielli P. K.; Silva, Taiara M.; Kommers, Glaucia D.; Alves, Sydney H.; Santurio, Janio M.			Chemically induced disseminated pythiosis in BALB/c mice: A new experimental model for Pythium insidiosum infection	PLOS ONE			English	Article							INVASIVE PULMONARY ASPERGILLOSIS; IN-VITRO; IMMUNITY; IMMUNOTHERAPY; CELLS	Pythiosis is a severe and life-threatening disease that affects humans and various animal species. We report a model of vascular/disseminated pythiosis occurring after subcutaneous inoculation of 2 x 10(4) Pythium insidiosum zoospores/mL in immunocompromised BALB/c mice. For this model, we carried out two rounds of experiments. First, we evaluated two protocols of immunosuppression before inoculation: cyclophosphamide at 150 mg/kg (CYP group) and cyclophosphamide 200 mg/kg plus hydrocortisone acetate at 250 mg/kg (CYP+HCA group). It was not possible to obtain mortality in the CYP group; however, the combination of CYP+HCA altered disease outcomes, with mortality rates reaching 60%. Second, we used the CYP+HCA immunosuppression protocol to analyze the histological and immunological statuses triggered by disease. When we inoculated immunocompetent mice with P. insidiosum zoospores, self-healing occurred via increased levels of IL-2, IFN-gamma and IL-17A, which are characteristic of the Th1/Th17 cytokine response. For infected and immunosuppressed mice, the cytokine profiles showed high levels of IL-10, IL-6 and TNF-alpha. Increased IL-10 values are related to fungal infection susceptibility and led us to speculate that infection may be established through suppression of the host immune response. In addition, histopathological evaluation of the kidneys and liver demonstrated the presence of hyphae and the cellular findings suggested an acute vascular inflammation that mimics vascular/disseminated pythiosis in humans. This is the first murine model for pythiosis that is useful both for understanding the pathogenesis of this disease and for evaluating new treatment approaches.	[Tondolo, Juliana S. M.; Loreto, Erico S.; Ledur, Pauline C.; Santurio, Janio M.] Univ Fed Santa Maria, Dept Microbiol & Parasitol, Programa Posgrad Farmacol, Ctr Ciencias Saude, Santa Maria, RS, Brazil; [Loreto, Erico S.; Alves, Sydney H.] Univ Fed Santa Maria, Dept Microbiol & Parasitol, Programa Posgrad Ciencias Farmaceut, Ctr Ciencias Saude, Santa Maria, RS, Brazil; [Jesus, Francielli P. K.] Univ Fed Rio Grande do Sul, Inst Quim, Lab Proc Tecnol & Catalise, Programa Posgrad Quim Organ, Porto Alegre, RS, Brazil; [Silva, Taiara M.] Univ Fed Santa Maria, Dept Patol, Ctr Ciencias Rurais, Programa Posgrad Med Vet, Santa Maria, RS, Brazil; [Kommers, Glaucia D.] Univ Fed Santa Maria, Dept Patol, Ctr Ciencias Saude, Lab Patol Vet, Santa Maria, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM); Universidade Federal do Rio Grande do Sul; Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM)	Santurio, JM (corresponding author), Univ Fed Santa Maria, Dept Microbiol & Parasitol, Programa Posgrad Farmacol, Ctr Ciencias Saude, Santa Maria, RS, Brazil.	janio.santurio@gmail.com	de Loreto, Érico Silva/E-1605-2013; Tondolo, Juliana/AAA-4385-2021	de Loreto, Érico Silva/0000-0003-0408-5294; Tondolo, Juliana/0000-0001-5036-3270; Christ Ledur, Pauline/0000-0002-0781-7721; Santurio, Janio/0000-0001-6286-9076	CNPq	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	E. S. L. is a PhD fellow of Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil (PNPD-CAPES), and J. M. S. is a Scholarship Research Productivity of CNPq.	Azevedo MI, 2012, VET MICROBIOL, V159, P141, DOI 10.1016/j.vetmic.2012.03.030; Balloy V, 2005, INFECT IMMUN, V73, P494, DOI 10.1128/IAI.73.1.494-503.2005; Belmonte R, 2014, INFECT IMMUN, V82, P4518, DOI 10.1128/IAI.02196-14; Botton SA, 2011, CURR MICROBIOL, V62, P1225, DOI 10.1007/s00284-010-9781-4; Capilla J, 2007, MED MYCOL, V45, P657, DOI 10.1080/13693780701644140; Cenci E, 2000, J IMMUNOL, V165, P381, DOI 10.4049/jimmunol.165.1.381; Cyktor JC, 2011, INFECT IMMUN, V79, P2964, DOI 10.1128/IAI.00047-11; DIXON DM, 1989, INFECT IMMUN, V57, P1452, DOI 10.1128/IAI.57.5.1452-1456.1989; dos Santos CEP, 2014, J EQUINE VET SCI, V34, P270, DOI 10.1016/j.jevs.2013.06.003; Dycus DL, 2015, J AM ANIM HOSP ASSOC, V51, P385, DOI 10.5326/JAAHA-MS-6217; Gaastra W, 2010, VET MICROBIOL, V146, P1, DOI 10.1016/j.vetmic.2010.07.019; Gabriel AL, 2008, PESQUI VET BRASIL, V28, P583, DOI 10.1590/S0100-736X2008001200003; Hahtapornsawan S, 2014, ANN VASC SURG, V28, DOI 10.1016/j.avsg.2014.04.020; Huang HB, 2010, MBIO, V1, DOI 10.1128/mBio.00164-10; Huyan XH, 2011, INT IMMUNOPHARMACOL, V11, P1293, DOI 10.1016/j.intimp.2011.04.011; Jesus FPK, 2016, ANTIMICROB AGENTS CH, V60, P87, DOI 10.1128/AAC.01480-15; Kirkpatrick WR, 2013, CURR FUNGAL INFECT R, V7, P68, DOI 10.1007/s12281-012-0126-6; Krajaejun T, 2008, J INFECT DIS ANTIMIC, V25, P45; Krajaejun T, 2006, CLIN INFECT DIS, V43, P569, DOI 10.1086/506353; Lass-Florl C, 2013, MYCOSES, V56, P403, DOI 10.1111/myc.12052; Lerksuthirat T, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02352-16, 10.1128/aac.02352-16]; Lewis RE, 2009, MED MYCOL, V47, pS271, DOI 10.1080/13693780802227159; Li Xiao-hong, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P1; Loreto ES, 2014, ANTIMICROB AGENTS CH, V58, P7534, DOI 10.1128/AAC.02680-13; Mendoza L, 2004, MYCOSES, V47, P14, DOI 10.1046/j.1439-0507.2003.00950.x; MENDOZA L, 1988, MYCOPATHOLOGIA, V104, P59, DOI 10.1007/BF00437925; MENDOZA L, 1993, J CLIN MICROBIOL, V31, P2967, DOI 10.1128/JCM.31.11.2967-2973.1993; Mendoza L, 2013, CURR FUNGAL INFECT R, V7, P198, DOI 10.1007/s12281-013-0144-z; Permpalung N, 2015, J ANTIMICROB CHEMOTH, V70, P1885, DOI 10.1093/jac/dkv008; Ramappa Muralidhar, 2017, Cornea, V36, P511, DOI 10.1097/ICO.0000000000001162; Romani L, 2006, TRENDS MICROBIOL, V14, P183, DOI 10.1016/j.tim.2006.02.003; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Santurio JM, 2003, VACCINE, V21, P2535, DOI 10.1016/S0264-410X(03)00035-5; Sheppard DC, 2004, ANTIMICROB AGENTS CH, V48, P1908, DOI 10.1128/AAC.48.5.1908-1911.2004; Tondolo JSM, 2017, CARBOHYD POLYM, V157, P719, DOI 10.1016/j.carbpol.2016.10.053; Wanachiwanawin W, 2004, VACCINE, V22, P3613, DOI 10.1016/j.vaccine.2004.03.031; Wuthrich M, 2011, J CLIN INVEST, V121, P554, DOI 10.1172/JCI43984; Zanette RA, 2013, MICROBIOL IMMUNOL, V57, P732, DOI 10.1111/1348-0421.12082	38	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177868	10.1371/journal.pone.0177868	http://dx.doi.org/10.1371/journal.pone.0177868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542438	Green Submitted, Green Published, gold			2022-12-26	WOS:000401672600026
J	Bruce, MA; Martins, D; Duru, K; Beech, BM; Sims, M; Harawa, N; Vargas, R; Kermah, D; Nicholas, SB; Brown, A; Norris, KC				Bruce, Marino A.; Martins, David; Duru, Kenrik; Beech, Bettina M.; Sims, Mario; Harawa, Nina; Vargas, Roberto; Kermah, Dulcie; Nicholas, Susanne B.; Brown, Arleen; Norris, Keith C.			Church attendance, allostatic load and mortality in middle aged adults	PLOS ONE			English	Article							3RD NATIONAL-HEALTH; RELIGIOUS SERVICES; RACIAL DISPARITIES; AMERICAN WOMEN; OLDER-ADULTS; ALL-CAUSE; FREQUENCY; SPIRITUALITY; MACARTHUR; STRESS	Importance Religiosity has been associated with positive health outcomes. Hypothesized pathways for this association include religious practices, such as church attendance, that result in reduced stress. Objective The objective of this study was to examine the relationship between religiosity (church attendance), allostatic load (AL) (a physiologic measure of stress) and all-cause mortality in middle-aged adults. Design, setting and participants Data for this study are from NHANES III (1988-1994). The analytic sample (n = 5449) was restricted to adult participants, who were between 40-65 years of age at the time of interview, had values for at least 9 out of 10 clinical/biologic markers used to derive AL, and had complete information on church attendance. Main outcomes and measures The primary outcomes were AL and mortality. AL was derived from values for metabolic, cardiovascular, and nutritional/inflammatory clinical/biologic markers. Mortality was derived from a probabilistic algorithm matching the NHANES III Linked Mortality File to the National Death Index through December 31, 2006, providing up to 18 years follow-up. The primary predictor variable was baseline report of church attendance over the past 12 months. Cox proportional hazard logistic regression models contained key covariates including socioeconomic status, self-rated health, co-morbid medical conditions, social support, healthy eating, physical activity, and alcohol intake. Results Churchgoers (at least once a year) comprised 64.0% of the study cohort (n = 3782). Non-churchgoers had significantly higher overall mean AL scores and higher prevalence of high-risk values for 3 of the 10 markers of AL than did churchgoers. In bivariate analyses non-churchgoers, compared to churchgoers, had higher odds of an AL score (2-3) under bar (OR 1.24; 95% CI 1.01, 1.50) or >= 4 (OR 1.38; 95% CI 1.11, 1.71) compared to AL score of 0-1. More frequent churchgoers (more than once a week) had a 55% reduction of all-cause mortality risk compared with non-churchgoers. (HR 0.45, CI 0.24-0.85) in the fully adjusted model that included AL. Conclusions and relevance We found a significant association between church attendance and mortality among middle-aged adults after full adjustments. AL, a measure of stress, only partially explained differences in mortality between church and non-church attendees. These findings suggest a potential independent effect of church attendance on mortality.	[Bruce, Marino A.] Vanderbilt Univ, Ctr Res Mens Hlth, 221 Kirkland Hall, Nashville, TN 37235 USA; [Martins, David] Charles R Drew Univ Sch Med & Sci, Dept Internal Med, Los Angeles, CA USA; [Martins, David; Duru, Kenrik; Vargas, Roberto; Nicholas, Susanne B.; Brown, Arleen; Norris, Keith C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Beech, Bettina M.] Univ Mississippi, Med Ctr, John D Bower Sch Populat Hlth, Dept Populat Hlth Sci, Jackson, MS 39216 USA; [Sims, Mario] Univ Mississippi, Med Ctr, Dept Internal Med, Jackson, MS 39216 USA; [Harawa, Nina] Charles R Drew Univ Sch Med & Sci, Dept Psychiat, Los Angeles, CA USA; [Harawa, Nina] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA; [Kermah, Dulcie] Charles R Drew Univ Sch Med & Sci, Dept Res, Los Angeles, CA USA; [Kermah, Dulcie] Charles R Drew Univ Sch Med & Sci, Inst Life Sci, Los Angeles, CA USA	Vanderbilt University; Charles R. Drew University of Medicine & Science; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Charles R. Drew University of Medicine & Science; University of California System; University of California Los Angeles; Charles R. Drew University of Medicine & Science; Charles R. Drew University of Medicine & Science	Bruce, MA (corresponding author), Vanderbilt Univ, Ctr Res Mens Hlth, 221 Kirkland Hall, Nashville, TN 37235 USA.	marino.bruce@vanderbilt.edu		Brown, Arleen/0000-0001-9948-8955; Harawa, Nina T./0000-0002-7486-8393	National Institutes of Health [UL1TR000445, 1K01HL88735, 1R25HL126145, P20MD000182, UL1TR000124, P30AG021684, P60MD002249]; Department of Health and Human Services' Office of Minority Health [1CPIMP091054-04]; NIH [UL1TR000445, 1K01HL88735, 1R25HL126145, P20MD000182, UL1TR000124, P30AG021684, P60MD002249, U54MD008176]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124, UL1TR000445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL126145, K01HL088735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021684] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD008176, P20MD000182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services' Office of Minority Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported in part by National Institutes of Health grants UL1TR000445 (MB), 1K01HL88735 (MB), 1R25HL126145 (BB), P20MD000182 (KN,DM), UL1TR000124 (KN,AB), P30AG021684 (KN,KD), P60MD002249 (MS), U54MD008176 (MS),and a grant from the Department of Health and Human Services' Office of Minority Health 1CPIMP091054-04 (BB).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no financial disclosures or conflicts of interest.; This work was supported in part by NIH grants UL1TR000445 (MB), 1K01HL88735 (MB), 1R25HL126145 (BB), P20MD000182 (KN, DM), UL1TR000124 (KN, AB), P30AG021684 (KN, KD), P60MD002249 (MS), U54MD008176 (MS), and a grant from the Department of Health and Human Services' Office of Minority Health 1CPIMP091054-04 (BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no financial disclosures or conflicts of interest.	[Anonymous], 1994, Vital Health Stat 1, P1; BANKS R, 1980, J SCHOOL HEALTH, V50, P195, DOI 10.1111/j.1746-1561.1980.tb07373.x; Bellingham R, 1989, Am J Health Promot, V4, P18, DOI 10.4278/0890-1171-4.1.18; Beydoun MA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3744-z; Brown I., 1978, ETA SIGMA GAM, V10, P12; Buck AC, 2009, SOC SCI MED, V68, P314, DOI 10.1016/j.socscimed.2008.10.010; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Chapman L S, 1987, Am J Health Promot, V2, P12, DOI 10.4278/0890-1171-2.2.12; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Durkheim E, 1965, ELEMENTARY FORMS REL; Duru OK, 2012, J NATL MED ASSOC, V104, P89, DOI 10.1016/S0027-9684(15)30120-6; ELKINS DN, 1988, J HUMANIST PSYCHOL, V28, P5, DOI 10.1177/0022167888284002; Ernecoff NC, 2015, JAMA INTERN MED, V175, P1662, DOI 10.1001/jamainternmed.2015.4124; Ferraro KF, 2014, SOC SCI MED, V120, P92, DOI 10.1016/j.socscimed.2014.08.030; Ferraro KF, 1999, AM SOCIOL REV, V64, P303, DOI 10.2307/2657534; FRASER GE, 1992, ARCH INTERN MED, V152, P1416, DOI 10.1001/archinte.152.7.1416; George LK, 2013, GERONTOLOGIST, V53, P898, DOI 10.1093/geront/gnt002; Geronimus AT, 2006, AM J PUBLIC HEALTH, V96, P826, DOI 10.2105/AJPH.2004.060749; Gillum RF, 2008, ANN EPIDEMIOL, V18, P124, DOI 10.1016/j.annepidem.2007.10.015; Gillum RF, 2006, ANN EPIDEMIOL, V16, P655, DOI 10.1016/j.annepidem.2005.11.002; Gillum RF, 2006, PSYCHOSOM MED, V68, P382, DOI 10.1097/01.psy.0000221253.90559.dd; Gillum RF, 2006, ANN BEHAV MED, V31, P30, DOI 10.1207/s15324796abm3101_6; Hatch SL, 2005, J GERONTOL B-PSYCHOL, V60, P130; Hummer RA, 1999, DEMOGRAPHY, V36, P273, DOI 10.2307/2648114; Jones SA, 2016, J SCI MED SPORT, V19, P1020, DOI 10.1016/j.jsams.2016.03.009; Karlamangla AS, 2006, PSYCHOSOM MED, V68, P500, DOI 10.1097/01.psy.0000221270.93985.82; Koenig H. G, 2001, HDB RELIG HLTH; Koenig Harold G, 2012, ISRN Psychiatry, V2012, P278730, DOI 10.5402/2012/278730; Koenig HG, 2004, J AM GERIATR SOC, V52, P554, DOI 10.1111/j.1532-5415.2004.52161.x; Koenig HG, 2012, HDB RELIG HLTH; Lawler-Row KA, 2009, J HEALTH PSYCHOL, V14, P43, DOI 10.1177/1359105308097944; Li SS, 2016, JAMA INTERN MED, V176, P777, DOI 10.1001/jamainternmed.2016.1615; Martins D, 2013, J HEALTH CARE POOR U, V24, P1235, DOI 10.1353/hpu.2013.0148; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; National Center for Health Statistics Centers for Disease Control and Prevention, 1998, PLAN OP 3 NAT HLTH N; National Center for Health Statistics. Office of Analysis and Epidemiology, 2009, 3 NAT HLTH NUTR EX S; Powell LH, 2003, AM PSYCHOL, V58, P36, DOI 10.1037/0003-066X.58.1.36; Russell R D, 1984, Health Educ, V15, P3; Seeman TE, 1997, ARCH INTERN MED, V157, P2259; Seeman TE, 2003, AM PSYCHOL, V58, P53, DOI 10.1037/0003-066X.58.1.53; Singh Darpan Kaur Mohinder, 2012, Indian J Psychol Med, V34, P399, DOI 10.4103/0253-7176.108234; Sprecher S, 2006, CURR RES SOC PSYCHOL, V11, P227; Steffen PR, 2005, ANN BEHAV MED, V30, P217, DOI 10.1207/s15324796abm3003_6; Stewart James A, 2006, J Physiol Anthropol, V25, P133, DOI 10.2114/jpa2.25.133; Thoits PA, 2011, J HEALTH SOC BEHAV, V52, P145, DOI 10.1177/0022146510395592; U.S. Department of Health and Human Services. National Center for Health Statistics, 1996, AN REP GUID 3 NAT HL	46	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177618	10.1371/journal.pone.0177618	http://dx.doi.org/10.1371/journal.pone.0177618			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DC	28520779	Green Published, gold, Green Submitted			2022-12-26	WOS:000401485500045
J	Moor, H				Moor, Helen			Life history trade-off moderates model predictions of diversity loss from climate change	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; DISTANCE SEED DISPERSAL; LONG-DISTANCE; ENVIRONMENTAL-CHANGE; COMMUNITY ECOLOGY; FUNCTIONAL TRAITS; SPATIAL-PATTERNS; EXTINCTION DEBT; RANGE SHIFTS; SIZE	Climate change can trigger species range shifts, local extinctions and changes in diversity. Species interactions and dispersal capacity are important mediators of community responses to climate change. The interaction between multispecies competition and variation in dispersal capacity has recently been shown to exacerbate the effects of climate change on diversity and to increase predictions of extinction risk dramatically. Dispersal capacity, however, is part of a species' overall ecological strategy and are likely to trade off with other aspects of its life history that influence population growth and persistence. In plants, a well-known example is the trade-off between seed mass and seed number. The presence of such a trade-off might buffer the diversity loss predicted by models with random but neutral (i.e. not impacting fitness otherwise) differences in dispersal capacity. Using a trait-based metacommunity model along a warming climatic gradient the effect of three different dispersal scenarios on model predictions of diversity change were compared. Adding random variation in species dispersal capacity caused extinctions by the introduction of strong fitness differences due an inherent property of the dispersal kernel. Simulations including a fitness-equalising trade-off based on empirical relationships between seed mass (here affecting dispersal distance, establishment probability, and seedling biomass) and seed number (fecundity) maintained higher initial species diversity and predicted lower extinction risk and diversity loss during climate change than simulations with variable dispersal capacity. Large seeded species persisted during climate change, but developed lags behind their climate niche that may cause extinction debts. Small seeded species were more extinction-prone during climate change but tracked their niches through dispersal and colonisation, despite competitive resistance from residents. Life history trade-offs involved in coexistence mechanisms may increase community resilience to future climate change and are useful guides for model development.	[Moor, Helen] Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden; [Moor, Helen] Swedish Univ Agr Sci, Swedish Species Informat Ctr, Uppsala, Sweden	Stockholm University; Swedish University of Agricultural Sciences	Moor, H (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden.; Moor, H (corresponding author), Swedish Univ Agr Sci, Swedish Species Informat Ctr, Uppsala, Sweden.	helen.moor@su.se		Moor, Helen/0000-0002-1340-2039	Strategic Research Programme EkoKlim, Stockholm University through the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)	Strategic Research Programme EkoKlim, Stockholm University through the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)	This research was financed by the Strategic Research Programme EkoKlim, Stockholm University (www.su.se/ekoklim), through the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS, www.formas.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2013, ECOL LETT, V16, P1294, DOI 10.1111/ele.12157; Amarasekare P, 2001, AM NAT, V158, P572, DOI 10.1086/323586; Ben-Hur E, 2012, ECOL LETT, V15, P1276, DOI 10.1111/j.1461-0248.2012.01850.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Coomes DA, 2003, TRENDS ECOL EVOL, V18, P283, DOI 10.1016/S0169-5347(03)00072-7; Corlett RT, 2013, TRENDS ECOL EVOL, V28, P482, DOI 10.1016/j.tree.2013.04.003; Dalling JW, 2002, J ECOL, V90, P557, DOI 10.1046/j.1365-2745.2002.00695.x; Debain S, 2003, ECOSCIENCE, V10, P168, DOI 10.1080/11956860.2003.11682764; Dullinger S, 2012, NAT CLIM CHANGE, V2, P619, DOI 10.1038/NCLIMATE1514; Ehrlen J, 2015, ECOL LETT, V18, P303, DOI 10.1111/ele.12410; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Gonzalez A, 2009, ANNU REV ECOL EVOL S, V40, P393, DOI 10.1146/annurev.ecolsys.39.110707.173349; Gottfried M, 2012, NATURE CLIMATE CHANG, P5; Henery ML, 2001, OIKOS, V92, P479, DOI 10.1034/j.1600-0706.2001.920309.x; Hodgson JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047141; Holt RD, 2005, OIKOS, V108, P18, DOI 10.1111/j.0030-1299.2005.13147.x; Holt RD, 2009, P NATL ACAD SCI USA, V106, P19659, DOI 10.1073/pnas.0905137106; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; Jakobsson A, 2000, OIKOS, V88, P494, DOI 10.1034/j.1600-0706.2000.880304.x; Jeganmohan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088344; Kearney M, 2010, PHILOS T R SOC B, V365, P3469, DOI 10.1098/rstb.2010.0034; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Kneitel JM, 2004, ECOL LETT, V7, P69, DOI 10.1046/j.1461-0248.2003.00551.x; Leishman MR, 2001, OIKOS, V93, P294, DOI 10.1034/j.1600-0706.2001.930212.x; Levine JM, 2002, AM NAT, V160, P452, DOI 10.1086/342073; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lonnberg K, 2013, OIKOS, V122, P1080, DOI 10.1111/j.1600-0706.2012.00249.x; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Moles AT, 2004, J ECOL, V92, P384, DOI 10.1111/j.0022-0477.2004.00880.x; Moles AT, 2006, OIKOS, V113, P91, DOI 10.1111/j.0030-1299.2006.14194.x; Moles AT, 2004, J ECOL, V92, P372, DOI 10.1111/j.0022-0477.2004.00884.x; Moles AT, 2003, ECOLOGY, V84, P3148, DOI 10.1890/02-0662; Muller-Landau HC, 2010, P NATL ACAD SCI USA, V107, P4242, DOI 10.1073/pnas.0911637107; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Norberg J, 2001, P NATL ACAD SCI USA, V98, P11376, DOI 10.1073/pnas.171315998; Norberg J, 2012, NAT CLIM CHANGE, V2, P747, DOI [10.1038/NCLIMATE1588, 10.1038/nclimate1588]; Normand S, 2014, ECOGRAPHY, V37, P1149, DOI 10.1111/ecog.01490; Ozinga WA, 2005, OIKOS, V108, P555, DOI 10.1111/j.0030-1299.2005.13632.x; Ozinga WA, 2009, ECOL LETT, V12, P66, DOI 10.1111/j.1461-0248.2008.01261.x; Parolo G, 2008, BASIC APPL ECOL, V9, P100, DOI 10.1016/j.baae.2007.01.005; Pearson RG, 2014, NAT CLIM CHANGE, V4, P217, DOI [10.1038/NCLIMATE2113, 10.1038/nclimate2113]; Singer A, 2016, ECOL MODEL, V326, P63, DOI 10.1016/j.ecolmodel.2015.11.007; Snell RS, 2014, GLOBAL ECOL BIOGEOGR, V23, P89, DOI 10.1111/geb.12106; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; Thompson K, 1993, SEED SIZE SHAPE PRED; Thomson FJ, 2011, J ECOL, V99, P1299, DOI 10.1111/j.1365-2745.2011.01867.x; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Turnbull LA, 2004, J ECOL, V92, P97, DOI 10.1111/j.1365-2745.2004.00856.x; Turnbull LA, 1999, J ECOL, V87, P899, DOI 10.1046/j.1365-2745.1999.00405.x; Turnbull LA, 2013, ECOL LETT, V16, P116, DOI 10.1111/ele.12056; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984; Urban MC, 2013, ANN NY ACAD SCI, V1297, P44, DOI 10.1111/nyas.12184; Urban MC, 2012, P ROY SOC B-BIOL SCI, V279, P2072, DOI 10.1098/rspb.2011.2367; Valladares F, 2014, ECOL LETT, V17, P1351, DOI 10.1111/ele.12348; van Bodegom PM, 2014, P NATL ACAD SCI USA, V111, P13733, DOI 10.1073/pnas.1304551110; Veloz SD, 2012, GLOBAL CHANGE BIOL, V18, P1698, DOI 10.1111/j.1365-2486.2011.02635.x; Violle C, 2009, J PLANT ECOL-UK, V2, P87, DOI 10.1093/jpe/rtp007; Vittoz P, 2007, BOT HELV, V117, P109, DOI 10.1007/s00035-007-0797-8; WESTOBY M, 1992, TRENDS ECOL EVOL, V7, P368, DOI 10.1016/0169-5347(92)90006-W; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Westoby M, 2006, TRENDS ECOL EVOL, V21, P261, DOI 10.1016/j.tree.2006.02.004; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Zickfeld K, 2013, J CLIMATE, V26, P5782, DOI 10.1175/JCLI-D-12-00584.1; Zurell D, 2016, GLOBAL CHANGE BIOL, V22, P2651, DOI 10.1111/gcb.13251	70	5	5	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177778	10.1371/journal.pone.0177778	http://dx.doi.org/10.1371/journal.pone.0177778			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520770	Green Submitted, Green Published, gold			2022-12-26	WOS:000401485500069
J	Puglisi, G; Leonetti, A; Landau, A; Fornia, L; Cerri, G; Borroni, P				Puglisi, Guglielmo; Leonetti, Antonella; Landau, Ayelet; Fornia, Luca; Cerri, Gabriella; Borroni, Paola			The role of attention in human motor resonance	PLOS ONE			English	Article							HUMAN CORTICOSPINAL PROJECTIONS; SELECTIVE ATTENTION; EXCITABILITY CHANGES; MIRROR NEURONS; HAND; MOVEMENT; MUSCLES; REPRESENTATION; FACILITATION; SPECIFICITY	Observation of others' actions evokes in primary motor cortex and spinal circuits of observers a subliminal motor resonance response, which reflects the motor program encoding observed actions. We investigated the role of attention in human motor resonance with four experimental conditions, explored in different subject groups: in the first explicit condition, subjects were asked to observe a rhythmic hand flexion-extension movement performed live in front of them. In two other conditions subjects had to monitor the activity of a LED light mounted on the oscillating hand. The hand was clearly visible but it was not the focus of subjects' attention: in the semi-implicit condition hand movement was relevant to task completion, while in the implicit condition it was irrelevant. In a fourth, baseline, condition subjects observed the rhythmic oscillation of a metal platform. Motor resonance was measured with the H-reflex technique as the excitability modulation of cortico-spinal motorneurons driving a hand flexor muscle. As expected, a normal resonant response developed in the explicit condition, and no resonant response in the baseline condition. Resonant responses also developed in both semi-implicit and implicit conditions and, surprisingly, were not different from each other, indicating that viewing an action is, per se, a powerful stimulus for the action observation network, even when it is not the primary focus of subjects' attention and even when irrelevant to the task. However, the amplitude of these responses was much reduced compared to the explicit condition, and the phase-lock between the time courses of observed movement and resonant motor program was lost. In conclusion, different parameters of the response were differently affected by subtraction of attentional resources with respect to the explicit condition: time course and muscle selection were preserved while the activation of motor circuits resulted in much reduced amplitude and lost its kinematic specificity.	[Puglisi, Guglielmo; Leonetti, Antonella; Borroni, Paola] Univ Milan, Sch Med, Dept Hlth Sci, Milan, Italy; [Leonetti, Antonella; Fornia, Luca; Cerri, Gabriella] Univ Milan, Sch Med, Dept Med Biotechnol & Translat Med, Milan, Italy; [Landau, Ayelet] Hebrew Univ Jerusalem, Dept Psychol, Jerusalem, Israel; [Landau, Ayelet] Hebrew Univ Jerusalem, Dept Cognit Sci, Jerusalem, Israel; [Fornia, Luca; Cerri, Gabriella] Humanitas Clin & Res Ctr, Rozzano, Italy	University of Milan; University of Milan; Hebrew University of Jerusalem; Hebrew University of Jerusalem; IRCCS Humanitas Research Hospital	Puglisi, G (corresponding author), Univ Milan, Sch Med, Dept Hlth Sci, Milan, Italy.	guglielmo.puglisi@gmail.com	Fornia, Luca/AAS-3166-2020; PUGLISI, GUGLIELMO/ABC-9155-2020	PUGLISI, GUGLIELMO/0000-0002-7690-1679; BORRONI, PAOLA ALICE/0000-0001-8955-3645; FORNIA, LUCA/0000-0002-8332-2886; LEONETTI, ANTONELLA/0000-0002-5500-4901; CERRI, GABRIELLA/0000-0002-7202-3792	Dipartimento di Scienze della Salute, Universita degli studi di Milano; Regione Lombardia [SAL-53, 16970]; University degli Studi di Milano	Dipartimento di Scienze della Salute, Universita degli studi di Milano; Regione Lombardia(Regione Lombardia); University degli Studi di Milano	Support was provided by Dipartimento di Scienze della Salute, Universita degli studi di Milano; and by Regione Lombardia, SAL-53,16970. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by funding from the University degli Studi di Milano and Project for International Scientific and Technological Cooperation (SAL-53, n.16970), from the Regione Lombardia.	Avenanti A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00185; Bach P, 2007, EXP BRAIN RES, V178, P509, DOI 10.1007/s00221-006-0756-4; Baldissera F, 2002, J PHYSIOL-LONDON, V539, P903, DOI 10.1113/jphysiol.2001.013282; BARGH JA, 1992, AM J PSYCHOL, V105, P181, DOI 10.2307/1423027; Bek J, 2016, EXP BRAIN RES, V234, P1819, DOI 10.1007/s00221-016-4570-3; Bien N, 2009, CEREB CORTEX, V19, P2338, DOI 10.1093/cercor/bhn251; Blakemore SJ, 2003, EXP BRAIN RES, V153, P239, DOI 10.1007/s00221-003-1597-z; Borroni P, 2005, BRAIN RES; Borroni P, 2008, SOC NEUROSCI-UK, V3, P276, DOI 10.1080/17470910701515269; Borroni P, 2011, EUR J NEUROSCI, V34, P662, DOI 10.1111/j.1460-9568.2011.07779.x; Bortoletto M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053248; Bourguignon M, 2013, NEUROIMAGE, V66, P500, DOI 10.1016/j.neuroimage.2012.10.038; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Catmur C, 2007, CURR BIOL, V17, P1527, DOI 10.1016/j.cub.2007.08.006; Cavallo A, 2012, CEREB CORTEX, V22, P710, DOI 10.1093/cercor/bhr157; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; Chong TTJ, 2008, NEUROIMAGE, V40, P298, DOI 10.1016/j.neuroimage.2007.11.030; Chong TTJ, 2009, NEUROPSYCHOLOGIA, V47, P786, DOI 10.1016/j.neuropsychologia.2008.12.008; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Costantini M, 2008, EXP BRAIN RES, V188, P341, DOI 10.1007/s00221-008-1369-x; Cracco E, 2016, SOC COGN AFFECT NEUR; Craighero L, 2002, NEUROPSYCHOLOGIA, V40, P492, DOI 10.1016/S0028-3932(01)00134-8; Cross KA, 2014, NEUROIMAGE, V91, P228, DOI 10.1016/j.neuroimage.2014.01.027; DECETY J, 1988, EUR ARCH PSY CLIN N, V238, P33, DOI 10.1007/BF00381078; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Eaves DL, 2016, BRAIN COGNITION, V106, P90, DOI 10.1016/j.bandc.2016.04.013; Eaves DL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00028; EPSTEIN M L, 1980, Journal of Sport Psychology, V2, P211; Esposti R, 2005, EXP BRAIN RES, V162, P436, DOI 10.1007/s00221-004-2120-x; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0177; Gallese V, 2009, PSYCHOL RES-PSYCH FO, V73, P486, DOI 10.1007/s00426-009-0232-4; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Georgopoulos A., 2000, CURRENT OPINION NEUR, P238; Gowen E, 2010, BRAIN COGNITION, V74, P288, DOI 10.1016/j.bandc.2010.08.010; Grafton ST, 2007, HUM MOVEMENT SCI, V26, P590, DOI 10.1016/j.humov.2007.05.009; Heyes C, 2005, COGNITIVE BRAIN RES, V22, P233, DOI 10.1016/j.cogbrainres.2004.09.009; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Johansen-Berg H, 2002, EXP BRAIN RES, V142, P13, DOI 10.1007/s00221-001-0905-8; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Kraskov a, 2014, CORTICOSPINAL MIRROR, DOI doi.org/10.1113/jphysiol; Kraskov A, 2009, NEURON, V64, P922, DOI 10.1016/j.neuron.2009.12.010; LAVIE N, 1994, PERCEPT PSYCHOPHYS, V56, P183, DOI 10.3758/BF03213897; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Leonetti A, 2015, EXP BRAIN RES, V233, P3013, DOI 10.1007/s00221-015-4371-0; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Mattiassi ADA, 2014, J COGNITIVE NEUROSCI, V26, P2028, DOI 10.1162/jocn_a_00619; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; Mc Cabe SI, 2015, CEREB CORTEX, V25, P2229, DOI 10.1093/cercor/bhu029; Montagna M, 2005, EUR J NEUROSCI, V22, P1513, DOI 10.1111/j.1460-9568.2005.04336.x; Muthukumaraswamy SD, 2008, PSYCHOPHYSIOLOGY, V45, P896, DOI 10.1111/j.1469-8986.2008.00711.x; Naish KR, 2014, NEUROPSYCHOLOGIA, V64, P331, DOI 10.1016/j.neuropsychologia.2014.09.034; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Passingham RE, 1996, PHILOS T ROY SOC B, V351, P1473, DOI 10.1098/rstb.1996.0132; Perry A, 2010, NEUROREPORT, V21, P1050, DOI 10.1097/WNR.0b013e32833fcb71; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0420; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Sartori L, 2015, CORTEX, V70, P169, DOI 10.1016/j.cortex.2015.01.019; Sartori L, 2012, SOC NEUROSCI-UK, V7, P146, DOI 10.1080/17470919.2011.586579; SCHIEPPATI M, 1987, PROG NEUROBIOL, V28, P345, DOI 10.1016/0301-0082(87)90007-4; Sturmer B, 2000, J EXP PSYCHOL HUMAN, V26, P1746, DOI 10.1037//0096-1523.26.6.1746; Tamietto M, 2009, P NATL ACAD SCI USA, V106, P17661, DOI 10.1073/pnas.0908994106; Ubaldi S, 2015, CEREB CORTEX, V25, P1032, DOI 10.1093/cercor/bht295; Vigneswaran G, 2013, CURR BIOL, V23, P236, DOI 10.1016/j.cub.2012.12.006; Vogt S, 2003, NEUROPSYCHOLOGIA, V41, P941, DOI 10.1016/S0028-3932(02)00319-6; Vogt S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00807; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Woodruff CC, 2013, EXP BRAIN RES, V229, P507, DOI 10.1007/s00221-013-3612-3	77	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177457	10.1371/journal.pone.0177457	http://dx.doi.org/10.1371/journal.pone.0177457			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DC	28510605	gold, Green Submitted, Green Published			2022-12-26	WOS:000401485500031
J	Singh, M; Kumar, M; Thilges, K; Cho, MJ; Cigan, AM				Singh, Manjit; Kumar, Manish; Thilges, Katherine; Cho, Myeong-Je; Cigan, A. Mark			MS26/CYP704B is required for anther and pollen wall development in bread wheat (Triticum aestivum L.) and combining mutations in all three homeologs causes male sterility	PLOS ONE			English	Article							SPOROPOLLENIN SYNTHESIS; EXINE FORMATION; CYTOCHROME-P450; ARABIDOPSIS; GENOME; GENES; HYDROXYLATION; BIOSYNTHESIS; EVOLUTION; MUTANTS	Development of anthers and pollen represents an important aspect of the life cycle in flowering plants. Genes contributing to anther and pollen development have been widely studied in many plant species. Ms26/CYP704B genes play an important role in pollen development through biosynthesis of sporopollenin for pollen exine formation. To investigate the role of Ms26/CYP704B genes in anther and pollen development of bread wheat, mutations in the A-, B-, and D-homeologs of the putative Ms26/CYP704B gene were analyzed. Single and double homozygous mutants in any of the homeologs did not affect pollen development and male fertility. Triple homozygous mutants resulted in completely male sterile plants that were defective in pollen and anther development. Additionally, double homozygous-single heterozygous mutants were also male sterile although with varying levels of residual fertility. The fertility of these triple mutants was dependent upon the homeolog contributing the wildtype allele. Two heterologous Ms26/CYP704B genes, when transformed into a triple homozygous mutant background, completely restored male fertility, whereas a single gene was unable to restore fertility. Functional analysis of Ms26/CYP704B furthers the understanding of male fertility genes which can be utilized for the development of novel hybrid seed production systems in wheat.	[Singh, Manjit; Kumar, Manish; Thilges, Katherine; Cho, Myeong-Je; Cigan, A. Mark] DuPont Pioneer, Johnston, IA 50131 USA; [Cho, Myeong-Je] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Cigan, A. Mark] Genus, De Forest, WI USA	DuPont; Pioneer Hi-Bred International, Inc.; University of California System; University of California Berkeley	Singh, M (corresponding author), DuPont Pioneer, Johnston, IA 50131 USA.	manjit.singh@pioneer.com	Singh, Manjit/GWM-3934-2022	Singh, Manjit/0000-0002-5451-3659	DuPont Pioneer	DuPont Pioneer	The authors received no external funding for this work.The authors, employees of DuPont Pioneer, designed, conducted experiments, performed data analysis and wrote the manuscript. DuPont Pioneer provided support in the form of salaries for authors [MS, MK, KT, MC and AMC] and provided research facilities and resources and supported the decision to publish. The specific roles of these authors are articulated in the 'author contributions' section	Ahlers F, 2000, Z NATURFORSCH C, V55, P129; Akhunova AR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-505; Albertsen MC, 2009, INVENTORS NUCLEOTIDE; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ariizumi T, 2011, ANNU REV PLANT BIOL, V62, P437, DOI 10.1146/annurev-arplant-042809-112312; Bak Soren, 2011, Arabidopsis Book, V9, pe0144, DOI 10.1199/tab.0144; Borrill P, 2015, NEW PHYTOL, V208, P1008, DOI 10.1111/nph.13533; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Cigan AM, 2016, PLANT BIOTE IN PRESS; Colpitts CC, 2011, NEW PHYTOL, V192, P855, DOI 10.1111/j.1469-8137.2011.03858.x; Djukanovic V, 2013, PLANT J, V76, P888, DOI 10.1111/tpj.12335; Dobritsa AA, 2009, PLANT PHYSIOL, V151, P574, DOI 10.1104/pp.109.144469; Duan H, 2005, PLANT PHYSIOL, V137, P1067, DOI 10.1104/pp.104.055715; Feldman M, 2012, J EXP BOT, V63, P5045, DOI 10.1093/jxb/ers192; Gao HR, 2010, PLANT J, V61, P176, DOI 10.1111/j.1365-313X.2009.04041.x; Gomez JF, 2015, J INTEGR PLANT BIOL, V57, P876, DOI 10.1111/jipb.12425; GUILFORD WJ, 1988, PLANT PHYSIOL, V86, P134, DOI 10.1104/pp.86.1.134; HESS MW, 1993, PLANTA, V189, P139, DOI 10.1007/BF00201354; Klindworth DL, 2002, CROP SCI, V42, P1447, DOI 10.2135/cropsci2002.1447; Lei SL, 2007, THEOR APPL GENET, V115, P643, DOI 10.1007/s00122-007-0594-1; Li H, 2010, PLANT CELL, V22, P173, DOI 10.1105/tpc.109.070326; LOUKIDES CA, 1995, AM J BOT, V82, P1017, DOI 10.2307/2446231; Madlung A, 2013, Cytogenet Genome Res, V140, P270, DOI 10.1159/000351430; Marcussen T, 2014, SCIENCE, V345, DOI 10.1126/science.1250092; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; Morant M, 2007, PLANT CELL, V19, P1473, DOI 10.1105/tpc.106.045948; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; Quilichini TD, 2015, PHYTOCHEMISTRY, V113, P170, DOI 10.1016/j.phytochem.2014.05.002; SCOTT RJ, 1994, SOC EXP BIOL SEMIN S, V55, P49, DOI 10.1017/CBO9780511752339.006; Shi JX, 2015, TRENDS PLANT SCI, V20, P741, DOI 10.1016/j.tplants.2015.07.010; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Wiermann R, 2001, BIOPOLYMERS, V1, P209, DOI DOI 10.1002/3527600035.BPOL1007; Wu YZ, 2016, PLANT BIOTECHNOL J, V14, P1046, DOI 10.1111/pbi.12477; Yang XJ, 2014, J INTEGR PLANT BIOL, V56, P979, DOI 10.1111/jipb.12212; Yeats TH, 2013, PLANT PHYSIOL, V163, P5, DOI 10.1104/pp.113.222737; Yi B, 2010, PLANT J, V63, P925, DOI 10.1111/j.1365-313X.2010.04289.x; Zhang DB, 2016, SUBCELL BIOCHEM, V86, P315, DOI 10.1007/978-3-319-25979-6_13	38	28	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177632	10.1371/journal.pone.0177632	http://dx.doi.org/10.1371/journal.pone.0177632			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520767	gold, Green Submitted, Green Published			2022-12-26	WOS:000401485500048
J	Wilke, HJ; Herkommer, A; Werner, K; Liebsch, C				Wilke, Hans-Joachim; Herkommer, Andrea; Werner, Karin; Liebsch, Christian			In vitro analysis of the segmental flexibility of the thoracic spine	PLOS ONE			English	Article							LOAD-DISPLACEMENT CURVES; WHOLE LUMBAR SPINE; RIB CAGE; THORACOLUMBAR JUNCTION; MECHANICAL-PROPERTIES; INTERVERTEBRAL DISC; STEPWISE REDUCTION; CERVICAL-SPINE; SAGITTAL PLANE; STABILITY	Basic knowledge about the thoracic spinal flexibility is limited and to the authors' knowledge, no in vitro studies have examined the flexibility of every thoracic spinal segment under standardized experimental conditions using pure moments. In our in vitro study, 68 human thoracic functional spinal units including the costovertebral joints (at least n = 6 functional spinal units per segment from T1-T2 to T11-T12) were loaded with pure moments of +/- 7.5 Nm in flexion/extension, lateral bending, and axial rotation in a custom-built spine tester to analyze range of motion (ROM) and neutral zone (NZ). ROM and NZ showed symmetric motion behavior in all loading planes. In each loading direction, the segment T1-T2 exhibited the highest ROM. In flexion/extension, the whole thoracic region, with exception of T1-T2 (14 degrees), had an average ROM between 6 degrees and 8 degrees. In lateral bending, the upper thoracic region (T1-T7) was, with an average ROM between 10 degrees and 12 degrees, more flexible than the lower thoracic region (T7-T12) with an average ROM between 8 degrees and 9 degrees. In axial rotation, the thoracic region offered the highest overall flexibility with an average ROM between 10 degrees and 12 degrees in the upper and middle thoracic spine (T1-T10) and between 7 degrees and 8 degrees in the lower thoracic spine (T10-T12), while a trend of continuous decrease of ROM could be observed in the lower thoracic region (T7-T12). Comparing these ROM values with those in literature, they agree that ROM is lowest in flexion/extension and highest in axial rotation, as well as decreasing in the lower segments in axial rotation. Differences were found in flexion/extension and lateral bending in the lower segments, where, in contrast to the literature, no increase of the ROM from superior to inferior segments was found. The data of this in vitro study could be used for the validation of numerical models and the design of further in vitro studies of the thoracic spine without the rib cage, the verification of animal models, as well as the interpretation of already published human in vitro data.	[Wilke, Hans-Joachim; Herkommer, Andrea; Werner, Karin; Liebsch, Christian] Univ Ulm, Trauma Res Ctr Ulm, Inst Orthopaed Res & Biomech, Ulm, Germany	Ulm University	Wilke, HJ (corresponding author), Univ Ulm, Trauma Res Ctr Ulm, Inst Orthopaed Res & Biomech, Ulm, Germany.	hans-joachim.wilke@uni-ulm.de	Liebsch, Christian/AAY-9918-2020; Wilke, Hans-Joachim/M-6440-2014	Liebsch, Christian/0000-0003-1543-4728; Wilke, Hans-Joachim/0000-0001-6007-8844	German Research Council (DFG) [WI 1352/20-1]	German Research Council (DFG)(German Research Foundation (DFG))	This study was supported by the German Research Council (DFG), Project WI 1352/20-1 to (HJW).	Aebi M, 2003, EUR SPINE J, V12, pS202, DOI 10.1007/s00586-003-0609-9; ANDRIACCHI T, 1974, J BIOMECH, V7, P497, DOI 10.1016/0021-9290(74)90084-0; Aubin CE, 2008, SPINE, V33, P2143, DOI 10.1097/BRS.0b013e31817bd89f; Brasiliense LBC, 2011, SPINE, V36, pE1686, DOI 10.1097/BRS.0b013e318219ce84; COOPER C, 1992, TRENDS ENDOCRIN MET, V3, P224, DOI 10.1016/1043-2760(92)90032-V; FEIERTAG MA, 1995, SPINE, V20, P1604, DOI 10.1097/00007632-199507150-00009; Fujimori T, 2012, SPINE, V37, pE1318, DOI 10.1097/BRS.0b013e318267254b; GOEL VK, 1988, J ORTHOPAED RES, V6, P611, DOI 10.1002/jor.1100060419; GOEL VK, 1985, SPINE, V10, P543, DOI 10.1097/00007632-198507000-00008; GOODWIN RR, 1994, J BIOMECH, V27, P1049, DOI 10.1016/0021-9290(94)90221-6; GREGERSEN GG, 1967, J BONE JOINT SURG AM, VA 49, P247, DOI 10.2106/00004623-196749020-00003; Heuer F, 2007, J BIOMECH, V40, P795, DOI 10.1016/j.jbiomech.2006.03.016; Heuer F, 2007, J BIOMECH, V40, P271, DOI 10.1016/j.jbiomech.2006.01.007; Horton WC, 2005, SPINE, V30, P2014, DOI 10.1097/01.brs.0000180478.96494.88; Kettler A, 2011, EUR SPINE J, V20, P578, DOI 10.1007/s00586-010-1635-z; Liebsch C, 2016, EUR SPINE J, P1; Little JP, 2013, SCOLIOSIS, V8, P1; Magerl F, 1994, Eur Spine J, V3, P184, DOI 10.1007/BF02221591; Maiman DJ, 1991, CLIN NEUROSURG, V38, P296; Majdouline Y, 2009, MED BIOL ENG COMPUT, V47, P1143, DOI 10.1007/s11517-009-0509-1; MARKOLF KL, 1972, J BONE JOINT SURG AM, VA 54, P511, DOI 10.2106/00004623-197254030-00005; Meyer P. R., 1989, SURG SPINE TRAUMA; MIMURA M, 1994, SPINE, V19, P1371, DOI 10.1097/00007632-199406000-00011; Morita D, 2014, EUR SPINE J, V23, P673, DOI 10.1007/s00586-013-3088-7; Oda Itaru, 2002, Spine (Phila Pa 1976), V27, pE64, DOI 10.1097/00007632-200202010-00007; OXLAND TR, 1992, J ORTHOP RES, V10, P573, DOI 10.1002/jor.1100100412; PANJABI MM, 1977, ORTHOP CLIN N AM, V8, P169; PANJABI MM, 1993, SPINE, V18, P1298, DOI 10.1097/00007632-199308000-00009; PANJABI MM, 1976, J BONE JOINT SURG AM, V58, P642, DOI 10.2106/00004623-197658050-00011; PANJABI MM, 1981, ACTA ORTHOP SCAND, V52, P315, DOI 10.3109/17453678109050109; PANJABI MM, 1994, J BONE JOINT SURG AM, V76A, P413, DOI 10.2106/00004623-199403000-00012; Patwardhan AG, 2003, J ORTHOPAED RES, V21, P540, DOI 10.1016/S0736-0266(02)00202-4; POONI JS, 1986, SURG RADIOL ANAT, V8, P175, DOI 10.1007/BF02427846; SCHULTE K, 1989, SPINE, V14, P1116, DOI 10.1097/00007632-198910000-00015; Sham ML, 2005, BIOMED TECH, V50, P361, DOI 10.1515/BMT.2005.051; SINGER KP, 1988, SURG RADIOL ANAT, V10, P291, DOI 10.1007/BF02107901; Takeuchi T, 1999, SPINE, V24, P1414, DOI 10.1097/00007632-199907150-00005; Tawackoli W, 2004, SPINE, V29, P988, DOI 10.1097/00007632-200405010-00007; Volkheimer D, 2015, EUR SPINE J, V24, P1882, DOI 10.1007/s00586-015-4040-9; Wang XY, 2012, EUR SPINE J, V21, P1082, DOI 10.1007/s00586-011-2089-7; Watkins R, 2005, SPINE, V30, P1283, DOI 10.1097/01.brs.0000164257.69354.bb; Wen N, 1993, Eur Spine J, V2, P2, DOI 10.1007/BF00301048; White A.A., 1990, CLIN BIOMECH; WHITE AA, 1969, ACTA ORTHOP SCAND, VS, P7; Wilke H J, 1994, Eur Spine J, V3, P91, DOI 10.1007/BF02221446; Wilke H J, 1998, Eur Spine J, V7, P148, DOI 10.1007/s005860050045; Wilke HJ, 1998, ANAT REC, V251, P15, DOI 10.1002/(SICI)1097-0185(199805)251:1<15::AID-AR4>3.0.CO;2-D; WILKE HJ, 1995, SPINE, V20, P192, DOI 10.1097/00007632-199501150-00011; Willems JM, 1996, CLIN BIOMECH, V11, P311, DOI 10.1016/0268-0033(96)00017-4; WOOD KB, 1995, J BONE JOINT SURG AM, V77A, P1631, DOI 10.2106/00004623-199511000-00001; YAMAMOTO I, 1989, SPINE, V14, P1256, DOI 10.1097/00007632-198911000-00020	51	32	33	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177823	10.1371/journal.pone.0177823	http://dx.doi.org/10.1371/journal.pone.0177823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520819	Green Published, Green Submitted, gold			2022-12-26	WOS:000401485500075
J	Munoz-Castaneda, JR; Herencia, C; de Mier, MVPR; Rodriguez-Ortiz, ME; Diaz-Tocados, JM; Vergara, N; Martinez-Moreno, JM; Salmeron, MD; Richards, WG; Felsenfeld, A; Kuro-O, M; Almaden, Y; Rodriguez, M				Munoz-Castaneda, Juan R.; Herencia, Carmen; Victoria Pendon-Ruiz de Mier, Maria; Encarnacion Rodriguez-Ortiz, Maria; Diaz-Tocados, Juan M.; Vergara, Noemi; Martinez-Moreno, Julio M.; Dolores Salmeron, Maria; Richards, William G.; Felsenfeld, Arnold; Kuro-O, Makoto; Almaden, Yolanda; Rodriguez, Mariano			Differential regulation of renal Klotho and FGFR1 in normal and uremic rats	FASEB JOURNAL			English	Article						phosphaturia; FGF23; mineral metabolism; chronic kidney disease	GROWTH-FACTOR 23; CHRONIC KIDNEY-DISEASE; VITAMIN-D; FGF23; PHOSPHATE; EXPRESSION; CALCIFICATION; CALCIUM; INJURY; GENE	In renal failure, hyperphosphatemia occurs despite a marked elevation in serum fibroblast growth factor (FGF)-23. Abnormal regulation of the FGFR1-Klotho receptor complex may cause a resistance to the phosphaturic action of FGF23. The purpose of the present study was to investigate the regulation of renal Klotho and FGF receptor (FEFR)-1 in healthy and uremic rats induced by 5/6 nephrectomy. In normal rats, the infusion of rat recombinant FGF23 enhanced phosphaturia and increased renal FGFR1 expression; however, Klotho expression was reduced. Uremic rats on a high-phosphate (HP) diet presented hyperphosphatemia with marked elevation of FGF23 and an increased fractional excretion of phosphate (P) that was associated with a marked reduction of Klotho expression and an increase in FGFR1. After neutralization of FGF23 by anti-FGF23 administration, phosphaturia was still abundant, Klotho expression remained low, and the FGFR1 level was reduced. These results suggest that the expression of renal Klotho is modulated by phosphaturia, whereas the FGFR1 expression is regulated by FGF23. Calcitriol (CTR) administration prevented a decrease in renal Klotho expression. In HEK293 cells HP produced nuclear translocation of beta-catenin, together with a reduction in Klotho. Wnt/beta-catenin inhibition with Dkk-1 prevented the P-induced down-regulation of Klotho. The addition of CTR to HP medium was able to recover Klotho expression. In summary, high FGF23 levels increase FGFR1, whereas phosphaturia decreases Klotho expression through the activation of Wnt/beta-catenin pathway.	[Munoz-Castaneda, Juan R.; Herencia, Carmen; Victoria Pendon-Ruiz de Mier, Maria; Diaz-Tocados, Juan M.; Vergara, Noemi; Martinez-Moreno, Julio M.; Dolores Salmeron, Maria; Almaden, Yolanda; Rodriguez, Mariano] Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba, Spain; [Munoz-Castaneda, Juan R.; Rodriguez, Mariano] Hosp Univ Reina Sofia, Unidad Gest Clin UGC Nefrol, Cordoba, Spain; [Munoz-Castaneda, Juan R.; Herencia, Carmen; Victoria Pendon-Ruiz de Mier, Maria; Diaz-Tocados, Juan M.; Vergara, Noemi; Martinez-Moreno, Julio M.; Dolores Salmeron, Maria; Almaden, Yolanda; Rodriguez, Mariano] Univ Cordoba, Dept Med, Cordoba, Spain; [Munoz-Castaneda, Juan R.; Rodriguez, Mariano] Red Nacl Invest Nefrol REDinREN, Cordoba, Spain; [Almaden, Yolanda] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Cordoba, Spain; [Herencia, Carmen; Victoria Pendon-Ruiz de Mier, Maria; Diaz-Tocados, Juan M.; Vergara, Noemi; Martinez-Moreno, Julio M.; Dolores Salmeron, Maria] Hosp Univ Reina Sofia, Cordoba, Spain; [Encarnacion Rodriguez-Ortiz, Maria] Fdn Jimenez Diaz, Inst Invest Sanitaria, REDinREN, Lab Nefrol, Madrid, Spain; [Richards, William G.] Amgen Inc, Thousand Oaks, CA 91320 USA; [Felsenfeld, Arnold] Vet Affairs Greater Los Angeles Healthcare Syst, Dept Med, Los Angeles, CA USA; [Felsenfeld, Arnold] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Kuro-O, Makoto] Jichi Med Univ, Ctr Mol Med, Div Antiaging Med, Shimotsuke, Japan; [Almaden, Yolanda] Hosp Univ Reina Sofia, UGC Med Interna, Cordoba, Spain	Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Hospital Universitario Reina Sofia - Cordoba; Fundacion Jimenez Diaz; Amgen; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Jichi Medical University	Rodriguez, M (corresponding author), Univ Cordoba, Serv Nefrol REDinREN, Inst Maimonides Invest Biomed Cordoba, Hosp Univ Reina Sofia, Avd Menendez Pidal S-N, E-14004 Cordoba, Spain.	marianorodriguezportillo@gmail.com	Muñoz-Castañeda, Juan R./AFQ-3443-2022; Tocados, Juan Miguel Díaz/I-8254-2018; Martínez, Julio Manuel/AAA-6724-2020; Herencia, Carmen/AAA-6843-2020	Martínez, Julio Manuel/0000-0002-1945-5078; Rodriguez, Mariano/0000-0002-9380-6614; Munoz-Castaneda, Juan R/0000-0002-9341-0724; Diaz Tocados, Juan Miguel/0000-0001-5192-5212	Spanish government from the Programa Nacional I+D+I; Instituto de Salud Carlos III (ISCIII) - European Funds (FEDER) [PI14/00638, PI14/00467]; Consejeria de Economia, Innovacion, Ciencia y Empleo from the Junta de Andalucia [CVI-7925]; Framework Programme 7 Syskid UE Grant [FP7-241544]; EUTOX from the ISCIII; REDinREN from the ISCIII; Consejeria de Economia, Innovacion Grant from the Junta de Andalucia [CVI-7925]; ISCIII; Nicolas Monardes Programme, Consejeria de Salud-SAS (Junta de Andalucia); Laboratorios Rubio SA research award	Spanish government from the Programa Nacional I+D+I; Instituto de Salud Carlos III (ISCIII) - European Funds (FEDER); Consejeria de Economia, Innovacion, Ciencia y Empleo from the Junta de Andalucia; Framework Programme 7 Syskid UE Grant; EUTOX from the ISCIII; REDinREN from the ISCIII; Consejeria de Economia, Innovacion Grant from the Junta de Andalucia(Junta de Andalucia); ISCIII(Instituto de Salud Carlos III); Nicolas Monardes Programme, Consejeria de Salud-SAS (Junta de Andalucia)(Junta de Andalucia); Laboratorios Rubio SA research award	The authors thank Ignacio Lopez (Universidad de Cordoba) for criticism of the study and participation in the correction of the manuscript. This work was partially supported by a Spanish government grant from the Programa Nacional I+D+I 2008-2011 and Instituto de Salud Carlos III (ISCIII) Grants PI14/00638 and PI14/00467, cofinancing from European Funds (FEDER), Consejeria de Economia, Innovacion, Ciencia y Empleo (Grant CVI-7925) from the Junta de Andalucia, Framework Programme 7 Syskid UE Grant FP7-241544, and EUTOX and REDinREN from the ISCIII. N.V. and J.M.D.-T. were supported by Consejeria de Economia, Innovacion Grant CVI-7925 Ciencia y Empleo from the Junta de Andalucia. M.E.R.-O. is the recipient of a "Sara Borrell" research contract from the ISCIII. Y.A. and J.R.M.-C. are senior researchers supported by the Nicolas Monardes Programme, Consejeria de Salud-SAS (Junta de Andalucia). M.D.S. is supported by a Laboratorios Rubio SA research award. W.G.R. is employed by Amgen, Inc., and M.R. has received honorarium for lectures from Abbott, Amgen, Inc., Fresenius, and Shire. The remaining authors declare no conflicts of interest.	Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Canalejo R, 2010, J AM SOC NEPHROL, V21, P1125, DOI 10.1681/ASN.2009040427; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Faverman L, 2008, FEBS LETT, V582, P1552, DOI 10.1016/j.febslet.2008.03.053; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Forster RE, 2011, BIOCHEM BIOPH RES CO, V414, P557, DOI 10.1016/j.bbrc.2011.09.117; Gattineni J, 2014, AM J PHYSIOL-RENAL, V306, pF351, DOI 10.1152/ajprenal.00232.2013; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Guerrero F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089179; Hassan A, 2016, AM J PHYSIOL-RENAL, V310, pF217, DOI 10.1152/ajprenal.00332.2015; Haussler MR, 2012, REV ENDOCR METAB DIS, V13, P57, DOI 10.1007/s11154-011-9199-8; HAUT LL, 1980, KIDNEY INT, V17, P722, DOI 10.1038/ki.1980.85; Hiyama A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3830; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Isakova T, 2010, KIDNEY INT, V78, P947, DOI 10.1038/ki.2010.281; Kuro-o M, 2013, KIDNEY INT SUPPL, V3, P420, DOI 10.1038/kisup.2013.88; Liu JY, 2016, INT UROL NEPHROL, V48, P1313, DOI 10.1007/s11255-016-1291-2; Liu SG, 2008, J AM SOC NEPHROL, V19, P2342, DOI 10.1681/ASN.2007121301; Martinez-Moreno JM, 2012, AM J PHYSIOL-RENAL, V303, pF1136, DOI 10.1152/ajprenal.00684.2011; de Oca AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089525; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Olauson H, 2013, CURR OPIN NEPHROL HY, V22, P397, DOI 10.1097/MNH.0b013e32836213ee; Quinn SJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE310, DOI 10.1152/ajpendo.00460.2012; Rodriguez-Ortiz ME, 2012, J AM SOC NEPHROL, V23, P1190, DOI 10.1681/ASN.2011101006; Sastre C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083713; Shalhoub V, 2012, J CLIN INVEST, V122, P2543, DOI 10.1172/JCI61405; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Sugiura H, 2010, NEPHROL DIAL TRANSPL, V25, P60, DOI 10.1093/ndt/gfp451; Sun CY, 2012, KIDNEY INT, V81, P640, DOI 10.1038/ki.2011.445; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; Wolf M, 2012, KIDNEY INT, V82, P737, DOI 10.1038/ki.2012.176; Wolf M, 2011, J AM SOC NEPHROL, V22, P956, DOI 10.1681/ASN.2010080894; Wu AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057322; Zhou LL, 2013, J AM SOC NEPHROL, V24, P771, DOI 10.1681/ASN.2012080865	34	25	27	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3858	3867		10.1096/fj.201700006R	http://dx.doi.org/10.1096/fj.201700006R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28515153				2022-12-26	WOS:000408713300013
J	El Qaidi, S; Chen, K; Halim, A; Siukstaite, L; Rueter, C; Hurtado-Guerrero, R; Clausen, H; Hardwidge, PR				El Qaidi, Samir; Chen, Kangming; Halim, Adnan; Siukstaite, Lina; Rueter, Christian; Hurtado-Guerrero, Ramon; Clausen, Henrik; Hardwidge, Philip R.			NleB/SseK effectors from Citrobacter rodentium, Escherichia coli, and Salmonella enterica display distinct differences in host substrate specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN	Many Gram-negative bacterial pathogens use a syringe-like apparatus called a type III secretion system to inject virulence factors into host cells. Some of these effectors are enzymes that modify host proteins to subvert their normal functions. NleB is a glycosyltransferase that modifies host proteins with N-acetyl-Dglucosamine to inhibit antibacterial and inflammatory host responses. NleB is conserved among the attaching/effacing pathogens enterohemorrhagic Escherichia coli (EHEC), enteropathogenic E. coli (EPEC), and Citrobacter rodentium. Moreover, Salmonella enterica strains encode up to three NleB orthologs named SseK1, SseK2, and SseK3. However, there are conflicting reports regarding the activities and host protein targets among the NleB/SseK orthologs. Therefore, here we performed in vitro glycosylation assays and cell culture experiments to compare the activities and substrate specificities of these effectors. SseK1, SseK3, EHEC NleB1, EPEC NleB1, and C. rodentium NleB blocked TNF-mediated NF-kappa B pathway activation, whereas SseK2 and NleB2 did not. C. rodentium NleB, EHEC NleB1, and SseK1 glycosylated host GAPDH. C. rodentium NleB, EHEC NleB1, EPEC NleB1, and SseK2 glycosylated the FADD (Fas-associated death domain protein). SseK3 and NleB2 were not active against either substrate. We also found that EHEC NleB1 glycosylated two GAPDH arginine residues, Arg197 and Arg200, and that these two residues were essential for GAPDH-mediated activation of TNF receptorassociated factor 2 ubiquitination. These results provide evidence that members of this highly conserved family of bacterial virulence effectors target different host protein substrates and exhibit distinct cellular modes of action to suppress host responses.	[El Qaidi, Samir; Chen, Kangming; Hardwidge, Philip R.] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA; [Halim, Adnan; Siukstaite, Lina; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Dept Cellular Med, Copenhagen Ctr Glyc, DK-2200 Copenhagen N, Denmark; [Halim, Adnan; Siukstaite, Lina; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Dept Mol Med, Copenhagen Ctr Glyc, DK-2200 Copenhagen N, Denmark; [Halim, Adnan] Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA; [Rueter, Christian] Univ Munster, Ctr Mol Biol Inflammat, Inst Infectiol, D-48149 Munster, Germany; [Hurtado-Guerrero, Ramon] Univ Zaragoza, Inst Quim Fis Rocasolano, Consejo Super Invest Cient Joint Unit, Fdn ARAID, Edificio CEEI ARAGON, Zaragoza 500018, Spain; [Hurtado-Guerrero, Ramon] Univ Zaragoza, Inst Quim Fis Rocasolano, Consejo Super Invest Cient Joint Unit, Inst Biocomputat & Phys Complex Syst, Edificio CEEI ARAGON, Zaragoza 500018, Spain	Kansas State University; University of Copenhagen; University of Copenhagen; Rockefeller University; University of Munster; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza	Hardwidge, PR (corresponding author), Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA.	hardwidg@vet.k-state.edu	clausen, henrik/AAD-8016-2021	Siukstaite, Lina/0000-0002-0899-1916; Hurtado-Guerrero, Ramon/0000-0002-3122-9401; Clausen, Henrik/0000-0002-0915-5055; Halim, Adnan/0000-0003-1629-187X	NIAID, National Institutes of Health [AI093913, AI127973]; Danish National Research Foundation [DNRF107]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI093913, R21AI127973, R01AI099002] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Danish National Research Foundation(Danmarks Grundforskningsfond); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grants AI093913 and AI127973 from the NIAID, National Institutes of Health (to P. R. H.) and Danish National Research Foundation Grant DNRF107 (to A. H. and H. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baruch K, 2011, EMBO J, V30, P221, DOI 10.1038/emboj.2010.297; Brown NF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017824; Choy SLK, 2004, INFECT IMMUN, V72, P5115, DOI 10.1128/IAI.72.9.5115-5125.2004; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; Gao XF, 2013, CELL HOST MICROBE, V13, P87, DOI 10.1016/j.chom.2012.11.010; Gao XF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000708; Gunster RA, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00010-17; Kidwai AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070753; Li S, 2013, NATURE, V501, P242, DOI 10.1038/nature12436; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lung TWF, 2016, INFECT IMMUN, V84, P1346, DOI 10.1128/IAI.01523-15; Nguyen TN, 2006, NAT METHODS, V3, P135, DOI 10.1038/nmeth0206-135; Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524; Sen N, 2009, NEURON, V63, P81, DOI 10.1016/j.neuron.2009.05.024; Yang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138529; Yen HL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001231	16	42	50	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11423	11430		10.1074/jbc.M117.790675	http://dx.doi.org/10.1074/jbc.M117.790675			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28522607	Green Published, hybrid			2022-12-26	WOS:000405119600025
J	Gonzalez-Andrade, B; Santos-Lartigue, R; Flores-Trevino, S; Ramirez-Ochoa, NS; Bocanegra-Ibarias, P; Huerta-Torres, FJ; Mendoza-Olazaran, S; Villarreal-Trevino, L; Camacho-Ortiz, A; Villarreal-Vazquez, H; Garza-Gonzalez, E				Gonzalez-Andrade, Baltazar; Santos-Lartigue, Ramiro; Flores-Trevino, Samantha; Sonia Ramirez-Ochoa, Natalie; Bocanegra-Ibarias, Paola; Huerta-Torres, Francisco J.; Mendoza-Olazaran, Soraya; Villarreal-Trevino, Licet; Camacho-Ortiz, Adrian; Villarreal-Vazquez, Hipolito; Garza-Gonzalez, Elvira			The carriage of interleukin-1B-31*C allele plus Staphylococcus aureus and Haemophilus influenzae increases the risk of recurrent tonsillitis in a Mexican population	PLOS ONE			English	Article							BIOFILM FORMATION; TONSILLECTOMY; POLYMORPHISMS; PROMOTER	The aim of the present study was to estimate the relative contribution of immunogenetic and microbiological factors in the development of recurrent tonsillitis in a Mexican population. Patients (n = 138) with recurrent tonsillitis and an indication of tonsillectomy (mean age: 6.05 years +/- 3.00; median age: 5 years, female: 58; age range: 1 - 15 years) and 195 non-related controls older than 18 years and a medical history free of recurrent tonsillitis were included. To evaluate the microbial contribution, tonsil swab samples from both groups and extracted tonsil samples from cases were cultured. Biofilm production of isolated bacteria was measured. To assess the immunogenetic component, DNA from peripheral blood was genotyped for the TNFA-308G/A single-nucleotide polymorphism (SNP) and for the IL1B -31C/T SNP. Normal microbiota, but no pathogens or potential pathogens, were identified from all control sample cultures. The most frequent pathogenic species detected in tonsils from cases were Staphylococcus aureus (48.6%, 67/138) and Haemophilus influenzae (31.9%, 44/138), which were found more frequently in patient samples than in samples from healthy volunteers (P < 0.0001). Importantly, 41/54 (75.9%) S. aureus isolates were biofilm producers (18 weak and 23 strong), whereas 17/25 (68%) H. influenzae isolates were biofilm producers (10 weak, and 7 strong biofilm producers). Patients with at least one copy of the IL1B-31*C allele had a higher risk of recurrent tonsillitis (OR = 4.03; 95% CI = 1.27 - 14.27; P = 0.013). TNFA-308 G/A alleles were not preferentially distributed among the groups. When considering the presence of IL1B-31*C plus S. aureus, IL1B-31*C plus S. aureus biofilm producer, IL1B-31*C plus H. influenzae or IL1B-31*C plus H. influenzae biofilm producer, the OR tended to infinite. Thus, the presence of IL1B-31*C allele plus the presence of S. aureus and/or H. influenzae could be related to the development of tonsillitis in this particular Mexican population.	[Gonzalez-Andrade, Baltazar; Santos-Lartigue, Ramiro] Univ Autonoma Nuevo Leon, Serv Otorrinolaringol, Hosp Univ Dr Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico; [Flores-Trevino, Samantha; Bocanegra-Ibarias, Paola; Huerta-Torres, Francisco J.; Mendoza-Olazaran, Soraya; Garza-Gonzalez, Elvira] Univ Autonoma Nuevo Leon, Serv Gastroenterol, Hosp Univ Dr Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico; [Sonia Ramirez-Ochoa, Natalie] Hosp Materno Infantil Alta Especialidad, Secretaria Salud Nuevo Leon, Monterrey, Nuevo Leon, Mexico; [Villarreal-Trevino, Licet; Villarreal-Vazquez, Hipolito] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Dept Microbiol, Monterrey, Nuevo Leon, Mexico; [Camacho-Ortiz, Adrian] Univ Autonoma Nuevo Leon, Coordinac Epidemiol Hosp, Hosp Univ Dr Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon	Garza-Gonzalez, E (corresponding author), Univ Autonoma Nuevo Leon, Serv Gastroenterol, Hosp Univ Dr Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico.	elvira_garza_gzz@yahoo.com	Flores-Treviño, Samantha M/E-8601-2019; Flores-Treviño, Samantha/AAB-4537-2020	Flores-Treviño, Samantha M/0000-0003-1259-7425; Flores-Treviño, Samantha/0000-0003-1259-7425; Bocanegra-Ibarias, Paola/0000-0003-4602-3817; Mendoza-Olazaran, Soraya/0000-0001-5649-4810				Abdallah AN, 1999, EUR J IMMUNOGENET, V26, P249, DOI 10.1046/j.1365-2370.1999.00128.x; Baugh RF, 2011, OTOLARYNG HEAD NECK, V144, pS1, DOI 10.1177/0194599810389949; Bisno AL, 2004, CLIN INFECT DIS, V38, P1535, DOI 10.1086/392520; Capper R, 2001, CLIN OTOLARYNGOL, V26, P484, DOI 10.1046/j.1365-2273.2001.00508.x; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Furuta T, 2002, GASTROENTEROLOGY, V123, P92, DOI 10.1053/gast.2002.34156; Galli J, 2007, Acta Otorhinolaryngol Ital, V27, P134; Garza-Gonzalez E, 2005, INT J CANCER, V114, P237, DOI 10.1002/ijc.20718; Garza-Gonzalez E, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-70; GLEZEN WP, 1967, J AMER MED ASSOC, V202, P455, DOI 10.1001/jama.202.6.455; Liadaki K, 2011, CLIN VACCINE IMMUNOL, V18, P217, DOI 10.1128/CVI.00460-10; McIsaac WJ, 2000, CAN MED ASSOC J, V163, P811; McKerrow WS, 2002, AM FAM PHYSICIAN, V66, P1735; Mizrahi A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-400; Pelucchi C, 2012, CLIN MICROBIOL INFEC, V18, P1, DOI 10.1111/j.1469-0691.2012.03766.x; Prim MP, 2002, INT J PEDIATR OTORHI, V65, P35, DOI 10.1016/S0165-5876(02)00128-3; Puig C, 2014, INFECT IMMUN, V82, P1591, DOI 10.1128/IAI.01445-13; Randel A, 2011, AM FAM PHYSICIAN, V84, P566; Todorovic MM, 2013, BOSNIAN J BASIC MED, V13, P230; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Woo JH, 2012, ACTA OTO-LARYNGOL, V132, P1115, DOI 10.3109/00016489.2012.689859; Zautner AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009452	23	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178115	10.1371/journal.pone.0178115	http://dx.doi.org/10.1371/journal.pone.0178115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542534	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000402061500062
J	Miller, KI; Nadheeh, I; Jauharee, AR; Anderson, RC; Adam, MS				Miller, Kelsey I.; Nadheeh, Ibrahim; Jauharee, A. Riyaz; Anderson, R. Charles; Adam, M. Shiham			Bycatch in the Maldivian pole-and-line tuna fishery	PLOS ONE			English	Article							INDIAN-OCEAN; BY-CATCH; MORTALITY; DISCARDS; IMPACTS; CAUGHT	Tropical tuna fisheries are among the largest worldwide, with some having significant bycatch issues. However, pole-and-line tuna fisheries are widely believed to have low bycatch rates, although these have rarely been quantified. The Maldives has an important pole-and-line fishery, targeting skipjack tuna (Katsuwonus pelamis). In the Maldives, 106 pole-and-line tuna fishing days were observed between August 2014 and November 2015. During 161 fishing events, tuna catches amounted to 147 t: 72% by weight was skipjack, 25% yellowfin tuna (Thunnus albacares) and 3% other tunas. Bycatch (all non-tuna species caught plus all tuna discards) amounted to 951 kg (0.65% of total tuna catch). Most of the bycatch (95%) was utilized, and some bycatch was released alive, so dead discards were particularly low (0.02% of total tuna catch, or 22 kg per 100 t). Rainbow runner (Elagatis bipinnulata) and dolphinfish (Coryphaena hippurus) together constituted 93% of the bycatch. Live releases included small numbers of silky sharks (Carcharhinus falciformis) and seabirds (noddies, Anous tenuirostris and A. stolidus). Pole-and-line tuna fishing was conducted on free schools and schools associated with various objects (Maldivian anchored fish aggregating devices [aFADs], drifting FADs from western Indian Ocean purse seine fisheries, other drifting objects and seamounts). Free school catches typically included a high proportion of large skipjack and significantly less bycatch. Associated schools produced more variable tuna catches and higher bycatch rates. Fishing trips in the south had significantly lower bycatch rates than those in the north. This study is the first to quantify bycatch rates in the Maldives pole-and-line tuna fishery and the influence of school association on catch composition. Ratio estimator methods suggest roughly 552.6 t of bycatch and 27.9 t of discards are caught annually in the fishery (based on 2015 national catch), much less than other Indian Ocean tuna fisheries, e.g. gillnet, purse-seine, and longline.	[Miller, Kelsey I.; Nadheeh, Ibrahim; Anderson, R. Charles; Adam, M. Shiham] Int Pole & Line Fdn, London, England; [Jauharee, A. Riyaz; Adam, M. Shiham] Marine Res Ctr Male, Male, Maldives		Adam, MS (corresponding author), Int Pole & Line Fdn, London, England.; Adam, MS (corresponding author), Marine Res Ctr Male, Male, Maldives.	shiham.adam@ipnlf.org	Fennell, Hannah/AAI-1408-2019	Miller, Kelsey/0000-0002-3561-5836	International Pole & Line Foundation (IPNLF); Marine Research Centre of the Ministry of Fisheries and Agriculture	International Pole & Line Foundation (IPNLF); Marine Research Centre of the Ministry of Fisheries and Agriculture	Funding was from International Pole & Line Foundation (IPNLF) who works in the Maldives with the Ministry of Fisheries and Agriculture. Funding support was the for the authors KIM and IN in supporting their remunerations. The Marine Research Centre of the Ministry of Fisheries and Agriculture supported the logistics work and supported authors' work at the Centre.	Adam MS, 1998, TUNA FISHERY RESOURC, V3; Adam MS, 2006, COUNTRY REV MALDIVES, P383; Adam MS, 2015, IOTC2015SC18NR17; Adam MS, 2013, IOTC2013SC16NR17; Adam MS, 2014, IOTC2014SC17NR17; Adam MS, 2014, IOTC2014WPTT1626; Agnew DJ, 2014, ICES J MAR SCI, V71, P216, DOI 10.1093/icesjms/fst091; Ahusan M, 2016, JAUHAREE MALDIVES NA; Ali K., 2015, NATL PLAN ACTION CON; Amanda MJ, 2012, ICEJ MARINE SCI J; Amande J. M., 2008, IOTC2008WPEB12; Amande MJ, 2010, AQUAT LIVING RESOUR, V23, P353, DOI 10.1051/alr/2011003; Anderson R. C., 1991, IPTP, V6, P50; Anderson R. C., 1996, RASAIN NEWSLETTER, V16, P134; Anderson R.C., 1993, SHARK FISHERIES MALD; Anderson RC, 2009, IOTC2009WPEB08; Anderson RC, 2009, TECHNICAL ASSISTANCE; Anderson RC, 1997, PUBLIC ADM Q, P69; Anderson RC, 1996, P EXP CONS IND OC TU, P333; Anderson RC, 2009, IOTC2009WPEB07; Anderson RC, 1992, N S VARIATIONS DISTR, V10, P226; Anderson RC, 1996, REV MALDIVIAN TUNA F, V9, P30; Anderson RC, 1996, MALDIVES MARINE RES, V2, P41; Anderson RC, 1998, MALDIVES MARINE RES, V3, P1; Ardill D, 2011, REV BYCATCH DISCARD; Ash J. S., 1994, FORKTAIL, V10, P3; Bailey K, 1996, BY CATCH DISCARDS W; Baske A, 2012, ESTIMATING USE DRIFT; Bugoni L, 2008, FISH RES, V90, P217, DOI 10.1016/j.fishres.2007.10.013; Chassot E, 2011, ICES J MAR SCI, V68, P651, DOI 10.1093/icesjms/fsq195; Clucas I., 1997, FAO FISH CIRC; Dayaratne P., 1993, BOBPREP56; EPA, 2010, PROT BIRDS MALD, P3; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ 2; Filmalter JD, 2013, FRONT ECOL ENVIRON, V11, P291, DOI 10.1890/130045; Fonteneau A, 1999, WORLDWIDE REV PURSE; Gillett R, 2011, 560 FAO; Gillett R, 2016, 6 IPNLF; Gillett R., 2013, MALDIVES LIVEBAIT FI; Gilman EL, 2011, MAR POLICY, V35, P590, DOI 10.1016/j.marpol.2011.01.021; Hafiz A, 1988, IPTP COLLECTIVE VOLU, V3, P334; Hall MA, 1998, REV FISH BIOL FISHER, V8, P1, DOI 10.1023/A:1008854816580; Hall SJ, 2005, FISH FISH, V6, P134, DOI 10.1111/j.1467-2979.2005.00183.x; Hernandez-Garcia V, 2014, IOTC2014WPTT1618; Huang HW, 2010, FISH RES, V106, P261, DOI 10.1016/j.fishres.2010.08.005; IOTC, 2015, IOTC2015S19RE, P155; IOTC, 2015, IOTC2015WPEBRE; IOTC, 2009, IOTC2009WPEBRE; IOTC, 2015, IOTC2015SC18RE; IOTC, 2013, IOTC2013WPEB09INF17, P1; Ishimura G., 2010, FAO FISH AQUAC TECH; Itano D, 2004, INFFTWG317 TH STAND; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Jauharee A.R., 2012, IOTC212WPTT1, P4; Jauharee AR, 2012, IOTC2012WPEB839; Jauharee AR, 2015, MALDIVES POLE AND LI; JOSEPH J, 1994, OCEAN DEV INT LAW, V25, P1, DOI 10.1080/00908329409546023; Kelleher Kieran, 2005, FAO FISHERIES TECHNI; Kirby DS, 2014, MAR POLICY, V44, P419, DOI 10.1016/j.marpol.2013.10.008; Kumar KVA, 2015, J APPL ICHTHYOL, V31, P301, DOI 10.1111/jai.12682; Lawson I, 2001, 14 M STAND COMM TUN, V14, P42; Macfadyen G, 2009, LOST OTHERWISE DISCA; Maldeniya R, 1990, IPTP COLLECTIVE VOLU, V4, P108; MANIKU H, 1990, ACIAR PROC, V30, P22; Maufroy A, 2014, IOTC2014WPTT1621; Maufroy A, 2017, ICES J MAR SCI, V74, P215, DOI 10.1093/icesjms/fsw175; McCreary JP, 2013, PROG OCEANOGR, V112, P15, DOI 10.1016/j.pocean.2013.03.002; Miller KI, 2014, MALDIVES POLE AND LI; Moazzam Muhammad, 2014, Journal of the Marine Biological Association of India, V56, P85, DOI 10.6024/jmbai.2014.56.1.01750s-13; MoFA, 2014, BAS FISH STAT 2014; MoFA, 2012, BAS FISH STAT 2012; MRC, 1997, FISH MALD; NAQVI WA, 1991, OCEANOL ACTA, V14, P281; Nawaz R, 2014, ASSESSMENT CETACEAN, P89; Pauly D, 2016, NATURE COMMUNICATION, P7; Petersen SL, 2009, AFR J MAR SCI, V31, P191, DOI 10.2989/AJMS.2009.31.2.7.879; Poisson F, 2014, CAN J FISH AQUAT SCI, V71, P795, DOI 10.1139/cjfas-2013-0561; Romanov E, 2000, IOTC2000WPTT31; Shafeeg A, 1993, DHIVEHI RAAJEGI KAND; Shafeeg A, 1991, RASAIN, V11, P74; Shainee M, 2011, FISH RES, V109, P42, DOI 10.1016/j.fishres.2011.01.015; Sharma R, 2014, IOTC2014WPTT1642; Stelfox MR, 2015, HIGH MORTALITY OLIVE; Thiebot JB, 2016, AQUAT CONSERV, V26, P674, DOI 10.1002/aqc.2578; United Nations, 1982, UN CONV LAW SEA UN; Varghese SP, 2015, INDIAN J GEO-MAR SCI, V44, P26; Varghese SP, 2013, IOTC2013WPEB0936	87	16	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177391	10.1371/journal.pone.0177391	http://dx.doi.org/10.1371/journal.pone.0177391			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542258	gold, Green Published, Green Submitted			2022-12-26	WOS:000402061500021
J	Naik, MU; Naik, TU; Summer, R; Naik, UP				Naik, Meghna U.; Naik, Tejal U.; Summer, Ross; Naik, Ulhas P.			Binding of CIB1 to the alpha(IIb) tail of alpha(IIb)beta(3) is required for FAK recruitment and activation in platelets	PLOS ONE			English	Article							FOCAL ADHESION KINASE; GLYCOPROTEIN IIB/IIIA; CYTOPLASMIC TAIL; CALCIUM-BINDING; INTEGRIN; PROTEIN; SRC; ALPHA-IIB-BETA-3; PHOSPHORYLATION; FAMILY	Background It is believed that activation of c-Src bound to the integrin beta(3) subunit initiates outside-in signaling. The involvement of alpha(IIb)beta(3) in outside-in signaling is poorly understood. Objectives We have previously shown that CIB1 specifically interacts with the cytoplasmic domain of alpha(IIb) and is required for alpha(IIb)beta(3) outside-in signaling. Here we evaluated the role of CIB1 in regulating outside-in signaling in the absence of inside-out signaling. Methods We used alpha(IIb) cytoplasmic domain peptide and CIB1-function blocking antibody to inhibit interaction of CIB1 with alpha(IIb) subunit as well as Cib1(-/-) platelets to evaluate the consequence of CIB1 interaction with alpha(IIb) on outside-in signaling. Results Fibrinogen binding to alpha(IIb)beta(3) results in calcium-dependent interaction of CIB1 with alpha(IIb), which is not required for filopodia formation. Dynamic rearrangement of cytoskeleton results in CIB1-dependent recruitment of FAK to the alpha(IIb) complex and its activation. Disruption of the association of CIB1 and a IIb by incorporation of alpha(IIb) peptide or anti-CIB1 inhibited both FAK association and activation. Furthermore, FAK recruitment to the integrin complex was required for c-Src activation. Inhibition of c-Src had no effect on CIB1 accumulation with the integrin at the filopodia, suggesting that c-Src activity is not required for the formation of CIB1-alpha(IIb)-FAK complex. Conclusion Our results suggest that interaction of CIB1 with a IIb is one of the early events occurring during outside-in signaling. Furthermore, CIB1 recruits FAK to the alpha(IIb)beta(3) complex at the filopodia where FAK is activated, which in turn activates c-Src, resulting in propagation of outside-in signaling leading to platelet spreading.	[Naik, Meghna U.; Naik, Tejal U.; Summer, Ross; Naik, Ulhas P.] Thomas Jefferson Univ, Dept Med, Cardeza Ctr Vasc Biol, Philadelphia, PA 19107 USA	Jefferson University	Naik, UP (corresponding author), Thomas Jefferson Univ, Dept Med, Cardeza Ctr Vasc Biol, Philadelphia, PA 19107 USA.	ulhas.naik@jefferson.edu			National Heart Lung and Blood Institute [R01 HL57630, HL113188]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113188] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart Lung and Blood Institute grant R01 HL57630 and HL113188 to UPN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Salgado EG, 2005, J CELL BIOL, V170, P837, DOI 10.1083/jcb.200503125; CARR ME, 1995, THROMB HAEMOSTASIS, V73, P499; CLARK EA, 1994, TRENDS BIOCHEM SCI, V19, P464, DOI 10.1016/0968-0004(94)90131-7; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395; Judd BA, 2000, P NATL ACAD SCI USA, V97, P12056, DOI 10.1073/pnas.97.22.12056; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; Leisner TM, 2005, J CELL BIOL, V170, P465, DOI 10.1083/jcb.200502090; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; Liu JL, 2005, BLOOD, V105, P4345, DOI 10.1182/blood-2004-07-2718; Moores SL, 2000, MOL CELL BIOL, V20, P6364, DOI 10.1128/MCB.20.17.6364-6373.2000; Naik MU, 2009, J THROMB HAEMOST, V7, P1906, DOI 10.1111/j.1538-7836.2009.03581.x; Naik MU, 2014, BLOOD, V123, P1393, DOI 10.1182/blood-2013-04-496232; Naik MU, 2012, BLOOD, V119, P3352, DOI 10.1182/blood-2011-12-397398; Naik MU, 2003, BLOOD, V102, P3629, DOI 10.1182/blood-2003-05-1703; Naik MU, 2016, BLOOD; Naik U P, 1997, Curr Opin Hematol, V4, P317; NAIK UP, 1991, BIOCHIM BIOPHYS ACTA, V1092, P256, DOI 10.1016/0167-4889(91)90165-T; Naik UP, 2003, BLOOD, V102, P1355, DOI 10.1182/blood-2003-02-0591; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; NAIK UP, 1995, BIOCHEM J, V310, P155, DOI 10.1042/bj3100155; Niu HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047356; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; PELLETIER AJ, 1995, J BIOL CHEM, V270, P18133, DOI 10.1074/jbc.270.30.18133; PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; Schaller MD, 1999, MOL BIOL CELL, V10, P3489, DOI 10.1091/mbc.10.10.3489; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; Shock DD, 1999, BIOCHEM J, V342, P729, DOI 10.1042/0264-6021:3420729; Stephens G, 1998, J BIOL CHEM, V273, P20317, DOI 10.1074/jbc.273.32.20317; Thomas JW, 1999, J BIOL CHEM, V274, P36684, DOI 10.1074/jbc.274.51.36684; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; Tsuboi S, 2006, EMBO REP, V7, P506, DOI 10.1038/sj.embor.7400665; Tsuboi S, 2002, J BIOL CHEM, V277, P1919, DOI 10.1074/jbc.M110643200; Vallar L, 1999, J BIOL CHEM, V274, P17257, DOI 10.1074/jbc.274.24.17257; White C, 2006, J BIOL CHEM, V281, P20825, DOI 10.1074/jbc.M602175200; Yoon KW, 2009, P NATL ACAD SCI USA, V106, P17389, DOI 10.1073/pnas.0812259106; Yuan W, 2006, MOL CELL BIOL, V26, P8507, DOI 10.1128/MCB.01488-06; Yuan WP, 2006, J CELL BIOL, V172, P169, DOI 10.1083/jcb.200505131	40	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0176602	10.1371/journal.pone.0176602	http://dx.doi.org/10.1371/journal.pone.0176602			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542214	Green Published, gold, Green Submitted			2022-12-26	WOS:000402061500006
J	Totenhagen, JW; Bernstein, A; Yoshimaru, ES; Erickson, RP; Trouard, TP				Totenhagen, John W.; Bernstein, Adam; Yoshimaru, Eriko S.; Erickson, Robert P.; Trouard, Theodore P.			Quantitative magnetic resonance imaging of brain atrophy in a mouse model of Niemann-Pick type C disease	PLOS ONE			English	Article							NEUROFIBRILLARY TANGLES; SINGLE INJECTION; CORPUS-CALLOSUM; CHOLESTEROL; MICE; NEURODEGENERATION; CEREBELLAR; NPC1; DEGENERATION; EXPRESSION	In vivo magnetic resonance imaging (MRI) was used to investigate regional and global brain atrophy in the neurodegenerative Niemann Pick Type C1 (NPC1) disease mouse model. Imaging experiments were conducted with the most commonly studied mouse model of NPC1 disease at early and late disease states. High-resolution in vivo images were acquired at early and late stages of the disease and analyzed with atlas-based registration to obtain measurements of twenty brain region volumes. A two-way ANOVA analysis indicated eighteen of these regions were different due to genotype and thirteen showed a significant interaction with age and genotype. The ability to measure in vivo neurodegeneration evidenced by brain atrophy adds to the ability to monitor disease progression and treatment response in the mouse model.	[Totenhagen, John W.; Bernstein, Adam; Yoshimaru, Eriko S.; Trouard, Theodore P.] Univ Arizona, Biomed Engn Program, Tucson, AZ 85721 USA; [Erickson, Robert P.] Univ Arizona, Dept Pediat, Tucson, AZ 85721 USA; [Erickson, Robert P.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Erickson, Robert P.; Trouard, Theodore P.] Univ Arizona, Inst B105, Tucson, AZ 85721 USA; [Trouard, Theodore P.] Univ Arizona, Dept Med Imaging, Tucson, AZ 85721 USA; [Trouard, Theodore P.] Univ Arizona, McKight Brain Inst, Tucson, AZ 85721 USA; [Totenhagen, John W.] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Alabama System; University of Alabama Birmingham	Trouard, TP (corresponding author), Univ Arizona, Biomed Engn Program, Tucson, AZ 85721 USA.; Trouard, TP (corresponding author), Univ Arizona, Inst B105, Tucson, AZ 85721 USA.; Trouard, TP (corresponding author), Univ Arizona, Dept Med Imaging, Tucson, AZ 85721 USA.; Trouard, TP (corresponding author), Univ Arizona, McKight Brain Inst, Tucson, AZ 85721 USA.	trouard@email.arizona.edu		Trouard, Theodore/0000-0001-9461-2283	NIH NIBIB [R01EB000343]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB000809] Funding Source: NIH RePORTER	NIH NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the NIH NIBIB, R01EB000343. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2005, J NEUROSCI RES, V82, P811, DOI 10.1002/jnr.20685; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bae JS, 2010, CELL TISSUE RES, V340, P357, DOI 10.1007/s00441-010-0942-3; Battisti C, 2003, MOVEMENT DISORD, V18, P1405, DOI 10.1002/mds.10541; Borbon I, 2012, J ALZHEIMERS DIS, V30, P875, DOI 10.3233/JAD-2012-120199; Bowman EA, 2015, J NEUROL, V262, P2106, DOI 10.1007/s00415-015-7819-z; Calabrese E, 2015, DIFFUSION MRI TRACTO, P4628; Camargo F, 2001, LIFE SCI, V70, P131, DOI 10.1016/S0024-3205(01)01384-4; Caporali P, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0370-z; Chakravarty MM, 2013, HUM BRAIN MAPP, V34, P2635, DOI 10.1002/hbm.22092; Corrales JMD, 2004, DEVELOPMENT, V131, P5581, DOI 10.1242/dev.01438; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Deffieu MS, 2011, P NATL ACAD SCI USA, V108, P18932, DOI 10.1073/pnas.1110439108; Elrick MJ, 2010, HUM MOL GENET, V19, P837, DOI 10.1093/hmg/ddp552; German DC, 2001, J COMP NEUROL, V433, P415, DOI 10.1002/cne.1149; HIGASHI Y, 1993, ACTA NEUROPATHOL, V85, P175; Hsu YS, 1999, BONE MARROW TRANSPL, V24, P103, DOI 10.1038/sj.bmt.1701826; Huang JY, 2011, J FORMOS MED ASSOC, V110, P537, DOI 10.1016/S0929-6646(11)60080-6; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Iturriaga C, 2006, J NEUROL SCI, V249, P1, DOI 10.1016/j.jns.2006.05.054; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Lau MW, 2016, DISEASES, V4, P1; Lee R, 2014, PEDIATR NEUROL, V51, P669, DOI 10.1016/j.pediatrneurol.2014.07.028; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Lope-Piedrafita S, 2008, J NEUROSCI RES, V86, P2802, DOI 10.1002/jnr.21707; Luan Z, 2008, J NEUROL SCI, V268, P108, DOI 10.1016/j.jns.2007.11.018; Ma Y, 2008, FRONT NEUROANAT, V2, DOI 10.3389/neuro.05.001.2008; Maue RA, 2012, HUM MOL GENET, V21, P730, DOI 10.1093/hmg/ddr505; Nusca S, 2014, NEUROBIOL DIS, V70, P117, DOI 10.1016/j.nbd.2014.06.012; PALMERI S, 1994, NEURORADIOLOGY, V36, P20, DOI 10.1007/BF00599187; Patterson MC, 2003, NEUROLOGIST, V9, P301, DOI 10.1097/01.nrl.0000094627.78754.5b; Patterson MC, 2004, BBA-MOL CELL BIOL L, V1685, P77, DOI 10.1016/j.bbalip.2004.08.013; Paxinos George F K, 2012, PAULO, P360; Prasad A, 2000, J NEUROCHEM, V75, P1250, DOI 10.1046/j.1471-4159.2000.0751250.x; Rosenbaum AI, 2011, J NEUROCHEM, V116, P789, DOI 10.1111/j.1471-4159.2010.06976.x; Runz H, 2008, HUM MUTAT, V29, P345, DOI 10.1002/humu.20636; Sarna JR, 2003, J COMP NEUROL, V456, P279, DOI 10.1002/cne.10522; Sevin M, 2007, BRAIN, V130, P120, DOI 10.1093/brain/awl260; SUZUKI K, 1995, ACTA NEUROPATHOL, V89, P227; Totenhagen JW, 2012, J MAGN RESON IMAGING, V35, P528, DOI 10.1002/jmri.22837; Trouard TP, 2005, PEDIATR NEUROL, V33, P325, DOI 10.1016/j.pediatrneurol.2005.05.004; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; van Eede MC, 2013, NEUROIMAGE, V82, P226, DOI 10.1016/j.neuroimage.2013.06.004; Vance JE, 2011, CURR OPIN LIPIDOL, V22, P204, DOI 10.1097/MOL.0b013e3283453e69; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Voikar V, 2002, BEHAV BRAIN RES, V132, P1, DOI 10.1016/S0166-4328(01)00380-1; Walterfang M, 2010, NEUROLOGY; WEINTRAUB H, 1987, ACTA NEUROPATHOL, V74, P374, DOI 10.1007/BF00687215; Yamada A, 2001, BRAIN DEV-JPN, V23, P288, DOI 10.1016/S0387-7604(01)00209-1	50	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178179	10.1371/journal.pone.0178179	http://dx.doi.org/10.1371/journal.pone.0178179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542381	gold, Green Published, Green Submitted			2022-12-26	WOS:000402061500071
J	Araki, KS; Kubo, T; Kudoh, H				Araki, Kiwako S.; Kubo, Takuya; Kudoh, Hiroshi			Genet-specific DNA methylation probabilities detected in a spatial epigenetic analysis of a clonal plant population	PLOS ONE			English	Article							SENSITIVE AMPLIFICATION POLYMORPHISM; CYTOSINE METHYLATION; CPG METHYLATION; AFLP; RICE; ARABIDOPSIS; INHERITANCE; PATTERN; AUTOCORRELATION; MAINTENANCE	In sessile organisms such as plants, spatial genetic structures of populations show long-lasting patterns. These structures have been analyzed across diverse taxa to understand the processes that determine the genetic makeup of organismal populations. For many sessile organisms that mainly propagate via clonal spread, epigenetic status can vary between clonal individuals in the absence of genetic changes. However, fewer previous studies have explored the epigenetic properties in comparison to the genetic properties of natural plant populations. Here, we report the simultaneous evaluation of the spatial structure of genetic and epigenetic variation in a natural population of the clonal plant Cardamine leucantha. We applied a hierarchical Bayesian model to evaluate the effects of membership of a genet (a group of individuals clonally derived from a single seed) and vegetation cover on the epigenetic variation between ramets (clonal plants that are physiologically independent individuals). We sampled 332 ramets in a 20 m X 20 m study plot that contained 137 genets (identified using eight SSR markers). We detected epigenetic variation in DNA methylation at 24 methylation-sensitive amplified fragment length polymorphism (MS-AFLP) loci. There were significant genet effects at all 24 MS-AFLP loci in the distribution of subepiloci. Vegetation cover had no statistically significant effect on variation in the majority of MS-AFLP loci. The spatial aggregation of epigenetic variation is therefore largely explained by the aggregation of ramets that belong to the same genets. By applying hierarchical Bayesian analyses, we successfully identified a number of genet-specific changes in epigenetic status within a natural plant population in a complex context, where genotypes and environmental factors are unevenly distributed. This finding suggests that it requires further studies on the spatial epigenetic structure of natural populations of diverse organisms, particularly for sessile clonal species.	[Araki, Kiwako S.; Kudoh, Hiroshi] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Araki, Kiwako S.] Ritsumeikan Univ, Fac Life Sci, Dept Biotechnol, Kusatsu, Shiga, Japan; [Kubo, Takuya] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido, Japan	Kyoto University; Ritsumeikan University; Hokkaido University	Araki, KS (corresponding author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan.; Araki, KS (corresponding author), Ritsumeikan Univ, Fac Life Sci, Dept Biotechnol, Kusatsu, Shiga, Japan.	kiwakosa@fc.ritsumei.ac.jp	Kubo, Takuya/A-3414-2012; Kudoh, Hiroshi/AAF-9497-2019; Araki, Kiwako/E-8739-2013	Kubo, Takuya/0000-0001-6202-9624; Kudoh, Hiroshi/0000-0001-9777-4886; Araki, Kiwako/0000-0001-9134-7488	Global COE program of Kyoto University [A06]; Grants for Excellent Graduate Schools program of the Ministry of Education, Culture, Sports, Science & Technology (MEXT), Japan; Japan Society for the Promotion of Science (JSPS) Research Fellow [201100907]; MEXT [26840148, 26221106]; Grants-in-Aid for Scientific Research [26840148] Funding Source: KAKEN	Global COE program of Kyoto University(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants for Excellent Graduate Schools program of the Ministry of Education, Culture, Sports, Science & Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) Research Fellow(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Global COE program (A06) of Kyoto University; the Grants for Excellent Graduate Schools program of the Ministry of Education, Culture, Sports, Science & Technology (MEXT), Japan; Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS) Research Fellow 201100907 to KSA; the Grant-in-Aid for Young Scientists (B) 26840148, MEXT to KSA; the Grant-in-Aid for Scientific Research (S) 26221106, MEXT to HK.	Aina R, 2004, PHYSIOL PLANTARUM, V121, P472, DOI 10.1111/j.1399-3054.2004.00343.x; Akimoto K, 2007, ANN BOT-LONDON, V100, P205, DOI 10.1093/aob/mcm110; Araki K, 2007, PLANT ECOL, V189, P175, DOI 10.1007/s11258-006-9173-9; Araki KS, 2011, AM J BOT, V98, pE385, DOI 10.3732/ajb.1100242; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Ashikawa I, 2001, PLANT MOL BIOL, V45, P31, DOI 10.1023/A:1006457321781; Barnerjee S, 2004, HIERARCHICAL MODELIN; Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Boyko A, 2004, MUTAT RES, V572, P73; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Cao XF, 2000, P NATL ACAD SCI USA, V97, P4979, DOI 10.1073/pnas.97.9.4979; Cervera MT, 2002, MOL GENET GENOMICS, V268, P543, DOI 10.1007/s00438-002-0772-4; Charpentier A, 2001, EVOL ECOL, V15, P521, DOI 10.1023/A:1016057503722; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Chong SY, 2004, CURR OPIN GENET DEV, V14, P692, DOI 10.1016/j.gde.2004.09.001; Chybicki IJ, 2011, HEREDITY, V107, P589, DOI 10.1038/hdy.2011.51; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; de Kroon J.M, 1990, CLONAL GROWTH PLANTS; DEKROON H, 1995, J ECOL, V83, P143, DOI 10.2307/2261158; Douhovnikoff V, 2015, PLANT ECOL, V216, P227, DOI 10.1007/s11258-014-0430-z; Fang JG, 2007, PLANT BIOLOGY, V9, P526, DOI 10.1055/s-2007-964934; Franks SJ, 2004, AM J BOT, V91, P1345, DOI 10.3732/ajb.91.9.1345; Gao LX, 2010, PLANT CELL ENVIRON, V33, P1820, DOI 10.1111/j.1365-3040.2010.02186.x; Gelman A., 2003, BAYESIAN DATA ANAL; Herrera CM, 2011, MOL ECOL, V20, P1675, DOI 10.1111/j.1365-294X.2011.05026.x; Herrera CM, 2010, NEW PHYTOL, V187, P867, DOI 10.1111/j.1469-8137.2010.03298.x; Iida S, 2004, ADV BIOPHYS, V38, P141, DOI 10.1016/S0065-227X(04)80136-9; Imazio S, 2002, PLANT BREEDING, V121, P531, DOI 10.1046/j.1439-0523.2002.00762.x; Jackson J. B. C., 1985, POPULATION BIOL EVOL; Johannes F, 2008, NAT REV GENET, V9, P883, DOI 10.1038/nrg2467; Jump AS, 2007, MOL ECOL, V16, P925, DOI 10.1111/j.1365-294X.2006.03203.x; KEMPERMAN JA, 1976, CAN J BOT, V54, P2603, DOI 10.1139/b76-280; Keyte AL, 2006, J HERED, V97, P444, DOI 10.1093/jhered/esl023; Kudoh H, 1999, J ECOL, V87, P244, DOI 10.1046/j.1365-2745.1999.00355.x; Labra M, 2002, PLANT BIOLOGY, V4, P694, DOI 10.1055/s-2002-37398; Li XueLin, 2009, Acta Agronomica Sinica, V35, P588, DOI 10.3724/SP.J.1006.2009.00588; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Lu GY, 2007, J INTEGR PLANT BIOL, V49, P1599, DOI 10.1111/j.1774-7909.2007.00566.x; Monteuuis O, 2008, TREES-STRUCT FUNCT, V22, P779, DOI 10.1007/s00468-008-0238-3; PARKS JC, 1993, AM J BOT, V80, P537, DOI 10.2307/2445369; Paun O, 2010, MOL BIOL EVOL, V27, P2465, DOI 10.1093/molbev/msq150; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Richards CL, 2012, ECOL LETT, V15, P1016, DOI 10.1111/j.1461-0248.2012.01824.x; Richards CL, 2010, NEW PHYTOL, V187, P562, DOI 10.1111/j.1469-8137.2010.03369.x; Richards CL, 2004, ECOL LETT, V7, P1155, DOI 10.1111/j.1461-0248.2004.00674.x; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Richards EJ, 2011, CURR OPIN PLANT BIOL, V14, P204, DOI 10.1016/j.pbi.2011.03.009; Roff Derek A., 1992; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; Salmon A, 2008, PLANT SCI, V174, P61, DOI 10.1016/j.plantsci.2007.09.012; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Schmitz RJ, 2012, TRENDS PLANT SCI, V17, P149, DOI 10.1016/j.tplants.2012.01.001; Schulz B, 2014, MOL ECOL, V23, P3523, DOI 10.1111/mec.12835; Schulz B, 2013, MOL ECOL RESOUR, V13, P642, DOI 10.1111/1755-0998.12100; Sherman JD, 2002, GENOME, V45, P253, DOI 10.1139/g01-147; SILANDER JA, 1979, SCIENCE, V203, P658, DOI 10.1126/science.203.4381.658; Silvertown J, 2008, INT J PLANT SCI, V169, P157, DOI 10.1086/523357; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Takata M, 2005, BREEDING SCI, V55, P57, DOI 10.1270/jsbbs.55.57; TUOMI J, 1989, TRENDS ECOL EVOL, V4, P209, DOI 10.1016/0169-5347(89)90075-X; Van Kleunen M, 2001, ECOLOGY, V82, P3309, DOI 10.1890/0012-9658(2001)082[3309:AEOPFR]2.0.CO;2; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wenzel MA, 2014, MOL ECOL, V23, P4256, DOI 10.1111/mec.12833; Wright S, 1943, GENETICS, V28, P114; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986; Yang CY, 2011, AFR J BIOTECHNOL, V10, P874; Zhang YY, 2013, NEW PHYTOL, V197, P314, DOI 10.1111/nph.12010; Zhao XX, 2007, PLANT SCI, V172, P930, DOI 10.1016/j.plantsci.2007.01.002	75	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178145	10.1371/journal.pone.0178145	http://dx.doi.org/10.1371/journal.pone.0178145			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542457	Green Submitted, Green Published, gold			2022-12-26	WOS:000402058400061
J	Armant, O; Gombeau, K; El Houdigui, SM; Floriani, M; Camilleri, V; Cavalie, I; Adam-Guillermin, C				Armant, Olivier; Gombeau, Kewin; El Houdigui, Sophia Murat; Floriani, Magali; Camilleri, Virginie; Cavalie, Isabelle; Adam-Guillermin, Christelle			Zebrafish exposure to environmentally relevant concentration of depleted uranium impairs progeny development at the molecular and histological levels	PLOS ONE			English	Article							HUMAN OSTEOBLAST CELLS; GENE-EXPRESSION; DANIO-RERIO; WATERBORNE URANIUM; HEAVY-METALS; BIOACCUMULATION; TRANSFORMATION; CONTAMINATION; METHYLATION; METABOLISM	Uranium is an actinide naturally found in the environment. Anthropogenic activities lead to the release of increasing amounts of uranium and depleted uranium (DU) in the environment, posing potential risks to aquatic organisms due to radiological and chemical toxicity of this radionucleide. Although environmental contaminations with high levels of uranium have already been observed, chronic exposures of non-human species to levels close to the environmental quality standards remain scarcely characterized. The present study focused on the identification of the molecular pathways impacted by a chronic exposure of zebrafish to 20 mu g/L of DU during 10 days. The transcriptomic effects were evaluated by the use of the mRNAseq analysis in three organs of adult zebrafish, the brain the testis and the ovaries, and two developmental stages of the adult fish progeny, two-cells embryo and four-days larvae. The results highlight generic effects on the cell adhesion process, but also specific transcriptomic responses depending on the organ or the developmental stage investigated. The analysis of the transgenerational effects of DU-exposure on the four-day zebrafish larvae demonstrate an induction of genes involved in oxidative response (cat, mpx, sod1 and sod2), a decrease of expression of the two hatching enzymes (he1a and he1b), the deregulation of the expression of gene coding for the ATPase complex and the induction of cellular stress. Electron microscopy analysis of skeletal muscles on the four-days larvae highlights significant histological impacts on the ultrastructure of both the mitochondria and the myofibres. In addition, the comparison with the transcriptomic data obtained for the acetylcholine esterase mutant reveals the induction of protein-chaperons in the skeletal muscles of the progeny of fish chronically exposed to DU, pointing towards long lasting effects of this chemical in the muscles. The results presented in this study support the hypothesis that a chronic parental exposure to an environmentally relevant concentration of DU could impair the progeny development with significant effects observed both at the molecular level and on the histological ultrastructure of organs. This study provides a comprehensive transcriptomic dataset useful for ecotoxicological studies on other fish species at the molecular level. It also provides a key DU responsive gene, egr1, which may be a candidate biomarker for monitoring aquatic pollution by heavy metals.	[Armant, Olivier; Gombeau, Kewin; El Houdigui, Sophia Murat; Floriani, Magali; Camilleri, Virginie; Cavalie, Isabelle; Adam-Guillermin, Christelle] PRP ENV SERIS LECO, IRSN, Cadarache, St Paul Lez Dur, France		Armant, O (corresponding author), PRP ENV SERIS LECO, IRSN, Cadarache, St Paul Lez Dur, France.	olivier.armant@irsn.fr		armant, olivier/0000-0001-7101-9209; Murat El Houdigui, Sophia/0000-0002-0106-1572; Gombeau, Kewin/0000-0003-3062-6365; Adam-Guillermin, christelle/0000-0002-8833-0762	IRSN; European project COMET; 7th PCRD EURATOM [Fission-2012-3.4.1-604794]; NEEDS-Environment	IRSN; European project COMET; 7th PCRD EURATOM; NEEDS-Environment	This work was supported by IRSN, the European project COMET, 7th PCRD EURATOM (Fission-2012-3.4.1-604794) and NEEDS-Environment.; We want to thank Christelle Etard and Volker Middel (KIT, Germany) for their help in the analysis of the electron microscopy results. We thank Jacqueline Garnier Laplace and Francois Paquet for the critical reading of the manuscript. We also thank Pr. Uwe Strahle and Victor Gourain (KIT, Germany) at the Institute of Toxicology and Genetics for the sequencing of the NGS libraries. This work was supported by IRSN, the European project COMET, 7th PCRD EURATOM (Fission-2012-3.4.1604794) and NEEDS-Environment.	Al Kaddissi S, 2016, ENVIRON TOXICOL, V31, P211, DOI 10.1002/tox.22036; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Ansoborlo E, 2015, ENVIRON INT, V77, P1, DOI 10.1016/j.envint.2014.12.011; Anway MD, 2005, SCIENCE, P308; Armant O, 2016, DATA BRIEF, V8, P61, DOI 10.1016/j.dib.2016.05.007; Armant O, 2013, DEV BIOL, V380, P351, DOI 10.1016/j.ydbio.2013.05.006; Arzuaga X, 2010, J TOXICOL ENV HEAL B, V13, P527, DOI 10.1080/10937404.2010.509015; Augustine S, 2012, AQUAT TOXICOL, V118, P9, DOI 10.1016/j.aquatox.2012.02.029; Babb SG, 2001, DEV DYNAM, V221, P231, DOI 10.1002/dvdy.1132; Barillet S, 2007, ENVIRON TOXICOL CHEM, V26, P497, DOI 10.1897/06-243R.1; Barillet S, 2011, ENVIRON POLLUT, V159, P495, DOI 10.1016/j.envpol.2010.10.013; BEAUGELIN-SEILLER K. L., 2011, NEW URANIUM MINING B, P507; BETCHER RN, 1988, CAN J EARTH SCI, V25, P2089, DOI 10.1139/e88-193; Bourrachot S, 2008, AQUAT TOXICOL, V90, P29, DOI 10.1016/j.aquatox.2008.07.013; Bourrachot S, 2014, AQUAT TOXICOL, V154, P1, DOI 10.1016/j.aquatox.2014.04.018; Darolles C, 2010, TOXICOL LETT, V192, P337, DOI 10.1016/j.toxlet.2009.11.009; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Etard C, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0825-8; Fournier E, 2004, ENVIRON TOXICOL CHEM, V23, P1108, DOI 10.1897/02-604; Freeman JL, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00268; Frelon S, 2010, AQUAT TOXICOL, V100, P66; Gagnaire B, 2011, ECOTOXICOLOGY, V20, P187, DOI 10.1007/s10646-010-0570-4; Gombeau K, 2017, AQUAT TOXICOL, V184, P14, DOI 10.1016/j.aquatox.2016.12.004; Gombeau K, 2016, J ENVIRON RADIOACTIV, V154, P25, DOI 10.1016/j.jenvrad.2016.01.004; Haberle V, 2014, NATURE, V507, P381, DOI 10.1038/nature12974; IAEA, 2012, UR 2011 RES PROD DEM; Ibrulj Slavica, 2004, Med Arh, V58, P335; Iqbal K, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0619-z; Joseph P, 2009, TOXICOL APPL PHARM, V238, P272, DOI 10.1016/j.taap.2009.01.011; KAZANTZIS G, 1979, EUR J CLIN INVEST, V9, P3, DOI 10.1111/j.1365-2362.1979.tb01660.x; Le Guernic A, 2016, ECOTOXICOLOGY, V25, P1234, DOI 10.1007/s10646-016-1677-z; Lerebours A, 2009, ENVIRON TOXICOL CHEM, V28, P1271, DOI 10.1897/08-357.1; Liu C, CANC GENE THER, V5, P3; Liu CT, 1999, J BIOL CHEM, V274, P4400, DOI 10.1074/jbc.274.7.4400; Liu YF, 2001, FRONT BIOSCI-LANDMRK, V6, pD12, DOI 10.2741/Liu; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Milacic S, 2009, J RADIAT RES, V50, P213, DOI 10.1269/jrr.08131; Miller AC, 2004, MOL CELL BIOCHEM, V255, P247, DOI 10.1023/B:MCBI.0000007280.72510.96; Miller AC, 2003, J ENVIRON RADIOACTIV, V64, P247, DOI 10.1016/S0265-931X(02)00053-X; Miller AC, 2002, J INORG BIOCHEM, V91, P246, DOI 10.1016/S0162-0134(02)00391-4; Miller AC, 1998, ENVIRON HEALTH PERSP, V106, P465, DOI 10.1289/ehp.98106465; Miller AC, 2009, BIOCHIMIE, V91, P1328, DOI 10.1016/j.biochi.2009.03.010; Niederkorn JY, 2006, NAT IMMUNOL, V7, P354, DOI 10.1038/ni1328; Oliver J, 1916, J EXP MED, V23, P301, DOI 10.1084/jem.23.3.301; Pagel JI, 2012, INT J MOL SCI, V13, P13104, DOI 10.3390/ijms131013104; Papathanasiou K, 2005, Clin Exp Obstet Gynecol, V32, P58; Pereira S, 2012, AQUAT TOXICOL, V109, P11, DOI 10.1016/j.aquatox.2011.11.011; Racine R, 2009, J MOL NEUROSCI, V38, P159, DOI 10.1007/s12031-008-9145-8; Rozen S, 2000, Methods Mol Biol, V132, P365; Do RP, 2012, REPROD TOXICOL, V34, P614, DOI 10.1016/j.reprotox.2012.09.006; Salonen L., 1994, FUTUR GROUNDW RESOUR; Senf SM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00330; Tell G, 2000, NUCLEIC ACIDS RES, V28, P1099, DOI 10.1093/nar/28.5.1099; Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6; Wallerman O, 2009, NUCLEIC ACIDS RES, V37, P7498, DOI 10.1093/nar/gkp823; Weber GJ, 2013, TOXICOL SCI, V132, P458, DOI 10.1093/toxsci/kft017; Zhang HH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05416; Zhang YY, 2016, CHEMOSPHERE, V144, P304, DOI 10.1016/j.chemosphere.2015.08.079; Zhao ST, 2014, CELL MOL IMMUNOL, V11, P428, DOI 10.1038/cmi.2014.38	59	22	22	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177932	10.1371/journal.pone.0177932	http://dx.doi.org/10.1371/journal.pone.0177932			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531178	gold, Green Published, Green Submitted			2022-12-26	WOS:000402058400040
J	Eckhardt, B; Winkelstein, ER; Shu, MA; Carden, MR; McKnight, C; Jarlais, DCD; Glesby, MJ; Marks, K; Edlin, BR				Eckhardt, Benjamin; Winkelstein, Emily R.; Shu, Marla A.; Carden, Michael R.; McKnight, Courtney; Jarlais, Don C. Des; Glesby, Marshall J.; Marks, Kristen; Edlin, Brian R.			Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention	PLOS ONE			English	Article							VIRUS-INFECTION; SAN-FRANCISCO; UNITED-STATES; USERS; PREVALENCE; INTERVENTIONS; BALTIMORE; EXCHANGE; MARYLAND	Background Hepatitis C virus (HCV) infection remains a significant problem in the United States, with people who inject drugs (PWID) disproportionately afflicted. Over the last decade rates of heroin use have more than doubled, with young persons (18-25 years) demonstrating the largest increase. Methods We conducted a cross-sectional study in New York City from 2005 to 2012 among young people who injected illicit drugs, and were age 18 to 35 or had injected drugs for <= 5 years, to examine potentially modifiable factors associated with HCV among young adults who began injecting during the era of syringe services. Results Among 714 participants, the median age was 24 years; the median duration of drug injection was 5 years; 31% were women; 75% identified as white; 69% reported being homeless; and 48% [95% CI 44-52] had HCV antibodies. Factors associated with HCV included older age (adjusted odds ratio [AOR], 1.99 [1.52-2.63]; p<0.001), longer duration of injection drug use (AOR, 1.68 [1.39-2.02]; p<0.001), more frequent injection (AOR, 1.26 [1.09-1.45]; p = 0.001), using a used syringe with more individuals (AOR, 1.26 [1.10-1.46]; p = 0.001), less confidence in remaining uninfected (AOR, 1.32 [1.07-1.63]; p<0.001), injecting primarily in public or outdoors spaces (AOR, 1.90 [1.33-2.72]; p<0.001), and arrest for carrying syringes (AOR, 3.17 [1.95-5.17]; p<0.001). Conclusions Despite the availability of harm reduction services, the seroprevalence of HCV in young PWID in New York City remained high and constant during 2005-2012. Age and several injection behaviors conferred independent risk. Individuals were somewhat aware of their own risk. Public and outdoor injection and arrest for possession of a syringe are risk factors for HCV that can be modified through structural interventions.	[Eckhardt, Benjamin; Glesby, Marshall J.; Marks, Kristen] Weill Cornell Med, Dept Med, Div Infect Dis, New York, NY 10065 USA; [Winkelstein, Emily R.; Shu, Marla A.; Carden, Michael R.; Edlin, Brian R.] Natl Dev & Res Inst, Inst Infect Dis Res, New York, NY USA; [Shu, Marla A.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [McKnight, Courtney; Jarlais, Don C. Des] Icahn Sch Med Mt Sinai, Dept Psychiat, Baron Edmond de Rothschild Chem Dependency Inst, New York, NY 10029 USA; [Edlin, Brian R.] Weill Cornell Med, Dept Med, New York, NY USA	Cornell University; National Development & Research Institutes, Inc; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cornell University	Eckhardt, B (corresponding author), Weill Cornell Med, Dept Med, Div Infect Dis, New York, NY 10065 USA.	bje8@cornell.edu	Edlin, Brian R/F-2966-2018	Edlin, Brian R/0000-0001-8172-8797; Eckhardt, Benjamin/0000-0002-2846-9762; McKnight, Courtney A/0000-0001-8685-5381	National Institute on Drug Abuse [R01 DA016159, R01 DA021550, R01 DA029512]; Agency for Healthcare Research and Quality [T32 HS000066]; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA011041] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was supported by the National Institute on Drug Abuse [grant number R01 DA016159, R01 DA021550, and R01 DA029512]; and the Agency for Healthcare Research and Quality [grant number T32 HS000066].	Beletsky L, 2011, DRUG ALCOHOL DEPEN, V119, P145, DOI 10.1016/j.drugalcdep.2011.05.034; BELL J, 1990, MED J AUSTRALIA, V153, P274, DOI 10.5694/j.1326-5377.1990.tb136900.x; CDC Division of Viral Hepatitis, 2014, VIR HEP SURV; Coyle S L, 1998, Public Health Rep, V113 Suppl 1, P19; Diaz T, 2001, AM J PUBLIC HEALTH, V91, P23, DOI 10.2105/AJPH.91.1.23; Edlin BR, 2011, NATURE, V474, pS18, DOI 10.1038/474S18a; Edlin BR, 2009, GASTROENTEROLOGY, V136, P2412, DOI 10.1053/j.gastro.2009.04.040; Foderaro L., 2016, NY TIMES, pA1; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; Hagan H, 1999, AM J EPIDEMIOL, V149, P203, DOI 10.1093/oxfordjournals.aje.a009792; Hagan H, 2011, J INFECT DIS, V204, P74, DOI 10.1093/infdis/jir196; Hahn JA, 2002, J INFECT DIS, V186, P1558, DOI 10.1086/345554; Hahn JA, 2001, HEPATOLOGY, V34, P180, DOI 10.1053/jhep.2001.25759; Jones CM, 2015, MMWR MORB MORTAL WKL, V64; Jordan AE, 2015, DRUG ALCOHOL DEPEN, V152, P194, DOI 10.1016/j.drugalcdep.2015.03.039; Klevens RM, 2012, CLIN INFECT DIS, V55, pS3, DOI 10.1093/cid/cis393; Kwon JA, 2012, AIDS, V26, P2201, DOI 10.1097/QAD.0b013e3283578b5d; Lorvick J, 2001, AM J PUBLIC HEALTH, V91, P46, DOI 10.2105/AJPH.91.1.46; Ly KN, 2016, CLIN INFECT DIS; Morales JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065216; Marshall BDL, 2011, LANCET, V377, P1429, DOI 10.1016/S0140-6736(10)62353-7; Mateu-Gelabert P, 2015, J SUBST ABUSE TREAT, V48, P13, DOI 10.1016/j.jsat.2014.07.002; Mihailovic A, 2015, AIDS BEHAV, V19, P1792, DOI 10.1007/s10461-015-1048-4; NYSDOH/AIDS Institute -Harm Reduction Unit, 2015, NYS AUTH SYR EXCH PR; Page K, 2013, CLIN INFECT DIS, V57, pS32, DOI 10.1093/cid/cit300; Peters PJ, 2016, NEW ENGL J MED, V375, P229, DOI 10.1056/NEJMoa1515195; Potier C, 2014, DRUG ALCOHOL DEPEN, V145, P48, DOI 10.1016/j.drugalcdep.2014.10.012; Pouget ER, 2011, APHA 139 ANN M EXP W; Schulte M, 2015, J COMMUN HEALTH, V40, P940, DOI 10.1007/s10900-015-0016-2; Seal KH, 2005, J URBAN HEALTH, V82, P303, DOI 10.1093/jurban/jti053; Strathdee SA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008958; Suryaprasad AG, 2014, CLIN INFECT DIS, V59, P1411, DOI 10.1093/cid/ciu643; Tempalski B, 2013, TRENDS POPULATION PR, V8; THOMAS DL, 1995, MEDICINE, V74, P212, DOI 10.1097/00005792-199507000-00005; Thorpe LE, 2002, AM J EPIDEMIOL, V155, P645, DOI 10.1093/aje/155.7.645; Thorpe LE, 1999, HEPATITIS C VIRUS IN, P1997; Tseng FC, 2007, HEPATOLOGY, V46, P666, DOI 10.1002/hep.21765; Villano SA, 1997, J CLIN MICROBIOL, V35, P3274, DOI 10.1128/JCM.35.12.3274-3277.1997; Zibbell JE, 2015, MMWR-MORBID MORTAL W, V64, P453	39	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177341	10.1371/journal.pone.0177341	http://dx.doi.org/10.1371/journal.pone.0177341			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PW	28542351	gold, Green Published, Green Submitted			2022-12-26	WOS:000401672600008
J	Martenot, C; Gervais, O; Chollet, B; Houssin, M; Renault, T				Martenot, Claire; Gervais, Ophelie; Chollet, Bruno; Houssin, Maryline; Renault, Tristan			Haemocytes collected from experimentally infected Pacific oysters, Crassostrea gigas: Detection of ostreid herpesvirus 1 DNA, RNA, and proteins in relation with inhibition of apoptosis	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; TO-CELL SPREAD; OSHV-1 MU-VAR; IMMUNE-RESPONSE; TOMALES BAY; MORTALITY; THUNBERG; TRANSMISSION; CALIFORNIA; TYPE-1	Recent transcriptomic approaches focused on anti-viral immunity in molluscs lead to the assumption that the innate immune system, such as apoptosis, plays a crucial role against ostreid herpesvirus type 1 (OsHV-1), infecting Pacific cupped oyster, Crassostrea gigas. Apoptosis constitutes a major mechanism of anti-viral response by limiting viral spread and eliminating infected cells. In this way, an OsHV-1 challenge was performed and oysters were monitored at three times post injection to investigate viral infection and host response: 2h (early after viral injection in the adductor muscle), 24h (intermediate time), and 48h (just before first oyster mortality record). Virus infection, associated with high cumulative mortality rates (74% and 100%), was demonstrated in haemocytes by combining several detection techniques such as real-time PCR, real-time RT PCR, immunofluorescence assay, and transmission electron microscopy examination. High viral DNA amounts ranged from 5.46x10(4) to 3.68x10(5) DNA copies ng(-1) of total DNA, were detected in dead oysters and an increase of viral transcripts was observed from 2, 24, and 48hpi for the five targeted OsHV-1 genes encoding three putative membrane proteins (ORFs 25, 41, and 72), a putative dUTPase (ORF 75), and a putative apoptosis inhibitor (ORF 87). Apoptosis was studied at molecular and cellular levels with an early marker (phosphatidyl-serine externalisation measured by flow cytometry and epifluorescence microscopy) and a later parameter (DNA fragmentation by terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling assay (TUNEL)). The down-regulation of genes encoding proteins involved in the activation of the apoptotic pathway (TNF and caspase 3) and the up-regulation of genes encoding anti-apoptotic proteins (IAP-2, and Bcl-2) suggested an important anti-apoptosis phenomenon in haemocytes from OsHV-1 infected oysters at 24 and 48hpi. Additionally, more phosphatidyl-serines were externalized and more cells with DNA fragmentation were observed in haemocytes collected from artificial seawater injected oysters than in haemocytes collected from OsHV-1 infected oysters at 24 and 48hpi, suggesting an inhibition of the apoptotic process in presence of the virus. In conclusion, this study is the first to focus on C. gigas haemocytes, cells involved in the host immune defense, during an OsHV-1 challenge in controlled conditions by combining various and original approaches to investigate apoptosis at molecular and cellular levels.	[Martenot, Claire; Gervais, Ophelie; Chollet, Bruno] IFREMER, Inst Francais Rech Exploitat Mer, Lab Genet & Pathol Mollusques Marins, La Tremblade, France; [Houssin, Maryline] LABEO Frank Duncombe, Caen, France; [Renault, Tristan] IFREMER, Dept Ressources Biol & Environm, Nantes, France	Ifremer; Ifremer	Martenot, C (corresponding author), IFREMER, Inst Francais Rech Exploitat Mer, Lab Genet & Pathol Mollusques Marins, La Tremblade, France.	claire.martenot@ifremer.fr		Gervais, Ophelie/0000-0002-4303-3289	Institut Francais de Recherche pour l'Exploitation de la Mer; European project "MOLecular TRacing of viral pathogens in AQuaculture" (MOLTRAQ); European project "improving European mollusc aquaculture: disease detection and management" (Bivalife)	Institut Francais de Recherche pour l'Exploitation de la Mer; European project "MOLecular TRacing of viral pathogens in AQuaculture" (MOLTRAQ); European project "improving European mollusc aquaculture: disease detection and management" (Bivalife)	This study was supported by the Institut Francais de Recherche pour l'Exploitation de la Mer. This work received financial support from the European projects "MOLecular TRacing of viral pathogens in AQuaculture" (MOLTRAQ) and "improving European mollusc aquaculture: disease detection and management" (Bivalife). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaitua F, 2013, J VIROL, V87, P7921, DOI 10.1128/JVI.01172-13; Aleman N, 2001, J VIROL, V75, P469, DOI 10.1128/JVI.75.1.469-479.2001; Aranguren R., 2012, DETECTION HERPESVIRU; Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823; Batista FM, 2014, AQUAC RES; Bingham P., 2013, Surveillance (Wellington), V40, P20; Bivlaves Cheng T., 1981, INVERTEBRATE BLOOD C; Burge CA, 2006, DIS AQUAT ORGAN, V72, P31, DOI 10.3354/dao072031; Burge CA, 2011, DIS AQUAT ORGAN, V94, P107, DOI 10.3354/dao02314; Clegg TA, 2014, PREV VET MED, V113, P257, DOI 10.1016/j.prevetmed.2013.10.023; Cocchi F, 2000, J VIROL, V74, P3909, DOI 10.1128/JVI.74.8.3909-3917.2000; Corbeil S, 2015, J VIROL METHODS, V211, P43, DOI 10.1016/j.jviromet.2014.10.007; Cuff S, 1996, IMMUNOL CELL BIOL, V74, P527, DOI 10.1038/icb.1996.86; da Silva PM, 2008, DIS AQUAT ORGAN, V78, P181, DOI 10.3354/dao01874; Davison AJ, 2005, J GEN VIROL, V86, P41, DOI 10.1099/vir.0.80382-0; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; De Decker S, 2013, AQUACULTURE, V392, P1, DOI 10.1016/j.aquaculture.2013.01.033; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Domeneghetti S, 2014, FISH SHELLFISH IMMUN, V41, P37, DOI 10.1016/j.fsi.2014.05.023; Du T, 2012, P NATL ACAD SCI USA, V109, P14616, DOI 10.1073/pnas.1212661109; Dundon WG, 2011, AQUACULTURE, V314, P49, DOI 10.1016/j.aquaculture.2011.02.005; Estevez-Calvar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061502; Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0; Fisher W.S., 1986, P25; Friedman CS, 2005, DIS AQUAT ORGAN, V63, P33, DOI 10.3354/dao063033; Gagnaire B, 2006, FISH SHELLFISH IMMUN, V20, P536, DOI 10.1016/j.fsi.2005.07.003; Gagnaire B, 2004, FISH SHELLFISH IMMUN, V16, P501, DOI 10.1016/j.fsi.2003.08.007; Gagnaire B, 2007, AQUAT TOXICOL, V84, P92, DOI 10.1016/j.aquatox.2007.06.002; Gervais O, 2015, FISH SHELLFISH IMMUN, V46, P232, DOI 10.1016/j.fsi.2015.05.046; Green TJ, 2015, FISH SHELLFISH IMMUN, V47, P435, DOI 10.1016/j.fsi.2015.09.025; Grijalva-Chon JM, 2013, J FISH DIS, V36, P965, DOI 10.1111/jfd.12028; Hwang JY, 2013, J FISH DIS, V36, P969, DOI 10.1111/jfd.12093; Jee B.Y., 2013, DETECTION OSTREID HE; Jenkins C, 2013, DIS AQUAT ORGAN, V105, P109, DOI 10.3354/dao02623; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Jerome KR, 1999, J VIROL, V73, P8950, DOI 10.1128/JVI.73.11.8950-8957.1999; Jouaux A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-590; Keeling SE, 2014, DIS AQUAT ORGAN, V109, P231, DOI 10.3354/dao02735; Kleinschmidt MC, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-49; Koyama AH, 2000, MICROBES INFECT, V2, P1111, DOI 10.1016/S1286-4579(00)01265-X; Lagunoff M, 2003, INT REV IMMUNOL, V22, P373, DOI 10.1080/08830180305218; Le Bouffant R, 2008, EXP CELL RES, V314, P961, DOI 10.1016/j.yexcr.2007.12.014; Le Deuff RM, 1999, J GEN VIROL, V80, P1317, DOI 10.1099/0022-1317-80-5-1317; Lynch SA, 2012, PARASITOLOGY, V139, P1526, DOI 10.1017/S0031182012000881; Martenot C, 2012, AQUACULTURE, V338, P293, DOI 10.1016/j.aquaculture.2011.12.030; Martenot C, 2010, J VIROL METHODS, V170, P86, DOI 10.1016/j.jviromet.2010.09.003; Martenot C, 2016, J INVERTEBR PATHOL, V136, P124, DOI 10.1016/j.jip.2016.04.002; Martenot C, 2015, AQUACULTURE, V439, P1, DOI 10.1016/j.aquaculture.2015.01.012; Martenot C, 2011, VIRUS RES, V160, P25, DOI 10.1016/j.virusres.2011.04.012; Montagnaro S, 2013, J CELL BIOCHEM, V114, P2809, DOI 10.1002/jcb.24628; Moreau P, 2015, AUTOPHAGY; Morga B, 2009, FISH SHELLFISH IMMUN, V26, P836, DOI 10.1016/j.fsi.2009.03.018; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Negoescu A., 1997, BIOCHEMICA, P12; Nguyen ML, 2007, ADV VIRUS RES, V69, P67, DOI 10.1016/S0065-3527(06)69002-7; O'Brien V, 1998, J GEN VIROL, V79, P1833, DOI 10.1099/0022-1317-79-8-1833; Paul-Pont I, 2014, AQUACULTURE, V422, P146, DOI 10.1016/j.aquaculture.2013.12.009; Paul-Pont I, 2013, AQUACULTURE, V412, P202, DOI 10.1016/j.aquaculture.2013.07.038; Paul-Pont I, 2013, DIS AQUAT ORGAN, V105, P127, DOI 10.3354/dao02615; Peeler EJ, 2012, PREV VET MED, V105, P136, DOI 10.1016/j.prevetmed.2012.02.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prasad A, 2013, J VIROL, V87, P10641, DOI 10.1128/JVI.01178-13; RENAULT T, 1994, REV MED VET-TOULOUSE, V145, P735; Renault T, 2011, DEV COMP IMMUNOL, V35, P725, DOI 10.1016/j.dci.2011.02.004; Renault T, 1995, CELL TISSUE ORGAN CU, V17, P199; Renault T, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-3; Renault T, 2012, J VIROL, V86, P5942, DOI 10.1128/JVI.06534-11; Roque A, 2012, AQUACULTURE, V324, P303, DOI 10.1016/j.aquaculture.2011.10.018; Rosani U., 2014, ENV MICROBIOL; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Scherubl Christoph, 2005, J Inflamm (Lond), V2, P7, DOI 10.1186/1476-9255-2-7; Schikorski D, 2011, VIRUS RES, V155, P28, DOI 10.1016/j.virusres.2010.07.031; Schikorski D, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-27; Segarra A, 2014, VET RES, P45; Segarra A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-580; Segarra A, 2010, VIRUS RES, V153, P92, DOI 10.1016/j.virusres.2010.07.011; Silva MC, 2005, P NATL ACAD SCI USA, V102, P2081, DOI 10.1073/pnas.0409597102; Whittington RJ, 2015, AQUACULTURE, V437, P10, DOI 10.1016/j.aquaculture.2014.11.016; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	80	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177448	10.1371/journal.pone.0177448	http://dx.doi.org/10.1371/journal.pone.0177448			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542284	Green Published, gold			2022-12-26	WOS:000401672400045
J	Choi, J; Rajagopal, A; Xu, YF; Rabinowitz, JD; O'Shea, EK				Choi, Joonhyuk; Rajagopal, Abbhirami; Xu, Yi-Fan; Rabinowitz, Joshua D.; O'Shea, Erin K.			A systematic genetic screen for genes involved in sensing inorganic phosphate availability in Saccharomyces cerevisiae	PLOS ONE			English	Article							TRANSCRIPTION FACTOR PHO4; CYCLIN-CDK COMPLEX; INOSITOL PYROPHOSPHATES; YEAST; PHOSPHORYLATION; PHO80-PHO85; KINASE; CASSETTES; PATHWAYS; MUTANTS	Saccharomyces cerevisiae responds to changes in extracellular inorganic phosphate (P-i) availability by regulating the activity of the phosphate-responsive (PHO) signaling pathway, enabling cells to maintain intracellular levels of the essential nutrient P-i. P-i-limitation induces upregulation of inositol heptakisphosphate (IP7) synthesized by the inositol hexakisphosphate kinase Vip1, triggering inhibition of the Pho80/Pho85 cyclin-cyclin dependent kinase (CDK) complex by the CDK inhibitor Pho81, which upregulates the PHO regulon through the CDK target and transcription factor Pho4. To identify genes that are involved in signaling upstream of the Pho80/Pho85/Pho81 complex and how they interact with each other to regulate the PHO pathway, we performed genome-wide screens with the synthetic genetic array method. We identified more than 300 mutants with defects in signaling upstream of the Pho80/Pho85/Pho81 complex, including AAH1, which encodes an adenine deaminase that negatively regulates the PHO pathway in a Vip1-dependent manner. Furthermore, we showed that even in the absence of VIP1, the PHO pathway can be activated under prolonged periods of P-i starvation, suggesting complexity in the mechanisms by which the PHO pathway is regulated.	[Choi, Joonhyuk; Rajagopal, Abbhirami; O'Shea, Erin K.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA; [Choi, Joonhyuk; O'Shea, Erin K.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Choi, Joonhyuk; Rajagopal, Abbhirami; O'Shea, Erin K.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Rajagopal, Abbhirami; O'Shea, Erin K.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Xu, Yi-Fan; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Xu, Yi-Fan; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Choi, Joonhyuk] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Rajagopal, Abbhirami] Harris Cty Publ Hlth, Houston, TX USA; [O'Shea, Erin K.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Princeton University; Princeton University; California Institute of Technology; Howard Hughes Medical Institute	O'Shea, EK (corresponding author), Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA.; O'Shea, EK (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; O'Shea, EK (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.; O'Shea, EK (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.; O'Shea, EK (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	erin_oshea@harvard.edu	Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727	Howard Hughes Medical Institute; Samsung Scholarship; Mary Fieser fellowship; DOE Grant [DE-SC0012461]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Samsung Scholarship(Samsung); Mary Fieser fellowship; DOE Grant(United States Department of Energy (DOE))	Funded by Howard Hughes Medical Institute (http://www.hhmi.org): JC AR EKO. Samsung Scholarship (http://www.ssscholarship.com): JC. Mary Fieser fellowship (http://chemistry.harvard.edu): AR. DOE Grant DE-SC0012461 (https://science.energy.gov/): YX JDR.	AVERY L, 1992, TRENDS GENET, V8, P312, DOI 10.1016/0168-9525(92)90263-4; Boer VM, 2010, MOL BIOL CELL, V21, P198, DOI 10.1091/mbc.E09-07-0597; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; Byrne M, 2004, J MOL BIOL, V335, P57, DOI 10.1016/j.jmb.2003.10.035; Camblong J, 2009, GENE DEV, V23, P1534, DOI 10.1101/gad.522509; Castelnuovo M, 2013, NAT STRUCT MOL BIOL, V20, P851, DOI 10.1038/nsmb.2598; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; GANCEDO JM, 1973, BIOCHIMIE, V55, P205, DOI 10.1016/S0300-9084(73)80393-1; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang SD, 2005, GENETICS, V169, P1859, DOI 10.1534/genetics.104.038695; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673; Kaffman A, 1998, NATURE, V396, P482, DOI 10.1038/24898; KAFFMAN A, 1994, SCIENCE, V263, P1153, DOI 10.1126/science.8108735; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lee YS, 2008, NAT CHEM BIOL, V4, P25, DOI 10.1038/nchembio.2007.52; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Lin HY, 2010, METHODS MOL BIOL, V645, P103, DOI 10.1007/978-1-60327-175-2_7; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Oshima Y, 1997, GENES GENET SYST, V72, P323, DOI 10.1266/ggs.72.323; Pinson B, 2009, GENE DEV, V23, P1399, DOI 10.1101/gad.521809; Rebora K, 2001, MOL CELL BIOL, V21, P7901, DOI 10.1128/MCB.21.23.7901-7912.2001; Saiardi A, 2000, J BIOL CHEM, V275, P24686, DOI 10.1074/jbc.M002750200; SCHNEIDER KR, 1994, SCIENCE, V266, P122, DOI 10.1126/science.7939631; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Springer M, 2003, PLOS BIOL, V1, P261, DOI 10.1371/journal.pbio.0000028; Thomas MR, 2005, P NATL ACAD SCI USA, V102, P9565, DOI 10.1073/pnas.0501122102; TOHE A, 1973, J BACTERIOL, V113, P727, DOI 10.1128/JB.113.2.727-738.1973; Tong AHY, METHODS IN MOLECULAR, P171; Wilson MSC, 2013, BIOCHEM J, V452, P369, DOI 10.1042/BJ20130118; Wundenberg T, 2012, SYNTHESIS BIOL ACTIO, P979; Wykoff DD, 2007, MOL CELL, V27, P1005, DOI 10.1016/j.molcel.2007.07.022; Xu YF, 2012, MOL CELL, V48, P52, DOI 10.1016/j.molcel.2012.07.013; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155	43	12	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176085	10.1371/journal.pone.0176085	http://dx.doi.org/10.1371/journal.pone.0176085			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520786	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000401487700010
J	de Biase, D; Genestreti, G; Visani, M; Acquaviva, G; Di Battista, M; Cavallo, G; Paccapelo, A; Cancellieri, A; Trisolini, R; Esposti, RD; Bartolini, S; Pession, A; Tallini, G; Brandes, AA				de Biase, Dario; Genestreti, Giovenzio; Visani, Michela; Acquaviva, Giorgia; Di Battista, Monica; Cavallo, Giovanna; Paccapelo, Alexandro; Cancellieri, Alessandra; Trisolini, Rocco; Esposti, Roberta Degli; Bartolini, Stefania; Pession, Annalisa; Tallini, Giovanni; Brandes, Alba A.			The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinoma	PLOS ONE			English	Article							PAPILLARY THYROID CARCINOMAS; RANDOMIZED PHASE-3 TRIAL; EGFR MUTATIONS; KRAS MUTATIONS; 1ST-LINE TREATMENT; CANCER PATIENTS; TUMOR-CELLS; BRAF V600E; OPEN-LABEL; GEFITINIB	Background Epidermal Growth Factor Receptor (EGFR) molecular analysis is performed to assess the responsiveness to Tyrosine Kinase Inhibitors (TKIs) in patients with Non-Small Cell Lung Cancer (NSCLC). The existence of molecular intra-tumoral heterogeneity has been observed in lung cancers. The aim of the present study is to investigate if the percentage of mutated neoplastic cells within the tumor sample might influence the responsiveness to TKIs treatment. Material and methods A total of 931 cases of NSCLC were analyzed for EGFR mutational status (exon 18, 19, 20, 21) using Next Generation Sequencer. The percentage of mutated neoplastic cells was calculated after normalizing the percentage of mutated alleles obtained after next generation sequencer analysis with the percentage of neoplastic cells in each tumor. Results Next generation sequencing revealed an EGFR mutation in 167 samples (17.9%), mainly deletions in exon 19. In 18 patients treated with TKIs and with available follow-up, there was a significant correlation between the percentage of mutated neoplastic cells and the clinical response (P = 0.017). Patients with a percentage of mutated neoplastic cells greater than 56%, have a statistical trend (P = 0.081) for higher Overall Survival (26.3 months) when compared to those with a rate of mutated neoplastic cells lower than 56% (8.2 months). Conclusions The percentage of EGFR-mutated neoplastic cells in the tumor is associated with response to TKIs. A "quantitative result" of EGFR mutational status might provide useful information in order to recognize those patients which might have the greatest benefit from TKIs.	[de Biase, Dario; Pession, Annalisa] Univ Bologna, Azienda USL Bologna, Dept Pharm & Biotechnol, Mol Diagnost Unit, Bologna, Italy; [Genestreti, Giovenzio; Di Battista, Monica; Cavallo, Giovanna; Paccapelo, Alexandro; Esposti, Roberta Degli; Bartolini, Stefania; Brandes, Alba A.] AUSL Bologna, IRCCS Inst Neurol Sci, Dept Oncol, Bologna, Italy; [Visani, Michela; Acquaviva, Giorgia; Tallini, Giovanni] Univ Bologna, Azienda USL Bologna, Dipartimento Med Specialist Diagnost & Sperimenta, Dept Med,Mol Diagnost Unit,Sch Med, Bologna, Italy; [Cancellieri, Alessandra] Maggiore Hosp, AUSL Bologna, Anat Pathol Unit, Bologna, Italy; [Trisolini, Rocco] St Orsola Malpighi Hosp, Intervent Pulmol, Bologna, Italy	AUSL di Bologna; University of Bologna; AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); AUSL di Bologna; University of Bologna; AUSL di Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna	de Biase, D (corresponding author), Univ Bologna, Azienda USL Bologna, Dept Pharm & Biotechnol, Mol Diagnost Unit, Bologna, Italy.; Genestreti, G (corresponding author), AUSL Bologna, IRCCS Inst Neurol Sci, Dept Oncol, Bologna, Italy.	dario.debiase@unibo.it; g.genestreti@ausl.bologna.it	Tallini, Giovanni/F-7850-2013; de Biase, Dario/B-9274-2012; Visani, Michela/K-5597-2016	Tallini, Giovanni/0000-0003-0113-6682; de Biase, Dario/0000-0002-0609-8817; Visani, Michela/0000-0002-9051-2231; Trisolini, Rocco/0000-0002-1067-4696	Italian Government-Ministero della Salute [RF-2011-02350857, GR-2011-02350937]	Italian Government-Ministero della Salute	This work was supported in part by an Italian Government-Ministero della Salute (http://www.salute.gov.it/portale/p5_11.jsp) [Grant No. RF-2011-02350857 to G.T]; in part by an Italian Government-Ministero della Salute (http://www.salute.gov.it/portale/p5_11.jsp) [Grant No. GR-2011-02350937 to D.d.B]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altimari A, 2013, ONCOTARGETS THER, V6, P1057, DOI 10.2147/OTT.S42369; Bria E, 2015, ONCOTARGET, V6, P12783, DOI 10.18632/oncotarget.3727; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; de Biase D, 2014, J CLIN ENDOCR METAB, V99, pE1530, DOI 10.1210/jc.2013-4389; de Biase D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087651; de Biase D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083607; Di Maio M, 2012, J THORAC ONCOL, V7, P1830, DOI 10.1097/JTO.0b013e318275b327; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Gandolfi G, 2013, J CLIN ENDOCR METAB, V98, pE934, DOI 10.1210/jc.2012-3930; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gridelli C, 2012, J CLIN ONCOL, V30, P3002, DOI 10.1200/JCO.2011.41.2056; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; Johnson BE, 2005, CANCER RES, V65, P7525, DOI 10.1158/0008-5472.CAN-05-1257; Lindeman NI, 2013, J THORAC ONCOL, V8, P823, DOI 10.1097/JTO.0b013e318290868f; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mafficini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104979; Malapelle U, 2015, J CLIN PATHOL, V68, P739, DOI 10.1136/jclinpath-2015-203101; Marks JL, 2008, J THORAC ONCOL, V3, P111, DOI 10.1097/JTO.0b013e318160c607; Metro G, 2006, REV RECENT CLIN TRIA, V1, P1, DOI 10.2174/157488706775246157; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Ragazzi M, 2016, J CLIN PATHOL, V69, P440, DOI 10.1136/jclinpath-2015-203348; Rosell R, 2005, LUNG CANCER-J IASLC, V50, P25, DOI 10.1016/j.lungcan.2005.05.017; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Soh J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007464; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Travis WD., 2004, TRAVIS WB WHO CLASSI; Visani M, 2013, INT J SURG PATHOL, V21, P546, DOI 10.1177/1066896912475073; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yang CH, 2008, J CLIN ONCOL, V26, P2745, DOI 10.1200/JCO.2007.15.6695; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhou Q, 2011, J CLIN ONCOL, V29, P3316, DOI 10.1200/JCO.2010.33.3757	41	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177822	10.1371/journal.pone.0177822	http://dx.doi.org/10.1371/journal.pone.0177822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520821	Green Published, gold			2022-12-26	WOS:000401485500074
J	Fetherolf, MM; Boyd, SD; Taylor, AB; Kim, HJ; Wohlschlegel, JA; Blackburn, NJ; Hart, PJ; Winge, DR; Winkler, DD				Fetherolf, Morgan M.; Boyd, Stefanie D.; Taylor, Alexander B.; Kim, Hee Jong; Wohlschlegel, James A.; Blackburn, Ninian J.; Hart, P. John; Winge, Dennis R.; Winkler, Duane D.			Copper-zinc superoxide dismutase is activated through a sulfenic acid intermediate at a copper ion entry site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-ABSORPTION; CRYSTAL-STRUCTURE; CHAPERONE CCS; CU,ZN-SUPEROXIDE DISMUTASE; ATOMIC-RESOLUTION; HSOD1 MATURATION; SOD1; PROTEOMICS; MUTANTS; ABSENCE	Metallochaperones are a diverse family of trafficking molecules that provide metal ions to protein targets for use as cofactors. The copper chaperone for superoxide dismutase (Ccs1) activates immature copper-zinc superoxide dismutase (Sod1) by delivering copper and facilitating the oxidation of the Sod1 intramolecular disulfide bond. Here, we present structural, spectroscopic, and cell-based data supporting a novel copper-induced mechanism for Sod1 activation. Ccs1 binding exposes an electropositive cavity and proposed "entry site" for copper ion delivery on immature Sod1. Copper-mediated sulfenylation leads to a sulfenic acid intermediate that eventually resolves to form the Sod1 disulfide bond with concomitant release of copper into the Sod1 active site. Sod1 is the predominant disulfide bond-requiring enzyme in the cytoplasm, and this copper-induced mechanism of disulfide bond formation obviates the need for a thiol/disulfide oxidoreductase in that compartment.	[Fetherolf, Morgan M.; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Med, Sch Med, Salt Lake City, UT 84132 USA; [Fetherolf, Morgan M.; Winge, Dennis R.] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA; [Boyd, Stefanie D.; Winkler, Duane D.] Univ Texas Dallas, Dept Biol Sci, 800 W Campbell Rd, Richardson, TX 75080 USA; [Taylor, Alexander B.; Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Taylor, Alexander B.; Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Xray Crystallog Core Lab, San Antonio, TX 78229 USA; [Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Dept Vet Affairs, South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA; [Kim, Hee Jong; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Blackburn, Ninian J.] Oregon Hlth & Sci Univ, Inst Environm Hlth, Portland, OR 97239 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Oregon Health & Science University	Winkler, DD (corresponding author), Univ Texas Dallas, Dept Biol Sci, 800 W Campbell Rd, Richardson, TX 75080 USA.	duane.winkler@utdallas.edu		Kim, Hee Jong/0000-0002-0823-5301; Taylor, Alexander/0000-0003-3517-6033; Winkler, Duane D./0000-0003-1045-0323	National Institutes of Health [R01 GM110755, R01 GM054803, R01 NS39112, R01 GM112763, R01 GM120252]; United States Department of Veterans Affairs Merit Review Award [I01 BX002580]; Robert A. Welch Foundation [AQ-1399]; National Institutes of Health Training Grant [T32 DK007115]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054803, P41GM103403, R01GM120252, R01GM089778, P41GM103393, R01GM110755, R01GM112763, R01GM123725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039112] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs); Robert A. Welch Foundation(The Welch Foundation); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Institutes of Health Grants R01 GM110755, R01 GM054803, R01 NS39112, R01 GM112763, and R01 GM120252 (to D.R.W., N.J.B., P.J.H., J.A.W., and D.D.W., respectively); United States Department of Veterans Affairs Merit Review Award I01 BX002580 (to P.J.H.); and Robert A. Welch Foundation Grant AQ-1399 (to P.J.H.). The authors declare that they have no conflicts of interest with the contents of this article. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs, the United States government, or the National Institutes of Health.; Supported by National Institutes of Health Training Grant T32 DK007115.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; ASCONE I, 1993, FEBS LETT, V322, P165, DOI 10.1016/0014-5793(93)81560-M; Banci L, 2013, CHEMBIOCHEM, V14, P1839, DOI 10.1002/cbic.201300042; Banci L, 2013, NAT CHEM BIOL, V9, P297, DOI [10.1038/NCHEMBIO.1202, 10.1038/nchembio.1202]; Banci L, 2012, P NATL ACAD SCI USA, V109, P13555, DOI 10.1073/pnas.1207493109; Bauman AT, 2011, BIOCHEMISTRY-US, V50, P10819, DOI 10.1021/bi201193j; Binsted N, 1996, J SYNCHROTRON RADIAT, V3, P185, DOI 10.1107/S0909049596005651; BLACKBURN NJ, 1984, BIOCHEM J, V219, P985, DOI 10.1042/bj2190985; Brown NM, 2004, P NATL ACAD SCI USA, V101, P5518, DOI 10.1073/pnas.0401175101; Carroll MC, 2004, P NATL ACAD SCI USA, V101, P5964, DOI 10.1073/pnas.0308298101; Caruano-Yzermans AL, 2006, J BIOL CHEM, V281, P13581, DOI 10.1074/jbc.M601580200; CIRIOLO MR, 1990, J BIOL CHEM, V265, P11030; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DANCIS A, 1994, J BIOL CHEM, V269, P25660; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Eisses JF, 2000, BIOCHEMISTRY-US, V39, P7337, DOI 10.1021/bi000690j; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferraroni M, 1999, J MOL BIOL, V288, P413, DOI 10.1006/jmbi.1999.2681; Ferrer-Sueta G, 2011, CHEM RES TOXICOL, V24, P434, DOI 10.1021/tx100413v; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; GEORGE GN, 1995, EXAFSPAK; GURMAN SJ, 1995, J SYNCHROTRON RADIAT, V2, P56, DOI 10.1107/S0909049594009179; Jensen LT, 2005, J BIOL CHEM, V280, P41373, DOI 10.1074/jbc.M509142200; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kim S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6277; Kirby K, 2008, J BIOL CHEM, V283, P35393, DOI 10.1074/jbc.M807131200; Klomsiri C, 2010, METHOD ENZYMOL, V473, P77, DOI 10.1016/S0076-6879(10)73003-2; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lamb AL, 1999, NAT STRUCT BIOL, V6, P724; Lamb AL, 2000, BIOCHEMISTRY-US, V39, P1589, DOI 10.1021/bi992822i; Lamb AL, 2000, BIOCHEMISTRY-US, V39, P14720, DOI 10.1021/bi002207a; Leitch JM, 2009, J BIOL CHEM, V284, P21863, DOI 10.1074/jbc.M109.000489; Leonard SE, 2009, ACS CHEM BIOL, V4, P783, DOI 10.1021/cb900105q; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; Lo Conte M, 2013, J BIOL CHEM, V288, P26480, DOI 10.1074/jbc.R113.467738; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; Luchinat E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6502; Luk E, 2003, J BIOL INORG CHEM, V8, P803, DOI 10.1007/s00775-003-0482-3; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paulsen CE, 2009, CHEM BIOL, V16, P217, DOI 10.1016/j.chembiol.2009.01.003; PICKERING IJ, 1993, J AM CHEM SOC, V115, P9498, DOI 10.1021/ja00074a014; Polticelli F, 1998, PROTEIN SCI, V7, P2354, DOI 10.1002/pro.5560071112; Pope CR, 2013, P NATL ACAD SCI USA, V110, P20491, DOI 10.1073/pnas.1309820110; Proescher JB, 2008, HUM MOL GENET, V17, P1728, DOI 10.1093/hmg/ddn063; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rae TD, 2001, J BIOL CHEM, V276, P5166, DOI 10.1074/jbc.M008005200; RICHARDSON JS, 1975, P NATL ACAD SCI USA, V72, P1349, DOI 10.1073/pnas.72.4.1349; Schmidt PJ, 2000, J BIOL CHEM, V275, P33771, DOI 10.1074/jbc.M006254200; Schmidt PJ, 1999, J BIOL CHEM, V274, P23719, DOI 10.1074/jbc.274.34.23719; Sea KW, 2013, J BIOL INORG CHEM, V18, P985, DOI 10.1007/s00775-013-1047-8; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Winkler DD, 2009, BIOCHEMISTRY-US, V48, P3436, DOI 10.1021/bi8021735; Wong PC, 2000, P NATL ACAD SCI USA, V97, P2886, DOI 10.1073/pnas.040461197; Zempel KEC, 2016, J PROTEOME RES, V15, P4436, DOI 10.1021/acs.jproteome.6b00521	62	37	39	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12025	12040		10.1074/jbc.M117.775981	http://dx.doi.org/10.1074/jbc.M117.775981			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28533431	Green Published, hybrid			2022-12-26	WOS:000406053300003
J	Agostino, M; Poh, SOG; Dharmarajan, A				Agostino, Mark; Poh, Sebastian Otther-Gee; Dharmarajan, Arun			Structure-based prediction of Wnt binding affinities for Frizzled-type cysteine-rich domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN BINDING; DISHEVELLED DEP DOMAIN; SIDE-CHAIN; CELLS; INHIBITION; PATHWAY; CANCER; RECOGNITION; SELECTIVITY; ANTAGONIST	Wnt signaling pathways are of significant interest in development and oncogenesis. The first step in these pathways typically involves the binding of a Wnt protein to the cysteine-rich domain (CRD) of a Frizzled receptor. Wnt-Frizzled interactions can be antagonized by secreted Frizzled-related proteins (SFRPs), which also contain a Frizzled-like CRD. The large number of Wnts, Frizzleds, and SFRPs, as well as the hydrophobic nature of Wnt, poses challenges to laboratory-based investigations of interactions involving Wnt. Here, utilizing structural knowledge of a representative Wnt-FrizzledCRDinteraction, as well as experimentally determined binding affinities for a selection of Wnt-Frizzled CRD interactions, we generated homology models of Wnt-Frizzled CRD interactions and developed a quantitative structure-activity relationship for predicting their binding affinities. The derived model incorporates a small selection of terms derived from scoring functions used in proteinprotein docking, as well as an energetic term considering the contribution made by the lipid ofWntto the Wnt-Frizzled binding affinity. Validation with an external test set suggests that the model can accurately predict binding affinity for 75% of cases and that the error associated with the predictions is comparable with the experimental error. The model was applied to predict the binding affinities of the full range of mouse and human WntFrizzled and Wnt-SFRP interactions, indicating trends in Wnt binding affinity for Frizzled and SFRP CRDs. The comprehensive predictions made in this study provide the basis for laboratory- based studies of previously unexplored Wnt-Frizzled and Wnt-SFRP interactions, which, in turn, may reveal further Wnt signaling pathways.	[Agostino, Mark; Poh, Sebastian Otther-Gee; Dharmarajan, Arun] Curtin Univ, Sch Biomed Sci, Stem Cell & Canc Biol Lab, Kent St, Bentley, WA 6102, Australia; [Agostino, Mark; Poh, Sebastian Otther-Gee; Dharmarajan, Arun] Curtin Univ, Curtin Hlth Innovat Res Inst, Kent St, Bentley, WA 6102, Australia; [Agostino, Mark] Curtin Univ, Curtin Inst Computat, Kent St, Bentley, WA 6102, Australia	Curtin University; Curtin University; Curtin University	Agostino, M (corresponding author), Curtin Univ, Curtin Inst Computat, Kent St, Bentley, WA 6102, Australia.; Agostino, M (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Biomed Sci, Stem Cell & Canc Biol Lab, Kent St, Bentley, WA 6102, Australia.	Mark.Agostino@curtin.edu.au	Pohl, Sebastian Other-Gee/J-9455-2019; Agostino, Mark/H-5481-2019	Pohl, Sebastian Other-Gee/0000-0002-4294-9498; Agostino, Mark/0000-0002-1799-0392; Dharmarajan, Arun/0000-0002-6715-6005	National Health and Medical Research Council [GNT1054245]; Cancer Council of Western Australia Suzanne Cavanagh Early Career Investigator Grant; Raine Priming Grant; Curtin Institute for Computation; Curtin Research Fellowship; Rotary Club of Belmont; Australian Rotary Health Research Fund; Curtin University School of Biomedical Sciences; School of Biomedical Sciences (Curtin University); Commercialisation Advisory Board of Curtin University; Cancer Council of Western Australia; Actinogen Ltd., Perth, Western Australia	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Western Australia Suzanne Cavanagh Early Career Investigator Grant; Raine Priming Grant; Curtin Institute for Computation; Curtin Research Fellowship; Rotary Club of Belmont; Australian Rotary Health Research Fund; Curtin University School of Biomedical Sciences; School of Biomedical Sciences (Curtin University); Commercialisation Advisory Board of Curtin University; Cancer Council of Western Australia(Cancer Council Western Australia); Actinogen Ltd., Perth, Western Australia	Recipient of National Health and Medical Research Council C. J. Martin Early Career Fellowship GNT1054245, a Cancer Council of Western Australia Suzanne Cavanagh Early Career Investigator Grant, a Raine Priming Grant, Operational Research Support from the Curtin Institute for Computation, and a Curtin Research Fellowship. To whom correspondence should be addressed: Stem Cell and Cancer Biology Laboratory, School of Biomedical Sciences, Curtin Health Innovation Research Institute and Curtin Institute of Computation, Curtin University, Kent St., Bentley, Western Australia 6102, Australia. Tel.: 61892669719; E-mail: Mark. Agostino@curtin.edu.au.; Supported by funds from the Rotary Club of Belmont, Australian Rotary Health Research Fund, and Curtin University School of Biomedical Sciences.; Supported by strategic research funds from the School of Biomedical Sciences (Curtin University), Commercialisation Advisory Board of Curtin University, Cancer Council of Western Australia, and Actinogen Ltd., Perth, Western Australia.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agostino M, 2015, GLYCOBIOLOGY, V25, P101, DOI 10.1093/glycob/cwu095; Ahn VE, 2011, DEV CELL, V21, P862, DOI 10.1016/j.devcel.2011.09.003; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bertalovitz Alexander C, 2016, J Mol Signal, V11, P1, DOI 10.5334/1750-2187-11-1; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Byrne EFX, 2016, NATURE, V535, P517, DOI 10.1038/nature18934; Carmon KS, 2010, ANAL BIOCHEM, V401, P288, DOI 10.1016/j.ab.2010.03.009; Chang TH, 2015, ELIFE, V4, DOI 10.7554/eLife.06554; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng ZH, 2011, NAT STRUCT MOL BIOL, V18, P1204, DOI 10.1038/nsmb.2139; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Constantinou Thecla, 2008, J Mol Signal, V3, P10, DOI 10.1186/1750-2187-3-10; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Cui B, 2013, CANCER RES, V73, P3649, DOI 10.1158/0008-5472.CAN-12-3832; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Dijksterhuis JP, 2014, BRIT J PHARMACOL, V171, P1195, DOI 10.1111/bph.12364; Dijksterhuis JP, 2015, J BIOL CHEM, V290, P6789, DOI 10.1074/jbc.M114.612648; Doubravska L, 2011, CELL SIGNAL, V23, P837, DOI 10.1016/j.cellsig.2011.01.007; Galli LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026636; Gao XX, 2014, NAT CHEM BIOL, V10, P61, DOI [10.1038/NCHEMBIO.1392, 10.1038/nchembio.1392]; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Green J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009175; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Henry C, 2015, J CANCER RES CLIN, V141, P243, DOI 10.1007/s00432-014-1824-y; Hikasa H, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007955; Holstein TW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007922; Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kakugawa S, 2015, NATURE, V519, P187, DOI 10.1038/nature14259; Klein D, 2008, HEPATOLOGY, V47, P1018, DOI 10.1002/hep.22084; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Komiya Yuko, 2008, Organogenesis, V4, P68; Liu Y, 2008, J CELL BIOCHEM, V105, P497, DOI 10.1002/jcb.21848; Lopez-Rios J, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-19; Lyons JP, 2004, EXP CELL RES, V298, P369, DOI 10.1016/j.yexcr.2004.04.036; MacDonald BT, 2014, J BIOL CHEM, V289, P18122, DOI 10.1074/jbc.M114.575027; MacDonald BT, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007880; Madrzak J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7718; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Matsuyama M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000427; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Moal IH, 2015, BIOINFORMATICS, V31, P123, DOI 10.1093/bioinformatics/btu594; Mukherjee S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp318; Muley A, 2010, AM J PATHOL, V176, P1505, DOI 10.2353/ajpath.2010.090465; Nishi H, 2011, STRUCTURE, V19, P1807, DOI 10.1016/j.str.2011.09.021; Ohta K, 2011, P NATL ACAD SCI USA, V108, P14962, DOI 10.1073/pnas.1100513108; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Perumal V, 2016, EXP CELL RES, V341, P218, DOI 10.1016/j.yexcr.2016.02.008; Perumal V, 2015, INT J BIOCHEM CELL B, V64, P91, DOI 10.1016/j.biocel.2015.03.010; Pohl S, 2015, TUMOR BIOL, V36, P143, DOI 10.1007/s13277-014-2956-z; Pohl SG, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.14; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Resh MD, 2016, PROG LIPID RES, V63, P120, DOI 10.1016/j.plipres.2016.05.002; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; SMOLICH BD, 1993, MOL BIOL CELL, V4, P1267, DOI 10.1091/mbc.4.12.1267; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Stiegler AL, 2009, J MOL BIOL, V393, P1, DOI 10.1016/j.jmb.2009.07.091; Surana R, 2014, BBA-REV CANCER, V1845, P53, DOI 10.1016/j.bbcan.2013.11.004; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tauriello DVF, 2012, P NATL ACAD SCI USA, V109, pE812, DOI 10.1073/pnas.1114802109; Veerasamy R., 2011, INT J DRUG DISCOV, V3, P511, DOI DOI 10.1016/J.FEBSLET.2005.06.031; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wang C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5355; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wang YS, 1996, J BIOL CHEM, V271, P4468; Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005; Warrier S, 2013, ONCOL RES, V21, P93, DOI 10.3727/096504013X13786659070154; Wawrzak D, 2007, BIOCHEM BIOPH RES CO, V357, P1119, DOI 10.1016/j.bbrc.2007.04.069; Weierstall U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4309; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A; Wolf V, 1997, FEBS LETT, V417, P385, DOI 10.1016/S0014-5793(97)01324-0; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Xu CC, 2015, NAT REV MOL CELL BIO, V16, P742, DOI 10.1038/nrm4073; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; Yu AA, 2010, STRUCTURE, V18, P1311, DOI 10.1016/j.str.2010.07.010; Zhang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015386; Zhang SP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031127, 10.1371/journal.pone.0046853]; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152	94	21	22	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11218	11229		10.1074/jbc.M117.786269	http://dx.doi.org/10.1074/jbc.M117.786269			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28533339	Green Published, hybrid			2022-12-26	WOS:000405119600008
J	Li, C; Park, S; Zhang, XW; Dai, W; Xu, DZ				Li, Cen; Park, Soyoung; Zhang, Xiaowen; Dai, Wei; Xu, Dazhong			Mutual regulation between Polo-like kinase 3 and SIAH2 E3 ubiquitin ligase defines a regulatory network that fine-tunes the cellular response to hypoxia and nickel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; INDUCIBLE KINASE; DNA-DAMAGE; PLK3; POLO-LIKE-KINASE-3; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; PHOSPHORYLATION; DEGRADATION; HIF-1-ALPHA; STABILITY	Elevated cellular response to hypoxia, which contributes to cell transformation and tumor progression, is a prominent feature of malignant cells in solid tumors. Polo-like kinase 3 (Plk3) is a serine/threonine protein kinase known to inhibit the cellular response to hypoxia and tumorigenesis. Nickel compounds are well-established human carcinogens that induce tumorigenesis partly through their hypoxia-mimicking effects. Despite previous research efforts, the role of Plk3 in the hypoxic response induced by hypoxia or nickel is not completely understood. Here, we show that NiCl2 (Ni(II)) or hypoxia reduces the protein level and shortens the half-life of cytoplasmic Plk3 in a ubiquitin- proteasome-dependent manner. We identify SIAH2, a RING finger E3 ubiquitin ligase associated with the cellular hypoxic response, to be the ubiquitin E3 ligase that mediates the degradation of Plk3. We show that SIAH2 binds to Plk3 and mediates its ubiquitination primarily through its polo-box domain. We report that USP28, a deubiquitinase known to be inhibitable by Ni(II) or hypoxia, may also contribute to the suppression of the Plk3 protein by Ni(II). We also show that Plk3 in turn suppresses the SIAH2 protein level in a kinase activity-dependent manner. Our study revealed an interesting mutual regulation between Plk3 and SIAH2 and uncovered a regulatory network that functions to fine-tune the cellular hypoxic response. We propose that suppression of Plk3 expression contributes to carcinogenesis and tumor progression induced by nickel compounds.	[Li, Cen; Park, Soyoung; Zhang, Xiaowen; Xu, Dazhong] New York Med Coll, Dept Pathol, Sch Med, 15 Dana Rd, Valhalla, NY 10595 USA; [Dai, Wei] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA	New York Medical College; New York University	Xu, DZ (corresponding author), New York Med Coll, Dept Pathol, Sch Med, 15 Dana Rd, Valhalla, NY 10595 USA.	dazhong_xu@nymc.edu		Xu, Dazhong/0000-0001-9264-3342; Dai, Wei/0000-0003-0169-8327	National Institutes of Health [R21ES023862]; New York Medical College; New York Medical College Castle-Krob Research Endowment Fund under College's Intramural Research Support Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES023862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Medical College; New York Medical College Castle-Krob Research Endowment Fund under College's Intramural Research Support Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health Grant R21ES023862 (to D. X.), a startup fund from the New York Medical College (to D. X.), and funds from the New York Medical College Castle-Krob Research Endowment Fund under the College's Intramural Research Support Program (to D. X.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Alberts GF, 2004, CELL CYCLE, V3, P678; Bahassi EM, 2002, ONCOGENE, V21, P6633, DOI 10.1038/sj.onc.1205850; Bett JS, 2016, ESSAYS BIOCHEM, V60, P143, DOI 10.1042/EBC20160001; Chase D, 1998, BIOCHEM J, V333, P655, DOI 10.1042/bj3330655; Dai W, 2005, ONCOGENE, V24, P214, DOI 10.1038/sj.onc.1208270; Dai W, 2002, INT J ONCOL, V20, P121; de Carcer G, 2011, CELL CYCLE, V10, P2255, DOI 10.4161/cc.10.14.16494; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Flugel D, 2012, BLOOD, V119, P1292, DOI 10.1182/blood-2011-08-375014; Glover DM, 1996, J CELL BIOL, V135, P1681, DOI 10.1083/jcb.135.6.1681; Helmke C, 2016, ONCOGENE, V35, P135, DOI 10.1038/onc.2015.105; House CM, 2006, STRUCTURE, V14, P695, DOI 10.1016/j.str.2005.12.013; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Iida M, 2008, BIOCHEM J, V411, P27, DOI 10.1042/BJ20071394; Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Li Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008531; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Nakayama K, 2009, MOL CANCER RES, V7, P443, DOI 10.1158/1541-7786.MCR-08-0458; Park S, 2016, ONCOTARGET, V7, P8916, DOI 10.18632/oncotarget.6866; Perez M, 2012, J MOL CELL BIOL, V4, P316, DOI 10.1093/jmcb/mjs047; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Qi JF, 2013, CELL BIOCHEM BIOPHYS, V67, P15, DOI 10.1007/s12013-013-9636-2; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shah M, 2009, PIGM CELL MELANOMA R, V22, P799, DOI 10.1111/j.1755-148X.2009.00628.x; Ske-Hohlfeld I. B., 2008, CANC EPIDEMIOLOGY MO, P3; Wang L, 2008, J BIOL CHEM, V283, P25928, DOI 10.1074/jbc.M801326200; Weichert W, 2004, BRIT J CANCER, V90, P815, DOI 10.1038/sj.bjc.6601610; Wiest J, 2001, GENE CHROMOSOME CANC, V32, P384, DOI 10.1002/gcc.1204; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219; Wong CSF, 2013, CANCER RES, V73, P2400, DOI 10.1158/0008-5472.CAN-12-4348; Xie SQ, 2005, ONCOGENE, V24, P277, DOI 10.1038/sj.onc.1208218; Xu DZ, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-5; Xu DZ, 2010, J BIOL CHEM, V285, P39935, DOI 10.1074/jbc.M110.166462; Xu DZ, 2010, J BIOL CHEM, V285, P38944, DOI 10.1074/jbc.M110.160325; Yang YL, 2008, CANCER RES, V68, P4077, DOI 10.1158/0008-5472.CAN-07-6182; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zimmerman WC, 2007, P NATL ACAD SCI USA, V104, P1847, DOI 10.1073/pnas.0610856104; Zitouni S, 2014, NAT REV MOL CELL BIO, V15, P433, DOI 10.1038/nrm3819	41	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11431	11444		10.1074/jbc.M116.767178	http://dx.doi.org/10.1074/jbc.M116.767178			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28515325	Green Published, hybrid			2022-12-26	WOS:000405119600026
J	Santos, CL; Santos, RS; Moraes, L; Samary, CS; Felix, NS; Silva, JD; Morales, MM; Huhle, R; Abreu, MG; Schanaider, A; Silva, PL; Pelosi, P; Rocco, PRM				Santos, Cintia L.; Santos, Raquel S.; Moraes, Lillian; Samary, Cynthia S.; Felix, Nathane S.; Silva, Johnatas D.; Morales, Marcelo M.; Huhle, Robert; Abreu, Marcelo G.; Schanaider, Alberto; Silva, Pedro L.; Pelosi, Paolo; Rocco, Patricia R. M.			Effects of pressure support and pressure-controlled ventilation on lung damage in a model of mild extrapulmonary acute lung injury with intra-abdominal hypertension	PLOS ONE			English	Article							ABDOMINAL COMPARTMENT SYNDROME; END-EXPIRATORY PRESSURE; CRITICALLY-ILL PATIENTS; MECHANICAL VENTILATION; BIOLOGICAL IMPACT; PULMONARY; AIRWAY; OXYGENATION; VOLUME; INFLAMMATION	Intra-abdominal hypertension (IAH) may co-occur with the acute respiratory distress syndrome (ARDS), with significant impact on morbidity and mortality. Lung-protective controlled mechanical ventilation with low tidal volume and positive end-expiratory pressure (PEEP) has been recommended in ARDS. However, mechanical ventilation with spontaneous breathing activity may be beneficial to lung function and reduce lung damage in mild ARDS. We hypothesized that preserving spontaneous breathing activity during pressure support ventilation (PSV) would improve respiratory function and minimize ventilator-induced lung injury (VILI) compared to pressure-controlled ventilation (PCV) in mild extrapulmonary acute lung injury (ALI) with IAH. Thirty Wistar rats (334 +/- 55g) received Escherichia coli lipopolysaccharide intraperitoneally (1000 mu g) to induce mild extrapulmonary ALI. After 24h, animals were anesthetized and randomized to receive PCV or PSV. They were then further randomized into subgroups without or with IAH (15 mmHg) and ventilated with PCV or PSV (PEEP = 5cmH(2)O, driving pressure adjusted to achieve tidal volume = 6mL/kg) for 1h. Six of the 30 rats were used for molecular biology analysis and were not mechanically ventilated. The main outcome was the effect of PCV versus PSV on mRNA expression of interleukin (IL)-6 in lung tissue. Regardless of whether IAH was present, PSV resulted in lower mean airway pressure (with no differences in peak airway or peak and mean transpulmonary pressures) and less mRNA expression of biomarkers associated with lung inflammation (IL-6) and fibrogenesis (type III procollagen) than PCV. In the presence of IAH, PSV improved oxygenation; decreased alveolar collapse, interstitial edema, and diffuse alveolar damage; and increased expression of surfactant protein B as compared to PCV. In this experimental model of mild extrapulmonary ALI associated with IAH, PSV compared to PCV improved lung function and morphology and reduced type 2 epithelial cell damage.	[Santos, Cintia L.; Santos, Raquel S.; Moraes, Lillian; Samary, Cynthia S.; Felix, Nathane S.; Silva, Johnatas D.; Silva, Pedro L.; Rocco, Patricia R. M.] Univ Fed Rio de Janeiro, Lab Pulm Invest, Carlos Chagas Filho Inst Biophys, Av Carlos Chagas Filho S-N,Bloco G-014, Rio De Janeiro, RJ, Brazil; [Santos, Cintia L.; Schanaider, Alberto] Univ Fed Rio de Janeiro, Lab Expt Surg, Fac Med, Av Prof Rodolpho Paulo Rocco 225, Rio De Janeiro, RJ, Brazil; [Morales, Marcelo M.] Univ Fed Rio de Janeiro, Lab Cellular & Mol Physiol, Carlos Chagas Filho Inst Biophys, Av Carlos Chagas Filho S-N,Bloco G2-048, Rio De Janeiro, RJ, Brazil; [Huhle, Robert; Abreu, Marcelo G.] Tech Univ Dresden, Dept Anesthesiol & Intens Care Therapy, Pulm Engn Grp, Univ Hosp Carl Gustav Carus, Fetschertsr 74, Dresden, Germany; [Pelosi, Paolo] Univ Genoa, Dept Surg Sci & Integrated Diagnost, IRCCS AOU San Martino IST, Largo Rosanna Benzi 8, Genoa, Italy	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Genoa; IRCCS AOU San Martino IST	Rocco, PRM (corresponding author), Univ Fed Rio de Janeiro, Lab Pulm Invest, Carlos Chagas Filho Inst Biophys, Av Carlos Chagas Filho S-N,Bloco G-014, Rio De Janeiro, RJ, Brazil.	prmrocco@gmail.com	Rocco, Patricia/I-7460-2012; Silva, Johnatas D/I-6478-2017; Silva, Pedro Leme/AAD-8236-2019; Huhle, Robert/GYQ-7985-2022	Rocco, Patricia/0000-0003-1412-7136; Silva, Johnatas D/0000-0003-4379-4237; Silva, Pedro Leme/0000-0001-5838-4949; samary, cynthia/0000-0002-1860-4166; Pelosi, Paolo/0000-0001-5055-3023	Carlos Chagas Filho Rio de Janeiro State Research Foundation (FAPERJ), Rio de Janeiro, Brazil [E-26/103.118/2014]; Brazilian Council for Scientific and Technological Development (CNPq)), Brasilia, Brazil [471438/2012-0]	Carlos Chagas Filho Rio de Janeiro State Research Foundation (FAPERJ), Rio de Janeiro, Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian Council for Scientific and Technological Development (CNPq)), Brasilia, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Carlos Chagas Filho Rio de Janeiro State Research Foundation (FAPERJ; grant number E-26/103.118/2014), Rio de Janeiro, Brazil; and the Brazilian Council for Scientific and Technological Development (CNPq; grant number 471438/2012-0), Brasilia, Brazil.	Akamine R, 2007, J BIOCHEM BIOPH METH, V70, P481, DOI 10.1016/j.jbbm.2006.11.008; BAYDUR A, 1982, AM REV RESPIR DIS, V126, P788; Blanch L, 2015, INTENS CARE MED, V41, P633, DOI 10.1007/s00134-015-3692-6; Brochard L, 2017, AM J RESP CRIT CARE, V195, P438, DOI 10.1164/rccm.201605-1081CP; Carvalho AR, 2009, ANESTH ANALG, V109, P856, DOI 10.1213/ane.0b013e3181aff245; Carvalho NC, 2014, CRIT CARE MED, V42, pE702, DOI 10.1097/CCM.0000000000000605; Cortes-Puentes GA, 2015, CRIT CARE MED, V43, pE287, DOI 10.1097/CCM.0000000000001036; Cortes-Puentes GA, 2013, J TRAUMA ACUTE CARE, V74, P1468, DOI 10.1097/TA.0b013e31829243a7; De Waele JJ, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0879-8; Deeren DH, 2005, INTENS CARE MED, V31, P1577, DOI 10.1007/s00134-005-2802-2; Dolinay T, 2006, PHYSIOL GENOMICS, V26, P68, DOI 10.1152/physiolgenomics.00110.2005; Grasso F, 2008, AM J RESP CRIT CARE, V177, P412, DOI 10.1164/rccm.200707-1004OC; Guldner A, 2016, CRIT CARE MED, V44, pE854, DOI 10.1097/CCM.0000000000001721; Guldner A, 2014, ANESTHESIOLOGY, V120, P673, DOI 10.1097/ALN.0000000000000124; Henzler D, 2010, INTENS CARE MED, V36, P1427, DOI 10.1007/s00134-010-1827-3; Holodinsky JK, 2013, CRIT CARE, V17, DOI 10.1186/cc13075; Ke L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033125; Kirkpatrick AW, 2013, INTENS CARE MED, V39, P1190, DOI 10.1007/s00134-013-2906-z; Kiss T, 2016, BRIT J ANAESTH, V116, P708, DOI 10.1093/bja/aew093; Kopernik G, 1998, AM J OBSTET GYNECOL, V179, P1503, DOI 10.1016/S0002-9378(98)70016-X; Lima Ricardo Antonio Correia, 2011, Rev Col Bras Cir, V38, P417; Malbrain MLNG, 2014, MINERVA ANESTESIOL, V80, P293; Malbrain MLNG, 2004, INTENS CARE MED, V30, P822, DOI 10.1007/s00134-004-2169-9; Malbrain MLNG, 2005, CRIT CARE MED, V33, P315, DOI 10.1097/01.CCM.0000153408.09806.1B; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Moraes L, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0474-4; MUTOH T, 1992, J APPL PHYSIOL, V72, P575, DOI 10.1152/jappl.1992.72.2.575; Neumann P, 2005, CRIT CARE MED, V33, P1090, DOI 10.1097/01.CCM.0000163226.34868.0A; Padilha Gisele de A, 2016, Intensive Care Med Exp, V4, P35; Pellegrini M, 2016, AM J RESP CRIT CARE; Pelosi P, 2007, ACTA CLIN BELG, V62, P78, DOI 10.1179/acb.2007.62.s1.011; Pelosi P, 2012, CRIT CARE, V16, DOI 10.1186/cc11874; Putensen C, 2009, ANN INTERN MED, V151, P566, DOI 10.7326/0003-4819-151-8-200910200-00011; Quintel M, 2004, AM J RESP CRIT CARE, V169, P534, DOI 10.1164/rccm.200209-1060OC; Regli A, 2012, CRIT CARE, V16, DOI 10.1186/cc11840; Regli A, 2012, CRIT CARE MED, V40, P1879, DOI 10.1097/CCM.0b013e31824e0e80; Riva DR, 2008, CRIT CARE MED, V36, P1900, DOI 10.1097/CCM.0b013e3181760e5d; Roberts DJ, 2016, CURR OPIN CRIT CARE, V22, P174, DOI 10.1097/MCC.0000000000000289; Rocco PRM, 2012, CURR OPIN ANESTHESIO, V25, P123, DOI 10.1097/ACO.0b013e32834f8c7f; Rocco PRM, 2001, AM J RESP CRIT CARE, V164, P1067, DOI 10.1164/ajrccm.164.6.2007062; Saddy F, 2013, CRIT CARE, V17, DOI 10.1186/cc13051; Saddy F, 2010, INTENS CARE MED, V36, P1417, DOI 10.1007/s00134-010-1808-6; Samary CS, 2015, ANESTHESIOLOGY, V123, P423, DOI 10.1097/ALN.0000000000000716; Santos CL, 2012, INTENS CARE MED, V38, P499, DOI 10.1007/s00134-011-2451-6; Santos CL, 2014, CRIT CARE, V18, DOI 10.1186/cc13920; Santos CL SR, 2015, INTENS CARE MED, V3, pA806; Schmittgen Thomas D., 2008, V429, P89, DOI 10.1007/978-1-60327-040-3_7; Silva PL, 2016, EXPERT REV RESP MED, V10, P1243, DOI 10.1080/17476348.2016.1251842; Spieth PM, 2015, ANESTHESIOLOGY, V122, P106, DOI 10.1097/ALN.0000000000000415; Spieth PM, 2011, CRIT CARE MED, V39, P746, DOI 10.1097/CCM.0b013e318206bda6; Thille AW, 2006, INTENS CARE MED, V32, P1515, DOI 10.1007/s00134-006-0301-8; Vidal MG, 2008, CRIT CARE MED, V36, P1823, DOI 10.1097/CCM.0b013e31817c7a4d; Wrigge H, 2005, CRIT CARE, V9, pR780, DOI 10.1186/cc3908; Wrigge H, 2003, ANESTHESIOLOGY, V99, P376, DOI 10.1097/00000542-200308000-00019; Yoshida T, 2016, AM J RESP CRIT CARE; Yoshida T, 2017, AM J RESP CRIT CARE, V195, P985, DOI 10.1164/rccm.201604-0748CP; Yoshida T, 2016, CRIT CARE MED, V44, pE678, DOI 10.1097/CCM.0000000000001649; Yoshida T, 2013, AM J RESP CRIT CARE, V188, P1420, DOI 10.1164/rccm.201303-0539OC; Yoshida T, 2012, CRIT CARE MED, V40, P1578, DOI 10.1097/CCM.0b013e3182451c40	59	5	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178207	10.1371/journal.pone.0178207	http://dx.doi.org/10.1371/journal.pone.0178207			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542443	gold, Green Published, Green Submitted			2022-12-26	WOS:000402062800053
J	Daigle, RM; Archambault, P; Halpern, BS; Lowndes, JSS; Cote, IM				Daigle, Remi M.; Archambault, Philippe; Halpern, Benjamin S.; Lowndes, Julia S. Stewart; Cote, Isabelle M.			Incorporating public priorities in the Ocean Health Index: Canada as a case study	PLOS ONE			English	Article							ECOSYSTEM; INDICATORS; MANAGEMENT; BENEFITS	The Ocean Health Index (OHI) is a framework to assess ocean health by considering many benefits (called 'goals') provided by the ocean provides to humans, such as food provision, tourism opportunities, and coastal protection. The OHI framework can be used to assess marine areas at global or regional scales, but how various OHI goals should be weighted to reflect priorities at those scales remains unclear. In this study, we adapted the framework in two ways for application to Canada as a case study. First, we customized the OHI goals to create a national Canadian Ocean Health Index (COHI). In particular, we altered the list of iconic species assessed, added methane clathrates and subsea permafrost as carbon storage habitats, and developed a new goal, 'Aboriginal Needs', to measure access of Aboriginal people to traditional marine hunting and fishing grounds. Second, we evaluated various goal weighting schemes based on preferences elicited from the general public in online surveys. We quantified these public preferences in three ways: using Likert scores, simple ranks from a best-worst choice experiment, and model coefficients from the analysis of elicited choice experiment. The latter provided the clearest statistical discrimination among goals, and we recommend their use because they can more accurately reflect both public opinion and the trade-offs faced by policy-makers. This initial iteration of the COHI can be used as a baseline against which future COHI scores can be compared, and could potentially be used as a management tool to prioritise actions on a national scale and predict public support for these actions given that the goal weights are based on public priorities.	[Daigle, Remi M.; Archambault, Philippe] Univ Quebec Rimouski, Inst Sci Mer, Rimouski, PQ, Canada; [Daigle, Remi M.; Halpern, Benjamin S.; Lowndes, Julia S. Stewart] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Daigle, Remi M.; Cote, Isabelle M.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada; [Daigle, Remi M.; Archambault, Philippe] Univ Laval, Dept Biol, Quebec City, PQ, Canada; [Archambault, Philippe] Stanford Univ, Hopkins Marine Stn, Stanford, CA 94305 USA; [Halpern, Benjamin S.] Imperial Coll London, Silwood Pk, Ascot, Berks, England; [Halpern, Benjamin S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA USA	University of Quebec; Universite du Quebec a Rimouski; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Simon Fraser University; Laval University; Stanford University; Imperial College London; University of California System; University of California Santa Barbara	Daigle, RM (corresponding author), Univ Quebec Rimouski, Inst Sci Mer, Rimouski, PQ, Canada.; Daigle, RM (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA.; Daigle, RM (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada.; Daigle, RM (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ, Canada.	remi.daigle.1@ulaval.ca	Cote, Isabelle/ABD-5898-2021	Daigle, Remi/0000-0001-8832-4189; Lowndes, Julia/0000-0003-1682-3872	Natural Sciences and Engineering Research Council of Canada (NSERC) [NETGP 468437-14]; Quebec-Ocean (Fonds de recherche du Quebec Nature et technologies) [186795]; Fisheries and Ocean Canada	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Quebec-Ocean (Fonds de recherche du Quebec Nature et technologies); Fisheries and Ocean Canada	Funding for this study was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC)-funded Canadian Healthy Ocean Network (CHONe; NETGP 468437-14), Quebec-Ocean (Fonds de recherche du Quebec Nature et technologies 186795), and Fisheries and Ocean Canada.	Aboriginal Affairs and Northern Development Canada, 2013, 1 NAT PROF INT MAP; Aboriginal Affairs and Northern Development Canada, 2010, REG RES PRIC SURV; Aboriginal Affairs and Northern Development Canada, 2013, IN NUN MAP; Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; Archer D, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000854; Berghofer A, 2008, MAR POLICY, V32, P243, DOI 10.1016/j.marpol.2007.09.014; Brothers LL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052222; CAIRNS J, 1993, HYDROBIOLOGIA, V263, P1, DOI 10.1007/BF00006084; Canadian Index of Wellbeing. How are Canadians Really Doing?, 2012, AR CAN REALL DOING 2, P82; Chhun S, 2015, MAR RESOUR ECON, V30, P261, DOI 10.1086/681052; Cooke SJ, 2015, FISHERIES MANAG ECOL, V22, P1, DOI 10.1111/fme.12005; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2015, COMM STAT END WILDL; Costanza Robert, 1992, P239; Daigle RM, 2016, MAR POLICY, V74, P77, DOI 10.1016/j.marpol.2016.09.012; Daigle RM, 2017, ANAL FIGURE CREATION; Daigle RM, 2017, DATA WRANGLING INCOR; Dlugokencky E., 2014, TRENDS ATMOSPHERIC C; Downing A, 2011, INDIAN J TRADIT KNOW, V10, P57; Elfes CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092589; Fenical W, 1999, MONSOONS MICROBES UN; Fetterer F, 2013, SEA ICE INDEX; FINN A, 1992, J PUBLIC POLICY MARK, V11, P12, DOI 10.1177/074391569201100202; Fisheries and Oceans Canada G of C, 2008, AB FISH STRAT; Flynn TN, 2007, J HEALTH ECON, V26, P171, DOI 10.1016/j.jhealeco.2006.04.002; Granek EF, 2010, CONSERV BIOL, V24, P207, DOI 10.1111/j.1523-1739.2009.01355.x; Halpern BS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117863; Halpern BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098995; Halpern BS, 2013, MAR POLICY, V42, P68, DOI 10.1016/j.marpol.2013.01.019; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Heinz Center, 2008, STAT NAT EC 2008 MEA, P133; Inuit Circumpolar Council-Canada (ICC-Canada), 2008, SEA IC IS OUR HIGHW; Kershner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025248; Knap A, 2002, ENVIRON HEALTH PERSP, V110, P839, DOI 10.1289/ehp.02110839; KVENVOLDEN KA, 1993, REV GEOPHYS, V31, P173, DOI 10.1029/93RG00268; Leslie HM, 2007, FRONT ECOL ENVIRON, V5, P540, DOI 10.1890/060093; Lowndes JSS, 2015, PEERJ, V3, DOI 10.7717/peerj.1503; Portnov A, 2014, J GEOPHYS RES-BIOGEO, V119, P2082, DOI 10.1002/2014JG002685; Rapport DJ, 1998, TRENDS ECOL EVOL, V13, P397, DOI 10.1016/S0169-5347(98)01449-9; Samhouri JF, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00366.1; Selig ER, 2015, ECOSYST SERV, V16, P403, DOI 10.1016/j.ecoser.2014.11.007; Statistics Canada, 2014, TABL 326 0009 AV RET; Statistics Canada, 2014, TABL 326 0015 INT IN; Statistics Canada, 2014, TABL 326 0021 CONS P; Supreme Court of Canada, 1990, SUPR COURT JUDGM R V; UNESCO, 1996, STRAT PLAN ASS PRED; Whiteman G, 2013, NATURE, V499, P401, DOI 10.1038/499401a	46	12	13	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178044	10.1371/journal.pone.0178044	http://dx.doi.org/10.1371/journal.pone.0178044			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VE	28542394	Green Submitted, Green Published, gold			2022-12-26	WOS:000402061500055
J	Simkova, O; Frydlova, P; Zampachova, B; Frynta, D; Landova, E				Simkova, Olgas; Frydlova, Petra; Zampachova, Barbora; Frynta, Daniel; Landova, Eva			Development of behavioural profile in the Northern common boa (Boa imperator): Repeatable independent traits or personality?	PLOS ONE			English	Article							CONSISTENT INDIVIDUAL-DIFFERENCES; LIFE-HISTORY STRATEGIES; ANTIPREDATOR RESPONSES; GARTER SNAKE; GREAT TITS; COPING STYLES; OPEN-FIELD; INCUBATION-TEMPERATURE; DIGESTIVE PERFORMANCE; EXPLORATORY-BEHAVIOR	Recent studies of animal personality have focused on its proximate causation and ecological and evolutionary significance in particular, but the question of its development was largely overlooked. The attributes of personality are defined as between-individual differences in behaviour, which are consistent over time (differential consistency) and contexts (contextual generality) and both can be affected by development. We assessed several candidates for personality variables measured in various tests with different contexts over several life-stages (juveniles, older juveniles, subadults and adults) in the Northern common boa. Variables describing foraging/feeding decision and some of the defensive behaviours expressed as individual average values are highly repeatable and consistent. We found two main personality axes-one associated with foraging/feeding and the speed of decision, the other reflecting agonistic behaviour. Intensity of behaviour in the feeding context changes during development, but the level of agonistic behaviour remains the same. The juveniles and adults have a similar personality structure, but there is a period of structural change of behaviour during the second year of life (subadults). These results require a new theoretical model to explain the selection pressures resulting in this developmental pattern of personality. We also studied the proximate factors and their relationship to behavioural characteristics. Physiological parameters (heart and breath rate stress response) measured in adults clustered with variables concerning the agonistic behavioural profile, while no relationship between the juvenile/adult body size and personality concerning feeding/foraging and the agonistic behavioural profile was found. Our study suggests that it is important for studies of personality development to focus on both the structural and differential consistency, because even though behaviour is differentially consistent, the structure can change.	[Simkova, Olgas; Frydlova, Petra; Zampachova, Barbora; Frynta, Daniel; Landova, Eva] Charles Univ Prague, Dept Zool, Fac Sci, Prague, Czech Republic; [Zampachova, Barbora; Frynta, Daniel; Landova, Eva] Natl Inst Mental Hlth, Klecany, Czech Republic	Charles University Prague; National Institute of Mental Health - Czech Republic	Frynta, D; Landova, E (corresponding author), Charles Univ Prague, Dept Zool, Fac Sci, Prague, Czech Republic.; Frynta, D; Landova, E (corresponding author), Natl Inst Mental Hlth, Klecany, Czech Republic.	frynta@centrum.cz; evalandova@seznam.cz	Landova, Eva/R-8759-2017; Frynta, Daniel/L-7350-2016; Frýdlová, Petra/P-5008-2016; Zampachova, Barbora/R-9320-2017	Landova, Eva/0000-0001-8365-8710; Frynta, Daniel/0000-0002-1375-7972; Frýdlová, Petra/0000-0001-9385-9743; Zampachova, Barbora/0000-0002-6285-0495	MEYS under NPU I program; Grant Agency of Charles University [1310414, 346315]; Czech Science Foundation (GACR) [17-15991S];  [LO1611]	MEYS under NPU I program; Grant Agency of Charles University; Czech Science Foundation (GACR)(Grant Agency of the Czech Republic); 	This study is a result of the research funded by the project Nr. LO1611 with financial support from the MEYS under the NPU I program (DF EL BZ) (http://www.msmt.cz/vyzkum-a-vyvoj-2/npu-i-lo-1). The project was supported by the Grant Agency of Charles University (1310414 and 346315) (DF EL) (http://www.cuni.cz/UKEN-65.html) and by the Czech Science Foundation (GACR) project Nr. 17-15991S (EL DF) (https://gacr.cz/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi AM, 1998, BRAIN RES BULL, V47, P57, DOI 10.1016/S0361-9230(98)00063-X; Aplin LM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1016; ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; ARNOLD SJ, 1984, ANIM BEHAV, V32, P1108, DOI 10.1016/S0003-3472(84)80227-4; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Bell AM, 2004, ANIM BEHAV, V68, P1339, DOI 10.1016/j.anbehav.2004.05.007; Bergmuller R, 2010, TRENDS ECOL EVOL, V25, P504, DOI 10.1016/j.tree.2010.06.012; Besson AA, 2016, BIOL REV, V91, P1065, DOI 10.1111/brv.12210; BOISSY A, 1995, Q REV BIOL, V70, P165, DOI 10.1086/418981; Bousquet CAH, 2015, ANIM BEHAV, V110, P145, DOI 10.1016/j.anbehav.2015.09.024; Briard L, 2015, ETHOLOGY, V121, P888, DOI 10.1111/eth.12402; BRODIE ED, 1993, ANIM BEHAV, V45, P851, DOI 10.1006/anbe.1993.1106; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; CANDLAND DK, 1969, ANN NY ACAD SCI, V159, P831, DOI 10.1111/j.1749-6632.1969.tb12982.x; Carazo P, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3275; Card DC, 2016, MOL PHYLOGENET EVOL, V102, P104, DOI 10.1016/j.ympev.2016.05.034; Careau V, 2012, PHYSIOL BIOCHEM ZOOL, V85, P543, DOI 10.1086/666970; Carere C, 2004, PHYSIOL BEHAV, V82, P905, DOI 10.1016/j.physbeh.2004.07.009; Carere C, 2005, ANIM BEHAV, V70, P795, DOI 10.1016/j.anbehav.2005.01.003; Carere C, 2010, CURR ZOOL, V56, P728, DOI 10.1093/czoolo/56.6.728; Carrasco JL, 2005, STAT MED, V24, P4021, DOI 10.1002/sim.2397; Carter AW, 2016, PHYSIOL BEHAV, V155, P46, DOI 10.1016/j.physbeh.2015.11.034; Caspi A, 2005, ANNU REV PSYCHOL, V56, P453, DOI 10.1146/annurev.psych.55.090902.141913; Chapman BB, 2013, PLOS ONE, V8; CHISZAR D, 1976, ANIM LEARN BEHAV, V4, P273, DOI 10.3758/BF03214049; CLARK CW, 1994, BEHAV ECOL, V5, P159, DOI 10.1093/beheco/5.2.159; Class B, 2016, BEHAV ECOL SOCIOBIOL, V70, P733, DOI 10.1007/s00265-016-2096-0; Cote J, 2007, P R SOC B, V274, P383, DOI 10.1098/rspb.2006.3734; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; de Boer SF, 2017, NEUROSCI BIOBEHAV R, V74, P401, DOI 10.1016/j.neubiorev.2016.07.008; delBarrio V, 1997, PERS INDIV DIFFER, V23, P327, DOI 10.1016/S0191-8869(97)00030-5; Dingemanse NJ, 2010, PHILOS T R SOC B, V365, P3947, DOI 10.1098/rstb.2010.0221; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; DuRant SE, 2008, GEN COMP ENDOCR, V156, P126, DOI 10.1016/j.ygcen.2007.12.004; Edenbrow M, 2013, OIKOS, V122, P667, DOI 10.1111/j.1600-0706.2012.20556.x; FLORES D, 1994, PHYSIOL BEHAV, V55, P1067, DOI 10.1016/0031-9384(94)90389-1; Frynta D, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1369-9; Gardner-Santana LC, 2009, COPEIA, P363, DOI 10.1643/CP-07-271; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Groothuis TGG, 2011, DEV PSYCHOBIOL, V53, P641, DOI 10.1002/dev.20574; Guenther A, 2014, ANIM BEHAV, V90, P131, DOI 10.1016/j.anbehav.2014.01.032; Guenther A, 2013, BEHAV ECOL, V24, P402, DOI 10.1093/beheco/ars177; Gullone E, 2000, J ADOLESCENCE, V23, P393, DOI 10.1006/jado.2000.0327; Gyuris E, 2012, ANIM BEHAV, V84, P103, DOI 10.1016/j.anbehav.2012.04.014; Hawlena D, 2006, BEHAV ECOL, V17, P889, DOI 10.1093/beheco/arl023; Hedrick AV, 2012, BEHAV ECOL SOCIOBIOL, V66, P407, DOI 10.1007/s00265-011-1286-z; Herborn KA, 2011, J EXP BIOL, V214, P1732, DOI 10.1242/jeb.051383; Herczeg G, 2013, J EVOLUTION BIOL, V26, P955, DOI 10.1111/jeb.12103; HERZOG H A JR, 1974, Herpetologica, V30, P285; HERZOG HA, 1992, DEV PSYCHOBIOL, V25, P199, DOI 10.1002/dev.420250305; HERZOG HA, 1988, ETHOLOGY, V77, P250; HERZOG HA, 1987, J COMP PSYCHOL, V101, P387, DOI 10.1037/0735-7036.101.4.387; HERZOG HA, 1986, J COMP PSYCHOL, V100, P372, DOI 10.1037/0735-7036.100.4.372; HERZOG HA, 1989, DEV PSYCHOBIOL, V22, P489, DOI 10.1002/dev.420220507; Hudson R, 2011, DEV PSYCHOBIOL, V53, P564, DOI 10.1002/dev.20535; Hynkova I, 2009, ZOOL SCI, V26, P623, DOI 10.2108/zsj.26.623; Jones KA, 2010, P ROY SOC B-BIOL SCI, V277, P625, DOI 10.1098/rspb.2009.1607; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kralj-Fiser S, 2014, ANIM BEHAV, V91, P41, DOI 10.1016/j.anbehav.2014.02.016; Landova E, 2013, BEHAV ECOL SOCIOBIOL, V67, P1113, DOI 10.1007/s00265-013-1536-3; Langkilde T, 2006, J EXP BIOL, V209, P1035, DOI 10.1242/jeb.02112; Le Galliard JF, 2015, J EVOLUTION BIOL, V28, P1144, DOI 10.1111/jeb.12641; Le Galliard JF, 2013, FUNCT ECOL, V27, P136, DOI 10.1111/1365-2435.12017; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Li H, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0217; Lillywhite HB, 1999, COMP BIOCHEM PHYS A, V124, P369, DOI 10.1016/S1095-6433(99)00129-4; LIND AJ, 1994, ANIM BEHAV, V48, P1261, DOI 10.1006/anbe.1994.1362; Lopez P, 2005, ANIM BEHAV, V69, P1, DOI 10.1016/j.anbehav.2004.05.010; Luttbeg B, 2010, PHILOS T R SOC B, V365, P3977, DOI 10.1098/rstb.2010.0207; Magnhagen C, 2007, BEHAV ECOL SOCIOBIOL, V61, P525, DOI 10.1007/s00265-006-0280-3; Mayer M, 2016, BEHAVIOUR, V153, P313, DOI 10.1163/1568539X-00003343; McCowan LSC, 2015, BEHAV ECOL, V26, P735, DOI 10.1093/beheco/aru239; McEvoy J, 2015, J ZOOL, V296, P58, DOI 10.1111/jzo.12217; Mell H, 2016, BEHAV ECOL SOCIOBIOL, V70, P951, DOI 10.1007/s00265-016-2117-z; Miller RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149849; MONTGOMERY GG, 1978, COPEIA, P532; Montiglio PO, 2014, J ANIM ECOL, V83, P720, DOI 10.1111/1365-2656.12174; Montiglio PO, 2012, ANIM BEHAV, V84, P1071, DOI 10.1016/j.anbehav.2012.08.010; Muller T, 2015, FRONT ZOOL, V12, DOI 10.1186/1742-9994-12-S1-S8; Naguib M, 2011, DEV PSYCHOBIOL, V53, P592, DOI 10.1002/dev.20533; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nyqvist MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031619; OSSENKOPP KP, 1994, BEHAV PROCESS, V31, P129, DOI 10.1016/0376-6357(94)90001-9; Ott BD, 2007, J EXP BIOL, V210, P340, DOI 10.1242/jeb.02626; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; Petelle MB, 2013, ANIM BEHAV, V86, P1147, DOI 10.1016/j.anbehav.2013.09.016; Reale D, 2009, J EVOLUTION BIOL, V22, P1599, DOI 10.1111/j.1420-9101.2009.01781.x; Reale D, 2012, ANIMAL PERSONALITY E; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Rodda G.H., 2009, GIANT CONSTRICTORS B; Schuett GW, 2005, J ZOOL, V267, P363, DOI 10.1017/S0952836905007624; Secor SM, 2001, COMP BIOCHEM PHYS A, V128, P565, DOI 10.1016/S1095-6433(00)00325-1; Secor SM, 2000, J EXP BIOL, V203, P2447; Sih A, 2003, ANIM BEHAV, V65, P29, DOI 10.1006/anbe.2002.2025; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sinn DL, 2008, ANIM BEHAV, V75, P433, DOI 10.1016/j.anbehav.2007.05.008; Sinn DL, 2005, J COMP PSYCHOL, V119, P99, DOI 10.1037/0735-7036.119.1.99; Siviter H, 2017, ANIM COGN, V20, P109, DOI 10.1007/s10071-016-1030-1; Smith BR, 2012, BEHAVIOUR, V149, P187, DOI 10.1163/156853912X634133; Snijders L, 2015, ANIM BEHAV, V109, P45, DOI 10.1016/j.anbehav.2015.07.037; Sommer-Trembo C, 2016, J ETHOL, V34, P155, DOI 10.1007/s10164-016-0460-1; Stamps JA, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00069; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Stamps JA, 2016, CURR OPIN BEHAV SCI, V12, P18, DOI 10.1016/j.cobeha.2016.08.008; Stamps JA, 2014, AM NAT, V184, P647, DOI 10.1086/678116; Stamps JA, 2010, PHILOS T R SOC B, V365, P4029, DOI 10.1098/rstb.2010.0218; Statsoft S, 2001, STATISTICA; STINNER JN, 1993, AM J PHYSIOL, V264, pR79, DOI 10.1152/ajpregu.1993.264.1.R79; Stowe M, 2007, J ORNITHOL, V148, pS179, DOI 10.1007/s10336-007-0145-1; Suchomelova P, 2015, BEHAV PROCESS, V120, P14, DOI 10.1016/j.beproc.2015.08.005; Talarovicova A, 2009, HORM BEHAV, V55, P235, DOI 10.1016/j.yhbeh.2008.10.010; Team RDC, 2012, R LANG ENV STAT COMP; Trillmich F, 2011, DEV PSYCHOBIOL, V53, P505, DOI 10.1002/dev.20573; Trnik M, 2011, J COMP PSYCHOL, V125, P22, DOI 10.1037/a0021186; Urszan TJ, 2015, OECOLOGIA, V178, P129, DOI 10.1007/s00442-014-3207-0; van Oers K, 2004, P ROY SOC B-BIOL SCI, V271, P65, DOI 10.1098/rspb.2003.2518; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344; Verbeek MEM, 1996, EXPLORATION AGGRESSI, P11; Vetter SG, 2016, ANIM BEHAV, V115, P193, DOI 10.1016/j.anbehav.2016.03.026; Webb JK, 2003, AUSTRAL ECOL, V28, P601, DOI 10.1046/j.1442-9993.2003.t01-1-01316.x; Weiss A, 2007, AM J PRIMATOL, V69, P1264, DOI 10.1002/ajp.20428; Wilson ADM, 2012, BEHAV ECOL, V23, P1316, DOI 10.1093/beheco/ars123; Wilson D, 2007, BIOL LETT-UK, V3, P40, DOI 10.1098/rsbl.2006.0574; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Wuerz Y, 2015, FRONT ZOOL, V12, DOI 10.1186/1742-9994-12-S1-S9; Zhao DP, 2015, CURR ZOOL, V61, P966, DOI 10.1093/czoolo/61.6.966	127	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177911	10.1371/journal.pone.0177911	http://dx.doi.org/10.1371/journal.pone.0177911			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542424	Green Published, Green Submitted, gold			2022-12-26	WOS:000402061500044
J	Ren, MY; Feng, RJ; Shi, HR; Lu, LF; Yun, TY; Peng, M; Guan, X; Zhang, H; Wang, JY; Zhang, XY; Li, CL; Chen, YJ; He, P; Zhang, YD; Xie, JH				Ren, Meng Yun; Feng, Ren Jun; Shi, Hou Rui; Lu, Li Fang; Yun, Tian Yan; Peng, Ming; Guan, Xiao; Zhang, Heng; Wang, Jing Yi; Zhang, Xi Yan; Li, Cheng Liang; Chen, Yan Jun; He, Peng; Zhang, Yin Dong; Xie, Jiang Hui			Expression patterns of members of the ethylene signaling-related gene families in response to dehydration stresses in cassava	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; PROLINE ACCUMULATION; MANIHOT-ESCULENTA; LOW-TEMPERATURE; ARABIDOPSIS; DROUGHT; PATHWAY; RECEPTOR; OVEREXPRESSION; RESISTANCE	Drought is the one of the most important environment stresses that restricts crop yield worldwide. Cassava (Manihot esculenta Crantz) is an important food and energy crop that has many desirable traits such as drought, heat and low nutrients tolerance. However, the mechanisms underlying drought tolerance in cassava are unclear. Ethylene signaling pathway, from the upstream receptors to the downstream transcription factors, plays important roles in environmental stress responses during plant growth and development. In this study, we used bioinformatics approaches to identify and characterize candidate Manihot esculenta ethylene receptor genes and transcription factor genes. Using computational methods, we localized these genes on cassava chromosomes, constructed phylogenetic trees and identified stress-responsive cis-elements within their 5' upstream regions. Additionally, we measured the trehalose and proline contents in cassava fresh leaves after drought, osmotic, and salt stress treatments, and then it was found that the regulation patterns of contents of proline and trehalose in response to various dehydration stresses were differential, or even the opposite, which shows that plant may take different coping strategies to deal with different stresses, when stresses come. Furthermore, expression profiles of these genes in different organs and tissues under non-stress and abiotic stress were investigated through quantitative real-time PCR (qRT-PCR) analyses in cassava. Expression profiles exhibited clear differences among different tissues under non-stress and various dehydration stress conditions. We found that the leaf and tuberous root tissues had the greatest and least responses, respectively, to drought stress through the ethylene signaling pathway in cassava. Moreover, tuber and root tissues had the greatest and least reponses to osmotic and salt stresses through ethylene signaling in cassava, respectively. These results show that these plant tissues had differential expression levels of genes involved in ethylene signaling in response to the stresses tested. Moreover, after several gene duplication events, the spatiotemporally differential expression pattern of homologous genes in response to abiotic and biotic stresses may imply their functional diversity as a mechanism for adapting to the environment. Our data provide a framework for further research on the molecular mechanisms of cassava resistance to drought stress and provide a foundation for breeding drought-resistant new cultivars.	[Ren, Meng Yun; Shi, Hou Rui; Yun, Tian Yan; Zhang, Heng; Li, Cheng Liang; Chen, Yan Jun; Zhang, Yin Dong] Hainan Univ, Coll Agron, Haikou, Peoples R China; [Feng, Ren Jun; Peng, Ming; Wang, Jing Yi; Zhang, Xi Yan; Xie, Jiang Hui] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Biol & Genet Resources Trop Crops, Haikou, Peoples R China; [Lu, Li Fang] Hainan Inst Sci & Technol, Haikou, Peoples R China; [Guan, Xiao] Chinese Res Inst Environm Sci, Beijing, Peoples R China; [He, Peng] Chinese Acad Trop Agr Sci, Rubber Res Inst, Minist Agr, Key Lab Rubber Biol, Danzhou, Hainan, Peoples R China	Hainan University; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Research Academy of Environmental Sciences; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Zhang, YD (corresponding author), Hainan Univ, Coll Agron, Haikou, Peoples R China.; Xie, JH (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Biol & Genet Resources Trop Crops, Haikou, Peoples R China.; He, P (corresponding author), Chinese Acad Trop Agr Sci, Rubber Res Inst, Minist Agr, Key Lab Rubber Biol, Danzhou, Hainan, Peoples R China.	penghe1974@163.com; 23300558@163.com; 2453880045@qq.com	WANG, JINGYI/GSJ-1241-2022		National Nature Science Foundation of China [31201603, 31501043]; National High Technology Research and Development Program of China (863 Programme) [2012AA101204-2]; Major Science and Technology program of Hainan [ZDZX2013023-1]; Hainan Natural Science Foundation [312050, 312051]; Graduate Outstanding Dissertation Cultivation Plan of Hainan University [15]; Natural Science Foundation of Hainan Province [312050, 312051]; Major Science and Technology Program of Hainan Province [ZDZX2013023-1]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Programme)(National High Technology Research and Development Program of China); Major Science and Technology program of Hainan; Hainan Natural Science Foundation; Graduate Outstanding Dissertation Cultivation Plan of Hainan University; Natural Science Foundation of Hainan Province; Major Science and Technology Program of Hainan Province	This study was supported by the National Nature Science Foundation of China (31201603, 31501043) to RJF; the National High Technology Research and Development Program of China (863 Programme; no. 2012AA101204-2) to MP; the Major Science and Technology program of Hainan (ZDZX2013023-1) to MP; the Hainan Natural Science Foundation (312050, 312051) to RJF and JYW; and the Graduate Outstanding Dissertation Cultivation Plan of Hainan University (15) to MYR; This research was supported by grants from the National Nature Science Foundation of China (31201603, 31501043), the National High Technology Research and Development Program of China (863 Programme; No. 2012AA101204-2), the Major Science and Technology Program of Hainan Province (CN) (ZDZX2013023-1), the Natural Science Foundation of Hainan Province (CN) (312050, 312051), and the Graduate Outstanding Dissertation Cultivation Plan of Hainan University (CN) (15).	Alonso JM, 2003, P NATL ACAD SCI USA, V100, P2992, DOI 10.1073/pnas.0438070100; Alves AAC, 2004, ANN BOT-LONDON, V94, P605, DOI 10.1093/aob/mch179; An D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-64; An FY, 2010, PLANT CELL, V22, P2384, DOI 10.1105/tpc.110.076588; Benavente LM, 2006, MOL BIOSYST, V2, P165, DOI 10.1039/b513874d; Calatayud PA, 2000, PHOTOSYNTHETICA, V38, P97, DOI 10.1023/A:1026704226276; Carretero CL, 2008, J PLANT NUTR, V31, P959, DOI 10.1080/01904160802043296; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Cheng MC, 2013, PLANT PHYSIOL, V162, P1566, DOI [10.1104/pp.113.221911, 10.1104]; Curtis J, 2004, PLANT PHYSIOL, V136, P3313, DOI 10.1104/pp.104.044024; DANIELLO A, 1985, ANAL BIOCHEM, V144, P610, DOI 10.1016/0003-2697(85)90160-5; ECKER JR, 1995, SCIENCE, V268, P667, DOI 10.1126/science.7732375; El-Sharkawy MA, 2006, PHOTOSYNTHETICA, V44, P481, DOI 10.1007/s11099-006-0063-0; ELSHARKAWY MA, 1987, PLANT SOIL, V100, P345, DOI 10.1007/BF02370950; Feng JX, 2005, PLANT MOL BIOL, V59, P853, DOI 10.1007/s11103-005-1511-0; Freitas FZ, 2004, MOL GENET GENOMICS, V272, P550, DOI 10.1007/s00438-004-1086-5; Garcia AB, 1997, PLANT PHYSIOL, V115, P159, DOI 10.1104/pp.115.1.159; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Gleadow R, 2016, J EXP BOT, V67, P5403, DOI 10.1093/jxb/erw302; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Hays DB, 2007, PLANT SCI, V172, P1113, DOI 10.1016/j.plantsci.2007.03.004; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Jansson C, 2009, APPL ENERG, V86, pS95, DOI 10.1016/j.apenergy.2009.05.011; Ji XM, 2011, PLANT PHYSIOL, V156, P647, DOI 10.1104/pp.111.176164; Kato K, 2009, PLANT PHYSIOL, V149, P1945, DOI 10.1104/pp.109.135582; Kim H, 2011, PLANT PHYSIOL, V156, P417, DOI 10.1104/pp.110.170621; Kondrak M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-74; Laban T. F., 2013, International Journal of Agriculture and Crop Sciences (IJACS), V5, P212; Lashbrook CC, 1998, PLANT J, V15, P243, DOI 10.1046/j.1365-313X.1998.00202.x; Laurentin A, 2003, ANAL BIOCHEM, V315, P143, DOI 10.1016/S0003-2697(02)00704-2; Li HJ, 2007, J PLANT GROWTH REGUL, V26, P106, DOI 10.1007/s00344-007-0015-3; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nassar NMA, 2008, GENET MOL RES, V7, P16, DOI 10.4238/vol7-1gmr389; Okogbenin E, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00093; Olsen KM, 2001, AM J BOT, V88, P131, DOI 10.2307/2657133; Peng JY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004664; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sato-Nara K, 1999, PLANT PHYSIOL, V120, P321, DOI 10.1104/pp.120.1.321; [山蓝 Shan Lan], 2002, [植物生理学通讯, Plant Physiology Communications], V38, P463; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tardieu F, 2014, PLANT PHYSIOL, V164, P1628, DOI 10.1104/pp.113.233353; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Verslues PE, 2014, PLANT PHYSIOL, V164, P144, DOI 10.1104/pp.113.224014; WALDREN RP, 1974, PLANT SOIL, V40, P689, DOI 10.1007/BF00010525; Walker AK, 2000, J BIOL CHEM, V275, P22166, DOI 10.1074/jbc.M001746200; Wang H, 2004, PLANT MOL BIOL, V55, P183, DOI 10.1007/s11103-004-0113-6; Whankaew S., 2015, African Journal of Biotechnology, V14, P745; Xie F, 2006, PLANT PHYSIOL, V142, P492, DOI 10.1104/pp.106.082628; Xu ZS, 2007, PLANT MOL BIOL, V65, P719, DOI 10.1007/s11103-007-9237-9; Yan SC, 2011, J SCI FOOD AGR, V91, P650, DOI 10.1002/jsfa.4226; Yau CP, 2004, J EXP BOT, V55, P547, DOI 10.1093/jxb/erh055; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang GY, 2009, J EXP BOT, V60, P3781, DOI 10.1093/jxb/erp214; Zhang GY, 2008, J EXP BOT, V59, P4095, DOI 10.1093/jxb/ern248; Zhang HB, 2004, PLANT MOL BIOL, V55, P825, DOI 10.1007/s11103-005-2140-3; Zhang ZY, 2007, J EXP BOT, V58, P2993, DOI 10.1093/jxb/erm151; Zhang ZJ, 2010, PLANTA, V232, P765, DOI 10.1007/s00425-010-1208-8; Zhuang J, 2011, MOL BIOL REP, V38, P745, DOI 10.1007/s11033-010-0162-7	63	9	11	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177621	10.1371/journal.pone.0177621	http://dx.doi.org/10.1371/journal.pone.0177621			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542282	Green Submitted, Green Published, gold			2022-12-26	WOS:000402058800020
J	Carlin, DA; Hapig-Ward, S; Chan, BW; Damrau, N; Riley, M; Caster, RW; Bethards, B; Siegel, JB				Carlin, Dylan Alexander; Hapig-Ward, Siena; Chan, Bill Wayne; Damrau, Natalie; Riley, Mary; Caster, Ryan W.; Bethards, Bowen; Siegel, Justin B.			Thermal stability and kinetic constants for 129 variants of a family 1 glycoside hydrolase reveal that enzyme activity and stability can be separately designed	PLOS ONE			English	Article							DIRECTED EVOLUTION; FUNCTION TRADEOFFS; PROTEIN STABILITY; STRUCTURAL BASES; SPECIFICITY; LANDSCAPES; COMPLEXES	Accurate modeling of enzyme activity and stability is an important goal of the protein engineering community. However, studies seeking to evaluate current progress are limited by small data sets of quantitative kinetic constants and thermal stability measurements. Here, we report quantitative measurements of soluble protein expression in E. coli, thermal stability, and Michaelis-Menten constants (k(cat), K-M, and k(cat)/K-M) for 129 designed mutants of a glycoside hydrolase. Statistical analyses reveal that functional T-m is independent of k(cat), K-M, and k(cat)/K-M in this system, illustrating that an individual mutation can modulate these functional parameters independently. In addition, this data set is used to evaluate computational predictions of protein stability using the established Rosetta and FoldX algorithms. Predictions for both are found to correlate only weakly with experimental measurements, suggesting improvements are needed in the underlying algorithms.	[Carlin, Dylan Alexander] Univ Calif Davis, Biophys Grad Grp, Davis, CA 95616 USA; [Hapig-Ward, Siena; Chan, Bill Wayne; Damrau, Natalie; Riley, Mary; Bethards, Bowen; Siegel, Justin B.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Siegel, Justin B.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Caster, Ryan W.] Univ Calif Davis, Genet Grad Grp, Davis, CA 95616 USA; [Siegel, Justin B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Siegel, JB (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.; Siegel, JB (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.	jbsiegel@ucdavis.edu			Defense Advanced Research Projects Agency (Energy) [DE-AR0000429]; Alfred P. Sloan Foundation [BR2014-012]; UC Davis start-up Funds	Defense Advanced Research Projects Agency (Energy); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); UC Davis start-up Funds	This work was supported by Defense Advanced Research Projects Agency (Energy) #DE-AR0000429, Alfred P. Sloan Foundation #BR2014-012 and UC Davis start-up Funds, all to JBS.	Beadle BM, 2002, J MOL BIOL, V321, P285, DOI 10.1016/S0022-2836(02)00599-5; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2009, P NATL ACAD SCI USA, V106, P9995, DOI 10.1073/pnas.0901522106; Carlin DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147596; Currin A, 2015, CHEM SOC REV, V44, P1172, DOI 10.1039/c4cs00351a; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Goldenzweig A, 2016, MOL CELL, V63, P337, DOI 10.1016/j.molcel.2016.06.012; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Isorna P, 2007, J MOL BIOL, V371, P1204, DOI 10.1016/j.jmb.2007.05.082; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD204, DOI 10.1093/nar/gkj103; Leaver-Fay A, 2013, METHOD ENZYMOL, V523, P109, DOI [10.1016/B978-0-12:394292-0.00006-0, 10.1016/B978-0-12-394292-0.00006-0]; MEIERING EM, 1992, J MOL BIOL, V225, P585, DOI 10.1016/0022-2836(92)90387-Y; Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230; Romero PA, 2015, P NATL ACAD SCI USA, V112, P7159, DOI 10.1073/pnas.1422285112; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Schrodinger L., PYMOL MOL GRAPHICS S; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; SHOICHET BK, 1995, P NATL ACAD SCI USA, V92, P452, DOI 10.1073/pnas.92.2.452; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; Sunden F, 2015, ELIFE, V4, DOI 10.7554/eLife.06181; Thomas VL, 2010, J MOL BIOL, V396, P47, DOI 10.1016/j.jmb.2009.11.005; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; van der Meer JY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10911; Whitehead TA, 2012, NAT BIOTECHNOL, V30, P543, DOI 10.1038/nbt.2214; Wolf C, 2015, J AM CHEM SOC, V137, P13106, DOI 10.1021/jacs.5b08325; Wrenbeck EE, 2017, CURR OPIN STRUC BIOL, V45, P36, DOI 10.1016/j.sbi.2016.11.001	31	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0176255	10.1371/journal.pone.0176255	http://dx.doi.org/10.1371/journal.pone.0176255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531185	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058400004
J	Fuss, J; Spassov, N; Begun, DR; Bohme, M				Fuss, Jochen; Spassov, Nikolai; Begun, David R.; Boehme, Madelaine			Potential hominin affinities of Graecopithecus from the Late Miocene of Europe	PLOS ONE			English	Article							PAN-TROGLODYTES-VERUS; OURANOPITHECUS-MACEDONIENSIS; GREAT APE; SAHELANTHROPUS-TCHADENSIS; DENTAL MORPHOLOGY; ROOT MORPHOLOGY; AUSTRALOPITHECUS-BAHRELGHAZALI; PLIOPLEISTOCENE HOMINIDS; PLIOCENE HOMINIDS; ENAMEL THICKNESS	The split of our own clade from the Panini is undocumented in the fossil record. To fill this gap we investigated the dentognathic morphology of Graecopithecus freybergi from Pyrgos Vassilissis (Greece) and cf. Graecopithecus sp. from Azmaka (Bulgaria), using new mu CT and 3D reconstructions of the two known specimens. Pyrgos Vassilissis and Azmaka are currently dated to the early Messinian at 7.175 Ma and 7.24 Ma. Mainly based on its external preservation and the previously vague dating, Graecopithecus is often referred to as nomen dubium. The examination of its previously unknown dental root and pulp canal morphology confirms the taxonomic distinction from the significantly older northern Greek hominine Ouranopithecus. Furthermore, it shows features that point to a possible phylogenetic affinity with hominins. G. freybergi uniquely shares p4 partial root fusion and a possible canine root reduction with this tribe and therefore, provides intriguing evidence of what could be the oldest known hominin.	[Fuss, Jochen; Boehme, Madelaine] Eberhard Karls Univ Tubingen, Dept Geosci, Sigwartstr 10, Tubingen, Germany; [Fuss, Jochen; Boehme, Madelaine] Senckenberg Ctr Human Evolut & Palaeoenvironm HEP, Sigwartstr 10, Tubingen, Germany; [Spassov, Nikolai] Bulgarian Acad Sci, Natl Museum Nat Hist, 1 Blvd Tzar Osvoboditel, Sofia, Bulgaria; [Begun, David R.] Univ Toronto, Dept Anthropol, Toronto, ON, Canada	Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Bulgarian Academy of Sciences; University of Toronto	Bohme, M (corresponding author), Eberhard Karls Univ Tubingen, Dept Geosci, Sigwartstr 10, Tubingen, Germany.; Bohme, M (corresponding author), Senckenberg Ctr Human Evolut & Palaeoenvironm HEP, Sigwartstr 10, Tubingen, Germany.	m.boehme@ifg.uni-tuebingen.de			German Science Foundation DFG [Bo 1550/19-1]	German Science Foundation DFG(German Research Foundation (DFG))	We acknowledge funding from the German Science Foundation DFG (grant Bo 1550/19-1 to MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; For access to fossil collections, technical and scientific collaboration we thank Wieland Binczik, Wolfgang Gerber, Katerina Harvati, George D. Koufos, Veronika Kuhnert, Siegbert Schuffler, Henrik Stohr, Harald Stollhofen, and Adrian Troscher. We would like to thank the Academic Editor Roberto Macchiarelli for his careful handling of this publication. We also thank Brigitte Senut and 10 anonymous reviewers for their comments. We acknowledge funding from the German Science Foundation DFG (grant Bo 1550/19-1 to MB).	Abbott SA., 1984, COMP STUDY TOOTH ROO; Alpagut B, 1996, NATURE, V382, P349, DOI 10.1038/382349a0; Andrews Peter, 2005, P103; Beauvilain A, 2008, S AFR J SCI, V104, P165; Begun D., 2015, REAL PLANET APES NEW; Begun DR, 2012, EVOL ANTHROPOL, V21, P10, DOI 10.1002/evan.20329; Begun DR, 2001, HOM EVOLUT CLIMAT CH, V2, P231; Begun DR, 2002, CAM S BIO EVOL ANTHR, V33, P339; Begun DR, 1998, AM J PHYS ANTHROPOL, V105, P279, DOI 10.1002/(SICI)1096-8644(199803)105:3<279::AID-AJPA2>3.0.CO;2-N; BEGUN DR, 2015, HDB PALEOANTHROPOLOG, P1261, DOI DOI 10.1007/978-3-642-39979-4_32; Bohme M, PLOS ONE UNPUB; Brunet M, 2005, NATURE, V434, P752, DOI 10.1038/nature03392; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Cobb SN, 2008, J ANAT, V212, P469, DOI 10.1111/j.1469-7580.2008.00866.x; de Bonis L, 1977, Geobios Lyon, V10, P849, DOI 10.1016/S0016-6995(77)80081-8; De Bonis Louis, 1997, P317; Emonet EG, 2014, ANAT REC, V297, P1927, DOI 10.1002/ar.22959; Emonet EG, 2014, AM J PHYS ANTHROPOL, V153, P116, DOI 10.1002/ajpa.22400; Emonet EG, 2012, J HUM EVOL, V62, P146, DOI 10.1016/j.jhevol.2011.11.011; Emonet EG, KHORATPITHECUS RAD H; Evans AR, 2016, NATURE, V530, P477, DOI 10.1038/nature16972; Giles E., 1963, J PHYSL ANTHR, V22, P129; Grine FE, 2002, S AFR J SCI, V98, P503; Gulec ES, 2007, ANTHROPOL SCI, V115, P153, DOI 10.1537/ase.070501; Haile-Selassie Y, 2004, SCIENCE, V303, P1503, DOI 10.1126/science.1092978; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Haile-Selassie Y, 2015, NATURE, V521, P483, DOI 10.1038/nature14448; Haile-Selassie Y, 2015, J HUM EVOL, V78, P44, DOI 10.1016/j.jhevol.2014.08.005; Haile-Selassie Yohannes, 2009, P159; Harris EF, 2001, AM J PHYS ANTHROPOL, V115, P223, DOI 10.1002/ajpa.1077; Hlusko LJ, 2004, AM J PHYS ANTHROPOL, V124, P223, DOI 10.1002/ajpa.10353; Humphrey LT, 1999, J ANAT, V195, P491, DOI 10.1046/j.1469-7580.1999.19540491.x; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P545, DOI 10.1002/ajpa.1330570406; Kimbel W.H., 2004, HUMAN EVOLUTION SERI; Koufos G. D., 2015, HDB PALEOANTHROPOLOG, V3, P1761; KOUFOS GD, 1993, AM J PHYS ANTHROPOL, V91, P225, DOI 10.1002/ajpa.1330910208; Koufos GD, 2016, GEOBIOS-LYON, V49, P45, DOI 10.1016/j.geobios.2016.01.008; Koufos George D., 2005, Annales de Paleontologie, V91, P227, DOI 10.1016/j.annpal.2005.05.001; Koufs GD, 2006, GEOBIOS-LYON, V39, P223, DOI 10.1016/j.geobios.2004.11.009; Kovacs I., 1971, DENT MORPHOLOGY EVOL, P211; Kunimatsu Y, 2007, P NATL ACAD SCI USA, V104, P19220, DOI 10.1073/pnas.0706190104; Kupczik K, 2005, CURRENT TRENDS DENT, P257; Lague MR, 2008, J ANAT, V213, P670, DOI 10.1111/j.1469-7580.2008.00989.x; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Lebatard AE, 2008, P NATL ACAD SCI USA, V105, P3226, DOI 10.1073/pnas.0708015105; Macchiarelli R, 2009, GEODIVERSITAS, V31, P851, DOI 10.5252/g2009n4a851; Manthi FK, 2012, S AFRICAN J SCI, V108; Martin L., 1984, Courier Forschungsinstitut Senckenberg, V69, P25; MARTIN LB, 1983, RELATIONSHIP LATER M; Martinon-Torres M, 2006, J HUM EVOL, V50, P523, DOI 10.1016/j.jhevol.2005.12.004; Moore NC, 2016, J HUM EVOL, V93, P46, DOI 10.1016/j.jhevol.2015.12.002; Moore NC, 2015, AM J PHYS ANTHROPOL, V158, P209, DOI 10.1002/ajpa.22776; Moore NC, 2013, AM J PHYS ANTHROPOL, V150, P632, DOI 10.1002/ajpa.22239; Pickford M, 2009, CR PALEVOL, V8, P413, DOI 10.1016/j.crpv.2008.11.003; Pozzi L, 2014, MOL PHYLOGENET EVOL, V75, P165, DOI 10.1016/j.ympev.2014.02.023; Richmond BG, 2008, SCIENCE, V319, P1662, DOI 10.1126/science.1154197; Schaller M, 2015, QUAT GEOCHRONOL, V29, P6, DOI 10.1016/j.quageo.2015.05.012; Semaw S, 2005, NATURE, V433, P301, DOI 10.1038/nature03177; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; Senut B., 2015, HDB PALEOANTHROPOLOG, P2043; Simpson SW, 2015, J HUM EVOL, V81, P68, DOI 10.1016/j.jhevol.2014.07.004; SMITH BH, 1984, AM J PHYS ANTHROPOL, V63, P39, DOI 10.1002/ajpa.1330630107; Smith TM, 2004, J HUM EVOL, V46, P551, DOI 10.1016/j.jhevol.2004.01.006; Spassov N, 2012, J HUM EVOL, V62, P138, DOI 10.1016/j.jhevol.2011.10.008; Spencer MA, 2003, AM J PHYS ANTHROPOL, V122, P325, DOI 10.1002/ajpa.10288; Suwa G, 2005, ANTHROPOL SCI, V113, P237; Suwa G, 2016, 1 HOMINOID MARAGHEH; Suwa G, 2009, SCIENCE, V326, P94, DOI 10.1126/science.1175824; Tobias PV, 1995, ASPECTS DENT BIOL PA, P283; TURNER CG, 1981, AM J PHYS ANTHROPOL, V54, P59, DOI 10.1002/ajpa.1330540108; Turner II C. G., 1991, ADV DENT ANTHR, P13; Uchida A., 1992, INTRASPECIES VARIATI; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; von FREYBERG B., 1951, ANN GEOL PAYS HELLTOIQUES, V3, P7; VONKOENIGSWALD GH, 1972, PROC K NED AKAD B-PH, V75, P385; Ward CV, 2001, J HUM EVOL, V41, P255, DOI 10.1006/jhev.2001.0507; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; WOOD BA, 1987, J ANAT, V154, P121; WOOD BA, 1988, J ANAT, V156, P107	80	26	28	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177127	10.1371/journal.pone.0177127	http://dx.doi.org/10.1371/journal.pone.0177127			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531170	Green Submitted, Green Published, gold			2022-12-26	WOS:000402058400011
J	McDonald, JT; Gao, XF; Steber, C; Breed, JL; Pollock, C; Ma, LL; Hlatky, L				McDonald, J. Tyson; Gao, Xuefeng; Steber, Cole; Breed, Jawon Lee; Pollock, Caitlin; Ma, Lili; Hlatky, Lynn			Host mediated inflammatory influence on glioblastoma multiforme recurrence following high-dose ionizing radiation	PLOS ONE			English	Article							LARGE GENE LISTS; TEMOZOLOMIDE ERA; SURVIVAL; CELLS; RADIOTHERAPY; SENESCENCE; PHENOTYPE; EXPOSURE; GROWTH; BETA	Despite optimal clinical treatment, glioblastoma multiforme (GBM) inevitably recurs. Standard treatment of GBM, exposes patients to radiation which kills tumor cells, but also modulates the molecular fingerprint of any surviving tumor cells and the cross-talk between those cells and the host. Considerable investigation of short-term (hours to days) post-irradiation tumor cell response has been undertaken, yet long-term responses (weeks to months) which are potentially even more informative of recurrence, have been largely overlooked. To better understand the potential of these processes to reshape tumor regrowth, molecular studies in conjunction with in silico modeling were used to examine short- and long-term growth dynamics. Despite survival of 2.55% and 0.009% following 8 or 16Gy, GBM cell populations in vitro showed a robust escape from cellular extinction and a return to pre-irradiated growth rates with no changes in long-term population doublings. In contrast, these same irradiated GBM cell populations injected in vivo elicited tumors which displayed significantly suppressed growth rates compared to their pre-irradiated counterparts. Transcriptome analysis days to weeks after irradiation revealed, 281 differentially expressed genes with a robust increase for cytokines, histones and C-C or C-X-C motif chemokines in irradiated cells. Strikingly, this same inflammatory signature in vivo for IL1A, CXCL1, IL6 and IL8 was increased in xenografts months after irradiation. Computational modeling of tumor cell dynamics indicated a host-mediated negative pressure on the surviving cells was a source of inhibition consistent with the findings resulting in suppressed tumor growth. Thus, tumor cells surviving irradiation may shift the landscape of population doubling through inflammatory mediators interacting with the host in a way that impacts tumor recurrence and affects the efficacy of subsequent therapies. Clues to more effective therapies may lie in the development and use of pre-clinical models of post-treatment response to target the source of inflammatory mediators that significantly alter cellular dynamics and molecular pathways in the early stages of tumor recurrence.	[McDonald, J. Tyson; Gao, Xuefeng; Steber, Cole; Breed, Jawon Lee; Pollock, Caitlin; Ma, Lili; Hlatky, Lynn] Ctr Canc Syst Biol, Boston, MA 02215 USA; [McDonald, J. Tyson] Hampton Univ, Canc Res Ctr, Hampton, VA 23668 USA; [Gao, Xuefeng] Shenzhen HRK Biotech Co Ltd, Shenzhen, Guangdong, Peoples R China	Hampton University	McDonald, JT (corresponding author), Ctr Canc Syst Biol, Boston, MA 02215 USA.; McDonald, JT (corresponding author), Hampton Univ, Canc Res Ctr, Hampton, VA 23668 USA.	john.mcdonald@hamptonu.edu		McDonald, John/0000-0003-4300-6827	National Institutes of Health's National Cancer Institute Integrative Cancer Biology Program (ICBP) [1U54CA149233]; ICBP Summer Cancer Research Fellowship/Internship Program; NCI Summer Cancer Research Fellowship/Internship Education	National Institutes of Health's National Cancer Institute Integrative Cancer Biology Program (ICBP); ICBP Summer Cancer Research Fellowship/Internship Program; NCI Summer Cancer Research Fellowship/Internship Education	This study was supported by the National Institutes of Health's National Cancer Institute Integrative Cancer Biology Program (ICBP, 1U54CA149233) to L.H.; the efforts of research fellows, J.L.B. and C.S., were generously supported by the ICBP Summer Cancer Research Fellowship/Internship Program. Shenzhen HRK Bio-tech provided support in the form of salaries for author Xuefeng Gao, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We would like to acknowledge the contributions of Betty Tarnowski of the NCI, along with Clare Lamont and Melissa Klumpar of CCSB, in facilitating the NCI Summer Cancer Research Fellowship/Internship Education and Outreach efforts under the NIH ICBP.	Beheshti A, 2015, CANCER RES, V75, P1134, DOI 10.1158/0008-5472.CAN-14-1053; Blaylock Russell L, 2013, Surg Neurol Int, V4, P15, DOI 10.4103/2152-7806.106577; Brush JM, 2009, INT J RADIAT BIOL, V85, P483, DOI 10.1080/09553000902883794; Chan JL, 2002, J CLIN ONCOL, V20, P1635, DOI 10.1200/JCO.20.6.1635; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Darefsky AS, 2012, CANCER-AM CANCER SOC, V118, P2163, DOI 10.1002/cncr.26494; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; Gao X, 2012, CANCER RES, V73, P1481, DOI DOI 10.1158/0008-5472.CAN-12-3429; Gao XF, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00138; Gao XF, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/249309; Hardee ME, 2012, CANCER RES, V72, P4119, DOI 10.1158/0008-5472.CAN-12-0546; HOCHBERG FH, 1980, NEUROLOGY, V30, P907, DOI 10.1212/WNL.30.9.907; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Lorimore SA, 2003, ONCOGENE, V22, P7058, DOI 10.1038/sj.onc.1207044; McBride WH, 2004, RADIAT RES, V162, P1, DOI 10.1667/RR3196; McDonald JT, 2014, INT J RADIAT BIOL, V90, P231, DOI 10.3109/09553002.2014.877175; McDonald JT, 2010, CANCER RES, V70, P8886, DOI 10.1158/0008-5472.CAN-10-0171; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Nicklin MJH, 2002, GENOMICS, V79, P718, DOI 10.1006/geno.2002.6751; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Roninson IB, 2003, CANCER RES, V63, P2705; Segerstrom L, 2008, INT J ONCOL, V33, P341, DOI 10.3892/ijo_00000014; Sen E, 2011, DRUG DISCOV TODAY, V16, P1044, DOI 10.1016/j.drudis.2011.09.003; Shaw E, 2000, INT J RADIAT ONCOL, V47, P291, DOI 10.1016/S0360-3016(99)00507-6; Sintupisut N, 2013, NUCL ACIDS RES; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Yeung YT, 2012, J NEURO-ONCOL, V109, P35, DOI 10.1007/s11060-012-0875-7; Zhang M, 2011, CANCER RES, V71, P7155, DOI 10.1158/0008-5472.CAN-11-1212	34	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178155	10.1371/journal.pone.0178155	http://dx.doi.org/10.1371/journal.pone.0178155			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542439	Green Published, Green Submitted, gold			2022-12-26	WOS:000402058400063
J	Rusciano, G; De Canditiis, C; Zito, G; Rubessa, M; Roca, MS; Carotenuto, R; Sasso, A; Gasparrini, B				Rusciano, Giulia; De Canditiis, Carolina; Zito, Gianluigi; Rubessa, Marcello; Roca, Maria Serena; Carotenuto, Rosa; Sasso, Antonio; Gasparrini, Bianca			Raman-microscopy investigation of vitrification-induced structural damages in mature bovine oocytes	PLOS ONE			English	Article							THAWED MOUSE OOCYTES; ZONA-PELLUCIDA; IN-VITRO; MEIOTIC SPINDLE; INVITRO FERTILIZATION; NONINVASIVE TOOL; OVINE OOCYTES; CRYOPRESERVATION; EMBRYOS; MICROSPECTROSCOPY	Although oocyte cryopreservation has great potentials in the field of reproductive technologies, it still is an open challenge in the majority of domestic animals and little is known on the biochemical transformation induced by this process in the different cellular compartments. Raman micro-spectroscopy allows the non-invasive evaluation of the molecular composition of cells, based on the inelastic scattering of laser photons by vibrating molecules. The aim of this work was to assess the biochemical modifications of both the zona pellucida and cytoplasm of vitrified/warmed in vitro matured bovine oocytes at different post-warming times. By taking advantage of Principal Component Analysis, we were able to shed light on the biochemical transformation induced by the cryogenic treatment, also pointing out the specific role of cryoprotective agents (CPs). Our results suggest that vitrification induces a transformation of the protein secondary structure from the alpha-helices to the beta-sheet form, while lipids tend to assume a more packed configuration in the zona pellucida. Both modifications result in a mechanical hardening of this cellular compartment, which could account for the reduced fertility rates of vitrified oocytes. Furthermore, biochemical modifications were observed at the cytoplasmic level in the protein secondary structure, with alpha-helices loss, suggesting cold protein denaturation. In addition, a decrease of lipid unsaturation was found in vitrified oocytes, suggesting oxidative damages. Interestingly, most modifications were not observed in oocytes exposed to CPs, suggesting that they do not severely affect the biochemical architecture of the oocyte. Nevertheless, in oocytes exposed to CPs decreased developmental competence and increased reactive oxygen species production were observed compared to the control. A more severe reduction of cleavage and blastocyst rates after in vitro fertilization was obtained from vitrified oocytes. Our experimental outcomes also suggest a certain degree of reversibility of the induced transformations, which renders vitrified oocytes more similar to untreated cells after 2 h warming.	[Rusciano, Giulia; Sasso, Antonio] Univ Naples Federico II, Dept Phys E Pancini, Via Cintia, I-80126 Naples, Italy; [Rusciano, Giulia; Sasso, Antonio] CNR, Natl Inst Opt INO, Via Campi Flegrei 34, I-80078 Pozzuoli, NA, Italy; [De Canditiis, Carolina; Gasparrini, Bianca] Univ Naples Federico II, Dept Vet Med & Anim Prod, Via F Delpino 1, I-80137 Naples, Italy; [Zito, Gianluigi] CNR, Inst Prot Biochem IBP, Via Pietro Castellino 111, I-80131 Naples, Italy; [Rubessa, Marcello] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Roca, Maria Serena] Ist Nazl Tumori Fdn G Pascale IRCCS, Expt Pharmacol Unit, Naples, Italy; [Carotenuto, Rosa] Univ Naples Federico II, Dept Biol, Via Cintia, I-80126 Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Illinois System; University of Illinois Urbana-Champaign; IRCCS Fondazione Pascale; University of Naples Federico II	Rusciano, G (corresponding author), Univ Naples Federico II, Dept Phys E Pancini, Via Cintia, I-80126 Naples, Italy.; Rusciano, G (corresponding author), CNR, Natl Inst Opt INO, Via Campi Flegrei 34, I-80078 Pozzuoli, NA, Italy.	giulia.rusciano@unina.it	Zito, Gianluigi/AAY-2420-2020; roca, maria serena/AAZ-1071-2020; Zito, Gianluigi/P-9424-2018; Rusciano, Giulia/A-2079-2010	Zito, Gianluigi/0000-0003-2376-0080; Zito, Gianluigi/0000-0003-2376-0080; Rusciano, Giulia/0000-0002-7152-5352; roca, maria serena/0000-0002-9621-0939				AMAN RR, 1994, BIOL REPROD, V50, P103, DOI 10.1095/biolreprod50.1.103; Attanasio L, 2010, REPROD DOMEST ANIM, V45, P997, DOI 10.1111/j.1439-0531.2009.01475.x; Best BP, 2015, REJUV RES, V18, P422, DOI 10.1089/rej.2014.1656; Bogliolo L, 2015, J ASSIST REPROD GEN, V32, P185, DOI 10.1007/s10815-014-0389-7; Bogliolo L, 2013, J ASSIST REPROD GEN, V30, P877, DOI 10.1007/s10815-013-0046-6; Bogliolo L, 2012, CRYOBIOLOGY, V64, P267, DOI 10.1016/j.cryobiol.2012.02.010; CARROLL J, 1990, J REPROD FERTIL, V90, P547, DOI 10.1530/jrf.0.0900547; CARROLL J, 1989, J REPROD FERTIL, V85, P489, DOI 10.1530/jrf.0.0850489; Chaves Dowglish F., 2016, CRYOBIOLOGY, V73, P324; Chen SU, 2009, TAIWAN J OBSTET GYNE, V48, P15, DOI 10.1016/S1028-4559(09)60030-9; Davidson B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067972; Ferreira MS, 2014, ANAL CHIM ACTA, V807, P96, DOI 10.1016/j.aca.2013.11.033; FUKU E, 1995, CRYOBIOLOGY, V32, P139, DOI 10.1006/cryo.1995.1013; GABER BP, 1978, BIOPHYS J, V21, P161, DOI 10.1016/S0006-3495(78)85516-7; Gardner D. K., 2009, TXB ASSISTED REPROD; Gualtieri R, 2011, HUM REPROD, V26, P2452, DOI 10.1093/humrep/der210; Gupta MK, 2010, FERTIL STERIL, V93, P2602, DOI 10.1016/j.fertnstert.2010.01.043; Khajehpour M, 2006, ANAL BIOCHEM, V348, P40, DOI 10.1016/j.ab.2005.10.009; Ko CS, 2008, ANIM REPROD SCI, V105, P272, DOI 10.1016/j.anireprosci.2007.03.010; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P300, DOI 10.1016/S1472-6483(10)60837-1; Kuwayama M., 2000, J ASSIST REPROD GEN, P477, DOI DOI 10.1023/A:1017399518757; Larman MG, 2006, REPRODUCTION, V131, P53, DOI 10.1530/rep.1.00878; Le Gal F, 1999, CRYOBIOLOGY, V38, P290, DOI 10.1006/cryo.1999.2172; Ledda S, 2007, REPROD FERT DEVELOP, V19, P13, DOI 10.1071/RD06126; Leibo SP, 2008, THERIOGENOLOGY, V69, P37, DOI 10.1016/j.theriogenology.2007.10.006; Lu JM, 2010, J CELL MOL MED, V14, P840, DOI 10.1111/j.1582-4934.2009.00897.x; MAGISTRINI M, 1980, EUR J CELL BIOL, V22, P699; Matson PL, 1997, HUM REPROD, V12, P1550, DOI 10.1093/humrep/12.7.1550; Matthaus C, 2008, METHOD CELL BIOL, V89, P275, DOI 10.1016/S0091-679X(08)00610-9; Mavrides A, 2005, EUR J OBSTET GYN R B, V118, P66, DOI 10.1016/j.ejogrb.2004.06.025; McEvoy TG, 2000, J REPROD FERTIL, V118, P163, DOI 10.1530/reprod/118.1.163; Moussa M, 2014, SCI CHINA LIFE SCI, V57, P903, DOI 10.1007/s11427-014-4689-z; Notingher I, 2006, EXPERT REV MED DEVIC, V3, P215, DOI 10.1586/17434440.3.2.215; Nottola SA, 2009, REPROD BIOMED ONLINE, V19, P17, DOI 10.1016/S1472-6483(10)60280-5; Odintsova NA, 2009, CRYOBIOLOGY, V59, P335, DOI 10.1016/j.cryobiol.2009.09.006; PARRISH JJ, 1986, THERIOGENOLOGY, V25, P591, DOI 10.1016/0093-691X(86)90143-3; Paynter SJ, 1999, HUM REPROD, V14, P2338, DOI 10.1093/humrep/14.9.2338; Prentice Jennifer R, 2010, Vet Med Int, V2011, DOI 10.4061/2011/146405; Rubessa M, 2011, THERIOGENOLOGY, V76, P1347, DOI 10.1016/j.theriogenology.2011.06.004; RUFFING NA, 1993, CRYOBIOLOGY, V30, P562, DOI 10.1006/cryo.1993.1059; Rusciano G, 2008, CARBON, V46, P335, DOI 10.1016/j.carbon.2007.11.052; Rusciano G, 2010, PHYS MEDICA, V26, P233, DOI 10.1016/j.ejmp.2010.02.001; Rusciano G, 2014, ACS NANO, V8, P12300, DOI 10.1021/nn504595k; Rusciano G, 2010, METHODS, V51, P27, DOI 10.1016/j.ymeth.2009.12.009; Saunders KM, 1999, BIOL REPROD, V61, P178, DOI 10.1095/biolreprod61.1.178; Somfai T, 2007, REPROD FERT DEVELOP, V19, P184, DOI 10.1071/RDv19n1Ab133; Sripunya N, 2010, J REPROD DEVELOP, V56, P176, DOI 10.1262/jrd.09-108H; Stachecki JJ, 2004, REPROD BIOMED ONLINE, V9, P152, DOI 10.1016/S1472-6483(10)62124-4; Succu S, 2010, MOL REPROD DEV, V74, P1337; Tamas S, 2007, CRYOBIOLOGY, V55, P115, DOI 10.1016/j.cryobiol.2007.06.008; TERVIT HR, 1972, J REPROD FERTIL, V30, P493, DOI 10.1530/jrf.0.0300493; Tian SJ, 2007, ANIM REPROD SCI, V101, P365, DOI 10.1016/j.anireprosci.2007.01.007; Topper EK, 1997, MOL REPROD DEV, V46, P344, DOI 10.1002/(SICI)1098-2795(199703)46:3&lt;344::AID-MRD13&gt;3.0.CO;2-Z; Vajta G, 2006, THERIOGENOLOGY, V65, P236, DOI 10.1016/j.theriogenology.2005.09.026; Vanroose G, 2000, BIOL REPROD, V62, P463, DOI 10.1095/biolreprod62.2.463; VINCENT C, 1990, J REPROD FERTIL, V89, P253, DOI 10.1530/jrf.0.0890253	56	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177677	10.1371/journal.pone.0177677	http://dx.doi.org/10.1371/journal.pone.0177677			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531193	Green Submitted, Green Published, gold			2022-12-26	WOS:000402058400023
J	Kontson, K; Marcus, I; Myklebust, B; Civillico, E				Kontson, Kimberly; Marcus, Ian; Myklebust, Barbara; Civillico, Eugene			Targeted box and blocks test: Normative data and comparison to standard tests	PLOS ONE			English	Article							TRANSRADIAL PROSTHESIS USERS; RELIABILITY; MOVEMENTS; STRATEGIES; DEXTERITY; VALIDITY; MOTION	Background The Box and Block Test (BBT) is a functional outcome measure that is commonly used across multiple clinical populations due to its benefits of ease and speed of implementation; reliable, objective measurement; and repetition of motion. In this study, we introduce a novel outcome measure called the targeted BBT that allows for the study of initiation, grasping, and transport of objects, and also of object release. These modifications to the existing test may increase the ecological validity of the measure while still retaining the previously stated benefits of the standard BBT. Methods 19 able-bodied subjects performed the targeted BBT and two other standard tests. Using an integrated movement analysis framework based on motion capture and ground force data, quantitative information about how subjects completed these tests were captured. Kinematic parameters at the wrist, elbow, shoulder, thorax, and head, as well as measures of postural control, were calculated and statistically compared across the three tests. Results In general, the targeted BBT required significantly higher RoM at the elbow, shoulder, thorax and head when compared to standard tests. Peak angles at these joints were also higher during performance of the targeted BBT. Peak angles and RoM values for the targeted BBT were close to those found in studies of movements of able-bodied individuals performing activities of daily living. Conclusion The targeted BBT allows analysis of repetitive movements, and may more closely model common real-world object manipulation scenarios in which a user is required to control a movement from pick-up to release.	[Kontson, Kimberly; Myklebust, Barbara; Civillico, Eugene] US FDA, Ctr Devices & Radiol Hlth, Off Sci & Engn Labs, Div Biomed Phys, Silver Spring, MD 20993 USA; [Marcus, Ian] US FDA, Ctr Devices & Radiol Hlth, Off Device Evaluat, Div Neurol & Phys Med Devices, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Kontson, K (corresponding author), US FDA, Ctr Devices & Radiol Hlth, Off Sci & Engn Labs, Div Biomed Phys, Silver Spring, MD 20993 USA.	Kimberly.Kontson@fda.hhs.gov	CIVILLICO, EUGENE/I-4417-2019	CIVILLICO, EUGENE/0000-0003-2209-9147; KONTSON, KIMBERLY/0000-0002-4978-6011	DARPA-BTO [IAA 224-14-6009]; FDA Critical Path Initiative [CPOSEL13]; DARPA HAPTIX through DARPA-FDA IAA [224-14-6009]	DARPA-BTO; FDA Critical Path Initiative; DARPA HAPTIX through DARPA-FDA IAA	This work was funded in part by an interagency agreement with DARPA-BTO (IAA 224-14-6009), and by the FDA Critical Path Initiative (CPOSEL13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Sophie Wang (University of Maryland), Sydney Barovsky (Marquette University), Heather Benz (FDA), Tiffany Ryan (Advanced Arm Dynamics) and Jacqueline Hebert (University of Alberta) for assistance with data acquisition and/or interpretation. This work was funded in part by DARPA HAPTIX under the auspices of Dr. Doug Weber through the DARPA-FDA IAA No. 224-14-6009, and by the FDA Critical Path Initiative (CPOSEL13). Disclaimer: The mention of commercial products, their sources, or their use in connection with material reported herein is not to be construed as an actual or implied endorsement of such products by DHHS.	Alt Murphy M, 2015, BMC NEUROLOGY, V15, P1; Bouwsema H, 2010, CLIN BIOMECH, V25, P523, DOI 10.1016/j.clinbiomech.2010.02.011; Canny ML, 2009, AM J OCCUP THER, V63, P506, DOI 10.5014/ajot.63.4.506; Carey SL, 2008, CLIN BIOMECH, V23, P1128, DOI 10.1016/j.clinbiomech.2008.05.008; Chen HM, 2009, NEUROREHAB NEURAL RE, V23, P435, DOI 10.1177/1545968308331146; Cirstea MC, 2000, BRAIN, V123, P940, DOI 10.1093/brain/123.5.940; Cornwell AS, 2012, J REHABIL RES DEV, V49, P395, DOI 10.1682/JRRD.2011.03.0040; Cromwell F., 1976, OCCUPATIONAL THERAPI; DESROSIERS J, 1994, ARCH PHYS MED REHAB, V75, P751; Gates DH, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.015487; Hebert JS, 2014, J REHABIL RES DEV, V51, P919, DOI 10.1682/JRRD.2013.10.0228; Hebert JS, 2012, J REHABIL RES DEV, V49, P1163, DOI 10.1682/JRRD.2011.10.0207; Karimi MT, 2011, J RES MED SCI, V16, P530; Karst Gregory M, 2005, J Neurol Phys Ther, V29, P170; Kontson K, 2017, IEEE T NEURAL SYST R; Lee G, 2008, SURG ENDOSC, V22, P1087, DOI 10.1007/s00464-007-9664-3; Levin MF, 2016, NEUROREHAB NEURAL RE, V30, P635, DOI 10.1177/1545968315613863; Liu W, 2013, J REHABIL RES DEV, V50, P71, DOI 10.1682/JRRD.2011.04.0074; Major MJ, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-132; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; Metzger AJ, 2012, ARCH PHYS MED REHAB, V93, P2029, DOI 10.1016/j.apmr.2012.03.011; Mobini A, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0070-0; Muray IA, 1999, DETERMINING UPPER LI; Oliveira LF, 1996, PHYSIOL MEAS, V17, P305, DOI 10.1088/0967-3334/17/4/008; Platz T, 2005, CLIN REHABIL, V19, P404, DOI 10.1191/0269215505cr832oa; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Raymakers JA, 2005, GAIT POSTURE, V21, P48, DOI 10.1016/j.gaitpost.2003.11.006; Resnik L, 2014, J REHABIL RES DEV, V51, P351, DOI 10.1682/JRRD.2013.08.0180	28	35	35	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177965	10.1371/journal.pone.0177965	http://dx.doi.org/10.1371/journal.pone.0177965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542374	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672600036
J	Durrer, KE; Allen, MS; von Herbing, IH				Durrer, Katherine E.; Allen, Michael S.; von Herbing, Ione Hunt			Genetically engineered probiotic for the treatment of phenylketonuria (PKU); assessment of a novel treatment in vitro and in the PAH(enu2) mouse model of PKU	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; LACTOBACILLUS; COLONIZATION; CELLS; MICE; GUT; EXPRESSION; MICROBIOTA; STRAINS; FLORA	Phenylketonuria (PKU) is a genetic disease characterized by the inability to convert dietary phenylalanine to tyrosine by phenylalanine hydroxylase. Given the importance of gut microbes in digestion, a genetically engineered microbe could potentially degrade some ingested phenylalanine from the diet prior to absorption. To test this, a phenylalanine lyase gene from Anabaena variabilis (AvPAL) was codon-optimized and cloned into a shuttle vector for expression in Lactobacillus reuteri 100-23C (pHENOMMenal). Functional expression of AvPAL was determined in vitro, and subsequently tested in vivo in homozygous PAH(enu2) (PKU model) mice. Initial trials of two PAH(enu2) homozygous (PKU) mice defined conditions for freeze-drying and delivery of bacteria. Animals showed reduced blood phe within three to four days of treatment with pHENOMMenal probiotic, and blood phe concentrations remained significantly reduced (P < 0.0005) compared to untreated controls during the course of experiments. Although pHENOMMenal probiotic could be cultured from fecal samples at four months post treatment, it could no longer be cultivated from feces at eight months post treatment, indicating eventual loss of the microbe from the gut. Preliminary screens during experimentation found no immune response to AvPAL. Collectively these studies provide data for the use of a genetically engineered probiotic as a potential treatment for PKU.	[Durrer, Katherine E.; von Herbing, Ione Hunt] Univ North Texas, Dept Biol Sci, Denton, TX USA; [Allen, Michael S.] Univ North Texas, Hlth Sci Ctr, Ctr Med Genet, Inst Mol Med, Ft Worth, TX 76107 USA; [Durrer, Katherine E.] Univ North Texas, Hlth Sci Ctr, Dept Mol & Med Genet, Ft Worth, TX USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	Allen, MS (corresponding author), Univ North Texas, Hlth Sci Ctr, Ctr Med Genet, Inst Mol Med, Ft Worth, TX 76107 USA.	Michael.Allen@unthsc.edu		Hunt von Herbing, Ione/0000-0003-4335-6878; Allen, Michael/0000-0003-2293-8078	National PKU Alliance; National Society for PKU (England)	National PKU Alliance; National Society for PKU (England)	This work was supported by National PKU Alliance, http://npkua.org/Research/Scientific-G rant-Requests, received scientific seed money grant for 2 years, 2012-2014; National Society for PKU (England), http://www.nspku.org/, donated $10,000.00 as supplement funds, not an official grant. The funders had no role in study design, data collection/analysis, decision to publish, or preparation of the manuscript.	Bellier S, 2005, AM J PHYSIOL-GASTR L, V288, pG151, DOI 10.1152/ajpgi.00048.2004; Brumm VL, 2010, MOL GENET METAB, V99, pS59, DOI 10.1016/j.ymgme.2009.10.182; Gamez A, 2005, MOL THER, V11, P986, DOI 10.1016/j.ymthe.2005.02.013; Hale JDF, 2005, J BACTERIOL, V187, P5036, DOI 10.1128/JB.187.14.5036-5039.2005; Hamman K, 2005, MOL THER, V12, P337, DOI 10.1016/j.ymthe.2005.03.025; Harding CO, 2003, J GENE MED, V5, P984, DOI 10.1002/jgm.432; Heng NCK, 1999, APPL ENVIRON MICROB, V65, P5378; Hoffmann M, 2008, J NUTR, V138, P1684, DOI 10.1093/jn/138.9.1684; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; JOHANSSON ML, 1993, APPL ENVIRON MICROB, V59, P15, DOI 10.1128/AEM.59.1.15-20.1993; Kang TS, 2010, MOL GENET METAB, V99, P4, DOI 10.1016/j.ymgme.2009.09.002; Lehrer J, 2014, BOWEL TRANSIT TIME M; Levy HL, 1999, P NATL ACAD SCI USA, V96, P1811, DOI 10.1073/pnas.96.5.1811; Liu JZ, 2002, ARTIF CELL BLOOD SUB, V30, P243, DOI 10.1081/BIO-120006117; Livingston M, 2010, IMMUNOL CELL BIOL, V88, P99, DOI 10.1038/icb.2009.71; Lizier M, 2010, FEMS MICROBIOL LETT, V308, P8, DOI 10.1111/j.1574-6968.2010.01978.x; MCCAMAN MW, 1962, J LAB CLIN MED, V59, P885; McDonald JD, 1997, PEDIATR RES, V42, P103, DOI 10.1203/00006450-199707000-00016; Moffitt MC, 2007, BIOCHEMISTRY-US, V46, P1004, DOI 10.1021/bi061774g; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Porta F, 2008, J INHERIT METAB DIS, V31, pS339, DOI 10.1007/s10545-008-0907-9; Roato I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014167; Sarkissian CN, 2008, P NATL ACAD SCI USA, V105, P20894, DOI 10.1073/pnas.0808421105; Sarkissian CN, 1999, P NATL ACAD SCI USA, V96, P2339, DOI 10.1073/pnas.96.5.2339; Shanahan F, 2002, BEST PRACT RES CL GA, V16, P915, DOI 10.1053/bega.2002.0342; TANNOCK GW, 1994, PLASMID, V31, P60, DOI 10.1006/plas.1994.1007; Tannock GW, 2005, APPL ENVIRON MICROB, V71, P8419, DOI 10.1128/AEM.71.12.8419-8425.2005; Valeur N, 2004, APPL ENVIRON MICROB, V70, P1176, DOI 10.1128/AEM.70.2.1176-1181.2004	28	30	32	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176286	10.1371/journal.pone.0176286	http://dx.doi.org/10.1371/journal.pone.0176286			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520731	Green Published, Green Submitted, gold			2022-12-26	WOS:000401487700011
J	Yeung, SE; Thornton, WL				Yeung, Sophie E.; Thornton, Wendy Loken			"Do it-yourself" : Home blood pressure as a predictor of traditional and everyday cognition in older adults	PLOS ONE			English	Article							AGED 75 YEARS; PULSE PRESSURE; INTELLECTUAL ABILITY; ARTERIAL STIFFNESS; RELATIVE UTILITY; VASCULAR HEALTH; STROKE RISK; HYPERTENSION; PERFORMANCE; BRAIN	Background Hypertension guidelines recommend home blood pressure (HBP) monitoring in adjunct to office blood pressure (OBP) for its greater reproducibility and prognostic utility in the prevention of cardiovascular outcomes, especially stroke. To date, the relationship between HBP and cognitive function remains unexplored. Methods We examined HBP as a cognitive predictor in a multi-ethnic group of community-dwelling adults aged 60 and over (N = 133) using neuropsychological measures and analyzed the data using multiple regression analyses. We also employed "everyday cognition" measures that have been found to have higher prognostic utility for real-world functioning than traditional cognitive tasks. Results Good to perfect HBP monitoring compliance over seven days was achieved by 88.7% of the participants with superior reliability (ICC >=.96) to office readings. Higher home systolic BP and pulse pressure predicted worse processing speed, executive function, and everyday cognitive function, whereas lower home diastolic BP predicted worse everyday cognition. Office readings were similarly associated with everyday cognitive function but with no other cognitive measures. Conclusion Our findings are the first to validate HBP as a predictor of neuropsychological function in older adults beyond cognitive screening. Differential relationships among blood pressure variables and specific cognitive domains were observed. With proper standardization and training, we demonstrated that HBP can be obtained in a multi-ethnic community-dwelling older adult cohort. Our findings emphasize the importance of employing blood pressure and cognitive measures that are adequately sensitive to detect vascular-related cognitive impairment in a relatively healthy population. Implications regarding proper HBP measurement for hypertension management, cognitive health, and everyday function are discussed.	[Yeung, Sophie E.; Thornton, Wendy Loken] Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada	Simon Fraser University	Thornton, WL (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada.	wthornto@sfu.ca			Social Sciences and Humanities Research Council [SSHRC 410-2010-0407]; SSHRC Joseph-Armand Bombardier Canada Graduate Scholarship Doctoral Award	Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); SSHRC Joseph-Armand Bombardier Canada Graduate Scholarship Doctoral Award	This work was supported in part by a Social Sciences and Humanities Research Council (SSHRC 410-2010-0407) grant awarded to Dr. Wendy Loken Thornton. Dr. Sophie E. Yeung was supported by a SSHRC Joseph-Armand Bombardier Canada Graduate Scholarship Doctoral Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyagari V, 2009, STROKE, V40, P2251, DOI 10.1161/STROKEAHA.108.531574; Allaire JC, 2006, AGING NEUROPSYCHOL C, V13, P207, DOI 10.1080/13825580490904228; Allaire JC, 2002, PSYCHOL AGING, V17, P101, DOI [10.1037//0882-7974.17.1.101, 10.1037/0882-7974.17.1.101]; Allaire JC, 1999, PSYCHOL AGING, V14, P627, DOI 10.1037/0882-7974.14.4.627; Artistico D, 2003, PSYCHOL AGING, V18, P68, DOI 10.1037/0882-7974.18.1.68; Asayama K, 2005, EUR HEART J, V26, P2026, DOI 10.1093/eurheartj/ehi330; Asayama K, 2004, STROKE, V35, P2356, DOI 10.1161/01.STR.0000141679.42349.9f; Beauchet O, 2010, REJUV RES, V13, P39, DOI 10.1089/rej.2009.0878; Birns J, 2009, J HUM HYPERTENS, V23, P86, DOI 10.1038/jhh.2008.80; Blankevoort CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070799; Bolli P, 2010, J HYPERTENS, V28, P1380, DOI 10.1097/HJH.0b013e32833ac964; Brown GG, 2009, NEUROPSYCHOLOGICAL A, P306; Campbell N, 2010, CANADIAN HYPERTENSIO; Campbell NRC, 2005, CAN J PUBLIC HEALTH, V96, P217, DOI 10.1007/BF03403694; Campo C, 2000, BLOOD PRESSURE, V9, P355; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cohen J., 2003, APPLIED MULTIPLE REG; Comrey A. L., 1992, A FIRST COURSE IN FA; Crichton GE, 2014, HYPERTENSION, V64, P1094, DOI 10.1161/HYPERTENSIONAHA.114.04282; Dahle CL, 2009, PSYCHOL AGING, V24, P154, DOI 10.1037/a0014283; Delis DC, 2001, DELIS KAPLAN EXECUTI; Delis DC, 2000, THE CALIFORNIA VERBA; DENNEY NW, 1989, PSYCHOL AGING, V4, P438, DOI 10.1037/0882-7974.4.4.438; DENNEY NW, 1981, J GERONTOL, V36, P323, DOI 10.1093/geronj/36.3.323; Fischer AL, 2017, J GERONTOL B-PSYCHOL, V72, P71, DOI 10.1093/geronb/gbw088; Fischer AL, 2014, J GERONTOL B-PSYCHOL, V69, P219, DOI 10.1093/geronb/gbs120; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gelb SR, 2010, NEUROPSYCHOLOGY, V24, P514, DOI 10.1037/a0018670; Gorelick PB, 2012, J AM SOC HYPERTENS, V6, P309, DOI 10.1016/j.jash.2012.08.004; Hense HW, 2002, NEPHROL DIAL TRANSPL, V17, P1547, DOI 10.1093/ndt/17.9.1547; Iadecola C, 2016, HYPERTENSION; Imai Y, 2004, INTERNAL MED, V43, P771, DOI 10.2169/internalmedicine.43.771; Kanemaru A, 2001, HYPERTENS RES, V24, P19, DOI 10.1291/hypres.24.19; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Knecht S, 2008, HYPERTENSION, V51, P663, DOI 10.1161/HYPERTENSIONAHA.107.105577; Lee ATC, 2013, J ALZHEIMERS DIS, V35, P687, DOI 10.3233/JAD-122116; Mallick S, 2009, AM J MED, V122, P803, DOI 10.1016/j.amjmed.2009.02.028; Mario B, 2009, INT J GERIATR PSYCH, V24, P509, DOI 10.1002/gps.2145; Mitchell GF, 2011, BRAIN, V134, P3398, DOI 10.1093/brain/awr253; Muller M, 2010, J HYPERTENS, V28, P1498, DOI 10.1097/HJH.0b013e32833951ef; Myers MG, 2010, HYPERTENSION, V55, P195, DOI 10.1161/HYPERTENSIONAHA.109.141879; Nagai M, 2008, J HYPERTENS, V26, P1636, DOI 10.1097/HJH.0b013e3283018333; Nilsson SE, 2007, AGING CLIN EXP RES, V19, P41, DOI 10.1007/BF03325209; Nishinaga M, 2005, HYPERTENS RES, V28, P657, DOI 10.1291/hypres.28.657; Obisesan TO, 2008, J AM GERIATR SOC, V56, P501, DOI 10.1111/j.1532-5415.2007.01592.x; Ohkubo T, 2004, J HYPERTENS, V22, P1099, DOI 10.1097/00004872-200406000-00009; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Parati G, 2009, HYPERTENSION; Parati G, 2010, BLOOD PRESS MONIT, V15, P100, DOI 10.1097/MBP.0b013e328338c63b; Parati G, 2009, LANCET, V373, P876, DOI 10.1016/S0140-6736(09)60526-2; Peters R, 2013, J HYPERTENS, V31, P1868, DOI 10.1097/HJH.0b013e3283622cc6; Pickering TG, 2008, HYPERTENSION, V52, P1, DOI 10.1161/HYPERTENSIONAHA.107.189011; Plichart M, 2013, BLOOD PRESS MONIT, V18, P208, DOI 10.1097/MBP.0b013e3283631b45; Posner HB, 2002, NEUROLOGY, V58, P1175, DOI 10.1212/WNL.58.8.1175; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Qiu CX, 2003, STROKE, V34, P594, DOI 10.1161/01.STR.0000060127.96986.F4; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raz N, 2007, NEUROPSYCHOLOGY, V21, P149, DOI 10.1037/0894-4105.21.2.149; Reynolds M.W, 1999, PROFESSIONAL MANUAL; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Sakakura K, 2007, AM J HYPERTENS, V20, P720, DOI 10.1016/j.amjhyper.2007.02.001; Sharp SI, 2011, INT J GERIATR PSYCH, V26, P661, DOI 10.1002/gps.2572; Shimbo D, 2007, AM J HYPERTENS, V20, P476, DOI 10.1016/j.amjhyper.2006.12.011; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; STEIGER JH, 1992, BEHAV RES METH INSTR, V24, P581, DOI 10.3758/BF03203611; Stergiou GS, 2002, J HYPERTENS, V20, P1987, DOI 10.1097/00004872-200210000-00018; Tadic M, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0386-0; Thornton AE, 2010, J CLIN EXP NEUROPSYC, V32, P299, DOI 10.1080/13803390903002209; Thornton WL, 2007, PSYCHOL AGING, V22, P470, DOI 10.1037/0882-7974.22.3.470; Thornton WL, 2013, INT J BEHAV DEV, V37, P13, DOI 10.1177/0165025412454028; Tsao CW, 2013, NEUROLOGY, V81, P984, DOI 10.1212/WNL.0b013e3182a43e1c; van Boxtel MPJ, 2006, J HUM HYPERTENS, V20, P5, DOI 10.1038/sj.jhh.1001934; Verberk WJ, 2005, J AM COLL CARDIOL, V46, P743, DOI 10.1016/j.jacc.2005.05.058; Wahlin A, 2006, PSYCHOL AGING, V21, P318, DOI 10.1037/0882-7974.21.2.318; Waldstein SR, 2008, HYPERTENSION, V51, P99, DOI 10.1161/HYPERTENSIONAHA.107.093674; Wang W, 2011, BLOOD PRESS MONIT, V16, P277, DOI 10.1097/MBP.0b013e32834e3ba6; Weatherbee SR, 2008, PSYCHOL AGING, V23, P216, DOI 10.1037/0882-7974.23.1.216; Wechsler D., 1997, WECHSLER ADULT INTEL; Willis SL, 1993, MANUAL FOR THE EVERY; World Health Organisation (WHO), 2002, THE WORLD HEALTH REP; Yaneva-Sirakova T, 2012, J CARDIOVASC MED, V13, P735, DOI 10.2459/JCM.0b013e328357ba78; Yasui D, 2010, AM J HYPERTENS, V23, P508, DOI 10.1038/ajh.2010.15; Yeung SE, 2011, AGING NEUROPSYCHOL C, V18, P733, DOI 10.1080/13825585.2011.609882	83	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177424	10.1371/journal.pone.0177424	http://dx.doi.org/10.1371/journal.pone.0177424			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DX	28520751	Green Published, gold, Green Submitted			2022-12-26	WOS:000401487700047
J	Franklin, SP; Burke, EE; Holmes, SP				Franklin, Samuel P.; Burke, Emily E.; Holmes, Shannon P.			The effect of platelet-rich plasma on osseous healing in dogs undergoing high tibial osteotomy	PLOS ONE			English	Article							LEVELING OSTEOTOMY; LONG BONES; BASIC SCIENCE; COMPLICATIONS; PROLIFERATION; MODEL; TIME	Objectives The purpose of this study was to investigate whether platelet-rich plasma (PRP) enhances osseous healing in conjunction with a high tibial osteotomy in dogs. Study design Randomized controlled trial. Methods Sixty-four client-owned pet dogs with naturally occurring rupture of the anterior cruciate ligament and that were to be treated with a high tibial osteotomy (tibial plateau leveling osteotomy) were randomized into the treatment or control group. Dogs in the treatment group received autologous platelet-rich plasma activated with calcium chloride and bovine thrombin to produce a well-formed PRP gel that was placed into the osteotomy at the time of surgery. Dogs in the control group received saline lavage of the osteotomy. All dogs had the osteotomy stabilized with identical titanium alloy implants and all aspects of the surgical procedure and post-operative care were identical among dogs of the two groups. Bone healing was assessed at exactly 28, 49, and 70 days after surgery with radiography and ultrasonography and with MRI at day 28. The effect of PRP on bone healing was assessed using a repeated measures analysis of covariance with radiographic and ultrasonographic data and using a t-test with the MRI data. Results Sixty dogs completed the study. There were no significant differences in age, weight, or gender distribution between the treatment and control groups. Twenty-seven dogs were treated with PRP and 33 were in the control group. The average platelet concentration of the PRP was 1.37x10(6) platelets/mu L (+/- 489x10(3)) with a leukocyte concentration of 5.45x10(3)/mu L (+/- 3.5x10(3)). All dogs demonstrated progressive healing over time and achieved clinically successful outcomes. Time since surgery and patient age were significant predictors of radiographic healing and time since surgery was a significant predictor of ultrasonographic assessment of healing. There was no significant effect of PRP treatment as assessed radio-graphically, ultrasonographically, or with MRI. Conclusion The PRP used in this study did not hasten osseous union in dogs treated with a high tibial osteotomy.	[Franklin, Samuel P.] Univ Georgia, Dept Small Anim Med & Surg, Athens, GA 30602 USA; [Franklin, Samuel P.] Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA; [Burke, Emily E.; Holmes, Shannon P.] Univ Georgia, Vet Biosci & Diagnost Imaging, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Franklin, SP (corresponding author), Univ Georgia, Dept Small Anim Med & Surg, Athens, GA 30602 USA.; Franklin, SP (corresponding author), Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA.	spfrank@uga.edu			AO Foundation; New Faculty Startup-Comparative Medical Research Donation Fund; Arthrex Vet Systems	AO Foundation; New Faculty Startup-Comparative Medical Research Donation Fund; Arthrex Vet Systems	Sam Franklin is a consultant for Arthrex Vet Systems. Sam Franklin is paid to consult on research investigations, products, and is paid (hourly) if teaching veterinary continuing education courses. Sam Franklin is not paid any salary and receives no royalties on any products and has no financial interest in any product. The PRP used in this study was produced using the Angel system (provided by Arthrex Vet Systems) and Arthrex Vet Systems provided materials support for this study. All financial support for this study was provided by the AO Foundation and by Sam Franklin using his New Faculty Startup-Comparative Medical Research Donation Fund; zero financial support was provided by Arthrex Vet Systems. No funding agency, including the AO Foundation or Arthrex, provided any support in the form of salaries for any authors of this study nor did any supporting/funding agency have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Arnoczky SP, 2013, SPORTS MED ARTHROSC, V21, P180, DOI 10.1097/JSA.0b013e3182999712; Barry S, 2010, VET COMP ORTHOPAED, V23, P385, DOI 10.3415/VCOT-10-01-0017; Bell A, 2016, ORTHOP CLIN N AM, V47, P365, DOI 10.1016/j.ocl.2015.09.010; Bergh MS, 2012, VET COMP ORTHOPAED, V25, P349, DOI 10.3415/VCOT-11-09-0122; Boswell SG, 2014, AM J SPORT MED, V42, P42, DOI 10.1177/0363546513507566; Brinker MR, 2016, ORTHOP CLIN N AM, V47, P67, DOI 10.1016/j.ocl.2015.08.009; Conkling AL, 2010, VET SURG, V39, P475, DOI 10.1111/j.1532-950X.2010.00656.x; Cook JL, 2010, VET SURG, V39, P905, DOI 10.1111/j.1532-950X.2010.00763.x; Silva Silmara Bonomi da, 2007, Cienc. Rural, V37, P1045, DOI 10.1590/S0103-84782007000400020; Diesen DL, 2008, VASCULAR, V16, pS29, DOI 10.2310/6670.2008.00031; Duerr FM, 2014, VET COMP ORTHOPAED, V27, P478, DOI 10.3415/VCOT-14-03-0047; Fitzpatrick N, 2010, VET SURG, V39, P460, DOI 10.1111/j.1532-950X.2010.00663.x; Franklin SP, 2015, AM J VET RES, V76, P822, DOI 10.2460/ajvr.76.9.822; Gianakos A, 2015, ORTHOPEDICS, V38, pE1079, DOI 10.3928/01477447-20151120-04; Hatakeyama I, 2014, TISSUE ENG PT A, V20, P874, DOI [10.1089/ten.tea.2013.0058, 10.1089/ten.TEA.2013.0058]; Intini G, 2009, BIOMATERIALS, V30, P4956, DOI 10.1016/j.biomaterials.2009.05.055; Iqbal Jameel, 2011, Curr Osteoporos Rep, V9, P258, DOI 10.1007/s11914-011-0080-1; Kieves NR, 2015, VET COMP ORTHOPAED, V28, P425, DOI 10.3415/VCOT-15-05-0084; Kim SE, 2012, VET SURG, V41, P465, DOI 10.1111/j.1532-950X.2012.00973.x; Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006; Malhotra A, 2013, ARCH ORTHOP TRAUM SU, V133, P153, DOI 10.1007/s00402-012-1641-1; Rabillard M, 2009, VET COMP ORTHOPAED, V22, P460, DOI 10.3415/VCOT-09-04-0048; Risselada M, 2007, VET RADIOL ULTRASOUN, V48, P368, DOI 10.1111/j.1740-8261.2007.00258.x; Risselada M, 2006, VET RADIOL ULTRASOUN, V47, P301, DOI 10.1111/j.1740-8261.2006.00144.x; Risselada M, 2005, VET SURG, V34, P99, DOI 10.1111/j.1532-950X.2005.00017.x; Risselada M, 2003, VET RADIOL ULTRASOUN, V44, P214, DOI 10.1111/j.1740-8261.2003.tb01274.x; Rodriguez IA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/392398; Roffi A, 2016, INT ORTHOPAEDICS; Sabzevari S, 2016, ARCH BONE JT SURG-AB, V4, P204; Sadeghi-Ataabadi M, 2017, MAT SCI ENG C-MATER, V71, P372, DOI 10.1016/j.msec.2016.10.001; Souza TFB, 2012, VET COMP ORTHOPAED, V25, P445, DOI 10.3415/VCOT-10-10-0146; Visser LC, 2010, VET SURG, V39, P811, DOI 10.1111/j.1532-950X.2010.00739.x; Wilke VL, 2005, JAVMA-J AM VET MED A, V227, P1604, DOI 10.2460/javma.2005.227.1604	33	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177597	10.1371/journal.pone.0177597	http://dx.doi.org/10.1371/journal.pone.0177597			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520812	gold, Green Published, Green Submitted			2022-12-26	WOS:000401485500042
J	Sopha, P; Ren, HY; Grove, DE; Cyr, DM				Sopha, Pattarawut; Ren, Hong Yu; Grove, Diane E.; Cyr, Douglas M.			Endoplasmic reticulum stress-induced degradation of DNAJB12 stimulates BOK accumulation and primes cancer cells for apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-kilodalton heat shock protein (Hsp70); endoplasmic reticulum stress (ER stress); endoplasmic reticulum-associated protein degradation (ERAD); post-transcriptional regulation; proteostasis; Hsp40; protein quality control	UNFOLDED PROTEIN RESPONSE; ER-ASSOCIATED DEGRADATION; QUALITY-CONTROL; MEMBRANE-PROTEINS; UBIQUITIN LIGASE; HSP70; PATHWAY; COMPLEX; CFTR; INHIBITOR	DNAJB12 (JB12) is an endoplasmic reticulum (ER)-associated Hsp40 family protein that recruits Hsp70 to the ER surface to coordinate the function of ER-associated and cytosolic chaperone systems in protein quality control. Hsp70 is stress-inducible, but paradoxically, we report here that JB12 was degraded by the proteasome during severe ER stress. Destabilized JB12 was degraded by ER-associated degradation complexes that contained HERP, Sel1L, and gp78. JB12 was the only ER-associated chaperone that was destabilized by reductive stress. JB12 knockdown by siRNA led to the induction of caspase processing but not the unfolded protein response. ER stress-induced apoptosis is regulated by the highly labile and ER-associated BCL-2 family member BOK, which is controlled at the level of protein stability by ER-associated degradation components. We found that JB12 was required in human hepatoma cell line 7 (Huh-7) liver cancer cells to maintain BOK at low levels, and BOK was detected in complexes with JB12 and gp78. Depletion of JB12 during reductive stress or by shRNA from Huh-7 cells was associated with accumulation of BOK and activation of Caspase 3, 7, and 9. The absence of JB12 sensitized Huh-7 to death caused by proteotoxic agents and the proapoptotic chemotherapeutic LCL-161. In summary, JB12 is a stress-sensitive Hsp40 whose degradation during severe ER stress provides a mechanism to promote BOK accumulation and induction of apoptosis.	[Sopha, Pattarawut; Ren, Hong Yu; Grove, Diane E.; Cyr, Douglas M.] Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Sopha, Pattarawut] Chulabhorn Grad Inst, Program Appl Biol Sci, 54 Kamphaeng Phet 6, Bangkok 10210, Thailand	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Chulabhorn Graduate Institute	Sopha, P; Cyr, DM (corresponding author), Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.; Sopha, P (corresponding author), Chulabhorn Grad Inst, Program Appl Biol Sci, 54 Kamphaeng Phet 6, Bangkok 10210, Thailand.	pattarawut@cgi.ac.th; dmcyr@med.unc.edu		Sopha, Pattarawut/0000-0001-8092-5828	National Institutes of Health [2RO1 GM56981]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 2RO1 GM56981. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Assimon VA, 2013, CURR PHARM DESIGN, V19, P404; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Bhat TA, 2017, BBA-REV CANCER, V1867, P58, DOI 10.1016/j.bbcan.2016.12.002; Chipuk JE, 2016, CURR BIOL, V26, pR473, DOI 10.1016/j.cub.2016.04.003; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; CYR DM, 1992, J BIOL CHEM, V267, P20927; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; Fernandez-Marrero Y, 2016, P NATL ACAD SCI USA, V113, pE492, DOI 10.1073/pnas.1516347113; Grove DE, 2011, MOL BIOL CELL, V22, P301, DOI 10.1091/mbc.E10-09-0760; Han S, 2007, J BIOL CHEM, V282, P26140, DOI 10.1074/jbc.M701969200; Hazari YM, 2016, TUMOR BIOL, V37, P14381, DOI 10.1007/s13277-016-5343-0; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Houck SA, 2014, MOL CELL, V54, P166, DOI 10.1016/j.molcel.2014.02.025; Houck SA, 2012, BBA-BIOMEMBRANES, V1818, P1108, DOI 10.1016/j.bbamem.2011.11.007; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kanehara K, 2010, J CELL BIOL, V188, P707, DOI 10.1083/jcb.200907055; Kausar H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-186; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Lee AS, 2006, CANCER BIOL THER, V5, P721, DOI 10.4161/cbt.5.7.3120; Li K, 2017, MOL CELL, V65, P52, DOI 10.1016/j.molcel.2016.10.027; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Llambi F, 2016, CELL, V165, P421, DOI 10.1016/j.cell.2016.02.026; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Miyata Y, 2013, ACS CHEM NEUROSCI, V4, P930, DOI 10.1021/cn300210g; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Nakajima S, 2011, MOL CELL BIOL, V31, P1710, DOI 10.1128/MCB.00939-10; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nillegoda NB, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00057; Qin Q, 2014, TUMOR BIOL, V35, P2565, DOI 10.1007/s13277-013-1338-2; Sabnis AJ, 2016, P NATL ACAD SCI USA, V113, P9015, DOI 10.1073/pnas.1603883113; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; Sopha P, 2012, CELL STRUCT FUNCT, V37, P177, DOI 10.1247/csf.12017; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; West AC, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.26; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yamamoto Y, 2010, CELL STRUCT FUNCT, V35, P107, DOI 10.1247/csf.10023; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhang T, 2015, MOL BIOL CELL, V26, P4438, DOI 10.1091/mbc.E15-06-0354	41	24	25	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11792	11803		10.1074/jbc.M117.785113	http://dx.doi.org/10.1074/jbc.M117.785113			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28536268	Green Published, hybrid			2022-12-26	WOS:000405485600017
J	Aquino-Martinez, R; Artigas, N; Gamez, B; Rosa, JL; Ventura, F				Aquino-Martinez, Ruben; Artigas, Natalia; Gamez, Beatriz; Luis Rosa, Jose; Ventura, Francesc			Extracellular calcium promotes bone formation from bone marrow mesenchymal stem cells by amplifying the effects of BMP-2 on SMAD signalling	PLOS ONE			English	Article							MORPHOGENETIC PROTEIN-2; OSTEOGENIC DIFFERENTIATION; EXPRESSION; PHOSPHORYLATION; STRATEGIES; RECEPTOR; SCAFFOLD; PATHWAY; CULTURE	Understanding the molecular events that regulate osteoblast differentiation is essential for the development of effective approaches to bone regeneration. In this study, we analysed the osteoinductive properties of extracellular calcium in bone marrow-derived mesenchymal stem cell (BM-MSC) differentiation. We cultured BM-MSCs in 3D gelatin scaffolds with Ca2+ and BMP-2 as osteoinductive agents. Early and late osteogenic gene expression and bone regeneration in a calvarial critical-size defect model demonstrate that extracellular Ca2+ enhances the effects of BMP-2 on Osteocalcin, Runx2 and Osterix expression and promotes bone regeneration in vivo. Moreover, we analysed the molecular mechanisms involved and observed an antagonistic effect between Ca2+ and BMP-2 on SMAD1/5, ERK and S6K signalling after 24 hours. More importantly, a cooperative effect between Ca2+ and BMP-2 on the phosphorylation of SMAD1/5, S6, GSK3 and total levels of beta-CATENIN was observed at a later differentiation time (10 days). Furthermore, Ca2+ alone favoured the phosphorylation of SMAD1, which correlates with the induction of Bmp2 and Bmp4 gene expression. These data suggest that Ca2+ and BMP-2 cooperate and promote an autocrine/paracrine osteogenic feed-forward loop. On the whole, these results demonstrate the usefulness of calcium-based bone grafts or the addition of exogenous Ca2+ in bone tissue engineering.	[Aquino-Martinez, Ruben; Artigas, Natalia; Gamez, Beatriz; Luis Rosa, Jose; Ventura, Francesc] Univ Barcelona, IDIBELL, Dept Ciencias Fisiol, Lhospitalet De Llobregat, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Ventura, F (corresponding author), Univ Barcelona, IDIBELL, Dept Ciencias Fisiol, Lhospitalet De Llobregat, Spain.	fventura@ub.edu	Rosa, Jose Luis/K-6685-2014; Ventura, Francesc/K-9700-2014; Ventura, Francesc/ABG-2285-2020	Rosa, Jose Luis/0000-0002-6161-5688; Ventura, Francesc/0000-0001-9673-9405; Ventura, Francesc/0000-0001-9673-9405; Artigas, Natalia/0000-0003-3290-2052; Aquino-Martinez, Ruben/0000-0003-1564-2279	Ministry of Education and Science of Spain [BFU2014-56313P]; Fundacio La Marato de TV3 [120330]; University of Barcelona	Ministry of Education and Science of Spain(Spanish Government); Fundacio La Marato de TV3; University of Barcelona	This work was supported by grants from the Ministry of Education and Science of Spain (BFU2014-56313P) and Fundacio La Marato de TV3 (120330). N. Artigas received a fellowship from the University of Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquino-Martinez R, 2016, TISSUE ENG PT A, V22, P41, DOI [10.1089/ten.tea.2015.0181, 10.1089/ten.TEA.2015.0181]; Axelrad TW, 2009, CYTOKINE GROWTH F R, V20, P481, DOI 10.1016/j.cytogfr.2009.10.003; Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020; Berger CEM, 2001, J BONE MINER RES, V16, P2092, DOI 10.1359/jbmr.2001.16.11.2092; Boskey Adele L, 2013, Bonekey Rep, V2, P447, DOI 10.1038/bonekey.2013.181; Carstens MH, 2005, J CRANIOFAC SURG, V16, P1023, DOI 10.1097/01.scs.0000186310.10957.2b; Chai YC, 2012, ACTA BIOMATER, V8, P3876, DOI 10.1016/j.actbio.2012.07.002; Chattopadhyay N, 2004, ENDOCRINOLOGY, V145, P3451, DOI 10.1210/en.2003-1127; Chenard KE, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/601549; Danciu TE, 2003, FEBS LETT, V536, P193, DOI 10.1016/S0014-5793(03)00055-3; Dvorak MM, 2004, CELL CALCIUM, V35, P249, DOI 10.1016/j.ceca.2003.10.014; Fromigue O, 2010, J BIOL CHEM, V285, P25251, DOI 10.1074/jbc.M110.110502; Gamez B, 2016, J BONE MINER RES; Gamez B, 2014, J MOL ENDOCRINOL, V52, pR179, DOI 10.1530/JME-13-0294; Hassan AH, 2015, J LIPOSOME RES, P1; Henkel J, 2013, BONE RES, V1, P216, DOI 10.4248/BR201303002; Ortuno MJ, 2010, J BIOL CHEM, V285, P31985, DOI 10.1074/jbc.M110.123612; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Leclerc C, 2011, BIOCHIMIE, V93, P2102, DOI 10.1016/j.biochi.2011.06.032; Lefebvre V, 2010, CURR TOP DEV BIOL, V90, P291, DOI 10.1016/S0070-2153(10)90008-2; Maeda H, 2010, J ENDODONT, V36, P647, DOI 10.1016/j.joen.2009.12.024; Mandal CC, 2016, J BIOL CHEM, V291, P1148, DOI 10.1074/jbc.M115.668939; Moreau R, 1997, J BONE MINER RES, V12, P1984, DOI 10.1359/jbmr.1997.12.12.1984; Murphy CM, 2013, EUR CELLS MATER, V26, P120, DOI 10.22203/eCM.v026a09; Perez RA, 2012, J TISSUE ENG, V3, DOI 10.1177/2041731412439555; Rawashdeh MA, 2008, BRIT J ORAL MAX SURG, V46, P665, DOI 10.1016/j.bjoms.2008.07.184; Riccardi D, 2009, PFLUG ARCH EUR J PHY, V458, P1007, DOI 10.1007/s00424-009-0681-z; Rodriguez-Carballo E, 2011, J BONE MINER RES, V26, P718, DOI 10.1002/jbmr.260; Rohanizadeh R, 2008, J MATER SCI-MATER M, V19, P1173, DOI 10.1007/s10856-007-3154-y; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Stanovici J, 2016, CURR RES TRANSL MED, V64, P83, DOI 10.1016/j.retram.2016.04.006; Szpalski C, 2012, TISSUE ENG PART B-RE, V18, P246, DOI [10.1089/ten.TEB.2011.0427, 10.1089/ten.teb.2011.0427]; Tada H, 2010, BIOCHEM BIOPH RES CO, V394, P1093, DOI 10.1016/j.bbrc.2010.03.135; Takagishi Y, 2006, TISSUE ENG, V12, P927, DOI 10.1089/ten.2006.12.927; Tang M, 2014, J PERIODONTOL, V85, P1806, DOI 10.1902/jop.2014.140244; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Vaccaro Alexander R, 2002, Spine J, V2, P206, DOI 10.1016/S1529-9430(02)00180-8; Wei W, 2012, P NATL ACAD SCI USA, V109, P3143, DOI 10.1073/pnas.1200797109; Wicks SJ, 2000, MOL CELL BIOL, V20, P8103, DOI 10.1128/MCB.20.21.8103-8111.2000	41	55	58	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178158	10.1371/journal.pone.0178158	http://dx.doi.org/10.1371/journal.pone.0178158			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542453	Green Published, gold, Green Submitted			2022-12-26	WOS:000402062800046
J	Mayfield, AB; Chen, CS; Dempsey, AC				Mayfield, Anderson B.; Chen, Chii-Shiarng; Dempsey, Alexandra C.			Identifying corals displaying aberrant behavior in Fiji's Lau Archipelago	PLOS ONE			English	Article							REEF-BUILDING CORAL; POCILLOPORA-DAMICORNIS; ELEVATED-TEMPERATURE; GENE-EXPRESSION; PHYSIOLOGY; ANTHOZOAN; SYSTEM; HEALTH	Given the numerous threats against Earth's coral reefs, there is an urgent need to develop means of assessing reef coral health on a proactive timescale. Molecular biomarkers may prove useful in this endeavor because their expression should theoretically undergo changes prior to visible signs of health decline, such as the breakdown of the coral-dinoflagellate (genus Symbiodinium) endosymbiosis. Herein 13 molecular-and physiologicalscale biomarkers spanning both eukaryotic compartments of the anthozoan-Symbiodinium mutualism were assessed across 70 pocilloporid coral colonies sampled from reefs of Fiji's easternmost province, Lau. Eleven colonies were identified as outliers upon employment of a detection method based partially on the Mahalanobis distance; these corals were hypothesized to have been displaying aberrant sub-cellular behavior with respect to their gene expression signatures, as they were characterized not only by lower Symbiodinium densities, but also by higher levels of expression of several stress-targeted genes. Although these findings could suggest that the sampled colonies were physiologically compromised at the time of sampling, further studies are warranted to state conclusively whether these 11 scleractinian coral colonies are more stress-prone than nearby conspecifics that demonstrated statistically normal phenotypes.	[Mayfield, Anderson B.; Chen, Chii-Shiarng] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Mayfield, Anderson B.; Dempsey, Alexandra C.] Khaled bin Sultan Living Oceans Fdn, Annapolis, MD USA; [Mayfield, Anderson B.; Chen, Chii-Shiarng] Taiwan Coral Res Ctr, Pingtung, Taiwan; [Chen, Chii-Shiarng] Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Pingtung, Taiwan; [Chen, Chii-Shiarng] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan	National Museum of Marine Biology & Aquarium; National Dong Hwa University; National Sun Yat Sen University	Mayfield, AB (corresponding author), Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan.; Mayfield, AB (corresponding author), Khaled bin Sultan Living Oceans Fdn, Annapolis, MD USA.; Mayfield, AB (corresponding author), Taiwan Coral Res Ctr, Pingtung, Taiwan.	andersonblairmayfield@gmail.com		Mayfield, Anderson/0000-0003-0138-7844	Khaled bin Sultan Living Oceans Foundation	Khaled bin Sultan Living Oceans Foundation	The Khaled bin Sultan Living Oceans Foundation funded this work in its entirety, including a postdoctoral research fellowship to ABM. One author (ACD) is an employee of the funding organization and had a role in data collection and manuscript preparation.	Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Chen HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132519; Cheng YR, 2016, ZOOTAXA, V4174, P291, DOI 10.11646/zootaxa.4174.1.20; Clarke KR, 1994, CHANGE MARINE COMMUN; Correa AMS, 2009, MAR BIOL, V156, P2403, DOI 10.1007/s00227-009-1263-5; Downs CA, 2005, MAR POLLUT BULL, V51, P558, DOI 10.1016/j.marpolbul.2005.04.017; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Feder M.E., 1996, Society for Experimental Biology Seminar Series, V59, P79; Furla P, 2005, INTEGR COMP BIOL, V45, P595, DOI 10.1093/icb/45.4.595; GATES RD, 1990, CORAL REEFS, V8, P193, DOI 10.1007/BF00265010; Hochachka P. W., 2002, BIOCH ADAPTATION; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Huang YCA, 2011, MAR ECOL PROG SER, V423, P83, DOI 10.3354/meps08944; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Liu PJ, 2012, MAR POLLUT BULL, V64, P1129, DOI 10.1016/j.marpolbul.2012.03.031; Mayfield AB, 2013, CORAL REEFS, V32, P909, DOI 10.1007/s00338-013-1067-4; Mayfield AB, 2014, INT J MARINE SCI, V4, P1, DOI DOI 10.5376/IJMS.2014.04.0050; MAYFIELD AB, 2013, J MAR BIOL, V2013, P69369, DOI DOI 10.1155/2013/569361; Mayfield AB, 2016, CORAL REEFS ECOSYSTE, P13; Mayfield AB, 2007, COMP BIOCHEM PHYS A, V147, P1, DOI 10.1016/j.cbpa.2006.12.042; Mayfield AB, 2016, J MAR SCI ENG, V4, DOI 10.3390/jmse4030063; Mayfield Anderson B., 2016, Platax, V13, P1; Mayfield Anderson B., 2015, Platax, V12, P1; Mayfield AB, 2016, MOL ECOL, V25, P5944, DOI 10.1111/mec.13896; Mayfield Anderson B., 2014, Platax, V11, P1; Mayfield Anderson B., 2013, Platax, V10, P1; Mayfield AB, 2014, MOL ECOL, V23, P5816, DOI 10.1111/mec.12982; Mayfield Anderson B., 2012, Platax, V9, P1; Mayfield AB, 2013, MAR ENVIRON RES, V86, P1, DOI 10.1016/j.marenvres.2013.01.004; Mayfield AB, 2012, J EXP BIOL, V215, P4183, DOI 10.1242/jeb.071688; Mayfield AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026529; Mayfield AB, 2010, J EXP MAR BIOL ECOL, V395, P215, DOI 10.1016/j.jembe.2010.09.007; Mayfield AB, 2009, MOL ECOL RESOUR, V9, P462, DOI 10.1111/j.1755-0998.2008.02349.x; Peng SE, 2011, PROTEOMICS, V11, P3540, DOI 10.1002/pmic.201000552; Putnam HM, 2013, MAR BIOL, V160, P2157, DOI 10.1007/s00227-012-2129-9; Saul S, 2015, REMOTE SENS-BASEL, V7, P15894, DOI 10.3390/rs71215810; Schmidt-Roach S, 2014, ZOOL J LINN SOC-LOND, V170, P1, DOI 10.1111/zoj12092; Smith EG, 2013, CORAL REEFS, V32, P463, DOI 10.1007/s00338-012-0994-9; Sokal RR, 1995, BIOMETRY; Traylor-Knowles N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-585; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700	42	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177267	10.1371/journal.pone.0177267	http://dx.doi.org/10.1371/journal.pone.0177267			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542245	Green Published, Green Submitted, gold			2022-12-26	WOS:000402061500017
J	Meshram, NM; Shashank, PR; Sinha, T				Meshram, Naresh M.; Shashank, Pathour R.; Sinha, Twinkle			A new genus of leafhopper subtribe Paraboloponina (Hemiptera: Cicadellidae) with molecular phylogeny of related genera	PLOS ONE			English	Article							ALIGNMENT	A new leafhopper genus Chandra and species Chandra dehradunensis gen. nov., sp. nov. are described, illustrated from India and placed in the subtribe Paraboloponina (Cidadellidae: Deltocephalinae: Drabescini). This genus is closely associated with the genus Parabolopona Webb but differs in shape of the head, placement of antennae, male genitalia and molecular analysis using Histone H3 and COI genes confirmed the difference. The taxonomic and phylogenetic position of Chandra is discussed using morphological characters and preliminary molecular evidence of the new genus and related genus Parabolopona.	[Meshram, Naresh M.; Shashank, Pathour R.; Sinha, Twinkle] Indian Agr Res Inst, ICAR, Div Entomol, Natl Pusa Collect, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Meshram, NM (corresponding author), Indian Agr Res Inst, ICAR, Div Entomol, Natl Pusa Collect, New Delhi, India.	nmmeshram@gmail.com	PR, Shashank/A-2724-2016	PR, Shashank/0000-0002-8177-6091	DST-SERB [SB/YS/LS-126/2014]; Department of Science and Technology [SB/YS/LS-126/2014]	DST-SERB(Department of Science & Technology (India)Science Engineering Research Board (SERB), India); Department of Science and Technology(Department of Science & Technology (India))	Indian Agricultural Research Institute provided research facilities. Second author received funding for collections of insects from DST-SERB (SB/YS/LS-126/2014), this led to the discovery of new genus.; The author gratefully acknowledges Prof. C.A. Viraktamath for guidance on leafhoppers and Head, Division of Entomology, Indian Council of Agriculture Research-IARI, New Delhi for providing necessary permission. We thank Dr. V.V. Ramamurthy, Ex-professor, Division of Entomology, Indian Council of Agriculture Research-IARI, New Delhi for his guidance and encouragement. Department of Science and Technology grant (SB/YS/LS-126/2014) is gratefully acknowledged.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Dmitriev DA, 2004, ORIENT INSECTS, V38, P235, DOI 10.1080/00305316.2004.10417390; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KNIGHT W. J., 1965, ENTOMOL GAZ, V16, P129; Meshram NM, 2016, ZOOTAXA, V4114, P182, DOI 10.11646/zootaxa.4114.2.7; Ogden TH, 2003, CLADISTICS, V19, P432, DOI [10.1111/j.1096-0031.2003.tb00313.x, 10.1016/S0748-3007(03)00083-5]; OMAN PAUL WILSON, 1949, MEM ENT SOC WASHINGTON, V3, P1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shashank PR, 2014, APPL ENTOMOL ZOOL, V49, P283, DOI 10.1007/s13355-014-0248-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Virakatamath C.A., 1998, Bulletin of the Natural History Museum Entomology Series, V67, P153; Webb M.D., 1981, Bulletin of the British Museum (Natural History) Entomology, V43, P39; Zahniser JN, 2013, EUR J TAXON, V45, P1, DOI 10.5852/ejt.2013.45; Zhang Y., 1996, Bulletin of the Natural History Museum Entomology Series, V65, P1	16	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177644	10.1371/journal.pone.0177644	http://dx.doi.org/10.1371/journal.pone.0177644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542237	Green Published, Green Submitted, gold			2022-12-26	WOS:000402061500034
J	AlBadri, A; Lai, K; Wei, J; Landes, S; Mehta, PK; Li, Q; Johnson, D; Reis, SE; Kelsey, SF; Bittner, V; Sopko, G; Shaw, LJ; Pepine, CJ; Merzl, CNB				AlBadri, Ahmed; Lai, Kha; Wei, Janet; Landes, Sofy; Mehta, Puja K.; Li, Quanlin; Johnson, Delia; Reis, Steven E.; Kelsey, Sheryl F.; Bittner, Vera; Sopko, George; Shaw, Leslee J.; Pepine, Carl J.; Merzl, C. Noel Bairey			Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SERUM AMYLOID-A; CARDIOVASCULAR-DISEASE; CHEST-PAIN; MARKERS; INTERLEUKIN-6; RISK; ACTIVATION; DYSFUNCTION; OBESITY	Background Women with signs and symptoms of ischemia, no obstructive coronary artery disease (CAD) and preserved left ventricular ejection fraction (EF) often have diastolic dysfunction and experience elevated rates of major adverse cardiac events (MACE), including heart failure (HF) hospitalization with preserved ejection fraction (HFpEF). We evaluated the predictive value of inflammatory biomarkers for long-term HF hospitalization and all-cause mortality in these women. Methods We performed a cross-sectional analysis to investigate the relationships between inflammatory biomarkers [serum interleukin-6 (IL-6), C-reactive protein (hs-CRP) and serum amyloid A (SAA)] and median of 6 years follow-up for all-cause mortality and HF hospitalization among women with signs and symptoms of ischemia, non-obstructive CAD and preserved EF. Multivariable Cox regression analysis tested associations between biomarker levels and adverse outcomes. Results Among 390 women, mean age 56 +/- 11 years, median follow up of 6 years, we observed that there is continuous association between IL-6 level and HF hospitalization (adjusted hazard ratio [AHR] 2.5 [1.2-5.0], p = 0.02). In addition, we found significant association between IL6, SAA levels and all-cause mortality AHR (1.8 [1.1-3.0], p = 0.01) (1.5 [1.0-2.1], p = 0.04), respectively. Conclusion In women with signs and symptoms of ischemia, non-obstructive CAD and preserved EF, elevated IL-6 predicted HF hospitalization and all-cause mortality, while SAA level was only associated with all-cause mortality. These results suggest that inflammation plays a role in the pathogenesis of development of HFpEF, as well all-cause mortality.	[AlBadri, Ahmed; Lai, Kha; Wei, Janet; Landes, Sofy; Mehta, Puja K.; Merzl, C. Noel Bairey] Cedars Sinai Heart Inst, Barbra Streisand Womens Heart Ctr, Los Angeles, CA 90048 USA; [Li, Quanlin] Cedars Sinai Med Ctr, Biostat & Bioinformat Res Ctr, Los Angeles, CA 90048 USA; [Johnson, Delia; Reis, Steven E.; Kelsey, Sheryl F.] Univ Pittsburgh, Cardiovasc Inst, Pittsburgh, PA USA; [Bittner, Vera] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Sopko, George] NHLBI, Div Cardiovasc Dis, NIH, Bldg 10, Bethesda, MD 20892 USA; [Shaw, Leslee J.] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA; [Pepine, Carl J.] Univ Florida, Coll Med, Div Cardiovasc Med, Gainesville, FL USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Emory University; State University System of Florida; University of Florida	Merzl, CNB (corresponding author), Cedars Sinai Heart Inst, Barbra Streisand Womens Heart Ctr, Los Angeles, CA 90048 USA.	Noel.BaireylMerz@cshs.org		Reis, Steven/0000-0001-8023-0102; Pepine, Carl/0000-0002-6011-681X	National Heart, Lung and Blood Institutes [N01-HV-68161, N01-HV-68162, N01-HV68163, N01-HV-68164]; National Institute on Aging [U0164829, U01 HL649141, U01 HL649241, K23HL105787, T32HL69751, R01 HL090957, 1R03AG032631]; National Center for Research Resources [M01-RR00425]; National Center for Advancing Translational Sciences Grant [UL1TR000124, UL1TR001427]; Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ; Women's Guild of Cedars-Sinai Medical Center, Los Angeles, CA; Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA; QMED, Inc.; Laurence Harbor, NJ; Edythe L. Broad; Constance Austin Women's Heart Research Fellowships; Cedars-Sinai Medical Center, Los Angeles, California; Barbra Streisand Women's Cardiovascular Research and Education Program, Cedars-Sinai Medical Center, Los Angeles; Society for Women's Health Research (SWHR), Washington, D.C.; Linda Joy Pollin Women's Heart Health Program; Erika Glazer Women's Heart Health Project, Cedars-Sinai Medical Center, Los Angeles, California	National Heart, Lung and Blood Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences Grant; Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ; Women's Guild of Cedars-Sinai Medical Center, Los Angeles, CA; Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA; QMED, Inc.; Laurence Harbor, NJ; Edythe L. Broad; Constance Austin Women's Heart Research Fellowships; Cedars-Sinai Medical Center, Los Angeles, California; Barbra Streisand Women's Cardiovascular Research and Education Program, Cedars-Sinai Medical Center, Los Angeles; Society for Women's Health Research (SWHR), Washington, D.C.; Linda Joy Pollin Women's Heart Health Program; Erika Glazer Women's Heart Health Project, Cedars-Sinai Medical Center, Los Angeles, California	This work was supported by contracts from the National Heart, Lung and Blood Institutes nos. N01-HV-68161, N01-HV-68162, N01-HV68163, N01-HV-68164, grants U0164829, U01 HL649141, U01 HL649241, K23HL105787, T32HL69751, R01 HL090957, 1R03AG032631 from the National Institute on Aging, GCRC grant M01-RR00425 from the National Center for Research Resources, the National Center for Advancing Translational Sciences Grant UL1TR000124 and UL1TR001427, and grants from the Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ, The Women's Guild of Cedars-Sinai Medical Center, Los Angeles, CA, The Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA, and QMED, Inc., Laurence Harbor, NJ, the Edythe L. Broad and the Constance Austin Women's Heart Research Fellowships, Cedars-Sinai Medical Center, Los Angeles, California, the Barbra Streisand Women's Cardiovascular Research and Education Program, Cedars-Sinai Medical Center, Los Angeles, The Society for Women's Health Research (SWHR), Washington, D.C., The Linda Joy Pollin Women's Heart Health Program, and the Erika Glazer Women's Heart Health Project, Cedars-Sinai Medical Center, Los Angeles, California. This work is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or National Institutes of Health.`	Bakir M, 2016, INT J CARDIOL, V223, P936, DOI 10.1016/j.ijcard.2016.07.301; Cosin-Sales J, 2003, J AM COLL CARDIOL, V41, P1468, DOI 10.1016/S0735-1097(03)00243-2; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; Gulati M, 2009, ARCH INTERN MED, V169, P843, DOI 10.1001/archinternmed.2009.50; Hartman J, 2014, CARDIOL REV, V22, P147, DOI 10.1097/CRD.0000000000000021; HIROTA H, 1995, P NATL ACAD SCI USA, V92, P4862, DOI 10.1073/pnas.92.11.4862; Imhof A, 2001, LANCET, V357, P763, DOI 10.1016/S0140-6736(00)04170-2; Janssen SPM, 2005, CIRCULATION, V111, P996, DOI 10.1161/01.CIR.0000156469.96135.0D; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; Kip KE, 2005, AM HEART J, V150, P900, DOI 10.1016/j.ahj.2005.02.002; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Marroquin OC, 2005, AM HEART J, V150, P109, DOI 10.1016/j.ahj.2004.08.003; Merz CNB, 1999, J AM COLL CARDIOL, V33, P1453; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pischon T, 2003, OBES RES, V11, P1055, DOI 10.1038/oby.2003.145; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Shainkin-Kestenbaum R, 1996, Biomed Pept Proteins Nucleic Acids, V2, P79; Szmitko PE, 2003, CIRCULATION, V108, P2041, DOI 10.1161/01.CIR.0000089093.75585.98; Vasan RS, 2003, CIRCULATION, V107, P1486, DOI 10.1161/01.CIR.0000057810.48709.F6; Verma S, 2002, CIRCULATION, V106, P913, DOI 10.1161/01.CIR.0000029802.88087.5E; Verma S, 2004, CIRCULATION, V109, P2058, DOI 10.1161/01.CIR.0000127577.63323.24; Vilaro HT JR, 2014, CIRCULATION, V2014, P130; Wei J, 2016, AM J PHYSIOL-HEART C, V310, pH14, DOI 10.1152/ajpheart.00612.2015; Wollert KC, 1997, J MOL MED-JMM, V75, P492, DOI 10.1007/s001090050134; Yu XW, 2005, J PHYSIOL-LONDON, V566, P341, DOI 10.1113/jphysiol.2005.087478; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; Zhang HC, 2007, AM J PHYSIOL-HEART C, V292, pH2408, DOI 10.1152/ajpheart.01150.2006	30	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177684	10.1371/journal.pone.0177684	http://dx.doi.org/10.1371/journal.pone.0177684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542263	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672600020
J	Diniz, I; Figueiredo, A; Loureiro, A; Batista, D; Azinheira, H; Varzea, V; Pereira, AP; Gichuru, E; Moncada, P; Guerra-Guimaraes, L; Oliveira, H; Silva, MD				Diniz, Ines; Figueiredo, Andreia; Loureiro, Andreia; Batista, Dora; Azinheira, Helena; Varzea, Vitor; Pereira, Ana Paula; Gichuru, Elijah; Moncada, Pilar; Guerra-Guimaraes, Leonor; Oliveira, Helena; Silva, Maria do Ceu			A first insight into the involvement of phytohormones pathways in coffee resistance and susceptibility to Colletotrichum kahawae	PLOS ONE			English	Article							SALICYLIC-ACID; BERRY DISEASE; DEFENSE RESPONSES; ETHYLENE BIOSYNTHESIS; GENE-EXPRESSION; PLANT IMMUNITY; CELL-DEATH; NICOTIANA-BENTHAMIANA; ARABICA COFFEE; JASMONIC ACID	Understanding the molecular mechanisms underlying coffee-pathogen interactions are of key importance to aid disease resistance breeding efforts. In this work the expression of genes involved in salicylic acid (SA), jasmonic acid (JA) and ethylene (ET) pathways were studied in hypocotyls of two coffee varieties challenged with the hemibiotrophic fungus Colletotrichum kahawae, the causal agent of Coffee Berry Disease. Based on a cytological analysis, key time-points of the infection process were selected and qPCR was used to evaluate the expression of phytohormones biosynthesis, reception and responsive-related genes. The resistance to C. kahawae was characterized by restricted fungal growth associated with early accumulation of phenolic compounds in the cell walls and cytoplasmic contents, and deployment of hypersensitive reaction. Similar responses were detected in the susceptible variety, but in a significantly lower percentage of infection sites and with no apparent effect on disease development. Gene expression analysis suggests a more relevant involvement of JA and ET phytohormones than SA in this pathosystem. An earlier and stronger activation of the JA pathway observed in the resistant variety, when compared with the susceptible one, seems to be responsible for the successful activation of defense responses and inhibition of fungal growth. For the ET pathway, the down or non-regulation of ET receptors in the resistant variety, together with a moderate expression of the responsive-related gene ERF1, indicates that this phytohormone may be related with other functions besides the resistance response. However, in the susceptible variety, the stronger activation of ERF1 gene at the beginning of the necrotrophic phase, suggests the involvement of ET in tissue senescence. As far as we know, this is the first attempt to unveil the role of phytohormones in coffee-C. kahawae interactions, thus contributing to deepen our understanding on the complex mechanisms of plant signaling and defense.	[Diniz, Ines; Batista, Dora; Azinheira, Helena; Varzea, Vitor; Pereira, Ana Paula; Guerra-Guimaraes, Leonor; Silva, Maria do Ceu] Univ Lisbon, CIFC, ISA, Oeiras, Portugal; [Diniz, Ines; Loureiro, Andreia; Batista, Dora; Azinheira, Helena; Varzea, Vitor; Guerra-Guimaraes, Leonor; Oliveira, Helena; Silva, Maria do Ceu] Univ Lisbon, Linking Landscape Environm Agr & Food LEAF, ISA, Lisbon, Portugal; [Figueiredo, Andreia] Univ Lisbon, Fac Ciencias, BioISI Biosyst & Integrat Sci Inst, Lisbon, Portugal; [Batista, Dora] Univ Lisbon, Fac Ciencias, Computat Biol & Populat Genom Grp, cE3c, Lisbon, Portugal; [Gichuru, Elijah] Kenya Agr & Livestock Res Org, Coffee Res Inst, Ruiru, Kenya; [Moncada, Pilar] Ctr Nacl Invest Cafe Cenicafe, Manizales, Colombia	Universidade de Lisboa; Universidade de Lisboa; BIOISI; Universidade de Lisboa; Universidade de Lisboa	Diniz, I (corresponding author), Univ Lisbon, CIFC, ISA, Oeiras, Portugal.; Diniz, I (corresponding author), Univ Lisbon, Linking Landscape Environm Agr & Food LEAF, ISA, Lisbon, Portugal.	inesdiniz@isa.ulisboa.pt	Figueiredo, Andreia/G-2887-2014; Diniz, Inês/ABB-7791-2020; Azinheira, Helena/ADX-1184-2022; Loureiro, Andreia/Q-6716-2019; do Céu ML Silva, Maria/M-6236-2013; Batista, Dora/N-7385-2013; do Céu Silva, Maria/AAP-9668-2021	Figueiredo, Andreia/0000-0001-8156-7700; Diniz, Inês/0000-0003-0193-4385; Azinheira, Helena/0000-0002-9007-0082; Loureiro, Andreia/0000-0002-8886-545X; do Céu ML Silva, Maria/0000-0002-1628-7128; Batista, Dora/0000-0003-4031-8999; do Céu Silva, Maria/0000-0002-1628-7128; Varzea, Vitor/0000-0002-9507-3311; Oliveira, Helena/0000-0002-8274-9757; Guerra-Guimaraes, Leonor/0000-0002-9676-1036; Pereira, Ana Paula Mira Carmo/0000-0001-7469-8147	Portuguese national funds through Fundacao para a Ciencia e a Tecnologia [PTDC/AGR-GPL/112217/2009]; LEAF [UI/AGR/04129/2013];  [LEAF-AGR/04129/BPD/2015];  [SFRH/BPD/ 99712/2014];  [SFRH/BPD/104629/2014];  [SFRH/BD/ 84188/2012]	Portuguese national funds through Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); LEAF; ; ; ; 	This work was funded by Portuguese national funds through Fundacao para a Ciencia e a Tecnologia (www.fct.pt/) (PTDC/AGR-GPL/112217/2009), LEAF (UI/AGR/04129/2013) and grants LEAF-AGR/04129/BPD/2015, SFRH/BPD/ 99712/2014, SFRH/BPD/104629/2014, SFRH/BD/ 84188/2012 attributed to AL, AF, DB, ID.	Ahmad P, 2016, FRONT PLANT SCI; Amil-Ruiz F, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01036; An CF, 2011, J INTEGR PLANT BIOL, V53, P412, DOI 10.1111/j.1744-7909.2011.01043.x; Andolfo G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00987; Balmer D, 2013, PLANT J, V74, P213, DOI 10.1111/tpj.12114; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bennett M, 1996, PLANT J, V9, P851, DOI 10.1046/j.1365-313X.1996.9060851.x; BILES CL, 1990, PHYTOPATHOLOGY, V80, P732, DOI 10.1094/Phyto-80-732; Castro A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00580; Chen N, 2003, J EXP BOT, V54, P2449, DOI 10.1093/jxb/erg289; Damm U, 2014, STUD MYCOL, P49, DOI 10.1016/j.simyco.2014.09.003; Ding LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019008; Diniz I, 2015, PROCEEDINGS OF 25TH; Diniz I, 2014, XVI INTERNATIONAL CO; Diniz I, 2012, EUR J PLANT PATHOL, V133, P141, DOI 10.1007/s10658-011-9925-9; Silva Maria do Céu, 2006, Braz. J. Plant Physiol., V18, P119, DOI 10.1590/S1677-04202006000100010; Duan L, 2014, PHYSIOL PLANTARUM, V152, P486, DOI 10.1111/ppl.12192; Duan ZB, 2014, EUR J PLANT PATHOL, V140, P169, DOI 10.1007/s10658-014-0453-2; Figueiredo A, 2015, EUR J PLANT PATHOL, V142, P645, DOI 10.1007/s10658-015-0634-7; Figueiredo Andreia, 2013, BMC Res Notes, V6, P388, DOI 10.1186/1756-0500-6-388; Fino J, 2015, PROCEEDINGS OF 25TH; Firman ID, 1977, COFFEE BERRY DISEASE; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Gallie D. R., 2015, F1000PRIME REPORTS, V7, P1; Gichuru E. K., 2007, Agronomie Africaine, V19, P233; Gichuru EK, 2008, PLANT PATHOL, V57, P1117, DOI 10.1111/j.1365-3059.2008.01846.x; Gichuru E. K., 1997, Kenya Coffee, V62, P2441; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Grellet-Bournonville CF, 2012, PLANT PHYSIOL BIOCH, V54, P10, DOI 10.1016/j.plaphy.2012.01.019; Groen SC, 2014, J CHEM ECOL, V40, P700, DOI 10.1007/s10886-014-0474-5; Guerreiro A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00565; He J, 2016, J FOOD SAF; Heath MC, 1998, EUR J PLANT PATHOL, V104, P117, DOI 10.1023/A:1008645520976; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hindorf H, 2011, J ADV RES, V2, P109, DOI 10.1016/j.jare.2010.08.006; Janda M, 2015, ENVIRON EXP BOT, V114, P117, DOI 10.1016/j.envexpbot.2014.07.003; Jaulneau V, 2010, MOL PLANT MICROBE IN, V23, P1107, DOI 10.1094/MPMI-23-9-1107; Kazan K, 2014, PLANT CELL, V26, P2285, DOI 10.1105/tpc.114.125419; KENDE H, 1989, PLANT PHYSIOL, V91, P1, DOI 10.1104/pp.91.1.1; Kevany BM, 2008, PLANT BIOTECHNOL J, V6, P295, DOI 10.1111/j.1467-7652.2007.00319.x; Kubo Y, 2016, PHYSIOL MOL PLANT P, V95, P32, DOI 10.1016/j.pmpp.2016.02.008; Kumar D, 2014, PLANT SCI, V228, P127, DOI 10.1016/j.plantsci.2014.04.014; Lahey KA, 2004, MOL PLANT MICROBE IN, V17, P1394, DOI 10.1094/MPMI.2004.17.12.1394; Li W, 2003, J AM SOC HORTIC SCI, V128, P578, DOI 10.21273/JASHS.128.4.0578; Litholdo CG, 2015, PLANT CELL REP, V34, P1747, DOI 10.1007/s00299-015-1821-x; Liu GS, 2007, MOL PLANT MICROBE IN, V20, P1308, DOI 10.1094/MPMI-20-10-1308; Lou reiro A, 2013, PROCEEDINGS OF 24TH; Loureiro A, 2012, PHYSIOL MOL PLANT P, V77, P23, DOI 10.1016/j.pmpp.2011.11.002; Ma KW, 2016, PLANT MOL BIOL, V91, P713, DOI 10.1007/s11103-016-0452-0; MASABA DM, 1982, NETH J PLANT PATHOL, V88, P19, DOI 10.1007/BF01976423; McDonald L., 1926, T BR MYCOL SOC, V11, P145; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Merchante C, 2013, CURR OPIN PLANT BIOL, V16, P554, DOI 10.1016/j.pbi.2013.08.001; Miles TD, 2011, MOL PLANT PATHOL, V12, P463, DOI 10.1111/j.1364-3703.2010.00687.x; Muencha S, 2008, J PLANT PHYSIOL, V165, P41, DOI 10.1016/j.jplph.2007.06.008; Ohtsubo N, 1999, PLANT CELL PHYSIOL, V40, P808, DOI 10.1093/oxfordjournals.pcp.a029609; Omondi CO, 2006, PROCEEDINGS OF 21ST; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Pieterse MJ, 2012, ANNU REV DEV BIOL, V28, P489; Portal O, 2011, PLANT CELL REP, V30, P913, DOI 10.1007/s00299-011-1008-z; Prathima PT, 2013, APPL BIOCHEM BIOTECH, V171, P488, DOI 10.1007/s12010-013-0346-4; Ramiro DA, 2009, PLANT PATHOL, V58, P944, DOI 10.1111/j.1365-3059.2009.02122.x; RODRIGUES CJ, 1991, J PHYTOPATHOL, V131, P205, DOI 10.1111/j.1439-0434.1991.tb01189.x; Sa M., 2014, J SCI FOOD AGR, V94, P529, DOI [DOI 10.1002/JSFA.6288, 10.1002/jsfa.6288]; Sasek V, 2012, MOL PLANT MICROBE IN, V25, P1238, DOI 10.1094/MPMI-02-12-0033-R; Shan XC, 2006, PLANT CELL REP, V25, P241, DOI 10.1007/s00299-005-0063-8; Shantanu Das, 2015, Agricultural Reviews, V36, P133; Shibata Y, 2010, MOL PLANT MICROBE IN, V23, P1130, DOI 10.1094/MPMI-23-9-1130; Silva MC, 2002, PHYSIOL MOL PLANT P, V60, P169, DOI 10.1006/pmpp.2002.0389; Silva MC, 1999, INT J PLANT SCI, V160, P79, DOI 10.1086/314113; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Sugano S, 2013, PLANT PATHOL, V62, P1048, DOI 10.1111/ppa.12011; Tang WL, 2010, POSTHARVEST BIOL TEC, V57, P86, DOI 10.1016/j.postharvbio.2010.02.007; Torregrosa C, 2004, MOL PLANT MICROBE IN, V17, P909, DOI 10.1094/MPMI.2004.17.8.909; van der Vossen HAM, 2009, EUPHYTICA, V165, P105, DOI 10.1007/s10681-008-9769-3; VANDERVOSSEN HAM, 1980, EUPHYTICA, V29, P777, DOI 10.1007/BF00023225; VANDERVOSSEN HAM, 1976, EUPHYTICA, V25, P733, DOI 10.1007/BF00041613; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vargas WA, 2012, PLANT PHYSIOL, V158, P1342, DOI 10.1104/pp.111.190397; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wanigasekara UWNP, 2014, J NATL SCI FOUND SRI, V42, P101, DOI 10.4038/jnsfsr.v42i2.6994; Wasternack C, 2014, PLANT CELL REP, V33, P707, DOI 10.1007/s00299-014-1608-5; Yan SP, 2014, CURR OPIN PLANT BIOL, V20, P64, DOI 10.1016/j.pbi.2014.04.006; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Yu MM, 2009, POSTHARVEST BIOL TEC, V54, P153, DOI 10.1016/j.postharvbio.2009.07.001; Zubini P, 2009, PLANT PHYSIOL, V150, P1235, DOI 10.1104/pp.109.139543	86	11	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178159	10.1371/journal.pone.0178159	http://dx.doi.org/10.1371/journal.pone.0178159			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542545	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672600046
J	Oses, C; Olivares, B; Ezquer, M; Acosta, C; Bosch, P; Donoso, M; Leniz, P; Ezquerl, F				Oses, Carolina; Olivares, Belen; Ezquer, Marcelo; Acosta, Cristian; Bosch, Paul; Donoso, Macarena; Leniz, Patricio; Ezquerl, Fernando			Preconditioning of adipose tissue-derived mesenchymal stem cells with deferoxamine increases the production of pro-angiogenic, neuroprotective and anti-inflammatory factors: Potential application in the treatment of diabetic neuropathy	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; NERVE GROWTH-FACTOR; QUALITY-OF-LIFE; STROMAL CELLS; OXIDATIVE STRESS; BONE-MARROW; IN-VITRO; EPINEURIAL ARTERIOLES; PERIPHERAL NEUROPATHY; REPERFUSION INJURY	Diabetic neuropathy (DN) is one of the most frequent and troublesome complications of diabetes mellitus. Evidence from diabetic animal models and diabetic patients suggests that reduced availability of neuroprotective and pro-angiogenic factors in the nerves in combination with a chronic pro-inflammatory microenvironment and high level of oxidative stress, contribute to the pathogenesis of DN. Mesenchymal stem cells (MSCs) are of great interest as therapeutic agents for regenerative purposes, since they can secrete a broad range of cytoprotective and anti-inflammatory factors. Therefore, the use of the MSC secretome may represent a promising approach for DN treatment. Recent data indicate that the paracrine potential of MSCs could be boosted by preconditioning these cells with an environmental or pharmacological stimulus, enhancing their therapeutic efficacy. In the present study, we observed that the preconditioning of human adipose tissue-derived MSCs (AD-MSCs) with 150 mu M or 400 mu M of the iron chelator deferoxamine (DFX) for 48 hours, increased the abundance of the hypoxia inducible factor 1 alpha (HIF-1 alpha) in a concentration dependent manner, without affecting MSC morphology and survival. Activation of HIF-1 alpha led to the upregulation of the mRNA levels of pro-angiogenic factors like vascular endothelial growth factor alpha and angiopoietin 1. Furthermore this preconditioning increased the expression of potent neuroprotective factors, including nerve growth factor, glial cell-derived neurotrophic factor and neurotrophin-3, and cytokines with anti-inflammatory activity like IL4 and IL5. Additionally, we observed that these molecules, which could also be used as therapeutics, were also increased in the secretome of MSCs preconditioned with DFX compared to the secretome obtained from non-preconditioned cells. Moreover, DFX preconditioning significantly increased the total antioxidant capacity of the MSC secretome and they showed neuroprotective effects when evaluated in an in vitro model of DN. Altogether, our findings suggest that DFX preconditioning of AD-MSCs improves their therapeutic potential and should be considered as a potential strategy for the generation of new alternatives for DN treatment.	[Oses, Carolina; Ezquer, Marcelo; Ezquerl, Fernando] Univ Desarrollo, Fac Med, Clin Alemana, Ctr Med Regenerat, Av Las Condes, Santiago, Chile; [Olivares, Belen] Univ Desarrollo, Fac Med, Clin Alemana, Ctr Quim Med, Av Las Condes, Santiago, Chile; [Acosta, Cristian] Univ Nacl Cuyo, Fac Med, Inst Histol & Embriol Mendoza IHEM CONICET, Mendoza, Argentina; [Bosch, Paul; Donoso, Macarena] Univ Desarrollo, Fac Ingn, Av Plaza, Santiago, Chile; [Leniz, Patricio] Clin Alemana, Unidad Cirugia Plast Reparadora & Estet, Santiago, Chile	Clinica Alemana; Universidad del Desarrollo; Clinica Alemana; Universidad del Desarrollo; University Nacional Cuyo Mendoza; Universidad del Desarrollo; Clinica Alemana	Ezquerl, F (corresponding author), Univ Desarrollo, Fac Med, Clin Alemana, Ctr Med Regenerat, Av Las Condes, Santiago, Chile.	eezquer@udd.cl	Ezquer, Fernando/AHC-7601-2022	Acosta, Cristian/0000-0001-9333-5843; Ezquer, Fernando/0000-0002-7696-4215; Ezquer, Marcelo/0000-0002-2064-3041	FONDECYT [CIF-16 UDD, 1170712]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by the CIF-16 UDD grant and FONDECYT 1170712 grant awarded to Dr. Fernando Ezquer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Markus Uhrig, Dr. Anne Bliss and Dr. Carolina Rodriguez for proofreading the manuscript. This work was supported by the CIF-16 UDD grant and FONDECYT 1170712 grant awarded to Dr. Fernando Ezquer.	Acosta C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050442; Albers JW, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0473-5; Angoulvant D, 2011, J HEART LUNG TRANSPL, V30, P95, DOI 10.1016/j.healun.2010.08.023; Anitha M, 2006, J CLIN INVEST, V116, P344, DOI 10.1172/JCI26295; Apfel SC, 2002, INT REV NEUROBIOL, V50, P393; Apfel SC, 1999, AM J MED, V107, P345; Argoff CE, 2006, MAYO CLIN PROC, V81, pS12, DOI 10.1016/S0025-6196(11)61475-4; Argoff CE, 2006, MAYO CLIN PROC, V81, pS3, DOI 10.1016/S0025-6196(11)61474-2; Bansal V, 2006, POSTGRAD MED J, V82, P95, DOI 10.1136/pgmj.2005.036137; Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Carriere A, 2009, ARTERIOSCL THROM VAS, V29, P1093, DOI 10.1161/ATVBAHA.109.188318; Chacko SM, 2010, AM J PHYSIOL-CELL PH, V299, pC1562, DOI 10.1152/ajpcell.00221.2010; Chen J, 2015, CELL PHYSIOL BIOCHEM, V37, P1830, DOI 10.1159/000438545; Chu K, 2008, BRAIN RES, V1207, P182, DOI 10.1016/j.brainres.2008.02.043; Coppey LJ, 2003, FREE RADICAL RES, V37, P33, DOI 10.1080/1071576021000028442; Coppey LJ, 2001, DIABETES, V50, P1927, DOI 10.2337/diabetes.50.8.1927; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; De Francia S, 2012, J CHROMATOGR B, V893, P127, DOI 10.1016/j.jchromb.2012.02.047; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Ezquer M, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0299-y; Figueroa-Romero C, 2008, REV ENDOCR METAB DIS, V9, P301, DOI 10.1007/s11154-008-9104-2; Fiore M, 2009, REV NEUROSCIENCE, V20, P133; Frausin S, 2015, ACTA HISTOCHEM, V117, P329, DOI 10.1016/j.acthis.2015.02.005; Garcia-Olmo D, 2009, DIS COLON RECTUM, V52, P79, DOI 10.1007/DCR.0b013e3181973487; Greenberger JS, 2008, GENE THER, V15, P100, DOI 10.1038/sj.gt.3303004; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Han JW, 2016, CELL TRANSPLANT, V25, P313, DOI 10.3727/096368915X688209; Hoogduijn MJ, 2007, STEM CELLS DEV, V16, P597, DOI 10.1089/scd.2006.0110; Howland MA, 1996, J TOXICOL-CLIN TOXIC, V34, P491, DOI 10.3109/15563659609028006; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Kalichman MW, 1998, ACTA NEUROPATHOL, V95, P47, DOI 10.1007/s004010050764; Keats E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038752; Keilhoff G, 2006, CELL MOL NEUROBIOL, V26, P1235, DOI 10.1007/s10571-006-9029-9; Khan M, 2011, STEM CELLS DEV, V20, P67, DOI 10.1089/scd.2009.0397; Kim Bae Jin, 2011, Lab Anim Res, V27, P171, DOI 10.5625/lar.2011.27.2.171; Kim WS, 2008, J DERMATOL SCI, V49, P133, DOI 10.1016/j.jdermsci.2007.08.004; Kishi M, 2002, DIABETES, V51, P819, DOI 10.2337/diabetes.51.3.819; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Langlois A, 2008, TRANSPL P, V40, P473, DOI 10.1016/j.transproceed.2008.01.003; Lee HC, 2012, CIRC J, V76, P1750, DOI 10.1253/circj.CJ-11-1135; Lee SC, 2015, SURGERY, V157, P934, DOI 10.1016/j.surg.2014.12.016; Leinninger GM, 2006, NEUROBIOL DIS, V23, P11, DOI 10.1016/j.nbd.2006.01.017; Leinninger GM, 2004, J PERIPHER NERV SYST, V9, P26, DOI 10.1111/j.1085-9489.2004.09105.x; Liu LQ, 2013, CELL BIOL INT, V37, P551, DOI 10.1002/cbin.10097; Matsunaga A, 2007, EUR J PHARMACOL, V554, P12, DOI 10.1016/j.ejphar.2006.09.072; Miyajima S, 2006, DIABETES RES CLIN PR, V71, P272, DOI 10.1016/j.diabres.2005.07.005; Mizisin AP, 2004, DIABETES, V53, P1807, DOI 10.2337/diabetes.53.7.1807; Mizukami H, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00045; Naruse K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027458; Nishimori M, 2002, BLOOD, V99, P1995, DOI 10.1182/blood.V99.6.1995; Nouri F, 2016, CELL MOL NEUROBIOL, V36, P689, DOI 10.1007/s10571-015-0249-8; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Potier E, 2008, J TISSUE ENG REGEN M, V2, P272, DOI 10.1002/term.92; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x; Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103; Sart S, 2014, BIORESEARCH OPEN ACC, V3, P137, DOI 10.1089/biores.2014.0012; Schmeichel AM, 2003, DIABETES, V52, P165, DOI 10.2337/diabetes.52.1.165; Schratzberger P, 2001, J CLIN INVEST, V107, P1083, DOI 10.1172/JCI12188; Shi XH, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-69; Shibata T, 2008, DIABETES, V57, P3099, DOI 10.2337/db08-0031; Shimoshige Y, 2009, BRAIN RES, V1247, P182, DOI 10.1016/j.brainres.2008.10.018; Song L, 2004, FASEB J, V18, P980, DOI 10.1096/fj.03-1100fje; Sterne GD, 1997, EUR J NEUROSCI, V9, P1388, DOI 10.1111/j.1460-9568.1997.tb01493.x; Stevens MJ, 2000, DIABETES, V49, P1006, DOI 10.2337/diabetes.49.6.1006; Stubbs SL, 2012, STEM CELLS DEV, V21, P1887, DOI 10.1089/scd.2011.0289; Thum T, 2005, J AM COLL CARDIOL, V46, P1799, DOI 10.1016/j.jacc.2005.07.053; Tosaki T, 2008, EXP NEUROL, V213, P381, DOI 10.1016/j.expneurol.2008.06.017; Trivedi P, 2010, STEM CELLS DEV, V19, P1109, DOI 10.1089/scd.2009.0465; Ueno Y, 2002, J NUTR, V132, P897, DOI 10.1093/jn/132.5.897; Veves A, 2001, J CLIN INVEST, V107, P1215, DOI 10.1172/JCI13038; Vincent AM, 2005, ANTIOXID REDOX SIGN, V7, P1494, DOI 10.1089/ars.2005.7.1494; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019; Vincent AM, 2011, NAT REV NEUROL, V7, P573, DOI 10.1038/nrneurol.2011.137; Waszak P, 2012, STEM CELLS DEV, V21, P2789, DOI 10.1089/scd.2010.0566; Wei X, 2009, STEM CELLS, V27, P478, DOI 10.1634/stemcells.2008-0333; Yamakawa M, 2003, CIRC RES, V93, P664, DOI 10.1161/01.RES.0000093984.48643.D7; Yang D, 2016, CHIN J INTEGR MED, V22, P19, DOI 10.1007/s11655-015-2103-8; Yao YW, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-74; Yu SP, 2013, TRANSL STROKE RES, V4, P76, DOI 10.1007/s12975-012-0251-0	84	71	73	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178011	10.1371/journal.pone.0178011	http://dx.doi.org/10.1371/journal.pone.0178011			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542352	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672600041
J	Wilcox, SM; Arora, H; Munro, L; Xin, J; Fenninger, F; Johnson, LA; Pfeifer, CG; Choi, KB; Hou, J; Hoodless, PA; Jefferies, WA				Wilcox, Sara M.; Arora, Hitesh; Munro, Lonna; Xin, Jian; Fenninger, Franz; Johnson, Laura A.; Pfeifer, Cheryl G.; Choi, Kyung Bok; Hou, Juan; Hoodless, Pamela A.; Jefferies, Wilfred A.			The role of the innate immune response regulatory gene ABCF1 in mammalian embryogenesis and development	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; BINDING CASSETTE PROTEIN; INITIATION-FACTOR 2; TRANSLATIONAL CONTROL; KINASE GCN2; ABC50 INTERACTS; MOUSE; EIF2; PHOSPHORYLATION; DISRUPTION	ABCF1 is an ABC transporter family protein that has been shown to regulate innate immune response and is a risk gene for autoimmune pancreatitis and arthritis. Unlike other members of ABC transporter family, ABCF1 lacks trans-membrane domains and is thought to function in translation initiation through an interaction with eukaryotic translation initiation factor 2 (eIF2). To study ABCF1 expression and function in development and disease, we used a single gene trap insertion in the Abcf1 gene in murine embryonic stem cells (ES cells) that allowed lineage tracing of the endogenous Abcf1 promoter by following the expression of a beta-galactosidase reporter gene. From the ES cells, heterozygous mice (Abcf1+/-) were produced. No live born Abcf1-/-progeny were ever generated, and the lethality was not mouse strain-specific. Thus, we have determined that Abcf1 is an essential gene in development. Abcf1-/- mice were found to be embryonic lethal at 3.5 days post coitum (dpc), while Abcf1 +/- mice appeared developmentally normal. Abcf1+/- mice were fertile and showed no significant differences in their anatomy when compared with their wild type littermates. The Abcf1 promoter was found to be active in all organs in adult mice, but varies in levels of expression in specific cell types within tissues. Furthermore, we observed high promoter activity in the blastocysts and embryos. Overall, Abcf1 expression in embryos is required for development and its expression in adults was highly correlated with actively proliferating and differentiating cell types.	[Wilcox, Sara M.; Arora, Hitesh; Munro, Lonna; Xin, Jian; Fenninger, Franz; Johnson, Laura A.; Pfeifer, Cheryl G.; Choi, Kyung Bok; Jefferies, Wilfred A.] Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada; [Wilcox, Sara M.; Arora, Hitesh; Fenninger, Franz; Jefferies, Wilfred A.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada; [Johnson, Laura A.; Jefferies, Wilfred A.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Hou, Juan; Hoodless, Pamela A.] BC Canc Agcy, Terry Fox Lab, Vancouver, BC, Canada; [Hoodless, Pamela A.] Univ British Columbia, Dept Dev & Cell Biol, Vancouver, BC, Canada; [Hoodless, Pamela A.; Jefferies, Wilfred A.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Jefferies, Wilfred A.] Univ British Columbia, Ctr Blood Res, Vancouver, BC, Canada; [Jefferies, Wilfred A.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Jefferies, WA (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada.; Jefferies, WA (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada.; Jefferies, WA (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.; Jefferies, WA (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.; Jefferies, WA (corresponding author), Univ British Columbia, Ctr Blood Res, Vancouver, BC, Canada.; Jefferies, WA (corresponding author), Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada.	wilf@msi.ubc.ca		Hoodless, Pamela/0000-0003-1371-0725	CIHR [MOP-86739, MOP-133634, MOP-97900, NHG-107769]	CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by CIHR MOP-86739, CIHR MOP-133634, CIHR MOP-97900, and CIHR NHG-107769.	Bolon B, 2008, TOXICOL PATHOL, V36, P265, DOI 10.1177/0192623307312693; Bundschu K, 2006, GENE EXPR PATTERNS, V6, P247, DOI 10.1016/j.modgep.2005.08.003; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DEALDANA CRV, 1995, EMBO J, V14, P3184, DOI 10.1002/j.1460-2075.1995.tb07321.x; Friedel RH, 2005, P NATL ACAD SCI USA, V102, P13188, DOI 10.1073/pnas.0505474102; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Kaufman MH, 1999, ANATOMICAL BASIS MOU, Vxii; LAWSON SN, 1979, J NEUROCYTOL, V8, P265, DOI 10.1007/BF01236122; Lee MN, 2013, NAT IMMUNOL, V14, P179, DOI 10.1038/ni.2509; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lykke-Andersen K, 2008, MOL BIOL CELL, V19, P4383, DOI 10.1091/mbc.E08-02-0219; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; Matsson H, 2004, MOL CELL BIOL, V24, P4032, DOI 10.1128/MCB.24.9.4032-4037.2004; Ota M, 2007, IMMUNOGENETICS, V59, P45, DOI 10.1007/s00251-006-0178-2; Paytubi S, 2008, BIOCHEM J, V409, P223, DOI 10.1042/BJ20070811; Paytubi S, 2009, J BIOL CHEM, V284, P24061, DOI 10.1074/jbc.M109.031625; Phillips R, PLOS PATHOG, V6; Richard M, 1998, GENOMICS, V53, P137, DOI 10.1006/geno.1998.5480; Sood R, 2000, GENETICS, V154, P787; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Tyzack JK, 2000, J BIOL CHEM, V275, P34131, DOI 10.1074/jbc.M002868200; Vasiliou Vasilis, 2009, Human Genomics, V3, P281; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Xu HP, 2007, GLIA, V55, P1189, DOI 10.1002/glia.20535; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423	28	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0175918	10.1371/journal.pone.0175918	http://dx.doi.org/10.1371/journal.pone.0175918			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542262	gold, Green Published, Green Submitted			2022-12-26	WOS:000401672600001
J	Ganapathy, V; Manyanga, J; Brame, L; McGuire, D; Sadhasivam, B; Floyd, E; Rubenstein, DA; Ramachandran, I; Wagener, T; Queimado, L				Ganapathy, Vengatesh; Manyanga, Jimmy; Brame, Lacy; McGuire, Dehra; Sadhasivam, Balaji; Floyd, Evan; Rubenstein, David A.; Ramachandran, Ilangovan; Wagener, Theodore; Queimado, Lurdes			Electronic cigarette aerosols suppress cellular antioxidant defenses and induce significant oxidative DNA damage	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; CARBONYL-COMPOUNDS; SMOKE EXTRACTS; VAPOR EXTRACT; TOBACCO; CANCER; NICOTINE; MUTAGENICITY; SENESCENCE; ASSAY	Background Electronic cigarette (EC) aerosols contain unique compounds in addition to toxicants and carcinogens traditionally found in tobacco smoke. Studies are warranted to understand the public health risks of ECs. Objective The aim of this study was to determine the genotoxicity and the mechanisms induced by EC aerosol extracts on human oral and lung epithelial cells. Methods Cells were exposed to EC aerosol or mainstream smoke extracts and DNA damage was measured using the primer anchored DNA damage detection assay (q-PADDA) and 8-oxodG ELISA assay. Cell viability, reactive oxygen species (ROS) and total antioxidant capacity (TAC) were measured using standard methods. mRNA and protein expression were evaluated by RT-PCR and western blot, respectively. Results EC aerosol extracts induced DNA damage in a dose-dependent manner, but independently of nicotine concentration. Overall, EC aerosol extracts induced significantly less DNA damage than mainstream smoke extracts, as measured by q-PADDA. However, the levels of oxidative DNA damage, as indicated by the presence of 8-oxo-dG, a highly mutagenic DNA lesion, were similar or slightly higher after exposure to EC aerosol compared to mainstream smoke extracts. Mechanistically, while exposure to EC extracts significantly increased ROS, it decreased TAC as well as the expression of 8-oxoguanine DNA glycosylase (OGG1), an enzyme essential for the removal of oxidative DNA damage. Conclusions Exposure to EC aerosol extracts suppressed the cellular antioxidant defenses and led to significant DNA damage. These findings emphasize the urgent need to investigate the potential long-term cancer risk of exposure to EC aerosol for vapers and the general public.	[Ganapathy, Vengatesh; Manyanga, Jimmy; Brame, Lacy; McGuire, Dehra; Sadhasivam, Balaji; Queimado, Lurdes] Univ Oklahoma, Hlth Sci Ctr, Dept Otorhinolaryngol, Oklahoma City, OK 73106 USA; [Manyanga, Jimmy; Queimado, Lurdes] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol Hlth, Oklahoma City, OK 73106 USA; [Floyd, Evan] Univ Oklahoma, Hlth Sci Ctr, Dept Occupat & Environm Hlth, Oklahoma City, OK 73106 USA; [Rubenstein, David A.] SUNY Stony Brook, Dept Biomed Engn, New York, NY USA; [Ramachandran, Ilangovan] Univ Madras, Dept Endocrinol, Dr ALM Post Grad Inst Basic Med Sci, Taramani Campus, Madras, Tamil Nadu, India; [Wagener, Theodore; Queimado, Lurdes] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA; [Wagener, Theodore; Queimado, Lurdes] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Tobacco Res Ctr, Oklahoma City, OK 73106 USA; [Wagener, Theodore; Queimado, Lurdes] Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK 73106 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Madras; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Queimado, L (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Otorhinolaryngol, Oklahoma City, OK 73106 USA.; Queimado, L (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol Hlth, Oklahoma City, OK 73106 USA.; Queimado, L (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA.; Queimado, L (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Oklahoma Tobacco Res Ctr, Oklahoma City, OK 73106 USA.; Queimado, L (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK 73106 USA.	lurdes-queimado@ouhsc.edu	Queimado, Lurdes/L-7465-2013; Sadhasivam, Balaji/B-2084-2016; Queimado, Lurdes/AAY-2545-2021; Ganapathy, Vengatesh/B-6034-2019; Rubenstein, David/H-3570-2011	Queimado, Lurdes/0000-0002-1106-4873; Sadhasivam, Balaji/0000-0002-3207-4392; Queimado, Lurdes/0000-0002-1106-4873; Ganapathy, Vengatesh/0000-0002-1662-4921; Rubenstein, David/0000-0002-9495-9049	Oklahoma Tobacco Research Center; Presbyterian Health Foundation; Oklahoma Center for the Advancement of Science Technology; NATIONAL CANCER INSTITUTE [R33CA202898] Funding Source: NIH RePORTER	Oklahoma Tobacco Research Center; Presbyterian Health Foundation; Oklahoma Center for the Advancement of Science Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Oklahoma Tobacco Research Center (LQ), the Presbyterian Health Foundation (LQ) and by the Oklahoma Center for the Advancement of Science & Technology (LQ). Dr. Queimado holds a Presbyterian Health Foundation Endowed Chair in Otorhinolaryngology Position. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Administration USFaD Services DoHaP], 2012, HARMF POT HARMF CONS; Administration USFaD, 2014, SUMM RES LAB AN EL C, p[1, 1]; [Anonymous], 2012, AG CLASS IARC MON; Arrazola RA, 2015, MMWR-MORBID MORTAL W, V64, P381; Bahl V, 2012, REPROD TOXICOL, V34, P529, DOI 10.1016/j.reprotox.2012.08.001; Behar RZ, 2014, TOXICOL IN VITRO, V28, P198, DOI 10.1016/j.tiv.2013.10.006; Behar RZ, 2016, TOB CONTROL, V25, pii94, DOI 10.1136/tobaccocontrol-2016-053224; Bekki K, 2014, INT J ENV RES PUB HE, V11, P11192, DOI 10.3390/ijerph111111192; Bettcher DW, 2008, ANN ONCOL, V19, P230, DOI 10.1093/annonc/mdn435; Bian L, 2011, MED ONCOL, V28, pS560, DOI 10.1007/s12032-010-9655-4; Bouaoun L, 2016, HUM MUTAT, V37, P865, DOI 10.1002/humu.23035; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Cahn Z, 2011, J PUBLIC HEALTH POL, V32, P16, DOI 10.1057/jphp.2010.41; CDC, 2016, TOB BRAND PREF; Cheng TR, 2014, TOB CONTROL, V23, P11, DOI 10.1136/tobaccocontrol-2013-051482; Collins A, 2003, FREE RADICAL BIO MED, V34, P1089, DOI 10.1016/s0891-5849(03)00041-8; Cressey D, 2014, NATURE, V508, P159, DOI 10.1038/508159a; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Dillon D, 1998, MUTAGENESIS, V13, P19, DOI 10.1093/mutage/13.1.19; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Etter JF, 2011, ADDICTION, V106, P2017, DOI 10.1111/j.1360-0443.2011.03505.x; Farsalinos KE, 2014, THER ADV DRUG SAF, V5, P67, DOI 10.1177/2042098614524430; Farsalinos KE, 2013, INT J ENV RES PUB HE, V10, P5146, DOI 10.3390/ijerph10105146; Farsalinos KE, 2013, INT J ENV RES PUB HE, V10, P2500, DOI 10.3390/ijerph10062500; (FDA) UFaDA, DEEM TOB PROD BE SUB; Fracasso ME, 2006, TOXICOL LETT, V167, P131, DOI 10.1016/j.toxlet.2006.09.003; Friedberg Errol C., 2005, DNA REPAIR MUTAGENES; Ganapathy V, 2015, AM J PREV MED, V48, pS102, DOI 10.1016/j.amepre.2014.08.017; Gellner Candice A, 2016, Curr Protoc Neurosci, V77, DOI 10.1002/cpns.14; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Goniewicz ML, 2015, INT J DRUG POLICY; Hajek P, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0225-z; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Ji EH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154447; Kanaji N, 2014, AM J PHYSIOL-LUNG C, V307, pL364, DOI 10.1152/ajplung.00041.2014; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kaplan A, 2015, YES CAN FAM PHYS, V61, pe255; Kaplan A, 2015, CAN FAM PHYSICIAN, V61, P499; Kosmider L, 2014, NICOTINE TOB RES, V16, P1319, DOI 10.1093/ntr/ntu078; Kux L., 2016, DEEMING TOBACCO PROD; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Leigh NJ, 2016, TOB CONTROL, V25, pii81, DOI 10.1136/tobaccocontrol-2016-053205; Lerner CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116732; Lerner CA, 2015, ENVIRON POLLUT, V198, P100, DOI 10.1016/j.envpol.2014.12.033; Levitz Suzanne, 2015, Can Fam Physician, V61, P500; Levitz Suzanne, 2015, Can Fam Physician, V61, pe258; Lindell G, 1996, EUR J CLIN PHARMACOL, V51, P315, DOI 10.1007/s002280050204; Margham J, 2016, CHEM RES TOXICOL, V29, P1662, DOI 10.1021/acs.chemrestox.6b00188; Marian C, 2009, CANCER EPIDEM BIOMAR, V18, P3305, DOI 10.1158/1055-9965.EPI-09-1014; Maritz Gert S, 2009, Ther Adv Respir Dis, V3, P193, DOI 10.1177/1753465809343712; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; McAuley TR, 2012, INHAL TOXICOL, V24, P850, DOI 10.3109/08958378.2012.724728; McCauley L, 2012, CHEST, V141, P1110, DOI 10.1378/chest.11-1334; Mincer J., 2015, E CIGARETTE USAGE SU; Misra M, 2014, INT J ENV RES PUB HE, V11, P11325, DOI 10.3390/ijerph111111325; Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6; MULLENBACH R, 1989, TRENDS GENET, V5, P391; Neumann AS, 2005, MOL CARCINOGEN, V42, P65, DOI 10.1002/mc.20069; Nyunoya T, 2006, AM J RESP CELL MOL, V35, P681, DOI 10.1165/rcmb.2006-0169OC; Nyunoya T, 2009, AM J RESP CRIT CARE, V179, P279, DOI 10.1164/rccm.200802-320OC; Park SJ, 2014, CLIN CANCER RES, V20, DOI 10.1158/1078-0432.14AACRIASLC-B16; Pearson JL, 2012, AM J PUBLIC HEALTH, V102, P1758, DOI 10.2105/AJPH.2011.300526; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; Public Health England, 2015, E CIGARETTES EVIDENC; Queimado L, 1999, INT J CANCER, V81, P793, DOI 10.1002/(SICI)1097-0215(19990531)81:5<793::AID-IJC21>3.0.CO;2-4; Ramachandran I, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.219; Reis AMC, 2012, NUCLEIC ACIDS RES, V40, P206, DOI 10.1093/nar/gkr704; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Roemer E, BEITRAGE TABAK FORSC, P316; Romagna G, 2013, INHAL TOXICOL, V25, P354, DOI 10.3109/08958378.2013.793439; Ruan Yong-hua, 2007, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V25, P331; Rubenstein D, 2004, CIRCULATION, V109, P78, DOI 10.1161/01.CIR.0000108395.12766.25; Rubenstein DA, 2015, MOL IMMUNOL; Services USDoHaH, 2010, TOB SMOK CAUS DIS BI; Shukla PC, 2010, CAN J CARDIOL, V26, p13A, DOI 10.1016/S0828-282X(10)71055-2; Sundar IK, 2013, ANTIOXID REDOX SIGN, V18, P1956, DOI 10.1089/ars.2012.4863; Sussan TE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116861; Tackett AP, 2015, ADDICTION, V110, P868, DOI 10.1111/add.12878; Tayyarah R., 2014, ELECT CIGARETTE AERO; Thorne D, 2016, MUTAT RES-GEN TOX EN, V812, P29, DOI 10.1016/j.mrgentox.2016.10.005; Thorne D, 2017, TOXICOL LETT, V265, P170, DOI 10.1016/j.toxlet.2016.12.006; Thorne D, 2015, INHAL TOXICOL, V27, P629, DOI 10.3109/08958378.2015.1080773; Tudek B, 2007, MOL ASPECTS MED, V28, P258, DOI 10.1016/j.mam.2007.05.003; Wagener T.L., 2016, TOB CONTROL; Wagener TL, 2012, ADDICTION, V107, P1545, DOI 10.1111/j.1360-0443.2012.03826.x; Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9; Westenberger BJ, 2009, EVALUATION E CIGARET; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987; Wood L., RES MARKETS E CIGARE; Yu V, 2016, ORAL ONCOL, V52, P58, DOI 10.1016/j.oraloncology.2015.10.018; Zhou G, 2014, MOL CELL, V54, P960, DOI 10.1016/j.molcel.2014.04.024	92	87	91	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177780	10.1371/journal.pone.0177780	http://dx.doi.org/10.1371/journal.pone.0177780			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542301	gold, Green Published			2022-12-26	WOS:000401672400082
J	Michel, G; Blery, P; Henoux, M; Guicheux, J; Weiss, P; Brouard, S; Malard, O; Espitalier, F				Michel, Guillaume; Blery, Pauline; Henoux, Michael; Guicheux, Jerome; Weiss, Pierre; Brouard, Sophie; Malard, Olivier; Espitalier, Florent			Bone marrow cell extract promotes the regeneration of irradiated bone	PLOS ONE			English	Article							CALCIUM-PHOSPHATE SCAFFOLD; STEM-CELLS; RECONSTRUCTION; ANGIOGENESIS; OSTEORADIONECROSIS; INJECTION; RADIATION	Mandibular osteoradionecrosis is a severe side effect of radiotherapy after the treatment of squamous cell carcinomas of the upper aerodigestive tract. As an alternative to its treatment by micro-anastomosed free-flaps, preclinical tissular engineering studies have been developed. Total bone marrow (TBM) associated with biphasic calcium phosphate (BCP) significantly enhanced bone formation in irradiated bone. One mechanism, explaining how bone marrow cells can help regenerate tissues like this, is the paracrine effect. The bone marrow cell extract (BMCE) makes use of this paracrine mechanism by keeping only the soluble factors such as growth factors and cytokines. It has provided significant results in repairing various tissues, but has not yet been studied in irradiated bone reconstruction. The purpose of this study was to evaluate the effect of BMCE via an intraosseous or intravenous delivery, with a calcium phosphate scaffold, in irradiated bone reconstruction. Twenty rats were irradiated on their hind limbs with a single 80-Gy dose. Three weeks later, surgery was performed to create osseous defects. The intraosseous group (n = 12) studied the effect of BMCE in situ, with six combinations (empty defect, BCP, TBM, BCP-TBM, lysate only, BCP-lysate). After four different combinations of implantation (empty defect, BCP, TBM, BCP-TBM), the intravenous group (n = 8) received four intravenous injections of BMCE for 2 weeks. Five weeks after implantation, samples were explanted for histological and scanning electron microscopy analysis. Lysate immunogenicity was studied with various mixed lymphocyte reactions. Intravenous injections of BMCE led to a significant new bone formation compared to the intraosseous group. The BCP-TBM mixture remained the most effective in the intraosseous group. However, intravenous injections were more effective, with TBM placed in the defect, with or without biomaterials. Histologically, highly cellularized bone marrow was observed in the defects after intravenous injections, and not after an in situ use of the lysate. The mixed lymphocyte reactions did not show any proliferation after 3, 5, or 7 days of lysate incubation with lymphocytes from another species. This study evaluated the role of BMCE in irradiated bone reconstruction. There were significant results arguing in favor of BMCE intravenous injections. This could open new perspectives to irradiated bone reconstruction.	[Michel, Guillaume; Henoux, Michael; Malard, Olivier; Espitalier, Florent] CHU, Serv ORL & Chirurg & Cerv Faciale, Nantes, France; [Michel, Guillaume; Blery, Pauline; Henoux, Michael; Guicheux, Jerome; Weiss, Pierre; Malard, Olivier; Espitalier, Florent] Univ Nantes, LIOAD, INSERM, UMRS 791, Nantes, France; [Blery, Pauline; Weiss, Pierre] CHU, Serv Odontol Restauratrice & Chirurg, Nantes, France; [Brouard, Sophie] Univ Nantes, INSERM, UMR 1064, ITUN, Nantes, France	Nantes Universite; CHU de Nantes; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Michel, G (corresponding author), CHU, Serv ORL & Chirurg & Cerv Faciale, Nantes, France.; Michel, G (corresponding author), Univ Nantes, LIOAD, INSERM, UMRS 791, Nantes, France.	guillaumemichel@live.fr	guicheux, Jerome/F-7767-2013; Weiss, Pierre/P-1372-2014; Espitalier, Florent/P-6582-2014; Bléry, Pauline/P-6279-2014; Malard, Olivier/A-4742-2012; WEISS, Pierre/AAE-9260-2020	guicheux, Jerome/0000-0003-2754-3024; Weiss, Pierre/0000-0002-6159-8590; Malard, Olivier/0000-0003-1783-5066; WEISS, Pierre/0000-0002-6159-8590; Dugast, Emilie/0000-0001-7439-1903	"Ligue contre le cancer" foundation	"Ligue contre le cancer" foundation	The authors received grants from "Ligue contre le cancer" foundation. For the whole project, we recived 20 000 euros (https://www.ligue-cancer.net/).	Albersen M, 2010, J SEX MED, V7, P3331, DOI 10.1111/j.1743-6109.2010.01875.x; Angeli FS, 2012, OPEN CARDIOVASC MED, V6, P38, DOI 10.2174/1874192401206010038; Barth HD, 2011, BIOMATERIALS, V32, P8892, DOI 10.1016/j.biomaterials.2011.08.013; Bendeck MP, 2004, CIRC RES, V94, P138, DOI 10.1161/01.RES.0000117525.23089.1A; Byeon YE, 2010, CYTOTHERAPY, V12, P626, DOI 10.3109/14653249.2010.481665; Chang EI, 2012, HEAD NECK-J SCI SPEC, V34, P207, DOI 10.1002/hed.21715; Chen JJ, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20140184; Dambrain R., 1993, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V94, P140; Delanian S, 2005, HEAD NECK-J SCI SPEC, V27, P114, DOI 10.1002/hed.20121; Dudziak ME, 2000, PLAST RECONSTR SURG, V106, P1049, DOI 10.1097/00006534-200010000-00015; Epstein JB, 2012, CA-CANCER J CLIN, V62, P401, DOI 10.3322/caac.21157; Espitalier F, 2009, BIOMATERIALS, V30, P763, DOI 10.1016/j.biomaterials.2008.10.051; Fang CC, 2013, CARDIOVASC RES, V99, P146, DOI 10.1093/cvr/cvt060; Fang DD, 2015, SCI REP-UK, V5, DOI 10.1038/srep16017; Fenner M, 2010, J CRANIO MAXILL SURG, V38, P47, DOI 10.1016/j.jcms.2009.07.011; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Goh BT, 2008, INT J ORAL MAX SURG, V37, P597, DOI 10.1016/j.ijom.2008.03.002; Grove JE, 2004, STEM CELLS, V22, P487, DOI 10.1634/stemcells.22-4-487; Hopewell JW, 2003, MED PEDIATR ONCOL, V41, P208, DOI 10.1002/mpo.10338; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lerouxel E, 2006, BIOMATERIALS, V27, P4566, DOI 10.1016/j.biomaterials.2006.04.027; Li SH, 2012, BRAIN RES, V1444, P76, DOI 10.1016/j.brainres.2011.12.055; Malard O, 2005, BONE, V36, P323, DOI 10.1016/j.bone.2004.07.018; MARX RE, 1983, J ORAL MAXIL SURG, V41, P351, DOI 10.1016/S0278-2391(83)80005-6; Misuno K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087158; Mueller CK, 2009, RADIOTHER ONCOL, V93, P581, DOI 10.1016/j.radonc.2009.08.009; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Rajantie I, 2004, BLOOD, V104, P2084, DOI 10.1182/blood-2004-01-0336; Richmond J, 2014, J CELL PHYSIOL, V229, P139, DOI 10.1002/jcp.24441; SARRUT D, 2014, MED PHYS, V41, DOI DOI 10.1118/1.4871617; SKEDROS JG, 1993, J BIOMED MATER RES, V27, P57, DOI 10.1002/jbm.820270108; Timmers L, 2008, STEM CELL RES, V1, P129, DOI 10.1016/j.scr.2008.02.002; Tran SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061632; Wang YY, 2011, EUR J CELL BIOL, V90, P642, DOI 10.1016/j.ejcb.2011.03.005; Yeghiazarians Y, 2009, MOL THER, V17, P1250, DOI 10.1038/mt.2009.85	35	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178060	10.1371/journal.pone.0178060	http://dx.doi.org/10.1371/journal.pone.0178060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542343	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400137
J	Hsieh, YH				Hsieh, Ying-Hen			Ascertaining the impact of catastrophic events on dengue outbreak: The 2014 gas explosions in Kaohsiung, Taiwan	PLOS ONE			English	Article							VIRUS TRANSMISSION; INFECTIOUS-DISEASE; INTERVALS; THAILAND; ILLNESS; TSUNAMI; PATTERN; FLOODS; ASIA	Infectious disease outbreaks often occur in the aftermath of catastrophic events, either natural or man-made. While natural disasters such as typhoons/hurricanes, flooding and earthquakes have been known to increase the risk of infectious disease outbreak, the impact of anthropogenic disasters is less well-understood. Kaohsiung City is located in southern Taiwan, where most dengue outbreaks had occurred in the past two decades. It is also the center of petrochemical industry in Taiwan with pipelines running underneath city streets. Multiple underground gas explosions occurred in Kaohsiung in the evening of July 31, 2014 due to chemical leaks in the pipelines. The explosions caused 32 deaths, including five firefighters and two volunteer firefighters, and injured 321 persons. Historically, dengue outbreaks in southern Taiwan occurred mostly in small numbers of around 2000 cases or less, except in 2002 with over 5000 cases. However, in the months after the gas explosions, the city reported 14528 lab-confirmed dengue cases from August to December. To investigate the possible impact, if any, of the gas explosions on this record-breaking dengue outbreak, a simple mathematical model, the Richards model, is utilized to study the temporal patterns of the spread of dengue in the districts of Kaohsiung in the proximity of the explosion sites and to pinpoint the waves of infections that had occurred in each district in the aftermath of the gas explosions. The reproduction number of each wave in each district is also computed. In the aftermath of the gas explosions, early waves occurred 4-5 days (which coincides with the minimum of human intrinsic incubation period for dengue) later in districts with multiple waves. The gas explosions likely impacted the timing of the waves, but their impact on the magnitude of the 2014 outbreak remains unclear. The modeling suggests the need for public health surveillance and preparedness in the aftermath of future disasters.	[Hsieh, Ying-Hen] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Hsieh, Ying-Hen] China Med Univ, Ctr Infect Dis Educ & Res, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan	Hsieh, YH (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.; Hsieh, YH (corresponding author), China Med Univ, Ctr Infect Dis Educ & Res, Taichung, Taiwan.	hsieh@mail.cmu.edu.tw	Hsieh, Ying-Hen/E-9685-2010		Taiwan Ministry of Science and Technology [103-2314-B-039- 010-MY3, 103-2115-M-039-002-MY2]	Taiwan Ministry of Science and Technology	This work was supported by the Taiwan Ministry of Science and Technology (https://www.most.gov.tw/), grants (103-2314-B-039- 010-MY3, 103-2115-M-039-002-MY2).	Akashi K., 1932, TAIWAN J MED, V31, P767; Aldstadt J, 2007, STOCH ENV RES RISK A, V21, P487, DOI 10.1007/s00477-007-0132-3; Aldstadt J, 2012, TROP MED INT HEALTH, V17, P1076, DOI 10.1111/j.1365-3156.2012.03040.x; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Caceres JLH, 2010, ELECT J BIOMEDICINE, V1, P87; CLARKE EJ, 1967, TROP GEOGR MED, V19, P326; de Ville de Goyet C, 1985, EMERGENCY DISASTER M; Fanany D, 2012, INT J COLLAB RES INT, V4, P673; Flores F. C., 2003, 131 ANN M NOV 15 19; Howard Michael J., 1996, Emergency Medicine Clinics of North America, V14, P413, DOI 10.1016/S0733-8627(05)70259-5; Hsieh YH, 2009, TROP MED INT HEALTH, V14, P628, DOI 10.1111/j.1365-3156.2009.02277.x; Hsieh YH, 2013, TROP MED INT HEALTH, V18, P830, DOI 10.1111/tmi.12105; King Chwan-Chuen, 2000, Dengue Bulletin, V24, P1; Ko Y C, 1989, Gaoxiong Yi Xue Ke Xue Za Zhi, V5, P1; Kuno G, 2007, REV MED VIROL, V17, P327, DOI 10.1002/rmv.545; Oi T., 1943, TAIWAN J MED, V42, P734; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Saba H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1085; SHEARS P, 1988, LANCET, V2, P517, DOI 10.1016/S0140-6736(88)90173-0; SIDDIQUE AK, 1991, J DIARRHOEAL DIS RES, V9, P310; Taiwan Government Data Platform, 2016, DAIL CONF DENG CAS D; Tung TH, 2011, TAIWAN J PUBLIC HLTH, V30, P517; US Centers for Disease Control and Prevention (US CDC), LAB GUID DIAG TEST D; US Centers for Disease Control and Prevention (USCDC), 2016, EPIDEMIOLOGY; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wang SF, 2016, AM J TROP MED HYG, V94, P193, DOI 10.4269/ajtmh.15-0422; Wang SF, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.46; Wilder-Smith A, 2005, ANN ACAD MED SINGAP, V34, P625; Wiwanitkit V, 2007, TROP DOCT, V37, P194, DOI 10.1258/004947507781524575; World Health Organization, 2017, DENG SEV DENG	31	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177422	10.1371/journal.pone.0177422	http://dx.doi.org/10.1371/journal.pone.0177422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520740	Green Submitted, Green Published, gold			2022-12-26	WOS:000401487700046
J	Monforte, AD; Cozzi-Lepri, A; Ceccherini-Silberstein, F; De Luca, A; Lo Caputo, S; Castagna, A; Mussini, C; Cingolani, A; Tavelli, A; Shanyinde, M; Gori, A; Girardi, E; Andreoni, M; Antinori, A; Puoti, M				Monforte, Antonella d'Arminio; Cozzi-Lepri, Alessandro; Ceccherini-Silberstein, Francesca; De Luca, Andrea; Lo Caputo, Sergio; Castagna, Antonella; Mussini, Cristina; Cingolani, Antonella; Tavelli, Alessandro; Shanyinde, Milensu; Gori, Andrea; Girardi, Enrico; Andreoni, Massimo; Antinori, Andrea; Puoti, Massimo		Icona Fdn & Hepalcona Study Grp	Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort	PLOS ONE			English	Article							SOFOSBUVIR PLUS RIBAVIRIN; HEPATITIS-C; ANTIRETROVIRAL THERAPY; COINFECTED PATIENTS; GENOTYPE 1; HIV/HCV; VIRUS; BOCEPREVIR; LEDIPASVIR; CIRRHOSIS	Background Real-life data on access and response to direct antiviral agents (DAA) in HIV-HCV co-infected individuals are lacking. Methods HCV viremic, HIV-positive patients from Icona and Hepaicona cohorts naive to DAA by January 2013 were included. Access and predictors of starting DAA were evaluated. Switches of antiretroviral drugs at starting DAA were described. We calculated sustained virological response (SVR12) in those reaching 12 weeks after end-of-treatment (EOT), and defined treatment failure (TF) as discontinuation of DAA before EOT or non-SVR12. Statistical analyses included Kaplan-Meier curves, univariable and multivariable analyses evaluating predictors of access to DAA and of treatment outcome (non-SVR and TF). Results 2,607 patients included. During a median follow-up of 38 (IQR: 30-41) months, 920 (35.3%) patients started DAA. Eligibility for reimbursement was the strongest predictor to access to treatment: 761/1,090 (69.8%) eligible and 159/1,517 (10.5%) non-eligible to DAA reimbursement. Older age, HIV-RNA <= 50 copies/mL were associated to faster DAA initiation, higher CD4 count and HCV-genotype 3 with delayed DAA initiation in those eligible to DAA reimbursement. Up to 28% of patients (36% of those on ritonavir-boosted protease inhibitors, PI/r) underwent antiretroviral (ART) modification at DAA initiation. 545/595 (91.6%) patients reaching EOT achieved SVR12. Overall, TF occurred in 61/606 patients (10.1%), with 11 discontinuing DAA before EOT. Suboptimal DAA was the only independent predictor of both non-SVR12 (AHR 2.52, 95% CI: 1.24-5.12) and TF (AHR: 2.19; 95% CI: 1.13-4.22). Conclusions Only 35.3% had access to HCV treatment. Despite excellent rates of SVR12 rates (91.6%), only 21% (545/2,607) of our HIV-HCV co-infected patients are cured.	[Monforte, Antonella d'Arminio] Univ Milan, ASST St Paolo e Carlo, Dept Hlth Sci, Clin Infect & Trop Dis, Milan, Italy; [Cozzi-Lepri, Alessandro; Shanyinde, Milensu] UCL Med Sch, Div Populat Hlth, Dept Infect & Populat Hlth, Royal Free Campus, London, England; [Ceccherini-Silberstein, Francesca] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy; [De Luca, Andrea] Univ Siena, Dipartimento Biotecnol Med, UOC Infect Dis, Siena, Italy; [Lo Caputo, Sergio] Policlin Bari, UOC Infect Dis, Bari, Italy; [Castagna, Antonella] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Dept Infect Dis, Milan, Italy; [Mussini, Cristina] Univ Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, Infect Dis Clin, Modena, Italy; [Cingolani, Antonella] Catholic Univ Sacred Hearth, Dept Publ Hlth, Inst Clin Infect Dis, Rome, Italy; [Tavelli, Alessandro] Icona Fdn, Milan, Italy; [Gori, Andrea] Univ Milano Bicocca, ASST Monza Brianza San Gerardo Hosp, Div Infect Dis, Monza, Italy; [Girardi, Enrico] Natl Inst Infect Dis Lazzaro Spallanzani, Dept Epidemiol, Rome, Italy; [Andreoni, Massimo] Univ Roma Tor Vergata, Clin Infect Dis, Dept Syst Med, Rome, Italy; [Antinori, Andrea] Natl Inst Infect Dis Lazzaro Spallanzani, HIV AIDS Dept, Rome, Italy; [Puoti, Massimo] ASST Grande Osped Metropolitano Niguarda, Dept Infect Dis, Milan, Italy	University of Milan; University of London; University College London; University of Rome Tor Vergata; University of Siena; Universita degli Studi di Bari Aldo Moro; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universita di Modena e Reggio Emilia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Milano-Bicocca; IRCCS Lazzaro Spallanzani; University of Rome Tor Vergata; IRCCS Lazzaro Spallanzani	Monforte, AD (corresponding author), Univ Milan, ASST St Paolo e Carlo, Dept Hlth Sci, Clin Infect & Trop Dis, Milan, Italy.; Puoti, M (corresponding author), ASST Grande Osped Metropolitano Niguarda, Dept Infect Dis, Milan, Italy.	antonella.darminio@unimi.it; massimo.puoti@libero.it	Gori, Andrea/AAC-6078-2022; De Luca, Andrea/G-8810-2011; Mussini, Cristina/K-8672-2016; Castagna, Antonella/K-3280-2018; Antinori, Andrea/K-7125-2016; Di Maio, Velia Chiara/AGH-2628-2022; PELLICANO', GIOVANNI FRANCESCO/W-4077-2019; Puoti, Massimo/AAA-6580-2020; Ceccherini-Silberstein, Francesca/K-4762-2016; Andreoni, Masimo/AAL-2214-2020	De Luca, Andrea/0000-0002-9561-9193; Mussini, Cristina/0000-0002-6615-4198; Castagna, Antonella/0000-0002-8338-9714; Antinori, Andrea/0000-0003-2121-4684; PELLICANO', GIOVANNI FRANCESCO/0000-0002-9640-8742; Girardi, Enrico/0000-0001-8182-5896; Segala, Daniela/0000-0001-6133-0386; Lo Caputo, Sergio/0000-0002-4729-7548; Tavelli, Alessandro/0000-0001-5899-451X; CECCHERINI SILBERSTEIN, FRANCESCA/0000-0002-6024-5101; Puoti, Massimo/0000-0003-3278-7138; d'Arminio Monforte, Antonella/0000-0003-0073-1789				Boerekamps A, 2017, CROI; Castera L, 2014, HIV MED, V15, P30, DOI 10.1111/hiv.12082; Charlton M, 2015, GASTROENTEROLOGY, V149, P649, DOI 10.1053/j.gastro.2015.05.010; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; Cope R, 2015, AIDS PATIENT CARE ST, V29, P379, DOI 10.1089/apc.2015.0004; EACS, 2016, HIV GUID; Harrington PR, 2015, CLIN INFECT DIS, V61, P974, DOI 10.1093/cid/civ419; Hezode C, 2014, GASTROENTEROLOGY, V147, P132, DOI 10.1053/j.gastro.2014.03.051; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Molina JM, 2015, LANCET, V385, P1098, DOI 10.1016/S0140-6736(14)62483-1; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Naggie S, 2015, NEW ENGL J MED, V373, P705, DOI 10.1056/NEJMoa1501315; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Piroth L, 2016, LANCET, V388, P1051, DOI 10.1016/S0140-6736(16)31540-9; Poizot-Martin I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141164; Saeed S, 2016, CLIN INFECT DIS, V62, P919, DOI 10.1093/cid/civ1222; Saxena V, 2015, HEPATOLOGY, V62, P715, DOI 10.1002/hep.27922; Sogni P, 2016, CLIN INFECT DIS, V63, P763, DOI 10.1093/cid/ciw379; Sulkowski M, 2013, LANCET INFECT DIS, V13, P597, DOI 10.1016/S1473-3099(13)70149-X; Sulkowski MS, 2015, JAMA-J AM MED ASSOC, V313, P1223, DOI 10.1001/jama.2015.1328; Ward JW, 2015, NEW ENGL J MED, V373, P2678, DOI 10.1056/NEJMe1513245; Wyles DL, 2015, NEW ENGL J MED, V373, P714, DOI 10.1056/NEJMoa1503153	23	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177402	10.1371/journal.pone.0177402	http://dx.doi.org/10.1371/journal.pone.0177402			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520749	Green Published, gold, Green Submitted			2022-12-26	WOS:000401487700045
J	Diem, JE; Stauber, CE; Rothenberg, R				Diem, Jeremy E.; Stauber, Christine E.; Rothenberg, Richard			Heat in the southeastern United States: Characteristics, trends, and potential health impact	PLOS ONE			English	Article							ATMOSPHERIC CIRCULATION PATTERNS; GROUND-LEVEL OZONE; CLIMATE-CHANGE; AMBIENT OZONE; VECTOR-BORNE; TEMPERATURE; MORTALITY; URBAN; PROJECTIONS; HUMIDITY	High summer temperatures in extratropical areas have an impact on the public's health, mainly through heat stress, high air pollution concentrations, and the transmission of tropical diseases. The purpose of this study is to examine the current characteristics of heat events and future projections of summer apparent temperature (AT)-and associated health concerns-throughout the southeastern United States. Synoptic climatology was used to assess the atmospheric characteristics of extreme heat days (EHDs) from 1979-2015. Ozone concentrations also were examined during EHDs. Trends in summer-season AT over the 37-year period and correlations between AT and atmospheric circulation were determined. Mid-century estimates of summer AT were calculated using downscaled data from an ensemble of global climate models. EHDs throughout the Southeast were characterized by ridging and anticyclones over the Southeast and the presence of moist tropical air masses. Exceedingly high ozone concentrations occurred on EHDs in the Atlanta area and throughout central North Carolina. While summer ATs did not increase significantly from 1979-2015, summer ATs are projected to increase substantially by mid-century, with most the Southeast having ATs similar to that of present-day southern Florida (i.e., a tropical climate). High ozone concentrations should continue to occur during future heat events. Large urban areas are expected to be the most affected by the future warming, resulting from intensifying and expanding urban heat islands, a large increase in heat-vulnerable populations, and climate conditions that will be highly suitable for tropical-disease transmission by the Aedes aegypti mosquito. This nexus of vulnerability creates the potential for heat-related morbidity and mortality, as well as the appearance of disease not previously seen in the region. These effects can be attenuated by policies that reduce urban heat (e.g., cool roofs and green roofs) and that improve infrastructure (e.g. emergency services, conditioned space).	[Diem, Jeremy E.] Georgia State Univ, Dept Geosci, Atlanta, GA 30303 USA; [Stauber, Christine E.] Georgia State Univ, Sch Publ Hlth, Div Environm Hlth, Atlanta, GA 30303 USA; [Rothenberg, Richard] Georgia State Univ, Sch Publ Hlth, Div Epidemiol & Biostat, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Diem, JE (corresponding author), Georgia State Univ, Dept Geosci, Atlanta, GA 30303 USA.	jdiem@gsu.edu			National Institute of Minority Health and Health Disparities [1P20MD009572-01]	National Institute of Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The study was supported by funding from a National Institute of Minority Health and Health Disparities 1P20MD009572-01 grant to RR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abatzoglou JT, 2012, INT J CLIMATOL, V32, P772, DOI 10.1002/joc.2312; Anderson GB, 2013, ENVIRON HEALTH PERSP, V121, P1111, DOI 10.1289/ehp.1206273; Anderson GB, 2011, ENVIRON HEALTH PERSP, V119, P210, DOI 10.1289/ehp.1002313; Aneja P., 2000, CHEMOSPHERE GLOB CHA, V2, P157, DOI [10.1016/s1465-9972(00)00007-6, DOI 10.1016/S1465-9972(00)00007-6]; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bell ML, 2007, CLIMATIC CHANGE, V82, P61, DOI 10.1007/s10584-006-9166-7; Black E., 2004, WEATHER, V59, P217, DOI [10.1256/wea.74.04, DOI 10.1256/WEA.74.04]; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Butterworth MK, 2016, ENV HLTH PERSPECTIVE; Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114; Chen F, 2006, J APPL METEOROL CLIM, V45, P674, DOI 10.1175/JAM2345.1; Choudhary E, 2014, MMWR-MORBID MORTAL W, V63, P1; COMRIE AC, 1992, ATMOS ENVIRON B-URB, V26, P301, DOI 10.1016/0957-1272(92)90006-E; Cooper OR, 2000, J GEOPHYS RES-ATMOS, V105, P6855, DOI 10.1029/1999JD901015; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Davis JM, 1998, ATMOS ENVIRON, V32, P2505, DOI 10.1016/S1352-2310(98)00008-9; Davis RE, 2003, ENVIRON HEALTH PERSP, V111, P1712, DOI 10.1289/ehp.6336; Diem JE, 2006, J CLIMATE, V19, P613, DOI 10.1175/JCLI3645.1; Diem JE, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006836; Diem JE, 2010, J APPL METEOROL CLIM, V49, P2185, DOI 10.1175/2010JAMC2454.1; Diem JE, 2009, ATMOS ENVIRON, V43, P3902, DOI 10.1016/j.atmosenv.2009.04.050; Eisen L, 2014, J MED ENTOMOL, V51, P496, DOI 10.1603/ME13214; Environmental Protection Agency U. S, 2015, NAT AMB AIR QUAL STA; Fischer EM, 2013, NAT CLIM CHANGE, V3, P126, DOI [10.1038/nclimate1682, 10.1038/NCLIMATE1682]; Florida Department of Environmental Protection, 2012, FLOR OZ PART MATT QU; Georgescu M, 2014, P NATL ACAD SCI USA, V111, P2909, DOI 10.1073/pnas.1322280111; Giannini A, 2001, J CLIMATE, V14, P2867, DOI 10.1175/1520-0442(2001)014<2867:ICITET>2.0.CO;2; Greene S, 2011, WEATHER CLIM SOC, V3, P281, DOI 10.1175/WCAS-D-11-00055.1; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Helsel D. R., 2002, TECHNIQUES WATER RES, V4, pA3, DOI DOI 10.2307/1269385; Hou P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23792; Jia LW, 2016, J CLIMATE, V29, P4121, DOI 10.1175/JCLI-D-15-0471.1; Johnson DP, 2009, APPL GEOGR, V29, P419, DOI 10.1016/j.apgeog.2008.11.004; KALKSTEIN LS, 1989, ANN ASSOC AM GEOGR, V79, P44, DOI 10.1111/j.1467-8306.1989.tb00249.x; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI 10.1175/Bams-83-11-1631; Kirtman B, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P953; Konrad C.E., 2013, CLIMATE SE US, P8, DOI DOI 10.5822/978-1-61091-509-0_7; Kunkel KE, 1996, B AM METEOROL SOC, V77, P1507, DOI 10.1175/1520-0477(1996)077<1507:TJHWIT>2.0.CO;2; Kunkel KE, 2010, J CLIMATE, V23, P4447, DOI 10.1175/2010JCLI3349.1; Li D, 2013, J APPL METEOROL CLIM, V52, P2051, DOI 10.1175/JAMC-D-13-02.1; Loikith PC, 2012, J CLIMATE, V25, P7266, DOI 10.1175/JCLI-D-11-00709.1; Maier G, 2014, WEATHER CLIM SOC, V6, P253, DOI 10.1175/WCAS-D-13-00037.1; McGeehin MA, 2001, ENVIRON HEALTH PERSP, V109, P185, DOI 10.2307/3435008; McKinnon KA, 2016, NAT GEOSCI, V9, P389, DOI [10.1038/ngeo2687, 10.1038/NGEO2687]; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; Monaghan AJ, 2016, PLOS CURRENT OUTBREA; National Weather Service, 2014, MET CONV CALC HEAT I; Oke TR, 1992, BOUNDARY LAYER CLIMA; Palecki MA, 2001, B AM METEOROL SOC, V82, P1353, DOI 10.1175/1520-0477(2001)082<1353:TNAIOT>2.3.CO;2; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Pfister GG, 2014, J GEOPHYS RES-ATMOS, V119, P5559, DOI 10.1002/2013JD020932; Reid CE, 2012, ENVIRON HEALTH PERSP, V120, P1627, DOI 10.1289/ehp.1205251; Santer BD, 2003, J GEOPHYS RES, V301, P479; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203; Sheridan SC, 2002, INT J CLIMATOL, V22, P51, DOI 10.1002/joc.709; Sherwood SC, 2010, P NATL ACAD SCI USA, V107, P9552, DOI 10.1073/pnas.0913352107; SILLMAN S, 1995, J GEOPHYS RES-ATMOS, V100, P11497, DOI 10.1029/94JD02146; STEADMAN RG, 1979, J APPL METEOROL, V18, P861, DOI 10.1175/1520-0450(1979)018<0861:TAOSPI>2.0.CO;2; Stein AF, 2015, B AM METEOROL SOC, V96, P2059, DOI 10.1175/BAMS-D-14-00110.1; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; U. S. Census Bureau, 2011, RES POP DAT INT; Wu SL, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008917; Zhang YZ, 2016, P NATL ACAD SCI USA, V113, P10025, DOI 10.1073/pnas.1602563113	66	21	21	5	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177937	10.1371/journal.pone.0177937	http://dx.doi.org/10.1371/journal.pone.0177937			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520817	Green Published, Green Submitted, gold			2022-12-26	WOS:000401485500082
J	van der Hoeven, T; Browne, JL; Uiterwaal, CSPM; van der Ent, CK; Grobbee, DE; Dalmeijer, GW				van der Hoeven, Timothy; Browne, Joyce L.; Uiterwaal, Cuno S. P. M.; van der Ent, Cornelis K.; Grobbee, Diederick E.; Dalmeijer, Geertje W.			Antenatal coffee and tea consumption and the effect on birth outcome and hypertensive pregnancy disorders	PLOS ONE			English	Article							MATERNAL CAFFEINE INTAKE; FOLIC-ACID; RISK; WEIGHT; HOMOCYSTEINE; TRIMESTER; DRINKING; GROWTH	Background and objective Coffee and tea are commonly consumed during pregnancy. While several of their components, like caffeine, have strong pharmacological effects, the effect on the unborn fetus remains unclear. Caffeine intake has been associated with abortion, preterm birth and fetal growth restriction, but a general consensus on caffeine restriction is still lacking. We aimed to investigate antenatal coffee, tea and caffeine consumption and the effect on birth weight and length, gestational age at birth and hypertensive disorders in pregnancy. Methods A total of 936 healthy pregnancies from the WHISTLER birth cohort with data on coffee and tea consumption were included. Maternal and child characteristics as well as antenatal coffee and tea consumption were obtained through postpartum questionnaires. Reported consumption was validated using available preconceptional data. Caffeine intake was calculated from coffee and tea consumption. Linear and logistic regression was used to assess the association with birth outcome and hypertensive disorders. Results After adjustment for smoking and maternal age, a daily consumption of more than 300mg of caffeine compared to less than 100mg of caffeine was significantly associated with an increased gestational age (linear regression coefficient = 2.00 days, 95% CI = 0.12-4.21, P = 0.03). Tea consumption was significantly related to a higher risk of pregnancy induced hypertension (OR = 1.13, 95% CI = 1.04-1.23, P = 0.004). No associations concerning coffee consumption or birth weight and birth length were observed. Conclusions Daily caffeine consumption of more than 300mg is possibly associated with an increase in gestational age at birth. A possible relation between high tea consumption and increased risk for pregnancy induced hypertension warrants further research. For most outcomes, we found no significant associations with coffee or tea intake.	[van der Hoeven, Timothy; Browne, Joyce L.; Uiterwaal, Cuno S. P. M.; Grobbee, Diederick E.; Dalmeijer, Geertje W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van der Ent, Cornelis K.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Pulmonol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	van der Hoeven, T (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	trvanderhoeven@gmail.com		Van der Ent, Cornelis/0000-0002-2501-4121	Netherlands Organization for Health Research and Development [2001-1-1322]; GlaxoSmithKline Netherlands	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); GlaxoSmithKline Netherlands(GlaxoSmithKline)	The authors received no specific funding for this article. The WHISTLER birth cohort was supported with a grant from the Netherlands Organization for Health Research and Development (Grant 2001-1-1322) and by an unrestricted grant from GlaxoSmithKline Netherlands. GlaxoSmithKline had no role in study design, in the collection, analysis and interpretation of data, in the writing of the report and in the decision to submit the report for publication.	[Anonymous], 2010, Obstet Gynecol, V116, P467, DOI 10.1097/AOG.0b013e3181eeb2a1; Bakker R, 2011, AM J HYPERTENS, V24, P421, DOI 10.1038/ajh.2010.242; Bakker R, 2010, AM J CLIN NUTR, V91, P1691, DOI 10.3945/ajcn.2009.28792; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Bech BH, 2007, BMJ-BRIT MED J, V334, P409, DOI 10.1136/bmj.39062.520648.BE; Boylan S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2332; Cabrera C, 2006, J AM COLL NUTR, V25, P79, DOI 10.1080/07315724.2006.10719518; Centraal Bureau voor de Statistiek Nederland (CBS), 2013, BEV LENGT GEW BIJ GE; Chen LW, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0174-6; Chiaffarino F, 2006, EUR J CLIN NUTR, V60, P610, DOI 10.1038/sj.ejcn.1602358; Clausson B, 2002, AM J EPIDEMIOL, V155, P429, DOI 10.1093/aje/155.5.429; Cnattingius S, 2000, NEW ENGL J MED, V343, P1839, DOI 10.1056/NEJM200012213432503; Committee on Toxicity FSA UK, 2001, COT STAT REPR EFF CA; de la Calle M, 2003, EUR J OBSTET GYN R B, V107, P125, DOI 10.1016/S0301-2115(02)00305-6; DeJong-Potjer LC, 2011, HUISARTS WET, V54, P310; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Eskenazi B, 1999, EPIDEMIOLOGY, V10, P242, DOI 10.1097/00001648-199905000-00009; FENSTER L, 1991, AM J PUBLIC HEALTH, V81, P458, DOI 10.2105/AJPH.81.4.458; Goh YI, 2008, J OBSTET GYNAECOL, V28, P3, DOI 10.1080/01443610701814195; Greenwood DC, 2014, EUR J EPIDEMIOL, V29, P725, DOI 10.1007/s10654-014-9944-x; Grobbee DE, 2005, EUR J EPIDEMIOL, V20, P285, DOI 10.1007/s10654-004-5689-2; Grosso LM, 2001, EPIDEMIOLOGY, V12, P447, DOI 10.1097/00001648-200107000-00015; Hoyt AT, 2013, MATERN CHILD HLTH J; Infante-Rivard C, 2007, PAEDIATR PERINAT EP, V21, P300, DOI 10.1111/j.1365-3016.2007.00825.x; Jarosz M, 2012, EUR J OBSTET GYN R B, V160, P156, DOI 10.1016/j.ejogrb.2011.11.021; Katier N, 2004, EUR J EPIDEMIOL, V19, P895, DOI 10.1023/B:EJEP.0000040530.98310.0c; KIRKINEN P, 1983, AM J OBSTET GYNECOL, V147, P939, DOI 10.1016/0002-9378(83)90250-8; Klebanoff MA, 2002, AM J EPIDEMIOL, V155, P32, DOI 10.1093/aje/155.1.32; MARTIN TR, 1987, AM J EPIDEMIOL, V126, P813, DOI 10.1093/oxfordjournals.aje.a114718; Muhajarine N, 1997, CAN J PUBLIC HEALTH, V88, P375, DOI 10.1007/BF03403909; Nederlandse Vereniging voor Obstetrie en Gynaecologie (NVOG), 2005, HYP DIS PREGN V2 0 N; Newman M, 2006, COFFEE CONSUMPTION; Oesterheld JR, 1998, J CHILD ADOL PSYCHOP, V8, P161, DOI 10.1089/cap.1998.8.161; Okubo H, 2015, NUTR RES, V35, P309, DOI 10.1016/j.nutres.2015.02.009; Olthof MR, 2001, AM J CLIN NUTR, V73, P532; Parazzini F, 2005, EUR J CLIN NUTR, V59, P299, DOI 10.1038/sj.ejcn.1602052; PEACOCK JL, 1991, J EPIDEMIOL COMMUN H, V45, P159, DOI 10.1136/jech.45.2.159; Pollack AZ, 2010, FERTIL STERIL, V93, P304, DOI 10.1016/j.fertnstert.2009.07.992; Roseboom T J, 2001, Twin Res, V4, P293, DOI 10.1375/1369052012605; Sengpiel V, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-42; Sharbaf F. R., 2013, Journal of Family and Reproductive Health, V7, P127; Stichting Perinatale Registratie Nederland, NETH PER REG; Verhoef P, 2002, AM J CLIN NUTR, V76, P1244, DOI 10.1093/ajcn/76.6.1244; Vik T, 2003, PAEDIATR PERINAT EP, V17, P324, DOI 10.1046/j.1365-3016.2003.00507.x; WEATHERSBEE PS, 1977, POSTGRAD MED, V62, P64, DOI 10.1080/00325481.1977.11714605; Wei SQ, 2009, INT J GYNECOL OBSTET, V105, P123, DOI 10.1016/j.ijgo.2008.12.003; Weng XP, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.803; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	48	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177619	10.1371/journal.pone.0177619	http://dx.doi.org/10.1371/journal.pone.0177619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520809	gold, Green Published, Green Submitted			2022-12-26	WOS:000401485500046
J	Kuo, TF; Chen, TY; Jiang, ST; Chen, KW; Chiang, YM; Hsu, YJ; Liu, YJ; Chen, HM; Yokoyama, KK; Tsai, KC; Yeh, HH; Chen, YR; Yang, MT; Yang, CY; Yang, WC				Kuo, T-F; Chen, T-Y; Jiang, S-T; Chen, K-W; Chiang, Y-M; Hsu, Y-J; Liu, Y-J; Chen, H-M; Yokoyama, K. K.; Tsai, K-C; Yeh, H-H; Chen, Y-R; Yang, M-T; Yang, C-Y; Yang, W-C			Protein disulfide isomerase a4 acts as a novel regulator of cancer growth through the procaspase pathway	ONCOGENE			English	Article							INDUCED CELL-DEATH; INDUCED APOPTOSIS; STRESS; IDENTIFICATION; INHIBITION; EXPRESSION; VIABILITY; CARCINOMA; CASPASE-3; FAMILY	Protein disulfide isomerase a4 (PDIA4) is implicated in the growth and death of tumor cells; however, its molecular mechanism and therapeutic potential in cancer are unclear. Here, we found that PDIA4 expression was upregulated in a variety of tumor cell lines and human lung adenocarcinoma tissues. Knockdown and overexpression of PDIA4 in tumor cells showed that PDIA4 facilitated cell growth via the reduction of caspases 3 and 7 activity. Consistently, Lewis lung carcinoma cells overexpressing PDIA4 grew faster than did parental cells in tumor-bearing mice, as shown by a reduced survival rate, increased tumor size and metastasis, and decreased cell death and caspases 3 and 7 activity. PDIA4 knockdown resulted in opposite outcomes. Moreover, results obtained in mice with spontaneous hepatoma indicated that PDIA4 deficiency significantly reduced hepatic tumorigenesis and cyst formation and increased mouse survival, tumor death, and caspases 3 and 7 activity. Mechanistic studies illustrated that PDIA4 negatively regulated tumor cell death by inhibiting degradation and activation of procaspases 3 and 7 via their mutual interaction in a CGHC-dependent manner. Finally, we found that 1,2-dihydroxytrideca-5,7,9,11-tetrayne, a PDIA4 inhibitor, reduced tumor development via enhancement of caspase-mediated cell death in TSA tumor-bearing mice. These findings characterize PDIA4 as a negative regulator of cancer cell apoptosis and suggest that PDIA4 is a potential therapeutic target for cancer.	[Kuo, T-F; Chen, T-Y; Chen, K-W; Chiang, Y-M; Hsu, Y-J; Liu, Y-J; Chen, H-M; Chen, Y-R; Yang, M-T; Yang, C-Y; Yang, W-C] Acad Sinica, Agr Biotechnol Res Ctr, 128,Sect 2,Acad Rd, Taipei 11529, Taiwan; [Chen, T-Y] Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan; [Jiang, S-T] Natl Appl Res Labs, Natl Lab Anim Ctr, Taipei, Taiwan; [Yokoyama, K. K.] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Tsai, K-C] Natl Res Inst Chinese Med, Minist Hlth & Welf, Taipei, Taiwan; [Tsai, K-C] Taipei Med Univ, PhD Program Biotechnol Med, Taipei, Taiwan; [Yeh, H-H] Chia Nan Univ Pharm & Sci, Drug Discovery & Dev Ctr, Tainan, Taiwan; [Yang, M-T] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung, Taiwan; [Yang, M-T] Acad Sinica, Taiwan Int Grad Program, Mol & Biol Agr Sci, Taipei, Taiwan; [Yang, M-T] Natl Chung Hsing Univ, Taichung, Taiwan; [Yang, W-C] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan; [Yang, W-C] Natl Yang Ming Univ, Inst Pharmacol, Taipei, Taiwan; [Yang, W-C] Natl Taiwan Ocean Univ, Dept Aquaculture, Keelung, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Applied Research Laboratories - Taiwan; Kaohsiung Medical University; National Research Institute of Chinese Medicine; Taipei Medical University; Chia Nan University of Pharmacy & Science; National Chung Hsing University; Academia Sinica - Taiwan; National Chung Hsing University; National Chung Hsing University; National Yang Ming Chiao Tung University; National Taiwan Ocean University	Yang, WC (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, 128,Sect 2,Acad Rd, Taipei 11529, Taiwan.	wcyang@gate.sinica.edu.tw	Yang, Wen-Chin/D-3441-2015	Yang, Wen-Chin/0000-0001-6410-2581; YANG, CHUN-YEN/0000-0002-8672-2981	MOST [104-2320-B-037-033-My2, 104-2314-B-033-002];  [NHRI-EX103-10109B1];  [NHRI-EX106-10416S1];  [KMU-TP104G00];  [KMU-TP104G01];  [KMU-TP104A04];  [KMU-TP105E23];  [KMU-TP105E00];  [KMU-DT105005]	MOST(Ministry of Science & Technology (MOST), Republic of Korea); ; ; ; ; ; ; ; 	We thank the animal facility and the metabolomics facility of the Agricultural Biotechnology Research Center, and the mouse clinics of Academia Sinica for their technical assistance. We thank Drs Jim Stauffer (NCI) and Xin Chen (UCSF) for their SB plasmids, and the National RNAi Core Facility (Academia Sinica) for RNAi reagents. We also thank Ms Miranda Loney for editing the manuscript. This work was supported in part by MOST 104-2320-B-037-033-My2, and MOST 104-2314-B-033-002; NHRI-EX103-10109B1, and NHRI-EX106-10416S1, and KMU-TP104G00, KMU-TP104G01, KMU-TP104A04, KMU-TP105E23, KMU-TP105E23, KMU-TP105E00, and KMU-DT105005.	Almeida S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026454; Andreu CI, 2012, FEBS LETT, V586, P2826, DOI 10.1016/j.febslet.2012.07.023; Bratton SB, 2010, J CELL SCI, V123, P3209, DOI 10.1242/jcs.073643; Burgess JK, 2000, J BIOL CHEM, V275, P9758, DOI 10.1074/jbc.275.13.9758; Carbone DL, 2005, CHEM RES TOXICOL, V18, P1324, DOI 10.1021/tx050078z; Ciaffi M, 2006, GENE, V366, P209, DOI 10.1016/j.gene.2005.07.032; Ellerman DA, 2006, DEV CELL, V10, P831, DOI 10.1016/j.devcel.2006.03.011; FARQUHAR R, 1991, GENE, V108, P81, DOI 10.1016/0378-1119(91)90490-3; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Galligan JJ, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-6; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Goplen D, 2006, CANCER RES, V66, P9895, DOI 10.1158/0008-5472.CAN-05-4589; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hashida T, 2011, J TOXICOL SCI, V36, P1, DOI 10.2131/jts.36.1; Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200; Krepela E, 2006, J CANCER RES CLIN, V132, P57, DOI 10.1007/s00432-005-0048-6; LI X, 1991, MOL CELL BIOL, V11, P3446, DOI 10.1128/MCB.11.7.3446; Liu XW, 2004, BIOL CHEM, V385, P633, DOI 10.1515/BC.2004.078; Lovat PE, 2008, CANCER RES, V68, P5363, DOI 10.1158/0008-5472.CAN-08-0035; Manukyan D, 2008, THROMB RES, V122, pS19, DOI 10.1016/S0049-3848(08)70013-6; Na KS, 2007, MOL CELLS, V24, P261; Naguleswaran A, 2005, INT J PARASITOL, V35, P1459, DOI 10.1016/j.ijpara.2005.06.006; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Norgaard P, 2001, J CELL BIOL, V152, P553, DOI 10.1083/jcb.152.3.553; Ou W, 2006, VIROLOGY, V350, P406, DOI 10.1016/j.virol.2006.01.041; Parker R, 2001, MOL CELL BIOL, V21, P3220, DOI 10.1128/MCB.21.9.3220-3233.2001; Pawar H, 2011, CANCER BIOL THER, V12, P510, DOI 10.4161/cbt.12.6.16833; Rodriguez-Hernandez A, 2006, APOPTOSIS, V11, P131, DOI 10.1007/s10495-005-3276-y; Santana-Codina N, 2013, MOL CELL PROTEOMICS, V12, P2111, DOI 10.1074/mcp.M112.022772; Satoh M, 2005, CELL STRESS CHAPERON, V10, P211, DOI 10.1379/CSC-109R.1; Schultz-Norton JR, 2006, MOL ENDOCRINOL, V20, P1982, DOI 10.1210/me.2006-0006; Severino A, 2007, J AM COLL CARDIOL, V50, P1029, DOI 10.1016/j.jacc.2007.06.006; Stauffer JK, 2011, CANCER RES, V71, P2718, DOI 10.1158/0008-5472.CAN-10-2705; Tao GZ, 2013, J BIOL CHEM, V288, P17214, DOI 10.1074/jbc.M112.445965; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Tufo G, 2014, CELL DEATH DIFFER, V21, P685, DOI 10.1038/cdd.2013.193; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Xiong Y., 2012, INT J CELL BIOL, V2012, P273549, DOI 10.1155/2012/273549; Xu SL, 2012, P NATL ACAD SCI USA, V109, P16348, DOI 10.1073/pnas.1205226109; Yu SJ, 2012, J BIOENERG BIOMEMBR, V44, P101, DOI 10.1007/s10863-012-9416-5; Zahedi P, 2012, J CONTROL RELEASE, V158, P379, DOI 10.1016/j.jconrel.2011.11.025; Zhu Y, 2014, MOL CELL PROTEOMICS, V13, P2593, DOI 10.1074/mcp.M114.038786	43	22	22	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 28	2017	36	39					5484	5496		10.1038/onc.2017.156	http://dx.doi.org/10.1038/onc.2017.156			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FI4RG	28534513				2022-12-26	WOS:000411960500005
J	Lee, JY; Park, JH; Choi, HJ; Won, HY; Joo, HS; Shin, DH; Park, MK; Han, B; Kim, KP; Lee, TJ; Croce, CM; Kong, G				Lee, J-Y; Park, J-H; Choi, H-J; Won, H-Y; Joo, H-s; Shin, D-H; Park, M. K.; Han, B.; Kim, K. P.; Lee, T. J.; Croce, C. M.; Kong, G.			LSD1 demethylates HIF1 alpha to inhibit hydroxylation and ubiquitin-mediated degradation in tumor angiogenesis	ONCOGENE			English	Article							METASTASIS-ASSOCIATED PROTEIN-1; LYSINE METHYLATION; TRANSCRIPTIONAL REPRESSION; SET9-MEDIATED METHYLATION; ANDROGEN RECEPTOR; PROSTATE-CANCER; BREAST-CANCER; HISTONE; HYPOXIA; HIF-1-ALPHA	Lysine-specific demethylase 1 (LSD1), which has been considered as a potential therapeutic target in human cancer, has been known to regulate many biological functions through its non-histone substrates. Although LSD1-induced hypoxia-inducible factor alpha (HIF1 alpha) demethylation has recently been proposed, the effect of LSD1 on the relationship between HIF1 alpha post-translational modifications (PTMs) and HIF1 alpha-induced tumor angiogenesis remains to be elucidated. Here, we identify a new methylation site of the HIF1 alpha protein antagonized by LSD1 and the interplay between HIF1 alpha protein methylation and other PTMs in regulating tumor angiogenesis. LSD1 demethylates HIF1 alpha at lysine (K) 391, which protects HIF1 alpha against ubiquitin-mediated protein degradation. LSD1 also directly suppresses PHD2-induced HIF1 alpha hydroxylation, which has a mutually dependent interplay with Set9-mediated HIF1 alpha methylation. Moreover, the HIF1 alpha acetylation that occurs in a HIF1 alpha methylation-dependent manner is inhibited by the LSD1/NuRD complex. HIF1 alpha stabilized by LSD1 cooperates with CBP and MTA1 to enhance vascular endothelial growth factor (VEGF)induced tumor angiogenesis. Thus, LSD1 is a key regulator of HIF1 alpha/VEGF-mediated tumor angiogenesis by antagonizing the crosstalk between PTMs involving HIF1 alpha protein degradation.	[Lee, J-Y; Park, J-H; Kong, G.] Hanyang Univ, IBBR, Seoul, South Korea; [Choi, H-J; Won, H-Y; Joo, H-s; Kong, G.] Hanyang Univ, Dept Pathol, Coll Med, 222 Wangsimni Ro, Seoul 04763, South Korea; [Park, M. K.] Natl Canc Ctr, Goyang, South Korea; [Han, B.; Kim, K. P.] Kyung Hee Univ, Dept Appl Chem, Coll Appl Sci, Yongin, South Korea; [Lee, T. J.; Croce, C. M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	Hanyang University; Hanyang University; National Cancer Center - Korea (NCC); Kyung Hee University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Kong, G (corresponding author), Hanyang Univ, Dept Pathol, Coll Med, 222 Wangsimni Ro, Seoul 04763, South Korea.	gkong@hanyang.ac.kr	Young, Richard A/F-6495-2012; Choi, Hyuk Joong/AAF-7713-2019	Young, Richard A/0000-0001-8855-8647; Kim, Kwang Pyo/0000-0003-0095-3787; Choi, Hee-Joo/0000-0001-6432-8193	National Research Foundation of Korea (NRF) grants - Korean government [2015R1A2A1A10052578]; NATIONAL CANCER INSTITUTE [R35CA197706] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) grants - Korean government; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (No. 2015R1A2A1A10052578).	Amente S, 2010, ONCOGENE, V29, P3691, DOI 10.1038/onc.2010.120; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cho HS, 2011, CANCER RES, V71, P655, DOI 10.1158/0008-5472.CAN-10-2446; Cho MH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8821; Ferrari-Amorotti G, 2013, CANCER RES, V73, P235, DOI 10.1158/0008-5472.CAN-12-1739; Gaughan L, 2011, NUCLEIC ACIDS RES, V39, P1266, DOI 10.1093/nar/gkq861; Hino S, 2016, CANCER SCI, V107, P1187, DOI 10.1111/cas.13004; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Kashyap V, 2013, MOL ONCOL, V7, P555, DOI 10.1016/j.molonc.2013.01.003; Kim Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10347; Ko S, 2011, MOL ENDOCRINOL, V25, P433, DOI 10.1210/me.2010-0482; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Lee MH, 2012, ONCOGENE, V31, P5099, DOI 10.1038/onc.2012.2; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Li Q, 2011, CANCER RES, V71, P6899, DOI 10.1158/0008-5472.CAN-11-1523; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Liu X, 2015, NUCLEIC ACIDS RES, V43, P5081, DOI 10.1093/nar/gkv379; Morera L, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0223-4; Nair SS, 2013, MOL CELL, V49, P704, DOI 10.1016/j.molcel.2012.12.016; Nicolson GL, 2003, CLIN EXP METASTAS, V20, P19, DOI 10.1023/A:1022534217769; Page EL, 2008, MOL BIOL CELL, V19, P86, DOI 10.1091/mbc.E07-06-0612; Pakala SB, 2011, ONCOGENE, V30, P2230, DOI 10.1038/onc.2010.608; Park JH, 2011, ONCOGENE, V30, P4578, DOI 10.1038/onc.2011.174; Qin Y, 2014, CANCER LETT, V347, P225, DOI 10.1016/j.canlet.2014.02.013; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Serce N, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-13; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107; Yoo YG, 2006, EMBO J, V25, P1231, DOI 10.1038/sj.emboj.7601025; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100; Zhang XY, 2005, P NATL ACAD SCI USA, V102, P13968, DOI 10.1073/pnas.0502330102	42	68	69	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 28	2017	36	39					5512	5521		10.1038/onc.2017.158	http://dx.doi.org/10.1038/onc.2017.158			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FI4RG	28534506				2022-12-26	WOS:000411960500007
J	Sakai, E; Morita, M; Ohuchi, M; Kido, MA; Fukuma, Y; Nishishita, K; Okamoto, K; Itoh, K; Yamamoto, M; Tsukuba, T				Sakai, Eiko; Morita, Masanobu; Ohuchi, Masahiro; Kido, Mizuho A.; Fukuma, Yutaka; Nishishita, Kazuhisa; Okamoto, Kuniaki; Itoh, Ken; Yamamoto, Masayuki; Tsukuba, Takayuki			Effects of deficiency of Kelch-like ECH-associated protein 1 on skeletal organization: a mechanism for diminished nuclear factor of activated T cells cytoplasmic 1 during osteoclastogenesis	FASEB JOURNAL			English	Article						Blimp1; IRF-8; Nrf2; oxidative stress; MafB	PROMOTES OSTEOBLAST DIFFERENTIATION; NF-KAPPA-B; BONE HOMEOSTASIS; OXIDATIVE STRESS; DC-STAMP; NRF2; RANKL; PATHWAYS; EXPRESSION; TRANSCRIPTION	Kelch-like ECH-associated protein 1 (Keap1) binds to nuclear factor E2 p45-related factor 2 (Nrf2), a transcription factor for antioxidant enzymes, to suppress Nrf2 activation. The role of oxidative stress in many diseases supports the possibility that processes that are associated with Nrf2 activation might offer therapeutic potential. Nrf2 deficiency induces osteoclastogenesis, which is responsible for bone loss, by activating receptor activator of NF-kappa B ligand (RANKL)-mediated signaling; however, the effects of Keap1 deficiency remain unclear. By using Keap1-deficient newborn mice, we observed that talus and calcaneus bone formation was partially retarded and that osteoclast number was reduced in vivo without severe gross abnormalities. In addition, Keap1-deficient macrophages were unable to differentiate into osteoclasts in vitro via attenuation of RANKL-mediated signaling and expression of nuclear factor of activated T cells cytoplasmic 1 (NFATc1), a key transcription factor that is involved in osteoclastogenesis. Furthermore, Keap1 deficiency up-regulated the expression of Mafb, a negative regulator of NFATc1. RANKL-induced mitochondrial gene expression is required for down-regulation of IFN regulatory factor 8 (IRF-8), a negative transcriptional regulator of NFATc1. Our results indicate that Keap1 deficiency down-regulated peroxisome proliferator-activated receptor-gamma coactivator 1 beta and mitochondrial gene expression and up-regulated Irf8 expression. These results suggest that the Keap1/Nrf2 axis plays a critical role in NFATc1 expression and osteoclastogenic progression.	[Sakai, Eiko; Fukuma, Yutaka; Nishishita, Kazuhisa; Okamoto, Kuniaki; Tsukuba, Takayuki] Nagasaki Univ, Div Dent Pharmacol, Dept Dev & Reconstruct Med, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528588, Japan; [Morita, Masanobu; Yamamoto, Masayuki] Tohoku Univ, Dept Med Biochem, Grad Sch Med, Sendai, Miyagi, Japan; [Morita, Masanobu] Tohoku Univ, Dept Environm Hlth Sci & Mol Toxicol, Grad Sch Med, Sendai, Miyagi, Japan; [Ohuchi, Masahiro] Kyushu Univ, Dept Orthodont, Grad Dent Sci, Fukuoka, Japan; [Kido, Mizuho A.] Saga Univ, Dept Anat & Physiol, Fac Med, Saga, Japan; [Itoh, Ken] Hirosaki Univ, Dept Stress Response Sci, Grad Sch Med, Hirosaki, Aomori, Japan	Nagasaki University; Tohoku University; Tohoku University; Kyushu University; Saga University; Hirosaki University	Sakai, E (corresponding author), Nagasaki Univ, Div Dent Pharmacol, Dept Dev & Reconstruct Med, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	eiko-s@nagasaki-u.ac.jp	Tsukuba, Takayuki/I-9542-2018; Itoh, Ken/B-9506-2013; Yamamoto, Masayuki/A-4873-2010	Tsukuba, Takayuki/0000-0003-3322-1339; Itoh, Ken/0000-0002-5518-0729; Yamamoto, Masayuki/0000-0002-9073-9436; sakai, eiko/0000-0002-6776-6540	Japan Society for the Promotion of Science [25462892, 16K11480, 25293383, 26670906, 15H05298]; Grants-in-Aid for Scientific Research [26111002] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partly supported by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI) (25462892 and 16K11480 to E.S.; and 25293383, 26670906, and 15H05298 to T.T.). The authors thank Drs. Takeshi Moriishi, Mariko Naito, and Hideaki Hayashida (all from Nagasaki University) for their technical support and helpful discussions.	Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Fukuma Y, 2015, BIOFACTORS, V41, P222, DOI 10.1002/biof.1218; Hinoi E, 2007, BONE, V40, P337, DOI 10.1016/j.bone.2006.08.016; Hinoi E, 2006, J BIOL CHEM, V281, P18015, DOI 10.1074/jbc.M600603200; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Hu JP, 2008, EUR J PHARMACOL, V580, P70, DOI 10.1016/j.ejphar.2007.11.013; Hyeon S, 2013, FREE RADICAL BIO MED, V65, P789, DOI 10.1016/j.freeradbiomed.2013.08.005; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Itoh N, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00154; Iwaki F, 2016, EUR J PHARMACOL, V793, P14, DOI 10.1016/j.ejphar.2016.10.034; Kamiya T, 1998, J BIOCHEM-TOKYO, V123, P752; Karsenty G, 2003, NATURE, V423, P316, DOI 10.1038/nature01654; Khan NM, 2017, FREE RADICAL BIO MED, V106, P288, DOI 10.1016/j.freeradbiomed.2017.02.041; Kim BR, 2018, BIOCHEM BIOPH RES CO, V497, P1149, DOI 10.1016/j.bbrc.2017.01.107; Kim H, 2006, FEBS LETT, V580, P5661, DOI 10.1016/j.febslet.2006.09.015; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kim K, 2007, BLOOD, V109, P3253, DOI 10.1182/blood-2006-09-048249; Kim YR, 2010, J PATHOL, V220, P446, DOI 10.1002/path.2653; Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Lee JH, 2010, MOL PHARMACOL, V77, P17, DOI 10.1124/mol.109.057877; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Monteiro HP, 1996, FREE RADICAL BIO MED, V21, P323, DOI 10.1016/0891-5849(96)00051-2; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Nishikawa K, 2015, NAT MED, V21, P281, DOI 10.1038/nm.3774; Nishikawa K, 2010, J CLIN INVEST, V120, P3455, DOI 10.1172/JCI42528; Park CK, 2014, BONE, V63, P36, DOI 10.1016/j.bone.2014.01.025; Sakai E, 2016, PHYTOMEDICINE, V23, P828, DOI 10.1016/j.phymed.2016.04.002; Sakai E, 2012, J CELL BIOCHEM, V113, P486, DOI 10.1002/jcb.23372; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Sun YX, 2015, BONE, V74, P1, DOI 10.1016/j.bone.2014.12.066; Takahashi N, 1999, BIOCHEM BIOPH RES CO, V256, P449, DOI 10.1006/bbrc.1999.0252; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Thaler R, 2016, J BIOL CHEM, V291, P6754, DOI 10.1074/jbc.M115.678235; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wei W, 2012, P NATL ACAD SCI USA, V109, P3143, DOI 10.1073/pnas.1200797109; Wruck CJ, 2011, ANN RHEUM DIS, V70, P844, DOI 10.1136/ard.2010.132720; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007; Zheng H, 2006, J BIOL CHEM, V281, P15809, DOI 10.1074/jbc.M513225200	52	11	12	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4011	4022		10.1096/fj.201700177R	http://dx.doi.org/10.1096/fj.201700177R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28515152				2022-12-26	WOS:000408713300026
J	Gross, C; Ellison, B; Buchman, AS; Terasawa, E; VanderHorst, VG				Gross, Cassandra; Ellison, Brian; Buchman, Aron S.; Terasawa, Ei; VanderHorst, Veronique G.			A novel approach for assigning levels to monkey and human lumbosacral spinal cord based on ventral horn morphology	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURONS; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; RHESUS-MONKEY; ONUFS NUCLEUS; PELVIC FLOOR; ORGANIZATION; MUSCLES; MOTONEURONS	Proper identification of spinal cord levels is crucial for clinical-pathological and imaging studies in humans, but can be a challenge given technical limitations. We have previously demonstrated in non-primate models that the contours of the spinal ventral horn are determined by the position of motoneuron pools. These positions are preserved within and among individuals and can be used to identify lumbosacral spinal levels. Here we tested the hypothesis that this approach can be extended to identify monkey and human spinal levels. In 7 rhesus monkeys, we retrogradely labeled motoneuron pools that represent rostral, middle and caudal landmarks of the lumbosacral enlargement. We then aligned the lumbosacral enlargements among animals using absolute length, segmental level or a relative scale based upon rostral and caudal landmarks. Inter-animal matching of labeled motoneurons across the lumbosacral enlargement was most precise when using internal landmarks. We then reconstructed 3 human lumbosacral spinal cords, and aligned these based upon homologous internal landmarks. Changes in shape of the ventral horn were consistent among human subjects using this relative scale, despite marked differences in absolute length or age. These data suggest that the relative position of spinal motoneuron pools is conserved across species, including primates. Therefore, in clinical-pathological or imaging studies in humans, one can assign spinal cord levels to even single sections by matching ventral horn shape to standardized series.	[Gross, Cassandra; Ellison, Brian; VanderHorst, Veronique G.] Harvard Med Sch, Div Movement Disorders, Dept Neurol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Buchman, Aron S.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Terasawa, Ei] Wisconsin Natl Primate Res Ctr, Madison, WI USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Rush University	VanderHorst, VG (corresponding author), Harvard Med Sch, Div Movement Disorders, Dept Neurol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	vvanderh@bidmc.harvard.edu		Gross, Cassandra/0000-0001-6566-333X	National Institutes of Health, National Institute for Aging [R01 AG-47976]; National Institutes of Health of the Wisconsin National Primate Research Center [39-026]; RJG Foundation; NATIONAL INSTITUTE ON AGING [R01AG047976] Funding Source: NIH RePORTER	National Institutes of Health, National Institute for Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health of the Wisconsin National Primate Research Center; RJG Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the National Institutes of Health, National Institute for Aging R01 AG-47976; National Institutes of Health, Grant 39-026 of the Wisconsin National Primate Research Center; and the RJG Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacskai T, 2014, BRAIN STRUCT FUNCT, V219, P303, DOI 10.1007/s00429-012-0501-7; Brettschneider J, 2014, ACTA NEUROPATHOL, V128, P423, DOI 10.1007/s00401-014-1299-6; Cruz-Sanchez FF, 1998, J NEURAL TRANSM, V105, P689, DOI 10.1007/s007020050088; Del Tredici K, 2012, ACTA NEUROPATHOL, V124, P643, DOI 10.1007/s00401-012-1028-y; Dugger BN, 2013, J ALZHEIMERS DIS, V34, P529, DOI 10.3233/JAD-121864; HARDMAN VJ, 1985, NEUROSCI LETT, V60, P325, DOI 10.1016/0304-3940(85)90598-1; ILIYA AR, 1984, EXP NEUROL, V86, P272, DOI 10.1016/0014-4886(84)90186-9; Kennedy PGE, 1997, REV MED VIROL, V7, P131; Ko HY, 2004, SPINAL CORD, V42, P35, DOI 10.1038/sj.sc.3101538; KONNO H, 1986, J NEUROL SCI, V73, P193, DOI 10.1016/0022-510X(86)90130-9; KUTSCHER CL, 1987, BRAIN RES BULL, V19, P161, DOI 10.1016/0361-9230(87)90181-X; Langlet C, 2005, J NEUROPHYSIOL, V93, P2474, DOI 10.1152/jn.00909.2004; Mannen T, 2000, NEUROPATHOLOGY, V20, pS30; Onuf-Onufrowicz B., 1899, J NERV MENT DIS, V26, P498, DOI [DOI 10.1097/00005053-189908000-00006, 10.1097/00005053-189908000-00006]; Pullen AH, 1997, J ANAT, V191, P201, DOI 10.1046/j.1469-7580.1997.19120201.x; ROMANES GJ, 1951, J COMP NEUROL, V94, P313, DOI 10.1002/cne.900940209; ROPPOLO JR, 1985, J COMP NEUROL, V234, P475, DOI 10.1002/cne.902340406; Routal RV, 1999, J ANAT, V195, P211, DOI 10.1046/j.1469-7580.1999.19520211.x; Saito Y, 2000, NEUROLOGY, V55, P1727, DOI 10.1212/WNL.55.11.1727; SCHRODER HD, 1980, J COMP NEUROL, V192, P567, DOI 10.1002/cne.901920313; Schuld C, 2016, J SPINAL CORD MED, V39, P504, DOI 10.1080/10790268.2016.1180831; Sherrington C S, 1892, J Physiol, V13, P621; Shimizu H, 2010, ACTA NEUROPATHOL, V120, P439, DOI 10.1007/s00401-010-0699-5; Sumikura H, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0236-9; UEYAMA T, 1985, J COMP NEUROL, V232, P548, DOI 10.1002/cne.902320411; VanderHorst VG, 2015, ANN NEUROL, V78, P142, DOI 10.1002/ana.24430; VanderHorst VGJM, 2000, J COMP NEUROL, V424, P233, DOI 10.1002/1096-9861(20000821)424:2<233::AID-CNE4>3.0.CO;2-C; Vanderhorst VGJM, 1997, J COMP NEUROL, V382, P46; Wheeler-Kingshott CA, 2014, NEUROIMAGE, V84, P1082, DOI 10.1016/j.neuroimage.2013.07.014; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; WITELSON SF, 1991, SCHIZOPHRENIA BULL, V17, P583, DOI 10.1093/schbul/17.4.583; Yakovenko S, 2002, J NEUROPHYSIOL, V87, P1542, DOI 10.1152/jn.00479.2001; Yoshida M, 2007, NEUROPATHOLOGY, V27, P484, DOI 10.1111/j.1440-1789.2007.00841.x; Zariffa J, 2012, SPINE J, V12, P389, DOI 10.1016/j.spinee.2012.03.028	34	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177243	10.1371/journal.pone.0177243	http://dx.doi.org/10.1371/journal.pone.0177243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542213	Green Published, Green Submitted, gold			2022-12-26	WOS:000402061500016
J	Huh, CW; Youn, YH; Chung, H; Lee, YC; Park, H				Huh, Cheal Wung; Youn, Young Hoon; Chung, Hyunsoo; Lee, Yong Chan; Park, Hyojin			Functional restoration of the esophagus after peroral endoscopic myotomy for achalasia	PLOS ONE			English	Article							MOTILITY DISORDERS; POEM; OUTCOMES	Purpose Peroral endoscopic myotomy (POEM) is a new efficacious treatment option for achalasia. We propose to define "esophageal remodeling" as the functional restoration of the esophagus that involves decreased lower esophageal sphincter (LES) pressure, recovery of esophageal body peristalsis, and reduction of luminal diameter. The aim of this study was to investigate "esophageal remodeling" after POEM for achalasia. Materials and methods We analyzed data from a prospectively collected database of POEM subjects, which included preoperative and 2-month postoperative Eckardt symptom scores, and results from esophageal high resolution manometry (HRM) and barium esophagogram (BE). We recruited 23 patients (13 male; mean age: 53.9 years) whose preoperative and postoperative HRM and BE results were available, from among 30 patients with achalasia who underwent POEM at two institutions between July 2013 and December 2015. Results All patients achieved clinical treatment success (Eckardt score <= 3). Partial recovery of esophageal body peristalsis was noted in 1/5 patients with type I (20%), 6/11 with type II (54.5%), and 7/7 with type III (100%) achalasia after POEM. Pan-esophageal pressurization disappeared after POEM in 10/11 type II achalasia patients. The average diameter of the esophageal body after POEM was significantly decreased in all types of achalasia. Conclusion POEM provided excellent clinical symptomatic relief and esophageal remodeling in terms of restoration of peristalsis and reduction in diameter of the esophageal body, especially in patients with type III achalasia.	[Huh, Cheal Wung; Youn, Young Hoon; Lee, Yong Chan; Park, Hyojin] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Huh, Cheal Wung; Youn, Young Hoon; Park, Hyojin] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Internal Med, Seoul, South Korea; [Chung, Hyunsoo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU)	Youn, YH (corresponding author), Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea.; Youn, YH (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Internal Med, Seoul, South Korea.; Chung, H (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	dryoun@yuhs.ac; hschungmd@gmail.com	Chung, Hyunsoo/AAD-3634-2020	Chung, Hyunsoo/0000-0001-5159-357X; Huh, Cheal Wung/0000-0001-7327-8503; Lee, Yong Chan/0000-0001-8800-6906; park, hyojin/0000-0003-4814-8330; Youn, Young Hoon/0000-0002-0071-229X	Yonsei University College of Medicine [6-20103-0187]	Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant of Yonsei University College of Medicine (6-20103-0187). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a faculty research grant of Yonsei University College of Medicine (6-20103-0187)	Chan SM, 2016, DIGEST ENDOSC, V28, P27, DOI 10.1111/den.12507; Chiu PWY, 2013, GASTROINTEST ENDOSC, V77, P29, DOI 10.1016/j.gie.2012.08.018; Gockel I, 2007, AM SURGEON, V73, P327; Goldblum JR, 1996, GASTROENTEROLOGY, V111, P648, DOI 10.1053/gast.1996.v111.pm8780569; Hirano I, 2014, GASTROENTEROL CLIN N, V43, P297, DOI 10.1016/j.gtc.2014.02.015; Hu Y, 2016, J GASTROENTEROL, V51, P458, DOI 10.1007/s00535-015-1123-7; Inoue H, 2010, ENDOSCOPY, V42, P265, DOI 10.1055/s-0029-1244080; Kahrilas PJ, 2015, NEUROGASTROENT MOTIL, V27, P160, DOI 10.1111/nmo.12477; Kim TH, 2016, AM J PHYSIOL-GASTR L, V310, pG689, DOI 10.1152/ajpgi.00459.2015; Ling TS, 2014, J DIGEST DIS, V15, P352, DOI 10.1111/1751-2980.12153; Moon Jong Tae, 2008, Korean J Gastroenterol, V52, P16; Pandolfino JE, 2005, GASTROENTEROLOGY, V128, P209, DOI 10.1053/j.gastro.2004.11.008; Patel K, 2015, DIS ESOPHAGUS; Sharata AM, 2015, J GASTROINTEST SURG, V19, P161, DOI 10.1007/s11605-014-2610-5; Teitelbaum EN, 2014, SURG ENDOSC, V28, P3359, DOI 10.1007/s00464-014-3628-1; Ujiki MB, 2013, SURGERY, V154, P893, DOI 10.1016/j.surg.2013.04.042; Vaezi MF, 2013, AM J GASTROENTEROL, V108, P1238, DOI 10.1038/ajg.2013.196; Yao SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125942	18	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178414	10.1371/journal.pone.0178414	http://dx.doi.org/10.1371/journal.pone.0178414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542509	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058800056
J	Zhuge, WZ; Hou, CP; Jiao, YY; Yue, J; Tao, H; Yi, DY				Zhuge, Wenzhang; Hou, Chenping; Jiao, Yuanyuan; Yue, Jia; Tao, Hong; Yi, Dongyun			Robust auto-weighted multi-view subspace clustering with common subspace representation matrix	PLOS ONE			English	Article							REGRESSION; ALGORITHM	In many computer vision and machine learning applications, the data sets distribute on certain low-dimensional subspaces. Subspace clustering is a powerful technology to find the underlying subspaces and cluster data points correctly. However, traditional subspace clustering methods can only be applied on data from one source, and how to extend these methods and enable the extensions to combine information from various data sources has become a hot area of research. Previous multi-view subspace methods aim to learn multiple subspace representation matrices simultaneously and these learning task for different views are treated equally. After obtaining representation matrices, they stack up the learned representation matrices as the common underlying subspace structure. However, for many problems, the importance of sources and the importance of features in one source both can be varied, which makes the previous approaches ineffective. In this paper, we propose a novel method called Robust Auto-weighted Multi-view Subspace Clustering (RAMSC). In our method, the weight for both the sources and features can be learned automatically via utilizing a novel trick and introducing a sparse norm. More importantly, the objective of our method is a common representation matrix which directly reflects the common underlying subspace structure. A new efficient algorithm is derived to solve the formulated objective with rigorous theoretical proof on its convergency. Extensive experimental results on five benchmark multi-view datasets well demonstrate that the proposed method consistently outperforms the state-of-the-art methods.	[Zhuge, Wenzhang; Hou, Chenping; Tao, Hong; Yi, Dongyun] Natl Univ Def Technol, Dept Math & Syst Sci, Changsha, Hunan, Peoples R China; [Jiao, Yuanyuan] Natl Univ Def Technol, Coll Nine, Changsha, Hunan, Peoples R China; [Yue, Jia] Taiyuan Satellite Launch Ctr, Key Lab, Taiyuan, Shanxi, Peoples R China	National University of Defense Technology - China; National University of Defense Technology - China	Hou, CP (corresponding author), Natl Univ Def Technol, Dept Math & Syst Sci, Changsha, Hunan, Peoples R China.	hcpnudt@hotmail.com			National Natural Science Foundation of China [61473302, 61503396]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (61473302, 61503396). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asuncion A, 2007, UCI MACHINE LEARNING; BARTELS RH, 1972, COMMUN ACM, V15, P820, DOI 10.1145/361573.361582; Cai X., 2013, IJCAI; Cao XC, 2015, PROC CVPR IEEE, P586, DOI 10.1109/CVPR.2015.7298657; Costeira JP, 1998, INT J COMPUT VISION, V29, P159, DOI 10.1023/A:1008000628999; Dueck D, 2007, IEEE I CONF COMP VIS, P198; Elhamifar E, 2013, IEEE T PATTERN ANAL, V35, P2765, DOI 10.1109/TPAMI.2013.57; Fanti C, 2004, ADV NEUR IN, V16, P1603; Fei-Fei L., 2004, C COMP VIS PATT REC, P178, DOI [10.1109/CVPR.2004.109, DOI 10.1109/CVPR.2004.109]; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Gao HC, 2015, IEEE I CONF COMP VIS, P4238, DOI 10.1109/ICCV.2015.482; Gu Q, 2011, AAAI; Gu Q., 2009, P 18 ACM C INF KNOWL, P1337; Gu QQ, 2009, IEEE DATA MINING, P159, DOI 10.1109/ICDM.2009.32; Gui J, 2017, IEEE T NEUR NET LEAR, V28, P1490, DOI 10.1109/TNNLS.2016.2551724; Gui J, 2014, IEEE T CIRC SYST VID, V24, P211, DOI 10.1109/TCSVT.2013.2273652; Gui J, 2012, PATTERN RECOGN, V45, P2884, DOI 10.1016/j.patcog.2012.02.005; Gui J, 2010, NEUROCOMPUTING, V73, P2696, DOI 10.1016/j.neucom.2010.04.017; He X., 2005, ADV NEURAL INFORM PR, V16, P186; Hou CP, 2014, IEEE T CYBERNETICS, V44, P793, DOI 10.1109/TCYB.2013.2272642; Hu H, 2014, PROC CVPR IEEE, P3834, DOI 10.1109/CVPR.2014.484; Karasuyama M, 2012, IEEE T NEURAL NETWOR, V24, P1999; Karasuyama M, 2013, IEEE T NEUR NET LEAR, V24, P1999, DOI 10.1109/TNNLS.2013.2271327; Kumar A., 2011, ADV NEURAL INFORM PR, P1413; Lee YJ, 2009, INT J COMPUT VISION, V85, P143, DOI 10.1007/s11263-009-0252-y; Li YQ, 2015, AAAI CONF ARTIF INTE, P2750; Liu GC, 2013, IEEE T PATTERN ANAL, V35, P171, DOI 10.1109/TPAMI.2012.88; Lu CY, 2012, LECT NOTES COMPUT SC, V7578, P347, DOI 10.1007/978-3-642-33786-4_26; Luo D, 2011, IEEE T SYST MAN CY B, V6912, P405, DOI DOI 10.1109/TSMCB.2012.2202901; Luo DJ, 2011, LECT NOTES ARTIF INT, V6912, P405, DOI 10.1007/978-3-642-23783-6_26; Ng AY, 2002, ADV NEUR IN, V14, P849; Nie F., 2017, AAAI; Nie F., 2016, IJCAI; Nie F., 2010, ADV NEURAL INFORM PR, V2, P1813; Nie F., 2012, PROC 26 AAAI C ARTIF, P655; Nie FP, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P977, DOI 10.1145/2623330.2623726; Nie Feiping, 2016, AAAI; Shen HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082409; Sindhwani V., 2005, P 22 INT C MACHINE L, P74, DOI DOI 10.1145/1102351.1102455; Sun SL, 2011, LECT NOTES ARTIF INT, V7121, P209; Vidal R., 2005, TPAMI, V27, P1945, DOI DOI 10.1109/TPAMI.2005.244; Vidal R, 2011, IEEE SIGNAL PROC MAG, V28, P52, DOI 10.1109/MSP.2010.939739; Wang S, 2011, EFFICIENT SUBSPACE S; Winn J, 2005, IEEE I CONF COMP VIS, P756; Wu BY, 2014, INT C PATT RECOG, P1964, DOI 10.1109/ICPR.2014.343; Zhang CQ, 2015, IEEE I CONF COMP VIS, P1582, DOI 10.1109/ICCV.2015.185; Zhang Z, 2013, IEEE T IMAGE PROCESS, V22, P4640, DOI 10.1109/TIP.2013.2277780; Zhang Z, 2013, IEEE T KNOWL DATA EN, V25, P2192, DOI 10.1109/TKDE.2012.217	50	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0176769	10.1371/journal.pone.0176769	http://dx.doi.org/10.1371/journal.pone.0176769			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542234	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058800003
J	Bohme, M; Spassov, N; Ebner, M; Geraads, D; Hristova, L; Kirscher, U; Kotter, S; Linnemann, U; Prieto, J; Roussiakis, S; Theodorou, G; Uhlig, G; Winklhofer, M				Boehme, Madelaine; Spassov, Nikolai; Ebner, Martin; Geraads, Denis; Hristova, Latinka; Kirscher, Uwe; Koetter, Sabine; Linnemann, Ulf; Prieto, Jerome; Roussiakis, Socrates; Theodorou, George; Uhlig, Gregor; Winklhofer, Michael			Messinian age and savannah environment of the possible hominin Graecopithecus from Europe	PLOS ONE			English	Article							DEBRIS-FLOW DEPOSITS; DETRITAL ZIRCON AGES; LATE MIOCENE; CARBON ISOTOPES; SAHARA-DESERT; GRAIN-SIZE; CLIMATE; BULGARIA; LOESS; PROXY	Dating fossil hominids and reconstructing their environments is critically important for understanding human evolution. Here we date the potentially oldest hominin, Graecopithecus freybergi from Europe and constrain the environmental conditions under which it thrived. For the Graecopithecus-bearing Pikermi Formation of Attica/Greece, a saline aeolian dust deposit of North African (Sahara) provenance, we obtain an age of 7.37-7.11 Ma, which is coeval with a dramatic cooling in the Mediterranean region at the Tortonian-Messinian transition. Palaeobotanic proxies demonstrate C4-grass dominated wooded grassland-to-woodland habitats of a savannah biome for the Pikermi Formation. Faunal turnover at the Tortonian-Messinian transition led to the spread of new mammalian taxa along with Graecopithecus into Europe. The type mandible of G. freybergi from Pyrgos (7.175 Ma) and the single tooth (7.24 Ma) from Azmaka (Bulgaria) represent the first hominids of Messinian age from continental Europe. Our results suggest that major splits in the hominid family occurred outside Africa.	[Boehme, Madelaine; Ebner, Martin; Koetter, Sabine] Eberhard Karls Univ Tubingen, Dept Geosci, Tubingen, Germany; [Boehme, Madelaine; Koetter, Sabine] Senckenberg Ctr Human Evolut & Palaeoenvironm, Tubingen, Germany; [Spassov, Nikolai; Hristova, Latinka] Bulgarian Acad Sci, Natl Museum Nat Hist, Sofia, Bulgaria; [Geraads, Denis] Sorbonne Univ, CNRS, Museum Natl Hist Nat, CR2P,UMR 7207, CP 38, Paris, France; [Geraads, Denis] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Deutsch Pl 6, Leipzig, Germany; [Kirscher, Uwe] Ludwig Maximilians Univ Munchen, Dept Earth & Environm Sci, Geophys, Munich, Germany; [Linnemann, Ulf] Museum Mineral & Geol, GeoPlasmaLab, Senckenberg Nat Hist Collect Dresden, Dresden, Germany; [Prieto, Jerome] Ludwig Maximilians Univ Munchen, Dept Earth & Environm Sci, Palaeontol, Munich, Germany; [Roussiakis, Socrates; Theodorou, George] Univ Athens, Fac Geol & Geoenvironment, Athens, Greece; [Uhlig, Gregor] Leibniz Inst Polymer Res Dresden, Dresden, Germany; [Winklhofer, Michael] Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, Sch Math & Sci, Oldenburg, Germany; [Kirscher, Uwe] Curtin Univ, Ctr Excellence Core Crust Fluid Syst, Earth Dynam Res Grp, Australian Res Council, Perth, WA, Australia; [Kirscher, Uwe] Curtin Univ, Western Australian Sch Mines, Dept Appl Geol, Inst Geosci Res, Perth, WA, Australia	Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Bulgarian Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Max Planck Society; University of Munich; Senckenberg Gesellschaft fur Naturforschung (SGN); University of Munich; National & Kapodistrian University of Athens; Leibniz Institut fur Polymerforschung Dresden; Carl von Ossietzky Universitat Oldenburg; Curtin University; Curtin University	Bohme, M (corresponding author), Eberhard Karls Univ Tubingen, Dept Geosci, Tubingen, Germany.; Bohme, M (corresponding author), Senckenberg Ctr Human Evolut & Palaeoenvironm, Tubingen, Germany.	m.boehme@ifg.uni-tuebingen.de	Winklhofer, Michael/B-7349-2009; Geraads, Denis/AAY-6051-2020; Roussiakis, Socrates/AAL-5449-2021; GERAADS, Denis/AAC-7241-2021; Kirscher, Uwe/GYI-8992-2022; Kirscher, Uwe/AAG-9960-2020; Hristova, Latinka/GLS-2172-2022	Winklhofer, Michael/0000-0003-1352-9723; GERAADS, Denis/0000-0003-2475-8011; Kirscher, Uwe/0000-0003-4203-1430	German Science Foundation [BO1550/19-1, WI1828/4-2]; United Bulgarian Bank; German Science Foundation DFG [Bo 1550/19-1, Wi 1828/4-2]; European Union (SYNTHESYS) [AT-TAF-2283, GB-TAF-1678]; Special Account for Research Grants of the National and Kapodistrian University of Athens [70/3/9494, 70/3/10437, 70/4/3570, 70/4/11078, 70/3/12977]	German Science Foundation(German Research Foundation (DFG)); United Bulgarian Bank; German Science Foundation DFG(German Research Foundation (DFG)); European Union (SYNTHESYS); Special Account for Research Grants of the National and Kapodistrian University of Athens	This work was supported by the German Science Foundation, BO1550/19-1, WI1828/4-2, http://www.dfg.de/ and the United Bulgarian Bank, https://www.ubb.bg/eng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; For access to fossil collections, laboratory assistance, and/or performance of measurements we thank: Fabian Bonitz, Agnes Fatz, Andreas Gartner, Wolfgang Gerber, Jurgen Hoflinger, Gottfried Hofbauer, Mandy Hofmann, George Koufos, Michael Marks, Hartmut Schulz, Bernd Steinhilber, Henrik Star, Ellen Struve, Heiner Taubald, Peter Weidenbach, Johannes Zieger, and Raphael Zimmermann. We would like to thank the Academic Editor Roberto Macchiarelli for his careful handling of this publication. We are grateful to Todd Ehlers and Andrew P. Roberts for critical reading of a previous version of the manuscript. We also thank Brigitte Senut and 14 anonymous reviewers for their comments. We acknowledge funding from the German Science Foundation DFG (grant Bo 1550/19-1 to MB and Wi 1828/4-2 to MW), the United Bulgarian Bank (grant to NS), and the European Union (SYNTHESYS grants AT-TAF-2283 and GB-TAF-1678 to LH). Research in Pikermi has been supported by the Special Account for Research Grants of the National and Kapodistrian University of Athens 70/3/9494, 70/3/10437, 70/4/3570, 70/4/11078 and 70/3/12977 (grants to GT).	Alcala FJ, 2008, J HYDROL, V359, P189, DOI 10.1016/j.jhydrol.2008.06.028; Altumi MM, 2013, J AFR EARTH SCI, V79, P74, DOI 10.1016/j.jafrearsci.2012.11.007; Barboni D, 2007, PALAEOGEOGR PALAEOCL, V246, P454, DOI 10.1016/j.palaeo.2006.10.012; Begun DR, 2012, EVOL ANTHROPOL, V21, P10, DOI 10.1002/evan.20329; Bosmans JHC, 2015, QUATERNARY SCI REV, V123, P16, DOI 10.1016/j.quascirev.2015.06.008; BOUVRAIN G, 1988, Annales de Paleontologie, V74, P43; Bremond L, 2005, GLOBAL PLANET CHANGE, V45, P277, DOI 10.1016/j.gloplacha.2004.09.002; Burchfiel CB, 2000, GEOL SOC SPEC PUBL, V173, P325, DOI 10.1144/GSL.SP.2000.173.01.16; Cerling TE, 2011, NATURE, V476, P51, DOI 10.1038/nature10306; Chen J, 2008, GEOMORPHOLOGY, V93, P493, DOI 10.1016/j.geomorph.2007.03.011; Dietze M, 2013, EGU GEN ASS C, P2779; Dominguez-Rodrigo M, 2014, CURR ANTHROPOL, V55, P59, DOI 10.1086/674530; Douady CJ, 2003, P NATL ACAD SCI USA, V100, P8325, DOI 10.1073/pnas.0832467100; DRAGOMANOV L, 1981, Paleontologiya Stratigrafiya i Litologiya, V14, P65; Eckelmann K, 2014, GONDWANA RES, V25, P1484, DOI 10.1016/j.gr.2013.05.018; Eisenmann V., 1988, STUDYING FOSSIL HORS; Fomba KW, 2014, ATMOS CHEM PHYS, V14, P8883, DOI 10.5194/acp-14-8883-2014; Fox DL, 2012, GEOL SOC AM BULL, V124, P444, DOI 10.1130/B30401.1; Freyberg Bv, 1950, ANN GEOLOGIQUES PAYS, V3, P65; Freyberg Bv, 1949, ANN GEOLOGIQUES PAYS, V3, P7; Fuss J, PLOS ONE UNPUB; GAMBELL AW, 1962, TELLUS, V14, P91; Gaudry A., 1862, ANIMAUX FOSSILES GEO, P2; Goudie A.S., 2006, DESERT DUST GLOBAL S; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Guerin C, 2001, VERTEBRES TUROLIEN M, V1, P1; Herbert TD, 2016, NATURE GEOSCIENCE; Hilgen FJ, 1995, EARTH PLANET SC LETT, V136, P495, DOI 10.1016/0012-821X(95)00207-S; Hilgen FJ, 2000, EARTH PLANET SC LETT, V182, P237, DOI 10.1016/S0012-821X(00)00247-8; Husing SK, 2009, EARTH PLANET SC LETT, V282, P140, DOI 10.1016/j.epsl.2009.03.010; Katoh S, 2016, NATURE, V530, P215, DOI 10.1038/nature16510; KIRSCHVINK JL, 1980, GEOPHYS J ROY ASTR S, V62, P699, DOI 10.1111/j.1365-246X.1980.tb02601.x; Kojumdgieva E., 1979, PALEONTOL STRATIGR L, V11, P49; Komarek E.V., 1973, ECOLOGY SMOKE PARTIC; Konert M, 1997, SEDIMENTOLOGY, V44, P523, DOI 10.1046/j.1365-3091.1997.d01-38.x; Konidaris G. E., 2013, THESIS; Koufos George D., 2013, P595; Krinsley D.H, 2011, ATLAS QUARTZ SAND SU, Vsecond; Larrasoana JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076514; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Liebens J, 1997, GEOMORPHOLOGY, V21, P53, DOI 10.1016/S0169-555X(97)00036-6; Linnemann U, 2014, PRECAMBRIAN RES, V244, P236, DOI 10.1016/j.precamres.2013.08.007; Linnemann U, 2012, EARTH-SCI REV, V112, P126, DOI 10.1016/j.earscirev.2012.02.007; Linnemann U, 2011, LITHOS, V123, P188, DOI 10.1016/j.lithos.2011.01.010; Madanipour S, 2013, TECTONOPHYSICS, V608, P440, DOI 10.1016/j.tecto.2013.09.003; Madella M, 2005, ANN BOT-LONDON, V96, P253, DOI 10.1093/aob/mci172; Mahaney W., 2002, ATLAS SAND GRAIN SUR; Marinos G, ANN GEOLOGIQUES PAYS; Marinos G., 1955, GEOLOGICAL RECONNAIS, V18, P1; Markov Georgi N., 2008, Historia Naturalis Bulgarica, V19, P153; MCFADDEN PL, 1988, EARTH PLANET SC LETT, V87, P161, DOI 10.1016/0012-821X(88)90072-6; MCFADDEN PL, 1990, GEOPHYS J INT, V103, P725, DOI 10.1111/j.1365-246X.1990.tb05683.x; Mettos AI, 1992, GEOLOGICAL PALEOGRAP; Ohneiser C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9765; Orgetta M., 1979, ANN GEOL PAYS HELL, P909; Papanikolaou D, 2007, B GEOLOGICAL SOC GRE, V40; Papanikolaou DJ, 2007, TECTONICS, V26, DOI 10.1029/2006TC002007; Papp A., 1979, ANN GEOLOGIQUES PAYS, V29, P664; Pausas JG, 2012, GLOBAL ECOL BIOGEOGR, V21, P1074, DOI 10.1111/j.1466-8238.2012.00769.x; Pye K, 1995, QUATERNARY SCI REV, V14, P653, DOI 10.1016/0277-3791(95)00047-X; PYE K, 1983, J SEDIMENT PETROL, V53, P973; Rohling EJ, 2015, EARTH-SCI REV, V143, P62, DOI 10.1016/j.earscirev.2015.01.008; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Schaller M, 2015, QUAT GEOCHRONOL, V29, P6, DOI 10.1016/j.quageo.2015.05.012; Schuster M, 2006, SCIENCE, V311, P821, DOI 10.1126/science.1120161; Solounias N, 1999, PALEOECOLOGY PIKERMI, P436; Spassov N, 2012, J HUM EVOL, V62, P138, DOI 10.1016/j.jhevol.2011.10.008; Stamatis G, 2006, HYDROL PROCESS, V20, P2803, DOI 10.1002/hyp.6072; Stromberg CAE, 2007, PALAEOGEOGR PALAEOCL, V250, P18, DOI 10.1016/j.palaeo.2007.02.012; Stuchlik L., 2001, ATLAS POLLEN SPORES; SYMEONIDIS N, 1973, ANN NATURHISTORISCHE, V77, P125; Tassy P., 1986, NOUVEAUX ELEPHANTOID; Theodorou GE., 2010, P 19 C CARP BALK GEO, V99, P109; Tzanova A, 2015, EARTH PLANET SC LETT, V419, P71, DOI 10.1016/j.epsl.2015.03.016; Ujvari G, 2016, EARTH-SCI REV, V154, P247, DOI 10.1016/j.earscirev.2016.01.006; Vandenberghe J, 2013, EARTH-SCI REV, V121, P18, DOI 10.1016/j.earscirev.2013.03.001; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; Wack MR, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003985; Wagner A., 1839, GELEHRTE ANZEIGER BA, V8, P307; Watson G. S., 1956, GEOPHYS J INT, V7, P160, DOI [10.1111/j.1365-246X.1956.tb05561.x, DOI 10.1111/J.1365-246X.1956.TB05561.X]; Wynn JG, 2000, J HUM EVOL, V39, P411, DOI 10.1006/jhev.2000.0431; YAALON D. H., 1966, Sedi-mentology., V6, P315, DOI 10.1111/j.1365-3091.1966.tb01898.x; Zhang ZS, 2014, NATURE, V513, P401, DOI 10.1038/nature13705; Zijderveld J. D. A., 1967, METHODS PALEOMAGNETI, P254, DOI DOI 10.1016/B978-1-4832-2894-5.50049-5	84	47	47	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177347	10.1371/journal.pone.0177347	http://dx.doi.org/10.1371/journal.pone.0177347			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531204	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058400014
J	Singh, N; Barnes, SJ; Kennedy, S; Adams, JH				Singh, Naresh; Barnes, Samantha J.; Kennedy, Sandra; Adams, John H.			Experimental evaluation of cryopreservative solutions to maintain in vitro and in vivo infectivity of P. berghei sporozoites	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; MALARIA PARASITES; VACCINE; LINE	The rodent malaria parasite Plasmodium berghei is an excellent model organism for laboratory- based experimental evaluation of anti-malarial therapeutics prior to studies with human malaria parasites. The rodent model is especially important for evaluation of pre-erythrocytic ( PE) stage therapies, especially as current efforts to develop new PE vaccines and drugs is limited by access to P. falciparum and P. vivax sporozoites. Developing a more effective method for cryopreservation of sporozoites would help improve access to sporozoites for laboratories lacking suitable insectary facilities. In this study, P. berghei GFP-expressing sporozoites were purified from infected mosquitoes by manual dissection of salivary glands and different commercially-available, serum-free cryopreservative solutions were evaluated for efficient cryopreservation of the sporozoites. The cryopreservative solutions evaluated included CryoStor CS2, CryoSolutions DX5, CryoSolutions MC, Hestar 200, Voluven, Hetastarch, and Glycerolyte 57. The viability of fresh and post-thaw cryopreserved sporozoites was determined as a function of the relative sporozoite infectivity by infecting HC-04 cells in vitro, monitoring invasion and growth and development of liver stage parasites. Flow cytometer-based counting provided unbiased and fast quantitative assessment of parasite in vitro infection in infected HC-04 and in vivo infectivity was validated by injecting sporozoites IV into mice. CryoStor CS2 delivered the highest post-thaw recovery and infectivity of cryopreserved sporozoites. Sporozoites cryopreserved in CryoStor CS2 achieved 38% complete development of hepatic stages in HC-04 and 100% infectivity in mice. The cryopreservation method described here demonstrates a viable alternative for fresh Plasmodium sporozoites. The use of cryopreserved sporozoites should facilitate greater access to sporozoites for chemotherapeutic and vaccine research.	[Singh, Naresh; Barnes, Samantha J.; Kennedy, Sandra; Adams, John H.] Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Adams, JH (corresponding author), Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL 33620 USA.	jadams3@health.usf.edu	Adams, John H./ABB-8458-2020	Adams, John H./0000-0003-3707-7979	Bill and Melinda Gates Foundation [OPP1023643]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Support was provided by the Bill and Melinda Gates Foundation Grant No. OPP1023643 (JHA).; This work was supported by a grant from Bill and Melinda Gates Foundation Grant No. OPP1023643 (JHA). We thank Ashley Souza for assistance with manuscript preparation.	[Anonymous], 2014, METHODS ANOPHELES RE, V4; COLLINS WE, 1994, J PARASITOL, V80, P512, DOI 10.2307/3283184; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; HOLLINGDALE MR, 1985, T ROY SOC TROP MED H, V79, P206, DOI 10.1016/0035-9203(85)90335-9; Jeffery G. M., 1955, Experimental Parasitology, V4, P445, DOI 10.1016/0014-4894(55)90036-9; Kaushansky A, 2012, MOL BIOCHEM PARASIT, V183, P100, DOI 10.1016/j.molbiopara.2012.01.006; Leef J L, 1979, Bull World Health Organ, V57 Suppl 1, P87; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Sato Y, 2014, INFECT IMMUN, V82, P1164, DOI 10.1128/IAI.00758-13; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; Singh N, 2015, PARASITOLOGY INT; TOURAY MG, 1992, J EXP MED, V175, P1607, DOI 10.1084/jem.175.6.1607; WALLIKER D, 1971, NATURE, V232, P561, DOI 10.1038/232561a0; WEATHERS.AB, 1967, J PARASITOL, V53, P638, DOI 10.2307/3276732; WHO, 2015, WORLD MAL REP 2015	17	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177304	10.1371/journal.pone.0177304	http://dx.doi.org/10.1371/journal.pone.0177304			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531172	Green Submitted, gold, Green Published			2022-12-26	WOS:000402058400013
J	Yang, MM; Chadwick, AE; Dart, C; Kamishima, T; Quayle, JM				Yang, Mingming; Chadwick, Amy E.; Dart, Caroline; Kamishima, Tomoko; Quayle, John M.			Bioenergetic profile of human coronary artery smooth muscle cells and effect of metabolic intervention	PLOS ONE			English	Article							K-ATP CHANNELS; MITOCHONDRIAL BIOENERGETICS; SYSTEM; GROWTH; RATIO	Bioenergetics of artery smooth muscle cells is critical in cardiovascular health and disease. An acute rise in metabolic demand causes vasodilation in systemic circulation while a chronic shift in bioenergetic profile may lead to vascular diseases. A decrease in intracellular ATP level may trigger physiological responses while dedifferentiation of contractile smooth muscle cells to a proliferative and migratory phenotype is often observed during pathological processes. Although it is now possible to dissect multiple building blocks of bioenergetic components quantitatively, detailed cellular bioenergetics of artery smooth muscle cells is still largely unknown. Thus, we profiled cellular bioenergetics of human coronary artery smooth muscle cells and effects of metabolic intervention. Mitochondria and glycolysis stress tests utilizing Seahorse technology revealed that mitochondrial oxidative phosphorylation accounted for 54.5% of ATP production at rest with the remaining 45.5% due to glycolysis. Stress tests also showed that oxidative phosphorylation and glycolysis can increase to a maximum of 3.5 fold and 1.25 fold, respectively, indicating that the former has a high reserve capacity. Analysis of bioenergetic profile indicated that aging cells have lower resting oxidative phosphorylation and reduced reserve capacity. Intracellular ATP level of a single cell was estimated to be over 1.1 mM. Application of metabolic modulators caused significant changes in mitochondria membrane potential, intracellular ATP level and ATP: ADP ratio. The detailed breakdown of cellular bioenergetics showed that proliferating human coronary artery smooth muscle cells rely more or less equally on oxidative phosphorylation and glycolysis at rest. These cells have high respiratory reserve capacity and low glycolysis reserve capacity. Metabolic intervention influences both intracellular ATP concentration and ATP: ADP ratio, where subtler changes may be detected by the latter.	[Yang, Mingming; Kamishima, Tomoko; Quayle, John M.] Univ Liverpool, Dept Cellular & Mol Physiol, Liverpool, Merseyside, England; [Chadwick, Amy E.] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England; [Dart, Caroline] Univ Liverpool, Dept Biochem, Liverpool, Merseyside, England	University of Liverpool; University of Liverpool; University of Liverpool	Quayle, JM (corresponding author), Univ Liverpool, Dept Cellular & Mol Physiol, Liverpool, Merseyside, England.	jquayle@liv.ac.uk	Chadwick, Amy E/D-8633-2015	Chadwick, Amy E/0000-0002-7399-8655; Dart, Caroline/0000-0002-3509-8349; Yang, Mingming/0000-0003-4484-0979	China Scholarship Council; University of Liverpool	China Scholarship Council(China Scholarship Council); University of Liverpool	This work was supported by the China Scholarship Council and University of Liverpool. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg J, 2009, NAT METHODS, V6, P161, DOI [10.1038/NMETH.1288, 10.1038/nmeth.1288]; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897; DAUT J, 1990, SCIENCE, V247, P1341, DOI 10.1126/science.2107575; DAVIS S, 1985, J BIOL CHEM, V260, P3844; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; Foster MN, 2016, PHYSIOL REV, V96, P177, DOI 10.1152/physrev.00003.2015; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Kamishima T, 2002, AM J PHYSIOL-HEART C, V283, pH2431, DOI 10.1152/ajpheart.00865.2001; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Li J, 2013, DIABETOLOGIA, V56, P1577, DOI 10.1007/s00125-013-2894-0; McCarron JG, 2013, MICROCIRCULATION, V20, P317, DOI 10.1111/micc.12039; Mercer JR, 2014, PHARMACOL THERAPEUT, V141, P13, DOI 10.1016/j.pharmthera.2013.07.011; PAUL RJ, 1983, AM J PHYSIOL, V244, pC399, DOI 10.1152/ajpcell.1983.244.5.C399; PAUL RJ, 1980, HDB PHYSL          2, V2, P201; Perez J, 2010, BIOCHEM J, V428, P255, DOI 10.1042/BJ20100090; Pung YF, 2013, AM J PHYSIOL-HEART C, V305, pH1275, DOI 10.1152/ajpheart.00077.2013; Quayle JM, 2006, AM J PHYSIOL-HEART C, V291, pH71, DOI 10.1152/ajpheart.01107.2005; QUAYLE JM, 1994, J PHYSIOL-LONDON, V475, P9, DOI 10.1113/jphysiol.1994.sp020045; Tantama M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3550; Uebelhoer M, 2016, VASC PHARMACOL, V83, P4, DOI 10.1016/j.vph.2016.06.002	25	13	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177951	10.1371/journal.pone.0177951	http://dx.doi.org/10.1371/journal.pone.0177951			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542339	gold, Green Submitted, Green Published			2022-12-26	WOS:000401672600032
J	De la Rosa, D; Martinez-Garcia, MA; Giron, RM; Vendrell, M; Olveira, C; Borderias, L; Maiz, L; Torres, A; Martinez-Moragon, E; Rajas, O; Casas, F; Cordovilla, R; de Gracia, J				De la Rosa, David; Martinez-Garcia, Miguel-Angel; Maria Giron, Rosa; Vendrell, Montserrat; Olveira, Casilda; Borderias, Luis; Maiz, Luis; Torres, Antoni; Martinez-Moragon, Eva; Rajas, Olga; Casas, Francisco; Cordovilla, Rosa; de Gracia, Javier			Clinical impact of chronic obstructive pulmonary disease on non-cystic fibrosis bronchiectasis. A study on 1,790 patients from the Spanish Bronchiectasis Historical Registry	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; AIRWAY BACTERIA; ADULT PATIENTS; EXACERBATIONS; PREVALENCE; PREVENTION; COLONIZATION; ANTIBIOTICS; MORTALITY; ETIOLOGY	Background Few studies have evaluated the coexistence of bronchiectasis (BE) and chronic obstructive pulmonary disease (COPD) in series of patients diagnosed primarily with BE. The aim of this study was to analyse the characteristics of patients with BE associated with COPD included in the Spanish Bronchiectasis Historical Registry and compare them to the remaining patients with non-cystic fibrosis BE. Methods We conducted a multicentre observational study of historical cohorts, analysing the characteristics of 1,790 patients who had been included in the registry between 2002 and 2011. Of these, 158 (8.8%) were registered as BE related to COPD and were compared to the remaining patients with BE of other aetiologies. Results Patients with COPD were mostly male, older, had a poorer respiratory function and more frequent exacerbations. There were no differences in the proportion of patients with chronic bronchial colonisation or in the isolated microorganisms. A significantly larger proportion of patients with COPD received treatment with bronchodilators, inhaled steroids and intravenous antibiotics, but there was no difference in the use of long term oral or inhaled antibiotherapy. During a follow-up period of 3.36 years, the overall proportion of deaths was 13.8%. When compared to the remaining aetiologies, patients with BE associated with COPD presented the highest mortality rate. The multivariate analysis showed that the diagnosis of COPD in a patient with BE as a primary diagnosis increased the risk of death by 1.77. Conclusion Patients with BE related to COPD have the same microbiological characteristics as patients with BE due to other aetiologies. They receive treatment with long term oral and inhaled antibiotics aimed at controlling chronic bronchial colonisation, even though the current COPD treatment guidelines do not envisage this type of therapy. These patients' mortality is notably higher than that of remaining patients with non-cystic fibrosis BE.	[De la Rosa, David] Hosp Plato, Dept Pneumol, Barcelona, Spain; [Martinez-Garcia, Miguel-Angel] Hosp Requena, Dept Pneumol, Valencia, Spain; [Maria Giron, Rosa; Rajas, Olga] Hosp Univ Princesa, Inst Invest Sanitaria, Dept Pneumol, Madrid, Spain; [Vendrell, Montserrat] Hosp Josep Trueta Biomed Res Inst IDIBGI, Dept Pneumol, Girona, Spain; [Olveira, Casilda] Hosp Reg Univ Malaga, Inst Biomed Malaga IBIMA, Fac Med Malaga, Dept Pneumol, Malaga, Spain; [Borderias, Luis] Hosp Gen San Jorge, Dept Pneumol, Huesca, Spain; [Maiz, Luis] Hosp Ramon & Cajal, Dept Pneumol, Madrid, Spain; [Torres, Antoni] Hosp Clin Barcelona, Resp Inst, Barcelona, Spain; [Martinez-Moragon, Eva] Hosp Sagunto, Dept Pneumol, Valencia, Spain; [Casas, Francisco] Hosp Univ San Cecilio, Dept Pneumol, Granada, Spain; [Cordovilla, Rosa] Hosp Univ Salamanca, Dept Pneumol, Salamanca, Spain; [de Gracia, Javier] Hosp Univ Vall dHebron, Dept Pneumol, Barcelona, Spain; [Martinez-Garcia, Miguel-Angel] Hosp Univ & Politecn La Fe, Dept Pneumol, Valencia, Spain; [Martinez-Moragon, Eva] Hosp Univ Doctor Peset, Dept Pneumol, Valencia, Spain	Hospital de La Princesa; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Universidad de Malaga; Hospital Universidad San Jorge; Hospital Universitario Ramon y Cajal; University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitario San Cecilio; Hospital Universitari Vall d'Hebron; Hospital Universitari i Politecnic La Fe	De la Rosa, D (corresponding author), Hosp Plato, Dept Pneumol, Barcelona, Spain.	david.rosa@hospitalplato.com	De Gracia, Javier/H-8746-2017; Martinez-Garcia, Miguel/AAA-6349-2019; Vendrell, Montserrat/AAP-3635-2021; Torres, Antoni/H-6128-2017; De La Rosa Carrillo, David/AET-0317-2022	De Gracia, Javier/0000-0003-2830-1991; Martinez-Garcia, Miguel/0000-0002-7321-1891; Vendrell, Montserrat/0000-0002-6879-5757; Torres, Antoni/0000-0002-8643-2167; De La Rosa Carrillo, David/0000-0003-0753-1771; Casas, Francisco/0000-0002-8007-9323				Aliberti S, 2016, EUR RESPIR J, V47, P1113, DOI 10.1183/13993003.01899-2015; Martinez-Garcia MA, 2011, CHEST, V140, P1130, DOI 10.1378/chest.10-1758; Anwar GA, 2013, RESP MED, V107, P1001, DOI 10.1016/j.rmed.2013.04.013; BARKER AF, 1988, AM REV RESPIR DIS, V137, P969, DOI 10.1164/ajrccm/137.4.969; Brill SE, 2015, THORAX, V70, P930, DOI 10.1136/thoraxjnl-2015-207194; Canton R, 2005, CLIN MICROBIOL INFEC, V11, P690, DOI 10.1111/j.1469-0691.2005.01217.x; Chalmers JD, 2014, AM J RESP CRIT CARE, V189, P576, DOI 10.1164/rccm.201309-1575OC; Chevalier-Bidaud B, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-148; Dal Negro R, 2008, ADV THER, V25, P1019, DOI 10.1007/s12325-008-0105-2; Davies G, 2006, EUR RESPIR J, V28, P974, DOI 10.1183/09031936.06.00074605; Donath E, 2013, RESP MED, V107, P1385, DOI 10.1016/j.rmed.2013.05.004; Du QX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150532; Finch S, 2015, ANN AM THORAC SOC, V12, P1602, DOI 10.1513/AnnalsATS.201506-333OC; Gao YH, 2016, RESPIROLOGY; Garcha DS, 2012, THORAX, V67, P1075, DOI 10.1136/thoraxjnl-2012-201924; Garcia-Vidal C, 2009, EUR RESPIR J, V34, P1072, DOI 10.1183/09031936.00003309; Gatheral T, 2014, COPD, V11, P605, DOI 10.3109/15412555.2014.922174; Goeminne PC, 2014, RESP MED, V108, P287, DOI 10.1016/j.rmed.2013.12.015; Habesoglu MA, 2011, ANN THORAC MED, V6, P131, DOI 10.4103/1817-1737.82443; Haworth CS, 2014, RESP MED, V108, P1397, DOI 10.1016/j.rmed.2014.09.005; Keddissi JI, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/498205; Keistinen T, 1997, EUR RESPIR J, V10, P2784, DOI 10.1183/09031936.97.10122784; Kew KM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010115.pub2; King PT, 2006, RESP MED, V100, P2183, DOI 10.1016/j.rmed.2006.03.012; Lonni S, 2015, ANN AM THORAC SOC, V12, P1764, DOI 10.1513/AnnalsATS.201507-472OC; Martinez-Garcia C., 2003, HAEMATOLOGICA S6, V87, P204; Martinez-Garcia MA, 2014, EUR RESPIR J, V43, P1357, DOI 10.1183/09031936.00026313; Martinez-Garcia MA, 2007, CHEST, V132, P1565, DOI 10.1378/chest.07-0490; Martinez-Garcia MA, 2013, AM J RESP CRIT CARE, V187, P823, DOI 10.1164/rccm.201208-1518OC; Pasteur MC, 2010, THORAX, V65, P577, DOI 10.1136/thx.2010.142778; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120; Patel IS, 2004, AM J RESP CRIT CARE, V170, P400, DOI 10.1164/rccm.200305-648OC; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Quint JK, 2016, EUR RESPIR J, V47, P186, DOI 10.1183/13993003.01033-2015; Roberts HR, 2000, THORAX, V55, P198, DOI 10.1136/thorax.55.3.198; ROCA J, 1986, B EUR PHYSIOPATH RES, V22, P217; Sethi S, 2012, AM J RESP CRIT CARE, V185, pA3037; Sethi S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-10; Shoemark A, 2007, RESP MED, V101, P1163, DOI 10.1016/j.rmed.2006.11.008; Vendrell M, 2008, ARCH BRONCONEUMOL, V44, P629, DOI 10.1016/S1579-2129(08)60117-2; Wilson CB, 1997, EUR RESPIR J, V10, P1754, DOI 10.1183/09031936.97.10081754; Wilson R, 2013, J INFECTION, V67, P497, DOI 10.1016/j.jinf.2013.08.010	42	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177931	10.1371/journal.pone.0177931	http://dx.doi.org/10.1371/journal.pone.0177931			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542286	gold, Green Published, Green Submitted			2022-12-26	WOS:000401672400117
J	Honda, H; Hirano, T; Ueda, M; Kojima, S; Mashiba, S; Hayase, Y; Michihata, T; Shishido, K; Takahashi, K; Hosaka, N; Ikeda, M; Sanada, D; Shibata, T				Honda, Hirokazu; Hirano, Tsutomu; Ueda, Masashi; Kojima, Shiho; Mashiba, Shinichi; Hayase, Yasuyuki; Michihata, Tetsuo; Shishido, Kanji; Takahashi, Keiko; Hosaka, Nozomu; Ikeda, Misa; Sanada, Daisuke; Shibata, Takanori			Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis	PLOS ONE			English	Article							A-II; CHOLESTEROL EFFLUX; HDL; RISK; DISEASE; ATHEROSCLEROSIS; METABOLISM; MORTALITY; PROTEIN	Apolipoproteins are associated with survival among patients on hemodialysis (HD), but these associations might be influenced by dysfunctional (oxidized) high-density lipoprotein (HDL). We assessed associations among apolipoproteins and oxidized HDL, mortality and cardiovascular disease (CVD) events in patients on HD. This prospective observational study examined 412 patients on prevalent HD. Blood samples were obtained before dialysis at baseline to measure lipids, apolipoproteins, oxidized LDL, oxidized HDL, high-sensitivity C-reactive protein (hs-CRP) and interleukin (IL)-6 at baseline, and HDL-C and hs-CRP were measured 12 months later. Patients were then prospectively followed-up (mean, 40 months) and all-cause mortality and composite CVD events were analyzed. Associations between variables at baseline and clinical outcome were assessed by Cox proportional hazards modeling (n = 412) and Cox hazards modeling with a time-varying covariate with HDL-C and hs-CRP (n = 369). Quartiles of apolipoproteins and oxidized HDL were not associated with all-cause mortality. However, Cox proportional hazards models with quartiles of each variable adjusted for confounders and hs-CRP or IL-6 identified apolipoprotein (apo) B-to-apoA-I ratio (apoB/apoA-I) and oxidized HDL, but not apoA-I or apoA-II, as independent risk factors for composite CVD events. These associations were confirmed by Cox proportional hazards modeling with time-varying covariates for hs-CRP. ApoB/apoA-I was independently associated with composite CVD events in 1-standard deviation (SD) increase-of-variables models adjusted for the confounders, oxidized HDL and hs-CRP. However, these associations disappeared from the model adjusted with IL-6 instead of hs-CRP, and oxidized HDL and IL-6 were independently associated with composite CVD events. Findings resembled those from Cox proportional hazards modeling using time-varying covariates with HDL-C adjusted with IL-6. In conclusion, both oxidized HDL and apoB/apoA-I might be associated with CVD events in patients on prevalent HD, while associations of apoB/apoA-I with CVD events differed between models of apoB/apoA-I quartiles and 1-SD increases, and were influenced by IL-6.	[Honda, Hirokazu; Hosaka, Nozomu] Showa Univ, Koto Toyosu Hosp, Dept Med, Div Nephrol, Tokyo, Japan; [Honda, Hirokazu; Hosaka, Nozomu; Ikeda, Misa; Sanada, Daisuke; Shibata, Takanori] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo, Japan; [Hirano, Tsutomu] Showa Univ, Sch Med, Dept Med, Div Diabet Metab & Endocrinol, Tokyo, Japan; [Ueda, Masashi; Kojima, Shiho; Mashiba, Shinichi; Hayase, Yasuyuki] Ikagaku, Res Dev, Kyoto, Japan; [Michihata, Tetsuo] Ebara Clin, Dept Dialysis, Tokyo, Japan; [Shishido, Kanji] Kawasaki Clin, Dept Dialysis, Kawasaki, Kanagawa, Japan; [Takahashi, Keiko] Kitami Higashiyama Clin, Div Dialysis, Tokyo, Japan	Showa University; Showa University; Showa University	Honda, H (corresponding author), Showa Univ, Koto Toyosu Hosp, Dept Med, Div Nephrol, Tokyo, Japan.; Honda, H (corresponding author), Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo, Japan.	hondah@med.showa-u.ac.jp		Honda, Hirokazu/0000-0002-5634-6145				Alaupovic P, 1997, ARTERIOSCL THROM VAS, V17, P715, DOI 10.1161/01.ATV.17.4.715; [Anonymous], 2000, AM J KIDNEY DIS, V35, pS1, DOI DOI 10.1053/AJKD.2000.V35.AAJKD03517; Birjmohun RS, 2007, CIRCULATION, V116, P2029, DOI 10.1161/CIRCULATIONAHA.107.704031; Chadwick AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123138; Corsetti JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039110; Gugliucci A, 2015, CLIN CHIM ACTA, V439, P5, DOI 10.1016/j.cca.2014.09.016; Gugliucci A, 2012, J LIPIDS, V2012, DOI 10.1155/2012/726048; Holzer M, 2011, J AM SOC NEPHROL, V22, P1631, DOI 10.1681/ASN.2010111144; Honda H, 2006, AM J KIDNEY DIS, V47, P139, DOI 10.1053/j.ajkd.2005.09.014; Honda H, 2016, J ATHEROSCLER THROMB, V23, P81, DOI 10.5551/jat.30015; Honda H, 2012, ATHEROSCLEROSIS, V220, P493, DOI 10.1016/j.atherosclerosis.2011.10.038; Honda H, 2010, CLIN J AM SOC NEPHRO, V5, P1021, DOI 10.2215/CJN.06110809; HUANG YD, 1995, ARTERIOSCL THROM VAS, V15, P1412, DOI 10.1161/01.ATV.15.9.1412; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Ikewaki K, 2014, CLIN EXP NEPHROL, V18, P261, DOI 10.1007/s10157-013-0881-x; JOHNSON WJ, 1991, J LIPID RES, V32, P1993; Kalantar-Zadeh K, 2007, KIDNEY INT, V72, P1149, DOI 10.1038/sj.ki.5002491; Kaysen GA, 2014, NEPHROL DIAL TRANSPL, V29, P430, DOI 10.1093/ndt/gft370; Keane WF, 2013, J ATHEROSCLER THROMB, V20, P123, DOI 10.5551/jat.12849; Kennedy DJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000104; Kidney Disease Outcomes Quality Initiative (K/DOQI) Group, 2003, AM J KIDNEY DIS S, V41, pI; Kollerits B, 2016, NEPHROL DIAL TRANSPL, V31, P1901, DOI 10.1093/ndt/gfv428; Lubrano Valter, 2015, World J Exp Med, V5, P218, DOI 10.5493/wjem.v5.i4.218; Malle E, 2006, ARCH BIOCHEM BIOPHYS, V445, P245, DOI 10.1016/j.abb.2005.08.008; Nakajima T, 2000, ANN CLIN BIOCHEM, V37, P179, DOI 10.1258/0004563001899186; Navab KD, 2011, CURR PHARM DESIGN, V17, P17; Navab M, 2009, J LIPID RES, V50, pS145, DOI 10.1194/jlr.R800036-JLR200; Sato Y, 2016, CLIN J AM SOC NEPHRO, V11, P840, DOI 10.2215/CJN.09830915; Silbernagel G, 2015, J AM SOC NEPHROL, V26, P484, DOI 10.1681/ASN.2013080816; Sun J, 2016, CLIN J AM SOC NEPHRO, V11, P1163, DOI 10.2215/CJN.10441015; Sweetnam PM, 2000, EUR J CLIN INVEST, V30, P947, DOI 10.1046/j.1365-2362.2000.00725.x; Ueda M, 2007, CLIN CHIM ACTA, V378, P105, DOI 10.1016/j.cca.2006.11.002; Umemoto T, 2013, CIRC RES, V112, P1345, DOI 10.1161/CIRCRESAHA.111.300581; Vaziri ND, 2010, NAT REV NEPHROL, V6, P287, DOI 10.1038/nrneph.2010.36; Wang Y, 2013, ARTERIOSCL THROM VAS, V33, P224, DOI 10.1161/ATVBAHA.112.300445; Wiswedel I, 2008, BIOMARK INSIGHTS, V3, P419; Yamamoto S, 2012, J AM COLL CARDIOL, V60, P2372, DOI 10.1016/j.jacc.2012.09.013	37	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177980	10.1371/journal.pone.0177980	http://dx.doi.org/10.1371/journal.pone.0177980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542510	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400125
J	Lopopolo, A; Frank, SL; van den Bosch, A; Willems, RM				Lopopolo, Alessandro; Frank, Stefan L.; van den Bosch, Antal; Willems, Roel M.			Using stochastic language models (SLM) to map lexical, syntactic, and phonological information processing in the brain	PLOS ONE			English	Article							CORTEX; COMPREHENSION; FREQUENCY; SYSTEM; MEMORY; WORDS; AREAS; LOBE; TIME	Language comprehension involves the simultaneous processing of information at the phonological, syntactic, and lexical level. We track these three distinct streams of information in the brain by using stochastic measures derived from computational language models to detect neural correlates of phoneme, part-of-speech, and word processing in an fMRI experiment. Probabilistic language models have proven to be useful tools for studying how language is processed as a sequence of symbols unfolding in time. Conditional probabilities between sequences of words are at the basis of probabilistic measures such as surprisal and perplexity which have been successfully used as predictors of several behavioural and neural correlates of sentence processing. Here we computed perplexity from sequences of words and their parts of speech, and their phonemic transcriptions. Brain activity time locked to each word is regressed on the three model-derived measures. We observe that the brain keeps track of the statistical structure of lexical, syntactic and phonological information in distinct areas.	[Lopopolo, Alessandro; Frank, Stefan L.; van den Bosch, Antal; Willems, Roel M.] Radboud Univ Nijmegen, Ctr Language Studies, Nijmegen, Netherlands; [Willems, Roel M.] Radboud Univ Nijmegen, Donders Inst, Nijmegen, Netherlands; [van den Bosch, Antal] Royal Netherlands Acad Sci & Arts, Meertens Inst, Amsterdam, Netherlands; [Willems, Roel M.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Royal Netherlands Academy of Arts & Sciences; Meertens Institute (KNAW); Max Planck Society	Lopopolo, A (corresponding author), Radboud Univ Nijmegen, Ctr Language Studies, Nijmegen, Netherlands.	a.lopopolo@donders.ru.nl	van den Bosch, Antal/AAC-2164-2019	van den Bosch, Antal/0000-0003-2493-656X; Willems, Roel/0000-0002-4963-5387	Netherlands Organisation for Scientific Research (NWO) [024.001.006]; NWO Vidi [NWO-Vidi 276-89-007]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO Vidi(Netherlands Organization for Scientific Research (NWO))	The work presented here was funded by Netherlands Organisation for Scientific Research (NWO) Gravitation Grant 024.001.006 to the Language in Interaction Consortium and by NWO Vidi grant (NWO-Vidi 276-89-007).	Alario FX, 2006, BRAIN RES, V1076, P129, DOI 10.1016/j.brainres.2005.11.104; Anderson A. J., 2013, P 2013 C EMP METH NA, P1960; Anderson AJ, 2015, NEUROIMAGE, V120, P309, DOI 10.1016/j.neuroimage.2015.06.093; Baayen H. R., 1995, CELEX LEXICAL DATABA; Bar M., 2011, PREDICTIONBRAIN US, DOI [10.1093/acprof:Oso/9780195395518.001.0001, DOI 10.1093/ACPROF:OSO/9780195395518.001.0001]; Bennett CM, 2009, SOC COGN AFFECT NEUR, V4, P417, DOI 10.1093/scan/nsp053; Binder JR, 2011, TRENDS COGN SCI, V15, P527, DOI 10.1016/j.tics.2011.10.001; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Boston MF, 2008, J EYE MOVEMENT RES, V2; Brennan J, 2012, BRAIN LANG, V120, P163, DOI 10.1016/j.bandl.2010.04.002; Brennan JR, 2016, BRAIN LANG, V157, P81, DOI 10.1016/j.bandl.2016.04.008; Bubic A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00025; Busser B, 1999, 6 EUR C SPEECH COMM, P1999; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Daelemans W, MEMORY BASED LANGUAG, P3; Dronkers NF, 2004, COGNITION, V92, P145, DOI 10.1016/j.cognition.2003.11.002; Frank S., 2012, P 34 ANN C COGN SCI, P1554; Frank SL, 2015, BRAIN LANG, V140, P1, DOI 10.1016/j.bandl.2014.10.006; Frank SL, 2013, TOP COGN SCI, V5, P475, DOI 10.1111/tops.12025; Frank SL, 2011, PSYCHOL SCI, V22, P829, DOI 10.1177/0956797611409589; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Friston KJ, 2009, PHILOS T R SOC B, V364, P1211, DOI 10.1098/rstb.2008.0300; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Grodzinsky Y, 2008, TRENDS COGN SCI, V12, P474, DOI 10.1016/j.tics.2008.09.001; Haeseryn Walter, 1997, ALGEMENE NEDERLANDSE; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hagoort P, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00416; Hale John, 2001, 2 M N AM CHAPT ASS C; Herrmann B, 2012, HUM BRAIN MAPP, V33, P584, DOI 10.1002/hbm.21235; Hertrich I, 2016, NEUROSCI BIOBEHAV R, V68, P602, DOI 10.1016/j.neubiorev.2016.06.030; Indefrey P, 2004, PRELEXICAL LEXICAL P; Jackendoff R. S., 2002, FDN LANGUAGE BRAIN M; Jackendoff R, 2007, BRAIN RES, V1146, P2, DOI 10.1016/j.brainres.2006.08.111; Kemmerer David, 2014, COGNITIVE NEUROSCIEN; Keuleers E, 2010, BEHAV RES METHODS, V42, P643, DOI 10.3758/BRM.42.3.643; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Levy R, 2008, COGNITION, V106, P1126, DOI 10.1016/j.cognition.2007.05.006; Mendoza JE, 2011, HESCHLS GYRUS, P1243; Monsalve Irene Fernandez, 2012, P 13 C EUR CHAPT ASS, P398; Nastase S, 2014, HUM BRAIN MAPP, V35, P1111, DOI 10.1002/hbm.22238; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Obleser J, 2011, NEUROIMAGE, V56, P2310, DOI 10.1016/j.neuroimage.2011.03.035; Oostdijk N., 2000, P 2 INT C LANG RES E, P887; Pallier C, 2011, P NATL ACAD SCI USA, V108, P2522, DOI 10.1073/pnas.1018711108; Piantadosi ST, 2011, P NATL ACAD SCI USA, V108, P3526, DOI 10.1073/pnas.1012551108; Poser BA, 2010, NEUROIMAGE, V51, P261, DOI 10.1016/j.neuroimage.2010.01.108; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Sato M, 2009, BRAIN LANG, V111, P1, DOI 10.1016/j.bandl.2009.03.002; Schafer R, 2012, LREC 2012 - EIGHTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P486; Schlesewsky M., 2012, OPEN MED IMAGING J, V6, P47, DOI DOI 10.2174/1874347101206010047; Smith NJ, 2013, COGNITION, V128, P302, DOI 10.1016/j.cognition.2013.02.013; Snijders TM, 2009, CEREB CORTEX, V19, P1493, DOI 10.1093/cercor/bhn187; Stolcke A., 2002, P INT C SPOK LANG PR, V2, P901; Summerfield C, 2009, TRENDS COGN SCI, V13, P403, DOI 10.1016/j.tics.2009.06.003; Thompson-Schill SL, 2009, CURR DIR PSYCHOL SCI, V18, P259, DOI 10.1111/j.1467-8721.2009.01648.x; Tremblay P, 2016, NEUROIMAGE, V136, P106, DOI 10.1016/j.neuroimage.2016.05.018; Tremblay P, 2011, NEUROIMAGE, V57, P1561, DOI 10.1016/j.neuroimage.2011.05.067; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Willems RM, 2007, BRAIN LANG, V101, P278, DOI 10.1016/j.bandl.2007.03.004; Willems RM, 2016, CEREB CORTEX, V26, P2506, DOI 10.1093/cercor/bhv075; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058	63	26	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177794	10.1371/journal.pone.0177794	http://dx.doi.org/10.1371/journal.pone.0177794			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542396	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400084
J	Booth, TC; Larkin, TJ; Yuan, Y; Kettunen, MI; Dawson, SN; Scoffings, D; Canuto, HC; Vowler, SL; Kirschenlohr, H; Hobson, MP; Markowetz, F; Jefferies, S; Brindle, KM				Booth, Thomas C.; Larkin, Timothy J.; Yuan, Yinyin; Kettunen, Mikko I.; Dawson, Sarah N.; Scoffings, Daniel; Canuto, Holly C.; Vowler, Sarah L.; Kirschenlohr, Heide; Hobson, Michael P.; Markowetz, Florian; Jefferies, Sarah; Brindle, Kevin M.			Analysis of heterogeneity in T-2-weighted MR images can differentiate pseudoprogression from progression in glioblastoma	PLOS ONE			English	Article							CEREBRAL BLOOD-VOLUME; NEWLY-DIAGNOSED GLIOBLASTOMA; GLIOMAS RESPONSE ASSESSMENT; HIGH-GRADE GLIOMAS; PROGNOSTIC-FACTORS; RADIATION-THERAPY; WHITE-MATTER; 3.0 T; PERFUSION; BRAIN	Purpose To develop an image analysis technique that distinguishes pseudoprogression from true progression by analyzing tumour heterogeneity in T-2-weighted images using topological descriptors of image heterogeneity called Minkowski functionals (MFs). Methods Using a retrospective patient cohort (n = 50), and blinded to treatment response outcome, unsupervised feature estimation was performed to investigate MFs for the presence of outliers, potential confounders, and sensitivity to treatment response. The progression and pseudoprogression groups were then unblinded and supervised feature selection was performed using MFs, size and signal intensity features. A support vector machine model was obtained and evaluated using a prospective test cohort. Results The model gave a classification accuracy, using a combination of MFs and size features, of more than 85% in both retrospective and prospective datasets. A different feature selection method (Random Forest) and classifier (Lasso) gave the same results. Although not apparent to the reporting radiologist, the T-2-weighted hyperintensity phenotype of those patients with progression was heterogeneous, large and frond-like when compared to those with pseudoprogression. Conclusion Analysis of heterogeneity, in T-2-weighted MR images, which are acquired routinely in the clinic, has the potential to detect an earlier treatment response allowing an early change in treatment strategy. Prospective validation of this technique in larger datasets is required.	[Booth, Thomas C.; Larkin, Timothy J.; Kettunen, Mikko I.; Canuto, Holly C.; Kirschenlohr, Heide; Brindle, Kevin M.] Univ Cambridge, Dept Biochem, Cambridge, England; [Booth, Thomas C.; Larkin, Timothy J.; Yuan, Yinyin; Kettunen, Mikko I.; Canuto, Holly C.; Vowler, Sarah L.; Markowetz, Florian; Brindle, Kevin M.] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England; [Dawson, Sarah N.] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Clin Trials Unit, Cambridge, England; [Scoffings, Daniel] Addenbrookes Hosp, Dept Radiol, Cambridge, England; [Hobson, Michael P.] Univ Cambridge, Cavendish Lab, Battock Ctr Expt Astrophys, Cambridge, England; [Jefferies, Sarah] Addenbrookes Hosp, Dept Oncol, Cambridge, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Brindle, KM (corresponding author), Univ Cambridge, Dept Biochem, Cambridge, England.; Brindle, KM (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England.	kmb1001@cam.ac.uk	Scoffings, Daniel/GLS-1219-2022; Scoffings, Daniel/AAA-1649-2022; Kettunen, Mikko I/K-2299-2012	Kettunen, Mikko I/0000-0002-2004-660X; Dawson, Sarah/0000-0001-7401-2192; Yuan, Yinyin/0000-0002-8556-4707	Medical Research Council/Royal College of Radiologists (UK) Clinical Research Fellowship [G1000265]; Cancer Research UK Clinical Research Fellowship; Addenbrookes Charitable Trust Award; Cancer Research UK Programme grant [C197/A3514]; MRC [G1000265] Funding Source: UKRI; Cancer Research UK [17242, 16465, 19274, 22310] Funding Source: researchfish; Medical Research Council [G1000265] Funding Source: researchfish	Medical Research Council/Royal College of Radiologists (UK) Clinical Research Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK Clinical Research Fellowship; Addenbrookes Charitable Trust Award; Cancer Research UK Programme grant(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by Medical Research Council/Royal College of Radiologists (UK) Clinical Research Fellowship (G1000265); Cancer Research UK Clinical Research Fellowship; Addenbrookes Charitable Trust Award to TCB. Cancer Research UK Programme grant (C197/A3514) to KM B. www.mrc.ac.uk; www.cancerresearchuk.org/;; http//www act4addenbrookes.org.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Linera J, 2008, EUR J RADIOL, V67, P415, DOI 10.1016/j.ejrad.2008.02.045; Bauchet L, 2010, NEURO-ONCOLOGY, V12, P725, DOI 10.1093/neuonc/noq030; BLEEHEN NM, 1991, BRIT J CANCER, V64, P769, DOI 10.1038/bjc.1991.396; Boss A, 2007, J MAGN RESON IMAGING, V25, P924, DOI 10.1002/jmri.20893; Brandsma D, 2008, LANCET ONCOL, V9, P453, DOI 10.1016/S1470-2045(08)70125-6; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Canuto HC, 2009, MAGN RESON MED, V61, P1218, DOI 10.1002/mrm.21946; Cerasa A, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/924814; Chamberlain MC, 2007, J NEURO-ONCOL, V82, P81, DOI 10.1007/s11060-006-9241-y; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chaskis C, 2009, SURG NEUROL, V72, P423, DOI 10.1016/j.surneu.2008.09.023; Chu HH, 2013, RADIOLOGY, V269, P831, DOI 10.1148/radiol.13122024; Chu RX, 2016, J NEUROIMAGING, V26, P62, DOI 10.1111/jon.12271; Deistung A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057924; Dhermain FG, 2010, LANCET NEUROL, V9, P906, DOI 10.1016/S1474-4422(10)70181-2; Dydak U, 2006, NEUROIMAG CLIN N AM, V16, P269, DOI 10.1016/j.nic.2006.02.002; Ellingson BM, 2015, NEURO-ONCOLOGY, V17, P1188, DOI 10.1093/neuonc/nov095; Ellingson BM, 2014, NEURO-ONCOLOGY, V16, P2, DOI 10.1093/neuonc/nou224; Ellingson BM, 2012, NEURO-ONCOLOGY, V14, P333, DOI 10.1093/neuonc/nor220; European Medicines Agency, 2014, REF CHANG MARK AUTH; Filippini G, 2008, NEURO-ONCOLOGY, V10, P79, DOI 10.1215/15228517-2007-038; Gahramanov S, 2013, RADIOLOGY, V266, P842, DOI 10.1148/radiol.12111472; Galanis E, 2006, NEURO-ONCOLOGY, V8, P156, DOI 10.1215/15228517-2005-005; Galban CJ, 2011, CLIN CANCER RES, V17, P4751, DOI 10.1158/1078-0432.CCR-10-2098; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Gutierrez DR, 2014, AM J NEURORADIOL, V35, P1009, DOI 10.3174/ajnr.A3784; Hamel L, KNOWLEDGE DISCOVERY; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Henson JW, 2008, AM J NEURORADIOL, V29, P419, DOI 10.3174/ajnr.A0963; Hockstein NG, 2004, LARYNGOSCOPE, V114, P1701, DOI 10.1097/00005537-200410000-00005; Hodgdon T, 2015, RADIOLOGY, V276, P787, DOI 10.1148/radiol.2015142215; Hu LS, 2012, AM J NEURORADIOL, V33, P69, DOI 10.3174/ajnr.A2743; Hu LS, 2009, AM J NEURORADIOL, V30, P552, DOI 10.3174/ajnr.A1377; Hu LS, 2012, NEURO-ONCOLOGY, V14, P919, DOI 10.1093/neuonc/nos112; da Cruz LCH, 2011, AM J NEURORADIOL, V32, P1978, DOI 10.3174/ajnr.A2397; Jain R, 2014, RADIOLOGY, V272, P484, DOI 10.1148/radiol.14131691; JOHNSON PC, 1989, RADIOLOGY, V170, P211, DOI 10.1148/radiology.170.1.2535765; Julesz B., 1962, IRE T INFORM THEOR, V8, P84, DOI [10.1109/TIT.1962.1057698, DOI 10.1109/TIT.1962.1057698]; Kassner A, 2010, AM J NEURORADIOL, V31, P809, DOI 10.3174/ajnr.A2061; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lamborn KR, 2004, NEURO-ONCOLOGY, V6, P227, DOI 10.1215/S1152851703000620; Larkin TJ, 2014, MAGN RESON MED, V71, P402, DOI 10.1002/mrm.24644; Lee MC, 2005, J MAGN RESON IMAGING, V21, P683, DOI 10.1002/jmri.20298; Liu HL, 2011, MED PHYS, V38, P802, DOI 10.1118/1.3534197; Lupo JM, 2006, J MAGN RESON IMAGING, V24, P520, DOI 10.1002/jmri.20673; Lupo JM, 2005, AM J NEURORADIOL, V26, P1446; Lutz K, 2011, CLIN NEURORADIOL, V21, P199, DOI 10.1007/s00062-011-0080-7; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Mangla R, 2010, RADIOLOGY, V256, P575, DOI 10.1148/radiol.10091440; Martin-Landrove M, 2007, P ANN INT IEEE EMBS, P1306, DOI 10.1109/IEMBS.2007.4352537; MECKE KR, 1994, ASTRON ASTROPHYS, V288, P697; Mehrkens JH, 2008, J NEURO-ONCOL, V88, P27, DOI 10.1007/s11060-008-9526-4; Michielsen K., 2001, Physics Reports, V347, P461, DOI 10.1016/S0370-1573(00)00106-X; Moffat BA, 2005, P NATL ACAD SCI USA, V102, P5524, DOI 10.1073/pnas.0501532102; Nagesh V, 2008, INT J RADIAT ONCOL, V70, P1002, DOI 10.1016/j.ijrobp.2007.08.020; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Peters AM, 2007, MAGN RESON IMAGING, V25, P748, DOI 10.1016/j.mri.2007.02.014; Piroth MD, 2011, INT J RADIAT ONCOL, V80, P176, DOI 10.1016/j.ijrobp.2010.01.055; Polley MYC, 2010, NEURO-ONCOLOGY, V12, P274, DOI 10.1093/neuonc/nop034; Price SJ, 2003, CLIN RADIOL, V58, P455, DOI 10.1016/S0009-9260(03)00115-6; Rose CJ, 2009, MAGN RESON MED, V62, P488, DOI 10.1002/mrm.22003; Sanghera P, 2012, CLIN ONCOL-UK, V24, P216, DOI 10.1016/j.clon.2011.06.004; Segal E, 2007, NAT BIOTECHNOL, V25, P675, DOI 10.1038/nbt1306; Stivaros SM, 2016, PEDIATR RADIOL, V46, P73, DOI 10.1007/s00247-015-3444-3; Suh CH, 2013, AM J NEURORADIOL, V34, P2278, DOI 10.3174/ajnr.A3634; Swanson KR, 2008, BRIT J CANCER, V98, P113, DOI 10.1038/sj.bjc.6604125; Tsien C, 2010, J CLIN ONCOL, V28, P2293, DOI 10.1200/JCO.2009.25.3971; Tung GA, 2003, NEURORADIOLOGY, V45, P357, DOI 10.1007/s00234-003-0994-0; Ulmer S, 2012, NEURO-ONCOLOGY, V14, P482, DOI 10.1093/neuonc/nos003; Valery CA, 2001, J NEUROSURG, V94, P433, DOI 10.3171/jns.2001.94.3.0433; Vogelbaum MA, 2012, NEUROSURGERY, V70, P234, DOI 10.1227/NEU.0b013e318223f5a7; [王建锋 Wang Jianfeng], 2002, [中国工程科学, Engineering science], V4, P22; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wong CS, 2004, MOL INTERV, V4, P273, DOI 10.1124/mi.4.5.7; Yongbi MN, 2002, RADIOLOGY, V222, P569, DOI 10.1148/radiol.2222001697; Young RJ, 2013, CLIN IMAG, V37, P41, DOI 10.1016/j.clinimag.2012.02.016	77	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176528	10.1371/journal.pone.0176528	http://dx.doi.org/10.1371/journal.pone.0176528			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520730	Green Submitted, Green Published, gold			2022-12-26	WOS:000401487700020
J	Budnik, LT; Austel, N; Gadau, S; Kloth, S; Schubert, J; Jungnickel, H; Luch, A				Budnik, Lygia Therese; Austel, Nadine; Gadau, Sabrina; Kloth, Stefan; Schubert, Jens; Jungnickel, Harald; Luch, Andreas			Experimental outgassing of toxic chemicals to simulate the characteristics of hazards tainting globally shipped products	PLOS ONE			English	Article							HEALTH-RISK; EXPOSURE; DICHLOROMETHANE; CONTAINERS; EMISSIONS; FUMIGANTS; BENZENE; INDOOR; CANCER; RIOPA	Ambient monitoring analyses may identify potential new public health hazards such as residual levels of fumigants and industrial chemicals off gassing from products and goods shipped globally. We analyzed container air with gas chromatography coupled to mass spectrometry (TD-2D-GC-MS/FPD) and assessed whether the concentration of the volatiles benzene and 1,2-dichloroethane exceeded recommended exposure limits (REL). Products were taken from transport containers and analyzed for outgassing of volatiles. Furthermore, experimental outgassing was performed on packaging materials and textiles, to simulate the hazards tainting from globally shipped goods. The mean amounts of benzene in analyzed container air were 698-fold higher, and those of ethylene dichloride were 4.5-fold higher than the corresponding REL. More than 90% of all containers struck with toluene residues higher than its REL. For 1,2-dichloroethane 53% of containers, transporting shoes exceeded the REL. In standardized experimental fumigation of various products, outgassing of 1,2-dichloroethane under controlled laboratory conditions took up to several months. Globally produced transported products tainted with toxic industrial chemicals may contribute to the mixture of volatiles in indoor air as they are likely to emit for a long period. These results need to be taken into account for further evaluation of safety standards applying to workers and consumers.	[Budnik, Lygia Therese; Gadau, Sabrina; Kloth, Stefan] Univ Hamburg, Univ Med Ctr Hamburg Eppendorf, Inst Occupat & Maritime Med ZfAM, Occupat Toxicol & Immunol Unit, Hamburg, Germany; [Austel, Nadine; Schubert, Jens; Jungnickel, Harald; Luch, Andreas] German Fed Inst Risk Assessment BfR, Dept Chem & Prod Safety, Berlin, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Federal Institute for Risk Assessment	Budnik, LT (corresponding author), Univ Hamburg, Univ Med Ctr Hamburg Eppendorf, Inst Occupat & Maritime Med ZfAM, Occupat Toxicol & Immunol Unit, Hamburg, Germany.	LBudnik@uke.de		Austel, Nadine/0000-0001-6380-3773	German Federal Ministry for Education and Research, BMBF; German Federal Institute for Risk Assessment, BfR [1329-501, 1322-433, 8124797, 7031564]; BMBF; BfR; State Department of Health; WHO	German Federal Ministry for Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); German Federal Institute for Risk Assessment, BfR; BMBF(Federal Ministry of Education & Research (BMBF)); BfR; State Department of Health; WHO(World Health Organization)	The study was funded in parts by: the German Federal Ministry for Education and Research, BMBF (Project: OPTIMA, to LTB) and by the Strategic Research Program from the German Federal Institute for Risk Assessment, BfR (BfR Project 1329-501 to LTB; BfR Project 1322-433 to HJ; BfR Project 8124797 to LTB; BfR Project 7031564 to AL).; The authors would like to express our gratitude to our funding sources: BMBF, BfR and the State Department of Health for providing excellent laboratory facilities.; The study was a part of the WHO-GPA collaborating project "New chemical health risk hazards in transportation and warehousing of cargo due to the process of globalization" (LTB), the authors thank the WHO for support.	[Anonymous], 2012, HAZARD SURVEILLANCE; Barry KH, 2011, AM J EPIDEMIOL, V173, P404, DOI 10.1093/aje/kwq360; Batterman Stuart, 2014, Res Rep Health Eff Inst, P3; Baur X, 2015, HEALTH RISKS IN INTE; Baur X, 2014, INT MARIT HEALTH, V65, P142, DOI 10.5603/IMH.2014.0029; Baur X, 2010, OCCUP ENVIRON MED, V67, P207, DOI 10.1136/oem.2008.043893; Bolden AL, 2015, ENVIRON SCI TECHNOL, V49, P5261, DOI 10.1021/es505316f; Boor BE, 2014, ENVIRON SCI TECHNOL, V48, P3541, DOI 10.1021/es405625q; Budnik LT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064413; Budnik LT, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-5; Budnik LT, 2010, J ENVIRON MONITOR, V12, P936, DOI 10.1039/b918428g; Carugno M, 2012, ENVIRON HEALTH PERSP, V120, P2010; Cooper GS, 2011, INT J ENV RES PUB HE, V8, P3380, DOI 10.3390/ijerph8083380; Delfino RJ., 2002, ENV HLTH, V110; Edokpolo B, 2014, INT J ENV RES PUB HE, V11, P6354, DOI 10.3390/ijerph110606354; Fahrenholtz S, 2010, J CHROMATOGR A, V1217, P8298, DOI 10.1016/j.chroma.2010.10.085; Freedman DM, 2001, AM J PUBLIC HEALTH, V91, P564, DOI 10.2105/AJPH.91.4.564; French JE, 2015, ENVIRON HEALTH PERSP, V123, P237, DOI 10.1289/ehp.1408202; Infante-Rivard C, ENV HLTH; Kloth S, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-110; Knol-de Vos T, 2005, REPORT 609021033 200; Lupo PJ, 2011, ENVIRON HEALTH PERSP, V119, P397, DOI 10.1289/ehp.1002212; New-Zealand-Customs-Service, 2012, REPORT ON THE OUTCOM; OEHHA, 2015, AIR TOXICS REFERENCE; Polito T, 2007, DEV PACKAGING MACHIN; Preisser AM, 2012, INT MARIT HEALTH, V63, P133; Preisser AM, 2011, SCI TOTAL ENVIRON, V409, P3106, DOI 10.1016/j.scitotenv.2011.04.053; Raw GJ, 2004, J EXPO ANAL ENV EPID, V14, pS85, DOI 10.1038/sj.jea.7500363; Safe-Work-Australia, 2006, VENTILATION OF FUMIG; Schlosser PM, 2015, ENVIRON HEALTH PERSP, V123, P114, DOI 10.1289/ehp.1308030; Su FC, 2013, ENVIRON RES, V126, P192, DOI 10.1016/j.envres.2013.08.005; Su FC, 2012, ATMOS ENVIRON, V62, P97, DOI 10.1016/j.atmosenv.2012.06.038; Svedberg U, 2013, ANN OCCUP HYG, V57, P1128, DOI 10.1093/annhyg/met033; UNCTAD, 2013, CONTAINER PORT THROU; Verberk MM, 2012, NEUROTOXICOLOGY, V33, P742, DOI 10.1016/j.neuro.2012.06.005; Vlaanderen J, 2010, ENVIRON HEALTH PERSP, V118, P526, DOI 10.1289/ehp.0901127; Wang G, 2013, HUM EXP TOXICOL, V32, P983, DOI 10.1177/0960327112470270; Weisel CP, 2002, ENVIRON HEALTH PERSP, V110, P527, DOI 10.1289/ehp.02110s4527; Wible B, 2014, SCIENCE, V344, P1100, DOI 10.1126/science.344.6188.1100; Wolkoff P, 2003, INDOOR AIR, V13, P5, DOI 10.1034/j.1600-0668.13.s.6.1.x	40	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177363	10.1371/journal.pone.0177363	http://dx.doi.org/10.1371/journal.pone.0177363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520742	gold, Green Published, Green Submitted			2022-12-26	WOS:000401487700043
J	Saragusty, J; Lemma, A; Hildebrandt, TB; Goritz, F				Saragusty, Joseph; Lemma, Alemayehu; Hildebrandt, Thomas Bernd; Goeritz, Frank			Follicular size predicts success in artificial insemination with frozen-thawed sperm in donkeys	PLOS ONE			English	Article							EQUUS-ASINUS; SEMINAL PLASMA; SEMEN CRYOPRESERVATION; SEXUAL-BEHAVIOR; FERTILITY; PREGNANCY; CRYOPROTECTANT; PARAMETERS; FREQUENCY; OVULATION	In asses, semen collection, cryopreservation, and artificial insemination (AI) with frozen thawed semen have been scarcely described and success rate, particularly following AI, is reportedly low. In the absence of reliable protocols, assisted reproductive technologies cannot support the conservation efforts aimed at endangered wild ass species and domestic donkey breeds. Two experiments were conducted in this study. In experiment 1 we evaluated freezing Abyssinian donkey (N = 5, 4 ejaculates each) spermatozoa using three freezing extenders (Berliner Cryomedium + glycerol, BC+G; BotuCrio, BOTU; INRAFreeze, INRA) and two cryopreservation techniques (liquid nitrogen vapour, LNV; directional freezing, DF). Post-thaw evaluation indicated that BOTU and INRA were similar and both superior to BC+G (P <= 0.004 for all motility tests), and that DF was superior to LNV (P < 0.002 for all evaluation parameters). In experiment 2, relying on these results, we used Abyssinian donkey sperm frozen in BOTU and INRA by DF for AI (N = 20). Prior to AI, thawed samples were diluted in corresponding centrifugation media or autologous seminal fluids at 1: 1 ratio. No difference was found between BOTU and INRA or between the addition of seminal fluids or media, all resulting in similar to 50% pregnancy, and no differences were noted between males (N = 4). The size of pre-ovulatory follicle was a significant (P = 0.001) predictor for AI success with 9/10 pregnancies occurring when follicular size ranged between 33.1-37.4 mm, no pregnancy when it was smaller, and only one when larger. A number of ass species face the risk of extinction. Knowledge gained in this study on the Abyssinian donkey can be customised and transferred to its closely related endangered species and breeds.	[Saragusty, Joseph; Hildebrandt, Thomas Bernd; Goeritz, Frank] Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany; [Lemma, Alemayehu] Addis Ababa Univ, Coll Vet Med & Agr, Debre Zeit, Ethiopia	Leibniz Institut fur Zoo und Wildtierforschung; Addis Ababa University	Saragusty, J (corresponding author), Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany.	saragusty@gmail.com	Saragusty, Joseph/M-5030-2016	Saragusty, Joseph/0000-0002-9274-7800	Open Access Fund of the Leibniz Association	Open Access Fund of the Leibniz Association	Funding for this project was kindly provided by the Vienna Zoo - Tiergarten SchoEnbrunn, Vienna, Austria (http://www. zoovienna.at), as part of their support of a comprehensive study on reproduction and assisted reproduction of asses. The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders or any body associated with them had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha D, 2016, REPROD FERT DEVELOP, V28, P1990, DOI 10.1071/RD14449; Alghamdi AS, 2005, ANIM REPROD SCI, V89, P242; Alvarez AL, 2006, ANIM REPROD SCI, V94, P89, DOI 10.1016/j.anireprosci.2006.04.026; Andrabi SMH, 2007, ANIM REPROD SCI, V99, P223, DOI 10.1016/j.anireprosci.2006.07.002; Arav A, 2014, REPROD FERT DEVELOP, V26, P83, DOI 10.1071/RD13295; BARKER C. A. V., 1957, CANADIAN JOUR COMP MED AND VET SCI, V21, P47; BLOTTNER S, 1998, ADV ETHOL S, V33, P9; Canisso IF, 2011, EQUINE VET J, V43, P179, DOI 10.1111/j.2042-3306.2010.00130.x; Canisso IF, 2010, THERIOGENOLOGY, V73, P56, DOI 10.1016/j.theriogenology.2009.07.026; Conforti VA, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.112.105353; Contri A, 2012, ANIM REPROD SCI, V136, P74, DOI 10.1016/j.anireprosci.2012.10.022; Contri A, 2010, ANIM REPROD SCI, V120, P136, DOI 10.1016/j.anireprosci.2010.02.018; Cortes-Gutierrez EI, 2008, THERIOGENOLOGY, V69, P1022, DOI 10.1016/j.theriogenology.2008.02.002; de Cervantes M, 1605, DON QUIXOTE; FAO, 2007, STAT WORLDAN GEN R; Gacitua H., 2005, Reproduction in Domestic Animals, V40, P383; Gastal MO, 1997, THERIOGENOLOGY, V47, P627, DOI 10.1016/S0093-691X(97)00021-6; Gastal MO, 1996, THERIOGENOLOGY, V46, P593, DOI 10.1016/0093-691X(96)00211-7; Hayakawa H, 2007, REPROD FERT DEVELOP, V19, P176, DOI 10.1071/RDv19n1Ab118; Hermes R, 2009, THERIOGENOLOGY, V71, P393, DOI 10.1016/j.theriogenology.2008.10.008; Hermes R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057616; Hildebrandt TB, 2012, THERIOGENOLOGY, V78, P1398, DOI 10.1016/j.theriogenology.2012.06.014; Hildebrandt TB, 2009, THERIOGENOLOGY, V72, P1065, DOI 10.1016/j.theriogenology.2009.06.026; Jepsen RJ, 2010, J EQUINE VET SCI, V30, P651, DOI 10.1016/j.jevs.2010.10.001; Lemma A, 2006, J VET MED A, V53, P1, DOI 10.1111/j.1439-0442.2006.00777.x; Lemma A, 2006, J EQUINE VET SCI, V26, P18, DOI 10.1016/j.jevs.2005.09.015; Loomis PR, 2001, ANIM REPROD SCI, V68, P191, DOI 10.1016/S0378-4320(01)00156-7; McDonnell SM, 2010, JHI; Miro J, 2005, THERIOGENOLOGY, V63, P1706, DOI 10.1016/j.theriogenology.2004.07.022; Moehlman P. D., 2008, IUCN RED LIST THREAT; Moehlman PD, 2008, EQUUS AFRICANUS IUCN; O'Brien JK, 2006, REPROD FERT DEVELOP, V18, P319, DOI 10.1071/RD05108; Okazaki T, 2012, J ANDROL, V33, P990, DOI 10.2164/jandrol.111.015115; Oliveira JV, 2006, ANIM REPROD SCI, V94, P82, DOI 10.1016/j.anireprosci.2006.04.010; Ortiz I, 2015, REPROD FERT DEVELOP, V27, P332, DOI 10.1071/RD13246; Pearson R.A., 2000, GUIDE LIVE WEIGHT ES; Perry GA, 2005, P NATL ACAD SCI USA, V102, P5268, DOI 10.1073/pnas.0501700102; Pablos MTP, 2015, J ZOO WILDLIFE MED, V46, P517, DOI 10.1638/2014-0243.1; Pukazhenthi BS, 2004, REPROD FERT DEVELOP, V16, P33, DOI 10.1071/RD03076; Qeusada F, 2013, REPROD FERT DEVELOP, V25, P154, DOI 10.1071/RDv25n1Ab14; Rahman MS, 2012, J REPROD DEVELOP, V58, P219, DOI 10.1262/jrd.11-111T; Reid CE, 2009, THERIOGENOLOGY, V71, P275, DOI 10.1016/j.theriogenology.2008.07.009; Robeck TR, 2011, THERIOGENOLOGY, V76, P267, DOI 10.1016/j.theriogenology.2011.02.003; Robeck TR, 2010, THERIOGENOLOGY, V74, P989, DOI 10.1016/j.theriogenology.2010.04.028; Rota A, 2012, THERIOGENOLOGY, V78, P1846, DOI 10.1016/j.theriogenology.2012.07.015; Rota A, 2008, THERIOGENOLOGY, V69, P176, DOI 10.1016/j.theriogenology.2007.09.003; Sa MF, 2010, ANIM REPROD SCI, V120, P23, DOI 10.1016/j.anireprosci.2010.03.007; Sabatini C, 2014, REPROD DOMEST ANIM, V49, P989, DOI 10.1111/rda.12419; Sales JNS, 2011, THERIOGENOLOGY, V76, P427, DOI 10.1016/j.theriogenology.2011.02.019; Saragusty J, 2007, REPROD DOMEST ANIM, V42, P610, DOI 10.1111/j.1439-0531.2006.00831.x; Saragusty J, 2010, THERIOGENOLOGY, V74, P1256, DOI 10.1016/j.theriogenology.2010.05.031; Saragusty J, 2009, THERIOGENOLOGY, V71, P1425, DOI 10.1016/j.theriogenology.2009.01.019; Saragusty J, 2006, THERIOGENOLOGY, V66, P775, DOI 10.1016/j.theriogenology.2006.01.055; Saragusty Joseph, 2016, Zoo Biology, V34, P280, DOI 10.1002/zoo.21284; Saragusty J, 2015, METHODS MOL BIOL, V1257, P381, DOI 10.1007/978-1-4939-2193-5_19; Saragusty J, 2009, BIOTECHNOL BIOENG, V104, P719, DOI 10.1002/bit.22435; Saragusty J, 2009, ANIM REPROD SCI, V115, P255, DOI 10.1016/j.anireprosci.2008.11.010; Saragusty J, 2009, ANIM REPROD SCI, V115, P10, DOI 10.1016/j.anireprosci.2008.11.005; Tanco VM, 2011, BIOL REPROD, V85, P452, DOI 10.1095/biolreprod.111.091876; Trimeche A, 1998, THERIOGENOLOGY, V50, P793, DOI 10.1016/S0093-691X(98)00184-8; Trimeche A, 1996, THERIOGENOLOGY, V45, P1015, DOI 10.1016/0093-691X(96)00029-5; Trimeche A, 1997, CRYOBIOLOGY, V34, P385, DOI 10.1006/cryo.1997.2009; Vidament A, 2005, ANIM REPROD SCI, V89, P115, DOI 10.1016/j.anireprosci.2005.07.003; Vidament M, 2005, ANIM REPROD SCI, V89, P302; Vidament M, 2009, ANIM REPROD SCI, V112, P22, DOI 10.1016/j.anireprosci.2008.03.016	65	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0175637	10.1371/journal.pone.0175637	http://dx.doi.org/10.1371/journal.pone.0175637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520723	gold, Green Published, Green Submitted			2022-12-26	WOS:000401487700004
J	Evankovich, J; Lear, T; Mckelvey, A; Dunn, S; Londino, J; Liu, Y; Chen, BB; Mallampalli, RK				Evankovich, John; Lear, Travis; Mckelvey, Alison; Dunn, Sarah; Londino, James; Liu, Yuan; Chen, Bill B.; Mallampalli, Rama K.			Receptor for advanced glycation end products is targeted by FBXO10 for ubiquitination and degradation	FASEB JOURNAL			English	Article						ubiquitin; acute lung injury; F-box proteins	LUNG INJURY; CELL-DEATH; RAGE; PROTEOLYSIS; PROTEASOME; STABILITY; DAMPS	The receptor for advanced glycation end products (RAGE) is a highly expressed cell membrane receptor serving to anchor lung epithelia to matrix components, and it also amplifies inflammatory signaling during acute lung injury. However, mechanisms that regulate its protein concentrations in cells remain largely unknown. Here we show that RAGE exhibits an extended life span in lung epithelia (t(1/2) 6 h), is monoubiquitinated at K374, and is degraded in lysosomes. The RAGE ligand ODN2006, a synthetic oligodeoxynucleotide resembling pathogenic hypomethylated CpG DNA, promotes rapid lysosomal RAGE degradation through activation of protein kinase C zeta (PKC zeta), which phosphorylates RAGE. PKC zeta overexpression enhances RAGE degradation, while PKC zeta knockdown stabilizes RAGE protein levels and prevents ODN2006-mediated degradation. We identify that RAGE is targeted by the ubiquitin E3 ligase subunit F-box protein O10 (FBXO10), which associates with RAGE to mediate its ubiquitination and degradation. FBXO10 depletion in cells stabilizes RAGE and is required for ODN2006-mediated degradation. These data suggest that modulation of regulators involved in ubiquitin-mediated disposal of RAGE might serve as unique molecular inputs directing RAGE cellular concentrations and downstream responses, which are critical in an array of inflammatory disorders, including acute lung injury.	[Evankovich, John; Londino, James; Liu, Yuan; Chen, Bill B.; Mallampalli, Rama K.] Univ Pittsburgh, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA; [Evankovich, John; Liu, Yuan; Chen, Bill B.; Mallampalli, Rama K.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA; [Lear, Travis; Mckelvey, Alison; Dunn, Sarah] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Mallampalli, RK (corresponding author), Univ Pittsburgh, UPMC Montefiore, Div Pulm Allergy & Crit Care Med, Dept Med, NW 628 Montefiore,3459 Fifth Ave, Pittsburgh, PA 15213 USA.	mallampalirk@upmc.edu	Londino, James/GXH-4404-2022; Londino, James/GXH-2306-2022	Londino, James/0000-0001-7647-6927; Lear, Travis/0000-0001-9156-0844	U.S. National Institutes of Health, National Heart Lung, and Blood [HL096376, HL097376, HL098174, 5T32HL007563-28, P01 HL114453, HL116472, HL132862]; U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Bio-medical Laboratory Research and Development; Merit Review Award from the U.S. Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098174, F32HL137258, R01HL116472, R01HL096376, P01HL114453, T32HL007563, R01HL132862, R01HL097376, R01HL081784, UH3HL123502] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002200] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart Lung, and Blood; U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Bio-medical Laboratory Research and Development(US Department of Veterans Affairs); Merit Review Award from the U.S. Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in part, by U.S. National Institutes of Health, National Heart Lung, and Blood Grants HL096376, HL097376, HL098174, 5T32HL007563-28, and P01 HL114453 (to R.K.M.), and HL116472 and HL132862 (to B.B.C.); and by the U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Bio-medical Laboratory Research and Development, as well as a Merit Review Award from the U.S. Department of Veterans Affairs (to R.K.M.). B.B.C. and R.K.M are co-senior authors.	Calfee CS, 2008, THORAX, V63, P1083, DOI 10.1136/thx.2008.095588; CARDON LR, 1994, P NATL ACAD SCI USA, V91, P3799, DOI 10.1073/pnas.91.9.3799; Chen BB, 2014, CELL REP, V7, P476, DOI 10.1016/j.celrep.2014.02.048; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; Chiorazzi M, 2013, P NATL ACAD SCI USA, V110, P3943, DOI 10.1073/pnas.1217271110; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Coon TA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3881; Franz J, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/912713; Guo WA, 2012, INTENS CARE MED, V38, P1588, DOI 10.1007/s00134-012-2624-y; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hu YB, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/s40035-015-0041-1; Jabaudon M, 2015, AM J RESP CRIT CARE, V192, P191, DOI 10.1164/rccm.201501-0020OC; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Lear T, 2016, J EXP MED, V213, P1029, DOI 10.1084/jem.20151229; Liu YW, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.150; Milutinovic PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088259; Mrozek S, 2016, CHEST, V150, P998, DOI 10.1016/j.chest.2016.03.016; Nakahira K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001577; Nakamura T, 2011, CLIN BIOCHEM, V44, P601, DOI 10.1016/j.clinbiochem.2010.12.014; Pradella A., 2010, CRIT CARE, V14, P194; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ramsgaard L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020132; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Sakaguchi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023132; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Sessa L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086903; Shirasawa M, 2004, GENES CELLS, V9, P165, DOI 10.1111/j.1356-9597.2004.00712.x; Simmons JD, 2013, ANN SURG, V258, P591, DOI 10.1097/SLA.0b013e3182a4ea46; Sirois CM, 2014, J EXP MED, V211; Skaar JR, 2014, NAT REV DRUG DISCOV, V13, P889, DOI 10.1038/nrd4432; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Vadasz I, 2012, CHEST, V141, P763, DOI 10.1378/chest.11-1660; van Zoelen MAD, 2009, J IMMUNOL, V182, P4349, DOI 10.4049/jimmunol.0801199; Weathington NM, 2013, AM J RESP CRIT CARE, V188, P530, DOI 10.1164/rccm.201304-0754PP; Wittkowski H, 2007, CRIT CARE MED, V35, P1369, DOI 10.1097/01.CCM.0000262386.32287.29; Zhang L, 2008, J BIOL CHEM, V283, P35507, DOI 10.1074/jbc.M806948200; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhao J, 2012, NAT IMMUNOL, V13, P651, DOI 10.1038/ni.2341; Zou CB, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7793	40	14	14	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3894	3903		10.1096/fj.201700031R	http://dx.doi.org/10.1096/fj.201700031R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28515150	Green Published			2022-12-26	WOS:000408713300016
J	Gonzales-Zubiate, FA; Okuda, EK; Da Cunha, JPC; Oliveira, CC				Gonzales-Zubiate, Fernando A.; Okuda, Ellen K.; Da Cunha, Julia P. C.; Oliveira, Carla Columbano			Identification of karyopherins involved in the nuclear import of RNA exosome subunit Rrp6 in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-RIBOSOMAL-RNA; LARGE GENE LISTS; HUMAN PM-SCL; LOCALIZATION SIGNALS; BINDING PROTEIN; CELL-CYCLE; SYSTEMATIC IDENTIFICATION; MASS-SPECTROMETRY; YEAST EXOSOME; COMPLEX	The exosome is a conserved multiprotein complex essential for RNA processing and degradation. The nuclear exosome is a key factor for pre-rRNA processing through the activity of its catalytic subunits, Rrp6 and Rrp44. In Saccharomyces cerevisiae, Rrp6 is exclusively nuclear and has been shown to interact with exosome cofactors. With the aim of analyzing proteins associated with the nuclear exosome, in this work, we purified the complex with Rrp6-TAP, identified the co-purified proteins by mass spectrometry, and found karyopherins to be one of the major groups of proteins enriched in the samples. By investigating the biological importance of these protein interactions, we identified Srp1, Kap95, and Sxm1 as the most important karyopherins for Rrp6 nuclear import and the nuclear localization signals recognized by them. Based on the results shown here, we propose a model of multiple pathways for the transport of Rrp6 to the nucleus.	[Gonzales-Zubiate, Fernando A.; Okuda, Ellen K.; Oliveira, Carla Columbano] Univ Sao Paulo, Inst Chem, Dept Biochem, Ave Prof Lineu Prestes 748, BR-05508000 Sao Paulo, SP, Brazil; [Da Cunha, Julia P. C.] Ctr Res Toxins Immune Response & Cell Signaling C, Butantan Inst, Ctr Toxins Immune Response & Cell Signaling, Cell Cycle Lab, BR-05503900 Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Instituto Butantan	Oliveira, CC (corresponding author), Univ Sao Paulo, Inst Chem, Dept Biochem, Ave Prof Lineu Prestes 748, BR-05508000 Sao Paulo, SP, Brazil.	ccoliv@iq.usp.br	da Cunha, Julia PC/K-8553-2017; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Gonzales-Zubiate, Fernando A/O-2709-2014; Oliveira, Carla C/F-2323-2011	da Cunha, Julia PC/0000-0003-0466-8879; Gonzales-Zubiate, Fernando A/0000-0001-9519-4079; Oliveira, Carla C/0000-0002-1098-9241	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [10/51842-3, 15/06477-9]; FAPESP Postdoctoral Fellowship [2012/50196-6.]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP Postdoctoral Fellowship	This work was supported in part by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grants 10/51842-3 and 15/06477-9 (to C. C. O.).; Supported by FAPESP Postdoctoral Fellowship 2012/50196-6.	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Aragao AZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043521; Bakhrat A, 2006, J BIOL CHEM, V281, P12218, DOI 10.1074/jbc.M600238200; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Caesar S, 2006, MOL CELL BIOL, V26, P3170, DOI 10.1128/MCB.26.8.3170-3180.2006; Canavan R, 2007, NUCLEIC ACIDS RES, V35, P6268, DOI 10.1093/nar/gkm691; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Feigenbutz M, 2013, J BIOL CHEM, V288, P15959, DOI 10.1074/jbc.M112.445759; Franke J, 2001, J CELL SCI, V114, P2641; Fries T, 2007, J BIOL CHEM, V282, P19292, DOI 10.1074/jbc.M700217200; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIETZ RD, 1988, GENE, V74, P535, DOI 10.1016/0378-1119(88)90186-2; Goldfeder MB, 2010, FEBS J, V277, P2838, DOI 10.1111/j.1742-4658.2010.07701.x; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Graham AC, 2009, MOL BIOL CELL, V20, P2242, DOI 10.1091/mbc.E08-08-0825; Granato DC, 2008, FEBS J, V275, P4164, DOI 10.1111/j.1742-4658.2008.06565.x; Grosshans H, 2001, J CELL BIOL, V153, P745, DOI 10.1083/jcb.153.4.745; Guthrie C., 1991, GUIDE YEAST GENETICS, V194; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hodges JL, 2005, MOL BIOL CELL, V16, P3200, DOI 10.1091/mbc.E04-11-0990; Hood JK, 1998, J BIOL CHEM, V273, P35142, DOI 10.1074/jbc.273.52.35142; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jin R, 2008, MOL BIOL CELL, V19, P284, DOI 10.1091/mbc.E07-05-0519; Kim BJ, 2006, J BIOL CHEM, V281, P12041, DOI 10.1074/jbc.M512630200; Kimura M, 2014, TRAFFIC, V15, P727, DOI 10.1111/tra.12174; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lange A, 2008, J BIOL CHEM, V283, P12926, DOI 10.1074/jbc.M800898200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee DCY, 1999, J BIOL CHEM, V274, P29031, DOI 10.1074/jbc.274.41.29031; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lourenco RF, 2013, J PROTEOME RES, V12, P5912, DOI 10.1021/pr400972x; Lusk CP, 2007, NAT REV MOL CELL BIO, V8, P414, DOI 10.1038/nrm2165; Luz JS, 2007, BIOCHIMIE, V89, P686, DOI 10.1016/j.biochi.2007.01.011; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; Makino DL, 2015, NATURE, V524, P54, DOI 10.1038/nature14865; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Morehouse H, 1999, P NATL ACAD SCI USA, V96, P12542, DOI 10.1073/pnas.96.22.12542; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Mosammaparast N, 2002, EMBO J, V21, P6527, DOI 10.1093/emboj/cdf647; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; Nguyen BA, 2009, BMC BIOINFORMATICS, V10, P202, DOI [10.1186/1471-2105-10-202, DOI 10.1186/1471-2105-10-202]; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Oliveira CC, 2002, NUCLEIC ACIDS RES, V30, P4186, DOI 10.1093/nar/gkf545; Phillips S, 2003, RNA, V9, P1098, DOI 10.1261/rna.5560903; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Reis CC, 2007, GENETICS, V175, P993, DOI 10.1534/genetics.106.065987; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Sambrook J., 2001, MOL CLONING LAB MANU; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schaper S, 2005, J CELL SCI, V118, P1473, DOI 10.1242/jcs.01739; Schilders G, 2005, NUCLEIC ACIDS RES, V33, P6795, DOI 10.1093/nar/gki982; Schlenstedt G, 1997, EMBO J, V16, P6237, DOI 10.1093/emboj/16.20.6237; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schneider C, 2012, MOL CELL, V48, P422, DOI 10.1016/j.molcel.2012.08.013; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stage-Zimmermann T, 2000, MOL BIOL CELL, V11, P3777, DOI 10.1091/mbc.11.11.3777; Suel KE, 2009, J BIOL CHEM, V284, P15416, DOI 10.1074/jbc.M809384200; Sydorskyy Y, 2003, MOL CELL BIOL, V23, P2042, DOI 10.1128/MCB.23.6.2042-2054.2003; Synowsky SA, 2009, J MOL BIOL, V385, P1300, DOI 10.1016/j.jmb.2008.11.011; Tran EJ, 2014, BBA-MOL CELL RES, V1843, P2784, DOI 10.1016/j.bbamcr.2014.08.003; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Wasmuth EV, 2014, NATURE, V511, P435, DOI 10.1038/nature13406; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Zanchin NIT, 1999, NUCLEIC ACIDS RES, V27, P1283, DOI 10.1093/nar/27.5.1283	77	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12267	12284		10.1074/jbc.M116.772376	http://dx.doi.org/10.1074/jbc.M116.772376			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28539363	hybrid, Green Published			2022-12-26	WOS:000406053300023
J	Zempel, H; Dennissen, FJA; Kumar, Y; Luedtke, J; Biernat, J; Mandelkow, EM; Mandelkow, E				Zempel, Hans; Dennissen, Frank J. A.; Kumar, Yatender; Luedtke, Julia; Biernat, Jacek; Mandelkow, Eva-Maria; Mandelkow, Eckhard			Axodendritic sorting and pathological missorting of Tau are isoform-specific and determined by axon initial segment architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; HIPPOCAMPAL-NEURONS; POLARIZED NEURONS; DIFFUSION BARRIER; DENDRITIC SPINES; NERVOUS-SYSTEM; PROTEIN-TAU; EXPRESSION; MICE; MICROTUBULES	Subcellular mislocalization of the microtubule-associated protein Tau is a hallmark of Alzheimer disease (AD) and other tauopathies. Six Tau isoforms, differentiated by the presence or absence of a second repeat or of N-terminal inserts, exist in the human CNS, but their physiological and pathological differences have long remained elusive. Here, we investigated the properties and distributions of human and rodent Tau isoforms in primary forebrain rodent neurons. We found that the Tau diffusion barrier (TDB), located within the axon initial segment (AIS), controls retrograde (axon-to-soma) and anterograde (soma-to-axon) traffic of Tau. Tau isoforms without the N-terminal inserts were sorted efficiently into the axon. However, the longest isoform (2N4R-Tau) was partially retained in cell bodies and dendrites, where it accelerated spine and dendrite growth. The TDB (located within the AIS) was impaired when AIS components (ankyrin G, EB1) were knocked down or when glycogen synthase kinase-3 beta (GSK3 beta; an AD-associated kinase tethered to the AIS) was overexpressed. Using superresolution nanoscopy and live-cell imaging, we observed that microtubules within the AIS appeared highly dynamic, a feature essential for the TDB. Pathomechanistically, amyloid-beta insult caused cofilin activation and F-actin remodeling and decreased microtubule dynamics in the AIS. Concomitantly with these amyloid-beta-induced disruptions, the AIS/TDB sorting function failed, causing AD-like Tau missorting. In summary, we provide evidence that the human and rodent Tau isoforms differ in axodendritic sorting and amyloid-beta-induced missorting and that the axodendritic distribution of Tau depends on AIS integrity.	[Zempel, Hans; Dennissen, Frank J. A.; Kumar, Yatender; Luedtke, Julia; Biernat, Jacek; Mandelkow, Eva-Maria; Mandelkow, Eckhard] German Ctr Neurodegenerat Dis DZNE, Ludwig Erhard Allee 2, D-53127 Bonn, Germany; [Zempel, Hans; Dennissen, Frank J. A.; Luedtke, Julia; Biernat, Jacek; Mandelkow, Eva-Maria; Mandelkow, Eckhard] CAESAR Res Ctr, D-53175 Bonn, Germany; [Zempel, Hans; Kumar, Yatender; Mandelkow, Eva-Maria; Mandelkow, Eckhard] Max Planck Inst Metab Res, D-50931 Cologne, Germany; [Zempel, Hans] Univ Bonn, D-53113 Bonn, Germany; [Kumar, Yatender] NSIT, New Delhi, India	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Center of Advanced European Studies & Research (CAESAR); University of Bonn; Netaji Subhas University of Technology	Zempel, H; Mandelkow, E (corresponding author), German Ctr Neurodegenerat Dis DZNE, Ludwig Erhard Allee 2, D-53127 Bonn, Germany.	hans.zempel@dzne.de; eckhard.mandelkow@dzne.de	Kumar, Yatender/AAG-1920-2020	Dennissen, Frank/0000-0001-7446-122X	German Center for Neurodegenerative Diseases (DZNE); Max-Planck Society (MPG); Metlife Foundation; Tau Consortium	German Center for Neurodegenerative Diseases (DZNE)(Helmholtz Association); Max-Planck Society (MPG)(Max Planck Society); Metlife Foundation; Tau Consortium	This work was supported by the German Center for Neurodegenerative Diseases (DZNE), Max-Planck Society (MPG), Metlife Foundation, and Tau Consortium. The authors declare that they have no conflicts of interest with the contents of this article.	Andreadis A, 2012, J CELL PHYSIOL, V227, P1220, DOI 10.1002/jcp.22842; Aronov S, 2001, J NEUROSCI, V21, P6577, DOI 10.1523/JNEUROSCI.21-17-06577.2001; Baas PW, 2011, DEV NEUROBIOL, V71, P403, DOI 10.1002/dneu.20818; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bender KJ, 2012, ANNU REV NEUROSCI, V35, P249, DOI 10.1146/annurev-neuro-062111-150339; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buffington SA, 2011, EUR J NEUROSCI, V34, P1609, DOI 10.1111/j.1460-9568.2011.07875.x; Bullmann T, 2009, INT J DEV NEUROSCI, V27, P591, DOI 10.1016/j.ijdevneu.2009.06.001; Chen Q, 2012, NEUROCHEM INT, V60, P233, DOI 10.1016/j.neuint.2011.12.013; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Coppola G, 2012, HUM MOL GENET, V21, P3500, DOI 10.1093/hmg/dds161; Cruz DA, 2009, J COMP NEUROL, V514, P353, DOI 10.1002/cne.22006; Dawson HN, 2001, J CELL SCI, V114, P1179; Delacourte A, 1998, ANN NEUROL, V43, P193, DOI 10.1002/ana.410430209; Dickson D, 2011, J MOL NEUROSCI, V45, P384, DOI 10.1007/s12031-011-9589-0; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; Goedert M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006254; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Hara M, 2013, ACTA NEUROPATHOL, V125, P565, DOI 10.1007/s00401-013-1097-6; Hatch RJ, 2017, ACTA NEUROPATHOL, V133, P717, DOI 10.1007/s00401-017-1674-1; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Hirokawa N, 1996, J CELL BIOL, V132, P667, DOI 10.1083/jcb.132.4.667; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jones SL, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6808293; Jones SL, 2014, J CELL BIOL, V205, P67, DOI 10.1083/jcb.201401045; Kam TI, 2014, CELL MOL LIFE SCI, V71, P4803, DOI 10.1007/s00018-014-1706-0; Kim YT, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00048; KOBAYASHI T, 1992, NATURE, V359, P647, DOI 10.1038/359647a0; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Konzack S, 2007, J NEUROSCI, V27, P9916, DOI 10.1523/JNEUROSCI.0927-07.2007; Kremer A, 2011, J NEUROSCI, V31, P18036, DOI 10.1523/JNEUROSCI.4859-11.2011; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Leterrier C, 2016, CURR TOP MEMBR, V77, P185, DOI 10.1016/bs.ctm.2015.10.005; Leterrier C, 2011, P NATL ACAD SCI USA, V108, P8826, DOI 10.1073/pnas.1018671108; Liu C, 2016, J BIOL CHEM, V291, P8173, DOI 10.1074/jbc.M115.641902; Medina M, 2014, EXPERT OPIN THER TAR, V18, P69, DOI 10.1517/14728222.2013.843670; Morita T, 2009, J BIOL CHEM, V284, P27734, DOI 10.1074/jbc.M109.008177; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; PALAY SL, 1968, J CELL BIOL, V38, P193, DOI 10.1083/jcb.38.1.193; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Riano E, 2009, J NEUROCHEM, V108, P1277, DOI 10.1111/j.1471-4159.2009.05875.x; Sayas CL, 2015, J NEUROCHEM, V133, P653, DOI 10.1111/jnc.13091; Sergeant N, 1999, J NEUROCHEM, V72, P1243, DOI 10.1046/j.1471-4159.1999.0721243.x; Sohn PD, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0109-0; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Straube A, 2007, CURR BIOL, V17, P1318, DOI 10.1016/j.cub.2007.06.058; Sydow A, 2011, J NEUROSCI, V31, P2511, DOI 10.1523/JNEUROSCI.5245-10.2011; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7; Tapia M, 2013, CELL MOL LIFE SCI, V70, P105, DOI 10.1007/s00018-012-1059-5; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; Trabzuni D, 2012, HUM MOL GENET, V21, P4094, DOI 10.1093/hmg/dds238; Van der Jeugd A, 2012, ACTA NEUROPATHOL, V123, P787, DOI 10.1007/s00401-012-0987-3; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Zempel H, 2017, METHODS MOL BIOL, V1523, P335, DOI 10.1007/978-1-4939-6598-4_21; Zempel H, 2017, METHODS MOL BIOL, V1523, P327, DOI 10.1007/978-1-4939-6598-4_20; Zempel H, 2013, EMBO J, V32, P2920, DOI 10.1038/emboj.2013.207; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zempell H, 2014, TRENDS NEUROSCI, V37, P721, DOI 10.1016/j.tins.2014.08.004	67	66	66	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12192	12207		10.1074/jbc.M117.784702	http://dx.doi.org/10.1074/jbc.M117.784702			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28536263	Green Published, hybrid			2022-12-26	WOS:000406053300017
J	Taylor, AB; Roberts, KM; Cao, XH; Clark, NE; Holloway, SP; Donati, E; Polcaro, CM; Pica-Mattoccia, L; Tarpley, RS; McHardy, SF; Cioli, D; LoVerde, PT; Fitzpatrick, PF; Hart, PJ				Taylor, Alexander B.; Roberts, Kenneth M.; Cao, Xiaohang; Clark, Nathaniel E.; Holloway, Stephen P.; Donati, Enrica; Polcaro, Chiara M.; Pica-Mattoccia, Livia; Tarpley, Reid S.; McHardy, Stanton F.; Cioli, Donato; LoVerde, Philip T.; Fitzpatrick, Paul F.; Hart, P. John			Structural and enzymatic insights into species-specific resistance to schistosome parasite drug therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SUBSTRATE-INHIBITION; SULFOTRANSFERASE; OXAMNIQUINE; MECHANISM; MANSONI; COMPLEX	The antischistosomal prodrug oxamniquine is activated by a sulfotransferase (SULT) in the parasitic flatworm Schistosoma mansoni. Of the three main human schistosome species, only S. mansoni is sensitive to oxamniquine therapy despite the presence of SULT orthologs in Schistosoma hematobium and Schistosoma japonicum. The reason for this species-specific drug action has remained a mystery for decades. Here we present the crystal structures of S. hematobium and S. japonicum SULTs, including S. hematobium SULT in complex with oxamniquine. We also examined the activity of the three enzymes in vitro; surprisingly, all three are active toward oxamniquine, yet we observed differences in catalytic efficiency that implicate kinetics as the determinant for species-specific toxicity. These results provide guidance for designing oxamniquine derivatives to treat infection caused by all species of schistosome to combat emerging resistance to current therapy.	[Taylor, Alexander B.; Cao, Xiaohang; Clark, Nathaniel E.; Holloway, Stephen P.; LoVerde, Philip T.; Fitzpatrick, Paul F.; Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [LoVerde, Philip T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Taylor, Alexander B.; Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Xray Crystallog Core Lab, San Antonio, TX 78229 USA; [Roberts, Kenneth M.] Univ South Carolina, Dept Chem & Phys, Aiken, SC 29801 USA; [Donati, Enrica; Polcaro, Chiara M.; Cioli, Donato] CNR, Inst Chem Methodol, Via Solaria Km 29-500, I-00015 Rome, Italy; [Pica-Mattoccia, Livia] CNR, Inst Cell Biol & Neurobiol, Via E Ramarini 32, I-00015 Rome, Italy; [Tarpley, Reid S.; McHardy, Stanton F.] Univ Texas San Antonio, Ctr Innovat Drug Discovery, Dept Chem, San Antonio, TX 78249 USA; [Hart, P. John] South Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Consiglio Nazionale delle Ricerche (CNR); Istituto di Metodologie Chimiche (IMC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); University of Texas System; University of Texas at San Antonio (UTSA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Taylor, AB; Fitzpatrick, PF; Hart, PJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	taylorab@uthscsa.edu; fitzpatrickp@uthscsa.edu; hartp@uthscsa.edu		Taylor, Alexander/0000-0003-3517-6033; Roberts, Kenneth/0000-0001-7389-0559	University of Texas Health Science Center at San Antonio Office of the Vice President for Research; Cancer Therapy and Research Center (National Institutes of Health) [P30 CA054174]; National Institute of General Medical Sciences, National Institutes of Health [P41 GM103403]; National Institutes of Health Office of Research Infrastructure Programs High-End Instrumentation Grant [S10 RR029205]; DOE Office of Science [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI115691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	University of Texas Health Science Center at San Antonio Office of the Vice President for Research; Cancer Therapy and Research Center (National Institutes of Health); National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health Office of Research Infrastructure Programs High-End Instrumentation Grant; DOE Office of Science(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support for the X-ray Crystallography Core Laboratory by the University of Texas Health Science Center at San Antonio Office of the Vice President for Research and the Cancer Therapy and Research Center (National Institutes of Health Grant P30 CA054174) is gratefully acknowledged. This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by National Institute of General Medical Sciences, National Institutes of Health Grant P41 GM103403. The Pilatus 6M detector on 24-ID-C beam line is funded by National Institutes of Health Office of Research Infrastructure Programs High-End Instrumentation Grant S10 RR029205. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barnett AC, 2004, J BIOL CHEM, V279, P18799, DOI 10.1074/jbc.M312253200; Beck L, 2001, MEM I OSWALDO CRUZ, V96, P165, DOI 10.1590/S0074-02762001000900025; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; CIOLI D, 1995, PHARMACOL THERAPEUT, V68, P35, DOI 10.1016/0163-7258(95)00026-7; CIOLI D, 1992, EXP PARASITOL, V75, P425, DOI 10.1016/0014-4894(92)90255-9; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gentile R, 2008, ACTA TROP, V108, P175, DOI 10.1016/j.actatropica.2008.09.003; Greenberg RM, 2013, PARASITOLOGY, V140, P1534, DOI 10.1017/S0031182013000231; Gulcan HO, 2011, ARCH BIOCHEM BIOPHYS, V507, P232, DOI 10.1016/j.abb.2010.12.027; Hotez PJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P467; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kakuta Y, 1998, TRENDS BIOCHEM SCI, V23, P129, DOI 10.1016/S0968-0004(98)01182-7; Kakuta Y, 1997, NAT STRUCT BIOL, V4, P904, DOI 10.1038/nsb1197-904; Kakuta Y, 1998, J BIOL CHEM, V273, P27325, DOI 10.1074/jbc.273.42.27325; KATZ N., 1973, Revista da Sociedade Brasileira de Medicina Tropical, V7, P381, DOI 10.1590/S0037-86821973000600008; KAYE B, 1976, ANN TROP MED PARASIT, V70, P323, DOI 10.1080/00034983.1976.11687128; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lu LY, 2008, MOL PHARMACOL, V73, P660, DOI 10.1124/mol.107.041038; Marforio TD, 2015, BIOCHEMISTRY-US, V54, P4404, DOI 10.1021/acs.biochem.5b00343; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melcher K, 2000, ANAL BIOCHEM, V277, P109, DOI 10.1006/abio.1999.4383; Pica-Mattoccia L, 2006, MEM I OSWALDO CRUZ, V101, P307, DOI 10.1590/S0074-02762006000900048; Roberts KM, 2014, BIOCHEMISTRY-US, V53, P2672, DOI 10.1021/bi500267c; ROGERS SH, 1971, SCIENCE, V172, P1057, DOI 10.1126/science.172.3987.1057; Stjernschantz E, 2010, MOL CELL ENDOCRINOL, V317, P127, DOI 10.1016/j.mce.2009.12.001; Taylor AB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004132; Teramoto T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2593; Teramoto T, 2009, BIOCHEM BIOPH RES CO, V383, P83, DOI 10.1016/j.bbrc.2009.03.146; Valentim CLL, 2013, SCIENCE, V342, P1385, DOI 10.1126/science.1243106	31	16	18	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11154	11164		10.1074/jbc.M116.766527	http://dx.doi.org/10.1074/jbc.M116.766527			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28536265	Green Published, hybrid			2022-12-26	WOS:000405119600003
J	Magzal, F; Sela, S; Szuchman-Sapir, A; Tamir, S; Michelis, R; Kristal, B				Magzal, Faiga; Sela, Shifra; Szuchman-Sapir, Andrea; Tamir, Snait; Michelis, Regina; Kristal, Batya			In-vivo oxidized albumin - a pro-inflammatory agent in hypoalbuminemia	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; NITRIC-OXIDE SYNTHASE; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; GENE-EXPRESSION; RENAL-DISEASE; HEMODIALYSIS	Hypoalbuminemia of Hemodialysis (HD) patients is an independent cardiovascular risk factor, however, there is no mechanistic explanation between hypoalbuminemia and vascular injury. In the event of oxidative stress and inflammation to which HD patients are exposed, albumin is oxidized and undetected by common laboratory methods, rendering an apparent hypoalbuminemia. We wanted to show that these circulating modified oxidized albumin molecules cause direct vascular damage, mediating inflammation. Once these in-vivo albumin modifications were reduced in-vitro, the apparent hypoalbuminemia concomitantly with its inflammatory effects, were eliminated. Albumin modification profiles from 14 healthy controls (HC) and 14 HD patients were obtained by mass spectrometry (MS) analyses before and after reduction in-vitro, using redox agent 1,4 dithiothreitol (DTT). Their inflammatory effects were explored by exposing human umbilical endothelial cells (HUVEC) to all these forms of albumin. Albumin separated from hypoalbuminemic HD patients increased endothelial mRNA expression of cytokines and adhesion molecules, and augmented secretion of IL-6. This endothelial inflammatory state was almost fully reverted by exposing HUVEC to the in-vitro reduced HD albumin. MS profile of albumin modifications peaks was similar between HD and HC, but the intensities of the various peaks were significantly different. Abolishing the reversible oxidative modifications by DTT prevented endothelial injury and increased albumin levels. The irreversible modifications such as glycation and sulfonation show low intensities in HD albumin profiles and are nearly unobserved in HC. We showed, for the first time, a mechanistic link between hypoalbuminemia and the pro-inflammatory properties of in-vivo oxidized albumin, initiating vascular injury.	[Magzal, Faiga; Sela, Shifra; Michelis, Regina] Galilee Med Ctr, Eliachar Res Lab, Nahariyya, Israel; [Magzal, Faiga; Sela, Shifra; Kristal, Batya] Bar Ilan Univ, Fac Med Galilee, Safed, Israel; [Magzal, Faiga; Szuchman-Sapir, Andrea; Tamir, Snait] MIGAL Galilee Res Inst, Lab Human Hlth & Nutr Sci, Kiryat Shmona, Israel; [Kristal, Batya] Galilee Med Ctr, Dept Hypertens & Nephrol, Nahariyya, Israel	Western Galilee Hospital; Bar Ilan University; Western Galilee Hospital	Kristal, B (corresponding author), Bar Ilan Univ, Fac Med Galilee, Safed, Israel.; Kristal, B (corresponding author), Galilee Med Ctr, Dept Hypertens & Nephrol, Nahariyya, Israel.	BatyaK@gmc.gov.il			Bar IIan University Faculty of Medicine; Council for Higher Education in Israel scholarship	Bar IIan University Faculty of Medicine; Council for Higher Education in Israel scholarship	This work was supported by Bar IIan University Faculty of Medicine - grant to Faiga Magzal; and Council for Higher Education in Israel scholarship to Faiga Magzal. There are no other funding sources.	Anraku M, 2001, J PHARM SCI, V100, P3968; Bar-Or D, 2005, CRIT CARE MED, V33, P1638, DOI 10.1097/01.CCM.0000169876.14858.91; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Danielski M, 2003, AM J KIDNEY DIS, V42, P286, DOI 10.1016/S0272-6386(03)00653-X; FORSTERMANN U, 1994, HYPERTENSION, V23, P1121, DOI 10.1161/01.HYP.23.6.1121; Jofre R, 2006, J AM SOC NEPHROL, V17, pS274, DOI 10.1681/ASN.2006080926; Kalantar-Zadeh K, 2005, NEPHROL DIAL TRANSPL, V20, P1880, DOI 10.1093/ndt/gfh941; Kawakami A, 2006, FEBS J, V273, P3346, DOI 10.1111/j.1742-4658.2006.05341.x; Lim PS, 2007, NEPHROLOGY, V12, P18, DOI 10.1111/j.1440-1797.2006.00745.x; Mao P, 2014, J PROTEOME RES, V13, P1560, DOI 10.1021/pr401074t; Marin V, 2001, J IMMUNOL METHODS, V254, P183, DOI 10.1016/S0022-1759(01)00408-2; Mera K, 2005, BIOCHEM BIOPH RES CO, V334, P1322, DOI 10.1016/j.bbrc.2005.07.035; Michelis R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159839; Michelis R, 2013, FREE RADICAL BIO MED, V60, P49, DOI 10.1016/j.freeradbiomed.2013.02.005; Michelis R, 2010, BIOCHEM BIOPH RES CO, V401, P137, DOI 10.1016/j.bbrc.2010.09.027; Nagumo K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085216; Ogasawara Y, 2007, J CHROMATOGR B, V845, P157, DOI 10.1016/j.jchromb.2006.08.006; Rashid G, 2004, KIDNEY INT, V66, P1099, DOI 10.1111/j.1523-1755.2004.00860.x; Regazzoni L, 2013, FREE RADICAL RES, V47, P172, DOI 10.3109/10715762.2012.756139; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Soejima A, 2004, BLOOD PURIFICAT, V22, P525, DOI 10.1159/000082524; Spoto B, 2012, NUTR METAB CARDIOVAS, V22, P981, DOI 10.1016/j.numecd.2011.01.005; Taverna M, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-4; Vielhauer V, 2004, KIDNEY BLOOD PRESS R, V27, P226, DOI 10.1159/000079867; Xiao S, 2001, AM J PHYSIOL-RENAL, V280, pF989, DOI 10.1152/ajprenal.2001.280.6.F989	25	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177799	10.1371/journal.pone.0177799	http://dx.doi.org/10.1371/journal.pone.0177799			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542419	gold, Green Published, Green Submitted			2022-12-26	WOS:000402061500038
J	Petry, SF; Sharifpanah, F; Sauer, H; Linn, T				Petry, Sebastian Friedrich; Sharifpanah, Fatemeh; Sauer, Heinrich; Linn, Thomas			Differential expression of islet glutaredoxin 1 and 5 with high reactive oxygen species production in a mouse model of diabesity	PLOS ONE			English	Article							NF-KAPPA-B; PANCREATIC BETA-CELLS; DIETARY IRON RESTRICTION; S-GLUTATHIONYLATION; INTERACTING PROTEIN; GLUCOSE TOXICITY; OXIDATIVE STRESS; REDOX CONTROL; 3 PICOT; THIOREDOXIN	The onset and progression of diabetes mellitus type 2 is highly contingent on the amount of functional beta-cell mass. An underlying cause of beta-cell decay in diabetes is oxidative stress, which markedly affects the insulin producing pancreatic cells due to their poor antioxidant defence capacity. Consequently, disturbances of cellular redox signaling have been implicated to play a major role in beta-cell loss in diabetes mellitus type 2. There is evidence suggesting that the glutaredoxin (Grx) system exerts a protective role for pancreatic islets, but the exact mechanisms have not yet been elucidated. In this study, a mouse model for diabetes mellitus type 2 was used to gain further insight into the significance of Grx for the islets of Langerhans in the diabetic metabolism. We have observed distinct differences in the expression levels of Grx in pancreatic islets between obese, diabetic db mice and lean, non-diabetic controls. This finding is the first report about a decrease of Grx expression levels in pancreatic islets of diabetic mice which was accompanied by declining insulin secretion, increase of reactive oxygen species (ROS) production level, and cell cycle alterations. These data demonstrate the essential role of the Grx system for the beta-cell during metabolic stress which may provide a new target for diabetes mellitus type 2 treatment.	[Petry, Sebastian Friedrich; Linn, Thomas] Justus Liebig Univ, Ctr Internal Med, Clin Res Unit, Giessen, Germany; [Sharifpanah, Fatemeh; Sauer, Heinrich] Justus Liebig Univ, Dept Physiol, Fac Med, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Petry, SF (corresponding author), Justus Liebig Univ, Ctr Internal Med, Clin Res Unit, Giessen, Germany.	sebastian.petry@innere.med.uni-giessen.de	Sharifpanah, Fatemeh/I-5199-2018	Sharifpanah, Fatemeh/0000-0001-7435-1805; Petry, Sebastian Friedrich/0000-0002-3496-9894	University of Giessen; Center of Internal Medicine	University of Giessen; Center of Internal Medicine	General funding from University of Giessen and Center of Internal Medicine granted to Clinical Research Unit were used for realization of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; ARKHAMMAR P, 1994, J BIOL CHEM, V269, P2743; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Berndt C, 2007, ANTIOXID REDOX SIGN, V9, P151, DOI 10.1089/ars.2007.9.151; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; Bolt HM, 2009, EXCLI J, V8, P241; Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Cooksey RC, 2010, AM J PHYSIOL-ENDOC M, V298, pE1236, DOI 10.1152/ajpendo.00022.2010; Curi R, 2016, PLOS ONE, V11; Daily D, 2001, J BIOL CHEM, V276, P1335, DOI 10.1074/jbc.M008121200; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; DISIMPLICIO P, 1995, EUR J CLIN INVEST, V25, P665; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dong KL, 2016, FREE RADICAL BIO MED, V101, P334, DOI 10.1016/j.freeradbiomed.2016.10.007; Du YT, 2014, ACTA DIABETOL, V51, P225, DOI 10.1007/s00592-013-0498-2; Enoksson M, 2005, BIOCHEM BIOPH RES CO, V327, P774, DOI 10.1016/j.bbrc.2004.12.067; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Gavin JR, 1999, DIABETES CARE, V22, pS5; Godoy JR, 2011, BBA-GEN SUBJECTS, V1810, P2, DOI 10.1016/j.bbagen.2010.05.006; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; Hanschmann EM, 2011, THESIS; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Hansen JB, 2012, CELL METAB, V16, P449, DOI 10.1016/j.cmet.2012.09.001; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Haunhorst P, 2013, MOL BIOL CELL, V24, P1895, DOI 10.1091/mbc.E12-09-0648; Haunhorst P, 2010, BIOCHEM BIOPH RES CO, V394, P372, DOI 10.1016/j.bbrc.2010.03.016; Hirota K, 2000, BIOCHEM BIOPH RES CO, V274, P177, DOI 10.1006/bbrc.2000.3106; HOLMGREN A, 1979, J BIOL CHEM, V254, P3664; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Ikeda Y, 2013, AM J PHYSIOL-RENAL, V304, pF1028, DOI 10.1152/ajprenal.00473.2012; ISLAM MS, 1993, FEBS LETT, V319, P128, DOI 10.1016/0014-5793(93)80051-U; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Kato N, 2008, CELL IMMUNOL, V251, P62, DOI 10.1016/j.cellimm.2008.04.005; Kilimnik G, 2009, AM J PHYSIOL-ENDOC M, V297, pE1331, DOI 10.1152/ajpendo.00479.2009; Kim S, 2007, P NATL ACAD SCI USA, V104, P1913, DOI 10.1073/pnas.0610690104; Kluth O, 2011, DIABETOLOGIA, V54, P605, DOI 10.1007/s00125-010-1973-8; KRIPPEITDREWS P, 1994, PFLUG ARCH EUR J PHY, V426, P552, DOI 10.1007/BF00378534; Kubisch HM, 1997, DIABETES, V46, P1563, DOI 10.2337/diabetes.46.10.1563; Lai Y, 2005, TRANSPLANTATION, V79, P1530, DOI 10.1097/01.TP.0000163506.40189.65; Lekli I, 2010, GENE THER, V17, P478, DOI 10.1038/gt.2010.9; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Li N, 2012, DIABETES, V61, P2842, DOI 10.2337/db12-0009; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Liu XJ, 2015, BIOCHEM BIOPH RES CO, V464, P730, DOI 10.1016/j.bbrc.2015.07.016; Lundberg M, 2004, BIOCHEM BIOPH RES CO, V319, P801, DOI 10.1016/j.bbrc.2004.04.199; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; Murata H, 2003, J BIOL CHEM, V278, P50226, DOI 10.1074/jbc.M310171200; Pai HV, 2007, ANTIOXID REDOX SIGN, V9, P2027, DOI 10.1089/ars.2007.1642; Reinbothe TM, 2009, MOL ENDOCRINOL, V23, P893, DOI 10.1210/me.2008-0306; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Sauer H, 2012, INT J ONCOL, V40, P501, DOI 10.3892/ijo.2011.1230; Seghieri G, 2000, CLIN CHIM ACTA, V299, P109, DOI 10.1016/S0009-8981(00)00283-7; Shelton MD, 2007, J BIOL CHEM, V282, P12467, DOI 10.1074/jbc.M610863200; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Takahashi HK, 2014, BIOCHEM J, V460, P411, DOI 10.1042/BJ20131361; Takashima Y, 1999, IMMUNOL LETT, V68, P397, DOI 10.1016/S0165-2478(99)00087-5; THORENS B, 1992, J CLIN INVEST, V90, P77, DOI 10.1172/JCI115858; Tretter L, 2000, J NEUROSCI, V20, P8972; Ullrich V, 2006, J INORG BIOCHEM, V100, P2079, DOI 10.1016/j.jinorgbio.2006.09.019; Ward NE, 2000, BIOCHEMISTRY-US, V39, P10319, DOI 10.1021/bi000781g; Warwar N, 2006, DIABETES, V55, P590, DOI 10.2337/diabetes.55.03.06.db05-0001; Wetzelberger K, 2010, J BIOL CHEM, V285, P26135, DOI 10.1074/jbc.M110.146423; Witte S, 2000, J BIOL CHEM, V275, P1902, DOI 10.1074/jbc.275.3.1902	72	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0176267	10.1371/journal.pone.0176267	http://dx.doi.org/10.1371/journal.pone.0176267			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542222	gold, Green Published, Green Submitted			2022-12-26	WOS:000402061500005
J	Chen, L; Lu, D; Wang, T; Li, Z; Zhao, Y; Jiang, Y; Zhang, Q; Cao, Q; Fang, K; Xing, Y; Qin, L				Chen, Liangke; Lu, Dan; Wang, Teng; Li, Zhi; Zhao, Yanyan; Jiang, Yichen; Zhang, Qing; Cao, Qingqin; Fang, Kefeng; Xing, Yu; Qin, Ling			Identification and expression analysis of starch branching enzymes involved in starch synthesis during the development of chestnut (Castanea mollissima Blume) cotyledons	PLOS ONE			English	Article							RICE ENDOSPERM; PHYSICOCHEMICAL PROPERTIES; AMYLOPECTIN BIOSYNTHESIS; ESCHERICHIA-COLI; AMYLOSE; INCREASES; ISOFORMS; GRAINS; GENES; MAIZE	Chinese chestnut (Castanea mollissima Blume) is native to China and distributes widely in arid and semi-arid mountain area with barren soil. As a perennial crop, chestnut is an alternative food source and acts as an important commercial nut tree in China. Starch is the major metabolite in nuts, accounting for 46 similar to 64% of the chestnut dry weight. The accumulation of total starch and amylopectin showed a similar increasing trend during the development of nut. Amylopectin contributed up to 76% of the total starch content at 80 days after pollination (DAP). The increase of total starch mainly results from amylopectin synthesis. Among genes associated with starch biosynthesis, CmSBEs (starch branching enzyme) showed significant increase during nut development. Two starch branching enzyme isoforms, CmSBE I and CmSBE II, were identified from chestnut cotyledon using zymogram analysis. CmSBE I and CmSBE II showed similar patterns of expression during nut development. The accumulations of CmSBE transcripts and proteins in developing cotyledons were characterized. The expressions of two CmSBE genes increased from 64 DAP and reached the highest levels at 77 DAP, and SBE activity reached its peak at 74 DAP. These results suggested that the CmSBE enzymes mainly contributed to amylopectin synthesis and influenced the amylopectin content in the developing cotyledon, which would be beneficial to chestnut germplasm selection and breeding.	[Chen, Liangke; Lu, Dan; Wang, Teng; Li, Zhi; Zhao, Yanyan; Jiang, Yichen; Xing, Yu; Qin, Ling] Beijing Agr Univ, Beijing Collaborat Innovat Ctr Ecoenvironm Improv, Coll Plant Sci & Technol, Beijing, Peoples R China; [Zhang, Qing] Beijing Agr Univ, Beijing Key Lab Agr Applicat & New Tech, Beijing, Peoples R China; [Cao, Qingqin] Minist Agr, Key Lab Urban Agr North China, Beijing, Peoples R China; [Fang, Kefeng] Beijing Agr Univ, Coll Landscape Architecture, Beijing, Peoples R China	Beijing University of Agriculture; Beijing University of Agriculture; Ministry of Agriculture & Rural Affairs; Beijing University of Agriculture	Xing, Y; Qin, L (corresponding author), Beijing Agr Univ, Beijing Collaborat Innovat Ctr Ecoenvironm Improv, Coll Plant Sci & Technol, Beijing, Peoples R China.	xingyubua@163.com; qinlingbac@126.com		Qin, Ling/0000-0002-9814-5771	National Natural Science Foundation of China [31370679, 31672135]; Beijing Science and Technology Plan Project [Z161100000916011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Science and Technology Plan Project	This work was supported by the National Natural Science Foundation of China (Grant No. 31370679, No. 31672135) and Beijing Science and Technology Plan Project (Z161100000916011).	Alexander RD, 2006, PROTEOMICS, V6, P1886, DOI 10.1002/pmic.200500548; Botticella E, 2012, MOL GENET GENOMICS, V287, P515, DOI 10.1007/s00438-012-0694-8; BOYER CD, 1978, CARBOHYD RES, V61, P321, DOI 10.1016/S0008-6215(00)84492-4; Brummell DA, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0143-y; Carciofi M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-223; Chang JW, 2010, J AGR FOOD CHEM, V58, P10437, DOI 10.1021/jf102129f; Cheng L., 2009, BIOLOGY, P10; Cogez V, 2013, PLOS ONE, V8; Crofts N, 2015, J EXP BOT, V66, P4469, DOI 10.1093/jxb/erv212; Diego F, 2013, AM J POTATO RES; Gounga ME, 2008, J ZHEJIANG UNIV-SC B, V9, P675, DOI 10.1631/jzus.B0820138; GUAN HP, 1995, P NATL ACAD SCI USA, V92, P964, DOI 10.1073/pnas.92.4.964; Hamada S, 2002, J BIOL CHEM, V277, P16538, DOI 10.1074/jbc.M110497200; Hanyu YC, 2013, J AGR FOOD CHEM, V61, P379; He ZF, 1981, PROG BIOCHEM BIOPHYS, V1, P70; Higgins JE, 2013, J SCI FOOD AGR, V93, P2137, DOI 10.1002/jsfa.6019; Hikaru S, 2008, PLANT CELL, V20, P1833; Jiang LL, 2013, TRANSGENIC RES, V22, P1133, DOI 10.1007/s11248-013-9717-4; Kim WS, 2005, PLANTA, V220, P689, DOI 10.1007/s00425-004-1386-3; Ko YT, 2009, J AGR FOOD CHEM, V57, P871, DOI 10.1021/jf802544b; Kubo A, 2005, PLANT PHYSIOL, V137, P43, DOI 10.1104/pp.104.051359; Lai YC, 2016, FOOD CHEM, V199, P556, DOI 10.1016/j.foodchem.2015.12.053; Li C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125507; Li Q, 2016, FOOD CHEM, V201, P80, DOI 10.1016/j.foodchem.2016.01.068; Li XL, 2016, CARBOHYD POLYM, V137, P459, DOI 10.1016/j.carbpol.2015.10.079; Lin JH, 2013, CARBOHYD POLYM, V98, P1553, DOI 10.1016/j.carbpol.2013.07.039; Liu FS, 2016, PLANT BIOTECHNOL J, V14, P976, DOI 10.1111/pbi.12453; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; MARTIN C, 1995, PLANT CELL, V7, P971, DOI 10.1105/tpc.7.7.971; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; Nakamura Y, 2010, PLANT CELL PHYSIOL, V51, P776, DOI 10.1093/pcp/pcq035; Nozaki K, 2001, BIOSCI BIOTECH BIOCH, V65, P1141, DOI 10.1271/bbb.65.1141; Qin GZ, 2007, MOL CELL PROTEOMICS, V6, P425, DOI 10.1074/mcp.M600179-MCP200; Rahman S, 2001, PLANT PHYSIOL, V125, P1314, DOI 10.1104/pp.125.3.1314; Regina A, 2006, P NATL ACAD SCI USA, V103, P3546, DOI 10.1073/pnas.0510737103; Smith AM, 1997, ANNU REV PLANT PHYS, V48, P65, DOI 10.1146/annurev.arplant.48.1.67; Sun CX, 1996, PHYSIOL PLANTARUM, V96, P474, DOI 10.1111/j.1399-3054.1996.tb00461.x; Syahariza ZA, 2013, FOOD CHEM, V136, P742, DOI 10.1016/j.foodchem.2012.08.053; Szydlowski N, 2011, J EXP BOT, V62, P4547, DOI 10.1093/jxb/err172; TAIRA K, 1991, NUCLEIC ACIDS RES, V19, P5125, DOI 10.1093/nar/19.19.5125; Takeda Y, 1999, CARBOHYD POLYM, V38, P109, DOI 10.1016/S0144-8617(98)00105-2; Tetlow IJ, 2011, SEED SCI RES, V21, P5, DOI 10.1017/S0960258510000292; Tetlow IJ, 2004, PLANT CELL, V16, P694, DOI 10.1105/tpc.017400; Wang GP, 2008, HEBEI FRUITS, V4, P6; Wei CX, 2010, J AGR FOOD CHEM, V58, P11097, DOI 10.1021/jf1024533; Wu AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065768; Yandeau-Nelson MD, 2011, PLANT PHYSIOL, V156, P479, DOI 10.1104/pp.111.174094; Zhang L, 2015, J AGR FOOD CHEM, V63, P929, DOI 10.1021/jf505247d	51	8	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177792	10.1371/journal.pone.0177792	http://dx.doi.org/10.1371/journal.pone.0177792			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542293	Green Published, Green Submitted, gold			2022-12-26	WOS:000402058800026
J	Lewandowska, DW; Schreiber, PW; Schuurmans, MM; Ruehe, B; Zagordi, O; Bayard, C; Greiner, M; Geissberger, FD; Capaul, R; Zbinden, A; Boni, J; Benden, C; Mueller, NJ; Trkola, A; Huber, M				Lewandowska, Dagmara W.; Schreiber, Peter W.; Schuurmans, Mace M.; Ruehe, Bettina; Zagordi, Osvaldo; Bayard, Cornelia; Greiner, Michael; Geissberger, Fabienne D.; Capaul, Riccarda; Zbinden, Andrea; Boni, Jurg; Benden, Christian; Mueller, Nicolas J.; Trkola, Alexandra; Huber, Michael			Metagenomic sequencing complements routine diagnostics in identifying viral pathogens in lung transplant recipients with unknown etiology of respiratory infection	PLOS ONE			English	Article							BRONCHIOLITIS OBLITERANS SYNDROME; DNA LEVELS; TT VIRUS; HERPESVIRUSES; CHILDREN; LIBRARY; IMPACT; TRACT; HHV-7	Background Lung transplant patients are a vulnerable group of immunosuppressed patients that are prone to frequent respiratory infections. We studied 60 episodes of respiratory symptoms in 71 lung transplant patients. Almost half of these episodes were of unknown infectious etiology despite extensive routine diagnostic testing. Methods We re-analyzed respiratory samples of all episodes with undetermined etiology in order to detect potential viral pathogens missed/not accounted for in routine diagnostics. Respiratory samples were enriched for viruses by filtration and nuclease digestion, whole nucleic acids extracted and randomly amplified before high throughput metagenomic virus sequencing. Viruses were identified by a bioinformatic pipeline and confirmed and quantified using specific real-time PCR. Results In completion of routine diagnostics, we identified and confirmed a viral etiology of infection by our metagenomic approach in four patients (three Rhinovirus A, one Rhinovirus B infection) despite initial negative results in specific multiplex PCR. Notably, the majority of samples were also positive for Torque teno virus (TTV) and Human Herpesvirus 7 (HHV-7). While TTV viral loads increased with immunosuppression in both throat swabs and blood samples, HHV-7 remained at low levels throughout the observation period and was restricted to the respiratory tract. Conclusion This study highlights the potential of metagenomic sequencing for virus diagnostics in cases with previously unknown etiology of infection and in complex diagnostic situations such as in immunocompromised hosts.	[Lewandowska, Dagmara W.; Ruehe, Bettina; Zagordi, Osvaldo; Geissberger, Fabienne D.; Capaul, Riccarda; Zbinden, Andrea; Boni, Jurg; Trkola, Alexandra; Huber, Michael] Univ Zurich, Inst Med Virol, Zurich, Switzerland; [Schreiber, Peter W.; Bayard, Cornelia; Greiner, Michael; Mueller, Nicolas J.] Univ Hosp Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Schuurmans, Mace M.; Benden, Christian] Univ Hosp Zurich, Div Pulm Med, Zurich, Switzerland; [Ruehe, Bettina] London Sch Hyg & Trop Med, London, England	University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of London; London School of Hygiene & Tropical Medicine	Huber, M (corresponding author), Univ Zurich, Inst Med Virol, Zurich, Switzerland.	huber.michael@virology.uzh.ch	Mueller, Nicolas J./B-6864-2013; Trkola, Alexandra/K-2115-2012; Boeni, Juerg/B-8386-2015; Huber, Michael/B-8509-2015; Benden, Christian/E-9774-2012	Mueller, Nicolas J./0000-0002-1059-3191; Trkola, Alexandra/0000-0003-1013-876X; Huber, Michael/0000-0002-0384-0000; Schuurmans, Mace M./0000-0001-5404-7566	Clinical Research Priority Program 'Viral Infectious Diseases' of the University of Zurich	Clinical Research Priority Program 'Viral Infectious Diseases' of the University of Zurich	Funding was provided by the Clinical Research Priority Program 'Viral Infectious Diseases' of the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Berger C, 2001, J MED VIROL, V64, P505, DOI 10.1002/jmv.1078; Berger C, 2007, J MED VIROL, V79, P1147, DOI 10.1002/jmv.20899; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carratala Jordi, 2012, Enferm Infecc Microbiol Clin, V30 Suppl 2, P63, DOI 10.1016/S0213-005X(12)70084-8; De Clercq E, 2001, REV MED VIROL, V11, P381, DOI 10.1002/rmv.336; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Emery VC, 2001, CLIN INFECT DIS, V32, P1357, DOI 10.1086/320000; Fisher CE, 2016, CLIN INFECT DIS, V62, P313, DOI 10.1093/cid/civ871; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; FROUSSARD P, 1992, NUCLEIC ACIDS RES, V20, P2900, DOI 10.1093/nar/20.11.2900; Garbino J, 2004, AM J RESP CRIT CARE, V170, P1197, DOI 10.1164/rccm.200406-781OC; Gorzer I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122975; Gorzer I, 2014, J HEART LUNG TRANSPL, V33, P320, DOI 10.1016/j.healun.2013.12.007; Gregson AL, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-016-0529-6; Hall RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/j.jviromet.2013.08.035; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Khalifah AP, 2004, AM J RESP CRIT CARE, V170, P181, DOI 10.1164/rccm.200310-1359OC; Kidd IM, 2000, TRANSPLANTATION, V69, P2400, DOI 10.1097/00007890-200006150-00032; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Kumar D, 2010, CURR OPIN INFECT DIS, V23, P374, DOI 10.1097/QCO.0b013e32833bc19d; Lewandowska DW, 2015, DIAGN MICR INFEC DIS, V83, P133, DOI 10.1016/j.diagmicrobio.2015.06.017; Li L, 2015, J VIROL METHODS, V213, P139, DOI 10.1016/j.jviromet.2014.12.002; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; Maggi F, 2003, J VIROL, V77, P2418, DOI 10.1128/JVI.77.4.2418-2425.2003; Maggi F, 2001, J MED VIROL, V65, P418, DOI 10.1002/jmv.2051; Magnusson J, 2013, TRANSPLANTATION, V95, P383, DOI 10.1097/TP.0b013e318271d7f0; Manuel O, 2009, TRANSPLANTATION, V87, P719, DOI 10.1097/TP.0b013e3181963262; Mendez JC, 2001, J INFECT DIS, V183, P179, DOI 10.1086/317929; Mokili JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/j.coviro.2011.12.004; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Petty TJ, 2014, J CLIN MICROBIOL, V52, P3351, DOI 10.1128/JCM.01389-14; Quan PL, 2010, EMERG INFECT DIS, V16, P918, DOI 10.3201/eid1606.091536; Razonable RR, 2013, AM J TRANSPLANT, V13, P67, DOI 10.1111/ajt.12008; Sayah DM, 2013, CLIN TRANSPLANT, V27, pE64, DOI 10.1111/ctr.12054; Schuurmans M.M., 2013, SWISS MED WEEKLY, V143; Schuurmans MM, 2012, RESPIRATION, V84, P163, DOI 10.1159/000339345; Schuurmans MM, 2014, EURASIAN J PULMONOL, V16, P144, DOI 10.5152/ejp.2014.87597; Schwartz KL, 2014, PEDIATRICS, V133, pE1541, DOI 10.1542/peds.2013-3344; Solonenko SA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-320; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Wunderli W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027483; Young JC, 2015, AM J TRANSPLANT, V15, P200, DOI 10.1111/ajt.13031; Yun ZB, 2000, TRANSPLANTATION, V69, P1733; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	47	42	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177340	10.1371/journal.pone.0177340	http://dx.doi.org/10.1371/journal.pone.0177340			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542207	gold, Green Accepted, Green Published			2022-12-26	WOS:000402058800016
J	Siegmund, K; Thuille, N; Wachowicz, K; Hermann-Kleiter, N; Baier, G				Siegmund, Kerstin; Thuille, Nikolaus; Wachowicz, Katarzyna; Hermann-Kleiter, Natascha; Baier, Gottfried			Protein kinase C theta is dispensable for suppression mediated by CD25(+) CD4(+) regulatory T cells	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PKC-THETA; IN-VIVO; TRANSCRIPTION FACTOR; IMMUNOLOGICAL SYNAPSE; IL-17 PRODUCTION; ACTIVATION; RECEPTOR; DIFFERENTIATION; FOXP3	The activation of conventional T cells upon T cell receptor stimulation critically depends on protein kinase C theta (PKC theta). However, its role in regulatory T (Treg) cell function has yet to be fully elucidated. Using siRNA or the potent and PKC family-selective pharmacological inhibitor AEB071, we could show that murine Treg-mediated suppression in vitro is independent of PKC theta function. Likewise, Treg cells of PKC theta-deficient mice were fully functional, showing a similar suppressive activity as wild-type CD25(+) CD4(+) T cells in an in vitro suppression assay. Furthermore, in vitro-differentiated wild-type and PKC theta-deficient iTreg cells showed comparable Foxp3 expression as well as suppressive activity. However, we observed a reduced percentage of Foxp3(+) CD25(+) CD4(+) T cells in the lymphatic organs of PKC theta-deficient mice. Taken together, our results suggest that while PKC. is involved in Treg cell differentiation in vivo, it is dispensable for Treg-mediated suppression.	[Siegmund, Kerstin; Thuille, Nikolaus; Wachowicz, Katarzyna; Hermann-Kleiter, Natascha; Baier, Gottfried] Med Univ Innsbruck, Dept Pharmacol & Genet, Innsbruck, Austria	Medical University of Innsbruck	Siegmund, K; Baier, G (corresponding author), Med Univ Innsbruck, Dept Pharmacol & Genet, Innsbruck, Austria.	kerstin.siegmund@i-med.ac.at; Gottfried.Baier@i-med.ac.at	Kleiter, Natascha/I-5101-2018; Bellaire-Siegmund, Kerstin/AAA-9702-2021; Bellaire-Siegmund, Kerstin/D-4774-2018	Kleiter, Natascha/0000-0003-4389-9813; Bellaire-Siegmund, Kerstin/0000-0002-3654-1170; Bellaire-Siegmund, Kerstin/0000-0002-3654-1170; Thuille, Nikolaus/0000-0002-2253-3946; Baier, Gottfried/0000-0002-2085-8325	FWF Austrian Science Fund [M1636-B23, 25044-B21, P28694-B30]; Medical University Innsbruck for young scientists MUI-START [2013042002]; Austrian Science Fund (FWF) [M 1636] Funding Source: researchfish	FWF Austrian Science Fund(Austrian Science Fund (FWF)); Medical University Innsbruck for young scientists MUI-START; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the FWF Austrian Science Fund ("Lise-Meitner" M1636-B23 to KS, 25044-B21 to GB, and P28694-B30 to NH-K) and by the intramural funding program of the Medical University Innsbruck for young scientists MUI-START, project 2013042002 (to KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2006, AUTOIMMUNITY, V39, P469, DOI 10.1080/08916930600907954; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chuck MI, 2010, J IMMUNOL, V184, P2476, DOI 10.4049/jimmunol.0902876; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; Evenou JP, 2009, J PHARMACOL EXP THER, V330, P792, DOI 10.1124/jpet.109.153205; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gavin MA, 2002, NAT IMMUNOL, V3, P33, DOI 10.1038/ni743; Gruber T, 2009, MOL IMMUNOL, V46, P2071, DOI 10.1016/j.molimm.2009.02.030; Gupta S, 2008, MOL IMMUNOL, V46, P213, DOI 10.1016/j.molimm.2008.08.275; He XH, 2014, J INVEST DERMATOL, V134, P975, DOI 10.1038/jid.2013.459; Hickman SP, 2006, J IMMUNOL, V177, P2186, DOI 10.4049/jimmunol.177.4.2186; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Iype T, 2010, J IMMUNOL, V185, P6115, DOI 10.4049/jimmunol.1000622; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006580; Kong KF, 2014, NAT IMMUNOL, V15, P465, DOI 10.1038/ni.2866; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; Kwon MJ, 2012, J IMMUNOL, V188, P5887, DOI 10.4049/jimmunol.1102941; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Li MO, 2016, NAT REV IMMUNOL, V16, P220, DOI 10.1038/nri.2016.26; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Ma J, 2012, J IMMUNOL, V188, P5337, DOI 10.4049/jimmunol.1102979; Marsland BJ, 2007, J IMMUNOL, V178, P3466, DOI 10.4049/jimmunol.178.6.3466; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; Martin B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3209; Meisel M, 2013, IMMUNITY; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Ohayon A, 2010, INFECT IMMUN, V78, P4195, DOI 10.1128/IAI.00465-10; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Ramsdell F, 2014, NAT REV IMMUNOL, V14, P343, DOI 10.1038/nri3650; Salek-Ardakani S, 2005, J IMMUNOL, V175, P7635, DOI 10.4049/jimmunol.175.11.7635; Salek-Ardakani S, 2004, J IMMUNOL, V173, P6440, DOI 10.4049/jimmunol.173.10.6440; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schmidt AM, 2015, J IMMUNOL, V194, P4362, DOI 10.4049/jimmunol.1402384; Shen SD, 2010, J BIOL CHEM, V285, P35393, DOI 10.1074/jbc.M110.145052; Siegmund K, 2011, J IMMUNOL, V186, P3452, DOI 10.4049/jimmunol.1003491; Sims TN, 2007, CELL, V129, P773, DOI 10.1016/j.cell.2007.03.037; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tai X, 2013, IMMUNITY, V38, P1116, DOI 10.1016/j.immuni.2013.02.022; Tan SL, 2006, J IMMUNOL, V176, P2872, DOI 10.4049/jimmunol.176.5.2872; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Vahl JC, 2014, IMMUNITY, V41, P722, DOI 10.1016/j.immuni.2014.10.012; von Essen M, 2006, J IMMUNOL, V176, P7502, DOI 10.4049/jimmunol.176.12.7502; Wachowicz K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096401; Yan DP, 2015, P NATL ACAD SCI USA, V112, P14942, DOI 10.1073/pnas.1520393112; Yokosuka T, 2010, IMMUNITY, V33, P326, DOI 10.1016/j.immuni.2010.09.006; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068	54	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0175463	10.1371/journal.pone.0175463	http://dx.doi.org/10.1371/journal.pone.0175463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531229	gold, Green Published, Green Submitted			2022-12-26	WOS:000402058400002
J	Ogna, VF; Blanchard, A; Vargas-Poussou, R; Ogna, A; Baron, S; Bertocchio, JP; Prot-Bertoye, C; Nevoux, J; Dubourg, J; Maruani, G; Mendes, M; Garcia-Castano, A; Treard, C; Lepottier, N; Houillier, P; Courbebaisse, M				Ogna, Valentina Forni; Blanchard, Anne; Vargas-Poussou, Rosa; Ogna, Adam; Baron, Stephanie; Bertocchio, Jean-Philippe; Prot-Bertoye, Caroline; Nevoux, Jerome; Dubourg, Julie; Maruani, Gerard; Mendes, Margarida; Garcia-Castano, Alejandro; Treard, Cyrielle; Lepottier, Nelly; Houillier, Pascal; Courbebaisse, Marie			Signification of distal urinary acidification defects in hypocitraturic patients	PLOS ONE			English	Article							RENAL TUBULAR-ACIDOSIS; SJOGRENS-SYNDROME; CITRATE; EXCRETION; MUTATIONS; BAND-3	Background and objectives Hypocitraturia has been associated with metabolic acidosis and mineral disorders. The aim of this study was to investigate the occurrence of urinary acidification defects underlying hypocitraturia. Materials and methods This retrospective observational study included 67 patients (32 men), aged 40.7 +/- 15.1 years with hypocitraturia (< 1.67 mmol /24-h) and nephrolithiasis, nephrocalcinosis, and/or bone demineralization, referred to our center from 2000 to 2015. We aimed to assess renal distal acidification capacity, prevalence and mechanisms of urinary acidification defects. Patients with low baseline plasma HCO3-(< 22 mmol/L) were studied by bicarbonate loading or furo-semide/fludrocortisone tests. Patients with normal baseline plasma HCO3- had an ammonium-chloride challenge test. A normal response was a decrease in urinary pH < 5.3 and an increase in urinary NH4+ >= 33 mu mol/min and defined idiopathic hypocitraturia. Results Eleven patients (16.4%) had low HCO3- and overt distal acidification defect. Three had a mutation in the gene encoding AE1, 4 had Gougerot-Sjogren syndrome and no cause was found in the remaining 4 cases. Fifty-six patients (83.6%) had normal HCO3-; of those, 33 (58.9%) had idiopathic hypocitraturia. Among the 23 (41%) remaining patients, 12 were unable to increase urinary NH4+ excretion (among them, 8 were able to decrease urinary pH and 4 were not) whereas 11 were able to increase urinary NH4+ excretion but unable to decrease urinary pH. These 11 patients had higher fasting urinary calcium, reflecting bone resorption, than the other 12 patients: median 0.41 [0.24-0.47] vs. 0.22 [0.08-0.37] mmol/mmol creatinine (P = 0.04). Conclusions Patients with hypocitraturia and normal plasma HCO3- frequently show a latent acidification defect that can be further dissected into one of several subtypes based on urinary pH and NH4+ response to the acid load. Those patients with impaired urine acidification capacity but preserved NH4+ excretion exhibit particularly high calciuria and should be identified to optimize nephrolithiasis prevention.	[Ogna, Valentina Forni; Blanchard, Anne; Dubourg, Julie; Mendes, Margarida] Hop Europeen Georges Pompidou, AP HP, Ctr Invest Clin, Paris, France; [Blanchard, Anne; Vargas-Poussou, Rosa] Ctr Reference Malad Renales Hereditaires Enfant &, Paris, France; [Blanchard, Anne; Baron, Stephanie; Bertocchio, Jean-Philippe; Prot-Bertoye, Caroline; Houillier, Pascal; Courbebaisse, Marie] Univ Paris 05, Fac Med, Paris, France; [Vargas-Poussou, Rosa; Garcia-Castano, Alejandro; Treard, Cyrielle; Lepottier, Nelly] Hop Europeen Georges Pompidou, AP HP, Serv Genet, Paris, France; [Ogna, Adam; Maruani, Gerard] Hop Raymond Poincare, AP HP, INSERM CIC 14 29, Garches, France; [Baron, Stephanie; Bertocchio, Jean-Philippe; Prot-Bertoye, Caroline; Houillier, Pascal; Courbebaisse, Marie] Hop Europeen Georges Pompidou, AP HP, Unite Renale, Dept Physiol, Paris, France; [Nevoux, Jerome] Hop Bicetre, AP HP, Serv ORL, Paris, France; [Nevoux, Jerome] Univ Paris Saclay, Paris, France; [Nevoux, Jerome] INSERM 1182, Paris, France; [Maruani, Gerard; Courbebaisse, Marie] CNRS, UMR 8253, INSERM U1151, Inst Necker Enfants Malades, Paris, France; [Courbebaisse, Marie] CNRS ERL8228, INSERM, UMR 51138, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Courbebaisse, M (corresponding author), Univ Paris 05, Fac Med, Paris, France.; Courbebaisse, M (corresponding author), Hop Europeen Georges Pompidou, AP HP, Unite Renale, Dept Physiol, Paris, France.; Courbebaisse, M (corresponding author), CNRS, UMR 8253, INSERM U1151, Inst Necker Enfants Malades, Paris, France.	marie.courbebaisse@aphp.fr	; Bertocchio, Jean-Philippe/Q-1768-2016	prot-bertoye, caroline/0000-0003-1373-1323; BLANCHARD, Anne/0000-0002-0815-0586; Bertocchio, Jean-Philippe/0000-0002-4104-702X; Dubourg, Julie/0000-0002-5514-8075; Baron, Stephanie/0000-0002-0375-6968				Arrabal-Polo MA, 2013, BJU INT, V111, P622, DOI 10.1111/j.1464-410X.2012.11292.x; Arampatzis S, 2012, UROL RES, V40, P53, DOI 10.1007/s00240-011-0397-3; Araujo NC, 2000, BRAZ J MED BIOL RES, V33, P205, DOI 10.1590/S0100-879X2000000200007; Baffle D, NEPHROL DIAL TRANSPL, V27, P3691; BATLLE DC, 1981, KIDNEY INT, V20, P389, DOI 10.1038/ki.1981.151; Bruce LJ, 1997, J CLIN INVEST, V100, P1693, DOI 10.1172/JCI119694; BUCKALEW VM, 1968, AM J MED, V45, P32, DOI 10.1016/0002-9343(68)90005-3; CARLISLE EJF, 1991, PEDIATR NEPHROL, V5, P242, DOI 10.1007/BF01095965; Chow K, 2004, KIDNEY INT, V65, P1724, DOI 10.1111/j.1523-1755.2004.00566.x; COHEN EP, 1992, J AM SOC NEPHROL, V3, P264; Dhayat NA, 2015, J AM SOC NEPHROL; DONNELLY S, 1992, AM J KIDNEY DIS, V19, P272, DOI 10.1016/S0272-6386(13)80009-1; DUBOSE TD, 1985, J CLIN INVEST, V75, P1116, DOI 10.1172/JCI111805; ELKINTON JR, 1960, AM J MED, V29, P554, DOI 10.1016/0002-9343(60)90090-5; Forni Ogna V, BMC MED, V13, P40; Fry AC, 2012, J AM SOC NEPHROL, V23, P1238, DOI 10.1681/ASN.2012020112; HALPERIN ML, 1974, J CLIN INVEST, V53, P669, DOI 10.1172/JCI107604; HESS B, 1994, NEPHROL DIAL TRANSPL, V9, P642, DOI 10.1093/ndt/9.6.642; Jorgensen K., 1987, SCAND J CLIN LAB INV, P287; KOK DJ, 1990, KIDNEY INT, V37, P51, DOI 10.1038/ki.1990.7; NUTBOURNE D, 1961, CLIN SCI, V20, P263; Pongchaiyakul C, 2004, NEPHROL DIAL TRANSPL, V19, P3029, DOI 10.1093/ndt/gfh534; Rysava R, 1997, NEPHROL DIAL TRANSPL, V12, P1869, DOI 10.1093/ndt/12.9.1869; SIMPSON DP, 1983, AM J PHYSIOL, V244, pF223, DOI 10.1152/ajprenal.1983.244.3.F223; Vallet M, 2015, KIDNEY INT, V88, P137, DOI 10.1038/ki.2015.52; Vargas-Poussou R, 2006, J AM SOC NEPHROL, V17, P1437, DOI 10.1681/ASN.2005121305; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Walsh SB, 2007, KIDNEY INT, V71, P1310, DOI 10.1038/sj.ki.5002220; WRONG O, 1959, Q J MED, V28, P259; WRONG OM, 1993, Q J MED, V86, P513, DOI 10.1093/qjmed/86.8.513	30	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177329	10.1371/journal.pone.0177329	http://dx.doi.org/10.1371/journal.pone.0177329			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542241	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672600007
J	Calciano, L; Corsico, AG; Pirina, P; Trucco, G; Jarvis, D; Janson, C; Accordini, S				Calciano, Lucia; Corsico, Angelo Guido; Pirina, Pietro; Trucco, Giulia; Jarvis, Deborah; Janson, Christer; Accordini, Simone			Assessment of asthma severity in adults with ever asthma: A continuous score	PLOS ONE			English	Article							RESPIRATORY SYMPTOMS; PERSISTENT ASTHMA; YOUNG-ADULTS; DETERMINANTS; DIAGNOSIS; CHILDREN; BURDEN; INDEX	Background In epidemiological studies, continuous measures of asthma severity should be used to catch the heterogeneity of phenotypes. This study aimed at developing and validating continuous measures of asthma severity in adult patients with ever asthma from the general population, to be used in epidemiological studies. Methods Respiratory symptoms, anti-asthmatic treatment and lung function were measured on 520 patients with ever asthma aged 20-64 years from the general Italian population (GEIRD study; 2007/2010). The variables that represent the same dimension of asthma severity were identified through an exploratory factor analysis and were summarized through a multiple factor analysis. Results Only respiratory symptoms and anti-asthmatic treatment were summarized in a continuous score (STS). STS ranges from 0 (no symptoms/treatment) to 10 (maximum symptom frequency and treatment intensity). STS was positively correlated with the Global Initiative for Asthma classification of asthma severity computed on the 137 cases with a doctor's diagnosis (Spearman's coefficient = 0.61, p-value<0.0001) (concurrent validity). Furthermore, using a cohort of 1,097 European asthmatics (ECRHS II study; 1999/2002), increasing STS levels at baseline (1991/1993) were positively associated with long-term outcomes (hospitalization and lost workdays for breathing problems, asthma attack frequency and use of asthma controllers) (predictive validity). Finally, the STS scores computed from the GEIRD and ECRHS II data were comparable (Lin's coefficient = 0.95, p-value<0.0001) (replication analysis). Conclusions STS is a valid and replicable measure of asthma severity in adults, which could be used in association studies.	[Calciano, Lucia; Accordini, Simone] Univ Verona, Dept Diagnost & Publ Hlth, Unit Epidemiol & Med Stat, Verona, Italy; [Corsico, Angelo Guido] Univ Pavia, IRCCS, Div Resp Dis, San Matteo & Hosp Fdn, Pavia, Italy; [Pirina, Pietro] Univ Sassari, Inst Resp Dis, Sassari, Italy; [Trucco, Giulia] Univ Turin, Dept Publ Hlth & Pediat, Turin, Italy; [Jarvis, Deborah] Imperial Coll, Natl Heart & Lung Inst, London, England; [Janson, Christer] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	University of Verona; IRCCS Fondazione San Matteo; University of Pavia; University of Sassari; University of Turin; Imperial College London; Uppsala University	Calciano, L (corresponding author), Univ Verona, Dept Diagnost & Publ Hlth, Unit Epidemiol & Med Stat, Verona, Italy.	lucia.calciano@univr.it	Corsico, Angelo Guido/AAC-8138-2019	Corsico, Angelo Guido/0000-0002-8716-4694; Jarvis, Deborah/0000-0002-1753-3896; Calciano, Lucia/0000-0001-9801-5080	Cariverona Foundation; Italian Ministry of Health [RF-2009-1471235]; Chiesi Farmaceutici; Italian Medicines Agency (AIFA)	Cariverona Foundation(Fondazione Cariverona); Italian Ministry of Health(Ministry of Health, Italy); Chiesi Farmaceutici(Chiesi Pharmaceuticals Inc); Italian Medicines Agency (AIFA)	The GEIRD project was funded by the Cariverona Foundation (Bando 2006), the Italian Ministry of Health (RF-2009-1471235), Chiesi Farmaceutici and the Italian Medicines Agency (AIFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2013, WIRES COMPUT STAT, V5, P149, DOI 10.1002/wics.1246; Accordini S, 2008, ALLERGY, V63, P116, DOI 10.1111/j.1398-9995.2007.01523.x; Accordini S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151292; Accordini S, 2013, INT ARCH ALLERGY IMM, V160, P93, DOI 10.1159/000338998; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; [Anonymous], 2014, GLOB STRAT ASTHM MAN; Awasthi S, 2012, INDIAN J PEDIATR, V79, P1311, DOI 10.1007/s12098-012-0817-6; Bacharier LB, 2004, AM J RESP CRIT CARE, V170, P426, DOI 10.1164/rccm.200308-1178OC; Bai J, 1998, CHEST, V114, P1343, DOI 10.1378/chest.114.5.1343; Bildstrup L, 2015, J ASTHMA, V52, P687, DOI 10.3109/02770903.2015.1005840; Birnbaum HG, 2009, J ASTHMA, V46, P67, DOI 10.1080/02770900802503099; Blakey JD, 2012, CLIN EXP ALLERGY, V42, P617, DOI 10.1111/j.1365-2222.2012.03962.x; Bouzigon E, 2007, EUR RESPIR J, V30, P253, DOI 10.1183/09031936.00162206; Cazzoletti L, 2010, INT ARCH ALLERGY IMM, V151, P70, DOI 10.1159/000232572; de Marco R, 2005, INT ARCH ALLERGY IMM, V138, P225, DOI 10.1159/000088723; de Marco R, 2010, INT ARCH ALLERGY IMM, V152, P255, DOI 10.1159/000283034; Drasgow F., 1988, ENCY STAT SCI; Gorsuch R.L., 1988, HDB MULTIVARIATE EXP, P231, DOI DOI 10.1007/978-1-4613-0893-5_6; Hastie AT, 2010, J ALLERGY CLIN IMMUN, V125, P1028, DOI 10.1016/j.jaci.2010.02.008; Killian KJ, 2000, AM J RESP CRIT CARE, V162, P490, DOI 10.1164/ajrccm.162.2.9905079; Lang A, 2010, PEDIAT ALLERG IMM-UK, V21, P945, DOI 10.1111/j.1399-3038.2010.01072.x; Lowhagen O, 2012, ALLERGY, V67, P713, DOI 10.1111/j.1398-9995.2012.02821.x; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; Marks GB, 2005, EUR RESPIR J, V26, P3, DOI 10.1183/09031936.05.00055305; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; Osborne J. W., 2012, PRACTICAL ASSESSMENT, V17, P15, DOI DOI 10.7275/H0BD-4D11; Pekkanen J, 2005, EUR RESPIR J, V26, P28, DOI 10.1183/09031936.05.00120104; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabe KF, 2004, J ALLERGY CLIN IMMUN, V114, P40, DOI 10.1016/j.jaci.2004.04.042; Rage E, 2009, OCCUP ENVIRON MED, V66, P182, DOI 10.1136/oem.2007.038349; Raherison C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007146; Ringsberg KC, 2002, RESP MED, V96, P305, DOI 10.1053/rmed.2001.1281; Rose G., 1992, STRATEGY PREVENTIVE; Sistek D, 2001, EUR RESPIR J, V17, P214, DOI 10.1183/09031936.01.17202140; Sunyer J, 2007, ALLERGY, V62, P142, DOI 10.1111/j.1398-9995.2006.01184.x; Sunyer J, 2004, RESP MED, V98, P1025, DOI 10.1016/j.rmed.2004.01.013; The European Community Respiratory Health Survey Steering Committee. The European Community Respiratory Health Survey II, 2002, EUR RESPIR J, V20, P1071; THOMPSON S, 1984, EUR J RESPIR DIS, V65, P185; Ungar WJ, 2002, AM J RESP CRIT CARE, V165, P190, DOI 10.1164/ajrccm.165.2.2102012; Wan YI, 2012, THORAX, V67, P762, DOI 10.1136/thoraxjnl-2011-201262; Weiss K B, 1993, Pharmacoeconomics, V4, P14, DOI 10.2165/00019053-199304010-00004; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8	43	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177538	10.1371/journal.pone.0177538	http://dx.doi.org/10.1371/journal.pone.0177538			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542217	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400050
J	Harada, H; Kai, H; Shibata, R; Niiyama, H; Nishiyama, Y; Murohara, T; Yoshida, N; Katoh, A; Ikeda, H				Harada, Haruhito; Kai, Hisashi; Shibata, Rei; Niiyama, Hiroshi; Nishiyama, Yasuhiro; Murohara, Toyoaki; Yoshida, Noriko; Katoh, Atsushi; Ikeda, Hisao			New diagnostic index for sarcopenia in patients with cardiovascular diseases	PLOS ONE			English	Article							DISTAL MYOPATHY; RIMMED VACUOLES; ADIPONECTIN; DEFINITION; CONSENSUS	Background Sarcopenia is an aging and disease-related syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength, with the risk of frailty and poor quality of life. Sarcopenia is diagnosed by a decrease in skeletal muscle index (SMI) and reduction of either handgrip strength or gait speed. However, measurement of SMI is difficult for general physicians because it requires special equipment for bioelectrical impedance assay or dual-energy X-ray absorptiometry. The purpose of this study was, therefore, to explore a novel, simple diagnostic method of sarcopenia evaluation in patients with cardiovascular diseases (CVD). Methods We retrospectively investigated 132 inpatients with CVD (age: 72 +/- 12 years, age range: 27-93 years, males: 61%) Binomial logistic regression and correlation analyses were used to assess the associations of sarcopenia with simple physical data and biomarkers, including muscle-related inflammation makers and nutritional markers. Results Sarcopenia was present in 29.5% of the study population. Serum concentrations of adiponectin and sialic acid were significantly higher in sarcopenic than non-sarcopenic CVD patients. Stepwise multivariate binomial logistic regression analysis revealed that adiponectin, sialic acid, sex, age, and body mass index were independent factors for sarcopenia detection. Sarcopenia index, obtained from the diagnostic regression formula for sarcopenia detection including the five independent factors, indicated a high accuracy in ROC curve analysis (sensitivity 94.9%, specificity 69.9%) and the cutoff value for sarcopenia detection was -1.6134. Sarcopenia index had a significant correlation with the conventional diagnostic parameters of sarcopenia. Conclusions Our new sarcopenia index using simple parameters would be useful for diagnosing sarcopenia in CVD patients.	[Harada, Haruhito; Kai, Hisashi; Niiyama, Hiroshi; Nishiyama, Yasuhiro; Katoh, Atsushi] Kurume Univ, Med Ctr, Dept Cardiol, Kurume, Fukuoka, Japan; [Shibata, Rei] Nagoya Univ, Dept Adv Cardiovasc Therapeut, Nagoya, Aichi, Japan; [Murohara, Toyoaki] Nagoya Univ, Dept Cardiol, Nagoya, Aichi, Japan; [Yoshida, Noriko] Kurume Univ, Inst Hlth & Sports Sci, Kurume, Fukuoka, Japan; [Ikeda, Hisao] Teikyo Univ, Fac Fukuoka Med Technol, Dept Phys Therapy, Omuta, Japan	Kurume University; Nagoya University; Nagoya University; Kurume University; Teikyo University	Harada, H (corresponding author), Kurume Univ, Med Ctr, Dept Cardiol, Kurume, Fukuoka, Japan.	harada_haruhito@med.kurume-u.ac.jp						Abou-Samra M, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0051-9; Celeste FV, 2014, HUM MUTAT, V35, P915, DOI 10.1002/humu.22583; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Fiaschi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034782; Fiaschi T, 2009, CELL RES, V19, P584, DOI 10.1038/cr.2009.39; Goto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081929; Hanisch F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080520; Harada H, 2016, J NUTR HLTH AGING; Huang C, 2015, NUTR METAB CARDIOVAS, V25, P594, DOI 10.1016/j.numecd.2015.03.010; Hui XY, 2012, BRIT J PHARMACOL, V165, P574, DOI 10.1111/j.1476-5381.2011.01395.x; Ignacio de Ulíbarri J., 2005, Nutr. Hosp., V20, P38; Karvonen-Gutierrez CA, 2015, J GERONTOL A; Kung T, 2011, J CACHEXIA SARCOPENI, V2, P63, DOI 10.1007/s13539-011-0020-z; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Malicdan MCV, 2007, HUM MOL GENET, V16, P2669, DOI 10.1093/hmg/ddm220; Malicdan MCV, 2007, HUM MOL GENET, V16, P115, DOI 10.1093/hmg/ddl446; Sente T, 2016, J CACHEXIA SARCOPENI, V7, P261, DOI 10.1002/jcsm.12086; Shibata R, 2012, CURR MED CHEM, V19, P5459, DOI 10.2174/092986712803833164; Tanimoto Y, 2012, ARCH GERONTOL GERIAT, V55, pE9, DOI 10.1016/j.archger.2012.06.015; Xue QL, 2011, CLIN GERIATR MED, V27, P1, DOI 10.1016/j.cger.2010.08.009	21	31	32	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178123	10.1371/journal.pone.0178123	http://dx.doi.org/10.1371/journal.pone.0178123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542531	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400144
J	Lains, I; Duarte, D; Barros, AS; Martins, AS; Gil, J; Miller, JB; Marques, M; Mesquita, TAN; Kim, IK; Cachulo, MD; Vavvas, D; Carreira, IM; Murta, JN; Silva, R; Miller, JW; Husain, D; Gil, AM				Lains, Ines; Duarte, Daniela; Barros, Antonio S.; Martins, Ana Sofia; Gil, Joao; Miller, John B.; Marques, Marco; Mesquita, Tania; Kim, Ivana K.; da Luz Cachulo, Maria; Vavvas, Demetrios; Carreira, Isabel M.; Murta, Joaquim N.; Silva, Rufino; Miller, Joan W.; Husain, Deeba; Gil, Ana M.			Human plasma metabolomics in age-related macular degeneration (AMD) using nuclear magnetic resonance spectroscopy	PLOS ONE			English	Article							OXIDATIVE STRESS; NMR-SPECTROSCOPY; METABONOMICS; SIGNATURES; PREVALENCE; DISEASE; CANCER; EYE	Purpose To differentiate the plasma metabolomic profile of patients with age related macular degeneration (AMD) from that of controls, by Nuclear Magnetic Resonance (NMR) spectroscopy. Methods Two cohorts (total of 396 subjects) representative of central Portugal and Boston, USA phenotypes were studied. For each cohort, subjects were grouped according to AMD stage (early, intermediate and late). Multivariate analysis of plasma NMR spectra was performed, followed by signal integration and univariate analysis. Results Small changes were detected in the levels of some amino acids, organic acids, dimethyl sulfone and specific lipid moieties, thus providing some biochemical information on the disease. The possible confounding effects of gender, smoking history and age were assessed in each cohort and found to be minimal when compared to that of the disease. A similar observation was noted in relation to age-related comorbidities. Furthermore, partially distinct putative AMD metabolite fingerprints were noted for the two cohorts studied, reflecting the importance of nutritional and other lifestyle habits in determining AMD metabolic response and potential biomarker fingerprints. Notably, some of the metabolite changes detected were noted as potentially differentiating controls from patients diagnosed with early AMD. Conclusion For the first time, this study showed metabolite changes in the plasma of patients with AMD as compared to controls, using NMR. Geographical origins were seen to affect AMD patients A metabolic profile and some metabolites were found to be valuable in potentially differentiating controls from early stage AMD patients. Metabolomics has the potential of identifying biomarkers for AMD, and further work in this area is warranted.	[Lains, Ines; Miller, John B.; Kim, Ivana K.; Vavvas, Demetrios; Miller, Joan W.; Husain, Deeba] Harvard Med Sch, Massachusetts Eye & Ear, Dept Ophthalmol, Boston, MA USA; [Lains, Ines; Gil, Joao; Marques, Marco; da Luz Cachulo, Maria; Carreira, Isabel M.; Murta, Joaquim N.; Silva, Rufino] Univ Coimbra FMUC, Fac Med, Coimbra, Portugal; [Lains, Ines; Gil, Joao; Marques, Marco; Mesquita, Tania; da Luz Cachulo, Maria; Silva, Rufino] Assoc Innovat & Biomed Res Light & Image AIBILI, Coimbra, Portugal; [Lains, Ines; Gil, Joao; Marques, Marco; da Luz Cachulo, Maria; Murta, Joaquim N.; Silva, Rufino] CHUC, Dept Ophthalmol, Coimbra, Portugal; [Duarte, Daniela; Barros, Antonio S.; Martins, Ana Sofia; Gil, Ana M.] Univ Aveiro, Dept Chem, CICECO Aveiro Inst Mat, UA, Aveiro, Portugal	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Aveiro	Gil, AM (corresponding author), Univ Aveiro, Dept Chem, CICECO Aveiro Inst Mat, UA, Aveiro, Portugal.	agil@ua.pt	Murta, Joaquim/V-5494-2017; Silva, Rufino M/J-2817-2012; Carreira, Isabel M/C-7711-2018; Gil, Ana/O-3871-2019; Miller, John J/GZG-5663-2022; Barros, António S./B-5847-2009; Duarte, Daniela/AAD-3491-2020	Murta, Joaquim/0000-0001-8926-5176; Silva, Rufino M/0000-0001-8676-0833; Carreira, Isabel M/0000-0001-6842-1707; Gil, Ana/0000-0003-3766-4364; Barros, António S./0000-0002-9103-5852; Duarte, Daniela/0000-0001-9460-1162; Quadrado Gil, Joao/0000-0001-9032-1008; Martins, Ana Sofia/0000-0001-6865-5853; Cachulo, Maria Luz/0000-0002-0900-4548; Vavvas, Demetrios/0000-0002-8622-6478; Husain, Deeba/0000-0002-8494-0950; Kim, Ivana/0000-0003-0310-6129; Lains, Ines/0000-0002-8136-4724	Portuguese Foundation for Science and Technology [HMSP-ICJ/0006/2013]; Miller Retina Research Fund (MEE); Miller Champalimaud Award (MEE); CICECOAveiro Institute of Materials [POCI-01-0145FEDER-007679, UlD /CTM/50011/2013]; national funds through the FCT/MEC; FEDER; FCT funds; Fundacao para a Ciencia e a Tecnologia (FCT) [HMSP-ICJ/ 0006/2013]; NATIONAL EYE INSTITUTE [R21EY023079, R01EY025362] Funding Source: NIH RePORTER	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Miller Retina Research Fund (MEE); Miller Champalimaud Award (MEE); CICECOAveiro Institute of Materials; national funds through the FCT/MEC(Portuguese Foundation for Science and Technology); FEDER(European Commission); FCT funds(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This project was funded by the Portuguese Foundation for Science and Technology (HMSP-ICJ/0006/2013), the Miller Retina Research Fund (MEE) and the Miller Champalimaud Award (MEE). This work was also developed within the scope of the project CICECOAveiro Institute of Materials, POCI-01-0145FEDER-007679 (FCT ref. UlD /CTM/50011/2013), financed by national funds through the FCT/MEC and when appropriate co-financed by FEDER under the PT2020 Partnership Agreement. We also acknowledge the Portuguese National NMR Network (RNRMN), supported by FCT funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by the Fundacao para a Ciencia e a Tecnologia (FCT) (HMSP-ICJ/ 0006/2013), the Miller Retina Research Fund (MEE) and the Miller Champalimaud Award (MEE). This work was also developed within the scope of the project CICECO-Aveiro Institute of Materials, POCI-01-0145-FEDER-007679 (FCT Ref. UID /CTM /50011/2013), financed by national funds through the FCT/MEC and when appropriate co-financed by FEDER under the PT2020 Partnership Agreement. AMG acknowledges the Portuguese National NMR Network (RNRMN), supported by FCT funds.	Age-Related Eye Dis Study Res Grp, 2001, AM J OPHTHALMOL, V132, P668; Barba I, 2010, INVEST OPHTH VIS SCI, V51, P4416, DOI 10.1167/iovs.10-5348; Burgess LG, 2015, INVEST OPHTH VIS SCI, V56, P5020, DOI 10.1167/iovs.15-16702; Cachulo MD, 2015, OPHTHALMOLOGICA, V233, P119, DOI 10.1159/000371584; Chen LY, 2016, DIABETES, V65, P1099, DOI 10.2337/db15-0661; Chen LY, 2011, J PROTEOME RES, V10, P4876, DOI 10.1021/pr2004874; Danis RP, 2013, INVEST OPHTH VIS SCI, V54, P4548, DOI 10.1167/iovs.13-11804; Diaz SO, 2013, J PROTEOME RES, V12, P2946, DOI 10.1021/pr4002355; Duarte IF, 2012, PROG NUCL MAG RES SP, V62, P51, DOI 10.1016/j.pnmrs.2011.11.002; Duarte IF, 2010, VIRCHOWS ARCH, V457, P715, DOI 10.1007/s00428-010-0993-6; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Guo JG, 2014, GRAEF ARCH CLIN EXP, V252, P925, DOI 10.1007/s00417-014-2619-1; Handa JT, 2012, MOL ASPECTS MED, V33, P418, DOI 10.1016/j.mam.2012.03.006; Hedges L. V., 1981, J ED STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; Hong T, 2011, SURV OPHTHALMOL, V56, P184, DOI 10.1016/j.survophthal.2010.08.007; Karamichos D, 2015, EXP EYE RES, V132, P1, DOI 10.1016/j.exer.2015.01.007; Klein R, 2014, JAMA OPHTHALMOL, V132, P446, DOI 10.1001/jamaophthalmol.2013.7671; Li M, 2014, MOL BIOSYST, V10, P1055, DOI 10.1039/c3mb70386j; Li X, 2011, MOL BIOSYST, V7, P2228, DOI 10.1039/c0mb00341g; Martens H., 1992, MULTIVARIATE CALIBRA; Midelfart A, 2009, ACTA OPHTHALMOL, V87, P697, DOI 10.1111/j.1755-3768.2009.01516.x; Mitta VP, 2013, JAMA OPHTHALMOL, V131, P507, DOI 10.1001/jamaophthalmol.2013.2303; Nicholson JK, 2012, NATURE, V491, P384, DOI 10.1038/nature11708; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Osborn MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072737; Pinto J, 2014, ANALYST, V139, P1168, DOI 10.1039/c3an02188b; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Rocha CM, 2011, J PROTEOME RES, V10, P4314, DOI 10.1021/pr200550p; Sobrin L, 2013, PROG RETIN EYE RES; Suhre K, 2012, NAT REV GENET, V13, P759, DOI 10.1038/nrg3314; Tan SZ, 2016, EYE, V30, P773, DOI 10.1038/eye.2016.37; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Ugurlu N, 2013, CURR EYE RES, V38, P497, DOI 10.3109/02713683.2013.774023; Veselkov KA, 2009, ANAL CHEM, V81, P56, DOI 10.1021/ac8011544; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yonekawa Y, 2015, J CLIN MED, V4, P343, DOI 10.3390/jcm4020343; Young Stephen P, 2009, J Ocul Biol Dis Infor, V2, P235; Young SP, 2009, MOL VIS, V15, P1210	40	39	40	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177749	10.1371/journal.pone.0177749	http://dx.doi.org/10.1371/journal.pone.0177749			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542375	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400075
J	Rhee, EJ; Cho, JH; Lee, DY; Kwon, H; Park, SE; Park, CY; Oh, KW; Park, SW; Lee, WY				Rhee, Eun-Jung; Cho, Jung Hwan; Lee, Da Young; Kwon, Hyemi; Park, Se Eun; Park, Cheol-Young; Oh, Ki-Won; Park, Sung-Woo; Lee, Won-Young			Insulin resistance contributes more to the increased risk for diabetes development in subjects with low lipoprotein(a) level than insulin secretion	PLOS ONE			English	Article							GLYCEMIC CONTROL; NIDDM PATIENTS; ASSOCIATION; MELLITUS; GLUCOSE; HOMEOSTASIS; DISEASE; SIZE	Background Recent studies suggest an association between Lipoprotein(a) [Lp(a)] and the development of diabetes mellitus. We analyzed the association between baseline Lp(a) levels and diabetes development after 4 years of follow-up, in a population of apparently healthy Korean subjects. Methods A total of 2,536 non-diabetic participants (mean age: 41 years, men: 92%) of a health checkup program were included in the study. Diabetes development was defined by fasting blood glucose >= 126 mg/ dL, HbA1c >= 6.5%, and self-reported treatment of diabetes. Homeostasis model assessment (HOMA) indices were used to assess insulin resistance (IR) and insulin secretion (IS). Presence of IR and impaired IS was defined by being in the highest quartile of HOMA-IR and in the lowest quartile HOMA-IS. Results After four years, 3.4% of the participants developed diabetes. The odds ratio (OR) of developing diabetes was lowest in the 4th quartile group of baseline Lp(a) (0.323 [95% CI 0.153-0.685]) with the 1st quartile group as the reference. The subjects with both IR & impaired IS plus baseline Lp(a)<50 mg/dL showed the higher OR for diabetes development compared with those without IR and normal IS as the reference (67.277 [20.218-223.871], and those with IR plus Lp(a)<50 mg/ dL showed higher OR for diabetes than in those with impaired IS and Lp(a)<50 mg/ dL (3.811 [1.938-7.495] vs. 3.452 [1.620-7.353]). Conclusions The subjects with low baseline Lp(a) level showed higher risk for development of diabetes compared with high baseline Lp(a) level, and this was prominent in those with IR than in those with impaired IS.	[Rhee, Eun-Jung; Cho, Jung Hwan; Lee, Da Young; Kwon, Hyemi; Park, Se Eun; Park, Cheol-Young; Oh, Ki-Won; Park, Sung-Woo; Lee, Won-Young] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Endocrinol & Metab, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, WY (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Endocrinol & Metab, Seoul, South Korea.	drlwy@hanmail.net	Rhee, Eun-Jung/M-9294-2015; , Da Young Lee/AAA-1843-2021; LEE, WON-YOUNG/C-7249-2018	Rhee, Eun-Jung/0000-0002-6108-7758; , Da Young Lee/0000-0002-8211-2393; LEE, WON-YOUNG/0000-0002-1082-7592				[Anonymous], 2017, DIABETES CARE, V40, pS1, DOI 10.2337/dc17-S001; Bacova Z, 2012, MED CHEM, V8, P65; BERG K, 1963, ACTA PATHOL MIC SC, V59, P369; Boffa MB, 2004, CLIN BIOCHEM, V37, P333, DOI 10.1016/j.clinbiochem.2003.12.007; Bonfleur ML, 2010, BBA-MOL CELL BIOL L, V1801, P183, DOI 10.1016/j.bbalip.2009.10.012; BRUCKERT E, 1990, JAMA-J AM MED ASSOC, V263, P35, DOI 10.1001/jama.1990.03440010033016; Bustos P, 2005, J PEDIATR ENDOCR MET, V18, P257; CHANG CJ, 1995, DIABETES CARE, V18, P1191, DOI 10.2337/diacare.18.8.1191; Ding L, 2015, J LIPID RES, V56, P920, DOI 10.1194/jlr.P049015; DUELL PB, 1994, DIABETES CARE, V17, P1135, DOI 10.2337/diacare.17.10.1135; Habib SS, 2009, ARQ BRAS CARDIOL, V93, P28, DOI 10.1590/S0066-782X2009000700006; HAFFNER SM, 1991, DIABETES CARE, V14, P302, DOI 10.2337/diacare.14.4.302; HIRAGA T, 1995, DIABETES CARE, V18, P241, DOI 10.2337/diacare.18.2.241; Kamstrup PR, 2013, LANCET DIABETES ENDO, V1, P220, DOI 10.1016/S2213-8587(13)70064-0; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mora S, 2010, CLIN CHEM, V56, P1252, DOI 10.1373/clinchem.2010.146779; Neele DM, 1999, DIABETOLOGIA, V42, P41, DOI 10.1007/s001250051110; Nielsen LB, 1997, ARTERIOSCL THROM VAS, V17, P905, DOI 10.1161/01.ATV.17.5.905; Rainwater DL, 1998, ARTERIOSCL THROM VAS, V18, P1335, DOI 10.1161/01.ATV.18.8.1335; RAINWATER DL, 1994, DIABETES, V43, P942, DOI 10.2337/diabetes.43.7.942; RUIZ J, 1994, DIABETOLOGIA, V37, P585, DOI 10.1007/s001250050151; SCANU AM, 1992, J INTERN MED, V231, P679, DOI 10.1111/j.1365-2796.1992.tb01257.x; Schwartz Kendra L, 2005, BMC Fam Pract, V6, P28, DOI 10.1186/1471-2296-6-28; Seo MH, 2011, J CLIN ENDOCR METAB, V96, pE2050, DOI 10.1210/jc.2011-1857; Wada M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149452; Ye Z, 2014, DIABETES, V63, P332, DOI 10.2337/db13-1144	26	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177500	10.1371/journal.pone.0177500	http://dx.doi.org/10.1371/journal.pone.0177500			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510610	Green Submitted, Green Published, gold			2022-12-26	WOS:000401485500032
J	Li, X; Kang, Y; Roife, D; Lee, Y; Pratt, M; Perez, MR; Dai, B; Koay, EJ; Fleming, JB				Li, X.; Kang, Y.; Roife, D.; Lee, Y.; Pratt, M.; Perez, M. R.; Dai, B.; Koay, E. J.; Fleming, J. B.			Prolonged exposure to extracellular lumican restrains pancreatic adenocarcinoma growth	ONCOGENE			English	Article							CANCER; CELLS; EXPRESSION; DORMANCY	We previously demonstrated that pancreatic stellate cells within pancreatic ductal adenocarcinoma (PDAC) stroma secrete lumican and its presence is associated with prolonged survival of patients with localized PDAC. Here, we observed that extracellular lumican decreases PDAC tumour cell growth in xenograft and syngeneic orthotopic animal models, and induces growth inhibition of low-passage human PDAC cells in a species-specific manner. PDAC cells grown in variant culture conditions and exposed to extracellular lumican display typical characterizations of cancer cell in a quiescent state, such as growth inhibition, apoptosis, G0/G1 arrest and chemoresistance. Importantly, extracellular lumican is associated with diminished ERK1/2 phosphorylation and increased p38 phosphorylation within PDAC cells. We further demonstrated that extracellular lumican physically binds with EGFR to trigger EGFR internalization and downregulation of EGFR and its downstream signal molecule ERK. Lumican enhances casitas B-lineage lymphoma expression, which stabilized the TGF beta Type II receptor sensitizing PDAC cells to TGF beta-mediated activation of p38 and SMAD signals. These provide a mechanism for the shift in signalling and phenotypic changes we observed after prolonged exposure to lumican. Together, our findings demonstrate that stromal lumican restrains PDAC cell growth through mediating cell entry into a quiescent state.	[Li, X.; Kang, Y.; Pratt, M.; Perez, M. R.; Dai, B.; Fleming, J. B.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1515 Holcombe Blvd,Unit 1484, Houston, TX 77030 USA; [Roife, D.] Univ Texas MD Anderson Canc Ctr, Dept Gen Surg, 1515 Holcombe Blvd,Unit 1484, Houston, TX 77030 USA; [Lee, Y.; Koay, E. J.] Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, 1515 Holcombe Blvd,Unit 1484, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Fleming, JB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1515 Holcombe Blvd,Unit 1484, Houston, TX 77030 USA.	jbflemin@mdanderson.org		Roife, David/0000-0001-9052-2248	Skip Viragh Family Foundation; W. Smith Foundation; National Institutes of Health (NIH) [T32CA009599]; CABI GE in-kind grant;  [U54 CA210181-01]; NATIONAL CANCER INSTITUTE [U54CA210181, T32CA009599] Funding Source: NIH RePORTER	Skip Viragh Family Foundation; W. Smith Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CABI GE in-kind grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Skip Viragh Family Foundation (to JF), the W. Smith Foundation (to JF), National Institutes of Health (NIH) grant T32CA009599 (to DR and MRP), U54 CA210181-01 'Center for Immunotherapeutic Transport Oncophysics (CITO)' grant (to EK), and CABI GE in-kind grant (to EK). This research was conducted at the MD Anderson Cancer Center for Advanced Biomedical Imaging in-part with equipment support from General Electric Healthcare.	Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684; Bui AT, 2015, CELL CYCLE, V14, P1218, DOI 10.1080/15384101.2015.1014145; Baba H, 2001, JPN CIRC J, V65, P445, DOI 10.1253/jcj.65.445; Bragado P, 2013, NAT CELL BIOL, V15, P1351, DOI 10.1038/ncb2861; Gruber T, 2013, J MOL CELL BIOL, V5, P358, DOI 10.1093/jmcb/mjt017; Ishiwata T, 2007, ONCOL REP, V18, P537; Kang JM, 2012, ONCOGENE, V31, P5123, DOI 10.1038/onc.2012.18; Kang Y, 2016, CLIN CANCER RES, V22, P4934, DOI 10.1158/1078-0432.CCR-15-2780; Kim MP, 2012, ANN SURG ONCOL, V19, pS395, DOI 10.1245/s10434-011-1839-4; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Li X, 2016, ONCOGENE, V35, P4881, DOI 10.1038/onc.2016.20; Li XQ, 2014, CLIN CANCER RES, V20, P6529, DOI 10.1158/1078-0432.CCR-14-0970; Lu YP, 2002, PATHOL INT, V52, P519, DOI 10.1046/j.1440-1827.2002.01384.x; Maykel J, 2014, DIGEST DIS SCI, V59, P1169, DOI 10.1007/s10620-014-3168-5; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Proia DA, 2005, CELL CYCLE, V4, P1022, DOI 10.4161/cc.4.8.1903; Ranganathan AC, 2006, CELL CYCLE, V5, P1799, DOI 10.4161/cc.5.16.3109; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Salm SN, 2005, J CELL BIOL, V170, P81, DOI 10.1083/jcb.200412015; Suetsugu A, 2012, J CELL BIOCHEM, V113, P2290, DOI 10.1002/jcb.24099; Williams KE, 2011, CANCER MICROENVIRON, V4, P115, DOI 10.1007/s12307-010-0056-1; Yamamoto T, 2012, CANCER LETT, V320, P31, DOI 10.1016/j.canlet.2012.01.023; Yamanaka O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082730; Zuo W, 2013, MOL CELL, V49, P499, DOI 10.1016/j.molcel.2012.12.002	24	25	26	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 21	2017	36	38					5432	5438		10.1038/onc.2017.125	http://dx.doi.org/10.1038/onc.2017.125			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FH7PJ	28534517	Green Accepted			2022-12-26	WOS:000411382100009
J	Larsen, ISB; Narimatsu, Y; Joshi, HJ; Yang, Z; Harrison, OJ; Brasch, J; Shapiro, L; Honig, B; Vakhrushev, SY; Clausen, H; Halim, A				Larsen, Ida Signe Bohse; Narimatsu, Yoshiki; Joshi, Hiren Jitendra; Yang, Zhang; Harrison, Oliver J.; Brasch, Julia; Shapiro, Lawrence; Honig, Barry; Vakhrushev, Sergey Y.; Clausen, Henrik; Halim, Adnan			Mammalian O-mannosylation of cadherins and plexins is independent of protein O-mannosyltransferases 1 and 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; ALPHA-DYSTROGLYCAN; GLYCAN STRUCTURES; MANNOSE GLYCOPROTEOME; MUSCULAR-DYSTROPHY; RIBITOL-PHOSPHATE; GLYCOSYLATION; POMT1; RECOGNITION; MUTATIONS	Protein O-mannosylation is found in yeast and metazoans, and a family of conserved orthologous protein O-mannosyltransferases is believed to initiate this important post-translational modification. We recently discovered that the cadherin superfamily carries O-linked mannose (O-Man) glycans at highly conserved residues in specific extracellular cadherin domains, and it was suggested that the function of E-cadherin was dependent on the O-Man glycans. Deficiencies in enzymes catalyzing O-Man biosynthesis, including the two human protein O-mannosyltransferases, POMT1 and POMT2, underlie a subgroup of congenital muscular dystrophies designated alpha-dystroglycanopathies, because deficient O-Man glycosylation of alpha-dystroglycan disrupts laminin interaction with alpha-dystroglycan and the extracellular matrix. To explore the functions of O-Man glycans on cadherins and protocadherins, we used a combinatorial gene-editing strategy in multiple cell lines to evaluate the role of the two POMTs initiating O-Man glycosylation and the major enzyme elongating O-Man glycans, the protein O-mannose alpha-1,2-N-acetylglucosaminyltransferase, POMGnT1. Surprisingly, O-mannosylation of cadherins and protocadherins does not require POMT1 and/or POMT2 in contrast to alpha-dystroglycan, and moreover, the O-Man glycans on cadherins are not elongated. Thus, the classical and evolutionarily conserved POMT O-mannosylation pathway is essentially dedicated to alpha-dystroglycan and a few other proteins, whereas a novel O-mannosylation process in mammalian cells is predicted to serve the large cadherin superfamily and other proteins.	[Larsen, Ida Signe Bohse; Narimatsu, Yoshiki; Joshi, Hiren Jitendra; Yang, Zhang; Vakhrushev, Sergey Y.; Clausen, Henrik; Halim, Adnan] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark; [Harrison, Oliver J.; Brasch, Julia; Shapiro, Lawrence; Honig, Barry] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Shapiro, Lawrence; Honig, Barry] Columbia Univ, Dept Syst Biol, Zuckerman Mind Brain Behav Inst, New York, NY 10032 USA; [Honig, Barry] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	University of Copenhagen; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Halim, A (corresponding author), Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA.	halim@sund.ku.dk	clausen, henrik/AAD-8016-2021; Shapiro, Lawrence/AAE-7172-2019; Vakhrushev, Sergey Y/A-7638-2014; Yang, Zhang/I-8934-2016; Narimatsu, Yoshiki/G-8388-2019; Joshi, Hiren/B-5739-2016	Vakhrushev, Sergey Y/0000-0002-0418-5765; Clausen, Henrik/0000-0002-0915-5055; Yang, Zhang/0000-0002-4756-5813; Narimatsu, Yoshiki/0000-0003-1428-5695; Joshi, Hiren/0000-0002-8192-2829; Halim, Adnan/0000-0003-1629-187X; Honig, Barry/0000-0002-1835-1031	A. P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene For-maal; Kirsten og Freddy Johansen Fonden; Carlsberg Foundation; Novo Nordisk Foundation; European Union [704228]; Danish Research Councils; National Science Foundation (NSF) [MCB-1412472]; National Institutes of Health [R01-GM10751, R01GM118584]; University of Copenhagen Program of Excellence; Danish National Research Foundation [DNRF107]; Novo Nordisk Fonden [NNF15OC0016548] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118584, R01GM107571] Funding Source: NIH RePORTER; Direct For Biological Sciences [1412472] Funding Source: National Science Foundation	A. P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene For-maal; Kirsten og Freddy Johansen Fonden; Carlsberg Foundation(Carlsberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Union(European Commission); Danish Research Councils(Det Frie Forskningsrad (DFF)); National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Copenhagen Program of Excellence; Danish National Research Foundation(Danmarks Grundforskningsfond); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by A. P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til Almene For-maal, Kirsten og Freddy Johansen Fonden, The Carlsberg Foundation, The Novo Nordisk Foundation, The European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie Grant 704228, The Danish Research Councils, National Science Foundation (NSF) Grant MCB-1412472 (to B. H.), National Institutes of Health Grants R01-GM10751 and R01GM118584 (to L. S.), the University of Copenhagen Program of Excellence, and the Danish National Research Foundation Grant DNRF107. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akasaka-Manya K, 2011, BIOCHEM BIOPH RES CO, V411, P721, DOI 10.1016/j.bbrc.2011.07.012; Amano K, 2008, P NATL ACAD SCI USA, V105, P3232, DOI 10.1073/pnas.0710412105; Avsar-Ban E, 2010, GLYCOBIOLOGY, V20, P1089, DOI 10.1093/glycob/cwq069; Balci B, 2005, NEUROMUSCULAR DISORD, V15, P271, DOI 10.1016/j.nmd.2005.01.013; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bartels MF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166119; Bausewein D, 2016, J BIOL CHEM, V291, P18006, DOI 10.1074/jbc.M116.739128; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Bleckmann C, 2009, BIOL CHEM, V390, P627, DOI 10.1515/BC.2009.044; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Breloy I, 2008, J BIOL CHEM, V283, P18832, DOI 10.1074/jbc.M802834200; Breloy I, 2012, BIOL CHEM, V393, P709, DOI 10.1515/hsz-2012-0214; Carvalho S, 2016, ONCOTARGET, V7, P65231, DOI 10.18632/oncotarget.11245; Chai WG, 1999, EUR J BIOCHEM, V263, P879, DOI 10.1046/j.1432-1327.1999.00572.x; Dwyer CA, 2012, NEUROSCIENCE, V220, P47, DOI 10.1016/j.neuroscience.2012.06.026; FINNE J, 1979, J BIOL CHEM, V254, P295; Gerin I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11534; Gill DJ, 2013, P NATL ACAD SCI USA, V110, pE3152, DOI 10.1073/pnas.1305269110; Gill DJ, 2010, J CELL BIOL, V189, P843, DOI 10.1083/jcb.201003055; Girrbach V, 2003, J BIOL CHEM, V278, P12554, DOI 10.1074/jbc.M212582200; Halim A, 2015, P NATL ACAD SCI USA, V112, P15648, DOI 10.1073/pnas.1511743112; Halmo SM, 2017, J BIOL CHEM, V292, P2101, DOI 10.1074/jbc.M116.764712; Harrison R, 2012, GLYCOBIOLOGY, V22, P662, DOI 10.1093/glycob/cws002; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Kanagawa M, 2016, CELL REP, V14, P2209, DOI 10.1016/j.celrep.2016.02.017; KRUSIUS T, 1986, J BIOL CHEM, V261, P8237; Kuwabara N, 2016, P NATL ACAD SCI USA, V113, P9280, DOI 10.1073/pnas.1525545113; Lommel M, 2013, P NATL ACAD SCI USA, V110, P21024, DOI 10.1073/pnas.1316753110; Lommel M, 2011, J BIOL CHEM, V286, P39768, DOI 10.1074/jbc.M111.281196; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2003, BIOCHEM BIOPH RES CO, V306, P93, DOI 10.1016/S0006-291X(03)00924-0; Martinez T, 2007, J CHROMATOGR A, V1156, P183, DOI 10.1016/j.chroma.2007.04.050; MENGELING BJ, 1995, P NATL ACAD SCI USA, V92, P502, DOI 10.1073/pnas.92.2.502; Mercuri E, 2006, NEUROMUSCULAR DISORD, V16, P446, DOI 10.1016/j.nmd.2006.03.016; Nakamura N, 2010, GLYCOBIOLOGY, V20, P381, DOI 10.1093/glycob/cwp189; Neubert P, 2016, CURR OPIN CELL BIOL, V41, P100, DOI 10.1016/j.ceb.2016.04.010; Neubert P, 2016, MOL CELL PROTEOMICS, V15, P1323, DOI 10.1074/mcp.M115.057505; Nilsson J, 2010, GLYCOBIOLOGY, V20, P1160, DOI 10.1093/glycob/cwq082; Pacharra S, 2013, J PROTEOME RES, V12, P1764, DOI 10.1021/pr3011028; Pacharra S, 2012, J PROTEOME RES, V11, P3955, DOI 10.1021/pr200996y; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Praissman JL, 2016, ELIFE, V5, DOI 10.7554/eLife.14473; Praissman JL, 2014, BIOCHEMISTRY-US, V53, P3066, DOI 10.1021/bi500153y; Rubinstein R, 2015, CELL, V163, P629, DOI 10.1016/j.cell.2015.09.026; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; SMITH PL, 1990, P NATL ACAD SCI USA, V87, P7275, DOI 10.1073/pnas.87.18.7275; Stalnaker SH, 2010, J BIOL CHEM, V285, P24882, DOI 10.1074/jbc.M110.126474; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Toledo AG, 2012, GLYCOBIOLOGY, V22, P1413, DOI 10.1093/glycob/cws109; Tran DT, 2012, J BIOL CHEM, V287, P20967, DOI 10.1074/jbc.M112.370387; van Meel E, 2014, P NATL ACAD SCI USA, V111, P3532, DOI 10.1073/pnas.1401417111; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Vester-Christensen MB, 2013, P NATL ACAD SCI USA, V110, P21018, DOI 10.1073/pnas.1313446110; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Yang Z, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv126; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	62	27	27	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11586	11598		10.1074/jbc.M117.794487	http://dx.doi.org/10.1074/jbc.M117.794487			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28512129	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000405119600037
J	Wang, CX; Pallan, PS; Zhang, W; Lei, L; Yoshimoto, FK; Waterman, MR; Egli, M; Guengerich, FP				Wang, Chunxue; Pallan, Pradeep S.; Zhang, Wei; Lei, Li; Yoshimoto, Francis K.; Waterman, Michael R.; Egli, Martin; Guengerich, F. Peter			Functional analysis of human cytochrome P450 21A2 variants involved in congenital adrenal hyperplasia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							21-HYDROXYLASE DEFICIENCY; CIRCULAR-DICHROISM; MUTATIONS; 17,20-LYASE; B(5); STEROIDOGENESIS; DEUTERIUM; P450C17	Cytochrome P450 (P450, CYP) 21A2 is the major steroid 21-hydroxylase, converting progesterone to 11-deoxycorticosterone and 17 alpha-hydroxyprogesterone (17 alpha-OH-progesterone) to 11-deoxycortisol. More than 100 CYP21A2 variants give rise to congenital adrenal hyperplasia (CAH). We previously reported a structure of WT human P450 21A2 with bound progesterone and now present a structure bound to the other substrate (17 alpha-OH-progesterone). We found that the 17 alpha-OH-progesterone-and progesterone-bound complex structures are highly similar, with only some minor differences in surface loop regions. Twelve P450 21A2 variants associated with either salt-wasting or nonclassical forms of CAH were expressed, purified, and analyzed. The catalytic activities of these 12 variants ranged from 0.00009% to 30% of WT P450 21A2 and the extent of heme incorporation from 10% to 95% of the WT. Substrate dissociation constants (K-s) for four variants were 37-13,000-fold higher than for WT P450 21A2. Cytochrome b(5), which augments several P450 activities, inhibited P450 21A2 activity. Similar to the WT enzyme, high noncompetitive intermolecular kinetic deuterium isotope effects (>= 5.5) were observed for all six P450 21A2 variants examined for 21-hydroxylation of 21-d(3)-progesterone, indicating that C-H bond breaking is a rate-limiting step over a 104-fold range of catalytic efficiency. Using UV-visible and CD spectroscopy, we found that P450 21A2 thermal stability assessed in bacterial cells and with purified enzymes differed among salt-wasting-and nonclassical-associated variants, but these differences did not correlate with catalytic activity. Our in-depth investigation of CAH-associated P450 21A2 variants reveals critical insight into the effects of disease-causing mutations on this important enzyme.	[Wang, Chunxue; Pallan, Pradeep S.; Zhang, Wei; Lei, Li; Yoshimoto, Francis K.; Waterman, Michael R.; Egli, Martin; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA; [Wang, Chunxue] Vanderbilt Univ, Med Ctr, Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA; [Yoshimoto, Francis K.] Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA	Vanderbilt University; Vanderbilt University; University of Texas System; University of Texas at San Antonio (UTSA)	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.; Egli, M (corresponding author), Dept Biochem, 868A Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	martin.egli@vanderbilt.edu; f.guengerich@vanderbilt.edu	Wang, Chunxue/E-1840-2018	Wang, Chunxue/0000-0002-7462-9077; Yoshimoto, Francis/0000-0002-2308-2999; Zhang, Wei/0000-0001-9459-680X	National Institutes of Health [R01 GM103937]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM103937 (to M. E. and F. P. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Auchus R. J., 2015, CYTOCHROME P450 STRU, P851; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; CHEN YH, 1971, BIOCHEM BIOPH RES CO, V44, P1285, DOI 10.1016/S0006-291X(71)80225-5; Daniels F., 1966, PHYS CHEM, P612; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; Haider S, 2013, P NATL ACAD SCI USA, V110, P2605, DOI 10.1073/pnas.1221133110; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; Idkowiak J, 2012, J CLIN ENDOCR METAB, V97, pE465, DOI 10.1210/jc.2011-2413; Johnston Wayne A, 2013, Methods Mol Biol, V987, P189, DOI 10.1007/978-1-62703-321-3_17; KATAGIRI M, 1982, BIOCHEM BIOPH RES CO, V108, P379, DOI 10.1016/0006-291X(82)91877-0; KATAGIRI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P343, DOI 10.1006/abbi.1995.1173; Kok RC, 2010, J CLIN ENDOCR METAB, V95, P994, DOI 10.1210/jc.2008-1745; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; New MI, 2003, MOL CELL ENDOCRINOL, V211, P75, DOI 10.1016/j.mce.2003.09.013; NORTHROP DB, 1982, METHOD ENZYMOL, V87, P607; OMURA T, 1964, J BIOL CHEM, V239, P2379; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Pallan PS, 2015, MOL ENDOCRINOL, V29, P1375, DOI 10.1210/ME.2015-1127; Pallan PS, 2015, J BIOL CHEM, V290, P13128, DOI 10.1074/jbc.M115.646307; Parsa AA, 2017, J STEROID BIOCHEM, V165, P2, DOI 10.1016/j.jsbmb.2016.06.015; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Soardi FC, 2008, J CLIN ENDOCR METAB, V93, P2416, DOI 10.1210/jc.2007-2594; TUSIELUNA MT, 1990, J BIOL CHEM, V265, P20916; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245; Yoshimoto FK, 2016, J BIOL CHEM, V291, P17143, DOI 10.1074/jbc.M116.732966; Yoshimoto FK, 2012, BIOCHEMISTRY-US, V51, P7064, DOI 10.1021/bi300895w; Zhao B, 2012, J BIOL CHEM, V287, P10613, DOI 10.1074/jbc.M111.323501	32	25	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10767	10778		10.1074/jbc.M117.792465	http://dx.doi.org/10.1074/jbc.M117.792465			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28539365	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000404391000002
J	Joestl, J; Lang, N; Bukaty, A; Tiefenboeck, TM; Platzer, P				Joestl, Julian; Lang, Nikolaus; Bukaty, Adam; Tiefenboeck, Thomas M.; Platzer, Patrick			Osteoporosis associated vertebral fractures-Health economic implications	PLOS ONE			English	Article							VITAMIN-D; PERCUTANEOUS VERTEBROPLASTY; NONSURGICAL MANAGEMENT; COMPRESSION FRACTURES; KYPHOPLASTY; PREVALENCE; SURVIVAL; IMPACT; RISK	Introduction Osteoporosis-associated vertebral fractures represent an increasing clinical and public health problem, one with important socioeconomic effects within western countries. The purpose of this study was to analyse demographic, medical, gender and socioeconomic aspects of osteoporotic vertebral fractures of the thoracic or lumbar spine over a period of at least 10-years. Material and methods Included for analysis were 694 patients who had suffered a vertebral fracture due to primary or secondary osteoporosis, and who were treated at our Level-I trauma center between 2000 and 2013. Collected data included demographic, medical and socioeconomic aspects. Results Clinical results revealed that 669 patients (96%) were treated conservatively. The remaining 25 patients (4%) underwent surgical therapy: 4 were treated with vertebroplasty, 15 with kyphoplasty and 6 patients with posterior stabilization. The mean age was 75.6 years (range: 50-98), with the vast majority of patients being female (n = 515). A statistically significant demographic difference (i.e., increase) in fractures was observed between the age groups 60-69 and 70-79 (p = 0.041). Concerning socioeconomic aspects, statistical analysis showed that the number of sick leaves and the need for professional domestic help was higher in female patients. Concerning treatment costs, statistical analysis did not reveal any significant differences between female and male patients. Conclusion Significant gender differences-to the detriment of the female population-could be demonstrated within this study. A regrettably low rate of adequate treatment after diagnosis of osteoporosis and its associated fractures-specifically relating to primary and secondary prevention-could also be identified. To prospectively avoid complications and consequential cost increases, more awareness of the necessity for prevention, early diagnosis and adequate treatment of osteoporosis and its related fractures should be considered.	[Joestl, Julian; Lang, Nikolaus; Tiefenboeck, Thomas M.; Platzer, Patrick] Med Univ Vienna, Dept Trauma Surg, Vienna, Austria; [Bukaty, Adam] Med Univ Vienna, Div Gen Anaesthesia & Intens Care Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Joestl, J (corresponding author), Med Univ Vienna, Dept Trauma Surg, Vienna, Austria.	julian.joestl@meduniwien.ac.at		Tiefenboeck, Thomas/0000-0002-8698-8341				Amin S, 2014, J BONE MINER RES, V29, P581, DOI 10.1002/jbmr.2072; Aras EL, 2015, COST EFFECTIVENESS S; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Chen AT, 2013, J BONE JOINT SURG AM, V95A, P1729, DOI 10.2106/JBJS.K.01649; Chen LX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123153; Cooper C, 1992, J BONE MINER RES, V7; Dempster David W, 2011, Am J Manag Care, V17 Suppl 6, pS164; Epstein S, 2006, DRUG AGING, V23, P617, DOI 10.2165/00002512-200623080-00001; Felsenberg D, 2002, J BONE MINER RES, V17, P716; Haussler B, 2007, OSTEOPOROSIS INT, V18, P77, DOI 10.1007/s00198-006-0206-y; Hazzard MA, 2014, ASIAN SPINE J, V8, P605, DOI 10.4184/asj.2014.8.5.605; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Hillmeier J, 2004, ORTHOPADE, V33, P893, DOI 10.1007/s00132-004-0669-5; Hilmi I, 2013, J CLIN ENDOCR METAB, V98, P2415, DOI 10.1210/jc.2013-1147; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Lange A, 2014, SPINE, V39, P318, DOI 10.1097/BRS.0000000000000135; Lindsay R, 2001, JAMA-J AM MED ASSOC, V285, P320, DOI 10.1001/jama.285.3.320; Maier GS, 2015, BONE JOINT J, V97B, P89, DOI 10.1302/0301-620X.97B1.34558; Orsini LS, 2005, OSTEOPOROSIS INT, V16, P359, DOI 10.1007/s00198-004-1694-2; Papanastassiou ID, 2012, EUR SPINE J, V21, P1826, DOI 10.1007/s00586-012-2314-z; Qu B, 2014, OSTEOPOROSIS INT, V25, P1853, DOI 10.1007/s00198-014-2699-0; Svedbom A, 2013, OSTEOPOROSIS INT, V24, P355, DOI 10.1007/s00198-012-2102-y; Wang H, 2015, PAIN PHYSICIAN, V18, P209; Yan DL, 2011, ARCH ORTHOP TRAUM SU, V131, P645, DOI 10.1007/s00402-010-1188-y	24	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178209	10.1371/journal.pone.0178209	http://dx.doi.org/10.1371/journal.pone.0178209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542552	Green Published, Green Submitted, gold			2022-12-26	WOS:000402058400069
J	Liu, ZY; He, KW; Ma, QH; Yu, Q; Liu, CY; Ndege, I; Wang, XZ; Yu, ZY				Liu, Zhaoyun; He, Kewen; Ma, Qinghua; Yu, Qian; Liu, Chenyu; Ndege, Isabella; Wang, Xinzhao; Yu, Zhiyong			Autophagy inhibitor facilitates gefitinib sensitivity in vitro and in vivo by activating mitochondrial apoptosis in triple negative breast cancer	PLOS ONE			English	Article							CELL LUNG-CANCER; TYROSINE KINASE INHIBITOR; OXYGEN SPECIES ROS; ENHANCED AUTOPHAGY; CYCLE ARREST; EGFR; GROWTH; RESISTANCE; SURVIVAL; FAMILY	Epidermal growth factor receptor (EGFR) is over-expressed in about 50% of Triple negative breast cancers (TNBCs), but EGFR inhibitors have not been effective in treating TNBC patients. Increasing evidence supports that autophagy was related to drug resistance at present. However, the role and the mechanism of autophagy to the treatment of TNBC remain unknown. In the current study, we investigated the effect of autophagy inhibitor to gefitinib (Ge) in TNBC cells in vitro and in nude mice vivo. Our study demonstrated that inhibition of autophagy by 3-Methyladenine or bafilomycin A1 improved Ge's sensitivity to MDA-MB-231 and MDA-MB-468 cells, as evidence from stronger inhibition of cell vitality and colony formation, higher level of G0/G1 arrest and DNA damage, and these effects were verified in nude mice vivo. Our data showed that the mitochondrial-dependent apoptosis pathway was activated in favor of promoting apoptosis in the therapy of Ge combined autophagy inhibitor, as the elevation of BAX/Bcl-2, Cytochrome C, and CASP3. These results demonstrated that targeting autophagy should be considered as an effective therapeutic strategy to enhance the sensitivity of EGFR inhibitors on TNBC.	[Liu, Zhaoyun; He, Kewen; Ndege, Isabella] Univ Jinan, Shandong Acad Med Sci, Sch Med & Life Sci, Jinan, Shandong, Peoples R China; [Liu, Zhaoyun; He, Kewen; Ma, Qinghua; Ndege, Isabella; Wang, Xinzhao; Yu, Zhiyong] Shandong Univ, Shandong Canc Hosp, Shandong Acad Med Sci, Dept Oncol, Jinan, Shandong, Peoples R China; [Yu, Qian] Univ Kentucky, Coll Med, Lexington, KY USA; [Liu, Chenyu] Emory Univ, Dept Biol, Winship Canc Inst, Atlanta, GA 30322 USA	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of Jinan; University of Kentucky; Emory University	Yu, ZY (corresponding author), Shandong Univ, Shandong Canc Hosp, Shandong Acad Med Sci, Dept Oncol, Jinan, Shandong, Peoples R China.	drzhiyongyu@aliyun.com			Natural Science Foundation of Shandong Province [ZR2015HM055]; key research and development plan of Shandong Province [2016GSF201185]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); key research and development plan of Shandong Province	The reagents were supported by the Grants from the Natural Science Foundation of Shandong Province (ZR2015HM055). The URL is http://jihIx.sdste.gov.cn/STDPMS/ZR/ ProjectAppitcation/MyProjectList.aspx, and ZYY received the funding; Laboratory supplies was supported by the Grants from the key research and development plan of Shandong Province (2016GSF201185). The URL is http://jihIx.sdstc. gov.cniSTDPMS/GG/ProtectApplication/MyProjectList.aspx, and ZYY received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anido J, 2003, CLIN CANCER RES, V9, P1274; Bao PP, 2015, EPIDEMIOLOGY, V26, P909, DOI 10.1097/EDE.0000000000000373; Baselga J, 2005, J CLIN ONCOL, V23, P5323, DOI 10.1200/JCO.2005.08.326; Bellizzi A, 2015, INT J ONCOL, V46, P1214, DOI 10.3892/ijo.2014.2805; Chen M, 2014, INT J MOL MED, V34, P276, DOI 10.3892/ijmm.2014.1772; Cufi S, 2012, ONCOTARGET, V3, P1600; Dragowska WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076503; Guo JY, 2013, CELL, V155, P1216, DOI 10.1016/j.cell.2013.11.019; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018691; He JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129842; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Hsin-Ling Y, 2016, INT J MOL SCI, V17; Huang J, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.22; Huang SW, 2013, TOXICOL APPL PHARM, V267, P113, DOI 10.1016/j.taap.2012.12.016; Janmaat ML, 2003, ONCOLOGIST, V8, P576, DOI 10.1634/theoncologist.8-6-576; Jeong Chul-Ho, 2016, J Cancer Prev, V21, P13, DOI 10.15430/JCP.2016.21.1.13; Kang M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020321; Karsli-Uzunbas G, 2014, CANCER DISCOV, V4, P914, DOI 10.1158/2159-8290.CD-14-0363; Kavitha N, 2017, J ETHNOPHARMACOL, V201, P42, DOI 10.1016/j.jep.2017.02.041; Kim SJ, 2015, INT J MOL SCI, V16, P21486, DOI 10.3390/ijms160921486; Lee JG, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0285-4; Li M, 2016, INT J MOL SCI, V17; Li YY, 2013, LUNG CANCER, V81, P354, DOI 10.1016/j.lungcan.2013.05.012; Liu DL, 2014, J FORMOS MED ASSOC, V113, P141, DOI 10.1016/j.jfma.2012.10.017; Liu TR, 2011, MOL CANCER THER, V10, P1460, DOI 10.1158/1535-7163.MCT-10-0925; Masui A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162786; Moulder SL, 2001, CANCER RES, V61, P8887; Mukai S, 2016, INT J ONCOL, V48, P45, DOI 10.3892/ijo.2015.3237; Pawlowska E, 2015, INT J MOL SCI, V16, P27535, DOI 10.3390/ijms161126049; Renault TT, 2014, J BIOL CHEM, V289, P26481, DOI 10.1074/jbc.M114.569632; Ribback S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101618; Sakuma Y, 2013, LAB INVEST, V93, P1137, DOI 10.1038/labinvest.2013.102; Schointuch MN, 2014, GYNECOL ONCOL, V134, P346, DOI 10.1016/j.ygyno.2014.05.015; Sharma K, 2014, AUTOPHAGY, V10, P2346, DOI 10.4161/15548627.2014.993283; Shen H, 2017, ONCOL RES; Shi YG, 2006, CURR OPIN CELL BIOL, V18, P677, DOI 10.1016/j.ceb.2006.09.006; Sickmier EA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163366; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Smith PM, 2016, F1000RESEARCH, V5; Sobhakumari A, 2013, TOXICOL APPL PHARM, V272, P736, DOI 10.1016/j.taap.2013.07.013; Strohecker AM, 2013, CANCER DISCOV, V3, P1272, DOI 10.1158/2159-8290.CD-13-0397; Sugita S, 2015, BIOCHEM BIOPH RES CO, V461, P28, DOI 10.1016/j.bbrc.2015.03.162; Sui XB, 2014, MOL CLIN ONCOL, V2, P8, DOI 10.3892/mco.2013.187; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tang MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119135; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tricarico PM, 2015, INT J MOL SCI, V16, P16067, DOI 10.3390/ijms160716067; Wang CX, 2009, ANNU REV GENET, V43, P95, DOI 10.1146/annurev-genet-102108-134850; Wang XD, 2001, GENE DEV, V15, P2922; Williams CB, 2015, ADV CANCER RES, V127, P253, DOI 10.1016/bs.acr.2015.04.008; Xie L, 2016, ONCOTARGET, V7, P1651, DOI 10.18632/oncotarget.6410; Xu H, 2005, MOL CANCER THER, V4, P435; Yang ZY, 2015, CURR CANCER DRUG TAR, V15, P215, DOI 10.2174/1568009615666150126161939; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang LH, 2016, APOPTOSIS, V21, P473, DOI 10.1007/s10495-016-1214-9; Zhu YX, 2016, CELL PHYSIOL BIOCHEM, V40, P297, DOI 10.1159/000452546; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	58	34	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177694	10.1371/journal.pone.0177694	http://dx.doi.org/10.1371/journal.pone.0177694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531218	gold, Green Published, Green Submitted			2022-12-26	WOS:000402058400025
J	Stein, AM; Munive, V; Fernandez, AM; Nunez, A; Aleman, IT				Miki Stein, Angelica; Munive, Victor; Fernandez, Ana M.; Nunez, Angel; Torres Aleman, Ignacio			Acute exercise does not modify brain activity and memory performance in APP/PS1 mice	PLOS ONE			English	Article							MOUSE MODEL; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; THETA RHYTHM; EEG; ASSOCIATION; NETWORK; SLEEP; OSCILLATIONS; SUPPRESSION	Age is the main risk factor for Alzheimer A s disease (AD). With an increasingly aging population, development of affordable screening techniques to determine cognitive status will help identify population-at-risk for further follow-up. Because physical exercise is known to modulate cognitive performance, we used it as a functional test of cognitive health. Mice were submitted to treadmill running at moderate speed for 30 min, and their brain activity was monitored before and after exercise using electrocorticogram (ECG) recordings. After exercise, normal, but not APP/PS1 mice, a well established AD model, showed significantly increased ECG theta rhythm. At the same time normal, but not AD mice, showed significantly enhanced performance in a spatial memory test after exercise. Therefore, we postulate that a running bout coupled to pre-and post-exercise brain activity recordings will help identify individuals with cognitive alterations, by determining the presence or absence of exercise-specific changes in brain activity. Work in humans using a bout of moderate exercise plus electroencephalography, a clinically affordable procedure, is warranted.	[Miki Stein, Angelica; Munive, Victor; Fernandez, Ana M.; Torres Aleman, Ignacio] Cajal Inst Neurobiol, Madrid, Spain; [Miki Stein, Angelica; Munive, Victor; Fernandez, Ana M.; Torres Aleman, Ignacio] Ciberned, Madrid, Spain; [Miki Stein, Angelica] Univ Estadual Paulista, Sao Paulo, Brazil; [Nunez, Angel] Univ Autonoma Madrid, Sch Med, Madrid, Spain	CIBERNED; Universidade Estadual Paulista; Autonomous University of Madrid	Aleman, IT (corresponding author), Cajal Inst Neurobiol, Madrid, Spain.; Aleman, IT (corresponding author), Ciberned, Madrid, Spain.	torres@cajal.csic.es	Herrera, Victor Munive/AAW-4463-2020; Stein, Angelica/ABE-3716-2020; Nuñez, Angel/Y-9137-2019; Torres-Aleman, Ignacio/A-1613-2008	Stein, Angelica/0000-0002-2404-808X; Nuñez, Angel/0000-0002-8013-4812; Torres-Aleman, Ignacio/0000-0001-8107-7947; Fernandez, Ana M./0000-0001-5160-3854	Capes [PDSE 99999.010743/2014-06]; Fapesp [2013/19729-0]; Universidade Estadual Paulista (Brazil); FPI fellowship; Ciberned;  [SAF2013-40710-R/SAF2016-76462 AEI/FEDER]	Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Universidade Estadual Paulista (Brazil); FPI fellowship(Spanish Government); Ciberned(Instituto de Salud Carlos III); 	AMS was supported by Capes PDSE 99999.010743/2014-06 and Fapesp 2013/19729-0, Universidade Estadual Paulista (Brazil). VM is a recipient of an FPI fellowship. We are thankful to L. Guinea for excellent technical support. This work was funded by grants SAF2013-40710-R/SAF2016-76462 AEI/FEDER, and by Ciberned.	Born HA, 2015, NEUROSCIENCE, V286, P251, DOI 10.1016/j.neuroscience.2014.11.051; Born HA, 2014, J NEUROSCI, V34, P3826, DOI 10.1523/JNEUROSCI.5171-13.2014; Boyle PA, 2009, ARCH NEUROL-CHICAGO, V66, P1339, DOI 10.1001/archneurol.2009.240; Brummer V, 2011, MED SCI SPORT EXER, V43, P1863, DOI 10.1249/MSS.0b013e3182172a6f; Byun KH, 2014, NEUROIMAGE, V98, P336, DOI 10.1016/j.neuroimage.2014.04.067; Crabbe JB, 2004, PSYCHOPHYSIOLOGY, V41, P563, DOI 10.1111/j.1469-8986.2004.00176.x; Dimitrova J, 2016, AGING CLIN EXP RES; Dubois B, 2016, ALZHEIMERS DEMENT, V12, P292, DOI 10.1016/j.jalz.2016.02.002; Enders H, 2016, J NEUROPHYSIOL, V115, P379, DOI 10.1152/jn.00497.2015; Faigle R, 2013, J CLIN NEUROPHYSIOL, V30, P505, DOI 10.1097/WNP.0b013e3182a73db9; Fernandez AM, 2012, MOL PSYCHIATR, V17, P705, DOI 10.1038/mp.2011.128; Fonseca LC, 2009, CLIN EEG NEUROSCI, V40, P168, DOI 10.1177/155005940904000309; Forbes D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub3; Goutagny R, 2013, EUR J NEUROSCI, V37, P1896, DOI 10.1111/ejn.12233; Hoffmann K, 2016, J ALZHEIMERS DIS, V50, P443, DOI 10.3233/JAD-150817; Huttenrauch M, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.65; Hyodo K, 2016, NEUROIMAGE, V125, P291, DOI 10.1016/j.neuroimage.2015.09.062; Ittner AA, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0149-z; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Jyoti A, 2015, NEUROBIOL AGING, V36, P2768, DOI 10.1016/j.neurobiolaging.2015.07.001; Jyoti A, 2010, J ALZHEIMERS DIS, V22, P873, DOI 10.3233/JAD-2010-100879; Kamijo K, 2009, J GERONTOL B-PSYCHOL, V64, P356, DOI 10.1093/geronb/gbp030; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Lulic T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173672; Mancuso M, 2003, EXP NEUROL, V182, P421, DOI 10.1016/S0014-4886(03)00092-X; Muller J, 2017, MAYO CLIN PROC, V92, P211, DOI 10.1016/j.mayocp.2016.10.020; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Patten AR, 2013, LEARN MEMORY, V20, P642, DOI 10.1101/lm.030635.113; Paul CM, 2009, BEHAV BRAIN RES, V203, P151, DOI 10.1016/j.bbr.2009.05.022; Pedersen BK, 2009, EXP PHYSIOL, V94, P1153, DOI 10.1113/expphysiol.2009.048561; Platt B, 2011, BIOCHEM SOC T, V39, P874, DOI 10.1042/BST0390874; Rivas J, 1996, EXP BRAIN RES, V108, P113; Ropelle ER, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000465; Rubio SE, 2012, FASEB J, V26, P4458, DOI 10.1096/fj.12-208413; SARTER M, 1988, PSYCHOPHARMACOLOGY, V94, P491, DOI 10.1007/BF00212843; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Schneider F, 2014, PHYSIOL BEHAV, V135, P25, DOI 10.1016/j.physbeh.2014.05.041; Sellers KK, 2016, CELL REP, V16, P2864, DOI 10.1016/j.celrep.2016.08.055; Shah H, 2016, LANCET NEUROL, V15, P1283, DOI 10.1016/S1474-4422(16)30235-6; Siette J, 2014, LEARN MEMORY, V21, P73, DOI 10.1101/lm.032557.113; Siwek ME, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/781731; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; STRANAHAN AM, 2008, NEUROBIOL AGING; Takimoto M, 2014, J APPL PHYSIOL, V116, P1238, DOI 10.1152/japplphysiol.01288.2013; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; van der Hiele K, 2007, CLIN NEUROPHYSIOL, V118, P1931, DOI 10.1016/j.clinph.2007.05.070; Vertes RP, 2005, HIPPOCAMPUS, V15, P923, DOI 10.1002/hipo.20118; Vissing J, 1996, J CEREBR BLOOD F MET, V16, P729, DOI 10.1097/00004647-199607000-00025; Winter B, 2007, NEUROBIOL LEARN MEM, V87, P597, DOI 10.1016/j.nlm.2006.11.003	49	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178247	10.1371/journal.pone.0178247	http://dx.doi.org/10.1371/journal.pone.0178247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542392	Green Published, Green Submitted, gold			2022-12-26	WOS:000402058400072
J	Zhu, XH; Li, B; Ma, CM; Zhu, C; Wu, L; Liu, H				Zhu, Xiao Hong; Li, Bing; Ma, Chun Mei; Zhu, Cheng; Wu, Li; Liu, Hui			Late Neolithic phytolith and charcoal records of human activities and vegetation change in Shijiahe culture, Tanjialing site, China	PLOS ONE			English	Article							ORYZA-SATIVA POACEAE; ENVIRONMENTAL-CHANGE; CLIMATE-CHANGE; HOLOCENE; ARCHAEOLOGY; YANGTZE; COLLAPSE; WILD; SEA; CLASSIFICATION	There is significant archaeological evidence marking the collapse of the Shijiahe culture in the middle reaches of the Yangtze River in China during the late Neolithic Period. However, the causes for this cultural collapse remain unclear. Our sedimentary records from a 3.3 m long profile and 76 phytolith and charcoal samples from the Tanjialing archaeological sites provide records of interactions between an ancient culture and vegetation change. During the early Shijiahe culture (c, 4850-4400 cal BP), the climate was warm and humid. Fire was intensively used to clear the vegetation. In the mid-period of the Shijiahe culture (c, 4400-4200 cal BP), the climate became slightly dry-cold and this was accompanied by decreasing water, leading to settlements. From c, 4200 cal BP, severe drought eroded the economic foundation of rice-cultivation. These conditions forced people to abandon the Shijiahe ancient city to find water in other regions, leading to the collapse of the Shijiahe culture.	[Zhu, Xiao Hong; Ma, Chun Mei; Zhu, Cheng] Nanjing Univ, Coll Geog & Oceanog Sci, Nanjing, Jiangsu, Peoples R China; [Zhu, Xiao Hong] Jiangxi Normal Univ, Coll Business, Nanchang, Jiangxi, Peoples R China; [Li, Bing] Hebei Normal Univ, Coll Resources & Environm, Shijiazhuang, Peoples R China; [Wu, Li] Anhui Normal Univ, Coll Terr Resources & Tourism, Wuhu, Peoples R China; [Wu, Li] Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian, Peoples R China; [Liu, Hui] Hubei Prov Inst Cultural Rel & Archaeol, Wuhan, Peoples R China	Nanjing University; Jiangxi Normal University; Hebei Normal University; Anhui Normal University; Chinese Academy of Sciences; Institute of Earth Environment, CAS	Ma, CM; Zhu, C (corresponding author), Nanjing Univ, Coll Geog & Oceanog Sci, Nanjing, Jiangsu, Peoples R China.	chunmeima@nju.edu.cn; zhuchengnj@126.com	Wu, Li/E-3821-2013	Wu, Li/0000-0003-2578-2769	National Natural Science Foundation of China [41171163, 41371204]; Major Program of National Social Science Foundation of China [11ZD183]; Open Foundation of State Key Laboratory of Loess and Quaternary Geology, Institute of Earth Environment, CAS [SKLLQG1422]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of National Social Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Foundation of State Key Laboratory of Loess and Quaternary Geology, Institute of Earth Environment, CAS(Chinese Academy of Sciences); Priority Academic Program Development of Jiangsu Higher Education Institutions	This research was jointly funded by the National Natural Science Foundation of China (Grant Nos. 41171163, 41371204), Major Program of National Social Science Foundation of China (Grant No. 11&ZD183), Open Foundation of State Key Laboratory of Loess and Quaternary Geology, Institute of Earth Environment, CAS (Grant No. SKLLQG1422) and Priority Academic Program Development of Jiangsu Higher Education Institutions.	Andersen ST, 1986, PALAEOECOLOGICAL STU, P165; [Anonymous], 1997, EARTH SCI FRONT; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; BROWN DA, 1984, J ARCHAEOL SCI, V11, P345, DOI 10.1016/0305-4403(84)90016-5; Chen F. H., 1991, HOLOCENE, V1, P151, DOI [DOI 10.1177/095968369100100207, 10.1177/095968369100100207]; Chen FH, 1999, J PALEOLIMNOL, V22, P159, DOI 10.1023/A:1008093300257; CLARK JS, 1988, QUATERNARY RES, V30, P81, DOI 10.1016/0033-5894(88)90089-0; Cullen HM, 2000, GEOLOGY, V28, P379, DOI 10.1130/0091-7613(2000)28<379:CCATCO>2.0.CO;2; Dalfes N, 1997, NATO ASI SER, P1; deMenocal PB, 2001, SCIENCE, V292, P667, DOI 10.1126/science.1059827; Deng ZH, 2013, ARCHAEOLOGY, P91; Feng DL, 1998, ACTA PHYTOPATHOLOGIC, V28; Fujiwara H, 1978, ARCHAEOLOGY NATURAL, V11, P9; Fuller DQ, 2006, J WORLD PREHIST, V20, P1, DOI 10.1007/s10963-006-9006-8; Fuller DQ, 2009, WORLD ARCHAEOL, V41, P88, DOI 10.1080/00438240802668321; Goudie AS, 2006, GEOMORPHOLOGY, V79, P384, DOI 10.1016/j.geomorph.2006.06.023; Grimm E.C., 1992, TILIA SOFTWARE VERSI; GRIMM EC, 1987, COMPUT GEOSCI, V13, P13, DOI 10.1016/0098-3004(87)90022-7; Gu Y., 2013, EARTH SCI J CHINA U, V38, P133; Guo LX, 2000, JIANGHAN ARCHAEOLOGY, V110, P3; Guo WM, 2010, CULTURE SOC LIYANG P, V95, P312; Hu C, 2008, EARTH PLANETARY SCI, V266; Hubei Provincial Institute of Cultural Relic and Archaeology, 2009, JIANGHAN ARCHAEOL, V110, P3; Ian J., 2010, COMPLETED TRANSLATIO, P937; Itzstein-Davey F, 2007, HOLOCENE, V17, P875, DOI 10.1177/0959683607080517; Itzstein-Davey F, 2007, J ARCHAEOL SCI, V34, P2101, DOI 10.1016/j.jas.2007.02.018; Jian ZM, 2000, EARTH PLANET SC LETT, V184, P305, DOI 10.1016/S0012-821X(00)00321-6; JIANG QH, 1995, REV PALAEOBOT PALYNO, V89, P481, DOI 10.1016/0034-6667(95)00033-9; Joergensen RG, 1996, SOIL BIOL BIOCHEM, V28, P33, DOI 10.1016/0038-0717(95)00101-8; Jones D.M., 2002, ENV ARCHAEOLOGY GUID; Kerr RA, 1998, SCIENCE, V279, P325, DOI 10.1126/science.279.5349.325; Kirch PV, 2005, ANNU REV ENV RESOUR, V30, P409, DOI 10.1146/annurev.energy.29.102403.140700; Kondo R., 1994, OPAL PHYTOLITHS NZ; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; Li B, 2013, QUATERN INT, V308, P45, DOI 10.1016/j.quaint.2013.05.041; [李宜垠 Li Yiyin], 2009, [古地理学报, Journal of Palaeogeography], V11, P702; Liu JQ, 2000, CHINESE SCI BULL, V45, P1712, DOI 10.1007/BF02898993; Lu HY, 2006, QUATERNARY SCI REV, V25, P945, DOI 10.1016/j.quascirev.2005.07.014; Lu HouYuan, 1997, Estado actual de los estudios de fitolitos en suelas y plantas. Primer encuentro Europeo sobre el estudio de fitolitos., P159; Lu HY, 2003, ESTUAR COAST SHELF S, V58, P587, DOI 10.1016/S0272-7714(03)00137-9; Mao X, 2014, EARTH SCI J CHINA U, V39, P1545; Meng H.P., 2012, ARCHAEOLOGY, V8, P29; Meng HP, 1997, PREHISTORIC CULTURE, P80; MILLSPAUGH SH, 1995, HOLOCENE, V5, P283, DOI 10.1177/095968369500500303; Mulholland S. C., 1992, PHYTOLITH SYSTEMATIC, P65; Ohlson M, 2000, HOLOCENE, V10, P519, DOI 10.1191/095968300667442551; PATTERSON JM, 1987, J ADOLESCENCE, V10, P163, DOI 10.1016/S0140-1971(87)80086-6; Pearsall D.M., 2013, PALEOETHNOBOTANY HDB; PEARSALL DM, 1995, ECON BOT, V49, P183, DOI 10.1007/BF02862923; Perry CA, 2000, P NATL ACAD SCI USA, V97, P12433, DOI 10.1073/pnas.230423297; Piperno D.R., 2006, PHYTOLITH COMPREHENS; Piperno D. R., 1998, SILICA BODIES TROPIC; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Runge F, 1999, REV PALAEOBOT PALYNO, V107, P23, DOI 10.1016/S0034-6667(99)00018-4; Shi CX, 2009, EARTH SCI FRONTIERS, V16, P20; Shijiahe Archaeological Team, 2003, SHIJ ARCH REP DENGJ, P281; Shijiahe Archaeological Team, 1999, SHIJ ARCH REP, P51; Tinner W, 1998, HOLOCENE, V8, P31, DOI 10.1191/095968398667205430; TWISS PC, 1969, SOIL SCI SOC AM PRO, V33, P109, DOI 10.2136/sssaj1969.03615995003300010030x; Wang F., 1999, CHINESE GEOGR SCI, V9, P87; Wang Jian, 2009, Journal of Landscape Research, V1, P60; Wang S., 1992, CLIMATES ENV HOLOCEN, P146; Wang WM, 2003, CHINESE SCI BULL, V48, P2005, DOI 10.1360/02wd0447; Wang Xiaocui, 2012, Hupo Kexue, V24, P480; Wang Y., 1993, STUDY PHYTOLITH ITS; Wei KY, 1998, J QUATERNARY SCI, V13, P55, DOI 10.1002/(SICI)1099-1417(199801/02)13:1<55::AID-JQS332>3.0.CO;2-S; WEISS H, 1993, SCIENCE, V261, P995, DOI 10.1126/science.261.5124.995; Weiss H, 2001, SCIENCE, V291, P609, DOI 10.1126/science.1058775; Weiss H., 2000, ENV DISASTER ARCHAEO, P75; Wu L, 2015, CENTRAL CHINA ACTA G, V70, P1149; Wu L., 2012, GEOSCI FRONT, V3, P875, DOI [DOI 10.1016/j.gsf.2012.02.006, 10.1016/j.gsf.2012.02.006]; Wu WX, 2004, QUATERN INT, V117, P153, DOI 10.1016/S1040-6182(03)00125-3; Xu J.H., 1998, SCI CHINA SER D, V28, P366; Yang X.D, 1998, J LAKE SCI, V10, P23; Yang Zhirong, 1998, SCI GEOGRAPHICA SINI, V18, P479; YAO TD, 1992, ANN GLACIOL, V16, P21; Yasuda Y, 2004, QUATERN INT, V123, P149, DOI 10.1016/j.quaint.2004.02.016; Yoshida S, 1962, SOIL SCI PLANT NUTR, V8; Yuan SX, 1994, CULTURAL RELICS, P89; Zhao ZJ, 1998, ECON BOT, V52, P134, DOI 10.1007/BF02861201; Zheng Z, 2000, QUATERNARY RES, V53, P330, DOI 10.1006/qres.1999.2126; Zhu C., 1997, ACTA GEOGRAPH SIN, V52, P268; [朱诚 ZHU Cheng], 2007, [地理学报, Acta Geographica Sinica], V62, P227; Zhu Y.X., 1997, CHINESE SCI BULL, V42, P1972	85	7	8	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177287	10.1371/journal.pone.0177287	http://dx.doi.org/10.1371/journal.pone.0177287			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542219	gold, Green Submitted, Green Published			2022-12-26	WOS:000401672600006
J	Fang, J; Xiao, L; Chen, R; Zhao, ZH				Fang, Jie; Xiao, Li; Chen, Rebecca; Zhao, Zhihe			Conditional removal of the canonical TGF-beta 1 signaling delays condylar cartilage degeneration induced by a partial discectomy in mice	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TEMPOROMANDIBULAR-JOINT; ARTICULAR-CARTILAGE; TGF-BETA; OSTEOARTHRITIS; CHONDROCYTES; GENE; DIFFERENTIATION; INHIBITION; RECEPTOR	Recent emerging data indicate that the increase in the expression and activity of the transforming growth factor beta 1 (Tgf-beta 1) signaling may have detrimental effect to mature articular cartilage of knee joints. However, there is no information about whether or not this is the case in condylar cartilages. The objective of this study is to investigate the protein expression and activity of Tgf-beta 1 signaling in degenerative condylar cartilages. We also investigate biological effects of the conditional deletion of transforming growth factor receptor type II (Tgfbr2) in condylar cartilage of adult mice after a partial discectomy. Two mouse models of osteoarthritis (OA) were used to examine protein expressions of Tgf-beta 1 and p-Smad2/3 in condylar cartilages at early degenerative stages. In addition, cartilage specific Tgfbr2-deficient adult mice were subjected to a partial discectomy. The morphological condition of condylar cartilages was evaluated in mice at 4 and 12 weeks after the surgery. We found that protein levels of Tgf-beta 1 and p-Smad2/3 were increased in the degenerative condylar cartilage of the mouse models. The conditional removal of Tgfbr2 in mature condylar cartilage significantly delayed the progressive progression of the cartilage degeneration induced by a partial discectomy. We conclude that the increase in the expression and activity of Tgf-beta 1 signaling may have detrimental effect to mature condylar cartilages. Therefore, inhibition of Tgf-beta 1 signaling may be able to protect condylar cartilages from being degraded in mature temporomandibular joints.	[Fang, Jie; Zhao, Zhihe] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China; [Fang, Jie; Xiao, Li; Chen, Rebecca] Harvard Sch Dent Med, Dept Dev Biol, Boston, MA USA; [Xiao, Li] Sichuan Acad Med Sci, Dept Stomatol, Chengdu, Sichuan, Peoples R China; [Xiao, Li] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China	Sichuan University; Harvard University; Harvard School of Dental Medicine; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Zhao, ZH (corresponding author), Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China.	zhzhao@scu.edu.cn		Zhao, Zhihe/0000-0003-2955-1706	National Natural Science Foundation of China [31470904]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by grant from the National Natural Science Foundation of China, 31470904 (to ZHZ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker AC, 2001, OSTEOARTHR CARTILAGE, V9, P128, DOI 10.1053/joca.2000.0368; Chen R, 2015, AM J PATHOL, V185, P2875, DOI 10.1016/j.ajpath.2015.07.003; Cohen WA, 2014, J ORAL PATHOL MED, V43, P162, DOI 10.1111/jop.12113; Dimitroulis G, 2005, INT J ORAL MAX SURG, V34, P345, DOI 10.1016/j.ijom.2004.10.013; GALERA P, 1992, J CELL PHYSIOL, V153, P596, DOI 10.1002/jcp.1041530322; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goldberg MB, 1999, J OROFAC PAIN, V13, P291; Heinemeier KM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8335; Jiao K, 2014, J DENT RES, V93, P140, DOI 10.1177/0022034513513034; Kawamura I, 2012, J BIOL CHEM, V287, P29101, DOI 10.1074/jbc.M112.349415; LI Y, 1995, CELL, V80, P423, DOI 10.1016/0092-8674(95)90492-1; Long E, 2016, ARCH ORAL BIOL, V67, P68, DOI 10.1016/j.archoralbio.2016.03.004; Osterberg Tor, 1992, Journal of Craniomandibular Disorders, V6, P237; Schlaak JF, 1996, CLIN EXP RHEUMATOL, V14, P155; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Shen J, 2013, ARTHRITIS RHEUM-US, V65, P3107, DOI 10.1002/art.38122; Tanaka E, 2008, J DENT RES, V87, P296, DOI 10.1177/154405910808700406; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; VANBEUNINGEN HM, 1994, LAB INVEST, V71, P279; Xu L, 2003, ARTHRITIS RHEUM, V48, P2509, DOI 10.1002/art.11233; Xu L, 2009, OSTEOARTHR CARTILAGE, V17, P917, DOI 10.1016/j.joca.2009.01.002; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143	23	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177826	10.1371/journal.pone.0177826	http://dx.doi.org/10.1371/journal.pone.0177826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542404	Green Submitted, gold, Green Published			2022-12-26	WOS:000401672400092
J	Long, S				Long, Stephen			Short-term impacts and value of a periodic no take zone (NTZ) in a community-managed small-scale lobster fishery, Madagascar	PLOS ONE			English	Article							PANULIRUS-HOMARUS-RUBELLUS; SPINY-LOBSTERS; FISHING EFFORT; BIODIVERSITY; COMANAGEMENT; LIVELIHOODS; RESOURCES; OUTCOMES; COAST; REEF	The small-scale lobster fisheries of Madagascar's impoverished southeast coast account for the majority of national catch and export, making a significant contribution to the regional economy. Data suggests catches have declined, likely due to over-exploitation. In response, the community of Sainte Luce has established a locally managed marine area (LMMA) to manage their lobster fishery, including a 13 km 2 periodic no take zone (NTZ). Participatory monitoring data were used to assess compliance, identify changes in catch per unit effort (CPUE) associated with the NTZ and consider the short-term value of the NTZ. Compliance is low for measures dictated by national legislation (minimum landing size (MLS), national closed season, prohibition on landing berried females), but may be higher for those designed by the community (NTZ). Upon NTZ opening in July 2015, an estimated 435% increase in catch was observed compared with the mean for the preceding five months, a product of increased effort and significantly higher CPUE. Zero Altered Negative Binomial modelling showed CPUE was significantly higher during the NTZ opening in 2015 and in 2016 when the opening period had been moved. Whilst it is unlikely that tangible ecological benefits have accrued from NTZ operation, there have been important socio-economic effects. Specifically, there was a 33% increase in the price fishers received, a significant effect at the bottom of the value chain. Temporary increases in catch and income acted as a catalyst, engaging neighbouring communities in fishery management, resulting in two additional NTZs. Attention is drawn to the fact that current national legislation may be sub-optimal and should be reviewed. Successful management of the regional fishery will require the state and industry to support communities in adopting community-based management. The NTZ measure considered here may be an effective tool to achieve this.	[Long, Stephen] SEED Madagascar, Ambinanikely, Tolagnaro, Madagascar; [Long, Stephen] UCL, Dept Geog, London, England	University of London; University College London	Long, S (corresponding author), SEED Madagascar, Ambinanikely, Tolagnaro, Madagascar.; Long, S (corresponding author), UCL, Dept Geog, London, England.	stephen.long@seedmadagascar.org		Long, Stephen/0000-0001-8454-9364	Food and Agriculture Organisation (FAO)-SmartFish programme of the Indian Ocean Commission (IOC), Mauritius; Jeremy Willson Charitable Trust (JWCT); Institut Halieutique et des Sciences Marines (IHSM)	Food and Agriculture Organisation (FAO)-SmartFish programme of the Indian Ocean Commission (IOC), Mauritius; Jeremy Willson Charitable Trust (JWCT); Institut Halieutique et des Sciences Marines (IHSM)	The study was funded by the Food and Agriculture Organisation (FAO)-SmartFish programme of the Indian Ocean Commission (IOC), Mauritius. SL received financial support to meet personal costs from the Jeremy Willson Charitable Trust (JWCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research would not have possible without: the staff of ONG Azafady and SEED Madagascar particularly E. Ellis and S. Randrianantenaina; data collection by C. Andry, assisted by international volunteers from the SEED Madagascar Conservation and Pioneer programmes; and the co-operation of collecteurs, rabbateurs and operateurs (Madapeche and Martin Pecheur). Data from Fig 1 was provided by DRRHP/URL, with thanks to C. Razafimandimby (DRRHP), E. Ranaivoson (URL) and A. Suzelys (URL). P. Clark of the Natural History Museum provided taxonomic assistance. Additional support from the Institut Halieutique et des Sciences Marines (IHSM) was provided by T. Lavitra, M. Rabenevanana and J. Victor, who produced a French translation of the abstract. M. Darling served as an invaluable sounding board for statistical approaches. Comments on the draft manuscript from A. Burtenshaw-Devries and M. Jacobs were extremely helpful. The comments from anonymous reviewers significantly improved the final manuscript.	Al-Marzouqi A., 2007, Western Indian Ocean Journal of Marine Science, V6, P159; Allison EH, 2001, MAR POLICY, V25, P377, DOI 10.1016/S0308-597X(01)00023-9; Antona M, 2004, ENVIRON DEV ECON, V9, P825, DOI 10.1017/S1355770X04001640; Barnes-Mauthe M, 2013, FISH RES, V147, P175, DOI 10.1016/j.fishres.2013.05.011; Bartlett CY, 2009, CONSERV BIOL, V23, P1475, DOI 10.1111/j.1523-1739.2009.01293.x; Benbow S, 2014, AFR J MAR SCI, V36, P31, DOI 10.2989/1814232X.2014.893256; Bene C, 2010, DEV POLICY REV, V28, P325, DOI 10.1111/j.1467-7679.2010.00486.x; BOOTH JD, 1994, CRUSTACEANA, V66, P271, DOI 10.1163/156854094X00035; Booth JD, 2000, SPINY LOBSTERS FISHE, P556; Caddy JF, 1998, CANADIAN SPECIAL PUB, P359; Charbonnier D, 1961, LA PECHE MARITIME, P1; Chubb C., 2000, SPINY LOBSTERS FISHE, P243; Cinner J, 2014, CONSERV LETT, V7, P224, DOI 10.1111/conl.12057; Clausen A., 2013, NATURAL CAPITAL ACCO; Cohen PJ, 2013, GLOBAL ENVIRON CHANG, V23, P1702, DOI 10.1016/j.gloenvcha.2013.08.010; Cohen PJ, 2013, MAR POLICY, V37, P278, DOI 10.1016/j.marpol.2012.05.010; De Bruin GHP, 1962, SPINY LOBSTERS CEYLO; Fabinyi M, 2010, HUM ECOL, V38, P415, DOI 10.1007/s10745-010-9329-z; FAO, 2007, FAO FISHERIES TECHNI; FIGIS (Fisheries Global Information System), 2015, FISH COMM TRAD 1976, P1976; FIGIS (Fisheries Global Information System), 2015, GLOB CAPT PROD 1950; Food and Agriculture Organization (FAO), 2009, GLOB C SMALL SCAL FI; Ganzhorn JU, 2001, ORYX, V35, P346, DOI 10.1046/j.1365-3008.2001.00201.x; Gendron L, 2002, CAN J FISH AQUAT SCI, V59, P899, DOI 10.1139/F02-068; GEORGE RW, 1967, EVOLUTION, V21, P803, DOI 10.1111/j.1558-5646.1967.tb03435.x; Gnanalingam G, 2015, MAR POLICY, V61, P39, DOI 10.1016/j.marpol.2015.06.033; Govan H., 2009, STATUS POTENTIAL LOC; Harris A., 2011, MADAGASCAR CONSERV D, V6; Harris A., 2007, MADAG CONSERV DEV, V2, P43, DOI DOI 10.4314/MCD.V2I1.44129; Health N Council MR, 2004, AUSTR COD PRACT CAR; Hogg Forrest, 2013, Palms, V57, P133; Holloway G., 2014, Madagascar Conservation and Development, V9, P36, DOI 10.4314/mcd.v9i1.7; Holthius LB, 1991, MARINE LOBSTERS WORL; Holthuis UB, 2006, ZOOSYSTEMA, V28, P417; Jackman S., 2008, PSCL CLASSES METHODS; Jacquet J, 2008, CONSERV BIOL, V22, P832, DOI 10.1111/j.1523-1739.2008.00978.x; Jupiter SD, 2012, CORAL REEFS, V31, P321, DOI 10.1007/s00338-012-0888-x; Jupiter Stacy D., 2014, Pacific Conservation Biology, V20, P165; Kaufmann JC, 2014, EARTH CONSERV DEV, P320; Kennington WJ, 2013, LOBSTERS: BIOLOGY, MANAGEMENT, AQUACULTURE AND FISHERIES, 2ND EDITION, P36; Kulmiye AJ, 2006, AFR J MAR SCI, V28, P51, DOI 10.2989/18142320609504133; Kulmiye AJ, 2005, NEW ZEAL J MAR FRESH, V39, P539, DOI 10.1080/00288330.2005.9517332; Le Manach F, 2012, MAR POLICY, V36, P218, DOI 10.1016/j.marpol.2011.05.007; LeManach F., 2011, FISHERIES CTR RES RE, V19, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; MAEP, 2004, TCPMAGO170A MAEP; Malleret-King D., 2006, NEW GLASS ARCHITECTU; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; Mayol T, 2013, MADAG CONSERV DEV, V8, P91, DOI [10.4314/MCD.V8I2.8, DOI 10.4314/mcd.v8i2.8]; Mohan R, 1997, MAR FRESHWATER RES, V48, P1085, DOI 10.1071/MF97157; Monnereau I, 2015, MARE PUBL SER, V13, P223, DOI 10.1007/978-3-319-17034-3_12; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Oliver TA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129075; Pauly D., 2006, MAR STUD MAST, V4, P7, DOI DOI 10.1126/SCIENCE.279.5352.860.PMID:9452385; Pauly D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10244; Phillips BF, 2005, NEW ZEAL J MAR FRESH, V39, P231, DOI 10.1080/00288330.2005.9517303; Phillips BF, 2013, LOBSTERS: BIOLOGY, MANAGEMENT, AQUACULTURE AND FISHERIES, 2ND EDITION, P289; POLLOCK DE, 1993, B MAR SCI, V53, P937; Pomeroy RS, 2011, SMALL-SCALE FISHERIES MANAGEMENT: FRAMEWORKS AND APPROACHES FOR THE DEVELOPING WORLD, P75, DOI 10.1079/9781845936075.0075; R Core Team, 2021, R LANGUAGE ENV STAT; RADHAKRISHNAN EV, 1995, CRUSTACEANA, V68, P151, DOI 10.1163/156854095X01303; Rakotondrazafy Andriamampandry R., 2015, MEDITERRANEA EB; Rakotoson LR, 2006, OCEAN COAST MANAGE, V49, P855, DOI 10.1016/j.ocecoaman.2006.08.003; Reddy MM, 2014, J CRUSTACEAN BIOL, V34, P773, DOI 10.1163/1937240X-00002284; Rocliffe S., 2016, EXPERIENCES PERIODIC; Sabatini G, TOLAGNARO MADAGASCAR; Sadovy Y, 2005, FISH FISH, V6, P167, DOI 10.1111/j.1467-2979.2005.00186.x; Salas S, 2007, FISH RES, V87, P5, DOI 10.1016/j.fishres.2007.06.015; Scales IR, 2014, EARTH CONSERV DEV, P1; Skinner F., 2016, PHASE 2 PROJECT COMM; Stamatopoulos C., 2004, SAFETY SAMPLING METH; Stamatopoulos Constantine, 2002, SAMPLE BASED FISHERY; Steyn E, 2011, NEW ZEAL J MAR FRESH, V45, P85, DOI 10.1080/00288330.2010.538067; Tewfik A, 2004, FISH RES, V69, P21, DOI 10.1016/j.fishres.2004.04.004; United Nations Development Programme (UNDP), 2015, HUM DEV REP 2015 WOR; Vega A., 1991, 19 CRIP LA PAZ SECR, V19; World Bank, 2015, MAD SYST COUNTR DIAG; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zuur Alain F., 2009, P1	78	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177858	10.1371/journal.pone.0177858	http://dx.doi.org/10.1371/journal.pone.0177858			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542323	Green Submitted, Green Published, gold			2022-12-26	WOS:000401672400103
J	Kim, KJ; Kwon, SH; Yun, JH; Jeong, HS; Kim, HR; Lee, E; Ye, SK; Cho, CH				Kim, K-J; Kwon, S-H; Yun, J-H; Jeong, H-S; Kim, H-R; Lee, Eh; Ye, S-K; Cho, C-H			STAT3 activation in endothelial cells is important for tumor metastasis via increased cell adhesion molecule expression	ONCOGENE			English	Article							NF-KAPPA-B; SIGNAL TRANSDUCER; CANCER; ANGIOGENESIS; GROWTH; RECRUITMENT; INHIBITION; MECHANISMS; MIGRATION; CYTOKINES	Metastasis is a life-threatening feature of cancer and is primarily responsible for cancer patient mortality. Cross talk between tumor cells and endothelium is important for tumor progression and metastasis. However, very little is known about the mechanisms by which endothelial cells (ECs) that are close to tumor cells, respond to the tumor cells during tumor progression and metastasis. In this study, we exploited the use of EC-specific signal transducer activator of transcription 3 (STAT3) knockout mice to investigate the role of STAT3 in ECs in tumor progression and metastasis. We found that the loss of STAT3 in ECs did not affect primary Lewis lung carcinoma (LLC) tumor growth, but it reduced in vivo LLC metastasis in experimental and spontaneous metastasis models. Mechanistically, STAT3 activation upregulated cell adhesion molecule expression, including E-selectin and P-selectin, in murine endothelial MS-1 cells treated with tumor cell-conditioned media in vitro and in pre-metastatic lungs of tumor-bearing mice in vivo. We also found that both E-selectin and P-selectin were, at least in part, responsible for STAT3-induced adhesion and invasion of LLC cells through an EC monolayer. However, tumor cell-conditioned media from B16F10 melanoma cells did not activate STAT3 in MS-1 cells. As a result, EC STAT3 knockout did not affect B16F10 melanoma cell metastasis. In addition, various human cancer cells activated STAT3 in human ECs (HUVECs), resulting in increased cell adhesion molecule expression. Collectively, our findings demonstrate that STAT3 activation in ECs promotes tumor metastasis through the induction of cell adhesion molecules, demonstrating a role for ECs in response to tumor cells during tumor metastasis.	[Kim, K-J; Kwon, S-H; Yun, J-H; Jeong, H-S; Ye, S-K; Cho, C-H] Seoul Natl Univ, Dept Pharmacol, Coll Med, 103 Daehakro Dong, Seoul 110799, South Korea; [Kim, H-R] Seoul Natl Univ, Dept Anat & Cell Biol, Coll Med, Seoul, South Korea; [Lee, Eh] Catholic Univ Korea, Dept Physiol, Coll Med, Seoul, South Korea; [Ye, S-K; Cho, C-H] Seoul Natl Univ, Ischem Hypox Dis Inst, Coll Med, Seoul, South Korea; [Cho, C-H] Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Catholic University of Korea; Seoul National University (SNU); Seoul National University (SNU)	Ye, SK; Cho, CH (corresponding author), Seoul Natl Univ, Dept Pharmacol, Coll Med, 103 Daehakro Dong, Seoul 110799, South Korea.	sangkyu@snu.ac.kr; iamhyun@snu.ac.kr		Kwon, Sun-Ho/0000-0003-1592-0638; Kim, Hang-Rae/0000-0002-3983-6193; Lee, Eun Hui/0000-0003-4555-1730	National Research Foundation of Korea grant - Korea government [2014R1A2A1A11050981, 2012R1A5A2A44671346]	National Research Foundation of Korea grant - Korea government	We acknowledge Daeho So for technical support of EV isolation and depletion, and Dr Jong-Wan Park for helpful suggestions during the course of this work. This work is supported by the National Research Foundation of Korea grant funded by the Korea government (2014R1A2A1A11050981 and 2012R1A5A2A44671346 to CHC).	Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Deng JH, 2012, CANCER CELL, V21, P642, DOI 10.1016/j.ccr.2012.03.039; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Gout S, 2008, CLIN EXP METASTAS, V25, P335, DOI 10.1007/s10585-007-9096-4; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hiratsuka S, 2011, P NATL ACAD SCI USA, V108, P3725, DOI 10.1073/pnas.1100446108; Hwang JA, 2009, MOL CANCER RES, V7, P1920, DOI 10.1158/1541-7786.MCR-09-0041; JAHROUDI N, 1995, J NEURO-ONCOL, V23, P99, DOI 10.1007/BF01053415; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407; Kim HJ, 2013, BBA-MOL BASIS DIS, V1832, P183, DOI 10.1016/j.bbadis.2012.09.002; Klemke M, 2007, J CELL PHYSIOL, V212, P368, DOI 10.1002/jcp.21029; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Laubli H, 2010, CANCER MICROENVIRON, V3, P97, DOI 10.1007/s12307-010-0043-6; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Lee HT, 2015, ONCOTARGET, V6, P10016, DOI 10.18632/oncotarget.3540; Liu Y, 2016, CANCER CELL, V30, P668, DOI 10.1016/j.ccell.2016.09.011; Lu T, 2004, ONCOGENE, V23, P2138, DOI 10.1038/sj.onc.1207332; Lu T, 2004, CELL CYCLE, V3, P1114; MACKAY F, 1993, J EXP MED, V177, P1277, DOI 10.1084/jem.177.5.1277; Miller AM, 2010, ALCOHOL CLIN EXP RES, V34, P719, DOI 10.1111/j.1530-0277.2009.01141.x; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; PARHAR RS, 1987, J EXP MED, V165, P14, DOI 10.1084/jem.165.1.14; Qian F, 2005, BIOCHEM BIOPH RES CO, V333, P1269, DOI 10.1016/j.bbrc.2005.06.039; Rao RM, 2007, CIRC RES, V101, P234, DOI 10.1161/CIRCRESAHA.107.151860b; Ray Subrata, 1999, Journal of Environmental Pathology Toxicology and Oncology, V18, P251; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Roland CL, 2007, SURGERY, V141, P705, DOI 10.1016/j.surg.2007.01.016; Sengupta TK, 1996, P NATL ACAD SCI USA, V93, P9499, DOI 10.1073/pnas.93.18.9499; Severgnini M, 2004, AM J PHYSIOL-LUNG C, V286, pL1282, DOI 10.1152/ajplung.00349.2003; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Teng CB, 2004, REPRODUCTION, V128, P197, DOI 10.1530/rep.1.00053; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Yang XP, 2005, ARTERIOSCL THROM VAS, V25, P1395, DOI 10.1161/01.ATV.0000168428.96177.24; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yun JH, 2017, J CELL PHYSIOL, V232, P1123, DOI 10.1002/jcp.25575; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014525; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhuang GL, 2012, EMBO J, V31, P3513, DOI 10.1038/emboj.2012.183	51	42	43	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 28	2017	36	39					5445	5459		10.1038/onc.2017.148	http://dx.doi.org/10.1038/onc.2017.148			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FI4RG	28534515				2022-12-26	WOS:000411960500002
J	Singh, KH; Jha, B; Dwivedy, A; Choudhary, E; Arpitha, GN; Ashraf, A; Arora, D; Agarwal, N; Biswal, BK				Singh, Khundrakpam Herojit; Jha, Bhavya; Dwivedy, Abhisek; Choudhary, Eira; Arpitha, G. N.; Ashraf, Anam; Arora, Divya; Agarwal, Nisheeth; Biswal, Bichitra Kumar			Characterization of a secretory hydrolase from Mycobacterium tuberculosis sheds critical insight into host lipid utilization by M. tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPASE ACTIVITY; PROTEIN; TRIACYLGLYCEROL; PERSISTENCE; FAMILY; WALL	Mycobacterium tuberculosis causes tuberculosis in humans and predominantly infects alveolar macrophages. To survive inside host lesions and to evade immune surveillance, this pathogen has developed many strategies. For example, M. tuberculosis uses host-derived lipids/fatty acids as nutrients for prolonged persistence within hypoxic host microenvironments. M. tuberculosis imports these metabolites through its respective transporters, and in the case of host fatty acids, a pertinent question arises: does M. tuberculosis have the enzyme(s) for cleavage of fatty acids from host lipids? We show herein that a previously uncharacterized membrane-associated M. tuberculosis protein encoded by Rv2672 is conserved exclusively in actinomycetes, exhibits both lipase and protease activities, is secreted into macrophages, and catalyzes host lipid hydrolysis. In light of these functions, we annotated Rv2672 as mycobacterial secreted hydrolase 1 (Msh1). Furthermore, we found that this enzyme is up-regulated both in an in vitro model of hypoxic stress and in a mouse model of M. tuberculosis infection, suggesting that the pathogen requires Msh1 under hypoxic conditions. Silencing Msh1 expression compromised the ability of M. tuberculosis to proliferate inside lipid-rich foamy macrophages but not under regular culture conditions in vitro, underscoring Msh1' s importance for M. tuberculosis persistence in lipid-rich microenvironments. Of note, this is the first report providing insight into the mechanism of host lipid catabolism by an M. tuberculosis enzyme, augmenting our current understanding of how M. tuberculosis meets its nutrient requirements under hypoxic conditions.	[Singh, Khundrakpam Herojit; Jha, Bhavya; Dwivedy, Abhisek; Arpitha, G. N.; Ashraf, Anam; Arora, Divya; Biswal, Bichitra Kumar] Natl Inst Immunol, Aruna Asaf Ali Marg, Delhi 110067, India; [Choudhary, Eira; Agarwal, Nisheeth] Vaccine & Infect Dis Res Ctr, Translat Hlth Sci & Technol Inst, Faridabad 121001, Haryana, India; [Choudhary, Eira] Symbiosis Int Univ, Symbiosis Sch Biomed Sci, Pune 412115, Maharashtra, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); Symbiosis International University; Symbiosis School of Biological Sciences (SSBS)	Biswal, BK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, Delhi 110067, India.	bbiswal@nii.ac.in	International, Symbiosis School of Biological Sciences Symbiosis/AAD-7708-2019; Dwivedy, Abhisek/AAV-4406-2021	Herojit Singh, Khundrakpam/0000-0001-9699-2187; Dwivedy, Abhisek/0000-0001-9745-8138; Biswal, Bichitra/0000-0002-5927-3244; Jha, Bhavya/0000-0002-0944-4279	National Institute of Immunology (NII), New Delhi; Department of Biotechnology, Government of India [BT/PR8616/MED/29/793/2013]	National Institute of Immunology (NII), New Delhi; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by core grants from the National Institute of Immunology (NII), New Delhi (to B. K. B.) and Department of Biotechnology, Government of India Extramural Grant BT/PR8616/MED/29/793/2013 (to N. A.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from the Department of Biotechnology, Government of India.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Baek SH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001065; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Choudhary E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7267; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Falcone DJ, 1998, J BIOL CHEM, V273, P31480, DOI 10.1074/jbc.273.47.31480; Flynn JL, 2005, TRENDS MICROBIOL, V13, P98, DOI 10.1016/j.tim.2005.01.005; Guo J, 2015, ENZYME MICROB TECH, V71, P8, DOI 10.1016/j.enzmictec.2015.01.005; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Hoppe A, 1996, PHYTOCHEMISTRY, V42, P973, DOI 10.1016/0031-9422(96)00051-9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee W, 2013, J BIOL CHEM, V288, P6788, DOI 10.1074/jbc.M112.445056; Lovewell RR, 2016, CURR OPIN MICROBIOL, V29, P30, DOI 10.1016/j.mib.2015.10.002; Low KL, 2009, J BACTERIOL, V191, P5037, DOI 10.1128/JB.00530-09; Lun SC, 2007, J BIOL CHEM, V282, P18348, DOI 10.1074/jbc.M700035200; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Mori M, 2001, J LIPID RES, V42, P1771; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Pencreach G, 1996, ENZYME MICROB TECH, V18, P417, DOI 10.1016/0141-0229(95)00120-4; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Rezwan M, 2007, J MICROBIOL METH, V68, P32, DOI 10.1016/j.mimet.2006.05.016; Russell DG, 2010, CELL HOST MICROBE, V8, P68, DOI 10.1016/j.chom.2010.06.002; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Schue M, 2010, FASEB J, V24, P1893, DOI 10.1096/fj.09-144766; Smith NH, 2009, NAT REV MICROBIOL, V7, P537, DOI 10.1038/nrmicro2165; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Zahrt TC, 2003, MICROBES INFECT, V5, P159, DOI 10.1016/S1286-4579(02)00083-7; Zhao QJ, 2014, J INTERF CYTOK RES, V34, P686, DOI 10.1089/jir.2013.0071	38	26	28	2	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11326	11335		10.1074/jbc.M117.794297	http://dx.doi.org/10.1074/jbc.M117.794297			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28515317	Green Published, hybrid			2022-12-26	WOS:000405119600016
J	Goulas, T; Ksiazek, M; Garcia-Ferrer, I; Sochaj-Gregorczyk, AM; Waligorska, I; Wasylewski, M; Potempa, J; Gomis-Ruth, FX				Goulas, Theodoros; Ksiazek, Miroslaw; Garcia-Ferrer, Irene; Sochaj-Gregorczyk, Alicja M.; Waligorska, Irena; Wasylewski, Marcin; Potempa, Jan; Gomis-Rueth, F. Xavier			A structure-derived snap-trap mechanism of a multispecific serpin from the dysbiotic human oral microbiome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ANTITHROMBIN-III; REACTIVE CENTER LOOP; CRYSTAL-STRUCTURE; TANNERELLA-FORSYTHIA; PORPHYROMONAS-GINGIVALIS; STRUCTURE REFINEMENT; TREPONEMA-DENTICOLA; PROTEASE COMPLEX; MACROMOLECULAR CRYSTALLOGRAPHY; 3-DIMENSIONAL STRUCTURE	Enduring host-microbiome relationships are based on adaptive strategies within a particular ecological niche. Tannerella forsythia is a dysbiotic member of the human oral microbiome that inhabits periodontal pockets and contributes to chronic periodontitis. To counteract endopeptidases from the host or microbial competitors, T. forsythia possesses a serpin-type proteinase inhibitor called miropin. Although serpins from animals, plants, and viruses have been widely studied, those from prokaryotes have received only limited attention. Here we show that miropin uses the serpin-type suicidal mechanism. We found that, similar to a snap trap, the protein transits from a metastable native form to a relaxed triggered or induced form after cleavage of a reactive-site target bond in an exposed reactive-center loop. The prey peptidase becomes covalently attached to the inhibitor, is dragged 75 angstrom apart, and is irreversibly inhibited. This coincides with a large conformational rearrangement of miropin, which inserts the segment upstream of the cleavage site as an extra beta-strand in a central beta-sheet. Standard serpins possess a single target bond and inhibit selected endopeptidases of particular specificity and class. In contrast, miropin uniquely blocked many serine and cysteine endopeptidases of disparate architecture and substrate specificity owing to several potential target bonds within the reactive-center loop and to plasticity in accommodating extra beta-strands of variable length. Phylogenetic studies revealed a patchy distribution of bacterial serpins incompatible with a vertical descent model. This finding suggests that miropin was acquired from the host through horizontal gene transfer, perhaps facilitated by the long and intimate association of T. forsythia with the human gingiva.	[Goulas, Theodoros; Garcia-Ferrer, Irene; Gomis-Rueth, F. Xavier] CSIC, Mol Biol Inst Barcelona, Maria de Maeztu Unit Excellence, Proteolysis Lab,Struct Biol Unit, E-08028 Barcelona, Spain; [Ksiazek, Miroslaw; Sochaj-Gregorczyk, Alicja M.; Waligorska, Irena; Wasylewski, Marcin; Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, PL-30387 Krakow, Poland; [Sochaj-Gregorczyk, Alicja M.] Jagiellonian Univ, Malopolska Ctr Biotechnol, PL-30387 Krakow, Poland; [Ksiazek, Miroslaw; Potempa, Jan] Univ Louisville, Dept Oral Immunol & Infect Dis, Sch Dent, Louisville, KY 40202 USA; [Garcia-Ferrer, Irene] EMBL Outstn Grenoble, 71 Ave Martyrs,CS 90181, F-38042 Grenoble 9, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Jagiellonian University; Jagiellonian University; University of Louisville; European Molecular Biology Laboratory (EMBL)	Gomis-Ruth, FX (corresponding author), CSIC, Mol Biol Inst Barcelona, Maria de Maeztu Unit Excellence, Proteolysis Lab,Struct Biol Unit, E-08028 Barcelona, Spain.	xgrcri@ibmb.csic.es	Potempa, Jan/AAA-6850-2021; Goulas, Theodoros/H-1951-2015	Goulas, Theodoros/0000-0002-6938-5493; Gomis-Ruth, F. Xavier/0000-0002-6848-6874; Potempa, Jan/0000-0002-3600-7461	Secretaria de Estado de Investigacion, Desarrollo e Innovacion [BFU2015-64487-R, MDM-2014-0435, BIO2013-49320-EXP]; Narodowe Centrum Nauki [2015/17/B/NZ1/00666, 1306/MOB/IV/2015/0, 2012/04/A/NZ1/00051, 2016/21/B/NZ1/00292]; Ministerstwo Nauki i Szkolnictwa Wyzszego Grant [2975/7.PR/13/2014/2]; Seventh Framework Programme Grant [FP7-HEALTH-2012-306029-2]; Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya [2014SGR9]; National Institute of Dental and Craniofacial Research, National Institutes of Health [R21DE026280]; Spanish Ministry for Economy and Competitiveness [JCI-2012-13573]; European Synchrotron Radiation Facility; Ministry of Science and Higher Education; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE026280] Funding Source: NIH RePORTER	Secretaria de Estado de Investigacion, Desarrollo e Innovacion; Narodowe Centrum Nauki(National Science Centre, Poland); Ministerstwo Nauki i Szkolnictwa Wyzszego Grant; Seventh Framework Programme Grant; Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya(Generalitat de Catalunya); National Institute of Dental and Craniofacial Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Spanish Ministry for Economy and Competitiveness(Spanish Government); European Synchrotron Radiation Facility; Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by Secretaria de Estado de Investigacion, Desarrollo e Innovacion Grants BFU2015-64487-R, MDM-2014-0435, and BIO2013-49320-EXP; Narodowe Centrum Nauki Grants 2015/17/B/NZ1/00666, "Mobility Plus" 1306/MOB/IV/2015/0, 2012/04/A/NZ1/00051, and 2016/21/B/NZ1/00292; Ministerstwo Nauki i Szkolnictwa Wyzszego Grant 2975/7.PR/13/2014/2; Seventh Framework Programme Grant FP7-HEALTH-2012-306029-2 "TRIGGER"; Departament d'Innovacio, Universitats i Empresa, Generalitat de Catalunya Grant 2014SGR9; National Institute of Dental and Craniofacial Research, National Institutes of Health Grant R21DE026280; Spanish Ministry for Economy and Competitiveness "Juan de la Cierva" Research Contract JCI-2012-13573 (to T. G.); and funding from the European Synchrotron Radiation Facility. The Structural Biology Unit of Molecular Biology Institute of Barcelona is a "Maria de Maeztu" Unit of Excellence of the Spanish Ministry of Economy, Innovation and Competitiveness. The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a partner of the Leading National Research Center (KNOW) supported by the Ministry of Science and Higher Education. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adler CJ, 2013, NAT GENET, V45, P450, DOI 10.1038/ng.2536; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arolas JL, 2011, ANGEW CHEM INT EDIT, V50, P10357, DOI 10.1002/anie.201103262; Baird TT, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P2594, DOI 10.1016/B978-0-12-382219-2.00575-5; Bamford CV, 2007, INFECT IMMUN, V75, P4364, DOI 10.1128/IAI.00258-07; Baquero F, 2012, CLIN MICROBIOL INFEC, V18, P2, DOI 10.1111/j.1469-0691.2012.03916.x; BAUMANN U, 1992, J MOL BIOL, V226, P1207, DOI 10.1016/0022-2836(92)91062-T; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; BRUCH M, 1988, J BIOL CHEM, V263, P16626; CARRELL R, 1985, TRENDS BIOCHEM SCI, V10, P20, DOI 10.1016/0968-0004(85)90011-8; Cerda-Costa N, 2011, MOL MICROBIOL, V79, P119, DOI 10.1111/j.1365-2958.2010.07434.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dahl SW, 1996, J BIOL CHEM, V271, P25083, DOI 10.1074/jbc.271.41.25083; Dahlen JR, 1998, J BIOL CHEM, V273, P1851, DOI 10.1074/jbc.273.4.1851; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De La Fuente C, 2013, ARCHAEOMETRY, V55, DOI 10.1111/j.1475-4754.2012.00707.x; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Engh RA, 1995, TRENDS BIOTECHNOL, V13, P503, DOI 10.1016/S0167-7799(00)89013-7; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Fulton KF, 2005, J BIOL CHEM, V280, P8435, DOI 10.1074/jbc.M410206200; Garcia-Castellanos R, 2003, J BIOL CHEM, V278, P39897, DOI 10.1074/jbc.M307199200; Garcia-Ferrer I, 2015, P NATL ACAD SCI USA, V112, P8290, DOI 10.1073/pnas.1506538112; GETTINS P, 1988, BIOCHEMISTRY-US, V27, P3634, DOI 10.1021/bi00410a017; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Goulas T, 2017, BIOL CHEM, V398, P975, DOI 10.1515/hsz-2016-0329; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; Graycar TP., 2013, HDB PROTEOLYTIC ENZY, V3rd ed., P3148, DOI [DOI 10.1016/B978-0-12-382219-2.00693-1, 10.1016/B978-0-12-382219-2.00693-1]; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; HOPKINS PCR, 1993, BIOCHEMISTRY-US, V32, P7650, DOI 10.1021/bi00081a008; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; HUNT LT, 1980, BIOCHEM BIOPH RES CO, V95, P864, DOI 10.1016/0006-291X(80)90867-0; Huntington JA, 2011, J THROMB HAEMOST, V9, P26, DOI 10.1111/j.1538-7836.2011.04360.x; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Huntington James A., 2001, Science Progress, V84, P125, DOI 10.3184/003685001783239032; Irving JA, 2003, STRUCTURE, V11, P387, DOI 10.1016/S0969-2126(03)00057-1; Irving JA, 2002, MOL BIOL EVOL, V19, P1881, DOI 10.1093/oxfordjournals.molbev.a004012; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Ishihara K, 2010, BIOL CHEM, V391, P1047, DOI 10.1515/BC.2010.113; Ivanov D, 2006, J BIOL CHEM, V281, P17246, DOI 10.1074/jbc.M601678200; Johnson DM, 2010, P NATL ACAD SCI USA, V107, P20576, DOI 10.1073/pnas.1010270107; Juanhuix J, 2014, J SYNCHROTRON RADIAT, V21, P679, DOI 10.1107/S160057751400825X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantyka T, 2010, BIOCHIMIE, V92, P1644, DOI 10.1016/j.biochi.2010.06.004; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Ksiazek M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00312; Ksiazek M, 2015, J BIOL CHEM, V290, P658, DOI 10.1074/jbc.M114.601716; Kuo LC, 2008, PUBLIC HEALTH, V122, P417, DOI 10.1016/j.puhe.2007.07.004; Lang EK, 2013, INT J SYST EVOL MICR, V63, P4354, DOI 10.1099/ijs.0.056440-0; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Leevvenhoeck A., 1683, PHILOS T, V14, P568; Leishman Shaneen J, 2010, J Oral Microbiol, V2, DOI 10.3402/jom.v2i0.5781; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; Mailhot JM, 1998, J CLIN PERIODONTOL, V25, P578, DOI 10.1111/j.1600-051X.1998.tb02491.x; Maixner F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099994; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MOUREY L, 1993, J MOL BIOL, V232, P223, DOI 10.1006/jmbi.1993.1378; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nelson D, 1999, J BIOL CHEM, V274, P12245, DOI 10.1074/jbc.274.18.12245; Nonaka M, 2014, FEMS MICROBIOL LETT, V354, P60, DOI 10.1111/1574-6968.12426; O'Flynn C, 2015, GENOME BIOL EVOL, V7, P3397, DOI 10.1093/gbe/evv220; Olson ST, 2011, PROG MOL BIOL TRANSL, V99, P185, DOI 10.1016/S1877-1173(11)99005-X; Ostergaard H, 2000, J BIOL CHEM, V275, P33272, DOI 10.1074/jbc.M004633200; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POTEMPA J, 1988, SCIENCE, V241, P699, DOI 10.1126/science.2456616; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Riewald M, 1996, J BIOL CHEM, V271, P14526, DOI 10.1074/jbc.271.24.14526; Roberts TH, 2004, J MOL EVOL, V59, P437, DOI 10.1007/s00239-004-2635-6; SANKARAN K, 1995, METHOD ENZYMOL, V250, P683; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; Shimotahira N, 2013, INFECT IMMUN, V81, P1198, DOI 10.1128/IAI.00983-12; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P15781; Staniec D, 2015, J BIOL CHEM, V290, P27248, DOI 10.1074/jbc.M115.648782; STEIN PE, 1990, NATURE, V347, P99, DOI 10.1038/347099a0; Tanner ACR, 2006, PERIODONTOL 2000, V42, P88, DOI 10.1111/j.1600-0757.2006.00184.x; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Topic Berislav, 2012, Acta Med Acad, V41, P119, DOI 10.5644/ama2006-124.45; Tribble GD, 2012, MBIO, V3, DOI 10.1128/mBio.00231-11; Warinner C, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0376; Warinner C, 2014, NAT GENET, V46, P336, DOI 10.1038/ng.2906; WEI AZ, 1994, NAT STRUCT BIOL, V1, P251, DOI 10.1038/nsb0494-251; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Weyrich LS, 2017, NATURE, V544, P357, DOI 10.1038/nature21674; Whisstock J, 1998, TRENDS BIOCHEM SCI, V23, P63, DOI 10.1016/S0968-0004(97)01172-9; Whisstock JC, 2006, CURR OPIN STRUC BIOL, V16, P761, DOI 10.1016/j.sbi.2006.10.005; Whisstock JC, 2010, J BIOL CHEM, V285, P24307, DOI 10.1074/jbc.R110.141408; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109; Yamasaki M, 2002, J MOL BIOL, V315, P113, DOI 10.1006/jmbi.2001.5056; Ye S, 2001, NAT STRUCT BIOL, V8, P979, DOI 10.1038/nsb1101-979; Zhang QW, 2008, J MOL BIOL, V376, P1348, DOI 10.1016/j.jmb.2007.12.050; Zhang Q, 2007, EMBO REP, V8, P658, DOI 10.1038/sj.embor.7400986; Zheng B, 2009, BIOCHEM BIOPH RES CO, V380, P143, DOI 10.1016/j.bbrc.2009.01.057; Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200	107	13	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10883	10898		10.1074/jbc.M117.786533	http://dx.doi.org/10.1074/jbc.M117.786533			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28512127	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000404391000012
J	Fernandez-Sanchez, L; Bravo-Osuna, I; Lax, P; Arranz-Romera, A; Maneu, V; Esteban-Perez, S; Pinilla, I; Puebla-Gonzalez, MD; Herrero-Vanrell, R; Cuenca, N				Fernandez-Sanchez, Laura; Bravo-Osuna, Irene; Lax, Pedro; Arranz-Romera, Alicia; Maneu, Victoria; Esteban-Perez, Sergio; Pinilla, Isabel; del Mar Puebla-Gonzalez, Maria; Herrero-Vanrell, Rocio; Cuenca, Nicolas			Controlled delivery of tauroursodeoxycholic acid from biodegradable microspheres slows retinal degeneration and vision loss in P23H rats	PLOS ONE			English	Article							PHOTORECEPTOR CELL-DEATH; CONTROLLED DRUG-DELIVERY; RETINITIS-PIGMENTOSA; GANGLION-CELLS; MOUSE MODELS; RHODOPSIN; TUDCA; PLGA; BILE; SURVIVAL	Successful drug therapies for treating ocular diseases require effective concentrations of neuroprotective compounds maintained over time at the site of action. The purpose of this work was to assess the efficacy of intravitreal controlled delivery of tauroursodeoxycholic acid (TUDCA) encapsulated in poly(D, L-lactic-co-glycolic acid) (PLGA) microspheres for the treatment of the retina in a rat model of retinitis pigmentosa. PLGA microspheres (MSs) containing TUDCA were produced by the O/W emulsion-solvent evaporation technique. Particle size and morphology were assessed by light scattering and scanning electronic microscopy, respectively. Homozygous P23H line 3 rats received a treatment of intravitreal injections of TUDCA-PLGA MSs. Retinal function was assessed by electroretinography at P30, P60, P90 and P120. The density, structure and synaptic contacts of retinal neurons were analyzed using immunofluorescence and confocal microscopy at P90 and P120. TUDCA-loaded PLGA MSs were spherical, with a smooth surface. The production yield was 78%, the MSs mean particle size was 23 mu m and the drug loading resulted 12.5 +/- 0.8 mu g TUDCA/mg MSs. MSs were able to deliver the loaded active compound in a gradual and progressive manner over the 28-day in vitro release study. Scotopic electroretinografic responses showed increased ERG a- and b-wave amplitudes in TUDCA-PLGA-MSstreated eyes as compared to those injected with unloaded PLGA particles.TUDCA-PLGAMSs- treated eyes showed more photoreceptor rows than controls. The synaptic contacts of photoreceptors with bipolar and horizontal cells were also preserved in P23H rats treated with TUDCA-PLGA MSs. This work indicates that the slow and continuous delivery of TUDCA from PLGA-MSs has potential neuroprotective effects that could constitute a suitable therapy to prevent neurodegeneration and visual loss in retinitis pigmentosa.	[Fernandez-Sanchez, Laura; Lax, Pedro; Cuenca, Nicolas] Univ Alicante, Dept Physiol Genet & Microbiol, Alicante, Spain; [Bravo-Osuna, Irene; Arranz-Romera, Alicia; Esteban-Perez, Sergio; del Mar Puebla-Gonzalez, Maria; Herrero-Vanrell, Rocio] Univ Complutense Madrid, Fac Pharm, Dept Pharm & Pharmaceut Technol, Madrid, Spain; [Maneu, Victoria] Univ Alicante, Dept Opt Pharmacol & Anat, Alicante, Spain; [Pinilla, Isabel] Lozano Blesa Univ Hosp, Dept Ophthalmol, Zaragoza, Spain; [Pinilla, Isabel] Aragon Inst Hlth Res IIS Aragon, Zaragoza, Spain; [Herrero-Vanrell, Rocio] San Carlos Clin Hosp IdISSC, Sanit Res Inst, Madrid, Spain; [Herrero-Vanrell, Rocio] Univ Complutense Madrid, Ind Pharm Inst, Madrid, Spain; [Cuenca, Nicolas] Univ Alicante, Inst Ramon Margalef, Alicante, Spain	Universitat d'Alacant; Complutense University of Madrid; Universitat d'Alacant; Lozano Blesa University Clinical Hospital; Complutense University of Madrid; Universitat d'Alacant	Cuenca, N (corresponding author), Univ Alicante, Dept Physiol Genet & Microbiol, Alicante, Spain.; Herrero-Vanrell, R (corresponding author), Univ Complutense Madrid, Fac Pharm, Dept Pharm & Pharmaceut Technol, Madrid, Spain.; Herrero-Vanrell, R (corresponding author), San Carlos Clin Hosp IdISSC, Sanit Res Inst, Madrid, Spain.; Herrero-Vanrell, R (corresponding author), Univ Complutense Madrid, Ind Pharm Inst, Madrid, Spain.; Cuenca, N (corresponding author), Univ Alicante, Inst Ramon Margalef, Alicante, Spain.	rociohv@ucm.es; cuenca@ua.es	bravo-osuna, irene/M-3469-2015; Cuenca, Nicolas/I-2007-2015; Pérez, Sergio Esteban/K-6400-2017; Maneu, Victoria/N-4147-2014; Lax, Pedro/M-9074-2014; Fernandez-Sanchez, Laura/AAB-5663-2019	bravo-osuna, irene/0000-0003-3133-7872; Cuenca, Nicolas/0000-0002-6767-5710; Pérez, Sergio Esteban/0000-0003-4832-0778; Maneu, Victoria/0000-0002-5265-1361; Lax, Pedro/0000-0001-6931-1008; Fernandez-Sanchez, Laura/0000-0002-3629-0156	Spanish Ministry of Economy and Competitiveness [MINECO-FEDER BFU2015-67139-R, MICINN-FEDER MAT 2013-43127R]; Institute de Salud Carlos III [RETICS-FEDER RD16/0008/0016, RD16/0008/0009]; Complutense Research Group [UCM920415]; Generalitat Valenciana [PROMETEO/2016/158]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Institute de Salud Carlos III(Instituto de Salud Carlos III); Complutense Research Group; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by The Spanish Ministry of Economy and Competitiveness (MINECO-FEDER BFU2015-67139-R, to NC; MICINN-FEDER MAT 2013-43127R to RH-V) (http://www.mineco.gob.es); Institute de Salud Carlos III (RETICS-FEDER RD16/0008/0016, to NC; RD16/0008/0009 to RH-V) (http://www.oftared.com/); Complutense Research Group (UCM920415) to RH-V (https://www.ucm.es/); and Generalitat Valenciana PROMETEO/2016/158 to NC (http://www.gva.es).	Abrego G, 2015, EUR J PHARM BIOPHARM, V95, P261, DOI 10.1016/j.ejpb.2015.01.026; Andres-Guerrero V, 2015, J CONTROL RELEASE, V211, P105, DOI 10.1016/j.jconrel.2015.05.279; Arango-Gonzalez B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112142; Boatright JH, 2006, MOL VIS, V12, P1706; Boatright Jeffrey H, 2009, J Ocul Biol Dis Infor, V2, P149; Castro-Caldas M, 2012, MOL NEUROBIOL, V46, P475, DOI 10.1007/s12035-012-8295-4; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Checa-Casalengua P, 2011, J CONTROL RELEASE, V156, P92, DOI 10.1016/j.jconrel.2011.06.023; Chennamaneni SR, 2013, J CONTROL RELEASE, V167, P53, DOI 10.1016/j.jconrel.2013.01.007; COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384; Cortez LM, 2015, J VIROL, V89, P7660, DOI 10.1128/JVI.01165-15; Cuenca N, 2004, NEUROSCIENCE, V127, P301, DOI 10.1016/j.neuroscience.2004.04.042; Cuenca N, 2014, PROG RETIN EYE RES, V43, P17, DOI 10.1016/j.preteyeres.2014.07.001; Doonan F, 2005, INVEST OPHTH VIS SCI, V46, P3530, DOI 10.1167/iovs.05-0248; Drack AV, 2012, INVEST OPHTH VIS SCI, V53, P100, DOI 10.1167/iovs.11-8544; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Duan WM, 2002, CELL TRANSPLANT, V11, P195; Elia AE, 2015, EUR J NEUROL; Esquiva G, 2013, INVEST OPHTH VIS SCI, V54, P4605, DOI 10.1167/iovs.13-12120; Fernandez-Sanchez L, 2015, MOLECULES, V20, P13875, DOI 10.3390/molecules200813875; Fernaandez-Saanchez L, 2014, INVEST OPHTH VIS SCI, V55, P6059, DOI 10.1167/iovs.14-14421; Fernandez-Sanchez L, 2012, HUM GENE THER, V23, P1290, DOI 10.1089/hum.2012.067; Fernandez-Sanchez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043074; Fernandez-Sanchez L, 2011, INVEST OPHTH VIS SCI, V52, P4998, DOI 10.1167/iovs.11-7496; Fu YB, 2014, ADV EXP MED BIOL, V801, P791, DOI 10.1007/978-1-4614-3209-8_99; Garcia-Ayuso D, 2010, EXP EYE RES; Garcia-Ayuso D, 2015, INVEST OPHTH VIS SCI, V56, P4592, DOI 10.1167/iovs.15-16808; Gaspar JM, 2013, NEUROSCIENCE, V253, P380, DOI 10.1016/j.neuroscience.2013.08.053; Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3; GIORDANO GG, 1995, CURR EYE RES, V14, P761, DOI 10.3109/02713689508995797; Gomez-Vicente V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137826; Gong J, 2006, BRAIN RES, V1082, P73, DOI 10.1016/j.brainres.2006.01.111; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Herrero-Vanrell R, 2001, ADV DRUG DELIVER REV, V52, P5, DOI 10.1016/S0169-409X(01)00200-9; Herrero-Vanrell R, 2011, INVEST OPHTHALMOL, V52, P3251, DOI 10.1016/i.exer.2015.10.012; Herrero-Vanrell R, 2014, PROG RETIN EYE RES, V42, P27, DOI 10.1016/j.preteyeres.2014.04.002; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Jiang C, 2007, MOL VIS, V13, P1783; Jones BW, 2012, JPN J OPHTHALMOL, V56, P289, DOI 10.1007/s10384-012-0147-2; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; Kaur J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022181; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Keene CD, 2002, P NATL ACAD SCI USA, V99, P10671, DOI 10.1073/pnas.162362299; KHOOBEHI B, 1991, OPHTHALMIC SURG LAS, V22, P175; Kolomiets B, 2010, NEUROBIOL DIS, V38, P47, DOI 10.1016/j.nbd.2009.12.025; Lawson EC, 2016, ADV EXP MED BIOL, V854, P431, DOI 10.1007/978-3-319-17121-0_57; Lax P, 2011, J PINEAL RES, V50, P183, DOI 10.1111/j.1600-079X.2010.00827.x; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Mantopoulos D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024245; Mao SR, 2007, INT J PHARM, V334, P137, DOI 10.1016/j.ijpharm.2006.10.036; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Mitragotri S, 2014, NAT REV DRUG DISCOV, V13, P655, DOI 10.1038/nrd4363; Muller LPD, 2015, J COMP NEUROL, V523, P1443, DOI 10.1002/cne.23751; Noailles A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0186-3; Oveson BC, 2011, J NEUROCHEM, V116, P144, DOI 10.1111/j.1471-4159.2010.07092.x; Paganelli F, 2010, EXPERT OPIN DRUG DEL, V7, P955, DOI 10.1517/17425247.2010.498817; Phillips MJ, 2008, INVEST OPHTH VIS SCI, V49, P2148, DOI 10.1167/iovs.07-1012; Pinilla I, 2005, NEUROSCI LETT, V382, P16, DOI 10.1016/j.neulet.2005.02.055; Pinilla I, 2016, EXP EYE RES, V150, P122, DOI 10.1016/j.exer.2015.10.012; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Puthussery T, 2010, ADV EXP MED BIOL, V664, P525, DOI 10.1007/978-1-4419-1399-9_60; RADOMSKY ML, 1990, BIOMATERIALS, V11, P619, DOI 10.1016/0142-9612(90)90018-L; Ran X, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau047; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Rong XF, 2014, INT J NANOMED, V9, P3057, DOI 10.2147/IJN.S64100; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Veloso Jr AA., 1997, INVEST OPHTHALMOL, V38; Viana RJS, 2009, CELL MOL LIFE SCI, V66, P1094, DOI 10.1007/s00018-009-8746-x; WONG P, 1994, BIOCHEM CELL BIOL, V72, P489, DOI 10.1139/o94-066; Yasukawa T, 2004, PROG RETIN EYE RES, V23, P253, DOI 10.1016/j.preteyeres.2004.02.003; Zhang HB, 2003, INVEST OPHTH VIS SCI, V44, P2858, DOI 10.1167/iovs.03-0072; Zhang T, 2012, INVEST OPHTH VIS SCI, V53, P3349, DOI 10.1167/iovs.12-9851	73	36	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177998	10.1371/journal.pone.0177998	http://dx.doi.org/10.1371/journal.pone.0177998			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542454	Green Submitted, Green Published, gold			2022-12-26	WOS:000402062800034
J	Jeon, JP; Koh, IU; Choi, NH; Kim, BJ; Han, BG; Lee, S				Jeon, Jae-Pil; Koh, In-Uk; Choi, Nak-Hyun; Kim, Bong-Jo; Han, Bok-Ghee; Lee, Suman			Differential DNA methylation of MSI2 and its correlation with diabetic traits	PLOS ONE			English	Article							EPIGENOME-WIDE ASSOCIATION; ADIPOSE-TISSUE; EXPRESSION; BMI; HYPERGLYCEMIA; EPIGENETICS; SIGNATURE; ENHANCER; SMOKING; INSULIN	Differential DNA methylation with hyperglycemia is significantly associated with Type 2 Diabetes (T2D). Longtime extended exposure to high blood glucose levels can affect the epigenetic signatures in all organs. However, the relevance of the differential DNA methylation changes with hyperglycemia in blood with pancreatic islets remains unclear. We investigated differential DNA methylation in relation to glucose homeostasis based on the Oral Glucose Tolerance Test (OGTT) in a population-based cohort. We found a total of 382 differential methylation sites from blood DNA in hyperglycemia and type 2 diabetes subgroups using a longitudinal and cross-sectional approach. Among them, three CpG sites were overlapped; they were mapped to the MSI2 and CXXC4 genes. In a DNA methylation replication study done by pyrosequencing (n = 440), the CpG site of MSI2 were shown to have strong associations with the T2D group (p value = 2.20E-16). The differential methylation of MSI2 at chr17:55484635 was associated with diabetes-related traits, in particular with insulin sensitivity (QUICKI, p value = 2.20E-16) and resistance (HOMA-IR, p value = 1.177E-07). In human pancreatic islets, at the single-base resolution (using whole-genome bisulfite sequencing), the 292 CpG sites in the +/- 5kb at chr17: 55484635 were found to be significantly hypo-methylated in donors with T2D (average decrease = 13.91%, 95% confidence interval (CI) = 4.18 similar to 17.06) as compared to controls, and methylation patterns differed by sex (-9.57%, CI = -16.76 similar to -6.89) and age (0.12%, CI = -11.17 similar to 3.77). Differential methylation of the MSI2 gene (chr17: 55484635) in blood and islet cells is strongly related to hyperglycemia. Our findings suggest that epigenetic perturbation on the target site of MSI2 gene in circulating blood and pancreatic islets should represent or affect hyperglycemia.	[Jeon, Jae-Pil] Natl Res Inst Hlth, Ctr Biomed Sci, Cheongju, South Korea; [Koh, In-Uk; Choi, Nak-Hyun; Kim, Bong-Jo; Han, Bok-Ghee; Lee, Suman] Natl Res Inst Hlth, Ctr Genome Sci, Cheongju, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science	Han, BG; Lee, S (corresponding author), Natl Res Inst Hlth, Ctr Genome Sci, Cheongju, South Korea.	bokghee@nih.go.kr; smnl93@gmail.com			Korean National Institute of Health [2009-N00435-00, 2014-ND73001-00, 2016-NI73004-00, 2017-NI73003-00]	Korean National Institute of Health	This work was supported by intramural grants (2009-N00435-00, 2014-ND73001-00, 2016-NI73004-00 and 2017-NI73003-00) from the Korean National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Yong-Sung Kim and Jong Ryul Park at KRIBB for advising pyrosequencing experiment. This work was supported by intramural grants (2009-N00435-00, 2014-ND73001-00, 2016-NI73004-00 and 2017-NI73003-00) from the Korean National Institute of Health. Epidemiological and biochemical data including the OGTT and DNA samples for this study were provided by the National Biobank of Korea and the Korean Genome and Epidemiology Study (KoGES) according to the approval of the sample and data access committee.	Alegra-Torres JA, 2011, EPIGENOMICS-UK, V3, P267, DOI [10.2217/EPI.11.22, 10.2217/epi.11.22]; Campion J, 2010, PROG MOL BIOL TRANSL, V94, P291, DOI 10.1016/S1877-1173(10)94011-8; Choi HJ, 2012, PHYSIOL GENOMICS, V44, P1179, DOI 10.1152/physiolgenomics.00179.2011; Danovi SA, 2010, NAT REV CANCER, V10, P602, DOI 10.1038/nrc2919; Dayeh T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004160; Demerath EW, 2015, HUM MOL GENET, V24, P4464, DOI 10.1093/hmg/ddv161; Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4; Dogan MV, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-151; Drong AW, 2012, CLIN PHARMACOL THER, V92, P707, DOI 10.1038/clpt.2012.149; ELAYAT AA, 1995, J ANAT, V186, P629; Florath I, 2016, DIABETOLOGIA, V59, P130, DOI 10.1007/s00125-015-3773-7; Goto T, 2005, TRANSPL P, V37, P3430, DOI 10.1016/j.transproceed.2005.09.041; Hall E, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0522-z; Hidalgo B, 2014, DIABETES, V63, P801, DOI 10.2337/db13-1100; Hope KJ, 2011, CURR OPIN HEMATOL, V18, P203, DOI 10.1097/MOH.0b013e328347888a; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; Kim Y, 2016, INT J EPIDEMIOL; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim Unhee, 2012, Methods Mol Biol, V863, P359, DOI 10.1007/978-1-61779-612-8_23; Multhaup ML, 2015, CELL METAB, V21, P138, DOI 10.1016/j.cmet.2014.12.014; Na YK, 2014, MOL CELLS, V37, P467, DOI 10.14348/molcells.2014.0073; Nilsson E, 2014, DIABETES, V63, P2962, DOI 10.2337/db13-1459; Park JH, 2007, BIOCHEM BIOPH RES CO, V358, P513, DOI 10.1016/j.bbrc.2007.04.169; Ronn T, 2015, HUM MOL GENET, V24, P3792, DOI 10.1093/hmg/ddv124; Sales LB, 2013, TOXICOL IN VITRO, V27, P1634, DOI 10.1016/j.tiv.2013.04.005; Shim SM, 2016, J HUM GENET, V61, P241, DOI 10.1038/jhg.2015.140; Song MA, 2007, ELECTROPHORESIS, V28, P2379, DOI 10.1002/elps.200600852; Szabat M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.119; Tekpli X, 2012, INT J CANCER, V131, P1509, DOI 10.1002/ijc.27421; Teschendorff AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008274; Volkmar M, 2012, EMBO J, V31, P1405, DOI 10.1038/emboj.2011.503; Wang XL, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-87; Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]	34	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177406	10.1371/journal.pone.0177406	http://dx.doi.org/10.1371/journal.pone.0177406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542303	Green Published, gold, Green Submitted			2022-12-26	WOS:000402061500022
J	Kaffarnik, MF; Ahmadi, N; Lock, JF; Wuensch, T; Pratschke, J; Stockmann, M; Malinowski, M				Kaffarnik, Magnus F.; Ahmadi, Navid; Lock, Johan F.; Wuensch, Tilo; Pratschke, Johann; Stockmann, Martin; Malinowski, Maciej			Correlation between plasma endothelin-1 levels and severity of septic liver failure quantified by maximal liver function capacity (LiMAx test). A prospective study	PLOS ONE			English	Article							HEPATIC-DYSFUNCTION; EARLY-DIAGNOSIS; RECEPTOR; TRANSPLANTATION; MORTALITY; SEPSIS; INJURY; ALPHA	Aim To investigate the relationship between the degree of liver dysfunction, quantified by maximal liver function capacity (LiMAx test) and endothelin-1, TNF-alpha and IL-6 in septic surgical patients. Methods 28 septic patients (8 female, 20 male, age range 35-80y)were prospectively investigated on a surgical intensive care unit. Liver function, defined by LiMAx test, and measurements of plasma levels of endothelin-1, TNF-alpha and IL-6 were carried out within the first 24 hours after onset of septic symptoms, followed by day 2, 5 and 10. Patients were divided into 2 groups (group A: LiMAx >= 100 mu g/kg/h, moderate liver dysfunction; group B: LiMAx < 100 mu g/kg/h, severe liver dysfunction) for analysis and investigated regarding the correlation between endothelin-1 and the severity of liver failure, quantified by LiMAx test. Results Group B showed significant higher results for endothelin-1 than patients in group A(P = 0.01, d5; 0.02, d10). For TNF-alpha, group B revealed higher results than group A, with a significant difference on day 10 (P = 0.005). IL-6 showed a non-significant trend to higher results in group B. The Spearman's rank correlation coefficient revealed a significant correlation between LiMAx and endothelin-1 (-0.434; P < 0.001), TNF-alpha (-0.515; P < 0.001) and IL-6 (-0.590; P < 0.001). Conclusions Sepsis-related hepatic dysfunction is associated with elevated plasma levels of endothelin-1, TNF-alpha and IL-6. Low LiMAx results combined with increased endothelin-1 and TNF-alpha and a favourable correlation between LiMAx and cytokine values support the findings of a crucial role of Endothelin-1 and TNF-alpha in development of septic liver failure.	[Kaffarnik, Magnus F.; Ahmadi, Navid; Lock, Johan F.; Wuensch, Tilo; Pratschke, Johann; Stockmann, Martin; Malinowski, Maciej] Charite Univ Med Berlin, Dept Gen Visceral & Transplantat Surg, Augustenburger Pl 1, Berlin, Germany; [Lock, Johan F.] Univ Hosp Wuerzburg, Dept Gen Visceral Vasc & Paediat Surg, Wurzburg, Germany; [Malinowski, Maciej] Univ Hosp Homburg, Dept Gen Visceral Vasc & Paediat Surg, Homburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg; Universitatsklinikum des Saarlandes	Kaffarnik, MF (corresponding author), Charite Univ Med Berlin, Dept Gen Visceral & Transplantat Surg, Augustenburger Pl 1, Berlin, Germany.	magnus.kaffarnik@charite.de	Lock, Johan/AAA-8114-2020	Lock, Johan/0000-0002-9007-3937; Ahmadi, Navid/0000-0003-3246-5905	Charite-University Hospital, Berlin	Charite-University Hospital, Berlin	The study was funded by research grants of the Charite-University Hospital, Berlin. B.R.A.H. M.S. GmbH, (Hennigsdorf, Germany) supported this study by provision of CT-proET-1 assay kits (BRAHMS CRproET1 Kryptor, Material Transfer Agreement). This does not alter our adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahde R, 2014, HEPATOLOGY, V59, P1107, DOI 10.1002/hep.26766; Bahde R, 2013, HEPATOLOGY, V57, P320, DOI 10.1002/hep.26005; Battistini B, 1996, SHOCK, V5, P167, DOI 10.1097/00024382-199603000-00002; Brauner JS, 2000, INTENS CARE MED, V26, P305, DOI 10.1007/s001340051154; Brienza N, 2006, INTENS CARE MED, V32, P267, DOI 10.1007/s00134-005-0023-3; Chan CC, 2001, HEPATOLOGY, V33, P816, DOI 10.1053/jhep.2001.23079; Demirci E, 2015, DRUG RES, V65, P272, DOI 10.1055/s-0034-1377024; Eakes AT, 1998, AM J PHYSIOL-GASTR L, V274, pG1068, DOI 10.1152/ajpgi.1998.274.6.G1068; Freeman BD, 2014, LIFE SCI, V118, P110, DOI 10.1016/j.lfs.2014.04.021; Harbrecht BG, 2002, J TRAUMA, V53, P517, DOI 10.1097/00005373-200209000-00020; Iwai M, 1998, HEPATOLOGY, V28, P503, DOI 10.1002/hep.510280230; Kaffarnik MF, 2013, CRIT CARE, V17, DOI 10.1186/cc13089; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Lock JF, 2010, LIVER TRANSPLANT, V16, P172, DOI 10.1002/lt.21973; McKenna S, 2015, J IMMUNOL, V195, P3866, DOI 10.4049/jimmunol.1501017; Nagai H, 2010, J SURG RES, V162, P46, DOI 10.1016/j.jss.2007.07.024; Norris EJ, 2013, SHOCK, V39, P168, DOI 10.1097/SHK.0b013e3182736688; Oki M, 2014, LIFE SCI, V118, P364, DOI 10.1016/j.lfs.2014.02.008; Papassotiriou J, 2006, CLIN CHEM, V52, P1144, DOI 10.1373/clinchem.2005.065581; Piechota Mariusz, 2007, J Intensive Care Med, V22, P232, DOI 10.1177/0885066607301444; Quinto BMR, 2015, CYTOKINE, V71, P255, DOI 10.1016/j.cyto.2014.10.024; Schuetz P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-22; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stockmann M, 2010, TRANSPL INT, V23, P1023, DOI 10.1111/j.1432-2277.2010.01089.x; Stockmann M, 2010, HPB, V12, P139, DOI 10.1111/j.1477-2574.2009.00151.x; Stockmann M, 2009, ANN SURG, V250, P119, DOI 10.1097/SLA.0b013e3181ad85b5; Strassburg CP, 2003, BEST PRACT RES CL GA, V17, P369, DOI 10.1016/S1521-6918(03)00025-8; Struck J, 2005, PEPTIDES, V26, P2482, DOI 10.1016/j.peptides.2005.05.010; Tschaikowsky K, 2000, CRIT CARE MED, V28, P1854, DOI 10.1097/00003246-200006000-00028; Wanecek M, 2000, EUR J PHARMACOL, V407, P1, DOI 10.1016/S0014-2999(00)00675-0; Zhao Ruo-Zhi, 2005, Biochem Biophys Res Commun, V327, P985, DOI 10.1016/j.bbrc.2004.12.109	31	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178237	10.1371/journal.pone.0178237	http://dx.doi.org/10.1371/journal.pone.0178237			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542386	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058800050
J	Macedo, RS; Teixeira, WG; Correa, MM; Martins, GC; Vidal-Torrado, P				Macedo, Rodrigo S.; Teixeira, Wenceslau G.; Correa, Marcelo M.; Martins, Gilvan C.; Vidal-Torrado, Pablo			Pedogenetic processes in anthrosols with pretic horizon (Amazonian Dark Earth) in Central Amazon, Brazil	PLOS ONE			English	Article							INDIAN BLACK EARTH; CARBON; TERRA	Anthrosols known as Amazonian Dark Earth (ADE) have borne witness to the intensification of sedentary patterns and the demographic increase in Central Amazon. As a result, a recurring pattern has been observed of mounds with ADE arising from domestic activities and the disposal of waste. The objective of this research was to demonstrate the relationship of these anthropic activities with pedogenetic formation processes of ADE in the municipality of Iranduba, Brazil. Disturbed and undisturbed soil samples were taken from two areas of ADE (pretic horizon) and from a non-anthropic pedon. Physical, chemical, micromorphological and SEM-EDS analyses were performed. The coarse material of the pretic horizons consisted predominantly of quartz, iron nodules, ceramics and charcoal fragments, and the fine material is organo-mineral. There was a direct relationship between the color of pretic horizons and the number of charcoal fragments. The thickness of the ADE results from the redistribution of charcoal at depth through bioturbation, transforming subsurface horizons into anthropic horizons. ADE presents granular microaggregates of geochemical and zoogenetic origin. Degradation of iron nodules is intensified in pretic horizons, promoting a reverse pedogenic process contributing to the xanthization process. Surprisingly the anthropic activities also favor clay dispersion and argilluviation; clay coatings on the ceramic fragments and in the pores demonstrate that this is a current process. Processes identified as contributing to ADE genesis included: i) addition of organic residues and ceramic artifacts (cumulization) with the use of fire; ii) mechanical action of humans, roots and macrofauna (bioturbation); iii) melanization of deeper horizons as a result of bioturbation; iv) argilluviation and degradation of iron nodules. This study offers new support to archaeological research in respect to ADE formation processes in Central Amazon and confirmed the hypothesis that ancient anthropic activities may trigger and/or accelerate pedogenetic processes previously credited only to natural causes.	[Macedo, Rodrigo S.; Vidal-Torrado, Pablo] Univ Sao Paulo, Soil Sci Dept, Piracicaba, SP, Brazil; [Teixeira, Wenceslau G.] Embrapa Solos, Rio De Janeiro, RJ, Brazil; [Correa, Marcelo M.] Univ Fed Rural Pernambuco, Unidade Acad Garanhuns, Garanhuns, PE, Brazil; [Martins, Gilvan C.] Embrapa Amazonia Ocidental, Manaus, Amazonas, Brazil	Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal Rural de Pernambuco (UFRPE); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Vidal-Torrado, P (corresponding author), Univ Sao Paulo, Soil Sci Dept, Piracicaba, SP, Brazil.	pvidal@usp.br	Correa, Marcelo/AAI-1232-2021; Vidal-Torrado, Pablo/C-4020-2012; Teixeira, Wenceslau G/P-3723-2014	Correa, Marcelo/0000-0003-0929-4634; Vidal-Torrado, Pablo/0000-0001-9228-9910; Teixeira, Wenceslau G/0000-0002-2010-6078	Sao Paulo Research Foundation (FAPESP)/Brazil [FAPESP 2010/51934-5, FAPESP 2012/06064-8]; CAPES [FAPESP 2010/51934-5, FAPESP 2012/06064-8]; EMBRAPA; CNPq [304741/2013-2]	Sao Paulo Research Foundation (FAPESP)/Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); EMBRAPA(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by Sao Paulo Research Foundation (FAPESP)/Brazil and CAPES, by granting PhD scholarships within the country (FAPESP 2010/51934-5) and abroad (FAPESP 2012/06064-8). EMBRAPA is a government research institution (https://www.embrapa.br/en/home) which provided financial support in the form of authors' salaries and/or research materials to authors WGT and GCM. CNPq provided a research grant of PVT (304741/2013-2). The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully thank the FAPESP (2010/51934-5) and CAPES for the doctoral scholarships granted to the first author and CNPq (304741/2013-2) for the research grant of the last author. We would like to thank Embrapa Amazonia Ocidental-Amazonas/Brasil for the logistic support and the Caldeirao Project. We would like to give thanks to Marcia Regina Calegari for enormous help in the fieldwork and the technicians Sonia Moraes and Jose Luiz Vicente for the preparation of the thin sections.	[Anonymous], 1966, AMAZON SOILS RECONNA; Archanjo BS, 2014, ENVIRON SCI TECHNOL, V48, P7445, DOI 10.1021/es501046b; Arroyo-Kalin M., 2009, P99, DOI 10.1007/978-1-4020-9031-8_5; Arroyo-Kalin M., 2009, P33, DOI 10.1007/978-1-4020-9031-8_3; Arroyo-Kalin MA, 2010, ARQUEOLOGIA AMAZONIC, V2, P367; Arroyo-Kalin M, 2012, QUATERN INT, V249, P4, DOI 10.1016/j.quaint.2011.08.004; Birk JJ, 2011, J ARCHAEOL SCI, V38, P1209, DOI 10.1016/j.jas.2010.12.015; Bouma J., 1990, MICROMORPHOLOGY HYDR, P257, DOI [10.1016/S0166-2481(08)70338-6, DOI 10.1016/S0166-2481(08)70338-6]; BREWER R, 1976, FABRIC MINERAL ANAL; Bullock P, 1985, HDB THIN SECTION DES; Coelho M. R., 2001, Revista Brasileira de Ciencia do Solo, V25, P371, DOI 10.1590/S0100-06832001000200013; Cooper M, 2005, SCI AGR, V62, P256, DOI 10.1590/S0103-90162005000300009; Costa ML, 2011, AN ACAD BRAS CIENC, V73, P461; Empresa Brasileira de Pesquisa Agropecuaria-Embrapa, 2011, MAN MET AN SOL; Heckenberger MJ, 1999, LAT AM ANTIQ, V10, P353, DOI 10.2307/971962; IBGE, 2007, BAS CART INT DIG BRA; IUSS Working Group WRB, 2015, 106 IUSS; Jungerius PD, 1999, CATENA, V34, P349, DOI 10.1016/S0341-8162(98)00106-4; Kampf N, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P77, DOI 10.1007/1-4020-2597-1_5; Kampf N., 2005, TOPICS SOIL SCI, V6, P277; Kern DC, 2004, AMAZONIAN DARK EARTHS: EXPLORATIONS IN SPACE AND TIME, P19; Lemos VP, 2009, REM-REV ESC MINAS, V62, P139, DOI 10.1590/S0370-44672009000200004; Lima HN, 2002, GEODERMA, V110, P1, DOI 10.1016/S0016-7061(02)00141-6; Lima HN, 2010, TERRAS PRETAS INDIO, P212; Lindbo DL, 2010, INTERPRETATION OF MICROMORPHOLOGICAL FEATURES OF SOILS AND REGOLITHS, P129, DOI 10.1016/B978-0-444-53156-8.00008-8; Madari BE, 2010, TERRAS PRETAS INDIO, P172; Murphy C.P., 1986, THIN SECTION PREPARA; Nakamura F. M., 2014, Diversity, V6, P339, DOI 10.3390/d6020339; Neves EG, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P29, DOI 10.1007/1-4020-2597-1_3; Neves EG, 2006, ARQUEOLOGIA AMAZOINA; Oonk S, 2009, J ARCHAEOL SCI, V36, P1215, DOI 10.1016/j.jas.2009.01.010; Ruivo MDP, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P243, DOI 10.1007/1-4020-2597-1_13; Santos RD., 2013, MANUAL DESCRICAO COL, V6; Schaefer CEGR, 2004, AUST J SOIL RES, V42, P401, DOI 10.1071/SR03106; Schaefer CER, 2001, AUST J SOIL RES, V39, P909, DOI 10.1071/SR00093; Schellekens J, 2017, GEODERMA, V288, P154, DOI 10.1016/j.geoderma.2016.11.001; Schmidt MJ, 2014, J ARCHAEOL SCI, V42, P152, DOI 10.1016/j.jas.2013.11.002; Silva AMS, 1999, NEW J CHEM, V23, P329, DOI 10.1590/S0100-06831999000200017; SOMBROEK WG, 1993, AMBIO, V22, P417; Souza KR, 2011, THESIS; Tardy Y., 1992, PETROLOGIE LATERITES, P459; Taube PS, 2013, ORG GEOCHEM, V58, P96, DOI 10.1016/j.orggeochem.2013.02.004; Teixeira WG, 2008, DIGITAL SOIL MAPPING WITH LIMITED DATA, P327, DOI 10.1007/978-1-4020-8592-5_29; Teixeira WG, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P271, DOI 10.1007/1-4020-2597-1_15; Zech W., 1990, Humic substances in soil and crop sciences: selected readings. Proceedings of a symposium cosponsored by the International Humic Substances Society, Chicago, Illinois, December 2, 1985., P187	45	25	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178038	10.1371/journal.pone.0178038	http://dx.doi.org/10.1371/journal.pone.0178038			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542442	gold, Green Submitted, Green Published			2022-12-26	WOS:000402058800034
J	Jensen, EM; Sevatdal, S; Bakke, MJ; Kaur, K; Horsberg, TE				Jensen, Elena Myhre; Sevatdal, Sigmund; Bakke, Marit Jorgensen; Kaur, Kiranpreet; Horsberg, Tor Einar			A selection study on a laboratory-designed population of salmon lic (Lepeophtheirus salmonis) using organophosphate and pyrethroid pesticides	PLOS ONE			English	Article							SEA LICE; ATLANTIC SALMON; ACETYLCHOLINESTERASE; DELTAMETHRIN; SALAR; INFECTIONS; RESISTANCE; CRUSTACEA; BIOMARKER; EXPOSURE	Resistance towards antiparasitic agents in the salmon louse (Lepeophtheirus salmonis) is a widespread problem along the Norwegian coast, reducing treatments efficacies and slowing down the envisioned expansion of Norwegian salmon production. The present study was conducted in order to assess the efficacies of two of the most widely used anti-parasitic substances -azamethiphos and deltamethrin-as well as assessing the benefit of having a resistant genotype compared to being fully sensitive when exposed to one of these substances. Atlantic salmon were exposed to a mix of salmon lice copepodids from a fully sensitive, a double resistant and a multi-resistant strain. Once the lice reached pre-adult stages, one group was exposed to 100 mu g/L azamethiphos for 60 minutes, the other to 2 mu g/L deltamethrin for 30 minutes, and the last was kept in a seawater control. Detached lice were collected at a series of time points following exposure, and all lice (immobilized and surviving) were analysed for both pyrethroid (sensitive "S" and resistant "R") and azamethiphos (fully sensitive "SS", heterozygous resistant "RS" and fully resistant "RR") resistance markers. We found that the efficacies of deltamethrin on parasites with genotype S and R were 70.3 and 13.2%, respectively. The overall efficacy of the deltamethrin treatment was 32.3%. The efficacies of azamethiphos on parasites with genotype SS, RS and RR were 100, 80 and 19.1%, respectively. The overall efficacy of the azamethiphos treatment was 80.4%. Survival analyses revealed that the median survival time in deltamethrin-sensitive and-resistant parasites were 16.8 and > 172 hours, respectively. The differences were even more pronounced in the azamethiphos-treated group, where SS, RS and RR parasites survived for 0.26, 6.6 and > 172 hours, respectively. The substantial differences in survival between sensitive and resistant lice following treatment demonstrate the ability of medicinal treatments to drive genetic selection towards a much more resistant salmon lice population within a very short time span if there is no influx of sensitive genotypes.	[Jensen, Elena Myhre; Bakke, Marit Jorgensen; Kaur, Kiranpreet; Horsberg, Tor Einar] Norwegian Univ Life Sci, Sea Lice Res Ctr, Fac Vet Med, Oslo, Norway; [Sevatdal, Sigmund] VESO, Oslo, Norway	Norwegian University of Life Sciences	Jensen, EM (corresponding author), Norwegian Univ Life Sci, Sea Lice Res Ctr, Fac Vet Med, Oslo, Norway.	elena.myhre.jensen@nmbu.no	Kaur, Kiran/R-3535-2018	Kaur, Kiran/0000-0002-7285-5513	Norwegian Seafood Research Fund - FHF [900838]; Norwegian Research Council through the Centre for Innovation, Sea Lice Research Centre [NFR 203513/030]	Norwegian Seafood Research Fund - FHF; Norwegian Research Council through the Centre for Innovation, Sea Lice Research Centre	The study was financially supported by the Norwegian Seafood Research Fund - FHF, grant number 900838. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The financial support was provided as support for rental of vet-lab capacities. The study was also financially supported by the Norwegian Research Council through the Centre for Innovation, Sea Lice Research Centre, grant number NFR 203513/030. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, and provided only financial support in the form of salaries to [EMJ, KK & MJB]. One of the authors of the study [SS] is employed by the commercial company VESO, Oslo, Norway, and contributed to study design, data collection and preparation of the manuscript. The company VESO, however, had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific role of each author is articulated in the 'author contributions' section.	Aaen SM, 2015, TRENDS PARASITOL, V31, P72, DOI 10.1016/j.pt.2014.12.006; Altman DG, 1992, PRACTICAL STAT MED R, P365; [Anonymous], 2016, STATUS NORSKE LAKSEB; Badiou A, 2008, CHEM-BIOL INTERACT, V175, P406, DOI 10.1016/j.cbi.2008.05.040; Bjorn PA, 1998, CAN J ZOOL, V76, P970, DOI 10.1139/cjz-76-5-970; Corbett JR, 1974, BIOCH MODE ACTION PE; Costello MJ, 2009, J FISH DIS, V32, P115, DOI 10.1111/j.1365-2761.2008.01011.x; Denholm I, 2002, PEST MANAG SCI, V58, P528, DOI 10.1002/ps.482; Fallang A, 2005, DIS AQUAT ORGAN, V65, P129, DOI 10.3354/dao065129; Fallang A, 2004, PEST MANAG SCI, V60, P1163, DOI 10.1002/ps.932; Fast MD, 2006, FISH SHELLFISH IMMUN, V21, P228, DOI 10.1016/j.fsi.2005.11.010; Grimnes A, 1996, J FISH BIOL, V48, P1179, DOI 10.1111/j.1095-8649.1996.tb01813.x; Hamre LA, 2009, PARASITOL INT, V58, P451, DOI 10.1016/j.parint.2009.08.009; Hartl DL, 2006, PRINCIPLES POPULATIO; Heuch PA, 2003, J FISH DIS, V26, P539, DOI 10.1046/j.1365-2761.2003.00490.x; Hossain MM, 2004, NEUROTOXICOLOGY, V25, P825, DOI 10.1016/j.neuro.2004.01.002; Tu HT, 2012, CHEMOSPHERE, V86, P83, DOI 10.1016/j.chemosphere.2011.09.022; Jansen PA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149006; Kaur K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149264; Kaur K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124220; Krkosek M, 2005, P ROY SOC B-BIOL SCI, V272, P689, DOI 10.1098/rspb.2004.3027; Liu YJ, 2014, PREV VET MED, V117, P469, DOI 10.1016/j.prevetmed.2014.08.018; Mattilsynet, RETH MIDL RED GODKJ; McEwan GF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139128; Nilsen F. E., 2013, Patent application, Patent No. [CA2920588A1, 2920588]; Nolan DT, 1999, CAN J FISH AQUAT SCI, V56, P947, DOI 10.1139/cjfas-56-6-947; Sevatdal S, 2005, PEST MANAG SCI, V61, P772, DOI 10.1002/ps.1057; Sevatdal S, 2003, AQUACULTURE; SHI MA, 2004, BMC EVOLUT BIOL, V4, P1; Soderlund DM, 2012, ARCH TOXICOL, V86, P165, DOI 10.1007/s00204-011-0726-x; Tarpai R. N, 2016, SURVEILLANCE PROGRAM; Toumi H, 2015, CHEMOSPHERE, V120, P351, DOI 10.1016/j.chemosphere.2014.07.087	32	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178068	10.1371/journal.pone.0178068	http://dx.doi.org/10.1371/journal.pone.0178068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531206	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000402058400056
J	Lv, FS; Yang, XP; Cui, CJ; Su, CH				Lv, Fengshou; Yang, Xiaopeng; Cui, Chuanju; Su, Chunhe			Exogenous expression of Drp1 plays neuroprotective roles in the Alzheimer ' s disease in the A beta 42 transgenic Drosophila model	PLOS ONE			English	Article							INDUCED MITOCHONDRIAL DYSFUNCTION; AMYLOID PRECURSOR PROTEIN; DYNAMIN-RELATED PROTEIN-1; ABNORMAL INTERACTION; SYNAPTIC DAMAGE; FISSION; BETA; TAU; PHOSPHORYLATION; INHIBITION	Background Alzheimer's disease (AD) is one of the most common neurodegenerative disorders. Recent studies have shown that mitochondrial dysfunction is a causative factor of AD. Drp1 (Dynamin- related protein 1), a regulator of mitochondrial fission, shows neuroprotective effects on Parkinson's disease. In this study, we investigate the effect and mechanism of Drp1 on A beta 42 transgenic Drosophila. Methods Elav-gal4/UAS>A beta 42 transgenic Drosophila model was constructed using Elav-gal4 promoter. The effects of Drp1 on the lifespan, motor ability and neuronal degeneration of the transgenic Drosophila were explored by over-expressing Drp1 in the A beta 42 transgenic Drosophila. ATP levels in the brain tissues of A beta 42 transgenic Drosophila were detected using high performance liquid chromatography (HPLC). Results Exogenous expression of Drp1 promoted crawling ability, reduced the levels of ATP in Drosophila brain and suppressed the neuronal degeneration. Conclusion The protective effect of Drp1 on the A beta 42 transgenic Drosophila was achieved by protecting the mitochondrial function, suggesting that Drp1 may be a potential therapeutic strategies for AD.	[Lv, Fengshou] Henan Med Coll, Dept Pathol, Zhengzhou, Peoples R China; [Yang, Xiaopeng; Su, Chunhe] Zhengzhou Univ, Affiliated Hosp 2, Dept Neurol, Zhengzhou, Peoples R China; [Cui, Chuanju] Zhengzhou First Peoples Hosp, Dept Neurol, Zhengzhou, Peoples R China	Henan Medical College; Zhengzhou University	Yang, XP (corresponding author), Zhengzhou Univ, Affiliated Hosp 2, Dept Neurol, Zhengzhou, Peoples R China.	xiaopengyang1233@163.com						Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Filichia E, 2016, SCI REP-UK, V6, DOI 10.1038/srep32656; Gomez-Lazaro M, 2008, FREE RADICAL BIO MED, V44, P1960, DOI 10.1016/j.freeradbiomed.2008.03.009; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Jacobsen KT, 2009, CELL MOL LIFE SCI, V66, P2299, DOI 10.1007/s00018-009-0020-8; Kandimalla RJL, 2011, CURR ALZHEIMER RES, V8, P187; Kandimalla R, 2016, HUM MOL GENET, V25, P4881, DOI 10.1093/hmg/ddw312; Kandimalla R, 2016, BBA-MOL BASIS DIS, V1862, P814, DOI 10.1016/j.bbadis.2015.12.018; Kandimalla RJ, 2014, CURR ALZHEIMER RES, V11, P340, DOI 10.2174/1567205011666140331161027; Kandimalla RJ PS, 2013, BIOL OPEN; Kim B, 2016, FREE RADICAL BIO MED, V90, P184, DOI 10.1016/j.freeradbiomed.2015.11.015; Kim DI, 2016, BBA-MOL CELL RES, V1863, P2820, DOI 10.1016/j.bbamcr.2016.09.003; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Manczak M, 2016, HUM MOL GENET, V25, P5148, DOI 10.1093/hmg/ddw330; Manczak M, 2012, HUM MOL GENET, V21, P2538, DOI 10.1093/hmg/dds072; Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139; Meilandt WJ, 2009, J NEUROSCI, V29, P1977, DOI 10.1523/JNEUROSCI.2984-08.2009; Qi X, 2013, J CELL SCI, V126, P789, DOI 10.1242/jcs.114439; Rappold PM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6244; Verri M, 2012, INT J IMMUNOPATH PH, V25, P345, DOI 10.1177/039463201202500204; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Xie N, 2014, NEUROSCIENCE, V256, P36, DOI 10.1016/j.neuroscience.2013.10.011; Yan J, 2015, NEUROBIOL AGING, V36, P211, DOI 10.1016/j.neurobiolaging.2014.08.005	26	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0176183	10.1371/journal.pone.0176183	http://dx.doi.org/10.1371/journal.pone.0176183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531191	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058400003
J	Tzeng, HP; Lan, KC; Yang, TH; Chung, MN; Liu, SH				Tzeng, Huei-Ping; Lan, Kuo-Cheng; Yang, Ting-Hua; Chung, Min-Ni; Liu, Shing Hwa			Benzo[a] pyrene activates interleukin-6 induction and suppresses nitric oxide-induced apoptosis in rat vascular smooth muscle cells	PLOS ONE			English	Article							NF-KAPPA-B; POLYCYCLIC AROMATIC-HYDROCARBONS; NECROSIS-FACTOR-ALPHA; ANGIOTENSIN-II; UP-REGULATION; IN-VITRO; EXPRESSION; ATHEROSCLEROSIS; GENE; PROLIFERATION	Benzo[a] pyrene, a ubiquitous environmental pollutant, has been suggested to be capable of initiating and/or accelerating atherosclerosis. Accumulation of vascular smooth muscle cells (VSMCs) in vessel intima is a hallmark of atherosclerosis. Nitric oxide (NO) can suppress VSMCs proliferation and induce VSMCs apoptosis. NO plays a compensatory role in the vascular lesions to reduce proliferation and/or accelerate apoptosis of VSMCs. The aim of this study was to investigate whether benzo[a] pyrene can affect VSMCs growth and apoptosis induced by NO. Benzo[a] pyrene (1-30 mu mol/L) did not affect the cell number and cell cycle distribution in VSMCs under serum deprivation condition. Sodium nitroprusside (SNP), a NO donor, decreased cell viability and induced apoptosis in VSMCs. Benzo[a] pyrene significantly suppressed SNP-induced cell viability reduction and apoptosis. VSMCs cultured in conditioned medium from cells treated with benzo[a] pyrene could also prevent SNP-induced apoptosis. Benzo[a] pyrene was capable of inducing the activation of nuclear factor (NF)-kappa B and phosphorylation of p38 mitogen-activated protein kinase (MAPK) in VSMCs. Both NF-kappa B inhibitor and p38 MAPK inhibitor significantly reversed the anti-apoptotic effect of benzo[a] pyrene on SNP-treated VSMCs. Incubation of VSMCs with benzo[a] pyrene significantly and dose-dependently increased interleukin (IL)-6 production. A neutralizing antibody to IL-6 effectively reversed the anti-apoptotic effect of benzo[a] pyrene on SNP-treated VSMCs. Taken together, these results demonstrate for the first time that benzo[a] pyrene activates IL-6 induction and protects VSMCs from NO-induced apoptosis. These findings propose a new mechanism for the atherogenic effect of benzo[a] pyrene.	[Tzeng, Huei-Ping; Chung, Min-Ni; Liu, Shing Hwa] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei, Taiwan; [Lan, Kuo-Cheng] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Emergency Med, Taipei, Taiwan; [Yang, Ting-Hua] Natl Taiwan Univ, Coll Med, Dept Otolaryngol, Taipei, Taiwan; [Yang, Ting-Hua] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Liu, Shing Hwa] Natl Taiwan Univ, Coll Med, Dept Pediat, Taipei, Taiwan; [Liu, Shing Hwa] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	National Taiwan University; National Defense Medical Center; Tri-Service General Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Liu, SH (corresponding author), Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei, Taiwan.; Liu, SH (corresponding author), Natl Taiwan Univ, Coll Med, Dept Pediat, Taipei, Taiwan.; Liu, SH (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	shinghwaliu@ntu.edu.tw		LIU, SHING-HWA/0000-0002-9976-1197	Ministry of Science and Technology of Taiwan [MOST103-2314-B-002-035]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the grant from the Ministry of Science and Technology of Taiwan (MOST103-2314-B-002-035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MR, 2012, PHYSIOL GENOMICS, V44, P417, DOI 10.1152/physiolgenomics.00160.2011; Amrani Y, 2001, MOL PHARMACOL, V60, P646; Andres V, 1998, INT J MOL MED, V2, P81; Bangia KS, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0039-2; Baraldi E, 1997, J PEDIATR-US, V131, P381, DOI 10.1016/S0022-3476(97)80062-5; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Browatzki M, 2000, BASIC RES CARDIOL, V95, P98, DOI 10.1007/s003950050170; Chava KR, 2009, ARTERIOSCL THROM VAS, V29, P809, DOI 10.1161/ATVBAHA.109.185777; Chen RH, 1999, J BIOL CHEM, V274, P23013, DOI 10.1074/jbc.274.33.23013; Craig R, 2000, J BIOL CHEM, V275, P23814, DOI 10.1074/jbc.M909695199; Curfs DMJ, 2005, FASEB J, V19, P1290, DOI 10.1096/fj.04-2269fje; Funakoshi Y, 1999, HYPERTENSION, V34, P118, DOI 10.1161/01.HYP.34.1.118; Geng YJ, 1996, ARTERIOSCL THROM VAS, V16, P19, DOI 10.1161/01.ATV.16.1.19; HANSSON GK, 1994, J EXP MED, V180, P733, DOI 10.1084/jem.180.2.733; Hardonniere K, 2015, TOXICOL IN VITRO, V29, P1597, DOI 10.1016/j.tiv.2015.06.010; Hartman J, 2014, CARDIOL REV, V22, P147, DOI 10.1097/CRD.0000000000000021; Haunstetter A, 1998, CIRC RES, V82, P1111, DOI 10.1161/01.RES.82.11.1111; Hennig B, 2002, TOXICOL APPL PHARM, V181, P174, DOI 10.1006/taap.2002.9408; HOUGH JL, 1993, ARTERIOSCLER THROMB, V13, P1721, DOI 10.1161/01.ATV.13.12.1721; Hu TT, 2016, ENVIRON TOXICOL PHAR, V43, P54, DOI 10.1016/j.etap.2016.02.011; Hung MJ, 2010, J HYPERTENS, V28, P940, DOI 10.1097/HJH.0b013e32833992ef; Inanaga K, 2009, HYPERTENS RES, V32, P466, DOI 10.1038/hr.2009.47; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; ISNER JM, 1995, CIRCULATION, V91, P2703, DOI 10.1161/01.CIR.91.11.2703; Ito T, 2000, CIRCULATION, V102, P2522, DOI 10.1161/01.CIR.102.20.2522; Kapadia MR, 2009, NITRIC OXIDE-BIOL CH, V20, P279, DOI 10.1016/j.niox.2009.02.005; Kelm M, 1999, BBA-BIOENERGETICS, V1411, P273, DOI 10.1016/S0005-2728(99)00020-1; Kim YM, 1999, CIRC RES, V84, P253, DOI 10.1161/01.RES.84.3.253; KWON NS, 1994, FASEB J, V8, P529, DOI 10.1096/fasebj.8.8.8181671; Lau HKF, 2003, ATHEROSCLEROSIS, V166, P223, DOI 10.1016/S0021-9150(02)00333-7; Lee WY, 2007, AM J CARDIOL, V99, P99, DOI 10.1016/j.amjcard.2006.07.070; Li CH, 2010, TOXICOL SCI, V118, P544, DOI 10.1093/toxsci/kfq279; Li H, 2014, EXP BIOL MED, V239, P954, DOI 10.1177/1535370214527903; LOPPNOW H, 1990, J CLIN INVEST, V85, P731, DOI 10.1172/JCI114498; MAJESKY MW, 1990, TOXICOL PATHOL, V18, P554; Sanmarco LM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00626; Mehrhof FB, 2005, CIRC RES, V96, P958, DOI 10.1161/01.RES.0000166924.31219.49; Mikhailenko V. M., 2013, Experimental Oncology, V35, P318; MONCADA S, 1991, PHARMACOL REV, V43, P109; Napoli C, 2013, J AM COLL CARDIOL, V62, P89, DOI 10.1016/j.jacc.2013.03.070; Nicotera P, 1997, TRENDS PHARMACOL SCI, V18, P189, DOI 10.1016/S0165-6147(97)90619-2; Nishio E, 1996, BIOCHEM BIOPH RES CO, V221, P163, DOI 10.1006/bbrc.1996.0563; Oesterling E, 2008, TOXICOL APPL PHARM, V232, P309, DOI 10.1016/j.taap.2008.07.001; Park H, 2003, ANN NY ACAD SCI, V1005, P242, DOI 10.1196/annals.1288.036; Popowich DA, 2010, AM J PHYSIOL-HEART C, V298, pH2192, DOI 10.1152/ajpheart.00535.2009; Ramachandran A, 2002, P NATL ACAD SCI USA, V99, P6643, DOI 10.1073/pnas.102019899; Ramos KS, 1996, ARCH BIOCHEM BIOPHYS, V332, P213, DOI 10.1006/abbi.1996.0335; Ratajczak-Wrona W, 2013, INT J ORAL SCI, V5, P141, DOI 10.1038/ijos.2013.59; Sato S, 2014, SCI WORLD J, V2014; SCHWARZE MMK, 1995, CANCER RES, V55, P2262; SEINO Y, 1994, CYTOKINE, V6, P87, DOI 10.1016/1043-4666(94)90013-2; Snyder CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007059; Son YH, 2008, J CARDIOVASC PHARM, V51, P71, DOI 10.1097/FJC.0b013e31815bd23d; TANABE O, 1988, J IMMUNOL, V141, P3875; Tokunou T, 2001, ARTERIOSCL THROM VAS, V21, P1759, DOI 10.1161/hq1101.098489; Tsutamoto T, 1998, J AM COLL CARDIOL, V31, P391, DOI 10.1016/S0735-1097(97)00494-4; Tzeng HP, 2003, TOXICOL SCI, V75, P66, DOI 10.1093/toxsci/kfg164; VONDERLEYEN HE, 1995, P NATL ACAD SCI USA, V92, P1137, DOI 10.1073/pnas.92.4.1137; Wang G, 2015, J PHYSIOL-LONDON, V593, P3013, DOI 10.1113/JP270033; Waxman AB, 2009, AM J RESP CELL MOL, V41, P385, DOI 10.1165/rcmb.2008-0302OC; Xia P, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9583268; Yan ZP, 2000, J BIOL CHEM, V275, P4949, DOI 10.1074/jbc.275.7.4949; Yan ZQ, 1996, CIRC RES, V79, P38, DOI 10.1161/01.RES.79.1.38; Zahradka P, 2002, J MOL CELL CARDIOL, V34, P1609, DOI 10.1006/jmcc.2002.2111; Zhao M, 2002, ARCH BIOCHEM BIOPHYS, V400, P199, DOI 10.1016/S0003-9861(02)00028-0	66	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178063	10.1371/journal.pone.0178063	http://dx.doi.org/10.1371/journal.pone.0178063			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531207	Green Submitted, gold, Green Published			2022-12-26	WOS:000402058400055
J	Mohammed, H; Kassa, M; Assefa, A; Tadesse, M; Kebede, A				Mohammed, Hussein; Kassa, Moges; Assefa, Ashenafi; Tadesse, Mekonnen; Kebede, Amha			Genetic polymorphism of Merozoite Surface Protein-2 (MSP-2) in Plasmodium falciparum isolates from Pawe District, North West Ethiopia	PLOS ONE			English	Article							POPULATION-STRUCTURE; UNSTABLE MALARIA; DIVERSITY; CHILDREN; AREA; EPIDEMIOLOGY; MULTIPLICITY; INFECTIONS; DYNAMICS; DENSITY	Background In malaria endemic regions, Plasmodium falciparum infection is characterized by extensive genetic diversity. Describing this diversity provides important information about the local malaria situation. This study was conducted to evaluate the extent of genetic diversity of P. falciparum in Pawe district, North West Ethiopia, using the highly polymorphic merozoite surface protein 2 gene. Methods Atotal of 92 isolates from patients with uncomplicated P. falciparum attending Pawe Health Centre were collected from September to December 2013. Genomic DNA was extracted using the Chelex method and analyzed by length polymorphism following gel electrophoresis of DNA products from nested PCR of msp2 (block 3), targeting allelic families of FC27 and 3D7/IC. Results There were twenty-two different msp2 alleles, 11 corresponding to the 3D7/IC and 11 to the FC27 allelic family. The frequency of isolates of the msp2 3D7/IC allelic family was higher (51%) compared to FC27 (49%). The majority of the isolates (76%) contained multiple infections and the overall mean multiplicity of infection was 2.8 (CI 95% 2.55-3.03). The heterozygosity index was 0.66 for msp2. There was no statically significant difference in the multiplicity of infection by age or parasite density. Conclusions The results of this study show that P. falciparum polymorphismsare extensive in Northwest Ethiopia and most of the infections are composed of multiple clones.	[Mohammed, Hussein; Kassa, Moges; Assefa, Ashenafi; Tadesse, Mekonnen; Kebede, Amha] Ethiopian Publ Hlth Inst, Bacterial Parasit & Zoonot Dis Res Directorate, Addis Ababa, Ethiopia		Mohammed, H (corresponding author), Ethiopian Publ Hlth Inst, Bacterial Parasit & Zoonot Dis Res Directorate, Addis Ababa, Ethiopia.	hussein_ehnri@yahoo.com		Assefa, Ashenafi/0000-0001-6093-6685	Federal Ministry of Health Ethiopia (FMOH); International Atomic Energy Agency (IAEA); Ethiopian Public Health (EPHI); Federal Ministry of Health; Ethiopian Public Health Institute (EPHI)	Federal Ministry of Health Ethiopia (FMOH); International Atomic Energy Agency (IAEA)(International Atomic Energy Agency); Ethiopian Public Health (EPHI); Federal Ministry of Health; Ethiopian Public Health Institute (EPHI)	The study was funded by Federal Ministry of Health Ethiopia (FMOH), the International Atomic Energy Agency (IAEA) and Ethiopian Public Health (EPHI). The funders had no role in the study design, data collection and analysis, or collection and analysis, or decision to publication, and preparation of the manuscript.; We are grateful to the staffs of Pawe Health Center and the study participants. This study was supported by the Federal Ministry of Health, the International Atomic Energy Agency (IAEA) and Ethiopian Public Health Institute (EPHI). Wealsothank to Dr Robert Commons forreviewing andimproving themanuscript.	Anthony TG, 2005, J INFECT DIS, V191, P1558, DOI 10.1086/429338; Arnot D, 1998, T ROY SOC TROP MED H, V92, P580, DOI 10.1016/S0035-9203(98)90773-8; Atroosh WM, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-233; Babiker HA, 1999, T ROY SOC TROP MED H, V93, pS11, DOI 10.1016/S0035-9203(99)90321-8; Babiker HA, 2000, PARASITOLOGY, V120, P105, DOI 10.1017/S0031182099005387; Babiker HA, 1997, AM J TROP MED HYG, V56, P141, DOI 10.4269/ajtmh.1997.56.141; Bakhiet AMA, 2015, ACTA TROP, V148, P97, DOI 10.1016/j.actatropica.2015.04.013; Basco LK, 2004, AM J TROP MED HYG, V70, P238, DOI 10.4269/ajtmh.2004.70.238; Chitarra V, 1999, MOL CELL, V3, P457, DOI 10.1016/S1097-2765(00)80473-6; Dolmazon V, 2008, ACTA TROP, V107, P37, DOI 10.1016/j.actatropica.2008.04.012; Farnert A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-241; Federal Ministry of Health Ethiopia (FMOH), 2014, NAT STRAT P IN PRESS; Federal Ministry of Health of Ethiopia, 2014, HSDP 4 ANN PERF REP; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Gomez D, 2002, AM J TROP MED HYG, V67, P611, DOI 10.4269/ajtmh.2002.67.611; Hamid Muzamil M Abdel, 2013, N Am J Med Sci, V5, P95, DOI 10.4103/1947-2714.107524; Hoffmann EHE, 2006, GENE, V376, P224, DOI 10.1016/j.gene.2006.03.011; Khaireh BA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-201; Kiwanuka GN, 2009, J VECTOR DIS, V46, P1; Lawrence G, 2000, VACCINE, V18, P1925, DOI 10.1016/S0264-410X(99)00444-2; Mara SE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-419; Mayengue PI, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-276; Mohammed H, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0604-8; Mwingira F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-79; NEI M, 1978, GENETICS, V89, P583; Ntoumi F, 2001, Bull Soc Pathol Exot, V94, P183; Ntoumi F., 2001, Parassitologia (Rome), V42, P197; Ogouyemi-Hounto A, 2013, PARASITE, V20, DOI 10.1051/parasite/2013039; Ojurongbe O, 2011, W INDIAN MED J, V60, P19; Pembe IM, 2011, MALARIA J, V10, P276; Peyerl-Hoffmann G, 2001, TROP MED INT HEALTH, V6, P607, DOI 10.1046/j.1365-3156.2001.00761.x; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; President's Malaria Initiative Ethiopia, 2015, MAL OP PLAN FY; Smith T, 1999, T ROY SOC TROP MED H, V93, pS35, DOI 10.1016/S0035-9203(99)90325-5; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Soulama I, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-135; WHO, 2015, WORLDMALARIA REP	37	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177559	10.1371/journal.pone.0177559	http://dx.doi.org/10.1371/journal.pone.0177559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542247	Green Submitted, Green Published, gold			2022-12-26	WOS:000401672600017
J	Chen, YC; Chen, KD; Su, MC; Chin, CH; Chen, CJ; Liou, CW; Chen, TW; Chang, YC; Huang, KT; Wang, CC; Wang, TY; Chang, JC; Lin, YY; Zheng, YX; Lin, MC; Hsiao, CC				Chen, Yung-Che; Chen, Kuang-Den; Su, Mao-Chang; Chin, Chien-Hung; Chen, Chung-Jen; Liou, Chia-Wei; Chen, Ting-Wen; Chang, Ya-Chun; Huang, Kuo-Tung; Wang, Chin-Chou; Wang, Ting-Ya; Chang, Jen-Chieh; Lin, Yong-Yong; Zheng, Yi-Xin; Lin, Meng-Chih; Hsiao, Chang-Chun			Genome-wide gene expression array identifies novel genes related to disease severity and excessive daytime sleepiness in patients with obstructive sleep apnea	PLOS ONE			English	Article							NEUTROPHIL APOPTOSIS; INTERMITTENT HYPOXIA; ENDOTHELIAL FUNCTION; GALIG; CELLS; RISK	We aimed to identify novel molecular associations between chronic intermittent hypoxia with re-oxygenation and adverse consequences in obstructive sleep apnea (OSA). We analyzed gene expression profiles of peripheral blood mononuclear cells from 48 patients with sleep-disordered breathing stratified into four groups: primary snoring (PS), moderate to severe OSA (MSO), very severe OSA (VSO), and very severe OSA patients on long-term continuous positive airway pressure treatment (VSOC). Comparisons of the microarray gene expression data identified eight genes up-regulated with OSA and down-regulated with CPAP treatment, and five genes down-regulated with OSA and up-regulated with CPAP treatment. Protein expression levels of two genes related to endothelial tight junction (AMOT P130, and PLEKHH3), and three genes related to anti-or pro-apoptosis (BIRC3, ADAR1 P150, and LGALS3) were all increased in the VSO group, while AMOT P130 was further increased, and PLEKHH3, BIRC3, and ADAR1 P150 were all decreased in the VSOC group. Subgroup analyses revealed that AMOT P130 protein expression was increased in OSA patients with excessive daytime sleepiness, BIRC3 protein expression was decreased in OSA patients with hypertension, and LGALS3 protein expression was increased in OSA patients with chronic kidney disease. In vitro short-term intermittent hypoxia with re-oxygenation experiment showed immediate over-expression of ADAR1 P150. In conclusion, we identified a novel association between AMOT/PLEKHH3/BIRC3/ADAR1/LGALS3 over-expressions and high severity index in OSA patients. AMOT and GALIG may constitute an important determinant for the development of hypersomnia and kidney injury, respectively, while BIRC3 may play a protective role in the development of hypertension.	[Chen, Yung-Che; Su, Mao-Chang; Chin, Chien-Hung; Chang, Ya-Chun; Huang, Kuo-Tung; Wang, Chin-Chou; Wang, Ting-Ya; Lin, Yong-Yong; Zheng, Yi-Xin; Lin, Meng-Chih] Kaohsiung Chang Gung Mem Hosp, Dept Med, Div Pulm & Crit Care Med, Kaohsiung, Taiwan; [Chen, Yung-Che; Chen, Kuang-Den; Su, Mao-Chang; Chin, Chien-Hung; Chen, Chung-Jen; Liou, Chia-Wei; Chang, Ya-Chun; Huang, Kuo-Tung; Wang, Chin-Chou; Wang, Ting-Ya; Chang, Jen-Chieh; Lin, Yong-Yong; Zheng, Yi-Xin; Lin, Meng-Chih] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chen, Yung-Che; Su, Mao-Chang; Chin, Chien-Hung; Chang, Ya-Chun; Huang, Kuo-Tung; Wang, Chin-Chou; Lin, Meng-Chih] Kaohsiung Chang Gung Mem Hosp, Sleep Ctr, Kaohsiung, Taiwan; [Chen, Yung-Che; Lin, Meng-Chih] Chang Gung Univ, Dept Med, Taoyuan, Taiwan; [Chen, Kuang-Den; Chang, Jen-Chieh] Kaohsiung Chang Gung Mem Hosp, Ctr Translat Res Biomed Sci, Kaohsiung, Taiwan; [Su, Mao-Chang; Wang, Chin-Chou] Chang Gung Univ Sci & Technol, Chiayi, Taiwan; [Chen, Chung-Jen] Kaohsiung Chang Gung Mem Hosp, Div Rheumatol, Kaohsiung, Taiwan; [Liou, Chia-Wei] Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan; [Chen, Ting-Wen] Chang Gung Univ, Mol Med Res Ctr, Taoyuan, Taiwan; [Chen, Ting-Wen] Chang Gung Univ, Bioinformat Ctr, Taoyuan, Taiwan; [Hsiao, Chang-Chun] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Hsiao, Chang-Chun] Kaohsiung Chang Gung Mem Hosp, Ctr Shockwave Med & Tissue Engn, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Lin, MC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Med, Div Pulm & Crit Care Med, Kaohsiung, Taiwan.; Lin, MC (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Lin, MC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Sleep Ctr, Kaohsiung, Taiwan.; Lin, MC (corresponding author), Chang Gung Univ, Dept Med, Taoyuan, Taiwan.; Hsiao, CC (corresponding author), Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan.; Hsiao, CC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Ctr Shockwave Med & Tissue Engn, Kaohsiung, Taiwan.	mengchihlin@hotmail.com; cchsiao@mail.cgu.edu.tw	Chen, Ting-Wen/AAY-8473-2020; Chen, Yung-Che/AAL-5167-2020	Chen, Ting-Wen/0000-0003-4028-2375; Chen, Yung-Che/0000-0001-8695-5227; Hsiao, Chang-Chun/0000-0002-7275-4675	Ministry of Science and Technology, Taiwan [NMRPG8D6131/103-2314-B-182A-094-MY2, NMRPG8B6192/101-2314-B-182A-130-MY2]; Chang Gung Memorial Hospital [CMRPG8C1181-1182]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by grants from the Ministry of Science and Technology, Taiwan (NMRPG8D6131/103-2314-B-182A-094-MY2 & NMRPG8B6192/101-2314-B-182A-130-MY2 to M. C. Lin) and grants from Chang Gung Memorial Hospital (CMRPG8C1181-1182 to M.C. Lin), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Bruno RM, 2013, J HYPERTENS, V31, P1456, DOI 10.1097/HJH.0b013e328360f773; Calandria JM, 2015, CELL DEATH DIFFER; Chen YC, 2015, SLEEP BREATH, V19, P873, DOI 10.1007/s11325-014-1116-4; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057053; Citi Sandra, 2014, Small GTPases, V5, P1, DOI 10.4161/21541248.2014.973760; Duneau M, 2005, EXP CELL RES, V302, P194, DOI 10.1016/j.yexcr.2004.08.041; Dyugovskaya L, 2002, AM J RESP CRIT CARE, V165, P934, DOI 10.1164/ajrccm.165.7.2104126; Dyugovskaya L, 2008, AM J RESP CRIT CARE, V177, P544, DOI 10.1164/rccm.200705-675OC; Dyugovskaya L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-211; Dyugovskaya L, 2011, AM J RESP CELL MOL, V45, P154, DOI 10.1165/rcmb.2010-0025OC; Ernkvist M, 2006, FEBS J, V273, P2000, DOI 10.1111/j.1742-4658.2006.05216.x; George CX, 2014, J INTERF CYTOK RES, V34, P437, DOI 10.1089/jir.2014.0001; Hoffmann MS, 2007, ANTIOXID REDOX SIGN, V9, P661, DOI 10.1089/ars.2007.1589; Jennum P, 2015, NAT SCI SLEEP, V7, P43, DOI 10.2147/NSS.S75166; Khalyfa A, 2010, AM J RESP CRIT CARE, V181, P1114, DOI 10.1164/rccm.200909-1398OC; Khalyfa A, 2009, SLEEP MED, V10, P75, DOI 10.1016/j.sleep.2007.11.006; Marin JM, 2012, JAMA-J AM MED ASSOC, V307, P2169, DOI 10.1001/jama.2012.3418; Martorell L, 2009, MOL CELL BIOL, V29, P5828, DOI 10.1128/MCB.00945-09; Mollet L, 2013, MOL IMMUNOL, V56, P123, DOI 10.1016/j.molimm.2013.04.012; Nigita G, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00037; Paschoud S, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28755; Robinet P, 2010, BIOCHEM BIOPH RES CO, V392, P53, DOI 10.1016/j.bbrc.2009.12.162; Roudier E, 2009, J PHYSIOL-LONDON, V587, P4105, DOI 10.1113/jphysiol.2009.175554; Scheffzek K, 2012, FEBS LETT, V586, P2662, DOI 10.1016/j.febslet.2012.06.006; Song CM, 2012, ACTA OTO-LARYNGOL, V132, pS63, DOI 10.3109/00016489.2012.660729; Uyar M, 2015, SLEEP BREATH; Xia Y, 2015, ONCOTARGET, V6, P5426, DOI 10.18632/oncotarget.3101; Xu HJ, 2015, RESP CARE, V60, P749, DOI 10.4187/respcare.03739; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Zaniewska M, 2015, J NEUROCHEM	32	19	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176575	10.1371/journal.pone.0176575	http://dx.doi.org/10.1371/journal.pone.0176575			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520763	Green Published, Green Submitted, gold			2022-12-26	WOS:000401487700022
J	Loch, G; Zinke, I; Mori, T; Carrera, P; Schroer, J; Takeyama, H; Hoch, M				Loch, Gerrit; Zinke, Ingo; Mori, Tetsushi; Carrera, Pilar; Schroer, Jonas; Takeyama, Haruko; Hoch, Michael			Antimicrobial peptides extend lifespan in Drosophila	PLOS ONE			English	Article							INNATE IMMUNE HOMEOSTASIS; STEM-CELL PROLIFERATION; HOST-DEFENSE; BACTERIAL-INFECTION; TISSUE HOMEOSTASIS; ORAL INFECTION; GUT; MELANOGASTER; SYSTEM; EXPRESSION	Antimicrobial peptides (AMPs) are important defense molecules of the innate immune system. High levels of AMPs are induced in response to infections to fight pathogens, whereas moderate levels induced by metabolic stress are thought to shape commensal microbial communities at barrier tissues. We expressed single AMPs in adult flies either ubiquitously or in the gut by using the inducible GeneSwitch system to tightly regulate AMP expression. We found that activation of single AMPs, including Drosocin, resulted in a significant extension of Drosophila lifespan. These animals showed reduced activity of immune pathways over lifetime, less intestinal regenerative processes, reduced stress response and a delayed loss of gut barrier integrity. Furthermore, intestinal Drosocin induction protected the animals against infections with the natural Drosophila pathogen Pseudomonas entomophila, whereas a germ-reduced environment prevented the lifespan extending effect of Drosocin. Our study provides new insights into the crosstalk of innate immunity, intestinal homeostasis and ageing.	[Loch, Gerrit; Carrera, Pilar; Schroer, Jonas; Hoch, Michael] Univ Bonn, Life & Med Sci Inst LIMES, Mol Dev Biol, Bonn, Germany; [Zinke, Ingo] Univ Bonn, Life & Med Sci Inst LIMES, Mol Brain Physiol & Behav, Bonn, Germany; [Mori, Tetsushi; Takeyama, Haruko] Waseda Univ, Fac Sci & Engn, Tokyo, Japan	University of Bonn; University of Bonn; Waseda University	Hoch, M (corresponding author), Univ Bonn, Life & Med Sci Inst LIMES, Mol Dev Biol, Bonn, Germany.	m.hoch@uni-bonn.de	Mori, Tetsushi/C-1973-2017; Mori, Tetsushi/AAN-5656-2020	Mori, Tetsushi/0000-0001-7096-4161; 	DFG [SFB 645, SFB 704]; DFG (cluster of excellence ImmunoSensation); Young Researcher Overseas Visits Program for Vitalizing Brain Circulation by Oversees Training Program Division, International Program Department, Japan Society for the Promotion of Science	DFG(German Research Foundation (DFG)); DFG (cluster of excellence ImmunoSensation)(German Research Foundation (DFG)); Young Researcher Overseas Visits Program for Vitalizing Brain Circulation by Oversees Training Program Division, International Program Department, Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the DFG to M.H. (SFBs 645, 704 and cluster of excellence ImmunoSensation) (www.dfg.de) and the Young Researcher Overseas Visits Program for Vitalizing Brain Circulation by Oversees Training Program Division, International Program Department, Japan Society for the Promotion of Science to T.M. and H.T. (www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhouayri IG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077619; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Bonnay F, 2013, P NATL ACAD SCI USA, V110, P2957, DOI 10.1073/pnas.1221910110; Broderick NA, 2014, MBIO, V5, DOI 10.1128/mBio.01117-14; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Buchon N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-152; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; Clark RI, 2015, CELL REP, V12, P1656, DOI 10.1016/j.celrep.2015.08.004; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Fink C, 2016, MUCOSAL IMMUNOL, V9, P927, DOI 10.1038/mi.2015.112; Galac MR, 2011, MICROBES INFECT, V13, P673, DOI 10.1016/j.micinf.2011.02.005; Guani-Guerra E, 2010, CLIN IMMUNOL, V135, P1, DOI 10.1016/j.clim.2009.12.004; Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Kabil H, 2011, P NATL ACAD SCI USA, V108, P16831, DOI 10.1073/pnas.1102008108; Landis GN, 2015, AGING-US, V7, P53, DOI 10.18632/aging.100721; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Maroti G, 2011, RES MICROBIOL, V162, P363, DOI 10.1016/j.resmic.2011.02.005; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Peters BM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001067; Poirier L, 2008, AGING CELL, V7, P758, DOI 10.1111/j.1474-9726.2008.00421.x; Regan JC, 2016, ELIFE, V5, DOI 10.7554/eLife.10956; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Rera M, 2013, AGEING RES REV, V12, P436, DOI 10.1016/j.arr.2012.05.003; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013; Ridley EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036765; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Slack C, 2011, AGING CELL, V10, P735, DOI 10.1111/j.1474-9726.2011.00707.x; Suttmann Henrik, 2008, BMC Urol, V8, P5, DOI 10.1186/1471-2490-8-5; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; Varma D, 2014, J INSECT PHYSIOL, V69, P80, DOI 10.1016/j.jinsphys.2014.04.006; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zhao HW, 2011, J BIOL CHEM, V286, P6211, DOI 10.1074/jbc.M110.181206	47	26	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176689	10.1371/journal.pone.0176689	http://dx.doi.org/10.1371/journal.pone.0176689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520752	Green Published, Green Submitted, gold			2022-12-26	WOS:000401487700027
J	Carrel, M; Zahrieh, D; Young, SG; Oleson, J; Ryckman, KK; Wels, B; Simmons, DL; Saftlas, A				Carrel, Margaret; Zahrieh, David; Young, Sean G.; Oleson, Jacob; Ryckman, Kelli K.; Wels, Brian; Simmons, Donald L.; Saftlas, Audrey			High prevalence of elevated blood lead levels in both rural and urban Iowa newborns: Spatial patterns and area-level covariates	PLOS ONE			English	Article							NEW-ORLEANS; SOIL LEAD; PRENATAL EXPOSURE; MERCURY LEVELS; CHILDREN; HEALTH; SYRACUSE; CADMIUM; ASSOCIATIONS; ENVIRONMENT	Lead in maternal blood can cross the placenta and result in elevated blood lead levels in newborns, potentially producing negative effects on neurocognitive function, particularly if combined with childhood lead exposure. Little research exists, however, into the burden of elevated blood lead levels in newborns, or the places and populations in which elevated lead levels are observed in newborns, particularly in rural settings. Using similar to 2300 dried bloods spots collected within 1-3 days of birth among Iowa newborns, linked with the area of mother's residence at the time of birth, we examine the spatial patterns of elevated (>5 mu g/dL) blood lead levels and the ecological-level predictors of elevated blood lead levels. We find that one in five newborns exceed the 5 mu g/dL action level set by the US Centers for Disease Control & Prevention (CDC). Bayesian spatial zero inflated regression indicates that elevated blood lead in newborns is associated with areas of increased pre- 1940s housing and childbearing-age women with low educational status in both rural and urban settings. No differences in blood lead levels or the proportion of children exceeding 5 mu g/dL are observed between urban and rural maternal residence, though a spatial cluster of elevated blood lead is observed in rural counties. These characteristics can guide the recommendation for testing of infants at well-baby appointments in places where risk factors are present, potentially leading to earlier initiation of case management. The findings also suggest that rural populations are at as great of risk of elevated blood lead levels as are urban populations. Analysis of newborn dried blood spots is an important tool for lead poisoning surveillance in newborns and can direct public health efforts towards specific places and populations where lead testing and case management will have the greatest impact.	[Carrel, Margaret; Young, Sean G.] Univ Iowa, Dept Geog & Sustainabil Sci, Iowa City, IA 52242 USA; [Carrel, Margaret; Ryckman, Kelli K.; Saftlas, Audrey] Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA; [Zahrieh, David; Oleson, Jacob] Univ Iowa, Dept Biostat, Iowa City, IA USA; [Ryckman, Kelli K.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Wels, Brian; Simmons, Donald L.] Univ Iowa, State Hygien Lab, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Carrel, M (corresponding author), Univ Iowa, Dept Geog & Sustainabil Sci, Iowa City, IA 52242 USA.; Carrel, M (corresponding author), Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA.	Margaret-carrel@uiowa.edu	Young, Sean G/H-6469-2014	Young, Sean G/0000-0002-0054-0627; Ryckman, Kelli/0000-0002-9496-4147	University of Iowa Center for Health Effects of Environmental Contaminants (CHEEC)	University of Iowa Center for Health Effects of Environmental Contaminants (CHEEC)	This study was supported by a seed grant from the University of Iowa Center for Health Effects of Environmental Contaminants (CHEEC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aelion CM, 2012, HEALTH PLACE, V18, P774, DOI 10.1016/j.healthplace.2012.04.005; Agarwal DK, 2002, ENVIRON ECOL STAT, V9, P341, DOI 10.1023/A:1020910605990; ASCHENGRAU A, 1994, ENVIRON RES, V67, P125, DOI 10.1006/enrs.1994.1069; Banerjee S., 2014, HIERARCHICAL MODELIN; BELLINGER D, 1986, PEDIATRICS, V77, P826; Bellinger DC, 2008, CURR OPIN PEDIATR, V20, P172, DOI 10.1097/MOP.0b013e3282f4f97b; Bellinger DC, 2003, COMMENT NEW ENGLAND, V349; Best N., 2007, MESQUITE MODULAR SYS, V3; Brown MJ, 2011, ENVIRON RES, V111, P67, DOI 10.1016/j.envres.2010.10.003; Burm E, 2016, INT J HYG ENVIR HEAL, V219, P412, DOI 10.1016/j.ijheh.2016.04.004; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; CAPRIO RJ, 1974, ARCH ENVIRON HEALTH, V28, P195, DOI 10.1080/00039896.1974.10666468; Chiodo LM, 2004, NEUROTOXICOL TERATOL, V26, P359, DOI 10.1016/j.ntt.2004.01.010; CLARK S, 1991, Chemical Speciation and Bioavailability, V3, P163; COHEN CJ, 1973, JAMA-J AM MED ASSOC, V226, P1430, DOI 10.1001/jama.226.12.1430; DAVIES DJA, 1990, SCI TOTAL ENVIRON, V90, P13, DOI 10.1016/0048-9697(90)90182-T; Davis AM, 2011, J PEDIATR PSYCHOL, V36, P669, DOI 10.1093/jpepsy/jsq117; Ettinger Adrienne S., 2010, BREAST FEEDING; Garcia-Esquinas E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-841; Gilbert SG, 2006, NEUROTOXICOLOGY, V27, P693, DOI 10.1016/j.neuro.2006.06.008; Goyer RA, 1996, ENVIRON HEALTH PERSP, V104, P1050, DOI 10.2307/3433116; Harville EW, 2005, OCCUP ENVIRON MED, V62, P263, DOI 10.1136/oem.2003.012492; HAYES EB, 1994, PEDIATRICS, V93, P195; Hazards CoE, 1987, PEDIATRICS, V79, P457; Hertz-Picciotto I, 2000, AM J EPIDEMIOL, V152, P829, DOI 10.1093/aje/152.9.829; Hinwood A, 2014, CHEMOSPHERE, V108, P125, DOI 10.1016/j.chemosphere.2014.02.071; Holtrop TG, 1998, ARCH PEDIAT ADOL MED, V152, P455; Hruba F, 2012, ENVIRON INT, V41, P29, DOI 10.1016/j.envint.2011.12.001; HUBERMONT G, 1978, INT ARCH OCC ENV HEA, V41, P117, DOI 10.1007/BF00381796; Jacobs DE, 2006, ENVIRON RES, V102, P352, DOI 10.1016/j.envres.2005.12.015; Jacobs DE, 2002, ENVIRON HEALTH PERSP, V110, pA599, DOI 10.1289/ehp.021100599; Jedrychowski W, 2009, NEUROEPIDEMIOLOGY, V32, P270, DOI 10.1159/000203075; Johnson DL, 1996, ENVIRON GEOCHEM HLTH, V18, P81, DOI 10.1007/BF01771136; Johnson DL, 2002, ENVIRON GEOCHEM HLTH, V24, P375, DOI 10.1023/A:1020500504167; Jones EA, 2010, ENVIRON INT, V36, P649, DOI 10.1016/j.envint.2010.04.007; Jones RL, 2009, PEDIATRICS, V123, pe376, DOI 10.1542/peds.2007-3608; Kennedy C., 2016, MMWR-MORBID MORTAL W, P65; Laidlaw MAS, 2012, ATMOS ENVIRON, V49, P302, DOI 10.1016/j.atmosenv.2011.11.030; Laidlaw MAS, 2005, ENVIRON HEALTH PERSP, V113, P793, DOI 10.1289/ehp.7759; Lanphear BP, 1998, PEDIATRICS, V101, P264, DOI 10.1542/peds.101.2.264; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Lanphear BP, 1997, ENVIRON RES, V74, P67, DOI 10.1006/enrs.1997.3726; Lead Ayotte P., 1999, ARCH ENVIRON HEALTH, P54; LEPOW ML, 1975, ENVIRON RES, V10, P415, DOI 10.1016/0013-9351(75)90037-7; Levallois P, 2014, J EXPO SCI ENV EPID, V24, P185, DOI 10.1038/jes.2012.129; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; McLaine P, 2013, PEDIATRICS, V131, P1081, DOI 10.1542/peds.2012-2277; Mei JV, 2001, J NUTR, V131, p1631S, DOI 10.1093/jn/131.5.1631S; Mielke HW, 1999, ENVIRON RES, V81, P117, DOI 10.1006/enrs.1999.3966; Mielke HW, 1997, ENVIRON HEALTH PERSP, V105, P950, DOI 10.1289/ehp.97105950; Moyer TP, 1999, CLIN CHEM, V45, P2055; National Center for Environmental Health DoEaEHS, 2016, CDCS CHILDH LEAD POI; National Center for Environmental Health DoEaEHS, 2016, IOW DAT STAT SURV 20; NEEDLEMAN HL, 1990, JAMA-J AM MED ASSOC, V263, P673, DOI 10.1001/jama.263.5.673; NEEDLEMAN HL, 1979, NEW ENGL J MED, V300, P689, DOI 10.1056/NEJM197903293001301; NORMAN EH, 1994, PEDIATRICS, V94, P59; Oken E, 2008, AM J EPIDEMIOL, V167, P1171, DOI 10.1093/aje/kwn034; Parajuli RP, 2013, ENVIRON RES, V121, P45, DOI 10.1016/j.envres.2012.10.010; Pueschel SM., 1974, ENVIRON HEALTH PERSP, V7, P13, DOI [DOI 10.1289/EHP.74713, 10.1289/ehp.74713]; RABINOWITZ M, 1984, ARCH ENVIRON HEALTH, V39, P74, DOI 10.1080/00039896.1984.10545838; RHAINDS M, 1993, ARCH ENVIRON HEALTH, V48, P421, DOI 10.1080/00039896.1993.10545964; Riddell TJ, 2007, B WHO, V85; Robinson W., 1950, AM SOCIOLOGICAL REV; Rothenberg S, 1995, J EXPO ANAL ENV EPID, V6, P211; RUMMO JH, 1979, ARCH ENVIRON HEALTH, V34, P120, DOI 10.1080/00039896.1979.10667381; Sarkar M., 2011, AM HOMES VARY YEAR T; Schell LM, 2003, ENVIRON HEALTH PERSP, V111, P195, DOI 10.1289/ehp.5592; Schober SE, 2006, ENVIRON HEALTH PERSP, V114, P1538, DOI 10.1289/ehp.9123; SCHONFELD DJ, 1995, ARCH PEDIAT ADOL MED, V149, P447, DOI 10.1001/archpedi.1995.02170160101015; Scott LLF, 2011, INT ARCH OCC ENV HEA, V84, P513, DOI 10.1007/s00420-011-0624-9; SELVIN HC, 1958, AM J SOCIOL, V63, P607, DOI 10.1086/222356; Silver MK, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0148-6; Spielman SE, 2014, APPL GEOGR, V46, P147, DOI 10.1016/j.apgeog.2013.11.002; Srivuthana K, 1996, ARCH PEDIAT ADOL MED, V150, P498, DOI 10.1001/archpedi.1996.02170300052010; Stanton NV, 1999, CLIN CHEM, V45, P2229; Surkan PJ, 2007, NEUROTOXICOLOGY, V28, P1170, DOI 10.1016/j.neuro.2007.07.007; Tellez-Rojo MM, 2004, AM J EPIDEMIOL, V160, P668, DOI 10.1093/aje/kwh271; VEREBEY K, 1995, CLIN CHEM, V41, P469; Verebey K, 2000, CLIN CHEM, V46, P1024; Walkowiak J, 1998, NEUROTOXICOL TERATOL, V20, P511, DOI 10.1016/S0892-0362(98)00010-5; Wang CH, 2004, INT J HYG ENVIR HEAL, V207, P431, DOI 10.1078/1438-4639-00311; WEITZMAN M, 1993, JAMA-J AM MED ASSOC, V269, P1647, DOI 10.1001/jama.269.13.1647; Wengrovitz Anne M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Wong Y, 1995, CLIN CHEM 1995 AM AS; Yiin LM, 2000, ENVIRON HEALTH PERSP, V108, P177, DOI 10.2307/3454518; Zahran S, 2013, ENVIRON SCI TECHNOL, V47, P2839, DOI 10.1021/es303854c	86	16	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177930	10.1371/journal.pone.0177930	http://dx.doi.org/10.1371/journal.pone.0177930			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DC	28520816	Green Published, gold			2022-12-26	WOS:000401485500081
J	Okumu, DO; East, MP; Levine, M; Herring, LE; Zhang, R; Gilbert, TSK; Litchfield, DW; Zhang, Y; Graves, LM				Okumu, Denis O.; East, Michael P.; Levine, Merlin; Herring, Laura E.; Zhang, Raymond; Gilbert, Thomas S. K.; Litchfield, David W.; Zhang, Yanping; Graves, Lee M.			BIRC6 mediates imatinib resistance independently of Mcl-1	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; PROTEIN-KINASE CK2; MYELOGENOUS LEUKEMIA; ACQUIRED-RESISTANCE; APOPTOSIS PROTEIN; CANCER-CELLS; BCR-ABL; INHIBITORS; SURVIVIN; IDENTIFICATION	Baculoviral IAP repeat containing 6 (BIRC6) is a member of the inhibitors of apoptosis proteins (IAPs), a family of functionally and structurally related proteins that inhibit apoptosis. BIRC6 has been implicated in drug resistance in several different human cancers, however mechanisms regulating BIRC6 have not been extensively explored. Our phosphoproteomic analysis of an imatinib-resistant chronic myelogenous leukemia (CML) cell line (MYL-R) identified increased amounts of a BIRC6 peptide phosphorylated at S480, S482, and S486 compared to imatinib-sensitive CML cells (MYL). Thus we investigated the role of BIRC6 in mediating imatinib resistance and compared it to the well-characterized anti-apoptotic protein, Mcl-1. Both BIRC6 and Mcl-1 were elevated in MYL-R compared to MYL cells. Lentiviral shRNA knockdown of BIRC6 in MYL-R cells increased imatinib-stimulated caspase activation and resulted in a similar to 20-25-fold increase in imatinib sensitivity, without affecting Mcl1. Treating MYL-R cells with CDK9 inhibitors decreased BIRC6 mRNA, but not BIRC6 protein levels. By contrast, while CDK9 inhibitors reduced Mcl-1 mRNA and protein, they did not affect imatinib sensitivity. Since the Src family kinase Lyn is highly expressed and active in MYL-R cells, we tested the effects of Lyn inhibition on BIRC6 and Mcl-1. RNAi-mediated knockdown or inhibition of Lyn (dasatinib/ponatinib) reduced BIRC6 protein stability and increased caspase activation. Inhibition of Lyn also increased formation of an N-terminal BIRC6 fragment in parallel with reduced amount of the BIRC6 phosphopeptide, suggesting that Lyn may regulate BIRC6 phosphorylation and stability. In summary, our data show that BIRC6 stability is dependent on Lyn, and that BIRC6 mediates imatinib sensitivity independently of Mcl-1 or CDK9. Hence, BIRC6 may be a novel target for the treatment of drug-resistant CML where Mcl-1 or CDK9 inhibitors have failed.	[Okumu, Denis O.; East, Michael P.; Herring, Laura E.; Zhang, Raymond; Gilbert, Thomas S. K.; Zhang, Yanping; Graves, Lee M.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27514 USA; [Okumu, Denis O.; East, Michael P.; Zhang, Yanping; Graves, Lee M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27514 USA; [Levine, Merlin] Univ N Carolina, Dept Chem, Chapel Hill, NC USA; [Herring, Laura E.; Gilbert, Thomas S. K.; Graves, Lee M.] Univ N Carolina, UNC Michael Hooker Prote Ctr, Chapel Hill, NC 27514 USA; [Litchfield, David W.] Western Univ, Schulich Sch Med & Dent, Dept Biochem, London, ON, Canada; [Zhang, Yanping] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Western University (University of Western Ontario); University of North Carolina; University of North Carolina Chapel Hill	Graves, LM (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27514 USA.; Graves, LM (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27514 USA.; Graves, LM (corresponding author), Univ N Carolina, UNC Michael Hooker Prote Ctr, Chapel Hill, NC 27514 USA.	lmg@med.unc.edu	Graves, Lee/AAG-5470-2021; , Proteomics Core UNC/AAH-3777-2022; Core, Vector/CAF-4832-2022; , Proteomics Core UNC/AFQ-7201-2022	Zhang, Raymond/0000-0001-6329-7225; Gilbert, Thomas/0000-0002-6833-6788	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007040] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007040] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Arend KC, 2017, MOL CELL PROTEOMICS, V16, pS263, DOI 10.1074/mcp.M116.065375; Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018; Belmar J, 2015, PHARMACOL THERAPEUT, V145, P76, DOI 10.1016/j.pharmthera.2014.08.003; Bhamidipati PK, 2013, THER ADV HEMATOL, V4, P103, DOI 10.1177/2040620712468289; Bingle CD, 2000, J BIOL CHEM, V275, P22136, DOI 10.1074/jbc.M909572199; Blanc-Brude OP, 2003, CLIN CANCER RES, V9, P2683; Borgo C, 2013, MOL ONCOL, V7, P1103, DOI 10.1016/j.molonc.2013.08.006; Bose Prithviraj, 2013, Leuk Res Rep, V2, P12; Bose P, 2013, EXPERT OPIN INV DRUG, V22, P723, DOI 10.1517/13543784.2013.789859; Carter BZ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1180; Carter BZ, 2006, BLOOD, V107, P1555, DOI 10.1182/blood-2004-12-4704; Cassuto O, 2012, ONCOTARGET, V3, P1557; Cavalcante LD, 2014, EUR J PHARMACOL, V741, P8, DOI [10.1010/j.ejphar.2014.07.041, 10.1016/j.ejphar.2014.07.041]; Chen LJ, 2017, EXPERT OPIN THER PAT, V27, P163, DOI 10.1080/13543776.2017.1249848; Chen X, 2016, J CANCER, V7, P314, DOI 10.7150/jca.13332; Cooper MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066755; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deveraux QL, 1999, GENES DEV; Dong X, 2013, J THORAC ONCOL, V8, P161, DOI 10.1097/JTO.0b013e31827d5237; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Duncan JS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001682; Foo J, 2014, J THEOR BIOL, V355, P10, DOI 10.1016/j.jtbi.2014.02.025; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Ge CM, 2015, P NATL ACAD SCI USA, V112, pE1210, DOI 10.1073/pnas.1418335112; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Gores GJ, 2012, GENE DEV, V26, P305, DOI 10.1101/gad.186189.111; Gringeri E, 2010, BIOCHEM J, V425, P401, DOI 10.1042/BJ20090902; Gyenis L, 2011, J PROTEOME RES, V10, P4887, DOI 10.1021/pr2008994; Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; Hitz C, 2005, GENESIS, V42, P91, DOI 10.1002/gene.20128; Huang JC, 2015, AM J CANCER RES, V5, P20; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Hussain SRA, 2007, CLIN CANCER RES, V13, P2144, DOI 10.1158/1078-0432.CCR-06-2294; Ito T, 2007, EUR J HAEMATOL, V78, P417, DOI 10.1111/j.1600-0609.2007.00835.x; Jabbour EJ, 2013, CL LYMPH MYELOM LEUK, V13, P515, DOI 10.1016/j.clml.2013.03.018; Kantarjian H, 2012, BLOOD, V119, P1981, DOI 10.1182/blood-2011-08-358135; Kelly KR, 2011, J CELL MOL MED, V15, P2057, DOI 10.1111/j.1582-4934.2010.01218.x; Kikuchi R, 2014, J BIOL CHEM, V289, P3457, DOI 10.1074/jbc.M113.514430; Kim A, 2015, ONCOTARGET, V6, P38225, DOI 10.18632/oncotarget.5425; Lamers F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-285; Lee S, 2016, NAT STRUCT MOL BIOL, V23, P600, DOI 10.1038/nsmb.3223; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Lopergolo A, 2009, BRIT J CANCER, V100, P739, DOI 10.1038/sj.bjc.6604927; Lotz K, 2004, MOL CELL BIOL, V24, P9339, DOI 10.1128/MCB.24.21.9339-9350.2004; Lu HS, 2015, ELIFE, V4, DOI 10.7554/eLife.06535; Luk SUI, 2014, ONCOTARGET, V5, P6896, DOI 10.18632/oncotarget.2229; Ma L, 2014, SCI TRANSLATIONAL; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Marin O, 2003, P NATL ACAD SCI USA, V100, P10193, DOI 10.1073/pnas.1733909100; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Miyata Y, 2009, CELL MOL LIFE SCI, V66, P1840, DOI 10.1007/s00018-009-9152-0; Mobahat M, 2014, INT J MOL SCI, V15, P2494, DOI 10.3390/ijms15022494; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; O'Hare T, 2011, CLIN CANCER RES, V17, P212, DOI 10.1158/1078-0432.CCR-09-3314; Oberoi-Khanuja TK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.311; Okabe S, 2013, BIOCHEM BIOPH RES CO, V435, P506, DOI 10.1016/j.bbrc.2013.05.022; Pasic I, 2017, LEUKEMIA RES, V55, P65, DOI 10.1016/j.leukres.2017.01.005; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Pohl C, 2008, CELL, V132, P832, DOI 10.1016/j.cell.2008.01.012; Polier G, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.66; Polier G, 2014, INT J CANC; Qiu XB, 2005, J BIOL CHEM, V280, P174, DOI 10.1074/jbc.M411430200; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Ribe EM, 2008, BIOCHEM J, V415, P165, DOI 10.1042/BJ20081118; Roskoski R, 2015, PHARMACOL RES, V94, P9, DOI 10.1016/j.phrs.2015.01.003; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schwarz LJ, 2014, J CLIN INVEST, V124, P5490, DOI 10.1172/JCI72573; Sharma A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.155; Sung KW, 2007, CLIN CANCER RES, V13, P5109, DOI 10.1158/1078-0432.CCR-07-0693; Tang W, 2014, J CANC; Thomas D, 2013, BLOOD, V122, P738, DOI 10.1182/blood-2012-08-447441; Van Houdt WJ, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011353-1, 10.1074/mcp.M111.011353]; Wang L, 2014, TUMOR BIOL, V35, P4891, DOI 10.1007/s13277-014-1641-6; Wang QZ, 2010, ACS CHEM BIOL, V5, P887, DOI 10.1021/cb100099h; Wang ZX, 2005, CANCER RES, V65, P8224, DOI 10.1158/0008-5472.CAN-05-0303; Wu P, 2016, DRUG DISCOV TODAY, V21, P5, DOI 10.1016/j.drudis.2015.07.008; Wu P, 2015, TRENDS PHARMACOL SCI, V36, P422, DOI 10.1016/j.tips.2015.04.005; Yeh YY, 2015, ONCOTARGET, V6, P2667, DOI 10.18632/oncotarget.2096; Zhang MY, 2011, PROTEOMICS, V11, P4632, DOI 10.1002/pmic.201100339; Zimmerman EI, 2010, MOL PHARMACOL, V78, P811, DOI 10.1124/mol.110.066258	84	13	15	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177871	10.1371/journal.pone.0177871	http://dx.doi.org/10.1371/journal.pone.0177871			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520795	Green Published, Green Submitted, gold			2022-12-26	WOS:000401485500079
J	Tallmadge, RL; Miller, SC; Parry, SA; Felippe, MJB				Tallmadge, Rebecca L.; Miller, Steven C.; Parry, Stephen A.; Felippe, Maria Julia B.			Antigen-specific immunoglobulin variable region sequencing measures humoral immune response to vaccination in the equine neonate	PLOS ONE			English	Article							B-CELL RESPONSES; MATERNAL ANTIBODIES; EXPERIMENTAL-INFECTION; SEROLOGICAL RESPONSE; PERIPHERAL-BLOOD; HEALTHY FOALS; ADULT HORSES; HEPATITIS-A; GENE; INFLUENZA	The value of prophylactic neonatal vaccination is challenged by the interference of passively transferred maternal antibodies and immune competence at birth. Taken our previous studies on equine B cell ontogeny, we hypothesized that the equine neonate generates a diverse immunoglobulin repertoire in response to vaccination, independently of circulating maternal antibodies. In this study, equine neonates were vaccinated with 3 doses of keyhole limpet hemocyanin (KLH) or equine influenza vaccine, and humoral immune responses were assessed using antigen-specific serum antibodies and B cell Ig variable region sequencing. An increase (p<0.0001) in serum KLH-specific IgG level was measured between days 21 and days 28, 35 and 42 in vaccinated foals from non-vaccinated mares. In vaccinated foals from vaccinated mares, serum KLH-specific IgG levels tended to increase at day 42 (p = 0.07). In contrast, serum influenza-specific IgG levels rapidly decreased (p <= 0.05) in vaccinated foals from vaccinated mares within the study period. Nevertheless, IGHM and IGHG sequences were detected in KLH- and influenza-sorted B cells of vaccinated foals, independently of maternal vaccination status. Immunoglobulin nucleotide germline identity, IGHV gene usage and CDR length of antigen-specific IGHG sequences in B cells of vaccinated foals revealed a diverse immunoglobulin repertoire with isotype switching that was comparable between groups and to vaccinated mares. The low expression of CD27 memory marker in antigen-specific B cells, and of cytokines in peripheral blood mononuclear cells upon in vitro immunogen stimulation indicated limited lymphocyte population expansion in response to vaccine during the study period.	[Tallmadge, Rebecca L.; Miller, Steven C.; Felippe, Maria Julia B.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Equine Immunol Lab, Ithaca, NY 14853 USA; [Parry, Stephen A.] Cornell Univ, Cornell Stat Consulting Unit, Ithaca, NY USA	Cornell University; Cornell University	Felippe, MJB (corresponding author), Cornell Univ, Coll Vet Med, Dept Clin Sci, Equine Immunol Lab, Ithaca, NY 14853 USA.	mbf6@cornell.edu		Felippe, Maria Julia B./0000-0002-6440-5272; Tallmadge, Rebecca/0000-0002-7466-5449	Agriculture and Food Research Initiative of the USDA National Institute of Food and Agriculture [2012-67015-19459]; Empire State Stem Cell Fund through New York State Department of Health [C026718]	Agriculture and Food Research Initiative of the USDA National Institute of Food and Agriculture; Empire State Stem Cell Fund through New York State Department of Health	This project was supported by the Agriculture and Food Research Initiative competitive grant number 2012-67015-19459 of the USDA National Institute of Food and Agriculture (MJBF, RLT) https://nifa.usda.gov/program/agriculture-and-food-research-initative-afri. The Cornell Biomedical Sciences Flow Cytometry core lab acknowledges support by the Empire State Stem Cell Fund through New York State Department of Health Contract #C026718. Opinions expressed here are solely those of the authors and do not necessarily reflect those of the Empire State Stem Cell Board, the New York State Department of Health, or the State of New York https://stemcell.ny.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agematsu Kazunaga, 2004, Nihon Rinsho Meneki Gakkai Kaishi, V27, P309; AGHOMO HO, 1990, VET RES COMMUN, V14, P415, DOI 10.1007/BF00343220; Ainsworth DM, 2002, VET IMMUNOL IMMUNOP, V84, P169, DOI 10.1016/S0165-2427(01)00400-7; Avanzini MA, 2010, INT J IMMUNOPATH PH, V23, P247, DOI 10.1177/039463201002300122; Badial PR, 2015, CLIN VACCINE IMMUNOL, V22, P1133, DOI 10.1128/CVI.00374-15; Banks EMS, 1999, J COMP PATHOL, V120, P1, DOI 10.1053/jcpa.1998.0250; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Battista JM, 2014, IMMUNOGENETICS, V66, P635, DOI 10.1007/s00251-014-0799-9; Bergmann-Leitner ES, 2014, VACCINES-BASEL, V2, P252, DOI 10.3390/vaccines2020252; Blasco E, 2001, VACCINE, V19, P4805, DOI 10.1016/S0264-410X(01)00211-0; Bordin AI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105367; Breathnach CC, 2006, VET IMMUNOL IMMUNOP, V112, P199, DOI 10.1016/j.vetimm.2006.02.010; BURSTYN DG, 1983, INFECT IMMUN, V41, P1150, DOI 10.1128/IAI.41.3.1150-1156.1983; CLAESSON BA, 1989, J PEDIATR-US, V114, P97, DOI 10.1016/S0022-3476(89)80611-0; Clarke E, 2016, EXPERT REV VACCINES, V15, P1305, DOI 10.1586/14760584.2016.1167602; Dagan R, 2000, PEDIATR INFECT DIS J, V19, P1045, DOI 10.1097/00006454-200011000-00004; DAUM RS, 1991, J INFECT DIS, V164, P1154, DOI 10.1093/infdis/164.6.1154; Davis EG, 2015, EQUINE VET J, V47, P667, DOI 10.1111/evj.12350; Edmonds JD, 2001, EQUINE VET J, V33, P658, DOI 10.2746/042516401776249282; Eisen HN, 2014, CANCER IMMUNOL RES, V2, P381, DOI 10.1158/2326-6066.CIR-14-0029; Endsley JJ, 2003, BIOLOGICALS, V31, P123, DOI 10.1016/S1045-1056(03)00027-7; ENGLUND JA, 1995, PEDIATRICS, V96, P580; FEENEY AJ, 1990, J EXP MED, V172, P1377, DOI 10.1084/jem.172.5.1377; Flaminio MJBF, 2009, CLIN VACCINE IMMUNOL, V16, P176, DOI 10.1128/CVI.00336-08; Flaminio MJBF, 1999, J VET INTERN MED, V13, P206, DOI 10.1892/0891-6640(1999)013&lt;0206:PBLSAI&gt;2.3.CO;2; Flaminio MJBF, 2000, VET IMMUNOL IMMUNOP, V73, P267, DOI 10.1016/S0165-2427(00)00149-5; Galson Jacob D, 2015, EBioMedicine, V2, P2070, DOI 10.1016/j.ebiom.2015.11.034; Galson JD, 2015, IMMUNOL CELL BIOL, V93, P885, DOI 10.1038/icb.2015.57; Hara Y, 2015, MOL IMMUNOL, V68, P617, DOI 10.1016/j.molimm.2015.10.003; Holbrook BC, 2016, VACCINE, V34, P4712, DOI 10.1016/j.vaccine.2016.08.010; Holmes MA, 2006, VET IMMUNOL IMMUNOP, V111, P67, DOI 10.1016/j.vetimm.2006.01.010; Ibrahim S, 2012, VET IMMUNOL IMMUNOP, V145, P7, DOI 10.1016/j.vetimm.2011.07.021; Jacks S, 2007, CLIN VACCINE IMMUNOL, V14, P669, DOI 10.1128/CVI.00042-07; JEFFCOTT LB, 1975, J REPROD FERTIL, P727; JEONG HD, 1988, J EXP MED, V168, P589, DOI 10.1084/jem.168.2.589; Kanra G, 2000, TURKISH J PEDIATR, V42, P105; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KLOBASA F, 1981, RES VET SCI, V31, P195, DOI 10.1016/S0034-5288(18)32494-9; Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014; LAVOIE JP, 1989, AM J VET RES, V50, P1598; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Littel-van den Hurk SV, 1999, VIRAL IMMUNOL, V12, P67, DOI 10.1089/vim.1999.12.67; Lohmann KL, 2013, CAN J VET RES, V77, P161; Lopez AM, 2003, VACCINE, V21, P3815, DOI 10.1016/S0264-410X(03)00329-3; MARTIN BR, 1973, AM J VET RES, V34, P1363; Merant C, 2009, VET IMMUNOL IMMUNOP, V131, P1, DOI 10.1016/j.vetimm.2009.03.002; Minke JM, 2007, J COMP PATHOL, V137, pS76, DOI 10.1016/j.jcpa.2007.04.016; MORGAN DO, 1975, J REPROD FERTIL, P735; Muirhead TL, 2008, J VET INTERN MED, V22, P654, DOI 10.1111/j.1939-1676.2008.0091.x; Mumford EL, 2003, EQUINE VET J, V35, P72, DOI 10.2746/042516403775467379; Mwila K, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00405-16; Nguyen TV, 2006, CLIN VACCINE IMMUNOL, V13, P475, DOI 10.1128/CVI.13.4.475-485.2006; Nguyen TV, 2006, VACCINE, V24, P2302, DOI 10.1016/j.vaccine.2005.11.043; Opriessnig T, 2008, CLIN VACCINE IMMUNOL, V15, P397, DOI 10.1128/CVI.00416-07; Pei Y, 2007, VET MICROBIOL, V125, P100, DOI 10.1016/j.vetmic.2007.05.007; PERLMUTTER RM, 1985, SCIENCE, V227, P1597, DOI 10.1126/science.3975629; PERRYMAN LE, 1980, AM J VET RES, V41, P1197; Pichichero ME, 2014, VACCINE, V32, P3886, DOI 10.1016/j.vaccine.2014.05.008; Prabakaran P, 2012, IMMUNOGENETICS, V64, P337, DOI 10.1007/s00251-011-0595-8; Prieto JMB, 2017, VET IMMUNOL IMMUNOP, V183, P60, DOI 10.1016/j.vetimm.2016.12.004; Pusterla N, 2011, J PARASITOL, V97, P281, DOI 10.1645/GE-2657.1; R Core Team, 2021, R LANGUAGE ENV STAT; Ryan C, 2010, CLIN VACCINE IMMUNOL, V17, P1896, DOI 10.1128/CVI.00328-10; Sheoran AS, 2000, AM J VET RES, V61, P1099, DOI 10.2460/ajvr.2000.61.1099; Shiokawa S, 1999, J IMMUNOL, V162, P6060; Souto-Carneiro MM, 1950, J IMMUNOL BALTIM MD, V175, P7425; Sturgill TL, 2014, VACCINE, V32, P1362, DOI 10.1016/j.vaccine.2014.01.032; Sturgill TL, 2010, J EQUINE VET SCI, V30, P359, DOI 10.1016/j.jevs.2010.05.008; Sun LS, 2012, DEV COMP IMMUNOL, V36, P534, DOI 10.1016/j.dci.2011.09.009; Sun Y, 2010, DEV COMP IMMUNOL, V34, P1009, DOI 10.1016/j.dci.2010.05.003; Tallmadge RL, 2014, DEV COMP IMMUNOL, V46, P171, DOI 10.1016/j.dci.2014.04.001; Tallmadge RL, 2013, DEV COMP IMMUNOL, V41, P33, DOI 10.1016/j.dci.2013.03.020; Tallmadge RL, 2009, DEV COMP IMMUNOL, V33, P1027, DOI 10.1016/j.dci.2009.05.002; VANMAANEN C, 1992, VET QUART, V14, P13, DOI 10.1080/01652176.1992.9694319; Varga J, 1997, VET MICROBIOL, V56, P205, DOI 10.1016/S0378-1135(97)00089-8; Walther S, 2015, DEV COMP IMMUNOL, V53, P303, DOI 10.1016/j.dci.2015.07.017; Wang HS, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00099; Weitkamp JH, 2005, HUM IMMUNOL, V66, P666, DOI 10.1016/j.humimm.2005.02.008; Willems F, 2009, EUR J IMMUNOL, V39, P26, DOI 10.1002/eji.200838391; Williams JV, 2009, MOL IMMUNOL, V47, P407, DOI 10.1016/j.molimm.2009.08.024; Wilson WD, 2001, EQUINE VET J, V33, P644, DOI 10.2746/042516401776249435; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0; ZINK MC, 1984, AM J VET RES, V45, P893	83	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177831	10.1371/journal.pone.0177831	http://dx.doi.org/10.1371/journal.pone.0177831			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520789	Green Published, Green Submitted, gold			2022-12-26	WOS:000401485500076
J	Lall, VK; Bruce, G; Voytenko, L; Drinkhill, M; Wellershaus, K; Willecke, K; Deuchars, J; Deuchars, SA				Lall, Varinder K.; Bruce, Gareth; Voytenko, Larysa; Drinkhill, Mark; Wellershaus, Kerstin; Willecke, Klaus; Deuchars, Jim; Deuchars, Susan A.			Physiologic regulation of heart rate and blood pressure involves connexin 36-containing gap junctions	FASEB JOURNAL			English	Article						sympathetic; cardiovascular; spinal cord; knockout models	SYMPATHETIC PREGANGLIONIC NEURONS; AUTONOMIC NERVOUS-SYSTEM; SPINAL-CORD; ADULT-RAT; IN-VITRO; MOUSE; VARIABILITY; BRAIN; HYPERTENSION; EXPRESSION	Chronically elevated sympathetic nervous activity underlies many cardiovascular diseases. Elucidating the mechanisms contributing to sympathetic nervous system output may reveal new avenues of treatment. The contribution of the gap junctional protein connexin 36 (Cx36) to the regulation of sympathetic activity and thus blood pressure and heart rate was determined using a mouse with specific genetic deletion of Cx36. Ablation of the Cx36 protein was confirmed in sympathetic preganglionic neurons of Cx36-knockout (KO) mice. Telemetric analysis from conscious Cx36 KO mice revealed higher variance in heart rate and blood pressure during rest and activity compared to wild-type (WT) mice, and smaller responses to chemoreceptor activation when anesthetized. In the working heart-brain stem preparation of the Cx36-KO mouse, respiratory-coupled sympathetic nerve discharge was attenuated and responses to chemoreceptor stimulation and noxious stimulation were blunted compared to WT mice. Using whole cell patch recordings, sympathetic preganglionic neurons in spinal cord slices of Cx36-KO mice displayed lower levels of spikelet activity compared to WT mice, indicating reduced gap junction coupling between neurons. Cx36 deletion therefore disrupts normal regulation of sympathetic outflow with effects on cardiovascular parameters.	[Lall, Varinder K.; Bruce, Gareth; Voytenko, Larysa; Deuchars, Jim; Deuchars, Susan A.] Univ Leeds, Sch Biomed Sci, Fac Biol Sci, Leeds, W Yorkshire, England; [Drinkhill, Mark] Univ Leeds, Inst Cardiovasc & Metab Med, Div Cardiovasc & Diabet Res, Leeds, W Yorkshire, England; [Wellershaus, Kerstin; Willecke, Klaus] Univ Bonn, Life & Med Sci Inst LIMES, Bonn, Germany	University of Leeds; University of Leeds; University of Bonn	Deuchars, SA (corresponding author), Univ Leeds, Sch Biomed Sci, Fac Biol Sci, Leeds, W Yorkshire, England.; Deuchars, SA (corresponding author), Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England.	s.a.deuchars@leeds.ac.uk		LAll, Varinder/0000-0003-1989-0130; Deuchars, Susan/0000-0002-1876-3239; Deuchars, Jim/0000-0002-4445-654X	British Heart Foundation [PG/08/120/26338]; Biotechnology and Biological Sciences Research Council [BB/1]; Wellcome Trust [WT093072MA]; BBSRC [BB/E001831/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E001831/1] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank B. Frater (University of Leeds) for expert technical assistance. Research conducted in these studies was supported by the British Heart Foundation (Grant PG/08/120/26338 to S.A.D.), the Biotechnology and Biological Sciences Research Council (Ph.D. studentship to V.K.L., and Grant BB/1 to J.D.), and the Wellcome Trust (Grant WT093072MA to S.A.D.).	Baudry S, 1997, J PHARM PHARMACOL, V49, P1086, DOI 10.1111/j.2042-7158.1997.tb06047.x; Charkoudian N, 2009, MAYO CLIN PROC, V84, P822, DOI 10.1016/S0025-6196(11)60492-8; Condorelli DF, 2000, BRAIN RES REV, V32, P72, DOI 10.1016/S0165-0173(99)00068-5; Cummings DM, 2008, J NEUROSCI RES, V86, P2147, DOI 10.1002/jnr.21674; Deuchars SA, 2001, NEUROSCIENCE, V106, P433, DOI 10.1016/S0306-4522(01)00277-9; Deuchars SA, 2015, COMPR PHYSIOL, V5, P829, DOI 10.1002/cphy.c140020; Ferrari AU, 1996, AM J PHYSIOL-HEART C, V270, pH2143, DOI 10.1152/ajpheart.1996.270.6.H2143; Florea VG, 2014, CIRC RES, V114, P1815, DOI 10.1161/CIRCRESAHA.114.302589; Frank M, 2010, J CELL SCI, V123, P3605, DOI 10.1242/jcs.068668; Frisch C, 2005, BEHAV BRAIN RES, V157, P177, DOI 10.1016/j.bbr.2004.06.023; Head WS, 2012, DIABETES, V61, P1700, DOI 10.2337/db11-1312; Hirose M, 1998, ANESTHESIOLOGY, V89, P666, DOI 10.1097/00000542-199809000-00016; JULIEN C, 1990, AM J PHYSIOL, V259, pH1337, DOI 10.1152/ajpheart.1990.259.5.H1337; Lall VK, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-103; LAOTHAVORN P, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P51; Lee SC, 2014, J NEUROSCI, V34, P13170, DOI 10.1523/JNEUROSCI.0562-14.2014; Leslie J, 2000, J PHYSIOL-LONDON, V528P, p108P; Logan SD, 1996, J PHYSIOL-LONDON, V495, P491, DOI 10.1113/jphysiol.1996.sp021609; LOW PA, 1978, ANN NEUROL, V4, P511, DOI 10.1002/ana.410040606; Malpas SC, 1998, PROG NEUROBIOL, V56, P65, DOI 10.1016/S0301-0082(98)00030-6; Mancia G, 2014, CIRC RES, V114, P1804, DOI 10.1161/CIRCRESAHA.114.302524; Marina N, 2008, AUTON NEUROSCI-BASIC, V139, P15, DOI 10.1016/j.autneu.2007.12.004; MARSHALL JM, 1994, PHYSIOL REV, V74, P543, DOI 10.1152/physrev.1994.74.3.543; Murray AR, 2016, AUTON NEUROSCI-BASIC, V199, P48, DOI 10.1016/j.autneu.2016.06.004; Ng FL, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0670-5; Nishie M, 2004, ACTA NEUROPATHOL, V107, P292, DOI 10.1007/s00401-003-0811-1; Paton JFR, 1996, J NEUROSCI METH, V65, P63, DOI 10.1016/0165-0270(95)00147-6; PICKERING AE, 1994, J PHYSIOL-LONDON, V480, P109, DOI 10.1113/jphysiol.1994.sp020345; Pierce ML, 2010, NEUROSCIENCE, V170, P827, DOI 10.1016/j.neuroscience.2010.07.007; Simms AE, 2007, J PHYSIOL-LONDON, V579, P473, DOI 10.1113/jphysiol.2006.124396; Stalbovskiy AO, 2014, J PHYSIOL-LONDON, V592, P2215, DOI 10.1113/jphysiol.2014.270769; Wellershaus K, 2008, EXP CELL RES, V314, P997, DOI 10.1016/j.yexcr.2007.12.024; Zolnik TA, 2016, J PHYSIOL-LONDON, V594, P2579, DOI 10.1113/JP271880	33	5	5	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3966	3977		10.1096/fj.201600919RR	http://dx.doi.org/10.1096/fj.201600919RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28533325	Green Published, hybrid			2022-12-26	WOS:000408713300022
J	Niu, GD; Franca, C; Zhang, GW; Roobsoong, W; Nguitragool, W; Wang, XH; Prachumsri, J; Butler, NS; Li, J				Niu, Guodong; Franca, Caio; Zhang, Genwei; Roobsoong, Wanlapa; Nguitragool, Wang; Wang, Xiaohong; Prachumsri, Jetsumon; Butler, Noah S.; Li, Jun			The fibrinogen-like domain of FREP1 protein is a broad-spectrum malaria transmission-blocking vaccine antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						infection; ligand-binding protein; malaria; parasite; vaccine; malaria transmission-blocking vaccine	PLASMODIUM-FALCIPARUM; CANDIDATES; ANTIBODIES	FREP1 in mosquito midguts facilitates Plasmodium falciparum parasite transmission. The fibrinogen-like (FBG) domain of FREP1 is highly conserved (>90% identical) among Anopheles species from different continents, suggesting that anti-FBG antibodies may block malaria transmission to all anopheline mosquitoes. Using standard membrane-feeding assays, anti-FREP1 polyclonal antibodies significantly blocked transmission of Plasmodium berghei and Plasmodium vivax to Anopheles gambiae and Anopheles dirus, respectively. Furthermore, in vivo studies of mice immunized with FBG achieved >75% blocking efficacy of P. berghei to A. gambiae without triggering immunopathology. Anti-FBG serum also reduced >81% of P. falciparum infection to A. gambiae. Finally, we showed that FBG interacts with Plasmodium gametocytes and ookinetes, revealing the molecular mechanism of its antibody transmission-blocking activity. Collectively, our data support that FREP1-mediated Plasmodium transmission to mosquitoes is a conserved pathway and that targeting the FBG domain of FREP1 will limit the transmission of multiple Plasmodium species to multiple Anopheles species.	[Franca, Caio; Zhang, Genwei; Li, Jun] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Roobsoong, Wanlapa; Nguitragool, Wang; Prachumsri, Jetsumon] Mahidol Univ, Fac Trop Med, Mahidol Vivax Res Ctr, Bangkok 10400, Thailand; [Butler, Noah S.] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA; [Niu, Guodong; Wang, Xiaohong; Li, Jun] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA	University of Oklahoma System; University of Oklahoma - Norman; Mahidol University; University of Iowa; State University System of Florida; Florida International University	Li, J (corresponding author), Florida Int Univ, Biomol Sci Inst, Dept Biol Sci, 11200 SW 8th St,OE 214, Miami, FL 33199 USA.	lij@fiu.edu	Prachumsri, Jetsumon/AAZ-7732-2021; Zhang, Genwei/AAB-3853-2022	Zhang, Genwei/0000-0002-5737-8413; Butler, Noah/0000-0002-1429-0796; Sattabongkot, Jetsumon/0000-0002-3938-4588; Nguitragool, Wang/0000-0002-5484-7130; Roobsoong, Wanlapa/0000-0002-1789-0439; Barbalho de Franca, Caio Martinelle/0000-0002-5056-7983	National Institutes of Health [R21AI115178]; National Science Foundation [1742644]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125657, R21AI115178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R21AI115178 and National Science Foundation Career Award 1742644. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or National Science Foundation.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000398; Armistead JS, 2014, INFECT IMMUN, V82, P818, DOI 10.1128/IAI.01222-13; Birkett AJ, 2013, VACCINE, V31, pB233, DOI 10.1016/j.vaccine.2013.02.040; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dinglasan RR, 2008, TRENDS PARASITOL, V24, P364, DOI 10.1016/j.pt.2008.05.002; Dinglasan RR, 2007, P NATL ACAD SCI USA, V104, P13461, DOI 10.1073/pnas.0702239104; Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117; Kapulu MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep11193; KASLOW DC, 1988, NATURE, V333, P74, DOI 10.1038/333074a0; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Li J, 2013, P NATL ACAD SCI USA, V110, P20675, DOI 10.1073/pnas.1321024110; Mambo G, 2008, INFECT IMMUN, V76, P2018, DOI 10.1128/IAI.01409-07; Miura K, 2013, INFECT IMMUN, V81, P4377, DOI 10.1128/IAI.01056-13; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Niu GD, 2015, SCI REP-UK, V5, DOI 10.1038/srep14694; Parasuraman S, 2010, J PHARMACOL PHARMACO, V1, P87, DOI 10.4103/0976-500X.72350; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002636; Zhang GW, 2015, J BIOL CHEM, V290, P16490, DOI 10.1074/jbc.M114.623165	20	22	22	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11960	11969		10.1074/jbc.M116.773564	http://dx.doi.org/10.1074/jbc.M116.773564			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28533429	Green Published, hybrid			2022-12-26	WOS:000405485600031
J	Gontijo, FD; de Melo, AT; Pascon, RC; Fernandes, L; Paes, HC; Alspaugh, JA; Vallim, MA				Gontijo, Fabiano de Assis; de Melo, Amanda Teixeira; Pascon, Renata C.; Fernandes, Larissa; Paes, Hugo Costa; Alspaugh, J. Andrew; Vallim, Marcelo A.			The role of Aspartyl aminopeptidase (Ape4) in Cryptococcus neoformans virulence and authophagy	PLOS ONE			English	Article							VACUOLE TARGETING PATHWAY; HIGH-TEMPERATURE GROWTH; USTILAGO-MAYDIS; PULMONARY INFECTION; CANDIDA-ALBICANS; SELF-DIGESTION; AUTOPHAGY; YEAST; CELL; IDENTIFICATION	In order to survive and cause disease, microbial pathogens must be able to proliferate at the temperature of their infected host. We identified novel microbial features associated with thermotolerance in the opportunistic fungal pathogen Cryptococcus neoformans using a random insertional mutagenesis strategy, screening for mutants with defective growth at 37 degrees C. Among several thermosensitive mutants, we identified one bearing a disruption in a gene predicted to encode the Ape4 aspartyl aminopeptidase protein. Ape4 metalloproteases in other fungi, including Saccharomyces cerevisiae, are activated by nitrogen starvation, and they are required for autophagy and the cytoplasm-to-vacuole targeting (Cvt) pathway. However, none have been previously associated with altered growth at elevated temperatures. We demonstrated that the C. neoformans ape4 mutant does not grow at 37 degrees C, and it also has defects in the expression of important virulence factors such as phospholipase production and capsule formation. C. neoformans Ape4 activity was required for this facultative intracellular pathogen to survive within macrophages, as well as for virulence in an animal model of cryptococcal infection. Similar to S. cerevisiae Ape4, the C. neoformans GFP-Ape4 fusion protein co-localized with intracytoplasmic vesicles during nitrogen depletion. APE4 expression was also induced by the combination of nutrient and thermal stress. Together these results suggest that autophagy is an important cellular process for this microbial pathogen to survive within the environment of the infected host.	[Gontijo, Fabiano de Assis; de Melo, Amanda Teixeira; Pascon, Renata C.; Vallim, Marcelo A.] Univ Fed Sao Paulo, Dept Ciencias Biol, Diadema, SP, Brazil; [Fernandes, Larissa] Univ Brasilia, Fac Ceilandia, Ceilandia, DF, Brazil; [Paes, Hugo Costa] Univ Brasilia, Fac Med, Brasilia, DF, Brazil; [Alspaugh, J. Andrew] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Brasilia; Universidade de Brasilia; Duke University	Vallim, MA (corresponding author), Univ Fed Sao Paulo, Dept Ciencias Biol, Diadema, SP, Brazil.	marcelo.vallim@unifesp.br	Alspaugh, Andrew/AAB-1664-2019; de melo, amanda teixeira/U-1811-2019; Pascon, Renata/E-1494-2012; Vallim, Marcelo/J-2624-2013	Alspaugh, Andrew/0000-0003-3009-627X; de melo, amanda teixeira/0000-0003-3867-8522; Pascon, Renata/0000-0001-9902-9396; Vallim, Marcelo/0000-0002-6929-0566; Fernandes, Larissa/0000-0002-2814-7501	FAPESP [2007/50536-3, 2015/04400-9, 2011/51298-4, 2016/14542-8]; NIH [AI050128, AI074677]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074677, R01AI050128, R21AI050128, R56AI074677] Funding Source: NIH RePORTER	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by FAPESP grants (2007/50536-3 and 2015/04400-9) to MAV, (2011/51298-4 and 2016/14542-8) to RCP and NIH grants (AI050128 and AI074677) to JAA	Alspaugh JA, 2000, MOL MICROBIOL, V36, P352, DOI 10.1046/j.1365-2958.2000.01852.x; Brown SM, 2007, CURR OPIN MICROBIOL, V10, P320, DOI 10.1016/j.mib.2007.05.014; Cebollero E, 2009, BBA-MOL CELL RES, V1793, P1413, DOI 10.1016/j.bbamcr.2009.01.008; CHRISTENSEN WB, 1946, J BACTERIOL, V52, P461, DOI 10.1128/JB.52.4.461-466.1946; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; de Gontijo FA, 2014, FUNGAL GENET BIOL, V70, P12, DOI 10.1016/j.fgb.2014.06.003; Devenish RJ, 2015, CURR BIOL, V25, pR238, DOI 10.1016/j.cub.2015.01.045; Hecht Karen A, 2014, Cell Logist, V4, pe28023; Hu GG, 2008, MOL MICROBIOL, V69, P1456, DOI 10.1111/j.1365-2958.2008.06374.x; Kim J, 2000, ANNU REV BIOCHEM, V69, P303, DOI 10.1146/annurev.biochem.69.1.303; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2005, CURR BIOL, V15, pR282, DOI 10.1016/j.cub.2005.04.013; Kozubowski L, 2009, CELL MICROBIOL, V11, P370, DOI 10.1111/j.1462-5822.2008.01273.x; Kronstad James W., 2011, Mycobiology, V39, P143, DOI 10.5941/MYCO.2011.39.3.143; Lam WC, 2013, EUKARYOT CELL, V12, P118, DOI 10.1128/EC.05305-11; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li Shu Shun, 2010, Proc Am Thorac Soc, V7, P186, DOI 10.1513/pats.200907-063AL; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Magditch D. A., 2012, PLoS Pathogens, V8, pe1002936, DOI 10.1371/journal.ppat.1002936; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nadal M, 2010, MOL PLANT PATHOL, V11, P463, DOI [10.1111/J.1364-3703.2010.00620.X, 10.1111/j.1364-3703.2010.00620.x]; Nair U, 2012, AUTOPHAGY, V8, P780, DOI 10.4161/auto.19385; Nichols CB, 2009, EUKARYOT CELL, V8, P181, DOI 10.1128/EC.00351-08; Nicola AM, 2012, METHODS MOL BIOL, V844, P189, DOI 10.1007/978-1-61779-527-5_14; Nieto-Jacobo F, 2012, EUKARYOT CELL, V11, P1154, DOI 10.1128/EC.00115-12; O'Meara TR, 2014, MOL CELL BIOL, V34, P673, DOI 10.1128/MCB.01359-13; O'Meara TR, 2012, CLIN MICROBIOL REV, V25, P387, DOI 10.1128/CMR.00001-12; Odom A, 1997, EMBO J, V16, P2576, DOI 10.1093/emboj/16.10.2576; Oliveira DL, 2016, FUTURE MICROBIOL, V11, P1404, DOI 10.2217/fmb-2016-0090; Paiva JA, 2013, CURR OPIN INFECT DIS, V26, P168, DOI 10.1097/QCO.0b013e32835ebcb7; PALIWAL DK, 1978, A VAN LEEUW J MICROB, V44, P243, DOI 10.1007/BF00643226; Palmer GE, 2007, MICROBIOL-SGM, V153, P51, DOI 10.1099/mic.0.2006/001610-0; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; PRICE MF, 1982, SABOURAUDIA, V20, P7; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Reggiori F, 2013, GENETICS, V194, P341, DOI 10.1534/genetics.112.149013; Rex JH, 2001, CLIN MICROBIOL REV, V14, P643, DOI 10.1128/CMR.14.4.643-658.2001; Richie DL, 2007, EUKARYOT CELL, V6, P2437, DOI 10.1128/EC.00224-07; Shintani M, 2011, BIOMED RES-TOKYO, V32, P379, DOI 10.2220/biomedres.32.379; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Singh N, 2000, Transpl Infect Dis, V2, P101, DOI 10.1034/j.1399-3062.2000.020302.x; Skowyra Michael L, 2012, Methods Mol Biol, V845, P165, DOI 10.1007/978-1-61779-539-8_11; Suzuki K, 2011, DEV CELL, V21, P358, DOI 10.1016/j.devcel.2011.06.023; Tanaka C, 2014, J CELL BIOL, V207, P91, DOI 10.1083/jcb.201402128; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Umekawa M., 2012, INT J CELL BIOL, V2012, DOI [DOI 10.1155/2012/142634, 10.1155/ 2012/142634]; Vallim MA, 2005, EUKARYOT CELL, V4, P1066, DOI 10.1128/EC.4.6.1066-1078.2005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wagner-Vogel G, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0358-z; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Yokoyama R, 2006, FEBS J, V273, P192, DOI 10.1111/j.1742-4658.2005.05057.x; Yuga M, 2011, J BIOL CHEM, V286, P13704, DOI 10.1074/jbc.M110.173906; Zaragoza O, 2004, INFECT IMMUN, V72, P4271, DOI 10.1128/IAI.72.7.4271-4274.2004; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0; ZEBEDEE SL, 1994, ANTIMICROB AGENTS CH, V38, P1507, DOI 10.1128/AAC.38.7.1507	64	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177461	10.1371/journal.pone.0177461	http://dx.doi.org/10.1371/journal.pone.0177461			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542452	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800017
J	He, JW; Shao, GN; Wei, XJ; Huang, FL; Sheng, ZH; Tang, SQ; Hu, PS				He, Jiwai; Shao, Gaoneng; Wei, Xiangjin; Huang, Fenglin; Sheng, Zhonghua; Tang, Shaoqing; Hu, Peisong			Fine mapping and candidate gene analysis of qTAC8, a major quantitative trait locus controlling tiller angle in rice (Oryza sativa L.)	PLOS ONE			English	Article							PLANT ARCHITECTURE; SHOOT GRAVITROPISM; LAZY1	Rice tiller angle is an important agronomic trait that contributes to crop production and plays a vital role in high yield breeding. In this study, a recombinant inbred line (RIL) population derived from the cross of a glabrous tropical japonica rice D50 and an indica rice HB277, was used to investigate quantitative trait loci (QTLs) controlling rice tiller angle. Two major QTLs, qTAC8 and qTAC9, were detected. While qTAC9 mapped with a previously identified gene (TAC1), using a BC2F2 population qTAC8 was mapped to a 16.5 cM region between markers RM7049 and RM23175. Position of qTAC8 was narrowed to a 92 kb DNA region by two genetic segregating populations. Finally, one opening reading frame (ORF) was regarded as a candidate gene according to genomic sequencing and qRT-PCR analysis. In addition, a set of four near isogenic lines (NILs) were created to investigate the genetic relationship between those two QTLs, and one line carrying qTAC8 and qTAC9 presented additive effect of tiller angle, suggesting that these QTLs are involved in different genetic pathways. Our results provide a foundation for the cloning of qTAC8 and genetic improvement of the rice plant architecture.	[He, Jiwai; Shao, Gaoneng; Wei, Xiangjin; Huang, Fenglin; Sheng, Zhonghua; Tang, Shaoqing; Hu, Peisong] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Huang, Fenglin] Hunan Acad Agr Sci, Hunan Rice Res Inst, Changsha, Hunan, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Hunan Academy of Agricultural Sciences	Hu, PS (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China.	peisonghu@126.com	huang, fenglin/AAW-6130-2021	Wei, Xiangjin/0000-0002-1190-5222	National Key Research and Development Program of China [National Key Research and Development Program of China (2016YFD0101801]; National S&T Major Project of China [2016ZX08001006]; National Natural Science Foundation of China [31501285, 31521064]	National Key Research and Development Program of China; National S&T Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Research and Development Program of China (2016YFD0101801), the National S&T Major Project of China (2016ZX08001006) and the National Natural Science Foundation of China (grants 31501285, 31521064).; This work was supported by the National Key Research and Development Program of China (2016YFD0101801), the National S&T Major Project of China (2016ZX08001006) and the National Natural Science Foundation of China (grants 31501285, 31521064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YN, 2012, PLANT BIOTECHNOL J, V10, P139, DOI 10.1111/j.1467-7652.2011.00637.x; Dong HJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006412; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; Li ZK, 1999, EUPHYTICA, V109, P79, DOI 10.1023/A:1003533001014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Qian Q., 2000, YI CHUAN XUE BAO, V28, P29; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shao Gao-neng, 2009, Zhongguo Shuidao Kexue, V23, P94; Shen SQ, 2004, J AGR BIOTECH, V13, P16; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Wu XR, 2013, PLANT PHYSIOL, V161, P317, DOI 10.1104/pp.112.208496; Xu M, 2005, PLANT CELL PHYSIOL, V46, P1674, DOI 10.1093/pcp/pci183; Xu YB, 1998, CROP SCI, V38, P12, DOI 10.2135/cropsci1998.0011183X003800010002x; Xu YB, 1993, ACTA AGR ZHEJIANGENS, V1; Yang ShouRen, 1996, Chinese Journal of Rice Science, V10, P115; Yoshihara T, 2007, PLANT CELL PHYSIOL, V48, P678, DOI 10.1093/pcp/pcm042; Yu BS, 2007, PLANT J, V52, P891, DOI 10.1111/j.1365-313X.2007.03284.x; Yu Chuan-Yuan, 2005, Acta Genetica Sinica, V32, P948	22	13	14	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178177	10.1371/journal.pone.0178177	http://dx.doi.org/10.1371/journal.pone.0178177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542427	Green Published, gold, Green Submitted			2022-12-26	WOS:000402062800048
J	Schabort, DWP; Kilian, SG; du Preez, JC				Schabort, Du Toit W. P.; Kilian, Stephanus G.; du Preez, James C.			Elucidation of new condition-dependent roles for fructose-1,6-bisphosphatase linked to cofactor balances	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; UNCOUPLING PROTEINS; METABOLIC-FLUX; GLUCOSE; ACID; EXPRESSION	The cofactor balances in metabolism is of paramount importance in the design of a metabolic engineering strategy and understanding the regulation of metabolism in general. ATP, NAD(+) and NADP(+) balances are central players linking the various fluxes in central metabolism as well as biomass formation. NADP+ is especially important in the metabolic engineering of yeasts for xylose fermentation, since NADPH is required by most yeasts in the initial step of xylose utilisation, including the fast-growing Kluyveromyces marxianus. In this simulation study of yeast metabolism, the complex interplay between these cofactors was investigated; in particular, how they may affect the possible roles of fructose-1,6-bisphosphatase, the pentose phosphate pathway, glycerol production and the pyruvate dehydrogenase bypass. Using flux balance analysis, it was found that the potential role of fructose-1,6-bisphosphatase was highly dependent on the cofactor specificity of the oxidative pentose phosphate pathway and on the carbon source. Additionally, the excessive production of ATP under certain conditions might be involved in some of the phenomena observed, which may have been overlooked to date. Based on these findings, a strategy is proposed for the metabolic engineering of a future xylose-fermenting yeast for biofuel production.	[Schabort, Du Toit W. P.; Kilian, Stephanus G.; du Preez, James C.] Univ Free State, Dept Microbial Biochem & Food Biotechnol, Bloemfontein, South Africa	University of the Free State	Schabort, DWP (corresponding author), Univ Free State, Dept Microbial Biochem & Food Biotechnol, Bloemfontein, South Africa.	SchabortDWP@ufs.ac.za			National Research Foundation of South Africa (ZA), CSPG-Thuthuka (PhD Track) [TTK20110831000026600, UID: 80657]	National Research Foundation of South Africa (ZA), CSPG-Thuthuka (PhD Track)	This work was funded by the National Research Foundation of South Africa (ZA), CSPG-Thuthuka (PhD Track), http://www.nrf.ac.za/, Reference: TTK20110831000026600, UID: 80657, Awarded to: Mr WPD Schabort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DA, 2007, FEMS YEAST RES, V7, P819, DOI 10.1111/j.1567-1364.2007.00242.x; Alff-Tuomala S, 2016, APPL MICROBIOL BIOT, V100, P969, DOI 10.1007/s00253-015-7038-7; Basso TO, 2011, METAB ENG, V13, P694, DOI 10.1016/j.ymben.2011.09.005; Blank LM, 2005, FEMS YEAST RES, V5, P545, DOI 10.1016/j.femsyr.2004.09.008; de Kok S, 2012, FEMS YEAST RES, V12, P387, DOI 10.1111/j.1567-1364.2012.00799.x; Fischer E, 2004, ANAL BIOCHEM, V325, P308, DOI 10.1016/j.ab.2003.10.036; Fuhrer T, 2009, J BACTERIOL, V191, P2112, DOI 10.1128/JB.01523-08; Hahn-Hagerdal B, 2007, APPL MICROBIOL BIOT, V74, P937, DOI 10.1007/s00253-006-0827-2; Jarmuszkiewicz W, 2001, ACTA BIOCHIM POL, V48, P145; Klein CJL, 1998, MICROBIOL-SGM, V144, P13, DOI 10.1099/00221287-144-1-13; Krasowska A, 2010, BIOCHEM BIOPH RES CO, V395, P51, DOI 10.1016/j.bbrc.2010.03.133; Lertwattanasakul N, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0227-x; Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557; Luevano-Martinez LA, 2010, BBA-BIOENERGETICS, V1797, P81, DOI 10.1016/j.bbabio.2009.09.003; Luevano-Martinez LA, 2012, FEBS LETT, V586, P1073, DOI 10.1016/j.febslet.2012.03.009; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Naylor CE, 2001, ACTA CRYSTALLOGR D, V57, P635, DOI 10.1107/S0907444901003420; NEWSHOLME EA, 1984, TRENDS BIOCHEM SCI, V9, P277, DOI 10.1016/0968-0004(84)90165-8; NEWSHOLME EA, 1972, BIOCHEM J, V128, P89, DOI 10.1042/bj1280089; Papagianni M, 2007, BIOTECHNOL ADV, V25, P244, DOI 10.1016/j.biotechadv.2007.01.002; Peksel A, 2002, APPL MICROBIOL BIOT, V58, P157, DOI 10.1007/s00253-001-0839-x; Piper P, 1998, EMBO J, V17, P4257, DOI 10.1093/emboj/17.15.4257; Runquist D, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-49; Saint-Prix F, 2004, MICROBIOL-SGM, V150, P2209, DOI 10.1099/mic.0.26999-0; Schabort DTWP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156242; Schilling CH, 1999, BIOTECHNOL PROGR, V15, P288, DOI 10.1021/bp9900357; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Voet D., 2011, BIOCHEMISTRY	28	0	0	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177319	10.1371/journal.pone.0177319	http://dx.doi.org/10.1371/journal.pone.0177319			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542187	gold, Green Published, Green Submitted			2022-12-26	WOS:000402062800014
J	Boyle, NR; Sengupta, N; Morgan, JA				Boyle, Nanette R.; Sengupta, Neelanjan; Morgan, John A.			Metabolic flux analysis of heterotrophic growth in Chlamydomonas reinhardtii	PLOS ONE			English	Article							MICROALGA CHLORELLA PROTOTHECOIDES; BALANCE ANALYSIS; PHOTOAUTOTROPHIC METABOLISM; CARBON METABOLISM; ESCHERICHIA-COLI; MAPPING MATRICES; AMINO-ACID; NETWORKS; ACETATE; C-13	Despite the wealth of knowledge available for C. reinhardtii, the central metabolic fluxes of growth on acetate have not yet been determined. In this study, C-13-metabolic flux analysis (C-13-MFA) was used to determine and quantify the metabolic pathways of primary metabolism in C. reinhardtii cells grown under heterotrophic conditions with acetate as the sole carbon source. Isotopic labeling patterns of compartment specific biomass derived metabolites were used to calculate the fluxes. It was found that acetate is ligated with coenzyme A in the three subcellular compartments (cytosol, mitochondria and plastid) included in the model. Two citrate synthases were found to potentially be involved in acetyl-coA metabolism; one localized in the mitochondria and the other acting outside the mitochondria. Labeling patterns demonstrate that Acetyl-coA synthesized in the plastid is directly incorporated in synthesis of fatty acids. Despite having a complete TCA cycle in the mitochondria, it was also found that a majority of the malate flux is shuttled to the cytosol and plastid where it is converted to oxaloacetate providing reducing equivalents to these compartments. When compared to predictions by flux balance analysis, fluxes measured with C-13-MFA were found to be suboptimal with respect to biomass yield; C. reinhardtii sacrifices biomass yield to produce ATP and reducing equivalents.	[Boyle, Nanette R.; Sengupta, Neelanjan; Morgan, John A.] Purdue Univ, Sch Chem Engn, W Lafayette, IN 47907 USA; [Boyle, Nanette R.] Colorado Sch Mines, Dept Chem & Biol Engn, Golden, CO 80401 USA; [Sengupta, Neelanjan] Becton Dickinson Adv Bioproc, Cockeysville, MD USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Colorado School of Mines	Boyle, NR (corresponding author), Purdue Univ, Sch Chem Engn, W Lafayette, IN 47907 USA.; Boyle, NR (corresponding author), Colorado Sch Mines, Dept Chem & Biol Engn, Golden, CO 80401 USA.	nboyle@mines.edu	Morgan, John/B-8609-2018	Morgan, John/0000-0002-5326-4988; Sengupta, Neelanjan/0000-0003-4381-9588	National Science Foundation [NSF-MCB-0615700]; National Science Foundation Graduate Research Fellowship; NSF graduate research fellowship	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NSF graduate research fellowship(National Science Foundation (NSF))	National Science Foundation NSF-MCB-0615700 awarded to JAM and supported NS. NRB was supported by National Science Foundation Graduate Research Fellowship.; We would like to thank Dr. M. Spalding of Iowa State University for helpful discussion on the targeting of enzymes. We would also like to acknowledge J. O'Grady of Purdue University for his assistance with the calculation of biomass precursors. Nanette Boyle was supported with a NSF graduate research fellowship; Neelanjan Sengupta and John Morgan were supported by NSF-MCB-0615700.	Allen DK, 2007, PHYTOCHEMISTRY, V68, P2197, DOI 10.1016/j.phytochem.2007.04.010; Alonso AP, 2011, METAB ENG, V13, P96, DOI 10.1016/j.ymben.2010.10.002; Alonso AP, 2007, METAB ENG, V9, P419, DOI 10.1016/j.ymben.2007.06.002; Alonso AP, 2010, METAB ENG, V12, P488, DOI 10.1016/j.ymben.2010.04.002; Antoniewicz MR, 2007, METAB ENG, V9, P277, DOI 10.1016/j.ymben.2007.01.003; Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; Atteia A, 2009, MOL BIOL EVOL, V26, P1533, DOI 10.1093/molbev/msp068; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Beard DA, 2002, BIOPHYS J, V83, P79, DOI 10.1016/S0006-3495(02)75150-3; Blaby IK, 2013, PLANT CELL, V25, P4305, DOI 10.1105/tpc.113.117580; Boyle NR, 2012, J BIOL CHEM, V287, P15811, DOI 10.1074/jbc.M111.334052; Boyle NR, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-4; Chang RL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.52; Chen F, 1996, J APPL PHYCOL, V8, P15, DOI 10.1007/BF02186216; Chen F, 1996, PROCESS BIOCHEM, V31, P601, DOI 10.1016/S0032-9592(96)00006-4; Dal'Molin CGD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S4-S5; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fischer E, 2005, NAT GENET, V37, P636, DOI 10.1038/ng1555; GERHARDT R, 1984, PLANT PHYSIOL, V75, P542, DOI 10.1104/pp.75.3.542; Goodson C, 2011, EUKARYOT CELL, V10, P1592, DOI 10.1128/EC.05242-11; Grafahrend-Belau E, 2009, PLANT PHYSIOL, V149, P585, DOI 10.1104/pp.108.129635; Harris E., 2004, ADV PHOTOSYNTHESIS R, V7, P1; Harris E.H, 2009, INTRO CHLAMYDOMONAS; Hoppe A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-23; Imam S, 2015, PLANT J, V84, P1239, DOI 10.1111/tpj.13059; Iyer VV, 2008, PLANT CELL ENVIRON, V31, P506, DOI 10.1111/j.1365-3040.2008.01781.x; Johnson X, 2013, EUKARYOT CELL, V12, P776, DOI 10.1128/EC.00318-12; Knoop H, 2010, PLANT PHYSIOL; Kropat J, 2011, PLANT J, V66, P770, DOI 10.1111/j.1365-313X.2011.04537.x; Lee DY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-7; Lee JY, 2011, BIOTECHNOL BIOENG, V108, P742, DOI 10.1002/bit.22989; Li YT, 2010, METAB ENG, V12, P387, DOI 10.1016/j.ymben.2010.02.002; MacLeod JK, 2001, J MASS SPECTROM, V36, P500, DOI 10.1002/jms.147; Manichaikul A, 2009, NAT METHODS, V6, P589, DOI [10.1038/NMETH.1348, 10.1038/nmeth.1348]; Masakapalli SK, 2010, PLANT PHYSIOL, V152, P602, DOI 10.1104/pp.109.151316; Matsuda F, 2007, PHYTOCHEMISTRY, V68, P2290, DOI 10.1016/j.phytochem.2007.03.031; May P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-209; Merchant S. S., 2012, CURR OPIN BIOTECH, V23, P1; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Moellering ER, 2010, EUKARYOT CELL, V9, P97, DOI 10.1128/EC.00203-09; Montagud A, 2011, BIOTECHNOL J, V6, P330, DOI 10.1002/biot.201000109; Moroney JV, 2007, EUKARYOT CELL, V6, P1251, DOI 10.1128/EC.00064-07; Muthuraj M, 2013, PHOTOSYNTH RES, V118, P167, DOI 10.1007/s11120-013-9943-x; Petridou S, 1997, PLANT MOL BIOL, V33, P381, DOI 10.1023/A:1005728411921; Poolman MG, 2009, PLANT PHYSIOL, V151, P1570, DOI 10.1104/pp.109.141267; Qian X, 2017, BBA-BIOENERGETICS, V1858, P276, DOI 10.1016/j.bbabio.2016.12.007; RIENS B, 1991, PLANT PHYSIOL, V97, P227, DOI 10.1104/pp.97.1.227; SAMEJIMA H, 1958, J GEN MICROBIOL, V18, P107, DOI 10.1099/00221287-18-1-107; Schmidt K, 1999, J BIOTECHNOL, V71, P175, DOI 10.1016/S0168-1656(99)00021-8; Schmidt K, 1997, BIOTECHNOL BIOENG, V55, P831, DOI 10.1002/(SICI)1097-0290(19970920)55:6<831::AID-BIT2>3.0.CO;2-H; Schwender J, 2003, J BIOL CHEM, V278, P29442, DOI 10.1074/jbc.M303432200; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Selinski J, 2014, MOL PLANT, V7, P170, DOI 10.1093/mp/sst151; Shastri AA, 2005, BIOTECHNOL PROGR, V21, P1617, DOI 10.1021/bp050246d; Shastri AA, 2007, PHYTOCHEMISTRY, V68, P2302, DOI 10.1016/j.phytochem.2007.03.042; Sheehan J, 2009, NAT BIOTECHNOL, V27, P1128, DOI 10.1038/nbt1209-1128; Shlomi T, 2005, P NATL ACAD SCI USA, V102, P7695, DOI 10.1073/pnas.0406346102; Sriram G, 2004, PLANT PHYSIOL, V136, P3043, DOI 10.1104/pp.104.050625; Timmins M, 2009, J BIOL CHEM, V284, P35996, DOI 10.1074/jbc.A109.003541; Vu TT, 2013, BIOTECHNOL J, V8, P619, DOI 10.1002/biot.201200315; Vu TT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002460; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; Wiechert W, 1997, BIOTECHNOL BIOENG, V55, P101, DOI 10.1002/(SICI)1097-0290(19970705)55:1<101::AID-BIT12>3.0.CO;2-P; Wiechert W, 2001, METAB ENG, V3, P265, DOI 10.1006/mben.2001.0188; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; WILLEFORD KO, 1989, PLANT PHYSIOL, V90, P788, DOI 10.1104/pp.90.3.788; Williams TCR, 2010, PLANT PHYSIOL, V154, P311, DOI 10.1104/pp.110.158535; Wu C, 2015, PLANT PHYSIOL, V167, P586, DOI 10.1104/pp.114.250688; Xiong W, 2010, PLANT PHYSIOL, V154, P1001, DOI 10.1104/pp.110.158956; Zhang HM, 2003, BIOCHEM ENG J, V16, P211, DOI 10.1016/S1369-703X(03)00070-6; Zhao J, 2003, J BIOTECHNOL, V101, P101, DOI 10.1016/S0168-1656(02)00316-4; ZUPKE C, 1994, BIOTECHNOL PROGR, V10, P489, DOI 10.1021/bp00029a006; [No title captured]	74	31	32	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177292	10.1371/journal.pone.0177292	http://dx.doi.org/10.1371/journal.pone.0177292			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542252	Green Published, gold, Green Submitted			2022-12-26	WOS:000402061500018
J	Herrera-Carrillo, E; Ben Berkhout				Herrera-Carrillo, Elena; Ben Berkhout			Novel AgoshRNA molecules for silencing of the CCR5 co-receptor for HIV-1 infection	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; SHORT-INTERFERING RNAS; GENE-THERAPY; LENTIVIRAL VECTORS; MAMMALIAN-CELLS; SYSTEMATIC ANALYSIS; T-CELLS; SHRNA; DICER; EXPRESSION	Allogeneic transplantation of blood stem cells from a CCR5-Delta 32 homozygous donor to an HIV-infected individual, the "Berlin patient", led to a cure. Since then there has been a search for approaches that mimic this intervention in a gene therapy setting. RNA interference (RNAi) has evolved as a powerful tool to regulate gene expression in a sequence-specific manner and can be used to inactivate the CCR5 mRNA. Short hairpin RNA (shRNA) mole-cules can impair CCR5 expression, but these molecules may cause unintended side effects and they will not be processed in cells that lack Dicer, such as monocytes. Dicer-independent RNAi pathways have opened opportunities for new AgoshRNA designs that rely exclusively on Ago2 for maturation. Furthermore, AgoshRNA processing yields a single active guide RNA, thus reducing off-target effects. In this study, we tested different AgoshRNA designs against CCR5. We selected AgoshRNAs that potently downregulated CCR5 expression on human T cells and peripheral blood mononuclear cells (PBMC) and that had no apparent adverse effect on T cell development as assessed in a competitive cell growth assay. CCR5 knockdown significantly protected T cells from CCR5 tropic HIV-1 infection.	[Herrera-Carrillo, Elena; Ben Berkhout] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Ben Berkhout (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Lab Expt Virol,Dept Med Microbiol, Amsterdam, Netherlands.	b.berkhout@amc.uva.nl		Herrera Carrillo, Elena/0000-0001-9986-8552	Nederlandse Organisatie voor Wetenschappelijk Onderzoek - Chemische Wetenschappen (NWO-CW); Zorg Onderzoek Nederland - Medische Wetenschappen (ZonMw); Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Chemische Wetenschappen (NWO-CW); Zorg Onderzoek Nederland-Medische Wetenschappen (ZonMw)	Nederlandse Organisatie voor Wetenschappelijk Onderzoek - Chemische Wetenschappen (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); Zorg Onderzoek Nederland - Medische Wetenschappen (ZonMw)(Netherlands Organization for Health Research and Development); Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Chemische Wetenschappen (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); Zorg Onderzoek Nederland-Medische Wetenschappen (ZonMw)(Netherlands Organization for Health Research and Development)	This work was supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Chemische Wetenschappen (NWO-CW, Top Grant) and Zorg Onderzoek Nederland-Medische Wetenschappen (ZonMw, Translational Gene Therapy Grant). We thank Berend Hooibrink for expertise in cell sorting and maintenance of the flow cytometry facility. The authors declare no conflict of interest.; This work was supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek - Chemische Wetenschappen (NWO-CW, Top Grant) and Zorg Onderzoek Nederland - Medische Wetenschappen (ZonMw, Translational Gene Therapy Grant).	An DS, 2007, P NATL ACAD SCI USA, V104, P13110, DOI 10.1073/pnas.0705474104; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Berkhout B, 2014, FUTURE MICROBIOL, V9, P561, DOI 10.2217/fmb.14.5; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Coley W, 2010, J BIOL CHEM, V285, P31930, DOI 10.1074/jbc.M110.101709; Dharmacon, SID CENT; Doms RW, 2000, VIROLOGY, V276, P229, DOI 10.1006/viro.2000.0612; Eekels JJM, 2012, GENE THER, V19, P1058, DOI 10.1038/gt.2011.191; Egerer L, 2015, ADV EXP MED BIOL, V848, P191, DOI 10.1007/978-1-4939-2432-5_10; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Genscript, SIRN SOFTW; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Harwig A, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.19; Herrera-Carrillo E, 2015, GENE THER, V22, P485, DOI 10.1038/gt.2015.11; Herrera-Carrillo E, 2016, NUCL ACIDS RES; Herrera-Carrillo E, 2015, RNA BIOL, V12, P447, DOI 10.1080/15476286.2015.1022024; Herrera-Carrillo E, 2014, RNA, V20, P1410, DOI 10.1261/rna.043950.113; Herrera-Carrillo E, 2014, J VIROL METHODS, V203, P88, DOI 10.1016/j.jviromet.2014.03.021; Hutter G, 2014, NEW ENGL J MED, V371, P2437, DOI 10.1056/NEJMc1412279; Hutter G, 2011, AIDS, V25, P273, DOI 10.1097/QAD.0b013e328340fe28; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Invivogen, SIRN WIZ V3 1; Katlama C, 2013, LANCET, V381, P2109, DOI 10.1016/S0140-6736(13)60104-X; Kedzierska K, 2002, CURR MED CHEM, V9, P1893, DOI 10.2174/0929867023368935; Kiem HP, 2012, CELL STEM CELL, V10, P137, DOI 10.1016/j.stem.2011.12.015; KITANO K, 1990, BLOOD, V76, P1980; Knoepfel Stefanie A, 2012, World J Virol, V1, P79, DOI 10.5501/wjv.v1.i3.79; Kordelas L, 2014, NEW ENGL J MED, V371, P880, DOI 10.1056/NEJMc1405805; Kotsopoulou E, 2000, J VIROL, V74, P4839, DOI 10.1128/JVI.74.10.4839-4852.2000; Li MJ, 2005, METHOD ENZYMOL, V392, P218, DOI 10.1016/S0076-6879(04)92013-7; Liu YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128618; Liu YP, 2013, NUCLEIC ACIDS RES, V41, P3723, DOI 10.1093/nar/gkt036; Liu YP, 2011, METHODS MOL BIOL, V721, P293, DOI 10.1007/978-1-61779-037-9_18; Llibre JM, 2012, ANTIVIR THER, V17, P355, DOI 10.3851/IMP1917; Mcintyre GJ, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-1; Mock U, 2015, NUCLEIC ACIDS RES, V43, P5560, DOI 10.1093/nar/gkv469; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Naito Y, 2004, NUCLEIC ACIDS RES, V32, pW124, DOI 10.1093/nar/gkh442; Pang S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096445; Park YK, 2008, NUCLEIC ACIDS RES, V36, pW97, DOI 10.1093/nar/gkn280; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; Schopman NCT, 2010, ANTIVIR RES, V86, P204, DOI 10.1016/j.antiviral.2010.02.320; Schubert S, 2005, J MOL BIOL, V348, P883, DOI 10.1016/j.jmb.2005.03.011; Seppen J, 2002, J HEPATOL, V36, P459, DOI 10.1016/S0168-8278(01)00308-7; Shimizu S, 2010, BLOOD, V115, P1534, DOI 10.1182/blood-2009-04-215855; Shimizu Saki, 2009, Genet Vaccines Ther, V7, P8, DOI 10.1186/1479-0556-7-8; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Spanevello F, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.24; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Taxman DJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-7; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; ter Brake O, 2008, MOL THER, V16, P557, DOI 10.1038/sj.mt.6300382; ter Brake O, 2006, MOL THER, V14, P883, DOI 10.1016/j.ymthe.2006.07.007; Thermofisher, SYNTH RNAI ANAL; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; USHIJIMA H, 1993, PATHOBIOLOGY, V61, P145, DOI 10.1159/000163783; Weiss RA, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-57; Westerhout EM, 2007, NUCLEIC ACIDS RES, V35, P4322, DOI 10.1093/nar/gkm437; Whitehead, SIRN DES TOOL; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107; Yukl SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003347; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	71	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177935	10.1371/journal.pone.0177935	http://dx.doi.org/10.1371/journal.pone.0177935			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542329	Green Published, Green Submitted, gold			2022-12-26	WOS:000402061500045
J	Li, WJ; Xu, ST; Zhang, B; Zhu, YL; Hua, Y; Kong, X; Sun, LH; Hong, J				Li, Wenjie; Xu, Shouteng; Zhang, Biao; Zhu, Yelin; Hua, Yan; Kong, Xin; Sun, Lianhong; Hong, Jiong			Directed evolution to improve the catalytic efficiency of urate oxidase from Bacillus subtilis	PLOS ONE			English	Article							ASPERGILLUS-FLAVUS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; URICASE GENE; SP TB-90; HYPERURICEMIA; EXPRESSION; PURIFICATION; RASBURICASE; RESOLUTION	Urate oxidase is a key enzyme in purine metabolism and catalyzes the oxidation of uric acid to allantoin. It is used to treat hyperuricemia and gout, and also in a diagnostic kit. In this study, error-prone polymerase chain reaction and staggered extension process was used to generate a mutant urate oxidase with improved enzyme activity from Bacillus subtilis. After several rounds of mutagenesis and screening, two mutants 6E9 and 8E279 were obtained which exhibited 2.99 and 3.43 times higher catalytic efficiency, respectively. They also exhibited lower optimal reaction temperature and higher thermo-stability. D44V, Q268R and K285Q were identified as the three most beneficial amino acid substitutions introduced by site-directed mutagenesis. D44V/Q268R, which was obtained through random combination of the three mutants, displayed the highest catalytic activity. The Km, kcat/Km and enzyme activity of D44V/Q268R increased by 68%, 83% and 129% respectively, compared with that of wild-type urate oxidase. Structural modeling indicated that mutations far from the active site can have significant effects on activity. For many of them, the underlying mechanisms are still difficult to explain from the static structural model. We also compared the effects of the same set of single point mutations on the wild type and on the final mutant. The results indicate strong effects of epistasis, which may imply that the mutations affect catalysis through influences on protein dynamics besides equilibrium structures.	[Li, Wenjie; Xu, Shouteng; Zhang, Biao; Zhu, Yelin; Hua, Yan; Kong, Xin; Sun, Lianhong; Hong, Jiong] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Hong, J (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China.	hjiong@ustc.edu.cn	HONG, Jiong/N-1996-2013	HONG, Jiong/0000-0002-4592-7083; Kong, Xin/0000-0002-3734-2763	National Natural Science Foundation of China [31570082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China [31570082] (JH) http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balci H, 2014, APPL MICROBIOL BIOT, V98, P4467, DOI 10.1007/s00253-013-5476-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CADWELL RC, 1994, PCR METH APPL, V3, pS136; Campbell E, 2016, NAT CHEM BIOL, V12, P944, DOI [10.1038/NCHEMBIO.2175, 10.1038/nchembio.2175]; Chen ZY, 2008, APPL MICROBIOL BIOT, V79, P545, DOI 10.1007/s00253-008-1472-8; Colloch N, 1997, NAT STRUCT BIOL, V4, P947, DOI 10.1038/nsb1197-947; Dabbagh F, 2016, CURR PHARM BIOTECHNO, V17, P141, DOI 10.2174/1389201016666150907113055; Fan YH, 2007, APPL MICROBIOL BIOT, V76, P135, DOI 10.1007/s00253-007-0996-7; Feng J, 2015, APPL MICROBIOL BIOT, V99, P7973, DOI 10.1007/s00253-015-6520-6; Gabison L, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-32; Goldman SC, 2001, BLOOD, V97, P2998, DOI 10.1182/blood.V97.10.2998; Hibi T, 2016, BIOCHEMISTRY-US, V55, P724, DOI 10.1021/acs.biochem.5b01119; Jeha S, 2005, LEUKEMIA, V19, P34, DOI 10.1038/sj.leu.2403566; LEGOUX R, 1992, J BIOL CHEM, V267, P8565; Li JM, 2006, PROTEIN EXPRES PURIF, V49, P55, DOI 10.1016/j.pep.2006.02.003; Liu XJ, 2011, APPL MICROBIOL BIOT, V92, P529, DOI 10.1007/s00253-011-3244-0; Liu ZX, 2009, PHYS CHEM CHEM PHYS, V11, P333, DOI 10.1039/b811496j; Oda M, 2002, MOL BIOL EVOL, V19, P640, DOI 10.1093/oxfordjournals.molbev.a004123; Oue S, 1999, J BIOL CHEM, V274, P2344, DOI 10.1074/jbc.274.4.2344; Pfrimer P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/674908; Pui CH, 1997, LEUKEMIA, V11, P1813, DOI 10.1038/sj.leu.2400850; Pui CH, 2001, SEMIN HEMATOL, V38, P13, DOI 10.1053/shem.2001.29018; Retailleau P, 2004, ACTA CRYSTALLOGR D, V60, P453, DOI 10.1107/S0907444903029718; Shaaban MI, 2015, J MICROBIOL BIOTECHN, V25, P887, DOI 10.4014/jmb.1410.10041; van der Veen BA, 2004, FEBS LETT, V560, P91, DOI 10.1016/S0014-5793(04)00077-8; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854; Xu H-f, 2009, BIOCATAL BIOTRANSFOR, V21, P41; Yamamoto K, 1996, J BIOCHEM-TOKYO, V119, P80; Zhao HM, 1998, NAT BIOTECHNOL, V16, P258, DOI 10.1038/nbt0398-258; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhou SH, 2016, APPL MICROBIOL BIOT, V100, P10443, DOI 10.1007/s00253-016-7672-8; Zhu L, 2016, APPL MICROBIOL BIOT, V100, P5805, DOI 10.1007/s00253-016-7371-5	33	15	15	8	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177877	10.1371/journal.pone.0177877	http://dx.doi.org/10.1371/journal.pone.0177877			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531234	Green Submitted, Green Published, gold			2022-12-26	WOS:000402058400034
J	Zhang, LF; Cheng, XH; Bian, SN; Song, YH; Li, Q; Gao, MQ; Zhang, YQ; Shi, XC; Liu, XQ				Zhang, Lifan; Cheng, Xinhe; Bian, Sainan; Song, Yanhua; Li, Qiang; Gao, Mengqiu; Zhang, Yueqiu; Shi, Xiaochun; Liu, Xiaoqing			Utility of Th1-cell immune responses for distinguishing active tuberculosis from non-active tuberculosis: A case-control study	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; LATENT TUBERCULOSIS; DIAGNOSIS; INFECTION; METAANALYSIS; CELLS	Currently available Interferon-gamma release assay (IGRA) cannot reliably differentiate active TB (ATB) from non-active TB (non-ATB). A study was performed to evaluate the value of Mycobacterium tuberculosis (MTB) specific Th1 cell immune responses which test IFN-gamma and IL-2 simultaneous for differentiating ATB from non-ATB. Forty-nine newly diagnosed inpatients with ATB (26 pulmonary TB and 23 extrapulmonary TB) were enrolled as the ATB group. Forty-five volunteers with latent tuberculosis infection (LTBI) and twenty with evidence of previous TB were enrolled during the same period as the non-ATB group. Clinical examination and MTB specific Th1 cell immune responses were performed for all participants. After being stimulated with ESAT-6 and CFP-10, the median frequencies of single IL-2-, single IFN-gamma-, and dual IFN-gamma/ IL-2-secreting T-cells were all higher in the ATB group than in the non-ATB group (20(8-45) vs. 7(3-13), P<0.001; 131(44-308) vs. 10(6-27), P<0.001; 25(9- 74) vs. 7(3-23), P = 0.001, respectively). Evaluation of the diagnostic performance of detecting single IFN-gamma-secreting T cells for pulmonary TB employed a cutoff value of 35 iSFCs/ 250,000 PBMC. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (PLR), and negative likelihood ratio (NLR) were 92.3%, 80.0%, 64.9%, 96.3%, 4.62, and 0.10, respectively. For extrapulmonary TB, using a cutoff value of 23 iSFCs/ 250,000 PBMC, the sensitivity, specificity, PPV, NPV, PLR, and NLR were 91.3%, 76.9%, 58.3%, 96.2%, 3.96, and 0.11, respectively. When combining frequencies and proportion of single IFN-gamma-secreting T cells, the test sensitivity was 100% in parallel tests and the specificity was 87.7% in serial tests for pulmonary TB. MTB specific Th1 cell immune responses (FluoroSpot) had value for the differentiation of ATB and non-ATB. Further confirmatory studies are indicated.	[Zhang, Lifan; Cheng, Xinhe; Bian, Sainan; Zhang, Yueqiu; Shi, Xiaochun; Liu, Xiaoqing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Div Infect Dis, Beijing, Peoples R China; [Zhang, Lifan; Cheng, Xinhe; Bian, Sainan; Zhang, Yueqiu; Shi, Xiaochun; Liu, Xiaoqing] Peking Union Med Coll, Beijing, Peoples R China; [Zhang, Lifan; Liu, Xiaoqing] Chinese Acad Med Sci, Clin Epidemiol Unit, Int Epidemiol Network, Peking Union Med Coll Hosp, Beijing, Peoples R China; [Zhang, Lifan; Shi, Xiaochun; Liu, Xiaoqing] Chinese Acad Med Sci, Ctr TB Res, Beijing, Peoples R China; [Song, Yanhua; Li, Qiang; Gao, Mengqiu] Capital Med Univ, TB Dept, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Capital Medical University	Liu, XQ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Div Infect Dis, Beijing, Peoples R China.; Liu, XQ (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.; Liu, XQ (corresponding author), Chinese Acad Med Sci, Clin Epidemiol Unit, Int Epidemiol Network, Peking Union Med Coll Hosp, Beijing, Peoples R China.; Liu, XQ (corresponding author), Chinese Acad Med Sci, Ctr TB Res, Beijing, Peoples R China.	liuxq@pumch.cn			Beijing Municipal Science and Technology Commission [Z111107058811105]; Ministry of Science and Technology of the People's Republic of China [2014ZX10003003]; Chinese Academy of Medical Sciences (CAMS) Fund for Tuberculosis Research [2016ZX310183-4]; National Health and Family Planning Commission of the People's Republic of China [201402001]; Chinese Academy of Medical Sciences Initiative for Innovative Medicine [2016-I2M-1-013]	Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Chinese Academy of Medical Sciences (CAMS) Fund for Tuberculosis Research; National Health and Family Planning Commission of the People's Republic of China; Chinese Academy of Medical Sciences Initiative for Innovative Medicine	This work was supported by Beijing Municipal Science and Technology Commission (grant number Z111107058811105, http://www.bjkw.gov.cn/); Ministry of Science and Technology of the Peoples Republic of China (grant number 2014ZX10003003, http://www.most.gov.cn/); Chinese Academy of Medical Sciences (CAMS) Fund for Tuberculosis Research (grant number 2016ZX310183-4, http://www.pumc.edu.cn/); National Health and Family Planning Commission of the People's Republic of China (grant number 201402001, http://www.nhfpc.gov.cn/); and Chinese Academy of Medical Sciences Initiative for Innovative Medicine (grant number 2016-I2M-1-013, http://www.cams.ac.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal AN, 2015, J CLIN MICROBIOL, V53, P2451, DOI 10.1128/JCM.00823-15; Biselli R, 2010, CLIN MICROBIOL INFEC, V16, P1282, DOI 10.1111/j.1469-0691.2009.03104.x; Bittel P, 2014, INFECTION, V42, P539, DOI 10.1007/s15010-014-0588-2; Casey R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015619; Chee CBE, 2009, EUR J CLIN MICROBIOL, V28, P667, DOI 10.1007/s10096-008-0670-8; Chesov D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120006; Essone PN, 2014, RESPIRATION, V88, P251, DOI 10.1159/000365816; Gao L, 2015, LANCET INFECT DIS, V15, P310, DOI 10.1016/S1473-3099(14)71085-0; Janssens JP, 2007, EUR RESPIR J, V30, P722, DOI 10.1183/09031936.00028507; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Liu XQ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005200; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Ruan QL, 2016, CLIN RHEUMATOL, V35, P417, DOI 10.1007/s10067-014-2817-6; Sargentini V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-99; WANG L X, 2012, CHIN J ANTITUBERC, V34, P485; World Health Organization, 2015, GLOB TUB REP 2015; Zhang L, 2014, PLOS ONE, V9	19	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177850	10.1371/journal.pone.0177850	http://dx.doi.org/10.1371/journal.pone.0177850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531231	Green Submitted, gold, Green Published			2022-12-26	WOS:000402058400031
J	Parikh, A; Rizzo, JA; Canetta, P; Forster, C; Sise, M; Maarouf, O; Singer, E; Elger, A; Elitok, S; Schmidt-Ott, K; Barasch, J; Nickolas, TL				Parikh, Amay; Rizzo, John A.; Canetta, Pietro; Forster, Catherine; Sise, Meghan; Maarouf, Omar; Singer, Eugenia; Elger, Antje; Elitok, Saban; Schmidt-Ott, Kai; Barasch, Jonathon; Nickolas, Thomas L.			Does NGAL reduce costs? A cost analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) diagnosis	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; GELATINASE-ASSOCIATED LIPOCALIN; PROGNOSTIC STRATIFICATION; MORTALITY; BIOMARKERS; MODELS; PREDICTION; DIALYSIS; THERAPY	Introduction Urine neutrophil gelatinase-associated lipocalin (uNGAL) is a sensitive and specific diagnostic test for acute kidney injury (AKI) in the Emergency Department (ED), but its economic impact has not been investigated. We hypothesized that uNGAL used in combination with serum creatinine (sCr) would reduce costs in the management of AKI in patients presenting to the ED in comparison to using sCr alone. Materials and methods A cost simulation model was developed for clinical algorithms to diagnose AKI based on sCr alone vs. uNGAL plus sCr (uNGAL+sCr). A cost minimization analysis was performed to determine total expected costs for patients with AKI. uNGAL test characteristics were validated with eight-hundred forty-nine patients with sCr >= 1.5 from a completed study of 1635 patients recruited from EDs at two U.S. hospitals from 2007-8. Biomarker test, AKI work-up, and diagnostic imaging costs were incorporated. Results For a hypothetical cohort of 10,000 patients, the model predicted that the expected costs were $900 per patient (pp) in the sCr arm and $950 in the uNGAL+sCr arm. uNGAL+sCr resulted in 1,578 fewer patients with delayed diagnosis and treatment than sCr alone (2,013 vs. 436 pts) at center 1 and 1,973 fewer patients with delayed diagnosis and treatment than sCr alone at center 2 (2,227 vs. 254 patients). Although initial evaluation costs at each center were $50 pp higher in with uNGAL+sCr, total costs declined by $408 pp at Center 1 and by $522 pp at Center 2 due to expected reduced delays in diagnosis and treatment. Sensitivity analyses confirmed savings with uNGAL + sCr for a range of cost inputs. Discussion Using uNGAL with sCr as a clinical diagnostic test for AKI may improve patient management and reduce expected costs. Any cost savings would likely result from avoiding delays in diagnosis and treatment and from avoidance of unnecessary testing in patients given a false positive AKI diagnosis by use of sCr alone.	[Parikh, Amay; Canetta, Pietro; Forster, Catherine; Sise, Meghan; Barasch, Jonathon; Nickolas, Thomas L.] Columbia Univ, Med Ctr, New York, NY 10027 USA; [Rizzo, John A.] SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; [Rizzo, John A.] SUNY Stony Brook, Dept Econ, Stony Brook, NY 11794 USA; [Maarouf, Omar] Staten Isl Univ Hosp, Staten Isl, NY USA; [Singer, Eugenia; Elger, Antje; Elitok, Saban; Schmidt-Ott, Kai] Charite, Helios Clin Berlin, Max Delbruck Ctr Mol Med, Berlin, Germany	Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Northwell Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Parikh, A (corresponding author), Columbia Univ, Med Ctr, New York, NY 10027 USA.	amaypmd@gmail.edu	Parikh, Amay/G-6904-2016; Schmidt-Ott, Kai/F-4588-2011	Schmidt-Ott, Kai/0000-0002-7700-7142; Canetta, Pietro/0000-0003-1130-5486; Parikh, Amay/0000-0002-7332-0625; Forster, Catherine/0000-0002-6233-1070				[Anonymous], 2010, CLIN LAB FEE SCHED; Arora P, 1999, J AM SOC NEPHROL, V10, P1281; Bedford M., 2016, DEV RISK MODELS PRED; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bellomo R, 2006, CURR OPIN CRIT CARE, V12, P557, DOI 10.1097/01.ccx.0000247443.86628.68; Brown JR, 2016, AM J NEPHROL, V43, P261, DOI 10.1159/000445846; Chertow GM, 2006, KIDNEY INT, V70, P1120, DOI 10.1038/sj.ki.5001579; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Fischer MJ, 2005, AM J KIDNEY DIS, V46, P1049, DOI 10.1053/j.ajkd.2005.09.006; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; HOU SH, 1983, AM J MED, V74, P243, DOI 10.1016/0002-9343(83)90618-6; Kate RJ, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0277-4; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2000, NEPHROL DIAL TRANSPL, V15, P8, DOI 10.1093/oxfordjournals.ndt.a027977; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; Nickolas TL, 2008, ANN INTERN MED, V148, P810, DOI 10.7326/0003-4819-148-11-200806030-00003; Nickolas TL, 2008, CURR OPIN NEPHROL HY, V17, P127, DOI 10.1097/MNH.0b013e3282f4e525; Nickolas TL, 2012, J AM COLL CARDIOL, V59, P246, DOI 10.1016/j.jacc.2011.10.854; Nickolas TL, 2010, COMP URINAR IN PRESS; Obrador GT, 1998, AM J KIDNEY DIS, V31, P398, DOI 10.1053/ajkd.1998.v31.pm9506677; Parikh CR, 2006, AM J TRANSPLANT, V6, P1639, DOI 10.1111/j.1600-6143.2006.01352.x; Pronovost PJ, 2006, CRIT CARE MED, V34, pS18, DOI 10.1097/01.CCM.0000208369.12812.92; Shapiro NI, 2010, ANN EMERG MED, V56, P52, DOI 10.1016/j.annemergmed.2010.02.010; SHUSTERMAN N, 1987, AM J MED, V83, P65, DOI 10.1016/0002-9343(87)90498-0; Siew ED, 2009, J AM SOC NEPHROL, V20, P1823, DOI 10.1681/ASN.2008070673; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F; Wagener G, 2008, AM J KIDNEY DIS, V52, P425, DOI 10.1053/j.ajkd.2008.05.018; Wang L, 2008, NEPHRON CLIN PRACT, V108, pC176, DOI 10.1159/000117814; Wavamunno MD, 2005, KIDNEY INT, V67, pS128, DOI 10.1111/j.1523-1755.2005.09429.x; Ympa YP, 2005, AM J MED, V118, P827, DOI 10.1016/j.amjmed.2005.01.069; Zwang O, 2006, J HOSP MED, V1, P272, DOI 10.1002/jhm.115	34	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178091	10.1371/journal.pone.0178091	http://dx.doi.org/10.1371/journal.pone.0178091			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542336	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000401672600045
J	Zemanova, V; Pavlik, M; Pavlikova, D				Zemanova, Veronika; Pavlik, Milan; Pavlikova, Daniela			Cadmium toxicity induced contrasting patterns of concentrations of free sarcosine, specific amino acids and selected microelements in two Noccaea species	PLOS ONE			English	Article							ADENOSYL-L-METHIONINE; ABIOTIC STRESS; GLYCINE BETAINE; ALANINE AMINOTRANSFERASE; PLANT-RESPONSES; SOLANUM TORVUM; ACTIVE-SITE; CAERULESCENS; ARABIDOPSIS; METABOLISM	Cadmium (Cd) toxicity affects numerous metabolic processes in plants. In the presence of Cd, plants accumulate specific amino acids which may be beneficial to developing Cd tolerance. Our study aimed to characterize the changes in the metabolism of selected free amino acids that are associated with Cd tolerance, and investigate the levels of selected microelements in order to relate these changes to the adaptation strategies of two metallophytes-Noccaea caerulescens (Redlschlag, Austria) and Noccaea praecox (Mezica, Slovenia). The plants were exposed to Cd contamination (90 mg Cd/kg soil) for 120 days in a pot experiment. Our results showed higher Cd accumulation in N. praecox compared to N. caerulescens. Cadmium contamination reduced the zinc and nickel levels in both species and a mixed effect was determined for copper and manganese content. Differences in free amino acid metabolism were observed between the two metallophytes growing under Cd-free and Cd-loaded conditions. Under Cd-free conditions, aromatic amino acids (phenylalanine, tryptophan and tyrosine) and branched-chain amino acids (leucine, isoleucine and valine) were accumulated more in the leaves of N. praecox than in N. caerulescens. Cd stress increased the content of these amino acids in both species but this increase was significant only in N. caerulescens leaves. Marked differences in the responses of the two species to Cd stress were shown for alanine, phenylalanine, threonine and sarcosine. Cadmium contamination also induced an increase of threonine as alanine and sarcosine decrease, which was larger in N. caerulescens than in N. praecox. All these factors contribute to the higher adaptation of N. praecox to Cd stress.	[Zemanova, Veronika; Pavlik, Milan] Acad Sci Czech Republ, Inst Expt Bot, Isotope Lab, Prague, Czech Republic; [Pavlikova, Daniela] Czech Univ Life Sci, Dept Agroenvironm Chem & Plant Nutr, Fac Agrobiol Food & Nat Resources, Prague, Czech Republic	Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Czech University of Life Sciences Prague	Zemanova, V (corresponding author), Acad Sci Czech Republ, Inst Expt Bot, Isotope Lab, Prague, Czech Republic.; Pavlikova, D (corresponding author), Czech Univ Life Sci, Dept Agroenvironm Chem & Plant Nutr, Fac Agrobiol Food & Nat Resources, Prague, Czech Republic.	veronika.zemanova@biomed.cas.cz; pavlikova@af.czu.cz	Pavlíková, Daniela/V-4971-2018; Pavlík, Milan/G-7052-2014; Zemanová, Veronika/ADF-4648-2022; Zemanova, Veronika/I-2171-2018	Pavlíková, Daniela/0000-0003-3341-5053; Pavlík, Milan/0000-0003-4209-9937; Zemanova, Veronika/0000-0001-7115-8348	Czech University of Life Sciences - CIGA [20142004]; CIGA (Czech University of Life Sciences Prague) [20142004]	Czech University of Life Sciences - CIGA; CIGA (Czech University of Life Sciences Prague)	This research was supported by Czech University of Life Sciences - CIGA project No. 20142004. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by CIGA project No. 20142004 (Czech University of Life Sciences Prague).	Araujo WL, 2010, PLANT CELL, V22, P1549, DOI 10.1105/tpc.110.075630; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Bor M, 2009, ACTA PHYSIOL PLANT, V31, P655, DOI 10.1007/s11738-008-0255-2; Cakmak I, 2000, NEW PHYTOL, V146, P185, DOI 10.1046/j.1469-8137.2000.00630.x; Cosgrove DJ, 1999, ANNU REV PLANT PHYS, V50, P391, DOI 10.1146/annurev.arplant.50.1.391; DalCorso G, 2008, J INTEGR PLANT BIOL, V50, P1268, DOI 10.1111/j.1744-7909.2008.00737.x; Das ZA, 2016, ENVIRON EXP BOT, V122, P78, DOI 10.1016/j.envexpbot.2015.09.006; DITOPPI LS, 1999, ENV EXP BOT, V41; Egleston ES, 2008, LIMNOL OCEANOGR, V53, P2462, DOI 10.4319/lo.2008.53.6.2462; Fernandez-Ocana A, 2011, J PLANT PHYSIOL, V168, P1303, DOI 10.1016/j.jplph.2011.01.020; Field LS, 2002, J BIOENERG BIOMEMBR, V34, P373, DOI 10.1023/A:1021202119942; Garg R, 2015, PLANT MOL BIOL REP, V33, P388, DOI 10.1007/s11105-014-0753-x; Gonneau C, 2014, PLANT SOIL, V384, P271, DOI 10.1007/s11104-014-2208-4; Gosar M, 2011, APPL GEOCHEM, V26, P1855, DOI 10.1016/j.apgeochem.2011.06.009; He YH, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/471429; Hernandez LE, 1997, J EXP BOT, V48, P1375, DOI 10.1093/jxb/48.7.1375; Hjorth M, 2006, PESTIC BIOCHEM PHYS, V86, P138, DOI 10.1016/j.pestbp.2006.02.006; Ibrahim RK, 1998, PLANT MOL BIOL, V36, P1, DOI 10.1023/A:1005939803300; Jiang JS, 2016, PLANT SCI, V249, P93, DOI 10.1016/j.plantsci.2016.05.004; Jin SX, 2014, PLANT BIOTECHNOL J, V12, P1274, DOI 10.1111/pbi.12224; Joshi V, 2010, AMINO ACIDS, V39, P933, DOI 10.1007/s00726-010-0505-7; Kinnersley AM, 2000, CRIT REV PLANT SCI, V19, P479, DOI 10.1016/S0735-2689(01)80006-X; Komatsu S, 2009, AMINO ACIDS, V36, P137, DOI 10.1007/s00726-008-0043-8; Kramer U, 1996, NATURE, V379, P635, DOI 10.1038/379635a0; Krishnakumar RV, 1996, CRYST RES TECHNOL, V31, P203, DOI 10.1002/crat.2170310214; Li YT, 2003, CHEM COMMUN, P2884, DOI 10.1039/b310543a; Limami AM, 2008, J EXP BOT, V59, P2325, DOI 10.1093/jxb/ern102; Liu GS, 2010, PLANT CELL, V22, P3845, DOI 10.1105/tpc.110.079392; Liu XL, 2011, ECOTOXICOLOGY, V20, P1422, DOI 10.1007/s10646-011-0699-9; Martin S, 2012, BIOL PLANTARUM, V56, P729, DOI 10.1007/s10535-012-0056-8; Miyashita Y, 2007, PLANT J, V49, P1108, DOI 10.1111/j.1365-313X.2006.03023.x; Moffatt BA, 2001, PHYSIOL PLANTARUM, V113, P435, DOI 10.1034/j.1399-3054.2001.1130401.x; Mori T, 2013, BIOCHEM J, V455, P339, DOI 10.1042/BJ20130597; Mustafiz A, 2014, PLANT J, V78, P951, DOI 10.1111/tpj.12521; Mustafiz A, 2010, METHODS MOL BIOL, V639, P95, DOI 10.1007/978-1-60761-702-0_6; Nikiforova VJ, 2006, AMINO ACIDS, V30, P173, DOI 10.1007/s00726-005-0251-4; Niu XL, 2014, ENVIRON EXP BOT, V104, P16, DOI 10.1016/j.envexpbot.2014.03.003; Nuccio ML, 1998, PLANT J, V16, P487, DOI 10.1046/j.1365-313x.1998.00316.x; Oda A, 2005, PHYSIOL PLANTARUM, V124, P515, DOI 10.1111/j.1399-3054.2005.00528.x; Pavlik M, 2017, J PLANT PHYSIOL, V208, P94, DOI 10.1016/j.jplph.2016.09.014; Pavlik M, 2012, ECOTOX ENVIRON SAFE, V79, P101, DOI 10.1016/j.ecoenv.2011.12.009; Pavlik M, 2010, ECOTOX ENVIRON SAFE, V73, P1309, DOI 10.1016/j.ecoenv.2010.07.008; Pavlikova D, 2008, ECOTOX ENVIRON SAFE, V70, P223, DOI 10.1016/j.ecoenv.2007.07.006; Pavlikova D, 2014, J PLANT PHYSIOL, V171, P559, DOI 10.1016/j.jplph.2013.11.016; Pavlikova D, 2014, ECOTOX ENVIRON SAFE, V100, P166, DOI 10.1016/j.ecoenv.2013.10.028; Planchais S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00330; Polacco JC, 2013, PLANT SCI, V199, P79, DOI 10.1016/j.plantsci.2012.10.010; Popko J, 2010, PLANT BIOLOGY, V12, P242, DOI 10.1111/j.1438-8677.2009.00305.x; Puschenreiter M, 2005, PLANT SOIL, V271, P205, DOI 10.1007/s11104-004-2387-5; Reeves RD, 2001, INT J PHYTOREMEDIAT, V3, P145, DOI 10.1080/15226510108500054; Rice Evans CA, 1996, FREE RADIC BIOL MED, V20, P933, DOI DOI 10.1016/0891-5849(95)02227-9; Rocha M, 2010, PLANT PHYSIOL, V152, P1501, DOI 10.1104/pp.109.150045; Roje S, 2006, PHYTOCHEMISTRY, V67, P1686, DOI 10.1016/j.phytochem.2006.04.019; Sanjaya, 2008, PLANT CELL ENVIRON, V31, P1074, DOI 10.1111/j.1365-3040.2008.01819.x; Seher Y, 2013, PLANT SYST EVOL, V299, P403, DOI [10.1007/s00606-012-0730-5, 10.1007/s00606-]; Shah K, 2001, PLANT SCI, V161, P1135, DOI 10.1016/S0168-9452(01)00517-9; Signorelli S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115349; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Tamas L, 2015, J PLANT PHYSIOL, V173, P1, DOI 10.1016/j.jplph.2014.08.018; TAYLOR A, 1993, FASEB J, V7, P290, DOI 10.1096/fasebj.7.2.8440407; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Tewari BB, 2012, J CHIL CHEM SOC, V57, P995, DOI 10.4067/S0717-97072012000100009; Thornalley PJ, 1998, CHEM-BIOL INTERACT, V112, P137, DOI 10.1016/S0009-2797(97)00157-9; Turkel N, 2015, BIOINORG CHEM APPL, V2015, DOI 10.1155/2015/374782; Tzin Vered, 2010, Arabidopsis Book, V8, pe0132, DOI 10.1199/tab.0132; Verbruggen N, 2009, CURR OPIN PLANT BIOL, V12, P364, DOI 10.1016/j.pbi.2009.05.001; Visioli G, 2014, ENVIRON EXP BOT, V105, P10, DOI 10.1016/j.envexpbot.2014.04.001; Vogel-Mikus K, 2008, NEW PHYTOL, V179, P712, DOI 10.1111/j.1469-8137.2008.02519.x; Whittaker JW, 2002, INT J QUANTUM CHEM, V90, P1529, DOI 10.1002/qua.10422; Witt S, 2012, MOL PLANT, V5, P401, DOI 10.1093/mp/ssr102; Witte CP, 2011, PLANT SCI, V180, P431, DOI 10.1016/j.plantsci.2010.11.010; Xie Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115279; Xu J, 2012, NEW PHYTOL, V196, P125, DOI 10.1111/j.1469-8137.2012.04236.x; Xu J, 2012, NEW PHYTOL, V196, P110, DOI 10.1111/j.1469-8137.2012.04235.x; Yamaguchi M, 2010, PLANT CELL ENVIRON, V33, P223, DOI 10.1111/j.1365-3040.2009.02073.x; YANG WJ, 1995, PLANT PHYSIOL, V107, P621, DOI 10.1104/pp.107.2.621; Yoo H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3833; Zarubova P, 2015, ENVIRON SCI POLLUT R, V22, P18801, DOI 10.1007/s11356-015-5043-0; Zemanova V, 2014, PLANT SOIL ENVIRON, V60, P426, DOI 10.17221/544/2014-PSE; Zemanova V, 2016, ARCH ENVIRON CON TOX, V70, P464, DOI 10.1007/s00244-015-0198-8; Zemanova V, 2015, J PLANT PHYSIOL, V180, P27, DOI 10.1016/j.jplph.2015.02.012; Zoghlami LB, 2011, AFR J BIOTECHNOL, V10, P567	82	33	34	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177963	10.1371/journal.pone.0177963	http://dx.doi.org/10.1371/journal.pone.0177963			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542385	Green Submitted, Green Published, gold			2022-12-26	WOS:000401672600035
J	de la Tour, CB; Mathieu, M; Meyer, L; Dupaigne, P; Passot, F; Servant, P; Sommer, S; Le Cam, E; Confalonieri, F				de la Tour, Claire Bouthier; Mathieu, Martine; Meyer, Laura; Dupaigne, Pauline; Passot, Fanny; Servant, Pascale; Sommer, Suzanne; Le Cam, Eric; Confalonieri, Fabrice			In vivo and in vitro characterization of DdrC, a DNA damage response protein in Deinococcus radiodurans bacterium	PLOS ONE			English	Article							STRAND BREAK REPAIR; IONIZING-RADIATION; PPRA PROTEIN; RESISTANCE; RADIORESISTANCE; RECOMBINATION; REPLICATION; PERSPECTIVE; ACCURATE; GENOME	The bacterium Deinococcus radiodurans possesses a set of Deinococcus-specific genes highly induced after DNA damage. Among them, ddrC (dr0003) was recently re-annotated, found to be in the inverse orientation and called A2G07_00380. Here, we report the first in vivo and in vitro characterization of the corrected DdrC protein to better understand its function in irradiated cells. In vivo, the Delta ddrC null mutant is sensitive to high doses of UV radiation and the ddrC deletion significantly increases UV-sensitivity of Delta uvrA or Delta uvsE mutant strains. We show that the expression of the DdrC protein is induced after gamma-irradiation and is under the control of the regulators, DdrO and IrrE. DdrC is rapidly recruited into the nucleoid of the irradiated cells. In vitro, we show that DdrC is able to bind single-and double-stranded DNA with a preference for the single-stranded DNA but without sequence or shape specificity and protects DNA from various nuclease attacks. DdrC also condenses DNA and promotes circularization of linear DNA. Finally, we show that the purified protein exhibits a DNA strand annealing activity. Altogether, our results suggest that DdrC is a new DNA binding protein with pleiotropic activities. It might maintain the damaged DNA fragments end to end, thus limiting their dispersion and extensive degradation after exposure to ionizing radiation. DdrC might also be an accessory protein that participates in a single strand annealing pathway whose importance in DNA repair becomes apparent when DNA is heavily damaged.	[de la Tour, Claire Bouthier; Mathieu, Martine; Meyer, Laura; Passot, Fanny; Servant, Pascale; Sommer, Suzanne; Confalonieri, Fabrice] Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France; [Dupaigne, Pauline; Le Cam, Eric] Univ Paris Saclay, Univ Paris Sud, CNRS, Signalisat Noyaux & Innovat Cancerol,UMR 8126, 114 Rue E Vaillant, Villejuif, France; [Passot, Fanny] Lund Univ, Mol Cell Biol unit, Biol Dept, Lund, Sweden	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Lund University	de la Tour, CB (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France.	claire.bouthier@i2bc.paris-saclay.fr	Dupaigne, Pauline/C-6873-2019; Servant, pascale/V-9016-2017	Le cam, Eric/0000-0002-6832-6117; Passot, Fanny/0000-0002-0257-816X; Dupaigne, Pauline/0000-0001-7033-4055	Centre National de la Recherche Scientifique; University Paris-Sud, Electricite de France [RB2017-02]; Agence Nationale de la Recherche [ANR-12-BSV8-0012]; foundation ARC [SLS220120605310]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University Paris-Sud, Electricite de France; Agence Nationale de la Recherche(French National Research Agency (ANR)); foundation ARC	This work was supported by the Centre National de la Recherche Scientifique, the University Paris-Sud, Electricite de France (RB2017-02 to FC), the Agence Nationale de la Recherche (ANR-12-BSV8-0012 to ELC) and the foundation ARC (program SLS220120605310 to ELC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Confalonieri F, 2011, J PHYS CONF SER, V261, DOI 10.1088/1742-6596/261/1/012005; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; de Groot A, 2014, GENOME BIOL EVOL, V6, P932, DOI 10.1093/gbe/evu069; de Groot A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000434; de la Tour CB, 2011, DNA REPAIR, V10, P1223, DOI 10.1016/j.dnarep.2011.09.010; de la Tour CB, 2009, EXTREMOPHILES, V13, P827, DOI 10.1007/s00792-009-0270-2; Devigne A, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00036-15; Devigne A, 2015, MOL MICROBIOL, V96, P1069, DOI 10.1111/mmi.12991; Devigne A, 2013, DNA REPAIR, V12, P265, DOI 10.1016/j.dnarep.2013.01.004; Hamon L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm147; Harris DR, 2004, PLOS BIOL, V2, P1629, DOI 10.1371/journal.pbio.0020304; Hua X, 2016, GENOME ANNOUNC, V4; Ishino Y, 2015, CURR OPIN MICROBIOL, V25, P103, DOI 10.1016/j.mib.2015.05.010; Jolivet E, 2006, MOL MICROBIOL, V59, P338, DOI 10.1111/j.1365-2958.2005.04946.x; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; Kota S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085288; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Ludanyi M, 2014, MOL MICROBIOL, V94, P434, DOI 10.1111/mmi.12774; Makarova KS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000955; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; McGovern S, 2016, NUCLEIC ACIDS RES, V44, P4785, DOI 10.1093/nar/gkw149; Mennecier S, 2004, MOL GENET GENOMICS, V272, P460, DOI 10.1007/s00438-004-1077-6; MOSELEY BEB, 1983, J GEN MICROBIOL, V129, P2437; Murakami M, 2006, BBA-PROTEINS PROTEOM, V1764, P20, DOI 10.1016/j.bbapap.2005.10.017; Narumi I, 2004, MOL MICROBIOL, V54, P278, DOI 10.1111/j.1365-2958.2004.04272.x; Norais CA, 2009, J BIOL CHEM, V284, P21402, DOI 10.1074/jbc.M109.010454; Passot FM, 2015, MOL MICROBIOL, V97, P759, DOI 10.1111/mmi.13064; Selvam K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069007; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Sugiman-Marangos SN, 2016, P NATL ACAD SCI USA, V113, P4308, DOI 10.1073/pnas.1520847113; Tanaka M, 2005, J BACTERIOL, V187, P3693, DOI 10.1128/JB.187.11.3693-3697.2005; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Vujicic-Zagar A, 2009, J MOL BIOL, V386, P704, DOI 10.1016/j.jmb.2008.12.062; Wang LY, 2008, MOL MICROBIOL, V67, P1211, DOI 10.1111/j.1365-2958.2008.06113.x; Wang YG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122071; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Xu GZ, 2010, DNA REPAIR, V9, P805, DOI 10.1016/j.dnarep.2010.04.006	40	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177751	10.1371/journal.pone.0177751	http://dx.doi.org/10.1371/journal.pone.0177751			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542368	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400077
J	Kugita, M; Nishii, K; Yamaguchi, T; Suzuki, A; Yuzawa, Y; Horie, S; Higashihara, E; Nagao, S				Kugita, Masanori; Nishii, Kazuhiro; Yamaguchi, Tamio; Suzuki, Atsushi; Yuzawa, Yukio; Horie, Shigeo; Higashihara, Eiji; Nagao, Shizuko			Beneficial effect of combined treatment with octreotide and pasireotide in PCK rats, an orthologous model of human autosomal recessive polycystic kidney disease	PLOS ONE			English	Article							CONGENITAL HEPATIC-FIBROSIS; LIVER-DISEASE; SOMATOSTATIN ANALOGS; GROWTH; KINASE; CYSTOGENESIS; PROGRESSION; INHIBITION; ACTIVATION; SOM230	Increased intracellular cyclic AMP (cAMP) in renal tubular epithelia accelerates the progression of polycystic kidney disease (PKD). Thus, decreasing cAMP levels by an adenylyl cyclase inhibitory G protein activator is considered to be an effective approach in ameliorating PKD. In fact, pasireotide (PAS) was effective in reducing disease progression in animal models of PKD. However, hyperglycemia caused by the administration of PAS is an adverse effect in its clinical use. Whereas, co-administration of octreotide (OCT) with PAS did not increase serum glucose in normal rats. In the current study, we examined the efficacy of combined treatment with OCT and PAS in PCK rats, an autosomal recessive PKD model. Four-week-old PCK males were treated with the long-acting release type of OCT, PAS, or a combination of both (OCT/PAS) for 12 weeks. After termination, serum and renal tissue were used for analyses. Kidney weight, kidney weight per body weight, renal cyst area, renal Ki67 expression, and serum urea nitrogen were significantly decreased either in the PAS or OCT/PAS group, compared with vehicle. Renal tissue cAMP content was significantly decreased by PAS or OCT/PAS treatment, but not OCT, compared with vehicle. As a marker of cellular mTOR signaling activity, renal phospho-S6 kinase expression was significantly decreased by OCT/PAS treatment compared with vehicle, OCT, or PAS. Serum glucose was significantly increased by PAS administration, whereas no difference was shown between vehicle and OCT/PAS, possibly because serum glucagon was decreased either by the treatment of OCT alone or co-application of OCT/PAS. In conclusion, since serum glucose levels are increased by the use of PAS, its combination with OCT may reduce the risk of hyperglycemia associated with PAS monotherapy against PKD progression.	[Kugita, Masanori; Nagao, Shizuko] Fujita Hlth Univ, Educ & Res Ctr Anim Models Human Dis, Toyoake, Aichi, Japan; [Nishii, Kazuhiro] Fujita Hlth Univ, Sch Hlth Sci, Fac Rehabil, Toyoake, Aichi, Japan; [Yamaguchi, Tamio] Suzuka Univ Med Sci, Dept Clin Nutr, Fac Hlth Sci, Suzuka, Mie, Japan; [Suzuki, Atsushi] Fujita Hlth Univ, Div Endocrinol & Metab, Dept Internal Med, Toyoake, Aichi, Japan; [Yuzawa, Yukio] Fujita Hlth Univ, Dept Nephrol, Sch Med, Toyoake, Aichi, Japan; [Horie, Shigeo] Juntendo Univ, Dept Urol, Sch Med, Bunkyo Ku, Tokyo, Japan; [Higashihara, Eiji] Kyorin Univ, Dept Urol, Sch Med, Mitaka, Tokyo, Japan	Fujita Health University; Fujita Health University; Fujita Health University; Fujita Health University; Juntendo University; Kyorin University	Nagao, S (corresponding author), Fujita Hlth Univ, Educ & Res Ctr Anim Models Human Dis, Toyoake, Aichi, Japan.	shizun@fujita-hu.ac.jp		Nagao, Shizuko/0000-0003-2014-9411	 [22590351];  [15K08435]	; 	This work was supported by a Grant-in-Aid for Scientific Research (C) grant numbers: 22590351, 15K08435 (https://www.isps.go.jp/ english/index.html) to SN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caroli A, 2013, LANCET, V382, P1485, DOI 10.1016/S0140-6736(13)61407-5; Caroli A, 2010, CLIN J AM SOC NEPHRO, V5, P783, DOI 10.2215/CJN.05380709; Feng ZH, 2010, TRENDS CELL BIOL, V20, P427, DOI 10.1016/j.tcb.2010.03.004; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Grantham JJ, 2011, NAT REV NEPHROL, V7, P556, DOI 10.1038/nrneph.2011.109; Hogan MC, 2012, NEPHROL DIAL TRANSPL, V27, P3532, DOI 10.1093/ndt/gfs152; Hogan MC, 2010, J AM SOC NEPHROL, V21, P1052, DOI 10.1681/ASN.2009121291; Liu CY, 2013, MOL MED REP, V8, P861, DOI 10.3892/mmr.2013.1588; Masyuk TV, 2007, GASTROENTEROLOGY, V132, P1104, DOI 10.1053/j.gastro.2006.12.039; Masyuk TV, 2013, HEPATOLOGY, V58, P409, DOI 10.1002/hep.26140; Nagao S, 2003, KIDNEY INT, V63, P427, DOI 10.1046/j.1523-1755.2003.00755.x; Nagao S, 2006, J AM SOC NEPHROL, V17, P2220, DOI 10.1681/ASN.2006030251; NAKAMURA T, 1993, J AM SOC NEPHROL, V3, P1378; Sanzen T, 2001, AM J PATHOL, V158, P1605, DOI 10.1016/S0002-9440(10)64116-8; Schmid HA, 2008, MOL CELL ENDOCRINOL, V286, P69, DOI 10.1016/j.mce.2007.09.006; Schmid HA, 2012, J ENDOCRINOL, V212, P49, DOI 10.1530/JOE-11-0224; Shenouda M, 2014, AM J THER, V21, P164, DOI 10.1097/MJT.0b013e31824c3eb4; Sideris L, 2012, ONCOLOGIST, V17, P747, DOI 10.1634/theoncologist.2011-0458; Sweeney WE, 2011, PEDIATR NEPHROL, V26, P675, DOI 10.1007/s00467-010-1656-1; Torres VE, 2004, KIDNEY INT, V66, P1766, DOI 10.1111/j.1523-1755.2004.00952.x; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Turkbey B, 2009, PEDIATR RADIOL, V39, P100, DOI 10.1007/s00247-008-1064-x; Wang XF, 2005, J AM SOC NEPHROL, V16, P846, DOI 10.1681/ASN.2004121090; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Weckbecker G, 2002, ENDOCRINOLOGY, V143, P4123, DOI 10.1210/en.2002-220219; Willey CJ, 2016, NEPHROL DIAL TRANSPL, V19; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; Yoshihara D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081480; Yoshihara D, 2011, AM J PHYSIOL-RENAL, V300, pF465, DOI 10.1152/ajprenal.00460.2010	29	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177934	10.1371/journal.pone.0177934	http://dx.doi.org/10.1371/journal.pone.0177934			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542433	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400118
J	Paquette, R; Tanton, C; Burns, F; Prah, P; Shahmanesh, M; Field, N; Macdowall, W; Gravningen, K; Sonnenberg, P; Mercer, CH				Paquette, Rachelle; Tanton, Clare; Burns, Fiona; Prah, Philip; Shahmanesh, Maryam; Field, Nigel; Macdowall, Wendy; Gravningen, Kirsten; Sonnenberg, Pam; Mercer, Catherine H.			Illicit drug use and its association with key sexual risk behaviours and outcomes: Findings from Britain's third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)	PLOS ONE			English	Article							SUBSTANCE USE; TRANSMITTED INFECTIONS; UNPLANNED PREGNANCY; SENSATION SEEKING; BISEXUAL MEN; SOUTH LONDON; CLUB DRUGS; YOUNG MEN; GAY MEN; HEALTH	Objectives We explore the hypothesis that using illicit drugs other than, or in addition to, cannabis is associated with sexual risk behaviour and sexual health outcomes in the British population. Methods We analysed data, separately by gender, reported by sexually-active participants (those reporting > = 1 partners/past year) aged 16-44 years (3,395 men, 4,980 women) in Britain's third National Survey of Sexual Attitudes and Lifestyles (Natsal-3), a probability survey undertaken 2010-12 involving computer-assisted personal-interview and computer-assisted self-interview. Analyses accounted for the stratification, clustering and weighting of the data. Multivariable logistic regression was used to calculate adjusted odds ratios. Results Use of illicit drugs other than, or in addition to, cannabis in the past year was reported by 11.5% (95% Cl: 10.4%-12.8%) of men and 5.5% (4.8%-6.3%) of women. Use of these types of drugs was more common among those < 35 years, those who reported poor general and/or sexual health behaviours, e.g. binge drinking > = weekly (age-adjusted ORs, aAORs, 10.91 (6.27-18.97) men; 9.95 (6.11 -16.19) women); having > = 2 condomless partners in the past year (aAOR: 5.50 (3.61-8.39) men; 5.24 (3.07 -8.94) women). Participants reporting illicit drug use were more likely (than those who did not) to report sexual health clinic attendance (ORs after adjusting for age, sexual identity and partner numbers: 1.79 (1.28 -2.51) men; 1.99 (1.34-2.95) women), chlamydia testing (1.42 (1.06-1.92) men; 1.94 (1.40- 2.70) women), unplanned pregnancy (2.93 (1.39-6.17) women), and among men only, sexually transmitted infection diagnoses (3.10 (1.63-5.89)). Conclusions In Britain, those reporting recent illicit drug use were more likely to report other markers of poor general and sexual health. They were also more likely to attend sexual health clinics so these should be considered appropriate settings to implement holistic interventions to maximise health gain.	[Paquette, Rachelle; Tanton, Clare; Burns, Fiona; Prah, Philip; Shahmanesh, Maryam; Field, Nigel; Gravningen, Kirsten; Sonnenberg, Pam; Mercer, Catherine H.] UCL, Res Dept Infect & Populat Hlth, London, England; [Macdowall, Wendy] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London, England; [Gravningen, Kirsten] Univ Hosp North Norway, Dept Microbiol & Infect Control, Tromso, Norway	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; UiT The Arctic University of Tromso; University Hospital of North Norway	Mercer, CH (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	c.mercer@ucl.ac.uk	Field, Nigel/ABG-3948-2020	Mercer, Catherine/0000-0002-4220-5034; Field, Nigel/0000-0002-2825-6652; Tanton, Clare/0000-0002-4612-1858; Macdowall, Wendy/0000-0001-5868-8336; Shahmanesh, Maryam/0000-0001-7129-8535	Medical Research Council [G0701757]; Wellcome Trust [084840]; Economic and Social Research Council and Department of Health; MRC [G0701757] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Economic and Social Research Council and Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Natsal-3 was supported by grants from the Medical Research Council www.mrc.ac.uk; G0701757) and the Wellcome Trust (www.wellcome.as.uk; 084840), with contributions from the Economic and Social Research Council and Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Natsal-3 is a collaboration between University College London (London, UK), the London School of Hygiene and Tropical Medicine (London, UK), NatCen Social Research, Public Health England (formerly the Health Protection Agency), and the University of Manchester (Manchester, UK). Natsal-3 was supported by grants from the Medical Research Council (www.mrc.ac.uk; G0701757) and the Wellcome Trust (www.wellcome.ac.uk; 084840), with contributions from the Economic and Social Research Council and Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank the study participants; the team of interviewers from NatCen Social Research; and operations and computing staff from NatCen Social Research.	Barrett G, 2004, J EPIDEMIOL COMMUN H, V58, P426, DOI 10.1136/jech.2003.014787; Barrett G, 2002, SOC SCI MED, V55, P545, DOI 10.1016/S0277-9536(01)00187-3; Benotsch EG, 2013, J ADOLESCENT HEALTH, V52, P307, DOI 10.1016/j.jadohealth.2012.06.011; Bourne A, 2015, SEX TRANSM INFECT, V91, P564, DOI 10.1136/sextrans-2015-052052; Bourne A, 2016, J PUBLIC HLTH; Bourne A., 2014, CHEMSEX STUDY DRUG U; Bourne A, 2015, INT J DRUG POLICY, V26, P1171, DOI 10.1016/j.drugpo.2015.07.013; Brodbeck J, 2006, AIDS BEHAV, V10, P599, DOI 10.1007/s10461-006-9103-9; Brook G, 2014, INT J STD AIDS, V25, P391, DOI 10.1177/0956462413512807; Chakraborty K, 2011, INDIAN J MED RES, V133, P594; Craig R, 2011, HLTH SURVEY ENGLAND; Daskalopoulou M, 2014, LANCET HIV, V1, pE22, DOI 10.1016/S2352-3018(14)70001-3; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Downing MJ, 2015, J HLTH PSYCHOL; Elkins IJ, 2006, J ABNORM PSYCHOL, V115, P26, DOI 10.1037/0021-843X.115.1.26; Erens B, 2013, NAT SURV SEX ATT LIF, V1; Erens B, 2014, SEX TRANSM INFECT, V90, P84, DOI 10.1136/sextrans-2013-051359; Fendrich M, 2013, ADDICT BEHAV, V38, P1715, DOI 10.1016/j.addbeh.2012.09.005; Field N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010521; Field N, 2013, LANCET, V382, P1830, DOI 10.1016/S0140-6736(13)62222-9; Gahlinger PM, 2004, AM FAM PHYSICIAN, V69, P2619; Heiligenberg M, 2012, SEX TRANSM DIS, V39, P518, DOI 10.1097/OLQ.0b013e3182515601; Hickson F, 2010, ADDICT RES THEORY, V18, P14, DOI 10.3109/16066350902770433; Home Office, 2014, DRUG MIS FIND 2013 1; Hunter LJ, 2014, POSTGRAD MED J, V90, P133, DOI 10.1136/postgradmedj-2012-131428; Johnson MW, 2017, PSYCHOPHARMACOLOGY, V234, P599, DOI 10.1007/s00213-016-4493-5; Lewis J., 2007, RES ETHICS REV, V3, P73; Li J, 2014, SEX TRANSM INFECT, V90, P125, DOI 10.1136/sextrans-2013-051195; Macdowall W, 2013, LANCET, V382, P1845, DOI 10.1016/S0140-6736(13)62300-4; McKetin R, 2014, DRUG ALCOHOL REV, V33, P436, DOI 10.1111/dar.12147; Melendez-Torres GJ, 2016, CURR OPIN INFECT DIS, V29, P58, DOI 10.1097/QCO.0000000000000234; Mercer CH, 2007, AM J PUBLIC HEALTH, V97, P1126, DOI 10.2105/AJPH.2006.086439; Mercer CH, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3149-z; Mercer CH, 2013, LANCET, V382, P1781, DOI 10.1016/S0140-6736(13)62035-8; Metrik J, 2016, J STUD ALCOHOL DRUGS, V77, P104, DOI 10.15288/jsad.2016.77.104; Mohammed H, 2016, SEX TRANSM INFECT, V92, P454, DOI 10.1136/sextrans-2016-052740; Newcomb ME, 2014, DRUG ALCOHOL DEPEN, V141, P65, DOI 10.1016/j.drugalcdep.2014.05.005; Newcomb ME, 2011, AIDS BEHAV, V15, P565, DOI 10.1007/s10461-010-9832-7; Pappas MK, 2011, AIDS CARE, V23, P1410, DOI 10.1080/09540121.2011.565027; Park A, 2012, BRIT SOCIAL ATTITUDE; Quinn PD, 2013, DEV PSYCHOPATHOL, V25, P223, DOI 10.1017/S0954579412000284; SIMON W, 1986, ARCH SEX BEHAV, V15, P97, DOI 10.1007/BF01542219; Simon W., 2003, QUAL SOCIOL, V26, P491, DOI [10.1023/B:QUAS.0000005053.99846.e5, DOI 10.1023/B:QUAS.0000005053.99846.E5]; Singer M, 2017, LANCET, V389, P941, DOI 10.1016/S0140-6736(17)30003-X; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; Spauwen LWL, 2015, SEX TRANSM INFECT, V91, P31, DOI 10.1136/sextrans-2014-051626; Tolou-Shams M, 2013, J GAY LESBIAN MENT H, V17, P96, DOI 10.1080/19359705.2013.740210; United Nations Office on Drugs and Crime, 2015, 2015 WORLD DRUG REP; Wellings K, 2013, LANCET, V382, P1807, DOI 10.1016/S0140-6736(13)62071-1; Wellings K, 2013, LANCET, V382, P1759, DOI 10.1016/S0140-6736(13)62378-8; Wells BE, 2011, AIDS BEHAV, V15, P509, DOI 10.1007/s10461-010-9767-z; World Health Organization, 2006, DEF SEX HLTH REP TEC	52	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177922	10.1371/journal.pone.0177922	http://dx.doi.org/10.1371/journal.pone.0177922			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542366	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000401672400114
J	Takeuchi, N; Sugiyama, S; Inui, K; Kanemoto, K; Nishihara, M				Takeuchi, Nobuyuki; Sugiyama, Shunsuke; Inui, Koji; Kanemoto, Kousuke; Nishihara, Makoto			New paradigm for auditory paired pulse suppression	PLOS ONE			English	Article							PREPULSE INHIBITION; PREFRONTAL CORTEX; SCHIZOPHRENIA-PATIENTS; CORTICAL RESPONSES; BRAIN POTENTIALS; EVOKED RESPONSES; MARTINOTTI CELLS; P50 SUPPRESSION; GATING DEFICIT; ECHOIC MEMORY	Sensory gating is a mechanism of sensory processing used to prevent an overflow of irrelevant information, with some indexes, such as prepulse inhibition (PPI) and P50 suppression, often utilized for its evaluation. In addition, those are clinically important for diseases such as schizophrenia. In the present study, we investigated long-latency paired-pulse suppression of change-related cortical responses using magnetoencephalography. The test change-related response was evoked by an abrupt increase in sound pressure by 15 dB in a continuous sound composed of a train of 25-ms pure tones at 65 dB. By inserting a leading change stimulus (prepulse), we observed suppression of the test response. In Experiment 1, we examined the effects of conditioning-test intervals (CTI) using a 25-ms pure tone at 80 dB as both the test and prepulse. Our results showed clear suppression of the test response peaking at a CTI of 600 ms, while maximum inhibition was approximately 30%. In Experiment 2, the effects of sound pressure on prepulse were examined by inserting prepulses 600 ms prior to the test stimulus. We found that a paired-pulse suppression greater than 25% was obtained by prepulses larger than 77 dB, i.e., 12 dB louder than the background, suggesting that long latency suppression requires a relatively strong prepulse to obtain adequate suppression, different than short-latency paired-pulse suppression reported in previous studies. In Experiment 3, we confirmed similar levels of suppression using electroencephalography. These results suggested that two identical change stimuli spaced by 600 ms were appropriate for observing the long-latency inhibition. The present method requires only a short inspection time and is non-invasive.	[Takeuchi, Nobuyuki; Kanemoto, Kousuke] Aichi Med Univ, Neuropsychiat Dept, Nagakute, Aichi, Japan; [Sugiyama, Shunsuke] Gifu Univ, Dept Psychiat & Psychotherapy, Gifu, Japan; [Inui, Koji] Aichi Human Serv Ctr, Inst Human Dev Res, Kasugai, Aichi, Japan; [Inui, Koji] Natl Inst Physiol Sci, Dept Integrat Physiol, Okazaki, Aichi, Japan; [Nishihara, Makoto] Aichi Med Univ, Multidisciplinary Pain Ctr, Nagakute, Aichi, Japan	Aichi Medical University; Gifu University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Aichi Medical University	Takeuchi, N (corresponding author), Aichi Med Univ, Neuropsychiat Dept, Nagakute, Aichi, Japan.	jamjam053@yahoo.co.jp		Takeuchi, Nobuyuki/0000-0001-8252-3662	JSPS KAKENHI [JP25351001, JP25461791]; ImPACT Program of the Council [2015-PM11-23-01]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); ImPACT Program of the Council	This study was supported by JSPS KAKENHI Grant Numbers JP25351001 to K.I. and JP25461791 to M.N., and the ImPACT Program (2015-PM11-23-01) of the Council for Science, Technology, and Innovation (Cabinet Office, Government of Japan) to K.I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by JSPS KAKENHI Grant Numbers JP25351001 to K.I. and JP25461791 to M.N., and the ImPACT Program (2015-PM11-23-01) of the Council for Science, Technology, and Innovation (Cabinet Office, Government of Japan) to K.I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are grateful to Yasuyuki Takeshima for his technical support.	ADLER LE, 1982, BIOL PSYCHIAT, V17, P639; Amenedo E, 1998, BIOL PSYCHOL, V48, P235, DOI 10.1016/S0301-0511(98)00040-4; Anderer P, 1996, ELECTROEN CLIN NEURO, V99, P458, DOI 10.1016/S0013-4694(96)96518-9; Anokhin AP, 2007, SCHIZOPHR RES, V89, P312, DOI 10.1016/j.schres.2006.08.009; Becker J, 2011, ARQ NEURO-PSIQUIAT, V69, P460, DOI 10.1590/S0004-282X2011000400010; Boutros NN, 2006, J NEUROPSYCH CLIN N, V18, P409, DOI 10.1176/appi.neuropsych.18.3.409; Boutros NN, 2009, SCHIZOPHR RES, V113, P339, DOI 10.1016/j.schres.2009.05.019; BOWERY NG, 1993, ANNU REV PHARMACOL, V33, P109, DOI 10.1146/annurev.pa.33.040193.000545; Bramon E, 2004, SCHIZOPHR RES, V70, P315, DOI 10.1016/j.schres.2004.01.004; Brockhaus-Dumke A, 2008, BIOL PSYCHIAT, V64, P376, DOI 10.1016/j.biopsych.2008.02.006; Cadenhead KS, 2005, BIOL PSYCHIAT, V57, P1504, DOI 10.1016/j.biopsych.2005.03.003; Cheng CH, 2016, J AFFECT DISORDERS, V203, P199, DOI 10.1016/j.jad.2016.06.010; CULLUM CM, 1993, SCHIZOPHR RES, V10, P131, DOI 10.1016/0920-9964(93)90048-N; Dalecki A, 2011, PSYCHOPHYSIOLOGY, V48, P1692, DOI 10.1111/j.1469-8986.2011.01262.x; DeFelipe J, 1997, J CHEM NEUROANAT, V14, P1, DOI 10.1016/S0891-0618(97)10013-8; Fuerst DR, 2007, PSYCHOPHYSIOLOGY, V44, P620, DOI 10.1111/j.1469-8986.2007.00524.x; Ghisolfi ES, 2006, J PSYCHIATR RES, V40, P535, DOI 10.1016/j.jpsychires.2006.02.006; Greenwood TA, 2016, AM J PSYCHIAT, V173, P385, DOI 10.1176/appi.ajp.2015.15050605; Holstein DH, 2013, PSYCHIAT RES, V205, P117, DOI 10.1016/j.psychres.2012.08.013; Inui K, 2004, CEREB CORTEX, V14, P851, DOI 10.1093/cercor/bhh043; Inui K, 2006, CEREB CORTEX, V16, P18, DOI 10.1093/cercor/bhi080; Inui K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155972; Inui K, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-588; Inui K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-135; Inui K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-135; Inui K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-80; IRAGUI VJ, 1993, PSYCHOPHYSIOLOGY, V30, P10, DOI 10.1111/j.1469-8986.1993.tb03200.x; Javitt DC, 2015, AM J PSYCHIAT, V172, P17, DOI 10.1176/appi.ajp.2014.13121691; Karube F, 2004, J NEUROSCI, V24, P2853, DOI 10.1523/JNEUROSCI.4814-03.2004; Kawaguchi Y, 2002, J NEUROCYTOL, V31, P277, DOI 10.1023/A:1024126110356; Kodaira M, 2013, BEHAV BRAIN RES, V256, P27, DOI 10.1016/j.bbr.2013.07.045; Krishnamurthy P, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00060; Kunugi H, 2007, NEUROSCI RES, V59, P23, DOI 10.1016/j.neures.2007.05.006; Lewis DA, 2014, CURR OPIN NEUROBIOL, V26, P22, DOI 10.1016/j.conb.2013.11.003; LUND JS, 1993, J COMP NEUROL, V328, P282, DOI 10.1002/cne.903280209; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Melchitzky DS, 2008, SYNAPSE, V62, P456, DOI 10.1002/syn.20514; NAGAMOTO HT, 1989, BIOL PSYCHIAT, V25, P549, DOI 10.1016/0006-3223(89)90215-1; Nishihara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106553; Nishihara M, 2011, NEUROSCI RES, V71, P145, DOI 10.1016/j.neures.2011.07.004; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Otsuru N, 2012, PSYCHOPHARMACOLOGY, V224, P327, DOI 10.1007/s00213-012-2757-2; Potter D, 2006, SCHIZOPHRENIA BULL, V32, P692, DOI 10.1093/schbul/sbj050; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Smith DM, 2013, CLIN NEUROPHYSIOL, V124, P1329, DOI 10.1016/j.clinph.2013.02.004; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; Vogels TP, 2009, NAT NEUROSCI, V12, P483, DOI 10.1038/nn.2276; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Yamashiro K, 2011, PSYCHOPHYSIOLOGY, V48, P23, DOI 10.1111/j.1469-8986.2010.01038.x; Zaitsev AV, 2005, CEREB CORTEX, V15, P1178, DOI 10.1093/cercor/bhh218	50	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177747	10.1371/journal.pone.0177747	http://dx.doi.org/10.1371/journal.pone.0177747			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542290	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400074
J	Caspell-Garcia, C; Simuni, T; Tosun-Turgut, D; Wu, IW; Zhang, Y; Nalls, M; Singleton, A; Shaw, LA; Kang, JH; Trojanowski, JQ; Siderowf, A; Coffey, C; Lasch, S; Aarsland, D; Burn, D; Chahine, LM; Espay, AJ; Foster, ED; Hawkins, KA; Litvan, I; Richard, I; Weintraub, D				Caspell-Garcia, Chelsea; Simuni, Tanya; Tosun-Turgut, Duygu; Wu, I-Wei; Zhang, Yu; Nalls, Mike; Singleton, Andrew; Shaw, Leslie A.; Kang, Ju-Hee; Trojanowski, John Q.; Siderowf, Andrew; Coffey, Christopher; Lasch, Shirley; Aarsland, Dag; Burn, David; Chahine, Lana M.; Espay, Alberto J.; Foster, Eric D.; Hawkins, Keith A.; Litvan, Irene; Richard, Irene; Weintraub, Daniel		Parkinson's Progression Marker	Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DIAGNOSTIC-CRITERIA; PLANNING ABILITY; INITIATIVE PPMI; LEWY BODIES; DEMENTIA; INCIDENT; DECLINE; POLYMORPHISM; DISORDER	Objectives To assess the neurobiological substrate of initial cognitive decline in Parkinson's disease (PD) to inform patient management, clinical trial design, and development of treatments. Methods We longitudinally assessed, up to 3 years, 423 newly diagnosed patients with idiopathic PD, untreated at baseline, from 33 international movement disorder centers. Study outcomes were four determinations of cognitive impairment or decline, and biomarker predictors were baseline dopamine transporter (DAT) single photon emission computed tomography (SPECT) scan, structural magnetic resonance imaging (MRI; volume and thickness), diffusion tensor imaging (mean diffusivity and fractional anisotropy), cerebrospinal fluid (CSF; amyloid beta [A beta], tau and alpha synuclein), and 11 single nucleotide polymorphisms (SNPs) previously associated with PD cognition. Additionally, longitudinal structural MRI and DAT scan data were included. Univariate analyses were run initially, with false discovery rate = 0.2, to select biomarker variables for inclusion in multivariable longitudinal mixed-effect models. Results By year 3, cognitive impairment was diagnosed in 15-38% participants depending on the criteria applied. Biomarkers, some longitudinal, predicting cognitive impairment in multivariable models were: (1) dopamine deficiency (decreased caudate and putamen DAT availability); (2) diffuse, cortical decreased brain volume or thickness (frontal, temporal, parietal, and occipital lobe regions); (3) co-morbid Alzheimer's disease A beta amyloid pathology (lower CSF A beta 1-42); and (4) genes (COMT val/val and BDNF val/val genotypes). Conclusions Cognitive impairment in PD increases in frequency 50-200% in the first several years of disease, and is independently predicted by biomarker changes related to nigrostriatal or cortical dopaminergic deficits, global atrophy due to possible widespread effects of neurodegenerative disease, co-morbid Alzheimer's disease plaque pathology, and genetic factors.	[Caspell-Garcia, Chelsea; Coffey, Christopher] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA USA; [Simuni, Tanya] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Tosun-Turgut, Duygu; Wu, I-Wei; Zhang, Yu] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Nalls, Mike; Singleton, Andrew] NIA, Lab Neurogenet, NIH, Bethesda, MD 20892 USA; [Shaw, Leslie A.; Kang, Ju-Hee; Trojanowski, John Q.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Kang, Ju-Hee] Inha Univ, Sch Med, Dept Pharmacol & Clin Pharmacol, Incheon, South Korea; [Siderowf, Andrew] Avid Radiopharmaceut, Philadelphia, PA USA; [Lasch, Shirley] Inst Neurodegenerat Disorders, New Haven, CT USA; [Lasch, Shirley] Mol NeuroImaging LLC MNI, New Haven, CT USA; [Aarsland, Dag] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Old Age Psychiat, London, England; [Aarsland, Dag] Stavanger Univ Hosp, Ctr Age Related Med, Stavanger, Norway; [Burn, David] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne, Tyne & Wear, England; [Chahine, Lana M.; Weintraub, Daniel] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Espay, Alberto J.] Univ Cincinnati, Acad Hlth Ctr, Dept Neurol, Cincinnati, OH USA; [Hawkins, Keith A.] Yale Sch Med, Dept Psychiat, New Haven, CT USA; [Litvan, Irene] Univ Calif San Diego, Dept Neurosci, UCSD Movement Disorder Ctr, San Diego, CA 92103 USA; [Richard, Irene] Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA; [Richard, Irene] Univ Rochester, Sch Med & Dent, Dept Psychiat, Rochester, NY 14642 USA; [Weintraub, Daniel] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Weintraub, Daniel] Philadelphia Vet Affairs Med Ctr, Parkinsons Dis Res Educ & Clin Ctr PADRECC, Philadelphia, PA 19104 USA; [Weintraub, Daniel] Philadelphia Vet Affairs Med Ctr, MIRECC, Philadelphia, PA 19104 USA	University of Iowa; Northwestern University; Feinberg School of Medicine; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Pennsylvania; Pennsylvania Medicine; Inha University; University of London; King's College London; Stavanger University Hospital; Newcastle University - UK; University of Pennsylvania; Pennsylvania Medicine; University System of Ohio; University of Cincinnati; Yale University; University of California System; University of California San Diego; University of Rochester; University of Rochester; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Weintraub, D (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA.; Weintraub, D (corresponding author), Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.; Weintraub, D (corresponding author), Philadelphia Vet Affairs Med Ctr, Parkinsons Dis Res Educ & Clin Ctr PADRECC, Philadelphia, PA 19104 USA.; Weintraub, D (corresponding author), Philadelphia Vet Affairs Med Ctr, MIRECC, Philadelphia, PA 19104 USA.	Daniel.Weintraub@uphs.upenn.edu	Singleton, Andrew B/C-3010-2009; Espay, Alberto J./AAC-4255-2020; Litvan, Irene/X-9319-2018; Weintraub, Daniel/AAD-8309-2020; Weintraub, Daniel/AAC-5232-2020; Burn, David/ABD-6052-2021	Espay, Alberto J./0000-0002-3389-136X; Litvan, Irene/0000-0002-3485-3445; Weintraub, Daniel/0000-0003-0633-7168; Hawkins, Keith/0000-0003-3494-2103; Chahine, Lana/0000-0003-2521-7196; Tosun, Duygu/0000-0001-8644-7724; Aarsland, Dag/0000-0001-6314-216X; Burn, David/0000-0001-7658-1209; Zhang, Yu/0000-0001-8066-7275	Michael J. Fox Foundation; Abbvie; Avid Radiopharmaceuticals; Biogen; Bristol-Myers Squibb; Covance; GE Healthcare; Genentech; GlaxoSmithKline; Lilly; Lundbeck; Merck; Meso Scale Discovery; Pfizer; Piramal; Roche; Servier; UCB; NINDS [P50 NS053488]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS053488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010124] Funding Source: NIH RePORTER	Michael J. Fox Foundation; Abbvie(AbbVie); Avid Radiopharmaceuticals; Biogen(Biogen); Bristol-Myers Squibb(Bristol-Myers Squibb); Covance; GE Healthcare(General ElectricGE Healthcare); Genentech(Roche HoldingGenentech); GlaxoSmithKline(GlaxoSmithKline); Lilly(Eli Lilly); Lundbeck(Lundbeck Corporation); Merck(Merck & Company); Meso Scale Discovery; Pfizer(Pfizer); Piramal; Roche(Roche Holding); Servier(Servier); UCB(UCB Pharma SA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Michael J Fox Foundation for Parkinson's Research (michaeljtokorg) study design, data collection, decision to publish, preparation of manuscript. PPMI a public-private partnership is funded by the Michael J. Fox Foundation for Parkinson's Research and funding partners, including Abbvie, Avid Radiopharmaceuticals, Biogen, Bristol-Myers Squibb, Covance, GE Healthcare, Genentech, GlaxoSmithKline, Lilly, Lundbeck, Merck, Meso Scale Discovery, Pfizer, Piramal, Roche, Servier, and UCB. Dr. Andrew Siderowf is an employee of Avid Radiopharmaceuticals. Avid Radiopharmaceuticals provided support in the form of salary for Dr. Siderowf, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Siderowf's specific role is articulated in the 'author contributions' section. Also supported by NINDS P50 NS053488 (Trojanowski JQ-PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2003, ARCH NEUROL-CHICAGO, V60, P387, DOI 10.1001/archneur.60.3.387; Aarsland D, 2010, NEUROLOGY, V75, P1062, DOI 10.1212/WNL.0b013e3181f39d0e; Aarsland D, 2009, NEUROLOGY, V72, P1121, DOI 10.1212/01.wnl.0000338632.00552.cb; Adler CH, 2010, ACTA NEUROPATHOL, V120, P827, DOI 10.1007/s00401-010-0744-4; Alves G, 2014, NEUROLOGY, V82, P1784, DOI 10.1212/WNL.0000000000000425; Bohnen NI, 2015, JAMA NEUROL, V72, P194, DOI 10.1001/jamaneurol.2014.2757; Bohnen NI, 2009, NEUROLOGY, V73, P256, DOI 10.1212/WNL.0b013e3181b0bd3d; Buchhave P, 2012, ARCH GEN PSYCHIAT, V69, P98, DOI 10.1001/archgenpsychiatry.2011.155; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Dalrymple-Alford JC, 2010, NEUROLOGY, V75, P1717, DOI 10.1212/WNL.0b013e3181fc29c9; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Duncan GW, 2016, MOVEMENT DISORD, V31, P103, DOI 10.1002/mds.26312; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Evans A. C., 1993, NUCL SCI S MED IM C; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Foltynie T, 2005, J NEUROL, V252, P833, DOI 10.1007/s00415-005-0756-5; Foltynie T, 2004, MOVEMENT DISORD, V19, P885, DOI 10.1002/mds.20118; Gattellaro G, 2009, AM J NEURORADIOL, V30, P1222, DOI 10.3174/ajnr.A1556; Hurtig HI, 2000, NEUROLOGY, V54, P1916, DOI 10.1212/WNL.54.10.1916; Jellinger KA, 2002, J NEURAL TRANSM, V109, P329, DOI 10.1007/s007020200027; Kaasinen V, 2002, NEUROSCI BIOBEHAV R, V26, P785, DOI 10.1016/S0149-7634(02)00065-9; Kang JH, 2016, ACTA NEUROPATHOL, V131, P935, DOI 10.1007/s00401-016-1552-2; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Marek K, 2011, PROG NEUROBIOL, V95, P629, DOI 10.1016/j.pneurobio.2011.09.005; Morley JF, 2012, MOVEMENT DISORD, V27, P512, DOI 10.1002/mds.24946; Nalls MA, 2016, MOVEMENT DISORD, V31, P79, DOI 10.1002/mds.26374; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Pigott K, 2015, NEUROLOGY, V85, P1276, DOI 10.1212/WNL.0000000000002001; Poletti M, 2013, THER ADV PSYCHOPHARM, V3, P101, DOI 10.1177/2045125312470130; Ravina B, 2012, MOVEMENT DISORD, V27, P1392, DOI 10.1002/mds.25157; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Schuff N, 2015, MOVEMENT DISORD, V30, P1885, DOI 10.1002/mds.26325; Seto-Salvia N, 2011, ARCH NEUROL-CHICAGO, V68, P359, DOI 10.1001/archneurol.2011.17; Siderowf A, 2010, NEUROLOGY, V75, P1055, DOI 10.1212/WNL.0b013e3181f39a78; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Tsuang D, 2013, JAMA NEUROL, V70, P223, DOI 10.1001/jamaneurol.2013.600; Uribe C, 2016, MOVEMENT DISORD, V31, P699, DOI 10.1002/mds.26590; van der Kolk NM, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.08.023; Weintraub D, 2015, MOVEMENT DISORD, V30, P919, DOI 10.1002/mds.26170; Weintraub D, 2012, BRAIN, V135, P170, DOI 10.1093/brain/awr277; Weintraub D, 2011, MOVEMENT DISORD, V26, P1022, DOI 10.1002/mds.23664; Williams-Gray CH, 2007, BRAIN, V130, P1787, DOI 10.1093/brain/awm111; Williams-Gray CH, 2008, BRAIN, V131, P397, DOI 10.1093/brain/awm313; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245; Yarnall AJ, 2014, NEUROLOGY, V82, P308, DOI 10.1212/WNL.0000000000000066; ZWEIG RM, 1993, NEUROLOGY, V43, P986, DOI 10.1212/WNL.43.5.986	47	87	87	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0175674	10.1371/journal.pone.0175674	http://dx.doi.org/10.1371/journal.pone.0175674			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520803	Green Published, gold			2022-12-26	WOS:000401487700006
J	Lin, C; Wang, Y; Wang, Y; Zhang, S; Yu, L; Guo, C; Xu, H				Lin, C.; Wang, Y.; Wang, Y.; Zhang, S.; Yu, L.; Guo, C.; Xu, H.			Transcriptional and posttranscriptional regulation of HOXA13 by lncRNA HOTTIP facilitates tumorigenesis and metastasis in esophageal squamous carcinoma cells	ONCOGENE			English	Article							LONG NONCODING RNA; EPITHELIAL-MESENCHYMAL TRANSITION; HEPATOCELLULAR-CARCINOMA; LUNG-CANCER; PANCREATIC-CANCER; GENE-EXPRESSION; DOWN-REGULATION; POOR-PROGNOSIS; PROLIFERATION; PROGRESSION	The long non-coding RNA, HOTTIP, has an important role in tumorigenesis. It is known that HOTTIP regulates HOX gene family; however, its regulatory mechanism in esophageal squamous cell carcinoma (ESCC) remains elusive. In this study, we investigated the role of HOTTIP in ESCC and observed that HOTTIP/HOXA13 was upregulated in ESCC and promoted cell proliferation and metastasis in vivo and in vitro. Interestingly, harboring a miR-30b-binding site, HOTTIP as a molecular sponge mainly regulated miR-30b level in the nucleus and modulated the repression of HOXA13 mediated by miR-30b in the cytoplasm, resulting in the positive HOTTIP/HOXA13 correlation. In addition, HOTTIP upregulated snail1 by competitively binding miR-30b, subsequently promoting epithelial-mesenchymal transition (EMT) and invasion. HOTTIP directly bound the adaptor protein WDR5 and drove histone H3 lysine 4 trimethylation and HOXA13 gene transcription in ESCC cells. In conclusion, our findings indicated that HOTTIP modulated HOXA13 at both the transcriptional and posttranscriptional levels in ESCC cells and HOTTIP-miR-30b-HOXA13 axis may serve as potential diagnostic markers or drug targets for ESCC therapies.	[Lin, C.; Wang, Y.; Wang, Y.; Zhang, S.; Yu, L.; Guo, C.; Xu, H.] China Pharmaceut Univ, Ctr Peptide Drug Discovery & Dev, Dept Engn Res, Nanjing, Jiangsu, Peoples R China; [Lin, C.; Wang, Y.; Wang, Y.; Zhang, S.; Yu, L.; Guo, C.; Xu, H.] China Pharmaceut Univ, Dept State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; China Pharmaceutical University	Guo, C; Xu, H (corresponding author), China Pharmaceut Univ, Ctr Peptide Drug Discovery & Dev, Dept Engn Res, Nanjing, Jiangsu, Peoples R China.; Guo, C; Xu, H (corresponding author), China Pharmaceut Univ, Dept State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.	guocha@cpu.edu.cn; 13913925346@126.com			State Key Laboratory of Natural Medicines in China [SKLNMBZ201403]; National Science and Technology Major Projects of New Drugs in China [2012ZX09103301-004, 2014ZX09508007]; National Natural Science Foundation of China [30873073]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Central University Basic Scientific Research Business Expenses [2016ZPY009]	State Key Laboratory of Natural Medicines in China; National Science and Technology Major Projects of New Drugs in China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Central University Basic Scientific Research Business Expenses	We are very grateful to Nanjing General Hospital for providing ESCC tissues and Professor Yifeng Zhou who provided ESCC cell lines. This work was supported by Project Program of State Key Laboratory of Natural Medicines in China (no. SKLNMBZ201403); National Science and Technology Major Projects of New Drugs in China (2012ZX09103301-004 and 2014ZX09508007); National Natural Science Foundation of China (30873073); the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); the Central University Basic Scientific Research Business Expenses (2016ZPY009). We thank LetPub (www.letpub.com) for its linguistic assistance during the preparation of the manuscript.	Chen FJ, 2013, MOL CARCINOGEN, V52, P908, DOI 10.1002/mc.21944; Cheng CW, 2012, BREAST CANCER RES TR, V134, P1081, DOI 10.1007/s10549-012-2034-4; Cheng YT, 2015, ONCOTARGET, V6, P10840, DOI 10.18632/oncotarget.3450; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Deng HP, 2015, CELL MOL BIOL, V61, P34; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Feng TB, 2016, ONCOTARGET, V7, P16205, DOI 10.18632/oncotarget.7578; Gagnon KT, 2014, CELL REP, V6, P211, DOI 10.1016/j.celrep.2013.12.013; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Ge YX, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005726; George J, 2015, SEMIN LIVER DIS, V35, P63, DOI 10.1055/s-0034-1397350; Gu ZD, 2009, CANCER RES, V69, P4969, DOI 10.1158/0008-5472.CAN-08-4546; Guo B, 2011, CUAJ-CAN UROL ASSOC, V5, pE129, DOI DOI 10.5489/CUAJ.09118; Hajjari M, 2015, CANCER BIOL MED, V12, P1, DOI 10.7497/j.issn.2095-3941.2015.0006; Huang JW, 2013, CANCER SCI, V104, P1609, DOI 10.1111/cas.12291; Jin KZ, 2015, DRUG DES DEV THER, V9, P1247, DOI 10.2147/DDDT.S77597; Kao CJ, 2014, ONCOGENE, V33, P2495, DOI 10.1038/onc.2013.200; Kwak SY, 2015, FEBS J, V282, P1512, DOI 10.1111/febs.13238; Li W, 2014, GASTROENTEROLOGY, V146, P1714, DOI 10.1053/j.gastro.2014.03.002; Li WY, 2014, CANCER CELL, V25, P557, DOI 10.1016/j.ccr.2014.04.014; Li ZH, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0442-z; Liu ZH, 2016, ONCOTARGET, V7, P25350, DOI 10.18632/oncotarget.8129; Lu ZF, 2015, BLOOD, V126, P1730, DOI 10.1182/blood-2015-07-657999; Mohamadkhani A, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.18794; Pan F, 2014, INT J CLIN EXP PATHO, V7, P2838; Quagliata L, 2014, HEPATOLOGY, V59, P911, DOI 10.1002/hep.26740; Sugihara H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081839; Sun XL, 2017, J CELL PHYSIOL, V232, P625, DOI 10.1002/jcp.25466; Tsang FHC, 2015, LIVER INT, V35, P1597, DOI 10.1111/liv.12746; Wang Guang-Yu, 2014, Bull Cancer, V101, pE27, DOI 10.1684/bdc.2014.2023; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wei Y, 2014, J BIOL CHEM, V289, P10270, DOI 10.1074/jbc.C113.541417; Wu YT, 2015, CURR PHARM DESIGN, V21, P5017, DOI 10.2174/1381612821666150724115625; Xie H, 2015, BIOCHEM BIOPH RES CO, V463, P569, DOI 10.1016/j.bbrc.2015.05.096; Xu YP, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-173; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Ye ZX, 2015, INT J GYNECOL CANCER, V25, P1574, DOI 10.1097/IGC.0000000000000546; Yu HS, 2014, ONCOL LETT, V7, P799, DOI 10.3892/ol.2013.1754; Zhang H, 2015, TUMOR BIOL, V36, P8805, DOI 10.1007/s13277-015-3645-2; Zhong K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-703; Zhong ZP, 2014, MOL MED REP, V10, P2575, DOI 10.3892/mmr.2014.2494; Zhou XY, 2015, CELL PHYSIOL BIOCHEM, V36, P1440, DOI 10.1159/000430309	43	103	107	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 21	2017	36	38					5392	5406		10.1038/onc.2017.133	http://dx.doi.org/10.1038/onc.2017.133			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FH7PJ	28534516				2022-12-26	WOS:000411382100006
J	Ohnishi, T; Hashizume, C; Taniguchi, M; Furumoto, H; Han, J; Gao, RF; Kinami, S; Kosaka, T; Okazaki, T				Ohnishi, Toshio; Hashizume, Chieko; Taniguchi, Makoto; Furumoto, Hidehiro; Han, Jia; Gao, Rongfen; Kinami, Shinichi; Kosaka, Takeo; Okazaki, Toshiro			Sphingomyelin synthase 2 deficiency inhibits the induction of murine colitis-associated colon cancer	FASEB JOURNAL			English	Article						SMS2; ceramide; colon inflammation; tumorigenesis	SODIUM-INDUCED COLITIS; COLORECTAL-CANCER; ULCERATIVE-COLITIS; SMS2 DEFICIENCY; CELL APOPTOSIS; MICE; INFLAMMATION; CERAMIDE; ACTIVATION; ATHEROSCLEROSIS	Sphingomyelin synthase 2 (SMS2) is the synthetic enzyme of sphingomyelin (SM), which regulates membrane fluidity and microdomain structure. SMS2 plays a role in LPS-induced lung injury and inflammation; however, its role in inflammation-mediated tumorigenesis is unclear. We investigated the effect of SMS2 deficiency on dextran sodium sulfate (DSS)-induced murine colitis and found inhibition of DSS-induced inflammation in SMS2-deficient (SMS2(-/-)) mice. DSS treatment induced a significant increase in ceramide levels, with a decrease of SM levels in SMS2(-/-) colon tissue, and demonstrated attenuation of the elevation of both inflammation-related gene expression and proinflammatory cytokines and chemokines, leukocyte infiltration, and MAPK and signal transducer and activator of transcription 3 activation. After undergoing transplantation of wild-type bone marrow, SMS2(-/-) mice also exhibited inhibition of DSS-induced inflammation in the colon, which suggested that SMS2 deficiency in bone marrow-derived immune cells was not involved in the inhibition of colitis. Finally, in an azoxymethane/DSS-induced cancer model, SMS2 deficiency significantly decreased tumor incidence in the colon. Our results demonstrate that SMS2 deficiency inhibits DSS-induced colitis and subsequent colitis-associated colon cancer via inhibition of colon epithelial cell-mediated inflammation; therefore, inhibition of SMS2 may be a potential therapeutic target for human colitis and colorectal cancer.	[Ohnishi, Toshio; Kinami, Shinichi; Kosaka, Takeo] Kanazawa Med Univ, Med Res Inst, Div Gen & Digest Surg, Uchinada, Ishikawa, Japan; [Hashizume, Chieko; Furumoto, Hidehiro; Gao, Rongfen; Okazaki, Toshiro] Kanazawa Med Univ, Med Res Inst, Div Hematol Immunol, Uchinada, Ishikawa, Japan; [Han, Jia] Kanazawa Med Univ, Div Med Oncol, Dept Med, Med Res Inst, Uchinada, Ishikawa, Japan; [Taniguchi, Makoto] Kanazawa Med Univ, Med Res Inst, Dept Life Sci, Uchinada, Ishikawa, Japan; [Okazaki, Toshiro] Kanazawa Med Univ, Med Res Inst, Dept Adv Med, Uchinada, Ishikawa, Japan	Kanazawa Medical University; Kanazawa Medical University; Kanazawa Medical University; Kanazawa Medical University; Kanazawa Medical University	Okazaki, T (corresponding author), Kanazawa Med Univ, Div Hematol Immunol, Dept Med, 1-1 Daigaku, Uchinada, Ishikawa, Japan.	toshiroo@kanazawa-med.ac.jp	Taniguchi, Makoto/L-5757-2019	Taniguchi, Makoto/0000-0001-5920-8285	Takeda Science Foundation; Strategic Research Foundation Grant-Aided Project for Private Universities from the Japan Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [S1201004]; Kanazawa Medical University [H2012-15]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Strategic Research Foundation Grant-Aided Project for Private Universities from the Japan Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Kanazawa Medical University	This work was supported, in part, by the Takeda Science Foundation and grants from the Strategic Research Foundation Grant-Aided Project for Private Universities (Grant S1201004) from the Japan Ministry of Education, Culture, Sports, Science, and Technology (MEXT), and from Kanazawa Medical University (H2012-15; 2012-2016). The authors thank Dr. Yoshimichi Ueda (Kanazawa Medical University) for the pathologic assessment of mouse specimens. The authors also thank Dr. Hideo Ogiso (Kanazawa Medical University) for performing liquid chromatography-tandem mass spectrometry analysis.	Asano S, 2012, MOL CELL BIOL, V32, P3242, DOI 10.1128/MCB.00121-12; Bauer J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007197; Begagne E, 2014, J CLIN INVEST, V124, P5368, DOI 10.1172/JCI74188; Braun A, 2009, INFLAMM BOWEL DIS, V15, P1705, DOI 10.1002/ibd.20993; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Candido J, 2013, J CLIN IMMUNOL, V33, pS79, DOI 10.1007/s10875-012-9847-0; Chen Y, 2015, MOL CANCER THER, V14, P259, DOI 10.1158/1535-7163.MCT-14-0468-T; Clapper ML, 2007, ACTA PHARMACOL SIN, V28, P1450, DOI 10.1111/j.1745-7254.2007.00695.x; Dong LL, 2012, INT IMMUNOL, V24, P327, DOI 10.1093/intimm/dxs008; Fan YF, 2010, ARTERIOSCL THROM VAS, V30, P2114, DOI 10.1161/ATVBAHA.110.213363; Fischbeck A, 2011, GUT, V60, P55, DOI 10.1136/gut.2009.201988; Furuya H, 2011, CANCER METAST REV, V30, P567, DOI 10.1007/s10555-011-9304-1; Galadari S, 2015, APOPTOSIS, V20, P689, DOI 10.1007/s10495-015-1109-1; Garcia-Barros M, 2014, BBA-MOL CELL BIOL L, V1841, P773, DOI 10.1016/j.bbalip.2013.09.007; Gommeaux J, 2007, MOL CELL BIOL, V27, P2215, DOI 10.1128/MCB.01454-06; Gowda S, 2011, AM J PHYSIOL-LUNG C, V300, pL430, DOI 10.1152/ajplung.00208.2010; Grivennikov SI, 2013, SEMIN IMMUNOPATHOL, V35, P229, DOI 10.1007/s00281-012-0352-6; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Hayashi Y, 2014, J BIOL CHEM, V289, P30842, DOI 10.1074/jbc.M114.574285; Heinz LX, 2015, CELL REP, V11, P1919, DOI 10.1016/j.celrep.2015.05.006; Hertervig E, 1997, CANCER, V79, P448, DOI 10.1002/(SICI)1097-0142(19970201)79:3<448::AID-CNCR4>3.0.CO;2-E; Iwai K, 2003, J BIOL CHEM, V278, P9813, DOI 10.1074/jbc.M201867200; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Lakatos PL, 2008, WORLD J GASTROENTERO, V14, P3937, DOI 10.3748/wjg.14.3937; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Liu J, 2009, CIRC RES, V105, P295, DOI 10.1161/CIRCRESAHA.109.194613; Lu MH, 2012, J PHYSIOL-LONDON, V590, P4029, DOI 10.1113/jphysiol.2012.235846; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Nielsen MMB, 2016, SCI REP-UK, V6, DOI 10.1038/srep39571; Risco A, 2012, P NATL ACAD SCI USA, V109, P11200, DOI 10.1073/pnas.1207290109; Sawai H., 2015, BIOACTIVE SPHINGOLIP, P23; Schilling JD, 2013, J BIOL CHEM, V288, P2923, DOI 10.1074/jbc.M112.419978; Shakor ABA, 2011, J BIOL CHEM, V286, P36053, DOI 10.1074/jbc.M111.228593; Sjoqvist U, 2002, INFLAMM BOWEL DIS, V8, P258; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Taniguchi M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.82; Taniguchi M, 2014, BBA-MOL CELL BIOL L, V1841, P692, DOI 10.1016/j.bbalip.2013.12.003; Taniguchi M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416552; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Wang K, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.36; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yan GF, 2016, ONCOTARGET, V7, P33429, DOI 10.18632/oncotarget.7960; Zhang Y, 2011, BIOCHEM PHARMACOL, V82, P287, DOI 10.1016/j.bcp.2011.04.009	46	32	33	5	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3816	3830		10.1096/fj.201601225RR	http://dx.doi.org/10.1096/fj.201601225RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28522594				2022-12-26	WOS:000408713300010
J	Vishnivetskiy, SA; Lee, RJ; Zhou, XE; Franz, A; Xu, QY; Xu, HE; Gurevich, VV				Vishnivetskiy, Sergey A.; Lee, Regina J.; Zhou, X. Edward; Franz, Andreas; Xu, Qiuyi; Xu, H. Eric; Gurevich, Vsevolod V.			Functional role of the three conserved cysteines in the N domain of visual arrestin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arrestin; conformational change; photoreceptor; phototransduction; rhodopsin; activation; cysteines	PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; PHOSPHORYLATION-RECOGNITION; CONFORMATIONAL-CHANGES; BETA-ARRESTIN; RHODOPSIN; BINDING; ACTIVATION; SELECTIVITY; MECHANISM	Arrestins specifically bind active and phosphorylated forms of their cognate G protein-coupled receptors, blocking G protein coupling and often redirecting the signaling to alternative pathways. High-affinity receptor binding is accompanied by two major structural changes in arrestin: release of the C-tail and rotation of the two domains relative to each other. The first requires detachment of the arrestin C-tail from the body of the molecule, whereas the second requires disruption of the network of charge-charge interactions at the interdomain interface, termed the polar core. These events can be facilitated by mutations destabilizing the polar core or the anchoring of the C-tail that yield preactivated arrestins that bind phosphorylated and unphosphorylated receptors with high affinity. Here we explored the functional role in arrestin activation of the three native cysteines in the N domain, which are conserved in all arrestin subtypes. Using visual arrestin-1 and rhodopsin as a model, we found that substitution of these cysteines with serine, alanine, or valine virtually eliminates the effects of the activating polar core mutations on the binding to unphosphorylated rhodopsin while only slightly reducing the effects of the C-tail mutations. Thus, these three conserved cysteines play a role in the domain rotation but not in the C-tail release.	[Vishnivetskiy, Sergey A.; Lee, Regina J.; Franz, Andreas; Xu, Qiuyi; Gurevich, Vsevolod V.] Vanderbilt Univ, Nashville, TN 37232 USA; [Zhou, X. Edward; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, VARI SIMM Ctr,Ctr Struct & Funct Drug Targets, Shanghai 201203, Peoples R China; [Zhou, X. Edward; Xu, H. Eric] Van Andel Res Inst, Ctr Struct Biol & Drug Discovery, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Lee, Regina J.] NIDDK, Bioorgan Chem Lab, Mol Signaling Sect, NIH, Bethesda, MD 20892 USA; [Franz, Andreas] Free Univ Berlin, Takustr 6, D-14195 Berlin, Germany	Vanderbilt University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Van Andel Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Free University of Berlin	Gurevich, VV (corresponding author), Vanderbilt Univ, Nashville, TN 37232 USA.	vsevolod.gurevich@vanderbilt.edu	Gurevich, Vsevolod/A-3236-2008; Vishnivetskiy, Sergey/AAJ-8661-2020; Xu, H. Eric/ABD-7487-2021; Cote, Rick H/G-3363-2013	Gurevich, Vsevolod/0000-0002-3950-5351; Cote, Rick H/0000-0002-1573-6526; Lee, Regina/0000-0001-6091-8057; Xu, H. Eric/0000-0002-6829-8144	National Institutes of Health [EY011500, GM077561, GM109955, R35 GM122491, DK071662]; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122491, R01GM077561, R01GM109955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health R01 Grants EY011500, GM077561, and GM109955 (the latter two were replaced with R35 GM122491 (to V. V. G.) and DK071662 (to H. E. X.)). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; Granzin J, 2015, SCI REP-UK, V5, DOI 10.1038/srep15808; GrayKeller MP, 1997, BIOCHEMISTRY-US, V36, P7058, DOI 10.1021/bi963110k; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Gurevich VV, 1996, METHOD ENZYMOL, V275, P382; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2008, STRUCTURE, V16, P924, DOI 10.1016/j.str.2008.03.006; Hanson SM, 2007, EMBO J, V26, P1726, DOI 10.1038/sj.emboj.7601614; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Kim YJ, 2013, NATURE, V497, P142, DOI 10.1038/nature12133; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P18649; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Song X, 2009, CURR BIOL, V19, P700, DOI 10.1016/j.cub.2009.02.065; Sullivan LS, 2017, INVEST OPHTH VIS SCI, V58, P2774, DOI 10.1167/iovs.16-21341; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SA, 2013, J BIOL CHEM, V288, P11741, DOI 10.1074/jbc.M113.450031; Vishnivetskiy SA, 2013, J BIOL CHEM, V288, P3394, DOI 10.1074/jbc.M112.445437; Vishnivetskiy SA, 2010, J MOL BIOL, V395, P42, DOI 10.1016/j.jmb.2009.10.058; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034; Zhuang TD, 2013, P NATL ACAD SCI USA, V110, P942, DOI 10.1073/pnas.1215176110; Zhuang TD, 2010, BIOCHEMISTRY-US, V49, P10473, DOI 10.1021/bi101596g	40	6	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12496	12502		10.1074/jbc.M117.790386	http://dx.doi.org/10.1074/jbc.M117.790386			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28536260	Green Published, hybrid			2022-12-26	WOS:000406636900014
J	Yonezawa, T; Takahashi, H; Shikata, S; Liu, XX; Tamura, M; Asada, S; Fukushima, T; Fukuyama, T; Tanaka, Y; Sawasaki, T; Kitamura, T; Goyama, S				Yonezawa, Taishi; Takahashi, Hirotaka; Shikata, Shiori; Liu, Xiaoxiao; Tamura, Moe; Asada, Shuhei; Fukushima, Tsuyoshi; Fukuyama, Tomofusa; Tanaka, Yosuke; Sawasaki, Tatsuya; Kitamura, Toshio; Goyama, Susumu			The ubiquitin ligase STUB1 regulates stability and activity of RUNX1 and RUNX1-RUNX1T1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; E3 ubiquitin ligase; leukemia; nuclear transport; post-translational modification (PTM); protein degradation; transcription factor; ubiquitin ligase; ubiquitin-dependent protease; ubiquitylation (ubiquitination)	ACUTE MYELOID-LEUKEMIA; HISTONE DEACETYLASE INHIBITORS; RAR-ALPHA; DEGRADATION; PROTEIN; CHIP; CELLS; DIFFERENTIATION; UBIQUITYLATION; PROMOTES	RUNX1 is a member of RUNX transcription factors and plays important roles in hematopoiesis. Disruption of RUNX1 activity has been implicated in the development of hematopoietic neoplasms. Chromosomal translocations involving the RUNX1 gene are associated with several types of leukemia, including acute myeloid leukemia driven by a leukemogenic fusion protein RUNX1-RUNX1T1. Previous studies have shown that RUNX1 is an unstable protein and is subjected to proteolytic degradation mediated by the ubiquitin-proteasome pathway. However, the precise mechanisms of RUNX1 ubiquitination have not been fully understood. Furthermore, much less is known about the mechanisms to regulate the stability of RUNX1-RUNX1T1. In this study, we identified several RUNX1-interacting E3 ubiquitin ligases using a novel high-throughput binding assay. Among them, we found that STUB1 bound to RUNX1 and induced its ubiquitination and degradation mainly in the nucleus. Immunofluorescence analyses revealed that the STUB1-induced ubiquitination also promoted nuclear export of RUNX1, which probably contributes to the reduced transcriptional activity of RUNX1 in STUB1-overexpressing cells. STUB1 also induced ubiquitination of RUNX1-RUNX1T1 and down-regulated its expression. Importantly, STUB1 overexpression showed a substantial growth-inhibitory effect in myeloid leukemia cells that harbor RUNX1-RUNX1T1, whereas it showed only a marginal effect in other non-RUNX1-RUNX1T1 leukemia cells and normal human cord blood cells. Taken together, these data suggest that the E3 ubiquitin ligase STUB1 is a negative regulator of both RUNX1 and RUNX1-RUNX1T1. Activation of STUB1 could be a promising therapeutic strategy for RUNX1-RUNX1T1 leukemia.	[Yonezawa, Taishi; Shikata, Shiori; Liu, Xiaoxiao; Tamura, Moe; Asada, Shuhei; Fukushima, Tsuyoshi; Fukuyama, Tomofusa; Tanaka, Yosuke; Kitamura, Toshio; Goyama, Susumu] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan; [Takahashi, Hirotaka; Sawasaki, Tatsuya] Ehime Univ, Proteosci Ctr PROS, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan	University of Tokyo; Ehime University	Goyama, S (corresponding author), Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	goyama@ims.u-tokyo.ac.jp	Asada, Shuhei/GOZ-2495-2022; Kitamura, Toshio/AAA-2071-2021	Asada, Shuhei/0000-0001-6116-7996; Yonezawa, Taishi/0000-0002-7963-9434; Liu, Xiaoxiao/0000-0002-0023-4013; Fukuyama, Tomofusa/0000-0002-0709-3188; Sawasaki, Tatsuya/0000-0002-7952-0556	Leukemia Research Fund; Children's Cancer Association of Japan;  [15H06162]; Grants-in-Aid for Scientific Research [16H04729, 16H06579, 15H04855] Funding Source: KAKEN	Leukemia Research Fund; Children's Cancer Association of Japan; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Research Activity 15H06162 start-up (to S. G.), a grant from Leukemia Research Fund (to S. G.), and a grant from Children's Cancer Association of Japan (to S. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Barseguian K, 2002, P NATL ACAD SCI USA, V99, P15434, DOI 10.1073/pnas.242588499; Ben-Ami O, 2013, CELL REP, V4, P1131, DOI 10.1016/j.celrep.2013.08.020; Biggs JR, 2006, MOL CELL BIOL, V26, P7420, DOI 10.1128/MCB.00597-06; Bots M, 2014, BLOOD, V123, P1341, DOI 10.1182/blood-2013-03-488114; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; Dandekar DH, 2005, ANAL BIOCHEM, V342, P341, DOI 10.1016/j.ab.2005.02.006; Deshaies RJ, 2015, NAT CHEM BIOL, V11, P634, DOI 10.1038/nchembio.1887; Goyama S, 2016, LEUKEMIA, V30, P728, DOI 10.1038/leu.2015.275; Goyama S, 2015, ONCOGENE, V34, P3483, DOI 10.1038/onc.2014.305; Goyama S, 2013, J CLIN INVEST, V123, P3876, DOI 10.1172/JCI68557; Goyama S, 2011, INT J HEMATOL, V94, P126, DOI 10.1007/s12185-011-0858-z; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Huang G, 2011, BLOOD, V118, P6544, DOI 10.1182/blood-2010-11-317909; Ito Y, 2015, NAT REV CANCER, V15, P81, DOI 10.1038/nrc3877; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Kanno T, 1998, MOL CELL BIOL, V18, P2444, DOI 10.1128/MCB.18.5.2444; Kramer OH, 2008, FASEB J, V22, P1369, DOI 10.1096/fj.06-8050com; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Li XN, 2008, J CELL BIOL, V181, P959, DOI 10.1083/jcb.200711044; Link KA, 2010, J CELL PHYSIOL, V222, P50, DOI 10.1002/jcp.21950; LU J, 1995, MOL CELL BIOL, V15, P1651; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mulloy JC, 2003, BLOOD, V102, P4369, DOI 10.1182/blood-2003-05-1762; Mulloy JC, 2002, BLOOD, V99, P15, DOI 10.1182/blood.V99.1.15; Nagel S, 2002, J HEMATOTH STEM CELL, V11, P401, DOI 10.1089/152581602753658583; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Seo J, 2016, NAT CELL BIOL, V18, P291, DOI 10.1038/ncb3314; Shang Y, 2009, BIOCHEM BIOPH RES CO, V386, P242, DOI 10.1016/j.bbrc.2009.06.043; Takahashi H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156718; Takahashi H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-39; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Wang S, 2013, EUR J IMMUNOL, V43, P1034, DOI 10.1002/eji.201242554; Yang G, 2007, ONCOGENE, V26, P91, DOI 10.1038/sj.onc.1209760; Zhang DE, 1996, MOL CELL BIOL, V16, P1231	41	12	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12528	12541		10.1074/jbc.M117.785675	http://dx.doi.org/10.1074/jbc.M117.785675			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28536267	Green Published, hybrid			2022-12-26	WOS:000406636900017
J	Park, SL; Murphy, SE; Wilkens, LR; Stram, DO; Hecht, SS; Le Marchand, L				Park, Sungshim L.; Murphy, Sharon E.; Wilkens, Lynne R.; Stram, Daniel O.; Hecht, Stephen S.; Le Marchand, Loic			Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort study	PLOS ONE			English	Article							TOBACCO-SPECIFIC CARCINOGEN; GENETIC POLYMORPHISMS; ETHNIC/RACIAL GROUPS; NICOTINE METABOLISM; SMOKING-BEHAVIOR; DIFFERENT RISKS; CYTOCHROME-P450; DETERMINANTS; POPULATIONS; REDUCTION	While smoking is the primary cause of lung cancer, only 11-24% of smokers develop the malignancy over their lifetime. The primary addictive agent in tobacco smoke is nicotine and variation in nicotine metabolism may influence the smoking levels of an individual. Therefore, inter-individual variation in lung cancer risk among smokers may be due in part to differences in the activity of enzymes involved in nicotine metabolism. In most smokers, cytochrome P450 2A6 (CYP2A6)-catalyzed C-oxidation accounts for >75% of nicotine metabolism, and the activity of this enzyme has been shown to correlate with the amount of nicotine and carcinogens drawn from cigarettes. We prospectively evaluated the association of urinary biomarkers of nicotine uptake (total nicotine equivalents [TNE]) and CYP2A6 activity (ratio of urinary total trans-30-hydroxycotinine to cotinine) with lung cancer risk among 2,309 Multiethnic Cohort Study participants who were current smokers at time of urine collection; 92 cases were diagnosed during a mean follow-up of 9.5 years. We found that higher CYP2A6 activity and TNE was associated with increased lung cancer risk after adjusting for age, sex, race/ ethnicity, body mass index, smoking duration, and urinary creatinine (p's = 0.002). The association for CYP2A6 activity remained even after adjusting for self-reported cigarettes per day (CPD) (Hazard Ratio [HR] per unit increase in log-CYP2A6 activity = 1.52; p = 0.005) and after adjusting for TNE (HR = 1.46; p = 0.01). In contrast, the association between TNE and lung cancer risk was of borderline statistical significance when adjusted for CPD (HR = 1.53; p = 0.06) and not statistically significant when further adjusted for CYP2A6 activity (HR = 1.30; p = 0.22). These findings suggest that CYP2A6 activity provides information on lung cancer risk that is not captured by smoking history or a (short-term) biomarker of dose. CYP2A6 activity should be further studied as a risk biomarker for smoking-related lung cancer.	[Park, Sungshim L.; Stram, Daniel O.; Hecht, Stephen S.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90007 USA; [Murphy, Sharon E.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Wilkens, Lynne R.; Le Marchand, Loic] Univ Hawaii, Canc Ctr, Epidemiol Program, Honolulu, HI 96822 USA	University of Southern California; University of Minnesota System; University of Minnesota Twin Cities; Cancer Research Center of Hawaii; University of Hawaii System	Park, SL (corresponding author), Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90007 USA.; Le Marchand, L (corresponding author), Univ Hawaii, Canc Ctr, Epidemiol Program, Honolulu, HI 96822 USA.	sungship@usc.edu; Loic@cc.hawaii.edu			National Institute of Health/National Cancer Institute [5P01CA138338, P30CA014089, UM1CA164973]; NATIONAL CANCER INSTITUTE [P30CA077598, P01CA138338, P30CA071789] Funding Source: NIH RePORTER	National Institute of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institute of Health/National Cancer Institute, grant numbers: 5P01CA138338, P30CA014089, and UM1CA164973. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benowitz NL, 2002, J NATL CANCER I, V94, P108, DOI 10.1093/jnci/94.2.108; Derby KS, 2008, CANCER EPIDEM BIOMAR, V17, P3526, DOI 10.1158/1055-9965.EPI-08-0424; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fujieda M, 2004, CARCINOGENESIS, V25, P2451, DOI 10.1093/carcin/bgh258; Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; IARC, 2004, IARC MON EV CARC RIS, p[79, 557]; Jalas JR, 2005, CHEM RES TOXICOL, V18, P95, DOI 10.1021/tx049847p; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Liu T, 2013, ENVIRON MOL MUTAGEN, V54, P133, DOI 10.1002/em.21751; Loriot MA, 2001, PHARMACOGENETICS, V11, P39, DOI 10.1097/00008571-200102000-00005; Murphy SE, 2014, CARCINOGENESIS, V35, P2526, DOI 10.1093/carcin/bgu191; Nakajima M, 2007, CURR OPIN MOL THER, V9, P538; Nakajima M, 2006, CLIN PHARMACOL THER, V80, P282, DOI 10.1016/j.clpt.2006.05.012; Park SL, 2016, CARCINOGENESIS, V37, P269, DOI 10.1093/carcin/bgw012; Patel Y, 2014, CANC EPIDEMIOLOGY BI; Patel YM, 2016, CANC RES; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Spitz MR, 2006, CANC EPIDEMIOLOGY PR, P638; Strasser AA, 2011, CANCER EPIDEM BIOMAR, V20, P234, DOI 10.1158/1055-9965.EPI-10-0674; Tan W, 2001, INT J CANCER, V95, P96, DOI 10.1002/1097-0215(20010320)95:2&lt;96::AID-IJC1017&gt;3.0.CO;2-2; Wang HJ, 2003, CANCER RES, V63, P8057; Wassenaar CA, 2015, CARCINOGENESIS, V36, P99, DOI 10.1093/carcin/bgu235; Wassenaar CA, 2011, J NATL CANCER I, V103, P1342, DOI 10.1093/jnci/djr237; Yuan JM, 2016, INT J CANCER, V138, P2161, DOI 10.1002/ijc.29963	25	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178435	10.1371/journal.pone.0178435	http://dx.doi.org/10.1371/journal.pone.0178435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542511	Green Published, gold			2022-12-26	WOS:000402062800089
J	Willems, H; Jacobs, A; Hadiwikarta, WW; Venken, T; Valkenborg, D; Van Roy, N; Vandesompele, J; Hooyberghs, J				Willems, Hanny; Jacobs, An; Hadiwikarta, Wahyu Wijaya; Venken, Tom; Valkenborg, Dirk; Van Roy, Nadine; Vandesompele, Jo; Hooyberghs, Jef			Thermodynamic framework to assess low abundance DNA mutation detection by hybridization	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; TARGETED THERAPY; MICROARRAYS; KRAS; PARAMETERS	The knowledge of genomic DNA variations in patient samples has a high and increasing value for human diagnostics in its broadest sense. Although many methods and sensors to detect or quantify these variations are available or under development, the number of underlying physico-chemical detection principles is limited. One of these principles is the hybridization of sample target DNA versus nucleic acid probes. We introduce a novel thermodynamics approach and develop a framework to exploit the specific detection capabilities of nucleic acid hybridization, using generic principles applicable to any platform. As a case study, we detect point mutations in the KRAS oncogene on a microarray platform. For the given platform and hybridization conditions, we demonstrate the multiplex detection capability of hybridization and assess the detection limit using thermodynamic considerations; DNA containing point mutations in a background of wild type sequences can be identified down to at least 1% relative concentration. In order to show the clinical relevance, the detection capabilities are confirmed on challenging formalin-fixed paraffin-embedded clinical tumor samples. This enzyme-free detection framework contains the accuracy and efficiency to screen for hundreds of mutations in a single run with many potential applications in molecular diagnostics and the field of personalised medicine.	[Willems, Hanny; Jacobs, An; Hadiwikarta, Wahyu Wijaya; Venken, Tom; Valkenborg, Dirk; Hooyberghs, Jef] VITO, Flemish Inst Technol Res, Mol, Belgium; [Hadiwikarta, Wahyu Wijaya] KULeuven, Inst Theoret Phys, Leuven, Belgium; [Valkenborg, Dirk] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Diepenbeek, Belgium; [Van Roy, Nadine; Vandesompele, Jo] Univ Ghent, CMGG, Ghent, Belgium; [Vandesompele, Jo] Univ Ghent, CRIG, Ghent, Belgium; [Hooyberghs, Jef] Hasselt Univ, Theoret Phys, Diepenbeek, Belgium	VITO; KU Leuven; Hasselt University; Ghent University; Ghent University; Hasselt University	Hooyberghs, J (corresponding author), VITO, Flemish Inst Technol Res, Mol, Belgium.; Hooyberghs, J (corresponding author), Hasselt Univ, Theoret Phys, Diepenbeek, Belgium.	jef.hooyberghs@vito.be	Vandesompele, Jo/W-3411-2018	Vandesompele, Jo/0000-0001-6274-0184; Willems, Hanny/0000-0001-9848-1997; VALKENBORG, Dirk/0000-0002-1877-3496; Venken, Tom/0000-0003-0773-1810				Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Ben-Yoav H, 2015, BIOSENS BIOELECTRON, V64, P579, DOI 10.1016/j.bios.2014.09.069; Burden CJ, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016004; Camp ER, 2015, CLIN CANCER RES, V21, P3578, DOI 10.1158/1078-0432.CCR-14-2900; Carlon E, 2006, PHYSICA A, V362, P433, DOI 10.1016/j.physa.2005.09.067; Cornett EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055919; Fuchs J, 2010, BIOPHYS J, V99, P1886, DOI 10.1016/j.bpj.2010.07.002; Gaudet M, 2009, METHODS MOL BIOL, V578, P415, DOI 10.1007/978-1-60327-411-1_26; Ginot F, 1997, HUM MUTAT, V10, P1; Hadiwikarta WW, 2015, BIOSENS BIOELECTRON, V64, P411, DOI 10.1016/j.bios.2014.09.043; Hadiwikarta WW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks475; Hadiwikarta WW, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt682; Halperin A, 2006, J PHYS-CONDENS MAT, V18, pS463, DOI 10.1088/0953-8984/18/18/S01; Harrison A, 2013, NUCLEIC ACIDS RES, V41, P2779, DOI 10.1093/nar/gks1358; Hooyberghs J, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.012901; Hooyberghs J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp109; Hooyberghs J, 2010, BIOSENS BIOELECTRON, V26, P1692, DOI 10.1016/j.bios.2010.07.039; Irving D, 2010, J PHYS CHEM B, V114, P7631, DOI 10.1021/jp100860z; Joda H, 2015, ANAL BIOCHEM, V474, P66, DOI 10.1016/j.ab.2014.11.021; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Noguera DR, 2014, APPL MICROBIOL BIOT, V98, P9595, DOI 10.1007/s00253-014-6165-x; Siena S, 2009, JNCI-J NATL CANCER I, V101, P1308, DOI 10.1093/jnci/djp280; Stancescu M, 2016, J AM CHEM SOC, V138, P13465, DOI 10.1021/jacs.6b05628; Trapp C, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-20; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; van Grinsven B, 2011, LAB CHIP, V11, P1656, DOI 10.1039/c1lc20027e; van Krieken JHJM, 2008, VIRCHOWS ARCH, V453, P417, DOI 10.1007/s00428-008-0665-y; Wei BM, 2015, ANAL CHEM, V87, P2058, DOI 10.1021/ac504797e	28	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177384	10.1371/journal.pone.0177384	http://dx.doi.org/10.1371/journal.pone.0177384			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542229	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800016
J	Xu, MNA; Heidmarsson, S; Thorsteinsdottir, M; Eiriksson, FF; Omarsdottir, S; Olafsdottir, ES				Xu, Maonian; Heidmarsson, Starri; Thorsteinsdottir, Margret; Eiriksson, Finnur F.; Omarsdottir, Sesselja; Olafsdottir, Elin S.			DNA barcoding and LC-MS metabolite profiling of the lichen-forming genus Melanelia: Specimen identification and discrimination focusing on Icelandic taxa	PLOS ONE			English	Article							PARMELIACEAE LECANORALES; MONTANELIA PARMELIACEAE; SECONDARY METABOLITES; PARMELIOID LICHENS; ASCOMYCOTA; DIVERSITY; FAMILY; FUNGI; MS/MS; MELANOHALEA	Taxa in the genus Melanelia (Parmeliaceae, Ascomycota) belong to a group of saxicolous lichens with brown to black foliose thalli, which have recently undergone extensive changes in circumscription. Taxa belonging to Parmeliaceae are prolific producers of bioactive compounds, which have also been traditionally used for chemotaxonomic purposes. However, the chemical diversity of the genus Melanelia and the use of chemical data for species discrimination in this genus are largely unexplored. In addition, identification based on morphological characters is challenging due to few taxonomically informative characters. Molecular identification methods, such as DNA barcoding, have rarely been applied to this genus. This study aimed to identify the Melanelia species from Iceland using DNA barcoding approach, and to explore their chemical diversity using chemical profiling. Chemometric tools were used to see if lichen metabolite profiles determined by LC-MS could be used for the identification of Icelandic Melanelia species. Barcoding using the fungal nuclear ribosomal internal transcribed spacer region (nrITS) successfully identified three Melalenlia species occurring in Iceland, together with Montanelia disjuncta (Basionym: Melanelia disjuncta). All species formed monophyletic clades in the neighbor-joining nrITS gene tree. However, high intraspecific genetic distance of M. stygia suggests the potential of unrecognized species lineages. Principal component analysis (PCA) of metabolite data gave a holistic overview showing that M. hepatizon and M. disjuncta were distinct from the rest, without the power to separate M. agnata and M. stygia due to their chemical similarity. Orthogonal partial least-squares to latent structures-discriminate analysis (OPLS-DA), however, successfully distinguished M. agnata and M. stygia by identifying statistically significant metabolites, which lead to class differentiation. This work has demonstrated the potential of DNA barcoding, chemical profiling and chemometrics in identification of Melanelia species.	[Xu, Maonian; Thorsteinsdottir, Margret; Eiriksson, Finnur F.; Omarsdottir, Sesselja; Olafsdottir, Elin S.] Univ Iceland, Fac Pharmaceut Sci, Reykjavik, Iceland; [Heidmarsson, Starri] Iceland Inst Nat Hist, Akureyri Div, Akureyri, Iceland; [Thorsteinsdottir, Margret; Eiriksson, Finnur F.] ArcticMass, Reykjavik, Iceland	University of Iceland	Olafsdottir, ES (corresponding author), Univ Iceland, Fac Pharmaceut Sci, Reykjavik, Iceland.	elinsol@hi.is	Heiðmarsson, Starri/GVU-6467-2022; Heidmarsson, Starri/A-8305-2009; Olafsdottir, Elin Soffia/A-6946-2008	Heiðmarsson, Starri/0000-0003-0329-6882; Heidmarsson, Starri/0000-0003-0329-6882; Olafsdottir, Elin Soffia/0000-0001-7305-7129; Xu, Maonian/0000-0002-4346-8020	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA [606895]; Bergthora and Thorsteinn Scheving Thorsteinsson Fund	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 under REA; Bergthora and Thorsteinn Scheving Thorsteinsson Fund	The study was financially supported by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/ under REA grant agreement No. 606895 (http://cordis.europa.eu/project/rcn/109122_en.html) as well as a minor contribution from Bergthora and Thorsteinn Scheving Thorsteinsson Fund. The funders provided support in the form of salaries for author [MX], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section. The commercial affiliation Arctic Mass has no financial or competing interests in this study but two of the authors MT and FFE are partially affiliated there. Arctic Mass had the role of providing access to instruments (mass spectrometers) used in the study.	Arup U, 2007, MYCOLOGIA, V99, P42, DOI 10.3852/mycologia.99.1.42; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Blanco O, 2006, MOL PHYLOGENET EVOL, V39, P52, DOI 10.1016/j.ympev.2005.12.015; Blanco O, 2004, MYCOL RES, V108, P873, DOI 10.1017/S0953756204000723; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Crespo A, 2010, TAXON, V59, P1735, DOI 10.1002/tax.596008; Cubero OF, 1999, PLANT SYST EVOL, V216, P243, DOI 10.1007/BF01084401; CULBERSON WL, 1986, BRYOLOGIST, V89, P123, DOI 10.2307/3242752; DIVAKAR P.K, 2017, FUNGAL DIVERS, P1; Divakar PK, 2015, NEW PHYTOL, V208, P1217, DOI 10.1111/nph.13553; Divakar PK, 2012, AM J BOT, V99, P2014, DOI 10.3732/ajb.1200258; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elix J.A., 2001, AUSTRALASIAN LICHENO, V48, P6; ESSLINGER TL, 1978, MYCOTAXON, V7, P45; Fujimura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023426; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Guzow-Krzeminska B, 2003, LICHENOLOGIST, V35, P83, DOI 10.1006/lich.2002.0429; HOLZMANN G, 1990, PHYTOCHEMISTRY, V29, P2277, DOI 10.1016/0031-9422(90)83052-3; Huneck S., 1996, IDENTIFICATION LICHE; Kelly LJ, 2011, NEW PHYTOL, V191, P288, DOI 10.1111/j.1469-8137.2011.03677.x; KRISTINSSON H, 1974, Lichenologist (London), V6, P141, DOI 10.1017/S0024282974000223; KRISTINSSON H, 1969, Bryologist, V72, P344; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Latkowska E, 2015, PHYTOCHEMISTRY, V118, P116, DOI 10.1016/j.phytochem.2015.08.016; Pogam P, 2015, ANAL CHEM, V87, P10421, DOI 10.1021/acs.analchem.5b02531; Leavitt SD, 2016, FUNGAL BIOL-UK, V120, P1374, DOI 10.1016/j.funbio.2016.06.001; Leavitt SD, 2015, MOL PHYLOGENET EVOL, V90, P85, DOI 10.1016/j.ympev.2015.04.029; Leavitt SD, 2014, ORG DIVERS EVOL, V14, P11, DOI 10.1007/s13127-013-0147-1; Leavitt SD, 2013, MOL PHYLOGENET EVOL, V66, P138, DOI 10.1016/j.ympev.2012.09.013; Liebeke M, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0615; Lumbsch HT, 1998, LICHENOLOGIST, V30, P357, DOI 10.1006/lich.1998.0147; McEvoy M, 2006, MYCOL PROG, V5, P221, DOI 10.1007/s11557-006-0514-9; Mittermeier VK, 2015, MOLECULES, V20, P18047, DOI 10.3390/molecules201018047; Musharraf SG, 2015, ANAL METHODS-UK, V7, P6066, DOI [10.1039/c5ay01091h, 10.1039/C5AY01091H]; Nelsen MP, 2011, LICHENOLOGIST, V43, P537, DOI 10.1017/S0024282911000508; Nylander J.A.A, 2004, MRMODELTEST V2; Parrot D, 2013, PHYTOCHEMISTRY, V89, P114, DOI 10.1016/j.phytochem.2013.02.002; Gomez-Serranillos MP, 2014, RSC ADV, V4, P59017, DOI 10.1039/c4ra09104c; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rossello-Mora R, 2008, ISME J, V2, P242, DOI 10.1038/ismej.2007.93; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Singh G, 2013, FUNGAL BIOL-UK, V117, P715, DOI 10.1016/j.funbio.2013.08.001; Spier L, 2007, LICHENOLOGIST, V39, P57, DOI 10.1017/S0024282906006517; Stocker-Worgotter E, 2004, BRYOLOGIST, V107, P152, DOI 10.1639/0007-2745(2004)107[0152:SCOLFC]2.0.CO;2; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THELL A, 1995, NOVA HEDWIGIA, V60, P407; Thell A., 2011, NORDIC LICHEN FLORA, V4; Thi Huyen V, 2016, LICHENOL, V48, P323; Wang HY, 2009, MYCOTAXON, V107, P163, DOI 10.5248/107.163; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Xu MN, 2016, PHYTOMEDICINE, V23, P441, DOI 10.1016/j.phymed.2016.02.012	53	11	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178012	10.1371/journal.pone.0178012	http://dx.doi.org/10.1371/journal.pone.0178012			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542495	Green Submitted, Green Published, gold			2022-12-26	WOS:000402061500053
J	Nyiro, JU; Kombe, IK; Sande, CJ; Kipkoech, J; Kiyuka, PK; Onyango, CO; Munywoki, PK; Kinyanjui, TM; Nokes, DJ				Nyiro, Joyce U.; Kombe, Ivy K.; Sande, Charles J.; Kipkoech, James; Kiyuka, Patience K.; Onyango, Clayton O.; Munywoki, Patrick K.; Kinyanjui, Timothy M.; Nokes, D. James			Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, Kenya	PLOS ONE			English	Article							ANTIBODY-RESPONSE; BIRTH COHORT; INFECTION; PARAINFLUENZA; INFANTS; MEASLES; DISEASE; LIVE; REINFECTION; PARAMETERS	Background Respiratory syncytial virus (RSV) is an important cause of lower respiratory tract disease in early life and a target for vaccine prevention. Data on the age-prevalence of RSV specific antibodies will inform on optimizing vaccine delivery. Methods Archived plasma samples were randomly selected within age strata from 960 children less than 145 months of age admitted to Kilifi County Hospital pediatric wards between 2007 and 2010. Samples were tested for antibodies to RSV using crude virus IgG ELISA. Seroprevalence (and 95% confidence intervals) was estimated as the proportion of children with specific antibodies above a defined cut-off level. Nested catalytic models were used to explore different assumptions on antibody dynamics and estimate the rates of decay of RSV specific maternal antibody and acquisition of infection with age, and the average age of infection. Results RSV specific antibody prevalence was 100% at age 0-<1month, declining rapidly over the first 6 months of life, followed by an increase in the second half of the first year of life and beyond. Seroprevalence was lowest throughout the age range 5-11 months; all children were seropositive beyond 3 years of age. The best fit model to the data yielded estimates for the rate of infection of 0.78/person/year (95% CI 0.65-0.97) and 1.69/person/year (95% CI 1.27-2.04) for ages 0-<1 year and 1-<12 years, respectively. The rate of loss of maternal antibodies was estimated as 2.54/year (95% CI 2.30-2.90), i.e. mean duration 4.7 months. The mean age at primary infection was estimated at 15 months (95% CI 13-18). Conclusions The rate of decay of maternal antibody prevalence and subsequent age-acquisition of infection are rapid, and the average age at primary infection early. The vaccination window is narrow, and suggests optimal targeting of vaccine to infants 5 months and above to achieve high seroconversion.	[Nyiro, Joyce U.; Kombe, Ivy K.; Sande, Charles J.; Kipkoech, James; Kiyuka, Patience K.; Munywoki, Patrick K.; Nokes, D. James] Ctr Geog Med Res Coast, KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Sande, Charles J.] Univ Oxford, Dept Paediat, Oxford, England; [Onyango, Clayton O.] Kenya Govt Med Res Ctr, Ctr Dis Control & Prevent, Kisumu, Kenya; [Kinyanjui, Timothy M.] Univ Manchester, Sch Math, Manchester, Lancs, England; [Nokes, D. James] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England; [Nokes, D. James] Univ Warwick, WIDER, Coventry, W Midlands, England	University of Oxford; Kenya Medical Research Institute; University of Manchester; University of Warwick; University of Warwick	Kombe, IK (corresponding author), Ctr Geog Med Res Coast, KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.	ikombe@kemri-wellcome.org	Kinyanjui, Timothy/S-8489-2019; Munywoki, Patrick K./GQP-4775-2022	Munywoki, Patrick K./0000-0001-9419-7155; Kiyuka, Patience/0000-0002-3257-5920; Kombe, Ivy/0000-0003-1228-8227; Sande, Charles/0000-0002-8364-6063; Kinyanjui, Timothy/0000-0001-5461-4946	Wellcome Trust UK [102975, 084633]	Wellcome Trust UK(Wellcome Trust)	This work is supported by the Wellcome Trust UK,Grant ref: [102975]; [084633] (https://wellcome.ac.uki) to DJN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaku M, 2009, MEM I OSWALDO CRUZ, V104, P897, DOI 10.1590/S0074-02762009000600013; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; BRUSSOW H, 1991, J INFECT DIS, V163, P679, DOI 10.1093/infdis/163.3.679a; CHANOCK R, 1967, B WORLD HEALTH ORGAN, V37, P363; COONEY MK, 1975, AM J EPIDEMIOL, V101, P532, DOI 10.1093/oxfordjournals.aje.a112125; Cox MJ, 1998, J MED VIROL, V55, P234, DOI 10.1002/(SICI)1096-9071(199807)55:3&lt;234::AID-JMV9&gt;3.0.CO;2-2; Faneye Adedayo, 2014, Afr J Infect Dis, V8, P36; FARRINGTON CP, 1990, STAT MED, V9, P953, DOI 10.1002/sim.4780090811; GRENFELL BT, 1985, J HYG-CAMBRIDGE, V95, P419, DOI 10.1017/S0022172400062859; GRIFFITHS D. A., 1974, Applied Statistics, V23, P330, DOI 10.2307/2347126; HALL CB, 1976, NEW ENGL J MED, V294, P414, DOI 10.1056/NEJM197602192940803; Karron RA, 2005, J INFECT DIS, V191, P1093, DOI 10.1086/427813; Karron RA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8463; KATZMANN W, 1984, THEOR POPUL BIOL, V25, P125, DOI 10.1016/0040-5809(84)90016-9; Kinyanjui TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138018; Kucharski AJ, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002082; Kutsaya A, 2016, EPIDEMIOL INFECT, V144, P1622, DOI 10.1017/S0950268815003143; Lee MS, 2005, HUM VACCINES, V1, P6, DOI 10.4161/hv.1.1.1424; MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P111, DOI 10.1017/S0950268800065614; Mossong J, 2004, EPIDEMIOL INFECT, V132, P1121, DOI 10.1017/S0950268804002754; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Nokes DJ, 2009, CLIN INFECT DIS, V49, P1341, DOI 10.1086/606055; Noyola DE, 2005, PEDIATR INFECT DIS J, V24, P1049, DOI 10.1097/01.inf.0000190026.58557.93; Ochola R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008088; Ohuma EO, 2012, AM J EPIDEMIOL, V176, P794, DOI 10.1093/aje/kws257; Sande CJ, 2013, J MED VIROL, V85, P2020, DOI 10.1002/jmv.23696; Siegrist C A, 1998, Dev Biol Stand, V95, P133; Vynnycky E., 2010, INTRO INFECT DIS MOD, DOI DOI 10.1038/NRMICRO1845; WELLIVER RC, 1980, J PEDIATR-US, V96, P808, DOI 10.1016/S0022-3476(80)80547-6; Williams BG, 1995, EPIDEMIOL INFECT, V115, P603, DOI 10.1017/S0950268800058763; WILLIAMS BG, 1994, PARASITOL TODAY, V10, P489, DOI 10.1016/0169-4758(94)90163-5; Wright PF, 2007, VACCINE, V25, P7372, DOI 10.1016/j.vaccine.2007.08.014; Wright PF, 2000, J INFECT DIS, V182, P1331, DOI 10.1086/315859; Zoubir AM, 1998, IEEE SIGNAL PROC MAG, V15, P56, DOI 10.1109/79.647043	34	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177803	10.1371/journal.pone.0177803	http://dx.doi.org/10.1371/journal.pone.0177803			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531224	Green Published, Green Submitted, gold			2022-12-26	WOS:000402058400029
J	Yoshimoto, T; Oka, H; Katsuhira, J; Fujii, T; Masuda, K; Tanaka, S; Matsudaira, K				Yoshimoto, Takahiko; Oka, Hiroyuki; Katsuhira, Junji; Fujii, Tomoko; Masuda, Katsuhiko; Tanaka, Sakae; Matsudaira, Ko			Prognostic psychosocial factors for disabling low back pain in Japanese hospital workers	PLOS ONE			English	Article							FEAR-AVOIDANCE BELIEFS; RISK-FACTORS; PSYCHOLOGICAL DISTRESS; EPIDEMIOLOGIC-RESEARCH; QUESTIONNAIRE FABQ; NEW-ONSET; PREVALENCE; DISABILITY; INSTRUMENTS; PERFORMANCE	Background Although the occupational health field has identified psychosocial factors as risk factors for low back pain that causes disability, the association between disabling low back pain and psychosocial factors has not been examined adequately in Japanese hospital workers. Therefore, this study examined the association between low back pain, which interfered with work, and psychosocial factors in Japanese hospital workers. Method This cross-sectional study was conducted at a hospital in Japan. In total, 280 hospital workers were recruited from various occupational settings. Of these, 203 completed a self-administered questionnaire that included items concerning individual characteristics, severity of low back pain, fear-avoidance beliefs (Fear-Avoidance Beliefs Questionnaire), somatic symptoms (Somatic Symptom Scale-8), psychological distress (K6), workaholism, and work-related psychosocial factors (response rate: 72.5%). Logistic regression was used to explore risk factors associated with disabling low back pain. Results Of the 203 participants who completed questionnaires, 36 (17.7%) reported low back pain that interfered with their work. Multivariate analyses with individual factors and occupations adjusted for showed statistically significant associations between disabling low back pain and fear-avoidance beliefs (adjusted odds ratio [OR]: 2.619, 95% confidence interval [CI]: 1.003-6.538], somatic symptoms (OR: 4.034, 95% CI: 1.819-9.337), and interpersonal stress at work (OR: 2.619, 95% CI: 1.067-6.224). Conclusions Psychosocial factors, such as fear-avoidance beliefs, somatic symptoms, and interpersonal relationships at work, were important risk factors in low back pain that interfered with work in Japanese hospital workers. With respect to occupational health, consideration of psychosocial factors is required to reduce disability related to low back pain.	[Yoshimoto, Takahiko] Kameda Med Ctr, Dept Rehabil, Chiba, Japan; [Oka, Hiroyuki; Fujii, Tomoko; Matsudaira, Ko] Univ Tokyo, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr, Tokyo, Japan; [Katsuhira, Junji] Niigata Univ Hlth & Welf, Dept Prosthet & Orthot & Assist Technol, Fac Med Technol, Niigata, Japan; [Masuda, Katsuhiko] Inc Med Inst Yoseikai, Tokyo, Japan; [Tanaka, Sakae] Univ Tokyo, Dept Orthopaed Surg, Tokyo, Japan	University of Tokyo; Niigata University; University of Tokyo	Oka, H (corresponding author), Univ Tokyo, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr, Tokyo, Japan.	okah-tky@umin.ac.jp	Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414	Industrial Disease Clinical Research Grants [14020301]	Industrial Disease Clinical Research Grants	KM (Matsudaira) reports grants from Industrial Disease Clinical Research Grants (No. 14020301). URL: http://www.mhlw.go.jp/seisakunitsuite/bunya/koyou_roudou/roudoukijun/rousai/hojokin/0000051021.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Obaidi SM, 2005, SPINE, V30, P1051, DOI 10.1097/01.brs.0000160848.94706.83; Bener A, 2013, J PAIN RES, V6, P95, DOI 10.2147/JPR.S40740; Black J.T, 1992, MULTIVARIATE DATA AN; Coggon D, 2013, PAIN, V154, P1769, DOI 10.1016/j.pain.2013.05.039; Coggon D, 2013, OCCUP ENVIRON MED, V70, P575, DOI 10.1136/oemed-2012-101316; Coggon D, 2013, PAIN, V154, P856, DOI 10.1016/j.pain.2013.02.008; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; Davis KG, 2002, SPINE, V27, P2645, DOI 10.1097/00007632-200212010-00003; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; Fritz JM, 2001, PAIN, V94, P7, DOI 10.1016/S0304-3959(01)00333-5; Fujii T, 2013, EUR SPINE J, V22, P432, DOI 10.1007/s00586-012-2439-0; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Gierk B, 2014, JAMA INTERN MED, V174, P399, DOI 10.1001/jamainternmed.2013.12179; Harkness EF, 2003, RHEUMATOLOGY, V42, P959, DOI 10.1093/rheumatology/keg265; Hilfiker R, 2007, EUR SPINE J, V16, P1755, DOI 10.1007/s00586-007-0433-8; Hoogendoorn WE, 2000, SPINE, V25, P2114, DOI 10.1097/00007632-200008150-00017; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Katsuhira J, 2013, SPINE, V38, pE832, DOI 10.1097/BRS.0b013e31829360e5; Kawakami N, 2005, PREV MED, V41, P471, DOI 10.1016/j.ypmed.2005.01.001; Kendall NAS, 2009, TACKLING MUSCULOSKEL; Kent PM, 2005, CHIROPR OSTEOPAT, P1313; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kikuchi S, 2008, EUR SPINE J, V17, pS421, DOI 10.1007/s00586-008-0747-1; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Krismer M, 2007, BEST PRACT RES CL RH, V21, P77, DOI 10.1016/j.berh.2006.08.004; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Linton SJ, 2001, J OCCUP REHABIL, V11, P53, DOI 10.1023/A:1016656225318; Matsudaira K., 2016, JPN PSYCHOSOM MED, V56, P931; Matsudaira K, 2015, IND HEALTH, V53, P368, DOI 10.2486/indhealth.2014-0260; Matsudaira K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093924; Matsudaira K, 2014, J ORTHOP SCI, V19, P26, DOI 10.1007/s00776-013-0471-5; Matsudaira K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075140; Matsudaira K, 2012, SPINE, V37, P1324, DOI 10.1097/BRS.0b013e3182498382; Matsudaira K, 2011, OCCUP ENVIRON MED, V68, P191, DOI 10.1136/oem.2009.053645; Melloh M, 2009, INT ORTHOP, V33, P301, DOI 10.1007/s00264-008-0707-8; Ministry of Health Labour and Welfare, 2015, OCCUPATIONAL DISEASE; Muto S, 2006, IND HEALTH, V44, P123, DOI 10.2486/indhealth.44.123; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Sakakibara T, 2013, PAIN PHYSICIAN, V16, P603; Schaufeli WB, 2009, CROSS-CULT RES, V43, P320, DOI 10.1177/1069397109337239; Shaw WS, 2013, BEST PRACT RES CL RH, V27, P637, DOI 10.1016/j.berh.2013.09.012; Steenstra IA, 2005, OCCUP ENVIRON MED, V62, P851, DOI 10.1136/oem.2004.015842; Steffens D, 2016, JAMA INTERN MED, V176, P199, DOI 10.1001/jamainternmed.2015.7431; Takura T, 2015, J ORTHOP SCI, V20, P750, DOI 10.1007/s00776-015-0730-8; Vargas-Prada S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153748; Vargas-Prada S, 2013, OCCUP ENVIRON MED, V70, P57, DOI 10.1136/oemed-2011-100637; Vlaeyen JWS, 2002, CLIN J PAIN, V18, P251, DOI 10.1097/00002508-200207000-00006; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wada K, 2013, IND HEALTH, V51, P482, DOI 10.2486/indhealth.2013-0016; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Waddell G, 2001, OCCUP MED-OXFORD, V51, P124, DOI 10.1093/occmed/51.2.124; Werneke MW, 2009, ARCH PHYS MED REHAB, V90, P768, DOI 10.1016/j.apmr.2008.11.008; Wertli MM, 2014, SPINE J, V14, P816, DOI 10.1016/j.spinee.2013.09.036; Wood PB, 2006, PAIN, V120, P230, DOI 10.1016/j.pain.2005.12.014	55	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177908	10.1371/journal.pone.0177908	http://dx.doi.org/10.1371/journal.pone.0177908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8UA	28531194	Green Published, Green Submitted, gold			2022-12-26	WOS:000402058400037
J	Zeng, FQ; Biligetu, B; Coulman, B; Schellenberg, MP; Fu, YB				Zeng, Fangqin; Biligetu, Bill; Coulman, Bruce; Schellenberg, Michael P.; Fu, Yong-Bi			RNA-Seq analysis of gene expression for floral development in crested wheatgrass (Agropyron cristatum L.)	PLOS ONE			English	Article							FLOWERING-TIME GENE; DISRUPTS CIRCADIAN-RHYTHMS; LOCUS-T; MOLECULAR CHARACTERIZATION; DIFFERENTIAL EXPRESSION; PHOTOPERIODIC CONTROL; TRANSCRIPTION FACTOR; ALLELIC VARIATION; ARABIDOPSIS; VERNALIZATION	Crested wheatgrass [Agropyron cristatum L. (Gaertn.)] is widely used for early spring grazing in western Canada and the development of late maturing cultivars which maintain forage quality for a longer period is desired. However, it is difficult to manipulate the timing of floral transition, as little is known about molecular mechanism of plant maturity in this species. In this study, RNA-Seq and differential gene expression analysis were performed to investigate gene expression for floral initiation and development in crested wheatgrass. Three cDNA libraries were generated and sequenced to represent three successive growth stages by sampling leaves at the stem elongation stage, spikes at boot and anthesis stages. The sequencing generated 25,568,846; 25,144,688 and 25,714,194 qualified Illumina reads for the three successive stages, respectively. De novo assembly of all the reads generated 311,671 transcripts with a mean length of 487 bp, and 152,849 genes with an average sequence length of 669 bp. A total of 48,574 (31.8%) and 105,222 (68.8%) genes were annotated in the Swiss-Prot and NCBI non-redundant (nr) protein databases, respectively. Based on the Kyoto Encyclopedia of Genes and Genome (KEGG) pathway database, 9,723 annotated sequences were mapped onto 298 pathways, including plant circadian clock pathway. Specifically, 113 flowering time-associated genes, 123 MADS-box genes and 22 CONSTANS-LIKE (COL) genes were identified. A COL homolog DN52048-c0-g4 which was clustered with the flowering time genes AtCO and OsHd1 in Arabidopsis (Arabidopsis thaliana L.) and rice (Oryza sativa L.), respectively, showed specific expression in leaves and could be a CONSTANS (CO) candidate gene. Taken together, this study has generated a new set of genomic resources for identifying and characterizing genes and pathways involved in floral transition and development in crested wheatgrass. These findings are significant for further understanding of the molecular basis for late maturity in this grass species.	[Zeng, Fangqin; Biligetu, Bill; Coulman, Bruce] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada; [Schellenberg, Michael P.] Agr & Agri Food Canada, Swift Current Res & Dev Ctr, Swift Current, SK, Canada; [Fu, Yong-Bi] Agr & Agri Food Canada, Saskatoon Res & Dev Ctr, Plant Gene Resources Canada, Saskatoon, SK, Canada	University of Saskatchewan; Agriculture & Agri Food Canada; Agriculture & Agri Food Canada	Biligetu, B (corresponding author), Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada.; Fu, YB (corresponding author), Agr & Agri Food Canada, Saskatoon Res & Dev Ctr, Plant Gene Resources Canada, Saskatoon, SK, Canada.	bill.biligetu@usask.ca; yong-bi.fu@agr.gc.ca		Coulman, Bruce/0000-0001-9813-8435	Beef Cattle Research Council; AAFC GF2 funds	Beef Cattle Research Council; AAFC GF2 funds	This work was supported by Beef Cattle Research Council and AAFC GF2 funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Mr. Gregory Peterson and Ms. Carolee Horbach for their technical assistance in the research project; Dr. Dwayne Hegedus and Ms. Cathy Coutu at Agriculture and Agri-Food Canada-Saskatoon Research and Development Centre for the access to the Blast2go software; Mr. Brian J. Haas at Klarman Cell Observatory, Broad Institute, USA, for his kind help and suggestions of Trinity; and Drs. Sateesh Kagale and Yifang Tan at National Research Council, Saskatoon, Saskatchewan, and Dr. Jihua Xu at the University of Saskatchewan for their critical reading and valuable comments on the early version of the manuscript. Thanks also go to the three anonymous reviewers and editor for their helpful comments to improve the manuscript. The research was funded by the Beef Cattle Research Council of Canada and AAFC GF2 funds.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Benjamini Y, 2001, ANN STAT, V29, P1165; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; CHOUARD P, 1960, ANNU REV PLANT PHYS, V11, P191, DOI 10.1146/annurev.pp.11.060160.001203; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Danilevskaya ON, 2008, PLANT PHYSIOL, V146, P250, DOI 10.1104/pp.107.109538; Davidson NM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0410-6; Dennis Elizabeth S., 2009, Journal of Biology (London), V8, P57, DOI 10.1186/jbiol156; Devlin PF, 1999, PLANT PHYSIOL, V119, P909, DOI 10.1104/pp.119.3.909; Devlin PF, 1998, PLANT CELL, V10, P1479, DOI 10.1105/tpc.10.9.1479; DEWEY D R, 1984, P209; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Distelfeld A, 2009, PLANT PHYSIOL, V149, P245, DOI 10.1104/pp.108.129353; Dornelas M. C., 2006, Floriculture, ornamental and plant biotechnology, P272; Dornelas Marcelo Carnier, 2005, Braz. J. Plant Physiol., V17, P255, DOI 10.1590/S1677-04202005000200009; Dubcovsky J, 2005, MOL BREEDING, V15, P395, DOI 10.1007/s11032-005-0084-6; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Faure S, 2007, GENETICS, V176, P599, DOI 10.1534/genetics.106.069500; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Greenup A, 2009, ANN BOT-LONDON, V103, P1165, DOI 10.1093/aob/mcp063; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; Huang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-1; Karsai I, 2005, THEOR APPL GENET, V110, P1458, DOI 10.1007/s00122-005-1979-7; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ledger Susan, 2001, Plant Journal, V26, P15, DOI 10.1046/j.1365-313x.2001.01003.x; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2005, PLANT PHYSIOL, V137, P149, DOI 10.1104/pp.104.052811; MOORE KJ, 1991, AGRON J, V83, P1073, DOI 10.2134/agronj1991.00021962008300060027x; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nemoto Y, 2003, PLANT J, V36, P82, DOI 10.1046/j.1365-313X.2003.01859.x; Pankievicz VCS, 2016, PLANT MOL BIOL, V90, P589, DOI 10.1007/s11103-016-0430-6; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Preston JC, 2006, GENETICS, V174, P421, DOI 10.1534/genetics.106.057125; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Sasani S, 2009, J EXP BOT, V60, P2169, DOI 10.1093/jxb/erp098; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; SHARROCK RA, 1989, GENE DEV, V3, P1745, DOI 10.1101/gad.3.11.1745; Somers DE, 1998, DEVELOPMENT, P125; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sullivan JA, 2003, DEV BIOL, V260, P289, DOI 10.1016/S0012-1606(03)00212-4; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trevaskis B, 2006, PLANT PHYSIOL, V140, P1397, DOI 10.1104/pp.105.073486; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yan L, 2004, THEOR APPL GENET, V109, P1677, DOI 10.1007/s00122-004-1796-4; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Zagotta MT, 1996, PLANT J, V10, P691, DOI 10.1046/j.1365-313X.1996.10040691.x; Zhang JP, 2015, GENOMICS, V106, P129, DOI 10.1016/j.ygeno.2015.04.003; Zhao P, 2016, FRONT PLANT SCI, V7	70	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177417	10.1371/journal.pone.0177417	http://dx.doi.org/10.1371/journal.pone.0177417			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531235	Green Published, Green Submitted, gold			2022-12-26	WOS:000402058400017
J	Gonzalez-Jaranay, M; Tellez, L; Roa-Lopez, A; Gomez-Moreno, G; Moreu, G				Gonzalez-Jaranay, Maximino; Tellez, Luis; Roa-Lopez, Antonio; Gomez-Moreno, Gerardo; Moreu, Gerardo			Periodontal status during pregnancy and postpartum	PLOS ONE			English	Article							EXPERIMENTAL GINGIVITIS; HEALTH; WOMEN; DISEASE; HORMONES; PLAQUE; CPITN	Objectives Different studies have documented an association between periodontal disease and low birth-weight delivery. Hence, knowledge of periodontal status during pregnancy and postpartum is important in order to reduce the risks of both diseases. This study aimed to analyze periodontal status at successive stages of pregnancy and 3-6 weeks postpartum in women with initial periodontal alterations. Materials and methods Ninety-six pregnant women were examined at 8-10 weeks (pregnancy diagnosis, baseline), 21-23 weeks and 34-36 weeks of gestation and at 40 days postpartum to record plaque scores, clinically assessed gingival inflammation and probing depth (mean depth and % sites with depth > 3 mm). Bivariate and multivariate analyses were performed. Type 1 (alpha) error was established at 0.05 Results Plaque Index increased (p = 0.043) throughout pregnancy (baseline, 42%+/- 0.18); 21-23 weeks, 42.6%+/- 0.14; 34-36 weeks, 45.6%+/- 0.13 and decreased postpartum (44.8%+/- 0-13). Gingival Index increased (p < 0.001) throughout pregnancy (baseline, 56.7%+/- 0.20; 21-23 weeks, 66.36%+/- 0.17; 34-36 weeks, 74.5%+/- 0.18) and decreased postpartum (59.3% +/- 0.21). Probing Depth increased (p < 0.001) throughout pregnancy (baseline, 2.51 +/- 0.05; 21-23 weeks, 2.63 +/- 0.053; 34-36 weeks 2.81 +/- 0.055) and decreased postpartum (2.54 +/- 0.049). Percentage of sites with Probing Depth > 3 mm increased (p < 0.001) throughout pregnancy (baseline, 17.6%+/- 0.16; 21-23 weeks, 23.9%+/- 0.17; 34-36 weeks, 31.1%+/- 0.17) and decreased postpartum (21.2%+/- 0.17) but remained significantly (p < 0.02) higher than at baseline. Conclusion Periodontal status deteriorates during gestation but improves postpartum.	[Gonzalez-Jaranay, Maximino; Tellez, Luis; Roa-Lopez, Antonio; Gomez-Moreno, Gerardo; Moreu, Gerardo] Univ Granada, Dept Periodontol, Fac Dent, Granada, Spain	University of Granada	Moreu, G (corresponding author), Univ Granada, Dept Periodontol, Fac Dent, Granada, Spain.	gmoreu@ugr.es	López, Antonio Roa/R-2430-2019	López, Antonio Roa/0000-0001-7486-0933				Abraham-Inpijn L, 1996, Stomatologiia (Mosk), V75, P15; AINAMO J, 1975, INT DENT J, V25, P229; Amar S, 2000, PERIODONTOL, V1994, P79; BRABIN BJ, 1985, REV INFECT DIS, V7, P579; Chung LH, 2014, COMMUNITY DENT ORAL, V42, P151, DOI 10.1111/cdoe.12075; COHEN DW, 1969, J PERIODONTOL, V40, P563, DOI 10.1902/jop.1969.40.10.563; Consensus report, 1996, ANN PERIODONTOL, V1, P390; Cruz SS, 2009, COMMUNITY DENT ORAL, V37, P527, DOI 10.1111/j.1600-0528.2009.00492.x; Culhane J F, 2001, Matern Child Health J, V5, P127, DOI 10.1023/A:1011305300690; Figuero E, 2013, J CLIN PERIODONTOL, V40, P457, DOI 10.1111/jcpe.12053; Friedlander AH, 2007, ORAL SURG ORAL MED O, V103, P157, DOI 10.1016/j.tripleo.2006.08.001; Garbero I, 2001, PERIODONCIA, V11, P51; Gursoy M, 2010, J PERIODONTAL RES, V45, P496, DOI 10.1111/j.1600-0765.2009.01264.x; Gursoy M, 2008, J CLIN PERIODONTOL, V35, P576, DOI 10.1111/j.1600-051X.2008.01236.x; Hansen PJ, 1998, J REPROD IMMUNOL, V40, P63, DOI 10.1016/S0165-0378(98)00035-7; Kolodzinsky E, 1999, REV FUNDACION JUAN J, V9, P25; KORNMAN KS, 1980, J PERIODONTAL RES, V15, P111, DOI 10.1111/j.1600-0765.1980.tb00265.x; LOE H, 1965, J PERIODONTOL, V36, P209, DOI 10.1902/jop.1965.36.3.209; Machuca G, 1999, J PERIODONTOL, V70, P779, DOI 10.1902/jop.1999.70.7.779; Mascarenhas P, 2003, J CLIN PERIODONTOL, V30, P671, DOI 10.1034/j.1600-051X.2003.00055.x; Maybodi FR, 2015, INT J REPROD BIOMED, V13, P107; MIYAZAKI H, 1991, J CLIN PERIODONTOL, V18, P751, DOI 10.1111/j.1600-051X.1991.tb00067.x; Moreu G, 2005, J CLIN PERIODONTOL, V32, P622, DOI 10.1111/j.1600-051X.2005.00722.x; Offenbacher S, 2001, Ann Periodontol, V6, P164, DOI 10.1902/annals.2001.6.1.164; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; ONEIL TCA, 1979, J PERIODONTOL, V50, P178; Piliphat W, 2008, COMMUNITY DENT ORAL, V36, P3; Priddy K D, 1997, J Obstet Gynecol Neonatal Nurs, V26, P388, DOI 10.1111/j.1552-6909.1997.tb02720.x; RABERDURLACHER JE, 1993, J PERIODONTOL, V64, P211, DOI 10.1902/jop.1993.64.3.211; RABERDURLACHER JE, 1994, J CLIN PERIODONTOL, V21, P549, DOI 10.1111/j.1600-051X.1994.tb01172.x; RABERDURLACHER JE, 1991, J PERIODONTOL, V62, P663, DOI 10.1902/jop.1991.62.11.663; Smith JL, 1999, J FOOD PROTECT, V62, P818, DOI 10.4315/0362-028X-62.7.818; SOORIYAMOORTHY M, 1989, J CLIN PERIODONTOL, V16, P201, DOI 10.1111/j.1600-051X.1989.tb01642.x; Soory M, 2000, Dent Update, V27, P380; Suresh L, 2004, ORAL SURG ORAL MED O, V97, P672, DOI 10.1016/j.tripleo.2004.02.002; Tartaro S, 1970, Arch Stomatol (Napoli), V11, P65; Taylor DD, 2002, J REPROD IMMUNOL, V54, P15, DOI 10.1016/S0165-0378(01)00067-5; Tilakaratne A, 2000, J CLIN PERIODONTOL, V27, P787, DOI 10.1034/j.1600-051x.2000.027010787.x; Tsai C C, 1995, Gaoxiong Yi Xue Ke Xue Za Zhi, V11, P265; van Steenberghe D, 1997, CLIN PERIODONTOLOGY, P332; VITTEK J, 1982, J CLIN ENDOCR METAB, V54, P608, DOI 10.1210/jcem-54-3-608; Wellinghausen N, 2001, BRIT J NUTR, V85, pS81, DOI 10.1079/BJN2000298; ZACHARIASEN RD, 1993, WOMEN HEALTH, V20, P21, DOI 10.1300/J013v20n02_02	43	34	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178234	10.1371/journal.pone.0178234	http://dx.doi.org/10.1371/journal.pone.0178234			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28538740	Green Submitted, Green Published, gold			2022-12-26	WOS:000401672600047
J	Naito, H; Takahashi, T; Kamada, M; Morino, H; Yoshino, H; Hattori, N; Maruyama, H; Kawakami, H; Matsumoto, M				Naito, Hiroyuki; Takahashi, Tetsuya; Kamada, Masaki; Morino, Hiroyuki; Yoshino, Hiroyo; Hattori, Nobutaka; Maruyama, Hirofumi; Kawakami, Hideshi; Matsumoto, Masayasu			First report of a Japanese family with spinocerebellar ataxia type 10: The second report from Asia after a report from China	PLOS ONE			English	Article							ATTCT REPEAT EXPANSION; HEXANUCLEOTIDE REPEAT; BRAZILIAN FAMILIES; FREQUENCY-ANALYSIS; RNA TOXICITY; SCA10; POPULATION; PHENOTYPE; DISEASE; MODEL	Spinocerebellar ataxia type 10 (SCA10) is an autosomal-dominant cerebellar ataxia that is variably accompanied by epilepsy and other neurological disorders. It is caused by an expansion of the ATTCT pentanucleotide repeat in intron 9 of the ATXN10 gene. Until now, SCA10 was almost exclusively found in the American continents, while no cases had been identified in Japan. Here, we report the first case of an SCA10 family from Japan. The clinical manifestations in our cases were cerebellar ataxia accompanied by epilepsy, hyperreflexia and cognitive impairment. Although the primary pathology in SCA10 in humans is reportedly the loss of Purkinje cells, brain MRI revealed frontal lobe atrophy with white matter lesions. This pathology might be associated with cognitive dysfunction, indicating that the pathological process is not limited to the cerebellum. Examination of the SNPs surrounding the SCA10 locus in the proband showed the "C-expansion-G-G-C" haplotype, which is consistent with previously reported SCA10-positive individuals. This result was consistent with the findings that the SCA10 mutation may have occurred before the migration of Amerindians from East Asia to North America and the subsequent spread of their descendants throughout North and South America.	[Naito, Hiroyuki; Takahashi, Tetsuya; Maruyama, Hirofumi; Matsumoto, Masayasu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan; [Kamada, Masaki] Kagawa Univ, Sch Med, Dept Neurol Intractable Dis Res, Takamatsu, Kagawa, Japan; [Morino, Hiroyuki; Kawakami, Hideshi] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Epidemiol, Hiroshima, Japan; [Yoshino, Hiroyo] Juntendo Univ, Sch Med, Res Inst Dis Old Age, Tokyo, Japan; [Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Tokyo, Japan; [Matsumoto, Masayasu] Hoshigaoka Med Ctr, Japan Community Hlth Care Org, Osaka, Japan	Hiroshima University; Kagawa University; Hiroshima University; Juntendo University; Juntendo University	Takahashi, T (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan.	tetakaha@mac.com	Kawakami, Hideshi/ABE-4077-2021; Maruyama, Hirofumi/B-9333-2011; Kawakami, Hideshi/A-2086-2009; Morino, Hiroyuki/H-9583-2013; Takahashi, Tetsuya/ABG-8566-2021; Hattori, Nobutaka/ACR-0069-2022	Kawakami, Hideshi/0000-0002-1405-0901; Maruyama, Hirofumi/0000-0001-7613-8717; Kawakami, Hideshi/0000-0002-1405-0901; Morino, Hiroyuki/0000-0002-5190-3547; Takahashi, Tetsuya/0000-0001-6891-0842; 				Almeida T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004553; Ashizawa Tetsuo, 2012, Handb Clin Neurol, V103, P507, DOI 10.1016/B978-0-444-51892-7.00032-2; Basri R, 2007, J HUM GENET, V52, P848, DOI 10.1007/s10038-007-0182-x; Brusco A, 2004, ARCH NEUROL-CHICAGO, V61, P727, DOI 10.1001/archneur.61.5.727; Bushara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081342; Choubtum L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0425-y; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Depondt C, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000094; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Du JT, 2015, J BIOL CHEM, V290, P5979, DOI 10.1074/jbc.M114.621607; Fujigasaki H, 2002, ANN NEUROL, V51, P408, DOI 10.1002/ana.10126; Grewal RP, 2002, ARCH NEUROL-CHICAGO, V59, P1285, DOI 10.1001/archneur.59.8.1285; Kapur SS, 2012, ARCH NEUROL-CHICAGO, V69, P1200, DOI 10.1001/archneurol.2011.3044; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Kobayashi H, 2011, AM J HUM GENET, V89, P121, DOI 10.1016/j.ajhg.2011.05.015; Leonardi L, 2014, J NEUROL, V261, P1691, DOI 10.1007/s00415-014-7394-8; Lin X, 2005, CEREBELLUM, V4, P37, DOI 10.1080/14734220510007897; Matsumura R, 2003, ACTA NEUROL SCAND, V107, P38, DOI 10.1034/j.1600-0404.2003.01347.x; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; Matsuura T, 1999, ANN NEUROL, V45, P407, DOI 10.1002/1531-8249(199903)45:3<407::AID-ANA21>3.0.CO;2-D; McFarland KN, 2014, NEUROGENETICS, V15, P59, DOI 10.1007/s10048-013-0385-6; McFarland KN, 2013, EUR J HUM GENET, V21, P1272, DOI 10.1038/ejhg.2013.32; Mulligan CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003199; Ng ASL, 2015, NEUROLOGY, V85, P2060, DOI 10.1212/WNL.0000000000002045; Nozaki H, 2007, MOVEMENT DISORD, V22, P857, DOI 10.1002/mds.21443; Ogaki K, 2013, PARKINSONISM RELAT D, V19, P15, DOI 10.1016/j.parkreldis.2012.06.019; Rasmussen A, 2001, ANN NEUROL, V50, P234, DOI 10.1002/ana.1081; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Roxburgh RH, 2013, J NEUROL SCI, V324, P176, DOI 10.1016/j.jns.2012.09.030; Sugihara K, 2012, MOVEMENT DISORD, V27, P1158, DOI 10.1002/mds.25092; Teive HAG, 2004, NEUROLOGY, V63, P1509; Teive HAG, 2012, CLINICS, V67, P443, DOI 10.6061/clinics/2012(05)07; Tsuji S, 2008, CEREBELLUM, V7, P189, DOI 10.1007/s12311-008-0028-x; Vale J, 2010, EUR J NEUROL, V17, P124, DOI 10.1111/j.1468-1331.2009.02757.x; Wang Jun-ling, 2010, Zhonghua Yixue Yichuanxue Zazhi, V27, P501, DOI 10.3760/cma.j.issn.1003-9406.2010.05.006; Wang Junling, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P482, DOI 10.3969/j.issn.1672-7347.2011.06.003; Wang K, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000026; White M, 2012, J NEUROSCI RES, V90, P706, DOI 10.1002/jnr.22786; White MC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000984; Xia GB, 2013, J NEUROL NEUROSUR PS, V84, P1409, DOI 10.1136/jnnp-2013-305080	40	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177955	10.1371/journal.pone.0177955	http://dx.doi.org/10.1371/journal.pone.0177955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542277	Green Submitted, Green Published, gold			2022-12-26	WOS:000401672600034
J	Kaindoa, EW; Matowo, NS; Ngowo, HS; Mkandawile, G; Mmbando, A; Finda, M; Okumu, FO				Kaindoa, Emmanuel W.; Matowo, Nancy S.; Ngowo, Halfan S.; Mkandawile, Gustav; Mmbando, Arnold; Finda, Marcelina; Okumu, Fredros O.			Interventions that effectively target Anopheles funestus mosquitoes could significantly improve control of persistent malaria transmission in south-eastern Tanzania	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; WESTERN KENYA; DIPTERA; VECTOR; CULICIDAE; IDENTIFICATION; ELISA; AREA; CHALLENGE; RIVULORUM	Malaria is transmitted by many Anopheles species whose proportionate contributions vary across settings. We re-assessed the roles of Anopheles arabiensis and Anopheles funestus, and examined potential benefits of species-specific interventions in an area in southeastern Tanzania, where malaria transmission persists, four years after mass distribution of long-lasting insecticide-treated nets (LLINs). Monthly mosquito sampling was done in randomly selected households in three villages using CDC light traps and back-pack aspirators, between January-2015 and January-2016, four years after the last mass distribution of LLINs in 2011. Multiplex polymerase chain reaction (PCR) was used to identify members of An. funestus and Anopheles gambiae complexes. Enzyme-linked immunosorbent assay (ELISA) was used to detect Plasmodium sporozoites in mosquito salivary glands, and to identify sources of mosquito blood meals. WHO susceptibility assays were done on wild caught female An. funestus s.l, and physiological ages approximated by examining mosquito ovaries for parity. A total of 20,135 An. arabiensis and 4,759 An. funestus were collected. The An. funestus group consisted of 76.6% An. funestus s.s, 2.9% An. rivulorum, 7.1% An. leesoni, and 13.4% unamplified samples. Of all mosquitoes positive for Plasmodium, 82.6% were An. funestus s.s, 14.0% were An. arabiensis and 3.4% were An. rivulorum. An. funestus and An. arabiensis contributed 86.21% and 13.79% respectively, of annual entomological inoculation rate (EIR). An. arabiensis fed on humans (73.4%), cattle (22.0%), dogs (3.1%) and chicken (1.5%), but An. funestus fed exclusively on humans. The An. funestus populations were 100% susceptible to organophosphates, pirimiphos methyl and malathion, but resistant to permethrin (10.5% mortality), deltamethrin (18.7%), lambda-cyhalothrin (18.7%) and DDT (26.2%), and had reduced susceptibility to bendiocarb (95%) and propoxur (90.1%). Parity rate was higher in An. funestus (65.8%) than An. arabiensis (44.1%). Though An. arabiensis is still the most abundant vector species here, the remaining malaria transmission is predominantly mediated by An. funestus, possibly due to high insecticide resistance and high survival probabilities. Interventions that effectively target An. funestus mosquitoes could therefore significantly improve control of persistent malaria transmission in south-eastern Tanzania.	[Kaindoa, Emmanuel W.; Matowo, Nancy S.; Ngowo, Halfan S.; Mkandawile, Gustav; Mmbando, Arnold; Finda, Marcelina; Okumu, Fredros O.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Morogoro, Tanzania; [Kaindoa, Emmanuel W.; Okumu, Fredros O.] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Matowo, Nancy S.] Univ Witwatersrand, Wits Res Inst Malaria, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa; [Ngowo, Halfan S.; Okumu, Fredros O.] Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland; [Mmbando, Arnold] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland	Ifakara Health Institute; University of Witwatersrand; University of Witwatersrand; University of Basel; Swiss Tropical & Public Health Institute	Kaindoa, EW (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Morogoro, Tanzania.; Kaindoa, EW (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa.	ekaindoa@ihi.or.tz	Ngowo, Halfan/AFS-8039-2022	Ngowo, Halfan/0000-0003-2789-0261; Kaindoa, Dr. Emmanuel W/0000-0001-6170-5694; Matowo, Nancy/0000-0002-2302-3796	Wellcome Trust; Association of Physicians of Great Britain and Ireland [100540/Z/12/Z]; Consortium for Advanced Research Training in Africa (CARTA); Wellcome Trust (UK) [087547/Z/08/Z]; Carnegie Corporation of New York [B 8606.R02]; Sida [54100029]; Wellcome Masters Fellowship [WT104029/Z/14/Z]; Wellcome Trust Intermediate Research Fellowship [WT102350/Z/13/Z]; World Health Organization, Special Program for Research and Training in Tropical Diseases [B40445]	Wellcome Trust(Wellcome TrustEuropean Commission); Association of Physicians of Great Britain and Ireland; Consortium for Advanced Research Training in Africa (CARTA); Wellcome Trust (UK)(Wellcome Trust); Carnegie Corporation of New York; Sida; Wellcome Masters Fellowship; Wellcome Trust Intermediate Research Fellowship(Wellcome Trust); World Health Organization, Special Program for Research and Training in Tropical Diseases(World Health Organization)	EK was supported by Wellcome Trust and the Association of Physicians of Great Britain and Ireland for funding this research (Grant Number: 100540/Z/12/Z), EK is also supported by the Consortium for Advanced Research Training in Africa (CARTA), which is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Wellcome Trust (UK) (Grant No: 087547/Z/08/Z), the Carnegie Corporation of New York (Grant No-B 8606.R02), Sida (Grant No:54100029)), NSM received financial supports from Wellcome Masters Fellowship, Grant number: WT104029/Z/14/Z. FOO is also supported by a Wellcome Trust Intermediate Research Fellowship (Grant number: WT102350/Z/13/Z) and a grant from World Health Organization, Special Program for Research and Training in Tropical Diseases (Grant No. B40445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1962, WHO MONOGRAPHIES SER; [Anonymous], OPEN TROP MED J; Bashar K, 2013, ACTA TROP, V125, P220, DOI 10.1016/j.actatropica.2012.10.004; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; BEIER JC, 1990, J MED ENTOMOL, V27, P377, DOI 10.1093/jmedent/27.3.377; BEIER JC, 1988, J MED ENTOMOL, V25, P9, DOI 10.1093/jmedent/25.1.9; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bonner K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-73; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Chaccour C, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1063-y; Coetzee M, 2004, INSECT BIOCHEM MOLEC, V34, P599, DOI 10.1016/j.ibmb.2004.03.012; Cohuet A, 2004, J MED ENTOMOL, V41, P901, DOI 10.1603/0022-2585-41.5.901; Cohuet A, 2003, AM J TROP MED HYG, V69, P200, DOI 10.4269/ajtmh.2003.69.200; Dabire KR, 2007, J MED ENTOMOL, V44, P990, DOI 10.1603/0022-2585(2007)44[990:AFDCIA]2.0.CO;2; Durnez L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-195; Geubbels E, 2015, INT J EPIDEMIOL, V44, P848, DOI 10.1093/ije/dyv068; Gillies M, 1987, ANOPHELINAE AFRICA S; GILLIES M. T., 1960, BULL ENT RES, V51, P243, DOI 10.1017/S0007485300057953; Huho B, 2013, INT J EPIDEMIOL, V42, P235, DOI 10.1093/ije/dys214; Kaindoa EW, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1268-8; Kawada H, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-230; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022574; Killeen GF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-121; Kirby MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-2; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; LINES JD, 1991, B ENTOMOL RES, V81, P77, DOI 10.1017/S0007485300053268; Lwetoijera DW, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-57; Lwetoijera DW, 2014, MALARIA J, V13, P1; Maia MF, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-124; Maia MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045794; Mandike R., 2014, STRATEGY 2014 2020 P; Matowo NS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145653; Matowo NS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-137; Mboera LEG, 1998, AM J TROP MED HYG, V59, P595, DOI 10.4269/ajtmh.1998.59.595; McCann RS, 2014, AM J TROP MED HYG, V90, P597, DOI 10.4269/ajtmh.13-0614; Morgan JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011872; Mulamba C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110058; Mwangangi JM, 2013, PARASITE VECTOR, V6, P1; Mwangungulu SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156388; National Malaria Control Program NMCP Ghana, 2013, EP PROF MAL ITS CONT; National Malaria Control Programme (NMCP), 2015, TANZ SUPPL ENV ASS I; Oxborough RM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-37; Pinheiro J, 2020, R PACKAGE VERSION 31; Renggli S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-85; Russell TL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-187; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Sicuri E, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-307; Skaug H., 2013, GEN LINEAR MIXED MOD; SMITH T, 1993, ACTA TROP, V54, P55, DOI 10.1016/0001-706X(93)90068-M; Sougoufara S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-125; Stevenson JC, 2016, J MED ENTOMOL; Sturrock HJ, 2013, TARGETING ASYMPTOMAT; Tanzania National Malaria Control Program Ifakara Health Institute World Health Organization, 2013, EP PROF MAL ITS CONT; United Republic of Tanzania, 2016, TANZ DEM HLTH SURV M; WHO, 2016, WORLD MALARIA REPORT; WHO, 2013, TEST PROC INS RES MA; Wilkes TJ, 1996, MED VET ENTOMOL, V10, P108, DOI 10.1111/j.1365-2915.1996.tb00092.x; World Health Organization, 1975, MAN PRACT ENT MALA 2, P1	58	65	65	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177807	10.1371/journal.pone.0177807	http://dx.doi.org/10.1371/journal.pone.0177807			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542335	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000401672400087
J	Kamina, AD; Williams, N				Kamina, Anyango D.; Williams, Noreen			Non-canonical binding interactions of the RNA recognition motif (RRM) domains of P34 protein modulate binding within the 5S ribonucleoprotein particle (5S RNP)	PLOS ONE			English	Article							SMALL NUCLEAR RIBONUCLEOPROTEIN; RIBOSOMAL-RNA; CRYSTAL-STRUCTURE; I-TASSER; DYNAMICS; BIOGENESIS; COMPLEX	RNA binding proteins are involved in many aspects of RNA metabolism. In Trypanosoma brucei, our laboratory has identified two trypanosome-specific RNA binding proteins P34 and P37 that are involved in the maturation of the 60S subunit during ribosome biogenesis. These proteins are part of the T. brucei 5S ribonucleoprotein particle (5S RNP) and P34 binds to 5S ribosomal RNA (rRNA) and ribosomal protein L5 through its N-terminus and its RNA recognition motif (RRM) domains. We generated truncated P34 proteins to determine these domains' interactions with 5S rRNA and L5. Our analyses demonstrate that RRM1 of P34 mediates the majority of binding with 5S rRNA and the N-terminus together with RRM1 contribute the most to binding with L5. We determined that the consensus ribonucleoprotein (RNP) 1 and 2 sequences, characteristic of canonical RRM domains, are not fully conserved in the RRM domains of P34. However, the aromatic amino acids previously described to mediate base stacking interactions with their RNA target are conserved in both of the RRM domains of P34. Surprisingly, mutation of these aromatic residues did not disrupt but instead enhanced 5S rRNA binding. However, we identified four arginine residues located in RRM1 of P34 that strongly impact L5 binding. These mutational analyses of P34 suggest that the binding site for 5S rRNA and L5 are near each other and specific residues within P34 regulate the formation of the 5S RNP. These studies show the unique way that the domains of P34 mediate binding with the T. brucei 5S RNP.	[Williams, Noreen] Univ Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14214 USA; Univ Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Williams, N (corresponding author), Univ Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14214 USA.	nw1@buffalo.edu			National Institutes of Health (NIH) [R01 GM110227, R01 GM092719, R01 GM092719 S1]; NIH [T32 A107614]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092719, R01GM110227] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants (http://www.nih.gov) R01 GM110227, R01 GM092719 to NW, supplement R01 GM092719 S1 to ADK, and by the NIH training grant T32 A107614.	Asano N, 2015, NUCLEIC ACIDS RES, V43, P4746, DOI 10.1093/nar/gkv305; Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; Beckmann BM, 2016, PFLUG ARCH EUR J PHY, V468, P1029, DOI 10.1007/s00424-016-1819-4; Ciganda M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041398; Ciganda M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030029; Ciganda M, 2011, WIRES RNA, V2, P523, DOI 10.1002/wrna.74; Clayton C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003680; Daubner GM, 2013, CURR OPIN STRUC BIOL, V23, P100, DOI 10.1016/j.sbi.2012.11.006; Deka P, 2005, J MOL BIOL, V347, P719, DOI 10.1016/j.jmb.2005.01.046; DiNitto JP, 2003, J MOL BIOL, V330, P979, DOI 10.1016/S0022-2836(03)00685-5; DiNitto JP, 2001, BIOCHEMISTRY-US, V40, P12645, DOI 10.1021/bi011439m; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Franco JR, 2014, CLIN EPIDEMIOL, V6, P257, DOI 10.2147/CLEP.S39728; Gamalinda M, 2014, GENE DEV, V28, P198, DOI 10.1101/gad.228825.113; Hargous Y, 2006, EMBO J, V25, P5126, DOI 10.1038/sj.emboj.7601385; Hellman KM, 2007, EUKARYOT CELL, V6, P1766, DOI 10.1128/EC.00119-07; JESSEN TH, 1991, EMBO J, V10, P3447, DOI 10.1002/j.1460-2075.1991.tb04909.x; Kharde S, 2015, NUCLEIC ACIDS RES, V43, P7083, DOI 10.1093/nar/gkv640; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Kishore S, 2010, BRIEF FUNCT GENOMICS, V9, P391, DOI 10.1093/bfgp/elq028; Kolev NG, 2014, CELL MICROBIOL, V16, P482, DOI 10.1111/cmi.12268; Lafontaine DLJ, 2001, NAT REV MOL CELL BIO, V2, P514, DOI 10.1038/35080045; Lisbin MJ, 2000, GENETICS, V155, P1789; Mackereth CD, 2012, CURR OPIN STRUC BIOL, V22, P287, DOI 10.1016/j.sbi.2012.03.013; Madru C, 2015, GENE DEV, V29, P1432, DOI 10.1101/gad.260349.115; Matthews KR, 2015, MOL BIOCHEM PARASIT, V200, P30, DOI 10.1016/j.molbiopara.2015.01.006; McLaughlin KJ, 2011, BIOCHEMISTRY-US, V50, P1429, DOI 10.1021/bi102057m; Muto Y, 2012, WIRES RNA, V3, P229, DOI 10.1002/wrna.1107; Nagai K, 1995, Nucleic Acids Symp Ser, P1; NAGAI K, 1995, TRENDS BIOCHEM SCI, V20, P235, DOI 10.1016/S0968-0004(00)89024-6; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; Perez-Canadillas JM, 2001, CURR OPIN STRUC BIOL, V11, P53, DOI 10.1016/S0959-440X(00)00164-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prohaska K, 2009, EUKARYOT CELL, V8, P77, DOI 10.1128/EC.00234-08; Rideau AP, 2006, NAT STRUCT MOL BIOL, V13, P839, DOI 10.1038/nsmb1137; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schellenberg MJ, 2006, P NATL ACAD SCI USA, V103, P1266, DOI 10.1073/pnas.0508048103; SHAMOO Y, 1995, NUCLEIC ACIDS RES, V23, P725, DOI 10.1093/nar/23.5.725; Szymanski M, 2003, BIOCHEM J, V371, P641, DOI 10.1042/BJ20020872; Tsuda K, 2011, NUCLEIC ACIDS RES, V39, P1538, DOI 10.1093/nar/gkq854; Umaer K, 2014, EUKARYOT CELL, V13, P727, DOI 10.1128/EC.00307-13; Umaer MC, 2016, ENCY CELL BIOL, P288; Wang I, 2014, NUCLEIC ACIDS RES, V42, P5949, DOI 10.1093/nar/gku193; Wang L, 2013, EUKARYOT CELL, V12, P559, DOI 10.1128/EC.00004-13; Wang L, 2013, EUKARYOT CELL, V12, P322, DOI 10.1128/EC.00316-12; Wilson DN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011536; Wurst M, 2009, MOL BIOCHEM PARASIT, V163, P61, DOI 10.1016/j.molbiopara.2008.09.001; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang J, 1997, MOL BIOCHEM PARASIT, V87, P145, DOI 10.1016/S0166-6851(97)00060-1; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	52	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177890	10.1371/journal.pone.0177890	http://dx.doi.org/10.1371/journal.pone.0177890			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542332	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400108
J	Klymus, KE; Marshall, NT; Stepien, CA				Klymus, Katy E.; Marshall, Nathaniel T.; Stepien, Carol A.			Environmental DNA (eDNA) metabarcoding assays to detect invasive invertebrate species in the Great Lakes	PLOS ONE			English	Article							PRIMERS; BARCODE; PCR; IDENTIFICATION; DEGRADATION; TEMPERATURE; REVEALS; REGION	Describing and monitoring biodiversity comprise integral parts of ecosystem management. Recent research coupling metabarcoding and environmental DNA (eDNA) demonstrate that these methods can serve as important tools for surveying biodiversity, while significantly decreasing the time, expense and resources spent on traditional survey methods. The literature emphasizes the importance of genetic marker development, as the markers dictate the applicability, sensitivity and resolution ability of an eDNA assay. The present study developed two metabarcoding eDNA assays using the mtDNA 16S RNA gene with lllumina MiSeq platform to detect invertebrate fauna in the Laurentian Great Lakes and surrounding waterways, with a focus for use on invasive bivalve and gastropod species monitoring. We employed careful primer design and in vitro testing with mock communities to assess ability of the markers to amplify and sequence targeted species DNA, while retaining rank abundance information. In our mock communities, read abundances reflected the initial input abundance, with regressions having significant slopes (p < 0.05) and high coefficients of determination (R-2) for all comparisons. Tests on field environmental samples revealed similar ability of our markers to measure relative abundance. Due to the limited reference sequence data available for these invertebrate species, care must be taken when analyzing results and identifying sequence reads to species level. These markers extend eDNA metabarcoding research for molluscs and appear relevant to other invertebrate taxa, such as rotifers and bryozoans. Furthermore, the sphaeriid mussel assay is group-specific, exclusively amplifying bivalves in the Sphaeridae family and providing species-level identification. Our assays provide useful tools for managers and conservation scientists, facilitating early detection of invasive species as well as improving resolution of mollusc diversity.	[Klymus, Katy E.; Marshall, Nathaniel T.; Stepien, Carol A.] Univ Toledo, Great Lakes Genet Genom Lab, Dept Environm Sci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Klymus, Katy E.] US Geol Survey, Columbia Environm Res Ctr, Columbia, MO USA; [Stepien, Carol A.] NOAA, Pacific Marine Environm Lab, 7600 Sand Point Way Ne, Seattle, WA 98115 USA	University System of Ohio; University of Toledo; United States Department of the Interior; United States Geological Survey; National Oceanic Atmospheric Admin (NOAA) - USA	Stepien, CA (corresponding author), Univ Toledo, Great Lakes Genet Genom Lab, Dept Environm Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.; Stepien, CA (corresponding author), NOAA, Pacific Marine Environm Lab, 7600 Sand Point Way Ne, Seattle, WA 98115 USA.	carol.stepien@noaa.gov	Stepien, Carol Ann/GWU-8631-2022; Stepien, Carol A./A-7898-2011; A.Stepien, Carol/AAW-5270-2020	Stepien, Carol A./0000-0002-5544-4333; Marshall, Nathaniel/0000-0002-0548-4273; Klymus, Katy/0000-0002-8843-6241	USEPA (Environmental Protection Agency) [GLRI GL 00E01289, GL -00E01149, GL-00E01898]	USEPA (Environmental Protection Agency)	This study was supported by the USEPA (Environmental Protection Agency) (GLRI GL 00E01289) to Dr. Carol A Stepien; USEPA (Environmental Protection Agency) (GL -00E01149) to Dr. Carol A Stepien; USEPA (Environmental Protection Agency) (GL-00E01898) to Dr. Carol A Stepien. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Beng KC, 2016, SCI REP-UK, V6, DOI 10.1038/srep24965; Blanco-Bercial L, 2014, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.cdf8b74881f87e3b01d56b43791626d2; Blankenship LE, 2005, MOL ECOL, V14, P891, DOI 10.1111/j.1365-294X.2005.02448.x; Blomquist Thomas, 2015, Biomol Detect Quantif, V5, P30; Cannon MV, 2016, SCI REP-UK, V6, DOI 10.1038/srep22908; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carew ME, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-45; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Darling JA, 2011, ENVIRON RES, V111, P978, DOI 10.1016/j.envres.2011.02.001; Deagle BE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0562; Deiner K, 2016, NAT COMMUN, V7, P1, DOI 10.1038/ncomms12544; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eichmiller JJ, 2016, ENVIRON SCI TECHNOL, V50, P1859, DOI 10.1021/acs.est.5b05672; Evans NT, 2016, MOL ECOL RESOUR, V16, P29, DOI 10.1111/1755-0998.12433; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Handley LL, 2015, BIOL J LINN SOC, V115, P17; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Karlsson AO, 2007, FORENSIC SCI INT, V173, P16, DOI 10.1016/j.forsciint.2007.01.019; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Lydeard C, 1997, MOL PHYLOGENET EVOL, V7, P117, DOI 10.1006/mpev.1996.0377; McMurdie P, 2014, BIOM INTERFACE PACKA; Minton RL, 2003, MOL ECOL, V12, P75, DOI 10.1046/j.1365-294X.2003.01719.x; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052; National Oceanic and Atmospheric Administration, 2012, GREAT LAK AQ NON SPE; Ohio EPA, 2014, BIOL WATER QUALITY S; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Pierre Taberlet, 2012, MOL ECOL, V2012, P5; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; R Core Team, 2021, R LANGUAGE ENV STAT; Riaz T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr732; Ryberg M, 2015, MOL ECOL, V24, P5770, DOI 10.1111/mec.13444; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Simberloff D, 2014, ECOL ENG, V65, P112, DOI 10.1016/j.ecoleng.2013.08.004; Sinniger F, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00092; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; US Army Corps of Engineers, 2014, GLMRIS REP NONN SPEC; US Environmental Protection Agency, 2009, PRED FUT INTR NON SP; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; Wu LY, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0450-4; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x; Zentilin L, 2007, NAT PROTOC, V2, P2092, DOI 10.1038/nprot.2007.299	57	73	77	6	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177643	10.1371/journal.pone.0177643	http://dx.doi.org/10.1371/journal.pone.0177643			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542313	Green Submitted, gold, Green Published			2022-12-26	WOS:000401672400062
J	Zhai, XW; Zhang, L; Guo, YF; Yang, Y; Wang, DM; Zhang, Y; Li, P; Niu, YF; Feng, QL; Wu, BW; Cao, JM; Liu, QH				Zhai, Xu-Wen; Zhang, Li; Guo, Yun-Fei; Yang, Ying; Wang, Dong-Ming; Zhang, Yan; Li, Pan; Niu, Yi-Fan; Feng, Qi-Long; Wu, Bo-Wei; Cao, Ji-Min; Liu, Qing-Hua			The /(K1)/Kir2.1 channel agonist zacopride prevents and cures acute ischemic arrhythmias in the rat	PLOS ONE			English	Article							TRANSIENT OUTWARD CURRENT; ACTION-POTENTIAL DURATION; ACUTE MYOCARDIAL-ISCHEMIA; TRANSGENIC UP-REGULATION; RECTIFIER K+ CHANNELS; VENTRICULAR-TACHYCARDIA; POTASSIUM CURRENT; GUINEA-PIG; CARDIAC EXCITABILITY; ATRIAL-FIBRILLATION	Arrhythmogenesis in acute myocardial infarction (MI) is associated with depolarization of resting membraine potential (RMP) and decrease of inward rectifier potassium current (/(K1)) in cardiomyocytes. However, clinical anti-arrhythmic agents that primarily act on RMP by enhancing the /(K1) channel are not currently available. We hypothesized that zacopride, a selective and moderate agonist of the /(K1)/Kir2.1 channels, prevents and cures acute ischemic arrhythmias. To test this viewpoint, adult Sprague-Dawley (SD) rats were subjected to MI by ligating the left main coronary artery. The antiarrhythmic effects of zacopride (i.v. infusion) were observed in the settings of pre-treatment (zacopride given 3 min prior to coronary occlusion), post-treatment (zacopride given 3 min after coronary occlusion) and therapeutic treatment (zacopride given 30 s after the onset of the first sustained ventricular tachycardia (VT)/ventricular fibrillation (VF) post MI). In all the three treatment modes, zacopride (15 mu g/ kg) inhibited MI-induced ventricular tachyarrhythmias, as shown by significant decreases in the premature ventricular contraction (PVC) and the duration and incidence of VT or VF. In Langendorff perfused rat hearts, the antiarrhythmic effect of 1 mu mol/L zacopride were reversed by 1 mu mol/L BaCl2, a blocker of /K-1 channel. Patch clamp results in freshly isolated rat ventricular myocytes indicated that zacopride activated the /K-1 channel and thereby reversed hypoxia-induced RMP depolarization and action potential duration (APD) prolongation. In addition, zacopride (1 mu mol/L) suppressed hypoxia-or isoproterenol-induced delayed afterdepolarizations (DADs). In Kir2. x transfected Chinese hamster ovary (CHO) cells, zacopride activated the Kir2.1 homomeric channel but not the Kir2.2 or Kir2.3 channels. These results support our hypothesis that moderately enhancing /K-1/Kir2.1 currents as by zacopride rescues ischemia-and hypoxia-induced RMP depolarization, and thereby prevents and cures acute ischemic arrhythmias. This study brings a new viewpoint to antiarrhythmic theories and provides a promising target for the treatment of acute ischemic arrhythmias.	[Zhai, Xu-Wen; Feng, Qi-Long; Wu, Bo-Wei] Shanxi Med Univ, Dept Physiol, Taiyuan, Peoples R China; [Zhang, Li] Shanxi Prov Childrens Hosp, Taiyuan, Peoples R China; [Guo, Yun-Fei; Yang, Ying; Zhang, Yan; Li, Pan; Niu, Yi-Fan; Liu, Qing-Hua] Shanxi Med Univ, Dept Pathophysiol, Taiyuan, Peoples R China; [Wang, Dong-Ming] Shanxi Med Univ, Hosp 2, Taiyuan, Peoples R China; [Cao, Ji-Min] Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Dept Physiol,Inst Basic Med Sci, Beijing, Peoples R China	Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Liu, QH (corresponding author), Shanxi Med Univ, Dept Pathophysiol, Taiyuan, Peoples R China.; Cao, JM (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Dept Physiol,Inst Basic Med Sci, Beijing, Peoples R China.	caojimin@126.com; liuqh20041206@163.com	Liu, Qinghua/HCH-3099-2022		National Natural Science Foundation of China [31200864, 81670313]; Shanxi Scholarship Council of China [2016-059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanxi Scholarship Council of China	This work was supported by grants from the National Natural Science Foundation of China (No. 31200864 to QL and No. 81670313 to JC) and Research Project Supported by Shanxi Scholarship Council of China (No. 2016-059 to QL).	Anumonwo JMB, 2010, J MOL CELL CARDIOL, V48, P45, DOI 10.1016/j.yjmcc.2009.08.013; APKON M, 1991, J GEN PHYSIOL, V97, P973, DOI 10.1085/jgp.97.5.973; Baldo MP, 2008, J CARDIOVASC PHARM, V52, P375, DOI 10.1097/FJC.0b013e31818a2bb0; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; Cha TJ, 2004, CIRCULATION, V110, P1520, DOI 10.1161/01.CIR.0000142052.03565.87; Cherry EM, 2004, AM J PHYSIOL-HEART C, V286, pH2332, DOI 10.1152/ajpheart.00747.2003; Chung MK, 1997, CIRCULATION, V95, P2517, DOI 10.1161/01.CIR.95.11.2517; CLARKSON CW, 1983, CIRC RES, V52, P543, DOI 10.1161/01.RES.52.5.543; Collins A, 2005, J CELL PHYSIOL, V202, P76, DOI 10.1002/jcp.20093; CORABOEUF E, 1980, J PHYSIOL-PARIS, V76, P97; Curtis MJ, 2013, PHARMACOL THERAPEUT, V139, P213, DOI 10.1016/j.pharmthera.2013.04.008; de Boer TP, 2010, ACTA PHYSIOL, V199, P243, DOI 10.1111/j.1748-1716.2010.02108.x; Dhamoon AS, 2005, HEART RHYTHM, V2, P316, DOI 10.1016/j.hrthm.2004.11.012; Dhamoon AS, 2004, CIRC RES, V94, P1332, DOI 10.1161/01.RES.0000128408.66946.67; Elnakish MT, 2017, PHARMACOL RES, V115, P309, DOI 10.1016/j.phrs.2016.11.033; Gaborit N, 2005, CIRCULATION, V112, P471, DOI 10.1161/CIRCULATIONAHA.104.506857; Gomez R, 2009, CIRC RES, V105, P383, DOI 10.1161/CIRCRESAHA.109.197558; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRIS AS, 1954, SCIENCE, V119, P200, DOI 10.1126/science.119.3085.200; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Huang SS, 2001, DRUG DEVELOP RES, V53, P244, DOI 10.1002/ddr.1193; ITO H, 1992, PFLUG ARCH EUR J PHY, V422, P280, DOI 10.1007/BF00376214; JANUARY CT, 1989, CIRC RES, V64, P977, DOI 10.1161/01.RES.64.5.977; Jung CB, 2012, EMBO MOL MED, V4, P180, DOI 10.1002/emmm.201100194; KOUMI S, 1995, J PHYSIOL-LONDON, V486, P661, DOI 10.1113/jphysiol.1995.sp020842; Li JD, 2004, AM J PHYSIOL-HEART C, V287, pH2790, DOI 10.1152/ajpheart.00114.2004; Li Shanshuang, 2006, Exp Clin Cardiol, V11, P280; Liu QH, 2012, J CARDIOVASC PHARM, V59, P37, DOI 10.1097/FJC.0b013e3182350bcc; Liu YG, 1997, AM J PHYSIOL-HEART C, V273, pH1637, DOI 10.1152/ajpheart.1997.273.4.H1637; Lopatin AN, 2001, J MOL CELL CARDIOL, V33, P625, DOI 10.1006/jmcc.2001.1344; Lopatin AN, 2014, CARDIAC ELECTROPHYSI, P33; Mackall JA, 2010, CARDIAC INTENSIVE CA, P3; MILL JG, 1991, BRAZ J MED BIOL RES, V24, P855; Nerbonne JM, 2000, J PHYSIOL-LONDON, V525, P285, DOI 10.1111/j.1469-7793.2000.t01-1-00285.x; Piao L, 2007, BASIC RES CARDIOL, V102, P416, DOI 10.1007/s00395-007-0659-y; POGWIZD SM, 1994, CIRCULATION, V90, P1441, DOI 10.1161/01.CIR.90.3.1441; Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193; Pogwizd SM, 1997, CIRCULATION, V95, P2528, DOI 10.1161/01.CIR.95.11.2528; Samie FH, 2001, CIRC RES, V89, P1216, DOI 10.1161/hh2401.100818; SCHOMIG A, 1991, EUR HEART J, V12, P38, DOI 10.1093/eurheartj/12.suppl_F.38; Sedlis S P, 1992, Cardiovasc Clin, V22, P3; Sejersted OM, 2000, PHYSIOL REV, V80, P1411, DOI 10.1152/physrev.2000.80.4.1411; Shaw RM, 1997, CARDIOVASC RES, V35, P256, DOI 10.1016/S0008-6363(97)00093-X; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; Sun XY, 2005, J PHYSIOL-LONDON, V564, P411, DOI 10.1113/jphysiol.2004.077263; TANDE PM, 1990, J CARDIOVASC PHARM, V16, P401, DOI 10.1097/00005344-199009000-00008; TERZIC A, 1995, AM J PHYSIOL-CELL PH, V269, pC525, DOI 10.1152/ajpcell.1995.269.3.C525; Verkerk AO, 1996, J MOL CELL CARDIOL, V28, P2443, DOI 10.1006/jmcc.1996.0237; Watanabe I, 1997, J CARDIOVASC ELECTR, V8, P1229, DOI 10.1111/j.1540-8167.1997.tb01012.x; WIT AL, 1992, HEART CARDIOVASCULAR, P2113; Workman AJ, 2000, BASIC RES CARDIOL, V95, P250, DOI 10.1007/s003950050188; Zhang HG, 2005, CARDIOVASC RES, V66, P493, DOI 10.1016/j.cardiores.2005.01.020; Zhang L, 2013, SCI CHINA LIFE SCI, V56, P788, DOI 10.1007/s11427-013-4531-z	53	15	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177600	10.1371/journal.pone.0177600	http://dx.doi.org/10.1371/journal.pone.0177600			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542320	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400056
J	Zhang, Y; Hu, Y; Wang, JL; Yao, H; Wang, H; Liang, L; Li, C; Shi, H; Chen, Y; Fang, JY; Xu, J				Zhang, Y.; Hu, Y.; Wang, J-L; Yao, H.; Wang, H.; Liang, L.; Li, C.; Shi, H.; Chen, Y.; Fang, J-Y; Xu, J.			Proteomic identification of ERP29 as a key chemoresistant factor activated by the aggregating p53 mutant Arg282Trp	ONCOGENE			English	Article							GAIN-OF-FUNCTION; PROTEIN 29 ERP29; CANCER CELLS; UNFOLDED PROTEIN; EXPRESSION; APOPTOSIS; GENE; DNA; CHEMOTHERAPY; PROGRESSION	Mutation of the TP53 gene represents a prevalent genetic alteration in human cancers, and a subset of p53 mutants may form amyloid-like aggregates that contribute to the gain of oncogenic functions (GOFs) and chemoresistance. Here we identify the pathways that may mediate the aggregation-associated GOF by using combined proteomic analysis and genome-wide recruitment profiling. Mass spectrometry revealed activation of unfolded protein response (UPR) pathway and upregulation of endoplasmic reticulum protein 29 (ERp29) in (R282W)TP53-expressing cells that were exposed to cisplatin stress. Chromatin immunoprecipitation sequencing identified a significant 'CCCASS' binding motif of Arg282Trp, which is present in the promoter region of ERP29 gene. The mutant p53 upregulated ERP29 mRNA and protein expression levels, whereas targeting ERP29 by specific small interfering RNAs suppressed the chemoresistant effect of Arg282Trp. The anti-aggregation peptide ReACp53 significantly decreased ERP29 expression and suppressed the chemoresistant effect. These findings highlight a role of ERP29 in the acquired chemoresistance of cancer cells expressing the aggregating p53 mutant Arg282Trp. Our results also suggest that ERP29-mediated GOF can be targeted by the anti-aggregation peptide ReACp53.	[Zhang, Y.; Hu, Y.; Wang, J-L; Yao, H.; Wang, H.; Liang, L.; Li, C.; Chen, Y.; Fang, J-Y; Xu, J.] Shanghai Jiao Tong Univ, Key Lab Gastroenterol & Hepatol,Renji Hosp, State Key Lab Oncogenes & Related Genes,Sch Med, Div Gastroenterol & Hepatol,Minist Hlth, Shanghai, Peoples R China; [Zhang, Y.; Hu, Y.; Wang, J-L; Yao, H.; Wang, H.; Liang, L.; Li, C.; Chen, Y.; Fang, J-Y; Xu, J.] Shanghai Inst Digest Dis, Shanghai, Peoples R China; [Hu, Y.] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Shi, H.] Sichuan Univ, West China Hosp, Div Canc Biotherapy, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China; [Shi, H.] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu, Sichuan, Peoples R China; [Shi, H.] Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Sichuan University; Sichuan University	Xu, J (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Renji Hosp, Sch Med, Shanghai 200001, Peoples R China.	jiexu@sjtu.edu.cn	Xu, Jie/K-3712-2019; li, chu/GPS-7224-2022	Xu, Jie/0000-0001-9163-3898; zhang, yao/0000-0003-1174-7049; Li, Chushu/0000-0001-6658-2208	National Natural Science Foundation of China [81572326, 81322036, 81272383, 81421001, 81320108024, 81530072, 81602518, 81502015, 81572303]; Top-Notch Young Talents Program of China [ZTZ2015-48]; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support [20152514]; National Key Research & Development (RD) Plan [2016YFC0906000, 2016YFC0906002]; National Key Technology Support Program [2015BAI13B07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Top-Notch Young Talents Program of China; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support; National Key Research & Development (RD) Plan; National Key Technology Support Program(National Key Technology R&D Program)	This project was supported by grants from National Natural Science Foundation of China (81572326, 81322036, 81272383, 81421001, 81320108024, 81530072, 81602518, 81502015 and 81572303); Top-Notch Young Talents Program of China (ZTZ2015-48); Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support (20152514); National Key Research & Development (R&D) Plan (2016YFC0906000 and 2016YFC0906002); and National Key Technology Support Program (2015BAI13B07). The sponsors of this study had no role in the collection of the data, the analysis and interpretation of the data, the decision to submit the manuscript for publication or the writing of the manuscript.	Acin S, 2011, J PATHOL, V225, P479, DOI 10.1002/path.2971; Al-Rawashdeh FY, 2010, EUR J GASTROEN HEPAT, V22, P1099, DOI 10.1097/MEG.0b013e3283378405; Ali A, 2014, CANCER LETT, V354, P87, DOI 10.1016/j.canlet.2014.07.045; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Chen SH, 2015, SCI REP-UK, V5, DOI 10.1038/srep14723; Chen SH, 2015, FEBS OPEN BIO, V5, P91, DOI 10.1016/j.fob.2015.01.004; Cheung EC, 2010, CURR OPIN CELL BIOL, V22, P186, DOI 10.1016/j.ceb.2009.12.006; Chiang MF, 2012, BIOMED PHARMACOTHER, V66, P433, DOI 10.1016/j.biopha.2012.03.003; Cino EA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32535; Coffill CR, 2012, EMBO REP, V13, P638, DOI 10.1038/embor.2012.74; Das S, 2009, MOL BIOL CELL, V20, P2593, DOI 10.1091/mbc.E08-07-0790; Datta A, 2016, GENOM DATA, V8, P47, DOI 10.1016/j.gdata.2016.03.003; Di Fiore R, 2014, BONE, V60, P198, DOI 10.1016/j.bone.2013.12.021; Do PM, 2012, GENE DEV, V26, P830, DOI 10.1101/gad.181685.111; Dudgeon C, 2014, GENE DEV, V28, P2613, DOI 10.1101/gad.252148.114; Epple LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073267; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Gifford JB, 2016, MOL CANCER THER, V15, P1043, DOI 10.1158/1535-7163.MCT-15-0774; Guan Z, 2007, CANCER RES, V67, P10436, DOI 10.1158/0008-5472.CAN-07-1379; He C, 2017, CHEMOTHERAPY, V62, P43, DOI 10.1159/000446361; Hirsch I, 2014, APOPTOSIS, V19, P801, DOI 10.1007/s10495-013-0961-0; Hume MA, 2015, NUCLEIC ACIDS RES, V43, pD117, DOI 10.1093/nar/gku1045; Humpton TJ, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026146; Kim E, 2007, ONCOGENE, V26, P2185, DOI 10.1038/sj.onc.1210312; Kim MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120536; Kiprijanovska S., 2014, INT J PROTEOMICS, V2014, DOI DOI 10.1155/2014/594761; Krishnan SR, 2015, BREAST CANCER RES TR, V150, P487, DOI 10.1007/s10549-015-3339-x; Lasagna-Reeves CA, 2013, BIOCHEM BIOPH RES CO, V430, P963, DOI 10.1016/j.bbrc.2012.11.130; Lavra L, 2009, J PATHOL, V218, P66, DOI 10.1002/path.2510; Lee E, 2006, CANCER RES, V66, P7849, DOI 10.1158/0008-5472.CAN-06-1660; Levy CB, 2011, INT J BIOCHEM CELL B, V43, P60, DOI 10.1016/j.biocel.2010.10.017; Li D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.158; Lu Jin-Jian, 2015, Chin J Nat Med, V13, P673, DOI 10.1016/S1875-5364(15)30065-0; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Magdeldin S, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-16; Mantovani F, 2017, FEBS J, V284, P837, DOI 10.1111/febs.13948; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; May Caroline, 2012, Methods Mol Biol, V893, P37, DOI 10.1007/978-1-61779-885-6_3; Mori-Iwamoto S, 2007, INT J ONCOL, V31, P1345; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Neilsen PM, 2011, ONCOTARGET, V2, P1203; Nesslinger NJ, 2003, CANCER RES, V63, P2228; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Pi LH, 2014, ONCOL LETT, V7, P685, DOI 10.3892/ol.2013.1753; Polotskaia A, 2015, P NATL ACAD SCI USA, V112, pE1220, DOI 10.1073/pnas.1416318112; Qi L, 2012, MED ONCOL, V29, P721, DOI 10.1007/s12032-011-9929-5; Schwartz M, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0145-x; Silva JL, 2014, TRENDS BIOCHEM SCI, V39, P260, DOI 10.1016/j.tibs.2014.04.001; Song IK, 2016, SCI REP-UK, V6, DOI 10.1038/srep34432; Soragni A, 2016, CANCER CELL, V29, P90, DOI 10.1016/j.ccell.2015.12.002; Vaughan CA, 2012, BIOCHEM BIOPH RES CO, V428, P6, DOI 10.1016/j.bbrc.2012.09.029; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Walerych D, 2016, CELL CYCLE, V15, P3009, DOI 10.1080/15384101.2016.1215703; Walerych D, 2016, NAT CELL BIOL, V18, P897, DOI 10.1038/ncb3380; Walerych D, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00289; Wang X, 2014, ANN SURG ONCOL, V21, P1337, DOI 10.1245/s10434-013-3380-0; Xu J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.75; Xu J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04223; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Yang-Hartwich Y, 2015, ONCOGENE, V34, P3605, DOI 10.1038/onc.2014.296; Zhang DH, 2010, EXP CELL RES, V316, P3522, DOI 10.1016/j.yexcr.2010.08.014; Zhang Y, 2016, ONCOTARGET, V7, P11056, DOI 10.18632/oncotarget.7090; Zhou G, 2014, MOL CELL, V54, P960, DOI 10.1016/j.molcel.2014.04.024	66	17	19	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 28	2017	36	39					5473	5483		10.1038/onc.2017.152	http://dx.doi.org/10.1038/onc.2017.152			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FI4RG	28534505				2022-12-26	WOS:000411960500004
J	Wang, Q; Ma, J; Lu, Y; Zhang, S; Huang, J; Chen, J; Bei, JX; Yang, K; Wu, G; Huang, K; Chen, J; Xu, S				Wang, Q.; Ma, J.; Lu, Y.; Zhang, S.; Huang, J.; Chen, J.; Bei, J-X; Yang, K.; Wu, G.; Huang, K.; Chen, J.; Xu, S.			CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cells	ONCOGENE			English	Article							CYCLE-RELATED KINASE; TRANSCRIPTION FACTOR NRF2; PROTEASOMAL DEGRADATION; PROTEOMIC ANALYSIS; EMERGING ROLE; E3 LIGASE; PROLIFERATION; GENE; CHEMORESISTANCE; CARCINOMA	Radiochemoresistance is considered the main cause of local recurrence and distant metastasis in lung cancer. However, the underlying mechanisms of radiochemoresistance remain to be uncovered. In this study, we determine the functions of cell cyclerelated kinase (CDK20) in radiochemoresistance. CDK20 is a newly identified protein kinase, which plays critical roles in cell growth and proliferation in several types of cancer. Using tandem affinity purification technology, we provide evidences that CDK20 binds to the ubiquitin ligase Kelch-like ECH-associated protein 1 (KEAP1), which targets transcriptional factor nuclear factor erythroid-2-related factor 2 (NRF2) for degradation. We show that this interaction is mediated by an evolutionarily conserved ETGE motif on CDK20. Furthermore, we demonstrate that CDK20 competes with NRF2 for KEAP1 binding, enhances the transcriptional activity of NRF2 and lowers the cellular reactive oxygen species level. Moreover, CDK20-depleted cells display impaired cell proliferation, defective G2/M arrest and increased radiochemosensitivity in lung cancer. These phenotypes induced by CDK20 knockdown are partially dependent on NRF2 inactivation. More importantly, CDK20 is overexpressed in human lung cancer tissues, as determined by immunostaining. Collectively, our results suggest that CDK20 positively modulate the KEAP1-NRF2 cytoprotective pathway to regulate tumor progression and radiochemoresistance, implying that CDK20 is a novel, promising therapeutic target for lung cancer.	[Wang, Q.; Ma, J.; Lu, Y.; Zhang, S.; Huang, J.; Chen, J.; Yang, K.; Wu, G.; Xu, S.] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Ctr Canc, Wuhan, Hubei, Peoples R China; [Bei, J-X] Sun Yat Sen Univ, Ctr Canc, South China Collaborat Innovat Ctr Canc Med, State Key Lab Oncol,Dept Expt Res, Guangzhou, Guangdong, Peoples R China; [Huang, K.] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Clin Ctr Human Gene Res, Wuhan, Hubei, Peoples R China; [Huang, K.] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiol, Wuhan, Hubei, Peoples R China; [Chen, J.] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	Huazhong University of Science & Technology; State Key Lab Oncology South China; Sun Yat Sen University; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Texas System; UTMD Anderson Cancer Center	Yang, K; Xu, S (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Ctr Canc, Wuhan, Hubei, Peoples R China.	yangkunyu@medmail.com.cn; xsb723@hust.edu.cn	Bei, Jin-Xin/AAO-1259-2020		National Natural Science Foundation of China [81301719, 81372435]; State Key Laboratory of Oncology in South China [HN2014-10]; Wuhan Science and Technology Bureau [2015060101010041]; Department of Defense Era of Hope research scholar award [W81XWH-09-1-0409]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Oncology in South China; Wuhan Science and Technology Bureau; Department of Defense Era of Hope research scholar award(United States Department of Defense)	This work was supported by the National Natural Science Foundation of China (81301719 to SX), Open Funds of State Key Laboratory of Oncology in South China (HN2014-10 to SX), a grant from the Wuhan Science and Technology Bureau (2015060101010041 to SX), the National Natural Science Foundation of China (81372435 to KY) and Department of Defense Era of Hope research scholar award (W81XWH-09-1-0409 to JC).	Addario BJ, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.01.20; Bai XP, 2016, DRUG METAB REV, V48, P541, DOI 10.1080/03602532.2016.1197239; Camp ND, 2012, J BIOL CHEM, V287, P6539, DOI 10.1074/jbc.M111.316471; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chio IIC, 2016, CELL, V166, P963, DOI 10.1016/j.cell.2016.06.056; Feng H, 2015, J HEPATOL, V62, P1100, DOI 10.1016/j.jhep.2014.11.040; Hast BE, 2013, CANCER RES, V73, P2199, DOI 10.1158/0008-5472.CAN-12-4400; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Homma S, 2009, CLIN CANCER RES, V15, P3423, DOI 10.1158/1078-0432.CCR-08-2822; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Lee S, 2012, FREE RADICAL BIO MED, V53, P807, DOI 10.1016/j.freeradbiomed.2012.05.038; Liu Y, 2004, J BIOL CHEM, V279, P4507, DOI 10.1074/jbc.M309995200; Ma JL, 2012, MOL CELL BIOL, V32, P1506, DOI 10.1128/MCB.06271-11; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Mikell JL, 2015, J THORAC ONCOL, V10, P462, DOI 10.1097/JTO.0000000000000411; Mitsuishi Y, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00200; Ng SSM, 2007, J NATL CANCER I, V99, P936, DOI 10.1093/jnci/djm011; O'Connell MA, 2015, BIOCHEM SOC T, V43, P687, DOI 10.1042/BST20150069; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Singh A, 2008, CANCER RES, V68, P7975, DOI 10.1158/0008-5472.CAN-08-1401; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Tian Y, 2012, ONCOL LETT, V4, P601, DOI 10.3892/ol.2012.828; Wohlbold L, 2006, CELL CYCLE, V5, P546, DOI 10.4161/cc.5.5.2541; Xu S, 2011, ONCOGENE, V30, P2219, DOI 10.1038/onc.2010.596; Xu SB, 2014, MOL CELL PROTEOMICS, V13, P2986, DOI 10.1074/mcp.M113.036699; Xu Y, 2013, CANCER RES, V73, P4406, DOI 10.1158/0008-5472.CAN-12-4297; Yang Y, 2013, EMBO REP, V14, P741, DOI 10.1038/embor.2013.80; Yu Z, 2014, GUT, V63, P1793, DOI 10.1136/gutjnl-2013-305584; Zhan LJ, 2012, FREE RADICAL BIO MED, V53, P758, DOI 10.1016/j.freeradbiomed.2012.05.041; Zhang P, 2010, MOL CANCER THER, V9, P336, DOI 10.1158/1535-7163.MCT-09-0589; Zhou SN, 2013, CRIT REV ONCOL HEMAT, V88, P706, DOI 10.1016/j.critrevonc.2013.09.001	43	47	49	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 14	2017	36	37					5321	5330		10.1038/onc.2017.161	http://dx.doi.org/10.1038/onc.2017.161			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FG8HT	28534518				2022-12-26	WOS:000410671700010
J	Stevens, CM; Rayani, K; Singh, G; Lotfalisalmasi, B; Tieleman, DP; Tibbits, GF				Stevens, Charles M.; Rayani, Kaveh; Singh, Gurpreet; Lotfalisalmasi, Bairam; Tieleman, D. Peter; Tibbits, Glen F.			Changes in the dynamics of the cardiac troponin C molecule explain the effects of Ca2+-sensitizing mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-SENSITIZING MUTATIONS; HYPERTROPHIC CARDIOMYOPATHY; REGULATORY DOMAIN; CA2+ BINDING; N-DOMAIN; DILATED CARDIOMYOPATHY; STRUCTURAL TRANSITION; HIGH-THROUGHPUT; FORCE-FIELD; SIMULATIONS	Cardiac troponin C (cTnC) is the regulatory protein that initiates cardiac contraction in response to Ca2+. TnC binding Ca2+ initiates a cascade of protein-protein interactions that begins with the opening of the N-terminal domain of cTnC, followed by cTnC binding the troponin I switch peptide (TnI(SW)). We have evaluated, through isothermal titration calorimetry and molecular-dynamics simulation, the effect of several clinically relevant mutations (A8V, L29Q, A31S, L48Q, Q50R, and C84Y) on the Ca2+ affinity, structural dynamics, and calculated interaction strengths between cTnC and each of Ca2+ and TnI(SW). Surprisingly the Ca2+ affinity measured by isothermal titration calorimetry was only significantly affected by half of these mutations including L48Q, which had a 10-fold higher affinity than WT, and the Q50R and C84Y mutants, each of which had affinities 3-fold higher than wild type. This suggests that Ca2+ affinity of the N-terminal domain of cTnC in isolation is insufficient to explain the pathogenicity of these mutations. Molecular-dynamics simulation was used to evaluate the effects of these mutations on Ca2+ binding, structural dynamics, and TnI interaction independently. Many of the mutations had a pronounced effect on the balance between the open and closed conformations of the TnC molecule, which provides an indirect mechanism for their pathogenic properties. Our data demonstrate that the structural dynamics of the cTnC molecule are key in determining myofilament Ca2+ sensitivity. Our data further suggest that modulation of the structural dynamics is the underlying molecular mechanism for many disease mutations that are far from the regulatory Ca2+-binding site of cTnC.	[Stevens, Charles M.; Tibbits, Glen F.] British Columbia Childrens Hosp, Res Inst, Cardiovasc Sci, Vancouver, BC V5Z 4H4, Canada; [Stevens, Charles M.; Rayani, Kaveh; Lotfalisalmasi, Bairam; Tibbits, Glen F.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Tibbits, Glen F.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A IS6, Canada; [Singh, Gurpreet; Tieleman, D. Peter] Univ Calgary, Ctr Mol Simulat, Calgary, AB T2N 1N4, Canada; [Singh, Gurpreet; Tieleman, D. Peter] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	BC Childrens Hospital; University of British Columbia; Simon Fraser University; Simon Fraser University; University of Calgary; University of Calgary	Tibbits, GF (corresponding author), Simon Fraser Univ, Biomed Physiol & Kinesiol, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	tibbits@sfu.ca		Tibbits, Glen/0000-0002-2586-3115	Natural Sciences and Engineering Research Council of Canada; Canadian Institute of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (to G. F. T. and to D. P. T.) and Canadian Institute of Health Research (to G. F. T.). The authors declare that they have no conflicts of interest with the contents of this article.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Bordoli Lorenza, 2012, Methods Mol Biol, V857, P107, DOI 10.1007/978-1-61779-588-6_5; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cerutti DS, 2009, J CHEM THEORY COMPUT, V5, P2322, DOI 10.1021/ct9001015; Cordina NM, 2013, BIOCHEMISTRY-US, V52, P1950, DOI 10.1021/bi4000172; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Davis J, 2016, CELL, V165, P1147, DOI 10.1016/j.cell.2016.04.002; Davis JP, 2007, BIOPHYS J, V92, P3195, DOI 10.1529/biophysj.106.095406; Dewan S, 2016, J PHYS CHEM B, V120, P8264, DOI 10.1021/acs.jpcb.6b01950; Dong WJ, 1997, BIOPHYS J, V72, P850, DOI 10.1016/S0006-3495(97)78719-8; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; Feest ER, 2014, J MOL CELL CARDIOL, V72, P219, DOI 10.1016/j.yjmcc.2014.03.015; Genge CE, 2016, GENOME BIOL EVOL, V8, P994, DOI 10.1093/gbe/evw044; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gillis TE, 2003, BIOCHEMISTRY-US, V42, P6418, DOI 10.1021/bi0340494; Gillis TE, 2007, PHYSIOL GENOMICS, V32, P16, DOI 10.1152/physiolgenomics.00197.2007; Harada K, 2004, JPN J PHYSIOL, V54, P307, DOI 10.2170/jjphysiol.54.307; Hazard AL, 1998, PROTEIN SCI, V7, P2451, DOI 10.1002/pro.5560071123; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hoffmann B, 2001, Hum Mutat, V17, P524, DOI 10.1002/humu.1143; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Hwang PM, 2014, P NATL ACAD SCI USA, V111, P14412, DOI 10.1073/pnas.1410775111; JOHNSON JD, 1980, J BIOL CHEM, V255, P9635; Kekenes-Huskey PM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002777; Kirschenlohr HL, 2000, BIOCHEM J, V346, P385, DOI 10.1042/0264-6021:3460385; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Landstrom AP, 2008, J MOL CELL CARDIOL, V45, P281, DOI 10.1016/j.yjmcc.2008.05.003; Li AY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079363; Li H, 2015, J PHYS CHEM B, V119, P9401, DOI 10.1021/jp510560k; Li MX, 2015, GENE, V571, P153, DOI 10.1016/j.gene.2015.07.074; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Liang B, 2008, PHYSIOL GENOMICS, V33, P257, DOI 10.1152/physiolgenomics.00154.2007; Lindert S, 2015, BIOPHYS J, V108, P395, DOI 10.1016/j.bpj.2014.11.3461; Lindert S, 2012, BIOPHYS J, V103, P1784, DOI 10.1016/j.bpj.2012.08.058; Lindert S, 2012, J PHYS CHEM B, V116, P8449, DOI 10.1021/jp212173f; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; Marques MD, 2017, J BIOL CHEM, V292, P2379, DOI 10.1074/jbc.M116.765362; Martins AS, 2015, CIRC-CARDIOVASC GENE, V8, P653, DOI 10.1161/CIRCGENETICS.114.000957; McKay RT, 2000, BIOCHEMISTRY-US, V39, P12731, DOI 10.1021/bi001240u; Messer AE, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00315; Pall S, 2013, COMPUT PHYS COMMUN, V184, P2641, DOI 10.1016/j.cpc.2013.06.003; Parmacek MS, 2004, PROG CARDIOVASC DIS, V47, P159, DOI 10.1016/j.pcad.2004.07.003; Parvatiyar MS, 2012, J BIOL CHEM, V287, P31845, DOI 10.1074/jbc.M112.377713; Pinto JR, 2009, J BIOL CHEM, V284, P19090, DOI 10.1074/jbc.M109.007021; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Robertson IM, 2015, J MOL CELL CARDIOL, V87, P257, DOI 10.1016/j.yjmcc.2015.08.017; Robertson IM, 2014, BIOPHYS J, V106, p723A, DOI 10.1016/j.bpj.2013.11.3996; Schlecht W, 2016, CHEM BIOL DRUG DES, V87, P171, DOI 10.1111/cbdd.12651; Schmidtmann A, 2005, FEBS J, V272, P6087, DOI 10.1111/j.1742-4658.2005.05001.x; Seidman CE, 2011, CIRC RES, V108, P743, DOI 10.1161/CIRCRESAHA.110.223834; Semsarian C, 2015, J AM COLL CARDIOL, V65, P1249, DOI 10.1016/j.jacc.2015.01.019; Sevrieva I, 2014, J MOL CELL CARDIOL, V75, P181, DOI 10.1016/j.yjmcc.2014.07.015; Shettigar V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10794; Skowronsky RA, 2013, J BIOL INORG CHEM, V18, P49, DOI 10.1007/s00775-012-0948-2; Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d; Stevens CM, 2016, BIOPHYS J, V111, P38, DOI 10.1016/j.bpj.2016.05.029; Suarez MC, 2003, BIOCHEMISTRY-US, V42, P5522, DOI 10.1021/bi027102h; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tikunova SB, 2004, J BIOL CHEM, V279, P35341, DOI 10.1074/jbc.M405413200; Tikunova SB, 2002, BIOCHEMISTRY-US, V41, P6697, DOI 10.1021/bi011763h; Tikunova SB, 2010, BIOCHEMISTRY-US, V49, P1975, DOI 10.1021/bi901867s; van Spaendonck-Zwarts KY, 2010, CIRCULATION, V121, P2169, DOI 10.1161/CIRCULATIONAHA.109.929646; Wang D, 2012, BIOCHEMISTRY-US, V51, P4473, DOI 10.1021/bi3003007; Yap Kyoko L, 2002, Methods Mol Biol, V173, P317; Zhang XL, 2013, ACTA CRYSTALLOGR D, V69, P722, DOI 10.1107/S0907444913001182; Zot HG, 2016, ARCH BIOCHEM BIOPHYS, V601, P97, DOI 10.1016/j.abb.2016.03.011	69	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11915	11926		10.1074/jbc.M116.770776	http://dx.doi.org/10.1074/jbc.M116.770776			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28533433	hybrid, Green Published			2022-12-26	WOS:000405485600027
J	Baqir, M; Makol, A; Osborn, TG; Bartholmai, BJ; Ryu, JH				Baqir, Misbah; Makol, Ashima; Osborn, Thomas G.; Bartholmai, Brian J.; Ryu, Jay H.			Mycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; SYSTEMIC-SCLEROSIS; DOUBLE-BLIND; CYCLOPHOSPHAMIDE; HYPERTENSION; PLACEBO; PREDICTOR; SURVIVAL; TRIALS	Background and objective Interstitial lung disease (ILD) remains the number one cause of mortality in scleroderma (SSc). Our goal was to determine the effectiveness of mycophenolate mofetil (MMF) in treating SSc-ILD in a retrospective study. Methods A retrospective, computer-assisted search was performed to identify patients with SSc-ILD treated with MMF from 1997 through 2014. We used a novel software tool, Computer-Aided Lung Informatics for Pathology Evaluation and Rating (CALIPER), to quantify parenchymal lung abnormalities on high-resolution computed tomography. Lung function was evaluated at baseline, 6, 12, and 24 months of MMF therapy. Results We identified 46 patients (28 females) with SSc-ILD (mean age at diagnosis 55 y) treated with MMF for at least 1 year (majority on 2 gm/day). Twenty-one patients (45.7%) stopped using MMF during the follow up period after the first 12 months, and they took MMF for a median of 2.12 years (range, 0.91-8.93 years). Only 4 discontinued MMF because of disease progression. Compared to baseline, the mean percentage change in forced vital capacity (95% CI) at 6, 12, and 24 months, respectively, was 1.01% (-2.38%-4.39%) (n = 26), 2.06% (-1.09%-5.22%) (n = 31), and -0.07% (-3.31%-3.17%) (n = 30), and the mean percentage change in ILD as measured by CALIPER (95% CI) was -5.40% (-18.62%-7.83%) (n = 18), -1.51% (-14.69%-11.68%) (n = 17), and -8.35% (-20.71%-4.02%) (n = 22). The mean right ventricular systolic pressure (RVSP) remained stable over the study period. Conclusions MMF is well tolerated and slows the rate of decline in lung function in SSc-ILD patients, even at doses lower at 3 g/day.	[Baqir, Misbah; Ryu, Jay H.] Mayo Clin, Dept Internal Med, Div Pulm & Crit Care Med, Rochester, MN 55902 USA; [Makol, Ashima; Osborn, Thomas G.] Mayo Clin, Dept Internal Med, Div Rheumatol, Rochester, MN USA; [Bartholmai, Brian J.] Mayo Clin, Dept Radiol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Baqir, M (corresponding author), Mayo Clin, Dept Internal Med, Div Pulm & Crit Care Med, Rochester, MN 55902 USA.	baqir.misbah@mayo.edu		Makol, Ashima/0000-0002-8748-898X; Ryu, Jay/0000-0002-9576-2272	CTSA from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) [UL1 TR000135]	CTSA from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This publication was made possible by CTSA Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.	Gerbino AJ, 2008, CHEST, V133, P455, DOI 10.1378/chest.06-2861; Herzog EL, 2014, ARTHRITIS RHEUMATOL, V66, P1967, DOI 10.1002/art.38702; Hoyles RK, 2006, ARTHRITIS RHEUM-US, V54, P3962, DOI 10.1002/art.22204; Iudici M, 2015, AUTOIMMUN REV, V14, P575, DOI 10.1016/j.autrev.2015.02.002; Khanna D, 2011, ARTHRITIS RHEUM-US, V63, P3078, DOI 10.1002/art.30467; Koh ET, 1996, BRIT J RHEUMATOL, V35, P989; Koutroumpas A, 2010, CLIN RHEUMATOL, V29, P1167, DOI 10.1007/s10067-010-1498-z; Launay D, 2007, J RHEUMATOL, V34, P1005; Liossis SNC, 2006, RHEUMATOLOGY, V45, P1005, DOI 10.1093/rheumatology/kei211; Lopes AJ, 2011, J BRAS PNEUMOL, V37, P144, DOI 10.1590/S1806-37132011000200003; Nadrous HF, 2005, CHEST, V128, p616S, DOI 10.1378/chest.128.6_suppl.616S-a; Nannini C, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2534; Nathan SD, 2008, RESP MED, V102, P1305, DOI 10.1016/j.rmed.2008.03.022; Nihtyanova SI, 2007, RHEUMATOLOGY, V46, P442, DOI 10.1093/rheumatology/kel244; Panopoulos ST, 2013, LUNG, V191, P483, DOI 10.1007/s00408-013-9499-8; Simeon-Aznar CP, 2011, CLIN RHEUMATOL, V30, P1393, DOI 10.1007/s10067-011-1823-1; Plastiras SC, 2006, ARTHRIT RHEUM-ARTHR, V55, P598, DOI 10.1002/art.22099; STEEN VD, 1994, ARTHRITIS RHEUM, V37, P1283, DOI 10.1002/art.1780370903; Tashkin DP, 2006, NEW ENGL J MED, V354, P2655, DOI 10.1056/NEJMoa055120; Tashkin DP, 2016, LANCET RESP MED, V4, P708, DOI 10.1016/S2213-2600(16)30152-7; Tzouvelekis A, 2012, PULM MED, V2012, DOI 10.1155/2012/143637; Walker UA, 2007, ANN RHEUM DIS, V66, P754, DOI 10.1136/ard.2006.062901; White B, 2000, ANN INTERN MED, V132, P947, DOI 10.7326/0003-4819-132-12-200006200-00004; Zamora AC, 2008, RESP MED, V102, P150, DOI 10.1016/j.rmed.2007.07.021; Zhang YF, 2015, SCAND J RHEUMATOL, V44, P412, DOI 10.3109/03009742.2015.1023829	25	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177107	10.1371/journal.pone.0177107	http://dx.doi.org/10.1371/journal.pone.0177107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542177	Green Submitted, Green Published, gold			2022-12-26	WOS:000402062800008
J	Norregaard, K; Jorgensen, JT; Simon, M; Melander, F; Kristensen, LK; Bendix, PM; Andresen, TL; Oddershede, LB; Kjaer, A				Norregaard, Kamilla; Jorgensen, Jesper T.; Simon, Marina; Melander, Fredrik; Kristensen, Lotte K.; Bendix, Pol M.; Andresen, Thomas L.; Oddershede, Lene B.; Kjaer, Andreas			F-18-FDG PET/CT-based early treatment response evaluation of nanoparticle-assisted photothermal cancer therapy	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; GOLD NANOSHELLS; NANOMEDICINE; ABLATION; TUMORS; NANOMATRYOSHKAS; TRANSDUCERS; PENETRATION; MECHANISM; NANOCAGES	Within the field of nanoparticle-assisted photothermal cancer therapy, focus has mostly been on developing novel heat-generating nanoparticles with the right optical and dimensional properties. Comparison and evaluation of their performance in tumor-bearing animals are commonly assessed by changes in tumor volume; however, this is usually a late-occurring event. This study implements 2-deoxy-2-[F-18] fluoro-D-glucose positron emission tomography imaging to perform early evaluation of the treatment outcome of photothermal therapy. Silica-gold nanoshells (NS) are administered intravenously to nude mice bearing human neuroendocrine tumor xenografts and the tumors are irradiated by a near-infrared laser. The animals are positron emission tomography scanned with 2-deoxy-2-[F-18] fluoro-D-glucose one day before and one day after treatment. Using this setup, a significant decrease in tumor uptake of 2-deoxy-2-[F-18] fluoro-D-glucose is found already one day after therapy in the group receiving NS and laser treatment compared to control animals. At this time point no change in tumor volume can be detected. Moreover, the change in tumor uptake, is used to stratify the animals into responders and non-responders, where the responding group matched improved survival. Overall, these findings support the use of 2-deoxy-2-[F-18] fluoroD- glucose positron emission tomography imaging for preclinical and clinical evaluation and optimization of photothermal therapy.	[Norregaard, Kamilla; Jorgensen, Jesper T.; Simon, Marina; Kristensen, Lotte K.; Kjaer, Andreas] Rigshosp, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark; [Norregaard, Kamilla; Jorgensen, Jesper T.; Simon, Marina; Kristensen, Lotte K.; Kjaer, Andreas] Rigshosp, Cluster Mol Imaging, Copenhagen, Denmark; [Norregaard, Kamilla; Jorgensen, Jesper T.; Simon, Marina; Kristensen, Lotte K.; Kjaer, Andreas] Univ Copenhagen, Copenhagen, Denmark; [Melander, Fredrik; Andresen, Thomas L.] Tech Univ Denmark, DTU Nanotech, Ctr Nanomed & Theranost, Lyngby, Denmark; [Bendix, Pol M.; Oddershede, Lene B.] Univ Copenhagen, Niels Bohr Inst, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Technical University of Denmark; University of Copenhagen; Niels Bohr Institute	Kjaer, A (corresponding author), Rigshosp, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark.; Kjaer, A (corresponding author), Rigshosp, Cluster Mol Imaging, Copenhagen, Denmark.; Kjaer, A (corresponding author), Univ Copenhagen, Copenhagen, Denmark.	akjaer@sund.ku.dk	Jørgensen, Jesper Tranekjær/AAY-3085-2020; Kjaer, Andreas/E-8932-2015	Jørgensen, Jesper Tranekjær/0000-0001-7573-9596; Simon, Marina/0000-0001-8133-8668; Norregaard, Kamilla/0000-0003-1953-9703; Kjaer, Andreas/0000-0002-2706-5547; Bendix, Poul Martin/0000-0001-8838-8887; Andresen, Thomas Lars/0000-0002-1048-127X; Melander, Fredrik/0000-0002-3670-6633	Lun beckFonden [506800-50-34062]; Novo Nordisk Foundation [NNF140C0011361]; Lundbeck Foundation; Novo Nordisk Foundation; Lundbeck Foundation [R105-2011-9829] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0017912, NNF14OC0011361] Funding Source: researchfish	Lun beckFonden; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by Lun beckFonden (506800-50-34062), http://www.lundbeckfonden.com, LBO and AK, and by Novo Nordisk Foundation (NNF140C0011361), http://novonordiskfonden.dk, LBO and AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support from the Lundbeck Foundation and Novo Nordisk Foundation is gratefully acknowledged.	Ayala-Orozco C, 2014, J CONTROL RELEASE, V191, P90, DOI 10.1016/j.jconrel.2014.07.038; Ayala-Orozco C, 2014, ACS NANO, V8, P6372, DOI 10.1021/nn501871d; Bardhan R, 2010, NANO LETT, V10, P4920, DOI 10.1021/nl102889y; Blanco E, 2015, NAT BIOTECHNOL, V33, P941, DOI 10.1038/nbt.3330; Chen F, 2015, NANOMEDICINE-UK, V10, P1, DOI 10.2217/nnm.14.186; Chen JY, 2010, SMALL, V6, P811, DOI 10.1002/smll.200902216; Choi CHJ, 2010, P NATL ACAD SCI USA, V107, P1235, DOI 10.1073/pnas.0914140107; Coughlin AJ, 2014, SMALL, V10, P556, DOI 10.1002/smll.201302217; Danhier F, 2010, J CONTROL RELEASE, V148, P135, DOI 10.1016/j.jconrel.2010.08.027; Day ES, 2011, J NEURO-ONCOL, V104, P55, DOI 10.1007/s11060-010-0470-8; Gad SC, 2012, INT J TOXICOL, V31, P584, DOI 10.1177/1091581812465969; Hansen AE, 2015, ACS NANO, V9, P6985, DOI 10.1021/acsnano.5b01324; Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100; Huang XH, 2010, ACS NANO, V4, P5887, DOI 10.1021/nn102055s; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Jorgensen JT, 2016, SCI REP-UK, V6, DOI 10.1038/srep30076; Kelloff G, 2005, CLIN CANCER RES, V11, P2785, DOI 10.1158/1078-0432.CCR-04-2626; Liu Y, 2015, THERANOSTICS, V5, P946, DOI 10.7150/thno.11974; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; O'Neal DP, 2004, CANCER LETT, V209, P171, DOI 10.1016/j.canlet.2004.02.004; Pang B, 2016, ACS NANO, V10, P3121, DOI 10.1021/acsnano.5b07968; Schwartz JA, 2009, CANCER RES, V69, P1659, DOI 10.1158/0008-5472.CAN-08-2535; Stern JM, 2008, J UROLOGY, V179, P748, DOI 10.1016/j.juro.2007.09.018; Stern JM, 2016, INT J TOXICOL, V35, P38, DOI 10.1177/1091581815600170; Stolik S, 2000, J PHOTOCH PHOTOBIO B, V57, P90, DOI 10.1016/S1011-1344(00)00082-8; Sun XL, 2014, ACS NANO, V8, P8438, DOI 10.1021/nn502950t; Sykes EA, 2014, ACS NANO, V8, P5696, DOI 10.1021/nn500299p; Wang YC, 2013, ACS NANO, V7, P2068, DOI 10.1021/nn304332s; Webb JA, 2014, NANOSCALE, V6, P2502, DOI 10.1039/c3nr05112a; Xiao YL, 2012, THERANOSTICS, V2, P757, DOI 10.7150/thno.4756; Xie HA, 2010, INT J PHARMACEUT, V395, P324, DOI 10.1016/j.ijpharm.2010.06.005; Zhang F, 2015, THERANOSTICS, V5, P1444, DOI 10.7150/thno.13398	34	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177997	10.1371/journal.pone.0177997	http://dx.doi.org/10.1371/journal.pone.0177997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542311	Green Published, Green Submitted, gold			2022-12-26	WOS:000402061500052
J	Die, JV; Arora, R; Rowland, LJ				Die, Jose V.; Arora, Rajeev; Rowland, Lisa J.			Proteome dynamics of cold-acclimating Rhododendron species contrasting in their freezing tolerance and thermonasty behavior	PLOS ONE			English	Article							LOW-TEMPERATURE TOLERANCE; BOX RNA HELICASE; PERSICA L BATSCH; ARABIDOPSIS-THALIANA; SEASONAL-CHANGES; 25-KDA DEHYDRIN; GENE-EXPRESSION; LEAF MOVEMENTS; HARDINESS; STRESS	To gain a better understanding of cold acclimation in rhododendron and in woody perennials in general, we used the 2D-DIGE technique to analyze the rhododendron proteome during the seasonal development of freezing tolerance. We selected two species varying in their cold acclimation ability as well as their thermonasty response (folding of leaves in response to low temperature). Proteins were extracted from leaves of non-acclimated (NA) and cold acclimated (CA) plants of the hardier thermonastic species, R. catawbiense (Cata.), and from leaves of cold acclimated plants of the less hardy, non-thermonastic R. ponticum (Pont.). All three protein samples (Cata. NA, Cata. CA, and Pont. CA) were labeled with different CyDyes and separated together on a single gel. Triplicate gels were run and protein profiles were compared resulting in the identification of 72 protein spots that consistently had different abundances in at least one pair-wise comparison. From the 72 differential spots, we chose 56 spots to excise and characterize further by mass spectrometry (MS). Changes in the proteome associated with the seasonal development of cold acclimation were identified from the Cata. CA-Cata. NA comparisons. Differentially abundant proteins associated with the acquisition of superior freezing tolerance and with the thermonastic response were identified from the Cata. CA-Pont. CA comparisons. Our results indicate that cold acclimation in rhododendron involves increases in abundance of several proteins related to stress (freezing/desiccation tolerance), energy and carbohydrate metabolism, regulation/signaling, secondary metabolism (possibly involving cell wall remodeling), and permeability of the cell membrane. Cold acclimation also involves decreases in abundance of several proteins involved in photosynthesis. Differences in freezing tolerance between genotypes can probably be attributed to observed differences in levels of proteins involved in these functions. Also differences in freezing tolerance may be attributed to higher levels of some constitutive protective proteins in Cata. than in Pont. that may be required to overcome freeze damage, such as glutathione peroxidase, glutamine synthetase, and a plastid-lipid-associated protein.	[Die, Jose V.; Rowland, Lisa J.] ARS, USDA, Beltsville, MD 20705 USA; [Arora, Rajeev] Iowa State Univ, Dept Hort, Ames, IA USA	United States Department of Agriculture (USDA); Iowa State University	Rowland, LJ (corresponding author), ARS, USDA, Beltsville, MD 20705 USA.	Jeannine.Rowland@ars.usda.gov	Die, Jose V./H-3381-2019	Die, Jose V./0000-0002-7506-8590				Amme S, 2006, J EXP BOT, V57, P1537, DOI 10.1093/jxb/erj129; Arora R, 1997, PHYSIOL PLANTARUM, V101, P8, DOI 10.1034/j.1399-3054.1997.1010102.x; ARORA R, 1994, PLANT PHYSIOL, V105, P95, DOI 10.1104/pp.105.1.95; ARORA R, 1992, PLANT PHYSIOL, V99, P1562, DOI 10.1104/pp.99.4.1562; Baier M, 2005, J EXP BOT, V56, P1449, DOI 10.1093/jxb/eri161; Bertrand A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0751-2; Cansev A, 2009, J AGR SCI-CAMBRIDGE, V147, P51, DOI 10.1017/S0021859608008058; Chen KT, 2013, PLANT CELL ENVIRON, V36, P892, DOI 10.1111/pce.12027; Cutler AJ, 1999, TRENDS PLANT SCI, V4, P472, DOI 10.1016/S1360-1385(99)01497-1; Dai XB, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-321; Das K, 2014, FRONT ENV SCI-SWITZ, V2, DOI 10.3389/fenvs.2014.00053; Demmig-Adams B, 2006, NEW PHYTOL, V172, P11, DOI 10.1111/j.1469-8137.2006.01835.x; Die JV, 2016, ENVIRON EXP BOT, V124, P11, DOI 10.1016/j.envexpbot.2015.12.003; Die JV, 2014, ENVIRON EXP BOT, V106, P87, DOI 10.1016/j.envexpbot.2013.12.017; ESEN A, 1978, ANAL BIOCHEM, V89, P264, DOI 10.1016/0003-2697(78)90749-2; Fujii K, 2005, PROTEOMICS, V5, P4274, DOI 10.1002/pmic.200401286; Gong ZZ, 2005, PLANT CELL, V17, P256, DOI 10.1105/tpc.104.027557; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Guan QM, 2013, PLANT CELL, V25, P342, DOI 10.1105/tpc.112.108340; Gusta LV, 2013, PHYSIOL PLANTARUM, V147, P4, DOI 10.1111/j.1399-3054.2012.01611.x; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Harris GC, 2006, PLANT SCI, V170, P314, DOI 10.1016/j.plantsci.2005.08.024; Hauser F, 2011, CURR BIOL, V21, pR346, DOI 10.1016/j.cub.2011.03.015; Herman EM, 2006, J EXP BOT, V57, P3601, DOI 10.1093/jxb/erl111; Janmohammadi M, 2015, PHYTOCHEMISTRY, V117, P76, DOI 10.1016/j.phytochem.2015.06.003; Janska A, 2010, PLANT BIOLOGY, V12, P395, DOI 10.1111/j.1438-8677.2009.00299.x; Karlson D, 2002, J BIOL CHEM, V277, P35248, DOI 10.1074/jbc.M205774200; Kim JY, 2007, PLANT J, V50, P439, DOI 10.1111/j.1365-313X.2007.03057.x; Kim MH, 2009, J BIOL CHEM, V284, P23454, DOI 10.1074/jbc.M109.025791; Knight MR, 2012, NEW PHYTOL, V195, P737, DOI 10.1111/j.1469-8137.2012.04239.x; Kosova K, 2015, INT J MOL SCI, V16, P20913, DOI 10.3390/ijms160920913; Langenkamper G, 2001, J EXP BOT, V52, P1545, DOI 10.1093/jexbot/52.360.1545; Levitt J, 1980, CHILLING FREEZING HI; Li B, 2015, FRONT PLANT SCI, V6, P1600; Lim C. C., 1998, American Rhododendron Society Journal, V52, P143; Lim CC, 1998, J AM SOC HORTIC SCI, V123, P246, DOI 10.21273/JASHS.123.2.246; Lim CC, 1999, THEOR APPL GENET, V99, P912, DOI 10.1007/s001220051312; Lim CC, 2014, FRONT PLANT SCI, V5, P1562; Marian CO, 2004, NEW PHYTOL, V161, P773, DOI 10.1111/j.1469-8137.2003.01001.x; Nilsen ET, 2014, ENVIRON EXP BOT, V106, P34, DOI 10.1016/j.envexpbot.2014.01.005; NILSEN ET, 1992, BOT J LINN SOC, V110, P205, DOI 10.1111/j.1095-8339.1992.tb00291.x; Oquist G, 2003, ANNU REV PLANT BIOL, V54, P329, DOI 10.1146/annurev.arplant.54.072402 .115741; Peng YH, 2008, PHYSIOL PLANTARUM, V132, P44, DOI 10.1111/j.1399-3054.2007.00988.x; R_Core_Team, 2015, R LANG ENV STAT COMP; Renaut J, 2006, PHYSIOL PLANTARUM, V126, P97, DOI 10.1111/j.1399-3054.2006.00617.x; Renaut J, 2004, PLANT BIOLOGY, V6, P81, DOI 10.1055/s-2004-815733; Renaut J, 2008, TREE GENET GENOMES, V4, P589, DOI 10.1007/s11295-008-0134-4; Rstudio Team, 2015, RSTUDIO INT DEV R; SAKAI A, 1986, J AM SOC HORTIC SCI, V111, P273; Sakai A, 1987, COLD ACCLIMATION PLA, P97; Salzman RA, 1996, PLANT CELL ENVIRON, V19, P713, DOI 10.1111/j.1365-3040.1996.tb00406.x; Strimbeck GR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00884; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; Wang W, 2006, ELECTROPHORESIS, V27, P2782, DOI 10.1002/elps.200500722; Wang X, 2009, PLANT SCI, V177, P607, DOI 10.1016/j.plantsci.2009.08.009; Wang X, 2008, J AM SOC HORTIC SCI, V133, P768, DOI 10.21273/JASHS.133.6.768; Wei H, 2005, THEOR APPL GENET, V111, P1347, DOI 10.1007/s00122-005-0064-6; Wei H, 2005, PLANTA, V221, P406, DOI 10.1007/s00425-004-1440-1; WEISER CJ, 1970, SCIENCE, V169, P1269, DOI 10.1126/science.169.3952.1269; Wisniewski M, 2003, HORTSCIENCE, V38, P952, DOI 10.21273/HORTSCI.38.5.952; Wisniewski ME, 1993, CYTOLOGY HISTOLOGY H, P299; Youssef A, 2010, PLANT J, V61, P436, DOI 10.1111/j.1365-313X.2009.04067.x; Zarter CR, 2006, NEW PHYTOL, V172, P272, DOI 10.1111/j.1469-8137.2006.01815.x; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005	64	11	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177389	10.1371/journal.pone.0177389	http://dx.doi.org/10.1371/journal.pone.0177389			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542212	gold, Green Submitted, Green Published			2022-12-26	WOS:000402058800017
J	Giannoulatou, E; Maher, GJ; Ding, ZH; Gillis, AJM; Dorssers, LCJ; Hoischen, A; Rajpert-De Meyts, E; McVean, G; Wilkie, AOM; Looijenga, LHJ; Goriely, A				Giannoulatou, Eleni; Maher, Geoffrey J.; Ding, Zhihao; Gillis, Ad J. M.; Dorssers, Lambert C. J.; Hoischen, Alexander; Rajpert-De Meyts, Ewa; McVean, Gilean; Wilkie, Andrew O. M.; Looijenga, Leendert H. J.; Goriely, Anne		WGS500 Consortium	Whole-genome sequencing of spermatocytic tumors provides insights into the mutational processes operating in the male germline	PLOS ONE			English	Article							CARCINOMA IN-SITU; SELFISH SPERMATOGONIAL SELECTION; DE-NOVO MUTATIONS; CELL TUMORS; EXPRESSION PATTERN; POINT MUTATIONS; HUMAN TESTES; SEMINOMA; CANCER; DISORDERS	Adult male germline stem cells (spermatogonia) proliferate by mitosis and, after puberty, generate spermatocytes that undertake meiosis to produce haploid spermatozoa. Germ cells are under evolutionary constraint to curtail mutations and maintain genome integrity. Despite constant turnover, spermatogonia very rarely form tumors, so-called spermatocytic tumors (SpT). In line with the previous identification of FGFR3 and HRAS selfish mutations in a subset of cases, candidate gene screening of 29 SpTs identified an oncogenic NRAS mutation in two cases. To gain insights in the etiology of SpT and into properties of the male germline, we performed whole-genome sequencing of five tumors (4/5 with matched normal tissue). The acquired single nucleotide variant load was extremely low (similar to 0.2 per Mb), with an average of 6 (2-9) non-synonymous variants per tumor, none of which is likely to be oncogenic. The observed mutational signature of SpTs is strikingly similar to that of germline de novo mutations, mostly involving C>T transitions with a significant enrichment in the ACG trinucleotide context. The tumors exhibited extensive aneuploidy (50-99 autosomes/tumor) involving whole-chromosomes, with recurrent gains of chr9 and chr20 and loss of chr7, suggesting that aneuploidy itself represents the initiating oncogenic event. We propose that SpT etiology recapitulates the unique properties of male germ cells; because of evolutionary constraints to maintain low point mutation rate, rare tumorigenic driver events are caused by a combination of gene imbalance mediated via whole-chromosome aneuploidy. Finally, we propose a general framework of male germ cell tumor pathology that accounts for their mutational landscape, timing and cellular origin.	[Giannoulatou, Eleni; Maher, Geoffrey J.; Ding, Zhihao; Wilkie, Andrew O. M.; Goriely, Anne] Univ Oxford, Clin Genet Grp, MRC, Weatherall Inst Mol Med, Oxford, England; [Giannoulatou, Eleni; Maher, Geoffrey J.; Ding, Zhihao; Wilkie, Andrew O. M.; Goriely, Anne] Univ Oxford, Nuffield Div Clin Lab Sci, Radcliffe Dept Med, Oxford, England; [Gillis, Ad J. M.; Dorssers, Lambert C. J.; Looijenga, Leendert H. J.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Hoischen, Alexander] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [Rajpert-De Meyts, Ewa] Rigshosp, Copenhagen Univ Hosp, Dept Growth & Reprod, Copenhagen, Denmark; [McVean, Gilean] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Giannoulatou, Eleni] Univ New South Wales, Victor Chang Cardiac Res Inst, Sydney, NSW, Australia	University of Oxford; University of Oxford; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Rigshospitalet; University of Copenhagen; University of Oxford; Wellcome Centre for Human Genetics; University of New South Wales Sydney; Victor Chang Cardiac Research Institute	Goriely, A (corresponding author), Univ Oxford, Clin Genet Grp, MRC, Weatherall Inst Mol Med, Oxford, England.; Goriely, A (corresponding author), Univ Oxford, Nuffield Div Clin Lab Sci, Radcliffe Dept Med, Oxford, England.	anne.goriely@imm.ox.ac.uk	Hoischen, Alexander/D-1282-2013; Wilkie, Andrew/AAC-3820-2020; Goriely, Anne/AAR-1133-2020; Rajpert-De Meyts, Ewa/H-6526-2019; Looijenga, Leendert/B-8145-2019; Knight, Julian Charles/W-2399-2019; Hoischen, Alexander/AGF-7293-2022	Hoischen, Alexander/0000-0002-8072-4476; Wilkie, Andrew/0000-0002-2972-5481; Rajpert-De Meyts, Ewa/0000-0002-5946-7559; Looijenga, Leendert/0000-0002-8146-1911; Knight, Julian Charles/0000-0002-0377-5536; Hoischen, Alexander/0000-0002-8072-4476; Ding, Zhihao/0000-0003-0961-2284; Giannoulatou, Eleni/0000-0002-7084-6736; Goriely, Anne/0000-0001-9229-7216	Wellcome [091182, 102731]; Medical Research Council (MRC) through the WIMM Strategic Alliance [G0902418, MC_UU_12025]; High-Throughput Genomics core facility; Wellcome Trust [090532 Z/09/Z]	Wellcome; Medical Research Council (MRC) through the WIMM Strategic Alliance(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); High-Throughput Genomics core facility; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was primarily supported by grants from the Wellcome (www.wellcome.ac.uk) [091182 (to AG and AOMW) and 102731 (to AOMW)]. We acknowledge funding from the Medical Research Council (MRC-www.mrc.ac.uk) through the WIMM Strategic Alliance (G0902418 and MC_UU_12025) and the support of the High-Throughput Genomics core facility by the Wellcome Trust Grant 090532 Z/09/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Berney DM, 2016, HISTOPATHOLOGY, V69, P7, DOI 10.1111/his.12958; Bishop EF, 2007, MODERN PATHOL, V20, P1036, DOI 10.1038/modpathol.3800933; Boyle EA, 2014, BIOINFORMATICS, V30, P2670, DOI 10.1093/bioinformatics/btu353; Brabrand S, 2015, NEOPLASIA, V17, P167, DOI 10.1016/j.neo.2014.12.005; Carriere P, 2007, J UROLOGY, V178, P125, DOI 10.1016/j.juro.2007.03.024; Cha DS, 2012, BBA-MOL CELL RES, V1823, P1847, DOI 10.1016/j.bbamcr.2012.07.006; Chemes HE, 2001, INT J ANDROL, V24, P2, DOI 10.1046/j.1365-2605.2001.00260.x; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cutcutache I, 2015, EUR UROL, V68, P77, DOI 10.1016/j.eururo.2014.12.040; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ekvall S, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0239-1; Endo T, 2015, P NATL ACAD SCI USA, V112, pE2347, DOI 10.1073/pnas.1505683112; FLOYD C, 1988, CANCER-AM CANCER SOC, V61, P409, DOI 10.1002/1097-0142(19880115)61:2<409::AID-CNCR2820610234>3.0.CO;2-6; Ghazarian AA, 2015, CANCER-AM CANCER SOC, V121, P4181, DOI 10.1002/cncr.29643; Giannoulatou E, 2013, P NATL ACAD SCI USA, V110, P20152, DOI 10.1073/pnas.1311381110; Goldmann JM, 2016, NAT GENET; Goriely A, 2016, NAT GENET, V48, P823, DOI 10.1038/ng.3629; Goriely A, 2012, AM J HUM GENET, V90, P175, DOI 10.1016/j.ajhg.2011.12.017; Goriely A, 2009, NAT GENET, V41, P1247, DOI 10.1038/ng.470; Guo Y, 2008, CLIN ORTHOP RELAT R, V466, P2039, DOI 10.1007/s11999-008-0344-y; Hammoud SS, 2015, GENE DEV, V29, P2312, DOI 10.1101/gad.261925.115; Honecker F, 2004, J PATHOL, V203, P849, DOI 10.1002/path.1587; Hutson John M, 2012, Front Endocrinol (Lausanne), V3, P176, DOI 10.3389/fendo.2012.00176; Jorgensen Anne, 2014, Biomol Concepts, V5, P331, DOI 10.1515/bmc-2014-0014; Jorgensen A, 2013, J PATHOL, V229, P588, DOI 10.1002/path.4154; Jorgensen A, 2012, MOL HUM REPROD, V18, P523, DOI 10.1093/molehr/gas030; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kristensen DG, 2014, BRIT J CANCER, V110, P668, DOI 10.1038/bjc.2013.727; Kubo N, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1833-5; Kurtovic-Kozaric A, 2015, LEUKEMIA, V29, P126, DOI 10.1038/leu.2014.144; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lim J, 2011, J PATHOL, V224, P473, DOI 10.1002/path.2919; Litchfield K, 2016, NAT REV UROL; Litchfield K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6973; Liu YH, 2015, NATURE, V520, P697, DOI 10.1038/nature14418; Looijenga LHJ, 2011, J PATHOL, V224, P431, DOI 10.1002/path.2939; Looijenga LHJ, 2006, CANCER RES, V66, P290, DOI 10.1158/0008-5472.CAN-05-2936; Looijenga LHJ, 2003, APMIS, V111, P161, DOI 10.1034/j.1600-0463.2003.11101201.x; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Maher GJ, 2014, ANDROLOGY-US, V2, P304, DOI 10.1111/j.2047-2927.2013.00175.x; Maher GJ, 2016, P NATL ACAD SCI USA, V113, P2454, DOI 10.1073/pnas.1521325113; Matson CK, 2010, DEV CELL, V19, P612, DOI 10.1016/j.devcel.2010.09.010; Morris LGT, 2013, NAT GENET, V45, P253, DOI 10.1038/ng.2538; MULLER J, 1987, INT J ANDROL, V10, P147, DOI 10.1111/j.1365-2605.1987.tb00176.x; Newman AM, 2014, BIOINFORMATICS, V30, P3390, DOI 10.1093/bioinformatics/btu549; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Paulsson K, 2015, NAT GENET, V47, P672, DOI 10.1038/ng.3301; Pham Trang T, 2013, Genes Cancer, V4, P419, DOI 10.1177/1947601913513950; Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469; Rajpert-De Meyts E, 2003, HISTOPATHOLOGY, V42, P217, DOI 10.1046/j.1365-2559.2003.01587.x; Rajpert-De Meyts E, 2016, LANCET, V387, P1762, DOI 10.1016/S0140-6736(15)00991-5; Rijlaarsdam MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122146; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosenberg C, 1998, GENE CHROMOSOME CANC, V23, P286, DOI 10.1002/(SICI)1098-2264(199812)23:4<286::AID-GCC2>3.0.CO;2-6; SKAKKEBAEK NE, 1987, INT J ANDROL, V10, P19, DOI 10.1111/j.1365-2605.1987.tb00161.x; Stoop H, 2001, LAB INVEST, V81, P919, DOI 10.1038/labinvest.3780302; Suzuki T, 2010, MOL CELL BIOL, V30, P2473, DOI 10.1128/MCB.01093-09; TAKAHASHI H, 1993, CANCER-AM CANCER SOC, V72, P549, DOI 10.1002/1097-0142(19930715)72:2<549::AID-CNCR2820720235>3.0.CO;2-L; Taylor JC, 2015, NAT GENET, V47, P717, DOI 10.1038/ng.3304; Taylor-Weiner A, 2016, NATURE, V540, P114, DOI 10.1038/nature20596; Tsuchiy D, 2013, CURR BIOL, V23, P1505, DOI 10.1016/j.cub.2013.06.031; Turner TN, 2016, AM J HUM GENET, V98, P58, DOI 10.1016/j.ajhg.2015.11.023; Ulbright TM, 2016, WHO CLASSIFICATION T, P189; Verdorfer R, 2004, J PATHOL, V204, P277, DOI 10.1002/path.1634; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yau C, 2013, BIOINFORMATICS, V29, P2482, DOI 10.1093/bioinformatics/btt416; Zhang HE, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-244; Zhang T, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006293; Zuccala E, 2016, NAT REV GENET, V17, P7, DOI 10.1038/nrg.2015.13	73	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178169	10.1371/journal.pone.0178169	http://dx.doi.org/10.1371/journal.pone.0178169			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542371	Green Published, Green Submitted, gold			2022-12-26	WOS:000402058400066
J	Sauce, B; Goes, CP; Forti, I; do Monte, BGO; Watanabe, IM; Cunha, J; Peripato, AC				Sauce, Bruno; Goes, Carolina P.; Forti, Isabela; do Monte, Bruno Gabriel O.; Watanabe, Isabela M.; Cunha, Joao; Peripato, Andrea C.			A link between thrifty phenotype and maternal care across two generations of intercrossed mice	PLOS ONE			English	Article							FORCED SWIMMING TEST; ELEVATED PLUS-MAZE; INDIVIDUAL-DIFFERENCES; EPIGENETIC MECHANISMS; GENETIC ARCHITECTURE; MILK EJECTION; ANIMAL-MODEL; OPEN-FIELD; LG/J; STRESS	Maternal effects are causal influences from mother to offspring beyond genetic information, and have lifelong consequences for multiple traits. Previously, we reported that mice whose mothers did not nurse properly had low birth weight followed by rapid fat accumulation and disturbed development of some organs. That pattern resembles metabolic syndromes known collectively as the thrifty phenotype, which is believed to be an adaptation to a stressful environment which prepares offspring for reduced nutrient supply. The potential link between maternal care, stress reactivity, and the thrifty phenotype, however, has been poorly explored in the human and animal literature: only a couple of studies even mention (much less, test) these concepts under a cohesive framework. Here, we explored this link using mice of the parental inbred strains SM/J and LG/J-who differ dramatically in their maternal care-and the intercrossed generations F1 and F2. We measured individual differences in 15 phenotypes and used structural equation modeling to test our hypotheses. We found a remarkable relationship between thrifty phenotype and lower quality of maternal behaviors, including nest building, pup retrieval, grooming/licking, and nursing. To our knowledge, this is the first study to show, in any mammal, a clear connection between the natural variation in thrifty phenotype and maternal care. Both traits in the mother also had a substantial effect on survival rate in the F3 offspring. To our surprise, however, stress reactivity seemed to play no role in our models. Furthermore, the strain of maternal grandmother, but not of paternal grandmother, affected the variation of maternal care in F2 mice, and this effect was mediated by thrifty phenotype in F2. Since F1 animals were all genetically identical, this finding suggests that maternal effects pass down both maternal care and thrifty phenotype in these mice across generations via epigenetic transmission.	[Sauce, Bruno] Rutgers State Univ, Dept Psychol, Program Behav & Syst Neurosci, Piscataway, NJ USA; [Goes, Carolina P.] Univ Sao Paulo, Inst Biomed Sci, Program Cellular Biol & Histol, Sao Paulo, Brazil; [Forti, Isabela; do Monte, Bruno Gabriel O.; Watanabe, Isabela M.; Cunha, Joao; Peripato, Andrea C.] Univ Fed Sao Carlos, Ctr Hlth & Biol Sci, Dept Genet & Evolut, Sao Carlos, SP, Brazil	Rutgers State University New Brunswick; Universidade de Sao Paulo; Universidade Federal de Sao Carlos	Peripato, AC (corresponding author), Univ Fed Sao Carlos, Ctr Hlth & Biol Sci, Dept Genet & Evolut, Sao Carlos, SP, Brazil.	peripato@ufscar.br	Goes, Carolina P./AAG-3896-2019; Sauce, Bruno/X-4365-2018	Goes, Carolina P./0000-0002-4086-3519; Sauce, Bruno/0000-0002-9544-0150	Fundacao de Amparo a pesquisa do Estado de Sao Paulo [2004/14583-9, 2013/22339-0, 2007/06254-3]	Fundacao de Amparo a pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was funded by grants 2004/14583-9 and 2013/22339-0 from Fundacao de Amparo a pesquisa do Estado de Sao Paulo (http://www.fapesp.br/en/) to AP, and grant 2007/06254-3 from from Fundacao de Amparo a pesquisa do Estado de Sao Paulo (http://www.fapesp.br/en/) to BS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON TW, 1957, J AM STAT ASSOC, V52, P200, DOI 10.2307/2280845; Andreatini R, 1999, BRAZ J MED BIOL RES, V32, P1121, DOI 10.1590/S0100-879X1999000900011; Austin J.T., 2006, PSYCHOL RES HDB GUID, P241, DOI [DOI 10.4135/9781412976626.N16, 10.4135/9781412976626.n16]; Barnes SK, 2011, PROG BIOPHYS MOL BIO, V106, P323, DOI 10.1016/j.pbiomolbio.2010.12.005; Bekku N, 2005, PSYCHOPHARMACOLOGY, V183, P300, DOI 10.1007/s00213-005-0179-0; Berghanel A, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1304; BRINDLEY DN, 1989, CLIN SCI, V77, P453, DOI 10.1042/cs0770453; Bult A, 1997, BEHAV GENET, V27, P231, DOI 10.1023/A:1025610130282; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Champagne FA, 2007, PHYSIOL BEHAV, V91, P325, DOI 10.1016/j.physbeh.2007.03.014; Champagne FA, 2009, NEUROSCI BIOBEHAV R, V33, P593, DOI 10.1016/j.neubiorev.2007.10.009; Cheverud JM, 2001, MAMM GENOME, V12, P3, DOI 10.1007/s003350010218; Chiavegatto S, 2012, BRAIN BEHAV, V2, P365, DOI 10.1002/brb3.58; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Chou C.P., 1995, ESTIMATES TESTS STRU; Ducottet C, 2005, BEHAV BRAIN RES, V156, P153, DOI 10.1016/j.bbr.2004.05.018; Ehrich TH, 2005, DIABETES, V54, P1863, DOI 10.2337/diabetes.54.6.1863; Goes CP, 2012, MAMM GENOME, V23, P770, DOI 10.1007/s00335-012-9431-1; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HART BL, 1990, PHYSIOL BEHAV, V48, P383, DOI 10.1016/0031-9384(90)90332-X; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.1037/1082[HYPHEN]989X.12.1.58, 10.21427/D79B73]; Hrbek T, 2006, MAMM GENOME, V17, P417, DOI 10.1007/s00335-005-0038-7; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; HUIZINGA HA, 1986, LIVEST PROD SCI, V15, P11, DOI 10.1016/0301-6226(86)90051-5; Ibanez L, 2008, J CLIN ENDOCR METAB, V93, P2079, DOI 10.1210/jc.2007-2850; Ibanez L, 2006, J CLIN ENDOCR METAB, V91, P2153, DOI 10.1210/jc.2005-2778; Kline R.B., 2011, PRINCIPLES PRACTICE; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Lee HK, 1999, DIABETES RES CLIN PR, V45, P127, DOI 10.1016/S0168-8227(99)00042-X; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; MacKinnon DP, 2007, BEHAV RES METHODS, V39, P384, DOI 10.3758/BF03193007; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; MOODY TW, 1988, ANN NY ACAD SCI, V525, P281, DOI 10.1111/j.1749-6632.1988.tb38613.x; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Noguera JC, 2011, FUNCT ECOL, V25, P1144, DOI 10.1111/j.1365-2435.2011.01856.x; Numan M., 2003, HORM BR BEHAV; Peripato AC, 2004, J EVOLUTION BIOL, V17, P593, DOI 10.1111/j.1420-9101.2004.00702.x; Peripato AC, 2002, AM NAT, V160, pS173, DOI 10.1086/342900; Peripato AC, 2002, GENETICS, V162, P1341; Petry CJ, 1997, P NUTR SOC, V56, P233, DOI 10.1079/PNS19970028; Plotsky PM, 2005, NEUROPSYCHOPHARMACOL, V30, P2192, DOI 10.1038/sj.npp.1300769; Porsolt R D, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as14; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rasanen K, 2007, FUNCT ECOL, V21, P408, DOI 10.1111/j.1365-2435.2007.01246.x; Roseboom TJ, 2011, MATURITAS, V70, P141, DOI 10.1016/j.maturitas.2011.06.017; Rosmond R, 1998, J CLIN ENDOCR METAB, V83, P1853, DOI 10.1210/jc.83.6.1853; RUSSELL JA, 1980, J PHYSIOL-LONDON, V303, P403, DOI 10.1113/jphysiol.1980.sp013295; Sauce B, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00395; Sauce Bruno, 2012, Frontiers in Genetics, V3, P90, DOI 10.3389/fgene.2012.00090; Schafer JL, 2010, ANAL INCOMPLETE MULT; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Wells JCK, 2003, J THEOR BIOL, V221, P143, DOI 10.1006/jtbi.2003.3183; Wells JCK, 2011, AM J HUM BIOL, V23, P65, DOI 10.1002/ajhb.21100; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238	61	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177954	10.1371/journal.pone.0177954	http://dx.doi.org/10.1371/journal.pone.0177954			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542485	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672600033
J	Sandri, TL; Adukpo, S; Giang, DP; Nguetse, CN; Andrade, FA; Tong, HV; Toan, NL; Song, LH; Elumalai, P; Thangaraj, K; Valluri, VL; Ntoumi, F; Meyer, CG; Reason, IJD; Kremsner, PG; Velavan, TP				Sandri, Thaisa Lucas; Adukpo, Selorme; Dao Phuong Giang; Nguetse, Christian N.; Andrade, Fabiana Antunes; Hoang Van Tong; Nguyen Linh Toan; Le Huu Song; Elumalai, Preetham; Thangaraj, Kumarasamy; Valluri, Vijaya Lakshmi; Ntoumi, Francine; Meyer, Christian G.; de Messias Reason, Iara Jose; Kremsner, Peter G.; Velavan, Thirumalaisamy P.			Geographical distribution of complement receptor type 1 variants and their associated disease risk	PLOS ONE			English	Article							CANDIDATE GENE POLYMORPHISMS; C3B/C4B RECEPTOR; CR-1; MALARIA; IDENTIFICATION; BINDING; SUSCEPTIBILITY; ACTIVATION; MECHANISMS; EXPRESSION	Background Pathogens exert selective pressure which may lead to substantial changes in host immune responses. The human complement receptor type 1 (CR1) is an innate immune recognition glycoprotein that regulates the activation of the complement pathway and removes opsonized immune complexes. CR1 genetic variants in exon 29 have been associated with expression levels, C1q or C3b binding and increased susceptibility to several infectious diseases. Five distinct CR1 nucleotide substitutions determine the Knops blood group phenotypes, namely Kn(a/b), McC(a/b), Sl1/Sl2, Sl4/Sl5 and KCAM+/-. Methods CR1 variants were genotyped by direct sequencing in a cohort of 441 healthy individuals from Brazil, Vietnam, India, Republic of Congo and Ghana. Results The distribution of the CR1 alleles, genotypes and haplotypes differed significantly among geographical settings (p <= 0.001). CR1 variants rs17047660A/G (McC(a/b)) and rs17047661A/G (Sl1/Sl2) were exclusively observed to be polymorphic in African populations compared to the groups from Asia and South-America, strongly suggesting that these two SNPs may be subjected to selection. This is further substantiated by a high linkage disequilibrium between the two variants in the Congolese and Ghanaian populations. A total of nine CR1 haplotypes were observed. The CR1* AGAATA haplotype was found more frequently among the Brazilian and Vietnamese study groups; the CR1* AGAATG haplotype was frequent in the Indian and Vietnamese populations, while the CR1* AGAGTG haplotype was frequent among Congolese and Ghanaian individuals. Conclusion The African populations included in this study might have a selective advantage conferred to immune genes involved in pathogen recognition and signaling, possibly contributing to disease susceptibility or resistance.	[Sandri, Thaisa Lucas; Adukpo, Selorme; Nguetse, Christian N.; Hoang Van Tong; Meyer, Christian G.; Kremsner, Peter G.; Velavan, Thirumalaisamy P.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Sandri, Thaisa Lucas; Andrade, Fabiana Antunes; de Messias Reason, Iara Jose] Univ Fed Parana, Lab Mol mmunopathol, Curitiba, Parana, Brazil; [Adukpo, Selorme] Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana; [Dao Phuong Giang; Le Huu Song] 108 Mil Cent Hosp, Hanoi, Vietnam; [Dao Phuong Giang; Hoang Van Tong; Nguyen Linh Toan; Le Huu Song; Meyer, Christian G.; Velavan, Thirumalaisamy P.] Vietnamese German Ctr Med Res, Hanoi, Vietnam; [Nguyen Linh Toan] Vietnam Mil Med Univ, Hanoi, Vietnam; [Elumalai, Preetham] Kerala Univ Fisheries & Ocean Studies, Kochi, Kerala, India; [Thangaraj, Kumarasamy] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Prades, India; [Valluri, Vijaya Lakshmi] LEPRA Blue Peter Publ Hlth & Res Ctr, Hyderabad, Andhra Prades, India; [Ntoumi, Francine; Velavan, Thirumalaisamy P.] Fdn Congolaise Rech Med, Brazzaville, Rep Congo; [Meyer, Christian G.; Velavan, Thirumalaisamy P.] Duy Tan Univ, Da Nang, Vietnam	Eberhard Karls University of Tubingen; Universidade Federal do Parana; University of Ghana; Kerala University of Fisheries & Ocean Studies; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Duy Tan University	Velavan, TP (corresponding author), Univ Tubingen, Inst Trop Med, Tubingen, Germany.; Velavan, TP (corresponding author), Vietnamese German Ctr Med Res, Hanoi, Vietnam.; Velavan, TP (corresponding author), Fdn Congolaise Rech Med, Brazzaville, Rep Congo.; Velavan, TP (corresponding author), Duy Tan Univ, Da Nang, Vietnam.	velavan@medizin.uni-tuebingen.de	van Tong, Hoang/E-9448-2011; Valluri, Vijaya Lakshmi/S-9219-2019; Velavan, Thirumalaisamy P/C-1223-2010	van Tong, Hoang/0000-0002-7170-8810; Velavan, Thirumalaisamy P/0000-0002-9809-9883; Andrade, Fabiana/0000-0003-4116-2324; Jose de Messias Reason, Iara/0000-0002-5573-260X	CAPES (Coordenagao de Aperfeigoamento de Pessoal Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil); BMBF [BMBF BRA11/A33, 01DN11001]; CANTAM (Central Africa Network on Tuberculosis, HIV/AIDS and Malaria); EDCTP; Deutsche Forschungsgemeinschaft (DFG); Open Access Publishing Fund of Tuebingen University	CAPES (Coordenagao de Aperfeigoamento de Pessoal Superior); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); BMBF(Federal Ministry of Education & Research (BMBF)); CANTAM (Central Africa Network on Tuberculosis, HIV/AIDS and Malaria); EDCTP; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University	This work was supported by research grants from CAPES (Coordenagao de Aperfeigoamento de Pessoal Superior) for Thaisa Lucas Sandri and from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brasil) for lara Jose de Messias Reason. Also, bilateral cooperation support from BMBF to TPV (BMBF BRA11/A33; 01DN11001) for Thirumalaisamy P. Velavan is acknowledged. TPV and FN acknowledge the support from CANTAM (Central Africa Network on Tuberculosis, HIV/AIDS and Malaria), a network of excellence supported by EDCTP. The authors greatly acknowledge the support by the Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of Tuebingen University. Other authors received no specific funding for this work. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyaz M, 2012, IMMUNOBIOLOGY, V217, P204, DOI 10.1016/j.imbio.2011.07.023; Apinjoh TO, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-236; Backes C, 2015, ONCOTARGET, V6, P5918, DOI 10.18632/oncotarget.2950; Beck Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008297; Chakraborty P, 2001, J PARASITOL, V87, P1023, DOI 10.1645/0022-3395(2001)087[1023:MOMMRA]2.0.CO;2; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Diakite M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-250; Dominguez M, 2003, MICROBES INFECT, V5, P507, DOI 10.1016/S1286-4579(03)00071-6; Dominguez M, 2002, J EXP MED, V195, P451, DOI 10.1084/jem.20011319; Duru KC, 2015, EVOL BIOINFORM, V11, DOI 10.4137/EBO.S23132; Eid NA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-119; Erdei A, 2009, MOL IMMUNOL, V46, P2767, DOI 10.1016/j.molimm.2009.05.181; Fang YF, 1998, J IMMUNOL, V160, P5273; Fernie-King B, 2002, ANN RHEUM DIS, V61, P8; Fitness J, 2002, GENES IMMUN, V3, P441, DOI 10.1038/sj.gene.6363926; Fonseca MI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149792; Gomes JAS, 2012, IMMUNOBIOLOGY, V217, P1005, DOI 10.1016/j.imbio.2012.01.014; Haas KM, 2004, J IMMUNOL, V172, P5833, DOI 10.4049/jimmunol.172.10.5833; Hellwage J, 2002, J IMMUNOL, V169, P6935, DOI 10.4049/jimmunol.169.12.6935; Hinton PR, 2006, J IMMUNOL, V176, P346, DOI 10.4049/jimmunol.176.1.346; Holers VM, 2014, ANNU REV IMMUNOL, V32, P433, DOI 10.1146/annurev-immunol-032713-120154; Holton P, 2013, ANN HUM GENET, V77, P85, DOI 10.1111/ahg.12000; Horakova E, 2004, J IMMUNOL, V173, P4236, DOI 10.4049/jimmunol.173.6.4236; HOURCADE D, 1988, J EXP MED, V168, P1255, DOI 10.1084/jem.168.4.1255; Jacquet M, 2013, J IMMUNOL, V190, P3721, DOI 10.4049/jimmunol.1202451; Jiao B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144898; Kariuki SM, 2013, EPILEPSIA, V54, P990, DOI 10.1111/epi.12173; Keenan BT, 2012, HUM MOL GENET, V21, P2377, DOI 10.1093/hmg/dds054; KLICKSTEIN LB, 1988, J EXP MED, V168, P1699, DOI 10.1084/jem.168.5.1699; KLICKSTEIN LB, 1987, J EXP MED, V165, P1095, DOI 10.1084/jem.165.4.1095; Klop B, 2014, J BIOL CHEM, V289, P35421, DOI 10.1074/jbc.M114.573840; Krych-Goldberg M, 2002, TRENDS MOL MED, V8, P531, DOI 10.1016/S1471-4914(02)02419-X; Krych-Goldberg M, 2001, IMMUNOL REV, V180, P112, DOI 10.1034/j.1600-065X.2001.1800110.x; Kullo IJ, 2011, AM J HUM GENET, V89, P131, DOI 10.1016/j.ajhg.2011.05.019; Liu D, 2009, IMMUNOPHARM IMMUNOT, V31, P524, DOI 10.3109/08923970902845768; Malik M, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0048-1; McElroy JJ, 2013, HUM GENET, V132, P935, DOI 10.1007/s00439-013-1304-5; Mehlhop E, 2005, J VIROL, V79, P7466, DOI 10.1128/JVI.79.12.7466-7477.2005; Moulds J M, 2010, Immunohematology, V26, P2; Moulds JM, 2000, GENES IMMUN, V1, P325, DOI 10.1038/sj.gene.6363676; Moulds JM, 2004, TRANSFUSION, V44, P164, DOI 10.1111/j.1537-2995.2004.00615.x; Moulds JM, 2002, TRANSFUSION, V42, P251, DOI 10.1046/j.1537-2995.2002.00002.x; Moulds JM, 2001, BLOOD, V97, P2879, DOI 10.1182/blood.V97.9.2879; Noumsi GT, 2011, TRANSFUSION, V51, P2462, DOI 10.1111/j.1537-2995.2011.03161.x; Ogembo JG, 2013, CELL REP, V3, P371, DOI 10.1016/j.celrep.2013.01.023; Ren N, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001681; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Saranya B, 2016, INTERDISCIP SCI, V8, P35, DOI 10.1007/s12539-015-0279-4; Seregin SS, 2009, GENE THER, V16, P1245, DOI 10.1038/gt.2009.77; Sherif Fayroz F., 2015, Advances in Bioinformatics, V2015, P639367, DOI 10.1155/2015/639367; Sinha S, 2009, HUM IMMUNOL, V70, P244, DOI 10.1016/j.humimm.2009.02.001; Tettey R, 2015, PATHOG GLOB HEALTH, V109, P247, DOI 10.1179/2047773215Y.0000000011; Toure O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043987; Van Cauwenberghe C, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.03.008; Wang FS, 2005, CLIN EXP IMMUNOL, V139, P112, DOI 10.1111/j.1365-2249.2005.02681.x; WEIS JH, 1987, J IMMUNOL, V138, P312; Weiss L, 1989, Adv Nephrol Necker Hosp, V18, P249; Yu XF, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-56; Zhao L, 2015, J CANCER, V6, P525, DOI 10.7150/jca.10749; Zimmerman PA, 2003, GENES IMMUN, V4, P368, DOI 10.1038/sj.gene.6363980	60	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0175973	10.1371/journal.pone.0175973	http://dx.doi.org/10.1371/journal.pone.0175973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520715	Green Submitted, gold, Green Published			2022-12-26	WOS:000401487700009
J	Sieiro, D; Veron, N; Marcelle, C				Sieiro, Daniel; Veron, Nadege; Marcelle, Christophe			The chicken embryo as an efficient model to test the function of muscle fusion genes in amniotes	PLOS ONE			English	Article							CELL-CELL FUSION; MYOBLAST FUSION; DROSOPHILA; MYOGENESIS; GTPASES; REGENERATION; VERTEBRATES; MYOMAKER; FIBERS; FISH	The fusion of myoblasts into multinucleated myotubes is a crucial step of muscle growth during development and of muscle repair in the adult. While multiple genes were shown to play a role in this process, a vertebrate model where novel candidates can be tested and analyzed at high throughput and relative ease has been lacking. Here, we show that the early chicken embryo is a fast and robust model in which functional testing of muscle fusion candidate genes can be performed. We have used known modulators of muscle fusion, Rac1 and Cdc42, along with the in vivo electroporation of integrated, inducible vectors, to show that the chicken embryo is a suitable model in which their function can be tested and quantified. In addition to nuclei content, specific characteristics of the experimental model allow a fine characterization of additional morphological features that are nearly impossible to assess in other model organisms. This study should establish the chicken embryo as a cheap, reliable and powerful model in which novel vertebrate muscle fusion candidates can be evaluated.	[Sieiro, Daniel; Veron, Nadege; Marcelle, Christophe] Monash Univ, ARMI, Clayton, Vic, Australia; [Sieiro, Daniel; Marcelle, Christophe] Univ Claude Bernard Lyon1, Inst NeuroMyoGene INMG, Fac Med Laennec, Lyon, France	Australian Regenerative Medicine Institute; Monash University; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Marcelle, C (corresponding author), Monash Univ, ARMI, Clayton, Vic, Australia.; Marcelle, C (corresponding author), Univ Claude Bernard Lyon1, Inst NeuroMyoGene INMG, Fac Med Laennec, Lyon, France.	christophe.marcelle@monash.edu		Sieiro Mosti, Daniel/0000-0001-5750-5163; Marcelle, Christophe/0000-0002-9612-7609	National Health and Medical Research Council (NHMRC, Australia); Programme Avenir Lyon Saint-Etienne (PALSE) from the University of Lyon; State Government of Victoria; Australian Government; Association Francaise contre les Myopathies (AFM)	National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); Programme Avenir Lyon Saint-Etienne (PALSE) from the University of Lyon; State Government of Victoria; Australian Government(Australian GovernmentCGIAR); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This work was supported by grants from the National Health and Medical Research Council (NHMRC, Australia) to C.M. and N.V. and by the Programme Avenir Lyon Saint-Etienne (PALSE) from the University of Lyon to C.M. and D.S. The Australian Regenerative Medicine Institute is supported by grants from the State Government of Victoria and the Australian Government. The NeuroMyoGene Institute is supported by grants from the Association Francaise contre les Myopathies (AFM).	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Allen DL, 1999, MUSCLE NERVE, V22, P1350, DOI 10.1002/(SICI)1097-4598(199910)22:10<1350::AID-MUS3>3.0.CO;2-8; Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; Bruusgaard JC, 2003, J PHYSIOL-LONDON, V551, P467, DOI 10.1113/jphysiol.2003.045328; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Doberstein SK, 1997, J CELL BIOL, V136, P1249, DOI 10.1083/jcb.136.6.1249; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Gros J, 2004, DEV CELL, V6, P875, DOI 10.1016/j.devcel.2004.05.006; Gros J, 2009, NATURE, V457, P589, DOI 10.1038/nature07564; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; HALL ZW, 1989, CELL, V59, P771, DOI 10.1016/0092-8674(89)90597-7; Hamoud N, 2014, P NATL ACAD SCI USA, V111, P3745, DOI 10.1073/pnas.1313886111; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Kim JH, 2015, CURR OPIN GENET DEV, V32, P162, DOI 10.1016/j.gde.2015.03.006; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Millay DP, 2014, GENE DEV, V28, P1641, DOI 10.1101/gad.247205.114; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Moore CA, 2007, DEVELOPMENT, V134, P3145, DOI 10.1242/dev.001214; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Park SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10871; Pavlath GK, 2010, EXP CELL RES, V316, P3067, DOI 10.1016/j.yexcr.2010.05.025; Powell GT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001216; Rios AC, 2011, NATURE, V473, P532, DOI 10.1038/nature09970; Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; Sens KL, 2010, J CELL BIOL, V191, P1013, DOI 10.1083/jcb.201006006; Serralbo O, 2013, GENESIS, V51, P372, DOI 10.1002/dvg.22388; SHIMADA Y, 1971, J CELL BIOL, V48, P128, DOI 10.1083/jcb.48.1.128; Sieiro-Mosti D, 2014, DEVELOPMENT, V141, P3605, DOI 10.1242/dev.114546; Srinivas BP, 2007, NAT GENET, V39, P781, DOI 10.1038/ng2055; Sung BH, 2011, CURR BIOL, V21, pR121, DOI 10.1016/j.cub.2010.12.024; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Tixier V, 2010, EXP CELL RES, V316, P3019, DOI 10.1016/j.yexcr.2010.07.013; Vasyutina E, 2009, P NATL ACAD SCI USA, V106, P8935, DOI 10.1073/pnas.0902501106; Veron N, 2015, DEV BIOL, V407, P68, DOI 10.1016/j.ydbio.2015.08.007	37	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177681	10.1371/journal.pone.0177681	http://dx.doi.org/10.1371/journal.pone.0177681			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520772	Green Published, gold, Green Submitted			2022-12-26	WOS:000401485500054
J	Harada, K; Kitaguchi, T; Kamiya, T; Aung, KH; Nakamura, K; Ohta, K; Tsuboi, T				Harada, Kazuki; Kitaguchi, Tetsuya; Kamiya, Taichi; Aung, Kyaw Htet; Nakamura, Kazuaki; Ohta, Kunihiro; Tsuboi, Takashi			Lysophosphatidylinositol-induced activation of the cation channel TRPV2 triggers glucagon-like peptide-1 secretion in enteroendocrine L cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANNABINOID RECEPTOR; ENDOTHELIAL-CELLS; MEDIATED PHOSPHORYLATION; PROTEIN EXPRESSION; GLUTAG CELLS; F-ACTIN; GPR55; LYSOPHOSPHOLIPIDS; ISLETS; ACID	The lysophosphatidylinositol (LPI) has crucial roles in multiple physiological processes, including insulin exocytosis from pancreatic islets. However, the role of LPI in secretion of glucagon-like peptide-1 (GLP-1), a hormone that enhances glucose-induced insulin secretion, is unclear. Here, we used the murine enteroendocrine L cell line GLUTag and primary murine small intestinal cells to elucidate the mechanism of LPI-induced GLP-1 secretion. Exogenous LPI addition increased intracellular Ca2+ concentrations ([Ca2+](i)) in GLUTag cells and induced GLP-1 secretion from both GLUTag and acutely prepared primary intestinal cells. The [Ca2+](i) increase was suppressed by an antagonist for G protein-coupled receptor 55 (GPR55) and by silencing of GPR55 expression, indicating involvement of Gq and G12/13 signaling pathways in the LPI-induced increased [Ca2+](i) levels and GLP-1 secretion. However, GPR55 agonists did not mimic many of the effects of LPI. We also found that phospholipase C inhibitor and Rho-associated kinase inhibitor suppressed the [Ca2+](i) increase and that LPI increased the number of focal adhesions, indicating actin reorganization. Of note, blockage or silencing of transient receptor potential cation channel subfamily V member 2 (TRPV2) channels suppressed both the LPI-induced [Ca2+](i) increase and GLP-1 secretion. Furthermore, LPI accelerated TRPV2 translocation to the plasma membrane, which was significantly suppressed by a GPR55 antagonist. These findings suggest that TRPV2 activation via actin reorganization induced by Gq and G12/13 signaling is involved in LPI-stimulated GLP-1 secretion in enteroendocrine L cells. Because GPR55 agonists largely failed to mimic the effects of LPI, its actions on L cells are at least partially independent of GPR55 activation.	[Harada, Kazuki; Kamiya, Taichi; Ohta, Kunihiro; Tsuboi, Takashi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan; [Kitaguchi, Tetsuya] Waseda Biosci Res Inst Singapore WABIOS, Cell Signaling Grp, Singapore 138667, Singapore; [Kitaguchi, Tetsuya] Waseda Univ, Comprehens Res Org, Tokyo 1620041, Japan; [Aung, Kyaw Htet; Nakamura, Kazuaki] Natl Res Inst Child Hlth & Dev, Tokyo 1578535, Japan	University of Tokyo; Waseda University; National Center for Child Health & Development - Japan	Tsuboi, T (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	takatsuboi@bio.c.u-tokyo.ac.jp	Kitaguchi, Tetsuya/F-5260-2017; TSUBOI, Takashi/AAD-7976-2019; KITAGUCHI, TETSUYA/AAR-1895-2021	Kitaguchi, Tetsuya/0000-0001-6701-1933; TSUBOI, Takashi/0000-0001-8290-2021; KITAGUCHI, TETSUYA/0000-0001-6701-1933; Harada, Kazuki/0000-0002-0793-6851	Ministry of Education, Culture, Sports, Science, and Technology of Japan [26460289, 26291018]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research (26460289 (to T. T.) and 26291018 (to K. O.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Abeele FV, 2006, J BIOL CHEM, V281, P40174, DOI 10.1074/jbc.M605779200; AlSuleimani YM, 2015, BRIT J PHARMACOL, V172, P3043, DOI 10.1111/bph.13107; Andersson DA, 2007, J NEUROSCI, V27, P3347, DOI 10.1523/JNEUROSCI.4846-06.2007; Bondarenko A, 2010, BRIT J PHARMACOL, V161, P308, DOI 10.1111/j.1476-5381.2010.00744.x; Bondarenko AI, 2011, PFLUG ARCH EUR J PHY, V462, P245, DOI 10.1007/s00424-011-0977-7; Chun KH, 2012, ENDOCRINOLOGY, V153, P1649, DOI 10.1210/en.2011-1036; Claustre J, 1999, J ENDOCRINOL, V162, P271, DOI 10.1677/joe.0.1620271; CRUCIANI RA, 1993, P NATL ACAD SCI USA, V90, P3019, DOI 10.1073/pnas.90.7.3019; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Ezcurra M, 2013, CURR OPIN PHARMACOL, V13, P922, DOI 10.1016/j.coph.2013.08.013; Flint A, 1998, J CLIN INVEST, V101, P515, DOI 10.1172/JCI990; GETTYS TW, 1995, METABOLISM, V44, P771, DOI 10.1016/0026-0495(95)90191-4; Harada K, 2015, BIOCHEM BIOPH RES CO, V460, P1053, DOI 10.1016/j.bbrc.2015.03.151; Henstridge CM, 2010, BRIT J PHARMACOL, V160, P604, DOI 10.1111/j.1476-5381.2009.00625.x; Henstridge CM, 2009, FASEB J, V23, P183, DOI 10.1096/fj.08-108670; Hou JC, 2006, J BIOL CHEM, V281, P23307, DOI 10.1074/jbc.M603127200; Imbernon M, 2014, MOL CELL ENDOCRINOL, V383, P159, DOI 10.1016/j.mce.2013.12.011; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Kiuchi T, 2015, NAT METHODS, V12, P743, DOI [10.1038/nmeth.3466, 10.1038/NMETH.3466]; Kuipers D, 2014, J CELL SCI, V127, P1229, DOI 10.1242/jcs.138289; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Lawler OA, 2001, J BIOL CHEM, V276, P33596, DOI 10.1074/jbc.M104434200; Ma MT, 2010, J NEURAL TRANSM, V117, P301, DOI 10.1007/s00702-009-0355-1; Makide K, 2014, J LIPID RES, V55, P1986, DOI 10.1194/jlr.R046920; Moreno-Navarrete JM, 2012, DIABETES, V61, P281, DOI 10.2337/db11-0649; Martin NP, 2004, CELL SIGNAL, V16, P1397, DOI 10.1016/j.cellsig.2004.05.002; Matsuda N, 2000, N-S ARCH PHARMACOL, V361, P53, DOI 10.1007/s002109900169; McKillop AM, 2013, BRIT J PHARMACOL, V170, P978, DOI 10.1111/bph.12356; Meadows A., 2015, INT J OBES LOND, V40, P417, DOI DOI 10.1038/IJ0.2015.209; METZ SA, 1986, BIOCHEM BIOPH RES CO, V138, P720, DOI 10.1016/S0006-291X(86)80556-3; METZ SA, 1988, BIOCHIM BIOPHYS ACTA, V968, P239, DOI 10.1016/0167-4889(88)90013-4; Monet M, 2009, BBA-MOL CELL RES, V1793, P528, DOI 10.1016/j.bbamcr.2009.01.003; Nagasawa M, 2012, CELL CALCIUM, V51, P186, DOI 10.1016/j.ceca.2011.12.012; Nieto-Posadas A, 2012, NAT CHEM BIOL, V8, P78, DOI 10.1038/nchembio.712; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Oya M, 2013, J BIOL CHEM, V288, P4513, DOI 10.1074/jbc.M112.402677; Pan CY, 2007, J NEUROCHEM, V102, P944, DOI 10.1111/j.1471-4159.2007.04584.x; Porat-Shliom N, 2013, CELL MOL LIFE SCI, V70, P2099, DOI 10.1007/s00018-012-1156-5; Reimann F, 2004, DIABETOLOGIA, V47, P1592, DOI 10.1007/s00125-004-1498-0; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Romero-Zerbo SY, 2011, J ENDOCRINOL, V211, P177, DOI 10.1530/JOE-11-0166; Rudolf R, 2003, J CELL SCI, V116, P1339, DOI 10.1242/jcs.00317; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Tsuchiya A, 2015, J PHARMACOL SCI, V128, P179, DOI 10.1016/j.jphs.2015.07.001; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Waldeck-Weiermair M, 2008, J CELL SCI, V121, P1704, DOI 10.1242/jcs.020958; Xiong YM, 2013, MOL CELL ENDOCRINOL, V369, P119, DOI 10.1016/j.mce.2013.01.009; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270	49	18	19	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 30	2017	292	26					10855	10864		10.1074/jbc.M117.788653	http://dx.doi.org/10.1074/jbc.M117.788653			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EZ0JW	28533434	Green Published, hybrid			2022-12-26	WOS:000404391000010
J	Cetinel, S; Semenchenko, V; Cho, JY; Sharaf, MG; Damji, KF; Unsworth, LD; Montemagno, C				Cetinel, Sibel; Semenchenko, Valentyna; Cho, Jae-Young; Sharaf, Mehdi Ghaffari; Damji, Karim F.; Unsworth, Larry D.; Montemagno, Carlo			UV-B induced fibrillization of crystallin protein mixtures	PLOS ONE			English	Article							HUMAN GAMMA-D; SECONDARY STRUCTURE ANALYSES; CIRCULAR-DICHROISM SPECTRA; AMYLOID FIBRIL FORMATION; AGE-RELATED-CHANGES; ALPHA-A-CRYSTALLIN; TRYPTOPHAN FLUORESCENCE; LENS CRYSTALLINS; MECHANISM; CATARACT	Environmental factors, mainly oxidative stress and exposure to sunlight, induce the oxidation, cross-linking, cleavage, and deamination of crystallin proteins, resulting in their aggregation and, ultimately, cataract formation. Various denaturants have been used to initiate the aggregation of crystallin proteins in vitro. All of these regimens, however, are obviously far from replicating conditions that exist in vivo that lead to cataract formation. In fact, it is our supposition that only UV-B radiation may mimic the observed in vivo cause of crystallin alteration leading to cataract formation. This means of inducing cataract formation may provide the most appropriate in vitro platform for in-depth study of the fundamental cataractous fibril properties and allow for testing of possible treatment strategies. Herein, we showed that cataractous fibrils can be formed using UV-B radiation from alpha:beta:gamma crystallin protein mixtures. Characterization of the properties of formed aggregates confirmed the development of amyloid-like fibrils, which are in cross-beta-pattern and possibly in anti-parallel beta-sheet arrangement. Furthermore, we were also able to confirm that the presence of the molecular chaperone, alpha-crystallin, was able to inhibit fibril formation, as observed for 'naturally' occurring fibrils. Finally, the time-dependent fibrillation profile was found to be similar to the gradual formation of age-related nuclear cataracts. This data provided evidence for the initiation of fibril formation from physiologically relevant crystallin mixtures using UV-B radiation, and that the formed fibrils had several traits similar to that expected from cataracts developing in vivo.	[Cetinel, Sibel; Sharaf, Mehdi Ghaffari; Unsworth, Larry D.; Montemagno, Carlo] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB, Canada; [Cetinel, Sibel; Sharaf, Mehdi Ghaffari; Montemagno, Carlo] Univ Alberta, Ingenu Lab, Edmonton, AB, Canada; [Semenchenko, Valentyna; Cho, Jae-Young; Unsworth, Larry D.] Natl Inst Nanotechnol NINT, 11421,Saskatchewan Dr NW, Edmonton, AB, Canada; [Damji, Karim F.] Univ Alberta, Dept Ophthalmol & Visual Sci, Edmonton, AB, Canada	University of Alberta; University of Alberta; National Research Council Canada; University of Alberta	Unsworth, LD; Montemagno, C (corresponding author), Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB, Canada.; Montemagno, C (corresponding author), Univ Alberta, Ingenu Lab, Edmonton, AB, Canada.; Unsworth, LD (corresponding author), Natl Inst Nanotechnol NINT, 11421,Saskatchewan Dr NW, Edmonton, AB, Canada.	lunswort@ualberta.ca; montemag@ualberta.ca		Cho, Jae-Young/0000-0002-1868-6464	Alberta Innovates - Technology Futures [20090279/PSI14420-2011]; Canada Research Chair [229249]	Alberta Innovates - Technology Futures; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was funded by Alberta Innovates - Technology Futures (Grant # 20090279/PSI14420-2011) and Canada Research Chair (Award Reference # 229249 as Tier 1 in Integrative Technology). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Sampson L, 2010, J MOL BIOL, V401, P134, DOI 10.1016/j.jmb.2010.05.067; AMBACH W, 1994, DOC OPHTHALMOL, V88, P165, DOI 10.1007/BF01204614; [Anonymous], 1969, ACTA OPHTHALMOL, V47, P5; Bilbao J, 2010, JOURNAL OF GEOPHYSIC, P115; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Bolder SG, 2007, LANGMUIR, V23, P4144, DOI 10.1021/la063048k; Chen JJ, 2008, BIOCHEMISTRY-US, V47, P10705, DOI 10.1021/bi800499k; Chen JJ, 2006, BIOCHEMISTRY-US, V45, P11552, DOI 10.1021/bi060988v; Chen J, 2009, BIOCHEMISTRY-US, V48, P3708, DOI 10.1021/bi802177g; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Cormier AR, 2012, BIOMACROMOLECULES, V13, P1794, DOI 10.1021/bm300313h; Davies MJ, 2001, J PHOTOCH PHOTOBIO B, V63, P114, DOI 10.1016/S1011-1344(01)00208-1; Dyer JM, 2006, PHOTOCH PHOTOBIO SCI, V5, P698, DOI 10.1039/b603030k; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; Frederikse PH, 2000, CURR EYE RES, V20, P462, DOI 10.1076/0271-3683(200006)20:6;1-Y;FT462; Ganea E, 2001, CURR PROTEIN PEPT SC, V2, P205, DOI 10.2174/1389203013381107; GRAINGER RM, 1992, TRENDS GENET, V8, P349, DOI 10.1016/0168-9525(92)90280-H; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; HOTT JL, 1993, PHOTOCHEM PHOTOBIOL, V57, P312; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kessel L, 2011, BMC OPHTHALMOLOGY, P11; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Lampi KJ, 1998, EXP EYE RES, V67, P31, DOI 10.1006/exer.1998.0481; Lee JS, 1997, J PROTEIN CHEM, V16, P283, DOI 10.1023/A:1026305025816; Liao JH, 2002, BIOCHEM BIOPH RES CO, V295, P854, DOI 10.1016/S0006-291X(02)00784-2; Lin SY, 1999, J PHOTOCH PHOTOBIO B, V49, P29, DOI 10.1016/S1011-1344(99)00010-X; Ma ZX, 1998, EXP EYE RES, V67, P21, DOI 10.1006/exer.1998.0482; Mafia K, 2008, MOL VIS, V14, P234; Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Marchesan S, 2014, NANOSCALE, V6, P5172, DOI 10.1039/c3nr06752a; Markossian KA, 2009, INT J MOL SCI, V10, P1314, DOI 10.3390/ijms10031314; Meehan S, 2004, J BIOL CHEM, V279, P3413, DOI 10.1074/jbc.M308203200; Mizdrak J, 2008, FREE RADICAL BIO MED, V44, P1108, DOI 10.1016/j.freeradbiomed.2007.12.003; Moran SD, 2013, BIOCHEMISTRY-US, V52, P6169, DOI 10.1021/bi4008353; Moran SD, 2012, J AM CHEM SOC, V134, P18410, DOI 10.1021/ja307898g; Muranov KO, 2011, EXP EYE RES, V92, P76, DOI 10.1016/j.exer.2010.11.005; Oriowo OM, 2001, INVEST OPHTH VIS SCI, V42, P2596; Ostrovsky MA, 2002, MOL VIS, V8, P72; Peschek J, 2009, P NATL ACAD SCI USA, V106, P13272, DOI 10.1073/pnas.0902651106; Reddy GB, 2001, BIOCHEM BIOPH RES CO, V282, P712, DOI 10.1006/bbrc.2001.4642; Roberts JE, 2001, J PHOTOCH PHOTOBIO B, V64, P136, DOI 10.1016/S1011-1344(01)00196-8; Schafheimer N, 2013, PHOTOCHEM PHOTOBIOL, V89, P1106, DOI 10.1111/php.12096; Sergeev YV, 2005, INVEST OPHTH VIS SCI, V46, P3263, DOI 10.1167/iovs.05-0112; Sergeev YV, 2005, INVEST OPHTHALMOL, P46; SIEZEN RJ, 1983, BIOCHIM BIOPHYS ACTA, V748, P56, DOI 10.1016/0167-4838(83)90027-4; Sliney DH, 2005, PHOTOCHEM PHOTOBIOL, V81, P483, DOI 10.1562/2005-02-14-RA-439.1; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Su S, 2011, INVEST OPHTH VIS SCI, V52, P4182, DOI 10.1167/iovs.10-7094; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Varma SD, 2008, J OCUL PHARMACOL TH, V24, P439, DOI 10.1089/jop.2008.0035; Vazquez S, 2004, INVEST OPHTH VIS SCI, V45, P879, DOI 10.1167/iovs.03-0558; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wu JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102486; Xia Z, 2013, SCI REPORTS, P3; Yang JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130681; YU NT, 1975, J BIOL CHEM, V250, P2196; Zhou P, 2012, FASEB J, V26, P4897, DOI 10.1096/fj.12-213702; Zhu XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060146, 10.1371/journal.pone.0062731, 10.3389/fnsyn.2013.00008, 10.1371/journal.pone.0070631, 10.1371/journal.pone.0081900, 10.1371/journal.pone.0070686]	62	12	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177991	10.1371/journal.pone.0177991	http://dx.doi.org/10.1371/journal.pone.0177991			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542382	Green Published, gold, Green Submitted			2022-12-26	WOS:000402062800033
J	Copot, D; De Keyser, R; Derom, E; Ionescu, C				Copot, Dana; De Keyser, Robin; Derom, Eric; Ionescu, Clara			Structural changes in the COPD lung and related heterogeneity	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; FORCED OSCILLATION TECHNIQUE; RESPIRATORY IMPEDANCE; FRACTAL GEOMETRY; IDENTIFICATION; EMPHYSEMA; DEVICE; SYSTEM	This paper proposes a mathematical framework for understanding how the structural changes in the COPD lung reflect in model parameters. The core of the analysis is a correlation between the heterogeneity in the lung as COPD degree changes (GOLD II, III and IV) and the nonlinearity index evaluated using the forced oscillation technique. A low frequency evaluation of respiratory impedance models and nonlinearity degree is performed since changes in tissue mechanics are related to viscoelastic properties. Simulation analysis of our model indicates a good correlation to expected changes in heterogeneity and nonlinear effects. A total of 43 COPD diagnosed patients are evaluated, distributed as GOLD II (18), GOLD III (15) and GOLD IV (10). Experimental data supports the claims and indicate that the proposed model and index for nonlinearity is well-suited to capture COPD structural changes.	[Copot, Dana; De Keyser, Robin; Ionescu, Clara] Univ Ghent, Dept Elect Energy Syst & Automat, Technol Pk 914, B-9052 Ghent, Belgium; [Derom, Eric] Ghent Univ Hosp, Dept Resp Dis, Pintelaan 185,7K12, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University Hospital	Copot, D (corresponding author), Univ Ghent, Dept Elect Energy Syst & Automat, Technol Pk 914, B-9052 Ghent, Belgium.	dana.copot@ugent.be	Ionescu, Clara Mihaela/O-7006-2014; Copot, Dana/M-6345-2019	Ionescu, Clara Mihaela/0000-0001-7685-035X; Copot, Dana/0000-0002-6010-830X	Flanders Research Center (FWO) [1283415N]; project FWO [G008113N]	Flanders Research Center (FWO); project FWO	C. M. lonescu is a post-doc fellow of Flanders Research Center (FWO) grant nr. 1283415N. D. Copot acknowledges the support of the project FWO nr. G008113N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Bates JHT, 2009, LUNG MECHANICS: AN INVERSE MODELING APPROACH, P1, DOI 10.1017/CBO9780511627156; Boser SR, 2005, AM J RESP CRIT CARE, V172, P817, DOI 10.1164/rccm.200411-1463OC; Gabano JD, 2011, SIGNAL PROCESS, V91, P531, DOI 10.1016/j.sigpro.2010.02.005; Gabano JD, 2011, SIGNAL PROCESS, V91, P938, DOI 10.1016/j.sigpro.2010.09.013; HANTOS Z, 1986, J APPL PHYSIOL, V60, P123, DOI 10.1152/jappl.1986.60.1.123; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Ionescu C., 2014, 19 WORD C INT FED AU, P5363; Ionescu C., 2013, SERIES BIOENGINEERIN; Ionescu C., 2011, AM CONTR C; Ionescu C., 2009, IFAC P VOLUMES, V42, P994; Ionescu CM, 2014, IEEE T INSTRUM MEAS, V63, P124, DOI 10.1109/TIM.2013.2277519; Ionescu CM, 2011, IEEE T BIOMED CIRC S, V5, P83, DOI 10.1109/TBCAS.2010.2077636; Ionescu CM, 2009, IEEE T BIO-MED ENG, V56, P949, DOI 10.1109/TBME.2008.2007807; Irvin CG, 2000, AM J RESP CRIT CARE, V161, P50, DOI 10.1164/ajrccm.161.1.9804053; Karimi R., RESP RES, V15; Liou JL, 2010, WEAR, V268, P431, DOI 10.1016/j.wear.2009.08.033; Lopes R, 2009, MED IMAGE ANAL, V13, P634, DOI 10.1016/j.media.2009.05.003; LUTCHEN KR, 1987, FASEB J, V46, P510; Machado JT, 2011, COMMUN NONLINEAR SCI, V16, P1140, DOI 10.1016/j.cnsns.2010.05.027; Maes H, 2014, IEEE T INSTRUM MEAS, V63, P603, DOI 10.1109/TIM.2013.2282188; Magin Richard L., 2004, Critical Reviews in Biomedical Engineering, V32, P1, DOI 10.1615/CritRevBiomedEng.v32.10; Magleby R., 2008, 453 BEE; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; Olarte O, 2016, BIOMED SIGNAL PROCES, V30, P127, DOI 10.1016/j.bspc.2016.06.004; Oostveen E, 2003, EUR RESPIR J, V22, P1026, DOI 10.1183/09031936.03.00089403; Oustaloup A, 2014, DIVERSITY AND NON-INTEGER DIFFERENTIATION FOR SYSTEM DYNAMICS, P1, DOI 10.1002/9781118760864; Oustaloup A., 1995, DERIVATION NONENTIER; Parameswaran H, 2006, J APPL PHYSIOL, V100, P186, DOI 10.1152/japplphysiol.00424.2005; Petak F, 1998, J APPL PHYSIOL, V84, P1680, DOI 10.1152/jappl.1998.84.5.1680; PONDER E, 1962, J GEN PHYSIOL, V45, P545, DOI 10.1085/jgp.45.3.545; Sorensen L., 2009, P SPIE DIG LIB C MED, V7260, P1; Sorensen L, 2010, IEEE T MED IMAGING, V29, P559, DOI 10.1109/TMI.2009.2038575; SUKI B, 1992, RESP PHYSIOL, V90, P271, DOI 10.1016/0034-5687(92)90108-9; SUKI B, 1994, NATURE, V368, P615, DOI 10.1038/368615a0; Tourassi GD, 2001, COMPUT BIOL MED, V31, P15, DOI 10.1016/S0010-4825(00)00024-X; Weibel E.R., 1963, MORPHOMETRY HUMAN LU, DOI DOI 10.1007/978-3-642-87553-3; WEIBEL ER, 1991, AM J PHYSIOL, V261, pL361, DOI 10.1152/ajplung.1991.261.6.L361; West B. J., 1990, STUDIES NONLINEAR PH, V1; West JB., 2008, WESTS RESP PHYSL ESS, V9th	40	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177969	10.1371/journal.pone.0177969	http://dx.doi.org/10.1371/journal.pone.0177969			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542377	Green Submitted, Green Published, gold			2022-12-26	WOS:000402062800031
J	Takahashi, K; Kim, R; Lauhan, C; Park, Y; Nguyen, NG; Vestweber, D; Dominguez, MG; Valenzuela, DM; Murphy, AJ; Yancopoulos, GD; Gale, NW; Takahashi, T				Takahashi, Keiko; Kim, Rachel; Lauhan, Colette; Park, Yuna; Nguyen, Nghiep G.; Vestweber, Dietmar; Dominguez, Melissa G.; Valenzuela, David M.; Murphy, Andrew J.; Yancopoulos, George D.; Gale, Nicholas W.; Takahashi, Takamune			Expression of receptor-type protein tyrosine phosphatase in developing and adult renal vasculature	PLOS ONE			English	Article							BLOOD-VESSEL DEVELOPMENT; VE-PTP; IN-VIVO; RPTP-MU; SHEAR-STRESS; MICE; TIE-2; CADHERIN; CELLS; PHOSPHORYLATION	Renal vascular development is a coordinated process that requires ordered endothelial cell proliferation, migration, intercellular adhesion, and morphogenesis. In recent decades, studies have defined the pivotal role of endothelial receptor tyrosine kinases (RPTKs) in the development and maintenance of renal vasculature. However, the expression and the role of receptor tyrosine phosphatases (RPTPs) in renal endothelium are poorly understood, though coupled and counterbalancing roles of RPTKs and RPTPs are well defined in other systems. In this study, we evaluated the promoter activity and immunolocalization of two endothelial RPTPs, VE-PTP and PTP mu, in developing and adult renal vasculature using the heterozygous LacZ knock-in mice and specific antibodies. In adult kidneys, both VE-PTP and PTP mu were expressed in the endothelium of arterial, glomerular, and medullary vessels, while their expression was highly limited in peritubular capillaries and venous endothelium. VE-PTP and PTP mu promoter activity was also observed in medullary tubular segments in adult kidneys. In embryonic (E12.5, E13.5, E15.5, E17.5) and postnatal (P0, P3, P7) kidneys, these RPTPs were expressed in ingrowing renal arteries, developing glomerular microvasculature (as early as the S-shaped stage), and medullary vessels. Their expression became more evident as the vasculatures matured. Peritubular capillary expression of VE-PTP was also noted in embryonic and postnatal kidneys. Compared to VE-PTP, PTP mu immunoreactivity was relatively limited in embryonic and neonatal renal vasculature and evident immunoreactivity was observed from the P3 stage. These findings indicate 1) VE-PTP and PTP mu are expressed in endothelium of arterial, glomerular, and medullary renal vasculature, 2) their expression increases as renal vascular development proceeds, suggesting that these RPTPs play a role in maturation and maintenance of these vasculatures, and 3) peritubular capillary VE-PTP expression is down-regulated in adult kidneys, suggesting a role of VE-PTP in the development of peritubular capillaries.	[Takahashi, Keiko; Kim, Rachel; Lauhan, Colette; Park, Yuna; Takahashi, Takamune] Vanderbilt Univ, Sch Med, Div Nephrol & Hypertens, Nashville, TN 37212 USA; [Nguyen, Nghiep G.] Univ Oklahoma, Coll Med, Oklahoma City, OK 73190 USA; [Vestweber, Dietmar] Max Planck Inst Mol Biomed, Munster, Germany; [Dominguez, Melissa G.; Valenzuela, David M.; Murphy, Andrew J.; Gale, Nicholas W.] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA; [Yancopoulos, George D.; Takahashi, Takamune] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA	Vanderbilt University; University of Oklahoma System; University of Oklahoma Health Sciences Center; Max Planck Society; Regeneron; Vanderbilt University	Takahashi, T (corresponding author), Vanderbilt Univ, Sch Med, Div Nephrol & Hypertens, Nashville, TN 37212 USA.; Takahashi, T (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA.	takamune.takahashi@vanderbilt.edu		Kim, Rachel/0000-0002-0538-5195; Park, Yuna/0000-0001-9981-5493	National Institutes of Health (NIH) [DK 97332, HL109715, DK38517]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Heart, Lung, and Blood Institute (NHLBI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL109715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097332, R01DK038517] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants DK 97332 (TT), HL109715 (TT), and DK38517 (TT); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK http://www.niddk.nih.gov/; and the National Heart, Lung, and Blood Institute (NHLBI) http://www.nhlbi.nih.gov/.MGD, DMV, AJM, GDY, NWG are employees of Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. provided the VE-PTPtlacZ/+ mice, but did not have any additional role in the salary support, study design,data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 2003, NEPHROL DIAL TRANSPL, V18, P2, DOI 10.1093/ndt/gfg1056; Baumer S, 2006, BLOOD, V107, P4754, DOI 10.1182/blood-2006-01-0141; Bianchi C, 1999, EXP CELL RES, V248, P329, DOI 10.1006/excr.1999.4428; BRADYKALNAY SM, 1993, J CELL BIOL, V122, P961, DOI 10.1083/jcb.122.4.961; BRADYKALNAY SM, 1995, J CELL BIOL, V130, P977, DOI 10.1083/jcb.130.4.977; Broermann A, 2011, J EXP MED, V208, P2393, DOI 10.1084/jem.20110525; Craig SEL, 2015, SEMIN CELL DEV BIOL, V37, P108, DOI 10.1016/j.semcdb.2014.09.004; Desai CJ, 1997, CURR OPIN NEUROBIOL, V7, P70, DOI 10.1016/S0959-4388(97)80122-5; Dominguez MG, 2007, P NATL ACAD SCI USA, V104, P3243, DOI 10.1073/pnas.0611510104; Fachinger G, 1999, ONCOGENE, V18, P5948, DOI 10.1038/sj.onc.1202992; Frye M, 2015, J EXP MED, V212, P2267, DOI 10.1084/jem.20150718; GEBBINK MFBG, 1995, J CELL BIOL, V131, P251, DOI 10.1083/jcb.131.1.251; GEBBINK MFBG, 1993, J BIOL CHEM, V268, P16101; Gomez RA, 1997, MICROSC RES TECHNIQ, V39, P254, DOI 10.1002/(SICI)1097-0029(19971101)39:3<254::AID-JEMT5>3.0.CO;2-K; Gurnik S, 2016, ACTA NEUROPATHOL, V131, P753, DOI 10.1007/s00401-016-1551-3; Hayashi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2683; Kim W, 2006, J AM SOC NEPHROL, V17, P2474, DOI 10.1681/ASN.2006020109; Kolatsi-Joannou M, 2001, DEV DYNAM, V222, P120, DOI 10.1002/dvdy.1170; Koop EA, 2005, AM J PHYSIOL-HEART C, V288, pH1218, DOI 10.1152/ajpheart.00512.2004; Koop EA, 2003, INT J DEV BIOL, V47, P345; Langille BL, 2001, MICROCIRCULATION, V8, P195, DOI 10.1038/sj.mn.7800085; Mantilidewi KI, 2014, J BIOL CHEM, V289, P6451, DOI 10.1074/jbc.M113.529503; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Pitera JE, 2004, AM J PATHOL, V165, P1895, DOI 10.1016/S0002-9440(10)63242-7; Quaggin SE, 2008, DEVELOPMENT, V135, P609, DOI 10.1242/dev.001081; Robert B, 1998, AM J PHYSIOL-RENAL, V275, pF164, DOI 10.1152/ajprenal.1998.275.1.F164; Robert B, 1996, AM J PHYSIOL-RENAL, V271, pF744, DOI 10.1152/ajprenal.1996.271.3.F744; Robert B, 2001, PEDIATR NEPHROL, V16, P294, DOI 10.1007/s004670000534; Shen JK, 2014, J CLIN INVEST, V124, P4564, DOI 10.1172/JCI74527; Sui XF, 2005, AM J PATHOL, V166, P1247, DOI 10.1016/S0002-9440(10)62343-7; Takahashi T, 1998, KIDNEY INT, V53, P826, DOI 10.1046/j.1523-1755.1998.00822.x; Takahashi T, 2001, J AM SOC NEPHROL, V12, P2673, DOI 10.1681/ASN.V12122673; Wallner EI, 1997, MICROSC RES TECHNIQ, V39, P261; Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159; Woolf AS, 2009, J AM SOC NEPHROL, V20, P239, DOI 10.1681/ASN.2008020243; Yuan HT, 1999, J AM SOC NEPHROL, V10, P1722; Zondag GCM, 2000, J BIOL CHEM, V275, P11264, DOI 10.1074/jbc.275.15.11264	38	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177192	10.1371/journal.pone.0177192	http://dx.doi.org/10.1371/journal.pone.0177192			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542220	Green Published, gold, Green Submitted			2022-12-26	WOS:000402062800011
J	Edgar, GJ; Stuart-Smith, RD; Thomson, RJ; Freeman, DJ				Edgar, Graham J.; Stuart-Smith, Rick D.; Thomson, Russell J.; Freeman, Debbie J.			Consistent multi-level trophic effects of marine reserve protection across northern New Zealand	PLOS ONE			English	Article							REEF HABITATS; ROCKY; FISH; KELP; PATTERNS; DENSITY; CASCADE; INVERTEBRATES; ABUNDANCE; TRENDS	Through systematic Reef Life Survey censuses of rocky reef fishes, invertebrates and macroalgae at eight marine reserves across northern New Zealand and the Kermadec Islands, we investigated whether a system of no-take marine reserves generates consistent biodiversity outcomes. Ecological responses of reef assemblages to protection from fishing, including potential trophic cascades, were assessed using a control-impact design for the six marine reserves studied with associated reference sites, and also by comparing observations at reserve sites with predictions from random forest models that assume reserve locations are fished. Reserve sites were characterised by higher abundance and biomass of large fishes than fished sites, most notably for snapper Chrysophrys auratus, with forty-fold higher observed biomass inside relative to out. In agreement with conceptual models, significant reserve effects not only reflected direct interactions between fishing and targeted species (higher large fish biomass; higher snapper and lobster abundance), but also second order interactions (lower urchin abundance), third order interactions (higher kelp cover), and fourth order interactions (lower understory algal cover). Unexpectedly, we also found: (i) a consistent trend for higher (similar to 20%) Ecklonia cover across reserves relative to nearby fished sites regardless of lobster and urchin density, (ii) an inconsistent response of crustose coralline algae to urchin density, (iii) low cover of other understory algae in marine reserves with few urchins, and (iv) more variable fish and benthic invertebrate communities at reserve relative to fished locations. Overall, reef food webs showed complex but consistent responses to protection from fishing in well-enforced temperate New Zealand marine reserves. The small proportion of the northeastern New Zealand coastal zone located within marine reserves (similar to 0.2%) encompassed a disproportionately large representation of the full range of fish and benthic invertebrate biodiversity within this region.	[Edgar, Graham J.; Stuart-Smith, Rick D.] Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Thomson, Russell J.] Western Sydney Univ, Ctr Res Math, Parramatta Campus, Penrith, NSW, Australia; [Freeman, Debbie J.] Dept Conservat Te Papa Atawhai, Wellington, New Zealand	University of Tasmania; Western Sydney University	Edgar, GJ (corresponding author), Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	g.edgar@utas.edu.au	Stuart-Smith, Rick/I-5214-2019; Stuart-Smith, Rick D/M-1829-2013; Edgar, Graham/AAY-3797-2020; Thomson, Russell J/H-5653-2012	Stuart-Smith, Rick/0000-0002-8874-0083; Stuart-Smith, Rick D/0000-0002-8874-0083; Edgar, Graham/0000-0003-0833-9001; Thomson, Russell J/0000-0003-4949-4120	National Geographic Society [9223-12]; Department of Conservation, Science Investigation [4498]; Australian Research Council Linkage Grant [LP100200122]	National Geographic Society(National Geographic Society); Department of Conservation, Science Investigation; Australian Research Council Linkage Grant(Australian Research Council)	Field surveys were supported by National Geographic Society grant #9223-12 (http://www.nationalgeographic.com/explorers/grants-programs/cre/). Analysis of data from the New Zealand surveys was partly funded by the Department of Conservation, Science Investigation number 4498 (http://www.doc.govt.nz/), and Australian Research Council Linkage Grant LP100200122 (http://www.arc.gov.au/).; We thank Reef Life Survey divers who contributed to data collection: Peter Southwood, Andrew Green, Anna Berthelson, Bob Edgar, Charlie Bedford, Christine Kibele, Ian Shaw, Jared Kibele, Kirsten Rodgers, Paul Caiger, Richard Hughes and Sam Griffiths; Richard Taylor for assistance with local surveys; Toni Cooper, Just Berkhout and Jemina Stuart-Smith for data management and photoquadrat digitization; and Helen Curtis for producing Fig 1. Field surveys were supported by National Geographic Society grant #922312. Development of the Reef Life Survey program was facilitated by the Commonwealth Environment Research Facilities Program of the Australian Government. Analysis of data from the New Zealand surveys was partly funded by the Department of Conservation, Science Investigation number 4498, and Australian Research Council Linkage Grant LP100200122.	Althaus F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141039; Anderson MJ, 2004, J EXP MAR BIOL ECOL, V305, P191, DOI 10.1016/j.jembe.2003.12.011; Anderson MJ, 2008, PERMANOVA PRIMER GUI; ANDREW NL, 1993, MAR ECOL PROG SER, V99, P89, DOI 10.3354/meps099089; Babcock RC, 2013, NEW ZEAL J MAR FRESH, V47, P360, DOI 10.1080/00288330.2013.810160; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Ballantine B, 2014, BIOL CONSERV, V176, P297, DOI 10.1016/j.biocon.2014.01.014; Ballantine WJ, 2008, HYDROBIOLOGIA, V606, P35, DOI 10.1007/s10750-008-9347-7; Ballantine W.J., 1991, Leigh Laboratory Bulletin, V25, P1; Bates AE, 2014, NAT CLIM CHANGE, V4, P62, DOI 10.1038/NCLIMATE2062; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Center for International Earth Science Information Network (CIESIN) Food and Agriculture Organization of the United Nations (FAO) and Centro Internacional de Agricultura Tropical (CIAT), 2005, GRIDD POP WORLD VERS; COLE RG, 1992, MAR ECOL PROG SER, V82, P207, DOI 10.3354/meps082207; Cole RG, 1999, J ECOL, V87, P963, DOI 10.1046/j.1365-2745.1999.00418.x; Department of Conservation and Ministry of Environment, 2000, NEW ZEAL BIOD STR; Department of Conservation and Ministry of Fisheries, 2005, MAR PROT ARE POL IMP; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; Edgar GJ, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.7; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Edgar GJ, 2012, ENVIRON CONSERV, V39, P271, DOI 10.1017/S0376892912000185; Edgar GJ, 2009, ECOL APPL, V19, P1967, DOI 10.1890/09-0610.1; Edgar GJ, 2009, MAR ECOL PROG SER, V388, P51, DOI 10.3354/meps08149; Freeman DT, 2012, ENVIRON CONSERV, V39, P295, DOI 10.1017/S037689291200015X; Haggitt TR, 2003, MAR BIOL, V143, P1201, DOI 10.1007/s00227-003-1152-2; Hesse J, 2016, NEW ZEAL J MAR FRESH, V50, P339, DOI 10.1080/00288330.2016.1146309; JONES GP, 1992, J EXP MAR BIOL ECOL, V159, P217, DOI 10.1016/0022-0981(92)90038-C; KENNELLY SJ, 1993, J EXP MAR BIOL ECOL, V168, P35, DOI 10.1016/0022-0981(93)90115-5; Langlois TJ, 2005, CONSERV BIOL, V19, P1763, DOI 10.1111/j.1523-1739.2005.00278.x; Ling SD, 2008, OECOLOGIA, V156, P883, DOI 10.1007/s00442-008-1043-9; Melville AJ, 2001, AUSTRAL ECOL, V26, P102, DOI 10.1111/j.1442-9993.2001.01089.pp.x; Ministry of Fisheries and Department of Conservation, 2008, MAR PROT AR CLASS PR; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Newcombe EM, 2010, MAR ECOL PROG SER, V408, P161, DOI 10.3354/meps08589; Poore AGB, 2012, ECOL LETT, V15, P912, DOI 10.1111/j.1461-0248.2012.01804.x; Shears NT, 2008, ECOL APPL, V18, P1860, DOI 10.1890/07-1776.1; Shears NT, 2003, MAR ECOL PROG SER, V246, P1, DOI 10.3354/meps246001; Shears NT, 2002, OECOLOGIA, V132, P131, DOI 10.1007/s00442-002-0920-x; Shears NT, 2004, INDIRECT EFFECTS MAR; Silverman BW., 1986, DENSITY ESTIMATION S, DOI 10.1201/9781315140919; Soler GA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140270; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stuart-Smith RD, 2008, J EXP MAR BIOL ECOL, V365, P116, DOI 10.1016/j.jembe.2008.08.002; Stuart-Smith RD, 2017, BIOSCIENCE, V67, P134, DOI 10.1093/biosci/biw180; Taylor RB, 1998, MAR ECOL PROG SER, V172, P37, DOI 10.3354/meps172037; Thompson S., 1991, FISH CAPE RODNEY OKA; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x	46	21	21	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177216	10.1371/journal.pone.0177216	http://dx.doi.org/10.1371/journal.pone.0177216			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542268	Green Published, gold, Green Accepted			2022-12-26	WOS:000402061500015
J	Ashraf, Z; Rafiq, M; Nadeem, H; Hassan, M; Afzal, S; Waseem, M; Afzal, K; Latip, J				Ashraf, Zaman; Rafiq, Muhammad; Nadeem, Humaira; Hassan, Mubashir; Afzal, Samina; Waseem, Muhammad; Afzal, Khurram; Latip, Jalifah			Carvacrol derivatives as mushroom tyrosinase inhibitors; synthesis, kinetics mechanism and molecular docking studies	PLOS ONE			English	Article							BIOLOGICAL EVALUATION; ANTIOXIDANT; THYMOL; DOPAMINE; OXIDASES; QUALITY; ACID	The present work describesthe development of highly potent mushroom tyrosinase inhibitor better than the standard kojic acid. Carvacrol derivatives 4a-f and 6a-d having substituted benzoic acid and cinnamic acidresidues were synthesized with the aim to possess potent tyrosinase inhibitory activity. The structures of the synthesized compounds were ascertained by their spectroscopic data (FTIR, (HNMR)-H-1, (CNMR)-C-13 and Mass Spectroscopy). Mushroom tyrosinase inhibitory activity of synthesized compounds was determined and it was found that one of the derivative 6c possess higher activity (IC50 0.0167 mu M) than standard kojic acid (IC50 16.69 mu M). The derivatives 4c and 6b also showed good tyrosinase inhibitory activity with (IC50 16.69 mu M) and (IC50 16.69 mu M) respectively. Lineweaver-Burk and Dixon plots were used for the determination of kinetic mechanism of the compounds 4c and 6b and 6c. The kinetic analysis revealed that compounds 4c and 6b showed mixed-type inhibition while 6c is a non-competitive inhibitor having Ki values19 mu M, 10 mu M, and 0.05 mu Mrespectively. The enzyme inhibitory kinetics further showed that compounds 6b and 6c formed irreversible enzyme inhibitor complex while 4c bind reversibly with mushroom tyrosinase. The docking studies showed that compound 6c have maximum binding affinity against mushroom tyrosinase (PDBID: 2Y9X) with binding energy value (-7.90 kcal/mol) as compared to others. The 2-hydroxy group in compound 6c interacts with amino acid HIS85 which is present in active binding site. The wet lab results are in good agreement with the dry lab findings. Based upon our investigation we may propose that the compound 6c is promising candidate for the development of safe cosmetic agent.	[Ashraf, Zaman] Allama Iqbal Open Univ, Dept Chem, Islamabad, Pakistan; [Rafiq, Muhammad] Islamia Univ Bahawalpur, Dept Biochem & Biotechnol, Baghdad ul Jadeed Campus, Bahawalpur, Pakistan; [Nadeem, Humaira] Riphah Int Univ, Riphah Inst Pharmaceut Sci, Dept Pharmaceut Chem, Islamabad, Pakistan; [Hassan, Mubashir] Kongju Natl Univ, Dept Biol, Coll Nat Sci, Gongju, South Korea; [Afzal, Samina; Afzal, Khurram] BahauddinZakria Univ, Dept Pharm, Fac Pharm, Multan, Pakistan; [Waseem, Muhammad] Allama Iqbal Open Univ, Dept Biol, Islamabad, Pakistan; [Latip, Jalifah] Univ Kebangsaan Malaysia, Sch Chem Sci & Food Technol, Fac Sci & Technol, Bangi, Selangor, Malaysia	Islamia University of Bahawalpur; Kongju National University; Universiti Kebangsaan Malaysia	Latip, J (corresponding author), Univ Kebangsaan Malaysia, Sch Chem Sci & Food Technol, Fac Sci & Technol, Bangi, Selangor, Malaysia.	jalifah@ukm.edu.my	ashraf, zaman/AAH-2147-2021; Hassan, Mubashir/V-8187-2017	ashraf, zaman/0000-0002-6620-9080; Hassan, Mubashir/0000-0003-2532-1866	Universiti Kebangsaan Malaysia [DIP-2015-015]	Universiti Kebangsaan Malaysia	The authors are especially grateful to Universiti Kebangsaan Malaysia for financial assistance under the DIP-2015-015 research grant.	AESCHBACH R, 1994, FOOD CHEM TOXICOL, V32, P31, DOI 10.1016/0278-6915(84)90033-4; [Anonymous], 2008, STUD DISC VERS 2 1; Asanuma M, 2003, NEUROTOX RES, V5, P165, DOI 10.1007/BF03033137; Ashraf Z, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122151; Ashraf Z, 2015, J ENZYM INHIB MED CH, V30, P874, DOI 10.3109/14756366.2014.979346; Ashraf Z, 2015, BIOORGAN MED CHEM, V23, P5870, DOI 10.1016/j.bmc.2015.06.068; Ashraf Z, 2015, EUR J MED CHEM, V98, P203, DOI 10.1016/j.ejmech.2015.05.031; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen WC, 2015, SCI REP-UK, V5, DOI 10.1038/srep07995; Chen ZY, 2014, BIOORGAN MED CHEM, V22, P3279, DOI 10.1016/j.bmc.2014.04.060; Finlay AY, 1997, BRIT J DERMATOL, V136, P305, DOI 10.1111/j.1365-2133.1997.tb14934.x; Friedman M, 1996, J AGR FOOD CHEM, V44, P631, DOI 10.1021/jf950394r; Jukic M, 2005, CROAT CHEM ACTA, V78, P105; Kadekaro AL, 2003, ANN NY ACAD SCI, V994, P359, DOI 10.1111/j.1749-6632.2003.tb03200.x; Kim JM, 1995, J FOOD SCI, V60, P1364, DOI 10.1111/j.1365-2621.1995.tb04592.x; Lovell S.C., 2003, PROTEINS STRUCT FUNC, V50, P437, DOI [10.1002/prot.10286, DOI 10.1002/PROT.10286]; Lynde C B, 2006, Skin Therapy Lett, V11, P1; MAYER AM, 1987, PHYTOCHEMISTRY, V26, P11; Menezes JCJMDS, 2011, EUR J MED CHEM, V46, P773, DOI 10.1016/j.ejmech.2010.12.016; Miliovsky M, 2013, EUR J MED CHEM, V66, P185, DOI 10.1016/j.ejmech.2013.05.040; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Petit L., 2003, International Journal of Cosmetic Science, V25, P169, DOI 10.1046/j.1467-2494.2003.00182.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pires DEV, 2015, J MED CHEM, V58, P4066, DOI 10.1021/acs.jmedchem.5b00104; Prota G, 1995, Fortschr Chem Org Naturst, V64, P93; Prota G., 1992, MELANINS MELANOGENES; Qiu L, 2005, BIOORGAN MED CHEM, V13, P6206, DOI 10.1016/j.bmc.2005.06.034; Rattanangkool E, 2013, EUR J MED CHEM, V66, P296, DOI 10.1016/j.ejmech.2013.05.047; Rendon M, 2006, J AM ACAD DERMATOL, V54, pS272, DOI 10.1016/j.jaad.2005.12.039; Riley PA, 2003, PIGM CELL RES, V16, P548, DOI 10.1034/j.1600-0749.2003.00069.x; SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1; Seo WD, 2010, EUR J MED CHEM, V45, P2010, DOI 10.1016/j.ejmech.2010.01.049; Shiino M, 2001, BIOORGAN MED CHEM, V9, P1233, DOI 10.1016/S0968-0896(01)00003-7; SLOMINSKI A, 1990, J THEOR BIOL, V143, P123, DOI 10.1016/S0022-5193(05)80292-9; SLOMINSKI A, 1991, LIFE SCI, V48, P2075, DOI 10.1016/0024-3205(91)90164-7; SLOMINSKI A, 1991, EXPERIENTIA, V47, P721, DOI 10.1007/BF01958826; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Ultee A, 1998, J APPL MICROBIOL, V85, P211, DOI 10.1046/j.1365-2672.1998.00467.x; Uong A, 2010, J CELL PHYSIOL, V222, P38, DOI 10.1002/jcp.21935; van Holde KE, 2001, J BIOL CHEM, V276, P15563, DOI 10.1074/jbc.R100010200; Walsh SE, 2003, J APPL MICROBIOL, V94, P240, DOI 10.1046/j.1365-2672.2003.01825.x; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Xu YM, 1998, J NEUROSCI RES, V54, P691, DOI 10.1002/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F; Yamaguchi Y, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a017046; Yanishlieva NV, 1999, FOOD CHEM, V64, P59, DOI 10.1016/S0308-8146(98)00086-7; Yi W, 2010, EUR J MED CHEM, V45, P639, DOI 10.1016/j.ejmech.2009.11.007; Yi W, 2009, FOOD CHEM, V117, P381, DOI 10.1016/j.foodchem.2009.03.108; Zhu YJ, 2011, FOOD CHEM, V124, P298, DOI 10.1016/j.foodchem.2010.06.036	49	40	41	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178069	10.1371/journal.pone.0178069	http://dx.doi.org/10.1371/journal.pone.0178069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542395	gold, Green Published, Green Submitted			2022-12-26	WOS:000402058800036
J	He, R; Gu, XB; Lai, WM; Peng, XR; Yang, GY				He, Ran; Gu, Xiaobin; Lai, Weimin; Peng, Xuerong; Yang, Guangyou			Transcriptome-microRNA analysis of Sarcoptes scabiei and host immune response	PLOS ONE			English	Article							HOUSE-DUST MITE; IMD PATHWAYS; RNA-SEQ; DROSOPHILA; INFESTATION; ALIGNMENT; TOLL; GENERATION; REGULATORS; INHIBITORS	Scabies is a parasitic disease, caused by the mite Sarcoptes scabiei, and is considered one of the top 50 epidemic diseases and one the most common human skin disease, worldwide. Allergic dermatitis, including an intense itch, is a common symptom, however diagnosis is difficult and there is currently no effective vaccine. The goal of this study was to examine the immune interaction mechanism of both S. scabiei and infected hosts. mRNA-seq and micro-RNA-seq were conducted on the S. scabiei mite and on infected and uninfected hosts. We focused on differential expression of unigenes and microRNAs, as well as the real targets of unigenes in enriched immune signaling pathways. S. scabiei enhanced host immune function and decreased metabolism after infection, while the immune response of the host inhibited S. scabiei proliferation and metabolism signaling pathways. Differentially expressed unigenes of S. scabiei were enriched in the JAK-STAT signaling pathway and the Toll-like receptor signaling pathway. The differential expression analysis indicated that microRNAs of S. scabiei and hosts have major roles in regulating immune interactions between parasites and hosts.	[He, Ran; Gu, Xiaobin; Lai, Weimin; Yang, Guangyou] Sichuan Agr Univ, Dept Parasitol, Coll Vet Med, Wenjiang, Peoples R China; [Peng, Xuerong] Sichuan Agr Univ, Dept Chem, Coll Life & Basic Sci, Wenjiang, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Yang, GY (corresponding author), Sichuan Agr Univ, Dept Parasitol, Coll Vet Med, Wenjiang, Peoples R China.	guangyou1963@aliyun.com			Research Fund for the Chengdu Research of Giant Panda Breeding [CPF2014-17]	Research Fund for the Chengdu Research of Giant Panda Breeding	This work was supported by a grant from the Research Fund for the Chengdu Research of Giant Panda Breeding (Project No. CPF2014-17). The funder had no role in study design, sample collection, data analysis, preparation or publication of the manuscript.; This work was supported by a grant from the Research Fund for the Chengdu Research of Giant Panda Breeding (Project No. CPF2014-17). We would like to thank Hai Lin and Nengxing Shen (College of Veterinary Medicine, Sichuan Agricultural University, China) for their help.	Aalberse RC, 2000, J ALLERGY CLIN IMMUN, V106, P228, DOI 10.1067/mai.2000.108434; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews RM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000554; Andrews S., 2010, FASTQC QUALITY CONTR; Angelone-Alasaad S, 2015, PARASITE VECTOR, V8, P1; Arlian LG, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004188; Arlian LG, 2000, VET PARASITOL, V90, P315, DOI 10.1016/S0304-4017(00)00251-X; ARLIAN LG, 1988, J MED ENTOMOL, V25, P240, DOI 10.1093/jmedent/25.4.240; Arlian LG, 2002, ANNU REV ENTOMOL, V47, P395, DOI 10.1146/annurev.ento.47.091201.145224; Beckham SA, 2009, J BIOL CHEM, V284, P34413, DOI 10.1074/jbc.M109.061911; Berrios X, 2004, PEDIATR NEPHROL, V19, P306, DOI 10.1007/s00467-003-1340-9; Burge SW, 2012, NUCLEIC ACIDS RES; Casais R, 2015, VET PARASITOL, V214, P315, DOI 10.1016/j.vetpar.2015.07.011; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Devaney E, 2010, TRENDS PARASITOL, V26, P428, DOI 10.1016/j.pt.2010.05.003; Engelman D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002167; Enright AJ, 2004, GENOME BIOL, V5; Fang F, 2015, PARASITE VECTOR, V8, P1; Fischer K, 2003, AM J TROP MED HYG, V68, P61, DOI 10.4269/ajtmh.2003.68.1.0680061; Fischer K, 2014, INT J PARASITOL, V44, P955, DOI 10.1016/j.ijpara.2014.08.003; Gu XB, 2014, EXP APPL ACAROL, V63, P401, DOI 10.1007/s10493-014-9780-4; Gu XB, 2014, EXP APPL ACAROL, V62, P225, DOI 10.1007/s10493-013-9736-0; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hamel D, 2015, PARASITOL RES, V114, P535, DOI 10.1007/s00436-014-4215-z; Han HX, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-120; Hay RJ, 2012, CLIN MICROBIOL INFEC, V18, P313, DOI 10.1111/j.1469-0691.2012.03798.x; Hay RJ, 2014, J INVEST DERMATOL, V134, P1527, DOI 10.1038/jid.2013.446; Hoefig KP, 2008, CURR OPIN IMMUNOL, V20, P281, DOI 10.1016/j.coi.2008.05.005; Holt DC, 2013, CELL TISSUE RES, V351, P339, DOI 10.1007/s00441-012-1369-9; Hu L, 2016, PARASITOL RES, V115, P2661, DOI 10.1007/s00436-016-5013-6; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Karthikeyan K., 2009, INDIAN J DERMATOL, V75, P71; Kenyon F, 2002, VET PARASITOL, V105, P317, DOI 10.1016/S0304-4017(02)00015-8; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kozomara A., 2010, NUCLEIC ACIDS RES; Lalor PF, 2002, J IMMUNOL, V169, P983, DOI 10.4049/jimmunol.169.2.983; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levi A, 2011, LASER MED SCI, V26, P291, DOI 10.1007/s10103-011-0894-1; Liu QA, 2010, PARASITOL RES, V107, P501, DOI 10.1007/s00436-010-1927-6; Liu XS, 2014, PARASITOLOGY, V141, P725, DOI 10.1017/S0031182013002047; Mahmood W, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002525; Mika A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040489; Mika A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001563; Mika A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001331; Myllymaki H, 2014, SCAND J IMMUNOL, V79, P377, DOI 10.1111/sji.12170; Nong X, 2014, PARASITOL RES, V113, P1201, DOI 10.1007/s00436-014-3758-3; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Pearen MA, 2006, ENDOCRINOLOGY, V147, P5217, DOI 10.1210/en.2006-0447; Pearen MA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-448; Rampton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065354; Reynolds SL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002872; Rider SD, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1198-2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schulte LN, 2012, NUCLEIC ACIDS RES; Singh SK, 2014, VET PARASITOL, V206, P253, DOI 10.1016/j.vetpar.2014.10.024; Stewart GA, 2003, CLIN EXP ALLERGY, V33, P3, DOI 10.1046/j.1365-2222.2003.01601.x; Sun XH, 2014, TRENDS CARDIOVAS MED, V24, P105, DOI 10.1016/j.tcm.2013.09.002; Tanji T, 2005, TRENDS IMMUNOL, V26, P193, DOI 10.1016/j.it.2005.02.006; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; Terada Y, 2010, VET DERMATOL, V21, P608, DOI 10.1111/j.1365-3164.2010.00895.x; Thomas WR, 2010, TRENDS MOL MED, V16, P321, DOI 10.1016/j.molmed.2010.04.008; Toet HM, 2014, VET PARASITOL, V205, P263, DOI 10.1016/j.vetpar.2014.07.012; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Walton SF, 2004, ADV PARASIT, V57, P309, DOI 10.1016/S0065-308X(04)57005-7; Walton SF, 2007, CLIN MICROBIOL REV, V20, P268, DOI 10.1128/CMR.00042-06; Walton SF, 2010, CLIN VACCINE IMMUNOL, V17, P1428, DOI 10.1128/CVI.00195-10; Zhang RH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-336; Zhang RH, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-176; Zheng Y, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1353-1	71	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177733	10.1371/journal.pone.0177733	http://dx.doi.org/10.1371/journal.pone.0177733			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542251	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058800025
J	Hsieh, JH; Huang, RL; Lin, JA; Sedykh, A; Zhao, JH; Tice, RR; Paules, RS; Xia, MH; Auerbach, SS				Hsieh, Jui-Hua; Huang, Ruili; Lin, Ja-An; Sedykh, Alexander; Zhao, Jinghua; Tice, Raymond R.; Paules, Richard S.; Xia, Menghang; Auerbach, Scott S.			Real-time cell toxicity profiling of Tox21 10K compounds reveals cytotoxicity dependent toxicity pathway linkage	PLOS ONE			English	Article							CHEMICALS; MECHANISM; ASSAYS; PERTURBATIONS; DEATH	Cytotoxicity is a commonly used in vitro endpoint for evaluating chemical toxicity. In support of the U. S. Tox21 screening program, the cytotoxicity of similar to 10K chemicals was interrogated at 0, 8, 16, 24, 32, & 40 hours of exposure in a concentration dependent fashion in two cell lines (HEK293, HepG2) using two multiplexed, real-time assay technologies. One technology measures the metabolic activity of cells (i.e., cell viability, glo) while the other evaluates cell membrane integrity (i.e., cell death, flor). Using glo technology, more actives and greater temporal variations were seen in HEK293 cells, while results for the flor technology were more similar across the two cell types. Chemicals were grouped into classes based on their cytotoxicity kinetics profiles and these classes were evaluated for their associations with activity in the Tox21 nuclear receptor and stress response pathway assays. Some pathways, such as the activation of H2AX, were associated with the fast-responding cytotoxicity classes, while others, such as activation of TP53, were associated with the slow-responding cytotoxicity classes. By clustering pathways based on their degree of association to the different cytotoxicity kinetics labels, we identified clusters of pathways where active chemicals presented similar kinetics of cytotoxicity. Such linkages could be due to shared underlying biological processes between pathways, for example, activation of H2AX and heat shock factor. Others involving nuclear receptor activity are likely due to shared chemical structures rather than pathway level interactions. Based on the linkage between androgen receptor antagonism and Nrf2 activity, we surmise that a subclass of androgen receptor antagonists cause cytotoxicity via oxidative stress that is associated with Nrf2 activation. In summary, the real-time cytotoxicity screen provides informative chemical cytotoxicity kinetics data related to their cytotoxicity mechanisms, and with our analysis, it is possible to formulate mechanism-based hypotheses on the cytotoxic properties of the tested chemicals.	[Hsieh, Jui-Hua] Kelly Govt Solut, Durham, NC 27560 USA; [Huang, Ruili; Zhao, Jinghua; Xia, Menghang] NIH, Natl Ctr Advancing Translat Sci, Rockville, MD USA; [Lin, Ja-An] US FDA, Silver Spring, MD USA; [Sedykh, Alexander] Sciome, Durham, NC USA; [Tice, Raymond R.; Paules, Richard S.; Auerbach, Scott S.] NIEHS, Div Natl Toxicol Program, NIH, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Hsieh, JH (corresponding author), Kelly Govt Solut, Durham, NC 27560 USA.	jui-hua.hsieh@nih.gov		Paules, Richard S/0000-0001-9106-7486; Hsieh, Jui-Hua/0000-0003-1620-1571	Intramural Research Programs [Y2-ES-7020-01]; National Toxicology Program, NIEHS [ZIA ES103318-01]; NIEHS [HHSN273201700001C, HHSN271201500007I]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000040, ZIATR000038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103318] Funding Source: NIH RePORTER	Intramural Research Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Toxicology Program, NIEHS; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Financial support was provided by the Intramural Research Programs (Y2-ES-7020-01), National Toxicology Program, NIEHS (ZIA ES103318-01), and NIEHS contracts including Bioinformatics Support with Sciome (HHSN273201700001C) and with Kelly (HHSN271201500007I). Except J-HH (Kelly) and AS (Sciome) received salary through corresponding contracting company, the other authors are federal employees. The funder provided support in the form of salaries for authors [J-HH, RH, J-AL, AS, JZ, RRT, RSP, MX, and SSA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi YA, 2009, CHEM BIOL, V16, P712, DOI 10.1016/j.chembiol.2009.05.011; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Behl M, NEUROTOXICOL TERATOL; Browne P, 2015, ENVIRON SCI TECHNOL, V49, P8804, DOI 10.1021/acs.est.5b02641; Bruni G, 2016, NAT CHEM BIOL; Duellman SJ, 2015, ASSAY DRUG DEV TECHN, V13, P456, DOI 10.1089/adt.2015.669; Everitt BS., 2010, CAMBRIDGE DICT STAT, DOI [10.1017/CBO9780511779633, DOI 10.1017/CBO9780511779633]; Gray L, ANTI ANDROGENIC ACTI; Hsieh JH, 2015, J BIOMOL SCREEN, V20, P887, DOI 10.1177/1087057115581317; Huang R, 2014, SCI REP, P4; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Judson RS, 2015, TOXICOL SCI, V148, P137, DOI 10.1093/toxsci/kfv168; Kaneko H, 2005, BIOCHEM BIOPH RES CO, V328, P1101, DOI 10.1016/j.bbrc.2005.01.073; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Kim MT, 2016, ENVIRON HEALTH PERSP, V124, P634, DOI 10.1289/ehp.1509763; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Laszlo A, 2009, CANCER RES, V69, P2042, DOI 10.1158/0008-5472.CAN-08-1639; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Truong L, 2014, TOXICOL SCI, V137, P212, DOI 10.1093/toxsci/kft235; Martin MT, 2009, TOXICOL SCI, V110, P181, DOI 10.1093/toxsci/kfp080; McDonald JH, 2015, HDB BIOL STAT; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Pohlert T., 2016, R PACKAGE TREND NONP; Rotroff DM, 2014, ENVIRON SCI TECHNOL, V48, P8706, DOI 10.1021/es502676e; Rotroff DM, 2013, CHEM RES TOXICOL, V26, P1097, DOI 10.1021/tx400117y; Sedykh A, 2011, ENVIRON HEALTH PERSP, V119, P364, DOI 10.1289/ehp.1002476; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Sharma PM, 2015, PLOS ONE, P10; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sipes NS, ENV SCI TECHNOL; Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784; Vittinghoff E, 2012, REGRESSION METHODS B, P261; Wang YH, 2016, METHODS MOL BIOL, V1473, P123, DOI 10.1007/978-1-4939-6346-1_13; Xi ZK, 2014, COMPUT BIOL CHEM, V49, P23, DOI 10.1016/j.compbiolchem.2013.12.004; Xia M, 2008, ENVIRON HEALTH PERSP, V116, P284, DOI 10.1289/ehp.10727; Yu CN, 2016, NAT BIOTECHNOL, V34, P419, DOI 10.1038/nbt.3460; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099863	37	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177902	10.1371/journal.pone.0177902	http://dx.doi.org/10.1371/journal.pone.0177902			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531190	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058400036
J	Tun, STT; Lubell, Y; Dondorp, AM; Fieldman, T; Tun, KM; Celhay, O; Chan, XH; Saralamba, S; White, LJ				Tun, Sai Thein Than; Lubell, Yoel; Dondorp, Arjen M.; Fieldman, Tom; Tun, Kyaw Myo; Celhay, Olivier; Chan, Xin Hui; Saralamba, Sompob; White, Lisa J.			Identifying artemisinin resistance from parasite clearance half-life data with a simple Shiny web application	PLOS ONE			English	Article								The emergence of artemisinin-resistant Plasmodium falciparum malaria is a major threat to malaria elimination. New tools for supporting the surveillance of artemisinin resistance are critical for current and future malaria control and elimination strategies. We have developed an open-access, user-friendly, web-based tool to analyse parasite clearance half-life data of P. falciparum infected patients after treatment with artemisinin derivatives, so that resistance to artemisinin can be identified. The tool can be accessed at bit.ly/id_artemisinin_resistance.	[Tun, Sai Thein Than; Lubell, Yoel; Dondorp, Arjen M.; Celhay, Olivier; Chan, Xin Hui; Saralamba, Sompob; White, Lisa J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Lubell, Yoel; Dondorp, Arjen M.; Chan, Xin Hui; White, Lisa J.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Fieldman, Tom] Univ Cambridge, Sch Clin Med, Cambridge, England; [Tun, Kyaw Myo] Def Serv Med Acad, Yangon, Myanmar	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; University of Cambridge	Tun, STT (corresponding author), Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.	theinthantun.sai@gmail.com	Chan, Xin Hui S/ABA-5004-2021	Chan, Xin Hui S/0000-0002-9941-6975; White, Lisa/0000-0002-6523-185X; Saralamba, Sompob/0000-0002-5460-8447; Lubell, Yoel/0000-0002-0237-1070; Celhay, Olivier/0000-0002-2971-9110; Tun, Sai Thein Than/0000-0001-9733-8304	Bill and Melinda Gates Foundation [OPP1110500]; Wellcome-Trust Major Overseas Programme in SE Asia [106698/Z/14/Z]; MRC [1790394] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome-Trust Major Overseas Programme in SE Asia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Bill and Melinda Gates Foundation Investment number OPP1110500 awarded to LJW. It was also a part of the Wellcome-Trust Major Overseas Programme in SE Asia (grant number 106698/Z/14/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benaglia T, 2009, J STAT SOFTW, V32, P1; Chang W, SHINYDASHBOARD CREAT; Chang W, shinythemes: Themes for Shiny; Chang W., Shiny: Web Application Framework for R2020 R Package Version 1.4.0.2 2021; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; R Core Team, R LANG ENV STAT COMP; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Venables WN., 2002, MODERN APPL STAT S 4; White LJ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001823; White LJ, 2015, PDPHENO MIXTURE SOUR; World Health Organization, 2016, UPD ART ACT RES OCT	11	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177840	10.1371/journal.pone.0177840	http://dx.doi.org/10.1371/journal.pone.0177840			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531230	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058400030
J	Osamura, T; Kawakami, T; Kido, R; Ishii, M; Arai, H				Osamura, Tatsuya; Kawakami, Takuro; Kido, Reiko; Ishii, Masaharu; Arai, Hiroyuki			Specific expression and function of the A-type cytochrome c oxidase under starvation conditions in Pseudomonas aeruginosa	PLOS ONE			English	Article							RHODOBACTER-SPHAEROIDES; AEROBIC RESPIRATION; TERMINAL OXIDASES; ESCHERICHIA-COLI; PHOTOSYNTHESIS; SHEWANELLA; EVOLUTION; INSERTION; BACTERIA; PAO1	Pseudomonas aeruginosa has one A-type (caa(3)) and multiple C-type (cbb(3)) cytochrome c oxidases as well as two quinol oxidases for aerobic respiration. The caa(3) oxidase is highly efficient in creating a proton gradient across the cell membrane, but it is not expressed under normal growth conditions and its physiological role has not been investigated. In the present study, a mutant strain deficient in the coxBA-PA0107-coxC genes encoding caa(3) exhibited normal growth under any test conditions, but it had low relative fitness under carbon starvation conditions, indicating that the expression of caa(3) is advantageous under starvation conditions. A mutant that lacked four terminal oxidase gene clusters except for the cox genes was unable to grow aerobically because of low expression level of caa3. However, suppressor mutants that grew aerobically using caa(3) as the only terminal oxidase emerged after aerobic subculturing. Analyses of the suppressor mutants revealed that a mutation of roxS encoding a sensor kinase of a two-component regulator RoxSR was necessary for the aerobic growth in synthetic medium. Two additional mutations in the 50-flanking region of coxB were necessary for the aerobic growth in LB medium. Although the expression level of caa(3) was higher in the suppressor mutants, their growth rates were lower than when the other terminal oxidases were utilized, suggesting that caa(3) was not suited for utilization as the only terminal oxidase. Overexpression of the cox genes also inhibited the aerobic growth of the wild-type strain. These results indicate that caa(3) is tightly regulated to be expressed only under starvation conditions at low level and it functions in cooperation with other terminal oxidases to facilitate survival in nutrient starvation conditions.	[Osamura, Tatsuya; Kawakami, Takuro; Kido, Reiko; Ishii, Masaharu; Arai, Hiroyuki] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Arai, H (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo, Japan.	aharai@mail.ecc.u-tokyo.ac.jp			 [15H01393];  [20380046]	; 	This work was partially supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Oxygen Biology: a new criterion for integrated understanding of life (15H01393, HA) of The Ministry of Education, Culture, Sports, Science and Technology, Japan and a Grant-in-Aid for Scientific Research (B) (20380046, HA) of the Japan Society for the Promotion of Science (JSPS). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 2008, J BACTERIOL, V190, P286, DOI 10.1128/JB.01375-07; Arai H, 2014, J BACTERIOL, V196, P4206, DOI 10.1128/JB.02176-14; Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; BlondeletRouault MH, 1997, GENE, V190, P315, DOI 10.1016/S0378-1119(97)00014-0; BOSMA G, 1987, EUR J BIOCHEM, V165, P657, DOI 10.1111/j.1432-1033.1987.tb11491.x; Branden G, 2006, BBA-BIOENERGETICS, V1757, P1052, DOI 10.1016/j.bbabio.2006.05.020; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; FARINHA MA, 1990, J BACTERIOL, V172, P3496, DOI 10.1128/jb.172.6.3496-3499.1990; Flory JE, 1997, MICROBIOL-SGM, V143, P3101, DOI 10.1099/00221287-143-10-3101; Frangipani E, 2009, FEMS MICROBIOL LETT, V298, P234, DOI 10.1111/j.1574-6968.2009.01726.x; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; GABEL C, 1993, J BACTERIOL, V175, P128, DOI 10.1128/JB.175.1.128-132.1993; Hirai T, 2016, P NATL ACAD SCI USA, V113, P12815, DOI 10.1073/pnas.1613308113; Kawakami T, 2010, ENVIRON MICROBIOL, V12, P1399, DOI 10.1111/j.1462-2920.2009.02109.x; Kim YJ, 2007, J BACTERIOL, V189, P5617, DOI 10.1128/JB.00443-07; Kishikawa J, 2010, J BIOSCI BIOENG, V110, P42, DOI 10.1016/j.jbiosc.2009.12.006; Konstantinov AA, 1997, P NATL ACAD SCI USA, V94, P9085, DOI 10.1073/pnas.94.17.9085; Le Laz S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19726; Le Laz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086343; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LUDWIG B, 1980, BIOCHIM BIOPHYS ACTA, V594, P177, DOI 10.1016/0304-4173(80)90008-7; Lyons JA, 2012, NATURE, V487, P514, DOI 10.1038/nature11182; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SARASTE M, 1991, EUR J BIOCHEM, V195, P517, DOI 10.1111/j.1432-1033.1991.tb15732.x; SCHUMPERLI D, 1982, CELL, V30, P865, DOI 10.1016/0092-8674(82)90291-4; Schuster M, 2004, MOL MICROBIOL, V51, P973, DOI 10.1046/j.1365-2958.2003.03886.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; van Opijnen T, 2013, NAT REV MICROBIOL, V11, DOI 10.1038/nrmicro3033; Wu JA, 2010, MBIO, V1, DOI 10.1128/mBio.00272-10; Zhou GQ, 2013, ISME J, V7, P1752, DOI 10.1038/ismej.2013.62	32	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177957	10.1371/journal.pone.0177957	http://dx.doi.org/10.1371/journal.pone.0177957			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542449	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400120
J	Katano, I; Harada, K; Doi, H; Souma, R; Minamoto, T				Katano, Izumi; Harada, Ken; Doi, Hideyuki; Souma, Rio; Minamoto, Toshifumi			Environmental DNA method for estimating salamander distribution in headwater streams, and a comparison of water sampling methods	PLOS ONE			English	Article							JAPONICUS; ABUNDANCE; TOOL	Environmental DNA (eDNA) has recently been used for detecting the distribution of macroor-ganisms in various aquatic habitats. In this study, we applied an eDNA method to estimate the distribution of the Japanese clawed salamander, Onychodactylus japonicus, in headwater streams. Additionally, we compared the detection of eDNA and hand-capturing methods used for determining the distribution of O. japonicus. For eDNA detection, we designed a qPCR primer/probe set for O. japonicus using the 12S rRNA region. We detected the eDNA of O. japonicus at all sites (with the exception of one), where we also observed them by hand-capturing. Additionally, we detected eDNA at two sites where we were unable to observe individuals using the hand-capturing method. Moreover, we found that eDNA concentrations and detection rates of the two water sampling areas (stream surface and under stones) were not significantly different, although the eDNA concentration in the water under stones was more varied than that on the surface. We, therefore, conclude that eDNA methods could be used to determine the distribution of macroorganisms inhabiting headwater systems by using samples collected from the surface of the water.	[Katano, Izumi; Harada, Ken] Univ Hyogo, Sch Human Sci & Environm, 1-1-12 Shinzaike Honcho, Himeji, Hyogo, Japan; [Katano, Izumi] Nara Womens Univ, Fac Sci, Nara, Japan; [Doi, Hideyuki] Univ Hyogo, Grad Sch Simulat Studies, Chuo Ku, 7-1-28 Minatojima Minamimachi, Kobe, Hyogo, Japan; [Souma, Rio] Univ Hyogo, Grad Sch Human Sci & Environm, 1-1-12 Shinzaike Honcho, Himeji, Hyogo, Japan; [Minamoto, Toshifumi] Kobe Univ, Grad Sch Human Dev & Environm, Nada Ku, 3-11 Tsurukabuto, Kobe, Hyogo, Japan	University of Hyogo; Nara Womens University; University of Hyogo; University of Hyogo; Kobe University	Doi, H (corresponding author), Univ Hyogo, Grad Sch Simulat Studies, Chuo Ku, 7-1-28 Minatojima Minamimachi, Kobe, Hyogo, Japan.	hideyuki.doi@icloud.com	Minamoto, Toshifumi/C-6453-2009	Minamoto, Toshifumi/0000-0002-5379-1622; Katano, Izumi/0000-0002-1657-619X; Doi, Hideyuki/0000-0002-2701-3982	Environment Research and Technology Development Fund [4RF1302, 4- 1602]; Ministry of the Environment, Japan; JSPS KAKENHI [15K00596]	Environment Research and Technology Development Fund; Ministry of the Environment, Japan(Ministry of the Environment, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Environment Research and Technology Development Fund (4RF1302 and 4- 1602) of the Ministry of the Environment, Japan, and JSPS KAKENHI Grant Numbers 15K00596 for IK.; We thank H. Mitsuhashi, University of Hyogo, for suggesting field sampling sites. This study was supported by the Environment Research and Technology Development Fund (4RF1302 and 4-1602) of the Ministry of the Environment, Japan and JSPS KAKENHI Grant Numbers 15K00596 for IK.	Akita Y., 1996, ENCY ANIMAL JAPAN, V5, P23; [Anonymous], 2021, LANG ENV STAT COMP; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Doi H, 2017, FRESHWATER BIOL, V62, P30, DOI 10.1111/fwb.12846; Doi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122763; Dunker KJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162277; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Fukumoto S, 2015, J APPL ECOL, V52, P358, DOI 10.1111/1365-2664.12392; Hartman LJ, 2005, MOL CELL PROBE, V19, P51, DOI 10.1016/j.mcp.2004.07.006; HAYASE N, 1982, Japanese Journal of Ecology, V32, P395; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Ikeda K, 2016, CONSERV GENET RESOUR, V8, P231, DOI 10.1007/s12686-016-0541-z; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Jerde CL, 2016, ENVIRON SCI TECHNOL, V50, P8770, DOI 10.1021/acs.est.6b01761; Jerde CL, 2013, CAN J FISH AQUAT SCI, V70, P522, DOI 10.1139/cjfas-2012-0478; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Lacoursiere-Roussel A, 2016, MOL ECOL RESOUR, V16, P1401, DOI 10.1111/1755-0998.12522; Mahon AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058316; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Poyarkov NA, 2012, ZOOTAXA, P1; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Uchii K, 2016, MOL ECOL RESOUR, V16, P415, DOI 10.1111/1755-0998.12460; Wilcox TM, 2016, BIOL CONSERV, V194, P209, DOI 10.1016/j.biocon.2015.12.023; Yamamoto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149786; Yamanaka H, 2016, ECOL INDIC, V62, P147, DOI 10.1016/j.ecolind.2015.11.022; Yoshikawa N, 2008, MOL PHYLOGENET EVOL, V49, P249, DOI 10.1016/j.ympev.2008.07.016	34	31	34	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176541	10.1371/journal.pone.0176541	http://dx.doi.org/10.1371/journal.pone.0176541			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520733	Green Submitted, Green Published, gold			2022-12-26	WOS:000401487700021
J	Zhang, XH; Ruan, ZQ; You, XX; Wang, JT; Chen, JM; Peng, C; Shi, Q				Zhang, Xinhui; Ruan, Zhiqiang; You, Xinxin; Wang, Jintu; Chen, Jieming; Peng, Chao; Shi, Qiong			De novo assembly and comparative transcriptome analysis of the foot from Chinese green mussel (Perna viridis) in response to cadmium stimulation	PLOS ONE			English	Article							RNA-SEQ; MYTILUS-EDULIS; HEAVY-METALS; ASPERGILLUS-FLAVUS; GENE-EXPRESSION; BYSSUS; BINDING; PROTEIN; TYROSINASE; COLLAGEN	The Chinese green mussel, Perna viridis, is a marine bivalve with important economic values as well as biomonitoring roles for aquatic pollution. Byssus, secreted by the foot gland, has been proved to bind heavy metals effectively. In this study, using the RNA sequencing technology, we performed comparative transcriptomic analysis on the mussel feet with or without inducing by cadmium (Cd). Our current work is aiming at providing insights into the molecular mechanisms of byssus binding to heavy metal ions. The transcriptome sequencing generated a total of 26.13-Gb raw data. After a careful assembly of clean data, we obtained a primary set of 105,127 unigenes, in which 32,268 unigenes were annotated. Based on the expression profiles, we identified 9,048 differentially expressed genes (DEGs) between Cd treatment (50 or 100 mu g/L) at 48 h and the control, suggesting an extensive transcriptome response of the mussels during the Cd stimulation. Moreover, we observed that the expression levels of 54 byssus protein coding genes increased significantly after the 48-h Cd stimulation. In addition, 16 critical byssus protein coding genes were picked for profiling by quantitative real-time PCR (qRT-PCR). Finally, we reached a primary conclusion that high content of tyrosine (Tyr), cysteine (Cys), histidine (His) residues or the special motif plays an important role in the accumulation of heavy metals in byssus. We also proposed an interesting model for the confirmed byssal Cd accumulation, in which biosynthesis of byssus proteins may play simultaneously critical roles since their transcription levels were significantly elevated.	[Zhang, Xinhui; Shi, Qiong] Shenzhen Univ, Coll Life Sci & Oceanog, Lab Aquat Genom, Shenzhen, Peoples R China; [Zhang, Xinhui; Ruan, Zhiqiang; You, Xinxin; Chen, Jieming; Peng, Chao; Shi, Qiong] BGI, BGI Acad Marine Sci, Shenzhen Key Lab Marine Genom,BGI Fisheries, Guangdong Prov Key Lab Mol Breeding Marine Econ A, Shenzhen, Peoples R China; [Wang, Jintu] BGI, BGI Shenzhen, Shenzhen, Peoples R China	Shenzhen University; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI)	Shi, Q (corresponding author), Shenzhen Univ, Coll Life Sci & Oceanog, Lab Aquat Genom, Shenzhen, Peoples R China.; Shi, Q (corresponding author), BGI, BGI Acad Marine Sci, Shenzhen Key Lab Marine Genom,BGI Fisheries, Guangdong Prov Key Lab Mol Breeding Marine Econ A, Shenzhen, Peoples R China.	shiqiong@genomics.cn	You, Xinxin/AAL-2095-2020		BGI-Shenzhen; Special Fund For State Oceanic Administration Scientific Research in the Public Interest [201305018]; Shenzhen Special Program for Future Industrial Development [JSGG20141020113728803]; Zhenjiang Leading Talent Program for Innovation and Entrepreneurship;  [2014AA093501]	BGI-Shenzhen; Special Fund For State Oceanic Administration Scientific Research in the Public Interest; Shenzhen Special Program for Future Industrial Development; Zhenjiang Leading Talent Program for Innovation and Entrepreneurship; 	BGI-Shenzhen provided support in the form of salaries for authors for authors X. Zhang, Z. Ruan, J. Wang, J. Chen, CP, X. You and Q. Shi but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The work is supported by China Project (No. 2014AA093501), Special Fund For State Oceanic Administration Scientific Research in the Public Interest (No. 201305018), Shenzhen Special Program for Future Industrial Development (No. JSGG20141020113728803), and Zhenjiang Leading Talent Program for Innovation and Entrepreneurship.	Acosta V, 2004, CIENC MAR, V30, P323, DOI 10.7773/cm.v30i2.183; Aguilera F, 2014, ACTA BIOMATER, V10, P3855, DOI 10.1016/j.actbio.2014.03.031; Altermann E, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-60; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BAKER DH, 1987, J NUTR, V117, P1003, DOI 10.1093/jn/117.6.1003; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Choi YS, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-139; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coyne KJ, 1997, SCIENCE, V277, P1830, DOI 10.1126/science.277.5333.1830; Ferreira A. G, 2005, Braz. J. Biol., V65, P67, DOI 10.1590/S1519-69842005000100010; Giles NM, 2003, CHEM BIOL, V10, P677, DOI 10.1016/S1074-5521(03)00174-1; Goswami P, 2014, J ENVIRON SCI HEAL A, V49, P1564, DOI 10.1080/10934529.2014.938534; Guerette PA, 2013, NAT BIOTECHNOL, V31, P908, DOI 10.1038/nbt.2671; Hedlund J, 2009, BIOMACROMOLECULES, V10, P845, DOI 10.1021/bm801325j; HOLT GD, 1989, J BIOL CHEM, V264, P12138; Huang L, 2015, ENVIRON POLLUT, V196, P350, DOI 10.1016/j.envpol.2014.10.019; Hwang DS, 2010, J BIOL CHEM, V285, P25850, DOI 10.1074/jbc.M110.133157; Hwang DS, 2004, APPL ENVIRON MICROB, V70, P3352, DOI 10.1128/AEM.70.6.3352-3359.2004; INOUE K, 1995, J BIOL CHEM, V270, P6698, DOI 10.1074/jbc.270.12.6698; Iseli C, 1999, ESTSCAN PROGRAM DETE; Kalavacharla V, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-135; Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429; Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Leung PTY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-804; Lin JQ, 2013, FUNGAL GENET BIOL, V56, P78, DOI 10.1016/j.fgb.2013.04.007; Lin Q, 2007, P NATL ACAD SCI USA, V104, P3782, DOI 10.1073/pnas.0607852104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu QY, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0759; Lucas JM, 2002, J EXP BIOL, V205, P1807; Mejare M, 2001, TRENDS BIOTECHNOL, V19, P67, DOI 10.1016/S0167-7799(00)01534-1; Miao Y, 2015, MAR BIOTECHNOL, V17, P523, DOI 10.1007/s10126-015-9635-y; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicholson S, 2005, ENVIRON INT, V31, P121, DOI 10.1016/j.envint.2004.05.007; Numata K, 2014, BIOMACROMOLECULES, V15, P3206, DOI 10.1021/bm5009052; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pinto R, 2015, MAR POLLUT BULL, V91, P418, DOI 10.1016/j.marpolbul.2014.09.059; Qin XX, 1997, J BIOL CHEM, V272, P32623, DOI 10.1074/jbc.272.51.32623; Quig D, 1998, Altern Med Rev, V3, P262; Rebl A, 2014, MAR BIOTECHNOL, V16, P333, DOI 10.1007/s10126-013-9552-x; SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1; Spritz RA, 1997, J INVEST DERMATOL, V109, P207, DOI 10.1111/1523-1747.ep12319351; Suarez-Ulloa V, 2013, MAR DRUGS, V11, P4370, DOI 10.3390/md11114370; Suhre MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4392; Sun CJ, 2002, BIOMACROMOLECULES, V3, P1240, DOI 10.1021/bm0255903; Swann CP, 1998, COMP BIOCHEM PHYS B, V119, P755, DOI 10.1016/S0305-0491(98)00052-2; Szefer P, 1997, ARCH ENVIRON CON TOX, V32, P184, DOI 10.1007/s002449900173; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Waite JH, 1998, MATRIX BIOL, V17, P93, DOI 10.1016/S0945-053X(98)90023-3; WAITE JH, 1987, INT J ADHES ADHES, V7, P9, DOI 10.1016/0143-7496(87)90048-0; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xie YL, 2014, BIOINFORMATICS, V30, P1660, DOI 10.1093/bioinformatics/btu077; Yap CK, 2006, ECOTOX ENVIRON SAFE, V63, P413, DOI 10.1016/j.ecoenv.2005.02.005; Yap CK, 2003, HYDROBIOLOGIA, V498, P151, DOI 10.1023/A:1026221930811; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu JJ, 2011, FEMS MICROBIOL LETT, V322, P145, DOI 10.1111/j.1574-6968.2011.02345.x; Zhao H, 2006, BIOCHEMISTRY-US, V45, P14223, DOI 10.1021/bi061677n; Zhao X. K., 1994, TROPIC OCEANOLOGY, P62	60	10	10	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176677	10.1371/journal.pone.0176677	http://dx.doi.org/10.1371/journal.pone.0176677			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520756	Green Submitted, gold, Green Published			2022-12-26	WOS:000401487700026
J	Xie, G; Liu, X; Zhang, Y; Li, W; Liu, S; Chen, Z; Xu, B; Yang, J; He, L; Zhang, Z; Jin, T; Yi, X; Sun, L; Shang, Y; Liang, J				Xie, G.; Liu, X.; Zhang, Y.; Li, W.; Liu, S.; Chen, Z.; Xu, B.; Yang, J.; He, L.; Zhang, Z.; Jin, T.; Yi, X.; Sun, L.; Shang, Y.; Liang, J.			UTX promotes hormonally responsive breast carcinogenesis through feed-forward transcription regulation with estrogen receptor	ONCOGENE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; INTEGRATIVE GENOMICS VIEWER; H3K27ME3 DEMETHYLASE UTX; CANCER-CELLS; GENE-REGULATION; TUMOR MICROENVIRONMENT; ER-ALPHA; POLYCOMB; JMJD3; METHYLATION	UTX is implicated in embryonic development and lineage specification. However, how this X-linked histone demethylase contributes to the occurrence and progression of breast cancer remains to be clarified. Here we report that UTX is physically associated with estrogen receptor (ER) and functions in ER-regulated transcription. We showed that UTX coordinates with JHDM1D and CBP to direct H3K27 methylation-acetylation transition and to create a permissive chromatin state on ER targets. Genome-wide analysis of the transcriptional targets of UTX by ChIP-seq identified a set of genes such as chemokine receptor CXCR4 that are intimately involved in breast cancer tumorigenesis and metastasis. We demonstrated that UTX promotes the proliferation and migration of ER+ breast cancer cells. Interestingly, UTX itself is transactivated by ER, forming a feed-forward loop in the regulation of hormone response. Indeed, UTX is upregulated during ER+ breast cancer progression, and the expression level of UTX is positively correlated with that of CXCR4 and negatively correlated with the overall survival of ER+ breast cancer patients. Our study identified a feed-forward loop between UTX and ER in the regulation of hormonally responsive breast carcinogenesis, supporting the pursuit of UTX as an emerging therapeutic target for the intervention of certain ER+ breast cancer with specific epigenetic vulnerability.	[Xie, G.; Zhang, Y.; Li, W.; Liu, S.; Chen, Z.; Xu, B.; Yang, J.; He, L.; Zhang, Z.; Jin, T.; Yi, X.; Sun, L.; Shang, Y.; Liang, J.] Peking Univ, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res, Sch Basic Med Sci,Minist Educ,Hlth Sci Ctr, 38 Xueyuan Rd, Beijing 100191, Peoples R China; [Liu, X.; Shang, Y.] Tianjin Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Tianjin Key Lab Med Epigenet, Tianjin, Peoples R China; [Shang, Y.] Capital Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Beijing, Peoples R China	Peking University; Tianjin Medical University; Capital Medical University	Liang, J (corresponding author), Peking Univ, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res, Sch Basic Med Sci,Minist Educ,Hlth Sci Ctr, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	liang_jing@bjmu.edu.cn	Chen, Zhe/AAA-3235-2020	Chen, Zhe/0000-0002-5303-9879; Xie, Guojia/0000-0002-8250-6157	Ministry of Science and Technology of China [2014CB542004]; National Natural Science Foundation of China [31371301, 81572771, 91219201, 81130048]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants (973 Program: 2014CB542004 to JL and YS) from the Ministry of Science and Technology of China, and grants (31371301 and 81572771 to JL and 91219201 and 81130048 to YS) from the National Natural Science Foundation of China.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Benyoucef A, 2016, GENE DEV, V30, P508, DOI 10.1101/gad.276790.115; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; Chen YC, 2015, HEPATOLOGY, V61, P1591, DOI 10.1002/hep.27665; Choi HJ, 2015, EMBO REP, V16, P1288, DOI 10.15252/embr.201540244; Cui YK, 2006, MOL ENDOCRINOL, V20, P2020, DOI 10.1210/me.2005-0063; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Ezponda T, 2014, CLIN CANCER RES, V20, P5001, DOI 10.1158/1078-0432.CCR-13-2499; Guo F, 2016, ONCOGENE, V35, P816, DOI 10.1038/onc.2015.139; Harburg GC, 2011, J MAMMARY GLAND BIOL, V16, P257, DOI 10.1007/s10911-011-9225-1; Hart CD, 2015, NAT REV CLIN ONCOL, V12, P541, DOI 10.1038/nrclinonc.2015.99; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Ichinose H, 1997, GENE, V188, P95, DOI 10.1016/S0378-1119(96)00785-8; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kim JH, 2014, CANCER RES, V74, P1705, DOI 10.1158/0008-5472.CAN-13-1896; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lavery DN, 2005, BIOCHEM J, V391, P449, DOI 10.1042/BJ20050872; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee YH, 2014, TUMOR BIOL, V35, P7699, DOI 10.1007/s13277-014-2027-5; Liang J, 2013, ANNU REV PHYSIOL, V75, P225, DOI 10.1146/annurev-physiol-030212-183708; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mohammed H, 2013, CELL REP, V3, P342, DOI 10.1016/j.celrep.2013.01.010; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Ntziachristos P, 2014, NATURE, V514, P513, DOI 10.1038/nature13605; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Park UH, 2016, ONCOGENE, V35, P3742, DOI 10.1038/onc.2015.443; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rhodes LV, 2011, CANCER RES, V71, P603, DOI 10.1158/0008-5472.CAN-10-3185; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rocha-Viegas L, 2014, MOL CELL BIOL, V34, P3765, DOI 10.1128/MCB.00839-14; Scala S, 2015, CLIN CANCER RES, V21, P4278, DOI 10.1158/1078-0432.CCR-14-0914; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Simons SS, 2013, MOL CELL ENDOCRINOL, V376, P81, DOI 10.1016/j.mce.2013.06.007; Smith E, 2014, NAT STRUCT MOL BIOL, V21, P210, DOI 10.1038/nsmb.2784; Svotelis A, 2011, EMBO J, V30, P3947, DOI 10.1038/emboj.2011.284; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tsukada YI, 2010, GENE DEV, V24, P432, DOI 10.1101/gad.1864410; Van der Meulen J, 2015, BLOOD, V125, P13, DOI 10.1182/blood-2014-05-577270; Van der Meulen J, 2014, EPIGENETICS-US, V9, P658, DOI 10.4161/epi.28298; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Wade MA, 2015, NUCLEIC ACIDS RES, V43, P196, DOI 10.1093/nar/gku1298; Wang JK, 2010, GENE DEV, V24, P327, DOI 10.1101/gad.1882610; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Xu C, 2015, DRUG DES DEV THER, V9, P4953, DOI 10.2147/DDDT.S84932; Yu YC, 2014, DNA CELL BIOL, V33, P543, DOI 10.1089/dna.2013.2289; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang H, 2006, EMBO J, V25, P4223, DOI 10.1038/sj.emboj.7601306; Zhang XHF, 2013, CLIN CANCER RES, V19, P6389, DOI 10.1158/1078-0432.CCR-13-0838; Zwart W, 2011, EMBO J, V30, P4764, DOI 10.1038/emboj.2011.368	62	26	27	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 28	2017	36	39					5497	5511		10.1038/onc.2017.157	http://dx.doi.org/10.1038/onc.2017.157			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FI4RG	28534508				2022-12-26	WOS:000411960500006
J	Promworn, Y; Kaewprommal, P; Shaw, PJ; Intarapanich, A; Tongsima, S; Piriyapongsa, J				Promworn, Yuttachon; Kaewprommal, Pavita; Shaw, Philip J.; Intarapanich, Apichart; Tongsima, Sissades; Piriyapongsa, Jittima			ToNER: A tool for identifying nucleotide enrichment signals in feature-enriched RNA-seq data	PLOS ONE			English	Article							TRANSCRIPTOME	Background Biochemical methods are available for enriching 50 ends of RNAs in prokaryotes, which are employed in the differential RNA-seq (dRNA-seq) and the more recent Cappable-seq protocols. Computational methods are needed to locate RNA 50 ends from these data by statistical analysis of the enrichment. Although statistical-based analysis methods have been developed for dRNA-seq, they may not be suitable for Cappable-seq data. The more efficient enrichment method employed in Cappable-seq compared with dRNA-seq could affect data distribution and thus algorithm performance. Results We present Transformation of Nucleotide Enrichment Ratios (ToNER), a tool for statistical modeling of enrichment from RNA-seq data obtained from enriched and unenriched libraries. The tool calculates nucleotide enrichment scores and determines the global transformation for fitting to the normal distribution using the Box-Cox procedure. From the transformed distribution, sites of significant enrichment are identified. To increase power of detection, meta-analysis across experimental replicates is offered. We tested the tool on Cappableseq and dRNA-seq data for identifying Escherichia coli transcript 50 ends and compared the results with those from the TSSAR tool, which is designed for analyzing dRNA-seq data. When combining results across Cappable-seq replicates, ToNER detects more known transcript 50 ends than TSSAR. In general, the transcript 50 ends detected by ToNER but not TSSAR occur in regions which cannot be locally modeled by TSSAR. Conclusion ToNER uses a simple yet robust statistical modeling approach, which can be used for detecting RNA 50ends from Cappable-seq data, in particular when combining information from experimental replicates. The ToNER tool could potentially be applied for analyzing other RNA-seq datasets in which enrichment for other structural features of RNA is employed. The program is freely available for download at ToNER webpage (http://www4a. biotec.or.th/GI/tools/toner) and GitHub repository (https://github.com/PavitaKae/ToNER).	[Promworn, Yuttachon; Kaewprommal, Pavita; Shaw, Philip J.; Tongsima, Sissades; Piriyapongsa, Jittima] NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand; [Intarapanich, Apichart] NSTDA, Natl Elect & Comp Technol Ctr NECTEC, Pathum Thani, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); National Science & Technology Development Agency - Thailand; National Electronics & Computer Technology Center (NECTEC)	Piriyapongsa, J (corresponding author), NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand.	jittima.pir@biotec.or.th			platform technology, National Center for Genetic Engineering and Biotechnology, Thailand [P-15-51103, P-12-01270]	platform technology, National Center for Genetic Engineering and Biotechnology, Thailand	This project is supported by the platform technology, National Center for Genetic Engineering and Biotechnology, Thailand (http:// www.biotec.or.th) with grant number P-15-51103 and P-12-01270, funded to JP and PJS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amman F, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-89; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Cui XD, 2016, BIOINFORMATICS, V32, P378, DOI 10.1093/bioinformatics/btw281; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dugar G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003495; Ettwiller L, 2016, BMC GENOMICS, P17; Forstner KU, 2014, BIOINFORMATICS, V30, P3421, DOI 10.1093/bioinformatics/btu533; Gama-Castro S, 2016, NUCLEIC ACIDS RES, V44, pD133, DOI 10.1093/nar/gkv1156; Hardwick SA, 2016, NAT METHODS, V13, P792, DOI [10.1038/NMETH.3958, 10.1038/nmeth.3958]; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Jorjani H, 2014, BIOINFORMATICS, V30, P971, DOI 10.1093/bioinformatics/btt752; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meng J, 2014, METHODS, V69, P274, DOI 10.1016/j.ymeth.2014.06.008; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sibbritt T, 2013, WIRES RNA, V4, P397, DOI 10.1002/wrna.1166; Thomason MK, 2015, J BACTERIOL, V197, P18, DOI 10.1128/JB.02096-14; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484	20	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178483	10.1371/journal.pone.0178483	http://dx.doi.org/10.1371/journal.pone.0178483			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542466	Green Submitted, Green Published, gold			2022-12-26	WOS:000402062800097
J	Van Wynsberge, S; Andrefouet, S; Gaertner-Mazouni, N; Tiavouane, J; Grulois, D; Lefevre, J; Pinsky, ML; Fauvelot, C				Van Wynsberge, Simon; Andrefouet, Serge; Gaertner-Mazouni, Nabila; Tiavouane, Josina; Grulois, Daphne; Lefevre, Jerome; Pinsky, Malin L.; Fauvelot, Cecile			Considering reefscape configuration and composition in biophysical models advance seascape genetics	PLOS ONE			English	Article							CORAL-REEF; GIANT CLAM; POPULATION-STRUCTURE; LARVAL CONNECTIVITY; SELF-RECRUITMENT; DISPERSAL; LANDSCAPE; PATCHINESS; DRIVERS; ECOLOGY	Previous seascape genetics studies have emphasized the role of ocean currents and geographic distances to explain the genetic structure of marine species, but the role of benthic habitat has been more rarely considered. Here, we compared the population genetic structure observed in West Pacific giant clam populations against model simulations that accounted habitat composition and configuration, geographical distance, and oceanic currents. Dispersal determined by geographical distance provided a modelled genetic structure in better agreement with the observations than dispersal by oceanic currents, possibly due to insufficient spatial resolution of available oceanographic and coastal circulation models. Considering both habitat composition and configuration significantly improved the match between simulated and observed genetic structures. This study emphasizes the importance of a reefscape genetics approach to population ecology, evolution and conservation in the sea.	[Van Wynsberge, Simon; Gaertner-Mazouni, Nabila] Univ Polynesie Francaise, UMR EIO 241, Lab Excellence CORAIL, Tahiti, French Polynesi, France; [Van Wynsberge, Simon; Andrefouet, Serge; Tiavouane, Josina; Grulois, Daphne; Fauvelot, Cecile] Univ La Reunion, UMR ENTROPIE 9220, CNRS, Lab Excellence CORAIL,Ctr IRD Noumea,Inst Rech De, Noumea, New Caledonia; [Lefevre, Jerome] Ctr IRD Noumea, UMR LEGOS 065, Noumea, New Caledonia; [Lefevre, Jerome] Ctr IRD Noumea, UMR MIO 235, Noumea, New Caledonia; [Pinsky, Malin L.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ USA; [Pinsky, Malin L.] Rutgers State Univ, Inst Earth Ocean & Atmospher Sci, New Brunswick, NJ USA	Ifremer; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Rutgers State University New Brunswick; Rutgers State University New Brunswick	Van Wynsberge, S (corresponding author), Univ Polynesie Francaise, UMR EIO 241, Lab Excellence CORAIL, Tahiti, French Polynesi, France.; Van Wynsberge, S (corresponding author), Univ La Reunion, UMR ENTROPIE 9220, CNRS, Lab Excellence CORAIL,Ctr IRD Noumea,Inst Rech De, Noumea, New Caledonia.	simon.vanwynsberge@gmail.com	Pinsky, Malin L./K-2884-2015	Pinsky, Malin L./0000-0002-8523-8952; Lefevre, Jerome/0000-0001-9875-2398; Fauvelot, Cecile/0000-0003-0806-1222	Ministere de lEnseignement Superieur et de la Recherche; BeN-Co project (ZONECO program, New Caledonia); TriMax project (LabEx CORAIL, Agence Nationale de la Recherche)	Ministere de lEnseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); BeN-Co project (ZONECO program, New Caledonia); TriMax project (LabEx CORAIL, Agence Nationale de la Recherche)(French National Research Agency (ANR))	This work is part of SVW and JT PhD theses, supported by a fellowship from Ministere de lEnseignement Superieur et de la Recherche to Universite de la Polynesie francaise. Genetic analyses were co-funded by the BeN-Co project (ZONECO program, New Caledonia, www.zoneco.nc) and the TriMax project (LabEx CORAIL, Agence Nationale de la Recherche, www.labex-corail.fr). Sampling was conducted during cruises COBELO (http://dx.doi.org/10.17600/13100100) and BIBELOT (http://dx.doi.org/10.17600/14003700) on board RV Alis, and during the New Caledonia leg of the Global Reef Expedition of the Khaled Bin Sultan Living Ocean Foundation, on board RV Golden Shadow (www.livingoceansfoundation.org).	Alberto F, 2010, ECOLOGY, V91, P49, DOI 10.1890/09-0050.1; Andrefouet S, 2009, CORAL REEFS, V28, P691, DOI 10.1007/s00338-009-0503-y; Andrefouet S., 2006, P 10 INT COR REEF S, P1732; Belkhir K., 2004, GENETIX 4 05 POPULAT; Benzie JAH, 1997, EVOLUTION, V51, P768, DOI 10.1111/j.1558-5646.1997.tb03660.x; Bidegain G, 2013, ECOL MODEL, V268, P78, DOI 10.1016/j.ecolmodel.2013.07.020; Bonneton P, 2007, J COASTAL RES, P762; Carr SD, 2008, FISH OCEANOGR, V17, P1, DOI 10.1111/j.1365-2419.2007.00447.x; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Christie MR, 2010, MOL ECOL, V19, P1042, DOI 10.1111/j.1365-294X.2010.04524.x; Couvelard X, 2008, J PHYS OCEANOGR, V38, P2185, DOI 10.1175/2008JPO3903.1; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Crandall ED, 2012, MOL ECOL, V21, P5579, DOI 10.1111/mec.12031; Cravatte S, 2015, J MARINE SYST, V148, P249, DOI 10.1016/j.jmarsys.2015.03.004; Cuif M, 2014, PROG OCEANOGR, V122, P105, DOI 10.1016/j.pocean.2013.12.006; D'Aloia CC, 2014, MOL ECOL, V23, P2902, DOI 10.1111/mec.12782; D'Aloia CC, 2013, MOL ECOL, V22, P2563, DOI 10.1111/mec.12274; Davies SW, 2015, MOL ECOL, V24, P70, DOI 10.1111/mec.13005; DeBoer TS, 2008, CONSERV BIOL, V22, P1255, DOI 10.1111/j.1523-1739.2008.00983.x; Dumas P, 2014, J EXP MAR BIOL ECOL, V452, P63, DOI 10.1016/j.jembe.2013.12.002; ELLNER S, 1994, AM NAT, V143, P403, DOI 10.1086/285610; Fahrig L, 2005, ECOSYSTEM FUNCTION IN HETEROGENEOUS LANDSCAPES, P95, DOI 10.1007/0-387-24091-8_6; Fogarty MJ, 2007, OCEANOGRAPHY, V20, P112, DOI 10.5670/oceanog.2007.34; Friedman KJ, 2003, PACIFIC REGIONAL OCE; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Gilbert A, 2011, STATUT POPULATIONS I; Goudet J, 1996, GENETICS, V144, P1933; Grulois D, 2015, CONSERV GENET RESOUR, V7, P73, DOI 10.1007/s12686-014-0290-9; Guillot G, 2013, METHODS ECOL EVOL, V4, P336, DOI 10.1111/2041-210x.12018; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Iacchei M, 2013, MOL ECOL, V22, P3476, DOI 10.1111/mec.12341; JAMESON SC, 1976, PAC SCI, V30, P219; Johansson ML, 2015, MOL ECOL, V24, P4866, DOI 10.1111/mec.13371; Jones GP, 2009, CORAL REEFS, V28, P303, DOI 10.1007/s00338-008-0440-1; Kittiwattanawong Kongkiat, 1997, Phuket Marine Biological Center Special Publication, V17, P109; Kool JT, 2011, GLOBAL ECOL BIOGEOGR, V20, P695, DOI 10.1111/j.1466-8238.2010.00637.x; Kool JT, 2010, ECOGRAPHY, V33, P597, DOI 10.1111/j.1600-0587.2009.06012.x; Legendre P, 2015, METHODS ECOL EVOL, V6, P1239, DOI 10.1111/2041-210X.12425; Liggins L, 2013, GEOGR COMPASS, V7, P173, DOI 10.1111/gec3.12031; Lowe RJ, 2015, ANNU REV MAR SCI, V7, P43, DOI 10.1146/annurev-marine-010814-015834; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Lucas J. S, 1988, ACIAR MONOGRAPH, V9, P21; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; Nanninga GB, 2014, MOL ECOL, V23, P591, DOI 10.1111/mec.12623; Neo ML, 2015, J EXP MAR BIOL ECOL, V469, P76, DOI 10.1016/j.jembe.2015.04.012; Orsini L, 2013, MOL ECOL, V22, P583, DOI 10.1111/mec.12117; Pinsky ML, 2012, ECOL APPL, V22, P1257, DOI 10.1890/11-1240.1; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Riginos C, 2013, GEOGR COMPASS, V7, P197, DOI 10.1111/gec3.12032; Sale PF, 2010, PRESERVING REEF CONN; Selkoe KA, 2008, FISH FISH, V9, P363, DOI 10.1111/j.1467-2979.2008.00300.x; Selkoe KA, 2016, LANDSCAPE GENETICS: CONCEPTS, METHODS, APPLICATIONS, P220; Selkoe KA, 2010, MOL ECOL, V19, P3708, DOI 10.1111/j.1365-294X.2010.04658.x; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Simons RD, 2013, J MARINE SYST, V119, P19, DOI 10.1016/j.jmarsys.2013.03.004; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; von der Heyden S, 2014, B MAR SCI, V90, P123, DOI 10.5343/bms.2012.1079; Wantiez L, 2013, COMMUNAUTES BIOL HAB; Watson JR, 2010, MAR ECOL PROG SER, V401, P31, DOI 10.3354/meps08376; Weir B. S., 1996, GENETIC DATA ANAL; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White C, 2010, P R SOC B, V282; Wood S, 2014, GLOBAL ECOL BIOGEOGR, V23, P1, DOI 10.1111/geb.12101; WRIGHT S, 1946, GENETICS, V31, P39	68	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178239	10.1371/journal.pone.0178239	http://dx.doi.org/10.1371/journal.pone.0178239			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542261	gold, Green Published, Green Submitted			2022-12-26	WOS:000402062800058
J	Wen, JR; Scoles, DR; Facelli, JC				Wen, Jingran; Scoles, Daniel R.; Facelli, Julio C.			Molecular dynamics analysis of the aggregation propensity of polyglutamine segments	PLOS ONE			English	Article							SPINOCEREBELLAR ATAXIA TYPE-1; MONOMERIC POLYGLUTAMINE; CAG REPEAT; SIMULATIONS; PROTEIN; DISEASES; STABILITY; EXPANSION; PEPTIDES; GENE	Protein misfolding and aggregation is a pathogenic feature shared among at least ten polyglutamine (polyQ) neurodegenerative diseases. While solvent-solution interaction is a key factor driving protein folding and aggregation, the solvation properties of expanded polyQ tracts are not well understood. By using GPU-enabled all-atom molecular dynamics simulations of polyQ monomers in an explicit solvent environment, this study shows that solventpolyQ interaction propensity decreases as the lengths of polyQ tract increases. This study finds a predominance in long-distance interactions between residues far apart in polyQ sequences with longer polyQ segments, that leads to significant conformational differences. This study also indicates that large loops, comprised of parallel beta-structures, appear in long polyQ tracts and present new aggregation building blocks with aggregation driven by longdistance intra-polyQ interactions. Finally, consistent with previous observations using coarse-grain simulations, this study demonstrates that there is a gain in the aggregation propensity with increased polyQ length, and that this gain is correlated with decreasing ability of solvent-polyQ interaction. These results suggest the modulation of solvent-polyQ interactions as a possible therapeutic strategy for treating polyQ diseases.	[Wen, Jingran; Facelli, Julio C.] Univ Utah, Dept Biomed Informat, Salt Lake City, UT 84112 USA; [Scoles, Daniel R.] Univ Utah, Dept Neurol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Facelli, JC (corresponding author), Univ Utah, Dept Biomed Informat, Salt Lake City, UT 84112 USA.	Julio.Facelli@utah.edu		facelli, julio/0000-0003-1449-477X	Department of Biomedical Informatics in honor of Homer	Department of Biomedical Informatics in honor of Homer	JW was partially supported by the Richard A. Fay and Carole M. Fay Endowed Graduate Fellowship for the Department of Biomedical Informatics in honor of Homer R. Warner, MD, PhD.	Almeida B, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00076; Babin V, 2011, PROTEINS, V79, P937, DOI 10.1002/prot.22935; Buchanan LE, 2014, P NATL ACAD SCI USA, V111, P5796, DOI 10.1073/pnas.1401587111; Case D., 2015, AMBER, V14; CHAN HS, 1991, ANNU REV BIOPHYS BIO, V20, P447, DOI 10.1146/annurev.biophys.20.1.447; Chiang HL, 2014, J COMPUT CHEM, V35, P1430, DOI 10.1002/jcc.23633; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; Deng L, 2012, J PHYS CHEM B, V116, P10135, DOI 10.1021/jp210683n; Gedde U. W., 1999, POLYM PHYS; Hayre NR, 2012, BIOPHYS J, V102, P1443, DOI 10.1016/j.bpj.2012.02.017; Hong L, 2009, J POLYM SCI POL PHYS, V47, P207, DOI 10.1002/polb.21634; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ignatova Z, 2006, J BIOL CHEM, V281, P12959, DOI 10.1074/jbc.M511523200; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Laghaei R, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3383244; Lakhani VV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000772; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Matilla-Duenas A, 2014, CEREBELLUM, V13, P269, DOI 10.1007/s12311-013-0539-y; Matilla-Duenas A, 2010, CEREBELLUM, V9, P148, DOI 10.1007/s12311-009-0144-2; Michalik A, 2003, HUM MOL GENET, V12, pR173, DOI 10.1093/hmg/ddg295; Miettinen MS, 2012, J PHYS CHEM B, V116, P10259, DOI 10.1021/jp305065c; Mishra R, 2015, ORG BIOMOL CHEM, V13, P4155, DOI 10.1039/c4ob02589j; Mohan RD, 2014, CURR OPIN GENET DEV, V26, P96, DOI 10.1016/j.gde.2014.06.008; Moradi M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002501; Nakano M, 2013, J MOL MODEL, V19, P1627, DOI 10.1007/s00894-012-1712-9; Nakano M, 2010, J PHYS CHEM B, V114, P7056, DOI 10.1021/jp9122024; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Racine J, 2006, J APPL ECONOMET, V21, P133, DOI 10.1002/jae.885; Rhys NH, 2013, SOFT MATTER, V9, P2359, DOI 10.1039/c2sm27565a; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Robertson AL, 2010, CURR MED CHEM, V17, P3058; Rub U, 2013, PROG NEUROBIOL, V104, P38, DOI 10.1016/j.pneurobio.2013.01.001; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Scarafone N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031253; Schafmeister CEAF, 1995, ROMANOVSKI VLADIMIR; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Stork M, 2005, BIOPHYS J, V88, P2442, DOI 10.1529/biophysj.104.052415; Tobelmann MD, 2011, BIOPHYS J, V100, P2773, DOI 10.1016/j.bpj.2011.04.028; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; Vitalis A, 2007, BIOPHYS J, V93, P1923, DOI 10.1529/biophysj.107.110080; Wang XL, 2006, PROTEINS, V63, P297, DOI 10.1002/prot.20761; Wang YT, 2010, J PHYS CHEM B, V114, P8735, DOI 10.1021/jp1007768; Wen J, 2016, J BIOMOLECULAR STRUC, P1; Wetzel R., 2010, MISFOLDING AGGREGATI, P305; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williamson TE, 2010, J MOL BIOL, V396, P1295, DOI 10.1016/j.jmb.2009.12.017; YAZAWA I, 1995, NAT GENET, V10, P99, DOI 10.1038/ng0595-99; Zhou ZL, 2011, J BIOMOL STRUCT DYN, V28, P743, DOI 10.1080/07391102.2011.10508603; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200	55	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178333	10.1371/journal.pone.0178333	http://dx.doi.org/10.1371/journal.pone.0178333			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542401	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800073
J	Liu, H; Rose, ME; Ma, XC; Culver, S; Dixon, CE; Graham, SH				Liu, Hao; Rose, Marie E.; Ma, Xiecheng; Culver, Sherman; Dixon, C. Edward; Graham, Steven H.			In vivo transduction of neurons with TAT-UCH-L1 protects brain against controlled cortical impact injury	PLOS ONE			English	Article							TERMINAL HYDROLASE L1; SPINAL-CORD-INJURY; DYSTROPHY GAD MOUSE; NEURODEGENERATIVE DISEASE; NERVOUS-SYSTEM; MUTANT UCH-L1; UBIQUITIN; UCHL1; AUTOPHAGY; AXONS	Many mechanisms or pathways are involved in secondary post-traumatic brain injury, such as the ubiquitin-proteasome pathway (UPP), axonal degeneration and neuronal cell apoptosis. UCH-L1 is a protein that is expressed in high levels in neurons and may have important roles in the UPP, autophagy and axonal integrity. The current study aims to evaluate the role of UCH-L1 in post-traumatic brain injury (TBI) and its potential therapeutic effects. A novel protein was constructed that fused the protein transduction domain (PTD) of transactivating transduction (TAT) protein with UCH-L1 (TAT-UCH-L1) in order to promote neuronal transduction. The TAT-UCH-L1 protein was readily detected in brain by immunoblotting and immunohistochemistry after i.p. administration in mice. TBI was induced in mice using the controlled cortical impact (CCI) model. TAT-UCH-L1 treatment significantly attenuated K48-linkage polyubiquitin (polyUb)-protein accumulation in hippocampus after CCI compared to vehicle controls, but had no effects on K65-linkage polyUb-protein. TAT-UCH-L1 treatment also attenuated expression of Beclin-1 and LC3BII after CCI. TAT-UCH-L1-treated mice had significantly increased spared tissue volumes and increased survival of CA3 neurons 21 d after CCI compared to control vehicle-treated mice. Axonal injury, detected by APP immunohistochemistry, was reduced in thalamus 24 h and 21 d after CCI in TAT-UCH-L1-treated mice. These results suggest that TAT-UCH-L1 treatment improves function of the UPP and decreases activation of autophagy after CCI. Furthermore, TATUCH- -L1 treatment also attenuates axonal injury and increases hippocampal neuronal survival after CCI. Taken together these results suggest that UCH-L1 may play an important role in the pathogenesis of cell death and axonal injury after TBI.	[Liu, Hao; Rose, Marie E.; Ma, Xiecheng; Culver, Sherman; Dixon, C. Edward; Graham, Steven H.] VA Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA 15219 USA; [Liu, Hao; Rose, Marie E.; Graham, Steven H.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Ma, Xiecheng; Culver, Sherman; Dixon, C. Edward] Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA USA; [Ma, Xiecheng; Culver, Sherman; Dixon, C. Edward] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Graham, SH (corresponding author), VA Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA 15219 USA.; Graham, SH (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA.	Steven.Graham@va.gov			Department of Veterans Affairs Rehabilitation Research & Development Service [1I01RX000310-01]; National Institutes of Health National Institute of Neurological Disorders and Stroke [R01NS37459]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037459] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000310] Funding Source: NIH RePORTER	Department of Veterans Affairs Rehabilitation Research & Development Service(US Department of Veterans Affairs); National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	Support was provided by the Department of Veterans Affairs Rehabilitation Research & Development Service [http://www.rehab.research.va.gov/]; 1I01RX000310-01 (SHG); and National Institutes of Health National Institute of Neurological Disorders and Stroke [http://www. ninds.nih.gov/]; R01NS37459 (SHG).	Acosta SA, 2015, STROKE, V46, P2616, DOI 10.1161/STROKEAHA.115.009854; Ahlgren S, 1996, ACTA NEUROPATHOL, V92, P49, DOI 10.1007/s004010050488; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Bilguvar K, 2013, P NATL ACAD SCI USA, V110, P3489, DOI 10.1073/pnas.1222732110; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Cartier AE, 2009, J NEUROSCI, V29, P7857, DOI 10.1523/JNEUROSCI.1817-09.2009; Castegna A, 2004, J NEUROCHEM, V88, P1540, DOI 10.1046/j.1471-4159.2003.02288.x; Chen FJ, 2010, P NATL ACAD SCI USA, V107, P1636, DOI 10.1073/pnas.0911516107; Costes S, 2014, AUTOPHAGY, V10, P1004, DOI 10.4161/auto.28478; Coulombe J, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00129; Frake RA, 2015, J CLIN INVEST, V125, P65, DOI 10.1172/JCI73944; Fry EJ, 2003, J COMP NEUROL, V466, P422, DOI 10.1002/cne.10904; Gong B, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00004; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Goto A, 2009, NEUROCHEM INT, V54, P330, DOI 10.1016/j.neuint.2008.12.012; Graham SH, 2017, AGEING RES REV, V34, P30, DOI 10.1016/j.arr.2016.09.011; Hill MD, 2012, LANCET NEUROL, V11, P942, DOI 10.1016/S1474-4422(12)70225-9; Huang WL, 2007, EUR J NEUROSCI, V25, P362, DOI 10.1111/j.1460-9568.2006.05284.x; Jara JH, 2015, CEREB CORTEX, V25, P4259, DOI 10.1093/cercor/bhu318; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kabuta T, 2008, J BIOL CHEM, V283, P23731, DOI 10.1074/jbc.M801918200; Kabuta T, 2008, HUM MOL GENET, V17, P1482, DOI 10.1093/hmg/ddn037; Kim H, 2014, 2014 EIGHTH IEEE/ACM INTERNATIONAL SYMPOSIUM ON NETWORKS-ON-CHIP (NOCS), P9, DOI 10.1109/NOCS.2014.7008756; Koharudin LMI, 2010, P NATL ACAD SCI USA, V107, P6835, DOI 10.1073/pnas.1002295107; Liu H, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.323; Liu H, 2016, BIOCHEM BIOPH RES CO, V472, P648, DOI 10.1016/j.bbrc.2016.03.003; Liu H, 2011, NEUROBIOL DIS, V41, P318, DOI 10.1016/j.nbd.2010.09.020; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Lombardino AJ, 2005, P NATL ACAD SCI USA, V102, P8036, DOI 10.1073/pnas.0503239102; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Nashmi R, 2001, BRAIN RES REV, V38, P165, DOI 10.1016/S0165-0173(01)00134-5; Noor NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062120; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Poon WW, 2013, J BIOL CHEM, V288, P16937, DOI 10.1074/jbc.M113.463711; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Shen H, 2006, APOPTOSIS, V11, P1049, DOI 10.1007/s10495-006-6303-8; SWANSON RA, 1990, STROKE, V21, P322, DOI 10.1161/01.STR.21.2.322; Todi SV, 2011, TRENDS NEUROSCI, V34, P370, DOI 10.1016/j.tins.2011.05.004; Tramutola A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2756068; Yin W, 2006, NEUROBIOL DIS, V21, P358, DOI 10.1016/j.nbd.2005.07.015; Zhang MM, 2012, J NEUROCHEM, V120, P1129, DOI 10.1111/j.1471-4159.2011.07644.x; Zhu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093334	45	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178049	10.1371/journal.pone.0178049	http://dx.doi.org/10.1371/journal.pone.0178049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542502	gold, Green Published, Green Submitted			2022-12-26	WOS:000402061500058
J	Noto, T; Barnagian, D; Castro, JB				Noto, Torben; Barnagian, Derrick; Castro, Jason B.			Genome-scale investigation of olfactory system spatial heterogeneity	PLOS ONE			English	Article							GENE-EXPRESSION; SENSORY NEURONS; MOUSE-BRAIN; BULB; PATTERNS; DOMAINS; INNATE; SUBDIVISIONS; ORGANIZATION; PROJECTIONS	The early olfactory system is organized in parallel, with numerous, specialized subsystems established by the modular and topographic projections of sensory inputs. While these anatomical sub-systems are in many cases demarcated by well-known marker genes, we stand to learn considerably more about their possible functional specializations from comprehensive, genome-scale descriptions of their molecular anatomy. Here, we leverage the resources of the Allen Brain Atlas (ABA)-a spatially registered compendium of gene expression for the mouse brain-to investigate the early olfactory system's genomic anatomy. We cluster thousands of genes across thousands of voxels in the ABA to derive several novel parcellations of the olfactory system, and concomitantly discover novel sets of enriched, subregion-specific genes that can serve as a starting point for future inquiry.	[Noto, Torben] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; [Barnagian, Derrick] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Castro, Jason B.] Bates Coll, Neurosci Program, Lewiston, ME 04240 USA	University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT)	Castro, JB (corresponding author), Bates Coll, Neurosci Program, Lewiston, ME 04240 USA.	jcastro@bates.edu			NIH-NIGMS [P20GM103423]; NSF-CAREER [NSF 1553279]	NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF-CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the NIH-NIGMS (P20GM103423) to JBC and NSF-CAREER NSF 1553279 to JBC.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip	Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5904, DOI 10.1111/bph.13349; Belgard TG, 2011, NEURON, V71, P605, DOI 10.1016/j.neuron.2011.06.039; Berghard A, 1996, J NEUROSCI, V16, P909; Bohland JW, 2010, METHODS, V50, P105, DOI 10.1016/j.ymeth.2009.09.001; Bozza T, 2009, NEURON, V61, P220, DOI 10.1016/j.neuron.2008.11.010; Cembrowski MS, 2016, NEURON, V89, P351, DOI 10.1016/j.neuron.2015.12.013; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Dong HW, 2009, P NATL ACAD SCI USA, V106, P11794, DOI 10.1073/pnas.0812608106; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Grange P, 2014, P NATL ACAD SCI USA, V111, P5397, DOI 10.1073/pnas.1312098111; Grange Pascal BJW, 2012, BRAIN GENE EXPRESSIO; Greer PL, 2016, CELL, V165, P1734, DOI 10.1016/j.cell.2016.05.001; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; Hawrylycz M, 2010, METHODS, V50, P113, DOI 10.1016/j.ymeth.2009.09.005; Hirota J, 2004, P NATL ACAD SCI USA, V101, P8751, DOI 10.1073/pnas.0400940101; Huilgol D, 2013, NAT NEUROSCI, V16, P157, DOI 10.1038/nn.3297; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Jia CP, 1997, DEV BRAIN RES, V102, P209, DOI 10.1016/S0165-3806(97)00097-7; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Lin DM, 2004, P NATL ACAD SCI USA, V101, P12718, DOI 10.1073/pnas.0404872101; Mainen ZF, 2007, NAT NEUROSCI, V10, P1511, DOI 10.1038/nn1207-1511; Menashe I, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003128; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Munger SD, 2010, CURR BIOL, V20, P1438, DOI 10.1016/j.cub.2010.06.021; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; Ng L, 2009, NAT NEUROSCI, V12, P356, DOI 10.1038/nn.2281; Paatero P, 1997, CHEMOMETR INTELL LAB, V37, P23, DOI 10.1016/S0169-7439(96)00044-5; Plato, 1956, PHAEDRUS; Ramsden HL, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004032; SHAPIRO LS, 1995, J MORPHOL, V224, P331, DOI 10.1002/jmor.1052240307; SHINOHARA H, 1992, J NEUROSCI, V12, P1275; Swanson LW, 2007, BRAIN RES REV, V55, P356, DOI 10.1016/j.brainresrev.2006.12.006; TANIGUCHI K, 1993, NEUROSCI LETT, V158, P185, DOI 10.1016/0304-3940(93)90260-R; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Yoshihara Y, 1997, J NEUROSCI, V17, P5830	40	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178087	10.1371/journal.pone.0178087	http://dx.doi.org/10.1371/journal.pone.0178087			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542411	Green Submitted, Green Published, gold			2022-12-26	WOS:000402061500060
J	Yhim, HY; Lee, J; Lee, JY; Lee, JO; Bang, SM				Yhim, Ho-Young; Lee, Juhyun; Lee, Ji Yun; Lee, Jeong-Ok; Bang, Soo-Mee			Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study	PLOS ONE			English	Article							ASSESSMENT SERVICE DATABASE; MAJOR ORTHOPEDIC-SURGERY; CLINICAL-PRACTICE GUIDELINES; ASIAN PATIENTS; TIME-COURSE; REPLACEMENT; THROMBOSIS; RISK; PREVENTION; HEALTH	Background Limited data is available regarding the pharmacological prophylaxis for venous thromboembolism (VTE) in Asian patients undergoing total knee arthroplasty or total hip arthroplasty (TKA/THA). Methods We performed a population-based epidemiological study using the Health Insurance Review and Assessment Service database to estimate the rate of pharmacological thromboprophylaxis and its impact on VTE in Korean patients who underwent TKA/THA between 2009 and 2013. Results We identified 306,912 cases (TKA, 261,260; THA, 45,652). The pharmacological thromboprophylaxis rate was 57.16% (TKA, 58.32%; THA, 50.51%), which increased from 42.81% in 2009 to 65.92% in 2013 (P = 0.0165). Both low-molecular-weight-heparin (22.42%) and rivar-oxaban (22.71%) were the most common drugs for prophylaxis. The number of patients aged >= 60 years (87.31% vs. 81.01%, P < 0.0001), cases requiring general anesthesia (20.70% vs. 18.37%, P < 0.0001), and cases requiring long hospital stay (median, 13 days vs. 12 days, P < 0.0001) were significantly greater in the pharmacological prophylaxis group. The incidence of VTE within 3 months of surgery was 1.52% (TKA, 1.46%; THA, 1.87%). Patients with pharmacological prophylaxis had higher VTE rates (TKA, 1.69% vs. 1.14%; THA, 2.30% vs. 1.43%) than those without prophylaxis, with advanced age, use of general anesthesia, and a longer hospital stay increasing the risk of VTE. However, rivaroxaban significantly reduced the incidence of VTE following TKA (0.82% vs. 1.14%; odd ratio [OR], 0.72; 95% CI, 0.65-0.79). Moreover, >= 10 days of pharmacological thromboprophylaxis was significantly associated with lower incidence of VTE after TKA (1.33% vs. 1.52%; OR, 0.87; 95% CI, 0.81-0.94). Conclusion This represents the largest epidemiological study showing a gradual increase in the use of pharmacological prophylaxis in Korean patients undergoing TKA/THA. Although the incidence of VTE is still low without pharmacological prophylaxis, this study demonstrates that the incidence of VTE can be reduced further using appropriate pharmacological thromboprophylaxis strategies.	[Yhim, Ho-Young] Chonbuk Natl Univ, Sch Med, Dept Internal Med, Jeonju, South Korea; [Yhim, Ho-Young] Chonbuk Natl Univ, Biomed Res Inst, Chonbuk Natl Univ Hosp, Res Inst Clin Med, Jeonju, South Korea; [Lee, Juhyun; Lee, Ji Yun; Lee, Jeong-Ok; Bang, Soo-Mee] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University Hospital; Seoul National University (SNU)	Bang, SM (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea.	smbang7@snu.ac.kr			Seoul National University Bundang Hospital [13-2015-025]	Seoul National University Bundang Hospital	This work was supported by a grant from the Seoul National University Bundang Hospital (13-2015-025). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would especially like to thank the Big Data Division, Healthcare Data Convergence Department, Korean Health Insurance Review & Assessment Services for data retrieval. This work was supported by a grant from Seoul National University Bundang Hospital (13-2015-025).	Bang SM, 2014, J KOREAN MED SCI, V29, P164, DOI 10.3346/jkms.2014.29.2.164; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Cohen AT, 2010, THROMB HAEMOSTASIS, V104, P919, DOI 10.1160/TH10-03-0190; Eikelboom JW, 2001, LANCET, V358, P9, DOI 10.1016/S0140-6736(00)05249-1; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Falck-Ytter Y, 2012, CHEST, V141, pE278S, DOI 10.1378/chest.11-2404; Haas SB, 2008, J BONE JOINT SURG AM, V90A, P2764; Jang MJ, 2011, J THROMB HAEMOST, V9, P2519, DOI 10.1111/j.1538-7836.2011.04518.x; Jang MJ, 2011, J THROMB HAEMOST, V9, P85, DOI 10.1111/j.1538-7836.2010.04108.x; Jorgensen CC, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003965; Kim DS, 2010, SOC WORK PUBLIC HLTH, V25, P127, DOI 10.1080/19371910903070333; Kim Kang-Il, 2013, Knee Surg Relat Res, V25, P43, DOI 10.5792/ksrr.2013.25.2.43; Lachiewicz Paul F, 2009, Instr Course Lect, V58, P795; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; Lee CH, 2013, J THROMB HAEMOST, V11, P1930, DOI 10.1111/jth.12375; Lee CH, 2012, J THROMB HAEMOST, V10, P56, DOI 10.1111/j.1538-7836.2011.04555.x; Leizorovicz A, 2005, J THROMB HAEMOST, V3, P28, DOI 10.1111/j.1538-7836.2004.01094.x; Leizorovicz A, 2007, HAEMATOLOGICA, V92, P1194, DOI 10.3324/haematol.10819; Liew Ngoh Chin, 2003, Asian J Surg, V26, P154, DOI 10.1016/S1015-9584(09)60375-4; Lussana F, 2014, THROMB RES, V134, P599, DOI 10.1016/j.thromres.2014.06.027; Pedersen AB, 2010, J BONE JOINT SURG AM, V92A, P2156, DOI 10.2106/JBJS.I.00882; Pedersen AB, 2015, THROMB RES, V135, P322, DOI 10.1016/j.thromres.2014.11.029; Pedersen AB, 2011, J BONE JOINT SURG AM, V93A, P1281, DOI [10.2106/JBJSJ.00676, 10.2106/JBJS.J.00676]; Piovella F, 2005, J THROMB HAEMOST, V3, P2664, DOI 10.1111/j.1538-7836.2005.01621.x; Rahme E, 2008, CAN MED ASSOC J, V178, P1545, DOI 10.1503/cmaj.071388; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Warwick D, 2007, J BONE JOINT SURG BR, V89B, P799, DOI 10.1302/0301-620X.89B6.18844; White RH, 1998, ARCH INTERN MED, V158, P1525, DOI 10.1001/archinte.158.14.1525; Yhim HY, 2014, J THROMB HAEMOST, V12, P1035, DOI 10.1111/jth.12611	29	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178214	10.1371/journal.pone.0178214	http://dx.doi.org/10.1371/journal.pone.0178214			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542415	Green Submitted, Green Published, gold			2022-12-26	WOS:000402061500073
J	Shah, D; Ali, M; Shukla, D; Jain, S; Aakalu, VK				Shah, Dhara; Ali, Marwan; Shukla, Deepak; Jain, Sandeep; Aakalu, Vinay Kumar			Effects of histatin-1 peptide on human corneal epithelial cells	PLOS ONE			English	Article							HUMAN SALIVA; PROLIFERATION; MIGRATION; ADHESION; ASSAYS; LINES; FATE	Purpose Ocular surface and corneal epithelial wounds are common and potentially debilitating problems. Ideal treatments for these injuries would promote epithelial healing without inflammation, infection and scarring. In addition the best treatments would be cost-efficient, effective, non-toxic and easily applied. Histatin-1 peptides have been shown to be safe and effective enhancers of epithelial wound healing in other model systems. We sought to determine whether histatin-1 peptides could enhance human corneal epithelial wound healing in vitro. Methods Histatin-1 peptides were applied to human corneal epithelial cells and compared over useful dose ranges in scratch assays using time-lapse microscopy. In addition, path finding analysis, cell spreading assays, toxicity and proliferation assays were performed to further characterize the effects of histatin-1 peptide on human corneal limbal epithelial ( HCLE). Results Histatin-1 enhanced human corneal epithelial wound healing in typical wound healing models. There was minimal toxicity and no significant enhancement of proliferation of corneal epithelium in response to histatin-1 application. Corneal epithelial spreading and pathfinding appeared to be enhanced by the application of histatin-1 peptides. Conclusions Histatin-1 peptide may enhance migration of HCLE cells and wound healing in vitro. These peptides may have benefit in corneal epithelial wounds and need to be investigated further.	[Shah, Dhara; Ali, Marwan; Aakalu, Vinay Kumar] Univ Illinois, Lacrimal Cell Biol Lab, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA; [Shukla, Deepak; Jain, Sandeep] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Aakalu, VK (corresponding author), Univ Illinois, Lacrimal Cell Biol Lab, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA.	vaakalu@uic.edu		Shukla, Deepak/0000-0002-3039-6953	National Eye Institute [K08 EY024339]; National Eye Institute Core grant [P30EY001792]; Eversight Research Grant; Fight For Sight; NATIONAL EYE INSTITUTE [K08EY024339, R01EY024966, R01EY023656, P30EY001792] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Eye Institute Core grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Eversight Research Grant; Fight For Sight; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute: K08 EY024339; National Eye Institute Core grant P30EY001792 (https://nei.nih.gov/); Fight For Sight: Grant in Aid (http://www.fightforsight.org/); Eversight Research Grant (http://eversightvision.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Naby W, 2017, INVEST OPHTH VIS SCI, V58, P1425, DOI 10.1167/iovs.16-19957; Ali M, 2016, CURR EYE RES, V9, P1; Ashby B.D., 2014, AUSTIN J CLIN OPHTHA, V1, P1017, DOI DOI 10.1073/pnas.1019055108; BAUM BJ, 1976, ARCH BIOCHEM BIOPHYS, V177, P427, DOI 10.1016/0003-9861(76)90455-0; Borrelli M, 2010, AM J OPHTHALMOL, V150, P894, DOI 10.1016/j.ajo.2010.05.010; Campese M, 2009, ARCH ORAL BIOL, V54, P345, DOI 10.1016/j.archoralbio.2008.11.010; Cao ZY, 2015, METHODS MOL BIOL, V1207, P317, DOI 10.1007/978-1-4939-1396-1_21; Duque A, 2011, J NEUROSCI, V31, P15205, DOI 10.1523/JNEUROSCI.3092-11.2011; Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Helmerhorst EJ, 2001, J BIOL CHEM, V276, P5643, DOI 10.1074/jbc.M008229200; Helmerhorst EJ, 2001, P NATL ACAD SCI USA, V98, P14637, DOI 10.1073/pnas.141366998; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Leong YY, 2015, OCUL SURF, V13, P103, DOI 10.1016/j.jtos.2014.10.003; Liu CY, 2015, PROG MOL BIOL TRANSL, V134, P61, DOI 10.1016/bs.pmbts.2015.05.002; Ljubimov AV, 2015, PROG RETIN EYE RES, V49, P17, DOI 10.1016/j.preteyeres.2015.07.002; Melino S, 2014, FEBS J, V281, P657, DOI 10.1111/febs.12612; Oudhoff MJ, 2008, FASEB J, V22, P3805, DOI 10.1096/fj.08-112003; Oudhoff MJ, 2009, FASEB J, V23, P3928, DOI 10.1096/fj.09-137588; Riss TL, 2004, CELL VIABILITY ASSAY; Shah D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148018; Singh Parul, 2013, Oman J Ophthalmol, V6, P83, DOI 10.4103/0974-620X.116624; van Dijk IA, 2015, FASEB J, V29, P3124, DOI 10.1096/fj.14-266825; Van Goethem F, 2006, TOXICOL IN VITRO, V20, P1, DOI 10.1016/j.tiv.2005.05.002; van 't Hof W, 2013, HISTATINS MULTIFUNCT, P167; Wang LY, 2011, MOL VIS, V17, P2835; Wirostko B, 2015, OCUL SURF, V13, P204, DOI 10.1016/j.jtos.2014.12.005	27	18	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5								10.1371/journal.pone.0178030	http://dx.doi.org/10.1371/journal.pone.0178030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542418	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058800033
J	Steffl, M; Chrudimsky, J; Tufano, JJ				Steffl, Michal; Chrudimsky, Jan; Tufano, James J.			Using relative handgrip strength to identify children at risk of sarcopenic obesity	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; GRIP STRENGTH; ADOLESCENTS; DEFINITION; WEAKNESS; HEALTH	Identifying children at risk of developing childhood sarcopenic obesity often requires specialized equipment and costly testing procedures, so cheaper and quicker methods would be advantageous, especially in field-based settings. The purpose of this study was to determine the relationships between the muscle-to-fat ratio (MFR) and relative handgrip strength, and to determine the ability of handgrip strength relative to body mass index (grip-to-BMI) to identify children who are at risk of developing sarcopenic obesity. Grip-to-BMI was measured in 730 Czech children (4 to 14 yrs). Bioelectrical impedance was used to estimate body fat mass and skeletal muscle mass, from which the MFR was calculated. The area under the curve (AUC) was 0.791 (95% CI 0.692-0.890, p < 0.001) in girls 4-9; 0.789 (95% CI 0.688-0.890, p < 0.001) in girls 10-14 years old; 0.719 (95% CI 0.607-0.831, p = 0.001) in boys 4-9; and 0.896 (95% CI 0.823-0.969, p < 0.001) in boys 10-14 years old. Calculated using the grip-to-BMI ratio, the OR (95% CI) for girls to be at risk of sarcopenic obesity identified by MFR was 9.918 (4.243-23.186, p < 0.001) and was 11.515 (4.280-30.982, p < 0.001) for boys. The grip-to-BMI ratio can be used to predict the presence of sarcopenic obesity in children, which can play a role in pediatric health interventions.	[Steffl, Michal; Chrudimsky, Jan; Tufano, James J.] Charles Univ Prague, Fac Phys Educ & Sport, Prague, Czech Republic	Charles University Prague	Tufano, JJ (corresponding author), Charles Univ Prague, Fac Phys Educ & Sport, Prague, Czech Republic.	james.j.tufano@gmail.com	Steffl, Michal/P-6804-2016; Tufano, James J/O-7363-2017; Tufano, James/AAD-4416-2019; Chrudimsky, Jan/J-6362-2017	Steffl, Michal/0000-0001-7297-8145; Tufano, James J/0000-0001-8325-0344; Tufano, James/0000-0001-8325-0344; Chrudimsky, Jan/0000-0003-0026-1916	 [Q 41]		This research was supported by the project Q 41. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the project Q 41.	Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Bianco A, 2015, INT J OCCUP MED ENV, V28, P445, DOI 10.13075/ijomeh.1896.00393; Biolo G, 2014, CLIN NUTR, V33, P737, DOI 10.1016/j.clnu.2014.03.007; Cauley JA, 2015, J CLIN DENSITOM, V18, P499, DOI 10.1016/j.jocd.2015.04.013; Coles N, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4116; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Cohen DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093150; Ertem K, 2003, ISOKINET EXERC SCI, V11, P219, DOI 10.3233/IES-2003-0150; Febrer A, 2010, J REHABIL MED, V42, P228, DOI 10.2340/16501977-0507; Fess E, 1981, CLIN ASSESSMENT RECO, V1st; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Janssen I, 2000, J APPL PHYSIOL, V89, P465, DOI 10.1152/jappl.2000.89.2.465; Kim K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153383; Legrand D, 2013, ARCH GERONTOL GERIAT, V57, P345, DOI 10.1016/j.archger.2013.06.003; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Matsudo VK, 2015, REV BRAS CIN DES HUM, V17, P1, DOI DOI 10.5007/1980-0037.2015V17N1P1; McCarthy HD, 2014, PEDIATR OBES, V9, P249, DOI 10.1111/j.2047-6310.2013.00168.x; McLean RR, 2014, J GERONTOL A-BIOL, V69, P576, DOI 10.1093/gerona/glu012; Morley JE, 2014, J CACHEXIA SARCOPENI, V5, P253, DOI 10.1007/s13539-014-0161-y; Norman K, 2011, CLIN NUTR, V30, P135, DOI 10.1016/j.clnu.2010.09.010; Park BS, 2013, DIABETES METAB J, V37, P458, DOI 10.4093/dmj.2013.37.6.458; Peterson MD, 2016, J AM MED DIR ASSOC, V17, P933, DOI 10.1016/j.jamda.2016.06.007; Ploegmakers JJW, 2013, J PHYSIOTHER, V59, P255, DOI 10.1016/S1836-9553(13)70202-9; ROSENBERG IH, 1989, AM J CLIN NUTR, V50, P1231, DOI 10.1093/ajcn/50.5.1231; Russell MK, 2015, NUTR CLIN PRACT, V30, P211, DOI 10.1177/0884533615570094; Seferian AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121799; Seferian AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113999; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; Wind AE, 2010, EUR J PEDIATR, V169, P281, DOI 10.1007/s00431-009-1010-4	29	37	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177006	10.1371/journal.pone.0177006	http://dx.doi.org/10.1371/journal.pone.0177006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542196	Green Published, Green Submitted, gold			2022-12-26	WOS:000402058800006
J	Cheong, SH; Sa, OG; Absalon-Medina, VA; Schneider, A; Butler, WR; Gilbert, RO				Cheong, Soon Hon; Sa Filho, Ocilon G.; Absalon-Medina, Victor A.; Schneider, Augusto; Butler, W. R.; Gilbert, Robert O.			Uterine and systemic inflammation influences ovarian follicular function in postpartum dairy cows	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; REPRODUCTIVE-PERFORMANCE; SUBCLINICAL ENDOMETRITIS; ENERGY-BALANCE; INTRAMAMMARY INFECTION; TRANSITION PERIOD; GRANULOSA-CELLS; 1ST OVULATION; RISK-FACTORS; FERTILITY	The objective of this study was to determine the effects of uterine and systemic inflammatory responses to uterine bacterial contamination at calving in dairy cows on the growth and ovulatory outcomes of the first dominant follicle postpartum. Ovulatory capability of the first dominant follicle postpartum was predicted in 53 multiparous cows by using a combination of follicle growth characteristics and circulating estradiol concentrations. Endotoxin levels were assayed in follicular fluid samples that were aspirated the day after ovulatory outcome prediction. Plasma levels of haptoglobin, a proinflammatory acute phase protein, and paraoxonase, a negative acute phase protein were determined. Uterine bacteria and inflammation were evaluated in three uterine fluid samples from each cow collected on the day of calving, the day after follicle aspiration, and at 35 days postpartum. Cows that had a strong initial uterine inflammatory response (robust recruitment of polymorphonuclear leukocytes of >= 35% and cows with uterine pH < 8.5 on the day of calving) were more likely to have an ovulatory first dominant follicle. Follicular fluid endotoxin levels were higher in non-ovulatory cows compared with ovulatory cows. Endotoxin levels in circulation were not different between ovulatory groups but were higher prepartum than on day 7 and 14 postpartum. Systemic inflammation characterized by elevated haptoglobin concentrations was higher in non-ovulatory cows despite similar bacterial contamination and circulating endotoxin levels. Paraoxonase activity in follicular fluid was significantly associated with the paraoxonase activity in plasma, however, plasma paraoxonase concentrations were not different between non-ovulatory and ovulatory cows. Cows with a higher uterine bacterial load on the day of calving had slower ovarian follicle growth. In summary, a robust uterine inflammatory response on the day of calving was positively associated with ovarian function while elevated systemic inflammation during the early postpartum period was negatively associated with the ovulatory status of the first dominant follicle postpartum.	[Cheong, Soon Hon; Gilbert, Robert O.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA; [Sa Filho, Ocilon G.; Absalon-Medina, Victor A.; Schneider, Augusto; Butler, W. R.] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA; [Absalon-Medina, Victor A.] Univ Penn, Sch Vet Med, Dept Clin Studies, New Bolton Ctr, Kennett Sq, PA 19348 USA; [Schneider, Augusto] Univ Fed Pelotas, Dept Nutr, Pelotas, Brazil; [Gilbert, Robert O.] Ross Univ, Sch Vet Med, Dept Clin Sci, Basseterre, St Kitts & Nevi	Cornell University; Cornell University; University of Pennsylvania; Universidade Federal de Pelotas	Cheong, SH; Gilbert, RO (corresponding author), Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA.; Gilbert, RO (corresponding author), Ross Univ, Sch Vet Med, Dept Clin Sci, Basseterre, St Kitts & Nevi.	cheong@cornell.edu; RoGilbert@rossvet.edu.kn	Gilbert, Robert/J-9107-2012; Schneider, Augusto/B-5011-2014; Butler, Walter/GQH-5350-2022	Gilbert, Robert/0000-0002-1528-243X; Schneider, Augusto/0000-0002-3410-2860; Cheong, Soon Hon/0000-0001-9002-7589; Butler, Walter/0000-0001-5195-7433	National Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2007-35203-18420]	National Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture	This project was supported by National Research Initiative Competitive Grant no. 2007-35203-18420 from the USDA National Institute of Food and Agriculture to ROG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battaglia DF, 1997, ENDOCRINOLOGY, V138, P4273, DOI 10.1210/en.138.10.4273; Beam SW, 1997, BIOL REPROD, V56, P133, DOI 10.1095/biolreprod56.1.133; Bionaz M, 2007, J DAIRY SCI, V90, P1740, DOI 10.3168/jds.2006-445; Bittar JHJ, 2014, J DAIRY SCI, V97, P3558, DOI 10.3168/jds.2013-7533; Bradley AJ, 2004, VET CLIN N AM-FOOD A, V20, P547, DOI 10.1016/j.cvfa.2004.06.010; Butler ST, 2006, J DAIRY SCI, V89, P2938, DOI 10.3168/jds.S0022-0302(06)72566-8; Butler ST, 2004, REPRODUCTION, V127, P537, DOI 10.1530/rep.1.00079; CANFIELD RW, 1990, DOMEST ANIM ENDOCRIN, V7, P323, DOI 10.1016/0739-7240(90)90038-2; Cheong SH, 2012, THERIOGENOLOGY, V77, P1217, DOI 10.1016/j.theriogenology.2011.10.029; Cheong SH, 2012, THERIOGENOLOGY, V77, P858, DOI 10.1016/j.theriogenology.2011.09.009; Cheong SH, 2011, J DAIRY SCI, V94, P762, DOI 10.3168/jds.2010-3439; Cheong SH, 2015, BIOL REPROD; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Crowe MA, 2008, REPROD DOMEST ANIM, V43, P20, DOI 10.1111/j.1439-0531.2008.01210.x; de Boer MW, 2014, J DAIRY SCI, V97, P3983, DOI 10.3168/jds.2013-7450; de Campos FT, 2017, THERIOGENOLOGY, V89, P244, DOI 10.1016/j.theriogenology.2016.11.013; Dourey A, 2011, RES VET SCI, V91, pE149, DOI 10.1016/j.rvsc.2010.11.011; ETHERINGTON WG, 1984, CAN J COMP MED, V48, P245; Galvao KN, 2010, REPROD DOMEST ANIM, V45, pE207, DOI 10.1111/j.1439-0531.2009.01517.x; Galvao KN, 2009, J DAIRY SCI, V92, P4906, DOI 10.3168/jds.2008-1984; Gilbert RO, 2005, THERIOGENOLOGY, V64, P1879, DOI 10.1016/j.theriogenology.2005.04.022; Gilbert RO, 2016, THERIOGENOLOGY, V85, P1367, DOI 10.1016/j.theriogenology.2015.10.045; Gilbert RO, 2012, REPROD FERT DEVELOP, V24, P252, DOI 10.1071/RD11915; Gobikrushanth M, 2016, THERIOGENOLOGY, V86, P1842, DOI 10.1016/j.theriogenology.2016.06.003; Green MJ, 2002, J DAIRY SCI, V85, P2589, DOI 10.3168/jds.S0022-0302(02)74343-9; Herath S, 2007, REPRODUCTION, V134, P683, DOI 10.1530/REP-07-0229; Huszenicza G, 1999, REPROD DOMEST ANIM, V34, P237, DOI 10.1111/j.1439-0531.1999.tb01246.x; Huzzey JM, 2009, J DAIRY SCI, V92, P621, DOI 10.3168/jds.2008-1526; JONES GE, 1984, RES VET SCI, V37, P87, DOI 10.1016/S0034-5288(18)31933-7; JUNEJA NL, 1965, FERTIL STERIL, V16, P361; Kasimanickam R, 2004, THERIOGENOLOGY, V62, P9, DOI 10.1016/j.theriogenology.2003.03.001; KNICKERBOCKER JJ, 1988, DOMEST ANIM ENDOCRIN, V5, P91, DOI 10.1016/0739-7240(88)90011-2; Krause ART, 2014, ANIM REPROD SCI, V145, P8, DOI 10.1016/j.anireprosci.2013.12.016; LeBlanc SJ, 2014, ANIMAL, V8, P54, DOI 10.1017/S1751731114000524; Lucy MC, 2001, J DAIRY SCI, V84, P1277, DOI 10.3168/jds.S0022-0302(01)70205-6; MARSCHKE RJ, 1985, J DAIRY SCI, V68, P1263, DOI 10.3168/jds.S0022-0302(85)80955-3; Mateus L, 2003, ANIM REPROD SCI, V76, P143, DOI 10.1016/S0378-4320(02)00248-8; Moore SG, 2014, J DAIRY SCI, V97, P2740, DOI 10.3168/jds.2013-7278; Moran B, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2938-1; OLSON JD, 1984, AM J VET RES, V45, P2251; PETER AT, 1990, THERIOGENOLOGY, V33, P1011, DOI 10.1016/0093-691X(90)90062-X; Quesnell RR, 2012, J DAIRY SCI, V95, P117, DOI 10.3168/jds.2011-4289; Riddle WT, 2007, THERIOGENOLOGY, V68, P395, DOI 10.1016/j.theriogenology.2007.05.050; Schneider A, 2013, REPROD DOMEST ANIM, V48, P989, DOI 10.1111/rda.12198; Schneider A, 2013, RES VET SCI, V95, P269, DOI 10.1016/j.rvsc.2013.02.010; Sheldon IM, 2002, REPRODUCTION, V123, P837, DOI 10.1530/rep.0.1230837; THATCHER WW, 1973, J DAIRY SCI, V56, P608, DOI 10.3168/jds.S0022-0302(73)85227-0; Vieira-Neto A, 2014, J DAIRY SCI, V97, P5415, DOI 10.3168/jds.2013-7725; Walsh RB, 2007, J DAIRY SCI, V90, P315, DOI 10.3168/jds.2007-0389; Williams EJ, 2007, THERIOGENOLOGY, V68, P549, DOI 10.1016/j.theriogenology.2007.04.056; Williams EJ, 2008, AM J REPROD IMMUNOL, V60, P462, DOI 10.1111/j.1600-0897.2008.00645.x	51	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177356	10.1371/journal.pone.0177356	http://dx.doi.org/10.1371/journal.pone.0177356			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542500	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672600009
J	de Aguiar, HJAC; Barros, LAC; Alves, DR; Mariano, CDF; Delabie, JHC; Pompolo, SD				Alves Cardoso de Aguiar, Hilton Jeferson; Campos Barros, Luisa Antonia; Alves, Danubia Rodrigues; Ferreira Mariano, Clea dos Santos; Charles Delabie, Jacques Hubert; das Gracas Pompolo, Silvia			Cytogenetic studies on populations of Camponotus rufipes (Fabricius, 1775) and Camponotus renggeri Emery, 1894 (Formicidae: Formicinae)	PLOS ONE			English	Article							ANTS HYMENOPTERA-FORMICIDAE; DINOPONERA-LUCIDA EMERY; CHROMOSOME EVOLUTION; KARYOTYPE EVOLUTION; SPECIES COMPLEX; HETEROCHROMATIN; MYRMICINAE; REGIONS; SEQUENCE; BANDS	Two valid ant species, Camponotus rufipes and Camponotus renggeri, have recently been the subject of a broad discussion with reference to taxa synonymization. Both species are quite common among the Neotropical myrmecofauna and share some unique traits, such as the shape of the scape and the pilosity patterns of the tibiae and scapes. A single morphological trait can help distinguish these species; however, only a combination of different approaches can enlighten our view of the complex phylogenetic relationships prevailing in the different populations of these two taxa. Therefore, focusing on the taxonomic issues concerning these two species, a cytogenetic survey including 10 populations of C. rufipes and two populations of C. renggeri was performed. In order to better understand the extent of the relationship between C. rufipes and C. renggeri, two common Neotropical Camponotus species, C. atriceps and C. cingulatus were taken as outgroups. All four species of Camponotus that were studied had 2n = 40 chromosomes (4sm+34st+2t); however, the abundance of chromosome rearrangements observed, combined with several chromosome markers, suggest that C. rufipes and C. renggeri are two good distinct species although closely related. The already reported chromosome translocation 2n = 39 (1m+4sm+32st+2t) for C. rufipes has been found in different populations as in the unprecedented chromosome inversions found both in C. rufipes and in C. renggeri populations. Within the C. renggeri chromosome inversions, both the heterozygous state 2n = 40 (1m+3sm+34st+2t) and the homozygous state, 2n = 40 (2m+2sm+34st+2t) were identified. However, only heterozygous specimens for chromosome inversions were found among C. rufipes, with karyotype configurations distinct from those found in C. renggeri, with 2n = 40 (1m+4sm+34st+2t). None of the populations studied showed signs of mosaic individuals. With respect to rDNA clusters, the 18S rDNA seemed to be more restricted inside the genome, as C. renggeri showed four 18S rDNA clusters, whereas, C. rufipes, C. atriceps, and C. cingulatus showed only two clusters. The chromosome locations of the 5S rDNA clusters were pointed for the first time in Formicidae, and showed itself to be more widely spread over the genome. By combining different chromosome banding approaches it was possible to demonstrate the crucial importance that chromosome inversions played on the karyotype evolution within these ants. The results also showed that chromosome translocations might be a consequence of the chromatin dynamic condition observed among Camponotus species. The homozygosis condition found in a C. renggeri from a Brazilian savanna population for chromosome inversions and the contrasting heterozygous condition for a different kind of chromosome inversion in C. rufipes from the Brazilian coastal rainforest, opens the window for a chromosome race hypothesis within the group C. renggeri and C. rufipes. The wide distribution, rich ecological interactions, genetic diversity, and morphological variability among C. renggeri and C. rufipes justify questioning of the actual taxonomic status of these species. The answer of this puzzle is clear when observing the number of 18S rDNA clusters of these ants, as C. rufipes has only two clusters whereas C. renggeri has four.	[Alves Cardoso de Aguiar, Hilton Jeferson; Campos Barros, Luisa Antonia; Alves, Danubia Rodrigues; das Gracas Pompolo, Silvia] Univ Fed Vicosa, Programa Posgrad Genet & Melhoramento, Vicosa, MG, Brazil; [Alves Cardoso de Aguiar, Hilton Jeferson; Campos Barros, Luisa Antonia] Univ Fed Amapa, Campus Binac, Oiapoque, Amapa, Brazil; [Ferreira Mariano, Clea dos Santos] CEPEC CEPLAC, Lab Mirmecol, Itabuna, BA, Brazil; [Ferreira Mariano, Clea dos Santos; Charles Delabie, Jacques Hubert] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ilheus, BA, Brazil; [Charles Delabie, Jacques Hubert] Univ Estadual Santa Cruz, Dept Ciencias Agr & Ambientais, Ilheus, BA, Brazil	Universidade Federal de Vicosa; Fundacao Universidade Federal do Amapa; Universidade Estadual de Santa Cruz; Universidade Estadual de Santa Cruz	de Aguiar, HJAC (corresponding author), Univ Fed Vicosa, Programa Posgrad Genet & Melhoramento, Vicosa, MG, Brazil.; de Aguiar, HJAC (corresponding author), Univ Fed Amapa, Campus Binac, Oiapoque, Amapa, Brazil.	hilton.aguiar@hotmail.com	Barros, Luísa A.C./A-4106-2017; Mariano, Cléa/GZM-2747-2022	Aguiar, Hilton/0000-0001-7738-1460; Delabie, Jacques Hubert Charles/0000-0002-2695-1061	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) [APQ-00259-13]; Conselho Nacional de Pesquisa (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/PNPD)	Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/PNPD)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was part of the DSc. thesis to author HJACA, and was supported by the Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) process No. APQ-00259-13. The authors wish to thank the Conselho Nacional de Pesquisa (CNPq) for the scholarship granted to HJACA and the research grant to JHCD. We also acknowledge the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/PNPD) for the postdoctoral grant provided to LACB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar HJAC, 2016, SOCIOBIOLOGY, V63, P777, DOI 10.13102/sociobiology.v63i2.948; [Anonymous], 2008, INSETOS SOCIAIS BIOL; Barros LAC, 2009, COMP CYTOGENET, V3, P97, DOI 10.3897/compcytogen.v3i2.16; Bertrand Y, 2006, SYST BIODIVERS, V4, P149, DOI 10.1017/S1477200005001908; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Bolton B., 2020, ONLINE CATALOG ANTS; Brady Sean G., 2000, P131; Barros LAC, 2016, COMP CYTOGENET, V10, P229, DOI 10.3897/CompCytogen.v10i2.7612; Barros LAC, 2015, CR BIOL, V338, P660, DOI 10.1016/j.crvi.2015.07.006; Barros LAC, 2014, FLA ENTOMOL, V97, P1694, DOI 10.1653/024.097.0444; Barros LAC, 2013, CARYOLOGIA, V66, P59, DOI 10.1080/00087114.2013.780443; Cardoso DC, 2012, COMP CYTOGENET, V6, P107, DOI 10.3897/CompCytogen.v6i2.2397; Castiglia R, 2003, GENETICA, V118, P33, DOI 10.1023/A:1022903112274; Cristiano MP, 2014, COMP CYTOGENET, V8, P223, DOI 10.3897/CompCytogen.v8i3.7510; DOBZHANSKY T, 1955, P NATL ACAD SCI USA, V41, P289, DOI 10.1073/pnas.41.5.289; Dubinin NP, 2010, COMP CYTOGENET, V4, P207, DOI 10.3897/compcytogen.v4i2.42; Mariano CDF, 2008, INSECT CONSERV DIVER, V1, P161, DOI 10.1111/j.1752-4598.2008.00022.x; Groc S, 2009, INSECT CONSERV DIVER, V2, P183, DOI 10.1111/j.1752-4598.2009.00060.x; HASHMI A A, 1973, Studia Entomologica, V16, P1; Hoffmann AA, 2004, TRENDS ECOL EVOL, V19, P482, DOI 10.1016/j.tree.2004.06.013; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Holldobler B., 2009, SUPERORGANISM; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; IMAI HT, 1994, JPN J GENET, V69, P137, DOI 10.1266/jjg.69.137; IMAI HT, 1988, JPN J GENET, V63, P159, DOI 10.1266/jjg.63.159; IMAI HT, 1991, JPN J GENET, V66, P635, DOI 10.1266/jjg.66.635; JOHN B, 1966, SCIENCE, V152, P711, DOI 10.1126/science.152.3723.711; Kavalco KF, 2009, GENET MOL BIOL, V32, P477, DOI 10.1590/S1415-47572009005000055; Kell LT, 2009, ICES J MAR SCI, V66, P1776, DOI 10.1093/icesjms/fsp181; King M., 1993, SPECIES EVOLUTION; Kouru KH, 2011, FERTIL STERIL, V95, P806, DOI 10.1016/j.fertnstert.2010.09.022; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Lorite P, 1997, HEREDITY, V78, P578, DOI 10.1038/hdy.1997.96; Lorite P, 2010, MYRMECOL NEWS, V13, P89; Mackay WP, 2004, SYSTEMATICS BIOL NEW; Malik HS, 2009, PROG MOL SUBCELL BIO, V48, P33, DOI 10.1007/978-3-642-00182-6_2; Mallet J, 2007, ENCY BIODIVERSITY, V5, P1, DOI [10.1016/B0-12-226865-2/00261-3, DOI 10.1016/B0-12-226865-2/00261-3]; Mariano C. S. F., 2001, Revista Brasileira de Entomologia, V45, P267; Mariano Clea dos Santos Ferreira, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/973897; Mariano Clea S.F., 2006, Myrmecologische Nachrichten, V8, P277; Martins C, 2006, GENETICA, V127, P133, DOI 10.1007/s10709-005-2674-y; MAYR E, 1970, P453; Mayr E, 2001, WHAT EVOLUTION IS CL; Navarro A, 2003, EVOLUTION, V57, P447, DOI 10.1554/0014-3820(2003)057[0447:APIGIP]2.0.CO;2; OKAZAKI S, 1993, MOL CELL BIOL, V13, P1424, DOI 10.1128/MCB.13.3.1424; Pereira JOP, 2006, THESIS; Perrin A, 2010, ANDROLOGIA, V42, P27, DOI 10.1111/j.1439-0272.2009.00951.x; Phillips RB, 2000, CHROMOSOME RES, V8, P27, DOI 10.1023/A:1009271017998; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Ronque MUV, 2016, ZOOL J LINN SOC-LOND, V176, P170, DOI 10.1111/zoj.12303; Rothballer A, 2013, CHROMOSOMA, V122, P415, DOI 10.1007/s00412-013-0417-x; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; SCHWEIZER D, 1980, CYTOGENET CELL GENET, V27, P190, DOI 10.1159/000131482; Seifert B, 2009, MYRMECOL NEWS, V12, P149; Sharma T, 2003, J BIOSCIENCES, V28, P189, DOI 10.1007/BF02706218; Shaw David D., 1998, Journal of Orthoptera Research, V7, P157; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Sumner AT, 1990, CHROMOSOME BANDING; White MJD, 1978, ANIMAL CYTOLOGY EVOL; WILSON E O, 1976, Studia Entomologica, V19, P187; WILSON EO, 1953, SYST ZOOL, V2, P97, DOI 10.2307/2411818; Zolessi LC, 1983, CARVOLOGIA, V36, P363	63	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177702	10.1371/journal.pone.0177702	http://dx.doi.org/10.1371/journal.pone.0177702			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520797	Green Published, Green Submitted, gold			2022-12-26	WOS:000401485500059
J	Patel, DP; Krausz, KW; Xie, C; Beyoglu, D; Gonzalez, FJ; Idle, JR				Patel, Daxesh P.; Krausz, Kristopher W.; Xie, Cen; Beyoglu, Diren; Gonzalez, Frank J.; Idle, Jeffrey R.			Metabolic profiling by gas chromatography-mass spectrometry of energy metabolism in high-fat diet-fed obese mice	PLOS ONE			English	Article							TRICARBOXYLIC-ACID CYCLE; PERFORMANCE LIQUID-CHROMATOGRAPHY; GUT MICROBIOTA; RESISTANT; LIVER; DERIVATIZATION; ADAPTATION; REVEALS; PATHWAY; WEIGHT	A novel, selective and sensitive single-ion monitoring (SIM) gas chromatography-mass spectrometry (GCMS) method was developed and validated for the determination of energy metabolites related to glycolysis, the tricarboxylic acid (TCA) cycle, glutaminolysis, and fatty acid beta-oxidation. This assay used N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide (MTBSTFA) containing 1% tert-butyldimethylchlorosilane (TBDMCS) as derivatizing reagent and was highly reproducible, sensitive, specific and robust. The assay was used to analyze liver tissue and serum from C57BL/6N obese mice fed a high-fat diet (HFD) and C57BL/6N mice fed normal chow for 8 weeks. HFD-fed mice serum displayed statistically significantly reduced concentrations of pyruvate, citrate, succinate, fumarate, and 2-oxoglutarate, with an elevated concentration of pantothenic acid. In liver tissue, HFD-fed mice exhibited depressed levels of glycolysis end-products pyruvate and lactate, glutamate, and the TCA cycle intermediates citrate, succinate, fumarate, malate, and oxaloacetate. Pantothenate levels were 3-fold elevated accompanied by a modest increased gene expression of Scl5a6 that encodes the pantothenate transporter SLC5A6. Since both glucose and fatty acids inhibit coenzyme A synthesis from pantothenate, it was concluded that these data were consistent with downregulated fatty acid beta-oxidation, glutaminolysis, glycolysis, and TCA cycle activity, due to impaired anaplerosis. The novel SIM GCMS assay provided new insights into metabolic effects of HFD in mice.	[Patel, Daxesh P.; Krausz, Kristopher W.; Xie, Cen; Gonzalez, Frank J.; Idle, Jeffrey R.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Beyoglu, Diren; Idle, Jeffrey R.] Univ Bern, Dept Clin Res, Hepatol Res Grp, Bern, Switzerland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Bern	Idle, JR (corresponding author), NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.; Idle, JR (corresponding author), Univ Bern, Dept Clin Res, Hepatol Res Grp, Bern, Switzerland.	idlejr@mail.nih.gov	Patel, Daxesh/AAC-3244-2019; Idle, Jeff/B-1152-2012	Idle, Jeff/0000-0002-6143-1520; Beyoglu, Diren/0000-0001-9882-5841	National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC005708, ZIABC005562] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by National Cancer Institute Intramural Program.	Abbrescia DI, 2012, ARCH BIOCHEM BIOPHYS, V518, P157, DOI 10.1016/j.abb.2011.12.021; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Boulange CL, 2013, J PROTEOME RES, V12, P1956, DOI 10.1021/pr400051s; Calderon-Santiago M, 2013, J PHARMACEUT BIOMED, V74, P178, DOI 10.1016/j.jpba.2012.10.029; Ciappio ED, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084583; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Falegan OS, 2017, METABOLITES, V7, DOI 10.3390/metabo7010006; FDA, 2013, GUID IND BIOAN METH; Fearnside JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001668; He QH, 2012, J NUTR BIOCHEM, V23, P133, DOI 10.1016/j.jnutbio.2010.11.007; Hwang H, 2010, DIABETES, V59, P33, DOI 10.2337/db09-0214; Jambocus NGS, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2391592; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Kim JY, 2010, J PROTEOME RES, V9, P4368, DOI 10.1021/pr100101p; Kim SH, 2009, ANAL BIOANAL CHEM, V395, P1117, DOI 10.1007/s00216-009-3054-8; Li HK, 2008, J PROTEOME RES, V7, P4775, DOI 10.1021/pr800352k; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Li SY, 2008, OBESITY, V16, P811, DOI 10.1038/oby.2007.116; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; Luo GH, 2016, SCI REP-UK, V6, P1, DOI [10.1038/srep35231, 10.1038/s41598-016-0027-y]; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; Martinez DL, 2014, BIOCHEM SOC T, V42, P1112, DOI 10.1042/BST20140124; MAWHINNEY TP, 1986, J CHROMATOGR, V361, P117, DOI 10.1016/S0021-9673(01)86899-0; Oberbach A, 2011, J PROTEOME RES, V10, P4769, DOI 10.1021/pr2005555; Ogden Cynthia L, 2010, NCHS Data Brief, P1; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Qian L, 2016, INT J MOL SCI, V17, P1; ROBISHAW JD, 1982, J BIOL CHEM, V257, P967; Schmid GM, 2004, PROTEOMICS, V4, P2270, DOI 10.1002/pmic.200300810; Schummer C, 2009, TALANTA, V77, P1473, DOI 10.1016/j.talanta.2008.09.043; Scully T, 2014, NATURE, V508, pS49, DOI 10.1038/508S49a; Serkova NJ, 2006, J HEPATOL, V44, P956, DOI 10.1016/j.jhep.2005.07.009; Shurubor YI, 2016, ANAL BIOCHEM, V503, P8, DOI 10.1016/j.ab.2016.03.004; Takahashi K, 2015, J NUTR SCI VITAMINOL, V61, P215, DOI 10.3177/jnsv.61.215; Tan B, 2014, ANAL BIOCHEM, V465, P134, DOI 10.1016/j.ab.2014.07.027; Toye AA, 2007, DIABETOLOGIA, V50, P1867, DOI 10.1007/s00125-007-0738-5; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vadlapudi AD, 2012, CURR DRUG TARGETS, V13, P994; Vial G, 2011, J HEPATOL, V54, P348, DOI 10.1016/j.jhep.2010.06.044; Waldram A, 2009, J PROTEOME RES, V8, P2361, DOI 10.1021/pr8009885; Walley AJ, 2009, NAT REV GENET, V10, P431, DOI 10.1038/nrg2594; WOMERSLEY C, 1984, INSECT BIOCHEM, V14, P395, DOI 10.1016/0020-1790(84)90095-7; WOMERSLEY C, 1982, J INVERTEBR PATHOL, V40, P406, DOI 10.1016/0022-2011(82)90179-3; Xu WX, 2012, J PROTEOME RES, V11, P3423, DOI 10.1021/pr300280t; Yang WJ, 2007, EPIDEMIOL REV, V29, P49, DOI 10.1093/epirev/mxm004; Yanovski SZ, 2014, JAMA-J AM MED ASSOC, V311, P74, DOI 10.1001/jama.2013.281361; Zhang XY, 2009, J PROTEOME RES, V8, P5188, DOI 10.1021/pr900524z	47	37	37	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177953	10.1371/journal.pone.0177953	http://dx.doi.org/10.1371/journal.pone.0177953			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520815	Green Published, gold, Green Submitted			2022-12-26	WOS:000401485500083
J	Tarafder, S; Chen, E; Jun, YN; Kao, K; Sim, KH; Back, J; Lee, FY; Lee, CH				Tarafder, Solaiman; Chen, Esther; Jun, Yena; Kao, Kristy; Sim, Kun Hee; Back, Jungho; Lee, Francis Y.; Lee, Chang H.			Tendon stem/progenitor cells regulate inflammation in tendon healing via JNK and STAT3 signaling	FASEB JOURNAL			English	Article						CTGF; TSC; CD146	MESENCHYMAL STEM-CELLS; COLLAGEN SPONGE CONSTRUCTS; EXTRACELLULAR-MATRIX; SILK SCAFFOLD; ANIMAL-MODELS; IMMUNOREGULATORY CYTOKINES; BIOMECHANICAL PROPERTIES; ACHILLES-TENDON; IMMUNE CELLS; IN-VIVO	Tendon stem/progenitor cells (TSCs) have been found in different anatomic locations and showed a promising regenerative potential. We identified a role of TSCs in the regulation of inflammation during healing of acute tendon injuries. Delivery of connective tissue growth factor (CTGF) into full-transected rat patellar tendons significantly increased the number of CD146(+) TSCs, leading to enhanced healing. In parallel, CTGF delivery significantly reduced the number of iNOS(+) M1 macrophages and increased the expression of anti-inflammatory IL-10 at 2 d after surgery, with over 85% CD146(+) TSCs expressing IL-10. By 1 wk, the elevated IL-10 expression remained, and IL-6 expression was significantly attenuated in CTGF-delivered tendon healing. Matrix metalloproteinase (MMP)-3 expression in CTGF-delivered tendon was organized along with the reorienting collagen fibers by 1 wk after surgery, in comparison with the control group showing the abundant MMP-3 expression localized at healing junction. Tissue inhibitor of metalloprotease (TIMP)-3 was expressed in CD146(+) TSCs at 1 wk with CTGF, in contrast to control with no TIMP-3 expression. In vitro, IL-10 expression was detected only when tendon cells were stimulated with IL-1 beta, and CTGF and significantly higher in CD146(+) TSCs than CD146(-) tendon cells. Similarly, TIMP-3 expression was detected only when treated with CTGF or CTGF and IL-1b that is significantly higher in CD146(+) TSCs compared to CD146(-) tendon cells. Signaling study with specific inhibitors and Western blot analysis demonstrated that CTGF-induced expression of IL-10 and TIMP-3 in CD146(+) TSCs are regulated by JNK/signal transducer and activator of transcription 3 signaling. Taken together, these findings suggest anti-inflammatory roles of CTGF-stimulated TSCs that are likely associated with improved tendon healing.	[Tarafder, Solaiman; Chen, Esther; Jun, Yena; Kao, Kristy; Sim, Kun Hee; Lee, Chang H.] Columbia Univ, Regenerat Engn Lab, Irving Med Ctr, 630 W 168 St VC12-230, New York, NY 10032 USA; [Back, Jungho; Lee, Francis Y.] Yale Univ, Sch Med, Dept Orthopaed & Rehabil, New Haven, CT USA	Columbia University; NewYork-Presbyterian Hospital; Yale University	Lee, CH (corresponding author), Columbia Univ, Regenerat Engn Lab, Irving Med Ctr, 630 W 168 St VC12-230, New York, NY 10032 USA.	chl2109@cumc.columbia.edu		Tarafder, Solaiman/0000-0001-9659-690X	U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research Grant [1R03 DE026794-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE026794] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study is partially supported by U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research Grant 1R03 DE026794-01 (to C.H.L.). The authors thank A. Tsu (Columbia University College of Dental Medicine) for administrative assistance.	Al-Sadi O, 2012, MUSCLES LIGAMENTS TE, V1, P68; Bedi A, 2010, AM J SPORT MED, V38, P308, DOI 10.1177/0363546509347366; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Chen JM, 2009, EXPERT REV MED DEVIC, V6, P61, DOI 10.1586/17434440.6.1.61; Davis ME, 2013, J APPL PHYSIOL, V115, P884, DOI 10.1152/japplphysiol.00137.2013; Del Buono A, 2012, J SHOULDER ELB SURG, V21, P200, DOI 10.1016/j.jse.2011.10.020; Fan HB, 2008, BIOMATERIALS, V29, P3324, DOI 10.1016/j.biomaterials.2008.04.012; Fan HB, 2009, BIOMATERIALS, V30, P4967, DOI 10.1016/j.biomaterials.2009.05.048; Fleming BC, 2009, AM J SPORT MED, V37, P1554, DOI 10.1177/0363546509332257; Gulotta LV, 2011, ARTHROSCOPY, V27, P1351, DOI 10.1016/j.arthro.2011.03.076; Hutchins AP, 2013, BRIEF FUNCT GENOMICS, V12, P489, DOI 10.1093/bfgp/elt028; James R, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025011; John T, 2010, J ORTHOP RES, V28, P1071, DOI 10.1002/jor.21079; Jones GC, 2006, ARTHRITIS RHEUM-US, V54, P832, DOI 10.1002/art.21672; Juncosa-Melvin N, 2005, TISSUE ENG, V11, P448, DOI 10.1089/ten.2005.11.448; Juncosa-Melvin N, 2006, TISSUE ENG, V12, P2291, DOI 10.1089/ten.2006.12.2291; Juncosa-Melvin N, 2006, TISSUE ENG, V12, P681, DOI 10.1089/ten.2006.12.681; Lake SP, 2008, DISABIL REHABIL, V30, P1530, DOI 10.1080/09638280701785460; Lee CH, 2015, J CLIN INVEST, V125, P2690, DOI [10.1172/JCI84508, 10.1172/JCI81589]; Lee CH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009696; Lee CH, 2010, J CLIN INVEST, V120, P3340, DOI 10.1172/JCI43230; Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X; Lee JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024381; Legemate K, 2016, J DENT RES, V95, P800, DOI 10.1177/0022034516642404; Legerlotz K, 2012, RHEUMATOLOGY, V51, P1161, DOI 10.1093/rheumatology/kes002; Liu J, 2012, TOXICOL SCI, V129, P363, DOI 10.1093/toxsci/kfs199; Lui PPY, 2011, SCAND J MED SCI SPOR, V21, P3, DOI 10.1111/j.1600-0838.2010.01164.x; Manning CN, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0059-4; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; Nirmalanandhan VS, 2008, TISSUE ENG PT A, V14, P1883, DOI 10.1089/ten.tea.2007.0125; Nourissat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012248; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Ouyang HW, 2006, TRANSPLANTATION, V82, P170, DOI 10.1097/01.tp.0000226232.79106.72; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Sahin H, 2012, J ORTHOP RES, V30, P1952, DOI 10.1002/jor.22147; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schulze-Tanzil G, 2011, SCAND J MED SCI SPOR, V21, P337, DOI 10.1111/j.1600-0838.2010.01265.x; Shen H, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0406-0; Shen WL, 2012, CELL TRANSPLANT, V21, P943, DOI 10.3727/096368911X627453; Spindler KP, 2006, J ORTHOP RES, V24, P401, DOI 10.1002/jor.20074; Staples KJ, 2007, J IMMUNOL, V178, P4779, DOI 10.4049/jimmunol.178.8.4779; Thomopoulos S, 2003, J ORTHOP RES, V21, P413, DOI 10.1016/S0736-0266(03)00057-3; Tozer Samuel, 2005, Birth Defects Research, V75, P226, DOI 10.1002/bdrc.20049; Tsuzaki M, 2003, J CELL BIOCHEM, V89, P556, DOI 10.1002/jcb.10534; Voleti PB, 2012, ANNU REV BIOMED ENG, V14, P47, DOI 10.1146/annurev-bioeng-071811-150122; Voloshin I, 2005, ARTHROSCOPY, V21, P1076, DOI 10.1016/j.arthro.2005.05.017; Wang F, 2007, J ORTHOP RES, V25, P378, DOI 10.1002/jor.20294; Warden SJ, 2007, BRIT J SPORT MED, V41, P232, DOI 10.1136/bjsm.2006.032342; Xu K, 2017, J TISSUE ENG REGEN M, V11, P1173, DOI 10.1002/term.2020; Yanez R, 2006, STEM CELLS, V24, P2582, DOI 10.1634/stemcells.2006-0228; Yang G, 2013, BIOMATERIALS, V34, P9295, DOI 10.1016/j.biomaterials.2013.08.054; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995	52	41	41	2	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3991	3998		10.1096/fj.201700071R	http://dx.doi.org/10.1096/fj.201700071R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28533328	Green Published			2022-12-26	WOS:000408713300024
J	Li, HR; Stumpfig, M; Zhang, CG; An, XX; Stubbe, J; Lill, R; Huang, MX				Li, Haoran; Stuempfig, Martin; Zhang, Caiguo; An, Xiuxiang; Stubbe, JoAnne; Lill, Roland; Huang, Mingxia			The diferric-tyrosyl radical cluster of ribonucleotide reductase and cytosolic iron-sulfur clusters have distinct and similar biogenesis requirements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; SMALL-SUBUNIT; PROTEIN BIOGENESIS; MATURATION; GLUTAREDOXIN; YEAST; PICOT; VITRO; DRE2	How each metalloprotein assembles the correct metal at the proper binding site presents challenges to the cell. The di-iron enzyme ribonucleotide reductase (RNR) uses a diferric-tyrosyl radical (Fe-2(III)-Y-center dot) cofactor to initiate nucleotide reduction. Assembly of this cofactor requires O-2, Fe-II, and a reducing equivalent. Recent studies show that RNR cofactor biosynthesis shares the same source of iron, in the form of [2Fe-2S]-GSH(2) from the monothiol glutaredoxin Grx3/4, and the same electron source, in the form of the Dre2-Tah18 electron transfer chain, with the cytosolic iron-sulfur protein assembly (CIA) machinery required for maturation of [4Fe-4S] clusters in cytosolic and nuclear proteins. Here, we further investigated the interplay between the formation of the Fe-2(III)-Y-center dot cofactor in RNR and the cellular iron-sulfur (Fe-S) protein biogenesis pathways by examining both the iron loading into the RNR beta subunit and the RNR catalytic activity in yeast mutants depleted of individual components of the mitochondrial iron-sulfur cluster assembly (ISC) and the CIA machineries. We found that both iron loading and cofactor assembly in RNR are dependent on the ISC machinery. Wealso found that Dre2 is required for RNR cofactor formation but appears to be dispensable for iron loading. None of the CIA components downstream of Dre2 was required for RNR cofactor formation. Thus, the pathways for RNR and Fe-S cluster biogenesis bifurcate after the Dre2-Tah18 step. We conclude that RNR cofactor biogenesis requires the ISC machinery to mature the Grx3/4 and Dre2 Fe-S proteins, which then function in iron and electron delivery to RNR, respectively.	[Li, Haoran; Stubbe, JoAnne] MIT, Dept Chem, Cambridge, MA 02139 USA; [Stubbe, JoAnne] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Stuempfig, Martin; Lill, Roland] Philipps Univ Marburg, Inst Zytobiol & Zytopathol, Robert Koch Str 6, D-35032 Marburg, Germany; [Zhang, Caiguo; Huang, Mingxia] Univ Colorado, Sch Med, Dept Dermatol, Aurora, CO 80045 USA; [Zhang, Caiguo; An, Xiuxiang; Huang, Mingxia] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Philipps University Marburg; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Lill, R (corresponding author), Philipps Univ Marburg, Inst Zytobiol & Zytopathol, Robert Koch Str 6, D-35032 Marburg, Germany.; Huang, MX (corresponding author), 12801 E 17th Ave,Mail Stop 8127, Aurora, CO 80045 USA.	lill@staff.uni-marburg.de; mingxia.huang@ucdenver.edu		Lill, Roland/0000-0002-8345-6518	National Institutes of Health [GM81393, CA125574]; Deutsche Forschungsgemeinschaft [SFB 987, SPP 1710, LI 415-5]; LOEWE program of the state of Hesse; Max-Planck Gesellschaft; NATIONAL CANCER INSTITUTE [R01CA125574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LOEWE program of the state of Hesse; Max-Planck Gesellschaft(Max Planck Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM81393 (to J. S. and M. H), and CA125574 (to M. H.) and by Deutsche Forschungsgemeinschaft (SFB 987, SPP 1710, LI 415-5), LOEWE program of the state of Hesse, and the Max-Planck Gesellschaft (to R. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An XX, 2006, GENETICS, V173, P63, DOI 10.1534/genetics.105.055236; ATKIN CL, 1973, J BIOL CHEM, V248, P7464; Burke D., 2000, METHODS YEAST GENETI; Cheng NH, 2011, FEBS J, V278, P2525, DOI 10.1111/j.1742-4658.2011.08178.x; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; Haunhorst P, 2013, MOL BIOL CELL, V24, P1895, DOI 10.1091/mbc.E12-09-0648; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Huang MX, 2014, J BIOL CHEM, V289, P28104, DOI 10.1074/jbc.R114.596684; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Kaplan CD, 2009, CHEM REV, V109, P4536, DOI 10.1021/cr9001676; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Minnihan EC, 2013, ACCOUNTS CHEM RES, V46, P2524, DOI 10.1021/ar4000407; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Netz DJA, 2014, TRENDS CELL BIOL, V24, P303, DOI 10.1016/j.tcb.2013.11.005; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Nguyen HHT, 1999, P NATL ACAD SCI USA, V96, P12339, DOI 10.1073/pnas.96.22.12339; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Ortigosa AD, 2006, BIOCHEMISTRY-US, V45, P12282, DOI 10.1021/bi0610404; Paul VD, 2015, BBA-MOL CELL RES, V1853, P1528, DOI 10.1016/j.bbamcr.2014.12.018; Perlstein DL, 2005, BIOCHEMISTRY-US, V44, P15366, DOI 10.1021/bi051616+; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; Saito Y, 2011, BIOCHEM BIOPH RES CO, V408, P329, DOI 10.1016/j.bbrc.2011.04.033; STEEPER JR, 1970, ANAL BIOCHEM, V34, P123, DOI 10.1016/0003-2697(70)90092-8; Stehling Oliver, 2007, Methods Mol Biol, V372, P325, DOI 10.1007/978-1-59745-365-3_24; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08; Zhang Y, 2014, P NATL ACAD SCI USA, V111, pE1695, DOI 10.1073/pnas.1405204111; Zhang Y, 2011, J BIOL CHEM, V286, P41499, DOI 10.1074/jbc.M111.294074	30	16	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11445	11451		10.1074/jbc.M117.786178	http://dx.doi.org/10.1074/jbc.M117.786178			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28515324	Green Published, hybrid			2022-12-26	WOS:000405119600027
J	Juneja, S; Gupta, A; Moon, S; Resch, S				Juneja, Sandeep; Gupta, Aastha; Moon, Suerie; Resch, Stephen			Projected savings through public health voluntary licences of HIV drugs negotiated by the Medicines Patent Pool (MPP)	PLOS ONE			English	Article							ANTIRETROVIRAL MEDICINES; IMPROVE ACCESS	The Medicines Patent Pool (MPP) was established in 2010 to ensure timely access to lowcost generic versions of patented antiretroviral (ARV) medicines in low-and middle-income countries (LMICs) through the negotiation of voluntary licences with patent holders. While robust data on the savings generated by MPP and other major global public health initiatives is important, it is also difficult to quantify. In this study, we estimate the savings generated by licences negotiated by the MPP for ARV medicines to treat HIV/AIDS in LMICs for the period 2010-2028 and generate a cost-benefit ratio-based on people living with HIV (PLHIVs) in any new countries which gain access to an ARV due to MPP licences and the price differential between originator's tiered price and generics price, within the period where that ARV is patented. We found that the direct savings generated by the MPP are estimated to be USD 2.3 billion (net present value) by 2028, representing an estimated cost-benefit ratio of 1: 43, which means for every USD 1 spent on MPP, the global public health community saves USD 43. The saving of USD 2.3 billion is equivalent to more than 24 million PLHIV receiving first-line ART in LMICs for 1 year at average prices today.	[Juneja, Sandeep; Gupta, Aastha] Med Patent Pool, Geneva, Switzerland; [Moon, Suerie; Resch, Stephen] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health	Gupta, A (corresponding author), Med Patent Pool, Geneva, Switzerland.	agupta@medicinespatentpool.org	juneja, sandeep/AAP-3404-2020	Juneja, Sandeep/0000-0002-3735-3120; Moon, Suerie/0000-0001-8504-1212				Accenture, 2012, ACC DEV PARTN INV BA; AMIN T, 2007, VOLUNTARY LICENSING; Gupta A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164619; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; Medecins Sans Frontieres, UNT WEB ANT PRIC RED; Medicines Patent Pool, MED PAT LIC DAT; Medicines Patent Pool, OR WORK MPP LIC AGR; Medicines Patent Pool, SUBL WORK MPP LIC AG; Medicines Patent Pool, IND ASS STAT KPMG; Medicines Patent Pool, PROGR ACH MED PAT PO; Moon S, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-39; [MPP UNITAID], PAT LIC ANT SNAPSH; 't Hoen E, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-15; UNAIDS, 2015, UND FAST TRACK ACC A; UNAIDS (Joint United Nations Programme on HIV and AIDS), 2016, FAST TRACK COMM END; Waning B, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-35; Waning B, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-9; [WIPO WTO WHO], 2013, PROM ACC MED TECHN I; WIPO, STUD PROM ACC MED TE; World Health Organization, GLOB PRIC REP MECH H; World Health Organization, 2007, VOL LIC PRACT PHARM; World Health Organization, CONS GUID US ANT DRU	22	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177770	10.1371/journal.pone.0177770	http://dx.doi.org/10.1371/journal.pone.0177770			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542239	Green Published, gold			2022-12-26	WOS:000402062800025
J	Noh, JY; Lim, S; Song, JY; Choi, WS; Jeong, HW; Heo, JY; Lee, J; Seo, YB; Lee, JS; Wie, SH; Kim, YK; Park, KH; Jung, SI; Kim, SW; Lee, SH; Lee, HS; Yoon, YH; Cheong, HJ; Kim, WJ				Noh, Ji Yun; Lim, Sooyeon; Song, Joon Young; Choi, Won Suk; Jeong, Hye Won; Heo, Jung Yeon; Lee, Jacob; Seo, Yu Bin; Lee, Jin-Soo; Wie, Seong Heon; Kim, Young Keun; Park, Kyung Hwa; Jung, Sook-In; Kim, Shin Woo; Lee, Sun Hee; Lee, Han Sol; Yoon, Young Hoon; Cheong, Hee Jin; Kim, Woo Joo			Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season	PLOS ONE			English	Article								In the 2016-2017 season, the A(H3N2) influenza epidemic presented an unusual early peak pattern compared with past seasons in South Korea. The interim vaccine effectiveness (VE) of influenza vaccination in preventing laboratory-confirmed influenza was estimated using test-negative design through the tertiary hospital-based influenza surveillance system in South Korea. From 1 September, 2016 to 7 January, 2017, adjusted VE of influenza vaccination in preventing laboratory-confirmed A(H3N2) was -52.1% (95% confidence interval [CI], -147.2 to 6.4); -70.0% (95% CI, -212.0 to 7.4) in 19-64 years and 4.3% (95% CI, -137.8 to 61.5) in the elderly. Circulating A(H3N2) viruses belonged to the three phylogenetic subclades of 3C. 2a, differently to A/Hong Kong/4801/2014, the current vaccine strain. Amino acid substitutions in hemagglutinin of circulating viruses seem to contribute to low VE. In conclusion, interim VE analysis presented that the protection of laboratory-confirmed influenza by seasonal influenza vaccination did not show the statistical significance in South Korea in the 2016-2017 influenza season.	[Noh, Ji Yun; Song, Joon Young; Choi, Won Suk; Cheong, Hee Jin; Kim, Woo Joo] Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea; [Noh, Ji Yun; Lim, Sooyeon; Song, Joon Young; Choi, Won Suk; Cheong, Hee Jin; Kim, Woo Joo] Korea Univ, Coll Med, Asia Pacific Influenza Inst, Seoul, South Korea; [Jeong, Hye Won; Heo, Jung Yeon] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Div Infect Dis, Cheongju, South Korea; [Lee, Jacob; Seo, Yu Bin] Hallym Univ, Sch Med, Kangnam Sacred Heart Hosp, Div Infect Dis,Dept Internal Med, Chunchon, South Korea; [Lee, Jin-Soo] Inha Univ, Coll Med, Dept Internal Med, Div Infect Dis, Incheon, South Korea; [Wie, Seong Heon] Catholic Univ Korea, Sch Med, St Vincents Hosp, Div Infect Dis,Dept Internal Med, Suwon, South Korea; [Kim, Young Keun] Yonsei Univ, Wonju Coll Med, Dept Infect Dis, Wonju, South Korea; [Park, Kyung Hwa; Jung, Sook-In] Chonnam Natl Univ, Med Sch, Dept Internal Med, Gwangju, South Korea; [Kim, Shin Woo] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea; [Lee, Sun Hee] Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea; [Lee, Han Sol; Kim, Woo Joo] Korea Univ, Coll Med, Brain Korea Plus Biomed Sci 21, Seoul, South Korea; [Yoon, Young Hoon] Korea Univ, Coll Med, Dept Emergency Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Chungbuk National University; Hallym University; Inha University; Catholic University of Korea; Yonsei University; Chonnam National University; Kyungpook National University; Pusan National University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Kim, WJ (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea.; Kim, WJ (corresponding author), Korea Univ, Coll Med, Asia Pacific Influenza Inst, Seoul, South Korea.; Kim, WJ (corresponding author), Korea Univ, Coll Med, Brain Korea Plus Biomed Sci 21, Seoul, South Korea.	wjkim@korea.ac.kr	Choi, Won Suk/V-2730-2017; LEE, SUN HEE/AAB-5714-2022; YOON, Young-Hoon/ABA-8810-2020	Choi, Won Suk/0000-0001-5874-4764; LEE, SUN HEE/0000-0003-2093-3628; Cheong, Hee Jin/0000-0002-2532-1463; Song, Joon Young/0000-0002-0148-7194; Yoon, Young-Hoon/0000-0002-1916-2080; Heo, Jung Yeon/0000-0002-6548-1939	TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea); Korea Healthcare Technology R&D Project by Ministry of Health & Welfare, Republic of Korea [A103001]; National Research Foundation of Korea (NRF) Grant - Korean Government (MSIP) [NRF-2016R1A5A1010148]	TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea); Korea Healthcare Technology R&D Project by Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea (NRF) Grant - Korean Government (MSIP)(National Research Foundation of Korea)	This work was supported by a grant of the TEPIK (Transgovernmental Enterprise for Pandemic Influenza in Korea), which is a part of the Korea Healthcare Technology R&D Project by Ministry of Health & Welfare, Republic of Korea (Grant no.: A103001) and by the National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MSIP) (NRF-2016R1A5A1010148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castilla J, 2017, EURO SURVEILLANCE B, V22; European Centre for Disease Prevention and Control, 2016, INFL VIR CHAR SUMM E; Feng S, 2016, VACCINE, V34, P1672, DOI 10.1016/j.vaccine.2016.02.039; Flannery B, 2017, MMWR-MORBID MORTAL W, V66, P167, DOI 10.15585/mmwr.mm6606a3; Flannery B, 2016, J INFECT DIS, V214, P1010, DOI 10.1093/infdis/jiw181; Harvala H, 2017, EURO SURVEILLANCE B, V22; Hergens MP, 2017, EURO SURVEILLANCE B, V22; Kee SY, 2007, J INFECTION, V55, P273, DOI 10.1016/j.jinf.2007.04.354; Kissling E, 2017, EURO SURVEILLANCE B, V22; Korea Centers for Disease Control and Prevention, WEEKL SENT SURV REP; Leung VK, 2016, EURO SURVEILLANCE B, V21; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Skowronski DM, 2017, EURO SURVEILLANCE B, V22; Song JY, 2013, J MED VIROL, V85, P910, DOI 10.1002/jmv.23548; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Valenciano M, 2016, EUROSURVEILLANCE, V21, P15, DOI 10.2807/1560-7917.ES.2016.21.7.30139; Valenciano M, 2015, VACCINE, V33, P2813, DOI 10.1016/j.vaccine.2015.04.012; WHO, REC COMP INFL VIR VA; World Health Organization, INFL LAB SURV INF GL	19	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178010	10.1371/journal.pone.0178010	http://dx.doi.org/10.1371/journal.pone.0178010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542417	Green Submitted, Green Published, gold			2022-12-26	WOS:000402062800035
J	Sigruener, A; Wolfrum, C; Boettcher, A; Kopf, T; Liebisch, G; Orso, E; Schmitz, G				Sigruener, Alexander; Wolfrum, Christian; Boettcher, Alfred; Kopf, Thomas; Liebisch, Gerhard; Orso, Evelyn; Schmitz, Gerd			Lipidomic and metabolic changes in the P4-type ATPase ATP10D deficient C57BL/6J wild type mice upon rescue of ATP10D function	PLOS ONE			English	Article							HIGH-THROUGHPUT QUANTIFICATION; GENETIC-CONTROL; HDL LEVELS; EXTRACTION; OBESITY; ACID; PHOSPHATIDYLCHOLINE; LIPIN-1; SAMPLES; MOUSE	Background Sequence variants near the human gene for P4-type ATPase, class V, type 10D (ATP10D) were shown to significantly associate with circulating hexosylceramide d18:1/16:0 and d18:1/24:1 levels, obesity, insulin resistance, plasma high density lipoprotein (HDL), coronary stenotic index and intracranial atherosclerotic index. In mice Atp10d is associated with HDL modulation and C57BL/6 mice expressing a truncated, non-functional form of ATP10D easily develop obesity and insulin resistance on high-fat diet. Results We analyzed metabolic differences of ATP10D deficient C57BL/6J wild type and ATP10D transgenic C57BL/6J BAC129 mice. ATP10D transgenic mice gain 25% less weight on high-fat diet concomitant with a reduced increase in fat cell mass but independent of adipocyte size change. ATP10D transgenic mice also had 26% lower triacylglycerol levels with approximately 76% bound to very low density lipoprotein while in ATP10D deficient wild type mice 57% are bound to low density lipoprotein. Furthermore increased oxygen consumption and CO2 production, 38% lower glucose and 69% lower insulin levels and better insulin sensitivity were observed in ATP10D transgenic mice. Besides decreased hexosylceramide species levels were detected. Part of these effects may be due to reduced hepatic stearoyl-CoA desaturase 1 (SCD1) expression in ATP10D transgenic mice, which was reflected by altered fatty acid and lipid species patterns. There was a significant decrease in the hepatic 18:1 to 18:0 free fatty acid ratio in transgenic mice. The ratio of 16:1 to 16:0 was not significantly different. Interestingly both ratios were significantly reduced in plasma total fatty acids. Summary In summary we found that ATP10D reduces high-fat diet induced obesity and improves insulin sensitivity. ATP10D transgenic mice showed altered hepatic expression of lipid-metabolism associated genes, including Scd1, along with changes in hepatic and plasma lipid species and plasma lipoprotein pattern.	[Sigruener, Alexander; Boettcher, Alfred; Kopf, Thomas; Liebisch, Gerhard; Orso, Evelyn; Schmitz, Gerd] Regensburg Univ, Med Ctr, Inst Clin Chem & Lab Med, Regensburg, Germany; [Wolfrum, Christian] ETH, Inst Mol Syst Biol, Zurich, Switzerland	University of Regensburg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Sigruener, A (corresponding author), Regensburg Univ, Med Ctr, Inst Clin Chem & Lab Med, Regensburg, Germany.	alexander.sigruener@ukr.de	Liebisch, Gerhard/G-6130-2010	Liebisch, Gerhard/0000-0003-4886-0811; Wolfrum, Christian/0000-0002-3862-6805	European Community's Seventh Framework Programme (FP7) [202272]	European Community's Seventh Framework Programme (FP7)	This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 202272, IP-Project LipidomicNet. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry KAZ, 2004, J AM SOC MASS SPECTR, V15, P1499, DOI 10.1016/j.jasms.2004.07.009; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown JM, 2010, CURR OPIN LIPIDOL, V21, P192, DOI 10.1097/MOL.0b013e32833854ac; Chen ZJ, 2008, ARTERIOSCL THROM VAS, V28, P1738, DOI 10.1161/ATVBAHA.108.171538; Deevska GM, 2011, BIOCHIMIE, V93, P32, DOI 10.1016/j.biochi.2010.05.016; Dhar MS, 2006, J NUTR BIOCHEM, V17, P811, DOI 10.1016/j.jnutbio.2006.01.002; Dhar MS, 2004, J NUTR, V134, P799, DOI 10.1093/jn/134.4.799; Ecker J, 2012, J CHROMATOGR B, V897, P98, DOI 10.1016/j.jchromb.2012.04.015; Flamant S, 2003, MAMM GENOME, V14, P21, DOI 10.1007/s00335-002-3032-3; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; Hicks AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000672; Hurst SE, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/152902; Innis-Whitehouse W, 1998, J LIPID RES, V39, P679; JIAO S, 1990, J LIPID RES, V31, P467; Kengia JT, 2013, ATHEROSCLEROSIS, V231, P158, DOI 10.1016/j.atherosclerosis.2013.08.034; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; Kopf T, 2013, J CHROMATOGR B, V938, P22, DOI 10.1016/j.jchromb.2013.08.016; LANDSCHULZ KT, 1994, BIOCHEM BIOPH RES CO, V200, P763, DOI 10.1006/bbrc.1994.1516; Langmann T, 2003, CLIN CHEM, V49, P230, DOI 10.1373/49.2.230; Liebisch G, 1999, J LIPID RES, V40, P1539; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Liebisch G, 2002, CLIN CHEM, V48, P2217; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Liebisch G, 2013, J LIPID RES; Machleder D, 1997, J CLIN INVEST, V99, P1406, DOI 10.1172/JCI119300; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Mauvoisin D, 2011, BIOCHIMIE, V93, P78, DOI 10.1016/j.biochi.2010.08.001; Mehrabian M, 2000, J LIPID RES, V41, P1936; Meissburger B, 2011, EMBO MOL MED, V3, P637, DOI 10.1002/emmm.201100172; Naito T, 2015, J BIOL CHEM, V290, P15004, DOI 10.1074/jbc.M115.655191; Nichols M, 2013, EUR HEART J, V34, P3028, DOI 10.1093/eurheartj/eht356; Paulusma CC, 2005, BBA-MOL BASIS DIS, V1741, P11, DOI 10.1016/j.bbadis.2005.04.006; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Riekhof WR, 2009, BBA-MOL CELL BIOL L, V1791, P620, DOI 10.1016/j.bbalip.2009.02.013; Scherer M, 2010, ANAL CHEM, V82, P8794, DOI 10.1021/ac1021826; Scherer M, 2010, J LIPID RES, V51, P2001, DOI 10.1194/jlr.D005322; Scherer M, 2009, CLIN CHEM, V55, P1218, DOI 10.1373/clinchem.2008.113779; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Summers SA, 2010, CURR OPIN LIPIDOL; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006	41	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178368	10.1371/journal.pone.0178368	http://dx.doi.org/10.1371/journal.pone.0178368			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542499	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800082
J	Zhang, YZ; Yu, YQ; Yuan, Y; Yu, K; Yang, HD; Li, XL; Min, XW; Zhang, C; He, MA; Zhang, XM; Wu, TC				Zhang, Yizhi; Yu, Yanqiu; Yuan, Yu; Yu, Kuai; Yang, Handong; Li, Xiulou; Min, Xinwen; Zhang, Ce; He, Meian; Zhang, Xiaomin; Wu, Tangchun			Association of drinking pattern with risk of coronary heart disease incidence in the middle-aged and older Chinese men: Results from the Dongfeng-Tongji cohort	PLOS ONE			English	Article							ALCOHOL-USE DISORDERS; CARDIOVASCULAR-DISEASE; CONSUMPTION; PREVALENCE; METAANALYSIS; METABOLISM; MORTALITY; ETHANOL; IMPACT; DEATH	Background Epidemiologic studies have found that moderate alcohol consumption was associated with a decreased risk of coronary heart disease (CHD) incidence. Nevertheless, whether the drinking pattern is associated with CHD incidence still remains inconclusive. Methods We included 8,469 Chinese men aged 45-81 years, who were free of CHD, stroke, or cancer at baseline from Dongfeng-Tongji cohort. A semi-structured questionnaire was used to collect information on alcohol consumption and other covariates. Cox proportional hazard regression model was applied to estimate the multivariable-adjusted hazard rations (HRs) and 95% confidence intervals (95% CIs). Results During an average of 4.36 years of follow-up, we identified 959 incident CHD events. Compared with non-drinkers, the multivariable-adjusted HR (95% CI) of CHD incidence was 0.84 (0.71-0.98) in current drinkers. With respect to drinking pattern, men who consumed 20.01-40 grams ethanol once a time had a 24% lower risk of incident CHD (HR = 0.76, 95% CI = 0.62, 0.94) compared with non-drinkers. The adjusted HRs (95% CI) of CHD incidence were 0.80 (0.65, 0.99), 1.02 (0.84, 1.22), and 0.75 (0.59-0.96) in subjects who consumed 0.01-10, 10.01-30, and > 30 grams ethanol per day, respectively. Participants who consumed 20.01-40 grams ethanol per time with less than 5 times per week had the lowest risk of CHD incidence (HR = 0.73, 95% CI = 0.52, 0.96). No significant associations were observed between type or frequency of alcohol consumption and CHD incidence. Conclusions Drinking was associated with a lower risk of CHD incidence in middle-aged and older Chinese men and moderate quantity of ethanol amounts once a time with lower frequency could been considered as a healthy drinking pattern, which might modify the relationship between alcohol consumption and incident CHD.	[Zhang, Yizhi; Yu, Yanqiu; Yuan, Yu; Yu, Kuai; He, Meian; Zhang, Xiaomin; Wu, Tangchun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Occupat & Environm Hlth, Tongji Med Coll, Wuhan, Peoples R China; [Zhang, Yizhi; Yu, Yanqiu; Yuan, Yu; Yu, Kuai; He, Meian; Zhang, Xiaomin; Wu, Tangchun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Minist Educ,Key Lab Environm & Hlth, Wuhan, Peoples R China; [Yang, Handong; Li, Xiulou; Min, Xinwen; Zhang, Ce] Hubei Univ Med, Dept Cardiovasc Dis, Dongfeng Cent Hosp, Shiyan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Hubei University of Medicine	Wu, TC (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Occupat & Environm Hlth, Tongji Med Coll, Wuhan, Peoples R China.; Wu, TC (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Minist Educ,Key Lab Environm & Hlth, Wuhan, Peoples R China.	wut@mails.tjmu.edu.cn	Zhang, Xiaomin/F-3206-2018; Zhang, Xiaomin/GVT-8927-2022	Min, Xinwen/0000-0002-8429-6560	National Natural Science Foundation of China [81230069, 81390542]; National Key Program of Research and Development of China [2016YFC0900800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Program of Research and Development of China	This research was supported by the National Natural Science Foundation of China (81230069 and 81390542) and the National Key Program of Research and Development of China (2016YFC0900800)	Albert CM, 1999, CIRCULATION, V100, P944, DOI 10.1161/01.CIR.100.9.944; Arriola L, 2010, HEART, V96, P124, DOI 10.1136/hrt.2009.173419; Athyros VG, 2007, ANGIOLOGY, V58, P689, DOI 10.1177/0003319707306146; Bazzano LA, 2009, INT J CARDIOL, V135, P78, DOI 10.1016/j.ijcard.2008.03.038; Bergmann MM, 2013, INT J EPIDEMIOL, V42, P1772, DOI 10.1093/ije/dyt154; Chen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053258; Cheng HG, 2015, ADDICTION, V110, P761, DOI 10.1111/add.12876; Cochrane J, 2003, ALCOHOL ALCOHOLISM, V38, P537, DOI 10.1093/alcalc/agg111; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Creswell KG, 2014, CLIN PSYCHOL SCI, V2, P602, DOI 10.1177/2167702613512795; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Fairbairn CE, 2015, CLIN PSYCHOL SCI, V3, P686, DOI 10.1177/2167702614548892; Hao W, 2005, ADDICTION, V100, P737, DOI 10.1111/j.1360-0443.2005.01036.x; He L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-34; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; Hou J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129677; Hurley TD, 2012, ALCOHOL RES-CURR REV, V34, P339; Lai XF, 2016, INT J CARDIOL, V224, P299, DOI 10.1016/j.ijcard.2016.09.035; Lee SL, 2015, BIOCHEM PHARMACOL, V95, P71, DOI 10.1016/j.bcp.2015.03.003; Li Z, 2016, INT J CARDIOL, V215, P257, DOI 10.1016/j.ijcard.2016.04.095; Millwood IY, 2013, INT J EPIDEMIOL, V42, P816, DOI 10.1093/ije/dyt078; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; Peirce RS, 2000, HEALTH PSYCHOL, V19, P28, DOI 10.1037/0278-6133.19.1.28; Pelletier R, 2009, PSYCHOSOM MED, V71, P301, DOI 10.1097/PSY.0b013e3181988175; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Rehm J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3026-9; Roerecke M, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0182-6; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Roth GA, 2015, NEW ENGL J MED, V372, P1333, DOI 10.1056/NEJMoa1406656; Samokhvalov AV, 2010, ALCOHOL CLIN EXP RES, V34, P1871, DOI 10.1111/j.1530-0277.2010.01275.x; Wang F, 2013, INT J EPIDEMIOL, V42, P731, DOI 10.1093/ije/dys053; World Health Organization, 1977, THE INTERNATIONAL CL; World Health Organization, INT STAT CLASS DIS H; Xiang YT, 2009, ALCOHOL CLIN EXP RES, V33, P1111, DOI 10.1111/j.1530-0277.2009.00933.x; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	36	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178070	10.1371/journal.pone.0178070	http://dx.doi.org/10.1371/journal.pone.0178070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542413	Green Submitted, gold, Green Published			2022-12-26	WOS:000402062800042
J	Comaskey, B; Roos, NP; Brownell, M; Enns, MW; Chateau, D; Ruth, CA; Ekuma, O				Comaskey, Brenda; Roos, Noralou P.; Brownell, Marni; Enns, Murray W.; Chateau, Dan; Ruth, Chelsea A.; Ekuma, Okechukwu			Maternal depression and anxiety disorders (MDAD) and child development: A Manitoba population-based study	PLOS ONE			English	Article							COGNITIVE-DEVELOPMENT; PRENATAL DEPRESSION; BEHAVIOR PROBLEMS; PHYSICAL HEALTH; CORTISOL-LEVELS; MENTAL-HEALTH; PREGNANCY; SYMPTOMS; MOTHERS; RISK	Objective To examine the association between maternal depression and anxiety disorders (MDAD) and child development assessed during the kindergarten year. Methods Administrative data from several health and social databases in Manitoba, Canada, were used to study 18,331 mother-child pairs. MDAD over the period from one year prior to the child's birth to the kindergarten year was defined using physician diagnoses and filled prescriptions. Child development was assessed during the kindergarten year using the Early Development Instrument (EDI) which measures vulnerability across five domains of development. Structural equation modeling was used to examine associations between timing, recurrence and severity of MDAD and child outcomes. Health at Birth (preterm, low birth weight, neonatal intensive care stay and long birth hospitalization), Family Context (teen mother, lone parent, socio-economic status (SES)), child age and child sex were covariates. Results MDAD had a modest negative association with child EDI scores across all models tested, particularly for social, emotional and physical development. Prenatal MDAD had a stronger negative association with outcomes than other time periods; however, recurrent MDAD had a stronger negative association with outcomes than any specific time period or MDAD severity. The influence of MDAD was mediated by Family Context, which had a strong, negative association with outcomes, particularly language and cognitive development. Conclusion The number of time periods a child was exposed to MDAD in early childhood was more negatively associated with five areas of child development than timing or severity. Prenatal exposure may be more sensitive to MDAD than other time periods. The familial context (teen mother, lone parenthood and low SES) had a stronger influence on child outcomes than MDAD. Findings can be used to inform interventions which address maternal mental health from the prenatal period onward, and to support disadvantaged families to encourage healthy birth outcomes, early childhood development and school readiness.	[Comaskey, Brenda; Roos, Noralou P.; Brownell, Marni; Enns, Murray W.; Chateau, Dan] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Comaskey, Brenda; Roos, Noralou P.; Brownell, Marni; Chateau, Dan; Ruth, Chelsea A.; Ekuma, Okechukwu] Manitoba Ctr Hlth Policy, Winnipeg, MB, Canada; [Enns, Murray W.] Univ Manitoba, Dept Psychiat, Winnipeg, MB, Canada; [Ruth, Chelsea A.] Univ Manitoba, Sect Neonatol, Dept Pediat, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba	Comaskey, B (corresponding author), Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada.; Comaskey, B (corresponding author), Manitoba Ctr Hlth Policy, Winnipeg, MB, Canada.	brenda.comaskey@gmail.com	Ruth, Chelsea/AAP-9657-2021	Roos, Noralou/0000-0002-0802-2082; Ruth, Chelsea/0000-0002-7097-0542; Enns, Murray/0000-0002-8375-0151; Brownell, Marni/0000-0001-7673-4404	Evelyn Shapiro Award for Health Services Research;  [2010-2011-33]	Evelyn Shapiro Award for Health Services Research; 	BC received funding from the Evelyn Shapiro Award for Health Services Research. The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; We gratefully acknowledge Manitoba Health, Seniors and Active Living, the Health Information Privacy Committee (HIPC) and Healthy Child Manitoba for access to the data. We also acknowledge the Manitoba Centre for Health Policy (MCHP) for use of the data in the Population Health Research Data Repository under project #2010-2011-33 and the programming support of Charles Burchill, MCHP Associate Director of Data Access and Use. The results and conclusions are those of the authors and no official endorsement by the Manitoba Centre for Health Policy, Manitoba Health, Seniors and Active Living, or other data providers is intended or should be inferred. B. Comaskey had full access to the data used in the study and takes full responsibility for integrity and accuracy of the data cleaning and analysis.	ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Appelbaum M, 1999, DEV PSYCHOL, V35, P1297; Bagner DM, 2010, J AM ACAD CHILD PSY, V49, P699, DOI 10.1016/j.jaac.2010.03.012; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bennett IM, 2010, PSYCHIAT SERV, V61, P386, DOI 10.1176/ps.2010.61.4.386; Berle JO, 2005, ARCH WOMEN MENT HLTH, V8, P181, DOI 10.1007/s00737-005-0090-z; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Bigatti SM, 2001, CHILD PSYCHIAT HUM D, V32, P147, DOI 10.1023/A:1012250824091; Brennan PA, 2000, DEV PSYCHOL, V36, P759, DOI 10.1037/0012-1649.36.6.759; Brownell M, 2012, ARE MANITOBAS CHILDR; Brownell MD, 2016, EARLY CHILD RES Q, V35, P6, DOI 10.1016/j.ecresq.2015.10.004; Chen JH, 2014, EARLY HUM DEV, V90, P73, DOI 10.1016/j.earlhumdev.2013.09.015; Cicchetti D, 1998, DEV PSYCHOPATHOL, V10, P283, DOI 10.1017/S0954579498001618; D'Angiulli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007692; Dietz PM, 2007, AM J PSYCHIAT, V164, P1515, DOI 10.1176/appi.ajp.2007.06111893; Dix T, 2014, DEV PSYCHOPATHOL, V26, P111, DOI 10.1017/S0954579413000898; Eisenhower AS, 2009, SOC SCI MED, V68, P89, DOI 10.1016/j.socscimed.2008.09.033; Elgar FJ, 2004, CLIN PSYCHOL REV, V24, P441, DOI 10.1016/j.cpr.2004.02.002; Essex MJ, 2001, BRIT J PSYCHIAT, V179, P151, DOI 10.1192/bjp.179.2.151; Feinstein L, 2004, CHILD DEV, V75, P1329, DOI 10.1111/j.1467-8624.2004.00743.x; Field T, 2008, INT J NEUROSCI, V118, P95, DOI 10.1080/00207450601042144; Field T, 2011, INFANT BEHAV DEV, V34, P1, DOI 10.1016/j.infbeh.2010.09.008; Fihrer I, 2009, J AFFECT DISORDERS, V119, P116, DOI 10.1016/j.jad.2009.03.001; Forget-Dubois N., 2007, EARLY EDUC DEV, V18, P405, DOI [10.1080/10409280701610796, DOI 10.1080/10409280701610796]; Fransoo RR, 2008, CAN J PUBLIC HEALTH, V99, P344, DOI 10.1007/BF03403769; Glover V, 2014, BEST PRACT RES CL OB, V28, P25, DOI 10.1016/j.bpobgyn.2013.08.017; Goodman SH, 1999, PSYCHOL REV, V106, P458, DOI 10.1037/0033-295X.106.3.458; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; Guhn M., 2007, EARLY EDUC DEV, V18, P369, DOI [10.1080/10409280701610622, DOI 10.1080/10409280701610622]; HAMMEN C, 1990, DEV PSYCHOL, V26, P24, DOI 10.1037/0012-1649.26.1.24; Hammen C, 2003, ARCH GEN PSYCHIAT, V60, P253, DOI 10.1001/archpsyc.60.3.253; Hatcher L., 1994, STEP BY STEP APPROAC; Hertzman C, 1999, DEVELOPMENTAL HEALTH AND THE WEALTH OF NATIONS, P21; Hertzman C, 2010, ANNU REV PUBL HEALTH, V31, P329, DOI 10.1146/annurev.publhealth.012809.103538; Huot RL, 2004, ANN NY ACAD SCI, V1032, P234, DOI 10.1196/annals.1314.028; Janus M., 2007, EARLY ED DEV, V18, P375, DOI [10.1080/10409280701610796a, DOI 10.1080/10409280701610796A]; Janus M, 2004, NORMATIVE DATA EARLY; Janus M, 2007, CAN J BEHAV SCI, V39, P1, DOI 10.1037/cjbs2007001; Janus M, 2011, SOC INDIC RES, V103, P283, DOI 10.1007/s11205-011-9846-1; Jensen SKG, 2014, DEPRESS ANXIETY, V31, P599, DOI 10.1002/da.22147; Jutte DP, 2010, ACAD PEDIATR, V10, P293, DOI 10.1016/j.acap.2010.06.008; Jutte DP, 2010, EPIDEMIOLOGY, V21, P314, DOI 10.1097/EDE.0b013e3181d61e61; Karoly LA., 2005, EARLY CHILDHOOD INTE; KELLER MB, 1986, ARCH GEN PSYCHIAT, V43, P930; Kline RB, 2005, PRINCIPLES PRACTICE; Kozyrskyj AL, 2008, AM J RESP CRIT CARE, V177, P142, DOI 10.1164/rccm.200703-381OC; Laplante DP, 2008, J AM ACAD CHILD PSY, V47, P1063, DOI 10.1097/CHI.0b013e31817eec80; Leckman-Westin E, 2009, J CHILD PSYCHOL PSYC, V50, P1176, DOI 10.1111/j.1469-7610.2009.02083.x; Lester BM, 2013, CLIN OBSTET GYNECOL, V56, P556, DOI 10.1097/GRF.0b013e318299d2a8; Letourneau NL, 2013, J PEDIATR NURS, V28, P223, DOI 10.1016/j.pedn.2012.07.014; LeWinn KZ, 2009, INT J EPIDEMIOL, V38, P1700, DOI 10.1093/ije/dyp200; Luoma I, 2001, J AM ACAD CHILD PSY, V40, P1367, DOI 10.1097/00004583-200112000-00006; McCain M.N., 2007, EARLY YEARS STUDY 2; Muhajarine N, 2011, SOC INDIC RES, V103, P299, DOI 10.1007/s11205-011-9847-0; Murray L, 1996, J CHILD PSYCHOL PSYC, V37, P927, DOI 10.1111/j.1469-7610.1996.tb01490.x; MURRAY L, 1992, J CHILD PSYCHOL PSYC, V33, P543, DOI 10.1111/j.1469-7610.1992.tb00890.x; Mustard CA, 1999, HEALTH PLACE, V5, P157, DOI 10.1016/S1353-8292(99)00008-8; O'Connor TG, 2002, J AM ACAD CHILD PSY, V41, P1470, DOI 10.1097/00004583-200212000-00019; O'Donnell KJ, 2014, DEV PSYCHOPATHOL, V26, P393, DOI 10.1017/S0954579414000029; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Pampalon R, 2009, HEALTH REP, V20, P85; Pariante CM, 2014, BIOCHEM SOC T, V42, P582, DOI 10.1042/BST20130246; Raposa E, 2014, J ADOLESCENT HEALTH, V54, P88, DOI 10.1016/j.jadohealth.2013.07.038; Roos LL, 2013, SOC INDIC RES, V110, P385, DOI 10.1007/s11205-011-9936-0; Rouse C, 2005, FUTURE CHILD, V15, P5, DOI 10.1353/foc.2005.0010; Santos R., 2012, EARLY DEV INSTRUMENT; SAS Institute Inc, 2011, SAS 9 3 COMP SOFTW; SAS Institute Inc, 2012, STRUCT EQ MOD US SAS; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Sohr-Preston SL, 2006, CLIN CHILD FAM PSYCH, V9, P65, DOI 10.1007/s10567-006-0004-2; WHO, 2013, GUID ATC CLASS DDD A; Zumbo B.D., 2007, EARLY EDUC DEV, V18, P453, DOI [10.1080/10409280701610838, DOI 10.1080/10409280701610838]	72	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177065	10.1371/journal.pone.0177065	http://dx.doi.org/10.1371/journal.pone.0177065			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VE	28542256	gold, Green Submitted, Green Published			2022-12-26	WOS:000402061500011
J	Zhang, XN; Ma, ZJ; Wang, Y; Sun, B; Guo, X; Pan, CQ; Chen, LM				Zhang, Xiao-na; Ma, Ze-jun; Wang, Ying; Sun, Bei; Guo, Xin; Pan, Cong-qing; Chen, Li-ming			Angelica Dahurica ethanolic extract improves impaired wound healing by activating angiogenesis in diabetes	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; TUBE FORMATION; IMPERATORIN; EXPRESSION; KINASE; GROWTH; ERK; INFLAMMATION; DYSFUNCTION	Abnormal angiogenesis plays an important role in impaired wound healing and development of chronic wounds in diabetes mellitus. Angelica dahurica radix is a common traditional Chinese medicine with wide spectrum medicinal effects. In this study, we analyzed the potential roles of Angelica dahurica ethanolic extract (ADEE) in correcting impaired angiogenesis and delayed wound healing in diabetes by using streptozotocin-induced diabetic rats. ADEE treatment accelerated diabetic wound healing through inducing angiogenesis and granulation tissue formation. The angiogenic property of ADEE was subsequently verified ex vivo using aortic ring assays. Furthermore, we investigated the in vitro angiogenic activity of ADEE and its underlying mechanisms using human umbilical vein endothelial cells. ADEE treatment induced HUVECs proliferation, migration, and tube formation, which are typical phenomena of angiogenesis, in dose-dependent manners. These effects were associated with activation of angiogenic signal modulators, including extracellular signal-regulated kinase 1/2 (ERK1/2), Akt, endothelial nitric oxide synthase (eNOS) as well as increased NO production, and independent of affecting VEGF expression. ADEE-induced angiogenic events were inhibited by the MEK inhibitor PD98059, the PI3K inhibitor Wortmannin, and the eNOS inhibitor L-NAME. Our findings highlight an angiogenic role of ADEE and its ability to protect against impaired wound healing, which may be developed as a promising therapy for impaired angiogenesis and delayed wound healing in diabetes.	[Zhang, Xiao-na] Tianjin Med Univ, Gen Hosp, Dept Endocrinol & Metab, Tianjin, Peoples R China; [Ma, Ze-jun; Wang, Ying; Sun, Bei; Guo, Xin; Pan, Cong-qing; Chen, Li-ming] Tianjin Med Univ, Collaborat Innovat Ctr Tianjin Med Epigenet 2011, Key Lab Hormone & Dev, Minist Hlth,Metab Dis Hosp, Tianjin, Peoples R China; [Ma, Ze-jun; Wang, Ying; Sun, Bei; Guo, Xin; Pan, Cong-qing; Chen, Li-ming] Tianjin Med Univ, Tianjin Inst Endocrinol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Pan, CQ; Chen, LM (corresponding author), Tianjin Med Univ, Collaborat Innovat Ctr Tianjin Med Epigenet 2011, Key Lab Hormone & Dev, Minist Hlth,Metab Dis Hosp, Tianjin, Peoples R China.; Pan, CQ; Chen, LM (corresponding author), Tianjin Med Univ, Tianjin Inst Endocrinol, Tianjin, Peoples R China.	cq.pan@163.com; xfx22081@vip.163.com			National Natural Science Foundation of China [81273916]; Youth Incubation Fund of Tianjin Medical University General Hospital [ZYYFY2016019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Incubation Fund of Tianjin Medical University General Hospital	This work was supported by the National Natural Science Foundation of China (No. 81273916) and Youth Incubation Fund of Tianjin Medical University General Hospital (No. ZYYFY2016019).	Amano K, 2003, HYPERTENSION, V41, P156, DOI 10.1161/01.HYP.0000053552.86367.12; [Anonymous], J NANOMATERIALS, DOI DOI 10.1155/2016/2319741; Bowling FL, 2015, NAT REV ENDOCRINOL, V11, P606, DOI 10.1038/nrendo.2015.130; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Buckley S, 1999, AM J PHYSIOL-LUNG C, V277, pL159, DOI 10.1152/ajplung.1999.277.1.L159; Cao YJ, 2013, PHYTOMEDICINE, V20, P1048, DOI 10.1016/j.phymed.2013.04.021; Chevallier A, 2001, ENCY MED PLANTS; Dasu MR, 2007, AM J PHYSIOL-ENDOC M, V293, pE337, DOI 10.1152/ajpendo.00718.2006; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Hashimoto A, 2006, ATHEROSCLEROSIS, V189, P350, DOI 10.1016/j.atherosclerosis.2006.01.022; Hsu PC, 2014, J ETHNOPHARMACOL, V156, P358, DOI 10.1016/j.jep.2014.08.029; Huang YH, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/308126; Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8; Ji LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056703; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Khanna S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009539; Lan CCE, 2013, DIABETES, V62, P2530, DOI 10.2337/db12-1714; Lee MY, 2011, FOOD CHEM TOXICOL, V49, P1047, DOI 10.1016/j.fct.2011.01.010; Li B, 2014, PHYTOCHEM ANALYSIS, V25, P229, DOI 10.1002/pca.2496; Li Y, 2015, ENDOCRINOLOGY, V156, P4257, DOI 10.1210/en.2015-1228; Lobmann R, 2002, DIABETOLOGIA, V45, P1011, DOI 10.1007/s00125-002-0868-8; Maiwulanjiang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116761; Malinda KM, 1999, FASEB J, V13, P53, DOI 10.1096/fasebj.13.1.53; Maver T, 2015, INT J DERMATOL, V54, P740, DOI 10.1111/ijd.12766; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Meadows KN, 2001, J BIOL CHEM, V276, P49289, DOI 10.1074/jbc.M108069200; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Nie H, 2009, CHIN J INTEGR MED, V15, P442, DOI 10.1007/s11655-009-0442-z; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pierce GF, 2001, AM J PATHOL, V159, P399, DOI 10.1016/S0002-9440(10)61709-9; RUBANYI GM, 1991, J CELL BIOCHEM, V46, P27, DOI 10.1002/jcb.240460106; Sarker SD, 2004, CURR MED CHEM, V11, P1479, DOI 10.2174/0929867043365189; Sawada N, 2014, CELL METAB, V19, P246, DOI 10.1016/j.cmet.2013.12.014; Shemyakin A, 2012, CIRCULATION, V126, P2943, DOI 10.1161/CIRCULATIONAHA.112.140335; Siqueira MF, 2010, DIABETOLOGIA, V53, P378, DOI 10.1007/s00125-009-1529-y; Somanath PR, 2008, ANGIOGENESIS, V11, P277, DOI 10.1007/s10456-008-9111-7; Takeo M, 2015, COLD SPRING HARB PER, V5; Toda N, 2010, PHARMACOL THERAPEUT, V127, P189, DOI 10.1016/j.pharmthera.2010.04.009; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Wang N, 2013, FITOTERAPIA, V90, P38, DOI 10.1016/j.fitote.2013.07.007; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; Yang BH, 2004, J CELL PHYSIOL, V200, P360, DOI 10.1002/jcp.20025; Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102; Zhang Xianqi, 2005, J Tradit Chin Med, V25, P219; Zhang Y, 2012, FITOTERAPIA, V83, P60, DOI 10.1016/j.fitote.2011.09.011; Zhao H, 2012, EUR J DERMATOL, V22, P58, DOI 10.1684/ejd.2011.1599; Zhao X, 2002, AM J PHYSIOL-HEART C, V283, pH2371, DOI 10.1152/ajpheart.00383.2002; ZICHE M, 1994, J CLIN INVEST, V94, P2036, DOI 10.1172/JCI117557	51	31	32	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177862	10.1371/journal.pone.0177862	http://dx.doi.org/10.1371/journal.pone.0177862			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542422	Green Published, gold, Green Submitted			2022-12-26	WOS:000402061500041
J	Banuelos, J; Cao, Y; Shin, SC; Bochner, BS; Avila, P; Li, SH; Jiang, X; Lingen, MW; Schleimer, RP; Lu, NZ				Banuelos, Jesus; Cao, Yun; Shin, Soon Cheon; Bochner, Bruce S.; Avila, Pedro; Li, Shihong; Jiang, Xin; Lingen, Mark W.; Schleimer, Robert P.; Lu, Nick Z.			Granulocyte colony-stimulating factor blockade enables dexamethasone to inhibit lipopolysaccharide-induced murine lung neutrophils	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; HIGH-DOSE METHYLPREDNISOLONE; G-CSF; GLUCOCORTICOID-RECEPTOR; BONE-MARROW; PLASMA-LEVELS; TNF-ALPHA; BLOOD; CELLS; EXPRESSION	Glucocorticoids promote neutrophilic inflammation, the mechanisms of which are poorly characterized. Using a lipopolysaccharide (LPS)-induced acute murine lung injury model, we determined the role of granulocyte colony-stimulating factor (G-CSF) in mouse lung neutrophil numbers in the absence and presence of dexamethasone, a potent glucocorticoid. G-CSF was blocked using a neutralizing antibody. Airway neutrophil numbers, cytokine levels, and lung injury parameters were measured. Glucocorticoid treatment maintained LPS-induced airway G-CSF while suppressing TNF and IL-6. The addition of anti-G-CSF antibodies enabled dexamethasone to decrease airway G-CSF, neutrophils, and lung injury scores. In LPS-challenged murine lungs, structural cells and infiltrating leukocytes produced G-CSF. In vitro using BEAS 2B bronchial epithelial cells, A549 lung epithelial cells, human monocyte-derived macrophages, and human neutrophils, we found that dexamethasone and proinflammatory cytokines synergistically induced G-CSF. Blocking G-CSF production in BEAS 2B cells using shRNAs diminished the ability of BEAS 2B cells to protect neutrophils from undergoing spontaneous apoptosis. These data support that G-CSF plays a role in upregulation of airway neutrophil numbers by dexamethasone in the LPS-induced acute lung injury model.	[Banuelos, Jesus; Cao, Yun; Shin, Soon Cheon; Bochner, Bruce S.; Avila, Pedro; Schleimer, Robert P.; Lu, Nick Z.] Northwestern Univ, Feinberg Sch Med, Div Allergy Immunol, Chicago, IL 60611 USA; [Li, Shihong; Jiang, Xin; Lingen, Mark W.] Univ Chicago, Dept Pharmacol, Chicago, IL 60637 USA; [Li, Shihong; Jiang, Xin; Lingen, Mark W.] Univ Chicago, Human Tissue Resource Ctr, Chicago, IL 60637 USA	Northwestern University; Feinberg School of Medicine; University of Chicago; University of Chicago	Lu, NZ (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Allergy Immunol, Chicago, IL 60611 USA.	nickzlu@northwestern.edu			National Institute of Allergy and Infectious Diseases [R56HL133058, R37HL068546, U19AI106683, R01AI72265]; Ernest S. Bazley Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL133058, R37HL068546] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ernest S. Bazley Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Allergy and Infectious Diseases, R56HL133058 (to NZL), R37HL068546 (to RPS), U19AI106683 (Chronic Rhinosinusitis Integrative Studies Program (CRISP) (to RPS), R01AI72265 (to BSB), and support from the Ernest S. Bazley Foundation (NZL, BSB, RPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, 2000, EUR RESPIR J, V15, P895, DOI 10.1034/j.1399-3003.2000.15e14.x; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Azoulay E, 2001, CHEST, V120, P1695, DOI 10.1378/chest.120.5.1695; Bajrami B, 2016, J EXP MED, V213, P1999, DOI 10.1084/jem.20160393; Banuelos J, 2016, ALLERGY, V71, P640, DOI 10.1111/all.12840; Banuelos J, 2016, ALLERGY; Banuelos J, 2016, CYTOKINE GROWTH F R, V31, P27, DOI 10.1016/j.cytogfr.2016.05.002; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Basu S, 2002, INT J MOL MED, V10, P3; BROUDY VC, 1987, J IMMUNOL, V139, P464; Cao Y, 2013, BLOOD, V121, P1553, DOI 10.1182/blood-2012-05-432336; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; COX G, 1992, AM J RESP CELL MOL, V7, P507, DOI 10.1165/ajrcmb/7.5.507; Crockard AD, 1998, INT J CLIN LAB RES, V28, P110, DOI 10.1007/s005990050029; DALE DC, 1975, J CLIN INVEST, V56, P808, DOI 10.1172/JCI108159; Files DC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010283; Henley D, 2016, PHARMACOL THERAPEUT, V166, P128, DOI 10.1016/j.pharmthera.2016.06.020; HOGG JC, 1995, ANNU REV PHYSIOL, V57, P97, DOI 10.1146/annurev.ph.57.030195.000525; Hsu J, 2012, J ALLERGY CLIN IMMUN, V129, pAB62, DOI 10.1016/j.jaci.2011.12.727; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Jilma B, 1998, J CLIN ENDOCR METAB, V83, P1037, DOI 10.1210/jc.83.3.1037; Jung HS, 2013, CURR PROB SURG, V50, P451, DOI 10.1067/j.cpsurg.2013.08.009; Karlin L, 2005, BONE MARROW TRANSPL, V36, P245, DOI 10.1038/sj.bmt.1705037; KOEFFLER HP, 1987, BLOOD, V70, P55; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lamontagne F, 2013, CAN MED ASSOC J, V185, P216, DOI 10.1503/cmaj.120582; Leung DYM, 1997, J EXP MED, V186, P1567, DOI 10.1084/jem.186.9.1567; LILES WC, 1995, BLOOD, V86, P3181; Lu NZ, 2006, PHARMACOL REV, V58, P782, DOI 10.1124/pr.58.4.9; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Peters AM, 1998, CLIN SCI, V94, P7, DOI 10.1042/cs0940007; Rankin SM, 2010, J LEUKOCYTE BIOL, V88, P241, DOI 10.1189/jlb.0210112; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schuld A, 2001, PSYCHONEUROENDOCRINO, V26, P65, DOI 10.1016/S0306-4530(00)00039-1; Semerad CL, 2002, IMMUNITY, V17, P413, DOI 10.1016/S1074-7613(02)00424-7; Sivertson KL, 2007, CELL IMMUNOL, V246, P34, DOI 10.1016/j.cellimm.2007.05.003; TAICHMAN RS, 1994, J EXP MED, V179, P1677, DOI 10.1084/jem.179.5.1677; Takahashi Y, 1999, ACTA HAEMATOL-BASEL, V101, P124, DOI 10.1159/000040937; Takatsuka H, 2002, CHEST, V121, P1716, DOI 10.1378/chest.121.5.1716; Trottier MD, 2008, P NATL ACAD SCI USA, V105, P2028, DOI 10.1073/pnas.0712003105; Tuncer AM, 1996, LEUKEMIA RES, V20, P265, DOI 10.1016/0145-2126(95)00140-9; Wakayama T, 1996, ENDOCR J, V43, P67, DOI 10.1507/endocrj.43.67; Witek-Janusek L, 1999, PEDIATR RES, V45, P224, DOI 10.1203/00006450-199902000-00011; Wu I, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.193; Yang ZG, 2017, EXP THER MED, V13, P1215, DOI 10.3892/etm.2017.4154; You QH, 2014, CYTOKINE, V66, P78, DOI 10.1016/j.cyto.2013.12.019; Zijlstra GJ, 2014, EUR RESPIR J, V44, P361, DOI 10.1183/09031936.00209513	48	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177884	10.1371/journal.pone.0177884	http://dx.doi.org/10.1371/journal.pone.0177884			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542361	Green Submitted, Green Published, gold			2022-12-26	WOS:000401672600028
J	Fujita, K; Tokuda, H; Kuroyanagi, G; Yamamoto, N; Kainuma, S; Kawabata, T; Sakai, G; Matsushima-Nishiwaki, R; Kozawa, O; Otsuka, T				Fujita, Kazuhiko; Tokuda, Haruhiko; Kuroyanagi, Gen; Yamamoto, Naohiro; Kainuma, Shingo; Kawabata, Tetsu; Sakai, Go; Matsushima-Nishiwaki, Rie; Kozawa, Osamu; Otsuka, Takanobu			HSP90 inhibitors potentiate PGF(2 alpha)-induced IL-6 synthesis via p38 MAP kinase in osteoblasts	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; INTERLEUKIN-6 SYNTHESIS; CYCLIC-AMP; RHO-KINASE; CANCER; 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN; PROSTAGLANDIN-E2; MECHANISMS; RESORPTION; PATHWAYS	Heat shock protein 90 (HSP90) that is ubiquitously expressed in various tissues, is recognized to be a major molecular chaperone. We have previously reported that prostaglandin F-2 alpha(PGF(2 alpha)), a potent bone remodeling mediator, stimulates the synthesis of interleukin-6 (IL-6) through p44/p42 mitogen-activated protein (MAP) kinase and p38 MAP kinase in osteoblast-like MC3T3-E1 cells, and that Rho-kinase acts at a point upstream of p38 MAP kinase. In the present study, we investigated the involvement of HSP90 in the PGF(2 alpha)-stimulated IL-6 synthesis and the underlying mechanism in MC3T3-E1 cells. Geldanamycin, an inhibitor of HSP90, significantly amplified both the PGF(2 alpha)-stimulated IL-6 release and the mRNA expression levels. In addition, other HSP90 inhibitors, 17-allylamino-17demethoxy-geldanamycin (17-AAG) and 17-dimethylamino-ethylamino-17-demethoxy-geldanamycin (17-DMAG) and onalespib, enhanced the PGF(2 alpha)-stimulated IL-6 release. Geldanamycin, 17-AAG and onalespib markedly strengthened the PGF(2 alpha)-induced phosphorylation of p38 MAP kinase. Geldanamycin and 17-AAG did not affect the PGF(2 alpha)-induced phosphorylation of p44/p42 MAP kinase and myosin phosphatase targeting subunit (MYPT-1), a substrate of Rho-kinase, and the protein levels of RhoA and Rho-kinase. In addition, HSP90-siRNA enhanced the PGF(2 alpha)-induced phosphorylation of p38 MAP kinase. Furthermore, SB203580, an inhibitor of p38 MAP kinase, significantly suppressed the amplification by geldanamycin, 17-AAG or 17-DMAG of the PGF(2 alpha)-stimulated IL-6 release. Our results strongly suggest that HSP90 negatively regulates the PGF(2 alpha)-stimulated IL-6 synthesis in osteoblasts, and that the effect of HSP90 is exerted through regulating p38 MAP kinase activation.	[Fujita, Kazuhiko; Kuroyanagi, Gen; Yamamoto, Naohiro; Kainuma, Shingo; Kawabata, Tetsu; Sakai, Go; Otsuka, Takanobu] Nagoya City Univ, Grad Sch Med Sci, Dept Orthoped Surg, Nagoya, Aichi, Japan; [Fujita, Kazuhiko; Tokuda, Haruhiko; Kuroyanagi, Gen; Yamamoto, Naohiro; Kainuma, Shingo; Kawabata, Tetsu; Sakai, Go; Matsushima-Nishiwaki, Rie; Kozawa, Osamu] Gifu Univ, Dept Pharmacol, Grad Sch Med, Gifu, Japan; [Tokuda, Haruhiko] Natl Ctr Geriatr & Gerontol, Biobank Med Genome Ctr, Dept Clin Lab, Obu, Aichi, Japan	Nagoya City University; Gifu University; National Center for Geriatrics & Gerontology	Kozawa, O (corresponding author), Gifu Univ, Dept Pharmacol, Grad Sch Med, Gifu, Japan.	okozawa@gifu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26462289, 15K10487]; Ministry of Health, Labour and Welfare of Japan [H25-Aging General-004]; National Center for Geriatrics and Gerontology (NCGG), Japan [25-4, 26-12]; Grants-in-Aid for Scientific Research [15K10487] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Center for Geriatrics and Gerontology (NCGG), Japan(National Center for Geriatrics & Gerontology); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by a Grant-in-Aid for Scientific Research (26462289, 15K10487) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a; a Grant-in-Aid for Scientific Research (H25-Aging General-004) from the Ministry of Health, Labour and Welfare of Japan, http://www.mhlw.go.jp/stf/ seisakunitsuite/bunya/hokabunya/kenkyujigyou/; the Research Funding for Longevity Sciences (25-4, 26-12) from National Center for Geriatrics and Gerontology (NCGG), Japan, http://www.ncgg.go.jpiresearch/index.html.; We are very grateful to Mrs.Yumiko Kurokawa for her skillful technical assistance. The present study was supported in part by a Grant-in-Aid for Scientific Research (26462289, 15K10487) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a Grant-in-Aid for Scientific Research (H25-Aging-General-004) from the Ministry of Health, Labour and Welfare of Japan, and the Research Funding for Longevity Sciences (25-4, 26-12) from National Center for Geriatrics and Gerontology (NCGG), Japan.	Adachi S, 2010, ONCOL REP, V23, P1709, DOI 10.3892/or_00000815; Agas D, 2013, J CELL PHYSIOL, V228, P25, DOI 10.1002/jcp.24117; Chim SM, 2013, CYTOKINE GROWTH F R, V24, P297, DOI 10.1016/j.cytogfr.2013.03.008; Chiosis G, 2006, EXPERT OPIN THER TAR, V10, P37, DOI 10.1517/14728222.10.1.37; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Fazzalari NL, 2011, OSTEOPOROSIS INT, V22, P2003, DOI 10.1007/s00198-011-1611-4; Ferraldeschi R, 2016, CANCER RES, V76, P2731, DOI 10.1158/0008-5472.CAN-15-2186; Franchimont N, 2005, BONE, V37, P601, DOI 10.1016/j.bone.2005.06.002; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Gardner CR, 2001, PROSTAG LEUKOTR ESS, V64, P117, DOI 10.1054/plef.2001.0250; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Jez JM, 2003, CHEM BIOL, V10, P361, DOI 10.1016/S1074-5521(03)00075-9; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kato K, 1996, J NEUROCHEM, V66, P946; Kozawa O, 1997, AM J PHYSIOL-ENDOC M, V272, pE208, DOI 10.1152/ajpendo.1997.272.2.E208; KOZAWA O, 1992, EXP CELL RES, V198, P130, DOI 10.1016/0014-4827(92)90158-5; Kozawa O, 2002, J CELL BIOCHEM, V86, P357, DOI 10.1002/jcb.10221; Kular J, 2012, CLIN BIOCHEM, V45, P863, DOI 10.1016/j.clinbiochem.2012.03.021; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Minamitani C, 2008, MOL CELL ENDOCRINOL, V291, P27, DOI 10.1016/j.mce.2008.05.011; Mori M, 2015, INT J ONCOL, V46, P47, DOI 10.3892/ijo.2014.2727; Ochel HJ, 2001, CELL STRESS CHAPERON, V6, P105, DOI 10.1379/1466-1268(2001)006<0105:GTPOAC>2.0.CO;2; Price JT, 2005, CANCER RES, V65, P4929, DOI 10.1158/0008-5472.CAN-04-4458; Prodromou C, 2016, BIOCHEM J, V473, P2439, DOI 10.1042/BCJ20160005; Prowse PDH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058898; RAISZ LG, 1990, ENDOCRINOLOGY, V126, P1076, DOI 10.1210/endo-126-2-1076; Sauvage F, 2017, J CONTROL RELEASE, V248, P133, DOI 10.1016/j.jconrel.2017.01.013; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Theoleyre S, 2004, CYTOKINE GROWTH F R, V15, P457, DOI 10.1016/j.cytogfr.2004.06.004; Tokuda H, 1999, CELL SIGNAL, V11, P325, DOI 10.1016/S0898-6568(98)00048-5; Verma S, 2016, BIOCHIMIE, V127, P227, DOI 10.1016/j.biochi.2016.05.018; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xu WP, 2007, CLIN CANCER RES, V13, P1625, DOI 10.1158/1078-0432.CCR-06-2966	38	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177878	10.1371/journal.pone.0177878	http://dx.doi.org/10.1371/journal.pone.0177878			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542188	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672600027
J	Wilson, NM; Gurney, ME; Dietrich, WD; Atkins, CM				Wilson, Nicole M.; Gurney, Mark E.; Dietrich, W. Dalton; Atkins, Coleen M.			Therapeutic benefits of phosphodiesterase 4B inhibition after traumatic brain injury	PLOS ONE			English	Article							CYCLIC-AMP-PHOSPHODIESTERASE; SELECTIVE PDE4B; LEUKOCYTE ACCUMULATION; SYNAPTIC PLASTICITY; BARRIER DISRUPTION; SIGNALING PATHWAY; RESPONSE ELEMENT; NEURONAL INJURY; GENE-EXPRESSION; PROTEIN-LEVELS	Traumatic brain injury (TBI) initiates a deleterious inflammatory response that exacerbates pathology and worsens outcome. This inflammatory response is partially mediated by a reduction in cAMP and a concomitant upregulation of cAMP-hydrolyzing phosphodiesterases (PDEs) acutely after TBI. The PDE4B subfamily, specifically PDE4B2, has been found to regulate cAMP in inflammatory cells, such as neutrophils, macrophages and microglia. To determine if PDE4B regulates inflammation and subsequent pathology after TBI, adult male Sprague Dawley rats received sham surgery or moderate parasagittal fluid-percussion brain injury (2 +/- 0.2 atm) and were then treated with a PDE4B - selective inhibitor, A33, or vehicle for up to 3 days post-surgery. Treatment with A33 reduced markers of microglial activation and neutrophil infiltration at 3 and 24 hrs after TBI, respectively. A33 treatment also reduced cortical contusion volume at 3 days post-injury. To determine whether this treatment paradigm attenuated TBI-induced behavioral deficits, animals were evaluated over a period of 6 weeks after surgery for forelimb placement asymmetry, contextual fear conditioning, water maze performance and spatial working memory. A33 treatment significantly improved contextual fear conditioning and water maze retention at 24 hrs post-training. However, this treatment did not rescue sensorimotor or working memory deficits. At 2 months after surgery, atrophy and neuronal loss were measured. A33 treatment significantly reduced neuronal loss in the pericontusional cortex and hippocampal CA3 region. This treatment paradigm also reduced cortical, but not hippocampal, atrophy. Overall, these results suggest that acute PDE4B inhibition may be a viable treatment to reduce inflammation, pathology and memory deficits after TBI.	[Wilson, Nicole M.; Dietrich, W. Dalton; Atkins, Coleen M.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Gurney, Mark E.] Tetra Discovery Partners, Grand Rapids, MI USA	University of Miami	Atkins, CM (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA.	catkins@med.miami.edu			National Institutes of Health/National Institute of Neurological Disorders and Stroke [RO1 NS056072]; WDD [F31 NS089351]; Miami Project to Cure Paralysis; National Institutes of Health/National Institute of Mental Health [R44 MH091791]; NATIONAL INSTITUTE OF MENTAL HEALTH [R43MH091791, R44MH091791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS089351, R01NS056072, R25NS083064] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); WDD; Miami Project to Cure Paralysis; National Institutes of Health/National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health/National Institute of Neurological Disorders and Stroke RO1 NS056072 to CMA and WDD, F31 NS089351 to NMW, and The Miami Project to Cure Paralysis. MEG acknowledges support by the National Institutes of Health/National Institute of Mental Health R44 MH091791. The funder, Tetra Discovery Partners, provided support in the form of salary for MEG, but did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'authors contributions' section.	Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Godoy DA, 2016, NEUROCRIT CARE, V25, P306, DOI 10.1007/s12028-016-0253-y; Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Ariga M, 2004, J IMMUNOL, V173, P7531, DOI 10.4049/jimmunol.173.12.7531; Atkins CM, 2012, J NEUROSCI RES, V90, P1861, DOI 10.1002/jnr.23069; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Atkins CM, 2013, NEUROSCI LETT, V532, P1, DOI 10.1016/j.neulet.2012.10.019; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; BIAGAS KV, 1992, J NEUROTRAUM, V9, P363, DOI 10.1089/neu.1992.9.363; Blackman BE, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203604; Blaya MO, 2014, J NEUROTRAUM, V31, P476, DOI [10.1089/NEU.2013.3135, 10.1089/neu.2013.3135]; Block F, 1997, NEUROREPORT, V8, P3829, DOI 10.1097/00001756-199712010-00033; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Chang CI, 2000, J IMMUNOL, V165, P2134, DOI 10.4049/jimmunol.165.4.2134; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Corraliza IM, 1995, BIOCHEM BIOPH RES CO, P206; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Dash PK, 2007, LEARN MEMORY, V14, P554, DOI 10.1101/lm.558707; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; DETMERS PA, 1994, J IMMUNOL, V153, P2137; Eigler A, 1998, J LEUKOCYTE BIOL, V63, P101, DOI 10.1002/jlb.63.1.101; Erdely A, 2006, AM J PHYSIOL-LUNG C, V290, pL534, DOI 10.1152/ajplung.00326.2005; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Ferrante CJ, 2012, ADV WOUND CARE, V1, P10, DOI 10.1089/wound.2011.0307; FitzGerald O, 2014, NAT REV RHEUMATOL, V10, P385, DOI 10.1038/nrrheum.2014.77; Flora G, 2013, CELL TRANSPLANT, V22, P2203, DOI 10.3727/096368912X658872; Fox D, 2014, CELL SIGNAL, V26, P657, DOI 10.1016/j.cellsig.2013.12.003; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gensel JC, 2015, BRAIN RES, V1619, P1, DOI 10.1016/j.brainres.2014.12.045; Ghosh M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-015-0463-9; Ghosh M, 2012, GLIA, V60, P1839, DOI 10.1002/glia.22401; Ghosh M, 2010, TRANSL NEUROSCI, V1, P101, DOI 10.2478/v10134-010-0012-0; Giembycz MA, 2010, DRUG DES DEV THER, V4, P147; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; GOTOH S, 1986, J IMMUNOL, V137, P643; Gray MJ, 2005, GENE, V353, P98, DOI 10.1016/j.gene.2005.04.004; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hagen TJ, 2014, BIOORG MED CHEM LETT, V24, P4031, DOI 10.1016/j.bmcl.2014.06.002; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hatinen S, 2008, RESTOR NEUROL NEUROS, V26, P493; Havekes R, 2016, J NEUROSCI, V36, P8936, DOI 10.1523/JNEUROSCI.0248-16.2016; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Houslay MD, 2010, NAT BIOTECHNOL, V28, P38, DOI 10.1038/nbt0110-38; James R, 2004, MOL CELL NEUROSCI, V26, P112, DOI 10.1016/j.mcn.2004.01.013; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Jin S-L Catherine, 2012, Chang Gung Med J, V35, P197; Jin SLC, 2005, J IMMUNOL, V175, P1523, DOI 10.4049/jimmunol.175.3.1523; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Keeling KL, 2000, J NEUROIMMUNOL, V105, P20, DOI 10.1016/S0165-5728(00)00183-1; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Lee J, 2005, J BIOL CHEM, V280, P40398, DOI 10.1074/jbc.C500140200; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Li LX, 2011, METAB BRAIN DIS, V26, P37, DOI 10.1007/s11011-011-9235-0; Li YF, 2011, J NEUROSCI, V31, P172, DOI 10.1523/JNEUROSCI.5236-10.2011; Lotocki G, 2004, J NEUROSCI, V24, P11010, DOI 10.1523/JNEUROSCI.3823-04.2004; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; LYNN WA, 1991, J IMMUNOL, V147, P3072; Ma DM, 1999, MOL PHARMACOL, V55, P50, DOI 10.1124/mol.55.1.50; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McKenzie S, 2011, NEURON, V71, P224, DOI 10.1016/j.neuron.2011.06.037; Meller R, 2005, J CEREBR BLOOD F MET, V25, P234, DOI 10.1038/sj.jcbfm.9600024; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Moretti L, 2012, LANCET NEUROL, P11; Moy AB, 1998, AM J PHYSIOL-LUNG C, V274, pL1024, DOI 10.1152/ajplung.1998.274.6.L1024; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P91, DOI 10.1038/nrd3657; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Naganuma K, 2009, BIOORG MED CHEM LETT, V19, P3174, DOI 10.1016/j.bmcl.2009.04.121; Nakamura M, 1999, J COMP NEUROL, V412, P681, DOI 10.1002/(SICI)1096-9861(19991004)412:4<681::AID-CNE9>3.0.CO;2-F; Oliva AA, 2012, J NEUROCHEM, V123, P1019, DOI 10.1111/jnc.12049; Pati S, 2011, STEM CELLS DEV, V20, P89, DOI 10.1089/scd.2010.0013; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Reyes-Irisarri E, 2008, SYNAPSE, V62, P74, DOI 10.1002/syn.20459; Reyes-Irisarri E, 2007, J NEUROPATH EXP NEUR, V66, P923, DOI 10.1097/nen.0b013e3181567c31; Robichaud A, 2002, J CLIN INVEST, V110, P1045, DOI 10.1172/JCI200215506; Robichaud A, 2001, NEUROPHARMACOLOGY, V40, P262, DOI 10.1016/S0028-3908(00)00142-8; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schaal SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043634; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SCHWABE U, 1976, MOL PHARMACOL, V12, P900; Sheldon KE, 2013, J IMMUNOL, V191, P2290, DOI 10.4049/jimmunol.1202102; Shepherd MC, 2004, BRIT J PHARMACOL, V142, P339, DOI 10.1038/sj.bjp.0705770; SHEPPARD H, 1975, J CYCLIC NUCL PROT, V1, P237; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Siegmund B, 1997, EUR J PHARMACOL, V321, P231, DOI 10.1016/S0014-2999(96)00947-8; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Soares HD, 1995, J NEUROSCI, V15, P8223; SOMMER N, 1995, NAT MED, V1, P244, DOI 10.1038/nm0395-244; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Sugerman DE, 2012, J TRAUMA ACUTE CARE, P73; Titus DJ, 2013, NEUROSCIENCE, V231, P182, DOI 10.1016/j.neuroscience.2012.12.002; Titus DJ, 2016, J NEUROSCI, V36, P7095, DOI 10.1523/JNEUROSCI.3212-15.2016; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Truettner JS, 2016, J CEREB BLOOD FLOW M; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; Utagawa A, 2008, BRAIN RES, V1207, P155, DOI 10.1016/j.brainres.2008.02.057; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Vander Top EA, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-61; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Wang P, 1999, MOL PHARMACOL, V56, P170, DOI 10.1124/mol.56.1.170; Wei LH, 2000, AM J PHYSIOL-CELL PH, V279, pC248, DOI 10.1152/ajpcell.2000.279.1.C248; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson NM, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00005; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Ye YQ, 2014, INT J MOL SCI, V15, P12651, DOI 10.3390/ijms150712651; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang C, 2017, SCI REP-UK, V7, DOI 10.1038/srep40115; Zhou XM, 2005, AM J PHYSIOL-LUNG C, V288, pL655, DOI 10.1152/ajplung.00327.2004; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59	128	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178013	10.1371/journal.pone.0178013	http://dx.doi.org/10.1371/journal.pone.0178013			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542295	Green Submitted, Green Published, gold			2022-12-26	WOS:000401672600042
J	Hakimi, O; Ternette, N; Murphy, R; Kessler, BM; Carr, A				Hakimi, Osnat; Ternette, Nicola; Murphy, Richard; Kessler, Benedikt M.; Carr, Andrew			A quantitative label-free analysis of the extracellular proteome of human supraspinatus tendon reveals damage to the pericellular and elastic fibre niches in torn and aged tissue	PLOS ONE			English	Article							ROTATOR CUFF TENDON; IN-SITU HYBRIDIZATION; CONNECTIVE-TISSUE; HEALING TENDON; MESSENGER-RNA; SHOULDER PAIN; VI COLLAGEN; EXPRESSION; LOCALIZATION; DEGENERATION	Tears of the human supraspinatus tendon are common and often cause painful and debilitating loss of function. Progressive failure of the tendon leading to structural abnormality and tearing is accompanied by numerous cellular and extra-cellular matrix (ECM) changes in the tendon tissue. This proteomics study aimed to compare torn and aged rotator cuff tissue to young and healthy tissue, and provide the first ECM inventory of human supraspinatus tendon generated using label-free quantitative LC-MS/MS. Employing two digestion protocols (trypsin and elastase), we analysed grain-sized tendon supraspinatus biopsies from older patients with torn tendons and from healthy, young controls. Our findings confirm measurable degradation of collagen fibrils and associated proteins in old and torn tendons, suggesting a significant loss of tissue organisation. A particularly marked reduction of cartilage oligomeric matrix protein (COMP) raises the possibility of using changes in levels of this glycoprotein as a marker of abnormal tissue, as previously suggested in horse models. Surprisingly, and despite using an elastase digestion for validation, elastin was not detected, suggesting that it is not highly abundant in human supraspinatus tendon as previously thought. Finally, we identified marked changes to the elastic fibre, fibrillin-rich niche and the pericellular matrix. Further investigation of these regions may yield other potential biomarkers and help to explain detrimental cellular processes associated with tendon ageing and tendinopathy.	[Hakimi, Osnat; Murphy, Richard; Carr, Andrew] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Ternette, Nicola] Univ Oxford, Jenner Inst, Oxford, England; [Kessler, Benedikt M.] Nuffield Dept Med, Mass Spectrometry Lab, TDI, Oxford, England; [Hakimi, Osnat] Fed Univ State Rio de Janeiro, Dept Genet & Mol Biol, Rio De Janeiro, Brazil	University of Oxford; University of Oxford; Jenner Institute; University of Oxford	Hakimi, O (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England.; Hakimi, O (corresponding author), Fed Univ State Rio de Janeiro, Dept Genet & Mol Biol, Rio De Janeiro, Brazil.	osnat.hakimi@unirio.br	Hakimi, Osnat/O-3889-2019; Kessler, Benedikt/AAY-8614-2021	Kessler, Benedikt/0000-0002-8160-2446; Hakimi, Osnat/0000-0002-8839-4846; Ternette, Nicola/0000-0002-9283-0743	NIHR (MSK Biomedical Research Unit)	NIHR (MSK Biomedical Research Unit)	The work presented in this manuscript was funded by NIHR (MSK Biomedical Research Unit).; This work was supported by the NIHR (MSK Biomedical Research Unit)	Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006; Bank RA, 1999, ANN RHEUM DIS, V58, P35, DOI 10.1136/ard.58.1.35; Bongers PM, 2001, BMJ-BRIT MED J, V322, P64, DOI 10.1136/bmj.322.7278.64; Buckley MR, 2013, CONNECT TISSUE RES, V54, P374, DOI 10.3109/03008207.2013.847096; Chaudhury S, 2011, J BONE JOINT SURG BR, V93B, P370, DOI 10.1302/0301-620X.93B3.25470; Chaudhury S, 2016, J SHOULDER ELBOW SUR; Dakin SG, 2014, J BIOL CHEM, V289, P4919, DOI 10.1074/jbc.M113.511972; Dean BJF, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0691-5; Dean BJF, 2014, BRIT J SPORT MED, V48, P1620, DOI 10.1136/bjsports-2013-093178; Fallon J, 2002, J ORTHOP RES, V20, P920, DOI 10.1016/S0736-0266(02)00032-2; Fenwick SA, 2002, ARTHRITIS RES, V4, P252, DOI 10.1186/ar416; Gibson MA, 1998, J HISTOCHEM CYTOCHEM, V46, P871, DOI 10.1177/002215549804600802; Goodier HCJ, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0947-8; Grant TM, 2013, J ANAT, V222, P573, DOI 10.1111/joa.12048; Hamada K, 1997, J ORTHOPAED RES, V15, P24, DOI 10.1002/jor.1100150105; HATAMOCHI A, 1989, J BIOL CHEM, V264, P3494; Izu Y, 2011, MATRIX BIOL, V30, P53, DOI 10.1016/j.matbio.2010.10.001; Jensen SA, 2016, BIOCHEM J, V473, P827, DOI 10.1042/BJ20151108; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Karonen T, 1997, BRIT J DERMATOL, V137, P51, DOI 10.1046/j.1365-2133.1997.17671859.x; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; Kobayashi N, 2007, J BIOL CHEM, V282, P11805, DOI 10.1074/jbc.M611029200; Lamande SR, 1998, J BIOL CHEM, V273, P7423, DOI 10.1074/jbc.273.13.7423; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Little D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096526; Lo IKY, 2005, ARTHROSCOPY, V21, P645, DOI 10.1016/j.arthro.2005.03.008; Murphy RJ, 2013, OPER TECH ORTHOP, V23, P56, DOI 10.1053/j.oto.2013.05.003; Nho SJ, 2008, AM J SPORT MED, V36, P987, DOI 10.1177/0363546508317344; Penner AS, 2002, J BIOL CHEM, V277, P35044, DOI 10.1074/jbc.M206363200; RILEY GP, 1994, ANN RHEUM DIS, V53, P359, DOI 10.1136/ard.53.6.359; Ritty TM, 2003, STRUCTURE, V11, P1179, DOI 10.1016/S0969-2126(03)00181-3; Ritty TM, 2002, ANAT RECORD, V268, P430, DOI 10.1002/ar.10175; ROARK EF, 1995, J HISTOCHEM CYTOCHEM, V43, P401, DOI 10.1177/43.4.7534784; Sardone F, 2015, MATRIX BIOL; Sejersen MHJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119974; Sengle G, 2015, MATRIX BIOL, V47, P3, DOI 10.1016/j.matbio.2015.05.002; Shindle MK, 2011, J SHOULDER ELB SURG, V20, P917, DOI 10.1016/j.jse.2011.02.015; Shirachi I, 2011, ARTHROSCOPY, V27, P1173, DOI 10.1016/j.arthro.2011.03.078; Smith RKW, 1997, MATRIX BIOL, V16, P255, DOI 10.1016/S0945-053X(97)90014-7; Sodersten F, 2012, CONNECTIVE TISSUE RE, V54; Soedersten F, 2010, RES VET SCI, V88, P251; Sugawara Y, 2010, J PERIODONTAL RES, V45, P52, DOI 10.1111/j.1600-0765.2008.01196.x; Thakkar D, 2014, CONNECT TISSUE RES, V55, P397, DOI 10.3109/03008207.2014.959119; Thomopoulos S, 2002, J ORTHOP RES, V20, P454, DOI 10.1016/S0736-0266(01)00144-9; Thorpe C. T., 2016, J ANATOMY; Thorpe CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20455; Tilley JMR, 2014, BONE JOINT RES, V3, P252, DOI 10.1302/2046-3758.38.2000251; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yamaguchi K, 2006, J BONE JOINT SURG AM, V88A, P1699, DOI 10.2106/JBJS.E.00835	49	18	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							0177656	10.1371/journal.pone.0177656	http://dx.doi.org/10.1371/journal.pone.0177656			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542244	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400064
J	Neitlich, PN; Hoef, JMV; Berryman, SD; Mines, A; Geiser, LH; Hasselbach, LM; Shiel, AE				Neitlich, Peter N.; Hoef, Jay M. Ver; Berryman, Shanti D.; Mines, Anaka; Geiser, Linda H.; Hasselbach, Linda M.; Shiel, Alyssa E.			\Trends in spatial patterns of heavy metal deposition on national park service lands along the Red Dog Mine haul road, Alaska, 2001-2006	PLOS ONE			English	Article								Spatial patterns of Zn, Pb and Cd deposition in Cape Krusenstern National Monument (CAKR), Alaska, adjacent to the Red Dog Mine haul road, were characterized in 2001 and 2006 using Hylocomium moss tissue as a biomonitor. Elevated concentrations of Cd, Pb, and Zn in moss tissue decreased logarithmically away from the haul road and the marine port. The metals concentrations in the two years were compared using Bayesian posterior predictions on a new sampling grid to which both data sets were fit. Posterior predictions were simulated 200 times both on a coarse grid of 2,357 points and by distance-based strata including subsets of these points. Compared to 2001, Zn and Pb concentrations in 2006 were 31 to 54% lower in the 3 sampling strata closest to the haul road (0-100, 100-2000 and 2000-4000 m). Pb decreased by 40% in the stratum 4,000-5,000 m from the haul road. Cd decreased significantly by 38% immediately adjacent to the road (0-100m), had an 89% probability of a small decrease 100-2000 m from the road, and showed moderate probabilities (56-71%) for increase at greater distances. There was no significant change over time (with probabilities all <= 85%) for any of the 3 elements in more distant reference areas (40-60 km). As in 2001, elemental concentrations in 2006 were higher on the north side of the road. Reductions in deposition have followed a large investment in infrastructure to control fugitive dust escapement at the mine and port sites, operational controls, and road dust mitigation. Fugitive dust escapement, while much reduced, is still resulting in elevated concentrations of Zn, Pb and Cd out to 5,000 m from the haul road. Zn and Pb levels were slightly above arctic baseline values in southern CAKR reference areas.	[Neitlich, Peter N.; Berryman, Shanti D.; Mines, Anaka; Hasselbach, Linda M.] Natl Pk Serv, Alaska Reg Off, Anchorage, AK 99501 USA; [Hoef, Jay M. Ver] NOAA, Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, Marine Mammal Lab, Seattle, WA 98115 USA; [Geiser, Linda H.] US Forest Serv, USDA, Washington, DC 20250 USA; [Shiel, Alyssa E.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	United States Department of the Interior; National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of Agriculture (USDA); United States Forest Service; Oregon State University	Neitlich, PN (corresponding author), Natl Pk Serv, Alaska Reg Off, Anchorage, AK 99501 USA.	peter_neitlich@nps.gov	Ver Hoef, Jay/C-8577-2017	Ver Hoef, Jay/0000-0003-4302-6895	National Park Service's Arctic Network (Inventory and Monitoring Program)	National Park Service's Arctic Network (Inventory and Monitoring Program)	This research was funded by the National Park Service's Arctic Network (Inventory and Monitoring Program). The authors worked for (or on behalf of) national parks partnered with the Arctic Network, rather than directly for the network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders did, however, provide a high-level review of the document for scientific merit. For more information about the NPS Arctic Network, please see: https:// science.riature.nps.gov/im/units/arcn/.; This research was funded by the National Park Service's Arctic Network, Inventory and Monitoring Program. We appreciate the reviews of this document from: Teck, Inc., Alison Kelley (Northwest Alaska Native Association), Scott Shock, Roxolana Kashuba and others (Exponent, Inc.), Dr. Robert Winfree (US National Park Service), Joel Hard (US National Park Service), Dr. Leigh Welling, (US National Park Service), Dr. Jim Lawler (US National Park Service), and Dr. Eric Wald (US National Park Service). Our great appreciation to Alex Rupprecht for field assistance. We appreciate the editorial suggestions of Dr. Vipin Chandra Kalia, Dr. Kendra Zamzow and an anonymous reviewer. Our thanks to Johanna Salatas (Teck, Inc) for compiling concentrate production data.	Alaska Department of Environmental Conservation, SPILL PREV RESP DIV; Alaska Department of Environmental Conservation, 2017, OIL OTH HAZ SUBST PO; Banerjee S., 2004, HIERARCHICAL MODELIN; Berger JO, 2001, J AM STAT ASSOC, V96, P1361, DOI 10.1198/016214501753382282; Brumbaugh WG, 2016, 20165096 US GEOL SUR; Brumbaugh WG, 2005, 20085040 US GEOL SUR; Brumbaugh WG, 2011, ENVIRON MONIT ASSESS, V182, P325, DOI 10.1007/s10661-011-1879-z; Brumbaugh WG, 2010, ENVIRON MONIT ASSESS, V170, P73, DOI 10.1007/s10661-009-1216-y; Brumelis G, 1997, ANN BOT-LONDON, V79, P679, DOI 10.1006/anbo.1997.0401; Csavina J, 2012, SCI TOTAL ENVIRON, V433, P58, DOI 10.1016/j.scitotenv.2012.06.013; Daly C, 2002, ALASKA AVERAGE MONTH; De Oliveira V, 1997, J AM STAT ASSOC, V92, P1422, DOI 10.1080/01621459.1997.10473663; Dolgopolova A, 2006, APPL GEOCHEM, V21, P563, DOI 10.1016/j.apgeochem.2005.12.014; ESRI, 2006, ARCGIS VERS 9 2 10 4; Exponent Inc., 2007, DEL MOUNT TRAN SYST; Exponent Inc., 2011, FUG DUST RISK MAN DU; FORD J, 1995, SCI TOTAL ENVIRON, V160-61, P323, DOI 10.1016/0048-9697(95)04366-9; Ford J., 2001, HEAVY METALS MOSSES; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Gough LP, 1988, 1458 USGS; Hasselbach L, 2005, SCI TOTAL ENVIRON, V348, P211, DOI 10.1016/j.scitotenv.2004.12.084; Jorgenson MT, 2009, NPSARCNNRTRD2009270; National Park Service, 2006, MANAGEMENT POLICIES; Panda S K, 2016, LICHENOLOGIST; Pye K., 1987, AEOLIAN DUST DUST DE; Sangster D. F., 2000, Environmental Reviews, V8, P115, DOI 10.1139/a00-008; SENES Consultants Limited, 2005, RED DOG OP; SENES Consultants Ltd, 2007, DRAFT EM SUMM REP FU; Sims D. B., 2013, Environment and Pollution, V2, P22; Tetra Tech, 2009, RED DOG MIN EXT AQQ; Trimble, 2005, GEOEXPLORER 2005 SER	31	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177936	10.1371/journal.pone.0177936	http://dx.doi.org/10.1371/journal.pone.0177936			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542369	Green Submitted, Green Published, gold			2022-12-26	WOS:000401672400119
J	Timmer, A; Peplies, J; Westphal, M; Kaltz, B; Ballauff, A; Classen, M; Laass, MW; Koletzko, S				Timmer, Antje; Peplies, Jenny; Westphal, Max; Kaltz, Birgit; Ballauff, Antje; Classen, Martin; Laass, Martin W.; Koletzko, Sibylle			Transition from pediatric to adult medical care - A survey in young persons with inflammatory bowel disease	PLOS ONE			English	Article							NORTH-AMERICAN SOCIETY; HEALTH-CARE; IMPROVE TRANSITION; READINESS SKILLS; ADOLESCENTS; PATIENT; IBD; RECOMMENDATIONS; GASTROENTEROLOGY; PERSPECTIVES	Background Transition to adult health services is a vulnerable phase in young persons with chronic disease. We describe how young persons with inflammatory bowel disease in Germany and Austria experience care during the transitional age, focusing on differences by type of provider (pediatric vs. adult specialist, no specialist). Methods This was a follow up survey in patients previously registered with a pediatric IBD registry. Patients aged 15 to 25 received a postal questionnaire, including a measure of health care experience and satisfaction. Descriptive analyses were stratified by age. Sub-analyses in the 18-20 year age group compared health care experience by type of provider. Determinants of early or late transfer were examined using multinomial logistic regression. Results 619 patients responded to the survey; 605 questionnaires were available for analysis. Usual age of completing transition was 18. Earlier transfer was more common with low parental SES (OR 1.8, 95% CI 0.7 to 4.6), and less common with advanced schooling (OR 0.5, 95% CI 0.2 to 1.2). Structured transition was uncommon. 48% of the respondents had not received any preceding transition advice. Overall satisfaction with IBD care was high, especially with respect to interpersonal aspects, but less so in aspects of continuity of care. Conclusions Despite high overall patient satisfaction, relevant deficiencies in transitional care were documented. Some of these were associated with lower parental social status. Differences in health care satisfaction by type of provider (adult vs. pediatric) were small.	[Timmer, Antje] Carl von Ossietzky Univ Oldenburg, Med Fac, Dept Hlth Serv Res, Div Epidemiol & Biometry, Oldenburg, Germany; [Timmer, Antje; Peplies, Jenny; Westphal, Max] Leibniz Inst Prevent Res & Epidemiol BIPS GmbH, Dept Clin Epidemiol, Bremen, Germany; [Peplies, Jenny] Inst Publ Hlth & Nursing Res IPP, Fac Human & Hlth Sci, Bremen, Germany; [Kaltz, Birgit] German Crohns Dis & Ulcerat Colitis Assoc Registe, Berlin, Germany; [Ballauff, Antje] Ctr Childrens & Adolescent Med, Krefeld, Germany; [Classen, Martin] Klinikum Links Der Weser, Childrens Hosp, Bremen, Germany; [Laass, Martin W.] Tech Univ, Childrens Hosp, Med Fac Carl Gustav Carus, Dresden, Germany; [Koletzko, Sibylle] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Div Pediat Gastroenterol & Hepatol, Munich, Germany	Carl von Ossietzky Universitat Oldenburg; Leibniz Institute for Prevention Research & Epidemiology (BIPS); Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Munich	Timmer, A (corresponding author), Carl von Ossietzky Univ Oldenburg, Med Fac, Dept Hlth Serv Res, Div Epidemiol & Biometry, Oldenburg, Germany.; Timmer, A (corresponding author), Leibniz Inst Prevent Res & Epidemiol BIPS GmbH, Dept Clin Epidemiol, Bremen, Germany.	antje.timmer@uni-oldenburg.de	Timmer, Antje/N-8056-2015	Timmer, Antje/0000-0001-9579-0516; Laass, Martin/0000-0003-3670-3640	DCCV Research Grant; patient organization DCCV	DCCV Research Grant; patient organization DCCV	This work was supported by 2009 DCCV Research Grant "Patient oriented Research in IBD" (AT); URL: https://www.dccv.de/betroffene-angehoerige/beratung-informationen/forschung/preistraeger-stipendiaten/. Funding was provided by the patient organization DCCV. BK (author) is an elected representative of DCCV and provided input into the study design, instrument development and manuscript preparation and review.	Amer Acad Pediat, 2011, PEDIATRICS, V128, P182, DOI 10.1542/peds.2011-0969; Baldassano R, 2002, J PEDIATR GASTR NUTR, V34, P245, DOI 10.1097/00005176-200203000-00001; Bensen R, 2016, J PEDIATR GASTR NUTR, V63, P488, DOI 10.1097/MPG.0000000000001199; Bishop J, 2014, ADOLESC HEALTH MED T, V5, P1, DOI 10.2147/AHMT.S37956; Bollegala Natasha, 2013, J Crohns Colitis, V7, pe55, DOI 10.1016/j.crohns.2012.05.010; Buderus S, 2015, DTSCH ARZTEBL INT, V112, P121, DOI 10.3238/arztebl.2015.0121; Campbell Fiona, 2016, Cochrane Database Syst Rev, V4, pCD009794, DOI 10.1002/14651858.CD009794.pub2; Cervesi C, 2013, J PEDIATR GASTR NUTR, V57, P39, DOI 10.1097/MPG.0b013e31828b5fd4; Cooley WC, 2013, JAMA PEDIATR, V167, P897, DOI 10.1001/jamapediatrics.2013.2578; Crow R, 2002, Health Technol Assess, V6, P1; de Silva PSA, 2014, INFLAMM BOWEL DIS, V20, P1458, DOI 10.1097/MIB.0000000000000045; Escher JC, 2009, DIGEST DIS, V27, P382, DOI 10.1159/000228578; Fernandes S., 2010, INT J CHILD ADOLESCE, V3, P507; Fishman LN, 2014, J PEDIATR GASTR NUTR, V59, P221, DOI 10.1097/MPG.0000000000000405; Goodhand J, 2011, J CROHNS COLITIS, V5, P509, DOI 10.1016/j.crohns.2011.03.015; Gray WN, 2016, INFLAMM BOWEL DIS, V22, P372, DOI 10.1097/MIB.0000000000000642; Gray WN, 2015, INFLAMM BOWEL DIS, V21, P1641, DOI 10.1097/MIB.0000000000000419; Gray WN, 2015, INFLAMM BOWEL DIS, V21, P1125, DOI 10.1097/MIB.0000000000000352; Greenley RN, 2010, J PEDIATR PSYCHOL, V35, P857, DOI 10.1093/jpepsy/jsp120; Hait E, 2006, INFLAMM BOWEL DIS, V12, P70, DOI 10.1097/01.MIB.0000194182.85047.6a; Heath G, 2016, PATIENT ED COUNS; Herrmann- Lingen C, 2011, HADS D HOSP ANXIETY; Huang JS, 2012, CLIN GASTROENTEROL H, V10, P626, DOI 10.1016/j.cgh.2012.02.017; Hummel TZ, 2013, J PEDIATR GASTR NUTR, V57, P219, DOI 10.1097/MPG.0b013e3182935474; Jockel KH, 1997, MEASUREMENT QUANTIFI; Kahn Stacy A, 2016, Gastroenterol Hepatol (N Y), V12, P403; Keller KM, 2010, MONATSSCHR KINDERH, V158, P738, DOI 10.1007/s00112-010-2196-2; Leung Y, 2011, INFLAMM BOWEL DIS, V17, P2169, DOI 10.1002/ibd.21576; Louis E, 2015, J CROHNS COLITIS, V9, P685, DOI 10.1093/ecco-jcc/jjv085; Mackner LM, 2013, J PEDIATR GASTR NUTR, V56, P449, DOI 10.1097/MPG.0b013e3182841263; Minden K, 2014, Z RHEUMATOL, V73, P526, DOI 10.1007/s00393-014-1377-0; Muther S, 2014, MONATSSCHR KINDERH, V162, P711, DOI 10.1007/s00112-014-3103-z; Paine CW, 2014, INFLAMM BOWEL DIS, V20, P2083, DOI 10.1097/MIB.0000000000000136; Plevinsky JM, 2014, CHILD CARE HLTH DEV; Radke M, 2015, DEUT MED WOCHENSCHR, V140, P673, DOI 10.1055/s-0041-101713; Rutishauser C, 2014, EUR J PEDIATR, V173, P1067, DOI 10.1007/s00431-014-2291-9; Sadlo A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-97; Scholz D, 2011, KINDER JUGENDMEDIZIN, V11, P283; Schwartz LA, 2011, CHILD CARE HLTH DEV, V37, P883, DOI 10.1111/j.1365-2214.2011.01282.x; Sebastian S, 2012, J CROHNS COLITIS, V6, P830, DOI 10.1016/j.crohns.2012.01.010; Sonneveld HM, 2013, CHILD CARE HLTH DEV, V39, P69, DOI 10.1111/j.1365-2214.2011.01354.x; Timmer A, 2012, DCCV J, V111, P81; Timmer A, 2009, J CLIN EPIDEMIOL, V62, P771, DOI 10.1016/j.jclinepi.2008.07.020; van Groningen J, 2012, INFLAMM BOWEL DIS, V18, P2310, DOI 10.1002/ibd.22937; van Staa AL, 2011, CHILD CARE HLTH DEV, V37, P821, DOI 10.1111/j.1365-2214.2011.01261.x; Whitfield EP, 2015, J PEDIATR GASTR NUTR, V60, P36, DOI 10.1097/MPG.0000000000000555; Winkler J., 2009, WISMAR DISCUSSION PA; Wright EK, 2014, INTERN MED J, V44, P490, DOI 10.1111/imj.12402; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zijlstra M, 2013, J CROHNS COLITIS, V7, pE375, DOI 10.1016/j.crohns.2013.02.017	50	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177757	10.1371/journal.pone.0177757	http://dx.doi.org/10.1371/journal.pone.0177757			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV3PV	28542322	Green Published, Green Accepted, gold			2022-12-26	WOS:000401672400078
J	Young, B; King, JL; Budowle, B; Armogida, L				Young, Brian; King, Jonathan L.; Budowle, Bruce; Armogida, Luigi			A technique for setting analytical thresholds in massively parallel sequencing-based forensic DNA analysis	PLOS ONE			English	Article							ION PGM(TM); KIT; PLATFORM; STRS; MICROHAPLOTYPES; MARKERS; UTILITY; SYSTEM; NOISE; LOCI	Amplicon (targeted) sequencing by massively parallel sequencing (PCR-MPS) is a potential method for use in forensic DNA analyses. In this application, PCR-MPS may supplement or replace other instrumental analysis methods such as capillary electrophoresis and Sanger sequencing for STR and mitochondrial DNA typing, respectively. PCR-MPS also may enable the expansion of forensic DNA analysis methods to include new marker systems such as single nucleotide polymorphisms (SNPs) and insertion/deletions (indels) that currently are assayable using various instrumental analysis methods including microarray and quantitative PCR. Acceptance of PCR-MPS as a forensic method will depend in part upon developing protocols and criteria that define the limitations of a method, including a defensible analytical threshold or method detection limit. This paper describes an approach to establish objective analytical thresholds suitable for multiplexed PCR-MPS methods. A definition is proposed for PCR-MPS method background noise, and an analytical threshold based on background noise is described.	[Young, Brian; Armogida, Luigi] NicheVis Forens, Akron, OH 44311 USA; [King, Jonathan L.; Budowle, Bruce] Univ North Texas, Hlth Sci Ctr, Ctr Human Identificat, 3500 Camp Bowie Blvd, Ft Worth, TX USA; [Budowle, Bruce] King Abdulaziz Univ, CEGMR, Jeddah, Saudi Arabia	University of North Texas System; University of North Texas Denton; University of North Texas Health Science Center; King Abdulaziz University	Young, B (corresponding author), NicheVis Forens, Akron, OH 44311 USA.	brian@nichevision.com		Young, Brian/0000-0001-5665-7990; King, Jonathan/0000-0003-4541-1789	National Institute of Justice, Office of Justice Programs, U.S. Department of Justice [2015-DN-BX- K067]; NicheVision, Inc.	National Institute of Justice, Office of Justice Programs, U.S. Department of Justice; NicheVision, Inc.	This work was supported in part by award no. 2015-DN-BX- K067, awarded by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice. The opinions, findings, and conclusions or recommendations expressed in this publication are those of the authors and do not necessarily reflect those of the U.S. Department of Justice. NicheVision, Inc. provided support in the form of salaries for authors BY, LA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applied Biosystems, APPL BIOS PUB; Bornman DM, 2012, BIOTECHNIQUES; Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; Bregu J, 2013, J FORENSIC SCI, V58, P120, DOI 10.1111/1556-4029.12008; Churchill JD, 2016, FORENSIC SCI INT-GEN, V20, P20, DOI 10.1016/j.fsigen.2015.09.009; Churchill JD, 2015, CROAT MED J, V56, P218, DOI 10.3325/cmj.2015.56.218; Coble MD, 2005, J FORENSIC SCI, V50, P43; Flores S, 2014, FORENSIC SCI INT-GEN, V10, P33, DOI 10.1016/j.fsigen.2014.01.005; Fordyce SL, 2015, FORENSIC SCI INT-GEN, V14, P132, DOI 10.1016/j.fsigen.2014.09.020; Friis SL, 2016, FORENSIC SCI INT-GEN, V21, P68, DOI 10.1016/j.fsigen.2015.12.006; Gettings KB, 2015, FORENSIC SCI GENE S; Gilder JR, 2007, J FORENSIC SCI, V52, P97, DOI 10.1111/j.1556-4029.2006.00318.x; Guo F, 2016, FORENSIC SCI INT-GEN, V23, P111, DOI 10.1016/j.fsigen.2016.04.004; Hoogenboom J, 2017, FORENSIC SCI INT-GEN, V27, P27, DOI 10.1016/j.fsigen.2016.11.007; Illumina, 2015, FORENSEQTM UN AN SOF; Kidd KK, 2014, FORENSIC SCI INT-GEN, V12, P215, DOI 10.1016/j.fsigen.2014.06.014; Leclair B., 2004, J FORENSIC SCI, V49, P1, DOI [10.1520/jfs2003312, DOI 10.1520/JFS2003312]; Novroski NMM, 2016, FORENSIC SCI INT-GEN, V25, P214, DOI 10.1016/j.fsigen.2016.09.007; Scheible M, 2014, FORENSIC SCI INT-GEN, V12, P107, DOI 10.1016/j.fsigen.2014.04.010; Schirmer M, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1341; Scientific Working Group on DNA Analysis Methods (SWGDAM), SWGDAM INT GUID AUT; Van Neste C, 2014, FORENSIC SCI INT-GEN, V9, P1, DOI 10.1016/j.fsigen.2013.10.012; Vilsen SB, 2015, FORENS SCI INT-GEN S, V5, pE416, DOI 10.1016/j.fsigss.2015.09.165; Warshauer DH, 2013, FORENSIC SCI INT-GEN, V7, P409, DOI 10.1016/j.fsigen.2013.04.005; Wendt FR, 2016, FORENSIC SCI INT-GEN, V25, P198, DOI 10.1016/j.fsigen.2016.09.005; Zeng XP, 2015, FORENSIC SCI INT-GEN, V19, P172, DOI 10.1016/j.fsigen.2015.07.015; Zubakov D, 2015, FORENSIC SCI INT-GEN, V17, P122, DOI 10.1016/j.fsigen.2015.04.002	27	13	13	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178005	10.1371/journal.pone.0178005	http://dx.doi.org/10.1371/journal.pone.0178005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542338	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400129
J	Abebrese, EL; Ali, SH; Arnold, ZR; Andrews, VM; Armstrong, K; Burns, L; Crowder, HR; Day, RT; Hsu, DG; Jarrell, K; Lee, G; Luo, Y; Mugayo, D; Raza, Z; Friend, K				Abebrese, Emmanuel L.; Ali, Syed H.; Arnold, Zachary R.; Andrews, Victoria M.; Armstrong, Katharine; Burns, Lindsay; Crowder, Hannah R.; Day, R. Thomas, Jr.; Hsu, Daniel G.; Jarrell, Katherine; Lee, Grace; Luo, Yi; Mugayo, Daphine; Raza, Zain; Friend, Kyle			Identification of human short introns	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; MESSENGER-RNA INTRONS; NONCODING RNAS; DNA-SEQUENCES; TRANSCRIPTION FACTOR; INTERNAL SEQUENCE; OVALBUMIN GENE; SPLICE SITES; HUMAN GENOME; SEQ	Canonical pre-mRNA splicing requires snRNPs and associated splicing factors to excise conserved intronic sequences, with a minimum intron length required for efficient splicing. Non-canonical splicing-intron excision without the spliceosome-has been documented; most notably, some tRNAs and the XBP1 mRNA contain short introns that are not removed by the spliceosome. There have been some efforts to identify additional short introns, but little is known about how many short introns are processed from mRNAs. Here, we report an approach to identify RNA short introns from RNA-Seq data, discriminating against small genomic deletions. We identify hundreds of short introns conserved among multiple human cell lines. These short introns are often alternatively spliced and are found in a variety of RNAs-both mRNAs and lncRNAs. Short intron splicing efficiency is increased by secondary structure, and we detect both canonical and non-canonical short introns. In many cases, splicing of these short introns from mRNAs is predicted to alter the reading frame and change protein output. Our findings imply that standard gene prediction models which often assume a lower limit for intron size fail to predict short introns effectively. We conclude that short introns are abundant in the human transcriptome, and short intron splicing represents an added layer to mRNA regulation.	[Abebrese, Emmanuel L.; Ali, Syed H.; Arnold, Zachary R.; Andrews, Victoria M.; Armstrong, Katharine; Burns, Lindsay; Crowder, Hannah R.; Day, R. Thomas, Jr.; Hsu, Daniel G.; Jarrell, Katherine; Lee, Grace; Luo, Yi; Mugayo, Daphine; Raza, Zain; Friend, Kyle] Washington & Lee Univ, Dept Chem & Biochem, Lexington, VA 24450 USA	Washington & Lee University	Friend, K (corresponding author), Washington & Lee Univ, Dept Chem & Biochem, Lexington, VA 24450 USA.	friendk@wlu.edu		Crowder, Hannah/0000-0002-0329-1048; Ali, Syed/0000-0003-0524-5376	Washington and Lee University-New Faculty Start-Up Grant; Washington and Lee University	Washington and Lee University-New Faculty Start-Up Grant; Washington and Lee University	This work was supported by Washington and Lee University-New Faculty Start-Up Grant to KF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Janice Friend for helpful comments in the preparation of this manuscript and the Dean of the College and Washington and Lee University for financial support (to KF).	Alioto TS, 2007, NUCLEIC ACIDS RES, V35, pD110, DOI 10.1093/nar/gkl796; Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019; Bai YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100864; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BLACK DL, 1985, CELL, V42, P737, DOI 10.1016/0092-8674(85)90270-3; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; Brown JA, 2012, P NATL ACAD SCI USA, V109, P19202, DOI 10.1073/pnas.1217338109; Bzymek M, 2001, P NATL ACAD SCI USA, V98, P8319, DOI 10.1073/pnas.111008398; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CATTERALL JF, 1978, NATURE, V275, P510, DOI 10.1038/275510a0; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; De Bona F, 2008, BIOINFORMATICS, V24, pI174, DOI 10.1093/bioinformatics/btn300; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Goffin L, 2006, MOL BIOL CELL, V17, P5309, DOI 10.1091/mbc.E06-04-0292; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; HALL SL, 1994, J MOL BIOL, V239, P357, DOI 10.1006/jmbi.1994.1377; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hong X, 2006, MOL BIOL EVOL, V23, P2392, DOI 10.1093/molbev/msl111; JACKSON IJ, 1991, NUCLEIC ACIDS RES, V19, P3795; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lee S, 2016, CELL, V164, P69, DOI 10.1016/j.cell.2015.12.017; Liang DM, 2014, GENE DEV, V28, P2233, DOI 10.1101/gad.251926.114; LOVETT ST, 1993, GENETICS, V135, P631; Lu YY, 2014, MOL CELL, V55, P758, DOI 10.1016/j.molcel.2014.06.032; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Maurel M, 2014, TRENDS BIOCHEM SCI, V39, P245, DOI 10.1016/j.tibs.2014.02.008; Oikawa D, 2010, NUCLEIC ACIDS RES, V38, P6265, DOI 10.1093/nar/gkq452; Papasaikas P, 2016, TRENDS BIOCHEM SCI, V41, P33, DOI 10.1016/j.tibs.2015.11.003; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; PIKIELNY CW, 1983, CELL, V34, P395, DOI 10.1016/0092-8674(83)90373-2; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; RUSKIN B, 1985, NATURE, V317, P732, DOI 10.1038/317732a0; Sakharkar Meena Kishore, 2004, In Silico Biology, V4, P387; Sasaki-Haraguchi N, 2012, BIOCHEM BIOPH RES CO, V423, P289, DOI 10.1016/j.bbrc.2012.05.112; SEIF I, 1979, NUCLEIC ACIDS RES, V6, P3387, DOI 10.1093/nar/6.10.3387; Shimada MK, 2015, INT J MOL SCI, V16, P10376, DOI 10.3390/ijms160510376; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Tarn WY, 1996, CELL, V84, P801, DOI 10.1016/S0092-8674(00)81057-0; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Turunen JJ, 2013, WIRES RNA, V4, P61, DOI 10.1002/wrna.1141; Uemura A, 2009, J CELL SCI, V122, P2877, DOI 10.1242/jcs.040584; WIERINGA B, 1984, CELL, V37, P915, DOI 10.1016/0092-8674(84)90426-4; Wilusz JE, 2012, GENE DEV, V26, P2392, DOI 10.1101/gad.204438.112; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshihisa T, 2003, MOL BIOL CELL, V14, P3266, DOI 10.1091/mbc.E02-11-0757; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zhang ZL, 2003, NUCLEIC ACIDS RES, V31, P5338, DOI 10.1093/nar/gkg745; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	59	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0175393	10.1371/journal.pone.0175393	http://dx.doi.org/10.1371/journal.pone.0175393			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520720	Green Submitted, Green Published, gold			2022-12-26	WOS:000401487700001
J	Evans, SD; Droser, ML; Gehling, JG				Evans, Scott D.; Droser, Mary L.; Gehling, James G.			Highly regulated growth and development of the Ediacara macrofossil Dickinsonia costata	PLOS ONE			English	Article							EVOLUTION; FOSSIL; BIOTA; VENDOBIONTA; PLACOZOANS; MORPHOLOGY; AFFINITY; ANNELIDA; ANIMALS; BIOLOGY	The Ediacara Biota represents the oldest fossil evidence for the appearance of animals but linking these taxa to specific clades has proved challenging. Dickinsonia is an abundant, apparently bilaterally symmetrical Ediacara fossil with uncertain affinities. We identified and measured key morphological features of over 900 specimens of Dickinsonia costata from the Ediacara Member, South Australia to characterize patterns in growth and morphology. Here we show that development in Dickinsonia costata was surprisingly highly regulated to maintain an ovoid shape via terminal addition and the predictable expansion of modules. This result, along with other characters found in Dickinsonia suggests that it does not belong within known animal groups, but that it utilized some of the developmental gene networks of bilaterians, a result predicted by gene sequencing of basal metazoans but previously unidentified in the fossil record. Dickinsonia thus represents an extinct clade located between sponges and the last common ancestor of Protostomes and Deuterostomes, and likely belongs within the Eumetazoa.	[Evans, Scott D.; Droser, Mary L.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Gehling, James G.] South Australia Museum, Adelaide, SA, Australia	University of California System; University of California Riverside; South Australian Museum	Evans, SD (corresponding author), Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA.	sevan004@ucr.edu		Evans, Scott/0000-0001-5654-8495	National Science Foundation [EAR-0074021]; National Aeronautics and Space Administration [NNG04GJ42G]; Australian Council Discovery Grant [DP0453393]; Geological Society of America; Society for Sedimentary Geology; Paleontological Society; Lewis and Clark fund for Exploration and Field Research in Astrobiology; National Science Foundation East Asia and Pacific Summer Institutes fellowship [1414911]; National Geographic Explorers Grant; National Aeronautics and Space Administration Astrobiology Institute [NNA15BB03A]	National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Australian Council Discovery Grant(Australian Research Council); Geological Society of America; Society for Sedimentary Geology; Paleontological Society; Lewis and Clark fund for Exploration and Field Research in Astrobiology; National Science Foundation East Asia and Pacific Summer Institutes fellowship(National Science Foundation (NSF)); National Geographic Explorers Grant(National Geographic Society); National Aeronautics and Space Administration Astrobiology Institute	This research was supported by a National Science Foundation grant (EAR-0074021) and a National Aeronautics and Space Administration Exobiology grant (NNG04GJ42G) to MLD; an Australian Council Discovery Grant (DP0453393) to JGG; and a Geological Society of America student research grant, a Society for Sedimentary Geology student research grant, a Paleontological Society student research grant, a Lewis and Clark fund for Exploration and Field Research in Astrobiology and a National Science Foundation East Asia and Pacific Summer Institutes fellowship (1414911) to SDE. This work was also supported in part by a National Geographic Explorers Grant to Dr. Mary L. Droser. MLD and SDE acknowledge support from the National Aeronautics and Space Administration Astrobiology Institute (NNA15BB03A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antcliffe JB, 2007, J GEOL SOC LONDON, V164, P49, DOI 10.1144/0016-76492006-080; Brasier MD, 2008, PALAEOGEOGR PALAEOCL, V270, P311, DOI 10.1016/j.palaeo.2008.07.018; Budd GE, 2015, BIOL REV; Cannon JT, 2016, NATURE, V530, P89, DOI 10.1038/nature16520; Cuthill JFH, 2014, P NATL ACAD SCI USA, V111, P13122, DOI 10.1073/pnas.1408542111; Droser ML, 2015, P NATL ACAD SCI USA, V112, P4865, DOI 10.1073/pnas.1403669112; Dzik J, 2003, INTEGR COMP BIOL, V43, P114, DOI 10.1093/icb/43.1.114; Dzik J, 2002, NEUES JAHRB GEOL P-M, P385; Dzik J, 2015, PRECAMBRIAN RES, V269, P139, DOI 10.1016/j.precamres.2015.08.015; Erwin DH, 2002, DEVELOPMENT, V129, P3021; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; Erwin DH, 2009, PHILOS T R SOC B, V364, P2253, DOI 10.1098/rstb.2009.0038; Evans SD, 2015, PALAEOGEOGR PALAEOCL, V434, P28, DOI 10.1016/j.palaeo.2015.02.006; Fedonkin Mikhail A., 2003, Paleontological Research, V7, P9, DOI 10.2517/prpsj.7.9; Fischer A, 2004, BIOESSAYS, V26, P314, DOI 10.1002/bies.10409; Fusco G, 2004, AM NAT, V163, P167, DOI 10.1086/381042; Fusco G, 2012, EVOLUTION, V66, P314, DOI 10.1111/j.1558-5646.2011.01447.x; Gehling JG, 2013, GEOLOGY, V41, P447, DOI 10.1130/G33881.1; Gehling JG, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P43; Gehling JG, 1999, PALAIOS, V14, P40, DOI 10.2307/3515360; Giere O, 2002, ORG DIVERS EVOL, V2, P289, DOI 10.1078/1439-6092-00044; Glaessner M. F., 1966, Palaeontology, V9, P599; Gold DA, 2015, EVOL DEV, V17, P315, DOI 10.1111/ede.12168; Halanych KM, 2015, J EXP BIOL, V218, P592, DOI 10.1242/jeb.111872; Hannibal RL, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-35; Ivantsov AY, 2007, PALEONTOL J+, V41, P113, DOI 10.1134/S0031030107020013; JENKINS RJF, 1992, ORIGIN EARLY EVOLUTI, P131; Jenner RA, 2004, EVOL DEV, V6, P372, DOI 10.1111/j.1525-142X.2004.04045.x; Joel LV, 2014, J PALEO, V88, P235; KLINGENBERG CP, 1992, J ZOOL, V227, P453, DOI 10.1111/j.1469-7998.1992.tb04406.x; Laflamme M, 2013, GONDWANA RES, V23, P558, DOI 10.1016/j.gr.2012.11.004; Laumer CE, 2015, CURR BIOL, V25, P2000, DOI 10.1016/j.cub.2015.06.068; Maruyama YK, 2004, BIOL BULL-US, V206, P55, DOI 10.2307/1543198; Naimark EB, 2009, PALEONTOL J+, V43, P12, DOI 10.1134/S003103010901002X; PEARSE V B, 1989, Pacific Science, V43, P117; Pearse VB, 2007, INTEGR COMP BIOL, V47, P677, DOI 10.1093/icb/icm015; Pisani D, 2015, P NATL ACAD SCI USA, V112, P15402, DOI 10.1073/pnas.1518127112; Retallack GJ, 2007, ALCHERINGA, V31, P215, DOI 10.1080/03115510701484705; Robinson JM, 2013, J EXP ZOOL PART B, V9999B, P1; RUNNEGAR B, 1982, ALCHERINGA, V6, P223, DOI 10.1080/03115518208565415; SEILACHER A, 1992, J GEOL SOC LONDON, V149, P607, DOI 10.1144/gsjgs.149.4.0607; Seilacher Adolf, 2003, Paleontological Research, V7, P43, DOI 10.2517/prpsj.7.43; Sperling EA, 2010, EVOL DEV, V12, P201, DOI 10.1111/j.1525-142X.2010.00404.x; SPRIGG REG C., 1949, TRANS ROYAL SOC S AUSTRALIA, V73, P72; Struck TH, 2014, MOL BIOL EVOL, V31, P1833, DOI 10.1093/molbev/msu143; Syed Tareq, 2002, Senckenbergiana Lethaea, V82, P315; Tarhan LG, 2016, GEOLOGY, V44, P951, DOI 10.1130/G38542.1; Tweedt SM, 2015, ADV MAR GENOMICS, V2, P47, DOI 10.1007/978-94-017-9642-2_3; WADE M, 1972, Memoirs of the Queensland Museum, V16, P171; Xiao SH, 2009, TRENDS ECOL EVOL, V24, P31, DOI 10.1016/j.tree.2008.07.015; Zhang XL, 2006, ACTA GEOL SIN-ENGL, V80, P636	51	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176874	10.1371/journal.pone.0176874	http://dx.doi.org/10.1371/journal.pone.0176874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520741	Green Published, gold, Green Submitted			2022-12-26	WOS:000401487700031
J	Heber, SD; Hetterich, H; Lorbeer, R; Bayerl, C; Machann, J; Auweter, S; Storz, C; Schlett, CL; Nikolaou, K; Reiser, M; Peters, A; Bamberg, F				Heber, Sophia D.; Hetterich, Holger; Lorbeer, Roberto; Bayerl, Christian; Machann, Juergen; Auweter, Sigrid; Storz, Corinna; Schlett, Christopher L.; Nikolaou, Konstantin; Reiser, Maximilian; Peters, Annette; Bamberg, Fabian			Pancreatic fat content by magnetic resonance imaging in subjects with prediabetes, diabetes, and controls from a general population without cardiovascular disease	PLOS ONE			English	Article							BLOOD-GLUCOSE CONCENTRATION; BETA-CELL FUNCTION; ADIPOSE-TISSUE; RISK; STEATOSIS; LIVER; QUANTIFICATION; MRI; ASSOCIATION; COMPARTMENTS	Background/Objective Despite the relevance of pancreatic fat content in the development of metabolic diseases, its association with impaired glucose metabolism, diabetes, and other adipose tissue compartments remains unclear. Thus, we determined differences in pancreatic fat content by magnetic resonance imaging (MRI) between subjects with prediabetes, diabetes, and normal controls in a cohort from the general population. Methods Subjects without history of cardiovascular disease with established diabetes or prediabetes as well as normal controls were included and underwent whole-body MRI on a 3T scanner. Pancreatic fat content was quantified by measuring the proton-density fat fraction (PDFFpanc) using a 3D multi-echo GRE sequence (increment: 1.23 ms, 6 echoes) by placing ROIs in the pancreatic head, body, and tail by independent readers. In addition, hepatic fat content as well as abdominal subcutaneous and visceral adipose tissue (SAT and VAT) were measured by multi-echo GRE and 3D 2-point volume-interpolated DIXON MRI, respectively. Univariate and multivariate analyses were employed to determine associations. Results A total of 385 subjects were included in the analysis (median age: 57 years, 58.2% males), of them 53 were classified as subjects with diabetes, 95 as prediabetes, and 237 as controls (13.8%, 24.7%, and 61.6%; respectively). The median PDFFpanc was 5.2% [IQR 3.3-9.4], and significantly higher in subjects with prediabetes and diabetes as compared to controls (PDFFpanc: 6.2% [IQR: 3.5-12] vs. 8.6% [IQR: 4.3-17.5] vs. 4.9% [3.1-7.4], p<0.001, respectively). After adjusting for age, gender and BMI the association was attenuated (all p>0.12). While in univariate analysis BMI, PDFFhepatic, SAT and VAT were associated with PDFFpanc (all p<0.05), only VAT predicted PDFFpanc independently (beta: 0.02, 95%-confidence interval: 0.01-0.04, p<0.001). Conclusion While pancreatic fat content differs significantly between subjects with prediabetes, diabetes and controls, this association may be confounded by age, gender, and the amount of VAT in this cross-sectional study.	[Heber, Sophia D.; Storz, Corinna; Nikolaou, Konstantin; Bamberg, Fabian] Univ Tubingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Hetterich, Holger; Lorbeer, Roberto; Bayerl, Christian; Auweter, Sigrid; Reiser, Maximilian] Ludwig Maximilian Univ Hosp, Inst Clin Radiol, Munich, Germany; [Machann, Juergen] Univ Hosp Tuebingen, Dept Diagnost & Intervent Radiol, Sect Expt Radiol, Tubingen, Germany; [Machann, Juergen] Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis IDM, Tubingen, Germany; [Machann, Juergen] German Ctr Diabet Res DZD, Tubingen, Germany; [Schlett, Christopher L.] Heidelberg Univ, Dept Radiol Diagnost & Intervent Radiol, Heidelberg, Germany; [Reiser, Maximilian; Peters, Annette; Bamberg, Fabian] German Ctr Cardiovasc Dis Res DZHK eV, Munich, Germany; [Peters, Annette] Ludwig Maximilian Univ Hosp, Inst Cardiovasc Prevent, Munich, Germany; [Peters, Annette] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Bamberg, F (corresponding author), Univ Tubingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany.; Bamberg, F (corresponding author), German Ctr Cardiovasc Dis Res DZHK eV, Munich, Germany.	Fabian.bamberg@uni-tuebingen.de	Storz, Corinna/ABE-2433-2020; Peters, Annette/A-6117-2011	Storz, Corinna/0000-0001-5589-1849; Peters, Annette/0000-0001-6645-0985; Schlett, Christopher/0000-0002-1576-1481	German Research Foundation (DFG, Bonn, Germany); German Centre for Cardiovascular Disease Research (DZHK, Berlin, Germany); Centre for Diabetes Research (DZD e.V., Neuherberg, Germany)	German Research Foundation (DFG, Bonn, Germany)(German Research Foundation (DFG)); German Centre for Cardiovascular Disease Research (DZHK, Berlin, Germany); Centre for Diabetes Research (DZD e.V., Neuherberg, Germany)	This study was funded by the German Research Foundation (DFG, Bonn, Germany), the German Centre for Cardiovascular Disease Research (DZHK, Berlin, Germany) and the Centre for Diabetes Research (DZD e.V., Neuherberg, Germany).	Andersson G, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0120-8; Bamberg F, 2016, DIABETES; Bashir MR, 2015, AM J ROENTGENOL, V204, P297, DOI 10.2214/AJR.14.12457; Begovatz P, 2015, DIABETOLOGIA, V58, P1646, DOI 10.1007/s00125-015-3544-5; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Cole BK, 2010, HYPERTENSION, V55, P715, DOI 10.1161/HYPERTENSIONAHA.109.148049; Dall TM, 2014, DIABETES CARE, V37, P3172, DOI 10.2337/dc14-1036; Danaei G, 2006, LANCET, V368, P1651, DOI 10.1016/S0140-6736(06)69700-6; Dong Z, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003858; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Han TS, 2016, JRSM CARDIOVASC DIS, V5, DOI 10.1177/2048004016633371; Heni M, 2010, DIABETES-METAB RES, V26, P200, DOI 10.1002/dmrr.1073; Hetterich H, 2015, EUR RADIOL; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Hwang YC, 2015, DIABETES CARE, V38, P2100, DOI 10.2337/dc15-0625; Idilman IS, 2015, ABDOM IMAGING, V40, P1512, DOI 10.1007/s00261-015-0385-0; James C, 2011, DIABETES CARE, V34, P387, DOI 10.2337/dc10-1314; Kim SY, 2014, RADIOLOGY, V271, P104, DOI 10.1148/radiol.13122883; Kuhn JP, 2015, RADIOLOGY, V276, P129, DOI 10.1148/radiol.15140446; Lesmana CRA, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0404-1; Macauley M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126825; Mathieu P, 2014, REV ENDOCR METAB DIS, V15, P289, DOI 10.1007/s11154-014-9299-3; Mathur A, 2009, J AM COLL SURGEONS, V208, P989, DOI 10.1016/j.jamcollsurg.2008.12.026; Neeland IJ, 2012, JAMA-J AM MED ASSOC, V308, P1150, DOI 10.1001/2012.jama.11132; Ou HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062561; Patel NS, 2013, ALIMENT PHARM THER, V37, P630, DOI 10.1111/apt.12237; Patel NS, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/498296; Pitt Henry A, 2007, HPB (Oxford), V9, P92, DOI 10.1080/13651820701286177; Preis SR, 2009, CIRCULATION, V119, P1728, DOI 10.1161/CIRCULATIONAHA.108.829176; Reeder SB, 2010, MAGN RESON IMAGING C, V18, P337, DOI 10.1016/j.mric.2010.08.013; Rossi AP, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.5; Rossi AP, 2011, OBESITY, V19, P1747, DOI 10.1038/oby.2011.114; Ruf E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-312; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Schneider ALC, 2016, DIABETES CARE, V39, P772, DOI 10.2337/dc15-1335; Schwenzer NF, 2010, INVEST RADIOL, V45, P788, DOI 10.1097/RLI.0b013e3181f10fe1; Sepe PS, 2011, GASTROINTEST ENDOSC, V73, P987, DOI 10.1016/j.gie.2011.01.015; Smith U, 2015, J CLIN INVEST, V125, P1790, DOI 10.1172/JCI81507; van der Zijl NJ, 2011, J CLIN ENDOCR METAB, V96, P459, DOI 10.1210/jc.2010-1722; Wong VWS, 2014, AM J GASTROENTEROL, V109, P589, DOI 10.1038/ajg.2014.1; World Health Organization, 2006, DEF DIAGN DIAB MELL; Wurslin C, 2010, J MAGN RESON IMAGING, V31, P430, DOI 10.1002/jmri.22036; Yamazaki H, 2016, DIABETES CARE	43	37	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177154	10.1371/journal.pone.0177154	http://dx.doi.org/10.1371/journal.pone.0177154			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520813	gold, Green Submitted, Green Published			2022-12-26	WOS:000401487700038
J	Song, SY; Shin, JH; Hyeon, SY; Kim, D; Kang, WK; Choi, SH; Kim, YJ; Kim, EY				Song, Seung Yeon; Shin, Joo Hee; Hyeon, Su Yeong; Kim, Donguk; Kang, Won Ku; Choi, Soo-Han; Kim, Yae-Jean; Kim, Eun Young			Pediatric fluoroquinolone prescription in South Korea before and after a regulatory intervention: A nationwide study, 2007-2015	PLOS ONE			English	Article							ANTIMICROBIAL STEWARDSHIP INTERVENTION; ANTIBIOTIC USE; QUINOLONE RESISTANCE; TRACT-INFECTIONS; CHILDREN; COMMUNITY; POPULATION; EMERGENCE; COUNTRIES; DECREASE	Objective To investigate the impact of national implementation of age restriction on fluoroquinolone prescription in children and adolescents. Methods Data collected from the database of Health Insurance Review and Assessment Service in South Korea, a national health insurance system to analyze fluoroquinolone prescribing practice in children and adolescents younger than 18 years, between 2007 and 2015. The age restriction was implemented in December 2009. The annual prescription rate of FQ per 100,000 person-years was calculated and an autoregressive model was used to predict the prescription pattern if an intervention had not occurred. Results A total of 505,859 children received systemic fluoroquinolone during the study period D 297,054 ciprofloxacin, and 208,805 levofloxacin. After implementation of the drug utilization review program, the annual prescription rate for ciprofloxacin declined by 97.5% ( from 840 to 21 per 100,000 person-years, P < 0.001), and for levofloxacin by 96.4% ( from 598 to 11 per 100,000 person-years, P < 0.001). The decline was more dramatic in the outpatient setting than in the inpatient setting for both drugs. Conclusion The dramatic and sustained decline in prescription number and change in prescription pattern after the regulatory action suggests that the implementation under drug utilization review program was successful in controlling excessive and inappropriate use of fluoroquinolones in children, possibly guiding towards more judicious and selective prescription behavior.	[Song, Seung Yeon; Kang, Won Ku; Kim, Eun Young] Chung Ang Univ, Dept Hlth Social & Clin Pharm, Coll Pharm, Seoul, South Korea; [Shin, Joo Hee] Chungnam Natl Univ, Dept Clin Pharm, Coll Pharm, Daejun, South Korea; [Hyeon, Su Yeong; Kim, Donguk] Sungkyunkwan Univ, Dept Stat, Seoul, South Korea; [Choi, Soo-Han] Hallym Univ, Dept Pediat, Dongtan Sacred Heart Hosp, Gyeonggi Do, South Korea; [Kim, Yae-Jean] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea	Chung Ang University; Chungnam National University; Sungkyunkwan University (SKKU); Hallym University; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, EY (corresponding author), Chung Ang Univ, Dept Hlth Social & Clin Pharm, Coll Pharm, Seoul, South Korea.; Kim, YJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea.	yaejeankim@skku.edu; eykimjcb777@cau.ac.kr		Kim, EunYoung/0000-0003-3525-8805	Korea Food and Drug Administration [1172KFDA294]; National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [NRF-2015R1A5A1008958]	Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea); National Research Foundation of Korea (NRF) grant - Korean government (MSIP)(National Research Foundation of Korea)	This research was supported by a grant from the Korea Food and Drug Administration (1172KFDA294) and National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (NRF-2015R1A5A1008958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam HJ, 2009, INT J ANTIMICROB AG, V34, P82, DOI 10.1016/j.ijantimicag.2009.02.002; Bradley JS, 2014, PEDIATRICS, V134, pE146, DOI 10.1542/peds.2013-3636; Bradley JS, 2011, PEDIATRICS, V128, pE1034, DOI 10.1542/peds.2011-1496; Burkhardt JE, 1997, CLIN INFECT DIS, V25, P1196, DOI 10.1086/516119; Chalumeau M, 2003, PEDIATRICS, V111, pE714, DOI 10.1542/peds.111.6.e714; Choi Soo-Han, 2013, Korean J Pediatr, V56, P196, DOI 10.3345/kjp.2013.56.5.196; de Lastours V, 2014, J ANTIMICROB CHEMOTH, V69, P3393, DOI 10.1093/jac/dku283; European Medicines Agency, 2008, CIPR BAYER ART 30 RE; Finkelstein JA, 2013, JAMA-J AM MED ASSOC, V309, P2388, DOI 10.1001/jama.2013.6288; Genuini M, 2014, INT J CLIN PHARM TH, V52, P940, DOI 10.5414/CP202103; Gerber JS, 2014, JAMA-J AM MED ASSOC, V312, P2569, DOI 10.1001/jama.2014.14042; Gerber JS, 2013, JAMA-J AM MED ASSOC, V309, P2345, DOI 10.1001/jama.2013.6287; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Grady R, 2003, PEDIATR INFECT DIS J, V22, P1128, DOI 10.1097/01.inf.0000101994.25947.12; Hay AD, 2016, BMJ BRIT MED J, V352, pI939, DOI DOI 10.1136/BMJ.I939; Heo JH, 2013, INT J MED INFORM, V82, P987, DOI 10.1016/j.ijmedinf.2013.07.001; Hersh AL, 2011, PEDIATRICS, V128, P1053, DOI 10.1542/peds.2011-1337; Hsueh PR, 2011, J INFECTION, V63, P114, DOI 10.1016/j.jinf.2011.05.015; Kim Logyoung, 2013, [Health Policy and Mangemnet, 보건행정학회지], V23, P152; Kimland E, 2012, CLIN PHARMACOL THER, V91, P796, DOI 10.1038/clpt.2012.26; Korea Ministry of Food and Drug Safety, 2009, PUBL ANN ADD LIST AG; Lau Sheung-Mei, 2004, Journal of Microbiology Immunology and Infection, V37, P185; Lee JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161937; Lee YS, 2014, ARCH PHARM RES, V37, P1295, DOI 10.1007/s12272-014-0333-5; Low DE, 2005, CLIN INFECT DIS, V40, P236, DOI 10.1086/426822; MacDougall C, 2005, CLIN INFECT DIS, V41, P435, DOI 10.1086/432056; Mandell LA, 2003, CLIN INFECT DIS, V37, P1405, DOI 10.1086/380488; Marra F, 2006, J ANTIMICROB CHEMOTH, V58, P830, DOI 10.1093/jac/dkl275; Murray TS, 2007, PEDIATR ANN, V36, P336, DOI 10.3928/0090-4481-20070601-09; Na KH, 2017, AM J OPHTHALMOL, V176, P157, DOI 10.1016/j.ajo.2017.01.014; Neuhauser MM, 2003, JAMA-J AM MED ASSOC, V289, P885, DOI 10.1001/jama.289.7.885; Perz JF, 2002, JAMA-J AM MED ASSOC, V287, P3103, DOI 10.1001/jama.287.23.3103; Pichichero ME, 2007, JAMA-J AM MED ASSOC, V298, P1772, DOI 10.1001/jama.298.15.1772; Porta A, 2010, EUR J CLIN PHARMACOL, V66, P919, DOI 10.1007/s00228-010-0842-1; Powell KR, 2006, PEDIATRICS, V118, P1287, DOI 10.1542/peds.2006-1722; Principi N, 2015, INT J ANTIMICROB AG, V45, P341, DOI 10.1016/j.ijantimicag.2015.01.004; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Rubin MA, 2005, CLIN INFECT DIS, V40, P546, DOI 10.1086/427500; Sabharwal V, 2006, PEDIATR INFECT DIS J, V25, P257, DOI 10.1097/01.inf.0000205799.35780.f3; Sarma JB, 2015, J HOSP INFECT, V91, P68, DOI 10.1016/j.jhin.2015.05.006; Shin JY, 2014, PHARMACOEPIDEM DR S, V23, P1320, DOI 10.1002/pds.3696; Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395; Steinke D, 2001, CLIN INFECT DIS, V33, pS193, DOI 10.1086/321848; US Food and Drug Administration, 2016, FDA DRUG SAF COMM FD; US Food and Drug Administration, 2004, CIPR CIPR HYDR 2004; US Food and Drug Administration, 2008, LEV LEV LAB 2008; Weiss K, 2011, CLIN INFECT DIS, V53, P433, DOI 10.1093/cid/cir409; Yang ZT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-245; Yoon YK, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002100; Youngster I, 2017, J PEDIATR-US, V182, P239, DOI 10.1016/j.jpeds.2016.11.027	50	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176420	10.1371/journal.pone.0176420	http://dx.doi.org/10.1371/journal.pone.0176420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520738	gold, Green Published, Green Submitted			2022-12-26	WOS:000401487700017
J	Lee, TC; Bonnici, AA; Tamblyn, R; McDonald, EG				Lee, Todd C.; Bonnici, Andre A.; Tamblyn, Robyn; McDonald, Emily G.			Inpatient Z-drug use commonly exceeds safe dosing recommendations	PLOS ONE			English	Article							INSOMNIA; MEDICATIONS; DISCHARGE; ADULTS	Importance In 2016 recommendations for safer prescribing practices were circulated to all doctors in one of Canada's largest provinces, by the college of physicians, following a coroner's inquest into a vehicular death related to Z-drug use. We sought to determine how frequently Z-drug prescriptions in our institution were not adhering to these recommendations. Design Retrospective cohort study. Setting McGill University Health Centre, an 832-bed tertiary care institution in Montreal, Canada. Participants All adult non-obstetrical patients admitted between April 1, 2015 and March 31, 2016. Exposure The receipt of at least one dose of Z-drug as determined by pharmacy records. Main outcomes and measures Adherence to four recommendations related to starting dose, maximal dose, concomitant drug administration, and duration of use were evaluated. Results 1,409 unique patients received a Z-drug during 1,783 admissions representing use in 9.3% of non-obstetrical patients. Standing orders were seen in 42% (745/1783) of admissions. Non-conformity with the coroner's recommendations was common. Overall, 672/1783 (38%) admissions involved a patient receiving more than the recommended daily maximum dose (643/999 older patients, 64%). Of 607 admissions which were longer than 10 days, 257 (39%) involved a prescription which exceeded 10 days. Conclusions and relevance A coroner's recommendation that doctors receive instructions about safe Z-drug prescribing is unprecedented, and was likely required given that use of Z-drugs occurs at doses and durations that often exceed best practice recommendations. Similar interventions may be required in other jurisdictions.	[Lee, Todd C.; Tamblyn, Robyn; McDonald, Emily G.] McGill Univ, Hlth Ctr, Dept Med, Montreal, PQ, Canada; [Lee, Todd C.; McDonald, Emily G.] McGill Univ, Hlth Ctr, Clin Practice Assessment Unit, Montreal, PQ, Canada; [Lee, Todd C.; Tamblyn, Robyn] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Bonnici, Andre A.] McGill Univ, Hlth Ctr, Pharm Dept, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University	McDonald, EG (corresponding author), McGill Univ, Hlth Ctr, Dept Med, Montreal, PQ, Canada.; McDonald, EG (corresponding author), McGill Univ, Hlth Ctr, Clin Practice Assessment Unit, Montreal, PQ, Canada.	emily.mcdonald@mcgill.ca	McDonald, Emily/AAS-8905-2020	Lee, Todd/0000-0002-2267-4239				AGS Choosing Wisely Workgroup, 2013, J AM GERIATRICS SOC, V61, P622; Alessi-Severini Silvia, 2014, CMAJ Open, V2, pE208, DOI 10.9778/cmajo.20130076; College des medecins du Quebec, 2016, IM ZOP NOUV POS REC; Ford ES, 2014, SLEEP, V37, P1283, DOI 10.5665/sleep.3914; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Grad R, 1999, J AM GERIATR SOC, V47, P184, DOI 10.1111/j.1532-5415.1999.tb04576.x; Health Canada, 2014, IMOVANE ZOP NEW DOS; Kapil V, 2014, BRIT J PSYCHIAT, V205, P407, DOI 10.1192/bjp.bp.114.149252; Lee TC, 2016, JAMA INTERNAL MED; McDonald EG, 2015, AM J MED, V128, P193, DOI 10.1016/j.amjmed.2014.10.016; Moloney ME, 2011, AM J PUBLIC HEALTH, V101, P1429, DOI 10.2105/AJPH.2010.300014; Overdyk FJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150214; Qaseem A, 2016, ANN INTERN MED, V165, P125, DOI 10.7326/M15-2175; Regie de l'assurance maladie du Quebec, LIST MED; Scales DC, 2016, J GEN INTERN MED, V31, P196, DOI 10.1007/s11606-015-3501-5; Tamblyn R, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-150; US Food and Drug Administration, 2014, FDA DRUG SAF COMM FD	17	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177645	10.1371/journal.pone.0177645	http://dx.doi.org/10.1371/journal.pone.0177645			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV1DC	28520804	Green Published, gold, Green Submitted			2022-12-26	WOS:000401485500051
J	Zhou, QQ; Chen, ZD; Lee, JW; Li, XH; Sun, WJ				Zhou, Qiongqiong; Chen, Zhidan; Lee, Jinwook; Li, Xinghui; Sun, Weijiang			Proteomic analysis of tea plants (Camellia sinensis) with purple young shoots during leaf development	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; GREEN TEA; ANTHOCYANIN DEGRADATION; TRANSGENIC TOBACCO; CHALCONE ISOMERASE; STRESS RESPONSES; ORYZA-SATIVA; LEAVES; BINDING; EXPRESSION	Tea products made from purple leaves are highly preferred by consumers due to the health benefits. This study developed a proteome reference map related to color changes during leaf growth in tea (Camellia sinensis) plant with purple young shoots using two-dimensional electrophoresis (2-DE). Forty-six differentially expressed proteins were detected in the gel and successfully identified by using MALDI-TOF/TOF-MS. The pronounced changes in the proteomic profile between tender purple leaves (TPL) and mature green leaves (MGL) included: 1) the lower activity of proteins associated with CO2 assimilation, energy metabolism and photo flux efficiency and higher content of anthocyanins in TPL than those in MGL may protect tender leaves against photo-damage; 2) the higher abundance of chalcone synthase (CHS), chalcone isomerase (CHI) and flavonol synthase (FLS) likely contributes to the synthesis of anthocyanins, catechins and flavonols in TPL tissues; 3) higher abundance of stress response proteins, such as glutathione S-transferases (GST) and phospholipid hydroperoxide glutathione peroxidase (PHGPx), could enhance the tolerance of TPL tissues to adverse condition in; and 4) the increased abundance of proteins related to protein synthesis, nucleic acids and cell wall proteins should be beneficial for the proliferation and expansion of leaf cell in TPL tissues. qPCR analysis showed that the expression of differentially abundant proteins was regulated at the transcriptional level. Therefore, the results indicated that higher abundance of CHI and CHS may account for the production of the purple-shoot phenotype in Wuyiqizhong 18 and thereby, enhancing the anthocyanin biosynthesis. The higher abundance of glutamine synthetase (GS) proteins related to the theanine biosynthesis may improve the flavor of tea products from TPL materials. Thus, this work should help to understand the molecular mechanisms underlying the changes in leaf color alteration.	[Zhou, Qiongqiong; Chen, Zhidan; Sun, Weijiang] Fujian Agr & Forestry Univ, Anxi Coll Tea Sci, Fuzhou, Peoples R China; [Zhou, Qiongqiong] Henan Agr Univ, Coll Hort, Zhengzhou, Peoples R China; [Lee, Jinwook] Mokpo Natl Univ, Dept Hort Sci, Muan, South Korea; [Li, Xinghui] Nanjing Agr Univ, Tea Res Inst, Nanjing, Jiangsu, Peoples R China	Fujian Agriculture & Forestry University; Henan Agricultural University; Mokpo National University; Nanjing Agricultural University	Sun, WJ (corresponding author), Fujian Agr & Forestry Univ, Anxi Coll Tea Sci, Fuzhou, Peoples R China.	swj8103@126.com	Lee, Jinwook/G-4515-2011	Lee, Jinwook/0000-0001-6547-2509	National 863 Program [2013AA10260605]; Science and Technology Major Project of Fujian province [2015NZ0002-1]; earmarked fund for Modern Agro-industry Technology Research System [CARS-23]	National 863 Program; Science and Technology Major Project of Fujian province; earmarked fund for Modern Agro-industry Technology Research System	This work was supported by funding from the National 863 Program (2013AA10260605), Science and Technology Major Project of Fujian province (2015NZ0002-1) and the earmarked fund for Modern Agro-industry Technology Research System (CARS-23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Barragan A, 2014, BIOL PLANTARUM, V58, P567, DOI 10.1007/s10535-014-0427-4; Borovsky Y, 2004, THEOR APPL GENET, V109, P23, DOI 10.1007/s00122-004-1625-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai G, 2010, J EXP BOT, V61, P623, DOI 10.1093/jxb/erp395; Caruso G, 2008, ANAL BIOANAL CHEM, V391, P381, DOI 10.1007/s00216-008-2008-x; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; Chen JC, 2004, PLANT MOL BIOL, V55, P521, DOI 10.1007/s11103-004-0590-7; Chen MY, 2017, SCI REP-UK, V7, DOI 10.1038/srep44743; Deng WW, 2008, PHYTOCHEM LETT, V1, P115, DOI 10.1016/j.phytol.2008.06.002; Fujiki H, 2005, CHEM REC, V5, P119, DOI 10.1002/tcr.20039; Geleijnse JM, 1999, ARCH INTERN MED, V159, P2170, DOI 10.1001/archinte.159.18.2170; Hatlestad GJ, 2015, NAT GENET, V47, P92, DOI 10.1038/ng.3163; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Hodgson JM, 2010, MOL ASPECTS MED, V31, P495, DOI 10.1016/j.mam.2010.09.004; Hsu CP, 2012, J AGR FOOD CHEM, V60, P3686, DOI 10.1021/jf204619n; Jiang LH, 2013, J AGR FOOD CHEM, V61, P3306, DOI 10.1021/jf304860u; Joshi R, 2015, FOOD CHEM, V176, P357, DOI 10.1016/j.foodchem.2014.12.067; Kaneko S, 2006, J AGR FOOD CHEM, V54, P2688, DOI 10.1021/jf0525232; Katam R, 2016, J PROTEOMICS, V143, P209, DOI 10.1016/j.jprot.2016.05.031; Kerio LC, 2013, FOOD CHEM, V136, P1405, DOI 10.1016/j.foodchem.2012.09.066; Kerio LC, 2012, FOOD CHEM, V131, P31, DOI 10.1016/j.foodchem.2011.08.005; Kilel EC, 2013, FOOD CHEM, V141, P769, DOI 10.1016/j.foodchem.2013.03.051; Kim JS, 2008, PLANT J, V55, P455, DOI 10.1111/j.1365-313X.2008.03518.x; Kim JY, 2007, PLANT J, V50, P439, DOI 10.1111/j.1365-313X.2007.03057.x; Kim JY, 2010, J EXP BOT, V61, P2317, DOI 10.1093/jxb/erq058; KOPCZAK SD, 1992, PLANT CELL, V4, P539, DOI 10.1105/tpc.4.5.539; Li Caihong, 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.4103/0366-6999.147330; Li F, 2006, PLANT PHYSIOL BIOCH, V44, P455, DOI 10.1016/j.plaphy.2006.08.006; Li WJ, 2000, BBA-GENE STRUCT EXPR, V1493, P225, DOI 10.1016/S0167-4781(00)00152-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maayan I, 2008, PHYSIOL PLANTARUM, V134, P547, DOI 10.1111/j.1399-3054.2008.01150.x; Manetas Y, 2003, FUNCT PLANT BIOL, V30, P265, DOI 10.1071/FP02226; Manetas Y, 2002, PHOTOSYNTHETICA, V40, P349, DOI 10.1023/A:1022614722629; Molina-Rueda JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056421; Muir SR, 2001, NAT BIOTECHNOL, V19, P470, DOI 10.1038/88150; Nesumi A, 2012, JARQ-JPN AGR RES Q, V46, P321, DOI 10.6090/jarq.46.321; Nishihara M, 2005, FEBS LETT, V579, P6074, DOI 10.1016/j.febslet.2005.09.073; Nissim-Levi A, 2003, J HORTIC SCI BIOTECH, V78, P61, DOI 10.1080/14620316.2003.11511588; Oren-Shamir M, 2009, PLANT SCI, V177, P310, DOI 10.1016/j.plantsci.2009.06.015; Peng HY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1462-z; Rashid K, 2014, NUTR NEUROSCI, V17, P178, DOI 10.1179/1476830513Y.0000000081; Saravanan RS, 2004, PROTEOMICS, V4, P2522, DOI 10.1002/pmic.200300789; Sharma RK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-53; Steyn WJ, 2002, NEW PHYTOL, V155, P349, DOI 10.1046/j.1469-8137.2002.00482.x; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Terashima I, 2009, PLANT CELL PHYSIOL, V50, P684, DOI 10.1093/pcp/pcp034; Vaknin H, 2005, PLANTA, V222, P19, DOI 10.1007/s00425-005-1509-5; Wei K, 2012, FOOD CHEM, V130, P720, DOI 10.1016/j.foodchem.2011.07.092; Yamamoto T, 1997, CHEM APPL GREEN TEA, P160; You X, 2014, TREES-STRUCT FUNCT, V28, P1383, DOI 10.1007/s00468-014-1042-x; Zafra-Stone S, 2007, MOL NUTR FOOD RES, V51, P675, DOI 10.1002/mnfr.200700002; Zhai CZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073989; Zhang KM, 2011, BIOL PLANTARUM, V55, P361, DOI 10.1007/s10535-011-0055-1; Zheng JL, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1921-9; Zhou QQ, 2016, J SCI FOOD AGR, V96, P1982, DOI 10.1002/jsfa.7308	56	15	18	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177816	10.1371/journal.pone.0177816	http://dx.doi.org/10.1371/journal.pone.0177816			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520776	gold, Green Published			2022-12-26	WOS:000401485500072
J	Pasquali, CC; Islam, Z; Adamoski, D; Ferreira, IM; Righeto, RD; Bettini, J; Portugal, RV; Yue, WWY; Gonzalez, A; Dias, SMG; Ambrosio, ALB				Pasquali, Camila Cristina; Islam, Zeyaul; Adamoski, Douglas; Ferreira, Igor Monteze; Righeto, Ricardo Diogo; Bettini, Jefferson; Portugal, Rodrigo Villares; Yue, Wyatt Wai-yin; Gonzalez, Ana; Gomes Dias, Sandra Martha; Berteli Ambrosio, Andre Luis			The origin and evolution of human glutaminases and their atypical C-terminal ankyrin repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PHYLOGENETIC ANALYSIS; STRUCTURAL BASIS; RAT-KIDNEY; PROTEIN; GENOME; METABOLISM; SYSTEM; EXPRESSION; INSIGHTS	On the basis of tissue-specific enzyme activity and inhibition by catalytic products, Hans Krebs first demonstrated the existence of multiple glutaminases in mammals. Currently, two human genes are known to encode at least four glutaminase isoforms. However, the phylogeny of these medically relevant enzymes remains unclear, prompting us to investigate their origin and evolution. Using prokaryotic and eukaryotic glutaminase sequences, we built a phylogenetic tree whose topology suggested that the multidomain architecture was inherited from bacterial ancestors, probably simultaneously with the hosting of the proto-mitochondrion endo-symbiont. Wepropose an evolutionary model wherein the appearance of the most active enzyme isoform, glutaminase C (GAC), which is expressed in many cancers, was a late retrotransposition event that occurred in fishes from the Chondrichthyes class. The ankyrin (ANK) repeats in the glutaminases were acquired early in their evolution. To obtain information on ANK folding, we solved two high-resolution structures of the ANK repeat-containing C termini of both kidney-type glutaminase (KGA) and GLS2 isoforms (glutaminase B and liver-type glutaminase). We found that the glutaminase ANK repeats form unique intramolecular contacts through two highly conserved motifs; curiously, this arrangement occludes a region usually involved in ANK-mediated protein-protein interactions. We also solved the crystal structure of full-length KGA and present a small-angle X-ray scattering model for full-length GLS2. These structures explain these proteins' compromised ability to assemble into catalytically active supra-tetrameric filaments, as previously shown for GAC. Collectively, these results provide information about glutaminases that may aid in the design of isoform-specific glutaminase inhibitors.	[Pasquali, Camila Cristina; Islam, Zeyaul; Adamoski, Douglas; Ferreira, Igor Monteze; Gomes Dias, Sandra Martha; Berteli Ambrosio, Andre Luis] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, BR-13083970 Sao Paulo, Brazil; [Ferreira, Igor Monteze; Yue, Wyatt Wai-yin] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Righeto, Ricardo Diogo; Bettini, Jefferson; Portugal, Rodrigo Villares] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Nanotecnol, BR-13083970 Sao Paulo, Brazil; [Righeto, Ricardo Diogo] Univ Estadual Campinas, Sch Elect & Comp Engn, BR-13083852 Sao Paulo, Brazil; [Gonzalez, Ana] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Righeto, Ricardo Diogo] Univ Basel, Ctr Cellular Imaging & NanoAnalyt C CINA, Biozentrum, CH-4058 Basel, Switzerland	University of Oxford; Universidade Estadual de Campinas; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Basel	Dias, SMG (corresponding author), Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, BR-13083970 Sao Paulo, Brazil.; Ambrosio, ALB (corresponding author), CNPEM, LNBio, Lab Nacl Biociencias, Rua Giuseppe Maximo Scolfaro 10-000, BR-13083970 Sao Paulo, Brazil.	sandra.dias@lnbio.cnpem.br; andre.ambrosio@lnbio.cnpem.br	Ambrosio, Andre/AAB-1178-2020; Dias, Sandra/AAB-7042-2019; Adamoski, Douglas/J-8570-2014; Portugal, Rodrigo V/H-3951-2012; Bettini, Jefferson/G-4554-2013; Islam, Zeyaul/AAZ-5625-2020	Adamoski, Douglas/0000-0001-5062-2586; Portugal, Rodrigo V/0000-0002-8136-904X; Bettini, Jefferson/0000-0001-7316-0804; Islam, Zeyaul/0000-0002-5444-3910	LNBio; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	LNBio; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank LNBio for accessibility to core facilities as well as for financial support. We are very grateful to Dr. Alessandra Girasole for expert technical support. We thank the Biotechnology group at the SGC Oxford for cloning and expression testing of glutaminase constructs. We thank Dr. Artur T. Cordeiro and Americo T. Ranzani for help with crystallographic data collection. We thank Dr. Wah Chiu for access to the cryo-electron microscopy facility at Baylor College of Medicine. We acknowledge the staff of all the beamlines used in this work. The KGA.ANK and GLS2.ANK data were collected during the RapiData 2015 Course for Data Collection and Structure Solving. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and National Institutes of Health, National Institute of General Medical Sciences Grant P41GM103393.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; [Anonymous], 1987, FUNDAMENTALS COMP VE; BERGSTROM J, 1974, J APPL PHYSIOL, V36, P693, DOI 10.1152/jappl.1974.36.6.693; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Brown G, 2008, BIOCHEMISTRY-US, V47, P5724, DOI 10.1021/bi800097h; Campos-Sandoval JA, 2007, INT J BIOCHEM CELL B, V39, P765, DOI 10.1016/j.biocel.2006.12.002; Cassago A, 2012, P NATL ACAD SCI USA, V109, P1092, DOI 10.1073/pnas.1112495109; Chiswell BP, 2008, P NATL ACAD SCI USA, V105, P20677, DOI 10.1073/pnas.0811415106; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; Colombo SL, 2010, P NATL ACAD SCI USA, V107, P18868, DOI 10.1073/pnas.1012362107; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; CURTHOYS NP, 1976, ARCH BIOCHEM BIOPHYS, V172, P162, DOI 10.1016/0003-9861(76)90062-X; de Beer T, 1998, SCIENCE, V281, P1357, DOI 10.1126/science.281.5381.1357; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; DeLaBarre B, 2011, BIOCHEMISTRY-US, V50, P10764, DOI 10.1021/bi201613d; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elgadi KM, 1999, PHYSIOL GENOMICS, V1, P51, DOI 10.1152/physiolgenomics.1999.1.2.51; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hesketh GG, 2014, DEV CELL, V29, P591, DOI 10.1016/j.devcel.2014.04.010; Holzer S, 2013, J MOL BIOL, V425, P4154, DOI 10.1016/j.jmb.2013.08.022; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; KREBS HANS ADOLF, 1935, BIOCHEM JOUR, V29, P1951; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Li YC, 2010, J VIROL, V84, P3331, DOI 10.1128/JVI.02332-09; Liu J, 2014, ONCOTARGET, V5, P2635, DOI 10.18632/oncotarget.1862; Lukey MJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11321; Martin-Rufian M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038380; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Mosavi LK, 2002, P NATL ACAD SCI USA, V99, P16029, DOI 10.1073/pnas.252537899; Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277; Olalla L, 2002, J BIOL CHEM, V277, P38939, DOI 10.1074/jbc.C200373200; Olalla L, 2008, J NEUROSCI RES, V86, P281, DOI 10.1002/jnr.21505; Pace NR, 2009, MICROBIOL MOL BIOL R, V73, P565, DOI 10.1128/MMBR.00033-09; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Rathore MG, 2012, INT J BIOCHEM CELL B, V44, P1448, DOI 10.1016/j.biocel.2012.05.011; Robin G, 2014, J MOL BIOL, V426, P3729, DOI 10.1016/j.jmb.2014.08.013; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Ferreira APS, 2013, J BIOL CHEM, V288, P28009, DOI 10.1074/jbc.M113.501346; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Szeliga M, 2015, NEUROCHEM INT, V88, P6, DOI 10.1016/j.neuint.2014.11.004; Szeliga M, 2014, TUMOR BIOL, V35, P1855, DOI 10.1007/s13277-013-1247-4; Takeda S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000416; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; van Heel M., 2012, INT TABLES CRYSTALLO, VF, P624, DOI [10.1107/97809553602060000875, DOI 10.1107/97809553602060000875]; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Zhang C, 2016, ELIFE, V5, DOI 10.7554/eLife.10727	75	12	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11572	11585		10.1074/jbc.M117.787291	http://dx.doi.org/10.1074/jbc.M117.787291			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28526749	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000405119600036
J	Fang, JS; Wang, L; Li, YC; Lian, WW; Pang, XC; Wang, H; Yuan, DS; Wang, Q; Liu, AL; Du, GH				Fang, Jiansong; Wang, Ling; Li, Yecheng; Lian, Wenwen; Pang, Xiaocong; Wang, Hong; Yuan, Dongsheng; Wang, Qi; Liu, Ai-Lin; Du, Guan-Hua			AlzhCPI: A knowledge base for predicting chemical-protein interactions towards Alzheimer's disease	PLOS ONE			English	Article							TARGET-DIRECTED LIGANDS; DRUG DISCOVERY; MULTITARGET; DATABASE; MODELS; QSAR	Alzheimer's disease (AD) is a complicated progressive neurodegeneration disorder. To confront AD, scientists are searching for multi-target-directed ligands (MTDLs) to delay disease progression. The in silico prediction of chemical-protein interactions (CPI) can accelerate target identification and drug discovery. Previously, we developed 100 binary classifiers to predict the CPI for 25 key targets against AD using the multi-target quantitative structureactivity relationship (mt-QSAR) method. In this investigation, we aimed to apply the mtQSAR method to enlarge the model library to predict CPI towards AD. Another 104 binary classifiers were further constructed to predict the CPI for 26 preclinical AD targets based on the naive Bayesian (NB) and recursive partitioning (RP) algorithms. The internal 5-fold cross-validation and external test set validation were applied to evaluate the performance of the training sets and test set, respectively. The area under the receiver operating characteristic curve (ROC) for the test sets ranged from 0.629 to 1.0, with an average of 0.903. In addition, we developed a web server named AlzhCPI to integrate the comprehensive information of approximately 204 binary classifiers, which has potential applications in network pharmacology and drug repositioning. AlzhCPI is available online at http://rcidm.org/AlzhCPI/index. html. To illustrate the applicability of AlzhCPI, the developed system was employed for the systems pharmacology-based investigation of shichangpu against AD to enhance the understanding of the mechanisms of action of shichangpu from a holistic perspective.	[Fang, Jiansong; Wang, Hong; Yuan, Dongsheng; Wang, Qi] Guangzhou Univ Chinese Med, Inst Clin Pharmacol, Guangzhou, Guangdong, Peoples R China; [Fang, Jiansong; Wang, Qi] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Dept Encephalopathy, Guangzhou, Guangdong, Peoples R China; [Wang, Ling; Li, Yecheng] South China Univ Technol, Sch Biosci & Bioengn, Guangdong Prov Key Lab Fermentat & Enzyme Engn, Preincubator Innovat Drugs & Med, Guangzhou, Guangdong, Peoples R China; [Lian, Wenwen; Pang, Xiaocong; Liu, Ai-Lin; Du, Guan-Hua] Chinese Acad Med Sci, Inst Mat Med, Beijing, Peoples R China; [Lian, Wenwen; Pang, Xiaocong; Liu, Ai-Lin; Du, Guan-Hua] Peking Union Med Coll, Beijing, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; South China University of Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, Q (corresponding author), Guangzhou Univ Chinese Med, Inst Clin Pharmacol, Guangzhou, Guangdong, Peoples R China.; Wang, Q (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 2, Dept Encephalopathy, Guangzhou, Guangdong, Peoples R China.; Liu, AL; Du, GH (corresponding author), Chinese Acad Med Sci, Inst Mat Med, Beijing, Peoples R China.; Liu, AL; Du, GH (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	wqitcm@qq.com; liuailin@imm.ac.cn; dugh@imm.ac.cn		Wang, Qi/0000-0001-7626-676X	National Natural Science Foundation of China [81603318, 81673627, 81473740]; CAMS Initiative for Innovative Medicine [2016-I2M-3007]; Guangdong Provincial Major Science and Technology for Special Program of China [2012A080202017]; South China Chinese Medicine Collaborative Innovation Center [A1AFD01514A05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Initiative for Innovative Medicine; Guangdong Provincial Major Science and Technology for Special Program of China; South China Chinese Medicine Collaborative Innovation Center	This work was supported by the National Natural Science Foundation of China (No. 81603318, No. 81673627, No. 81473740), CAMS Initiative for Innovative Medicine (No.2016-I2M-3007), Guangdong Provincial Major Science and Technology for Special Program of China (No.2012A080202017), and South China Chinese Medicine Collaborative Innovation Center (No.A1AFD01514A05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (No. 81603318, No.81673627, No.81473740), CAMS Initiative for Innovative Medicine (No.201612M-3-007), Guangdong Provincial Major Science and Technology for Special Program of China (No.2012A080202017).	Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Anand R, 2014, NEUROPHARMACOLOGY, V76, P27, DOI 10.1016/j.neuropharm.2013.07.004; Baig MH, 2016, CURR PHARM DESIGN, V22, P572, DOI 10.2174/1381612822666151125000550; Boutet E, 2016, METHODS MOL BIOL, V1374, P23, DOI 10.1007/978-1-4939-3167-5_2; Cao YY, 2013, MOL DIVERS, V17, P515, DOI 10.1007/s11030-013-9452-z; Chen L, 2011, MOL PHARMACEUT, V8, P889, DOI 10.1021/mp100465q; Cheng FX, 2012, MOL BIOSYST, V8, P2373, DOI 10.1039/c2mb25110h; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Durant JL, 2002, J CHEM INF COMP SCI, V42, P1273, DOI 10.1021/ci010132r; Fang JS, 2015, J CHEM INF MODEL, V55, P149, DOI 10.1021/ci500574n; Fang JS, 2015, MOL DIVERS, V19, P149, DOI 10.1007/s11030-014-9561-3; Fang JS, 2013, J CHEM INF MODEL, V53, P3009, DOI 10.1021/ci400331p; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Guzior N, 2015, CURR MED CHEM, V22, P373; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; [胡增峣 Hu Zengyao], 2012, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V28, P252; Huang L, 2014, EUR J MED CHEM, V87, P429, DOI 10.1016/j.ejmech.2014.09.081; Kotecha R, 2016, ONCOTARGET, V7, P52517, DOI 10.18632/oncotarget.9593; Koutsoukas A, 2011, J PROTEOMICS, V74, P2554, DOI 10.1016/j.jprot.2011.05.011; Kuhn M, 2014, NUCLEIC ACIDS RES, V42, pD401, DOI 10.1093/nar/gkt1207; Li G., 2013, ZHONGCAOYAO, V44, P808; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Luo C, 2014, J CHINA PRESCRIPTION, V12, P120; Luo ZH, 2013, J MED CHEM, V56, P9089, DOI 10.1021/jm401047q; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Medina-Franco JL, 2013, DRUG DISCOV TODAY, V18, P495, DOI 10.1016/j.drudis.2013.01.008; Misra S, 2013, NEUROL SCI, V34, P831, DOI 10.1007/s10072-013-1316-x; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Qin C, 2014, NUCLEIC ACIDS RES, V42, pD1118, DOI 10.1093/nar/gkt1129; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Rognan D, 2010, MOL INFORM, V29, P176, DOI 10.1002/minf.200900081; Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Wang SC, 2012, MOL PHARMACEUT, V9, P996, DOI 10.1021/mp300023x; [吴春华 Wu Chunhua], 2014, [中国药物化学杂志, Chinese Journal of Medicinal Chemistry], V24, P209; Wu TY, 2011, TAIWAN J OBSTET GYNE, V50, P131, DOI 10.1016/j.tjog.2011.04.004; Xue RC, 2013, NUCLEIC ACIDS RES, V41, pD1089, DOI 10.1093/nar/gks1100; Yan X, 2012, MOL DIVERS, V16, P759, DOI 10.1007/s11030-012-9403-0; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707; Zanni R, 2014, CURR COMPUT-AID DRUG, V10, P129, DOI 10.2174/157340991002140708105124; Zhang F, 2015, BIOMED CHROMATOGR, V29, P890, DOI 10.1002/bmc.3371; Zhang S, 2016, MOL NEUROBIOL, V53, P83, DOI 10.1007/s12035-014-8950-z; Zheng MH, 2014, MOL DIVERS, V18, P829, DOI 10.1007/s11030-014-9545-3	44	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178347	10.1371/journal.pone.0178347	http://dx.doi.org/10.1371/journal.pone.0178347			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542505	Green Submitted, Green Published, gold			2022-12-26	WOS:000402062800077
J	Karttunen, MJ; Czopka, T; Goedhart, M; Early, JJ; Lyons, DA				Karttunen, Marja J.; Czopka, Tim; Goedhart, Marieke; Early, Jason J.; Lyons, David A.			Regeneration of myelin sheaths of normal length and thickness in the zebrafish CNS correlates with growth of axons in caliber	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS LESIONS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; OLIGODENDROCYTE PRECURSOR CELLS; SPINAL-CORD-INJURY; CONDUCTION-VELOCITY; PROGENITOR CELLS; MOUSE MODEL; IN-VIVO; REMYELINATION	Demyelination is observed in numerous diseases of the central nervous system, including multiple sclerosis (MS). However, the endogenous regenerative process of remyelination can replace myelin lost in disease, and in various animal models. Unfortunately, the process of remyelination often fails, particularly with ageing. Even when remyelination occurs, it is characterised by the regeneration of myelin sheaths that are abnormally thin and short. This imperfect remyelination is likely to have implications for the restoration of normal circuit function and possibly the optimal metabolic support of axons. Here we describe a larval zebrafish model of demyelination and remyelination. We employ a drug-inducible cell ablation system with which we can consistently ablate 2/3rds of oligodendrocytes in the larval zebrafish spinal cord. This leads to a concomitant demyelination of 2/3rds of axons in the spinal cord, and an innate immune response over the same time period. We find restoration of the normal number of oligodendrocytes and robust remyelination approximately two weeks after induction of cell ablation, whereby myelinated axon number is restored to control levels. Remarkably, we find that myelin sheaths of normal length and thickness are regenerated during this time. Interestingly, we find that axons grow significantly in caliber during this period of remyelination. This suggests the possibility that the active growth of axons may stimulate the regeneration of myelin sheaths of normal dimensions.	[Karttunen, Marja J.; Czopka, Tim; Goedhart, Marieke; Early, Jason J.; Lyons, David A.] Univ Edinburgh, Ctr Neuroregenerat, MS Soc Ctr Translat Res, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Midlothian, Scotland; [Czopka, Tim] Tech Univ Munich, Inst Neuronal Cell Biol, Munich, Germany	University of Edinburgh; Technical University of Munich	Lyons, DA (corresponding author), Univ Edinburgh, Ctr Neuroregenerat, MS Soc Ctr Translat Res, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Midlothian, Scotland.	david.lyons@ed.ac.uk	Czopka, Tim/N-4970-2015	Czopka, Tim/0000-0002-6824-8112; Lyons, David/0000-0003-1166-4454; Early, Jason/0000-0003-4313-6445	Lister Institute of Preventative Medicine; Medical Research Council [1292846] Funding Source: researchfish; Wellcome Trust [102836/Z/13/Z] Funding Source: researchfish	Lister Institute of Preventative Medicine; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Lister Institute of Preventative Medicine (DL), Research Prize (no grant number), http://www.lister-institute.org.uk/.	Albert M, 2007, BRAIN PATHOL, V17, P129, DOI 10.1111/j.1750-3639.2006.00043.x; Almeida R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164432; Almeida RG, 2011, DEVELOPMENT, V138, P4443, DOI 10.1242/dev.071001; Bechler ME, 2015, CURR BIOL, V25, P2411, DOI 10.1016/j.cub.2015.07.056; Bin JM, BPL, V2, P3; Birchmeier C, 2008, GLIA, V56, P1491, DOI 10.1002/glia.20753; Bjartmar C, 2003, J NEUROL SCI, V206, P165, DOI 10.1016/S0022-510X(02)00069-2; BLAKEMORE WF, 1981, J NEUROL SCI, V49, P273, DOI 10.1016/0022-510X(81)90084-8; BLAKEMORE WF, 1974, NATURE, V249, P577, DOI 10.1038/249577a0; BRILL MH, 1977, J NEUROL NEUROSUR PS, V40, P769, DOI 10.1136/jnnp.40.8.769; BUNGE MB, 1961, J BIOPHYS BIOCHEM CY, V10, P67, DOI 10.1083/jcb.10.1.67; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Chung A-Y, 2013, MOL CELLS; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Davie CA, 1995, BRAIN, V118, P1583, DOI 10.1093/brain/118.6.1583; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Deshmukh VA, 2013, NATURE, V502, P327, DOI 10.1038/nature12647; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; Ettle B, 2016, MOL NEUROBIOL MOL NE, P1; Etxeberria A, 2016, J NEUROSCI, V36, P6937, DOI 10.1523/JNEUROSCI.0908-16.2016; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; Fang Y, 2014, BIOL OPEN; Fields RD, 2015, NAT REV NEUROSCI, V16, P756, DOI 10.1038/nrn4023; Filley CM, 2016, J NEUROPHYSIOL, V116, P2093, DOI 10.1152/jn.00221.2016; Ford MC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9073; Franklin RJM, 1999, J NEUROSCI RES, V58, P207, DOI 10.1002/(SICI)1097-4547(19991015)58:2<207::AID-JNR1>3.0.CO;2-1; Franklin RJM, 2002, NEUROREPORT, V13, P923, DOI 10.1097/00001756-200205240-00001; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Franklin RJM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020594; Franklin RJM, 2012, NAT REV NEUROL, V8, P624, DOI 10.1038/nrneurol.2012.200; Fyffe-Maricich SL, 2013, J NEUROSCI, V33, P18402, DOI 10.1523/JNEUROSCI.2381-13.2013; Gautier HOB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9518; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Ginsberg MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044736; GLEDHILL RF, 1973, NATURE, V244, P443, DOI 10.1038/244443a0; Goebbels S, 2016, NAT NEUROSCI; Goldschmidt T, 2009, NEUROLOGY, V72, P1914, DOI 10.1212/WNL.0b013e3181a8260a; Gritsch S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6472; HALTER JA, 1991, J THEOR BIOL, V148, P345, DOI 10.1016/S0022-5193(05)80242-5; Hickey WF, 1999, J NEUROIMMUNOL, V98, P37, DOI 10.1016/S0165-5728(99)00079-X; Hines JH, 2015, NAT NEUROSCI, V18, P683, DOI 10.1038/nn.3992; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; James ND, 2011, J NEUROSCI, V31, P18543, DOI 10.1523/JNEUROSCI.4306-11.2011; Kasibhatla S., 2006, CSH PROTOC, V2006; Kaya F, 2012, J NEUROSCI, V32, P12885, DOI 10.1523/JNEUROSCI.2252-12.2012; KOLES ZJ, 1972, J PHYSIOL-LONDON, V227, P351, DOI 10.1113/jphysiol.1972.sp010036; Kotter MR, 2001, GLIA, V35, P204, DOI 10.1002/glia.1085; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Koudelka S, 2016, CURR BIOL, P1; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Lee S, 2012, NAT METHODS, V9, P917, DOI 10.1038/nmeth.2105; Liebetanz D, 2006, EXP NEUROL, V202, P217, DOI 10.1016/j.expneurol.2006.05.032; Lloyd AF, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00060; Locatelli G, 2012, NAT NEUROSCI, V15, P543, DOI 10.1038/nn.3062; Love S, 2006, J CLIN PATHOL, V59, P1151, DOI 10.1136/jcp.2005.031195; Lucchinetti C, 1999, BRAIN, V122, P2279, DOI 10.1093/brain/122.12.2279; LUDWIN SK, 1984, J NEUROL SCI, V64, P193, DOI 10.1016/0022-510X(84)90037-6; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; Mei F, 2014, NAT MED, P1; Mei F, 2016, ELIFE, V5, DOI 10.7554/eLife.18246; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Micheva KD, 2016, ELIFE, V5, DOI 10.7554/eLife.15784; MOORE JW, 1978, BIOPHYS J, V21, P147, DOI 10.1016/S0006-3495(78)85515-5; Munzel EJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0077-y; Natrajan MS, 2015, BRAIN, V138, P3581, DOI 10.1093/brain/awv289; Nave KA, 2014, JAMA PSYCHIAT, V71, P582, DOI 10.1001/jamapsychiatry.2014.189; Olmos-Serrano JL, 2016, DOWN SYNDROME DEVELO, P1; OZAWA K, 1994, BRAIN, V117, P1311, DOI 10.1093/brain/117.6.1311; Papastefanaki F, 2015, GLIA, V63, P1101, DOI 10.1002/glia.22809; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; PERIER O, 1965, BRAIN, V88, P937, DOI 10.1093/brain/88.5.937; Pohl HBF, 2011, J NEUROSCI, V31, P1069, DOI 10.1523/JNEUROSCI.5035-10.2011; Powers BE, 2013, P NATL ACAD SCI USA, V110, P4075, DOI 10.1073/pnas.1210293110; PRINEAS JW, 1979, ANN NEUROL, V5, P22, DOI 10.1002/ana.410050105; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Saab AS, 2013, CURR OPIN NEUROBIOL, V23, P1065, DOI 10.1016/j.conb.2013.09.008; Saab AS, 2016, NEURON, P1; Safaiyan S, 2016, NAT NEUROSCI, V19, P995, DOI 10.1038/nn.4325; Samanta J, 2015, NATURE, V526, P448, DOI 10.1038/nature14957; Seidl AH, 2014, NEUROSCIENCE, V276, P126, DOI 10.1016/j.neuroscience.2013.06.047; Sekizar S, 2015, DEV NEUROSCI-BASEL, V37, P232, DOI 10.1159/000380817; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; SMITH KJ, 1979, NATURE, V280, P395, DOI 10.1038/280395a0; Tomassy GS, 2016, TRENDS CELL BIOL, V26, P135, DOI 10.1016/j.tcb.2015.09.002; Tomassy GS, 2014, SCIENCE, V344, P319, DOI 10.1126/science.1249766; Traka M, 2010, BRAIN, V133, P3017, DOI 10.1093/brain/awq247; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; Wake H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8844; WAXMAN SG, 1972, J CELL BIOL, V53, P210, DOI 10.1083/jcb.53.1.210; WAXMAN SG, 1972, NATURE-NEW BIOL, V238, P217, DOI 10.1038/newbio238217a0; WAXMAN SG, 1984, BRAIN RES, V292, P179, DOI 10.1016/0006-8993(84)90905-3; WAXMAN SG, 1970, NATURE, V227, P283, DOI 10.1038/227283a0; Williams A, 2007, GLIA, V55, P1300, DOI 10.1002/glia.20546; Wolswijk G, 1998, J NEUROSCI, V18, P601; Yeung MSY, 2014, CELL, V159, P766, DOI 10.1016/j.cell.2014.10.011; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002	99	22	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178058	10.1371/journal.pone.0178058	http://dx.doi.org/10.1371/journal.pone.0178058			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542521	Green Submitted, Green Published, gold			2022-12-26	WOS:000402062800041
J	Rodriguez-Lopez, M; Wagner, P; Perez-Vicente, R; Crispi, F; Merlo, J				Rodriguez-Lopez, Merida; Wagner, Philippe; Perez-Vicente, Raquel; Crispi, Fatima; Merlo, Juan			Revisiting the discriminatory accuracy of traditional risk factors in preeclampsia screening	PLOS ONE			English	Article							GESTATIONAL HYPERTENSION; 1ST-TRIMESTER PREDICTION; PREGNANCY; SMOKING; OBESITY; COHORT; HEALTH	Background Preeclampsia (PE) is associated with a high risk of perinatal morbidity and mortality. However, there is no consensus in the definition of high-risk women. Aim To question current definition of high PE risk and propose a definition that considers individual heterogeneity to improves risk classification. Methods A stratified analysis by parity was conducted using the Swedish Birth Register between 2002-2010 including 626.600 pregnancies. The discriminatory accuracy (DA) of traditional definitions of high-risk women was compared with a new definition based on 1) specific combinations of individual variables and 2) a centile cut-off of the probability of PE predicted by a multiple logistic regression model. Results None of the classical risk-factors alone reached an acceptable DA. In multiparous, any combination of a risk-factor with previous PE or HBP reached a + LR> 10. The combination of obesity and multiple pregnancy reached a good DA particularly in the presence of previous preeclampsia (positive likelihood ratio (LR+) = 26.5 or chronic hypertension (HBP) LR+ = 40.5. In primiparous, a LR+> 15 was observed in multiple pregnancies with the simultaneous presence of obesity and diabetes mellitus or with HBP. Predicted probabilities above 97 centile in multiparous and 99 centile in primiparous provided high (LR+ = 12.5), and moderate (LR+ = 5.85), respectively. No one risk factor alone or in combination provided a LR-sufficiently low to rule-out the disease. Conclusions In preeclampsia prediction the combination of specific risk factors provided a better discriminatory accuracy than traditional single risk approach. Our results contribute to a more personalized risk estimation of preeclampsia.	[Rodriguez-Lopez, Merida; Wagner, Philippe; Perez-Vicente, Raquel; Merlo, Juan] Lund Univ, Fac Med, Unit Social Epidemiol, Malmo, Sweden; [Rodriguez-Lopez, Merida; Crispi, Fatima] Univ Barcelona, Fetal I D Fetal Med Res Ctr, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Hosp Clin, Barcelona, Spain; [Rodriguez-Lopez, Merida; Crispi, Fatima] Univ Barcelona, Hosp St Joan de Deu, Inst Clin Ginecol Obstet & Neonatol, Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain; [Rodriguez-Lopez, Merida; Crispi, Fatima] Ctr Biomed Res Rare Dis CIBER ER, Barcelona, Spain	Lund University; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Rodriguez-Lopez, M (corresponding author), Lund Univ, Fac Med, Unit Social Epidemiol, Malmo, Sweden.; Rodriguez-Lopez, M (corresponding author), Univ Barcelona, Fetal I D Fetal Med Res Ctr, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Hosp Clin, Barcelona, Spain.; Rodriguez-Lopez, M (corresponding author), Univ Barcelona, Hosp St Joan de Deu, Inst Clin Ginecol Obstet & Neonatol, Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain.; Rodriguez-Lopez, M (corresponding author), Ctr Biomed Res Rare Dis CIBER ER, Barcelona, Spain.	merida.rdguez@gmail.com	Rodriguez-Lopez, Merida/N-9273-2017; Merlo, Juan/E-2136-2011	Rodriguez-Lopez, Merida/0000-0001-8245-0811; Merlo, Juan/0000-0001-8379-9708	Erasmus + Programme of the European Union [2013-0040]; Swedish Research Council (PI: JM) [2013-2484]; "la Caixa" Foundation; Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); AGAUR SGR [928]	Erasmus + Programme of the European Union; Swedish Research Council (PI: JM)(Swedish Research Council); "la Caixa" Foundation(La Caixa Foundation); Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); AGAUR SGR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	This work was partially supported by the Erasmus + Programme of the European Union (Framework Agreement number: 2013-0040) to MR-L. This publication reflects the views only of the author, and the Commission cannot be held responsible for any use, which may be made of the information contained therein. This work was also supported by the Swedish Research Council (PI: JM, 2013-2484). Additionally, the research leading to these results has received funding from "la Caixa" Foundation; Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK) and AGAUR 2014 SGR grant no 928. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy, 2013, OBSTET GYNECOL, V122, P1122, DOI [DOI 10.1097/01.AOG.0000437382.03963.88, 10.1097/01.AOG.0000437382.03963.88]; Bartsch E, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1753; Baschat AA, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.04.018; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Choi BCK, 1997, EPIDEMIOLOGY, V8, P80, DOI 10.1097/00001648-199701000-00013; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Craici Iasmina, 2008, Ther Adv Cardiovasc Dis, V2, P249, DOI 10.1177/1753944708094227; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Egeland GM, 2016, HYPERTENSION, V67, P1173, DOI 10.1161/HYPERTENSIONAHA.116.07099; England LJ, 2002, AM J OBSTET GYNECOL, V186, P1035, DOI 10.1067/mob.2002.122404; Goetzinger KR, 2014, AM J PERINAT, V31, P1049, DOI 10.1055/s-0034-1371705; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; HUNTER S, 1992, BRIT HEART J, V68, P540; Juarez SP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005388; Khoury MJ, 2016, AM J PREV MED, V50, P398, DOI 10.1016/j.amepre.2015.08.031; Kotsis V, 2010, HYPERTENS RES, V33, P386, DOI 10.1038/hr.2010.9; Li X, 2016, PREGNANCY HYPERTENS, V6, P66, DOI 10.1016/j.preghy.2015.11.004; McGee S, 2002, J GEN INTERN MED, V17, P646; Merlo J, 2003, J EPIDEMIOL COMMUN H, V57, P550, DOI 10.1136/jech.57.8.550; Merlo J, 2013, WORKING PAPERS UNIT; Merlo J, 2015, EUR J PUBLIC HEALTH, V25, P910, DOI 10.1093/eurpub/ckv209; Milne F, 2005, BRIT MED J, V330, P576, DOI 10.1136/bmj.330.7491.576; Moon M, J MATERN FETAL NEONA, V28, P2028; Munkhaugen J, 2009, NEPHROL DIAL TRANSPL, V24, P3744, DOI 10.1093/ndt/gfp320; North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875; Oliveira N, 2014, ULTRASOUND OBST GYN, V44, P279, DOI 10.1002/uog.13435; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Petersson K, BMC HLTH SERV RES, V14, P364; Poon LCY, 2010, J HUM HYPERTENS, V24, P104, DOI 10.1038/jhh.2009.45; Poon LC, 2014, OBSTET GYNECOL INT, V2014, DOI 10.1155/2014/297397; Redman CW, HEART, V97, P1967; Roberts CL, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000101; Robinson C, 2015, AM J PERINATOL; Ros HS, 1998, AM J EPIDEMIOL, V147, P1062; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sohlberg S, 2012, AM J HYPERTENS, V25, P120, DOI 10.1038/ajh.2011.175; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Wikstrom AK, 2010, HYPERTENSION, V55, P1254, DOI 10.1161/HYPERTENSIONAHA.109.147082; World Health Organization, 2011, WHO REC PREV TREATM; Wright D, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.02.018; Yoo Wonsuk, 2012, Int J Appl Sci Technol, V2, P268	43	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178528	10.1371/journal.pone.0178528	http://dx.doi.org/10.1371/journal.pone.0178528			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542517	gold, Green Submitted, Green Published			2022-12-26	WOS:000402062800101
J	Watts, AG; Miniota, J; Joseph, HA; Brady, OJ; Kraemer, MUG; Grills, AW; Morrison, S; Esposito, DH; Nicolucci, A; German, M; Creatore, MI; Nelson, B; Johansson, MA; Brunette, G; Hay, SI; Khan, K; Cetron, M				Watts, Alexander G.; Miniota, Jennifer; Joseph, Heather A.; Brady, Oliver J.; Kraemer, Moritz U. G.; Grills, Ardath W.; Morrison, Stephanie; Esposito, Douglas H.; Nicolucci, Adriano; German, Matthew; Creatore, Maria I.; Nelson, Bradley; Johansson, Michael A.; Brunette, Gary; Hay, Simon I.; Khan, Kamran; Cetron, Marty			Elevation as a proxy for mosquito-borne Zika virus transmission in the Americas	PLOS ONE			English	Article							AEDES-AEGYPTI; VECTORIAL CAPACITY; DENGUE; ALBOPICTUS; CHIKUNGUNYA; BEHAVIOR; CLIMATE; IMPACT; FEVER; RISK	Introduction When Zika virus (ZIKV) first began its spread from Brazil to other parts of the Americas, national-level travel notices were issued, carrying with them significant economic consequences to affected countries. Although regions of some affected countries were likely unsuitable for mosquito-borne transmission of ZIKV, the absence of high quality, timely surveillance data made it difficult to confidently demarcate infection risk at a sub-national level. In the absence of reliable data on ZIKV activity, a pragmatic approach was needed to identify subnational geographic areas where the risk of ZIKV infection via mosquitoes was expected to be negligible. To address this urgent need, we evaluated elevation as a proxy for mosquito-borne ZIKV transmission. Methods For sixteen countries with local ZIKV transmission in the Americas, we analyzed (i) modelled occurrence of the primary vector for ZIKV, Aedes aegypti, (ii) human population counts, and (iii) reported historical dengue cases, specifically across 100-meter elevation levels between 1,500m and 2,500m. Specifically, we quantified land area, population size, and the number of observed dengue cases above each elevation level to identify a threshold where the predicted risks of encountering Ae. aegypti become negligible. Results Above 1,600m, less than 1% of each country's total land area was predicted to have Ae. aegypti occurrence. Above 1,900m, less than 1% of each country's resident population lived in areas where Ae. aegypti was predicted to occur. Across all 16 countries, 1.1% of historical dengue cases were reported above 2,000m. Discussion These results suggest low potential for mosquito-borne ZIKV transmission above 2,000m in the Americas. Although elevation is a crude predictor of environmental suitability for ZIKV transmission, its constancy made it a pragmatic input for policy decision-making during this public health emergency.	[Watts, Alexander G.; Miniota, Jennifer; Nicolucci, Adriano; German, Matthew; Creatore, Maria I.; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Joseph, Heather A.; Grills, Ardath W.; Morrison, Stephanie; Esposito, Douglas H.; Nelson, Bradley; Brunette, Gary; Cetron, Marty] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Brady, Oliver J.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England; [Brady, Oliver J.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford, England; [Kraemer, Moritz U. G.; Hay, Simon I.] Univ Oxford, Oxford Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England; [Morrison, Stephanie] Ctr Dis Control & Prevent, Eagle Med Serv, LLC Div Global Migrat & Quarantine, Atlanta, GA USA; [Creatore, Maria I.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Johansson, Michael A.] Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR USA; [Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Khan, Kamran] Univ Toronto, Div Infect Dis, Dept Med, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Centers for Disease Control & Prevention - USA; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of Oxford; Centers for Disease Control & Prevention - USA; University of Toronto; Centers for Disease Control & Prevention - USA; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Toronto	Watts, AG (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.	wattsa@smh.ca	Brady, Oliver/P-9421-2019; Hay, Simon Iain/F-8967-2015	Brady, Oliver/0000-0002-3235-2129; Hay, Simon Iain/0000-0002-0611-7272; Johansson, Michael/0000-0002-5090-7722	U.S. Centers for Disease Control and Prevention; Canadian Institutes of Health Research; Bill & Melinda Gates Foundation [OPP1119467, OPP1093011, OPP1106023, OPP1132415]; Senior Research Fellowship from the Wellcome Trust [095066]; RAPIDD program of the Science & Technology Directorate; Department of Homeland Security; International Research Consortium on Dengue Risk Assessment Management and Surveillance (IDAMS; European Commission 7th Framework Programme) [21893]	U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Senior Research Fellowship from the Wellcome Trust; RAPIDD program of the Science & Technology Directorate; Department of Homeland Security(United States Department of Homeland Security (DHS)); International Research Consortium on Dengue Risk Assessment Management and Surveillance (IDAMS; European Commission 7th Framework Programme)	Funding for this research came in part from the U.S. Centers for Disease Control and Prevention and the Canadian Institutes of Health Research. OJB is funded by a grant from the Bill & Melinda Gates Foundation (OPP1119467). SIH is funded by a Senior Research Fellowship from the Wellcome Trust (#095066), and grants from the Bill & Melinda Gates Foundation (OPP1119467, OPP1093011, OPP1106023 and OPP1132415). SIH would also like to acknowledge funding support from the RAPIDD program of the Science & Technology Directorate, and the Department of Homeland Security. MUGK receives funding from the International Research Consortium on Dengue Risk Assessment Management and Surveillance (IDAMS; European Commission 7th Framework Programme (#21893).	Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617; Anderson JR, 2006, AM J TROP MED HYG, V75, P886, DOI 10.4269/ajtmh.2006.75.886; Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338; Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351; Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968; Cetron M, 2016, MMWR-MORBID MORTAL W, V65, P267, DOI 10.15585/mmwr.mm6510e1; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; Chowell G, 2008, EPIDEMIOL INFECT, V136, P1667, DOI 10.1017/S0950268808000290; Chowell G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-164; Danielson J. J., 2011, GLOBAL MULTIRESOLUTI, DOI 10.3133/ofr20111073; Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026; Fong IW, 2017, EMERG INF DIS 21ST C, P101, DOI 10.1007/978-3-319-50890-0_6; Fuller DO, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014011; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; Hagenlocher M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-36; Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5; Kraemer MUG, 2016, TRENDS PARASITOL, V32, P19, DOI 10.1016/j.pt.2015.09.006; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244; Messina JP, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.4; Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9; ORNL, 2014, LANDSCAN 2013; Pan American Health Organization WHO, 2016, ZIK EP UPD; Paz-Bailey G., 2017, N ENGL J MED, DOI [10.1056/NEJMoa1613108, DOI 10.1056/NEJMOA1613108]; Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2; Shlim DR, 2009, CDC HLTH INFORM INT, P242; Stone CM, 2012, AM J TROP MED HYG, V87, P727, DOI 10.4269/ajtmh.2012.12-0123; Suarez M. F., 1981, Biomedica, V1, P225; Thavara U, 2001, J VECTOR ECOL, V26, P172; Thu Hlaing Myat, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P280; Townsend Peterson A, 2016, PLOS CURR; US Census Bureau, 2013, WORLD POP HIST EST W; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; WHO, 2017, DENG SEV DENG; Woolhouse M, 2011, PHILOS T R SOC B, V366, P2045, DOI 10.1098/rstb.2010.0387; World Health Organization, 2005, INT HLTH REG, P82, DOI [10.1177/146642407109100301, DOI 10.1177/146642407109100301]	39	22	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178211	10.1371/journal.pone.0178211	http://dx.doi.org/10.1371/journal.pone.0178211			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542540	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000402061500072
J	Lu, Y; Gu, YC; Ding, XW; Wang, JQ; Chen, JW; Miao, CH				Lu, Yan; Gu, Yuechao; Ding, Xiaowei; Wang, Jiaqiang; Chen, Jiawei; Miao, Changhong			Intracellular Ca2+ homeostasis and JAK1/STAT3 pathway are involved in the protective effect of propofol on BV2 microglia against hypoxia-induced inflammation and apoptosis	PLOS ONE			English	Article							HIPPOCAMPAL-NEURONS; CELLS; ISCHEMIA; RECEPTOR; INJURY; BRAIN; STAT3; PHOSPHORYLATION; ACTIVATION; RESPONSES	Background Perioperative hypoxia may induce microglial inflammation and apoptosis, resulting in brain injury. The neuroprotective effect of propofol against hypoxia has been reported, but the underlying mechanisms are far from clear. In this study, we explored whether and how propofol could attenuate microglia BV2 cells from CoCl2-induced hypoxic injury. Methods Mouse microglia BV2 cells were pretreated with propofol, and then stimulated with CoCl2. TNF-alpha level in the culture medium was measured by ELISA kit. Cell apoptosis and intracellular calcium concentration were measured by flow cytometry analysis. The effect of propofol on CoCl2-modulated expression of Ca2+/Calmodulin (CaM)-dependent protein kinase II (CAMKII alpha), phosphorylated CAMKIIa (pCAMKII alpha), STAT3, pSTAT3(Y705), pSTAT3(S727), ERK1/2, pERK1/2, pNFkB(p65), pro-caspase3, cleaved caspase 3, JAK1, pJAK1, JAK2, pJAK2 were detected by Western blot. Results In BV2 cell, CoCl2 treatment time-dependently increased TNF-alpha release and induced apoptosis, which were alleviated by propofol. CoCl2 (500 mu mol/L, 8h) treatment increased intracellular Ca2+ level, and caused the phosphorylation of CAMKIIa, ERK1/2 and NFkB (p65), as well as the activation of caspase 3. More importantly, these effects could be modulated by 25 mu mol/L propofol via maintaining intracellular Ca2+ homeostasis and via up-regulating the phosphorylation of JAK1 and STAT3 at Tyr705. Conclusion Propofol could protect BV2 microglia from hypoxia-induced inflammation and apoptosis. The potential mechanisms may involve the maintaining of intracellular Ca2+ homeostasis and the activation of JAK1/STAT3 pathway.	[Lu, Yan; Gu, Yuechao; Ding, Xiaowei; Wang, Jiaqiang; Chen, Jiawei; Miao, Changhong] Fudan Univ, Shanghai Canc Ctr, Dept Anesthesiol, Shanghai Shi, Peoples R China; [Lu, Yan; Gu, Yuechao; Ding, Xiaowei; Wang, Jiaqiang; Chen, Jiawei; Miao, Changhong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai Shi, Peoples R China	Fudan University; Fudan University	Chen, JW; Miao, CH (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Anesthesiol, Shanghai Shi, Peoples R China.; Chen, JW; Miao, CH (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai Shi, Peoples R China.	jiawei_chen@hotmail.com; anesthesiology2016@126.com			Nature Science Foundation of Shanghai [14ZR1407500]	Nature Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This work was supported by the Nature Science Foundation of Shanghai (No: 14ZR1407500).	Anttila J.E., 2016, PROG NEUROPSYCHOPHAR; Banerjee C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004018; Bell JR, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00096; Ben Haim L, 2015, J NEUROSCI, V35, P2817, DOI 10.1523/JNEUROSCI.3516-14.2015; Breit A, 2015, MOL ENDOCRINOL, V29, P445, DOI 10.1210/me.2014-1300; Chen H, 2016, INT J OPTOMECHATRONI, V10, P1, DOI 10.1080/15599612.2015.1095956; Chen J, 2015, NEUROSCIENCE, V305, P117, DOI 10.1016/j.neuroscience.2015.07.076; Farber K, 2006, GLIA, V54, P656, DOI 10.1002/glia.20412; Geiseler SJ, 2016, NEUROSCIENCE, V334, P39, DOI 10.1016/j.neuroscience.2016.07.034; Hillmer EJ, 2016, CYTOKINE GROWTH F R, V31, P1, DOI 10.1016/j.cytogfr.2016.05.001; Hoffmann A, 2003, J NEUROSCI, V23, P4410; Kim OS, 2002, J BIOL CHEM, V277, P40594, DOI 10.1074/jbc.M203885200; KOCHS E, 1992, ANESTHESIOLOGY, V76, P245, DOI 10.1097/00000542-199202000-00014; Korvers L, 2016, CELL CALCIUM; Kovalovich K, 2001, J BIOL CHEM, V276, P26605, DOI 10.1074/jbc.M100740200; Lam SY, 2012, HISTOCHEM CELL BIOL, V137, P303, DOI 10.1007/s00418-011-0900-5; Lee SH, 2015, STEM CELLS, V33, P1490, DOI 10.1002/stem.1938; Lemoine S, 2013, ANESTHESIOLOGY, V118, P1373, DOI 10.1097/ALN.0b013e31828a7039; Li HR, 2017, BIOMED PHARMACOTHER, V86, P324, DOI 10.1016/j.biopha.2016.12.036; Li J, 2014, ACTA BIOMATER, V10, P2866, DOI 10.1016/j.actbio.2014.02.032; Mandal T, 2014, CELL SIGNAL, V26, P1725, DOI 10.1016/j.cellsig.2014.04.003; McDonough A, 2016, NEUROTHERAPEUTICS, V13, P748, DOI 10.1007/s13311-016-0465-z; Milanovic D, 2016, NEUROTOX RES, V30, P434, DOI 10.1007/s12640-016-9629-1; Muraoka O, 2003, NEUROCHEM INT, V42, P591, DOI 10.1016/S0197-0186(02)00160-2; Murase S, 2014, EUR J NEUROSCI, V39, P557, DOI 10.1111/ejn.12412; Murase S, 2012, J NEUROSCI, V32, P15511, DOI 10.1523/JNEUROSCI.2940-12.2012; Shao JX, 2013, J NEUROIMMUNOL, V254, P83, DOI 10.1016/j.jneuroim.2012.09.012; Shimizu T, 2016, MOL CELL BIOL, V36, P2728, DOI 10.1128/MCB.00139-16; Xiong XY, 2016, PROG NEUROBIOL, V142, P23, DOI 10.1016/j.pneurobio.2016.05.001; Yan Z, 2016, CLIN IMMUNOL; Yang P, 2014, CELL BIOCHEM BIOPHYS, V70, P1527, DOI 10.1007/s12013-014-0088-0; Yoo YC, 2013, J SURG RES, V183, P783, DOI 10.1016/j.jss.2013.02.017; You L, 2011, MOL BIOL REP, V38, P437, DOI 10.1007/s11033-010-0126-y; Yuan L, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0541-7; Zhang DX, 2014, BRAIN INJURY, V28, P1758, DOI 10.3109/02699052.2014.947624; Zhang J., 2016, OXID MED CELL LONGEV, V2016; Zhang T, 2016, NAT MED, V22, P175, DOI 10.1038/nm.4017; Zhang Y, 2016, NEUROTOX RES; Zhou CH, 2015, ANESTH ANALG, V120, P1361, DOI 10.1213/ANE.0000000000000645; Zhou JM, 2016, CELL STRESS CHAPERON, V21, P1037, DOI 10.1007/s12192-016-0728-y; Zhou R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082729; Zhu ML, 2015, ANESTH ANALG, V120, P781, DOI 10.1213/ANE.0000000000000616	42	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178098	10.1371/journal.pone.0178098	http://dx.doi.org/10.1371/journal.pone.0178098			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542400	Green Submitted, Green Published, gold			2022-12-26	WOS:000402058800038
J	Wang, XH; Zhang, DJ; Guan, B; Qi, Q; Tong, SZ				Wang, Xuehong; Zhang, Dongjie; Guan, Bo; Qi, Qing; Tong, Shouzheng			Optimum water supplement strategy to restore reed wetland in the Yellow River Delta	PLOS ONE			English	Article							PHRAGMITES-AUSTRALIS; COASTAL WETLAND; CLIMATE-CHANGE; SOIL; SALINITY; IMPACTS; GROWTH; DEPTH; CHINA; PLANT	In order to supply optimum water to restore reed wetlands used for bird habitats, a field investigation and greenhouse experiment were conducted. Three water supplementation stages (early stage at 20 May, middle stage at 20 July and later stage at 20 September, respectively) and five depths (0, 10, 15, 20 and 35 cm over the surface, respectively) were established, with three replicates for each treatment combination. Reed growth characteristics (survival rate, height, density and biomass) and soil properties of field investigation and experiment were recorded to determine the impacts of water supplementation on reed wet-land restoration. The field investigation showed that reeds in natural wetlands grow better than those in degraded wetlands and soil properties in degraded wetlands were significantly different from soils in natural wetlands. With freshwater supplementation, reed growth characteristics and soil properties greatly improved. As water depth increased, reed growth decreased gradually. Reeds grew best in shallow water depth (<= 10cm) than in the greater flooding depths. Saturated soils with no standing water at the early stage of reed growth increased reed survival and water depth can be increased as the reeds grow. During the process of water supplementation, soil salinity was reduced significantly. Soil salinity was reduced dramatically at early and middle stages of reed growth, but it increased slightly at the later stage. Soil pH increased greatly during the experiment. Soil total nitrogen (TN) and total organic carbon (TOC) showed contrasting changes, with soil TN decreasing and TOC increasing. To best manage reed wetlands restoration, we suggest saturating wetland in the spring to stimulate reed germination, increasing surface water depth up to 15cm at the stage of reed rapid growth, and then reducing water depth during the later growth stage.	[Wang, Xuehong; Zhang, Dongjie; Qi, Qing; Tong, Shouzheng] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Wetland Ecol & Environm, Changchun, Jilin, Peoples R China; [Zhang, Dongjie; Qi, Qing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Guan, Bo] Chinese Acad Sci, Yantai Inst Coastal Zone Res YIC, Key Lab Coastal Environm Proc & Ecol Remediat, Yantai, Shandong, Peoples R China	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS	Tong, SZ (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Wetland Ecol & Environm, Changchun, Jilin, Peoples R China.	tongshouzheng@neigae.ac.cn		DONGJIE, ZHANG/0000-0002-2768-9077	National Natural Science Foundation of China [41301052, 31300325]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This paper is supported by the National Natural Science Foundation of China (41301052 and 1300325), http://www.nsfc.gov.cn/publish/portal1/.	Abegunrin TP, 2016, CATENA, V139, P167, DOI 10.1016/j.catena.2015.12.014; Akbarimoghaddam H., 2011, Trakia Journal of Sciences, V9, P43; Bano A, 2009, BIOL FERT SOILS, V45, P405, DOI 10.1007/s00374-008-0344-9; Coops H, 1996, AQUAT BOT, V54, P11, DOI 10.1016/0304-3770(96)01025-X; Cui BS, 2009, ECOL ENG, V35, P1090, DOI 10.1016/j.ecoleng.2009.03.022; [崔保山 CUI BaoShan], 2008, [生态学报, Acta Ecologica Sinica], V28, P1408; DAVIS T, 1994, RAMS CONV MAN GUID C; Deegan BM, 2007, AQUAT BOT, V86, P309, DOI 10.1016/j.aquabot.2006.11.006; Dwire KA, 2004, OECOLOGIA, V139, P309, DOI 10.1007/s00442-004-1498-2; Garbey C, 2006, HYDROBIOLOGIA, V570, P41, DOI 10.1007/s10750-006-0159-3; Gorai M, 2010, FLORA MORPHOL DISTRI, p1 ; Greenwood ME, 2006, WETLANDS, V26, P854, DOI 10.1672/0277-5212(2006)26[854:EOSATO]2.0.CO;2; Guan B, 2011, CLEAN-SOIL AIR WATER, V39, P1029, DOI 10.1002/clen.201000557; HELLINGS SE, 1992, J APPL ECOL, V29, P41, DOI 10.2307/2404345; Hu YC, 2005, J PLANT NUTR SOIL SC, V168, P541, DOI 10.1002/jpln.200420516; Kaelke CM, 2003, PLANT SOIL, V254, P167, DOI 10.1023/A:1024903912325; Kaur B, 2000, APPL SOIL ECOL, V15, P283, DOI 10.1016/S0929-1393(00)00079-2; Lal R, 2001, CLIMATIC CHANGE, V51, P35, DOI 10.1023/A:1017529816140; Li SN, 2009, ECOL ENG, V35, P1719, DOI 10.1016/j.ecoleng.2009.07.009; Mamilov A, 2004, SOIL SCI PLANT NUTR, V50, P839, DOI 10.1080/00380768.2004.10408544; Meyerson LA, 2000, WETLANDS ECOLOGY MAN, V8, P89, DOI DOI 10.1023/A:1008432200133; Mitsch WJ, 2005, ECOL ENG, V24, P243, DOI 10.1016/j.ecoleng.2005.02.006; Mitsch WJ, 1996, ECOL APPL, V6, P77, DOI 10.2307/2269554; Mu CongRu, 2000, Chinese Journal of Applied Ecology, V11, P123; Pathak H, 1998, SOIL BIOL BIOCHEM, V30, P695, DOI 10.1016/S0038-0717(97)00208-3; Paul D, 2013, J BASIC MICROB, V53, P101, DOI 10.1002/jobm.201100288; Rasul G, 2006, APPL SOIL ECOL, V31, P1, DOI 10.1016/j.apsoil.2005.04.007; Shand P, 2017, PROCED EARTH PLAN SC, V17, P456, DOI 10.1016/j.proeps.2016.12.115; Shrivastava P, 2015, SAUDI J BIOL SCI, V22, P123, DOI 10.1016/j.sjbs.2014.12.001; Strand JA, 2001, J ECOL, V89, P166, DOI 10.1046/j.1365-2745.2001.00530.x; Surendran U, 2016, AGR WATER MANAGE, V178, P21, DOI 10.1016/j.agwat.2016.08.016; Tiner R.W., 1999, WETLAND INDICATORS G; Vaezi AR, 2017, SCI TOTAL ENVIRON, V583, P382, DOI 10.1016/j.scitotenv.2017.01.078; Vretare V, 2001, AQUAT BOT, V69, P127, DOI 10.1016/S0304-3770(01)00134-6; Wallace J, 2012, J HYDROL, V475, P84, DOI 10.1016/j.jhydrol.2012.09.032; Wang SL, 2013, MAR POLLUT BULL, V76, P7, DOI 10.1016/j.marpolbul.2013.08.025; Wang XH, 2012, ENVIRON MANAGE, V49, P325, DOI 10.1007/s00267-011-9757-6; White SD, 2002, AQUAT BOT, V73, P115, DOI 10.1016/S0304-3770(02)00010-4; Wijte AHBM, 1996, AM J BOT, V83, P1337, DOI 10.2307/2446119; Xue XZ, 2004, J ENVIRON MANAGE, V71, P271, DOI 10.1016/j.jenvman.2004.03.006; Yang ZF, 2009, COMMUN NONLINEAR SCI, V14, P2469, DOI 10.1016/j.cnsns.2007.12.015; Yu JB, 2012, CLEAN-SOIL AIR WATER, V40, P1154, DOI 10.1002/clen.201100743; Yu W.Y., 2008, ACTA ECOL SIN, V28, P4594, DOI [10.1016/S1872-2032(08)60081-5, DOI 10.1016/S1872-2032(08)60081-5]	43	9	9	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177692	10.1371/journal.pone.0177692	http://dx.doi.org/10.1371/journal.pone.0177692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542169	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058800023
J	Bhattarai, G; Mehlenbacher, SA				Bhattarai, Gehendra; Mehlenbacher, Shawn A.			In silico development and characterization of tri-nucleotide simple sequence repeat markers in hazelnut (Corylus avellana L.)	PLOS ONE			English	Article							FILBERT BLIGHT RESISTANCE; GENETIC-LINKAGE MAP; MICROSATELLITE MARKERS; TRANSCRIPTOME SEQUENCES; GENOTYPING APPLICATIONS; NULL ALLELES; SSR-MARKERS; TRANSFERABILITY; LOCI; GENOME	Plant genomes are now sequenced rapidly and inexpensively. In silico approaches allow efficient development of simple sequence repeat markers, also known as microsatellite markers, from these sequences. A search of the genome sequence of 'Jefferson' hazelnut (Corylus avellana L.) identified 8,708 tri-nucleotide simple sequence repeats with at least five repeat units, and stepwise removal of the less promising sequences led to the development of 150 polymorphic markers. Fragments in the 'Jefferson' sequence containing trinucleotide repeats were used as references and aligned with genomic sequences from seven other cultivars. Following in silico alignment, sequences that showed variation in number of repeat units were selected and primer pairs were designed for 243 of them. Screening on agarose gels identified 173 as polymorphic. Removal of duplicate and previously published sequences reduced the number to 150, for which fluorescent primers and capillary electrophoresis were used for amplicon sizing. These were characterized using 50 diverse hazelnut accessions. Of the 150, 132 generated the expected one or two alleles per accession while 18 amplified more than two amplicons in at least one accession. Diversity parameters of the 132 marker loci averaged 4.73 for number of alleles, 0.51 for expected heterozygosity (H-e), 0.49 for observed heterozygosity (H-o), 0.46 for polymorphism information content (PIC), and 0.04 for frequency of null alleles. The clustering of the 50 accessions in a dendrogram constructed from the 150 markers confirmed the wide genetic diversity and presence of three of the four major geographic groups: Central European, Black Sea, and Spanish-Italian. In the mapping population, 105 loci segregated, of which 101 were assigned to a linkage group (LG), with positions well-dispersed across all 11 LGs. These new markers will be useful for cultivar fingerprinting, diversity studies, genome comparisons, mapping, and alignment of the linkage map with the genome sequence and physical map.	[Bhattarai, Gehendra; Mehlenbacher, Shawn A.] Oregon State Univ, Dept Hort, 4017 ALS Bldg, Corvallis, OR 97331 USA	Oregon State University	Mehlenbacher, SA (corresponding author), Oregon State Univ, Dept Hort, 4017 ALS Bldg, Corvallis, OR 97331 USA.	shawn.mehlenbacher@oregonstate.edu	Bhattarai, Gehendra/ABE-4356-2020; Bhattarai, Gehendra/N-2851-2019	Bhattarai, Gehendra/0000-0002-2381-1629; Bhattarai, Gehendra/0000-0002-2381-1629	Oregon Hazelnut Commission; Oregon Agricultural Experiment Station; U.S. Department of Agriculture, Specific Cooperative Agreement; USDA-NIFA Agriculture and Food Research Initiative Competitive [2014-67013-22421]	Oregon Hazelnut Commission; Oregon Agricultural Experiment Station; U.S. Department of Agriculture, Specific Cooperative Agreement; USDA-NIFA Agriculture and Food Research Initiative Competitive	This work was supported by Oregon Hazelnut Commission to SM; Oregon Agricultural Experiment Station to SM; U.S. Department of Agriculture, Specific Cooperative Agreement to SM and the USDA-NIFA Agriculture and Food Research Initiative Competitive Grant 2014-67013-22421 to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; Bassil NV, 2005, ACTA HORTIC, P105, DOI 10.17660/ActaHortic.2005.686.13; Bassil NV, 2005, J AM SOC HORTIC SCI, V130, P543, DOI 10.21273/JASHS.130.4.543; Beltramo C, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0450-6; Boccacci P, 2006, GENOME, V49, P598, DOI 10.1139/G06-017; Boccacci P, 2005, MOL ECOL NOTES, V5, P934, DOI 10.1111/j.1471-8286.2005.01121.x; Boccacci P, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0195-7; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Chen HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132519; Colburn BC, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-016-0616-2; Colburn BC, 2015, J AM SOC HORTIC SCI, V140, P191, DOI 10.21273/JASHS.140.2.191; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Csencsics D, 2010, J HERED, V101, P789, DOI 10.1093/jhered/esq069; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Gao CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110638; Ghislain M, 2004, THEOR APPL GENET, V108, P881, DOI 10.1007/s00122-003-1494-7; Gimenes MA, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-9; Gokirmak T, 2009, GENET RESOUR CROP EV, V56, P147, DOI 10.1007/s10722-008-9352-8; Gurcan K, 2010, MOL BREEDING, V26, P551, DOI 10.1007/s11032-010-9464-7; Gurcan K, 2010, TREE GENET GENOMES, V6, P513, DOI 10.1007/s11295-010-0269-y; Gurcan K, 2010, J AM SOC HORTIC SCI, V135, P159, DOI 10.21273/JASHS.135.2.159; Guo WZ, 2007, GENETICS, V176, P527, DOI 10.1534/genetics.107.070375; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; Kalinowski ST, 2006, CONSERV GENET, V7, P991, DOI 10.1007/s10592-006-9134-9; Kumari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067742; Lai YL, 2003, MOL BIOL EVOL, V20, P2123, DOI 10.1093/molbev/msg228; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li ML, 2009, MOL BREEDING, V24, P41, DOI 10.1007/s11032-009-9270-2; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lunde CF, 2000, HORTSCIENCE, V35, P729, DOI 10.21273/HORTSCI.35.4.729; Martins WS, 2009, BIOINFORMATION, V3, P282, DOI 10.6026/97320630003282; Mehlenbacher SA, 2006, GENOME, V49, P122, DOI 10.1139/G05-091; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Mnejja M, 2010, TREE GENET GENOMES, V6, P689, DOI 10.1007/s11295-010-0284-z; Moretzsohn MC, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-40; MURRAY V, 1993, NUCLEIC ACIDS RES, V21, P2395, DOI 10.1093/nar/21.10.2395; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Parida SK, 2010, GENOME, V53, P55, DOI [10.1139/G09-084, 10.1139/g09-084]; Parida SK, 2009, THEOR APPL GENET, V118, P327, DOI 10.1007/s00122-008-0902-4; PEMBERTON JM, 1995, MOL ECOL, V4, P249, DOI 10.1111/j.1365-294X.1995.tb00214.x; Richard GF, 2000, EMBO REP, V1, P122, DOI 10.1093/embo-reports/kvd031; Rowley E., 2016, THESIS; Sathuvalli VR, 2011, TREE GENET GENOMES, V7, P337, DOI 10.1007/s11295-010-0335-5; Sathuvalli VR, 2013, TREE GENET GENOMES, V9, P1109, DOI 10.1007/s11295-013-0626-8; Sathuvalli VR, 2012, HORTSCIENCE, V47, P570, DOI 10.21273/HORTSCI.47.5.570; Sathuvalli VR, 2011, J AM SOC HORTIC SCI, V136, P350, DOI 10.21273/JASHS.136.5.350; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vukosavljev M, 2015, MOL ECOL RESOUR, V15, P17, DOI 10.1111/1755-0998.12289; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Wang ML., 2009, G3GENES GENOMES GENE, V3, P54; Wang Y, 2008, J AM SOC HORTIC SCI, V133, P692, DOI 10.21273/JASHS.133.5.692; Whankaew S, 2013, AFRICAN J BIOTECHNOL, V10, P1768; WRIGHT JM, 1994, REV FISH BIOL FISHER, V4, P384, DOI 10.1007/BF00042912	58	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178061	10.1371/journal.pone.0178061	http://dx.doi.org/10.1371/journal.pone.0178061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531233	Green Submitted, gold, Green Published			2022-12-26	WOS:000402058400054
J	Moriki, T; Nakamura, T; Kamijo, Y; Nishimura, Y; Banno, M; Kinoshita, T; Uenishi, H; Tajima, F				Moriki, Takashi; Nakamura, Takeshi; Kamijo, Yoshi-ichiro; Nishimura, Yukihide; Banno, Motohiko; Kinoshita, Tokio; Uenishi, Hiroyasu; Tajima, Fumihiro			Noninvasive positive pressure ventilation enhances the effects of aerobic training on cardiopulmonary function	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; END-EXPIRATORY PRESSURE; MAXIMAL OXYGEN INTAKE; CARDIORESPIRATORY FITNESS; DIASTOLIC VOLUMES; PHYSICAL-ACTIVITY; HEALTHY-MEN; BED REST; EXERCISE; PREDICTION	Purpose The purpose of this study was to determine the effect of aerobic training under noninvasive positive pressure ventilation (NPPV) on maximal oxygen uptake (VO2max). Methods Ten healthy young male volunteers participated in the study. Before the training, stroke volume (SV) and cardiac output (CO) were measured in all subjects under 0, 4, 8, and 12 cmH(2)O NPPV at rest. Then, the subjects exercised on a cycle ergometer at 60% of pretraining VO2max for 30 min daily for 5 consecutive days with/without NPPV. The 5-day exercise protocol was repeated after a three-week washout period without/with NPPV. The primary endpoint was changes in VO2max. The secondary endpoints were changes in SV, CO, maximum heart rate (HRmax), maximum respiratory rate (RRmax), maximum expiratory minute volume (VEmax) and the percent change in plasma volume (PV). Results NPPV at 12 cmH(2)O significantly reduced SV and CO at rest. VO2max significantly increased after 5 days training with and without NPPV, but the magnitude of increase in VO2max after training under 12 cmH(2)O NPPV was significantly higher than after training without NPPV. VEmax significantly increased after training under NPPV, but not after training without NPPV. HRmax and RRmax did not change during training irrespective of NPPV. The percent change in PV was similar between training with and without NPPV. The 5-day training program with NPPV resulted in greater improvement in VO2max than without NPPV. Conclusions Aerobic training under NPPV has add-on effects on VO2max and exercise-related health benefits in healthy young men.	[Moriki, Takashi; Kamijo, Yoshi-ichiro; Nishimura, Yukihide; Banno, Motohiko; Kinoshita, Tokio; Uenishi, Hiroyasu; Tajima, Fumihiro] Wakayama Med Univ, Dept Rehabil Med, Wakayama, Wakayama, Japan; [Nakamura, Takeshi] Yokohama City Univ, Sch Med, Dept Rehabil Med, Yokohama, Kanagawa, Japan	Wakayama Medical University; Yokohama City University	Nakamura, T (corresponding author), Yokohama City Univ, Sch Med, Dept Rehabil Med, Yokohama, Kanagawa, Japan.	take_n@yokohama-cu.ac.jp	Kamijo, Yoshi-ichiro/AAH-2810-2020	Nishimura, Yukihide/0000-0002-5365-1347	MEXT KAKENHI Grant [JP15K01382]; Ministry of Education, Culture, Sports, Science and Technology (MEXT)	MEXT KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by MEXT KAKENHI Grant Number JP15K01382. The URLs of Ministry of Education, Culture, Sports, Science and Technology (MEXT) is http://www.mext.go.jp/en/index.htm. Author who received funding is TN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham KA, 2002, J PHYSIOL-LONDON, V541, P653, DOI 10.1113/jphysiol.2001.013462; ASTRAND PO, 1956, PHYSIOL REV, V36, P307; Baisch F, 2000, EUR J CLIN INVEST, V30, P1055, DOI 10.1046/j.1365-2362.2000.00750.x; BALKE B, 1959, U S Armed Forces Med J, V10, P675; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; BRUCE RA, 1973, AM HEART J, V85, P546, DOI 10.1016/0002-8703(73)90502-4; Buchan DS, 2012, J PUBLIC HEALTH RES, V1, P59, DOI 10.4081/jphr.2012.e11; COOPER KH, 1968, J AMER MED ASSOC, V203, P201, DOI 10.1001/jama.203.3.201; CURETON KJ, 1995, MED SCI SPORT EXER, V27, P445; DORINSKY PM, 1983, CHEST, V84, P210, DOI 10.1378/chest.84.2.210; Fernhall Bo, 2008, J Health Hum Serv Adm, V30, P468; FEWELL JE, 1980, CIRC RES, V47, P467, DOI 10.1161/01.RES.47.3.467; FEWELL JE, 1980, CIRC RES, V46, P125, DOI 10.1161/01.RES.46.1.125; Goodman JM, 2005, J APPL PHYSIOL, V98, P454, DOI 10.1152/japplphysiol.00258.2004; Gordon D, 2014, EUR J APPL PHYSIOL, V114, P21, DOI 10.1007/s00421-013-2743-3; Haller JM, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.124; HENKE KG, 1988, J APPL PHYSIOL, V64, P135, DOI 10.1152/jappl.1988.64.1.135; Hill AV, 1923, Q J MED, V16, P135, DOI 10.1093/qjmed/os-16.62.135; Holm Paige, 2004, BMC Physiol, V4, P9, DOI 10.1186/1472-6793-4-9; JARDIN F, 1981, NEW ENGL J MED, V304, P387, DOI 10.1056/NEJM198102123040703; Jones AM, 2000, SPORTS MED, V29, P373, DOI 10.2165/00007256-200029060-00001; JONES NL, 1979, B EUR PHYSIOPATH RES, V15, P321; Kilmer David D, 2005, Phys Med Rehabil Clin N Am, V16, P1053, DOI 10.1016/j.pmr.2005.08.014; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Lee DC, 2011, BRIT J SPORT MED, V45, P504, DOI 10.1136/bjsm.2009.066209; Levine BD, 2008, J PHYSIOL-LONDON, V586, P25, DOI 10.1113/jphysiol.2007.147629; Luecke T, 2005, CRIT CARE, V9, P607, DOI 10.1186/cc3877; Perhonen MA, 2001, J APPL PHYSIOL, V91, P645, DOI 10.1152/jappl.2001.91.2.645; Puente-Maestu Luis, 2006, Int J Chron Obstruct Pulmon Dis, V1, P381, DOI 10.2147/copd.2006.1.4.381; Saltin B., 1968, CIRCULATION, V38, P1, DOI 10.1161/01.CIR.38.1.1; Shibasaki M, 2009, AM J PHYSIOL-REG I, V297, pR1706, DOI 10.1152/ajpregu.00242.2009; STORER TW, 1990, MED SCI SPORT EXER, V22, P704, DOI 10.1249/00005768-199010000-00024; STROHL KP, 1981, J APPL PHYSIOL, V51, P1471, DOI 10.1152/jappl.1981.51.6.1471; Sugiura H, 2013, J PHYS THER SCI, V25, P1491, DOI 10.1589/jpts.25.1491; Swain DP, 2002, MED SCI SPORT EXER, V34, P152, DOI 10.1097/00005768-200201000-00023; VANDERSCHANS GP, 1994, CHEST, V105, P782, DOI 10.1378/chest.105.3.782; VIQUERAT CE, 1983, CHEST, V83, P509, DOI 10.1378/chest.83.3.509; Wasserman K, 1997, CHEST, V112, P1091, DOI 10.1378/chest.112.4.1091; Watenpaugh DE, 2000, J APPL PHYSIOL, V89, P218, DOI 10.1152/jappl.2000.89.1.218; Wibmer T, 2014, RESP CARE, V59, P699, DOI 10.4187/respcare.02668	40	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178003	10.1371/journal.pone.0178003	http://dx.doi.org/10.1371/journal.pone.0178003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531211	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058400048
J	Cheng, QP; Li, HX; Xu, YL; Chen, S; Liao, YH; Deng, F; Li, JF				Cheng, Qunpeng; Li, Hongxia; Xu, Yilu; Chen, Song; Liao, Yuhua; Deng, Fang; Li, Jianfen			Study on the adsorption of nitrogen and phosphorus from biogas slurry by NaCl-modified zeolite	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; WASTE-WATER; NATURAL ZEOLITE; AQUEOUS-SOLUTION; ACTIVATED CARBON; ION-EXCHANGE; AMMONIUM REMOVAL; PIG SLURRY; FLY-ASH; ADSORBENT	A NaCl-modified zeolite was used to simultaneously remove nitrogen and phosphate from biogas slurry. The effect of pH, contact time and dosage of absorbants on the removal efficiency of nitrogen and phosphate were studied. The results showed that the highest removal efficiency of NH4+-N (92.13%) and PO43--P (90.3%) were achieved at pH 8. While the zeolite doses ranged from 0.5 to 5 g/100 ml, NH4+-N and PO43--P removal efficiencies ranged from 5.19% to 94.94% and 72.16% to 91.63% respectively. The adsorption isotherms of N and P removal with NaCl-modified zeolite were well described by Langmuir models, suggesting the homogeneous sorption mechanisms. While through intra-particle diffusion model to analyze the influence of contact time, it showed that the adsorption process of NH4+-N and PO43--P followed the second step of intra-particle diffusion model. The surface diffusion adsorption step was very fast which was finished in a short time.	[Cheng, Qunpeng; Li, Hongxia; Li, Jianfen] Wuhan Polytech Univ, Sch Chem & Environm Engn, Wuhan, Peoples R China; [Xu, Yilu] Univ Newcastle, Global Ctr Environm Remediat, Adv Technol Ctr, Fac Sci & Informat Technol, Callaghan, NSW, Australia; [Liao, Yuhua; Deng, Fang; Li, Jianfen] Huazhong Univ Sci & Technol, Sch Environm Sci & Engn, Wuhan, Peoples R China	Wuhan Polytechnic University; University of Newcastle; Huazhong University of Science & Technology	Li, JF (corresponding author), Wuhan Polytech Univ, Sch Chem & Environm Engn, Wuhan, Peoples R China.	whpu123@126.com			Wuhan Polytechnic University [2015070504020222]; Wuhan high-tech industry science and technology innovation team projects [2015070504020222]	Wuhan Polytechnic University; Wuhan high-tech industry science and technology innovation team projects	This research was supported by Wuhan high-tech industry science and technology innovation team projects (No. 2015070504020222) from Wuhan Polytechnic University.r This research was supported by Wuhan high-tech industry science and technology innovation team projects (No. 2015070504020222). The authors would also like to thank the Analytical and Test Center of Huazhong University of Science and Technology for carrying out the analysis of samples.r I confirmed that the research support from, "Wuhan high-tech industry science and technology innovation team projects (No. 2015070504020222)" was an academic grant from Wuhan Polytechnic University.	Alshameri A, 2014, J TAIWAN INST CHEM E, V45, P554, DOI 10.1016/j.jtice.2013.05.008; APHA, 1995, STANDARD METHODS EXA; Chen KN, 2013, ENVIRON TECHNOL, V34, P1489, DOI 10.1080/09593330.2012.758659; Chen XY, 2012, BIORESOURCE TECHNOL, V110, P79, DOI 10.1016/j.biortech.2012.01.096; Cheng S, 2016, RSC ADV, V6, P78936, DOI 10.1039/c6ra14082c; Egashira R, 2012, PROCEDIA ENGINEER, V42, P49, DOI 10.1016/j.proeng.2012.07.394; Fenton O, AGR WASTEWATERS; Fenton O, 2012, ALGAL RES, V1, P49, DOI 10.1016/j.algal.2012.03.003; Flynn CJO, 2013, J ENVIRON MANAGE, V128, P690, DOI 10.1016/j.jenvman.2013.06.020; Garg RN, 2005, ENVIRON MONIT ASSESS, V107, P1, DOI 10.1007/s10661-005-2021-x; Guo XJ, 2013, J ENVIRON SCI-CHINA, V25, P954, DOI 10.1016/S1001-0742(12)60115-6; Huang HM, 2010, J HAZARD MATER, V175, P247, DOI 10.1016/j.jhazmat.2009.09.156; Inglezakis VJ, 2005, J COLLOID INTERF SCI, V281, P68, DOI 10.1016/j.jcis.2004.08.082; Jiang C, 2013, J COLLOID INTERF SCI, V402, P246, DOI 10.1016/j.jcis.2013.03.057; Jones Susan H, 2010, NANOPOROUS CARBON ZE; Karadag D, 2006, J HAZARD MATER, V136, P604, DOI 10.1016/j.jhazmat.2005.12.042; Li WY, 2016, PROCESS SAF ENVIRON, V102, P150, DOI 10.1016/j.psep.2016.03.001; Lin L, 2014, SEP PURIF TECHNOL, V133, P351, DOI 10.1016/j.seppur.2014.07.010; Lin L, 2013, BIORESOURCE TECHNOL, V136, P302, DOI 10.1016/j.biortech.2013.02.106; Magriotis ZM, 2014, APPL CLAY SCI, V91-92, P55, DOI 10.1016/j.clay.2014.02.007; Maranon E, 2006, J HAZARD MATER, V137, P1402, DOI 10.1016/j.jhazmat.2006.03.069; Meng SL, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1556-7; Murnane JG, 2016, ZEOLITE COMBINED ALU; O'Flynn CJ, 2012, J ENVIRON MANAGE, V113, P78, DOI 10.1016/j.jenvman.2012.08.026; O' Flynn CJ, 2013, ENVIRON SCI POLLUT R, V20, P6019, DOI 10.1007/s11356-013-1630-0; Onyango MS, 2007, IND ENG CHEM RES, V46, P894, DOI 10.1021/ie060742m; Saeedi R, 2012, ENVIRON ENG SCI, V29, P93, DOI 10.1089/ees.2011.0077; Saltali K, 2007, J HAZARD MATER, V141, P258, DOI 10.1016/j.jhazmat.2006.06.124; Sen Gupta S, 2014, RSC ADV, V4, P28537, DOI 10.1039/c4ra03673e; Sprynskyy M, 2005, SEP PURIF TECHNOL, V46, P155, DOI 10.1016/j.seppur.2005.05.004; Terry PA, 2009, ENVIRON ENG SCI, V26, P691, DOI 10.1089/ees.2007.0222; Thornton A, 2007, J HAZARD MATER, V147, P883, DOI 10.1016/j.jhazmat.2007.01.111; Nguyen TC, 2015, CHEM ENG J, V270, P393, DOI 10.1016/j.cej.2015.02.047; Ugurlu M, 2011, MICROPOR MESOPOR MAT, V139, P173, DOI 10.1016/j.micromeso.2010.10.039; von Eckstaedt SV, 2016, CHEMOSPHERE, V144, P257, DOI 10.1016/j.chemosphere.2015.08.048; Wang H, 2016, RSC ADV, V6, P55809, DOI 10.1039/c6ra12169a; Wang JZ, 2012, J ENVIRON QUAL, V41, P1221, DOI 10.2134/jeq2011.0373; Wang YQ, 2006, J HAZARD MATER, V136, P735, DOI 10.1016/j.jhazmat.2006.01.002; Yu Q, 2016, RSC ADV; Zhao Y, 2016, ENV ENG SCI; Zhu NY, 2016, CHEMOSPHERE, V164, P32, DOI 10.1016/j.chemosphere.2016.08.036	41	29	29	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0176109	10.1371/journal.pone.0176109	http://dx.doi.org/10.1371/journal.pone.0176109			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542420	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672600002
J	Krah, A; Kato-Yamada, Y; Takada, S				Krah, Alexander; Kato-Yamada, Yasuyuki; Takada, Shoji			The structural basis of a high affinity ATP binding epsilon subunit from a bacterial ATP synthase	PLOS ONE			English	Article							THERMOPHILIC F-1-ATPASE; ESCHERICHIA-COLI; INHIBITOR PROTEIN; BOVINE F-1-ATPASE; HIGH-THROUGHPUT; FORCE; MITOCHONDRIAL; ROTATION; SITE; TRANSITIONS	The epsilon subunit from bacterial ATP synthases functions as an ATP sensor, preventing ATPase activity when the ATP concentration in bacterial cells crosses a certain threshold. The R103A/R115A double mutant of the e subunit from thermophilic Bacillus PS3 has been shown to bind ATP two orders of magnitude stronger than the wild type protein. We use molecular dynamics simulations and free energy calculations to derive the structural basis of the high affinity ATP binding to the R103A/R115A double mutant. Our results suggest that the double mutant is stabilized by an enhanced hydrogen-bond network and fewer repulsive contacts in the ligand binding site. The inferred structural basis of the high affinity mutant may help to design novel nucleotide sensors based on the e subunit from bacterial ATP synthases.	[Krah, Alexander; Takada, Shoji] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto, Japan; [Krah, Alexander] Korea Inst Adv Study, Sch Computat Sci, Seoul, South Korea; [Kato-Yamada, Yasuyuki] Rikkyo Univ, Dept Life Sci, Coll Sci, Toshima Ku, Tokyo, Japan	Kyoto University; Korea Institute for Advanced Study (KIAS); Rikkyo University	Krah, A (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto, Japan.; Krah, A (corresponding author), Korea Inst Adv Study, Sch Computat Sci, Seoul, South Korea.	alexkrah@kias.re.kr		Krah, Alexander/0000-0001-8871-5550	Japan Society for the Promotion of Science [P13705]; JSPS KAKENHI [15K07013]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	AK was supported by a Postdoctoral Fellowship for Foreign Researchers from the Japan Society for the Promotion of Science (JSPS-ID: P13705) (https://www.jsps.go.ip/). Computational resources have been provided by the Okazaki Research Centre for Computational Sciences (to ST; https://ccportal.ims.ac.jp/en/). Part of this work was supported by JSPS KAKENHI (15K07013 to YKY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002561; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cabezon E, 2000, J BIOL CHEM, V275, P28353, DOI 10.1074/jbc.C000427200; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; Cabezon E, 2001, EMBO J, V20, P6990, DOI 10.1093/emboj/20.24.6990; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; Dimroth P, 1997, BBA-BIOENERGETICS, V1318, P11, DOI 10.1016/S0005-2728(96)00127-2; DROBINSKAYA IY, 1985, FEBS LETT, V182, P419, DOI 10.1016/0014-5793(85)80346-X; Espinosa E, 1998, CHEM PHYS LETT, V285, P170, DOI 10.1016/S0009-2614(98)00036-0; Feniouk BA, 2010, BIOPHYS J, V98, P434, DOI 10.1016/j.bpj.2009.10.023; Ferguson SA, 2016, P NATL ACAD SCI USA, V113, P10860, DOI 10.1073/pnas.1612035113; Hatsugai N, 2012, PLANT CELL PHYSIOL, V53, P1768, DOI 10.1093/pcp/pcs119; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Homeyer N, 2014, J CHEM THEORY COMPUT, V10, P3331, DOI 10.1021/ct5000296; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HYNDMAN DJ, 1994, J BIOL CHEM, V269, P28871; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Kato S, 2007, J BIOL CHEM, V282, P37618, DOI 10.1074/jbc.M707509200; Kato-Yamada Y, 2005, FEBS LETT, V579, P6875, DOI 10.1016/j.febslet.2005.11.036; Kato-Yamada Y, 2003, J BIOL CHEM, V278, P36013, DOI 10.1074/jbc.M306140200; Kato-Yamada Y, 2016, BIOCHEM BIOPH RES CO, V469, P1129, DOI 10.1016/j.bbrc.2015.12.121; Kioka H, 2014, P NATL ACAD SCI USA, V111, P273, DOI 10.1073/pnas.1318547111; Krah A, 2016, BBA-BIOENERGETICS, V1857, P332, DOI 10.1016/j.bbabio.2016.01.007; Krah A, 2015, PROG BIOPHYS MOL BIO, V119, P94, DOI 10.1016/j.pbiomolbio.2015.06.005; Krah A, 2015, BBA-BIOENERGETICS, V1847, P1101, DOI 10.1016/j.bbabio.2015.05.018; Krah A, 2010, BBA-BIOENERGETICS, V1797, P763, DOI 10.1016/j.bbabio.2010.04.014; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; SHARP KA, 1990, J PHYS CHEM-US, V94, P7684, DOI 10.1021/j100382a068; Shirakihara Y, 2015, FEBS J, V282, P2895, DOI 10.1111/febs.13329; Sobti M, 2016, ELIFE, V5, DOI 10.7554/eLife.21598; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Uhlin U, 1997, STRUCTURE, V5, P1219, DOI 10.1016/S0969-2126(97)00272-4; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; WILKENS S, 1995, NAT STRUCT BIOL, V2, P961, DOI 10.1038/nsb1195-961; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104; Yagi H, 2010, BIOCHEM J, V425, P85, DOI 10.1042/BJ20091247; Yaginuma H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06522; Yoshida T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39618	57	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177907	10.1371/journal.pone.0177907	http://dx.doi.org/10.1371/journal.pone.0177907			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542497	Green Submitted, Green Published, gold			2022-12-26	WOS:000401672400111
J	Laroque, A; Min-Oo, G; Tam, M; Ponka, P; Stevenson, MM; Gros, P				Laroque, Aurelie; Min-Oo, Gundula; Tam, Mifong; Ponka, Prem; Stevenson, Mary M.; Gros, Philippe			The mouse Char10 locus regulates severity of pyruvate kinase deficiency and susceptibility to malaria	PLOS ONE			English	Article							RECOMBINANT CONGENIC STRAINS; CEREBRAL MALARIA; GENETIC-CONTROL; RESISTANCE LOCUS; RED-CELL; INFECTION; ANEMIA; MICE; IDENTIFICATION; EXPRESSION	Pyruvate kinase (PKLR) deficiency protects mice and humans against blood-stage malaria. Although mouse strain AcB62 carries a malaria-protective Pklr(I90N) genetic mutation, it is phenotypically susceptible to blood stage malaria induced by infection with Plasmodium chabaudi AS, suggesting a genetic modifier of the Pklr(I90N) protective effect. Linkage analysis in a F2 cross between AcB62 (Pklr(I90N)) and another PK deficient strain CBA/Pk (Pklr(G338D)) maps this modifier (designated Char10) to chromosome 9 (LOD = 10.8, 95% Bayesian CI = 50.7-75Mb). To study the mechanistic basis of the Char10 effect, we generated an incipient congenic line (Char10C) that harbors the Char10 chromosome 9 segment from AcB62 fixed on the genetic background of CBA/Pk. The Char10 effect is shown to be highly penetrant as the Char10C line recapitulates the AcB62 phenotype, displaying high parasitemia following P. chabaudi infection, compared to CBA/Pk. Char10C mice also display a reduction in anemia phenotypes associated with the Pklr(G338D) mutation including decreased splenomegaly, decreased circulating reticulocytes, increased density of mature erythrocytes, increased hematocrit, as well as decreased iron overload in kidney and liver and decreased serum iron. Erythroid lineage analyses indicate that the number of total TER119(+) cells as well as the numbers of the different CD71(+)/CD44(+) erythroblast sub-populations were all found to be lower in Char10C spleen compared to CBA/Pk. Char10C mice also displayed lower number of CFU-E per spleen compared to CBA/Pk. Taken together, these results indicate that the Char10 locus modulates the severity of pyruvate kinase deficiency by regulating erythroid responses in the presence of PK-deficiency associated haemolytic anemia.	[Laroque, Aurelie; Min-Oo, Gundula; Gros, Philippe] McGill Univ, Biochem Dept, Montreal, PQ, Canada; [Tam, Mifong; Stevenson, Mary M.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Ponka, Prem] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Ponka, Prem] McGill Univ, Physiol Dept, Montreal, PQ, Canada	McGill University; McGill University; Lady Davis Institute; McGill University; McGill University	Gros, P (corresponding author), McGill Univ, Biochem Dept, Montreal, PQ, Canada.	philippe.gros@mcgill.ca			Canadian Institutes for Health Research [MOP-119342]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by research grants to PG from the Canadian Institutes for Health Research (MOP-119342). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves J, 2010, BLOOD CELL MOL DIS, V44, P62, DOI 10.1016/j.bcmd.2009.09.008; Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; Ayi K, 2008, NEW ENGL J MED, V358, P1805, DOI 10.1056/NEJMoa072464; Ayi K, 2009, J INFECT DIS, V200, P1289, DOI 10.1086/605843; Bagot S, 2002, P NATL ACAD SCI USA, V99, P9919, DOI 10.1073/pnas.152215199; Berghout J, 2010, GENES IMMUN, V11, P310, DOI 10.1038/gene.2009.79; Bongfen SE, 2009, TRENDS PARASITOL, V25, P417, DOI 10.1016/j.pt.2009.05.012; Burt RA, 1999, IMMUNOGENETICS, V50, P278, DOI 10.1007/s002510050603; Campino S, 2005, GENES IMMUN, V6, P416, DOI 10.1038/sj.gene.6364219; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; DEMANT P, 1986, IMMUNOGENETICS, V24, P416, DOI 10.1007/BF00377961; Diwan A, 2007, P NATL ACAD SCI USA, V104, P6794, DOI 10.1073/pnas.0610666104; Dondorp AM, 1999, BRIT J HAEMATOL, V105, P505, DOI 10.1111/j.1365-2141.1999.01367.x; Foote SJ, 1997, NAT GENET, V17, P380, DOI 10.1038/ng1297-380; Fortin A, 1997, NAT GENET, V17, P382, DOI 10.1038/ng1297-382; Fortin A, 2001, P NATL ACAD SCI USA, V98, P10793, DOI 10.1073/pnas.191288998; Fortin A, 2001, GENOMICS, V74, P21, DOI 10.1006/geno.2001.6528; Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331; Hernandez-Valladares M, 2004, MAMM GENOME, V15, P390, DOI 10.1007/s00335-004-3042-4; Jelkmann W, 2013, TRANSFUS MED HEMOTH, V40, P302, DOI 10.1159/000356193; Khatib R, 2009, PEDIATR RADIOL, V39, P17, DOI 10.1007/s00247-008-1049-9; Koulnis M, 2011, JOVE-J VIS EXP, DOI 10.3791/2809; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Laroque A, 2012, GENES IMMUN, V13, P155, DOI 10.1038/gene.2011.67; Libregts SF, 2011, BLOOD, V118, P2578, DOI 10.1182/blood-2010-10-315218; Lin E, 2006, INFECT IMMUN, V74, P5814, DOI 10.1128/IAI.01690-05; Machado P, 2010, BRIT J HAEMATOL, V149, P775, DOI 10.1111/j.1365-2141.2010.08165.x; Min-Oo G, 2005, CELL MICROBIOL, V7, P753, DOI 10.1111/j.1462-5822.2005.00524.x; Min-Oo G, 2004, GENES IMMUN, V5, P168, DOI 10.1038/sj.gene.6364069; Min-Oo G, 2003, NAT GENET, V35, P357, DOI 10.1038/ng1260; Min-Oo G, 2010, GENES IMMUN, V11, P113, DOI 10.1038/gene.2009.78; Min-Oo G, 2007, J EXP MED, V204, P511, DOI 10.1084/jem.20061252; Min-Oo G, 2007, BLOOD CELL MOL DIS, V39, P63, DOI 10.1016/j.bcmd.2007.03.003; Min-Oo G, 2010, ANTIMICROB AGENTS CH, V54, P3262, DOI 10.1128/AAC.01719-09; Min-Oo G, 2010, EXP PARASITOL, V125, P315, DOI 10.1016/j.exppara.2010.02.009; Ohno T, 2004, IMMUNOGENETICS, V56, P675, DOI 10.1007/s00251-004-0739-1; Ohno T, 2001, IMMUNOGENETICS, V53, P736, DOI 10.1007/s00251-001-0390-z; Perkins DJ, 2011, INT J BIOL SCI, V7, P1427, DOI 10.7150/ijbs.7.1427; Rocha JL, 2004, MAMM GENOME, V15, P100, DOI 10.1007/s00335-003-2308-6; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Su Z, 2005, INFECT IMMUN, V73, P3531, DOI 10.1128/IAI.73.6.3531-3539.2005; TORRANCE JD, 1980, TISSUE IRON STORES, P90; Torre S, 2013, GENES IMMUN, V14, P249, DOI 10.1038/gene.2013.16; TURRINI F, 1992, BLOOD, V80, P801; Weatherall DJ, 2008, BRIT J HAEMATOL, V141, P276, DOI 10.1111/j.1365-2141.2008.07085.x; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009	46	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177818	10.1371/journal.pone.0177818	http://dx.doi.org/10.1371/journal.pone.0177818			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542307	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400089
J	Pezzoli, P; Antfolk, J; Santtila, P				Pezzoli, Patrizia; Antfolk, Jan; Santtila, Pekka			Phenotypic factor analysis of psychopathology reveals a new body-related transdiagnostic factor	PLOS ONE			English	Article							INTERMITTENT EXPLOSIVE DISORDER; SUBSTANCE USE DISORDERS; MENTAL-DISORDERS; HIERARCHICAL STRUCTURE; PSYCHIATRIC-DISORDERS; LIFETIME COMORBIDITY; PREDICTIVE-VALIDITY; GENDER-DIFFERENCES; BIFACTOR MODELS; META-STRUCTURE	Comorbidity challenges the notion of mental disorders as discrete categories. An increasing body of literature shows that symptoms cut across traditional diagnostic boundaries and interact in shaping the latent structure of psychopathology. Using exploratory and confirmatory factor analysis, we reveal the latent sources of covariation among nine measures of psychopathological functioning in a population-based sample of 13024 Finnish twins and their siblings. By implementing unidimensional, multidimensional, second-order, and bifactor models, we illustrate the relationships between observed variables, specific, and general latent factors. We also provide the first investigation to date of measurement invariance of the bifactor model of psychopathology across gender and age groups. Our main result is the identification of a distinct "Body" factor, alongside the previously identified Internalizing and Externalizing factors. We also report relevant cross-disorder associations, especially between body-related psychopathology and trait anger, as well as substantial sex and age differences in observed and latent means. The findings expand the meta-structure of psychopathology, with implications for empirical and clinical practice, and demonstrate shared mechanisms underlying attitudes towards nutrition, self-image, sexuality and anger, with gender-and age-specific features.	[Pezzoli, Patrizia; Antfolk, Jan; Santtila, Pekka] Abo Akad Univ, Dept Psychol, Turku, Finland; [Antfolk, Jan] Turku Brain & Mind Ctr, Turku, Finland	Abo Akademi University	Pezzoli, P (corresponding author), Abo Akad Univ, Dept Psychol, Turku, Finland.	patrizia.pezzoli@abo.fi	Pezzoli, Patrizia/AAI-1996-2019; Antfolk, Jan/D-2926-2018	Pezzoli, Patrizia/0000-0002-2425-5249; Antfolk, Jan/0000-0003-0334-4987	Academy of Finland [298513, 287800]	Academy of Finland(Academy of Finland)	This work was supported by Academy of Finland (http://www.aka.fi/en), grants 298513 (JA) and 287800 (PS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Albrecht A., 2014, J SOCIAL SCI RES, V6, P915, DOI 10.24297/jssr.v6i1.3453; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], VERS 23 0; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Blanco C, 2013, JAMA PSYCHIAT, V70, P199, DOI 10.1001/jamapsychiatry.2013.281; Bonifay W., 2017, SCIENCE; Brodbeck J, 2014, COMPR PSYCHIAT, V55, P714, DOI 10.1016/j.comppsych.2013.11.001; Bruno Falissard, 2012, PSY VAR PROC US PSYC; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; BYRNE BM, 1989, PSYCHOL BULL, V105, P456, DOI 10.1037/0033-2909.105.3.456; Carragher N, 2015, SOC PSYCH PSYCH EPID, V50, P339, DOI 10.1007/s00127-014-1004-z; Caspi A, 2014, CLIN PSYCHOL SCI, V2, P119, DOI 10.1177/2167702613497473; Chen FF, 2005, STRUCT EQU MODELING, V12, P471, DOI 10.1080/10705510701301834; Chen FN, 2001, SOCIOL METHOD RES, V29, P468, DOI 10.1177/0049124101029004003; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Derogatis, 2001, BRIEF SYMPTOM INVENT; Derogatis LR, 2002, J SEX MARITAL THER, V28, P317, DOI 10.1080/00926230290001448; Derogatis LR, 1998, DEROGATIS SEXUAL FUN, P269; Dowle M., 2017, PACKAGE DATA TABLE R; Eaton N. R, 2010, CONT DIRECTIONS PSYC, P223; Eaton NR, 2015, SOC PSYCH PSYCH EPID, V50, P171, DOI 10.1007/s00127-014-1001-2; Eaton NR, 2013, J ABNORM PSYCHOL, V122, P86, DOI 10.1037/a0029598; Eaton NR, 2012, J ABNORM PSYCHOL, V121, P282, DOI 10.1037/a0024780; Eaton NR, 2011, PSYCHOL AGING, V26, P987, DOI 10.1037/a0024406; Epskamp S., 2021, PACKAGE PSYCHONETRIC; Espeset EMS, 2012, EUR EAT DISORD REV, V20, P451, DOI 10.1002/erv.2183; Fincham D, 2009, PSYCHOPATHOLOGY, V42, P92, DOI 10.1159/000203341; Forbes M. K., 2015, ARCH SEX BEHAV, P1; Forbes MK, 2013, ARCH SEX BEHAV, V42, P23, DOI 10.1007/s10508-012-9948-0; Forbush KT, 2013, PSYCHOL MED, V43, P97, DOI 10.1017/S0033291712001092; Forbush KT, 2010, J ABNORM PSYCHOL, V119, P282, DOI 10.1037/a0019189; GARNER DM, 1979, PSYCHOL MED, V9, P273, DOI 10.1017/S0033291700030762; Giovanni Abbate-Daga, 2011, Depress Res Treat, V2011, P194732, DOI 10.1155/2011/194732; Green SB, 2015, EDUC MEAS-ISSUES PRA, V34, P14, DOI 10.1111/emip.12100; Hancock GR, 1997, MEAS EVAL COUNS DEV, V30, P91, DOI 10.1080/07481756.1997.12068926; Hare R. D., 2003, HARE PSYCHOPATHY CHE, V2nd; Haslam N, 2012, PSYCHOL MED, V42, P903, DOI 10.1017/S0033291711001966; Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Johansson A, 2013, TWIN RES HUM GENET, V16, P150, DOI 10.1017/thg.2012.108; Kendler K. S., 2011, AM J PSYCHIAT; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P929, DOI 10.1001/archpsyc.60.9.929; Kenny D. A., 1998, RESPECIFICATION LATE; Kessler RC, 2006, ARCH GEN PSYCHIAT, V63, P669, DOI 10.1001/archpsyc.63.6.669; Kessler RC, 2011, ARCH GEN PSYCHIAT, V68, P90, DOI 10.1001/archgenpsychiatry.2010.180; Keyes KM, 2013, PSYCHOL MED, V43, P1673, DOI 10.1017/S0033291712002292; Keyes KM, 2016, DEPRESS ANXIETY, V33, P101, DOI 10.1002/da.22428; Kim H, 2015, J ABNORM PSYCHOL, V124, P1064, DOI 10.1037/abn0000113; Kotov R, 2011, SCHIZOPHRENIA BULL, V37, P1168, DOI 10.1093/schbul/sbq024; Kotov R, 2011, ARCH GEN PSYCHIAT, V68, P1003, DOI 10.1001/archgenpsychiatry.2011.107; Kramer MD, 2008, PSYCHOL MED, V38, P51, DOI 10.1017/S0033291707001572; Krueger RF, 2003, J ABNORM PSYCHOL, V112, P437, DOI 10.1037/0021-843X.112.3.437; Krueger RF, 2007, J ABNORM PSYCHOL, V116, P645, DOI 10.1037/0021-843X.116.4.645; Krueger RF, 2015, WORLD PSYCHIATRY, V14, P27, DOI 10.1002/wps.20175; Lahey BB, 2012, J ABNORM PSYCHOL, V121, P971, DOI 10.1037/a0028355; Lubke GH, 2005, PSYCHOL METHODS, V10, P21, DOI 10.1037/1082-989X.10.1.21; Markon KE, 2011, PSYCHOL BULL, V137, P856, DOI 10.1037/a0023678; MCDONALD RP, 1978, BRIT J MATH STAT PSY, V31, P59, DOI 10.1111/j.2044-8317.1978.tb00573.x; Milhausen RR, 2015, ARCH SEX BEHAV, V44, P1621, DOI 10.1007/s10508-014-0328-9; Mitchell KS, 2014, INT J EAT DISORDER, V47, P860, DOI 10.1002/eat.22300; Morey LC, 2013, J ABNORM PSYCHOL, V122, P836, DOI 10.1037/a0034003; Munn-Chernoff MA, 2013, BEHAV GENET, V43, P427, DOI 10.1007/s10519-013-9603-0; Muthen B, 2006, ADDICTION, V101, P6, DOI 10.1111/j.1360-0443.2006.01583.x; Muthen BO, 1995, SOCIOL METHODOL, V25, P267, DOI 10.2307/271070; Nackers LM, 2015, MENOPAUSE, V22, P1175, DOI 10.1097/GME.0000000000000452; Noordhof A, 2015, J ABNORM CHILD PSYCH, V43, P577, DOI 10.1007/s10802-014-9923-4; Oberski D, 2014, J STAT SOFTW, V57, P1; Peat CM, 2011, PSYCHOL MEN MASCULIN, V12, P195, DOI 10.1037/a0021478; Pornprasertmanit S., 2013, SEMTOOLS USEFUL TOOL; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Raiche G, 2010, NFACTORS R PACKAGE P; Reise SP, 2012, MULTIVAR BEHAV RES, V47, P667, DOI 10.1080/00273171.2012.715555; Reise SP, 2010, J PERS ASSESS, V92, P544, DOI 10.1080/00223891.2010.496477; Ruscio J., 2006, INTRO TAXOMETRIC MET; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Seeley JR, 2011, J ABNORM PSYCHOL, V120, P308, DOI 10.1037/a0022621; Shallcross AJ, 2013, J PERS SOC PSYCHOL, V104, P734, DOI 10.1037/a0031180; Slevec JH, 2011, CLIN PSYCHOL REV, V31, P515, DOI 10.1016/j.cpr.2010.12.002; Spielberger C. D., 1999, PSYCHOL ASSESSMENT R; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Steinmetz H., 2013, METHODOLOGY; Striegel-Moore RH, 2009, INT J EAT DISORDER, V42, P471, DOI 10.1002/eat.20625; Team RC, 2016, LANG ENV STAT COMP; van de Schoot R, 2012, EUR J DEV PSYCHOL, V9, P486, DOI 10.1080/17405629.2012.686740; Werner KB, 2015, PSYCHIAT ANN, V45, P195, DOI 10.3928/00485713-20150401-08; Witkiewitz K, 2013, J ABNORM CHILD PSYCH, V41, P223, DOI 10.1007/s10802-012-9674-z; Wittchen HU, 2009, INT J METH PSYCH RES, V18, P189, DOI 10.1002/mpr.298; Wright AGC, 2015, PSYCHOL MED, V45, P2309, DOI 10.1017/S0033291715000252; Wright AGC, 2013, J ABNORM PSYCHOL, V122, P281, DOI 10.1037/a0030133; Yoshimasu K, 2011, PSYCHIAT RES, V186, P384, DOI 10.1016/j.psychres.2010.07.018	93	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177674	10.1371/journal.pone.0177674	http://dx.doi.org/10.1371/journal.pone.0177674			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542328	Green Submitted, Green Published, gold			2022-12-26	WOS:000401672400066
J	Kalm, K; Norris, D				Kalm, Kristjan; Norris, Dennis			Reading positional codes with fMRI: Problems and solutions	PLOS ONE			English	Article							SHORT-TERM-MEMORY; PREFRONTAL CORTEX; SERIAL ORDER; FRONTAL-CORTEX; WORKING-MEMORY; MOTOR AREA; SEQUENCES; TIME; REPRESENTATION; INFORMATION	Neural mechanisms which bind items into sequences have been investigated in a large body of research in animal neurophysiology and human neuroimaging. However, a major problem in interpreting this data arises from a fact that several unrelated processes, such as memory load, sensory adaptation, and reward expectation, also change in a consistent manner as the sequence unfolds. In this paper we use computational simulations and data from two fMRI experiments to show that a host of unrelated neural processes can masquerade as sequence representations. We show that dissociating such unrelated processes from a dedicated sequence representation is an especially difficult problem for fMRI data, which is almost exclusively the modality used in human experiments. We suggest that such fMRI results must be treated with caution and in many cases the assumed neural representation might actually reflect unrelated processes.	[Kalm, Kristjan; Norris, Dennis] MRC, Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge CB2 7EF, England		Kalm, K (corresponding author), MRC, Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge CB2 7EF, England.	kristjan.kalm@mrc-cbu.cam.ac.uk		Norris, Dennis/0000-0001-9257-317X; Kalm, Kristjan/0000-0001-5396-432X	UK Medical Research Council intramural grant [MCA0605PR30]; MRC [MC_UU_00005/11] Funding Source: UKRI; Medical Research Council [MC_UU_00005/11] Funding Source: researchfish	UK Medical Research Council intramural grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded via the UK Medical Research Council intramural grant MCA0605PR30.	Allen TA, 2016, J NEUROSCI, V36, P1547, DOI 10.1523/JNEUROSCI.2874-15.2016; Amiez C, 2007, P NATL ACAD SCI USA, V104, P13786, DOI 10.1073/pnas.0706220104; Averbeck BB, 2006, NAT NEUROSCI, V9, P276, DOI 10.1038/nn1634; Averbeck BB, 2003, EXP BRAIN RES, V150, P142, DOI 10.1007/s00221-003-1417-5; Averbeck BB, 2007, J NEUROSCI, V27, P2204, DOI 10.1523/JNEUROSCI.4483-06.2007; BARONE P, 1989, EXP BRAIN RES, V78, P447; Berdyyeva TK, 2011, J NEUROPHYSIOL, V105, P2547, DOI 10.1152/jn.00903.2010; Berdyyeva TK, 2010, J NEUROPHYSIOL, V104, P141, DOI 10.1152/jn.00639.2009; Brown GDA, 2000, PSYCHOL REV, V107, P127, DOI 10.1037/0033-295X.107.1.127; Burgess N, 2006, J MEM LANG, V55, P627, DOI 10.1016/j.jml.2006.08.005; Carpenter AF, 1999, SCIENCE, V283, P1752, DOI 10.1126/science.283.5408.1752; Crowe DA, 2014, J NEUROSCI, V34, P11972, DOI 10.1523/JNEUROSCI.2177-14.2014; De-Wit L, 2016, PSYCHONOMIC B REV; DeVito LM, 2011, J NEUROSCI, V31, P3169, DOI 10.1523/JNEUROSCI.4202-10.2011; DuBrow S, 2016, NEUROBIOLOGY LEARNIN; DuBrow S, 2014, J NEUROSCI, V34, P13998, DOI 10.1523/JNEUROSCI.2535-14.2014; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Fujii N, 2005, P NATL ACAD SCI USA, V102, P9032, DOI 10.1073/pnas.0503541102; Gelfand JR, 2003, NEURON, V38, P831, DOI 10.1016/S0896-6273(03)00285-X; Ginther MR, 2011, J NEUROSCI, V31, P2706, DOI 10.1523/JNEUROSCI.3413-10.2011; Gouws AD, 2014, J NEUROSCI, V34, P10347, DOI 10.1523/JNEUROSCI.0164-14.2014; Henson R, 1997, Q J EXPT PSYCHOL; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; Heusser A, 2016, NATURE NEUROSCIENCE, V19; Howard MW, 2002, J MATH PSYCHOL, V46, P269, DOI 10.1006/jmps.2001.1388; Hsieh LT, 2015, NEUROIMAGE, V121, P78, DOI 10.1016/j.neuroimage.2015.07.040; Hsieh LT, 2014, NEURON, V81, P1165, DOI 10.1016/j.neuron.2014.01.015; Hurlstone MJ, 2014, PSYCHOL BULL, V140, P339, DOI 10.1037/a0034221; Hyde RA, 2012, NAT NEUROSCI, V15, P1430, DOI 10.1038/nn.3208; Inoue M, 2006, J NEUROPHYSIOL, V95, P1008, DOI 10.1152/jn.00552.2005; Isoda M, 2004, J NEUROPHYSIOL, V92, P653, DOI 10.1152/jn.01201.2003; Kalm K, 2017, NEUROIMAGE; Kalm K, 2014, J NEUROSCI, V34, P6879, DOI 10.1523/JNEUROSCI.4104-13.2014; Kraus BJ, 2013, NEURON, V78, P1090, DOI 10.1016/j.neuron.2013.04.015; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; Larsson J, 2012, CEREB CORTEX, V22, P567, DOI 10.1093/cercor/bhr119; LEE CL, 1981, J EXP PSYCHOL-HUM L, V7, P149, DOI 10.1037/0278-7393.7.3.149; Lehn H, 2009, J NEUROSCI, V29, P3475, DOI 10.1523/JNEUROSCI.5370-08.2009; MacDonald CJ, 2013, J NEUROSCI, V33, P14607, DOI 10.1523/JNEUROSCI.1537-13.2013; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; Maier A, 2008, NAT NEUROSCI, V11, P1193, DOI 10.1038/nn.2173; Mankin EA, 2012, P NATL ACAD SCI USA, V109, P19462, DOI 10.1073/pnas.1214107109; Manns JR, 2007, NEURON, V56, P530, DOI 10.1016/j.neuron.2007.08.017; Merchant H, 2013, J NEUROSCI, V33, P9082, DOI 10.1523/JNEUROSCI.5513-12.2013; Nakajima T, 2009, J NEUROPHYSIOL, V101, P1883, DOI 10.1152/jn.90636.2008; Naya Y, 2011, SCIENCE, V333, P773, DOI 10.1126/science.1206773; Nieder A, 2006, SCIENCE, V313, P1431, DOI 10.1126/science.1130308; Nieder A, 2012, P NATL ACAD SCI USA, V109, P11860, DOI 10.1073/pnas.1204580109; Ninokura Y, 2004, J NEUROPHYSIOL, V91, P555, DOI 10.1152/jn.00694.2003; Page MPA, 1998, PSYCHOL REV, V105, P761, DOI 10.1037/0033-295X.105.4.761-781; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; PETRIDES M, 1991, P ROY SOC B-BIOL SCI, V246, P299, DOI 10.1098/rspb.1991.0158; Rangel LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4181; Rottschy C, 2012, NEUROIMAGE, V60, P830, DOI 10.1016/j.neuroimage.2011.11.050; Smith AT, 2000, NEUROREPORT, V11, P271, DOI 10.1097/00001756-200002070-00010; Summerfield C, 2008, NAT NEUROSCI, V11, P1004, DOI 10.1038/nn.2163; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255	57	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176585	10.1371/journal.pone.0176585	http://dx.doi.org/10.1371/journal.pone.0176585			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520725	Green Published, gold, Green Submitted			2022-12-26	WOS:000401487700023
J	Aboulela, M; Tanaka, Y; Nishimura, K; Mano, S; Nishimura, M; Ishiguro, S; Kimura, T; Nakagawa, T				Aboulela, Mostafa; Tanaka, Yuji; Nishimura, Kohji; Mano, Shoji; Nishimura, Mikio; Ishiguro, Sumie; Kimura, Tetsuya; Nakagawa, Tsuyoshi			Development of an R4 dual-site (R4DS) gateway cloning system enabling the efficient simultaneous cloning of two desired sets of promoters and open reading frames in a binary vector for plant research	PLOS ONE			English	Article							MATRIX ATTACHMENT REGIONS; TRANSGENE EXPRESSION; STABLE TRANSFORMATION; RESISTANCE GENE; DNA CLONING; ARABIDOPSIS; PROTEIN; MARKER; DIFFERENTIATION; RECOMBINATION	Vast numbers of proteins work cooperatively to exert their functions in various cells. In order to understand the functions and molecular mechanisms of these proteins in plants, analyses of transgenic plants that concomitantly express two protein-coding genes are often required. We developed a novel Gateway cloning technology-compatible binary vector system, the R4 dual-site (R4DS) Gateway cloning system, which enables the easy and efficient cloning of two desired sets of promoters and open reading frames (ORFs) into a binary vector using promoter and ORF entry clones. In this system, C-terminal fusions with 17 kinds of tags including visible reporters and epitope tags are available for each ORF, and selection by four kinds of resistance markers is possible. We verified that the R4DS Gateway cloning system functioned well in Arabidopsis thaliana by observing the expression and localization patterns of fluorescent proteins fused with organelle-targeting signals and driven by stomatal-lineage specific promoters. We also confirmed that the two cloning sites in the R4DS Gateway cloning system were equivalent and independently regulated. The results obtained indicate that the R4DS Gateway cloning system facilitates detailed comparisons of the expression patterns of two promoters as well as co-localization and interaction analyses of two proteins in specific cells in plants.	[Aboulela, Mostafa; Tanaka, Yuji; Nishimura, Kohji; Nakagawa, Tsuyoshi] Shimane Univ, Interdisciplinary Ctr Sci Res, Org Res, Dept Mol & Funct Genom, Matsue, Shimane, Japan; [Aboulela, Mostafa; Nishimura, Kohji; Nakagawa, Tsuyoshi] Tottori Univ, United Grad Sch Agr Sci, Bioresources Sci, Tottori, Japan; [Aboulela, Mostafa] Assiut Univ, Fac Sci, Dept Bot & Microbiol, Assiut, Egypt; [Mano, Shoji] Natl Inst Basic Biol, Dept Evolutionary Biol & Biodivers, Okazaki, Aichi, Japan; [Mano, Shoji] SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan; [Nishimura, Mikio] Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi, Japan; [Ishiguro, Sumie] Nagoya Univ, Grad Sch Bioagr Sci, Dept Biol Mech & Funct, Nagoya, Aichi, Japan; [Kimura, Tetsuya] Mie Univ, Grad Sch Bioresources, Dept Life Sci, Tsu, Mie, Japan; [Nishimura, Mikio] Natl Inst Basic Biol, Res Enhancement Strategy Off, Okazaki, Aichi, Japan	Shimane University; Tottori University; Egyptian Knowledge Bank (EKB); Assiut University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Nagoya University; Mie University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Nakagawa, T (corresponding author), Shimane Univ, Interdisciplinary Ctr Sci Res, Org Res, Dept Mol & Funct Genom, Matsue, Shimane, Japan.; Nakagawa, T (corresponding author), Tottori Univ, United Grad Sch Agr Sci, Bioresources Sci, Tottori, Japan.	tnakagaw@life.shimane-u.ac.jp	Ishiguro, Sumie/AAH-2592-2019; ISHIGURO, Sumie/I-6903-2014	Ishiguro, Sumie/0000-0002-6160-7434; Mano, Shoji/0000-0003-1323-3308; Nishimura, Mikio/0000-0001-7960-9721; Tanaka, Yuji/0000-0002-2447-8389; Aboulela, Mostafa/0000-0003-3932-2384	KAKENHI Grant from Japan Society for the Promotion of Science (JSPS) [JP26440157, JP15K07109]; Japan Agency for Medical Research and Development, AMED	KAKENHI Grant from Japan Society for the Promotion of Science (JSPS); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This work was supported by KAKENHI Grant from Japan Society for the Promotion of Science (JSPS) [Grant-in-Aid for Scientific Research (C) No. JP26440157 to SM and No. JP15K07109 to TN] and Research Program on Hepatitis from Japan Agency for Medical Research and Development, AMED, to MN. URL for Kakenhi: http://www.jsps.go.jp/english/e-grants/index.html; URL for AMED: http://www.amed.go.jp/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Benhamed M, 2008, PLANT J, V56, P493, DOI 10.1111/j.1365-313X.2008.03606.x; Berger D, 2000, GENE DEV, V14, P1119; Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023; Buntru M, 2013, TRANSGENIC RES, V22, P153, DOI 10.1007/s11248-012-9640-0; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cheng ZQ, 2001, MOL BREEDING, V7, P317, DOI 10.1023/A:1011655214556; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Chubet RG, 1996, BIOTECHNIQUES, V20, P136; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dafny-Yelin M, 2007, PLANT PHYSIOL, V145, P1118, DOI 10.1104/pp.107.106104; Fernandez AI, 2009, PLANT PHYSIOL, V151, P1729, DOI 10.1104/pp.109.147546; Ghareeb H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00246; Gong W, 2004, PLANT PHYSIOL, V135, P773, DOI 10.1104/pp.104.042176; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Halpin C, 2005, PLANT BIOTECHNOL J, V3, P141, DOI 10.1111/j.1467-7652.2004.00113.x; Han KH, 1997, TRANSGENIC RES, V6, P415, DOI 10.1023/A:1018439518649; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; He ZM, 2016, J GENET GENOMICS, V43, P199, DOI 10.1016/j.jgg.2016.02.005; Hecker A, 2015, PLANT PHYSIOL, V168, P776, DOI 10.1104/pp.15.00533; Hino T, 2011, BIOSCI BIOTECH BIOCH, V75, P1848, DOI 10.1271/bbb.110331; Huang J, 2006, PLANT CELL, V18, P1226, DOI 10.1105/tpc.105.037259; JEFFERSON RA, 1987, EMBO J, V6, P3901; Karimi M, 2007, PLANT PHYSIOL, V145, P1144, DOI 10.1104/pp.107.106989; Karimi M, 2007, PLANT PHYSIOL, V145, P1183, DOI 10.1104/pp.107.110411; Kawakami S., 1997, PLANT BIOTECHNOL, V14, P127; Kim S, 2010, TRANSGENIC RES, V19, P489, DOI 10.1007/s11248-009-9330-8; Kimura T, 2013, BIOSCI BIOTECH BIOCH, V77, P430, DOI 10.1271/bbb.120877; Li MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100948; MLYNAROVA L, 1994, PLANT CELL, V6, P417, DOI 10.1105/tpc.6.3.417; Nakagawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P624, DOI 10.1271/bbb.70678; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Nakagawa T, 2009, PLANT BIOTECHNOL-NAR, V26, P275, DOI 10.5511/plantbiotechnology.26.275; Nakamura S, 2010, BIOSCI BIOTECH BIOCH, V74, P1315, DOI 10.1271/bbb.100184; NISHIMURA M, 1986, PLANT PHYSIOL, V81, P313, DOI 10.1104/pp.81.1.313; Petersen K, 2002, PLANT MOL BIOL, V49, P45, DOI 10.1023/A:1014464127973; Petersen LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024531; Pillitteri LJ, 2008, PLANT CELL PHYSIOL, V49, P934, DOI 10.1093/pcp/pcn067; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Pillitteri LJ, 2012, ANNU REV PLANT BIOL, V63, P591, DOI 10.1146/annurev-arplant-042811-105451; Pruneda-Paz JL, 2014, CELL REP, V8, P621, DOI 10.1016/j.celrep.2014.06.033; Ren F, 2010, J PLANT PHYSIOL, V167, P1412, DOI 10.1016/j.jplph.2010.03.021; Sakamoto W, 1996, PLANT PHYSIOL, V112, P1736; Sambrook J., 2001, MOL CLONING LAB MANU; Sasaki Y, 2004, J BIOTECHNOL, V107, P233, DOI 10.1016/j.jbiotec.2003.10.001; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Sherf BA, 1994, PROMEGA NOTES, V49, P14; Siligato R, 2016, PLANT PHYSIOL, V170, P627, DOI 10.1104/pp.15.01246; Singh T, 2009, PLANT J, V60, P488, DOI 10.1111/j.1365-313X.2009.03970.x; Spiker S, 1996, PLANT PHYSIOL, V110, P15, DOI 10.1104/pp.110.1.15; Sun QX, 2013, PLANT MOL BIOL, V83, P391, DOI 10.1007/s11103-013-0096-2; Tachiki K, 2009, J BIOSCI BIOENG, V108, P11, DOI 10.1016/j.jbiosc.2009.02.010; Tanaka Y, 2011, BIOSCI BIOTECH BIOCH, V75, P804, DOI 10.1271/bbb.110063; Verma D, 2005, PLANT SCI, V169, P704, DOI 10.1016/j.plantsci.2005.05.021; von Groll U, 2002, PLANT CELL, V14, P1527, DOI 10.1105/tpc.001016; Xie MT, 2001, NAT BIOTECHNOL, V19, P677, DOI 10.1038/90296; Yano D, 2003, P NATL ACAD SCI USA, V100, P8589, DOI 10.1073/pnas.1430749100	59	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177889	10.1371/journal.pone.0177889	http://dx.doi.org/10.1371/journal.pone.0177889			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520787	Green Submitted, Green Published, gold			2022-12-26	WOS:000401485500080
J	Ghosh, S; Forney, LA; Wanders, D; Stone, KP; Gettys, TW				Ghosh, Sujoy; Forney, Laura A.; Wanders, Desiree; Stone, Kirsten P.; Gettys, Thomas W.			An integrative analysis of tissue-specific transcriptomic and metabolomic responses to short-term dietary methionine restriction in mice	PLOS ONE			English	Article							OXIDATIVE STRESS; ENRICHMENT ANALYSIS; IN-VIVO; GLUTATHIONE; PATHWAY; LIVER; INFLAMMATION; GENES; ACID; COA	Dietary methionine restriction (MR) produces a coordinated series of transcriptional responses in peripheral tissues that limit fat accretion, remodel lipid metabolism in liver and adipose tissue, and improve overall insulin sensitivity. Hepatic sensing of reduced methionine leads to induction and release of fibroblast growth factor 21 (FGF21), which acts centrally to increase sympathetic tone and activate thermogenesis in adipose tissue. FGF21 also has direct effects in adipose to enhance glucose uptake and oxidation. However, an understanding of how the liver senses and translates reduced dietary methionine into these transcriptional programs remains elusive. A comprehensive systems biology approach integrating transcriptomic and metabolomic readouts in MR-treated mice confirmed that three interconnected mechanisms (fatty acid transport and oxidation, tricarboxylic acid cycle, and oxidative phosphorylation) were activated in MR-treated inguinal adipose tissue. In contrast, the effects of MR in liver involved up-regulation of anti-oxidant responses driven by the nuclear factor, erythroid 2 like 2 transcription factor, NFE2L2. Metabolomic analysis provided evidence for redox imbalance, stemming from large reductions in the master anti-oxidant molecule glutathione coupled with disproportionate increases in ophthalmate and its precursors, glutamate and 2-aminobutyrate. Thus, cysteine and its downstream product, glutathione, emerge as key early hepatic signaling molecules linking dietary MR to its metabolic phenotype.	[Ghosh, Sujoy] Pennington Biomed Res Ctr, Lab Computat Biol, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Ghosh, Sujoy; Forney, Laura A.; Stone, Kirsten P.; Gettys, Thomas W.] Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Ghosh, Sujoy] Duke NUS Grad Med Sch, Program Cardiovasc & Metab Disorders, Singapore, Singapore; [Ghosh, Sujoy] Duke NUS Grad Med Sch, Ctr Computat Biol, Singapore, Singapore; [Wanders, Desiree] Georgia State Univ, Dept Nutr, Atlanta, GA 30303 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; National University of Singapore; National University of Singapore; University System of Georgia; Georgia State University	Gettys, TW (corresponding author), Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	gettystw@pbrc.edu	Gettys, Thomas W/N-1964-2017; Stone, Kirsten/AAB-3804-2019; Bobart, Laura Forney/AAN-1244-2021	Gettys, Thomas W/0000-0001-7125-7995; Stone, Kirsten/0000-0001-5511-1638; Wanders, Desiree/0000-0003-2638-3954	American Diabetes Association [1-12-BS-58, 7-13-MI-05]; National Institutes of Health [DK-096311, 1F32DK098918-01, 3P30-GM118430, 3P30 DK072476]; National Medical Research Council and Ministry of Health, Singapore; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476, R01DK096311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM118430, P20GM103528] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Medical Research Council and Ministry of Health, Singapore; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by American Diabetes Association 1-12-BS-58 (TWG), National Institutes of Health DK-096311 (TWG), American Diabetes Association 7-13-MI-05 (TWG), National Institutes of Health 1F32DK098918-01 (DW). SG was supported by funding from the National Medical Research Council and Ministry of Health, Singapore. This work also made use of the Genomics core facilities supported by National Institutes of Health 3P30-GM118430 (TWG) and National Institutes of Health 3P30 DK072476.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRIDGES RJ, 1985, J BIOL CHEM, V260, P7304; Chagoyen M, 2011, BIOINFORMATICS, V27, P730, DOI 10.1093/bioinformatics/btr001; Chen B, 2015, J ENDOCRINOL, V225, pR83, DOI 10.1530/JOE-14-0662; Chen XL, 2004, CURR PHARM DESIGN, V10, P879, DOI 10.2174/1381612043452901; Dello SAWG, 2013, CLIN NUTR, V32, P325, DOI 10.1016/j.clnu.2012.10.008; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Fujii J, 2011, J CLIN BIOCHEM NUTR, V49, P70, DOI 10.3164/jcbn.10-138SR; Grimble RF, 2006, J NUTR, V136, p1660S, DOI 10.1093/jn/136.6.1660S; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Moffat C, 2014, J LIPID RES, V55, P2458, DOI 10.1194/jlr.M046961; Owen BM, 2014, CELL METAB, V20, P670, DOI 10.1016/j.cmet.2014.07.012; Perrone CE, 2012, J NUTRIGENET NUTRIGE, V5, P132, DOI 10.1159/000339347; Perrone CE, 2010, METABOLISM, V59, P1000, DOI 10.1016/j.metabol.2009.10.023; Plaisance EP, 2010, AM J PHYSIOL-REG I, V299, pR740, DOI 10.1152/ajpregu.00838.2009; RICHIE JP, 1994, FASEB J, V8, P1302, DOI 10.1096/fasebj.8.15.8001743; Satapati S, 2015, J CLIN INVEST, V125, P4447, DOI 10.1172/JCI82204; SHUG A, 1971, BIOCHEM BIOPH RES CO, V43, P557, DOI 10.1016/0006-291X(71)90650-4; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; STIPANUK MH, 1992, J NUTR, V122, P420, DOI 10.1093/jn/122.3.420; Stone KP, 2014, DIABETES, V63, P3721, DOI 10.2337/db14-0464; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun B, 2008, ONCOGENE, V27, P6228, DOI 10.1038/onc.2008.300; Tao SS, 2013, ANTIOXID REDOX SIGN, V19, P1647, DOI 10.1089/ars.2012.5117; van Eunen K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003186; Wanders D, 2017, DIABETES; Wanders D, 2016, DIABETES, V65, P1499, DOI 10.2337/db15-1324; Wanders D, 2015, FASEB J, V29, P2603, DOI 10.1096/fj.14-270348; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	35	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177513	10.1371/journal.pone.0177513	http://dx.doi.org/10.1371/journal.pone.0177513			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520765	Green Submitted, Green Published, gold			2022-12-26	WOS:000401485500034
J	Huber, S; Casagrande, F; Hug, MN; Wang, LS; Heine, P; Kummer, L; Pluckthun, A; Hennig, M				Huber, Sylwia; Casagrande, Fabio; Hug, Melanie N.; Wang, Lisha; Heine, Philipp; Kummer, Lutz; Pluckthun, Andreas; Hennig, Michael			SPR-based fragment screening with neurotensin receptor 1 generates novel small molecule ligands	PLOS ONE			English	Article							DRUG DISCOVERY; BIOPHYSICAL METHODS; HIT VALIDATION; A(2A) RECEPTOR; BINDING; IDENTIFICATION; EVOLUTION	The neurotensin receptor 1 represents an important drug target involved in various diseases of the central nervous system. So far, the full exploitation of potential therapeutic activities has been compromised by the lack of compounds with favorable physicochemical and pharmacokinetic properties which efficiently penetrate the blood-brain barrier. Recent progress in the generation of stabilized variants of solubilized neurotensin receptor 1 and its subsequent purification and successful structure determination presents a solid starting point to apply the approach of fragment-based screening to extend the chemical space of known neurotensin receptor 1 ligands. In this report, surface plasmon resonance was used as primary method to screen 6369 compounds. Thereby 44 hits were identified and confirmed in competition as well as dose-response experiments. Furthermore, 4 out of 8 selected hits were validated using nuclear magnetic resonance spectroscopy as orthogonal biophysical method. Computational analysis of the compound structures, taking the known crystal structure of the endogenous peptide agonist into consideration, gave insight into the potential fragment-binding location and interactions and inspires chemistry efforts for further exploration of the fragments.	[Huber, Sylwia; Casagrande, Fabio; Hug, Melanie N.; Wang, Lisha; Hennig, Michael] Roche Innovat Ctr Basel, Pharmaceut Res & Early Dev, Basel, Switzerland; [Heine, Philipp; Kummer, Lutz; Pluckthun, Andreas] Univ Zurich, Dept Biochem, Zurich, Switzerland; [Kummer, Lutz] G7 Therapeut AG, Schlieren, Switzerland; [Hennig, Michael] LeadXpro AG, Pk INNOVAARE, Villigen, Switzerland	Roche Holding; University of Zurich	Huber, S; Hennig, M (corresponding author), Roche Innovat Ctr Basel, Pharmaceut Res & Early Dev, Basel, Switzerland.	sylwia.huber@roche.com; michael.hennig@leadxpro.com		Heine, Philipp/0000-0003-4504-9003				Aristotelous T, 2013, ACS MED CHEM LETT, V4, P1005, DOI 10.1021/ml400312j; Barroso S, 2000, J BIOL CHEM, V275, P328, DOI 10.1074/jbc.275.1.328; Bayes M, 2005, METHOD FIND EXP CLIN, V27, P193; Blundell TL, 2002, NAT REV DRUG DISCOV, V1, P45, DOI 10.1038/nrd706; Bocquet N, 2015, BBA-BIOMEMBRANES, V1848, P1224, DOI 10.1016/j.bbamem.2015.02.014; Boehm HJ, 2000, J MED CHEM, V43, P2664, DOI 10.1021/jm000017s; Bollag G, 2012, NAT REV DRUG DISCOV, V11, P873, DOI 10.1038/nrd3847; Campos-Olivas R, 2011, CURR TOP MED CHEM, V11, P43, DOI 10.2174/156802611793611887; Carey LI, 2014, 26 NMU; Chen D, 2012, ACS CHEM BIOL, V7, P2064, DOI 10.1021/cb300436c; Chessari G, 2009, DRUG DISCOV TODAY, V14, P668, DOI 10.1016/j.drudis.2009.04.007; Choi SY, 1999, BRIT J PHARMACOL, V126, P1050, DOI 10.1038/sj.bjp.0702378; Christopher JA, 2015, MEDCHEMCOMM, V6, P947, DOI 10.1039/c5md00027k; Christopher JA, 2013, J MED CHEM, V56, P3446, DOI 10.1021/jm400140q; Congreve M, 2011, METHOD ENZYMOL, V493, P115, DOI 10.1016/B978-0-12-381274-2.00005-4; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Demeule M, 2014, J CLIN INVEST, V124, P1199, DOI 10.1172/JCI70647; Dias DM, 2014, PROG BIOPHYS MOL BIO, V116, P101, DOI 10.1016/j.pbiomolbio.2014.08.012; Egloff P, 2014, P NATL ACAD SCI USA, V111, pE655, DOI 10.1073/pnas.1317903111; Feifel D, 1999, J PHARMACOL EXP THER, V288, P710; Fruh V, 2010, CHEM BIOL, V17, P881, DOI 10.1016/j.chembiol.2010.06.011; Griebel G, 2012, NAT REV DRUG DISCOV, V11, P462, DOI 10.1038/nrd3702; Gully D, 1997, J PHARMACOL EXP THER, V280, P802; Gully D, 1995, FUNDAM CLIN PHARM, V9, P513, DOI 10.1111/j.1472-8206.1995.tb00528.x; Gururaja TL, 2007, CHEM BIOL, V14, P1105, DOI 10.1016/j.chembiol.2007.08.012; Harner MJ, 2013, J BIOMOL NMR, V56, P65, DOI 10.1007/s10858-013-9740-z; Hennig M, 2012, TOP CURR CHEM, V317, P115, DOI 10.1007/128_2011_225; Huber W, 2006, CURR PHARM DESIGN, V12, P3999, DOI 10.2174/138161206778743600; Jolas T, 1997, PROG NEUROBIOL, V52, P455, DOI 10.1016/S0301-0082(97)00025-7; KITABGI P, 1977, P NATL ACAD SCI USA, V74, P1846, DOI 10.1073/pnas.74.5.1846; Kobayashi M, 2010, J BIOMOL SCREEN, V15, P978, DOI 10.1177/1087057110375614; Maurer T, 2013, ENZYMES, V33, P15, DOI 10.1016/B978-0-12-416749-0.00002-6; Meltzer HY, 2004, AM J PSYCHIAT, V161, P975, DOI 10.1176/appi.ajp.161.6.975; Navratilova I, 2005, ANAL BIOCHEM, V339, P271, DOI 10.1016/j.ab.2004.12.017; Navratilova I, 2006, ANAL BIOCHEM, V355, P132, DOI 10.1016/j.ab.2006.04.021; Pajouhesh Hassan, 2005, NeuroRx, V2, P541, DOI 10.1602/neurorx.2.4.541; Perspicace S, 2009, J BIOMOL SCREEN, V14, P337, DOI 10.1177/1087057109332595; Petrie KA, 2004, NEUROPSYCHOPHARMACOL, V29, P1878, DOI 10.1038/sj.npp.1300494; Ranganathan A, 2017, ACS CHEM BIOL; Rich RL, 2011, ANAL BIOCHEM, V409, P267, DOI 10.1016/j.ab.2010.10.008; Roberts GCK, 1993, NMR MACROMOLECULES P, Vxviii; Robertson N, 2011, NEUROPHARMACOLOGY, V60, P36, DOI 10.1016/j.neuropharm.2010.07.001; Scott DJ, 2014, BBA-BIOMEMBRANES, V1838, P2817, DOI 10.1016/j.bbamem.2014.07.015; Scott DJ, 2013, J MOL BIOL, V425, P662, DOI 10.1016/j.jmb.2012.11.015; Scott DE, 2012, BIOCHEMISTRY-US, V51, P4990, DOI 10.1021/bi3005126; Shepherd CA, 2014, PROG BIOPHYS MOL BIO, V116, P113, DOI 10.1016/j.pbiomolbio.2014.09.008; Tate CG, 2012, TRENDS BIOCHEM SCI, V37, P343, DOI 10.1016/j.tibs.2012.06.003; Tyler BM, 1999, NEUROPHARMACOLOGY, V38, P1027, DOI 10.1016/S0028-3908(99)00011-8; Vulpetti A, 2013, CHEMMEDCHEM, V8, P2057, DOI 10.1002/cmdc.201300351; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Zamani L, 2015, S AFR J CHEM-S-AFR T, V68, P133, DOI 10.17159/0379-4350/2015/V68A19	51	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0175842	10.1371/journal.pone.0175842	http://dx.doi.org/10.1371/journal.pone.0175842			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28510609	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000401485500004
J	Lin, WK; Bolton, EL; Cortopassi, WA; Wang, YW; O'Brien, F; Maciejewska, M; Jacobson, MP; Garnham, C; Ruas, M; Parrington, J; Lei, M; Sitsapesan, R; Galione, A; Terrar, DA				Lin, Wee K.; Bolton, Emma L.; Cortopassi, Wilian A.; Wang, Yanwen; O'Brien, Fiona; Maciejewska, Matylda; Jacobson, Matthew P.; Garnham, Clive; Ruas, Margarida; Parrington, John; Lei, Ming; Sitsapesan, Rebecca; Galione, Antony; Terrar, Derek A.			Synthesis of the Ca2+ - mobilizing messengers NAADP and cADPR by intracellular CD38 enzyme in the mouse heart: Role in beta-adrenoceptor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-ADP-RIBOSE; CARDIAC SARCOPLASMIC-RETICULUM; DINUCLEOTIDE PHOSPHATE NAADP; RYANODINE RECEPTOR; RELEASE CHANNELS; CALCIUM-RELEASE; ACCURATE DOCKING; PK(A) VALUES; FORCE-FIELD; EADOCK DSS	Nicotinic acid adenine dinucleotide phosphate (NAADP) and cyclic ADP-ribose (cADPR) are Ca2+ -mobilizing messengers important for modulating cardiac excitation-contraction coupling and pathophysiology. CD38, which belongs to the ADP-ribosyl cyclase family, catalyzes synthesis of both NAADP and cADPR in vitro. However, it remains unclear whether this is the main enzyme for their production under physiological conditions. Here we show that membrane fractions from WT but not CD38(-/-) mouse hearts supported NAADP and cADPR synthesis. Membrane permeabilization of cardiac myocytes with saponin and/or Triton X-100 increased NAADP synthesis, indicating that intracellular CD38 contributes to NAADP production. The permeabilization also permitted immunostaining of CD38, with a striated pattern in WT myocytes, whereas CD38(-/-) myocytes and nonpermeabilized WT myocytes showed little or no staining, without striation. A component of beta-adrenoreceptor signaling in the heart involves NAADP and lysosomes. Accordingly, in the presence of isoproterenol, Ca2+ transients and contraction amplitudes were smaller in CD38(-/-) myocytes than in the WT. In addition, suppressing lysosomal function with bafilomycin A1 reduced the isoproterenol-induced increase in Ca2+ transients in cardiac myocytes from WT but not CD38(-/-) mice. Whole hearts isolated from CD38(-/-) mice and exposed to isoproterenol showed reduced arrhythmias. SAN4825, an ADP-ribosyl cyclase inhibitor that reduces cADPR and NAADP synthesis in mouse membrane fractions, was shown to bind to CD38 in docking simulations and reduced the isoproterenol-induced arrhythmias in WT hearts. These observations support generation of NAADP and cADPR by intracellular CD38, which contributes to effects of beta-adrenoreceptor stimulation to increase both Ca2+ transients and the tendency to disturb heart rhythm.	[Lin, Wee K.; Bolton, Emma L.; O'Brien, Fiona; Maciejewska, Matylda; Garnham, Clive; Ruas, Margarida; Parrington, John; Lei, Ming; Sitsapesan, Rebecca; Galione, Antony; Terrar, Derek A.] Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England; [Cortopassi, Wilian A.] Univ Oxford, Dept Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England; [Cortopassi, Wilian A.; Jacobson, Matthew P.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Wang, Yanwen] Univ Manchester, Fac Biol Med & Hlth, Manchester M13 9NT, Lancs, England	University of Oxford; University of Oxford; University of California System; University of California San Francisco; University of Manchester	Terrar, DA (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	derek.terrar@pharm.ox.ac.uk	Cortopassi, Wilian/P-3136-2014; Jacobson, Matthew/Y-5161-2018	Cortopassi, Wilian/0000-0001-8038-7847; Jacobson, Matthew/0000-0001-6262-655X; Terrar, Derek/0000-0001-9408-6594; Galione, Antony/0000-0002-4132-7646; Ruas, Margarida/0000-0002-4872-7618	British Heart Foundation (BHF); Medical Research Council; BHF Centre of Research Excellence (CRE); BHF; BHF CRE; Wellcome Trust	British Heart Foundation (BHF)(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BHF Centre of Research Excellence (CRE); BHF(British Heart Foundation); BHF CRE; Wellcome Trust(Wellcome Trust)	Funded by the British Heart Foundation (BHF), Medical Research Council, and BHF Centre of Research Excellence (CRE).; Funded by the BHF and BHF CRE.; Funded by a Wellcome Trust Senior Investigatorship and BHF CRE.	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Aston D, 2017, SCI REP-UK, V7, DOI 10.1038/srep40620; Bruzzone S., 2012, MESSENGER, V1, P34, DOI [10.1166/msr.2012.1007, DOI 10.1166/MSR.2012.1007]; Capel RA, 2015, J BIOL CHEM, V290, P30087, DOI 10.1074/jbc.M115.684076; Chini EN, 2009, CURR PHARM DESIGN, V15, P57, DOI 10.2174/138161209787185788; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Cockayne DA, 1998, BLOOD, V92, P1324, DOI 10.1182/blood.V92.4.1324.416k26_1324_1333; Collins TP, 2011, CELL CALCIUM, V50, P449, DOI 10.1016/j.ceca.2011.07.007; Cosker F, 2010, J BIOL CHEM, V285, P38251, DOI 10.1074/jbc.M110.125864; Davis LC, 2008, CURR BIOL, V18, P1612, DOI 10.1016/j.cub.2008.09.024; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; De Flora Antonio, 1998, Cell Biochemistry and Biophysics, V28, P45; Dorian P, 2005, J CARDIOVASC PHARM T, V10, pS15, DOI 10.1177/10742484050100i403; Ferrero E, 2014, FRONT BIOSCI-LANDMRK, V19, P986, DOI 10.2741/4262; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Galfre E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031956; Galione A, 2015, CELL CALCIUM, V58, P27, DOI 10.1016/j.ceca.2014.09.010; Genazzani AA, 1996, J BIOL CHEM, V271, P11599, DOI 10.1074/jbc.271.20.11599; Graeff R, 2006, J BIOL CHEM, V281, P28951, DOI 10.1074/jbc.M604370200; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Grosdidier A, 2011, J COMPUT CHEM, V32, P2149, DOI 10.1002/jcc.21797; Gul R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149125; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Hara-Yokoyama M, 2012, STRUCTURE, V20, P1585, DOI 10.1016/j.str.2012.06.017; Higashida H, 1999, J BIOL CHEM, V274, P33348, DOI 10.1074/jbc.274.47.33348; HOLMBERG SRM, 1990, BIOCHIM BIOPHYS ACTA, V1022, P187, DOI 10.1016/0005-2736(90)90113-3; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; JACKSON DG, 1990, J IMMUNOL, V144, P2811; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Jamur MC, 2010, METHODS MOL BIOL, V588, P63, DOI 10.1007/978-1-59745-324-0_9; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kannt A, 2012, N-S ARCH PHARMACOL, V385, P717, DOI 10.1007/s00210-012-0750-2; Laver DR, 2007, CLIN EXP PHARMACOL P, V34, P889, DOI 10.1111/j.1440-1681.2007.04708.x; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; Lewis AM, 2012, BIOCHEM BIOPH RES CO, V427, P326, DOI 10.1016/j.bbrc.2012.09.054; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li LW, 2015, J CELL SCI, V128, P951, DOI 10.1242/jcs.160689; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; Liu Q, 2006, J BIOL CHEM, V281, P32861, DOI 10.1074/jbc.M606365200; Liu Q, 2008, BIOCHEMISTRY-US, V47, P13966, DOI 10.1021/bi801642q; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; Macgregor AT, 2007, CELL CALCIUM, V41, P537, DOI 10.1016/j.ceca.2006.10.005; MAHONY L, 1988, PEDIATR RES, V24, P639, DOI 10.1203/00006450-198811000-00020; Meszaros LG, 1997, BIOCHEM BIOPH RES CO, V234, P252, DOI 10.1006/bbrc.1997.6620; MICHALAK M, 1988, BIOCHEM J, V253, P631, DOI 10.1042/bj2530631; Munshi C, 2000, J BIOL CHEM, V275, P21566, DOI 10.1074/jbc.M909365199; Nebel M, 2013, J BIOL CHEM, V288, P16017, DOI 10.1074/jbc.M112.441246; Noble JE, 2009, METHOD ENZYMOL, V463, P73, DOI 10.1016/S0076-6879(09)63008-1; Rakovic S, 1996, CURR BIOL, V6, P989, DOI 10.1016/S0960-9822(02)00643-7; Rakovic S, 1999, J BIOL CHEM, V274, P17820, DOI 10.1074/jbc.274.25.17820; Rakovic S., 2002, CYCLIC ADP RIBOSE NA, P319; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Sikkel MB, 2013, CARDIOVASC RES, V98, P286, DOI 10.1093/cvr/cvt012; SITSAPESAN R, 1990, J PHYSIOL-LONDON, V423, P425, DOI 10.1113/jphysiol.1990.sp018031; SITSAPESAN R, 1994, CIRC RES, V75, P596, DOI 10.1161/01.RES.75.3.596; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Terrar D. A., 2015, MESSENGER, V4, P23; Venturi E, 2012, CARDIOVASC THER, V30, P109, DOI 10.1111/j.1755-5922.2010.00236.x; Wachter SB, 2012, CARDIOLOGY, V122, P104, DOI 10.1159/000339271; Xie GH, 2003, BIOCHEM BIOPH RES CO, V307, P713, DOI 10.1016/S0006-291X(03)01240-3; Zhang H., 2013, MESSENGER, V2, P44, DOI [DOI 10.1166/msr.2013.1020, 10.1166/msr.2013.1020, DOI 10.1166/MSR.2013.1020]; Zhao YJ, 2015, BBA-MOL CELL RES, V1853, P2095, DOI 10.1016/j.bbamcr.2014.10.028; Zhao YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002700; Zhao YJ, 2011, J BIOL CHEM, V286, P22170, DOI 10.1074/jbc.M111.228379; Zissimopoulos S, 2005, J BIOL CHEM, V280, P5475, DOI 10.1074/jbc.M412954200	70	35	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13243	13257		10.1074/jbc.M117.789347	http://dx.doi.org/10.1074/jbc.M117.789347			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28539361	Green Published, hybrid			2022-12-26	WOS:000407465300014
J	Mori, T; Koyama, N; Tan, J; Segawa, T; Maeda, M; Town, T				Mori, Takashi; Koyama, Naoki; Tan, Jun; Segawa, Tatsuya; Maeda, Masahiro; Town, Terrence			Combination therapy with octyl gallate and ferulic acid improves cognition and neurodegeneration in a transgenic mouse model of Alzheimer's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; MODULATES BETA-SECRETASE; LONG-TERM POTENTIATION; GALLIC ACID; A-BETA; SYNAPTIC PLASTICITY; OXIDATIVE STRESS; INFLAMMATION; BIOAVAILABILITY; NEUROTOXICITY	To date, there is no effective Alzheimer's disease (AD)-modifying therapy. Nonetheless, combination therapy holds promise, and nutraceuticals (natural dietary compounds with therapeutic properties) and their synthetic derivatives are well-tolerated candidates. We tested whether combination therapy with octyl gallate (OG) and ferulic acid (FA) improves cognition and mitigates AD-like pathology in the presenilin-amyloid beta-protein precursor (PSAPP) transgenic mouse model of cerebral amyloidosis. One-year-old mice with established beta-amyloid plaques received daily doses of OG and FA alone or in combination for 3 months. PSAPP mice receiving combination therapy had statistically significant improved cognitive function versus OG or FA single treatment on some (but not all) measures. We also observed additional statistically significant reductions in brain parenchymal and cerebral vascular beta-amyloid deposits as well as brain amyloid beta-protein abundance in OG-plus FA-treated versus singly-treated PSAPP mice. These effects coincided with enhanced nonamyloidogenic amyloid beta-protein precursor (APP) cleavage, increased beta-secretase activity, and beta-secretase inhibition. We detected elevated expression of nonamyloidogenic soluble APP-alpha and the beta-secretase candidate, a disintegrin and metalloproteinase domain-containing protein 10. Correspondingly, amyloidogenic beta-carboxyl-terminal APP fragment and beta-site APP-cleaving enzyme 1 expression levels were reduced. In parallel, the ratio of beta-to beta-carboxyl-terminal APP fragment was decreased. OG and FA combination therapy strikingly attenuated neuroinflammation, oxidative stress, and synaptotoxicity. Co-treatment afforded additional statistically significant benefits on some, but not all, of these outcome measures. Taken together, these data provide preclinical proof-of-concept for AD combination therapy.	[Mori, Takashi; Koyama, Naoki] Saitama Med Ctr, Dept Biomed Sci, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan; [Mori, Takashi] Saitama Med Ctr, Dept Pathol, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan; [Mori, Takashi; Koyama, Naoki] Univ Kawagoe, Dept Biomed Sci, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan; [Mori, Takashi] Univ Kawagoe, Dept Pathol, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan; [Tan, Jun] Univ S Florida, Morsoni Coll Med, Silver Child Dev Ctr, Rashid Lab Dev Neurobiol, Tampa, FL 33613 USA; [Tan, Jun] Univ S Florida, Morsoni Coll Med, Dept Psychiat & Behav Neurosci, Neuroimmunol Lab, Tampa, FL 33613 USA; [Segawa, Tatsuya; Maeda, Masahiro] Immunobiol Labs Co Ltd, Fujioka, Gunma 3750005, Japan; [Town, Terrence] Univ Southern Calif, Keck Sch Med, Dept Physiol & Neurosci, Zilkha Neurogenet Inst, 1501 San Pablo St,Rm 337, Los Angeles, CA 90089 USA	Saitama Medical University; Saitama Medical University; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Immuno-Biological Laboratories Co. Ltd.; University of Southern California	Mori, T (corresponding author), Saitama Med Ctr, Dept Biomed Sci, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.; Mori, T (corresponding author), Saitama Med Ctr, Dept Pathol, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.; Mori, T (corresponding author), Univ Kawagoe, Dept Biomed Sci, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.; Mori, T (corresponding author), Univ Kawagoe, Dept Pathol, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.; Town, T (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Physiol & Neurosci, Zilkha Neurogenet Inst, 1501 San Pablo St,Rm 337, Los Angeles, CA 90089 USA.	t_mori@saitama-med.ac.jp; ttown@usc.edu			National Institutes of Health [R01NS076794]; Japan Society for the Promotion of Science [26430058]; Alzheimer's Association Zenith Fellows Award [ZEN-10-174633]; American Federation of Aging Research/Ellison Medical Foundation Julie Martin Mid-Career Award in Aging Research [M11472]; Zilkha Neurogenetic Institute of the Keck School of Medicine at the University of Southern California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076794] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alzheimer's Association Zenith Fellows Award(Alzheimer's Association); American Federation of Aging Research/Ellison Medical Foundation Julie Martin Mid-Career Award in Aging Research; Zilkha Neurogenetic Institute of the Keck School of Medicine at the University of Southern California; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS076794 (to T. T.), Grant-in-aid for Scientific Research (C) from the Japan Society for the Promotion of Science 26430058 (to T. M.), Alzheimer's Association Zenith Fellows Award ZEN-10-174633 (to T. T.), American Federation of Aging Research/Ellison Medical Foundation Julie Martin Mid-Career Award in Aging Research M11472 (to T. T.), and generous startup funds from the Zilkha Neurogenetic Institute of the Keck School of Medicine at the University of Southern California (to T. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilar F, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4248; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alzheimer's Disease International, 2015, GLOB IMP DEM WORLD A; Andreasson KI, 2016, J NEUROCHEM, V138, P653, DOI 10.1111/jnc.13667; Arendash GW, 2001, BRAIN RES, V891, P42, DOI 10.1016/S0006-8993(00)03186-3; Barla F, 2009, BIOSCI BIOTECH BIOCH, V73, P2335, DOI 10.1271/bbb.90365; BARNES DG, 1988, REGUL TOXICOL PHARM, V8, P471, DOI 10.1016/0273-2300(88)90047-5; Benzing WC, 1999, NEUROBIOL AGING, V20, P581, DOI 10.1016/S0197-4580(99)00065-2; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Dourson ML, 1996, REGUL TOXICOL PHARM, V24, P108, DOI 10.1006/rtph.1996.0116; Ferruzzi MG, 2009, J ALZHEIMERS DIS, V18, P113, DOI 10.3233/JAD-2009-1135; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; Gandhi S, 2004, J MOL NEUROSCI, V24, P137, DOI 10.1385/JMN:24:1:137; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; Hajipour S, 2016, BASIC CLIN NEUROSCI, V7, P97, DOI 10.15412/J.BCN.03070203; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hartman RE, 2005, J NEUROSCI, V25, P6213, DOI 10.1523/JNEUROSCI.0664-05.2005; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Ishida A, 1997, NEUROREPORT, V8, P2133, DOI 10.1097/00001756-199707070-00009; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Kanski J, 2002, J NUTR BIOCHEM, V13, P273, DOI 10.1016/S0955-2863(01)00215-7; Kim HS, 2004, BIOL PHARM BULL, V27, P120, DOI 10.1248/bpb.27.120; Kim KS, 2006, J NEUROSCI RES, V83, P497, DOI 10.1002/jnr.20754; Kim MJ, 2011, MOL NUTR FOOD RES, V55, P1798, DOI 10.1002/mnfr.201100262; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; King DL, 1999, BEHAV BRAIN RES, V103, P145, DOI 10.1016/S0166-4328(99)00037-6; Klyubin I, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-25; Konishi Y, 2004, J AGR FOOD CHEM, V52, P2527, DOI 10.1021/jf035366k; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Kubo I, 2001, BIOORG MED CHEM LETT, V11, P347, DOI 10.1016/S0960-894X(00)00656-9; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Liu YQ, 2013, BIOORG MED CHEM LETT, V23, P6336, DOI 10.1016/j.bmcl.2013.09.071; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Mori T, 2014, J BIOL CHEM, V289, P30303, DOI 10.1074/jbc.M114.568212; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055774; Mori T, 2012, J BIOL CHEM, V287, P6912, DOI 10.1074/jbc.M111.294025; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; Mouri A, 2007, FASEB J, V21, P2135, DOI 10.1096/fj.06-7685com; Obregon D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1781; Ono K, 2005, BIOCHEM BIOPH RES CO, V336, P444, DOI 10.1016/j.bbrc.2005.08.148; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serrano J, 2009, MOL NUTR FOOD RES, V53, pS310, DOI 10.1002/mnfr.200900039; Shahrzad S, 2001, J NUTR, V131, P1207, DOI 10.1093/jn/131.4.1207; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; Sultana R, 2005, J NEUROCHEM, V92, P749, DOI 10.1111/j.1471-4159.2004.02899.x; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Yan JJ, 2001, BRIT J PHARMACOL, V133, P89, DOI 10.1038/sj.bjp.0704047; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Zhang SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071913; Zhao ZH, 2004, J NUTR, V134, P3083, DOI 10.1093/jn/134.11.3083; Zhao ZH, 2008, FOOD CHEM, V109, P691, DOI 10.1016/j.foodchem.2008.02.039	71	31	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11310	11325		10.1074/jbc.M116.762658	http://dx.doi.org/10.1074/jbc.M116.762658			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28512130	Green Published, hybrid			2022-12-26	WOS:000405119600015
J	Amdisen, C; Jespersen, B; Moldrup, U; Keller, AK				Amdisen, Chris; Jespersen, Bente; Moldrup, Ulla; Keller, Anna K.			The unsuitability of implantable Doppler probes for the early detection of renal vascular complications - a porcine model for prevention of renal transplant loss	PLOS ONE			English	Article							COOK-SWARTZ DOPPLER; KIDNEY-TRANSPLANTATION; SURGICAL COMPLICATIONS; FREE FLAPS; THROMBOSIS; ISCHEMIA; MICRODIALYSIS; PIGS; FLOW	Background Vascular occlusion is a rare, but serious complication after kidney transplantation often resulting in graft loss. We therefore aimed to develop an experimental porcine model for stepwise reduction of the renal venous blood flow and to compare an implantable Doppler probe and microdialysis for fast detection of vascular occlusion. Methods In 20 pigs, implantable Doppler probes were placed on the renal artery and vein and a microdialysis catheter was placed in the renal cortex. An arterial flowprobe served as gold standard. Following two-hour baseline measurements, the pigs were randomised to stepwise venous occlusion, complete venous occlusion, complete arterial occlusion or controls. Results All parameters were stable through baseline measurements. Glutamate and lactate measured by microdialysis increased significantly (p = 0.02 and p = 0.03 respectively) 30 minutes after a 2/3 (66%) reduction in renal blood flow. The implantable Doppler probe was not able to detect flow changes until there was total venous occlusion. Microdialysis detected changes in local metabolism after both arterial and venous occlusion; the implantable Doppler probe could only detect vascular occlusions on the vessel it was placed. Conclusions We developed a new model for stepwise renal venous blood flow occlusion. Furthermore, the first comparison of the implantable Doppler probe and microdialysis for detection of renal vascular occlusions was made. The implantable Doppler probe could only detect flow changes after a complete occlusion, whereas microdialysis detected changes earlier, and could detect both arterial and venous occlusion. Based on these results, the implantable Doppler probe for early detection of vascular occlusions cannot be recommended.	[Amdisen, Chris] Aarhus Univ Hosp, Inst Clin Med, Aarhus, Denmark; [Amdisen, Chris; Jespersen, Bente] Aarhus Univ Hosp, Dept Renal Med, Aarhus, Denmark; [Moldrup, Ulla; Keller, Anna K.] Aarhus Univ Hosp, Dept Urol, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Amdisen, C (corresponding author), Aarhus Univ Hosp, Inst Clin Med, Aarhus, Denmark.; Amdisen, C (corresponding author), Aarhus Univ Hosp, Dept Renal Med, Aarhus, Denmark.	camd@clin.au.dk		Jespersen, Bente/0000-0001-7196-2870; Amdisen, Chris/0000-0003-3262-8524	Helen and Ejnar Biornows Foundation; Institute of Clinical Medicine, Aarhus University hospital; Soster & Verner Lipperts foundation; Institute of Clinical Medicine; Soster and Verner Lipperts foundation	Helen and Ejnar Biornows Foundation; Institute of Clinical Medicine, Aarhus University hospital; Soster & Verner Lipperts foundation; Institute of Clinical Medicine; Soster and Verner Lipperts foundation	This work was supported by the Helen and Ejnar Biornows Foundation (http://www.bjoemowsfond..dk/); Institute of Clinical Medicine, Aarhus University hospital (http://clin.au.dk/en/) and the Soster & Verner Lipperts foundation (http ://lippertsfond.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support was generously donated by: the Helen and Ejnar Bjornow foundation, the Institute of Clinical Medicine and the Soster and Verner Lipperts foundation. The funding sources had no involvement in any part of the study.	Aktas S, 2011, TRANSPL P, V43, P557, DOI 10.1016/j.transproceed.2011.01.007; Barba J, 2013, SCAND J UROL, V47, P63, DOI 10.3109/00365599.2012.700945; Brown ED, 2000, RADIOGRAPHICS, V20, P607, DOI 10.1148/radiographics.20.3.g00ma14607; Crane J, 2011, EXP CLIN TRANSPLANT, V9, P118; de Jong KP, 2012, TRANSPLANTATION, V94, P958, DOI 10.1097/TP.0b013e318269e6ad; Fonouni H, 2013, LANGENBECK ARCH SURG, V398, P87, DOI 10.1007/s00423-012-1010-0; Fonouni H, 2012, NEPHROL DIAL TRANSPL, V27, P541, DOI 10.1093/ndt/gfr308; Frost MW, 2015, MICROSURG, V35, P262, DOI 10.1002/micr.22331; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; HJORTDAL VE, 1994, PLAST RECONSTR SURG, V93, P375, DOI 10.1097/00006534-199402000-00024; HJORTDAL VE, 1992, PLAST RECONSTR SURG, V89, P521, DOI 10.1097/00006534-199203000-00021; Humar A, 2005, SEMIN DIALYSIS, V18, P505, DOI 10.1111/j.1525-139X.2005.00097.x; Keller AK, 2009, TRANSPL P, V41, P44, DOI 10.1016/j.transproceed.2008.10.089; Keller AK, 2013, MESSENGERS RENAL GRA, V45, P1172; Keller AK, 2013, TRANSPLANTATION, V95, P275, DOI 10.1097/TP.0b013e318276a1c8; Keller AK, 2008, J UROLOGY, V179, P371, DOI 10.1016/j.juro.2007.08.088; Keller AK, 2009, J UROLOGY, V182, P1854, DOI 10.1016/j.juro.2009.03.015; Oliver DW, 2005, BRIT J PLAST SURG, V58, P366, DOI 10.1016/j.bjps.2004.12.003; PENNY MJ, 1994, TRANSPLANTATION, V58, P565, DOI 10.1097/00007890-199409150-00007; Ponticelli C, 2009, NEPHROL DIAL TRANSPL, V24, P1388, DOI 10.1093/ndt/gfp003; Rozen W, 2010, J RECONSTR MICROSURG, V27; Rozen WM, 2010, MICROSURG, V30, P354, DOI 10.1002/micr.20720; Rozen WM, 2009, MICROSURGERY; Sayegh MH, 2004, NEW ENGL J MED, V351, P2761, DOI 10.1056/NEJMon043418; Schmulder A, 2011, MICROSURG, V31, P1, DOI 10.1002/micr.20816; Smit JM, 2009, J PLAST RECONSTR AES, V62, P1286, DOI 10.1016/j.bjps.2008.06.007; SWARTZ WM, 1988, PLAST RECONSTR SURG, V81, P149, DOI 10.1097/00006534-198802000-00001; Weld KJ, 2008, J ENDOUROL, V22, P571, DOI 10.1089/end.2007.0256; Weld KJ, 2009, J UROLOGY, V181, P878, DOI 10.1016/j.juro.2008.10.068; Whitaker IS, 2010, J RECONSTR MICROSURG, V26, P409, DOI 10.1055/s-0030-1249607	30	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178301	10.1371/journal.pone.0178301	http://dx.doi.org/10.1371/journal.pone.0178301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542429	Green Published, gold, Green Submitted			2022-12-26	WOS:000402062800066
J	Killick-Cole, CL; Singleton, WGB; Bienemann, AS; Asby, DJ; Wyatt, MJ; Boulter, LJ; Barua, NU; Gill, SS				Killick-Cole, Clare L.; Singleton, William G. B.; Bienemann, Alison S.; Asby, Daniel J.; Wyatt, Marcella J.; Boulter, Lisa J.; Barua, Neil U.; Gill, Steven S.			Repurposing the anti-epileptic drug sodium valproate as an adjuvant treatment for diffuse intrinsic pontine glioma	PLOS ONE			English	Article							CONVECTION-ENHANCED DELIVERY; HISTONE DEACETYLASE INHIBITOR; ACTIVATING ACVR1 MUTATIONS; BRAIN-STEM GLIOMA; LEUKEMIA-CELLS; PHASE-I; ACID; GLIOBLASTOMA; CARBOPLATIN; EXPRESSION	Targeting epigenetic changes in diffuse intrinsic pontine glioma (DIPG) may provide a novel treatment option for patients. This report demonstrates that sodium valproate, a histone deacetylase inhibitor (HDACi), can increase the cytotoxicity of carboplatin in an additive and synergistic manner in DIPG cells in vitro. Sodium valproate causes a dose-dependent decrease in DIPG cell viability in three independent ex vivo cell lines. Furthermore, sodium valproate caused an increase in acetylation of histone H3. Changes in cell viability were consistent with an induction of apoptosis in DIPG cells in vitro, determined by flow cytometric analysis of Annexin V staining and assessment of apoptotic markers by western blotting. Subsequently, immunofluorescent staining of neuronal and glial markers was used to determine toxicity in normal rat hippocampal cells. Pre-treatment of cells with sodium valproate enhanced the cytotoxic effects of carboplatin, in three DIPG cell lines tested. These results demonstrate that sodium valproate causes increased histone H3 acetylation indicative of HDAC inhibition, which is inversely correlated with a reduction in cell viability. Cell viability is reduced through an induction of apoptosis in DIPG cells. Sodium valproate potentiates carboplatin cytotoxicity and prompts further work to define the mechanism responsible for the synergy between these two drugs and determine in vivo efficacy. These findings support the use of sodium valproate as an adjuvant treatment for DIPG.	[Killick-Cole, Clare L.; Singleton, William G. B.; Bienemann, Alison S.; Asby, Daniel J.; Wyatt, Marcella J.; Boulter, Lisa J.; Barua, Neil U.; Gill, Steven S.] Univ Bristol, Sch Clin Sci, Funct Neurosurg Res Grp, Southmead Hosp, Learning & Res Bldg, Bristol, Avon, England; [Singleton, William G. B.; Barua, Neil U.; Gill, Steven S.] North Bristol NHS Trust, Dept Neurosurg, Bristol, Avon, England	Southmead Hospital; University of Bristol; North Bristol NHS Trust	Killick-Cole, CL; Gill, SS (corresponding author), Univ Bristol, Sch Clin Sci, Funct Neurosurg Res Grp, Southmead Hosp, Learning & Res Bldg, Bristol, Avon, England.; Gill, SS (corresponding author), North Bristol NHS Trust, Dept Neurosurg, Bristol, Avon, England.	clare.killick-cole@bristol.ac.uk; steven.gill@nbt.nhs.uk		Asby, Daniel/0000-0002-1219-8347; Singleton, William/0000-0001-8836-7613	Functional Neurosurgery Research Fund; MRC [MR/J005134/1, G0601745, MR/N001370/1] Funding Source: UKRI; Medical Research Council [G0601745, MR/J005134/1, MR/N001370/1] Funding Source: researchfish	Functional Neurosurgery Research Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Functional Neurosurgery Research Fund, held by Southmead Hospital Charities. SG and NB are advisers to Renishaw PLC. Neither Functional Neurosurgery Research Fund nor Renishaw had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arshad A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132266; Arvidsson Y, 2016, NEUROENDOCRINOLOGY, V103, P578, DOI 10.1159/000441849; Atmaca A, 2007, BRIT J CANCER, V97, P177, DOI 10.1038/sj.bjc.6603851; Barua NU, 2013, ACTA NEUROCHIR, V155, P1459, DOI 10.1007/s00701-013-1700-6; Barua NU, 2016, DRUG DELIV, V23, P167, DOI 10.3109/10717544.2014.908248; Barua NU, 2014, BRAIN PATHOL, V24, P117, DOI 10.1111/bpa.12082; Bokelmann I, 2008, MOL MED, V14, P20, DOI 10.2119/2007-00084.Bokelmann; Buczkowicz P, 2014, NAT GENET, V46, P451, DOI 10.1038/ng.2936; Castel D, 2015, ACTA NEUROPATHOL, V130, P815, DOI 10.1007/s00401-015-1478-0; Catalano MG, 2004, J CLIN ENDOCRINOLOGY, V90, P1383; Felix FHC, 2011, PEDIATR HEMAT ONCOL, V28, P556, DOI 10.3109/08880018.2011.563774; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cinatl J, 1997, ANTI-CANCER DRUG, V8, P958, DOI 10.1097/00001813-199711000-00007; Das CM, 2007, J NEURO-ONCOL, V85, P159, DOI 10.1007/s11060-007-9402-7; Donaldson SS, 2006, J CLIN ONCOL, V24, P1266, DOI 10.1200/JCO.2005.04.6599; Khuong-Quang DA, 2012, ACTA NEUROPATHOL, V124, P439, DOI 10.1007/s00401-012-0998-0; Falchook GS, 2013, INVEST NEW DRUG, V31, P1192, DOI 10.1007/s10637-013-0003-3; Felisbino MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029144; Fortunati N, 2008, CANCER LETT, V259, P156, DOI 10.1016/j.canlet.2007.10.006; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Grasso CS, 2015, NAT MED, V21, P555, DOI 10.1038/nm.3855; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Halvorson KG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118926; Hashizume R, 2014, NAT MED, V20, P1394, DOI 10.1038/nm.3716; Hashizume R, 2012, J NEURO-ONCOL, V110, P305, DOI 10.1007/s11060-012-0973-6; Hennika T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169485; Kawagoe R, 2002, LEUKEMIA RES, V26, P495, DOI 10.1016/S0145-2126(01)00151-5; Li YF, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00058; Marchion DC, 2005, CANCER RES, V65, P3815, DOI 10.1158/0008-5472.CAN-04-2478; Paugh BS, 2013, CANCER RES, V73, P6219, DOI 10.1158/0008-5472.CAN-13-1491; Pilatrino C, 2005, CANCER-AM CANCER SOC, V104, P101, DOI 10.1002/cncr.21132; Puget S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030313; Ramalingam SS, 2007, CLIN CANCER RES, V13, P3605, DOI 10.1158/1078-0432.CCR-07-0162; Redjal N, 2016, J NEURO-ONCOL, V127, P505, DOI 10.1007/s11060-016-2054-8; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Sawai H, 2011, BIOCHEM BIOPH RES CO, V411, P569, DOI 10.1016/j.bbrc.2011.06.186; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Singleton WGB, 2016, NEURO-ONCOLOGY, V18, P131; Taylor KR, 2014, NAT GENET, V46, P457, DOI 10.1038/ng.2925; van Zanten SEMV, 2015, EXPERT REV ANTICANC, V15, P157, DOI 10.1586/14737140.2015.974563; Wagner S, 2009, TURK J CANC, V39, P104; WIESER HG, 1991, EPILEPSY RES, V9, P154, DOI 10.1016/0920-1211(91)90028-E; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yeow WS, 2006, BRIT J CANCER, V94, P1436, DOI 10.1038/sj.bjc.6603132	45	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0176855	10.1371/journal.pone.0176855	http://dx.doi.org/10.1371/journal.pone.0176855			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542253	gold, Green Published, Green Submitted			2022-12-26	WOS:000402062800005
J	Holinka, LG; O'Donnell, V; Risatti, GR; Azzinaro, P; Arzt, J; Stenfeldt, C; Velazquez-Salinas, L; Carlson, J; Gladue, DP; Borca, MV				Holinka, Lauren G.; O'Donnell, Vivian; Risatti, Guillermo R.; Azzinaro, Paul; Arzt, Jonathan; Stenfeldt, Carolina; Velazquez-Salinas, Lauro; Carlson, Jolene; Gladue, Douglas P.; Borca, Manuel V.			Early protection events in swine immunized with an experimental live attenuated classical swine fever marker vaccine, FlagT4G	PLOS ONE			English	Article							HOG-CHOLERA VIRUS; INTERFERON SYNTHESIS; CHINESE STRAIN; VIRULENCE; CSFV; PESTIVIRUSES; INHIBITION; INFECTION; APOPTOSIS; CYTOKINES	Prophylactic vaccination using live attenuated classical swine fever (CSF) vaccines has been a very effective method to control the disease in endemic regions and during outbreaks in previously disease-free areas. These vaccines confer effective protection against the disease at early times post-vaccination although the mechanisms mediating the protection are poorly characterized. Here we present the events occurring after the administration of our in-house developed live attenuated marker vaccine, FlagT4Gv. We previously reported that FlagT4Gv intramuscular (IM) administered conferred effective protection against intranasal challenge with virulent CSFV (BICv) as early as 7 days post-vaccination. Here we report that FlagT4Gv is able to induce protection against disease as early as three days post-vaccination. Immunohistochemical testing of tissues from FlagT4Gv-inoculated animals showed that tonsils were colonized by the vaccine virus by day 3 post-inoculation. There was a complete absence of BICv in tonsils of FlagT4Gv-inoculated animals which had been intranasal (IN) challenged with BICv 3 days after FlagT4Gv infection, confirming that FlagT4Gv inoculation confers sterile immunity. Analysis of systemic levels of 19 different cytokines in vaccinated animals demonstrated an increase of IFN-alpha three days after FlagT4Gv inoculation compared with mock infected controls.	[Holinka, Lauren G.; O'Donnell, Vivian; Azzinaro, Paul; Arzt, Jonathan; Stenfeldt, Carolina; Velazquez-Salinas, Lauro; Carlson, Jolene; Gladue, Douglas P.; Borca, Manuel V.] ARS, Plum Isl Anim Dis Ctr, USDA, Greenport, NY 11944 USA; [O'Donnell, Vivian; Risatti, Guillermo R.] Univ Connecticut, Dept Pathobiol & Vet Sci, Storrs, CT USA; [Azzinaro, Paul; Velazquez-Salinas, Lauro] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Carlson, Jolene] Kansas State Univ, Coll Vet Med, Biosecur Res Inst, Manhattan, KS 66506 USA; [Carlson, Jolene] Kansas State Univ, Coll Vet Med, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA	United States Department of Agriculture (USDA); University of Connecticut; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; Kansas State University; Kansas State University	Borca, MV (corresponding author), ARS, Plum Isl Anim Dis Ctr, USDA, Greenport, NY 11944 USA.	manuel.borca@ars.usda.gov	Stenfeldt, Carolina/AAG-7940-2021; Gladue, Douglas/P-6280-2018; O'Donnell, Vivian/ACY-4611-2022; Velazquez-Salinas, Lauro/AAF-3951-2021	Gladue, Douglas/0000-0002-7894-0233; Stenfeldt, Carolina/0000-0002-2074-3886; Arzt, Jonathan/0000-0002-7517-7893	State of Kansas National Bio and Agro-Defense Facility Fund (NBAF); Institute for Infectious Animal Diseases (IIAD); ARS/USDA-University of Connecticut SCA [58-1940-1-190]	State of Kansas National Bio and Agro-Defense Facility Fund (NBAF); Institute for Infectious Animal Diseases (IIAD); ARS/USDA-University of Connecticut SCA	This project was partially funded through the State of Kansas National Bio and Agro-Defense Facility Fund (NBAF) and Institute for Infectious Animal Diseases (IIAD) Career Development Program. We also thank ARS/USDA-University of Connecticut SCA# 58-1940-1-190 for partially supporting this work. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank the Plum Island Animal Disease Center Animal Resource Branch for excellent technical assistance. This project was partially funded through the State of Kansas National Bio and Agro-Defense Facility Fund (NBAF) and Institute for Infectious Animal Diseases (IIAD) Career Development Program. We also thank ARS/USDA-University of Connecticut SCA# 58-1940-1-190 for partially supporting this work.	Becher P, 2003, VIROLOGY, V311, P96, DOI 10.1016/S0042-6822(03)00192-2; Bensaude E, 2004, J GEN VIROL, V85, P1029, DOI 10.1099/vir.0.19637-0; BIRONT P, 1987, VET MICROBIOL, V14, P105, DOI 10.1016/0378-1135(87)90002-2; Carlson J, 2016, VIRUSES, P8; Choi C, 2004, ARCH VIROL, V149, P875, DOI 10.1007/s00705-003-0275-6; DAHLE J, 1995, BERL MUNCH TIERARZTL, V108, P20; de Smit AJ, 2001, VACCINE, V19, P1467, DOI 10.1016/S0264-410X(00)00347-9; Dong XY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-286; EDWARDS S, 1991, VET MICROBIOL, V29, P101, DOI 10.1016/0378-1135(91)90118-Y; Fernandez-Sainz I, 2015, VIROLOGY, V483, P284, DOI 10.1016/j.virol.2015.04.024; Fernandez-Sainz I, 2010, J VIROL, V84, P1536, DOI 10.1128/JVI.02050-09; FERRARI M, 1992, COMP IMMUNOL MICROB, V15, P221, DOI 10.1016/0147-9571(92)90095-9; Graham SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029310; Graham SP, 2012, VACCINE, V30, P2742, DOI 10.1016/j.vaccine.2012.02.029; Holinka LG, 2014, VIROLOGY, V471, P13, DOI 10.1016/j.virol.2014.09.021; Holinka LG, 2009, VIROLOGY, V384, P106, DOI 10.1016/j.virol.2008.10.039; KADEN V, 1982, ARCH EXP VET MED, V36, P593; Lai SS, 1982, ROLES PROTECTION PIG, P126; Leifer I, 2009, J VIROL METHODS, V158, P114, DOI 10.1016/j.jviromet.2009.02.002; Magkouras I, 2008, J GEN VIROL, V89, P2501, DOI 10.1099/vir.0.2008/003749-0; REED L. J., 1938, AMER JOUR HYG, V27, P493; Renson P, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-9; Risatti GR, 2005, VIROLOGY, V343, P116, DOI 10.1016/j.virol.2005.08.015; Rosengard AM, 1999, MOL IMMUNOL, V36, P685, DOI 10.1016/S0161-5890(99)00081-4; Tamura T, 2012, J VIROL, V86, P8602, DOI 10.1128/JVI.00551-12; Tarradas J, 2014, VIRUS RES, V185, P82, DOI 10.1016/j.virusres.2014.03.004; TERPSTRA C, 1990, DEUT TIERARZTL WOCH, V97, P77; van Oirschot JT, 2003, VET MICROBIOL, V96, P367, DOI 10.1016/j.vetmic.2003.09.008	28	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177433	10.1371/journal.pone.0177433	http://dx.doi.org/10.1371/journal.pone.0177433			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542321	Green Submitted, Green Published, gold			2022-12-26	WOS:000402061500024
J	Arias-Mutis, OJ; Marrachelli, VG; Ruiz-Sauri, A; Alberola, A; Morales, JM; Such-Miquel, L; Monleon, D; Chorro, FJ; Such, L; Zarzoso, M				Julian Arias-Mutis, Oscar; Marrachelli, Vannina G.; Ruiz-Sauri, Amparo; Alberola, Antonio; Manuel Morales, Jose; Such-Miquel, Luis; Monleon, Daniel; Chorro, Francisco J.; Such, Luis; Zarzoso, Manuel			Development and characterization of an experimental model of diet-induced metabolic syndrome in rabbit	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; HIGH-FAT DIET; TYPE-2 DIABETES-MELLITUS; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; OBESITY; ATHEROSCLEROSIS; ACIDS; HYPERTENSION; POPULATION	Metabolic syndrome (MetS) has become one of the main concerns for public health because of its link to cardiovascular disease. Murine models have been used to study the effect of MetS on the cardiovascular system, but they have limitations for studying cardiac electrophysiology. In contrast, the rabbit cardiac electrophysiology is similar to human, but a detailed characterization of the different components of MetS in this animal is still needed. Our objective was to develop and characterize a diet-induced experimental model of MetS that allows the study of cardiovascular remodeling and arrhythmogenesis. Male NZW rabbits were assigned to control (n = 15) or MetS group (n = 16), fed during 28 weeks with high-fat, high-sucrose diet. We measured weight, morphological characteristics, blood pressure, glycaemia, standard plasma biochemistry and the metabolomic profile at weeks 14 and 28. Liver histological changes were evaluated using hematoxylin-eosin staining. A mixed model ANOVA or unpaired t-test were used for statistical analysis (P<0.05). Weight, abdominal contour, body mass index, systolic, diastolic and mean arterial pressure increased in the MetS group at weeks 14 and 28. Glucose, triglycerides, LDL, GOT-AST, GOT/GPT, bilirubin and bile acid increased, whereas HDL decreased in the MetS group at weeks 14 and 28. We found a 40% increase in hepatocyte area and lipid vacuoles infiltration in the liver from MetS rabbits. Metabolomic analysis revealed differences in metabolites related to fatty acids, energetic metabolism and microbiota, compounds linked with cardiovascular disease. Administration of high-fat and high-sucrose diet during 28 weeks induced obesity, glucose intolerance, hypertension, non-alcoholic hepatic steatosis and metabolic alterations, thus reproducing the main clinical manifestations of the metabolic syndrome in humans. This experimental model should provide a valuable tool for studies into the mechanisms of cardiovascular problems related to MetS, with special relevance in the study of cardiovascular remodeling, arrhythmias and SCD.	[Julian Arias-Mutis, Oscar; Marrachelli, Vannina G.; Monleon, Daniel; Chorro, Francisco J.] Hlth Res Inst INCLIVA, Valencia, Spain; [Julian Arias-Mutis, Oscar; Marrachelli, Vannina G.; Alberola, Antonio; Such, Luis] Univ Valencia, Dept Physiol, Valencia, Spain; [Ruiz-Sauri, Amparo; Monleon, Daniel] Univ Valencia, Dept Pathol, Valencia, Spain; [Manuel Morales, Jose] Univ Valencia, UCIM, Valencia, Spain; [Such-Miquel, Luis; Zarzoso, Manuel] Univ Valencia, Dept Physiotherapy, Valencia, Spain; [Chorro, Francisco J.] Clin Hosp Valencia, Dept Cardiol, Valencia, Spain; [Chorro, Francisco J.] Inst Salud Carlos III, CIBERCV, Madrid, Spain	University of Valencia; University of Valencia; University of Valencia; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Instituto de Salud Carlos III	Zarzoso, M (corresponding author), Univ Valencia, Dept Physiotherapy, Valencia, Spain.	manuel.zarzoso@uv.es	Monleon, Daniel/GNP-4083-2022; marrachelli, vannina G/L-6041-2014; Saurí, Amparo Ruiz/R-5395-2018; Zarzoso, Manuel/AAA-6129-2019; tatay, jose manuel morales/L-7972-2014; Monleon, Daniel/A-5078-2010; Chorro, Francisco J/AAB-6766-2020; Arias-Mutis, Oscar/AAA-5858-2019	Monleon, Daniel/0000-0002-4803-1573; marrachelli, vannina G/0000-0002-4097-3312; Zarzoso, Manuel/0000-0003-3372-4497; tatay, jose manuel morales/0000-0002-4404-6735; Monleon, Daniel/0000-0002-4803-1573; Such-Miquel, Luis/0000-0001-8499-7183; Alberola, Antonio/0000-0001-8531-4161	Generalitat Valenciana [GV2015-062, PROMETEOII/2014/037]; Universitat de Valencia [UV-INV-PRECOMP14-206372]; Ministry of Economy, Industry and Competitiviness of Spain [SAF2014-52875R]; Institutode Salud Carlos III [CB16/11/00486, PIE15/00013]	Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Universitat de Valencia; Ministry of Economy, Industry and Competitiviness of Spain; Institutode Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by Generalitat Valenciana (GV2015-062 and PROMETEOII/2014/037): http://www.ceice.gva.es/web/ciencia; Universitat de Valencia (UV-INV-PRECOMP14-206372): http://www.uv.es/uvweb/college/en/research-tech-transfer/funding/presentation-news-1285946409813.html; Ministry of Economy, Industry and Competitiviness of Spain (SAF2014-52875R): https://sede.micinn.gob.es/portal/site/eSede?lang_choosen=en; and Institutode Salud Carlos III (CB16/11/00486 and PIE15/00013): http://www.eng.isciii.es/ISCIII/es/general/index.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Generalitat Valenciana (GV2015-062), Universitat de Valencia (UV-INV-PRECOMP14-206372) to MZ, Ministry of Economy, Industry and Competitiviness of Spain (SAF2014-52875R) to DM, Generalitat Valenciana (PROMETEOII/2014/037) to FJC and Instituto de Salud Carlos III (CB16/11/00486 and PIE15/00013). We thank Mariano Munoz, Ana Diaz and Eva Blanch for their excellent technical assistance. The authors gratefully acknowledge useful discussions with Dr. Jose T. Real.	Abu Bakar MH, 2015, MOL BIOSYST, V11, P1742, DOI 10.1039/c5mb00158g; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alonso-Magdalena P, 2011, NAT REV ENDOCRINOL, V7, P346, DOI 10.1038/nrendo.2011.56; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Carroll JF, 1996, AM J PHYSIOL-HEART C, V271, pH373, DOI 10.1152/ajpheart.1996.271.1.H373; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; D'Aversa F, 2013, INTERN EMERG MED, V8, pS11, DOI 10.1007/s11739-013-0916-z; de Grooth GJ, 2004, J LIPID RES, V45, P1967, DOI 10.1194/jlr.R400007-JLR200; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fan J, 2000, J Atheroscler Thromb, V7, P26; Filippi A, 2008, J CARDIOVASC MED, V9, P595, DOI 10.2459/JCM.0b013e3282f2c9d0; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Greiner TU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110359; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Guo XY, 2016, DIABETES RES CLIN PR, V115, P76, DOI 10.1016/j.diabres.2016.03.007; Hall JE, 2015, CIRC RES, V116, P991, DOI 10.1161/CIRCRESAHA.116.305697; He XY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030300; Helfenstein T, 2011, INT J EXP PATHOL, V92, P40, DOI 10.1111/j.1365-2613.2010.00753.x; Hildrum B, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-220; Hookana E, 2011, HEART RHYTHM, V8, P1570, DOI 10.1016/j.hrthm.2011.06.031; Kaur P, 2013, MOL BIOSYST, V9, P307, DOI 10.1039/c2mb25384d; Krauss RM, 2004, MED CLIN N AM, V88, P897, DOI 10.1016/j.mcna.2004.04.004; Lengyel C, 2001, BRIT J PHARMACOL, V132, P101, DOI 10.1038/sj.bjp.0703777; Liu EQ, 2005, METABOLISM, V54, P132, DOI 10.1016/j.metabol.2004.07.021; Messana I, 1998, CLIN CHEM, V44, P1529; Morrow JP, 2014, ACTA PHYSIOL, V211, P13, DOI 10.1111/apha.12276; NELSON RW, 1990, AM J VET RES, V51, P1357; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Ning B, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0024-3; Panfilov AV, 2006, HEART RHYTHM, V3, P862, DOI 10.1016/j.hrthm.2005.12.022; Park S, 2015, MOL CELLS, V38, P587, DOI 10.14348/molcells.2015.0126; Polakof S, 2016, EUROPEAN J NUTR; Reuter S, 2015, ACTA PHYSIOL, V214, P291, DOI 10.1111/apha.12530; Sahebkar A, 2017, J CELLULAR PHYSL; Semenkovich CF, 1997, DIABETES, V46, P327, DOI 10.2337/diabetes.46.3.327; Stancakova A, 2012, DIABETES, V61, P1895, DOI 10.2337/db11-1378; van Bilsen M, 2014, ACTA PHYSIOL, V211, P476, DOI 10.1111/apha.12308; Verkest KR, 2014, VET J, V199, P24, DOI 10.1016/j.tvjl.2013.09.057; Vishram JKK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107294; Waqar AB, 2010, ATHEROSCLEROSIS, V213, P148, DOI 10.1016/j.atherosclerosis.2010.07.051; Wong SK, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0123-9; Xu FG, 2013, J CLIN ENDOCR METAB, V98, pE1060, DOI 10.1210/jc.2012-4132; Yin Weidong, 2002, Int J Exp Diabetes Res, V3, P179, DOI 10.1080/15604280214274; Yokota A, 2012, GUT MICROBES, V3, P455, DOI 10.4161/gmic.21216; Zarzoso M, 2014, ACTA PHYSIOL, V211, P36, DOI 10.1111/apha.12185; Zhang X, 2016, TOXICOL PATHOL, V44, P358, DOI 10.1177/0192623316630835; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071108; Zhao S, 2008, J ANIM PHYSIOL AN N, V92, P105, DOI 10.1111/j.1439-0396.2007.00723.x	48	22	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178315	10.1371/journal.pone.0178315	http://dx.doi.org/10.1371/journal.pone.0178315			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542544	Green Published, Green Submitted, gold			2022-12-26	WOS:000402058800054
J	Schulze, J; Kaiser, O; Paasche, G; Lamm, H; Pich, A; Hoffmann, A; Lenarz, T; Warnecke, A				Schulze, Jennifer; Kaiser, Odett; Paasche, Gerrit; Lamm, Hans; Pich, Andreas; Hoffmann, Andrea; Lenarz, Thomas; Warnecke, Athanasia			Effect of hyperbaric oxygen on BDNF-release and neuroprotection: Investigations with human mesenchymal stem cells and genetically modified NIH3T3 fibroblasts as putative cell therapeutics	PLOS ONE			English	Article							SPIRAL-GANGLION NEURONS; MARROW STROMAL CELLS; NEUROTROPHIC FACTOR; IN-VITRO; AUDITORY NEURONS; HAIR-CELLS; NEURITE OUTGROWTH; NITRIC-OXIDE; EXPRESSION; SURVIVAL	Hyperbaric oxygen therapy (HBOT) is a noninvasive widely applied treatment that increases the oxygen pressure in tissues. In cochlear implant (CI) research, intracochlear application of neurotrophic factors (NTFs) is able to improve survival of spiral ganglion neurons (SGN) after deafness. Cell-based delivery of NTFs such as brain-derived neurotrophic factor (BDNF) may be realized by cell-coating of the surface of the CI electrode. Human mesenchymal stem cells (MSC) secrete a variety of different neurotrophic factors and may be used for the development of a biohybrid electrode in order to release endogenously-derived neuroprotective factors for the protection of residual SGN and for a guided outgrowth of dendrites in the direction of the CI electrode. HBOT could be used to influence cell behaviour after transplantation to the inner ear. The aim of this study was to investigate the effect of HBOT on the proliferation, BDNF-release and secretion of neuroprotective factors. Thus, model cells (an immortalized fibroblast cell line (NIH3T3)-native and genetically modified) and MSCs were repeatedly (3 x - 10 x) exposed to 100% oxygen at different pressures. The effects of HBO on cell proliferation were investigated in relation to normoxic and normobaric conditions (NOR). Moreover, the neuroprotective and neuroregenerative effects of HBO-treated cells were analysed by cultivation of SGN in conditioned medium. Both, the genetically modified NIH3T3/BDNF and native NIH3T3 fibroblasts, showed a highly significant increased proliferation after five days of HBOT in comparison to normoxic controls. By contrast, the number of MSCs was decreased in MSCs treated with 2.0 bar of HBO. Treating SGN cultures with supernatants of fibroblasts and MSCs significantly increased the survival rate of SGN. HBO treatment did not influence (increase / reduce) this effect. Secretome analysis showed that HBO treatment altered the protein expression pattern in MSCs.	[Schulze, Jennifer; Kaiser, Odett; Paasche, Gerrit; Lamm, Hans; Lenarz, Thomas; Warnecke, Athanasia] Hannover Med Sch, Dept Otorhinolaryngol Head & Neck Surg, Hannover, Germany; [Schulze, Jennifer; Kaiser, Odett; Paasche, Gerrit; Lenarz, Thomas; Warnecke, Athanasia] Cluster Excellence Hearing4all, Hannover, Germany; [Pich, Andreas] Hannover Med Sch, Core Facil Prote, Hannover, Germany; [Hoffmann, Andrea] Hannover Med Sch, Dept Orthopaed Surg, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Schulze, J (corresponding author), Hannover Med Sch, Dept Otorhinolaryngol Head & Neck Surg, Hannover, Germany.; Schulze, J (corresponding author), Cluster Excellence Hearing4all, Hannover, Germany.	Schulze.Jennifer.HNO@mh-hannover.de	Warnecke, Athanasia/HHC-6174-2022; Hoffmann, Andrea/AAG-4488-2020	Hoffmann, Andrea/0000-0003-2318-8985	DFG Cluster of Excellence [EXC 1077/1]	DFG Cluster of Excellence(German Research Foundation (DFG))	This work was supported by DFG Cluster of Excellence EXC 1077/1 "Hearing4all", http:// hearing4all.eu/, JS, OK.	ARBER S, 1995, J CELL BIOL, V131, P1083, DOI 10.1083/jcb.131.4.1083; Arnhold S, 2006, EUR J CELL BIOL, V85, P551, DOI 10.1016/j.ejcb.2006.01.015; Bae KS, 2011, YONSEI MED J, V52, P401, DOI 10.3349/ymj.2011.52.3.401; Bailey EM, 2014, J NEUROSCI, V34, P13110, DOI 10.1523/JNEUROSCI.1014-14.2014; Budenz CL, 2015, SCI REP, V5, P1; Chikar JA, 2012, BIOMATERIALS, V33, P1982, DOI 10.1016/j.biomaterials.2011.11.052; Chow DC, 2001, BIOPHYS J, V81, P685, DOI 10.1016/S0006-3495(01)75733-5; Colombari GC, 2011, EUR ARCH OTO-RHINO-L, V268, P49, DOI 10.1007/s00405-010-1338-4; Conconi MT, 2003, J INVEST MED, V51, P227, DOI 10.1136/jim-51-04-24; Dimitrijevich SD, 1999, WOUND REPAIR REGEN, V7, P53; Fernandez KA, 2015, J NEUROSCI, V35, P7509, DOI 10.1523/JNEUROSCI.5138-14.2015; Flores-Otero J, 2011, J COMP NEUROL, V519, P1455, DOI 10.1002/cne.22576; Geng CK, 2015, ASIAN PAC J TROP MED, V8, P469, DOI [10.1016/j.apjtm.2015.05.001, 10.1016/S1995-7645(14)60362-X]; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Gillespie LN, 2001, NEUROREPORT, V12, P275, DOI 10.1097/00001756-200102120-00019; Gillespie LN, 2003, J NEUROSCI RES, V71, P785, DOI 10.1002/jnr.10542; Huang T, 2000, INT J DEV NEUROSCI, V18, P259, DOI 10.1016/S0736-5748(99)00094-5; Jin YL, 2013, CELL TISSUE RES, V351, P15, DOI 10.1007/s00441-012-1526-1; Jochim N, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-48; Kang Thomas S, 2004, Arch Facial Plast Surg, V6, P31, DOI 10.1001/archfaci.6.1.31; Kishino A, 2001, NEUROREPORT, V12, P1067, DOI 10.1097/00001756-200104170-00040; Kitaoka Y, 2016, EXP EYE RES, V152, P71, DOI 10.1016/j.exer.2016.09.007; Kondo T, 2005, P NATL ACAD SCI USA, V102, P4789, DOI 10.1073/pnas.0408239102; Kunnavatana SS, 2005, ARCH OTOLARYNGOL, V131, P809, DOI 10.1001/archotol.131.9.809; Lagarde MMM, 2013, J NEUROSCI, V33, P1564, DOI 10.1523/JNEUROSCI.3088-12.2013; Lai R. C., 2012, INT J PROTEOMICS, V2012, P1; Lamm K, 1998, ADV OTO-RHINO-LARYNG, V54, P59; Lee CC, 2006, J BIOMED SCI, V13, P143, DOI 10.1007/s11373-005-9037-7; LEFEBVRE PP, 1994, NEUROREPORT, V5, P865, DOI 10.1097/00001756-199404000-00003; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Lin SS, 2014, STEM CELL RES, V12, P260, DOI 10.1016/j.scr.2013.10.007; Matsuoka AJ, 2006, LARYNGOSCOPE, V116, P1363, DOI 10.1097/01.mlg.0000225986.18790.75; May LA, 2013, J CLIN INVEST, V123, P3577, DOI 10.1172/JCI68480; McGuinness SL, 2005, OTOL NEUROTOL, V26, P1064, DOI 10.1097/01.mao.0000185063.20081.50; Miller JM, 2007, J NEUROSCI RES, V85, P1959, DOI 10.1002/jnr.21320; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Monzack EL, 2013, HEARING RES, V303, P20, DOI 10.1016/j.heares.2013.01.008; Nakaizumi T, 2004, AUDIOL NEURO-OTOL, V9, P135, DOI 10.1159/000077264; Perez P, 2011, AGING DIS, V2, P231; Pirvola U, 1997, J NEUROBIOL, V33, P1019, DOI 10.1002/(SICI)1097-4695(199712)33:7<1019::AID-NEU11>3.0.CO;2-A; PIRVOLA U, 1992, P NATL ACAD SCI USA, V89, P9915, DOI 10.1073/pnas.89.20.9915; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; ROBERTS GP, 1994, BRIT J DERMATOL, V131, P630, DOI 10.1111/j.1365-2133.1994.tb04973.x; Roemer A, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0408-y; Sabirzhanov B, 2012, J NEUROCHEM, V123, P542, DOI 10.1111/j.1471-4159.2012.07927.x; Schack LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065943; Schack LM, 2013, STEM CELLS DEV, V22, P3226, DOI 10.1089/scd.2013.0290; Schimmang T, 2014, NEUROSCIENCE, V283, P26, DOI 10.1016/j.neuroscience.2014.07.025; Schwieger J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133680; Seo JH, 2012, YONSEI MED J, V53, P1059, DOI 10.3349/ymj.2012.53.6.1059; Shyu KG, 2008, LIFE SCI, V83, P65, DOI 10.1016/j.lfs.2008.05.005; Stover T, 2007, LARYNGO RHINO OTOL, V86, P352, DOI 10.1055/s-2006-945005; Teixeira FG, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0124-z; Thom SR, 2006, AM J PHYSIOL-HEART C, V290, pH1378, DOI 10.1152/ajpheart.00888.2005; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; Tompach PC, 1997, INT J ORAL MAX SURG, V26, P82, DOI 10.1016/S0901-5027(05)80632-0; Venetsanou K, 2012, EUR J APPL PHYSIOL, V112, P677, DOI 10.1007/s00421-011-2027-8; Villalobo A, 2006, FEBS J, V273, P2329, DOI 10.1111/j.1742-4658.2006.05250.x; Wan GQ, 2014, ELIFE, V3, DOI 10.7554/eLife.03564; Wang XL, 2007, NEUROREPORT, V18, P1753, DOI 10.1097/WNR.0b013e3282f0ec09; Warnecke A, 2007, NEUROREPORT, V18, P1683, DOI 10.1097/WNR.0b013e3282f0b5d7; Warnecke A, 2012, HEARING RES, V289, P86, DOI 10.1016/j.heares.2012.04.007; Wefstaedt P, 2005, NEUROREPORT, V16, P2011, DOI 10.1097/00001756-200512190-00008; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Wise AK, 2010, MOL THER, V18, P1111, DOI 10.1038/mt.2010.28; Yang HJ, 2016, J MOL NEUROSCI J MOL	66	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0178182	10.1371/journal.pone.0178182	http://dx.doi.org/10.1371/journal.pone.0178182			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542481	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058800045
J	Bertolino, M; Costa, G; Carella, M; Cattaneo-Vietti, R; Cerrano, C; Pansini, M; Quarta, G; Calcagnile, L; Bavestrello, G				Bertolino, Marco; Costa, Gabriele; Carella, Mirko; Cattaneo-Vietti, Riccardo; Cerrano, Carlo; Pansini, Maurizio; Quarta, Gianluca; Calcagnile, Lucio; Bavestrello, Giorgio			The dynamics of a Mediterranean coralligenous sponge assemblage at decennial and millennial temporal scales	PLOS ONE			English	Article							ROCKY BENTHIC COMMUNITIES; MASS-MORTALITY; MARINE; VARIABILITY; CLIMATE; DEMOSPONGIAE; PORIFERA; SPICULES; CNIDARIA; EOCENE	This paper concerns the changes occurred over both decennial and millennial spans of time in a sponge assemblage present in coralligenous biogenic build-ups growing at 15 m depth in the Ligurian Sea (Western Mediterranean). The comparison of the sponge diversity after a time interval of about 40 years (1973-2014) showed a significant reduction in species richness (about 45%). This decrease affected mainly the massive/erect sponges, and in particular the subclass Keratosa, with a species loss of 67%, while the encrusting and cavity dwelling sponges lost the 36% and 50%, respectively. The boring sponges lost only one species (25%). This changing pattern suggested that the inner habitat of the bioconstructions was less affected by the variations of the environmental conditions or by the human pressures which, on the contrary, strongly affected the species living on the surface of the biogenic build-ups. Five cores extracted from the bioherms, dating back to 3500 YBP, allowed to analyse the siliceous spicules remained trapped in them in order to obtain taxonomic information. Changes at generic level in diversity and abundance were observed at 500/250-years intervals, ranging between 19 and 33 genera. The number of genera showed a sharp decrease since 3500-3000 to 3000-2500 YBP. After this period, the genera regularly increased until 1500-1250 YBP, from when they progressively decreased until 1000-500 YBP. Tentatively, these changes could be related to the different climatic periods that followed one another in the Mediterranean area within the considered time span. The recent depletion in sponge richness recorded in the Ligurian coralligenous can be considered relevant. In fact, the analysis of the spicules indicated that the sponges living in these coralligenous habitats remained enough stable during 3000 years, but could have lost a significant part of their biodiversity in the last decades, coinciding with a series of warming episodes.	[Bertolino, Marco; Costa, Gabriele; Pansini, Maurizio; Bavestrello, Giorgio] Univ Genoa, DiSTAV, Genoa, Italy; [Carella, Mirko] CEAB Carrer Acces Cala St Francesc, Blanes, Spain; [Cattaneo-Vietti, Riccardo; Cerrano, Carlo] Univ Politecn Marche, DiSVA, Via Brecce Bianche, Ancona, Italy; [Quarta, Gianluca; Calcagnile, Lucio] Univ Salento, CEDAD, Via Arnesano, Lecce, Italy	University of Genoa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Marche Polytechnic University; University of Salento	Bavestrello, G (corresponding author), Univ Genoa, DiSTAV, Genoa, Italy.	giorgio.bavestrello@unige.it	Cerrano, Carlo/AAF-3557-2019; Costa, Gabriele/ABF-9784-2020	Cerrano, Carlo/0000-0001-9580-5546; Costa, Gabriele/0000-0003-1766-5247; BERTOLINO, Marco/0000-0003-3233-303X; Bavestrello, Giorgio/0000-0002-5428-2344	SIR grants (Italian Ministry for the Education) [RBSI14CH49]	SIR grants (Italian Ministry for the Education)	This study was financially supported by SIR grants (Italian Ministry for the Education #RBSI14CH49).; This study was financially supported by SIR grants (Italian Ministry for the Education #RBSI14CH49); we are indebted with Prof. Marco Ferrari (University of Genova) for his useful suggestions.	[Anonymous], 1985, W MEDITERRANEAN; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Bavestrello G, 2000, MAR ECOL PROG SER, V193, P241, DOI 10.3354/meps193241; Bertolino M, 2014, MAR ECOL-EVOL PERSP, V35, P149, DOI 10.1111/maec.12063; Bertolino M, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.336.5139; Betti F, 2017, MAR ECOL IN PRESS; Bianchi CN, 2014, MEDITERR MAR SCI, V15, P482, DOI 10.12681/mms.678; Boudouresque C. F, 2016, MARINE ANIMAL FOREST; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Calcinai B, 2015, MEDITERR MAR SCI, V16, P413, DOI 10.12681/mms.900; Caleagnile L, 2005, APPL RADIAT ISOTOPES, V62, P623, DOI 10.1016/j.apradiso.2004.08.047; Cebrian E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020211; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Cerrano C, 2001, MEDITERRANEAN ECOSYSTEMS: STRUCTURES AND PROCESSES, P235; Cerrano C, 2006, ITAL J ZOOL, V73, P355, DOI 10.1080/11250000600911675; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; D'Elia M, 2004, NUCL INSTRUM METH B, V223, P278, DOI 10.1016/j.nimb.2004.04.056; Dansgaard W, 1984, CLIMATE PROCESSES CL; Di Geronimo I, 2002, GEOBIOS-LYON, V35, P86, DOI 10.1016/S0016-6995(02)00050-5; Drake BL, 2012, J ARCHAEOL SCI, V39, P1862, DOI 10.1016/j.jas.2012.01.029; FANELLI G, 1994, MAR ECOL PROG SER, V110, P1, DOI 10.3354/meps110001; Fraschetti S, 2001, MAR ECOL PROG SER, V212, P1, DOI 10.3354/meps212001; Frisone V, 2014, FACIES, V60, P883, DOI 10.1007/s10347-014-0407-3; GAINO E, 1992, B ZOOL, V59, P79, DOI 10.1080/11250009209386652; Garrabou J, 2000, EUR J PHYCOL, V35, P1; Garrabou J, 2002, ESTUAR COAST SHELF S, V55, P493, DOI 10.1006/ecss.2001.0920; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; GOT H, 1968, VIE MILIEU B OCEANOG, V19, P9; Hong JS, 1980, THESIS U AIX MARSEIL, P1; Laborel J., 1961, REC TRAV ST MAR ENDO, V23, P37; Laubier L, 1966, ANN I OCEANOGRAPHIQU, V43, P139; Lukowiak M, 2016, CONTRIB ZOOL, V85, P13; Lukowiak M, 2013, PALAIOS, V28, P373, DOI 10.2110/palo.2012.p12-082r; Maldonado M, 2010, MAR BIOL, V157, P1577, DOI 10.1007/s00227-010-1431-7; Mann M.E., 2002, ENCYCLOP GLOB ENV CH, V1, P504; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; Pansini M., 1973, BOLLETTINO MUSEI IST, V41, P5; Piazzi L, 2012, MAR POLLUT BULL, V64, P2623, DOI 10.1016/j.marpolbul.2012.07.027; Puce S, 2009, MAR ECOL-EVOL PERSP, V30, P313, DOI 10.1111/j.1439-0485.2009.00283.x; Reale O, 2000, GLOBAL PLANET CHANGE, V25, P163, DOI 10.1016/S0921-8181(00)00002-3; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Reimer PJ, 2002, RADIOCARBON, V44, P159, DOI 10.1017/S0033822200064766; Santos GG, 2016, ZOOTAXA, V4158, P105, DOI 10.11646/zootaxa.4158.1.6; SARA M, 1970, Pubblicazioni della Stazione Zoologica di Napoli, V38, P174; Sartoretto S, 1996, AGE SETTLEMENT ACCUM; Sicre MA, 2008, EARTH PLANET SC LETT, V268, P137, DOI 10.1016/j.epsl.2008.01.011; Taricco C, 2009, CLIM PAST, V5, P171, DOI 10.5194/cp-5-171-2009; Teixido A N, 2013, PLOS ONE, V8; Teixido A N, 2011, PLOS ONE, V6; Wiedenmayer F, 1994, CONTRIBUTIONS KNOWLE	50	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177945	10.1371/journal.pone.0177945	http://dx.doi.org/10.1371/journal.pone.0177945			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531209	Green Published, gold, Green Submitted			2022-12-26	WOS:000402058400043
J	Demczuk, WHB; Martin, I; Hoang, L; Van Caeseele, P; Lefebvre, B; Horsman, G; Haldane, D; Gubbay, J; Ratnam, S; German, G; Bernier, JD; Strudwick, L; McGeer, A; Zhanel, GG; Van Domselaar, G; Graham, M; Mulvey, MR				Demczuk, Walter H. B.; Martin, Irene; Hoang, Linda; Van Caeseele, Paul; Lefebvre, Brigitte; Horsman, Greg; Haldane, David; Gubbay, Jonathan; Ratnam, Sam; German, Gregory; Bernier, Jennifer Daley; Strudwick, Lori; McGeer, Allison; Zhanel, George G.; Van Domselaar, Gary; Graham, Morag; Mulvey, Michael R.			Phylogenetic analysis of emergent Streptococcus pneumoniae serotype 22F causing invasive pneumococcal disease using whole genome sequencing	PLOS ONE			English	Article							CONJUGATE VACCINE; MOLECULAR EPIDEMIOLOGY; UNITED-STATES; RESISTANCE; ENGLAND; REPLACEMENT; ALGORITHM; WALES	Since implementation of the 13-valent polyvalent conjugate vaccine (PCV13) in Canada during 2010, the proportion of PCV13 serotypes causing invasive pneumococcal disease (IPD) has declined from 55% (n = 1492) in 2010 to 31% (n = 764) in 2014. A concurrent increase of non-PCV13 serotypes has occurred and 22F has become the most prevalent serotype in Canada increasing from 7% (n = 183) to 11% (n = 283). Core single nucleotide variant phylogenetic analysis was performed on 137 Streptococcus pneumoniae serotype 22F isolates collected across Canada from 2005-2015. Six phylogenetic lineages (n = 117) were identified among a serotype 22F/ST433 clonal complex (CC), including a recently expanding erythromycin- resistant clone. Erythromycin-resistance was observed in 25 isolates possessing ermB, mef or a 23S rRNA A2061G point mutation; 2 penicillin-resistant isolates had recombinant pbp1a, pbp2a and/or pbp2x; 3 tetracycline-resistant isolates contained tetM; and 1 isolate was multidrug-resistant. Virulence factor analysis indicated a high level of homogeneity among the 22F/ST433 clonal complex strains. A group of 6 phylogenetic outlier strains had differing MLST, antimicrobial resistance and molecular profiles suggestive of capsule switching events. While capsule switch events among S. pneumoniae serotype 22F has been observed, increasing prevalence of S. pneumoniae serotype 22F can be attributed to an evolving homogenous clone expanding nationally through local transmission events.	[Demczuk, Walter H. B.; Martin, Irene; Van Domselaar, Gary; Graham, Morag; Mulvey, Michael R.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Hoang, Linda] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Van Caeseele, Paul] Cadham Prov Lab, Winnipeg, MB, Canada; [Lefebvre, Brigitte] Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada; [Horsman, Greg] Saskatchewan Dis Control Lab, Regina, SK, Canada; [Haldane, David] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada; [Gubbay, Jonathan] Publ Hlth Ontario, Toronto, ON, Canada; [Ratnam, Sam] Newfoundland Publ Hlth Lab, St John, NF, Canada; [German, Gregory] Queen Elizabeth Hosp, Charlottetown, PE, Canada; [Bernier, Jennifer Daley] Stanton Territorial Hosp Lab, Yellowknife, NT, Canada; [Strudwick, Lori] Whitehorse Gen Hosp, Whitehorse, YT, Canada; [McGeer, Allison] Mt Sinai Hosp, Toronto Invas Bacterial Dis Network, Toronto, ON, Canada; [Zhanel, George G.] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada; [Van Domselaar, Gary; Graham, Morag] Publ Hlth Agcy Canada, Natl Microbiol Lab, Sci Technol Cores & Serv Div, Winnipeg, MB, Canada	Public Health Agency of Canada; Queen Elizabeth II Health Sciences Centre; McGill University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Manitoba; Public Health Agency of Canada	Mulvey, MR (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	Michael.Mulvey@phac-aspc.gc.ca	McGeer, Allison/AAB-6885-2020; Gubbay, Jonathan/Q-8580-2019; Demczuk, Walter/K-5994-2016	McGeer, Allison/0000-0001-5647-6137; Gubbay, Jonathan/0000-0003-0026-3786; Demczuk, Walter/0000-0003-3723-9843	Public Health Agency of Canada	Public Health Agency of Canada	This work was supported by funding from the Public Health Agency of Canada.; We thank Averil Griffith, Karla Montes and Ravinder Singh Lidder from the Streptococcus and Sexually Transmitted Diseases Unit at NML for their laboratory technical assistance; Franklin Bristow, Aaron Petkau, Philip Mabon, Shane Thiessen, Josh Adam, Thomas Matthews, Adrian Zetner, Cameron Sieffert, and Natalie Knox from the NML Science Technology Cores and Services Division for their infrastructure, technical support and guidance; and the NML Genomics Core Facility for their next generation sequencing and analytical expertise. This work was supported by funding from the Public Health Agency of Canada.	Almeida ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090974; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Ardanuy C, 2012, PLOS ONE, V27, P73; Ardanuy C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043619; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Blumental S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133885; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Caierao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111129; Chang QZ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0797-z; Chiba N, 2014, EMERG INFECT DIS, V20, P1132, DOI 10.3201/eid2007.131485; Clinical and Laboratory Standards Institute, 2016, PERF STANDANT SUSC T; Coffey TJ, 1998, MOL MICROBIOL, V27, P73, DOI 10.1046/j.1365-2958.1998.00658.x; Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625; Del Grosso M, 2006, ANTIMICROB AGENTS CH, V50, P3361, DOI 10.1128/AAC.00277-06; Depardieu F, 2001, ANTIMICROB AGENTS CH, V45, P319, DOI 10.1128/AAC.45.1.319-323.2001; European Centre for Disease Prevention and Control, 2015, ANN EP REP 2014 INV; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Geno KA, 2015, CLIN MICROBIOL REV, V28, P871, DOI 10.1128/CMR.00024-15; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Horacio AN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153602; Kendall BA, 2016, VACCINE, V34, P474, DOI 10.1016/j.vaccine.2015.12.010; Kim L, 2016, CLIN MICROBIOL REV, V29, P525, DOI 10.1128/CMR.00058-15; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Malhotra-Kumar S, 2005, ANTIMICROB AGENTS CH, V49, P4798, DOI 10.1128/AAC.49.11.4798-4800.2005; Marinier E, 2015, NEPTUNE A TOOL FOR R; Metcalf BJ, 2016, CLIN MICROBIOL INFEC, V22, DOI [10.1016/j.cmi.2015.08.027, 10.1016/j.cmi.2016.08.001]; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; Mosleh MN, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.12714; Nakano S, 2016, VACCINE, V34, P67, DOI 10.1016/j.vaccine.2015.11.015; Petkau A, 2010, BIOINFORMATICS, V26, P3125, DOI 10.1093/bioinformatics/btq588; Pichon B, 2013, J CLIN MICROBIOL, V51, P820, DOI 10.1128/JCM.01917-12; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Public Health Agency of Canada, NOT DIS ON LIN 2016; Public Health Agency of Canada. National Surveillance of Invasive Streptococcal Disease in Canada, 2014, ANN SUMM 2014; Ragonnet-Cronin M, 2013, BMC BIOINFORMATICS, P14; Schiffner-Rohe J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146338; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Siira L, 2014, MICROB DRUG RESIST, V20, P124, DOI 10.1089/mdr.2013.0156; Slotved HC, 2016, VACCINE, V34, P769, DOI 10.1016/j.vaccine.2015.12.056; Steens A, 2013, VACCINE, V31, P6232, DOI 10.1016/j.vaccine.2013.10.032; van der Linden M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131494; van Hoek AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039150; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Yildirim I, 2010, VACCINE, V29, P283, DOI 10.1016/j.vaccine.2010.10.032	51	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178040	10.1371/journal.pone.0178040	http://dx.doi.org/10.1371/journal.pone.0178040			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531208	Green Published, Green Submitted, gold			2022-12-26	WOS:000402058400053
J	Pegos, VR; Santos, RML; Medrano, FJ; Balan, A				Pegos, Vanessa R.; Santos, Rodrigo M. L.; Medrano, Francisco J.; Balan, Andrea			Structural features of PhoX, one of the phosphate-binding proteins from Pho regulon of Xanthomonas citri	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; TRANSPORTER; SPECIFICITY; ALIGNMENT; RECEPTOR; SYSTEM; PST	In Escherichia coli, the ATP-Binding Cassette transporter for phosphate is encoded by the pstSCAB operon. PstS is the periplasmic component responsible for affinity and specificity of the system and has also been related to a regulatory role and chemotaxis during depletion of phosphate. Xanthomonas citri has two phosphate-binding proteins: PstS and PhoX, which are differentially expressed under phosphate limitation. In this work, we focused on PhoX characterization and comparison with PstS. The PhoX three-dimensional structure was solved in a closed conformation with a phosphate engulfed in the binding site pocket between two domains. Comparison between PhoX and PstS revealed that they originated from gene duplication, but despite their similarities they show significant differences in the region that interacts with the permeases.	[Pegos, Vanessa R.] Univ Estadual Campinas, UNICAMP, IB, Campinas, SP, Brazil; [Pegos, Vanessa R.] Ctr Nacl Energia & Mat CNPEM, Lab Nacl Biociencias LNBio, Campinas, SP, Brazil; [Santos, Rodrigo M. L.] Univ Mogi Das Cruzes UMC, Mogi Das Cruzes, SP, Brazil; [Santos, Rodrigo M. L.] Univ Fed Sao Paulo, UNIFESP, Diadema, SP, Brazil; [Medrano, Francisco J.] CSIC, Ctr Invest Biol, Madrid, Spain; [Balan, Andrea] Univ Sao Paulo, Inst Ciencias Biomed II ICBII, Sao Paulo, SP, Brazil	Universidade Estadual de Campinas; Universidade de Mogi das Cruzes; Universidade Federal de Sao Paulo (UNIFESP); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Universidade de Sao Paulo	Balan, A (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed II ICBII, Sao Paulo, SP, Brazil.	abalan@usp.br	Medrano, Francisco Javier/ABF-9860-2020; Balan, Andrea/D-1891-2014	Balan, Andrea/0000-0001-6199-3198	Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES)" for Vanessa Pegos PhD fellowship; Fundagao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP" [2011/20468-1, 2013/09172-9]	Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES)" for Vanessa Pegos PhD fellowship; Fundagao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP"(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES)" for Vanessa Pegos PhD fellowship and the Fundagao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP" for the research grants 2011/20468-1 and 2013/09172-9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Burut-Archanai S, 2009, BIOCHEM BIOPH RES CO, V378, P383, DOI 10.1016/j.bbrc.2008.11.012; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Crepin S, 2011, VET MICROBIOL, V153, P82, DOI 10.1016/j.vetmic.2011.05.043; Dintner S, 2011, J BACTERIOL, V193, P3851, DOI 10.1128/JB.05175-11; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Ferraris DM, 2014, PROTEINS, V82, P2268, DOI 10.1002/prot.24548; Gebhard S, 2006, MICROBIOL-SGM, V152, P3453, DOI 10.1099/mic.0.29201-0; Gupta DK, 2014, CHEMOSPHERE, V108, P134, DOI 10.1016/j.chemosphere.2014.01.030; Jacobsen SM, 2008, FEMS IMMUNOL MED MIC, V52, P180, DOI 10.1111/j.1574-695X.2007.00358.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LUECKE H, 1990, NATURE, V347, P402, DOI 10.1038/347402a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monds RD, 2006, APPL ENVIRON MICROB, V72, P1910, DOI 10.1128/AEM.72.3.1910-1924.2006; Moreno-Letelier A, 2011, INT J EVOL BIOL, V2011, P1, DOI [10.4061/2011/781642, DOI 10.4061/2011/781642]; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nikata T, 1996, MOL GEN GENET, V250, P692, DOI 10.1007/s004380050122; Nylander JAA, 2004, MRMODELTEST ESCV2 PR; Pegos VR, 2014, ACTA CRYSTALLOGR F, V70, P1604, DOI 10.1107/S2053230X14021840; Pegos VR, 2014, J PROTEOMICS, V108, P78, DOI 10.1016/j.jprot.2014.05.005; Pireddu L, 2011, BIOINFORMATICS, V27, P2159, DOI 10.1093/bioinformatics/btr325; Rico-Jimenez M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28967; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanabe M, 2007, ACTA CRYSTALLOGR D, V63, P1185, DOI 10.1107/S0907444907048299; VANVEEN HW, 1994, BIOCHEMISTRY-US, V33, P1766, DOI 10.1021/bi00173a020; Vyas NK, 2003, STRUCTURE, V11, P765, DOI 10.1016/S0969-2126(03)00109-6; Wang ZM, 1997, NAT STRUCT BIOL, V4, P519, DOI 10.1038/nsb0797-519; WANNER BL, 1993, J CELL BIOCHEM, V51, P47, DOI 10.1002/jcb.240510110; Wittmore L, 2004, NUCLEIC ACIDS RES, V32, P668; Wu H, 1999, J BIOSCI BIOENG, V87, P273, DOI 10.1016/S1389-1723(99)80031-0; Yao NH, 1996, BIOCHEMISTRY-US, V35, P2079, DOI 10.1021/bi952686r	39	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0178162	10.1371/journal.pone.0178162	http://dx.doi.org/10.1371/journal.pone.0178162			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28542513	Green Published, Green Submitted, gold			2022-12-26	WOS:000402058400064
J	Xu, L; Guo, QX; Chang, GB; Qiu, LL; Liu, XP; Bi, YL; Zhang, Y; Wang, HZ; Lu, W; Ren, LC; Chen, Y; Zhang, Y; Xu, Q; Chen, GH				Xu, Lu; Guo, Qixin; Chang, Guobin; Qiu, Lingling; Liu, Xiangping; Bi, Yulin; Zhang, Yu; Wang, Hongzhi; Lu, Wei; Ren, Lichen; Chen, Ying; Zhang, Yang; Xu, Qi; Chen, Guohong			Discovery of microRNAs during early spermatogenesis in chicken	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; PRIMORDIAL GERM-CELLS; EXPRESSION; PATHWAY; GENES	Spermatogenesis is a complex process that involves many elements. However, until now, little is known at the molecular level about spermatogenesis in poultry. Here we investigated microRNAs and their target genes that may be involved in germ cell development and spermatogonial in chicken. We used next-generation sequencing to analyze miRNA expression profiles in three types of germline cells: primordial germ cells (PGCs), spermatogonial stem cells (SSCs), and spermatogonia (Sp) during early stage of spermatogenesis. After validated the candidate miRNAs and corresponding genes' expression in three types of cells, we found 15 miRNAs that were enriched 21 target genes that may be involved in spermatogenesis. Among the enriched miRNAs, miR-202-5p/3p were up-regulated in the Sp library and down-regulated in the PGCs library. Through RT-qPCR and Dual-Luciferase reporter assay, we confirmed that miR-202-5p bind to LIMK2 and involved in germ cell development. Collectively, we firstly discover the novel miRNAs, like miR-202-5p, and its related genes and pathways, expressed during the early spermatogonial stage in chicken, which will provide new clues for deciphering the molecular mechanism of the miRNAs regulating germline stem cell differentiation and spermatogenesis in chicken.	[Xu, Lu; Guo, Qixin; Chang, Guobin; Qiu, Lingling; Bi, Yulin; Zhang, Yu; Lu, Wei; Ren, Lichen; Chen, Ying; Zhang, Yang; Xu, Qi; Chen, Guohong] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China; [Liu, Xiangping; Wang, Hongzhi] Chinese Acad Agr Sci, Poultry Inst, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Chinese Academy of Agricultural Sciences	Chang, GB; Chen, GH (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China.	passioncgb@163.com; ghchen@yzu.edu.cn	XU, Qi/AID-2262-2022; Lu, Wei/AAE-2921-2022	Lu, Wei/0000-0002-4150-8674	National Natural Science Foundation of China [31372297]; International Agricultural Cooperation and Exchange Programme of China; Six Talent Peaks Project in Jiangsu Province [2015-NY-019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Agricultural Cooperation and Exchange Programme of China; Six Talent Peaks Project in Jiangsu Province	This work was supported by the National Natural Science Foundation of China (31372297), the International Agricultural Cooperation and Exchange Programme of China, and the Six Talent Peaks Project in Jiangsu Province (2015-NY-019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breau MA, 2013, P NATL ACAD SCI USA, V110, P16892, DOI 10.1073/pnas.1306282110; Chang GB, 2015, ANIM REPROD SCI, V162, P95, DOI 10.1016/j.anireprosci.2015.09.016; Chen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051724; Dabaja AA, 2015, BASIC CLIN ANDROL, V25, DOI 10.1186/s12610-015-0018-z; Govindaraju A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-82; Hermann BP, 2011, HUM REPROD, V26, P3222, DOI 10.1093/humrep/der343; Hicks JA, 2010, PHYSIOL GENOMICS, V41, P185, DOI 10.1152/physiolgenomics.00156.2009; Hocevar BA, 2003, EMBO J, V22, P3084, DOI 10.1093/emboj/cdg286; Hu YC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005019; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Karakaya C, 2015, FERTIL STERIL, V103, P1469, DOI 10.1016/j.fertnstert.2015.02.035; Kruger C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008978; Lee SI, 2011, P NATL ACAD SCI USA, V108, P10426, DOI 10.1073/pnas.1106141108; Li BiChun, 2002, Journal of Yangzhou University, Agricultural and Life Sciences Edition, V23, P18; Liu T, 2013, STEM CELLS DEV, V22, P1839, DOI 10.1089/scd.2012.0653; Ma Hao H M, 2012, PLOS ONE, V7; Martinovitch P. N., 1937, Nature London, V139, P413, DOI 10.1038/139413a0; Niu ZY, 2011, P NATL ACAD SCI USA, V108, P12740, DOI 10.1073/pnas.1109987108; Park TS, 2009, STEM CELLS, V27, P783, DOI 10.1002/stem.13; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Saitou M, 2012, COLD SPRING HARB PER, V4; Song H. -W., 2012, SPERMATOGENESIS, V2, P238, DOI [10.4161/spmg.22069, DOI 10.4161/SPMG.22069]; Struijk RB, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/903142; [孙敏 SUN Min], 2011, [生物技术, Biotechnology], V21, P16; Wainwright EN, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110155; Xu L, 2016, ANIM REPROD SCI, V166, P99, DOI 10.1016/j.anireprosci.2016.01.008; Zhang ZT, 2015, J BIOL CHEM, V290, P13605, DOI 10.1074/jbc.M114.601401	27	11	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177098	10.1371/journal.pone.0177098	http://dx.doi.org/10.1371/journal.pone.0177098			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531200	Green Submitted, gold, Green Published			2022-12-26	WOS:000402058400010
J	Motomura, K; Okada, N; Morita, H; Hara, M; Tamari, M; Orimo, K; Matsuda, G; Imadome, KI; Matsuda, A; Nagamatsu, T; Fujieda, M; Sago, H; Saito, H; Matsumoto, K				Motomura, Kenichiro; Okada, Naoko; Morita, Hideaki; Hara, Mariko; Tamari, Masato; Orimo, Keisuke; Matsuda, Go; Imadome, Ken-Ichi; Matsuda, Akio; Nagamatsu, Takeshi; Fujieda, Mikiya; Sago, Haruhiko; Saito, Hirohisa; Matsumoto, Kenji			A Rho-associated coiled-coil containing kinases (ROCK) inhibitor, Y-27632, enhances adhesion, viability and differentiation of human term placenta-derived trophoblasts in vitro	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; CELL-FUSION; E-CADHERIN; ACTIN CYTOSKELETON; EXPRESSION; CYTOTROPHOBLASTS; SYNCYTIN; CULTURE; MODELS; LINES	Although human term placenta-derived primary cytotrophoblasts (pCTBs) represent a good human syncytiotrophoblast (STB) model, in vitro culture of pCTBs is not always easily accomplished. Y-27632, a specific inhibitor of Rho-associated coiled-coil containing kinases (ROCK), reportedly prevented apoptosis and improved cell-to-substrate adhesion and culture stability of dissociated cultured human embryonic stem cells and human corneal endothelial cells. The Rho kinase pathway regulates various kinds of cell behavior, some of which are involved in pCTB adhesion and differentiation. In this study, we examined Y-27632's potential for enhancing pCTB adhesion, viability and differentiation. pCTBs were isolated from term, uncomplicated placentas by trypsin-DNase I-Dispase II treatment and purified by HLA class I-positive cell depletion. Purified pCTBs were cultured on uncoated plates in the presence of epidermal growth factor (10 ng/ml) and various concentrations of Y-27632. pCTB adhesion to the plates was evaluated by phase-contrast imaging, viability was measured by WST-8 assay, and differentiation was evaluated by immunofluorescence staining, expression of fusogenic genes and hCG-beta production. Ras-related C3 botulinum toxin substrate 1 (Rac1; one of the effector proteins of the Rho family) and protein kinase A (PKA) involvement was evaluated by using their specific inhibitors, NSC-23766 and H-89. We found that Y-27632 treatment significantly enhanced pCTB adhesion to plates, viability, cell-to-cell fusion and hCG-beta production, but showed no effects on pCTB proliferation or apoptosis. Furthermore, NSC-23766 and H-89 each blocked the effects of Y-27632, suggesting that Y-27632 significantly enhanced pCTB differentiation via Rac1 and PKA activation. Our findings suggest that Rac1 and PKA may be interactively involved in CTB differentiation, and addition of Y-27632 to cultures may be an effective method for creating a stable culture model for studying CTB and STB biology in vitro.	[Motomura, Kenichiro; Okada, Naoko; Morita, Hideaki; Hara, Mariko; Tamari, Masato; Orimo, Keisuke; Matsuda, Akio; Saito, Hirohisa; Matsumoto, Kenji] Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Tokyo, Japan; [Motomura, Kenichiro; Sago, Haruhiko] Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal Neonatal & Reprod Med, Tokyo, Japan; [Matsuda, Go; Imadome, Ken-Ichi] Natl Res Inst Child Hlth & Dev, Div Adv Med Virus Infect, Tokyo, Japan; [Nagamatsu, Takeshi] Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo, Japan; [Fujieda, Mikiya] Kochi Med Sch, Dept Pediat, Kochi, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; University of Tokyo; Kochi University	Motomura, K; Matsumoto, K (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Allergy & Clin Immunol, Tokyo, Japan.; Motomura, K (corresponding author), Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal Neonatal & Reprod Med, Tokyo, Japan.	motomura-k@ncchd.go.jp; matsumoto-k@ncchd.go.jp	Morita, Hideaki/S-2214-2016; 岡田, 直子/GRI-9555-2022; Nagamatsu, Takeshi/AAH-1402-2019; Nagamatsu, Takeshi/AAC-5201-2021; Morita, Hideaki/ADL-2008-2022	Morita, Hideaki/0000-0003-0928-8322; 岡田, 直子/0000-0002-3378-5778; Nagamatsu, Takeshi/0000-0003-1480-5785; Saito, Hirohisa/0000-0002-6630-8337	Ministry of Education, Culture, Sports, Science, and Technology [MEXT: 15K21655]; National Center for Child Health and Development [24-3]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT: 15K21655) to KMo (https://www.jsps.go.jp/english/indexhtml) and from the National Center for Child Health and Development (24-3) to KMa (Mtps://mw.ncchd.go.jp/center/information/entrusthtml#). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghababaei M, 2015, CELL DEATH DIFFER, V22, P1970, DOI 10.1038/cdd.2015.44; Apps R, 2009, IMMUNOLOGY, V127, P26, DOI 10.1111/j.1365-2567.2008.03019.x; Ark M, 2005, PLACENTA, V26, P81, DOI 10.1016/j.placenta.2004.03.012; Bachmann VA, 2013, P NATL ACAD SCI USA, V110, P8531, DOI 10.1073/pnas.1215902110; Benirschke K., 2012, PATHOLOGY HUMAN PLAC, P55, DOI DOI 10.1007/978-3-642-23941-0_6; Bilban M, 2010, PLACENTA, V31, P989, DOI 10.1016/j.placenta.2010.08.011; Borges M, 2003, PLACENTA, V24, P959, DOI 10.1016/S0143-4004(03)00173-5; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Chang CW, 2011, MOL CELL BIOL, V31, P3820, DOI 10.1128/MCB.05582-11; Collett GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030453; COUTIFARIS C, 1991, DEVELOPMENT, V113, P767; Daoud G, 2005, J PHYSIOL-LONDON, V566, P409, DOI 10.1113/jphysiol.2005.089326; Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110; Diaz P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090961; FEINMAN MA, 1986, J CLIN ENDOCR METAB, V63, P1211, DOI 10.1210/jcem-63-5-1211; Fradet S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040596; Frank HG, 2001, PLACENTA, V22, pS107, DOI 10.1053/plac.2001.0644; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gierman LM, 2015, PLACENTA, V36, P1246, DOI 10.1016/j.placenta.2015.09.004; Gonzalo P, 2010, DEV CELL, V18, P77, DOI 10.1016/j.devcel.2009.11.012; Guilbert LJ, 2002, PLACENTA, V23, P175, DOI 10.1053/plac.2001.0756; Haider S, 2016, P NATL ACAD SCI USA, V113, pE7710, DOI 10.1073/pnas.1612335113; Hiden U, 2013, AM J PATHOL, V182, P1563, DOI 10.1016/j.ajpath.2013.01.011; Ishikawa A, 2014, CYTOSKELETON, V71, P241, DOI 10.1002/cm.21165; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; KAO LC, 1988, DEV BIOL, V130, P693, DOI 10.1016/0012-1606(88)90361-2; Keryer G, 1998, J CELL SCI, V111, P995; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Knerr I, 2005, FEBS LETT, V579, P3991, DOI 10.1016/j.febslet.2005.06.029; Lin L, 2000, PLACENTA, V21, P73, DOI 10.1053/plac.1999.0443; Malhotra SS, 2015, SCI REP-UK, V5, DOI 10.1038/srep11210; Marchetti T, 2014, J THROMB HAEMOST, V12, P910, DOI 10.1111/jth.12570; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Morrish DW, 1997, PLACENTA, V18, P577, DOI 10.1016/0143-4004(77)90013-3; MORRISH DW, 1987, J CLIN ENDOCR METAB, V65, P1282, DOI 10.1210/jcem-65-6-1282; Nakamura F, 2013, BIOCHEM J, V453, P17, DOI 10.1042/BJ20130290; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Okumura N, 2016, SCI REP-UK, V6, DOI 10.1038/srep26113; Okumura N, 2014, INVEST OPHTH VIS SCI, V55, P318, DOI 10.1167/iovs.13-12225; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Orendi K, 2011, PLACENTA, V32, pS49, DOI 10.1016/j.placenta.2010.11.023; Park KH, 2012, TOXICOL SCI, V128, P247, DOI 10.1093/toxsci/kfs139; Petroff MG, 2006, METH MOLEC MED, V121, P203; Pidoux G, 2014, J CELL SCI, V127, P4172, DOI 10.1242/jcs.149609; Pidoux G, 2010, AM J PHYSIOL-CELL PH, V298, pC1517, DOI 10.1152/ajpcell.00484.2008; Riddell MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081273; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Shibukawa Y, 2010, MOL BIOL CELL, V21, P3973, DOI 10.1091/mbc.E10-03-0261; Thumkeo D, 2013, EUR J CELL BIOL, V92, P303, DOI 10.1016/j.ejcb.2013.09.002; Tsuji T, 2002, J CELL BIOL, V157, P819, DOI 10.1083/jcb.200112107; Williams JLR, 2008, AM J PHYSIOL-REG I, V295, pR1204, DOI 10.1152/ajpregu.00193.2008; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200	52	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177994	10.1371/journal.pone.0177994	http://dx.doi.org/10.1371/journal.pone.0177994			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542501	Green Submitted, gold, Green Published			2022-12-26	WOS:000401672600038
J	Nekimken, AL; Mazzochette, EA; Goodman, MB; Pruitt, BL				Nekimken, Adam L.; Mazzochette, Eileen A.; Goodman, Miriam B.; Pruitt, Beth L.			Forces applied during classical touch assays for Caenorhabditis elegans	PLOS ONE			English	Article							NEURONS; SENSITIVITY; MECHANICS; PROTEIN	For decades, Caenorhabditis elegans roundworms have been used to study the sense of touch, and this work has been facilitated by a simple behavioral assay for touch sensation. To perform this classical assay, an experimenter uses an eyebrow hair to gently touch a moving worm and observes whether or not the worm reverses direction. We used two experimental approaches to determine the manner and moment of contact between the eyebrow hair tool and freely moving animals and the forces delivered by the classical assay. Using high-speed video (2500 frames/second), we found that typical stimulus delivery events include a brief moment when the hair is contact with the worm's body and not the agar substrate. To measure the applied forces, we measured forces generated by volunteers mimicking the classical touch assay by touching a calibrated microcantilever. The mean (61 mu N) and median forces (26 mu N) were more than ten times higher than the 2-mu N force known to saturate the probability of evoking a reversal in adult C. elegans. We also considered the eyebrow hairs as an additional source of variation. The stiffness of the sampled eyebrow hairs varied between 0.07 and 0.41 N/m and was correlated with the free length of hair. Collectively, this work establishes that the classical touch assay applies enough force to saturate the probability of evoking reversals in adult C. elegans in spite of its variability among trials and experimenters and that increasing the free length of the hair can decrease the applied force.	[Nekimken, Adam L.; Goodman, Miriam B.; Pruitt, Beth L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Mazzochette, Eileen A.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Goodman, Miriam B.; Pruitt, Beth L.] Stanford Univ, Mol & Cellular Physiol Dept, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Pruitt, BL (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.; Pruitt, BL (corresponding author), Stanford Univ, Mol & Cellular Physiol Dept, Stanford, CA 94305 USA.	pruitt@stanford.edu		Pruitt, Beth L./0000-0002-4861-2124; Goodman, Miriam B./0000-0002-5810-1272	National Institute of Biomedical Imaging and Bioengineering [5R01EB006745-08]; National Institute of Neurological Disorders and Stroke [4R01NS047715-12]; National Institute of Neurological Disorders andStroke [5R01NS092099-02, 1F31NS100318-01]; National Institutes of Health [R01EB006745, R01NS092099, R01NS047715, F31NS100318]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS100318, R01NS047715] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Neurological Disorders andStroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Grant Number: 5R01EB006745-08 to BLP and MBG from the National Institute of Biomedical Imaging and Bioengineering (http://www.nibib.nih.gov/), Grant Number: 4R01NS047715-12 to MBG from the National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov/), Grant Number: 5R01NS092099-02 to MBG from the National Institute of Neurological Disorders andStroke (http://www.ninds.nih.gov/), and Grant Number: 1F31NS100318-01 to ALN from the National Institute of Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Matt Hopcroft, Frederic Loizeau, and Tom Larsen for helpful discussions; Anthony Ricci for the loan of the high-speed camera and stereomicroscope; Sylvia Fechner for performing the touch assays for high-speed video. This work was funded by in part by the National Institutes of Health under grants R01EB006745, R01NS092099, R01NS047715 and F31NS100318.	CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; Chalfie Martin, 2014, WormBook, DOI 10.1895/wormbook.1.172.1; Chen XY, 2014, J NEUROSCI, V34, P6522, DOI 10.1523/JNEUROSCI.0022-14.2014; Corsi AK, 2015, GENETICS, V200, P387, DOI 10.1534/genetics.115.176099; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; Park SJ, 2007, P NATL ACAD SCI USA, V104, P17376, DOI 10.1073/pnas.0702138104; Park SJ, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3574362; Petzold BC, 2013, INTEGR BIOL-UK, V5, P853, DOI [10.1039/c3ib20293c, 10.1039/c3b20293c]; Petzold BC, 2011, BIOPHYS J, V100, P1977, DOI 10.1016/j.bpj.2011.02.035; Pruitt BL, 2003, SENSOR ACTUAT A-PHYS, V104, P68, DOI 10.1016/S0924-4247(02)00485-5; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; THOMAS JH, 1990, GENETICS, V124, P855; Zhang SF, 2004, CURR BIOL, V14, P1888, DOI 10.1016/j.cub.2004.10.030; Zhang Y, 2002, MECH DEVELOP, V119, P3, DOI 10.1016/S0925-4773(02)00293-9	16	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178080	10.1371/journal.pone.0178080	http://dx.doi.org/10.1371/journal.pone.0178080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542494	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672600044
J	Marino, N; Illingworth, S; Kodialbail, P; Patel, A; Calderon, H; Lear, R; Fisher, KD; Champion, BR; Brown, ACN				Marino, Nalini; Illingworth, Sam; Kodialbail, Prithvi; Patel, Ashvin; Calderon, Hugo; Lear, Rochelle; Fisher, Kerry D.; Champion, Brian R.; Brown, Alice C. N.			Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes	PLOS ONE			English	Article							ADVERSE EVENTS; IPILIMUMAB; NIVOLUMAB; PEMBROLIZUMAB; ONCOLOGY	Oncolytic viruses which infect and kill tumour cells can also be genetically modified to express therapeutic genes that augment their anti-cancer activities. Modifying oncolytic viruses to produce effective cancer therapies is challenging as encoding transgenes often attenuates virus activity or prevents systemic delivery in patients due to the risk of off-target expression of transgenes in healthy tissues. To overcome these issues we aimed to generate a readily modifiable virus platform using the oncolytic adenovirus, enadenotucirev. Enadenotucirev replicates in human tumour cells but not cells from healthy tissues and can be delivered intravenously because it is stable in human blood. Here, the enadenotucirev genome was used to generate plasmids into which synthesised transgene cassettes could be directly cloned in a single step reaction. The platform enabled generation of panels of reporter viruses to identify cloning sites and transgene cassette designs where transgene expression could be linked to the virus life cycle. It was demonstrated using these viruses that encoded transgene proteins could be successfully expressed in tumour cells in vitro and tumours in vivo. The expression of transgenes did not impact either the oncolytic activity or selective properties of the virus. The effectiveness of this approach as a drug delivery platform for complex therapeutics was demonstrated by inserting multiple genes in the virus genome to encode full length anti-VEGF antibodies. Functional antibody could be synthesised and secreted from infected tumour cells without impacting the activity of the virus particle in terms of oncolytic potency, manufacturing yields or selectivity for tumour cells. In vivo, viral particles could be efficaciously delivered intravenously to disseminated orthotopic tumours.	[Marino, Nalini; Illingworth, Sam; Kodialbail, Prithvi; Patel, Ashvin; Calderon, Hugo; Lear, Rochelle; Fisher, Kerry D.; Champion, Brian R.; Brown, Alice C. N.] PsiOxus Therapeut Ltd, 154B Brook Dr,Milton Pk, Abingdon, Oxon, England		Brown, ACN (corresponding author), PsiOxus Therapeut Ltd, 154B Brook Dr,Milton Pk, Abingdon, Oxon, England.	alice.brown@psioxus.com	Calderon, Hugo/AAB-2006-2019	Calderon, Hugo/0000-0002-8902-4302	PsiOxus Therapeutics Ltd; Cancer Research UK [17720] Funding Source: researchfish	PsiOxus Therapeutics Ltd; Cancer Research UK(Cancer Research UK)	The work is funded by the investors of PsiOxus Therapeutics Ltd, a private company. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcoser SY, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-124; Andtbacka RHI, 2015, J CLIN ONCOL, V33, P2780, DOI 10.1200/JCO.2014.58.3377; BETT AJ, 1993, J VIROL, V67, P5911, DOI 10.1128/JVI.67.10.5911-5921.1993; Bird SW, 2015, VIROLOGY, V479, P444, DOI 10.1016/j.virol.2015.03.044; Buchbinder EI, 2016, NAT REV CLIN ONCOL, V13, P77, DOI 10.1038/nrclinonc.2015.237; Burns MC, 2016, EXPERT OPIN ORPHAN D, V4, P867, DOI 10.1080/21678707.2016.1191348; Calvo E, 2014, ANN ONCOL, V25, DOI 10.1093/annonc/mdu342.17; Calvo E, 2014, J CLIN ONCOL, V32, p5s; Cawood R, 2012, TRENDS MOL MED, V18, P564, DOI 10.1016/j.molmed.2012.07.007; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432; Di Y, 2014, GENE THER, V21, P440, DOI 10.1038/gt.2014.2; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Fisher K, 2006, CURR OPIN MOL THER, V8, P301; Greig SL, 2016, DRUGS, V76, P147, DOI 10.1007/s40265-015-0522-7; Heo J, 2013, NAT MED, V19, P329, DOI 10.1038/nm.3089; Hodi FS, 2016, LANCET ONCOL; Hoos A, 2016, NAT REV DRUG DISCOV, V15, P235, DOI 10.1038/nrd.2015.35; Hu JCC, 2006, CLIN CANCER RES, V12, P6737, DOI 10.1158/1078-0432.CCR-06-0759; Jin F, 2005, MOL THER, V12, P1052, DOI 10.1016/j.ymthe.2005.07.696; Kaufman HL, 2010, ANN SURG ONCOL, V17, P718, DOI 10.1245/s10434-009-0809-6; Keller BA, 2016, J MOL MED; Kelly E, 2007, MOL THER, V15, P651, DOI 10.1038/sj.mt.6300108; Knipe D.M.H., 2013, PETER FIELDS VIROLOG, V6th; Kuhn I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002409; Lawler S. E., 2016, JAMA ONCOL; Lichty BD, 2014, NAT REV CANCER, V14, P559, DOI 10.1038/nrc3770; Marquez-Rodas I, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.10.27; Marrone KA, 2016, CLIN PHARMACOL THER, V100, P242, DOI 10.1002/cpt.394; McNeish IA, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.tps5611; Michot JM, 2016, EUR J CANCER, V54, P139, DOI 10.1016/j.ejca.2015.11.016; Pol J, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1117740; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Tahtinen S, 2015, CANCER IMMUNOL RES, V3, P915, DOI 10.1158/2326-6066.CIR-14-0220-T; Tartari F, 2016, CANCER TREAT REV, V48, P20, DOI 10.1016/j.ctrv.2016.06.002; Tollefson A.E., 2007, METHODS MOL MED, V130, P223; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Wang S, 2016, CLIN CANC RES; Workenhe ST, 2014, MOL THER, V22, P123, DOI 10.1038/mt.2013.238; Zamarin D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008095	41	22	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177810	10.1371/journal.pone.0177810	http://dx.doi.org/10.1371/journal.pone.0177810			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542292	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400088
J	Yamazaki, T; Hatano, Y; Handa, T; Kato, S; Hoida, K; Yamamura, R; Fukuyama, T; Uematsu, T; Kobayashi, N; Kimura, H; Yamagata, K				Yamazaki, Taiga; Hatano, Yu; Handa, Tetsuya; Kato, Sakiko; Hoida, Kensuke; Yamamura, Rui; Fukuyama, Takashi; Uematsu, Takayuki; Kobayashi, Noritada; Kimura, Hiroshi; Yamagata, Kazuo			Targeted DNA methylation in pericentromeres with genome editing-based artificial DNA methyltransferase	PLOS ONE			English	Article							DE-NOVO METHYLATION; EMBRYONIC STEM-CELLS; MOUSE; CHROMATIN; DYNAMICS; HETEROCHROMATIN; VISUALIZATION; DEMETHYLATION; TRANSCRIPTION; DNMT3A	To study the impact of epigenetic changes on biological functions, the ability to manipulate the epigenetic status of certain genomic regions artificially could be an indispensable technology. "Epigenome editing" techniques have gradually emerged that apply TALE or CRISPR/Cas9 technologies with various effector domains isolated from epigenetic code writers or erasers such as DNA methyltransferase, 5-methylcytosine oxidase, and histone modification enzymes. Here we demonstrate that a TALE recognizing a major satellite, consisting of a repeated sequence in pericentromeres, could be fused with the bacterial CpG methyltransferase, SssI. ChIP-qPCR assays demonstrated that the fusion protein TALMaj-SssI preferentially bound to major chromosomal satellites in cultured cell lines. Then, TALMaj-SssI was expressed in fertilized mouse oocytes with hypomethylated major satellites (10-20% CpG islands). Bisulfite sequencing revealed that the DNA methylation status was increased specifically in major satellites (50-60%), but not in minor satellites or other repeat elements, such as Intracisternal A-particle (IAP) or long interspersed nuclear elements-1 (Line1) when the expression level of TALMaj-SssI is optimized in the cell. At a microscopic level, distal ends of chromosomes at the first mitotic stage were dramatically highlighted by the mCherry-tagged methyl CpG binding domain of human MBD1 (mCherry-MBD-NLS). Moreover, targeted DNA methylation to major satellites did not interfere with kinetochore function during early embryonic cleavages. Co-injection of dCas9 fused with SssI and guide RNA (gRNA) recognizing major satellite sequences enabled increment of the DNA methylation in the satellites, but a few off-target effects were also observed in minor satellites and retrotransposons. Although CRISPR can be applied instead of the TALE system, technical improvements to reduce off-target effects are required. We have demonstrated a new method of introducing DNA methylation without the need of other binding partners using the CpG methyltransferase, SssI.	[Yamazaki, Taiga; Yamamura, Rui; Fukuyama, Takashi; Uematsu, Takayuki; Kobayashi, Noritada] Kitasato Univ, Med Ctr, Div Biomed Res, Kitamoto, Saitama, Japan; [Hatano, Yu; Kato, Sakiko; Hoida, Kensuke; Yamagata, Kazuo] KINDAI Univ, Fac Biol Oriented Sci & Technol, Wakayama, Japan; [Handa, Tetsuya; Kimura, Hiroshi] Tokyo Inst Technol, Inst Innovat Res, Cell Biol Unit, Midori Ku, Yokohama, Kanagawa, Japan	Kitasato University; Tokyo Institute of Technology	Yamazaki, T (corresponding author), Kitasato Univ, Med Ctr, Div Biomed Res, Kitamoto, Saitama, Japan.; Yamagata, K (corresponding author), KINDAI Univ, Fac Biol Oriented Sci & Technol, Wakayama, Japan.	tyamazak@insti.kitasato-u.ac.jp; yamagata@waka.kindai.ac.jp	Kimura, Hiroshi/B-9524-2015; UEMATSU, TAKAYUKI/H-8034-2017	Kimura, Hiroshi/0000-0003-0854-083X; UEMATSU, TAKAYUKI/0000-0002-3680-7231; Handa, Tetsuya/0000-0001-7707-0195	JSPS KAKENHI [JP24700954, JP15K14924, JP25116005, JP25712035, JP26660250]; Kitasato University Medical Center; Kitasato University Research Grant; Grants-in-Aid for Scientific Research [15K14924, 16K09585] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kitasato University Medical Center; Kitasato University Research Grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers JP24700954 (TY), JP15K14924 (TY), JP25116005 (HK and KY), JP25712035 (KY) and JP26660250 (KY). This work was also supported by Grant-in-Aid for Research from Kitasato University Medical Center (TY), and Kitasato University Research Grant for Young Researchers (TY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstrup K, 2005, BRIT J CANCER, V92, P1934, DOI 10.1038/sj.bjc.6602560; Anton T, 2014, NUCLEUS-PHILA, V5, P163, DOI 10.4161/nucl.28488; Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518; Bernstein DL, 2015, J CLIN INVEST, V125, P1998, DOI 10.1172/JCI77321; Bollati V, 2009, CARCINOGENESIS, V30, P1330, DOI 10.1093/carcin/bgp149; Cadieux B, 2006, CANCER RES, V66, P8469, DOI 10.1158/0008-5472.CAN-06-1547; Chaikind B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096931; Chaikind B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044852; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Choi SH, 2009, INT J CANCER, V125, P723, DOI 10.1002/ijc.24384; Darii MV, 2009, BBA-PROTEINS PROTEOM, V1794, P1654, DOI 10.1016/j.bbapap.2009.07.016; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gowher H, 2005, J BIOL CHEM, V280, P13341, DOI 10.1074/jbc.M413412200; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hori T, 2014, DEV CELL, V29, P740, DOI 10.1016/j.devcel.2014.05.001; Hu JB, 2014, NUCLEIC ACIDS RES, V42, P4375, DOI 10.1093/nar/gku109; Kagiwada S, 2013, EMBO J, V32, P340, DOI 10.1038/emboj.2012.331; Kawasaki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep03658; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Kungulovski G, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0002-z; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li FY, 2007, NUCLEIC ACIDS RES, V35, P100, DOI 10.1093/nar/gkl1035; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Lo CL, 2017, SCI REP-UK, V7, DOI 10.1038/srep42047; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; Mizutani E, 2012, DEV BIOL, V364, P56, DOI 10.1016/j.ydbio.2012.01.001; Molina O, 2016, CHROMOSOME RES, V24, P495, DOI 10.1007/s10577-016-9539-3; Morita S, 2016, NAT BIOTECHNOL; Nettersheim D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082881; Okada T, 2007, CELL, V131, P1287, DOI 10.1016/j.cell.2007.10.045; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Rivenbark AG, 2012, EPIGENETICS-US, V7, P350, DOI 10.4161/epi.19507; Saksouk N, 2014, MOL CELL, V56, P580, DOI 10.1016/j.molcel.2014.10.001; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stolzenburg S, 2015, ONCOGENE, V34, P5427, DOI 10.1038/onc.2014.470; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Ueda J, 2014, STEM CELL REP, V2, P910, DOI 10.1016/j.stemcr.2014.05.008; Vojta A, 2016, NUCLEIC ACIDS RES, V44, P5615, DOI 10.1093/nar/gkw159; WADDINGTON CH, 1956, EVOLUTION, V10, P1, DOI 10.2307/2406091; Yamagata K, 2005, GENESIS, V43, P71, DOI 10.1002/gene.20158; Yamagata K, 2007, DEV BIOL, V312, P419, DOI 10.1016/j.ydbio.2007.09.041; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Yamazaki T, 2007, J REPROD DEVELOP, V53, P1035, DOI 10.1262/jrd.19059; Yamazaki T, 2007, DEV BIOL, V304, P409, DOI 10.1016/j.ydbio.2006.12.046	53	17	17	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177764	10.1371/journal.pone.0177764	http://dx.doi.org/10.1371/journal.pone.0177764			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542388	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400079
J	Aggarwal, R; Chen, Q; Goel, A; Seguy, N; Pendse, R; Ayer, T; Chhatwal, J				Aggarwal, Rakesh; Chen, Qiushi; Goel, Amit; Seguy, Nicole; Pendse, Razia; Ayer, Turgay; Chhatwal, Jagpreet			Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India	PLOS ONE			English	Article							GENOTYPE 1 INFECTION; QUALITY-OF-LIFE; UNITED-STATES; ALL-CAUSE; VIRUS; SOFOSBUVIR; LEDIPASVIR; FIBROSIS; INTERFERON-ALPHA-2B; PEGINTERFERON	Background & aims Availability of directly-acting antivirals (DAAs) has changed the treatment landscape of hepatitis C virus (HCV) infection. The high price of DAAs has restricted their use in several countries. However, in some countries such as India, generic DAAs are available at much cheaper price. This study examined whether generic DAAs could be cost-saving and how long it would take for the treatment to become cost-saving/effective. Methods A previously-validated, mathematical model was adapted to the HCV-infected population in India to compare the outcomes of no treatment versus treatment with DAAs. Model parameters were estimated from published studies. Cost-effectiveness of HCV treatment using available DAAs was calculated, using a payer's perspective. We estimated quality-adjusted life years (QALYs), disability-adjusted life years (DALYs), total costs, and incremental cost-effectiveness ratio of DAAs versus no treatment. One-way and probabilistic sensitivity analyses were conducted. Results Compared with no treatment, the use of generic DAAs in Indian HCV patients would increase the life expectancy by 8.02 years, increase QALYs by 3.89, avert 19.07 DALYs, and reduce the lifetime healthcare costs by $1,309 per-person treated. Treatment became cost-effective within 2 years, and cost-saving within 10 years of its initiation overall and within 5 years in persons with cirrhosis. Treating 10,000 HCV-infected persons could prevent 3400-3850 decompensated cirrhosis, 1800-2500 HCC, and 4000-4550 liver-related deaths. The results were sensitive to the costs of DAAs, pre- and post-treatment diagnostic tests and management of cirrhosis, and quality of life after sustained virologic response. Conclusions Treatment with generic DAAs available in India will improve patient outcomes, provide a good value for money within 2 years, and be ultimately cost-saving. Therefore, in this and similar settings, HCV treatment should be a priority from a public health as well an economic perspective.	[Aggarwal, Rakesh; Goel, Amit] Sanjay Gandhi Postgrad Inst Med Sci, Dept Gastroenterol, Lucknow, Uttar Pradesh, India; [Chen, Qiushi; Chhatwal, Jagpreet] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA; [Chen, Qiushi; Chhatwal, Jagpreet] Harvard Med Sch, Boston, MA 02115 USA; [Seguy, Nicole] WHO, India Country Off, New Delhi, India; [Pendse, Razia] WHO, Reg Off South East Asia, Communicable Dis Dept, New Delhi, India; [Ayer, Turgay] Georgia Inst Technol, H Milton Stewart Sch Ind & Syst Engn, Atlanta, GA 30332 USA	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; World Health Organization; National Centre for Disease Control (NCDC); World Health Organization; University System of Georgia; Georgia Institute of Technology	Chhatwal, J (corresponding author), Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA.; Chhatwal, J (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	JagChhatwal@mgh.harvard.edu	Chen, Qiushi/AAE-5002-2020; Aggarwal, Rakesh/D-1583-2009; Goel, Amit/H-2822-2019	Aggarwal, Rakesh/0000-0001-9689-494X; Chhatwal, Jagpreet/0000-0001-8741-4430; Goel, Amit/0000-0003-3525-9381	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bennett WG, 1997, ANN INTERN MED, V127, P855, DOI 10.7326/0003-4819-127-10-199711150-00001; Blach S, LANCET GAST IN PRESS; Cardoso AC, 2010, J HEPATOL, V52, P652, DOI 10.1016/j.jhep.2009.12.028; Chhatwal J, 2016, CLIN GASTROENTEROL H; Chhatwal J, 2016, PHARMACOECONOMICS, V34, P551, DOI 10.1007/s40273-015-0373-9; Chhatwal J, 2015, ANN INTERN MED, V162, P397, DOI 10.7326/M14-1336; Chhatwal J, 2013, VALUE HEALTH, V16, P973, DOI 10.1016/j.jval.2013.07.006; Chong CAKY, 2003, AM J GASTROENTEROL, V98, P630, DOI 10.1111/j.1572-0241.2003.07332.x; Davis KL, 2011, J CLIN GASTROENTEROL, V45, pE17, DOI 10.1097/MCG.0b013e3181e12c09; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Gimeno-Ballester V, 2015, EXPERT REV PHARM OUT, P1; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Iyengar S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002032; Kohli A, 2015, LANCET INFECT DIS, V15, P1049, DOI 10.1016/S1473-3099(15)00157-7; Linas BP, 2015, ANN INTERN MED, V162, P619, DOI 10.7326/M14-1313; McAdam-Marx C, 2011, J MANAGE CARE PHARM, V17, P531, DOI 10.18553/jmcp.2011.17.7.531; Najafzadeh M, 2015, ANN INTERN MED, V162, P407, DOI 10.7326/M14-1152; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Planas R, 2004, J HEPATOL, V40, P823, DOI 10.1016/j.jhep.2004.01.005; Raghavan P, 2016, EC TIMES        0401; Razavi H, 2013, HEPATOLOGY, V57, P2164, DOI 10.1002/hep.26218; Shah N, 2013, EXPERT OPIN INV DRUG, V22, P1107, DOI 10.1517/13543784.2013.806482; Siebert U, 2003, GUT, V52, P425, DOI 10.1136/gut.52.3.425; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Welzel TM, 2016, GUT; Westerhout K, 2015, J MED ECON, P1; WHO, 2016, WHO GUIDELINES SCREE; WHO, 2013, WHO METHODS DATA SOU; Wilson J, 2007, HEALTH TECHNOL ASSES, V11, P1; Wolfe RA, 2010, AM J TRANSPLANT, V10, P961, DOI 10.1111/j.1600-6143.2010.03021.x; World Health Organization, 2016, GLOB HLTH SECT STRAT; World Health Organization, 2016, VIT HEP STRAT INF MO	36	66	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176503	10.1371/journal.pone.0176503	http://dx.doi.org/10.1371/journal.pone.0176503			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520728	Green Published, gold, Green Submitted			2022-12-26	WOS:000401487700019
J	Berdan, EL; Finck, J; Johnston, PR; Waurick, I; Mazzoni, CJ; Mayer, F				Berdan, Emma L.; Finck, Jonas; Johnston, Paul R.; Waurick, Isabelle; Mazzoni, Camila J.; Mayer, Frieder			Transcriptome profiling of ontogeny in the acridid grasshopper Chorthippus biguttulus	PLOS ONE			English	Article							ACOUSTIC COMMUNICATION SIGNALS; DROSOPHILA TAKEOUT GENE; RNA-SEQ DATA; SEXUAL SELECTION; DUSKY-LIKE; ANNOTATION; ORTHOPTERA; CUTICLE; PATHWAY; PROTEIN	Acridid grasshoppers (Orthoptera: Acrididae) are widely used model organisms for developmental, evolutionary, and neurobiological research. Although there has been recent influx of orthopteran transcriptomic resources, many use pooled ontogenetic stages obscuring information about changes in gene expression during development. Here we developed a de novo transcriptome spanning 7 stages in the life cycle of the acridid grasshopper Chorthippus biguttulus. Samples from different stages encompassing embryonic development through adults were used for transcriptomic profiling, revealing patterns of differential gene expression that highlight processes in the different life stages. These patterns were validated with semi-quantitative RT-PCR. Embryonic development showed a strongly differentiated expression pattern compared to all of the other stages and genes upregulated in this stage were involved in signaling, cellular differentiation, and organ development. Our study is one of the first to examine gene expression during post-embryonic development in a hemimetabolous insect and we found that only the fourth and fifth instars had clusters of genes upregulated during these stages. These genes are involved in various processes ranging from synthesis of biogenic amines to chitin binding. These observations indicate that post-embryonic ontogeny is not a continuous process and that some instars are differentiated. Finally, genes upregulated in the imago were generally involved in aging and immunity. Our study highlights the importance of looking at ontogeny as a whole and indicates promising directions for future research in orthopteran development.	[Berdan, Emma L.; Finck, Jonas; Waurick, Isabelle; Mayer, Frieder] Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde Berlin, Berlin, Germany; [Finck, Jonas] Humboldt Univ, Dept Biol, Behav Physiol, Berlin, Germany; [Johnston, Paul R.] Free Univ Berlin, Berlin, Germany; [Mazzoni, Camila J.] Berlin Ctr Genom Biodivers Res, Berlin, Germany; [Mazzoni, Camila J.] Leibniz Inst Zoo & Wildtierforsch IZW, Berlin, Germany; [Mayer, Frieder] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany; [Berdan, Emma L.] Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden	Leibniz Institut fur Evolutions und Biodiversitatsforschung; Humboldt University of Berlin; Free University of Berlin; Leibniz Institut fur Zoo und Wildtierforschung; University of Gothenburg	Berdan, EL (corresponding author), Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde Berlin, Berlin, Germany.; Berdan, EL (corresponding author), Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden.	emma.berdan@gmail.com	Mazzoni, Camila/AAJ-9702-2020	Mazzoni, Camila/0000-0001-6758-5427; Johnston, Paul R./0000-0002-8651-4488; Berdan, Emma/0000-0002-6435-4604	Leibniz Association [SAW-2012-MfN-3]	Leibniz Association	The study is part of the GENART project funded by the Leibniz Association (SAW-2012-MfN-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PN, 2013, DEV BIOL, V379, P76, DOI 10.1016/j.ydbio.2013.04.012; BAEHR JC, 1979, J INSECT PHYSIOL, V25, P415, DOI 10.1016/0022-1910(79)90009-X; Bailey NW, 2013, G3-GENES GENOM GENET, V3, P225, DOI 10.1534/g3.112.004341; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENTLEY D, 1979, J EMBRYOL EXP MORPH, V54, P47; Berdan EL, 2016, MOL ECOL RESOUR, V16, P1478, DOI 10.1111/1755-0998.12530; Berdan EL, 2015, MOL ECOL, V24, P3918, DOI 10.1111/mec.13276; Bolognesi R, 2008, CURR BIOL, V18, P1624, DOI 10.1016/j.cub.2008.09.057; Chen DS, 2009, DEVELOPMENT, V136, P4133, DOI 10.1242/dev.039032; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Danks HV., 1987, INSECT DORMANCY AN E; Danley PD, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-109; Dauwalder B, 2002, GENE DEV, V16, P2879, DOI 10.1101/gad.1010302; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Finck J, 2016, J COMP PHYSIOL A, P1; Fraley C., 2012, TECHNICAL REPORT NO; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Greenfield Michael D., 1997, P197; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Gruntenko NE, 2008, J INSECT PHYSIOL, V54, P902, DOI 10.1016/j.jinsphys.2008.04.004; Guan X, 2006, P NATL ACAD SCI USA, V103, P16794, DOI 10.1073/pnas.0607616103; Gullan PJ, 2010, THE INSECTS AN OUTLI; Guo W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001291; Gupta T, 2003, DEVELOPMENT, V130, P6075, DOI 10.1242/dev.00817; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Helfert B, 1975, ZEITSCHRIFT FUR ANGE; HILBERT DW, 1983, ENVIRON ENTOMOL, V12, P1, DOI 10.1093/ee/12.1.1; Hombria James Castelli-Gair, 2013, JAKSTAT, V2, pe26089, DOI 10.4161/jkst.26089; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421; INGRISCH S, 1983, DEUT ENTOMOL Z, V30, P1; Ingrisch S, 1998, DIE HEUSCHRECKEN MIT; Jung I, 2011, FEBS LETT, V585, P1973, DOI 10.1016/j.febslet.2011.05.033; Kiel E, 2002, DIE EMBRYONALENTWICK; Klappert K, 2005, BEHAV ECOL SOCIOBIOL, V58, P36, DOI 10.1007/s00265-004-0902-6; Klappert K, 2003, ANIM BEHAV, V65, P225, DOI 10.1006/anbe.2002.2034; Kunst M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025613; LAKESHARLAN R, 1993, CELL TISSUE RES, V273, P97, DOI 10.1007/BF00304616; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li D, 2015, INSECT BIOCHEM MOLEC, V58, P46, DOI 10.1016/j.ibmb.2015.01.004; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ly LL, 2013, GENE, V520, P106, DOI 10.1016/j.gene.2013.02.036; Machens CK, 2001, J NEUROSCI, V21, P3215, DOI 10.1523/JNEUROSCI.21-09-03215.2001; Mayer F, 2010, EVOLUTION IN ACTION: CASE STUDIES IN ADAPTIVE RADIATION, SPECIATION AND THE ORIGIN OF BIODIVERSITY, P451, DOI 10.1007/978-3-642-12425-9_21; Merlin C, 2005, BIOCHEM BIOPH RES CO, V332, P4, DOI 10.1016/j.bbrc.2005.04.084; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Minelli Alessandro, 2013, P91; Nagaraj R, 2012, DEVELOPMENT, V139, P906, DOI 10.1242/dev.074252; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; PICHLER F., 1956, OSTERREICH ZOOL ZEITSCHR, V6, P513; Qiu Z, 2016, MOL ECOL RES; Qiu Z., 2016, INT J MOL SCI, V17, DOI [10.3390/ijms17071110, DOI 10.3390/ijms17071110]; Ragge DR, 1998, THE SONGS OF THE GRA; Ronacher B, 2008, J COMP PSYCHOL, V122, P252, DOI 10.1037/0735-7036.122.3.252; RUBTZOV I. A., 1934, BULL ENT RES, V25, P339, DOI 10.1017/S0007485300012736; Sanchez D, 2006, CURR BIOL, V16, P680, DOI 10.1016/j.cub.2006.03.024; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Schmidt A, 2008, J COMP PHYSIOL A, V194, P221, DOI 10.1007/s00359-007-0295-x; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Tassone EE, 2016, GIGASCIENCE, V5, DOI [10.1186/s13742-016-0109-6, 10.1186/s13742-016-0130-9]; Tauber E, 2003, BEHAV PROCESS, V64, P197, DOI 10.1016/S0376-6357(03)00135-9; Theissinger K, 2016, MAR GENOM, V28, P7, DOI 10.1016/j.margen.2016.02.006; Uvarov B, 1966, GRASSHOPPERS AND LOC; VANWINGERDEN WKRE, 1991, OECOLOGIA, V87, P417, DOI 10.1007/BF00634600; Vedenina Varvara, 2011, Journal of Orthoptera Research, V20, P109; von Helversen Otto, 1994, Progress in Zoology, V39, P253; vonHelversen D, 1997, J COMP PHYSIOL A, V180, P373, DOI 10.1007/s003590050056; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; Yoshioka Y, 2008, GENES CELLS, V13, P117, DOI 10.1111/j.1365-2443.2007.01155.x; Zeng V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061479	76	2	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177367	10.1371/journal.pone.0177367	http://dx.doi.org/10.1371/journal.pone.0177367			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520760	Green Published, Green Submitted, gold			2022-12-26	WOS:000401487700044
J	Iovita, R; Tuvi-Arad, I; Moncel, MH; Despriee, J; Voinchet, P; Bahain, JJ				Iovita, Radu; Tuvi-Arad, Inbal; Moncel, Marie-Helene; Despriee, Jackie; Voinchet, Pierre; Bahain, Jean-Jacques			High handaxe symmetry at the beginning of the European Acheulian: The data from la Noira (France) in context	PLOS ONE			English	Article							ELLIPTIC FOURIER-ANALYSIS; MORPHOMETRIC-ANALYSIS; CENTER REGION; STONE TOOLS; SHAPE; REDUCTION; INDEX; FORM; QUANTIFICATION; SETTLEMENTS	In the last few decades, new discoveries have pushed the beginning of the biface-rich European Acheulian from 500 thousand years (ka) ago back to at least 700 ka, and possibly to 1 million years (Ma) ago. It remains, however, unclear to date if handaxes arrived in Europe as a fully developed technology or if they evolved locally from core-and-flake industries. This issue is also linked with another long-standing debate on the existence and behavioral, cognitive, and social meaning of a possibly chronological trend for increased handaxe symmetry throughout the Lower Paleolithic. The newly discovered sites can provide a link between the much older Acheulian in Africa and the Levant and the well-known assemblages from the later European Acheulian, enabling a rigorous testing of these hypotheses using modern morphometric methods. Here we use the Continuous Symmetry Measure (CSM) method to quantify handaxe symmetry at la Noira, a newly excavated site in central France, which features two archaeological levels, respectively ca. 700 ka and 500 ka old. In order to provide a context for the new data, we use a large aggregate from the well-known 500 ka old site of Boxgrove, England. We show that handaxes from the oldest layer at la Noira, although on average less symmetric than both those from the younger layers at the same site and than those from Boxgrove, are nevertheless much more symmetric than other early Acheulian specimens evaluated using the CSM method. We also correlate trends in symmetry to degree of reduction, demonstrating that raw material availability and discard patterns may affect observed symmetry values. We conclude that it is likely that, by the time the Acheulian arrived in Europe, its makers were, from a cognitive and motor-control point of view, already capable of producing the symmetric variant of this technology.	[Iovita, Radu] Leibniz Forsch Inst Archaol, MONREPOS Archaeol Res Ctr, Neuwied, Germany; [Iovita, Radu] Leibniz Forsch Inst Archaol, Romisch German Zent Museum, Museum Human Behav Evolut, Neuwied, Germany; [Iovita, Radu] NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA; [Tuvi-Arad, Inbal] Open Univ Israel, Dept Nat Sci, Raanana, Israel; [Moncel, Marie-Helene; Despriee, Jackie; Voinchet, Pierre; Bahain, Jean-Jacques] Museum Natl Hist Nat, Inst Paleontol Humaine, CNRS, Dept Prehist,UMR 7194, Paris, France	New York University; Open University Israel; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Iovita, R (corresponding author), Leibniz Forsch Inst Archaol, MONREPOS Archaeol Res Ctr, Neuwied, Germany.; Iovita, R (corresponding author), Leibniz Forsch Inst Archaol, Romisch German Zent Museum, Museum Human Behav Evolut, Neuwied, Germany.; Iovita, R (corresponding author), NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA.	iovita@nyu.edu	Iovita, Radu/B-9580-2015; Bahain, Jean-Jacques/AAB-8910-2019	Iovita, Radu/0000-0001-9531-1159; Bahain, Jean-Jacques/0000-0002-1446-5568	Agence Nationale de la Recherche [2010 BLAN 2006 01]; Association Archea (Region Centre, France); Ministere de la Culture et de la Communication; Museum National d'Histoire Naturelle; Romisch-Germanisches Zentralmuseum, Leibniz-Forschungsinstitut fur Archaologie; Open University of Israel [501291, 503232]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Archea (Region Centre, France); Ministere de la Culture et de la Communication; Museum National d'Histoire Naturelle; Romisch-Germanisches Zentralmuseum, Leibniz-Forschungsinstitut fur Archaologie; Open University of Israel	This work received support from the Agence Nationale de la Recherche, grant no 2010 BLAN 2006 01 - MHM; the Association Archea (Region Centre, France) - MHM; the Ministere de la Culture et de la Communication - MHM; the Museum National d'Histoire Naturelle - MHM; the Romisch-Germanisches Zentralmuseum, Leibniz-Forschungsinstitut fur Archaologie - RI; The Open University of Israel Research Fund grant no's 501291 and 503232 - ITA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez S, 2005, COORDIN CHEM REV, V249, P1693, DOI 10.1016/j.ccr.2005.03.031; Andrefsky W, 2006, AM ANTIQUITY, V71, P743, DOI 10.2307/40035887; [Anonymous], 2015, NATURE, DOI [DOI 10.4207/PA.2011.ART53, DOI 10.1038/nature14464]; Aranda V, 2015, INTERNATIONAL CONFER, P270; Archer W, 2016, J HUM EVOL, V97, P58, DOI 10.1016/j.jhevol.2016.05.007; Archer W, 2010, J ARCHAEOL SCI, V37, P201, DOI 10.1016/j.jas.2009.09.033; Ashton NM, 2003, MULTIPLE APPROACHES, p109 ; Avnir D, 2013, NEXUS NETW J, V15, P171, DOI 10.1007/s00004-013-0144-x; Bailey SE, 2005, AM J PHYS ANTHROPOL, V126, P268, DOI 10.1002/ajpa.20037; Barsky D, 2013, CR PALEVOL, V12, P305, DOI 10.1016/j.crpv.2013.05.007; Barsky D, 2010, QUATERN INT, V223, P71, DOI 10.1016/j.quaint.2009.12.005; Beck C, 2002, J ANTHROPOL ARCHAEOL, V21, P481, DOI 10.1016/S0278-4165(02)00007-7; Bergman CA, 1990, BIG PUZZLE, P265; Beyene Y, 2013, P NATL ACAD SCI USA, V110, P1584, DOI 10.1073/pnas.1221285110; Beyries S, 1982, STUDIA PRAEHISTORICA, V2, P235; Boeda E, LES INDUSTRIES A OUT; Bonhomme V, 2014, J STAT SOFTW, V56, P1; Bordes F., 1961, TYPOLOGIE PALEOLITHI; Borel A, 2016, ARCHAEOMETRY; Borel A, 2013, J ANTHR ARCHAEOL; Buchanan B, 2006, J ARCHAEOL SCI, V33, P185, DOI 10.1016/j.jas.2005.07.008; Buchanan B, 2009, J ARCHAEOL SCI; Buchanan B, 2014, ARCHAEOL ANTHROP SCI, V6, P145, DOI 10.1007/s12520-013-0168-x; Cardillo M., 2010, MORPHOMETRICS NONMOR, P325, DOI DOI 10.1007/978-3-540-95853-6_15; Cardini A, 2004, ITAL J ZOOL, V71, P17, DOI 10.1080/11250000409356546; Clark JD, 1994, INTEGR PATHS PAST, V451, P69; Clarkson C, 2002, J ARCHAEOL SCI, V29, P65, DOI 10.1006/jasc.2001.0702; Claud E, 2008, LE STATUT FONCTIONNE; Cole J, 2015, SETTLEMENT SOC COGNI; Corbey R, 2016, EVOL ANTHROPOL, V25, P6, DOI 10.1002/evan.21467; CROMPTON RH, 1993, J HUM EVOL, V25, P175, DOI 10.1006/jhev.1993.1043; Daegling DJ, 2000, J HUM EVOL, V39, P107, DOI 10.1006/jhev.2000.0402; de Azevedo S, 2014, J ARCHAEOL SCI, V41, P297, DOI 10.1016/j.jas.2013.08.013; Despriee J, 2005, DONNEES RECENTES MOD, P431; Despriee J, 2007, QUATERNAIRE, V18, P349; Despriee J, 2011, QUATERNARY SCI REV, V30, P1474, DOI 10.1016/j.quascirev.2011.02.011; Despriee J, 2010, QUATERN INT, V223, P345, DOI 10.1016/j.quaint.2009.07.019; Dibble HL, 2009, J ARCHAEOL SCI, V36, P1945, DOI 10.1016/j.jas.2009.05.004; Dibble HL, 1999, LITHIC TECHNOL, V24, P38, DOI DOI 10.1080/01977261.1999.11720944; Dominguez-Rodrigo M, 2001, J HUM EVOL, V40, P289, DOI 10.1006/jhev.2000.0466; Dryzun C, 2012, CHEM COMMUN, V48, P5874, DOI 10.1039/c2cc17727g; Dryzun C, 2009, J MATER CHEM, V19, P2062, DOI 10.1039/b817497k; Eren MI, 2009, J ARCHAEOL SCI, V36, P1243, DOI 10.1016/j.jas.2009.01.011; FERSON S, 1985, SYST ZOOL, V34, P59, DOI 10.2307/2413345; Frere J, 1800, ARCHAEOLOGIA, V13, P204; Friess M, 2003, AM J PHYS ANTHROPOL, V122, P11, DOI 10.1002/ajpa.10286; Gallotti R, 2010, AFR ARCHAEOL REV, V27, P291, DOI 10.1007/s10437-010-9083-z; Chacon MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155316; GERO J, 1984, J FIELD ARCHAEOL, V11, P315, DOI 10.1179/009346984791535467; Gowlett J.A.J., 1994, AFR ARCHAEOL REV, V12, P3, DOI DOI 10.1007/BF01953037); Graham JH, 2010, SYMMETRY-BASEL, V2, P466, DOI 10.3390/sym2020466; Hiscock P, 2010, WORLD ARCHAEOL, V42, P545, DOI 10.1080/00438243.2010.517669; Hodgson D, 2015, J ARCHAEOL SCI-REP, V2, P204, DOI 10.1016/j.jasrep.2015.02.002; Hodgson D, 2011, SYMMETRY-BASEL, V3, P37, DOI 10.3390/sym3010037; Hodgson D, 2009, CR PALEVOL, V8, P93, DOI 10.1016/j.crpv.2008.10.009; Iovita R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029029; Iovita R, 2011, J HUM EVOL, V61, P61, DOI 10.1016/j.jhevol.2011.02.007; Iovita R, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P235, DOI 10.1007/978-1-4419-6861-6_10; Iovita R, 2009, J ARCHAEOL SCI, V36, P1447, DOI 10.1016/j.jas.2009.02.008; Jimenez-Arenas JM, 2011, J ARCHAEOL SCI, P1; Johnson J, 1981, YELLOW CREEK ARCHAEO, V2; KEELEY LH, 1981, NATURE, V293, P464, DOI 10.1038/293464a0; Key AJM, 2016, J ARCHAEOL METHOD TH; Kohn M, 1999, ANTIQUITY, V73, P518, DOI 10.1017/S0003598X00065078; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; KUHN SL, 1990, J ARCHAEOL SCI, V17, P583, DOI 10.1016/0305-4403(90)90038-7; Lefevre D, 2010, QUATERN INT, V223, P360, DOI 10.1016/j.quaint.2010.02.020; Lestrel P E, 1982, Prog Clin Biol Res, V101, P393; LESTREL PE, 1976, HUM BIOL, V48, P517; Li H, QUAT INT; Lin SC, 2013, AM ANTIQUITY, V78, P724, DOI 10.7183/0002-7316.78.4.724; Lycett SJ, 2006, J ARCHAEOL SCI, V33, P847, DOI 10.1016/j.jas.2005.10.014; Lycett SJ, 2011, J EVOLUTIONARY PSYCH, V9, P143, DOI [DOI 10.1016/J.JAA.2007.07.003, DOI 10.1556/JEP.9.2011.23.1]; Lycett SJ, 2008, J ARCHAEOL SCI, V35, P2640, DOI 10.1016/j.jas.2008.05.002; Lycett SJ, 2008, J ARCHAEOL SCI, V35, P553, DOI 10.1016/j.jas.2007.05.003; Lycett SJ, 2016, QUATERN INT, V411, P386, DOI 10.1016/j.quaint.2015.08.021; Machin AJ, 2007, J ARCHAEOL SCI, V34, P883, DOI 10.1016/j.jas.2006.09.008; Marchal F, 2000, J HUM EVOL, V38, P347, DOI 10.1006/jhev.1999.0360; Martinez K, 2016, J ANTHROPOL ARCHAEOL, V44, P87, DOI 10.1016/j.jaa.2016.09.003; McNabb J, 2015, J ARCHAEOL SCI-REP, V3, P100, DOI 10.1016/j.jasrep.2015.06.004; McPherron S., 2006, AXE AGE ACHEULIAN TO, P267; McPherron S. P., 1999, PREHISTOIRE EUROPEEN, V14, P9; McPherron SP, 2000, J ARCHAEOL SCI, V27, P655, DOI 10.1006/jasc.1999.0467; McPherron SP, 2003, MULTIPLE APPROACHES, P55; McPherron SP, 1995, LITHICS, P9; Mitchell J, 1997, MICROSCOPY ANAL, P15; Mitchell J, 1995, LITHICS, P64; Moncel M-H, COMPTES REN IN PRESS; Moncel MH, 2016, QUATERN INT, V393, P112, DOI 10.1016/j.quaint.2015.04.051; Moncel MH, 2015, J ANTHROPOL ARCHAEOL, V40, P302, DOI 10.1016/j.jaa.2015.09.005; Moncel MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075529; Nowell A, 2003, MULTIPLE APPROACHES, P193; Nowell A., 2009, PALEOANTHROPOLOGY, V2009, P77; Picin A, 2014, QUATERN INT, V350, P84, DOI 10.1016/j.quaint.2014.05.004; Pinsky M, 2008, J COMPUT CHEM, V29, P190, DOI 10.1002/jcc.20772; Piperno M, 1999, NOTARCHIRICO SITO PL; Pope M, 2015, LITHICS J LITHIC STU, P44; Pope M., 2006, LITHICS J LITHIC STU, V27, P47; Pope M, 2005, HOMINID INDIVIDUAL C, P81; Pope MI, 2002, SIGNIFICANCE BIFACE; Potts R, 1999, J HUM EVOL, V37, P747, DOI 10.1006/jhev.1999.0344; R Core Team, 2013, R LANG ENV STAT COMP; Roberts MB., 1999, BOXGROVE MIDDLE PLEI; Roberts MB, 1988, REV ARCHEOLOGIQUE PI, V1, P105, DOI DOI 10.3406/pica.1988.1581; ROCHE H, 1987, CR ACAD SCI II, V305, P529; Roche H., 1988, AFR ARCHAEOL REV, V6, P27, DOI [DOI 10.1007/BF01117111, DOI 10.1007/BF01117111)]; Roe D.A., 1968, P PREHIST SOC, VVolume 34, P1, DOI [DOI 10.1016/j.jhevol.2010.02.005, DOI 10.1017/S0079497X00013840]; ROHLF FJ, 1984, SYST ZOOL, V33, P302, DOI 10.2307/2413076; Saragusti I, 2005, J ARCHAEOL SCI, V32, P841, DOI 10.1016/j.jas.2005.01.002; Saragusti I, 1998, J ARCHAEOL SCI, P25; Schmittbuhl M, 2003, MATH GEOL, V35, P853, DOI 10.1023/B:MATG.0000007783.72366.0c; Scott GR, 2009, NATURE, V461, P82, DOI 10.1038/nature08214; Shchelinskii VE, 1994, EKSP TRASOLOGICHESKI, P22; Shen GJ, 2012, ANTHROPOLOGIE, V116, P1, DOI 10.1016/j.anthro.2011.12.007; Shipton C, 2015, J ARCHAEOL SCI-REP, V3, P408, DOI 10.1016/j.jasrep.2015.06.029; Shott M.J., 2005, LITHICS DOWN UNDER A, P109; Shott M, 2014, WORLD ARCHAEOL, V46, P1, DOI 10.1080/00438243.2013.879046; Spikins P, 2012, WORLD ARCHAEOL, V44, P378, DOI 10.1080/00438243.2012.725889; Texier P.-J., 2001, PRAEHISTORIA, V2, P51; Texier P.-J., 1995, EVOLUCION HUMANA EUR, V2, P403; Thulman DK, 2012, J ARCHAEOL SCI, V39, P1599, DOI 10.1016/j.jas.2012.01.004; Tuvi-Arad I, 2010, CHEM EDUC RES PRACT, V11, P48, DOI 10.1039/C001046B; Vallverdu A J, 2014, PLOS ONE, V9; Voinchet P, 2010, QUAT GEOCHRONOL, V5, P381, DOI 10.1016/j.quageo.2009.03.005; Wayman JL, 2010, LITHIC TECHNOL, V35, P171, DOI 10.1080/01977261.2010.11721089; White M. J., 1998, P PREHIST SOC, V66, P1; Wilson J, 2008, LITHIC TECHNOLOGY: MEASURES OF PRODUCTION, USE, AND CURATION, P86, DOI 10.1017/CBO9780511499661.005; Wynn T, 2002, BEHAV BRAIN SCI, V25, P389, DOI 10.1017/S0140525X02000079; ZABRODSKY H, 1992, J AM CHEM SOC, V114, P7843, DOI 10.1021/ja00046a033; ZABRODSKY H, 1995, IEEE T PATTERN ANAL, V17, P1154, DOI 10.1109/34.476508; Zayit A, 2011, CHIRALITY, V23, P17, DOI 10.1002/chir.20807; Zutovski K, 2016, QUATERN INT, V406, P227, DOI 10.1016/j.quaint.2015.01.033	132	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177063	10.1371/journal.pone.0177063	http://dx.doi.org/10.1371/journal.pone.0177063			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520745	Green Submitted, Green Published, gold			2022-12-26	WOS:000401487700035
J	Raghav, A; Ahmad, J; Alam, K				Raghav, Alok; Ahmad, Jamal; Alam, Khursheed			Nonenzymatic glycosylation of human serum albumin and its effect on antibodies profile in patients with diabetes mellitus	PLOS ONE			English	Article							ADVANCED GLYCATION ENDPRODUCTS; MODIFIED HUMAN DNA; METABOLIC SYNDROME; END-PRODUCTS; INFLAMMATORY RESPONSE; OXIDATIVE STRESS; URIC-ACID; RECEPTOR; RAGE; NEPHROPATHY	Background Albumin glycation and subsequent formation of advanced glycation end products (AGEs) correlate with diabetes and associated complications. Methods Human Serum Albumin (HSA) was modified with D-glucose for a 40 day period under sterile conditions at 37 degrees C. Modified samples along with native HSA (unmodified) were analyzed for structural modifications by UV and fluorescence, FTIR, Liquid chromatography mass spectrometry (LCMS) and X-ray crystallography. New-Zealand white female rabbits immunized with AGEs, represent auto-antibodies formation as assessed by competitive and direct binding enzyme-linked immunosorbent assay (ELISA). Neo-epitopesagainst In-vitro formed AGEs were characterized in patients with diabetes mellitus type 2 (n = 50), type 1 (n = 50), gestational diabetes (n = 50) and type 2 with chronic kidney disease (CKD) with eGFR level 60-89 mL/min (n = 50) from serum direct binding ELISA. Results Glycated-HSA showed a marked increase in hyperchromicity of 65.82%, 71.98%, 73.62% and 76.63% at. 280 nm along with anincreasein fluorescence intensity of 65.82%, 71.98%, 73.62% and 76.63% in glycated-HSA compared to native. FTIR results showed theshifting of Amide I peak from 1656 cm(-1) to 1659 cm(-1) and Amide II peak from 1554 cm(-1) to 1564 cm(-1) in glycated-HSA, with anew peak appearance of carbonyl group at 1737 cm-1. LCMS chromatogram of glycated-HSA showed thepresence of carboxymethyl lysine (CML) at 279.1 m/z. Immunological analysis showed high antibody titre> 1: 12,800 in theserum of rabbits immunized with glycated-HSA (modified with 400 mg/dL glucose) and inhibition of 84.65% at anantigen concentration of 20 mu g/mL. Maximum serum auto-antibody titre was found in T2DM (0.517 +/- 0.086), T1DM (0.108 +/- 0.092), GDM (0.611 +/- 0.041) and T2DM + CKD (0.096 +/- 0.25) patients immunized with glycated-HSA (modified with 400 mg/dL glucose). Conclusions Non-enzymatic glycosylation of HSA manifests immunological complications in diabetes mellitus due to change in its structure that enhances neo-epitopes generation.	[Raghav, Alok; Ahmad, Jamal] Aligarh Muslim Univ, JN Med Coll, Rajiv Gandhi Ctr Diabet & Endocrinol, Aligarh, Uttar Pradesh, India; [Alam, Khursheed] Aligarh Muslim Univ, JN Med Coll, Fac Med, Dept Biochem, Aligarh, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University	Ahmad, J (corresponding author), Aligarh Muslim Univ, JN Med Coll, Rajiv Gandhi Ctr Diabet & Endocrinol, Aligarh, Uttar Pradesh, India.	alokalig@gmail.com	Raghav, Alok/AAX-3419-2021	Ahmad, Jamal/0000-0001-9108-5019; Alam, Khursheed/0000-0001-9729-9966				Ahmadi SK, 2015, J BIOMOL STRUCT DYN, V33, P1880, DOI 10.1080/07391102.2014.977351; Alam K, 2007, CELL IMMUNOL, V247, P12, DOI 10.1016/j.cellimm.2007.06.007; Barnaby OS, 2011, CLIN CHIM ACTA, V412, P277, DOI 10.1016/j.cca.2010.10.018; Barros CMMR, 2007, CLINICS, V62, P327, DOI 10.1590/S1807-59322007000300019; BASSIOUNY AR, 1983, DIABETES, V32, P1182, DOI 10.2337/diabetes.32.12.1182; BENDEDOUCH D, 1983, J PHYS CHEM-US, V87, P1473, DOI 10.1021/j100232a003; Bennett P.H., 2010, JOSLINS DIABETES MEL; BOS OJM, 1989, J BIOL CHEM, V264, P953; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chen JF, 2010, MOL CELL BIOCHEM, V335, P137, DOI 10.1007/s11010-009-0250-y; Dixit K, 2005, LIFE SCI, V77, P2626, DOI 10.1016/j.lfs.2005.02.026; DOHERTY P, 1974, J CHEM PHYS, V61, P5426, DOI 10.1063/1.1681898; Giugliano D, 1996, DIABETES CARE, V19, P257, DOI 10.2337/diacare.19.3.257; GODING JW, 1978, J IMMUNOL METHODS, V20, P241, DOI 10.1016/0022-1759(78)90259-4; Guerin-Dubourg A, 2012, DIABETES METAB, V38, P171, DOI 10.1016/j.diabet.2011.11.002; Habib S, 2005, INT J BIOL MACROMOL, V35, P221, DOI 10.1016/j.ijbiomac.2005.02.005; Habib S, 2009, CELL IMMUNOL, V254, P117, DOI 10.1016/j.cellimm.2008.08.002; Heinig M, 2006, CLEV CLIN J MED, V73, P1059, DOI 10.3949/ccjm.73.12.1059; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hughes W.L, 1954, PROTEINS; Huijberts MSP, 2008, DIABETES-METAB RES, V24, pS19, DOI 10.1002/dmrr.861; Jaleel A, 2005, DIABETES CARE, V28, P645, DOI 10.2337/diacare.28.3.645; Kalia K, 2004, CLIN CHIM ACTA, V347, P169, DOI 10.1016/j.cccn.2004.04.016; Khan MWA, 2009, AUTOIMMUNITY, V42, P150, DOI 10.1080/08916930802468276; Khan MWA, 2010, INT ARCH ALLERGY IMM, V153, P207, DOI 10.1159/000312639; Khan ZA, 2007, EXP DIABETES RES, DOI 10.1155/2007/31867; KUME S, 1995, AM J PATHOL, V147, P654; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; MAKINO H, 1995, KIDNEY INT, V48, P517, DOI 10.1038/ki.1995.322; Moghaddam MM, 2014, LUMINESCENCE, V29, P314, DOI 10.1002/bio.2546; Monnier VM, 2008, ANN NY ACAD SCI, V1126, P81, DOI 10.1196/annals.1433.052; Moosavi-Movahedi AA, 2003, J PROTEIN CHEM, V22, P23, DOI 10.1023/A:1023011609931; MYINT T, 1995, BBA-MOL BASIS DIS, V1272, P73, DOI 10.1016/0925-4439(95)00067-E; Nakagawa T, 2005, NAT CLIN PRACT NEPHR, V1, P80, DOI 10.1038/ncpneph0019; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Neelofar K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172074; Oettl K, 2007, BRIT J PHARMACOL, V151, P580, DOI 10.1038/sj.bjp.0707251; Palm F, 2003, DIABETOLOGIA, V46, P1153, DOI 10.1007/s00125-003-1155-z; Raghav Alok, INT J BIOL MACROMOLE; Rahmelow K, 1996, ANAL BIOCHEM, V241, P5, DOI 10.1006/abio.1996.0369; Rasheed Z, 2006, AUTOIMMUNITY, V39, P479, DOI 10.1080/08916930600918472; RILEY DP, 1952, NATURE, V169, P138, DOI 10.1038/169138a0; Sakai H, 1996, NEPHROL DIAL TRANSPL, V11, P66; Schalkwijk CG, 1999, DIABETES, V48, P2446, DOI 10.2337/diabetes.48.12.2446; Schleicher, 1981, CLIN CHEM CLIN BIOCH, V19, P81; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Shibayama P, 1999, DIABETES, V48, P1842, DOI 10.2337/diabetes.48.9.1842; Sun N, 2013, INT J MOL MED, V32, P485, DOI 10.3892/ijmm.2013.1402; Turk Z, 2001, CLIN CHIM ACTA, V303, P105, DOI 10.1016/S0009-8981(00)00389-2; Uribarri J, 2007, J GERONTOL A-BIOL, V62, P427, DOI 10.1093/gerona/62.4.427; Xie JL, 2013, CELL SIGNAL, V25, P2185, DOI 10.1016/j.cellsig.2013.06.013; Yamagishi S, 2011, EXP GERONTOL, V46, P217, DOI 10.1016/j.exger.2010.11.007; Yan SF, 2009, J MOL MED, V87, P235, DOI 10.1007/s00109-009-0439-2; Zohreh S, 2014, PLOS ONE, V9	55	28	28	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176970	10.1371/journal.pone.0176970	http://dx.doi.org/10.1371/journal.pone.0176970			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520799	Green Published, Green Submitted, gold			2022-12-26	WOS:000401487700034
J	Hilton, BA; Liu, J; Cartwright, BM; Liu, YY; Breitman, M; Wang, YJ; Jones, R; Tang, H; Rusinol, A; Musich, PR; Zou, Y				Hilton, Benjamin A.; Liu, Ji; Cartwright, Brian M.; Liu, Yiyong; Breitman, Maya; Wang, Youjie; Jones, Rowdy; Tang, Hui; Rusinol, Antonio; Musich, Phillip R.; Zou, Yue			Progerin sequestration of PCNA promotes replication fork collapse and mislocalization of XPA in laminopathy-related progeroid syndromes	FASEB JOURNAL			English	Article						HGPS; lamin A; DNA DSBs; DNA repair; genome instability	NUCLEOTIDE EXCISION-REPAIR; DNA-POLYMERASE-DELTA; PIGMENTOSUM GROUP-A; DEFECTIVE MATURATION; GENOMIC INSTABILITY; DAMAGE RESPONSES; BREAK REPAIR; CELL-CYCLE; ATR; PRELAMIN	Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disorder that is caused by a point mutation in the LMNA gene, resulting in production of a truncated farnesylated-prelamin A protein (progerin). We previously reported that XPA mislocalized to the progerin-induced DNA double-strand break (DSB) sites, blocking DSB repair, which led to DSB accumulation, DNA damage responses, and early replication arrest in HGPS. In this study, the XPA mislocalization to DSBs occurred at stalled or collapsed replication forks, concurrent with a significant loss of PCNA at the forks, whereas PCNA efficiently bound to progerin. This PCNA sequestration likely exposed ds-ssDNA junctions at replication forks for XPA binding. Depletion of XPA or progerin each significantly restored PCNA at replication forks. Our results suggest that although PCNA is much more competitive than XPA in binding replication forks, PCNA sequestration by progerin may shift the equilibrium to favor XPA binding. Furthermore, we demonstrated that progerin-induced apoptosis could be rescued by XPA, suggesting that XPA-replication fork binding may prevent apoptosis in HGPS cells. Our results propose a mechanism for progerin-induced genome instability and accelerated replicative senescence in HGPS.	[Hilton, Benjamin A.; Cartwright, Brian M.; Liu, Yiyong; Breitman, Maya; Jones, Rowdy; Tang, Hui; Rusinol, Antonio; Musich, Phillip R.; Zou, Yue] East Tennessee State Univ, JH Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA; [Liu, Ji] Sichuan Univ, Dept Biochem & Mol Biol, West China Ctr Med Sci, Chengdu, Sichuan, Peoples R China; [Wang, Youjie] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Educ MOE,Key Lab Environm & Hlth, Wuhan, Hubei, Peoples R China	East Tennessee State University; Sichuan University; Huazhong University of Science & Technology	Zou, Y (corresponding author), East Tennessee State Univ, JH Quillen Coll Med, Box 70581, Johnson City, TN 37614 USA.	zouy@etsu.edu	Zou, Yue/ABA-8429-2020	Musich, Phillip/0000-0001-8816-4242	U.S. National Institutes of Health, National Institute on Aging [AG031503]; Progeria Research Foundation; East Tennessee State University Research Development Committee [E82083, E31231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM112168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG031503] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Progeria Research Foundation; East Tennessee State University Research Development Committee; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by U.S. National Institutes of Health, National Institute on Aging Grant AG031503 (to Y.Z.), a Progeria Research Foundation grant (to Y.Z.), and East Tennessee State University Research Development Committee Grants E82083 and E31231 (to P.R.M.).	Aliper AM, 2015, AGING-US, V7, P26, DOI 10.18632/aging.100717; Bailey R, 2015, NUCLEUS-PHILA, V6, P187, DOI 10.1080/19491034.2015.1035843; Buisson R, 2015, MOL CELL, V59, P1011, DOI 10.1016/j.molcel.2015.07.029; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104; Cao K, 2011, J CLIN INVEST, V121, P2833, DOI 10.1172/JCI43578; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; Chibazakura T, 2011, MOL CELL BIOL, V31, P248, DOI 10.1128/MCB.00630-10; Cobb AM, 2016, NUCLEUS-PHILA, V7, P498, DOI 10.1080/19491034.2016.1239685; Constantinescu D, 2010, EXP CELL RES, V316, P2747, DOI 10.1016/j.yexcr.2010.05.015; Corrigan DP, 2005, BIOCHEM J, V387, P129, DOI 10.1042/BJ20041359; Cortez D, 2015, DNA REPAIR, V32, P149, DOI 10.1016/j.dnarep.2015.04.026; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Ding SL, 2008, CLIN INTERV AGING, V3, P431, DOI 10.2147/CIA.S1957; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Errico A, 2012, CRIT REV BIOCHEM MOL, V47, P222, DOI 10.3109/10409238.2012.655374; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; Ewald B, 2008, ONCOGENE, V27, P6522, DOI 10.1038/onc.2008.316; Gilljam KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049199; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Gonzalo S, 2015, CURR OPIN CELL BIOL, V34, P75, DOI 10.1016/j.ceb.2015.05.007; Gordon LB, 2014, CELL, V156, P400, DOI 10.1016/j.cell.2013.12.028; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hicks WM, 2011, P NATL ACAD SCI USA, V108, P3108, DOI 10.1073/pnas.1019660108; Hilton B, 2014, BIOSCIENCE REP, V34, P831, DOI 10.1042/BSR20140158; Hutchison CJ, 2011, BIOCHEM SOC T, V39, P1715, DOI 10.1042/BST20110700; Li ZK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068297; Li ZK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028326; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Liu Y, 2008, FASEB J, V22, P603, DOI 10.1096/fj.07-8598com; Liu YY, 2006, J CELL SCI, V119, P4644, DOI 10.1242/jcs.03263; Lopez-Contreras AJ, 2015, GENE DEV, V29, P690, DOI 10.1101/gad.256958.114; Maloisel L, 2008, MOL CELL BIOL, V28, P1373, DOI 10.1128/MCB.01651-07; Manju K, 2006, J CELL SCI, V119, P2704, DOI 10.1242/jcs.03009; Mattout A, 2007, J CELL SCI, V120, P77, DOI 10.1242/jcs.03325; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Misteli T, 2005, NAT MED, V11, P718, DOI 10.1038/nm0705-718; Moir RD, 2000, J CELL BIOL, V149, P1179, DOI 10.1083/jcb.149.6.1179; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Morafraile EC, 2015, SCI REP-UK, V5, DOI 10.1038/srep07886; Musich PR, 2011, BIOCHEM SOC T, V39, P1764, DOI 10.1042/BST20110687; Musich PR, 2009, AGING-US, V1, P28, DOI 10.18632/aging.100012; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P965, DOI 10.1007/s00018-009-8734-1; Olive M, 2010, ARTERIOSCL THROM VAS, V30, P2301, DOI 10.1161/ATVBAHA.110.209460; Pacheco LM, 2014, AGING-US, V6, P1049, DOI 10.18632/aging.100709; Ricke RM, 2005, BIOL PROCED ONLINE, V7, P60, DOI 10.1251/bpo106; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Shumaker DK, 2008, J CELL BIOL, V181, P269, DOI 10.1083/jcb.200708155; Smith CE, 2009, MOL CELL BIOL, V29, P1432, DOI 10.1128/MCB.01469-08; Spann TP, 1997, J CELL BIOL, V136, P1201, DOI 10.1083/jcb.136.6.1201; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Sugitani N, 2014, J AM CHEM SOC, V136, P10830, DOI 10.1021/ja503020f; Tang H, 2012, AGING CELL, V11, P363, DOI 10.1111/j.1474-9726.2011.00779.x; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Widrow RJ, 1998, P NATL ACAD SCI USA, V95, P11246, DOI 10.1073/pnas.95.19.11246; Wu X, 2007, ONCOGENE, V26, P757, DOI 10.1038/sj.onc.1209828; Wu XM, 2006, CANCER RES, V66, P2997, DOI 10.1158/0008-5472.CAN-05-3403; Yang ZG, 2006, BIOCHEMISTRY-US, V45, P15921, DOI 10.1021/bi061626q	63	26	27	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3882	3893		10.1096/fj.201700014R	http://dx.doi.org/10.1096/fj.201700014R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28515154	Green Published			2022-12-26	WOS:000408713300015
J	Albertolle, ME; Kim, D; Nagy, LD; Yun, CH; Pozzi, A; Savas, U; Johnson, EF; Guengerich, P				Albertolle, Matthew E.; Kim, Donghak; Nagy, Leslie D.; Yun, Chul-Ho; Pozzi, Ambra; Savas, Uzen; Johnson, Eric F.; Guengerich, Peter			Heme-thiolate sulfenylation of human cytochrome P450 4A11 functions as a redox switch for catalytic inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOXIDE-BINDING PIGMENT; 20-HYDROXYEICOSATETRAENOIC ACID; T8590C POLYMORPHISM; KINETIC-ANALYSIS; NADPH OXIDASE; C-13-LABELED IODOACETANILIDE; LIVER MICROSOMES; N-ETHYLMALEIMIDE; BLOOD-PRESSURE; CYP4A11	Cytochrome P450 (P450, CYP) 4A11 is a human fatty acid omega-hydroxylase that catalyzes the oxidation of arachidonic acid to the eicosanoid 20-hydroxyeicosatetraenoic acid (20-HETE), which plays important roles in regulating blood pressure regulation. Variants of P450 4A11 have been associated with high blood pressure and resistance to anti-hypertensive drugs, and 20-HETE has both pro-and antihypertensive properties relating to increased vasoconstriction and natriuresis, respectively. These physiological activities are likely influenced by the redox environment, but the mechanisms are unclear. Here, we found that reducing agents (e. g. dithiothreitol and tris(2-carboxyethyl) phosphine) strongly enhanced the catalytic activity of P450 4A11, but not of 10 other human P450s tested. Conversely, added H2O2 attenuated P450 4A11 catalytic activity. Catalytic roles of five of the potentially eight implicated Cys residues of P450 4A11 were eliminated by site-directed mutagenesis. Using an isotope-coded dimedone/iododimedone-labeling strategy and mass spectrometry of peptides, we demonstrated that the heme-thiolate cysteine (Cys-457) is selectively sulfenylated in an H2O2 concentration-dependent manner. This sulfenylation could be reversed by reducing agents, including dithiothreitol and dithionite. Of note, we observed heme ligand cysteine sulfenylation of P450 4A11 ex vivo in kidneys and livers derived from CYP4A11 transgenic mice. We also detected sulfenylation of murine P450 4a12 and 4b1 heme peptides in kidneys. To our knowledge, reversible oxidation of the heme thiolate has not previously been observed in P450s and may have relevance for 20-HETE-mediated functions.	[Albertolle, Matthew E.; Kim, Donghak; Nagy, Leslie D.; Guengerich, Peter] Vanderbilt Univ, Sch Med, Dept Biochem, 6388 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA; [Kim, Donghak] Konkuk Univ, Dept Biol Sci, Seoul 05025, South Korea; [Yun, Chul-Ho] Chonnam Natl Univ, Sch Biol Sci & Technol, Gwangju 61186, South Korea; [Pozzi, Ambra] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Pozzi, Ambra] Vet Affairs Med Ctr, Nashville, TN 37232 USA; [Savas, Uzen; Johnson, Eric F.] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA	Vanderbilt University; Konkuk University; Chonnam National University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Scripps Research Institute	Guengerich, P (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 6388 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		Albertolle, Matthew E./0000-0003-4195-4006; Yun, Chul-Ho/0000-0003-2685-2968	National Institutes of Health [R35 CA090426, R01 GM118122, R01 DK095761, R01 CA162433, R01 HD004445, T32 ES007028, P30 CA068485]; Veterans Affairs [I01 BX002025-01]; National Research Foundation of Korea [NRF-2016R1A2B4006978]; American Heart Association [PRE33410007]; Veterans Affairs Senior Research Career Scientist award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD004445] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA090426, R01CA162433, R01CA090426, P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118122] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); National Research Foundation of Korea(National Research Foundation of Korea); American Heart Association(American Heart Association); Veterans Affairs Senior Research Career Scientist award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Institutes of Health Grants R35 CA090426 (to F. P. G.), R01 GM118122 (to F. P. G.), R01 DK095761 (to A. P.), R01 CA162433 (to A. P.), R01 HD004445 (to E. F. J.), and T32 ES007028 (to M. E. A.); Veterans Affairs Grant I01 BX002025-01 (to A. P.); and National Research Foundation of Korea Grant NRF-2016R1A2B4006978 (to C.-H. Y.). Some of the mass spectrometry work was funded in part by National Institutes of Health Grant P30 CA068485 (Vanderbilt-Ingram Cancer Center Support Grant). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by American Heart Association Predoctoral Fellowship PRE33410007.; Recipient of a Veterans Affairs Senior Research Career Scientist award.	ANFINSEN C, 1961, J BIOL CHEM, V236, P1361; Bodiga S, 2010, AM J PHYSIOL-LUNG C, V298, pL564, DOI 10.1152/ajplung.00298.2009; BURLEIGH BD, 1969, ANAL BIOCHEM, V27, P536, DOI 10.1016/0003-2697(69)90067-0; Capdevila JH, 2015, PROSTAG OTH LIPID M, V120, P40, DOI 10.1016/j.prostaglandins.2015.05.004; Cheng J, 2010, J PHARMACOL EXP THER, V332, P57, DOI 10.1124/jpet.109.159863; CHOUDHURY K, 1994, J BIOL CHEM, V269, P20239; Devarie-Baez NO, 2016, FREE RADICAL RES, V50, P172, DOI 10.3109/10715762.2015.1090571; Everse J.E.K.E., 1991, PEROXIDASES CHEM BIO, VI; Fan F, 2016, FRONT BIOSCI-LANDMRK, V21, P1427, DOI 10.2741/4465; Forman HJ, 2017, ARCH BIOCHEM BIOPHYS, V617, P26, DOI 10.1016/j.abb.2016.09.013; FRANKLIN MR, 1972, MOL PHARMACOL, V8, P711; Gainer JV, 2005, CIRCULATION, V111, P63, DOI 10.1161/01.CIR.0000151309.82473.59; Garcia V, 2017, CURR OPIN NEPHROL HY, V26, P74, DOI 10.1097/MNH.0000000000000302; Goswami P, 2007, ARKIVOC, P82, DOI 10.3998/ark.5550190.0008.f09; Guengerich F P, 1998, Methods Mol Biol, V107, P77; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; GUENGERICH FP, 1986, J BIOL CHEM, V261, P5051; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; Guengerich FP, 2004, BIOCHEMISTRY-US, V43, P10775, DOI 10.1021/bi0491393; Gupta V, 2014, BBA-GEN SUBJECTS, V1840, P847, DOI 10.1016/j.bbagen.2013.05.040; Han Y, 2013, CIRC J, V77, P1807, DOI 10.1253/circj.CJ-12-1211; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; Hanna IH, 2001, ARCH BIOCHEM BIOPHYS, V393, P255, DOI 10.1006/abbi.2001.2510; HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025; Hoch U, 2001, J BIOL CHEM, V276, P11339, DOI 10.1074/jbc.M009969200; Holman Jerry D, 2012, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1317s37; Hsu MH, 2017, J BIOL CHEM, V292, P5610, DOI 10.1074/jbc.M117.775494; Imai Y., 1978, CYTOCHROME P450, P37; Imig JD, 1996, AM J PHYSIOL-REG I, V270, pR217, DOI 10.1152/ajpregu.1996.270.1.R217; Kawashima H, 2000, ARCH BIOCHEM BIOPHYS, V378, P333, DOI 10.1006/abbi.2000.1831; Kim D, 2014, BIOCHEMISTRY-US, V53, P6161, DOI 10.1021/bi500710e; Kurono S, 2006, BIOORGAN MED CHEM, V14, P8197, DOI 10.1016/j.bmc.2006.09.023; KUTHAN H, 1982, EUR J BIOCHEM, V126, P583, DOI 10.1111/j.1432-1033.1982.tb06820.x; Laffer CL, 2008, HYPERTENSION, V51, P767, DOI 10.1161/HYPERTENSIONAHA.107.102921; Lakhkar A, 2016, AM J PHYSIOL-HEART C, V310, pH1107, DOI 10.1152/ajpheart.00961.2015; Lasker JM, 2000, J BIOL CHEM, V275, P4118, DOI 10.1074/jbc.275.6.4118; LeBrun LA, 2002, J BIOL CHEM, V277, P12755, DOI 10.1074/jbc.M112155200; Leichert LI, 2015, BIOL CHEM, V396, P389, DOI 10.1515/hsz-2014-0314; LIN TY, 1989, BIOCHEMISTRY-US, V28, P5282, DOI 10.1021/bi00438a054; LITTLE C, 1969, EUR J BIOCHEM, V10, P533, DOI 10.1111/j.1432-1033.1969.tb00721.x; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Malinouski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014564; Marnett L.J., 1986, CYTOCHROME P 450 STR, P29; Martinez S, 2014, J AM CHEM SOC, V136, P1186, DOI 10.1021/ja410462j; Mayer B, 2005, HYPERTENSION, V46, P766, DOI 10.1161/01.HYP.0000182658.04299.15; Muller DN, 2007, BIOCHEM J, V403, P109, DOI 10.1042/BJ20061328; MURAKAMI K, 1967, J BIOL CHEM, V242, P1102; Niwayama S, 2003, BIOORG MED CHEM LETT, V13, P2913, DOI 10.1016/S0960-894X(03)00503-1; OMURA T, 1964, J BIOL CHEM, V239, P2379; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ortiz de Montellano PR, 2015, CYTOCHROME P450 STRU; Pallan PS, 2015, J BIOL CHEM, V290, P13128, DOI 10.1074/jbc.M115.646307; PARSONAGE D, 1995, BIOCHEMISTRY-US, V34, P435, DOI 10.1021/bi00002a007; Patil PV, 2000, ANAL BIOCHEM, V286, P187, DOI 10.1006/abio.2000.4802; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Poulos T. L., 2015, CYTOCHROME P450 STRU, V4th, P3, DOI DOI 10.1007/978-3-319-12108-6_1; Savas U, 2009, J BIOL CHEM, V284, P16541, DOI 10.1074/jbc.M902074200; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Seo YH, 2011, ANGEW CHEM INT EDIT, V50, P1342, DOI 10.1002/anie.201007175; Shimada T, 2006, CHEM RES TOXICOL, V19, P288, DOI 10.1021/tx050291v; Shriner R. L., 1943, ORG SYNTH COLL, V2, P200; Sohl CD, 2010, J BIOL CHEM, V285, P17734, DOI 10.1074/jbc.M110.123711; Sreedhar B, 2007, SYNTHETIC COMMUN, V37, P4149, DOI 10.1080/00397910701574908; Sun CW, 1999, HYPERTENSION, V33, P414, DOI 10.1161/01.HYP.33.1.414; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Vaclavikova R, 2004, DRUG METAB DISPOS, V32, P666, DOI 10.1124/dmd.32.6.666; Williams JS, 2011, J HYPERTENS, V29, P1913, DOI 10.1097/HJH.0b013e32834aa786; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Wu CC, 2014, CARDIOL REV, V22, P1, DOI 10.1097/CRD.0b013e3182961659; Wu CC, 2011, PROSTAG OTH LIPID M, V96, P45, DOI 10.1016/j.prostaglandins.2011.06.006; Yamazaki H, 1997, ARCH BIOCHEM BIOPHYS, V342, P329, DOI 10.1006/abbi.1997.0125; Yamazaki H, 1996, ARCH BIOCHEM BIOPHYS, V325, P174, DOI 10.1006/abbi.1996.0022; Yun CH, 2005, J BIOL CHEM, V280, P12279, DOI 10.1074/jbc.M411019200; Zabet-Moghaddam M, 2008, BIOORG MED CHEM LETT, V18, P4891, DOI 10.1016/j.bmcl.2008.07.069; Zeng QH, 2010, AM J PHYSIOL-HEART C, V299, pH1109, DOI 10.1152/ajpheart.00067.2010; Zhang R, 2011, HYPERTENS RES, V34, P645, DOI 10.1038/hr.2011.8	77	17	17	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11230	11242		10.1074/jbc.M117.792200	http://dx.doi.org/10.1074/jbc.M117.792200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28533430	Green Published, hybrid			2022-12-26	WOS:000405119600009
J	Evers, C; Fischer, C; Dikow, N; Schott, S				Evers, Christina; Fischer, Christine; Dikow, Nicola; Schott, Sarah			Familial breast cancer: Genetic counseling over time, including patients A expectations and initiators considering the Angelina Jolie effect	PLOS ONE			English	Article							HEREDITARY BREAST; OVARIAN-CANCER; PRIMARY-CARE; RISK; IMPACT; WOMEN; BRCA1; HISTORY; ADHERENCE; AWARENESS	Purpose The German Consortium for hereditary breast/ovarian cancer (GC-HBOC) aims for nationwide access to professional, individualized yet structured care for families at high risk. The identification of such families remains key for optimal care. Our study evaluates counselees' characteristics, referral practices, expectations and motivations in respect to their first genetic consultation. The impact of the Angelina Jolie Effect (AJE) was prospectively assessed. Methods All counselees could participate through a questionnaire. Groups were built in respect to neoadjuvant chemotherapy (FT) and before/after AJE. Results The 917 (88.5%) counselees (FT: 8.2%) were on average female (97.3%), with a mean age of 44.6, had children (71.9%), higher education (88%), personal (46.4%) or at least one firstdegree relative (74.6%) with BC/OC or known BRCA1/2 mutation (11.8%), were in a relationship (76.1%), and living in a village (40.7%). The AJE is associated with significantly fewer cancelations (p = 0.005), more attendance among men (4.2% vs. 0.8%, p = 0.002), and people with familial BRCA1/2 (14.8% vs. 7.5%, p = 0.003). The majority seek information regarding their cancer risk (83%) or relatives' risk (74.8%), HBOC (69.1%), and surveillance programs for themselves (66.6%) or relatives (60.6%). Conclusion Enhanced media awareness of genetic cancer motivates patients, including other patient groups. A higher number of participants, including more men, are attending GC due to the AJE. In terms of the rising complexity of genetic testing, the analysis of patients' expectations and initiators for GC suggests that there is an urgent need to develop to participate motivation analysis. The factors revealed as impediments to accessing GC-HBOC guide recommendations to optimize access to genetic counseling. Medical educational programs for primary gynecologists and families at risk might be options to reach more participants.	[Evers, Christina; Fischer, Christine; Dikow, Nicola] Heidelberg Univ, Inst Human Genet, Heidelberg, Germany; [Schott, Sarah] Univ Hosp Heidelberg, Dept Gynecol & Obstet, Heidelberg, Germany; [Schott, Sarah] German Consortium Translat Canc Res DKTK, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Schott, S (corresponding author), Univ Hosp Heidelberg, Dept Gynecol & Obstet, Heidelberg, Germany.; Schott, S (corresponding author), German Consortium Translat Canc Res DKTK, Heidelberg, Germany.	sarah.schott@med.uni-heidelberg.de	Schott, Sarah/D-5242-2018	Schott, Sarah/0000-0002-1714-1147	Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	We acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing.	Armstrong J, 2015, JAMA ONCOL, V1, P1251, DOI 10.1001/jamaoncol.2015.3048; Armstrong J, 2015, J GENET COUNS, V24, P18, DOI 10.1007/s10897-014-9750-3; Armstrong K, 2005, JAMA-J AM MED ASSOC, V293, P1729, DOI 10.1001/jama.293.14.1729; Bhatti J, 2015, MED DECIS MAKING, V35, P4, DOI 10.1177/0272989X14558882; Borzekowski DLG, 2014, GENET MED, V16, P516, DOI 10.1038/gim.2013.181; Brain K, 2000, J MED GENET, V37, P197, DOI 10.1136/jmg.37.3.197; Burstein HJ, 2013, J NATL COMPR CANC NE, V11, P631, DOI 10.6004/jnccn.2013.0081; Christie J, 2012, ANN SURG ONCOL, V19, P4003, DOI 10.1245/s10434-012-2460-x; Cragun D, 2015, BREAST CANCER RES TR, V151, P169, DOI 10.1007/s10549-015-3374-7; Timoteo ARD, 2015, HERED CANCER CLIN PR, V13, DOI 10.1186/s13053-014-0022-x; Dunlop K, 2014, AUST FAM PHYSICIAN, V43, P76; Engel C, 2015, MED GENET-BERLIN, V27, P217, DOI 10.1007/s11825-015-0043-5; Evans DGR, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0442-6; Gadzicki D, 2011, J COMMUN GENET, V2, P53, DOI 10.1007/s12687-011-0042-4; Goldberg JI, 2006, EXPERT REV ANTICANC, V6, P1205, DOI 10.1586/14737140.6.8.1205; Hallowell N, 2005, J Genet Couns, V14, P207, DOI 10.1007/s10897-005-0384-3; Hallowell N, 2006, SOCIOL HEALTH ILL, V28, P969, DOI 10.1111/j.1467-9566.2006.00515.x; Kelly KM, 2015, J BEHAV MED, V38, P766, DOI 10.1007/s10865-014-9613-2; Knapke S, 2016, GENET MED, V18, P410, DOI 10.1038/gim.2015.98; Kosenko KA, 2015, J HEALTH COMMUN, V21, P1; Lerman C, 1996, JAMA-J AM MED ASSOC, V275, P1885, DOI 10.1001/jama.275.24.1885; Levy DE, 2011, GENET MED, V13, P349, DOI 10.1097/GIM.0b013e3182091ba4; Lodder L, 2001, EUR J HUM GENET, V9, P492, DOI 10.1038/sj.ejhg.5200668; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; McCarthy AM, 2013, CANCER-AM CANCER SOC, V119, P3596, DOI 10.1002/cncr.28268; Morgan D, 2010, GENET MED, V12, P25, DOI 10.1097/GIM.0b013e3181c60955; Nelson HD, 2014, ANN INTERN MED, V160, P255, DOI 10.7326/M13-1684; Noar SM, 2015, MED DECIS MAKING, V35, P16, DOI 10.1177/0272989X14556130; O'Neill SC, 2015, J COMMUN GENET, V6, P55, DOI 10.1007/s12687-014-0201-5; Pagan JA, 2009, AM J PREV MED, V37, P524, DOI 10.1016/j.amepre.2009.07.021; Quillin JM, 2014, J COMMUN GENET, V5, P179, DOI 10.1007/s12687-013-0161-1; Rhiem K, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3369; Sermijn E, 2016, FAM CANCER, V15, P155, DOI 10.1007/s10689-015-9854-4; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Staudigl C, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2472-1; Tai YC, 2007, J NATL CANCER I, V99, P1811, DOI 10.1093/jnci/djm203; Tinley ST, 2004, AM J MED GENET A, V125A, P5, DOI 10.1002/ajmg.a.20431; Vetter L, 2016, BREAST CANCER RES TR, V156, P289, DOI 10.1007/s10549-016-3748-5; Wood ME, 2014, J CLIN ONCOL, V32, P824, DOI 10.1200/JCO.2013.51.4661	39	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177893	10.1371/journal.pone.0177893	http://dx.doi.org/10.1371/journal.pone.0177893			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EV8VR	28542378	Green Published, gold, Green Submitted			2022-12-26	WOS:000402062800028
J	Neisius, U; Olson, E; Rossi, SH; Ibrahim, HA; Currie, G; Dominiczak, AF; Delles, C				Neisius, Ulf; Olson, Erin; Rossi, Sabrina H.; Ibrahim, Hagar A.; Currie, Gemma; Dominiczak, Anna F.; Delles, Christian			Evaluation of the systemic micro- and macrovasculature in stable angina: A case-control study	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ISCHEMIC-HEART-DISEASE; INTIMA-MEDIA THICKNESS; ENDOTHELIAL FUNCTION; PREDICTIVE-VALUE; CAROTID PLAQUE; RISK-FACTORS; ATHEROSCLEROSIS; DIAGNOSIS; GUIDELINES	Aims The diagnosis of stable angina involves the use of probability estimates based on clinical presentation, age, gender and cardiovascular risk factors. In view of the link between the cardiac and systemic vasculature we tested whether non-invasive measures of systemic micro-and macrovascular structure and function differentiate between individuals with flowlimiting coronary artery disease (CAD) and those with normal coronary arteries (NCA). Methods and results We recruited 84 patients undergoing elective coronary angiography for investigation of symptoms of stable angina. Patients were selected for either having significant CAD or NCA (n = 43/41; age, 56 +/- 7 vs 57 +/- 7 years, P = 0.309). Only microvascular endothelial function, measured using the Endo-PAT2000 device to determine reactive hyperaemia index (CAD vs. NCA; 1.9 [1.5; 2.3] vs. 2.1 [1.8; 2.4], P = 0.03) and sonographic carotid plaque score (CAD vs. NCA; 3.0 [1.5; 4.5] vs. 1.2 [0; 2.55], P< 0.001) were significantly different between patients with CAD and NCA. No significant differences were detected in reflection magnitude (CAD vs. NCA; 1.7 [1.5; 1.8] % vs 1.7 [1.5; 1.9] %, P = 0.342), pulse wave velocity (CAD vs. NCA; 7.8 +/- 1.4 m/sec vs. 8.3 +/- 1.5 m/sec, P = 0.186), carotid intima-media thickness (CAD vs. NCA; 0.73 +/- 0.10 mm vs. 0.75 +/- 0.10 mm, P = 0.518) or carotid distensibility (CAD vs. NCA; 3.8 +/- 1.2 10-3/kPa vs. 3.4 +/- 0.9 10-3/kPa, P = 0.092). Also, the c-statistic of the pre-test probability based on history and traditional risk factors (c = 0.665; 95% CI, 0.540-0.789) was improved by the addition of the inverse RHI (c = 0.720; 95% CI, 0.605-0.836), carotid plaque score (c = 0.770, 95% CI, 0.659-0.881), and of both markers in combination (c = 0.801; 95% CI, 0.701-0.900). Conclusion There are distinct differences in the systemic vasculature between patients with CAD and NCA that may have the potential to guide diagnostic and therapeutic decisions. Carotid artery plaque burden and microvascular function appear to be most promising in this context.	[Neisius, Ulf; Olson, Erin; Rossi, Sabrina H.; Ibrahim, Hagar A.; Currie, Gemma; Dominiczak, Anna F.; Delles, Christian] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Neisius, Ulf] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Cardiovasc Div, Boston, MA USA	University of Glasgow; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Delles, C (corresponding author), Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.	Christian.Delles@glasgow.ac.uk	Stefanadis, Christodoulos/ABH-2232-2020; Dominiczak, Anna F/P-9390-2017	Stefanadis, Christodoulos/0000-0001-5974-6454; Dominiczak, Anna F/0000-0003-4913-3608	European Union's Sixth Framework Programme Network of Excellence InGenious HyperCare; Seventh Framework Programme Collaborative Project EU-MASCARA; Seventh Framework Programme Collaborative Project HOMAGE; British Heart Foundation Centre of Excellence award [RE/13/5/30177]; National Institute for Health Research [ACF-2014-14-008] Funding Source: researchfish	European Union's Sixth Framework Programme Network of Excellence InGenious HyperCare; Seventh Framework Programme Collaborative Project EU-MASCARA; Seventh Framework Programme Collaborative Project HOMAGE; British Heart Foundation Centre of Excellence award; National Institute for Health Research(National Institute for Health Research (NIHR))	The study was supported by the European Unions Sixth Framework Programme Network of Excellence InGenious HyperCare (AFD), the Seventh Framework Programme Collaborative Projects EU-MASCARA and HOMAGE (CD) and the British Heart Foundation Centre of Excellence award RE/13/5/30177 (AFD). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fiadh AH, 2015, AM J CARDIOL, V115, P609, DOI 10.1016/j.amjcard.2014.12.011; Bonetti PO, 2004, J AM COLL CARDIOL, V44, P2137, DOI 10.1016/j.jacc.2004.08.062; Brook RD, 2006, ARTERIOSCL THROM VAS, V26, P656, DOI 10.1161/01.ATV.0000200079.18690.60; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Dzau VJ, 2006, CIRCULATION, V114, P2850, DOI 10.1161/CIRCULATIONAHA.106.655688; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; Genders TSS, 2011, EUR HEART J, V32, P1316, DOI 10.1093/eurheartj/ehr014; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; Hamburg NM, 2008, CIRCULATION, V117, P2467, DOI 10.1161/CIRCULATIONAHA.107.748574; Hollander M, 2002, CIRCULATION, V105, P2872, DOI 10.1161/01.CIR.0000018650.58984.75; Ikeda N, 2012, EUR HEART J, V33, P113, DOI 10.1093/eurheartj/ehr399; Inaba Y, 2012, ATHEROSCLEROSIS, V220, P128, DOI 10.1016/j.atherosclerosis.2011.06.044; Kallikazaros I, 1999, STROKE, V30, P1002, DOI 10.1161/01.STR.30.5.1002; Laurent S, 2015, EARLY VASCULAR AGING (EVA): NEW DIRECTIONS IN CARDIOVASCULAR PROTECTION, P105; Mancia G, 2007, BLOOD PRESSURE, V16, P135, DOI 10.1080/08037050701461084; Matsuo Y, 2012, ATHEROSCLEROSIS, V223, P365, DOI 10.1016/j.atherosclerosis.2012.05.023; Matsuzawa Y, 2015, CORONARY ARTERY DIS, V26, P231, DOI 10.1097/MCA.0000000000000208; Matsuzawa Y, 2010, J AM COLL CARDIOL, V55, P1688, DOI 10.1016/j.jacc.2009.10.073; Michelsen MM, 2016, JACC-CARDIOVASC IMAG, V9, P411, DOI 10.1016/j.jcmg.2016.02.005; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Neisius U, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0246-y; Pries AR, 2008, CARDIOVASC RES, V80, P165, DOI 10.1093/cvr/cvn136; PRYOR DB, 1991, AM J MED, V90, P553; PRYOR DB, 1993, ANN INTERN MED, V118, P81, DOI 10.7326/0003-4819-118-2-199301150-00001; Touboul PJ, 2007, CEREBROVASC DIS, V23, P75, DOI 10.1159/000097034; van der Meer IM, 2004, CIRCULATION, V109, P1089, DOI 10.1161/01.CIR.0000120708.59903.1B; Weissgerber A, 2016, CLIN RES CARDIOL, V105, P172, DOI 10.1007/s00392-015-0900-x; Westerhof BE, 2006, HYPERTENSION, V48, P595, DOI 10.1161/01.HYP.0000238330.08894.17	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178412	10.1371/journal.pone.0178412	http://dx.doi.org/10.1371/journal.pone.0178412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542516	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000402062800086
J	Schneeberger, PHH; Pothier, JF; Buhlmann, A; Duffy, B; Beuret, C; Utzinger, J; Frey, JE				Schneeberger, Pierre H. H.; Pothier, Joel F.; Buhlmann, Andreas; Duffy, Brion; Beuret, Christian; Utzinger, Jurg; Frey, Jurg E.			Development and evaluation of a bioinformatics approach for designing molecular assays for viral detection	PLOS ONE			English	Article							REAL-TIME PCR; USUTU-VIRUS; EPIDEMIOLOGY; HANTAVIRUS; INFECTION; DIAGNOSTICS; FLAVIVIRUS; EMERGENCE; ALIGNMENT; OUTBREAK	Background Viruses belonging to the Flaviviridae and Bunyaviridae families show considerable genetic diversity. However, this diversity is not necessarily taken into account when developing diagnostic assays, which are often based on the pairwise alignment of a limited number of sequences. Our objective was to develop and evaluate a bioinformatics workflow addressing two recurrent issues of molecular assay design: (i) the high intraspecies genetic diversity in viruses and (ii) the potential for cross-reactivity with close relatives. Methodology The workflow developed herein was based on two consecutive BLASTn steps; the first was utilized to select highly conserved regions among the viral taxon of interest, and the second was employed to assess the degree of similarity of these highly-conserved regions to close relatives. Subsequently, the workflow was tested on a set of eight viral species, including various strains from the Flaviviridae and Bunyaviridae families. Principal findings The genetic diversity ranges from as low as 0.45% variable sites over the complete genome of the Japanese encephalitis virus to more than 16% of variable sites on segment L of the Crimean-Congo hemorrhagic fever virus. Our proposed bioinformatics workflow allowed the selection-based on computing scores-of the best target for a diagnostic molecular assay for the eight viral species investigated. Conclusions/Significance Our bioinformatics workflow allowed rapid selection of highly conserved and specific genomic fragments among the investigated viruses, while considering up to several hundred complete genomic sequences. The pertinence of this workflow will increase in parallel to the number of sequences made publicly available. We hypothesize that our workflow might be utilized to select diagnostic molecular markers for higher organisms with more complex genomes, provided the sequences are made available.	[Schneeberger, Pierre H. H.; Frey, Jurg E.] Agroscope, Dept Methods Dev & Analyt, Wadenswil, Switzerland; [Schneeberger, Pierre H. H.; Beuret, Christian] Fed Off Civil Protect, Spiez Lab, Dept Virol, Spiez, Switzerland; [Schneeberger, Pierre H. H.; Utzinger, Jurg] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Schneeberger, Pierre H. H.; Utzinger, Jurg] Univ Basel, Basel, Switzerland; [Pothier, Joel F.; Duffy, Brion] Zurich Univ Appl Sci ZHAW, Inst Nat Resource Sci, Environm Genom & Syst Biol Res Grp, Wadenswil, Switzerland; [Buhlmann, Andreas] Agroscope, Inst Food Sci, Dept Foods Plant Origin, Wadenswil, Switzerland	Swiss Federal Research Station Agroscope; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Zurich University of Applied Sciences; Swiss Federal Research Station Agroscope	Schneeberger, PHH (corresponding author), Agroscope, Dept Methods Dev & Analyt, Wadenswil, Switzerland.; Schneeberger, PHH (corresponding author), Fed Off Civil Protect, Spiez Lab, Dept Virol, Spiez, Switzerland.; Schneeberger, PHH (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Schneeberger, PHH (corresponding author), Univ Basel, Basel, Switzerland.	pierre.schneeberger@unibas.ch	Pothier, Joël F./H-9344-2013	Pothier, Joël F./0000-0002-9604-7780; Schneeberger, Pierre/0000-0002-8586-4937	armasuisse project ARAMIS [2011/22-16 / 353003285]	armasuisse project ARAMIS	This work was supported by armasuisse project ARAMIS no. 2011/22-16 / 353003285. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Avise JC, 2012, MOLECULAR MARKERS NA; Beerenwinkel N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00329; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Burke DS, 2001, FIELDS VIROLOGY, P1043, DOI 10.1093/emboj/cdg270; Burt FJ, 2005, EPIDEMIOL INFECT, V133, P659, DOI 10.1017/S0950268805003730; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Fankhauser RL, 2002, J INFECT DIS, V186, P1, DOI 10.1086/341085; Ferreira AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112312; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Grobbelaar AA, 2011, EMERG INFECT DIS, V17, P2270, DOI 10.3201/eid1712.111035; Hartline J, 2013, AM J EMERG MED, V31, P978, DOI 10.1016/j.ajem.2013.02.001; Hujakka H, 2003, J VIROL METHODS, V108, P117, DOI 10.1016/S0166-0934(02)00282-3; Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5; Kopp A, 2013, MBIO, V4, DOI 10.1128/mBio.00322-13; LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI DOI 10.1093/BI0INF0RMATICS/BTM404; Leyssen P, 2000, CLIN MICROBIOL REV, V13, P67, DOI 10.1128/CMR.13.1.67-82.2000; Li DX, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.1; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; Montgomery JM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001840; Mulatti P, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-26; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Nikolay B, 2011, VECTOR-BORNE ZOONOT, V11, P1417, DOI 10.1089/vbz.2011.0631; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Petersen LR, 2012, NEW ENGL J MED, V367, P1281, DOI 10.1056/NEJMp1210537; Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; Roehr B, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6054; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schneeberger PHH, 2016, INFECT GENET EVOL, V40, P389, DOI 10.1016/j.meegid.2015.08.044; Sloan LM, 2008, J CLIN MICROBIOL, V46, P1996, DOI 10.1128/JCM.00032-08; Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Steinmetz HW, 2011, VET MICROBIOL, V148, P207, DOI 10.1016/j.vetmic.2010.09.018; Stephens ZD, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002195; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Belkum A, 2001, CLIN MICROBIOL REV, V14, P547, DOI 10.1128/CMR.14.3.547-560.2001; Vazquez A, 2011, EURO SURVEILL, V16; Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094; Wen HC, 2014, J CLIN MICROBIOL, V52, P3200, DOI 10.1128/JCM.00921-14	42	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178195	10.1371/journal.pone.0178195	http://dx.doi.org/10.1371/journal.pone.0178195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542435	Green Published, gold, Green Submitted			2022-12-26	WOS:000402062800051
J	Yeakley, JM; Shepard, PJ; Goyena, DE; VanSteenhouse, HC; McComb, JD; Seligmann, BE				Yeakley, Joanne M.; Shepard, Peter J.; Goyena, Diana E.; VanSteenhouse, Harper C.; McComb, Joel D.; Seligmann, Bruce E.			A trichostatin A expression signature identified by TempO-Seq targeted whole transcriptome profiling	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; GENE-EXPRESSION; DISCOVERY; MULTIPLEX	The use of gene expression signatures to classify compounds, identify efficacy or toxicity, and differentiate close analogs relies on the sensitivity of the method to identify modulated genes. We used a novel ligation-based targeted whole transcriptome expression profiling assay, TempO-Seq r, to determine whether previously unreported compound-responsive genes could be identified and incorporated into a broad but specific compound signature. TempO-Seq exhibits 99.6% specificity, single cell sensitivity, and excellent correlation with fold differences measured by RNA-Seq (R-2 = 0.9) for 20,629 targets. Unlike many expression assays, TempO-Seq does not require RNA purification, cDNA synthesis, or capture of targeted RNA, and lacks a 30 end bias. To investigate the sensitivity of the TempO-Seq assay to identify significantly modulated compound-responsive genes, we derived whole transcriptome profiles from MCF-7 cells treated with the histone deacetylase inhibitor Trichostatin A (TSA) and identified more than 9,000 differentially expressed genes. The TSA profile for MCF-7 cells overlapped those for HL-60 and PC-3 cells in the Connectivity Map (cMAP) database, suggesting a common TSA-specific expression profile independent of baseline gene expression. A 43-gene cell-independent TSA signature was extracted from cMAP and confirmed in TempO-Seq MCF-7 data. Additional genes that were not previously reported to be TSA responsive in the cMAP database were also identified. TSA treatment of 5 cell types revealed 1,136 differentially expressed genes in common, including 785 genes not previously reported to be TSA responsive. We conclude that TSA induces a specific expression signature that is consistent across widely different cell types, that this signature contains genes not previously associated with TSA responses, and that TempO-Seq provides the sensitive differential expression detection needed to define such compound-specific, cell-independent, changes in expression.	[Yeakley, Joanne M.; Shepard, Peter J.; Goyena, Diana E.; VanSteenhouse, Harper C.; McComb, Joel D.; Seligmann, Bruce E.] BioSpyder Technol Inc, Carlsbad, CA 92008 USA		Yeakley, JM (corresponding author), BioSpyder Technol Inc, Carlsbad, CA 92008 USA.	joyeakley@biospyder.com		VanSteenhouse, Harper/0000-0002-9401-5929	National Human Genome Research Institute, National Institutes of Health [R43HG007339, R44HG007815]; National Center for Advancing Translational Sciences, National Institutes of Health [HHSN271201300011C, HHSN271201400052C]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R44HG007339] Funding Source: NIH RePORTER	National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants R43HG007339 (JY) and R44HG007815 (JY) from the National Human Genome Research Institute, National Institutes of Health (https://www.genome.gov/), and by contracts HHSN271201300011C (JY) and HHSN271201400052C (JY) from the National Center for Advancing Translational Sciences, National Institutes of Health (http://ncats.nih.gov/).All authors are employed by BioSpyder Technologies, Inc. The funders provided support in the form of salaries for the authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bodi K, 2013, J Biomol Tech, V24, P73, DOI 10.7171/jbt.13-2402-002; Chen H, 2015, CANCERS, V7, P1699, DOI 10.3390/cancers7030859; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Foster WR, 2007, TOXICOL PATHOL, V35, P621, DOI 10.1080/01926230701419063; Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111; Johnson PH, 2002, MOL CANCER THER, V1, P1293; Johnson RL, 2008, ANAL BIOCHEM, V375, P237, DOI 10.1016/j.ab.2007.12.028; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Larman HB, 2014, NUCLEIC ACIDS RES, V42, P9146, DOI 10.1093/nar/gku636; Li Hairi, 2012, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0413s98; Li HR, 2012, P NATL ACAD SCI USA, V109, P4609, DOI 10.1073/pnas.1200305109; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; Micheva-Viteva S, 2011, J BIOL CHEM, V286, P21083, DOI 10.1074/jbc.M110.195537; Moore PS, 2004, BBA-MOL CELL RES, V1693, P167, DOI 10.1016/j.bbamcr.2004.07.001; Rau A, 2013, BIOINFORMATICS, V29, P2146, DOI 10.1093/bioinformatics/btt350; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson D., 2013, CANCER RES, V73, P4146, DOI [10.1158/1538-7445.am2013-4146, DOI 10.1158/1538-7445.AM2013-4146]; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	22	83	86	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178302	10.1371/journal.pone.0178302	http://dx.doi.org/10.1371/journal.pone.0178302			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542535	gold, Green Published, Green Submitted			2022-12-26	WOS:000402062800067
J	Kim, SJ; Cho, KJ; Oh, S				Kim, Seong Jae; Cho, Kyong Jin; Oh, Sejong			Development of machine learning models for diagnosis of glaucoma	PLOS ONE			English	Article							FIBER LAYER MEASUREMENTS; OPTICAL COHERENCE TOMOGRAPHY; DETECTION ABILITY; CLASSIFIERS; THICKNESS; MYOPIA; SENSITIVITY	The study aimed to develop machine learning models that have strong prediction power and interpretability for diagnosis of glaucoma based on retinal nerve fiber layer (RNFL) thickness and visual field (VF). We collected various candidate features from the examination of retinal nerve fiber layer (RNFL) thickness and visual field (VF). We also developed synthesized features from original features. We then selected the best features proper for classification (diagnosis) through feature evaluation. We used 100 cases of data as a test dataset and 399 cases of data as a training and validation dataset. To develop the glaucoma prediction model, we considered four machine learning algorithms: C5.0, random forest (RF), support vector machine (SVM), and k-nearest neighbor (KNN). We repeatedly composed a learning model using the training dataset and evaluated it by using the validation dataset. Finally, we got the best learning model that produces the highest validation accuracy. We analyzed quality of the models using several measures. The random forest model shows best performance and C5.0, SVM, and KNN models show similar accuracy. In the random forest model, the classification accuracy is 0.98, sensitivity is 0.983, specificity is 0.975, and AUC is 0.979. The developed prediction models show high accuracy, sensitivity, specificity, and AUC in classifying among glaucoma and healthy eyes. It will be used for predicting glaucoma against unknown examination records. Clinicians may reference the prediction results and be able to make better decisions. We may combine multiple learning models to increase prediction accuracy. The C5.0 model includes decision rules for prediction. It can be used to explain the reasons for specific predictions.	[Kim, Seong Jae] Gyeongsang Natl Univ, Coll Med, Dept Ophthalmol, Jinju, South Korea; [Cho, Kyong Jin] Dankook Univ, Coll Med, Dept Ophthalmol, Cheonan, South Korea; [Oh, Sejong] Dankook Univ, Dept Software Sci, Yongin, South Korea	Gyeongsang National University; Dankook University; Dankook University	Oh, S (corresponding author), Dankook Univ, Dept Software Sci, Yongin, South Korea.	sejongoh@dankook.ac.kr		Oh, Sejong/0000-0002-9365-274X	Dankook University	Dankook University	This study was conducted by the research fund of Dankook University in 2015.; This study was conducted by the research fund of Dankook University in 2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASMAN P, 1992, ARCH OPHTHALMOL-CHIC, V110, P812, DOI 10.1001/archopht.1992.01080180084033; Barella KA, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/789129; Bizios D, 2010, ACTA OPHTHALMOL, V88, P44, DOI 10.1111/j.1755-3768.2009.01784.x; Caruana Rich, 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865.[38]X; Chan KL, 2002, IEEE T BIO-MED ENG, V49, P963, DOI 10.1109/TBME.2002.802012; Choi YJ, 2013, INVEST OPHTH VIS SCI, V54, P2296, DOI 10.1167/iovs.12-10530; Dietterich T.G., 2002, HDB BRAIN THEORY NEU; Goldbaum MH, 2002, INVEST OPHTH VIS SCI, V43, P162; Kang SH, 2010, INVEST OPHTH VIS SCI, V51, P4075, DOI 10.1167/iovs.09-4737; Kotsiantis SB, 2007, FRONT ARTIF INTEL AP, V160, P3; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Leung CKS, 2006, INVEST OPHTH VIS SCI, V47, P5171, DOI 10.1167/iovs.06-0545; Liu B, 2016, BIOINFORMATICS, V32, P2411, DOI 10.1093/bioinformatics/btw186; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Ozdek SC, 2000, BRIT J OPHTHALMOL, V84, P264, DOI 10.1136/bjo.84.3.264; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Rauscher FM, 2009, J GLAUCOMA, V18, P501, DOI 10.1097/IJG.0b013e318193c2be; Seol BR, 2015, INVEST OPHTH VIS SCI, V56, P8306, DOI 10.1167/iovs.15-18141; Seong M, 2010, INVEST OPHTH VIS SCI, V51, P1446, DOI 10.1167/iovs.09-4258; Silva FR, 2013, ARQ BRAS OFTALMOL, V76, P170, DOI 10.1590/S0004-27492013000300008; Simundic AM, 2008, MED BIOL SCI, V22, P61; Tay E, 2005, AM J OPHTHALMOL, V139, P247, DOI 10.1016/j.ajo.2004.08.076; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192	25	98	104	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177726	10.1371/journal.pone.0177726	http://dx.doi.org/10.1371/journal.pone.0177726			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542342	Green Submitted, gold, Green Published			2022-12-26	WOS:000402058800024
J	Otsubo, Y; Hashimoto, K; Kanbe, T; Sumi, M; Moriuchi, H				Otsubo, Yoshikazu; Hashimoto, Kunio; Kanbe, Taro; Sumi, Muneichiro; Moriuchi, Hiroyuki			Association of cord blood chemokines and other biomarkers with neonatal complications following intrauterine inflammation	PLOS ONE			English	Article							RESPONSE SYNDROME; INTERLEUKIN-6; CYTOKINES; SEPSIS; RISK	Background Intrauterine inflammation has been associated with preterm birth and neonatal complications. Few reports have comprehensively investigated multiple cytokine profiles in cord blood and precisely identified surrogate markers for intrauterine inflammation. Aim To identify the cytokines and surrogate markers associated with intrauterine inflammation and subsequent neonatal complications. Patients and methods We analyzed cord blood samples from 135 patients admitted to the neonatal intensive care unit at Sasebo City General Hospital. We retrospectively determined the associations between the presence of neonatal complications and cord blood cytokines, prenatal factors, and laboratory data at birth. A total of 27 cytokines in the cord blood were measured using a bead-based array sandwich immunoassay. Results Both Th1 and Th2 cytokine levels were low, whereas the levels of growth factors and chemokines were high. In particular, chemokines IL-8, MCP-1, and MIP-1 alpha were significantly higher in very premature neonates when compared with more mature neonates. In addition, some have been shown to be associated with multiple neonatal complications, including patent ductus arteriosus (PDA), respiratory distress syndrome (RDS), and chronic lung disease (CLD). Similarly, the levels of N-terminal pro-brain natriuretic peptide, nucleated RBC, and urinary beta 2-microglobulin were associated with these complications and chemokine levels. Conclusions Our results suggest the association of inflammatory chemokines IL-8, MCP-1, and MIP-1 alpha with intrauterine inflammation, premature birth, and neonatal complications in these perinatal subjects. Furthermore, the association of the aforementioned biomarkers with PDA, RDS, and CLD may help establish early diagnostic measures to predict such neonatal complications following intrauterine inflammation.	[Otsubo, Yoshikazu; Kanbe, Taro; Sumi, Muneichiro] Sasebo City Gen Hosp, Dept Pediat, Sasebo, Nagasaki, Japan; [Otsubo, Yoshikazu; Hashimoto, Kunio; Moriuchi, Hiroyuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pediat, Nagasaki, Nagasaki, Japan	Nagasaki University	Otsubo, Y (corresponding author), Sasebo City Gen Hosp, Dept Pediat, Sasebo, Nagasaki, Japan.; Otsubo, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Pediat, Nagasaki, Nagasaki, Japan.	y-otsubo@hospital.sasebo.nagasaki.jp	Otsubo, Yoshikazu/I-7747-2019					Aukrust P, 1998, CIRCULATION, V97, P1136, DOI 10.1161/01.CIR.97.12.1136; Burns C, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00318; Dulay AT, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.040; Glezeva N, 2013, J CARDIOVASC TRANSL, V6, P545, DOI 10.1007/s12265-013-9456-1; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Gonzalez JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026877; Grisaru-Granovsky S, 2009, J CELL PHYSIOL, V218, P512, DOI 10.1002/jcp.21625; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Lahra MM, 2009, PEDIATRICS, V123, P1314, DOI 10.1542/peds.2008-0656; Lieberman E, 2000, PEDIATRICS, V105, P8, DOI 10.1542/peds.105.1.8; Ly Ngoc P, 2006, Clin Mol Allergy, V4, P13; Matoba N, 2009, PEDIATRICS, V123, P1320, DOI 10.1542/peds.2008-1222; Nishimaki S, 2009, J OBSTET GYNAECOL RE, V35, P472, DOI 10.1111/j.1447-0756.2008.00988.x; Oddie S, 2002, BRIT MED J, V325, P308, DOI 10.1136/bmj.325.7359.308; Otsubo Y, 2011, J JPN PEDIAT SOC, V115, p1543 ; Romero R, 2012, J PERINAT MED, V40, P19, DOI 10.1515/JPM.2011.100; Shah TA, 2010, PEDIATR RES, V68, P210, DOI 10.1203/00006450-201011001-00409; Takahashi N, 2010, CYTOKINE, V49, P331, DOI 10.1016/j.cyto.2009.11.024; Tutdibi E, 2012, J PERINAT MED, V40, P527, DOI 10.1515/jpm-2011-0204; Xia MD, 2009, EXPERT OPIN THER PAT, V19, P295, DOI 10.1517/13543770902755129; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P825, DOI 10.1016/S0002-9378(97)70276-X	21	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0175082	10.1371/journal.pone.0175082	http://dx.doi.org/10.1371/journal.pone.0175082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531215	Green Published, Green Submitted, gold			2022-12-26	WOS:000402058400001
J	Charkiewicz, K; Goscik, J; Blachnio-Zabielska, A; Raba, G; Sakowicz, A; Kalinka, J; Chabowski, A; Laudanski, P				Charkiewicz, Karol; Goscik, Joanna; Blachnio-Zabielska, Agnieszka; Raba, Grzegorz; Sakowicz, Agata; Kalinka, Jaroslaw; Chabowski, Adrian; Laudanski, Piotr			Sphingolipids as a new factor in the pathomechanism of preeclampsia - Mass spectrometry analysis	PLOS ONE			English	Article							CERAMIDE; PATHOPHYSIOLOGY; PROSTACYCLIN; METABOLISM	Objective(s) and design The aim of the study was to analyse a panel of 11 sphingolipids in plasma and three blood fractions (platelet-poor plasma, platelets and red blood cells) of women with mild preeclampsia. Materials and methods We recruited 21 women between 25-40 weeks gestation with diagnosed mild preeclampsia to the study group and 36 healthy women with uncomplicated pregnancies, who corresponded with the study group according to gestational age, to the control group. To assess the concentration of 11 sphingolipids in the blood plasma and blood fractions, we used ultra-high performance liquid chromatography coupled with triple quadrupole mass spectrometry (UHPLC/MS/MS). Results We showed a significant increase in the concentration of eight sphingolipids in the plasma of women with preeclampsia in comparison to the control group: Sph (p = 0.0032), S1P (p = 0.0289), C20-Cer (p < 0.0001), C18-Cer (p < 0.0001), C16-Cer (p = 0.012), C18: 1-Cer (p = 0.003), C22-Cer (p = 0.0071), and C24: 1-Cer (p = 0.0085). Conclusion We showed that selected sphingolipids, especially C20-Cer and C18-Cer, are totally new factors in the pathomechanism of PE and that these bioactive lipids may play an important role in apoptosis and autophagy.	[Charkiewicz, Karol; Laudanski, Piotr] Med Univ Bialystok, Dept Perinatol & Obstet, Bialystok, Poland; [Goscik, Joanna] Bialystok Tech Univ, Fac Comp Sci, Bialystok, Poland; [Blachnio-Zabielska, Agnieszka] Dept Hyg Epidemiol & Metab Disorders, Bialystok, Poland; [Blachnio-Zabielska, Agnieszka; Chabowski, Adrian] Med Univ Bialystok, Dept Physiol, Bialystok, Poland; [Raba, Grzegorz] Univ Rzeszow, Inst Obstet & Emergency Med, Zurawica, Podkarpackie, Poland; [Sakowicz, Agata] Med Univ Lodz, Dept Med Biotechnol, Lodz, Poland; [Kalinka, Jaroslaw] Med Univ Lodz, Dept Perinatol, Lodz, Poland	Medical University of Bialystok; Bialystok University of Technology; Medical University of Bialystok; University of Rzeszow; Medical University Lodz; Medical University Lodz	Laudanski, P (corresponding author), Med Univ Bialystok, Dept Perinatol & Obstet, Bialystok, Poland.	plauda@umb.edu.pl	Goscik, Joanna/S-6541-2018; Raba, Grzegorz/HGE-9974-2022; Chabowski, Adrian/T-2225-2018; Blachnio-Zabielsk, Agnieszka U/A-4879-2018	Goscik, Joanna/0000-0003-0433-6145; Chabowski, Adrian/0000-0002-7407-8156; Blachnio-Zabielsk, Agnieszka U/0000-0002-8055-0576; Raba, Grzegorz/0000-0002-9196-8548; Laudanski, Piotr/0000-0001-8955-8198; Kalinka, Jaroslaw/0000-0002-6956-4950; Sakowicz, Agata/0000-0002-5083-2046	National Science Centre, Poland [2015/19/N/NZ5/01434]; Leading National Scientific Center, Medical University of Bialystok, Poland [101/KNOW/2015, 36/KNOW/2013]; Polpharma Scientific Foundation	National Science Centre, Poland(National Science Centre, Poland); Leading National Scientific Center, Medical University of Bialystok, Poland; Polpharma Scientific Foundation	This work was supported by grant numbers: 2015/19/N/NZ5/01434 from National Science Centre, Poland and 101/KNOW/2015, 36/KNOW/2013 from The Leading National Scientific Center, Medical University of Bialystok, Poland. Study sponsored by a Polpharma Scientific Foundation.; This work was supported by grant numbers: 2015/19/N/NZ5/01434 from National Science Centre, Poland and 101/KNOW/2015, 36/KNOW/2013 from The Leading National Scientific Center, Medical University of Bialystok, Poland. Study sponsored by a Polpharma Scientific Foundation. The manuscript has undergone professional English editing by Elsevier editors. Details of ethics approval: The study protocol was approved by the Local Ethical Committee of Medical University of Bialystok, Poland, and an informed consent was obtained from each patient (no ethics committee approval: R-I-002/377/2016).	Anderson UD, 2012, PLACENTA, V33, pS42, DOI 10.1016/j.placenta.2011.11.021; Andraweera PH, 2017, REPROD BIOMED ONLINE; Berry C, 2001, AM J PHYSIOL-HEART C, V281, pH2337, DOI 10.1152/ajpheart.2001.281.6.H2337; Blachnio-Zabielska A, 2016, ADV MED SCI-POLAND, V61, P72, DOI 10.1016/j.advms.2015.09.006; Blachnio-Zabielska AU, 2012, RAPID COMMUN MASS SP, V26, P1134, DOI 10.1002/rcm.6216; Borodzicz S, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0053-y; Bounds Kelsey R, 2015, Front Cardiovasc Med, V2, P20, DOI 10.3389/fcvm.2015.00020; Carty DM, 2008, TRENDS CARDIOVAS MED, V18, P186, DOI 10.1016/j.tcm.2008.07.002; Carty DM, 2011, HYPERTENSION, V57, P561, DOI 10.1161/HYPERTENSIONAHA.110.164285; Charkiewicz K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127732; CHEN G, 1993, AM J OBSTET GYNECOL, V169, P1106, DOI 10.1016/0002-9378(93)90264-J; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Davison JM, 2004, J AM SOC NEPHROL, V15, P2440, DOI 10.1097/01.ASN.0000135975.90889.60; de Lima VJ, 2011, SAO PAULO MED J, V129, P73, DOI 10.1590/S1516-31802011000200004; Ermini Leonardo C I, 2013, MASS SPECTROMETRY IM, V34, pA10; Ganss R, 2017, TRENDS ENDOCRIN MET, V28, P73, DOI 10.1016/j.tem.2016.09.004; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hartmann D, 2012, INT J BIOCHEM CELL B, V44, P620, DOI 10.1016/j.biocel.2011.12.019; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Johnstone ED, 2005, J LIPID RES, V46, P1833, DOI 10.1194/jlr.M500095-JLR200; Kang Se-Chan, 2013, Front Endocrinol (Lausanne), V4, P67, DOI 10.3389/fendo.2013.00067; Kim SY, 2004, J KOREAN MED SCI, V19, P688, DOI 10.3346/jkms.2004.19.5.688; Kim Young Ju, 2013, Obstet Gynecol Sci, V56, P2, DOI 10.5468/OGS.2013.56.1.2; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; Koonen DPY, 2005, BBA-MOL CELL BIOL L, V1736, P163, DOI 10.1016/j.bbalip.2005.08.018; Laakso M., 2017, J LIPID RES; Laresgoiti-Servitje E, 2013, J LEUKOCYTE BIOL, V94, P247, DOI 10.1189/jlb.1112603; Laudanski P, 2016, PROSTAG OTH LIPID M, V123, P40, DOI 10.1016/j.prostaglandins.2016.04.005; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Lim MY, 2016, GUT; Liu HS, 1998, INT J GYNECOL OBSTET, V63, P1, DOI 10.1016/S0020-7292(98)00101-5; Melland-Smith M, 2015, AUTOPHAGY, V11, P653, DOI 10.1080/15548627.2015.1034414; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; NEIGER R, 1992, AM J PERINAT, V9, P378, DOI 10.1055/s-2007-999269; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Romanowicz L, 2010, PATHOBIOLOGY, V77, P78, DOI 10.1159/000278289; Romanowicz L, 2009, CLIN BIOCHEM, V42, P1719, DOI 10.1016/j.clinbiochem.2009.07.011; Seki N., 2013, PHARM PHARM, V4, P628, DOI DOI 10.4236/PP.2013.48089; SHAPIRO SS, 1965, ANAL VARIANCE TEST N; Siddiqui IA, 2014, ANN MED HEALTH SCI R, V4, P638, DOI 10.4103/2141-9248.139358; Sigruener A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085724; Soleymanlou N, 2005, J CLIN ENDOCR METAB, V90, P4299, DOI 10.1210/jc.2005-0078; Spijkers LJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021817; Thadhani R, 2004, J CLIN ENDOCR METAB, V89, P770, DOI 10.1210/jc.2003-031244; Vargas-Rojas MI, 2016, J MATERN-FETAL NEO M, V29, P1642, DOI 10.3109/14767058.2015.1057811; Wetzka B, 1997, HUM REPROD, V12, P2313, DOI 10.1093/humrep/12.10.2313; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yang J, 2004, CELL BIOCHEM BIOPHYS, V40, P323, DOI 10.1385/CBB:40:3:323; Yogi A, 2011, HYPERTENSION, V57, P809, DOI 10.1161/HYPERTENSIONAHA.110.162719; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Young MM, 2013, J LIPID RES, V54, P5, DOI 10.1194/jlr.R031278	52	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177601	10.1371/journal.pone.0177601	http://dx.doi.org/10.1371/journal.pone.0177601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542236	Green Submitted, gold, Green Published			2022-12-26	WOS:000401672600018
J	Pugazhendhi, S; Baskaran, K; Santhanam, S; Ramakrishna, BS				Pugazhendhi, Srinivasan; Baskaran, Kirankumar; Santhanam, Srikanth; Ramakrishna, Balakrishnan S.			Association of ATG16L1 gene haplotype with inflammatory bowel disease in Indians	PLOS ONE			English	Article							CROHNS-DISEASE; GASTROENTEROLOGY CONSENSUS; ULCERATIVE-COLITIS; ADAPTIVE IMMUNITY; SUSCEPTIBILITY; IL23R; POPULATION; NOD2; AUTOPHAGY; VARIANTS	Inflammatory bowel disease (IBD) is characterized by multigenic inheritance. Defects in autophagy related genes are considered to show genetic heterogeneity between populations. We evaluated the association of several single nucleotide polymorphisms (SNPs) in the autophagy related 16 like 1 (ATG16L1) gene with IBD in Indians. The ATG16L1 gene was genotyped for ten different SNPs using DNA extracted from peripheral blood of 234 patients with Crohn's disease (CD), 249 patients with ulcerative colitis (UC) and 393 healthy controls The SNPs rs2241880, rs4663396, rs3792106, rs10210302, rs3792109, rs2241877, rs6737398, rs11682898, rs4663402 and rs4663421 were genotyped using the Sequenom MassArray platform. PLINK was used for the association analysis and pairwise linkage disequilibrium (LD) values. Haplotype analysis was done using Haploview. All SNPs were in Hardy Weinberg equilibrium in cases and controls. The G allele at rs6737398 exhibited a protective association with both CD and UC. The T allele at rs4663402 and C allele at rs4663421 were positively associated with CD and UC. The T allele at rs2241877 exhibited protective association with UC only. The AA genotype at rs4663402 and the GG genotype at rs4663421 were protectively associated with both CD and UC. Haplotype analysis revealed that all the SNPs in tight LD (D' = 0.76-1.0) and organized in a single haplotype block. Haplotype D was positively associated with IBD (P = 5.8 x 10(-6) for CD and 0.002 for UC). SNPs in ATG16L1 were associated with IBD in Indian patients. The relevance to management of individual patients requires further study.	[Pugazhendhi, Srinivasan; Baskaran, Kirankumar; Santhanam, Srikanth; Ramakrishna, Balakrishnan S.] Christian Med Coll & Hosp, Wellcome Trust Res Lab, Vellore, Tamil Nadu, India; [Pugazhendhi, Srinivasan] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; [Ramakrishna, Balakrishnan S.] SRM Inst Med Sci, Madras, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore; University of Kansas; University of Kansas Medical Center; SRM Institute of Science & Technology Chennai	Ramakrishna, BS (corresponding author), Christian Med Coll & Hosp, Wellcome Trust Res Lab, Vellore, Tamil Nadu, India.; Ramakrishna, BS (corresponding author), SRM Inst Med Sci, Madras, Tamil Nadu, India.	wurama@hotmail.com	Ramakrishna, Balakrishnan/D-6808-2015; Srinivasan, Pugazhendhi/M-5184-2019	Srinivasan, Pugazhendhi/0000-0002-1748-1416; Ramakrishna, Balakrishnan/0000-0001-5090-9501				Baptista ML, 2008, INFLAMM BOWEL DIS, V14, P674, DOI 10.1002/ibd.20372; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baskaran K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114665; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Csongei V, 2010, WORLD J GASTROENTERO, V16, P176, DOI 10.3748/wjg.v16.i2.176; Cummings JRF, 2007, INFLAMM BOWEL DIS, V13, P941, DOI 10.1002/ibd.20162; de Souza HSP, 2016, NAT REV GASTRO HEPAT, V13, P13, DOI [10.1038/nrgastro.2016.186, 10.1038/nrgastro.2015.186]; Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Fowler EV, 2008, AM J GASTROENTEROL, V103, P2519, DOI 10.1111/j.1572-0241.2008.02023.x; Glas J, 2008, AM J GASTROENTEROL, V103, P682, DOI 10.1111/j.1572-0241.2007.01694.x; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Lakatos PL, 2008, DIGEST LIVER DIS, V40, P867, DOI 10.1016/j.dld.2008.03.022; Lappalainen M, 2008, INFLAMM BOWEL DIS, V14, P1118, DOI 10.1002/ibd.20431; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; McGovern DPB, 2015, GASTROENTEROLOGY, V149, P1163, DOI 10.1053/j.gastro.2015.08.001; Munz C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00009; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Okazaki T, 2008, INFLAMM BOWEL DIS, V14, P1528, DOI 10.1002/ibd.20512; Palomino-Morales RJ, 2009, GENES IMMUN, V10, P356, DOI 10.1038/gene.2009.25; Perricone C, 2008, GASTROENTEROLOGY, V134, P368, DOI 10.1053/j.gastro.2007.11.017; Peter I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-63; Prescott NJ, 2007, GASTROENTEROLOGY, V132, P1665, DOI 10.1053/j.gastro.2007.03.034; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramakrishna BS, 2015, INDIAN J GASTROENTER, V34, P3, DOI 10.1007/s12664-015-0539-6; Ramakrishna BS, 2012, INDIAN J GASTROENTER, V31, P307, DOI 10.1007/s12664-012-0259-0; Roberts RL, 2007, AM J GASTROENTEROL, V102, P2754, DOI 10.1111/j.1572-0241.2007.01525.x; Sadabad MS, 2015, GUT, V64, P1546, DOI 10.1136/gutjnl-2014-307289; Schmid D, 2006, J MOL MED-JMM, V84, P194, DOI 10.1007/s00109-005-0014-4; Sventoraityte J, 2010, WORLD J GASTROENTERO, V16, P359, DOI 10.3748/wjg.v16.i3.359; Van Limbergen J, 2013, GUT, V62, P331, DOI 10.1136/gutjnl-2012-303165; Walker DG, 2011, GUT, V60, pA223, DOI 10.1136/gut.2011.239301.470; Weersma RK, 2008, AM J GASTROENTEROL, V103, P621, DOI 10.1111/j.1572-0241.2007.01660.x; Yamazaki K, 2007, J HUM GENET, V52, P575, DOI 10.1007/s10038-007-0156-z; Yang SK, 2009, INFLAMM BOWEL DIS, V15, P1385, DOI 10.1002/ibd.20921; Zhang J, 2014, SCAND J GASTROENTERO, V49, P1201, DOI 10.3109/00365521.2014.936031; Zhi Jia, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P649	41	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178291	10.1371/journal.pone.0178291	http://dx.doi.org/10.1371/journal.pone.0178291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542425	gold, Green Published, Green Submitted			2022-12-26	WOS:000401672600049
J	Bianchi, E; Boekelheide, K; Sigman, M; Hall, SJ; Hwang, K				Bianchi, Enrica; Boekelheide, Kim; Sigman, Mark; Hall, Susan J.; Hwang, Kathleen			Ghrelin modulates testicular damage in a cryptorchid mouse model	PLOS ONE			English	Article							GERM-CELL APOPTOSIS; HORMONE SECRETAGOGUE RECEPTOR; HUMAN TESTIS; HEAT-STRESS; EXPRESSION; TEMPERATURE; SPERMATOGENESIS; SPERMATOCYTES; HYPERTHERMIA; GONADOTROPIN	Cryptorchidism or undescended testis (UDT) is a common congenital abnormality associated with increased risk for developing male infertility and testicular cancer. This study elucidated the effects of endogenous ghrelin or growth hormone secretagogue receptor (GHSR) deletion on mouse reproductive performance and evaluated the ability of ghrelin to prevent testicular damage in a surgical cryptorchid mouse model. Reciprocal matings with heterozygous/homozygous ghrelin and GHSR knockout mice were performed. Litter size and germ cell apoptosis were recorded and testicular histological evaluations were performed. Wild type and GHSR knockout adult mice were subjected to creation of unilateral surgical cryptorchidism that is a model of heat-induced germ cell death. All mice were randomly separated into two groups: treatment with ghrelin or with saline. To assess testicular damage, the following endpoints were evaluated: testis weight, seminiferous tubule diameter, percentage of seminiferous tubules with spermatids and with multinucleated giant cells. Our findings indicated that endogenous ghrelin deletion altered male fertility. Moreover, ghrelin treatment ameliorated the testicular weight changes caused by surgically induced cryptorchidism. Testicular histopathology revealed a significant preservation of spermatogenesis and seminiferous tubule diameter in the ghrelin-treated cryptorchid testes of GHSR KO mice, suggesting that this protective effect of ghrelin was mediated by an unknown mechanism. In conclusion, ghrelin therapy could be useful to suppress testicular damage induced by hyperthermia, and future investigations will focus on the underlying mechanisms by which ghrelin mitigates testicular damage.	[Bianchi, Enrica; Sigman, Mark; Hwang, Kathleen] Rhode Isl Hosp, Div Urol, Providence, RI 02903 USA; [Bianchi, Enrica; Boekelheide, Kim; Sigman, Mark; Hall, Susan J.; Hwang, Kathleen] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Hwang, K (corresponding author), Rhode Isl Hosp, Div Urol, Providence, RI 02903 USA.; Hwang, K (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.	Kathleen_Hwang@brown.edu	Sigman, Mark/P-3343-2019; Hwang, Kathleen/ABE-1339-2021	Bianchi, Enrica/0000-0002-8135-9730	Lifespan Hospital Research Fund; Krishnamurthi Endowment Fund	Lifespan Hospital Research Fund; Krishnamurthi Endowment Fund	This work was supported by Lifespan Hospital Research Fund and Krishnamurthi Endowment Fund.	Agoulnik AI, 2012, METHODS MOL BIOL, V825, P127, DOI 10.1007/978-1-61779-436-0_11; ALLAN DJ, 1992, CELL PROLIFERAT, V25, P241, DOI 10.1111/j.1365-2184.1992.tb01399.x; Arakawa Y, 2004, BIOMED RES-TOKYO, V25, P245, DOI 10.2220/biomedres.25.245; Barqawi A, 2004, ASIAN J ANDROL, V6, P47; Barreiro ML, 2004, MOL CELL ENDOCRINOL, V226, P1, DOI 10.1016/j.mce.2004.07.015; Barreiro ML, 2003, BIOL REPROD, V68, P1631, DOI 10.1095/biolreprod.102.008862; Barreiro ML, 2002, BIOL REPROD, V67, P1768, DOI 10.1095/biolreprod.102.006965; BARTKE A, 1995, ENDOCRINOLOGY, V136, P3, DOI 10.1210/en.136.1.3; BEAVER JP, 1995, EUR J CELL BIOL, V68, P47; Bianchi E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153968; Bianchi E, 2016, J SURG RES, V201, P226, DOI 10.1016/j.jss.2015.10.044; BILLIG H, 1995, ENDOCRINOLOGY, V136, P5, DOI 10.1210/en.136.1.5; Blanchard KT, 1996, TOXICOL APPL PHARM, V137, P141, DOI 10.1006/taap.1996.0066; Cataldo L, 1997, EXP CELL RES, V231, P206, DOI 10.1006/excr.1996.3447; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; De Ambrogi Marco, 2003, Med Sci Monit, V9, pRA217; Dong MH, 2006, CURR OPIN GASTROEN, V22, P599, DOI 10.1097/01.mog.0000245540.87784.75; Dundar M, 2005, PATHOL ONCOL RES, V11, P170; Feng HL, 1999, FERTIL STERIL, V71, P85, DOI 10.1016/S0015-0282(98)00401-4; Ferguson Lydia, 2013, Front Endocrinol (Lausanne), V4, P32, DOI 10.3389/fendo.2013.00032; Gaytan F, 2004, J CLIN ENDOCR METAB, V89, P400, DOI 10.1210/jc.2003-031375; Granado M, 2009, MOL CELL ENDOCRINOL, V309, P67, DOI 10.1016/j.mce.2009.06.006; Granata R, 2007, ENDOCRINOLOGY, V148, P512, DOI 10.1210/en.2006-0266; Green M. C., 1991, HDB GENETICALLY STAN; Heiskanen P, 1996, PEDIATR RES, V40, P351, DOI 10.1203/00006450-199608000-00026; Hikim APS, 2003, J STEROID BIOCHEM, V85, P175, DOI 10.1016/S0960-0760(03)00193-6; Hikim APS, 2003, ENDOCRINOLOGY, V144, P3167, DOI 10.1210/en.2003-0175; Huang CX, 2009, PEPTIDES, V30, P2286, DOI 10.1016/j.peptides.2009.09.004; Ikeda M, 1999, BIOL REPROD, V61, P393, DOI 10.1095/biolreprod61.2.393; Ilhan T, 2013, BIOTECH HISTOCHEM, V88, P10, DOI 10.3109/10520295.2012.724083; Ishikawa T, 2005, J ANDROL, V26, P281; Kheradmand A, 2009, ANDROLOGIA, V41, P335, DOI 10.1111/j.1439-0272.2009.00932.x; Kheradmand A, 2014, J PEDIATR SURG, V49, P593, DOI 10.1016/j.jpedsurg.2013.10.003; Kheradmand A, 2012, TISSUE CELL, V44, P308, DOI 10.1016/j.tice.2012.04.009; Kim MS, 2004, MOL ENDOCRINOL, V18, P2291, DOI 10.1210/me.2003-0459; Klonisch T, 2004, DEV BIOL, V270, P1, DOI 10.1016/j.ydbio.2004.02.018; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2001, TRENDS ENDOCRIN MET, V12, P118, DOI 10.1016/S1043-2760(00)00362-3; KORMANO M, 1967, J REPROD FERTIL, V14, P427; Kumar V, 2011, J ANDROL, V33, P114, DOI 10.2164/jandrol.110.011320; Li Y, 2009, J ANDROL, V30, P325, DOI 10.2164/jandrol.108.005934; Lin WW, 1997, FERTIL STERIL, V68, P1065, DOI 10.1016/S0015-0282(97)00372-5; Liu F, 2012, TISSUE CELL, V44, P281, DOI 10.1016/j.tice.2012.04.005; Liu KY, 2011, CELL PHYSIOL BIOCHEM, V27, P613, DOI 10.1159/000329983; Liu K, 2009, REGUL PEPTIDES, V155, P62, DOI 10.1016/j.regpep.2009.03.003; Lue YH, 2002, J ANDROL, V23, P799; Matsuki S, 2003, BIOCHEM BIOPH RES CO, V312, P843, DOI 10.1016/j.bbrc.2003.10.191; McKee KK, 1997, MOL ENDOCRINOL, V11, P415, DOI 10.1210/me.11.4.415; Miller DW, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-60; Morgentaler A, 1999, J ANDROL, V20, P189; Nagaya N, 2003, REGUL PEPTIDES, V114, P71, DOI 10.1016/S0167-0115(03)00117-4; NAKAMURA M, 1987, ARCH ANDROLOGY, V19, P127, DOI 10.3109/01485018708986808; NISHIMUNE Y, 1978, FERTIL STERIL, V29, P95; Perez-Crespo M, 2008, MOL REPROD DEV, V75, P40, DOI 10.1002/mrd.20759; Rasoulpour RJ, 2003, AM J PATHOL, V163, P2595, DOI 10.1016/S0002-9440(10)63614-0; Richburg JH, 1996, TOXICOL APPL PHARM, V137, P42, DOI 10.1006/taap.1996.0055; SHIKONE T, 1994, BIOL REPROD, V51, P865, DOI 10.1095/biolreprod51.5.865; Sirotkin AV, 2008, DOMEST ANIM ENDOCRIN, V34, P125, DOI 10.1016/j.domaniend.2006.11.005; Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Taati M, 2012, J PHYSIOL BIOCHEM, V68, P91, DOI 10.1007/s13105-011-0122-2; Tena-Sempere M, 2005, J Endocrinol Invest, V28, P26; Tena-Sempere M, 2002, ENDOCRINOLOGY, V143, P717, DOI 10.1210/en.143.2.717; van Brakel J, 2015, ANDROLOGY-US, V3, P888, DOI 10.1111/andr.12070; Wang W, 2010, REGUL PEPTIDES, V161, P43, DOI 10.1016/j.regpep.2009.12.017; Wierup N, 2002, REGUL PEPTIDES, V107, P63, DOI 10.1016/S0167-0115(02)00067-8; Yao P, 2007, FOOD CHEM TOXICOL, V45, P1333, DOI 10.1016/j.fct.2007.01.016; Yin YZ, 1998, BIOL REPROD, V58, P492, DOI 10.1095/biolreprod58.2.492	68	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177995	10.1371/journal.pone.0177995	http://dx.doi.org/10.1371/journal.pone.0177995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542403	gold, Green Published, Green Submitted			2022-12-26	WOS:000401672400128
J	Osigus, HJ; Eitel, M; Schierwater, B				Osigus, Hans-Juergen; Eitel, Michael; Schierwater, Bernd			Deep RNA sequencing reveals the smallest known mitochondrial micro exon in animals: The placozoan cox1 single base pair exon	PLOS ONE			English	Article							GENOME; EVOLUTION; DNA; ORGANIZATION; INTRONS; MTDNA	The phylum Placozoa holds a key position for our understanding of the evolution of mitochondrial genomes in Metazoa. Placozoans possess large mitochondrial genomes which harbor several remarkable characteristics such as a fragmented cox1 gene and trans-splicing cox1 introns. A previous study also suggested the existence of cox1 mRNA editing in Trichoplax adhaerens, yet the only formally described species in the phylum Placozoa. We have analyzed RNA-seq data of the undescribed sister species, Placozoa sp. H2 ("Panama" clone), with special focus on the mitochondrial mRNA. While we did not find support for a previously postulated cox1 mRNA editing mechanism, we surprisingly found two independent transcripts representing intermediate cox1 mRNA splicing stages. Both transcripts consist of partial cox1 exon as well as overlapping intron fragments. The data suggest that the cox1 gene harbors a single base pair (cytosine) micro exon. Furthermore, conserved group I intron structures flank this unique micro exon also in other placozoans. We discuss the evolutionary origin of this micro exon in the context of a self-splicing intron gain in the cox1 gene of the last common ancestor of extant placozoans.	[Osigus, Hans-Juergen; Eitel, Michael; Schierwater, Bernd] Univ Vet Med Hannover, Ecol & Evolut, ITZ, Hannover, Germany; [Schierwater, Bernd] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Schierwater, Bernd] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Schierwater, Bernd] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Eitel, Michael] Ludwig Maximilians Univ Munchen, Dept Earth & Environm Sci, Paleontol & Geobiol, Munich, Germany	University of Veterinary Medicine Hannover, Foundation; Yale University; American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); University of Munich	Osigus, HJ (corresponding author), Univ Vet Med Hannover, Ecol & Evolut, ITZ, Hannover, Germany.	h.j.osigus@ecolevol.de			Studienstiftung des deutschen Volkes; Deutsche Forschungsgemeinschaft [Schi 277/26-1, 29-1]	Studienstiftung des deutschen Volkes; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	HJO acknowledges a doctoral fellowship of the Studienstiftung des deutschen Volkes. This project has been funded by the Deutsche Forschungsgemeinschaft (Schi 277/26-1 & 29-1), http/www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; HJO acknowledges a doctoral fellowship of the Studienstiftung des deutschen Volkes. We would like to thank C. Heffelfinger, M. Moreno and S. L. Dellaporta for help and support.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P328, DOI 10.1016/j.ympev.2012.10.020; Breton S, 2014, TRENDS GENET, V30, P555, DOI 10.1016/j.tig.2014.09.002; Burger G, 2003, P NATL ACAD SCI USA, V100, P892, DOI 10.1073/pnas.0336115100; Burger G, 2009, TRENDS GENET, V25, P381, DOI 10.1016/j.tig.2009.07.003; Collins AG, 2005, INTEGR COMP BIOL, V45, P585, DOI 10.1093/icb/45.4.585; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; DeSalle R, 2017, FRONT BIOSCI-LANDMRK, V22, P873, DOI 10.2741/4522; Eitel M, 2010, MOL ECOL, V19, P2315, DOI 10.1111/j.1365-294X.2010.04617.x; Eitel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057131; Feindt W, 2016, MITOCHONDRIAL DNA B, V1, P574, DOI 10.1080/23802359.2016.1192510; Feindt W, 2016, MITOCHONDRIAL DNA B, V1, P497, DOI 10.1080/23802359.2016.1192504; Guo L, 2015, SCI REP-UK, V5, DOI 10.1038/srep18087; Herzog R, 2016, MITOCHONDRIAL DNA B, V1, P783, DOI 10.1080/23802359.2016.1186523; Irimia M, 2014, CELL, V159, P1511, DOI 10.1016/j.cell.2014.11.035; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kayal E, 2012, GENOME BIOL EVOL, V4, P1, DOI 10.1093/gbe/evr123; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Lavrov DV, 2007, INTEGR COMP BIOL, V47, P734, DOI 10.1093/icb/icm045; Lavrov DV, 2016, GENOME BIOL EVOL, V8, P2896, DOI 10.1093/gbe/evw195; Lavrov DV, 2013, MOL BIOL EVOL, V30, P865, DOI 10.1093/molbev/mss274; Li YI, 2015, GENOME RES, V25, P1, DOI 10.1101/gr.181990.114; Miyazawa H, 2012, ZOOL SCI, V29, P223, DOI 10.2108/zsj.29.223; Osigus HJ, 2013, MOL PHYLOGENET EVOL, V69, P339, DOI 10.1016/j.ympev.2013.07.016; Osigus HJ, 2013, MOL PHYLOGENET EVOL, V66, P551, DOI 10.1016/j.ympev.2012.05.028; Pett W, 2011, MITOCHONDR DNA, V22, P130, DOI 10.3109/19401736.2011.624611; SCHIERWATER B, 1991, J EXP ZOOL, V260, P413, DOI 10.1002/jez.1402600316; Schierwater B, 2005, BIOESSAYS, V27, P1294, DOI 10.1002/bies.20320; Schierwater B, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00005; Schierwater B, 2009, PLOS BIOL, V7, P36, DOI 10.1371/journal.pbio.1000020; Schuster A, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0928-9; Shao RF, 2012, GENOME BIOL EVOL, V4, P1088, DOI 10.1093/gbe/evs088; Signorovitch AY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030013; Xavier BB, 2012, FUNGAL BIOL-UK, V116, P802, DOI 10.1016/j.funbio.2012.04.013	35	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177959	10.1371/journal.pone.0177959	http://dx.doi.org/10.1371/journal.pone.0177959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542197	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400121
J	Piatek, MJ; Henderson, V; Fearn, A; Chaudhry, B; Werner, A				Piatek, Monica J.; Henderson, Victoria; Fearn, Amy; Chaudhry, Bill; Werner, Andreas			Ectopically expressed Slc34a2a sense-antisense transcripts cause a cerebellar phenotype in zebrafish embryos depending on RNA complementarity and Dicer	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; SODIUM-PHOSPHATE COTRANSPORTER; GENE-EXPRESSION; NONCODING RNAS; INJECTION; IDENTIFICATION; INTERFERENCE; SUPPRESSOR; DEFECTS; PROTEIN	Natural antisense transcripts (NATs) are complementary to protein coding genes and potentially regulate their expression. Despite widespread occurrence of NATs in the genomes of higher eukaryotes, their biological role and mechanism of action is poorly understood. Zebrafish embryos offer a unique model system to study sense-antisense transcript interplay at whole organism level. Here, we investigate putative antisense transcript-mediated mechanisms by ectopically co-expressing the complementary transcripts during early zebrafish development. In zebrafish the gene Slc34a2a (Na-phosphate transporter) is bi-directionally transcribed, the NAT predominantly during early development up to 48 hours after fertilization. Declining levels of the NAT, Slc34a2a(as), coincide with an increase of the sense transcript. At that time, sense and antisense transcripts co-localize in the endoderm at near equal amounts. Ectopic expression of the sense transcript during embryogenesis leads to specific failure to develop a cerebellum. The defect is RNA-mediated and dependent on sense-antisense complementarity. Overexpression of a Slc34a2a paralogue (Slc34a2b) or the NAT itself had no phenotypic consequences. Knockdown of Dicer rescued the brain defect suggesting that RNA interference is required to mediate the phenotype. Our results corroborate previous reports of Slc34a2a-related endo-siRNAs in two days old zebrafish embryos and emphasize the importance of coordinated expression of sense-antisense transcripts. Our findings suggest that RNAi is involved in gene regulation by certain natural antisense RNAs.	[Piatek, Monica J.; Henderson, Victoria; Fearn, Amy; Werner, Andreas] Newcastle Univ, Inst Cell & Mol Biosci, RNA Interest Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Chaudhry, Bill] Newcastle Univ, Int Ctr Life, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Werner, A (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, RNA Interest Grp, Newcastle Upon Tyne, Tyne & Wear, England.	andreas.werner@ncl.ac.uk			British Heart Foundation [PG/15/58/31611] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Andrews OE, 2014, SCI REP-UK, V4, DOI 10.1038/srep05222; [Anonymous], 2005, HIGH THROUGHPUT EXPR; Beiter T, 2009, CELL MOL LIFE SCI, V66, P94, DOI 10.1007/s00018-008-8381-y; Brand M, 1995, THE ZEBRAFISH SCIENC, V3, P2; Carlile M, 2008, PHYSIOL GENOMICS, V34, P95, DOI 10.1152/physiolgenomics.00004.2008; Carlile M, 2009, NUCLEIC ACIDS RES, V37, P2274, DOI 10.1093/nar/gkp088; Casadei R, 2011, GENE EXPR PATTERNS, V11, P271, DOI 10.1016/j.gep.2011.01.003; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; D'Aniello E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003689; Danesin C, 2009, DEV CELL, V16, P576, DOI 10.1016/j.devcel.2009.03.007; Echeverri K, 2007, DEV BIOL, V301, P388, DOI 10.1016/j.ydbio.2006.10.003; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Faghihi MA, 2009, NAT REV MOL CELL BIO, P10; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Faghihi MA, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r38; FJOSE A, 1992, MECH DEVELOP, V39, P51, DOI 10.1016/0925-4773(92)90025-F; Graham C, 2003, AM J PHYSIOL-RENAL, V284, pF727, DOI 10.1152/ajprenal.00356.2002; Gullerova M, 2012, NAT STRUCT MOL BIOL, V19, P1193, DOI 10.1038/nsmb.2392; Holder N, 1999, METH MOL B, V97, P487, DOI 10.1385/1-59259-270-8:487; Jin JM, 2014, METHODS MOL BIOL, V1173, P99, DOI 10.1007/978-1-4939-0931-5_9; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kelly A, 2011, BRIEF FUNCT GENOMICS, V10, P189, DOI 10.1093/bfgp/elr014; Khorkova O, 2014, HUM MOL GENET, V23, pR54, DOI 10.1093/hmg/ddu207; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kiyosawa H, 2003, GENOME RES, V13, P1324, DOI 10.1101/gr.982903; Lepoivre C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-914; Li YX, 2000, DEV BIOL, V217, P394, DOI 10.1006/dbio.1999.9540; Ling KH, 2016, GENOMICS, V107, P88, DOI 10.1016/j.ygeno.2016.01.006; Lopez P, 2016, MOL CELL BIOL, V36, P1480, DOI 10.1128/MCB.01096-15; Molder T, 2016, BIOTECHNIQUES, V61, P61, DOI 10.2144/000114441; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; Nalbant P, 1999, J PHYSIOL-LONDON, V520, P79, DOI 10.1111/j.1469-7793.1999.00079.x; Nusslein-Volhard Christiane, 2002, GREAT CLARENDON STRE; Oates AC, 2000, DEV BIOL, V224, P20, DOI 10.1006/dbio.2000.9761; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Piatek MJ, 2016, GENOMICS; Portal MM, 2015, NAT STRUCT MOL BIOL, V22, P89, DOI 10.1038/nsmb.2934; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Soumillon M, 2013, CELL REP, V3, P2179, DOI 10.1016/j.celrep.2013.05.031; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Tufarelli C, 2001, GENOMICS, V71, P307, DOI 10.1006/geno.2000.6394; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; Wagner CA, 2014, PFLUG ARCH EUR J PHY, V466, P139, DOI 10.1007/s00424-013-1418-6; Wang QQ, 2004, MICROBIOL MOL BIOL R, V68, P432, DOI 10.1128/MMBR.68.3.432-452.2004; Weinberg MS, 2016, NUCLEIC ACIDS RES, V44, P6505, DOI 10.1093/nar/gkw139; Werner A, 2001, AM J PHYSIOL-REG I, V280, pR301, DOI 10.1152/ajpregu.2001.280.2.R301; Werner A, 2007, PHYSIOL GENOMICS, V28, P294, DOI 10.1152/physiolgenomics.00127.2006; Werner A, 2009, RNA BIOL, V6, P43, DOI 10.4161/rna.6.1.7568; Westerfield M, 1993, ZEBRAFISH BOOK; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Yamanaka Y, 2015, CELL REP, V11, P967, DOI 10.1016/j.celrep.2015.04.011; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhao XF, 2008, FEBS J, V275, P2177, DOI 10.1111/j.1742-4658.2008.06371.x; Zhao ZX, 2001, DEV BIOL, V229, P215, DOI 10.1006/dbio.2000.9982; Zimmermann C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107023; Zucchelli S, 2015, RNA BIOL, V12, P771, DOI 10.1080/15476286.2015.1060395	58	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178219	10.1371/journal.pone.0178219	http://dx.doi.org/10.1371/journal.pone.0178219			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542524	Green Submitted, gold, Green Published			2022-12-26	WOS:000401672400145
J	Ullah, R; Khan, S; Ali, H; Bilal, M; Saleem, M				Ullah, Rahat; Khan, Saranjam; Ali, Hina; Bilal, Muhammad; Saleem, Muhammad			Identification of cow and buffalo milk based on Beta carotene and vitamin-A concentration using fluorescence spectroscopy	PLOS ONE			English	Article							RAMAN-SPECTROSCOPY; GEOGRAPHIC ORIGIN; CHEESE; INFECTION; TOOL; FAT	The current study presents the application of fluorescence spectroscopy for the identification of cow and buffalo milk based on beta-carotene and vitamin-A which is of prime importance from the nutritional point of view. All samples were collected from healthy animals of different breeds at the time of lactation in the vicinity of Islamabad, Pakistan. Cow and buffalo milk shows differences at fluorescence emission appeared at band position 382 nm, 440 nm, 505 nm and 525 nm both in classical geometry (right angle) setup as well as front face fluorescence setup. In front face fluorescence geometry, synchronous fluorescence emission shows clear differences at 410 nm and 440 nm between the milk samples of both these species. These fluorescence emissions correspond to fats, vitamin-A and beta-carotene. Principal Component Analysis (PCA) further highlighted these differences by showing clear separation between the two data sets on the basis of features obtained from their fluorescence emission spectra. These results indicate that classical geometry (fixed excitation wavelength) as well as front face (synchronous fluorescence emission) of cow and buffalo milk nutrients could be used as fingerprint from identification point of view. This same approach can effectively be used for the determination of adulterants in the milk and other dairy products.	[Ullah, Rahat; Khan, Saranjam; Ali, Hina; Bilal, Muhammad; Saleem, Muhammad] Natl Inst Lasers & Optron NILOP, Agri & Biophoton Div, Islamabad, Pakistan		Ullah, R; Khan, S (corresponding author), Natl Inst Lasers & Optron NILOP, Agri & Biophoton Div, Islamabad, Pakistan.	rahat_khalil@yahoo.com; k.saranjam@yahoo.com	Khan, Bilal/AAC-4207-2020; Ali, Hina/AAS-4353-2021; Bilal, Muhammad/A-5001-2017; Ullah, Rahat/AAX-6428-2021	Bilal, Muhammad/0000-0001-5937-7310; Ullah, Rahat/0000-0002-9836-6056				Abdi H., 2010, PRINCIPAL COMPONENT, V2; Ahmadi SK, 2015, J BIOMOL STRUCT DYN, V33, P1880, DOI 10.1080/07391102.2014.977351; Arnhold T, 2002, J NUTR, V132, P197, DOI 10.1093/jn/132.2.197; Birlouez-Aragon I, 1998, INT DAIRY J, V8, P771, DOI 10.1016/S0958-6946(98)00119-8; Boubellouta T, 2008, APPL SPECTROSC, V62, P490, DOI 10.1366/000370208784344406; Christensen J, 2003, J DAIRY SCI, V86, P1101, DOI 10.3168/jds.S0022-0302(03)73692-3; Dufour E, 1997, LAIT, V77, P657, DOI 10.1051/lait:1997647; Dufour E, 2001, INT DAIRY J, V11, P465, DOI 10.1016/S0958-6946(01)00086-3; Dufour E, 2000, INT DAIRY J, V10, P81, DOI 10.1016/S0958-6946(00)00025-X; Fragaki G, 2005, J AGR FOOD CHEM, V53, P2810, DOI 10.1021/jf040279t; Hammami M, 2010, FOOD CHEM, V122, P1344, DOI 10.1016/j.foodchem.2010.03.107; Jamshidkhan C, 2005, THERMOCHIM ACTA, V432, P106; Jamshidkhan C., 2006, JOURNAL OF COLLOID A, V299, P636; Karoui R, 2007, FOOD CHEM, V104, P409, DOI 10.1016/j.foodchem.2006.09.020; Karoui R, 2006, LAIT, V86, P155, DOI 10.1051/lait:2005047; Karoui R, 2005, LAIT, V85, P223, DOI 10.1051/lait:2005008; Karoui R, 2004, LAIT, V84, P359, DOI 10.1051/lait:2004010; Karoui R, 2003, LAIT, V83, P251, DOI 10.1051/lait:2003014; Khan S, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.9.095005; Khan S, 2016, BIOMED OPT EXPRESS, V7, P2249, DOI 10.1364/BOE.7.002249; Khan S, 2016, OPTIK, V127, P2086, DOI 10.1016/j.ijleo.2015.11.060; Kulmyrzaev A, 2002, LAIT, V82, P725, DOI 10.1051/lait:2002045; LiChan ECY, 1996, TRENDS FOOD SCI TECH, V7, P361, DOI 10.1016/S0924-2244(96)10037-6; Lindmark-Mansson H, 2003, INT DAIRY J, V13, P409, DOI 10.1016/S0958-6946(03)00032-3; Marouzi S, 2017, INT J BIOL MACROMOL, V97, P688, DOI 10.1016/j.ijbiomac.2017.01.047; Miller GD, 2007, HANDBOOK OF DAIRY FO; Moghaddam MM, 2014, LUMINESCENCE, V29, P314, DOI 10.1002/bio.2546; Omidvar Z, 2011, J BIOMOL STRUCT DYN, V29, P181, DOI 10.1080/07391102.2011.10507382; Parodi PW, 2004, AUST J DAIRY TECHNOL, V59, P3; Rodriguez MAP, 2014, FOOD CHEM, V156, P170, DOI 10.1016/j.foodchem.2014.01.092; Raynal-Ljutovac K, 2008, SMALL RUMINANT RES, V79, P57, DOI 10.1016/j.smallrumres.2008.07.009; Sharif-Barfeh Z, 2017, J SOLUTION CHEM, V46, P488, DOI 10.1007/s10953-017-0590-2; Skjervold PO, 2003, J FOOD SCI, V68, P1161, DOI 10.1111/j.1365-2621.2003.tb09618.x; Tome D, 2009, AM J CLIN NUTR, V90, p838S, DOI 10.3945/ajcn.2009.27462W; Ullah R, 2016, JOURNAL OF RAMAN SPE, V48, P363; Ullah R, 2016, JOURNAL OF RAMAN SPE; Ullah R, 2016, OPTIK, V127, P5186, DOI 10.1016/j.ijleo.2016.03.049; Wold JP, 2002, J DAIRY SCI, V85, P1693, DOI 10.3168/jds.S0022-0302(02)74242-2	38	26	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178055	10.1371/journal.pone.0178055	http://dx.doi.org/10.1371/journal.pone.0178055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542353	Green Submitted, Green Published, gold			2022-12-26	WOS:000401672400136
J	Pritchard, S; Jackson, MJ; Hikima, A; Lione, L; Benham, CD; Chaudhuri, KR; Rose, S; Jenner, P; Iravani, MM				Pritchard, Sara; Jackson, Michael J.; Hikima, Atsuko; Lione, Lisa; Benham, Christopher D.; Chaudhuri, K. Ray; Rose, Sarah; Jenner, Peter; Iravani, Mahmoud M.			Altered detrusor contractility in MPTP-treated common marmosets with bladder hyperreflexia	PLOS ONE			English	Article							NONCHOLINERGIC MOTOR TRANSMISSION; LOWER URINARY-TRACT; PARKINSONS-DISEASE; SMOOTH-MUSCLE; RAT MODEL; DYSFUNCTION; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; PATHOPHYSIOLOGY; DEGENERATION; RELAXATION	Bladder hyperreflexia is a common non-motor feature of Parkinson's disease. We now report on the contractility of the isolated primate detrusor strips devoid of nerve input and show that following MPTP, the amplitude and frequency of spontaneous contraction was increased. These responses were unaffected by dopamine D-1 and D-2 receptor agonists A77636 and ropinirole respectively. Contractions by exogenous carbachol, histamine or ATP were similar and no differences in the magnitude of noradrenaline-induced relaxation were seen in detrusor strip obtained from normal and MPTP-treated common marmosets (Callithrix jacchus). However, the neurogenic contractions following electrical field stimulation of the intrinsic nerves (EFS) were markedly greater in strips obtained from MPTP treated animals. EFS evoked non-cholinergic contractions following atropine were also greater but the contribution of the cholinergic innervation as a proportion of the overall contraction was smaller in the detrusor strips of MPTP treated animals, suggesting a preferential enhancement of the non-cholinergic transmission. Although dopaminergic mechanism has been proposed to underlie bladder hyperreflexia in MPTP-treated animals with intact bladder, the present data indicates that the increased neurogenically mediated contractions where no extrinsic innervation exists might be due to long-term adaptive changes locally as a result of the loss of the nigrostriatal output.	[Pritchard, Sara; Lione, Lisa; Benham, Christopher D.; Iravani, Mahmoud M.] Univ Hertfordshire, Dept Pharm Pharmacol & Postgrad Med, Hatfield, Herts, England; [Jackson, Michael J.; Hikima, Atsuko; Rose, Sarah; Jenner, Peter] Kings Coll London, Inst Pharmaceut Sci, Fac Life Sci & Med, Neurodegenerat Dis Res Grp, London, England; [Chaudhuri, K. Ray] Kings Hlth Partnership, London, England	University of Hertfordshire; University of London; King's College London; King's Health Partners	Iravani, MM (corresponding author), Univ Hertfordshire, Dept Pharm Pharmacol & Postgrad Med, Hatfield, Herts, England.	m.iravani@herts.ac.uk		Ray Chaudhuri, K/0000-0003-2815-0505; Iravani, Mahmoud/0000-0002-4905-9682; ROSE, SARAH/0000-0003-4723-7665				ALBANESE A, 1988, NEUROSCI LETT, V87, P46, DOI 10.1016/0304-3940(88)90143-7; Andersson K E, 1995, Scand J Urol Nephrol Suppl, V175, P43; Andersson KE, 2004, PHARMACOL REV, V56, P581, DOI 10.1124/pr.56.4.4; Andersson KE, 2003, EUR UROL, V43, P1, DOI 10.1016/S0302-2838(02)00540-7; Bayliss M, 1999, J UROLOGY, V162, P1833, DOI 10.1016/S0022-5347(05)68247-X; Blackett H, 2009, PARKINSONISM RELAT D, V15, P81, DOI 10.1016/j.parkreldis.2007.10.016; Bukhatwa S, 2009, J NEUROCHEM, V109, P52, DOI 10.1111/j.1471-4159.2009.05956.x; Burnstock G, 2014, PURINERG SIGNAL, V10, P103, DOI 10.1007/s11302-013-9395-y; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Chung BH, 1996, J UROLOGY, V155, P2090, DOI 10.1016/S0022-5347(01)66115-9; de Groat WC, 2006, BRIT J PHARMACOL, V147, pS25, DOI 10.1038/sj.bjp.0706604; FITZMAURICE H, 1985, BRIT J UROL, V57, P652, DOI 10.1111/j.1464-410X.1985.tb07025.x; Hallett P.J., NEUROBIOL DIS, V46, P258; Iravani MM, 2006, J NEUROCHEM, V96, P1315, DOI 10.1111/j.1471-4159.2005.03625.x; IRAVANI MM, 1994, BRIT J PHARMACOL, V113, P95, DOI 10.1111/j.1476-5381.1994.tb16179.x; Jackson MJ, 2007, EXP NEUROL, V204, P162, DOI 10.1016/j.expneurol.2006.10.005; KIRBY R, 1986, J NEUROL NEUROSUR PS, V49, P554, DOI 10.1136/jnnp.49.5.554; LUHESHI G, 1990, EUR J PHARMACOL, V185, P203, DOI 10.1016/0014-2999(90)90641-I; LUHESHI GN, 1990, J PHARM PHARMACOL, V42, P223, DOI 10.1111/j.2042-7158.1990.tb05396.x; McMurray G, 1998, BRIT J PHARMACOL, V123, P1579, DOI 10.1038/sj.bjp.0701774; Mitra R, 2015, J PARKINSON DIS, V5, P301, DOI 10.3233/JPD-140509; MOSS HE, 1985, EUR J PHARMACOL, V114, P311, DOI 10.1016/0014-2999(85)90375-9; Ruggieri MR, 2006, NAT CLIN PRACT UROL, V3, P206, DOI 10.1038/ncpuro0456; Sakakibara R, 2008, J NEURAL TRANSM, V115, P443, DOI 10.1007/s00702-007-0855-9; Sakakibara R, 2001, J NEUROL SCI, V187, P55, DOI 10.1016/S0022-510X(01)00521-4; Sakakibara R, 2012, NEUROBIOL DIS, V46, P565, DOI 10.1016/j.nbd.2011.10.002; Santoso AGH, 2011, NEUROUROL URODYNAM, V30, P619, DOI 10.1002/nau.21015; Seki S, 2001, NEUROUROL URODYNAM, V20, P105, DOI 10.1002/1520-6777(2001)20:1<105::AID-NAU12>3.3.CO;2-0; SJOGREN C, 1982, J UROLOGY, V128, P1368, DOI 10.1016/S0022-5347(17)53509-0; Smith L, 1996, MOVEMENT DISORD, V11, P125, DOI 10.1002/mds.870110203; Soler R, 2011, NEUROUROL URODYNAM, V30, P188, DOI 10.1002/nau.20917; Sui G, 2009, CELL CALCIUM, V45, P456, DOI 10.1016/j.ceca.2009.03.001; Winge K, 2005, EUR J NEUROL, V12, P842, DOI 10.1111/j.1468-1331.2005.01087.x; YOSHIMURA N, 1993, NEUROPHARMACOLOGY, V32, P315, DOI 10.1016/0028-3908(93)90151-R; Yoshimura N, 2003, BRIT J PHARMACOL, V139, P1425, DOI 10.1038/sj.bjp.0705388; Yoshimura N, 1998, J PHARMACOL EXP THER, V286, P228; ZAR MA, 1990, J UROLOGY, V143, P835, DOI 10.1016/S0022-5347(17)40112-1	37	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0175797	10.1371/journal.pone.0175797	http://dx.doi.org/10.1371/journal.pone.0175797			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520722	gold, Green Published, Green Submitted			2022-12-26	WOS:000401487700008
J	Thombare, K; Ntika, S; Wang, X; Krizhanovskii, C				Thombare, Ketan; Ntika, Stelia; Wang, Xuan; Krizhanovskii, Camilla			Long chain saturated and unsaturated fatty acids exert opposing effects on viability and function of GLP-1-producing cells: Mechanisms of lipotoxicity	PLOS ONE			English	Article							GLP-1 SECRETION; INSULIN-RESISTANCE; GLUCAGON; GLUCOSE; RESPONSES; ACTIVATION; PROTECTION; INTESTINE; METFORMIN; OBESITY	Background and aim Fatty acids acutely stimulate GLP-1 secretion from L-cells in vivo. However, a high fat diet has been shown to reduce the density of L-cells in the mouse intestine and a positive correlation has been indicated between L-cell number and GLP-1 secretion. Thus, the mechanism of fatty acid-stimulated GLP-1 secretion, potential effects of long-term exposure to elevated levels of different fatty acid species, and underlying mechanisms are not fully understood. In the present study, we sought to determine how long-term exposure to saturated (16:0) and unsaturated (18:1) fatty acids, by direct effects on GLP-1-producing cells, alter function and viability, and the underlying mechanisms. Methods GLP-1-secreting GLUTag cells were cultured in the presence/absence of saturated (16:0) and unsaturated (18:1) fatty acids (0.125 mM for 48 h, followed by analyses of viability and apoptosis, as well as involvement of fatty acid oxidation, free fatty acid receptors (FFAR1) and ceramide synthesis. In addition, effects on the expression of proglucagon, prohormone convertase 1/3 (PC1/3), free fatty acid receptors (FFAR1, FFAR3), sodium glucose cotransporter (SGLT) and subsequent secretory response were determined. Results Saturated (16:0) and unsaturated (18:1) fatty acids exerted opposing effects on the induction of apoptosis (1.4-fold increase in DNA fragmentation by palmitate and a 0.5-fold reduction by oleate; p<0.01). Palmitate-induced apoptosis was associated with increased ceramide content and co-incubation with Fumonisin B1 abolished this lipo apoptosis. Oleate, on the other hand, reduced ceramide content, and-unlike palmitate-upregulated FFAR1 and FFAR3, evoking a 2-fold increase in FFAR1-mediated GLP-1 secretion following acute exposure to 0.125 mmol/L palmitate; (p<0.05). Conclusion/Interpretation Saturated (16:0), but not unsaturated (18:1), fatty acids induce ceramide-mediated apoptosis of GLP-1-producing cells. Further, unsaturated fatty acids confer lipoprotection, enhancing viability and function of GLP-1-secreting cells. These data provide potential mechanistic insight contributing to reduced L-cell mass following a high fat diet and differential effects of saturated and unsaturated fatty acids on GLP-1 secretion in vivo.	[Thombare, Ketan; Ntika, Stelia; Wang, Xuan; Krizhanovskii, Camilla] Sodertalje Hosp, Dept Internal Med, Sodertalje, Sweden; [Krizhanovskii, Camilla] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Krizhanovskii, Camilla] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden	Karolinska Institutet; Uppsala University	Krizhanovskii, C (corresponding author), Sodertalje Hosp, Dept Internal Med, Sodertalje, Sweden.; Krizhanovskii, C (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.; Krizhanovskii, C (corresponding author), Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.	camilla.krizhanovskii@sll.se		Thombare, Ketan/0000-0002-0183-3376; Ntika, Stelia/0000-0001-5621-1446	Mats Kleberg Foundation; Folksam Research grants; ToreNilsons Stiftelse [20650*1]; Fredrik & Ingrid Thurings Siftelse [24910*1*13]	Mats Kleberg Foundation; Folksam Research grants; ToreNilsons Stiftelse; Fredrik & Ingrid Thurings Siftelse	Support was provided by: Mats Kleberg Foundation (http://www.matsklebergsstiftelse.se/en/BEVILJADE-BIDRAG/2014/) (Recipient:CK); Folksam Research grants (http://www.folksam.se/om-oss/om-folksam/sponsring-och-samarbeten/forskningsstiftelsen) (Recipient:CK);ToreNilsons Stiftelse (http://www.torenilsonsstiftelse.nu) Grant: 20650*1# (Recipient:CK); Fredrik & Ingrid Thurings Siftelse (http://www.thuringsstiftelse.com) Grant: 24910*1*13 (Recipient:CK).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was graciously funded by the Mats Kleberg Foundation, Folksam Research grants, Tore Nilsons Stiftelse and Fredrik & Ingrid Thurings Siftelse.	Baggio LL, 2004, DIABETES, V53, pS205, DOI 10.2337/diabetes.53.suppl_3.S205; Balks HJ, 1997, J CLIN ENDOCR METAB, V82, P786, DOI 10.1210/jc.82.3.786; Beglinger S, 2010, J CLIN ENDOCR METAB, V95, P879, DOI 10.1210/jc.2009-1062; Beysen C, 2002, DIABETOLOGIA, V45, P1533, DOI 10.1007/s00125-002-0964-9; Brubaker PL, 1998, ENDOCRINOLOGY, V139, P4108, DOI 10.1210/en.139.10.4108; Burcelin R, 2001, DIABETES, V50, P1720, DOI 10.2337/diabetes.50.8.1720; Christensen LW, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12551; DRUCKER DJ, 1994, MOL ENDOCRINOL, V8, P1646, DOI 10.1210/me.8.12.1646; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Guo DY, 2015, BIOCHEM BIOPH RES CO, V466, P740, DOI 10.1016/j.bbrc.2015.09.130; Hagberg CE, 2012, NATURE, V490, P426, DOI 10.1038/nature11464; Halpern KB, 2012, J BIOL CHEM, V287, P20154, DOI 10.1074/jbc.M112.358887; Hayashi H, 2014, METABOLISM, V63, P800, DOI 10.1016/j.metabol.2014.02.012; Hu W, 2011, J BIOL CHEM, V286, P16596, DOI 10.1074/jbc.M110.186916; Iwai K, 2003, J BIOL CHEM, V278, P9813, DOI 10.1074/jbc.M201867200; Kappe C, 2015, CLIN SCI, V129, P405, DOI 10.1042/CS20140719; Kappe C, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-70; Kappe C, 2013, J GASTROENTEROL, V48, P322, DOI 10.1007/s00535-012-0637-5; Kappe C, 2012, BIOCHEM BIOPH RES CO, V427, P91, DOI 10.1016/j.bbrc.2012.09.010; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; LEE YC, 1992, J BIOL CHEM, V267, P10705; Lindgren O, 2011, J CLIN ENDOCR METAB, V96, P2519, DOI 10.1210/jc.2011-0266; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Muscelli E, 2008, DIABETES, V57, P1340, DOI 10.2337/db07-1315; Petersen N, 2014, DIABETES, V63, P410, DOI 10.2337/db13-0991; Poreba MA, 2012, AM J PHYSIOL-ENDOC M, V303, pE899, DOI 10.1152/ajpendo.00116.2012; Rask E, 2001, DIABETES CARE, V24, P1640, DOI 10.2337/diacare.24.9.1640; Richards P, 2016, PEPTIDES, V77, P21, DOI 10.1016/j.peptides.2015.06.006; Sayers SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149549; Thomsen C, 2003, AM J CLIN NUTR, V77, P605, DOI 10.1093/ajcn/77.3.605; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; van Raalte DH, 2016, TRENDS ENDOCRIN MET, V27, P442, DOI 10.1016/j.tem.2016.04.009; Villena J, 2008, FREE RADICAL BIO MED, V44, P1146, DOI 10.1016/j.freeradbiomed.2007.12.017; Wichmann A, 2013, CELL HOST MICROBE, V14, P582, DOI 10.1016/j.chom.2013.09.012; Xiong YM, 2013, MOL CELL ENDOCRINOL, V369, P119, DOI 10.1016/j.mce.2013.01.009	37	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177605	10.1371/journal.pone.0177605	http://dx.doi.org/10.1371/journal.pone.0177605			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520810	Green Submitted, gold, Green Published			2022-12-26	WOS:000401485500043
J	Erickson, MA; Jude, J; Zhao, HJ; Rhea, EM; Salameh, TS; Jester, W; Pu, S; Harrowitz, J; Nguyen, N; Banks, WA; Panettieri, RA; Jordan-Sciutto, KL				Erickson, Michelle A.; Jude, Joseph; Zhao, Hengjiang; Rhea, Elizabeth M.; Salameh, Therese S.; Jester, William; Pu, Shelley; Harrowitz, Jenna; Ngan Nguyen; Banks, William A.; Panettieri, Reynold A., Jr.; Jordan-Sciutto, Kelly L.			Serum amyloid A: an ozone-induced circulating factor with potentially important functions in the lung-brain axis	FASEB JOURNAL			English	Article						air pollution; cytokines; acute-phase proteins; blood-brain barrier; microglia	HIGH-DENSITY-LIPOPROTEIN; CENTRAL-NERVOUS-SYSTEM; ACUTE-PHASE RESPONSE; PLASMA IL-12 LEVELS; AIR-POLLUTION; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; PARTICULATE MATTER; INHALED OZONE; IN-VIVO	Accumulating evidence suggests that O-3 exposure may contribute to CNS dysfunction. Here, we posit that inflammatory and acute-phase proteins in the circulation increase after O-3 exposure and systemically convey signals of O-3 exposure to the CNS. To model acute O-3 exposure, female Balb/c mice were exposed to 3 ppm O-3 or forced air for 2 h and were studied after 6 or 24 h. Of 23 cytokines and chemokines, only KC/CXCL1 was increased in blood 6 h after O-3 exposure. The acute-phase protein serum amyloid A (A-SAA) was significantly increased by 24 h, whereas C-reactive protein was unchanged. A-SAA in blood correlated with total leukocytes, macrophages, and neutrophils in bronchoalveolar lavage from O-3-exposed mice. A-SAA mRNA and protein were increased in the liver. We found that both isoforms of A-SAA completely crossed the intact blood-brain barrier, although the rate of SAA2.1 influx was approximately 5 times faster than that of SAA1.1. Finally, A-SAA protein, but not mRNA, was increased in the CNS 24 h post-O-3 exposure. Our findings suggest that A-SAA is functionally linked to pulmonary inflammation in our O-3 exposure model and that A-SAA could be an important systemic signal ofO(3) exposure to the CNS.	[Erickson, Michelle A.; Pu, Shelley; Harrowitz, Jenna; Jordan-Sciutto, Kelly L.] Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA; [Jude, Joseph; Zhao, Hengjiang; Jester, William; Ngan Nguyen; Panettieri, Reynold A., Jr.] Univ Penn, Dept Med, Div Pulm Allergy & Crit Care, Philadelphia, PA 19104 USA; [Erickson, Michelle A.; Rhea, Elizabeth M.; Salameh, Therese S.; Banks, William A.; Panettieri, Reynold A., Jr.] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA; [Erickson, Michelle A.; Rhea, Elizabeth M.; Salameh, Therese S.; Banks, William A.; Panettieri, Reynold A., Jr.] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Jude, Joseph; Jester, William] Rutgers State Univ, Rutgers Inst Translat Med & Sci, Child Hlth Inst, New Brunswick, NJ USA	University of Pennsylvania; University of Pennsylvania; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; Rutgers State University New Brunswick; Rutgers State University Medical Center	Erickson, MA (corresponding author), 1660 South Columbian Way,Bldg 32,Room 229, Seattle, WA 98108 USA.	mericks999@gmail.com	Banks, William A/K-1330-2017; Erickson, Michelle/AAR-8717-2021; Meredith, Elizabeth/AAM-4574-2021; Erickson, Michelle/U-7754-2019; panettieri, reynold/AAG-9485-2019; Erickson, Michelle/G-4815-2014	Banks, William A/0000-0002-0496-3619; Erickson, Michelle/0000-0002-2575-1594; Jester Jr., William/0000-0002-2872-6095; Harowitz, Jenna/0000-0001-7459-7821	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences [T32ES019851, F32ES025076]; NIH National Institute of Neurological Disorders and Stroke [R21NS093368]; NIH National Institute on Aging [T32AG000057]; NIH National Institute of Mental Health [R01MH106967, P30ES013508]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES025076, P30ES013508, T32ES019851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS093368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (Grants T32ES019851 to M.A.E. and J.J., and F32ES025076 to M.A.E.), NIH National Institute of Neurological Disorders and Stroke (Grant R21NS093368 to W.A.B. and T.S.S.), NIH National Institute on Aging (Grant T32AG000057 to E.M.R.); and NIH National Institute of Mental Health (Grants R01MH106967 to K.L.J.-S. and P30ES013508 to R.A.P.).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Akhter H, 2015, TOXICOL SCI, V147, P222, DOI 10.1093/toxsci/kfv124; Anthony D, 2013, AM J RESP CRIT CARE, V188, P179, DOI 10.1164/rccm.201211-2139OC; Balazs Z, 2004, J NEUROCHEM, V89, P939, DOI 10.1111/j.1471-4159.2004.02373.x; Banks WA, 2015, BRAIN BEHAV IMMUN, V44, P1, DOI 10.1016/j.bbi.2014.08.007; BANKS WA, 1988, BRAIN RES BULL, V21, P881, DOI 10.1016/0361-9230(88)90021-4; Banks WA, 2011, METHODS MOL BIOL, V789, P337, DOI 10.1007/978-1-61779-310-3_22; Baranova IN, 2010, J BIOL CHEM, V285, P8492, DOI 10.1074/jbc.M109.007526; Bartolak-Suki E, 2000, AMYLOID, V7, P111, DOI 10.3109/13506120009146247; Bender SJ, 2010, J VIROL, V84, P11030, DOI 10.1128/JVI.02688-09; BENDITT EP, 1979, P NATL ACAD SCI USA, V76, P4092, DOI 10.1073/pnas.76.8.4092; Bhalla DK, 1999, J TOXICOL ENV HEAL B, V2, P31, DOI 10.1080/109374099281232; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2; Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009; BOZIC CR, 1994, J BIOL CHEM, V269, P29355; Bozinovski S, 2008, AM J RESP CRIT CARE, V177, P269, DOI 10.1164/rccm.200705-678OC; Bozinovski S, 2012, P NATL ACAD SCI USA, V109, P935, DOI 10.1073/pnas.1109382109; Cai L, 2005, J BIOL CHEM, V280, P2954, DOI 10.1074/jbc.M411555200; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Chen JC, 2009, NEUROTOXICOLOGY, V30, P231, DOI 10.1016/j.neuro.2008.12.011; Chiba T, 2011, ARTERIOSCL THROM VAS, V31, P1326, DOI 10.1161/ATVBAHA.111.226159; Chiba T, 2009, J LIPID RES, V50, P1353, DOI 10.1194/jlr.M900089-JLR200; Chung TF, 2000, AMYLOID, V7, P105, DOI 10.3109/13506120009146246; Cooper PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010235; Cray C, 2009, COMPARATIVE MED, V59, P517; CUETO R, 1992, BIOCHEM BIOPH RES CO, V188, P129, DOI 10.1016/0006-291X(92)92359-6; De Buck M, 2016, CURR MED CHEM, V23, P1725, DOI 10.2174/0929867323666160418114600; De Buck M, 2015, J LEUKOCYTE BIOL, V98, P1049, DOI 10.1189/jlb.3A0315-085R; Devlin RB, 2012, CIRCULATION, V126, P104, DOI 10.1161/CIRCULATIONAHA.112.094359; Erickson MA, 2011, BRAIN BEHAV IMMUN, V25, P1637, DOI 10.1016/j.bbi.2011.06.006; Hernandez-Zimbron LF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2125643; Gackiere F, 2011, J NEUROCHEM, V117, P961, DOI 10.1111/j.1471-4159.2011.07267.x; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; Gonzalez-Guevara E, 2014, INHAL TOXICOL, V26, P485, DOI 10.3109/08958378.2014.922648; Goodman JE, 2015, CRIT REV TOXICOL, V45, P412, DOI 10.3109/10408444.2015.1031371; Guo JT, 2002, J NEUROSCI, V22, P5900; HATCH GE, 1994, AM J RESP CRIT CARE, V150, P676, DOI 10.1164/ajrccm.150.3.8087337; Hernandez-Zimbron LF, 2015, NEUROSCIENCE, V304, P340, DOI 10.1016/j.neuroscience.2015.07.011; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Jang WY, 2017, BRAIN RES, V1654, P55, DOI 10.1016/j.brainres.2016.09.003; Jung CR, 2015, J ALZHEIMERS DIS, V44, P573, DOI 10.3233/JAD-140855; Kahle JJ, 2015, ENVIRON HEALTH PERSP, V123, P310, DOI 10.1289/ehp.1307986; Kasahara DI, 2014, AM J PHYSIOL-LUNG C, V306, pL508, DOI 10.1152/ajplung.00235.2013; Kastin AJ, 2001, PEPTIDES, V22, P2127, DOI 10.1016/S0196-9781(01)00569-1; Kierstein S, 2008, ALLERGY, V63, P438, DOI 10.1111/j.1398-9995.2007.01587.x; Kierstein S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-85; Kim MH, 2016, J LIPID RES, V57, P969, DOI 10.1194/jlr.M062174; Kim MH, 2013, CYTOKINE, V61, P506, DOI 10.1016/j.cyto.2012.10.019; LASKIN DL, 1994, ENVIRON HEALTH PERSP, V102, P61, DOI 10.2307/3432216; Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371; Li F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080782; Liang JS, 1997, NEUROSCI LETT, V225, P73, DOI 10.1016/S0304-3940(97)00196-1; Liu J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0493-y; Lopez-Campos JL, 2013, INT J MED SCI, V10, P938, DOI 10.7150/ijms.6152; Mahley RW, 2016, ARTERIOSCL THROM VAS, V36, P1305, DOI 10.1161/ATVBAHA.116.307023; Miida T, 2006, BBA-MOL CELL BIOL L, V1761, P424, DOI 10.1016/j.bbalip.2006.03.013; Miller DB, 2015, TOXICOL APPL PHARM, V286, P65, DOI 10.1016/j.taap.2015.03.025; Millers DB, 2016, AM J RESP CRIT CARE, V193, P1382, DOI 10.1164/rccm.201508-1599OC; Montresor-Lopez JA, 2016, J EXPO SCI ENV EPID, V26, P162, DOI 10.1038/jes.2015.48; Mumaw CL, 2016, FASEB J, V30, P1880, DOI 10.1096/fj.201500047; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Pirozzi C, 2015, INT J ENV RES PUB HE, V12, P5061, DOI 10.3390/ijerph120505061; PRYOR WA, 1992, FREE RADICAL BIO MED, V12, P83, DOI 10.1016/0891-5849(92)90060-T; PRYOR WA, 1995, FREE RADICAL BIO MED, V19, P935, DOI 10.1016/0891-5849(95)02033-7; Rivas-Arancibia S, 2015, FRONT AGING NEUROSCI, V7, DOI [10.3389/fnagi.2015.00065, 10.3389/fnagi.7015.00065]; Rivas-Arancibia S, 2010, TOXICOL SCI, V113, P187, DOI 10.1093/toxsci/kfp252; Schroder R, 1999, VIRCHOWS ARCH, V434, P551, DOI 10.1007/s004280050383; Shaashua L, 2012, BRAIN BEHAV IMMUN, V26, P996, DOI 10.1016/j.bbi.2012.05.012; Shaashua L, 2014, PSYCHONEUROENDOCRINO, V42, P11, DOI 10.1016/j.psyneuen.2013.12.001; Sipe J, 1999, AMYLOID, V6, P67, DOI 10.3109/13506129908993291; SLADE R, 1985, AM REV RESPIR DIS, V131, P742; Stukas S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001156; Suissa L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004060; Thomson EM, 2007, ENVIRON RES, V105, P224, DOI 10.1016/j.envres.2007.06.005; Thomson EM, 2016, TOXICOL SCI, V152, P17, DOI 10.1093/toxsci/kfw061; Thomson EM, 2013, TOXICOL SCI, V135, P169, DOI 10.1093/toxsci/kft137; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Uhlson C, 2002, CHEM RES TOXICOL, V15, P896, DOI 10.1021/tx010183i; Vancza EM, 2009, TOXICOL SCI, V107, P535, DOI 10.1093/toxsci/kfn253; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wu Yun-Chun, 2015, Alzheimers Dement (Amst), V1, P220, DOI 10.1016/j.dadm.2014.11.015; Wynendaele E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142071; Xu XH, 2013, NEUROEPIDEMIOLOGY, V41, P2, DOI 10.1159/000345138; Ying ZK, 2016, INHAL TOXICOL, V28, P155, DOI 10.3109/08958378.2016.1146808; Yu J, 2000, LAB INVEST, V80, P1797, DOI 10.1038/labinvest.3780191; Yu Y, 2014, J ALZHEIMERS DIS, V38, P133, DOI 10.3233/JAD-130818; Zhang N, 2005, J IMMUNOL, V174, P8125, DOI 10.4049/jimmunol.174.12.8125	88	22	22	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					3950	3965		10.1096/fj.201600857RRR	http://dx.doi.org/10.1096/fj.201600857RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28533327	Green Published			2022-12-26	WOS:000408713300021
J	Schott, MB; Rasineni, K; Weller, SG; Schulze, RJ; Sletten, AC; Casey, CA; McNiven, MA				Schott, Micah B.; Rasineni, Karuna; Weller, Shaun G.; Schulze, Ryan J.; Sletten, Arthur C.; Casey, Carol A.; McNiven, Mark A.			beta-Adrenergic induction of lipolysis in hepatocytes is inhibited by ethanol exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipose triglyceride lipase (ATGL); adrenergic receptor; alcohol; cyclic AMP (cAMP); G protein-coupled receptor (GPCR); hepatocyte; lipid droplet; fatty liver	HORMONE-SENSITIVE LIPASE; ADIPOSE TRIGLYCERIDE LIPASE; LIPID DROPLETS; FATTY LIVER; HEPATIC GLUCONEOGENESIS; STIMULATED LIPOLYSIS; PROTEIN-KINASE; ATGL; METABOLISM; PROMOTES	In liver steatosis (i.e. fatty liver), hepatocytes accumulate many large neutral lipid storage organelles known as lipid droplets (LDs). LDs are important in the maintenance of energy homeostasis, but the signaling mechanisms that stimulate LD metabolism in hepatocytes are poorly defined. In adipocytes, catecholamines target the beta-adrenergic (beta-AR)/cAMP pathway to activate cytosolic lipases and induce their recruitment to the LD surface. Therefore, the goal of this study was to determine whether hepatocytes, like adipocytes, also undergo cAMP-mediated lipolysis in response to beta-AR stimulation. Using primary rat hepatocytes and human hepatoma cells, we found that treatment with the beta-AR agent isoproterenol caused substantial LD loss via activation of cytosolic lipases adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL). beta-Adrenergic stimulation rapidly activated PKA, which led to the phosphorylation of ATGL and HSL and their recruitment to the LD surface. To test whether this beta-AR-dependent lipolysis pathway was altered in a model of alcoholic fatty liver, primary hepatocytes from rats fed a 6-week EtOH-containing Lieber-DeCarli diet were treated with cAMP agonists. Compared with controls, EtOH-exposed hepatocytes showed a drastic inhibition in beta-AR/cAMP-induced LD breakdown and the phosphorylation of PKA substrates, including HSL. This observation was supported in VA-13 cells, an EtOH-metabolizing human hepatoma cell line, which displayed marked defects in both PKA activation and isoproterenol-induced ATGL translocation to the LD periphery. In summary, these findings suggest that beta-AR stimulation mobilizes cytosolic lipases for LD breakdown in hepatocytes, and perturbation of this pathway could be a major consequence of chronic EtOH insult leading to fatty liver.	[Schott, Micah B.; Weller, Shaun G.; Schulze, Ryan J.; McNiven, Mark A.] Mayo Clin, Dept Biochem & Mol Biol, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA; [Sletten, Arthur C.] Mayo Clin, Div Gastroenterol & Hepatol, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA; [Rasineni, Karuna; Casey, Carol A.] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE 68198 USA; [Casey, Carol A.] Nebraska Western Iowa Hlth Care Syst Res Serv, Omaha, NE 68105 USA	Mayo Clinic; Mayo Clinic; University of Nebraska System; University of Nebraska Medical Center	McNiven, MA (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.; McNiven, MA (corresponding author), Mayo Clin, Ctr Basic Res Digest Dis, 200 1st St SW, Rochester, MN 55905 USA.	mmcniven.mark@mayo.edu			National Institutes of Health [5R01DK044650, 5RO1AA020735, 5T32DK007352, P30DK084567]; Department of Veterans Affairs; Optical Morphology Core of the Mayo Clinic Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007352, R01DK044650, P30DK084567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020735] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Optical Morphology Core of the Mayo Clinic Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grants 5R01DK044650 (to M. A. M.), 5RO1AA020735 (to M. A. M. and C. A. C.), and 5T32DK007352 (to R. J. S. and M. B. S.); by funds from the Department of Veterans Affairs (to C. A. C); and by the Optical Morphology Core of the Mayo Clinic Center for Cell Signaling in Gastroenterology, National Institutes of Health Grant P30DK084567. The authors declare that they have no conflicts of interest with the contents of this article. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs, the United States government, or the National Institutes of Health.	Aquilano K, 2016, ONCOTARGET, V7, P23019, DOI 10.18632/oncotarget.8552; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Brasaemle D. L., 2016, CURRENT PROTOCOLS CE, V72; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; Carr RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097118; Casey CA, 2004, J APPL PHYSIOL, V96, P76, DOI 10.1152/japplphysiol.00375.2003; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Clemens DL, 2002, HEPATOLOGY, V35, P1196, DOI 10.1053/jhep.2002.32668; Dam-Larsen S, 2004, GUT, V53, P750, DOI 10.1136/gut.2003.019984; De A, 1999, ALCOHOL CLIN EXP RES, V23, P46, DOI 10.1111/j.1530-0277.1999.tb04022.x; DEBEER LJ, 1982, FEBS LETT, V140, P159, DOI 10.1016/0014-5793(82)80884-3; Depry C, 2011, MOL BIOSYST, V7, P52, DOI 10.1039/c0mb00079e; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; Farah BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098155; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Ganesan M, 2015, AM J PHYSIOL-GASTR L, V309, pG566, DOI 10.1152/ajpgi.00183.2015; Ghosh PM, 2012, J ENDOCRINOL, V213, P251, DOI 10.1530/JOE-11-0406; Granneman JG, 2011, J BIOL CHEM, V286, P5126, DOI 10.1074/jbc.M110.180711; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hoffman P L, 1987, Alcohol Alcohol Suppl, V1, P749; HOLM C, 1987, BIOCHEM BIOPH RES CO, V148, P99, DOI 10.1016/0006-291X(87)91081-3; Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134; KATZ MS, 1993, EXP GERONTOL, V28, P329, DOI 10.1016/0531-5565(93)90060-Q; Khan SA, 2015, DIABETES, V64, P418, DOI 10.2337/db14-0325; KREBS HA, 1969, BIOCHEM J, V112, P117, DOI 10.1042/bj1120117; Li ZY, 2016, J ASIAN NAT PROD RES, V2, P1; Liangpunsakul S, 2010, AM J PHYSIOL-GASTR L, V298, pG1004, DOI 10.1152/ajpgi.00482.2009; Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008; LIEBER CS, 1989, ALCOHOL ALCOHOLISM, V24, P197; Lizaso A, 2013, AUTOPHAGY, V9, P1228, DOI 10.4161/auto.24893; McVicker BL, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/978136; MORGAN NG, 1983, J BIOL CHEM, V258, P5103; NAGY LE, 1988, P NATL ACAD SCI USA, V85, P6973, DOI 10.1073/pnas.85.18.6973; O'Shea RS, 2010, AM J GASTROENTEROL, V105, P14, DOI 10.1038/ajg.2009.593; Oaks J, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00388; Ong KT, 2013, FASEB J, V27, P313, DOI 10.1096/fj.12-213454; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Pagadala M, 2012, TRENDS ENDOCRIN MET, V23, P365, DOI 10.1016/j.tem.2012.04.005; Pagnon J, 2012, ENDOCRINOLOGY, V153, P4278, DOI 10.1210/en.2012-1127; PILKIS SJ, 1995, ANNU REV BIOCHEM, V64, P799, DOI 10.1146/annurev.bi.64.070195.004055; Rasineni K, 2014, ALCOHOL CLIN EXP RES, V38, P327, DOI 10.1111/acer.12271; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Sathyanarayan A, 2017, CELL REP, V19, P1, DOI 10.1016/j.celrep.2017.03.026; Schroeder B, 2015, HEPATOLOGY, V61, P1896, DOI 10.1002/hep.27667; Schulze RJ, 2014, AUTOPHAGY, V10, P388, DOI 10.4161/auto.27486; Schulze RJ, 2013, J CELL BIOL, V203, P315, DOI 10.1083/jcb.201306140; Sekiya M, 2008, J LIPID RES, V49, P1829, DOI 10.1194/jlr.M800198-JLR200; Shen L, 2012, JOVE-J VIS EXP, DOI 10.3791/3917; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Straub BK, 2008, HEPATOLOGY, V47, P1936, DOI 10.1002/hep.22268; Takahashi Y, 2016, ONCOTARGET, V7, P20855, DOI 10.18632/oncotarget.8028; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wang C, 2015, HEPATOLOGY, V61, P870, DOI 10.1002/hep.27409; Wang H, 2009, J BIOL CHEM, V284, P32116, DOI 10.1074/jbc.M109.006726; Wang Y, 2013, ADV CIV ENG, V2013, DOI 10.1155/2013/189105; Whitsett M, 2015, WORLD J HEPATOL, V7, P2041, DOI 10.4254/wjh.v7.i16.2041; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; You M, 2004, GASTROENTEROLOGY, V127, P1798, DOI 10.1053/j.gastro.2004.09.049; Zhang SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29539	70	35	36	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11815	11828		10.1074/jbc.M117.777748	http://dx.doi.org/10.1074/jbc.M117.777748			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28515323	Green Published, hybrid			2022-12-26	WOS:000405485600019
J	Seleka, M; Treurnicht, FK; Tempia, S; Hellferscee, O; Mtshali, S; Cohen, AL; Buys, A; McAnerney, JM; Besselaar, TG; Pretorius, M; von Gottberg, A; Walaza, S; Cohen, C; Madhi, SA; Venter, M				Seleka, Mpho; Treurnicht, Florette K.; Tempia, Stefano; Hellferscee, Orienka; Mtshali, Senzo; Cohen, Adam L.; Buys, Amelia; McAnerney, Johanna M.; Besselaar, Terry G.; Pretorius, Marthi; von Gottberg, Anne; Walaza, Sibongile; Cohen, Cheryl; Madhi, Shabir A.; Venter, Marietjie			Epidemiology of influenza B/Yamagata and B/Victoria lineages in South Africa, 2005-2014	PLOS ONE			English	Article							B VIRUSES; MONOCLONAL-ANTIBODIES; EVOLUTIONARY PATTERN; ANTIGENIC DRIFT; INFECTION; HEMAGGLUTININ; VACCINE; PCR; RECOMMENDATIONS; SURVEILLANCE	Background Studies describing the epidemiology of influenza B lineages in South Africa are lacking. Methods We conducted a prospective study to describe the circulation of influenza B/Victoria and B/Yamagata lineages among patients of all ages enrolled in South Africa through three respiratory illness surveillance systems between 2005 and 2014: (i) the Viral Watch (VW) program enrolled outpatients with influenza-like illness (ILI) from private healthcare facilities during 2005-2014; (ii) the influenza-like illnesses program enrolled outpatients in public healthcare clinics (ILI/PHC) during 2012-2014; and (iii) the severe acute respiratory illnesses (SARI) program enrolled inpatients from public hospitals during 2009-2014. Influenza B viruses were detected by virus isolation during 2005 to 2009 and by real-time reverse transcription polymerase chain reaction from 2009-2014. Clinical and epidemiological characteristics of patients hospitalized with SARI and infected with different influenza B lineages were also compared using unconditional logistic regression. Results Influenza viruses were detected in 22% (8,706/39,804) of specimens from patients with ILI or SARI during 2005-2014, of which 24% (2,087) were positive for influenza B. Influenza B viruses predominated in all three surveillance systems in 2010. B/Victoria predominated prior to 2011 (except 2008) whereas B/Yamagata predominated thereafter (except 2012). B lineages co-circulated in all seasons, except in 2013 and 2014 for SARI and ILI/PHC surveillance. Among influenza B-positive SARI cases, the detection of influenza B/Yamagata compared to influenza B/Victoria was significantly higher in individuals aged 45-64 years (adjusted odds ratio [aOR]: 4.2; 95% confidence interval [CI]: 1.1-16.5) and >= 65 years (aOR: 12.2; 95% CI: 2.3-64.4) compared to children aged 0-4 years, but was significantly lower in HIV-infected patients (aOR: 0.4; 95% CI: 0.2-0.9). Conclusion B lineages co-circulated in most seasons except in 2013 and 2014. Hospitalized SARI cases display differential susceptibility for the two influenza B lineages, with B/Victoria being more prevalent among children and HIV-infected persons.	[Seleka, Mpho; Treurnicht, Florette K.; Tempia, Stefano; Hellferscee, Orienka; Buys, Amelia; McAnerney, Johanna M.; Pretorius, Marthi; von Gottberg, Anne; Walaza, Sibongile; Cohen, Cheryl; Madhi, Shabir A.] NHLS, NICD, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Tempia, Stefano] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Tempia, Stefano] Ctr Dis Control & Prevent, Influenza Program, Atlanta, GA USA; [Hellferscee, Orienka; von Gottberg, Anne] Univ Witwatersrand, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa; [Mtshali, Senzo] NHLS, NICD, Sequencing Core Facil, Johannesburg, South Africa; [Cohen, Adam L.; Besselaar, Terry G.] WHO, Global Influenza Program, Geneva, Switzerland; [Walaza, Sibongile; Madhi, Shabir A.] Univ Witwatersrand, Med Res Council, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Cohen, Cheryl] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa; [Venter, Marietjie] Univ Pretoria, Dept Med Virol, Zoonoses Res Unit, Pretoria, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Witwatersrand; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); World Health Organization; South African Medical Research Council; University of Witwatersrand; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; University of Pretoria	Treurnicht, FK (corresponding author), NHLS, NICD, Ctr Resp Dis & Meningitis, Johannesburg, South Africa.	florettet@nicd.ac.za	Hellferscee, Orienka/AAN-6202-2020; Venter, Marietjie/P-9604-2016	Hellferscee, Orienka/0000-0001-9246-8927; Venter, Marietjie/0000-0003-2696-824X; von Gottberg, Anne/0000-0002-0243-7455; Cohen, Cheryl/0000-0003-0376-2302; Pretorius, Marthi/0000-0003-2163-6158	National Institute for Communicable Diseases (NICD); US Centers for Disease Control and Prevention [5U51/IP000155]; National Center for Immunization and Respiratory Diseases (NCIRD) [U01IP001048] Funding Source: NIH RePORTER	National Institute for Communicable Diseases (NICD); US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the National Institute for Communicable Diseases (NICD) (http://www.nicd.ac.za/) and the US Centers for Disease Control and Prevention (https://www.cdc.gov/) grant number 5U51/IP000155.	Africa DoHRoS, 2017, NATIONAL INFLUENZA P; Barr IG, 2006, COMMUN DIS INTELL, V30, P350; Barr IG, 2016, EURO SURVEILLANCE BU, V21; BERTON MT, 1984, J VIROL, V52, P919, DOI 10.1128/JVI.52.3.919-927.1984; Besselaar TG, 2004, VIRUS RES, V103, P61, DOI 10.1016/j.virusres.2004.02.014; Besselaar TG, 2004, J MED VIROL, V73, P71, DOI 10.1002/jmv.20063; Budgell E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120226; Caini S, 2015, INFLUENZA OTHER RESP, V9, P3, DOI 10.1111/irv.12319; de Barros ENC, 2016, BRAZ J INFECT DIS, V20, P81, DOI 10.1016/j.bjid.2015.09.009; Cohen AL, 2014, EMERG INFECT DIS, V20, P1162, DOI 10.3201/eid2007.131869; Cohen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117716; Cohen C, 2015, PEDIATR INFECT DIS J, V34, P66, DOI 10.1097/INF.0000000000000478; Cohen C, 2013, EMERG INFECT DIS, V19, P1766, DOI 10.3201/eid1911.130546; Cohen JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139431; Fox A, 2015, J INFECTION, V70, P187, DOI 10.1016/j.jinf.2014.09.003; Francis T, 1940, SCIENCE, V92, P405, DOI 10.1126/science.92.2392.405; Gutierrez-Pizarraya A, 2012, J INFECTION, V65, P423, DOI 10.1016/j.jinf.2012.07.004; Heikkinen T, 2014, CLIN INFECT DIS, V59, P1519, DOI 10.1093/cid/ciu664; Jernigan DB, 2011, CLIN INFECT DIS, V52, pS36, DOI 10.1093/cid/ciq020; KANEGAE Y, 1990, J VIROL, V64, P2860, DOI 10.1128/JVI.64.6.2860-2865.1990; Klimov AI, 2012, VACCINE, V30, P6461, DOI 10.1016/j.vaccine.2012.07.089; Kuo SM, 2016, J FORMOS MED ASSOC, V115, P510, DOI 10.1016/j.jfma.2016.01.017; McAnerney JM, 2015, INFLUENZA OTHER RESP, V9, P209, DOI 10.1111/irv.12314; McAnerney JM, 2015, INFLUENZA OTHER RESP, V9, P143, DOI 10.1111/irv.12305; McAnerney JM, 2012, J INFECT DIS, V206, pS153, DOI 10.1093/infdis/jis575; Moa AM, 2017, INFLUENZA OTHER RESP, V11, P102, DOI 10.1111/irv.12432; Ntshoe GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094681; Owen R, 2008, COMMUN DIS INTELL, V32, P208; Perosa AH, 2015, MEM I OSWALDO CRUZ, V110, P606, DOI 10.1590/0074-02760150044; Pretorius MA, 2016, J CLIN VIROL, V75, P21, DOI 10.1016/j.jcv.2015.12.004; Pretorius MA, 2012, J INFECT DIS, V206, pS159, DOI 10.1093/infdis/jis538; Puig-Barbera J, 2015, GLOBAL INFLUENZA HOS; Radovanov J, 2015, SRP ARK CELOK LEK, V143, P429, DOI 10.2298/SARH1508429R; Schweiger B, 2000, J CLIN MICROBIOL, V38, P1552, DOI 10.1128/JCM.38.4.1552-1558.2000; Socan M, 2014, J CLIN VIROL, V61, P156, DOI 10.1016/j.jcv.2014.06.018; Vijaykrishna D, 2015, ELIFE, V4, DOI 10.7554/eLife.05055; Walaza S, 2016, SAMJ S AFR MED J, V106, P251, DOI [10.7196/samj.2016.v106i3.10586, 10.7196/SAMJ.2016.v106i3.10586]; Watzinger F, 2004, J CLIN MICROBIOL, V42, P5189, DOI 10.1128/JCM.42.11.5189-5198.2004; WEBSTER RG, 1981, J GEN VIROL, V54, P243, DOI 10.1099/0022-1317-54-2-243; WHO, 2014, WHO SURVEILLANCE CAS; Wolter N, 2014, J INFECT DIS, V210, P1649, DOI 10.1093/infdis/jiu326; Xu CL, 2015, AM J EPIDEMIOL, V182, P705, DOI 10.1093/aje/kwv110; YAMASHITA M, 1988, VIROLOGY, V163, P112, DOI 10.1016/0042-6822(88)90238-3	43	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177655	10.1371/journal.pone.0177655	http://dx.doi.org/10.1371/journal.pone.0177655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542324	Green Submitted, Green Published, gold			2022-12-26	WOS:000402062800021
J	Singh, D; Singh, CK; Kumari, S; Tomar, RSS; Karwa, S; Singh, R; Singh, RB; Sarkar, SK; Pal, M				Singh, Dharmendra; Singh, Chandan Kumar; Kumari, Shanti; Tomar, Ram Sewak Singh; Karwa, Sourabh; Singh, Rajendra; Singh, Raja Bahadur; Sarkar, Susheel Kumar; Pal, Madan			Discerning morpho-anatomical, physiological and molecular multiformity in cultivated and wild genotypes of lentil with reconciliation to salinity stress	PLOS ONE			English	Article							LENS-CULINARIS MEDIK.; SALT TOLERANCE; NACL SALINITY; SATIVA L.; GROWTH; MECHANISMS; FIELD; MICROSATELLITE; PEROXIDASE; METABOLISM	One hundred and sixty two genotypes of different Lens species were screened for salinity tolerance in hydroponics at 40, 80 and 120 mM sodium chloride (NaCl) for 30 d. The germination, seedling growth, biomass accumulation, seedling survivability, salinity scores, root and shoot anatomy, sodium ion (Na+), chloride ion (Cl-) and potassium ion (K+) concentrations, proline and antioxidant activities were measured to evaluate the performance of all the genotypes. The results were compared in respect of physiological (Na+, K+ and Cl-) and seed yield components obtained from field trials for salinity stress conducted during two years. Expression of salt tolerance in hydroponics was found to be reliable indicator for similarity in salt tolerance between genotypes and was evident in saline soil based comparisons. Impressive genotypic variation for salinity tolerance was observed among the genotypes screened under hydroponic and saline field conditions. Plant concentrations of Na+ and Cl- at 120 mM NaCl were found significantly correlated with germination, root and shoot length, fresh and dry weight of roots and shoots, seedling survivability, salinity scores and K+ under controlled conditions and ranked the genotypes along with their seed yield in the field. Root and shoot anatomy of tolerant line (PDL-1) and wild accession (ILWL-137) showed restricted uptake of Na+ and Cl- due to thick layer of their epidermis and endodermis as compared to sensitive cultigen (L-4076). All the genotypes were scanned using SSR markers for genetic diversity, which generated high polymorphism. On the basis of cluster analysis and population structure the contrasting genotypes were grouped into different classes. These markers may further be tested to explore their potential in marker-assisted selection.	[Singh, Dharmendra; Singh, Chandan Kumar; Kumari, Shanti] ICAR Indian Agr Res Inst, Div Genet, New Delhi, India; [Singh, Rajendra] ICAR Indian Agr Res Inst, Div Soil Sci & Agr Chem, New Delhi, India; [Singh, Raja Bahadur] Raja Balwant Singh Coll, ICAR All India Coordinated Res Project Salt Affec, Agra, Uttar Pradesh, India; [Tomar, Ram Sewak Singh] ICAR Natl Res Ctr Plant Biotechnol, Pusa Campus, New Delhi, India; [Karwa, Sourabh; Pal, Madan] ICAR Indian Agr Res Inst, Div Plant Physiol, New Delhi, India; [Sarkar, Susheel Kumar] ICAR Indian Agr Stat Res Inst, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Statistics Research Institute	Singh, D (corresponding author), ICAR Indian Agr Res Inst, Div Genet, New Delhi, India.; Singh, R (corresponding author), ICAR Indian Agr Res Inst, Div Soil Sci & Agr Chem, New Delhi, India.; Pal, M (corresponding author), ICAR Indian Agr Res Inst, Div Plant Physiol, New Delhi, India.	dsingh_gen@iari.res.in; rajendra.singh_phyto@yahoo.com; madanpal@yahoo.com	TOMAR, RAM SEWAK SINGH/AAF-5619-2021; karwa, sourabh D/O-5266-2018; PAL, MRINAL/ABG-9676-2020; Tomar, Dr. Rukam Singh/I-3474-2013	TOMAR, RAM SEWAK SINGH/0000-0001-9959-4395; karwa, sourabh D/0000-0002-6232-6765; PAL, MRINAL/0000-0002-1032-272X; Tomar, Dr. Rukam Singh/0000-0001-9156-5311	ICAR-Indian Agricultural Research Institute (IARI), New Delhi; National Phytotron Facility, IARI, New Delhi; Indian Agricultural Research Institute, New Delhi [JAN 09/16]; Indian Agricultural Research Institute, New Delhi	ICAR-Indian Agricultural Research Institute (IARI), New Delhi; National Phytotron Facility, IARI, New Delhi; Indian Agricultural Research Institute, New Delhi(Indian Council of Agricultural Research (ICAR)); Indian Agricultural Research Institute, New Delhi(Indian Council of Agricultural Research (ICAR))	This work was supported in part by the Director, Joint Director (Res), ICAR-Indian Agricultural Research Institute (IARI), New Delhi, Head, Division of Genetics and Incharge, National Phytotron Facility, IARI, New Delhi to carry out all the research activities, Indian Agricultural Research Institute, New Delhi, and Project no- JAN 09/16 [http://www.iari.res.in/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Director, Joint Director (Res), ICAR-Indian Agricultural Research Institute (IARI), New Delhi, Head, Division of Genetics and Incharge, National Phytotron Facility, IARI, New Delhi, for providing support to carry out all the research activities. The authors also acknowledge the support of Dr. Ashutosh Sarkar, Co-ordinator of ICARDA for providing seeds of various Lens species. We sincerely thank Dr. Shiv Kumar Agarwal for providing origin of wild accessions. The financial support from Indian Agricultural Research Institute, New Delhi is gratefully acknowledged	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Ahmad P., 2011, OXIDATIVE STRESS ROL; Ahmad Parvaiz, 2010, Archives of Agronomy and Soil Science, V56, P575, DOI 10.1080/03650340903164231; Akhtar P, 2009, PAK J BOT, V41, P3075; Al-Mutawa M. M., 2003, International Journal of Agriculture and Biology, V5, P226; Almodares A., 2007, Journal of Biological Sciences, V7, P1492; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bahmani K., 2015, Australian Journal of Crop Science, V9, P321; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Carrasco-Rios L, 2014, CHILEAN J AGR RES, V74; CASTILLO FJ, 1984, PLANT PHYSIOL, V74, P846, DOI 10.1104/pp.74.4.846; Ceccoli G, 2011, BIOCELL, V35, P9; Chartzoulakis K, 2000, SCI HORTIC-AMSTERDAM, V86, P247, DOI 10.1016/S0304-4238(00)00151-5; Daei G, 2009, J PLANT PHYSIOL, V166, P617, DOI 10.1016/j.jplph.2008.09.013; DEMELO DF, 1994, PLANT PHYSIOL BIOCH, V32, P405; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dua R. P., 1998, Indian Journal of Plant Physiology, V3, P102; Dua RP, 1997, INDIAN J AGR SCI, V67, P440; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ebbisa A., 2015, INT J INNOVATIVE APP, V3, P1; ELSHAIENY AHAH, 2015, EUR J EXP BIOL, V5, P22; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Farhana Naz, 2014, American-Eurasian Journal of Agricultural & Environmental Sciences, V14, P1304; Flood PJ, 2011, TRENDS PLANT SCI, V16, P327, DOI 10.1016/j.tplants.2011.02.005; Flowers T. J., 1983, Inorganic plant nutrition, P651; Gregorio GB, 1997, THESIS; Gupta M, 2012, J GENET, V91, P279, DOI 10.1007/s12041-012-0180-4; Hamwieh A, 2005, THEOR APPL GENET, V110, P669, DOI 10.1007/s00122-004-1892-5; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Ikram-ul-Haq, 2012, J ZHEJIANG UNIV-SC B, V13, P533, DOI 10.1631/jzus.B1200027; Ismail A, 2014, J EXP BOT, V65, P2963, DOI 10.1093/jxb/eru159; Jain N, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200539; James RA, 2011, J EXP BOT, V62, P2939, DOI 10.1093/jxb/err003; Jin L, 2008, ACTA AGRONO SIN, V34, P1901, DOI DOI 10.1016/S1875-2780(09)60015-8; Kahraman A, 2004, CROP SCI, V44, P13, DOI 10.2135/cropsci2004.0013; Kanawapee N, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue6-fulltext-4; Kaur S, 2014, THEOR APPL GENET, V127, P703, DOI 10.1007/s00122-013-2252-0; Kitajima K., 2000, Seeds: the ecology of regeneration in plant communities, P331, DOI 10.1079/9780851994321.0331; Krishnamurthy L, 2014, PLANT SCI, V227, P51, DOI 10.1016/j.plantsci.2014.07.001; Kushwaha UKS, 2015, AGR BIOL SCI J, V1, P16; Lawson T, 2012, CURR OPIN BIOTECH, V23, P215, DOI 10.1016/j.copbio.2011.12.012; Lee DH, 2001, J PLANT PHYSIOL, V158, P737, DOI 10.1078/0176-1617-00174; Liu K, 2004, POWER MARKER NEW GEN; Lopez R, 1999, SOIL SCI PLANT NUTR, V45, P659, DOI 10.1080/00380768.1999.10415829; MAAS E V, 1986, Applied Agricultural Research, V1, P12; Mahmood A., 2008, Agriculturae Conspectus Scientificus, V73, P137; Mansuri S. M., 2012, African Journal of Biotechnology, V11, P9362; Marschner H., 1986, Mineral nutrition of higher plants.; Marti MC, 2011, J EXP BOT, V62, P3863, DOI 10.1093/jxb/err076; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Murillo-Amador B, 2000, PHYTON-INT J EXP BOT, V67, P71; Murillo-Amador B, 2001, AUST J EXP AGR, V41, P81, DOI 10.1071/EA00055; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Paz RC, 2014, PLANT BIOLOGY, V16, P1042, DOI 10.1111/plb.12156; Poustini K, 2004, FIELD CROP RES, V85, P125, DOI 10.1016/S0378-4290(03)00157-6; Pritchard JK, 2000, GENETICS, V155, P945; Rengasamy P, 2006, J EXP BOT, V57, P1017, DOI 10.1093/jxb/erj108; Rohlf F. J., 2000, NTSYS PC NUMERICAL T; Sakina A, 2015, J AGRO CROP SCI; Samineni S, 2011, ENVIRON EXP BOT, V71, P260, DOI 10.1016/j.envexpbot.2010.12.014; Sarker BC, 2015, BANGL J BOT, V44, P73; Shahbaz M, 2013, CRIT REV PLANT SCI, V32, P237, DOI 10.1080/07352689.2013.758544; Shahzad A, 2012, GENET MOL RES, V11, P679, DOI 10.4238/2012.March.19.2; Singh D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147213; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanyolac B., 2010, J AGR BIOTECHNOL SUS, V2, P1; Tavakkoli E, 2012, J EXP BOT, V63, P3853, DOI 10.1093/jxb/ers085; Tavakkoli E, 2012, FIELD CROP RES, V127, P99, DOI 10.1016/j.fcr.2011.10.016; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Unal B. T., 2014, Bulgarian Journal of Agricultural Science, V20, P883; Vadez V, 2007, FIELD CROP RES, V104, P123, DOI 10.1016/j.fcr.2007.05.014; Viegas Ricardo Almeida, 1999, Revista Brasileira de Fisiologia Vegetal, V11, P153; Wang ZF, 2011, EUPHYTICA, V178, P297, DOI 10.1007/s10681-010-0287-8; Wei WX, 2003, PLANT SOIL, V250, P183, DOI 10.1023/A:1022832107999; Zeng LH, 2004, PLANT SCI, V166, P1275, DOI 10.1016/j.plantsci.2004.01.005	78	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177465	10.1371/journal.pone.0177465	http://dx.doi.org/10.1371/journal.pone.0177465			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542267	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800018
J	Battin, C; Hennig, A; Mayrhofer, P; Kunert, R; Zlabinger, GJ; Steinberger, P; Paster, W				Battin, Claire; Hennig, Annika; Mayrhofer, Patrick; Kunert, Renate; Zlabinger, Gerhard J.; Steinberger, Peter; Paster, Wolfgang			A human monocytic NF-kappa B fluorescent reporter cell line for detection of microbial contaminants in biological samples	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNE-RESPONSE; CUTTING EDGE; ESCHERICHIA-COLI; DENDRITIC CELLS; DROSOPHILA TOLL; IN-VITRO; ACTIVATION; LIPOPOLYSACCHARIDE; RECOGNITION	Sensing of pathogens by innate immune cells is essential for the initiation of appropriate immune responses. Toll-like receptors (TLRs), which are highly sensitive for various structurally and evolutionary conserved molecules derived from microbes have a prominent role in this process. TLR engagement results in the activation of the transcription factor NF-kappa B, which induces the expression of cytokines and other inflammatory mediators. The exquisite sensitivity of TLR signalling can be exploited for the detection of bacteria and microbial contaminants in tissue cultures and in protein preparations. Here we describe a cellular reporter system for the detection of TLR ligands in biological samples. The well-characterized human monocytic THP-1 cell line was chosen as host for an NF-kappa B-inducible enhanced green fluorescent protein reporter gene. We studied the sensitivity of the resultant reporter cells for a variety of microbial components and observed a strong reactivity towards TLR1/2 and TLR2/6 ligands. Mycoplasma lipoproteins are potent TLR2/6 agonists and we demonstrate that our reporter cells can be used as reliable and robust detection system for mycoplasma contaminations in cell cultures. In addition, a TLR4-sensitive subline of our reporters was engineered, and probed with recombinant proteins expressed in different host systems. Bacterially expressed but not mammalian expressed proteins induced strong reporter activity. We also tested proteins expressed in an E. coli strain engineered to lack TLR4 agonists. Such preparations also induced reporter activation in THP-1 cells highlighting the importance of testing recombinant protein preparations for microbial contaminations beyond endotoxins. Our results demonstrate the usefulness of monocytic reporter cells for high-throughput screening for microbial contaminations in diverse biological samples, including tissue culture supernatants and recombinant protein preparations. Fluorescent reporter assays can be measured on standard flow cytometers and in contrast to established detection methods, like luciferase-based systems or Limulus Amebocyte Lysate tests, they do not require costly reagents.	[Battin, Claire; Hennig, Annika; Steinberger, Peter; Paster, Wolfgang] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, Div Immune Receptors & Cell Activat T, Vienna, Austria; [Mayrhofer, Patrick; Kunert, Renate] Univ Nat Resources & Life Sci, Dept Biotechnol, Vienna, Austria; [Zlabinger, Gerhard J.] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, Div Clin & Expt Immunol, Vienna, Austria; [Paster, Wolfgang] Childrens Canc Res Inst, Dept Clin Cell Biol, Vienna, Austria; [Paster, Wolfgang] Childrens Canc Res Inst, FACS Core Unit, Vienna, Austria	Medical University of Vienna; University of Natural Resources & Life Sciences, Vienna; Medical University of Vienna; Saint Anna Children's Hospital; Saint Anna Children's Hospital	Steinberger, P; Paster, W (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, Div Immune Receptors & Cell Activat T, Vienna, Austria.; Paster, W (corresponding author), Childrens Canc Res Inst, Dept Clin Cell Biol, Vienna, Austria.; Paster, W (corresponding author), Childrens Canc Res Inst, FACS Core Unit, Vienna, Austria.	peter.steinberger@meduniwien.ac.at; wolfgang.paster@meduniwien.ac.at	Kunert, Renate E/B-9185-2018; Mayrhofer, Patrick/M-6458-2018	Kunert, Renate E/0000-0002-3397-3621; Battin, Claire/0000-0002-0254-8032; Steinberger, Peter/0000-0001-6848-4097; Paster, Wolfgang/0000-0002-5537-2886; Mayrhofer, Patrick/0000-0003-4763-5911; Zlabinger, Gerhard/0000-0002-7478-4173	Christian Doppler Society [PA624LI001]; Austrian Science Fund (FWF) [P 25056] Funding Source: researchfish	Christian Doppler Society; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the in-house project PA624LI001 and the Christian Doppler Society (https://www.cdg.ac.at; CD10262401) awarded to P.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SE, 2010, BIOLOGICALS, V38, P211, DOI 10.1016/j.biologicals.2010.03.002; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; Chanput W, 2014, INT IMMUNOPHARMACOL, V23, P37, DOI 10.1016/j.intimp.2014.08.002; COOPER JF, 1971, J LAB CLIN MED, V78, P138; De Nardo D, 2015, CYTOKINE, V74, P181, DOI 10.1016/j.cyto.2015.02.025; Deifl S, 2014, ALLERGY, V69, P1602, DOI 10.1111/all.12501; GAY NJ, 1991, NATURE, V351, P355, DOI 10.1038/351355b0; Geng S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13436; Gualdoni GA, 2015, SCI REP-UK, V5, DOI 10.1038/srep12016; Hasan U, 2005, J IMMUNOL, V174, P2942, DOI 10.4049/jimmunol.174.5.2942; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hofer J, 2016, FASEB J, V30, P1492, DOI 10.1096/fj.15-275594; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huang CJ, 2012, J IND MICROBIOL BIOT, V39, P383, DOI 10.1007/s10295-011-1082-9; Into T, 2004, CELL MICROBIOL, V6, P187, DOI 10.1046/j.1462-5822.2003.00356.x; ISSEKUTZ AC, 1983, J IMMUNOL METHODS, V61, P275, DOI 10.1016/0022-1759(83)90221-1; Jutz S, 2016, J IMMUNOL METHODS, V430, P10, DOI 10.1016/j.jim.2016.01.007; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; Lee HK, 2002, J IMMUNOL, V168, P4012, DOI 10.4049/jimmunol.168.8.4012; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Li Y, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-016-0113-6; LOZZIO BB, 1979, LEUKEMIA RES, V3, P363, DOI 10.1016/0145-2126(79)90033-X; Mamat U, 2008, MOL MICROBIOL, V67, P633, DOI 10.1111/j.1365-2958.2007.06074.x; Mamat U, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0241-5; Margreitter C, 2016, J MOL RECOGNIT, V29, P266, DOI 10.1002/jmr.2527; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Morris MC, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00680; Muroi M, 2003, INFECT IMMUN, V71, P3221, DOI 10.1128/IAI.71.6.3221-3226.2003; Muta T, 2001, EUR J BIOCHEM, V268, P4580, DOI 10.1046/j.1432-1327.2001.02385.x; Needham BD, 2013, P NATL ACAD SCI USA, V110, P1464, DOI 10.1073/pnas.1218080110; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Okusawa T, 2004, INFECT IMMUN, V72, P1657, DOI 10.1128/IAI.72.3.1657-1665.2004; Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003; Ratzinger F, 2014, SCI REP-UK, V4, DOI 10.1038/srep07438; Rosskopf S, 2016, SCI REP-UK, V6, DOI 10.1038/srep31580; Schwarz H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113840; Seya T, 2005, J ENDOTOXIN RES, V11, P369, DOI 10.1179/096805105X67292; Siednienko Jakub, 2009, V517, P3, DOI 10.1007/978-1-59745-541-1_1; Smith DR, 2017, REV FISH BIOL FISHER, V27, P135, DOI 10.1007/s11160-016-9461-y; Steinberger P, 2004, J IMMUNOL, V172, P2352, DOI 10.4049/jimmunol.172.4.2352; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tan YH, 2014, MOL CELL, V54, P212, DOI 10.1016/j.molcel.2014.03.012; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Uphoff CC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/267678; Yoshimura A, 1999, J IMMUNOL, V163, P1; Young L, 2010, NAT PROTOC, V5, P929, DOI 10.1038/nprot.2010.43; Zakharova E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009900; Zhang CY, 2013, CELL MOL IMMUNOL, V10, P84, DOI 10.1038/cmi.2012.57	59	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178220	10.1371/journal.pone.0178220	http://dx.doi.org/10.1371/journal.pone.0178220			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542462	Green Published, Green Submitted, gold			2022-12-26	WOS:000402061500075
J	Sengupta, N; Reardon, DC; Gerard, PD; Baldwin, WS				Sengupta, Namrata; Reardon, Delaney C.; Gerard, Patrick D.; Baldwin, William S.			Exchange of polar lipids from adults to neonates in Daphnia magna: Perturbations in sphingomyelin allocation by dietary lipids and environmental toxicants	PLOS ONE			English	Article							UNSATURATED FATTY-ACIDS; NUCLEAR RECEPTOR CAR; CHOLESTEROL HOMEOSTASIS; LIFE-SPAN; DROSOPHILA; METABOLISM; REPRODUCTION; DHR96; ACTIVATION; GROWTH	Because xenosensing nuclear receptors are also lipid sensors that regulate lipid allocation, we hypothesized that toxicant-induced modulation of HR96 activity would alter lipid profiles and the balance between adult survival and neonate production following exposure in Daphnia magna. Adult daphnids were exposed to unsaturated fatty acid-and toxicant-activators or inhibitors of HR96 and later starved to test whether chemical exposure altered allocation toward survival or reproduction. The HR96 activators, linoleic acid and atrazine, decreased reproduction as expected with concomitant changes in the expression of HR96 regulated genes such as magro. The HR96 inhibitors, docosahexaenoic acid (DHA) and triclosan, increased reproduction or neonate starvation survival, respectively. However, pre-exposure to triclosan increased in neonate survival at the expense of reproductive maturation. Lipidomic analysis revealed that sphingomyelins (SM) are predominantly found in neonates and therefore we propose are important in development. DHA and triclosan increased neonatal SM, consistent with HR96' s regulation of Niemann-Pick genes. While DHA altered expression of magro, Niemann-Pick 1b, mannosidase, and other HR96-regulated genes as expected, triclosan primarily perturbed sphingomyelinase and mannosidase expression indicating different but potentially overlapping mechanisms for perturbing SM. Overall, SM appears to be a key lipid in Daphnia maturation and further support was provided by carmofur, which inhibits sphingomyelin/ceramide metabolism and in turn severely represses Daphnia maturation and initial brood production. In conclusion, toxicants can perturb lipid allocation and in turn impair development and reproduction.	[Sengupta, Namrata; Baldwin, William S.] Clemson Univ, Environm Toxicol Program, Clemson, SC 29634 USA; [Reardon, Delaney C.; Baldwin, William S.] Clemson Univ, Biol Sci, Clemson, SC 29634 USA; [Gerard, Patrick D.] Clemson Univ, Math Sci, Clemson, SC USA	Clemson University; Clemson University; Clemson University	Baldwin, WS (corresponding author), Clemson Univ, Environm Toxicol Program, Clemson, SC 29634 USA.; Baldwin, WS (corresponding author), Clemson Univ, Biol Sci, Clemson, SC 29634 USA.	Baldwin@clemson.edu			National Institute of Environmental Health Sciences, National Institutes of Health [R15ES017321]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES017321] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences, a part of the National Institutes of Health (https://www. nih.gov), Grant number: R15ES017321, received by WSB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, ANN BOOK ASTM STAND, P1, DOI [10.1520/D2216-10.N, DOI 10.1520/D2216-10.N]; Baillie-Hamilton PF, 2002, J ALTERN COMPLEM MED, V8, P185, DOI 10.1089/107555302317371479; BALDWIN WS, 1995, ENVIRON TOXICOL CHEM, V14, P945, DOI 10.1002/etc.5620140604; Barata C, 1998, FUNCT ECOL, V12, P442, DOI 10.1046/j.1365-2435.1998.00201.x; Becker C, 2005, LIMNOL OCEANOGR, V50, P388, DOI 10.4319/lo.2005.50.1.0388; Benoit JB, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100008; Boersma M, 1997, EVOL ECOL, V11, P439, DOI 10.1023/A:1018484824003; Brett MT, 2006, LIMNOL OCEANOGR, V51, P2428, DOI 10.4319/lo.2006.51.5.2428; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; Brown MR, 1997, AQUACULTURE, V151, P315, DOI 10.1016/S0044-8486(96)01501-3; Bujold M, 2010, MOL CELL BIOL, V30, P793, DOI 10.1128/MCB.01327-09; Bunescu A, 2010, MOL BIOSYST, V6, P121, DOI 10.1039/b915417e; Bychek EA, 1999, BIOCHEMISTRY-MOSCOW+, V64, P543; Catala A, 2013, J LIPIDS, V2013, DOI 10.1155/2013/710290; Chang JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145818; Chevalier J, 2015, ENVIRON TOXICOL CHEM, V34, P1760, DOI 10.1002/etc.2979; Cutler RG, 2014, MECH AGEING DEV, V143, P9, DOI 10.1016/j.mad.2014.11.002; Dong B, 2009, P NATL ACAD SCI USA, V106, P18831, DOI 10.1073/pnas.0909731106; Du X, 2015, AQUAT TOXICOL, V165, P231, DOI 10.1016/j.aquatox.2015.06.009; Ferre A P, 2004, BIOL PEROXISOME P S1, V53, pS43; Ginjupalli GK, 2015, ENVIRON TOXICOL CHEM, V34, P527, DOI 10.1002/etc.2804; Ginjupalli GK, 2013, CHEMOSPHERE, V92, P1260, DOI 10.1016/j.chemosphere.2013.04.061; Greiner-Tollersrud O., 2000, LYSOSOMAL STORAGE DI; Grun F, 2009, MOL ENDOCRINOL, V23, P1127, DOI 10.1210/me.2008-0485; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hartwich M, 2012, OIKOS, V121, P1702, DOI 10.1111/j.1600-0706.2011.20461.x; Heckmann LH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-175; Hernandez J. P., 2009, Current Pharmacogenomics & Personalized Medicine, V7, P81; Herr DR, 2003, DEVELOPMENT, V130, P2443, DOI 10.1242/dev.00456; Horner MA, 2009, GENE DEV, V23, P2711, DOI 10.1101/gad.1833609; Huang WD, 2004, J CLIN INVEST, V113, P137, DOI 10.1172/JCI200418385; Hulbert AJ, 2005, BIOL REV, V80, P155, DOI 10.1017/S1464793104006578; Isaac Giorgis, 2007, Genet Eng (N Y), V28, P129, DOI 10.1007/978-0-387-34504-8_8; Jee BC, 2011, GYNECOL OBSTET INVES, V72, P32, DOI 10.1159/000322222; John K, 2016, AM J PHYSIOL-ENDOC M, V310, pE249, DOI 10.1152/ajpendo.00478.2015; Jordao R, 2016, SCI TOTAL ENVIRON, V545, P127, DOI 10.1016/j.scitotenv.2015.12.097; Jordao R, 2015, ENVIRON HEALTH PERSP, V123, P813, DOI 10.1289/ehp.1409163; Karimullina E, 2012, AQUAT TOXICOL, V116, P69, DOI 10.1016/j.aquatox.2012.03.005; King-Jones K, 2006, CELL METAB, V4, P37, DOI 10.1016/j.cmet.2006.06.006; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Koskinen H, 2004, BIOCHEM BIOPH RES CO, V320, P745, DOI 10.1016/j.bbrc.2004.06.024; Latta LC, 2011, J EXP ZOOL PART A, V315A, P610, DOI 10.1002/jez.710; Leao BCS, 2015, THERIOGENOLOGY, V84, P127, DOI 10.1016/j.theriogenology.2015.02.023; LeBlanc GA, 2012, ENVJMMONO201223JT033, P23; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Li YC, 2014, GEN COMP ENDOCR, V206, P30, DOI 10.1016/j.ygcen.2014.07.022; Lima D, 2015, J TOXICOL ENV HEAL A, V78, P747, DOI 10.1080/15287394.2015.1028301; Litoff EJ, 2014, GENE, V552, P116, DOI 10.1016/j.gene.2014.09.024; Lu CY, 2010, J NUTR BIOCHEM, V21, P338, DOI 10.1016/j.jnutbio.2009.01.007; Lu PP, 2015, HEPATOLOGY, V61, P1908, DOI 10.1002/hep.27719; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Lynn DA, 2015, P NATL ACAD SCI USA, V112, P15378, DOI 10.1073/pnas.1514012112; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Olmstead AW, 2002, J EXP ZOOL, V293, P736, DOI 10.1002/jez.10162; Phan VH, 2007, DEV BIOL, V309, P329, DOI 10.1016/j.ydbio.2007.07.021; Pizzirani D, 2013, J MED CHEM, V56, P3518, DOI 10.1021/jm301879g; Putman A, 2015, J PLANKTON RES, V37, P752, DOI 10.1093/plankt/fbv043; Ravet JL, 2012, INLAND WATERS, V2, P199, DOI 10.5268/IW-2.4.546; Roling J.A., 2006, ENVIRON TOXICOL CHEM, V25, P62; Roth AG, 2009, ANGEW CHEM INT EDIT, V48, P7560, DOI 10.1002/anie.200903288; Sadowski MC, 2014, ONCOTARGET, V5, P9362, DOI 10.18632/oncotarget.2433; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sengupta N, 2016, CHEMOSPHERE, V144, P2302, DOI 10.1016/j.chemosphere.2015.11.015; Sengupta N, 2015, CHEMOSPHERE, V128, P299, DOI 10.1016/j.chemosphere.2015.02.027; Shindo S, 2007, BIOCHEM J, V401, P735, DOI 10.1042/BJ20061238; Sieber MH, 2012, CELL METAB, V15, P122, DOI 10.1016/j.cmet.2011.11.011; Sieber MH, 2009, CELL METAB, V10, P481, DOI 10.1016/j.cmet.2009.10.010; Spruiell K, 2014, J BIOL CHEM, V289, P3244, DOI 10.1074/jbc.M113.494575; Taipale SJ, 2011, OIKOS, V120, P1674, DOI 10.1111/j.1600-0706.2011.19415.x; Tauler R, 2016, ENVIRON SCI TECHNOL, V50, P13565; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; US EPA, 2002, METH MEAS AC TOX EFF, P266; VERRETH J, 1994, AQUACULTURE, V126, P137, DOI 10.1016/0044-8486(94)90255-0; von Elert E, 2002, LIMNOL OCEANOGR, V47, P1764, DOI 10.4319/lo.2002.47.6.1764; Wacker A, 2007, FUNCT ECOL, V21, P738, DOI 10.1111/j.1365-2435.2007.01274.x; Wahlang B, 2016, TOXICOL SCI, V149, P396, DOI 10.1093/toxsci/kfv250; Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609; Zhang YQ, 2012, MOL ENDOCRINOL, V26, P272, DOI 10.1210/me.2011-1157	78	9	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178131	10.1371/journal.pone.0178131	http://dx.doi.org/10.1371/journal.pone.0178131			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542405	Green Published, Green Submitted, gold			2022-12-26	WOS:000402061500063
J	Trudeau, MP; Verma, H; Sampedro, F; Urriola, PE; Shurson, GC; Goyal, SM				Trudeau, Michaela P.; Verma, Harsha; Sampedro, Fernando; Urriola, Pedro E.; Shurson, Gerald C.; Goyal, Sagar M.			Environmental persistence of porcine coronaviruses in feed and feed ingredients	PLOS ONE			English	Article							EPIDEMIC DIARRHEA VIRUS; HEAT-TREATMENT; RISK-FACTORS; SALMONELLA; PREVALENCE; SURVIVAL; PEDV	Porcine Epidemic Diarrhea Virus (PEDV), Porcine Delta Corona Virus (PDCoV), and Transmissible Gastroenteritis Virus (TGEV) are major threats to swine health and contaminated feed plays a role in virus transmission. The objective of our study was to characterize inactivation of PEDV, PDCoV, and TGEV in various feed ingredient matrices. Samples of complete feed, spray dried porcine plasma, meat meal, meat and bone meal, blood meal, corn, soybean meal, and corn dried distillers grains with solubles were weighed (5 g/sample) into scintillation vials and inoculated with 1 mL of PEDV, PDCoV, or TGEV. Samples were incubated at room temperature for up to 56 days. Aliquots were removed at various time points followed by preparing serial 10-fold dilutions and inoculating in cell cultures to determine the amount of surviving virus. Inactivation kinetics were determined using the Weibull model, which estimates a delta value indicating the time necessary to reduce virus concentration by 1 log. Delta values of various ingredients were compared and analyzed as to their nutrient composition. Soybean meal had the greatest delta value (7.50 days) for PEDV (P < 0.06) as compared with all other ingredients. High delta values (P < 0.001) were observed in soybean meal for PDCoV (42.04 days) and TGEV (42.00 days). There was a moderate correlation between moisture content and the delta value for PDCoV (r = 0.49, P = 0.01) and TGEV (r = 0.41, P = 0.02). There was also a moderate negative correlation between TGEV survival and ether extract content (r = -0.51, P = 0.01). In conclusion, these results indicate that the first log reduction of PDCoV and TGEV takes the greatest amount of time in soybean meal. In addition to this, moisture and ether content appear to be an important determinant of virus survival in feed ingredients.	[Trudeau, Michaela P.; Urriola, Pedro E.; Shurson, Gerald C.] Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA; [Verma, Harsha; Sampedro, Fernando; Urriola, Pedro E.; Goyal, Sagar M.] Univ Minnesota, Vet Populat Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Goyal, SM (corresponding author), Univ Minnesota, Vet Populat Med, St Paul, MN 55108 USA.	goyal001@umn.edu	Sampedro, Fernando/AAH-8332-2020	Sampedro, Fernando/0000-0003-1155-2751; Shurson, Gerald/0000-0001-7095-4799; Urriola, Pedro E/0000-0003-4090-6627	National Pork Board [14-274]	National Pork Board	This study was funded by the National Pork Board (#14-274) and awarded to SG. More information can be found at http://www.pork.org/ pork-checkoff-research/pedv/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrpt.	Alonso C, 2014, VET RES, V45, DOI 10.1186/s13567-014-0073-z; [Anonymous], 2002, J FOOD PROTECT, V65, P999; Bowman AS, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0348-2; Cavanagh D, 2005, BIRK ADV INFECT DIS, P1; Cottingim KM, 2017, PORCINE HEALTH MANAG, V3, DOI 10.1186/s40813-016-0048-8; Cottingim KM, 2015, LEM C; de Groot RJ, 2012, VIRUS TAXONOMY, P806; Dee S, 2015, PORCINE HEALTH MANAG, V1, DOI 10.1186/s40813-015-0003-0; Dee S, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0176-9; DUNCAN MS, 1972, POULTRY SCI, V51, P797, DOI 10.3382/ps.0510797; Ganwu L, 2014, GENOME ANNOUNC, V2; Geeraerd AH, 2005, INT J FOOD MICROBIOL, V102, P95, DOI 10.1016/j.ijfoodmicro.2004.11.038; Gerber PF, 2014, VET MICROBIOL, V174, P86, DOI 10.1016/j.vetmic.2014.09.008; Goyal S.M., 2013, 13 215 ENV STABILITY, P1; Huang YW, 2013, MBIO, V4, DOI 10.1128/mBio.00737-13; Jaquette CB, 1996, APPL ENVIRON MICROB, V62, P2212, DOI 10.1128/AEM.62.7.2212-2215.1996; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; Leman AD, 1986, DIS SWINE, Vxiii; Mafart P, 2002, INT J FOOD MICROBIOL, V72, P107, DOI 10.1016/S0168-1605(01)00624-9; Mertens D., 2005, OFFICIAL METHODS ANA, V18th ed., P1; Norkin LC, 2012, VIROLOGY MOL BIOL PA, P235; Pasick J, 2014, TRANSBOUND EMERG DIS, V61, P397, DOI 10.1111/tbed.12269; Podolak R, 2010, J FOOD PROTECT, V73, P1919, DOI 10.4315/0362-028X-73.10.1919; Pujols J, 2014, VET MICROBIOL, V174, P427, DOI 10.1016/j.vetmic.2014.10.021; Quist-Rybachuk GV, 2015, VET MICROBIOL, V181, P283, DOI 10.1016/j.vetmic.2015.10.010; Sampedro F, 2014, RISK ASSESSMENT FEED; Schumacher L.L., 2015, KANSAS AGR EXP STN R, V1; Torres GJ, 2011, PREV VET MED, V98, P81, DOI 10.1016/j.prevetmed.2010.11.009; Trudeau M, 2015, LEM C; Trudeau MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158128; Van Immerseel F, 2006, AVIAN PATHOL, V35, P182, DOI 10.1080/03079450600711045; Whyte P, 2003, J FOOD SAFETY, V23, P13, DOI 10.1111/j.1745-4565.2003.tb00348.x; Woode G. N., 1969, Veterinary Bulletin, V39, P239; Zhang J., 2016, VIRUS RES	34	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0178094	10.1371/journal.pone.0178094	http://dx.doi.org/10.1371/journal.pone.0178094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542235	Green Published, Green Submitted, gold			2022-12-26	WOS:000402061500061
J	Shiehzadegan, S; Thuy, JLV; Szabla, N; Angilletta, MJ; VandenBrooks, JM				Shiehzadegan, Shayan; Thuy, Jacqueline Le Vinh; Szabla, Natalia; Angilletta, Michael J., Jr.; VandenBrooks, John M.			More oxygen during development enhanced flight performance but not thermal tolerance of Drosophila melanogaster	PLOS ONE			English	Article							TEMPERATURE-DEPENDENT BIOGEOGRAPHY; DISCONTINUOUS GAS-EXCHANGE; MALE BODY-SIZE; ATMOSPHERIC OXYGEN; SPECIES PRODUCTION; DESICCATION RESISTANCE; CARBON-DIOXIDE; LIMITATION; HYPOXIA; METABOLISM	High temperatures can stress animals by raising the oxygen demand above the oxygen supply. Consequently, animals under hypoxia could be more sensitive to heating than those exposed to normoxia. Although support for this model has been limited to aquatic animals, oxygen supply might limit the heat tolerance of terrestrial animals during energetically demanding activities. We evaluated this model by studying the flight performance and heat tolerance of flies (Drosophila melanogaster) acclimated and tested at different concentrations of oxygen (12%, 21%, and 31%). We expected that flies raised at hypoxia would develop into adults that were more likely to fly under hypoxia than would flies raised at normoxia or hyperoxia. We also expected flies to benefit from greater oxygen supply during testing. These effects should have been most pronounced at high temperatures, which impair locomotor performance. Contrary to our expectations, we found little evidence that flies raised at hypoxia flew better when tested at hypoxia or tolerated extreme heat better than did flies raised at normoxia or hyperoxia. Instead, flies raised at higher oxygen levels performed better at all body temperatures and oxygen concentrations. Moreover, oxygen supply during testing had the greatest effect on flight performance at low temperature, rather than high temperature. Our results poorly support the hypothesis that oxygen supply limits performance at high temperatures, but do support the idea that hyperoxia during development improves performance of flies later in life.	[Shiehzadegan, Shayan; Thuy, Jacqueline Le Vinh; Angilletta, Michael J., Jr.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Szabla, Natalia] Jagiellonian Univ, Inst Environm Studies, Krakow, Poland; [VandenBrooks, John M.] Midwestern Univ, Dept Physiol, Glendale, AZ 85308 USA	Arizona State University; Arizona State University-Tempe; Jagiellonian University; Midwestern University	VandenBrooks, JM (corresponding author), Midwestern Univ, Dept Physiol, Glendale, AZ 85308 USA.	jvandenbrooks@midwestern.edu		Szabla, Natalia/0000-0002-2925-9580	School of Life Sciences; Barrett Honors College at Arizona State University; Midwestern University; EU resources under the European Social Fund [POKL 04.01.01-00-053/09]	School of Life Sciences; Barrett Honors College at Arizona State University; Midwestern University; EU resources under the European Social Fund	This research was funded by the School of Life Sciences, the Barrett Honors College at Arizona State University, and Midwestern University. N. Szabla was supported by project co-founded from EU resources under the European Social Fund (POKL 04.01.01-00-053/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Marcin Czarnoleski for discussions related to the ideas in this paper. This research was funded by the School of Life Sciences, the Barrett Honors College at Arizona State University, and Midwestern University. N. Szabla was supported by project co-founded from EU resources under the European Social Fund (POKL 04.01.01-00-053/09).	Alcock J, 2006, ETHOLOGY, V112, P691, DOI 10.1111/j.1439-0310.2006.01204.x; Ali SS, 2010, J BIOL CHEM, V285, P32522, DOI 10.1074/jbc.M110.155432; Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516; Bartholomew NR, 2015, SCI REP-UK, V5, DOI 10.1038/srep15298; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Boardman L, 2012, P ROY SOC B-BIOL SCI, V279, P893, DOI 10.1098/rspb.2011.1243; Bubliy OA, 2012, J EVOLUTION BIOL, V25, P1180, DOI 10.1111/j.1420-9101.2012.02506.x; BURKETT BN, 1974, BIOL BULL-US, V147, P274, DOI 10.2307/1540449; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Callier V, 2015, J EXP BIOL, V218, P2927, DOI 10.1242/jeb.125849; Centanin L, 2010, J INSECT PHYSIOL, V56, P447, DOI 10.1016/j.jinsphys.2009.05.008; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Coelho JR, 2001, J INSECT BEHAV, V14, P345, DOI 10.1023/A:1011119312500; Condon C, 2015, ECOL EVOL, V5, P1873, DOI 10.1002/ece3.1472; Ern R, 2015, SCI REPORTS, P5; Feder ME, 1999, AM ZOOL, V39, P857; Frazier MR, 2001, PHYSIOL BIOCHEM ZOOL, V74, P641, DOI 10.1086/322172; Frederich M, 2000, AM J PHYSIOL-REG I, V279, pR1531, DOI 10.1152/ajpregu.2000.279.5.R1531; Gibbs AG, 1997, J EXP BIOL, V200, P1821; Greenberg S, 1996, J INSECT PHYSIOL, V42, P991, DOI 10.1016/S0022-1910(96)00071-6; Harrison JF, 1998, J EXP BIOL, V201, P1739; Harrison JF, 2010, ATMOSPHERIC OXYGEN L; Harrison JF, 2008, MOL MIGRATION PRESSU, P293; Harrison JF, 2013, ECOL EVOL, V3, P1305, DOI 10.1002/ece3.551; Harrison JF, 2010, P ROY SOC B-BIOL SCI, V277, P1937, DOI 10.1098/rspb.2010.0001; He JZ, 2013, COMP BIOCHEM PHYS A, V165, P207, DOI 10.1016/j.cbpa.2013.03.007; Heinrich EC, 2013, J EXP BIOL, V216, P4473, DOI 10.1242/jeb.088450; Henry JR, 2004, J EXP BIOL, V207, P3559, DOI 10.1242/jeb.01189; Hetz SK, 2005, NATURE, V433, P516, DOI 10.1038/nature03106; HILLEL D., 1971, Soil and Water: Physical Principles and Processes. (Physiological Ecology: a Series of Monographs and Treatises).; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; Hulbert AJ, 2003, J EXP BIOL, V206, P2303, DOI 10.1242/jeb.00399; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; Kaiser A, 2007, P NATL ACAD SCI USA, V104, P13198, DOI 10.1073/pnas.0611544104; Klok CJ, 2009, J EVOLUTION BIOL, V22, P2496, DOI 10.1111/j.1420-9101.2009.01866.x; Klok CJ, 2010, J INSECT PHYSIOL, V56, P461, DOI 10.1016/j.jinsphys.2009.08.004; Klok CJ, 2004, J EXP BIOL, V207, P2361, DOI 10.1242/jeb.01023; Le Vinh Thuy J, 2016, BIOL LETT; Lighton JRB, 2004, J EXP BIOL, V207, P4463, DOI 10.1242/jeb.01284; Logue JA, 2000, J EXP BIOL, V203, P2105; LOUDON C, 1989, J EXP BIOL, V147, P217; MARDEN JH, 1989, ECOLOGY, V70, P496, DOI 10.2307/1937553; Matthews PGD, 2012, BIOL LETTERS, V8, P682, DOI 10.1098/rsbl.2012.0137; Matzkin LM, 2007, FLY, V1, P268, DOI 10.4161/fly.5293; McCue MD, 2013, PHYSIOL BIOCHEM ZOOL, V86, P257, DOI 10.1086/669932; Molich AB, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.10901; Peck LS, 2005, J EXP ZOOL PART A, V303A, P968, DOI 10.1002/jez.a.211; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Portner HO, 2010, J EXP BIOL, P213; R Core Team, 2021, R LANGUAGE ENV STAT; Rascon B, 2010, J EXP BIOL, V213, P3441, DOI 10.1242/jeb.044867; Samejima Y, 2010, BEHAV ECOL SOCIOBIOL, V64, P685, DOI 10.1007/s00265-009-0886-3; Serrano-Meneses MA, 2007, ANIM BEHAV, V73, P987, DOI 10.1016/j.anbehav.2006.08.012; Smith AA, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0947; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; Suarez RK, 2000, PHYSIOL BIOCHEM ZOOL, V73, P765, DOI 10.1086/318112; Van Dijk PLM, 1999, J EXP BIOL, V202, P3611; Van Voorhies WA, 2009, J EXP BIOL, V212, P3132, DOI 10.1242/jeb.031179; VandenBrooks JM, 2012, EVOL BIOL, V39, P83, DOI 10.1007/s11692-011-9138-3; Verberk WCEP, 2013, INTEGR COMP BIOL, V53, P609, DOI 10.1093/icb/ict015; Verberk WCEP, 2016, COMP BIOCHEM PHYS A, V192, P64, DOI 10.1016/j.cbpa.2015.10.020; Verberk WCEP, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0473; WIGGLESWORTH VB, 1982, TISSUE CELL, V14, P501, DOI 10.1016/0040-8166(82)90043-X; Woods HA, 1999, AM ZOOL, V39, P244; Woods HA, 2004, J EXP BIOL, V207, P2267, DOI 10.1242/jeb.00991; Zuur Alain F., 2009, P1	69	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2017	12	5							e0177827	10.1371/journal.pone.0177827	http://dx.doi.org/10.1371/journal.pone.0177827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UE	28542380	Green Published, Green Submitted, gold			2022-12-26	WOS:000402058800027
J	Huntsman, BM; Falke, JA; Savereide, JW; Bennett, KE				Huntsman, Brock M.; Falke, Jeffrey A.; Savereide, James W.; Bennett, Katrina E.			The role of density-dependent and -independent processes in spawning habitat selection by salmon in an Arctic riverscape	PLOS ONE			English	Article							CHINOOK SALMON; POPULATION-DYNAMICS; STREAM SALMONIDS; PACIFIC SALMON; CLIMATE-CHANGE; SPECIES RANGE; COMPETITION; LANDSCAPES; ABUNDANCE; IMPACTS	Density-dependent (DD) and density-independent (DI) habitat selection is strongly linked to a species' evolutionary history. Determining the relative importance of each is necessary because declining populations are not always the result of altered DI mechanisms but can often be the result of DD via a reduced carrying capacity. We developed spatially and temporally explicit models throughout the Chena River, Alaska to predict important DI mechanisms that influence Chinook salmon spawning success. We used resource-selection functions to predict suitable spawning habitat based on geomorphic characteristics, a semi-distributed water-and-energy balance hydrologic model to generate stream flow metrics, and modeled stream temperature as a function of climatic variables. Spawner counts were predicted throughout the core and periphery spawning sections of the Chena River from escapement estimates (DD) and DI variables. Additionally, we used isodar analysis to identify whether spawners actively defend spawning habitat or follow an ideal free distribution along the riverscape. Aerial counts were best explained by escapement and reference to the core or periphery, while no models with DI variables were supported in the candidate set. Furthermore, isodar plots indicated habitat selection was best explained by ideal free distributions, although there was strong evidence for active defense of core spawning habitat. Our results are surprising, given salmon commonly defend spawning resources, and are likely due to competition occurring at finer spatial scales than addressed in this study.	[Huntsman, Brock M.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Falke, Jeffrey A.] Univ Alaska Fairbanks, US Geol Survey, Alaska Cooperat Fish & Wildlife Res Unit, Fairbanks, AK USA; [Savereide, James W.] Alaska Dept Fish & Game, Div Sport Fish, Fairbanks, AK USA; [Bennett, Katrina E.] Los Alamos Natl Lab, Los Alamos, NM USA; [Huntsman, Brock M.] New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA	University of Alaska System; University of Alaska Fairbanks; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks; Alaska Department of Fish & Game; United States Department of Energy (DOE); Los Alamos National Laboratory; New Mexico State University	Huntsman, BM (corresponding author), Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA.; Huntsman, BM (corresponding author), New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA.	brockhunts@gmail.com	Bennett, Katrina/AAE-6105-2019	Huntsman, Brock/0000-0003-4090-1949	State of Alaska; ADFG through the Chinook Salmon Research Initiative [G00008902-337930]	State of Alaska; ADFG through the Chinook Salmon Research Initiative	Funding for this research was provided by the State of Alaska and ADFG through the Chinook Salmon Research Initiative, grant awarded to Jeffrey A. Falke (Award #: G00008902-337930).	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Achord S, 2003, ECOL LETT, V6, P335, DOI 10.1046/j.1461-0248.2003.00438.x; ADFG Chinook Salmon Research Team, 2013, ADFG SPEC PUBL; Anderson JH, 2007, CAN J FISH AQUAT SCI, V64, P1143, DOI 10.1139/F07-087; [Anonymous], 1993, INTRO BOOTSTRAP; Barton K., 2015, MUMIN MULTIMODEL INF; Battin J, 2007, P NATL ACAD SCI USA, V104, P6720, DOI 10.1073/pnas.0701685104; Benda L, 2007, FOREST SCI, V53, P206; Bennett KE, 2015, J HYDROL, V527, P590, DOI 10.1016/j.jhydrol.2015.04.065; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Busch DS, 2013, RIVER RES APPL, V29, P297, DOI 10.1002/rra.1597; Casini M, 2012, P NATL ACAD SCI USA, V109, P8185, DOI 10.1073/pnas.1113286109; Charnov E, 1976, OPTIMAL FORAGING MAR, V9, P129; Clarke SE, 2008, J AM WATER RESOUR AS, V44, P459, DOI 10.1111/j.1752-1688.2008.00175.x; Connor EJ, 2004, N AM J FISH MANAGE, V24, P835, DOI 10.1577/M03-066.1; Cram JM, 2013, ENVIRON BIOL FISH, V96, P109, DOI 10.1007/s10641-012-0026-1; Crozier L, 2006, J ANIM ECOL, V75, P1100, DOI 10.1111/j.1365-2656.2006.01130.x; Crozier LG, 2010, J ANIM ECOL, V79, P342, DOI 10.1111/j.1365-2656.2009.01641.x; Decker S. J., 2010, THESIS; Dupuch A, 2014, OECOLOGIA, V174, P403, DOI 10.1007/s00442-013-2792-7; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Falcy MR, 2015, J ANIM ECOL, V84, P545, DOI 10.1111/1365-2656.12297; Falke JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079232; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gillis DM, 2012, CAN J FISH AQUAT SCI, V69, P1610, DOI 10.1139/F2012-091; Good TP, 2005, UPDATED STATUS FEDER; Grossman GD, 2013, ECOL MONOGR, V76, P217; Guo QF, 2005, OIKOS, V108, P47, DOI 10.1111/j.0030-1299.2005.13149.x; Halliday WD, 2014, J ZOOL, V294, P198, DOI 10.1111/jzo.12168; Halliday WD, 2016, OECOLOGIA, V181, P841, DOI 10.1007/s00442-016-3605-6; Heard William R., 2007, North Pacific Anadromous Fish Commission Bulletin, V4, P77; Hedger RD, 2005, J FISH BIOL, V67, P1054, DOI 10.1111/j.0022-1112.2005.00808.x; Hilborn R, 2013, P NATL ACAD SCI USA, V110, P6618, DOI 10.1073/pnas.1303653110; Hughes NF, 1998, ECOLOGY, V79, P281, DOI 10.1890/0012-9658(1998)079[0281:AMOHSB]2.0.CO;2; Huntsman BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091673; Jarema SI, 2009, GLOBAL CHANGE BIOL, V15, P508, DOI 10.1111/j.1365-2486.2008.01732.x; Keefer ML, 2015, J THERM BIOL, V48, P11, DOI 10.1016/j.jtherbio.2014.12.002; Keefer ML, 2014, REV FISH BIOL FISHER, V24, P333, DOI 10.1007/s11160-013-9334-6; Knight TW, 2008, ISR J ECOL EVOL, V54, P345, DOI 10.1560/IJEE.54.3-4.345; Knight TW, 1996, ECOLOGY, V77, P1756, DOI 10.2307/2265781; Liang X, 1994, J GEOPHYS RES-ATMOS, V99, P14415, DOI 10.1029/94JD00483; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; Matter AN, 2016, THESIS; Merkle JA, 2015, ECOLOGY, V96, P1793, DOI 10.1890/14-0805.1; Morita K, 2004, J APPL ECOL, V41, P962, DOI 10.1111/j.0021-8901.2004.00927.x; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; Morris DW, 2003, WILDLIFE RES, V30, P303, DOI 10.1071/WR02028; Morris DW, 2002, ECOLOGY, V83, P14; MORRIS DW, 1988, EVOL ECOL, V2, P253, DOI 10.1007/BF02214286; MORRIS DW, 1994, EVOL ECOL, V8, P387, DOI 10.1007/BF01238190; Morris DW, 1996, ECOLOGY, V77, P2352, DOI 10.2307/2265737; Moses MM, 2013, EVOL ECOL RES, V15, P809; Nelson GL, 1978, HYDROLOGIC INFORM LA; Neuswanger JR, 2015, CAN J FISH AQUAT SCI, V72, P1125, DOI 10.1139/cjfas-2014-0498; Neville HM, 2006, MOL ECOL, V15, P4589, DOI 10.1111/j.1365-294X.2006.03082.x; Nielson RM, 2013, ECOL EVOL, V3, P2233, DOI 10.1002/ece3.617; Nowicki P, 2009, OECOLOGIA, V161, P227, DOI 10.1007/s00442-009-1373-2; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Previtali MA, 2009, ECOLOGY, V90, P1996, DOI 10.1890/08-0405.1; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Pulliam RH, 1991, AM NAT             S, V137, P50; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; RODRIGUEZ MA, 1995, EVOL ECOL, V9, P169, DOI 10.1007/BF01237755; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; Savereide J.W., 2010, FISHERY DATA SERIES; Shochat E, 2005, OIKOS, V111, P159, DOI 10.1111/j.0030-1299.2005.13907.x; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Torgersen CE, 1999, ECOL APPL, V9, P301, DOI 10.1890/1051-0761(1999)009[0301:MTRASH]2.0.CO;2; Turchin P, 1999, OIKOS, V84, P153, DOI 10.2307/3546876; Turchin Peter, 1995, P19, DOI 10.1016/B978-012159270-7/50003-8; van Beest FM, 2014, J ANIM ECOL, V83, P147, DOI 10.1111/1365-2656.12115; van de Pol M, 2010, ECOLOGY, V91, P1192, DOI 10.1890/09-0410.1; VANDENBERGHE EP, 1989, EVOLUTION, V43, P125, DOI 10.1111/j.1558-5646.1989.tb04212.x; Venables WN, 2002, RANDOM MIXED EFFECTS; Walters AW, 2013, ECOL FRESHW FISH, V22, P508, DOI 10.1111/eff.12046; Ward EJ, 2015, GLOBAL CHANGE BIOL, V21, P2500, DOI 10.1111/gcb.12847; Wenger SJ, 2010, WATER RESOUR RES, V46, P10; Westley PAH, 2015, ECOLOGY, V96, P2823, DOI 10.1890/14-1630.1.sm; Williams CK, 2003, ECOLOGY, V84, P2654, DOI 10.1890/03-0038; Zuur A. F., 2013, BEGINNERS GUIDE GLM; Zuur AF, 2009, STAT BIOL HLTH, P269	84	12	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177467	10.1371/journal.pone.0177467	http://dx.doi.org/10.1371/journal.pone.0177467			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531202	gold, Green Submitted, Green Published			2022-12-26	WOS:000402058400018
J	Li, YW; Chiang, KY; Li, YH; Wu, SY; Liu, WT; Lin, CR; Wu, JL				Li, Ya-Wen; Chiang, Keng-Yu; Li, Yen-Hsing; Wu, Sung-Yu; Liu, Wangta; Lin, Chia-Ray; Wu, Jen-Leih			MiR-145 mediates zebrafish hepatic outgrowth through progranulin A signaling	PLOS ONE			English	Article							GRANULIN-EPITHELIN PRECURSOR; FRONTOTEMPORAL LOBAR DEGENERATION; HUMAN HEPATOCELLULAR-CARCINOMA; CANCER CELL-PROLIFERATION; HUMAN OVARIAN-CANCER; HUMAN BREAST-CANCER; GROWTH-FACTOR; EMBRYONIC-DEVELOPMENT; GENE-EXPRESSION; LIVER SPECIFICATION	MicroRNAs (miRs) are mRNA-regulatory molecules that fine-tune gene expression and modulate both processes of development and tumorigenesis. Our previous studies identified progranulin A (GrnA) as a growth factor which induces zebrafish hepatic outgrowth through MET signaling. We also found that miR-145 is one of potential fine-tuning regulators of GrnA involved in embryonic hepatic outgrowth. The low level of miR-145 seen in hepatocarinogenesis has been shown to promote pathological liver growth. However, little is known about the regulatory mechanism of miR-145 in embryonic liver development. In this study, we demonstrate a significant decrease in miR-145 expression during hepatogenesis. We modulate miR-145 expression in zebrafish embryos by injection with a miR-145 mimic or a miR-145 hairpin inhibitor. Altered embryonic liver outgrowth is observed in response to miR-145 expression modulation. We also confirm a critical role of miR-145 in hepatic outgrowth by using whole-mount in situ hybridization. Loss of miR-145 expression in embryos results in hepatic cell proliferation, and vice versa. Furthermore, we demonstrate that GrnA is a target of miR-145 and GrnA-induced MET signaling is also regulated by miR-145 as determined by luciferase reporter assay and gene expression analysis, respectively. In addition, co-injection of GrnA mRNA with miR-145 mimic or MO-GrnA with miR-145 inhibitor restores the liver defects caused by dysregulation of miR-145 expression. In conclusion, our findings suggest an important role of miR-145 in regulating GrnA-dependent hepatic outgrowth in zebrafish embryonic development.	[Li, Ya-Wen; Wu, Jen-Leih] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Li, Ya-Wen; Chiang, Keng-Yu; Wu, Sung-Yu; Lin, Chia-Ray; Wu, Jen-Leih] Acad Sinica, Inst Cellular & Organism Biol, Taipei, Taiwan; [Chiang, Keng-Yu] Natl Taiwan Univ, Dept Life Sci, Taipei, Taiwan; [Li, Yen-Hsing] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Liu, Wangta] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Liu, Wangta] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan; [Liu, Wangta] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan; [Liu, Wangta] Kaohsiung Med Univ, Lipid Sci & Aging Res Ctr, Kaohsiung, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan; National Taiwan University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University	Wu, JL (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.; Wu, JL (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei, Taiwan.	jlwu@gate.sinica.edu.tw			Ministry of Science and Technology (MOST) in Taiwan [104-2313-B-001-005]; Ministry of Science and Technology (MOST)	Ministry of Science and Technology (MOST) in Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China)	This research is supported by grant 104-2313-B-001-005 from the Ministry of Science and Technology (MOST) in Taiwan.; We thank the Taiwan Zebrafish Core Facility at Academia Sinica (TZCAS) is supported from the Ministry of Science and Technology (MOST) for zebrafish embryos and the Taiwan Mouse Clinic is supported from the National Research Program for Biopharmaceuticals (NRPB) at the Ministry of Science and Technology (MOST) for technical support. We thank Core Facility of the ICOB, Ms. Shin-Yi Du for technical support. We thank Prof. Jung San Huang in Saint Louis University for manuscript editing.	BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; Bogue CW, 2000, DEV DYNAM, V219, P84, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1028>3.0.CO;2-5; Boufraqech M, 2014, ENDOCR-RELAT CANCER, V21, P517, DOI 10.1530/ERC-14-0077; Breuhahn K, 2006, ONCOGENE, V25, P3787, DOI 10.1038/sj.onc.1209556; Cadieux B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-156; Chen Z, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-151; Cheung ST, 2004, CLIN CANCER RES, V10, P7629, DOI 10.1158/1078-0432.CCR-04-0960; Cho WCS, 2011, RNA BIOL, V8, P125, DOI 10.4161/rna.8.1.14259; Coolen M, 2012, DEV CELL, V22, P1052, DOI 10.1016/j.devcel.2012.03.003; Cuevas-Antonio R, 2010, CANCER INVEST, V28, P452, DOI 10.3109/07357900903346455; Donald CD, 2001, ANTICANCER RES, V21, P3739; Duncan SA, 2003, MECH DEVELOP, V120, P19, DOI 10.1016/S0925-4773(02)00328-3; Frampton G, 2012, GUT, V61, P268, DOI 10.1136/gutjnl-2011-300643; Gao P, 2011, J HEPATOL, V54, P1177, DOI 10.1016/j.jhep.2010.09.023; Goedert M, 2006, BRAIN, V129, P2808, DOI 10.1093/brain/awl291; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Hand NJ, 2009, HEPATOLOGY, V49, P618, DOI 10.1002/hep.22656; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Her GM, 2003, FEBS LETT, V538, P125, DOI 10.1016/S0014-5793(03)00157-1; Ho JC, 2008, HEPATOLOGY, V47, P1524, DOI 10.1002/hep.22191; Huang CX, 2015, FASEB J, V29, P4901, DOI 10.1096/fj.14-267104; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Karlsson J, 2001, MAR BIOTECHNOL, V3, P522, DOI 10.1007/s1012601-0053-4; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Laudadio I, 2012, GASTROENTEROLOGY, V142, P119, DOI 10.1053/j.gastro.2011.09.001; Law PTY, 2012, CARCINOGENESIS, V33, P1134, DOI 10.1093/carcin/bgs130; Li YH, 2010, J BIOL CHEM, V285, P41001, DOI 10.1074/jbc.M110.138743; Lu RQ, 2001, P NATL ACAD SCI USA, V98, P142, DOI 10.1073/pnas.011525198; Lu Y, 2014, GYNECOL ONCOL, V134, P364, DOI 10.1016/j.ygyno.2014.05.025; Lu Y, 2013, ONCOL REP, V29, P67, DOI 10.3892/or.2012.2084; Mackenzie IRA, 2006, BRAIN, V129, P3081, DOI 10.1093/brain/awl271; Noh JH, 2013, CANCER LETT, V335, P455, DOI 10.1016/j.canlet.2013.03.003; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Ong CHP, 2003, HISTOL HISTOPATHOL, V18, P1275, DOI 10.14670/HH-18.1275; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Smalheiser NR, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-139; Sun ZX, 2001, GENE DEV, V15, P3217, DOI 10.1101/gad946701; Tan XP, 2008, HEPATOLOGY, V47, P1667, DOI 10.1002/hep.22225; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu HJ, 2013, BIOCHEM BIOPH RES CO, V441, P693, DOI 10.1016/j.bbrc.2013.10.053; Xiong XK, 2015, BIOCHEM BIOPH RES CO, V465, P262, DOI 10.1016/j.bbrc.2015.08.013; Yan WJ, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/673108; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zeng L, 2009, P NATL ACAD SCI USA, V106, P17793, DOI 10.1073/pnas.0903693106; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	51	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177887	10.1371/journal.pone.0177887	http://dx.doi.org/10.1371/journal.pone.0177887			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531199	Green Submitted, Green Published, gold			2022-12-26	WOS:000402058400035
J	Dagnino-Leone, J; Figueroa, M; Mella, C; Vorphal, MA; Kerff, F; Vasquez, AJ; Bunster, M; Martinez-Oyanedel, J				Dagnino-Leone, Jorge; Figueroa, Maximiliano; Mella, Claudia; Alejandra Vorphal, Maria; Kerff, Frederic; Jose Vasquez, Aleikar; Bunster, Marta; Martinez-Oyanedel, Jose			Structural models of the different trimers present in the core of phycobilisomes from Gracilaria chilensis based on crystal structures and sequences	PLOS ONE			English	Article							TERMINAL ENERGY ACCEPTOR; CYANOBACTERIAL PHYCOBILISOMES; CONFORMATIONAL FLEXIBILITY; MOLECULAR CHARACTERIZATION; 2.2 ANGSTROM; L-CM; LIGHT; ALLOPHYCOCYANIN; LINKER; PHYCOCYANOBILIN	Phycobilisomes (PBS) are accessory light harvesting protein complexes that directionally transfer energy towards photosystems. Phycobilisomes are organized in a central core and rods radiating from it. Components of phycobilisomes in Gracilaria chilensis (Gch) are Phycobiliproteins (PBPs), Phycoerythrin (PE), and Phycocyanin (PC) in the rods, while Allophycocyanin (APC) is found in the core, and linker proteins (L). The function of such complexes depends on the structure of each component and their interaction. The core of PBS from cyanobacteria is mainly composed by cylinders of trimers of alpha and beta subunits forming heterodimers of Allophycocyanin, and other components of the core including subunits alpha(II) and beta(18). As for the linkers, Linker core (L-C) and Linker core membrane (L-CM) are essential for the final emission towards photoreaction centers. Since we have previously focused our studies on the rods of the PBS, in the present article we investigated the components of the core in the phycobilisome from the eukaryotic algae, Gracilaria chilensis and their organization into trimers. Transmission electron microscopy provided the information for a three cylinders core, while the three dimensional structure of Allophycocyanin purified from Gch was determined by X-ray diffraction method and the biological unit was determined as a trimer by size exclusion chromatography. The protein sequences of all the components of the core were obtained by sequencing the corresponding genes and their expression confirmed by transcriptomic analysis. These subunits have seldom been reported in red algae, but not in Gracilaria chilensis. The subunits not present in the crystallographic structure were modeled to build the different composition of trimers. This article proposes structural models for the different types of trimers present in the core of phycobilisomes of Gch as a first step towards the final model for energy transfer in this system.	[Dagnino-Leone, Jorge; Figueroa, Maximiliano; Mella, Claudia; Alejandra Vorphal, Maria; Jose Vasquez, Aleikar; Bunster, Marta; Martinez-Oyanedel, Jose] Univ Concepcion, Fac Ciencias Biol, Dept Bioquim & Biol Mol, Concepcion, Chile; [Kerff, Frederic] Univ Liege, Ctr Ingn Proteines, Liege, Belgium	Universidad de Concepcion; University of Liege	Bunster, M; Martinez-Oyanedel, J (corresponding author), Univ Concepcion, Fac Ciencias Biol, Dept Bioquim & Biol Mol, Concepcion, Chile.	mbunster@udec.cl; jmartine@udec.cl		Bunster, Marta/0000-0002-2261-2484; Dagnino-Leone, Jorge/0000-0002-5354-6782	FONDECYT [113.0256]; FONDECYT Doctoral [21120260]; CONICYT scholarship	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDECYT Doctoral; CONICYT scholarship(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by FONDECYT 113.0256 grant to MB, FONDECYT Doctoral grant 21120260 to JDL, CONICYT scholarship to JDL and CR_Lab Biofisica Molecular 2015-2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; Adir N., 2006, COMPLEX INTRACELLULA, VVolume 2, P47; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Vorphal MA, 2017, MAR GENOM, V31, P17, DOI 10.1016/j.margen.2016.11.001; Arteni AA, 2009, BBA-BIOENERGETICS, V1787, P272, DOI 10.1016/j.bbabio.2009.01.009; BIRD CJ, 1986, CAN J BOT, V64, P2928, DOI 10.1139/b86-387; CAPUANO V, 1991, J BIOL CHEM, V266, P7239; Chang LF, 2015, CELL RES, V25, P726, DOI 10.1038/cr.2015.59; Collen J, 2013, P NATL ACAD SCI USA, V110, P5247, DOI 10.1073/pnas.1221259110; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Contreras-Martel C, 2001, ACTA CRYSTALLOGR D, V57, P52, DOI 10.1107/S0907444900015274; Contreras-Martel C, 2007, BIOPHYS CHEM, V125, P388, DOI 10.1016/j.bpc.2006.09.014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Figueroa M, 2012, PROTEIN SCI, V21, P1921, DOI 10.1002/pro.2176; Frisch MJ, GAUSSIAN 09 REV A, V1; Gao X, 2012, MOL MICROBIOL, V85, P907, DOI 10.1111/j.1365-2958.2012.08152.x; GLAZER AN, 1989, J BIOL CHEM, V264, P1; Goller AH, 2001, CHEMPHYSCHEM, V2, P665, DOI 10.1002/1439-7641(20011119)2:11<665::AID-CPHC665>3.0.CO;2-O; Guan XY, 2007, INT J BIOL SCI, V3, P434; Hagopian JC, 2004, J MOL EVOL, V59, P464, DOI 10.1007/s00239-004-2638-3; Harris D, 2016, P NATL ACAD SCI USA, V113, pE1655, DOI 10.1073/pnas.1523680113; HOUMARD J, 1990, P NATL ACAD SCI USA, V87, P2152, DOI 10.1073/pnas.87.6.2152; Jallet D, 2012, BBA-BIOENERGETICS, V1817, P1418, DOI 10.1016/j.bbabio.2011.11.020; Kuzminov FI, 2014, J PHOTOCH PHOTOBIO B, V133, P153, DOI 10.1016/j.jphotobiol.2014.03.012; Liu JY, 1999, J BIOL CHEM, V274, P16945, DOI 10.1074/jbc.274.24.16945; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUNDELL DJ, 1983, J BIOL CHEM, V258, P902; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; MacColl R, 2004, BBA-BIOENERGETICS, V1657, P73, DOI 10.1016/j.bbabio.2004.04.005; MAXSON P, 1989, BIOCHIM BIOPHYS ACTA, V977, P40, DOI 10.1016/S0005-2728(89)80007-6; Mullineaux CW, 2008, PHOTOSYNTH RES, V95, P175, DOI 10.1007/s11120-007-9249-y; Piovesan D, 2017, NUCLEIC ACIDS RES, V45, pD1123, DOI 10.1093/nar/gkw1279; Reuter W, 1999, P NATL ACAD SCI USA, V96, P1363, DOI 10.1073/pnas.96.4.1363; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; Sun L, 2009, BACTERIOL RES DEV, P105; Tal O, 2014, J BIOL CHEM; Tang K, 2015, P NATL ACAD SCI USA, V112, P15880, DOI 10.1073/pnas.1519177113; Tu PH, 2009, J MOL STRUC-THEOCHEM, V894, P9, DOI 10.1016/j.theochem.2008.09.034; Watanabe M, 2013, PHOTOSYNTH RES, V116, P265, DOI 10.1007/s11120-013-9905-3; Webb B., 2002, CURRENT PROTOCOLS BI; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Zhao KH, 2005, BBA-BIOENERGETICS, V1706, P81, DOI 10.1016/j.bbabio.2004.09.008	43	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177540	10.1371/journal.pone.0177540	http://dx.doi.org/10.1371/journal.pone.0177540			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542288	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400051
J	Olson, LE; Squires, JR; Oakleaf, RJ; Wallace, ZP; Kennedy, PL				Olson, Lucretia E.; Squires, John R.; Oakleaf, Robert J.; Wallace, Zachary P.; Kennedy, Patricia L.			Predicting above-ground density and distribution of small mammal prey species at large spatial scales	PLOS ONE			English	Article							FERRUGINOUS HAWKS; PRESENCE-ABSENCE; TERM DECLINE; GREAT-BASIN; ABUNDANCE; POPULATION; VEGETATION; PRODUCTIVITY; RESPONSES; ECOSYSTEM	Grassland and shrub-steppe ecosystems are increasingly threatened by anthropogenic activities. Loss of native habitats may negatively impact important small mammal prey species. Little information, however, is available on the impact of habitat variability on density of small mammal prey species at broad spatial scales. We examined the relationship between small mammal density and remotely-sensed environmental covariates in shrub-steppe and grassland ecosystems in Wyoming, USA. We sampled four sciurid and leporid species groups using line transect methods, and used hierarchical distance-sampling to model density in response to variation in vegetation, climate, topographic, and anthropogenic variables, while accounting for variation in detection probability. We created spatial predictions of each species' density and distribution. Sciurid and leporid species exhibited mixed responses to vegetation, such that changes to native habitat will likely affect prey species differently. Density of white-tailed prairie dogs (Cynomys leucurus), Wyoming ground squirrels (Urocitellus elegans), and leporids correlated negatively with proportion of shrub or sagebrush cover and positively with herbaceous cover or bare ground, whereas least chipmunks showed a positive correlation with shrub cover and a negative correlation with herbaceous cover. Spatial predictions from our models provide a landscape-scale metric of above-ground prey density, which will facilitate the development of conservation plans for these taxa and their predators at spatial scales relevant to management.	[Olson, Lucretia E.; Squires, John R.] US Forest Serv, Rocky Mt Res Stn, USDA, Missoula, MT 59804 USA; [Oakleaf, Robert J.] Wyoming Game & Fish Dept, Lander, WY USA; [Wallace, Zachary P.; Kennedy, Patricia L.] Oregon State Univ, Dept Fisheries & Wildlife & Eastern Oregon Agr, Union, OR USA; [Wallace, Zachary P.; Kennedy, Patricia L.] Oregon State Univ, Nat Resource Program, Union, OR USA; [Wallace, Zachary P.] Univ Wyoming, Wyoming Nat Divers Database, Laramie, WY 82071 USA	United States Department of Agriculture (USDA); United States Forest Service; Oregon State University; Oregon State University; University of Wyoming	Olson, LE (corresponding author), US Forest Serv, Rocky Mt Res Stn, USDA, Missoula, MT 59804 USA.	lucretiaolson@fs.fed.us			United States Forest Service Rocky Mountain Research Station; Bureau of Land Management; Wyoming Game and Fish Department; Wyoming Wildlife Heritage Foundation; PacifiCorp; Pathfinder Renewable Wind Energy, LLC; Wyoming Governor's Office	United States Forest Service Rocky Mountain Research Station; Bureau of Land Management; Wyoming Game and Fish Department; Wyoming Wildlife Heritage Foundation; PacifiCorp; Pathfinder Renewable Wind Energy, LLC; Wyoming Governor's Office	Funding sources include United States Forest Service Rocky Mountain Research Station, Bureau of Land Management, Wyoming Game and Fish Department, Wyoming Wildlife Heritage Foundation, PacifiCorp, Pathfinder Renewable Wind Energy, LLC, and the Wyoming Governor's Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS LW, 1983, J APPL ECOL, V20, P403, DOI 10.2307/2403516; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson JE, 2001, ECOL MONOGR, V71, P531, DOI 10.1890/0012-9615(2001)071[0531:LSCIPS]2.0.CO;2; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Baker BW, 2013, ECOGRAPHY, V36, P230, DOI 10.1111/j.1600-0587.2012.07614.x; Beetle AA, 1982, AGRICULTRAL EXTENSIO, V779; Bradley Robert D., 2014, Occasional Papers Museum of Texas Tech University, V327, P1; Bruggeman JE, 2015, ECOL APPL, V25, P1932, DOI 10.1890/14-1591.1; Buckland S. T., 2001, INTRODUCTION TO DIST; Burnham K. P., 2002, MODEL SELECTION AND; CHAPMAN J A, 1978, Mammalian Species, P1; CLARK T W, 1970, Great Basin Naturalist, V30, P55; CLARK T W, 1971, Mammalian Species, V7, P1; Clark TW, 1987, MAMMALS IN WYOMING; Collins C. P., 2005, FERRUGINOUS HAWK BUT; Conn PB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141416; Copeland HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007400; Dail D, 2011, BIOMETRICS, V67, P577, DOI 10.1111/j.1541-0420.2010.01465.x; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Davies KW, 2011, BIOL CONSERV, V144, P2573, DOI 10.1016/j.biocon.2011.07.016; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Fedy BC, 2011, OECOLOGIA, V165, P915, DOI 10.1007/s00442-010-1768-0; Finn S.P., 2011, SAGEBRUSH ECOSYSTEM, P69; Fiske IJ, 2011, J STAT SOFTW, V43, P1; FLINDERS JT, 1975, J RANGE MANAGE, V28, P290, DOI 10.2307/3897779; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; GRANT WE, 1982, J MAMMAL, V63, P248, DOI 10.2307/1380634; Hanser S. E., 2011, SAGEBRUSH ECOSYSTEM, P337; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Homer CG, 2012, INT J APPL EARTH OBS, V14, P233, DOI 10.1016/j.jag.2011.09.012; HONEYCUTT RL, 1981, SOUTHWEST NAT, V26, P295, DOI 10.2307/3670908; JAKSIC FM, 1992, OECOLOGIA, V89, P90, DOI 10.1007/BF00319020; Jenness J, 2013, DEM SURFACE TOOLS FO; Jenness J, 2013, JENNESS ENTERP; Joseph LN, 2006, CONSERV BIOL, V20, P1679, DOI 10.1111/j.1523-1739.2006.00529.x; Keeley WH, 2016, J WILDLIFE MANAGE, V80, P1479, DOI 10.1002/jwmg.21130; Keinath DA, 2010, REPORT PREPARED FOR; Kery M, 2013, J BIOGEOGR, V40, P1463, DOI 10.1111/jbi.12087; Klute DS, 2003, BIOLOGICAL TECHNICAL; Knapp PA, 1996, GLOBAL ENVIRON CHANG, V6, P37, DOI 10.1016/0959-3780(95)00112-3; Knick ST, 2003, CONDOR, V105, P611, DOI 10.1650/7329; Knight D. H., 2014, MOUNTAINS AND PLAINS; Langen TA, 2015, WILDL MANAGE CONSERV, P57; LIM B K, 1987, Mammalian Species, P1, DOI 10.2307/3504001; MACLAREN PA, 1988, GREAT BASIN NAT, V48, P548; Noss RF, 1995, BIOLOGICAL REPORT 28; Nupp TE, 2000, J MAMMAL, V81, P512, DOI 10.1644/1545-1542(2000)081&lt;0512:LLCOSM&gt;2.0.CO;2; Olson LE, 2015, J RAPTOR RES, V49, P400, DOI 10.3356/rapt-49-04-400-412.1; Orrock JL, 2000, ECOL APPL, V10, P1356, DOI 10.1890/1051-0761(2000)010[1356:PPAAOA]2.0.CO;2; PARMENTER RR, 1983, OECOLOGIA, V59, P145, DOI 10.1007/BF00378831; Parmenter RR, 2003, ECOL MONOGR, V73, P1, DOI 10.1890/0012-9615(2003)073[0001:SMDEAF]2.0.CO;2; Pollock JF, 2006, CONSERV BIOL, V20, P882, DOI 10.1111/j.1523-1739.2006.00342.x; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; R. Core Team, 2015, R A LANGUAGE AND ENV; Reeves MC, 2006, RANGELAND ECOL MANAG, V59, P1, DOI 10.2111/1551-5028(2006)59[001:AIEOMP]2.0.CO;2; Rodewald P., 2015, BIRDS N AM; ROGOWITZ GL, 1991, J MAMMAL, V72, P796, DOI 10.2307/1381846; Rowland Mary M., 2010, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P673; Royle JA, 2004, ECOLOGY, V85, P1591, DOI 10.1890/03-3127; Ryall KL, 2006, ECOLOGY, V87, P1086, DOI 10.1890/0012-9658(2006)87[1086:ROPTLA]2.0.CO;2; Schmutz JK, 2008, J WILDLIFE MANAGE, V72, P1352, DOI 10.2193/2007-231; Schwarz CJ, 1999, STAT SCI, V14, P427; Sillett TS, 2012, ECOL APPL, V22, P1997, DOI 10.1890/11-1400.1; SMITH GW, 1985, J WILDLIFE MANAGE, V49, P699, DOI 10.2307/3801698; STEENHOF K, 1988, J ANIM ECOL, V57, P37, DOI 10.2307/4761; Steenweg R, 2016, BIOL CONSERV, V201, P192, DOI 10.1016/j.biocon.2016.06.020; Stokes EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010294; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Turner MG, 1989, LANDSCAPE ECOL, V3, P153, DOI 10.1007/BF00131534; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; Verts B.J., 2001, Mammalian Species, V653, P1, DOI 10.1644/1545-1410(2001)653<0001:TM>2.0.CO;2; Wallace ZP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152977; Wallace ZP, 2016, J WILDLIFE MANAGE, V80, P78, DOI 10.1002/jwmg.1000; Wang J, 2001, INT J REMOTE SENS, V22, P3827, DOI 10.1080/01431160010007033; Weiss A., 2001, P ESRI US C; Weller C., 2002, FRAGMENTING OUR LAND; West N. E., 1999, SAGEBRUSH STEPPE ECO, P15; White PJ, 1996, J MAMMAL, V77, P370, DOI 10.2307/1382810; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; WOFFINDEN ND, 1989, J WILDLIFE MANAGE, V53, P1127, DOI 10.2307/3809619; Zegers D.A., 1984, Mammalian Species, P1, DOI 10.2307/3503955	81	5	5	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0177165	10.1371/journal.pone.0177165	http://dx.doi.org/10.1371/journal.pone.0177165			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520757	Green Published, gold, Green Submitted			2022-12-26	WOS:000401487700039
J	Medland, NA; Chow, EPF; McMahon, JH; Elliott, JH; Hoy, JF; Fairley, CK				Medland, Nicholas A.; Chow, Eric P. F.; McMahon, James H.; Elliott, Julian H.; Hoy, Jennifer F.; Fairley, Christopher K.			Time from HIV diagnosis to commencement of antiretroviral therapy as an indicator to supplement the HIV cascade: Dramatic fall from 2011 to 2015	PLOS ONE			English	Article							PREVENTION; CARE	Introduction The HIV care cascade is increasingly used to evaluate HIV treatment programs at the population level. However, the cascade indicators lack the ability to show changes over time, which reduces their utility to guide health policy. Alternatives have been proposed but are complex or result in a delay in results. We propose a new indicator of ART uptake, the time from HIV diagnosis to commencement of ART, and compare it to the existing cascade indicator of proportion of patients on treatment and the WHO proposed cohort cascade indicator of proportion of patients on treatment within one year of diagnosis. Methods and materials Records from patients from the two largest HIV treatment centres in the state of Victoria, Australia (Melbourne Sexual Health Centre and The Alfred Hospital Department of Infectious Diseases) from 2011 to 2015 were extracted. The intervals between date of diagnosis, entry into care and initiation of ART were compared. Results and discussion From 2011 to 2015 the proportion of in-care patients who were on ART rose from 87% to 93% (p<0.0001). From 2011 to 2014, the proportion of patients in care and on ART within one year of diagnosis increased from 43.4% to 78.9% (p = 0.001). The median time from diagnosis to ART fell from 418 days (IQR: 91-1176) to 77 days (IQR: 39-290)(p< 0.001) by calendar year in which ART was commenced. Conclusions From 2011 to 2015 there were substantial and clinically important falls in the median time from diagnosis to commencing ART in those that commenced ART. The size of this dramatic change was not apparent when only reporting the proportion of patients on ART. Time to ART is a useful indicator and can be used to supplement existing cascade indicators in measuring progress toward universal ART coverage.	[Medland, Nicholas A.; Chow, Eric P. F.; Fairley, Christopher K.] Monash Univ, Cent Clin Sch, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [McMahon, James H.; Elliott, Julian H.; Hoy, Jennifer F.] Monash Univ, Cent Clin Sch, Alfred Hosp, Melbourne, Vic, Australia	Monash University; Florey Institute of Neuroscience & Mental Health; Monash University	Medland, NA (corresponding author), Monash Univ, Cent Clin Sch, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia.	nmedland@mshc.org.au	Hoy, Jennifer/AAK-7968-2020; Chow, Eric P.F./W-6684-2019	Chow, Eric P.F./0000-0003-1766-0657; McMahon, James/0000-0003-1460-5572; Medland, Nicholas Andrew/0000-0003-0403-8930; Christopher, Fairley/0000-0001-9081-1664; Hoy, Jennifer/0000-0002-6948-7086	Australian National Health and Medical Research Council [GNT1094518, 1091226, 1111099]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	` This work was supported by the Australian National Health and Medical Research Council to NAM (Postgraduate Scholarship Number GNT1094518), and to EPF Cand JHM (Early Career Fellowships numbers 1091226 and 1111099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], 2015, GUID US ANT AG HIV 1; Australasian Society of HIV Medicine, 2015, ANT GUID US DHSS GUI; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Grulich AE, 2016, C RETR OPP INF BOSTO; Lesko CR, 2016, AIDS, V30, P2227, DOI 10.1097/QAD.0000000000001183; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Mao LM, 2015, MED J AUSTRALIA, V202, P258, DOI 10.5694/mja14.00443; McMahon JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127726; Medland NA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20634; NSW Health, 2014, NSW HIV STRAT 2012 1; Obama B, 2013, EXECUTIVE ORDER HIV; [Pharmaceutical Benefits Advisory Committee Department of Health], 2013, 1 LIN ANT THER ART P; Rodger A, 2016, C RETR OPP INF BOST2; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; TEMPRANO Study Group, 2015, NEW ENGLAND J MED; The Kirby Institute, 2014, VIRAL HEPTATITIS AND; The Kirby Institute, 2015, HIV VIR HEP SEX TRAN; Toren KG, 2016, SEX TRANSM DIS, V43, P34, DOI 10.1097/OLQ.0000000000000376; World Health Organization, 2015, CONS STRAT INF GUID	20	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177634	10.1371/journal.pone.0177634	http://dx.doi.org/10.1371/journal.pone.0177634			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520807	gold, Green Submitted, Green Published			2022-12-26	WOS:000401485500049
J	Lo, PK; Zhang, YS; Yao, Y; Wolfson, B; Yu, J; Han, SY; Duru, N; Zhou, Q				Lo, Pang-Kuo; Zhang, Yongshu; Yao, Yuan; Wolfson, Benjamin; Yu, Justine; Han, Shu-Yan; Duru, Nadire; Zhou, Qun			Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma in situ through activation of TGF beta signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; EXPRESSION; METASTASIS; MIR-B-10; RB1CC1; MICROENVIRONMENT; BIOGENESIS; REGULATORS; CONVERSION	The normal myoepithelium has a tumor-suppressing nature and inhibits the progression of ductal carcinoma in situ (DCIS) into invasive ductal carcinoma (IDC). Conversely, a growing number of studies have shown that tumor-associated myoepithelial cells have a tumor-promoting effect. Moreover, the exact role of tumor-associated myoepithelial cells in the DCIS-to-IDC development remains undefined. To address this, we explored the role of tumor-associated myoepithelial cells in the DCIS-toIDC progression. We developed a direct coculture system to study the cell-cell interactions between DCIS cells and tumorassociated myoepithelial cells. Coculture studies indicated that tumor-associated myoepithelial cells promoted the invasive progression of a DCIS cell model in vitro, and mechanistic studies revealed that the interaction with DCIS cells stimulated tumor-associated myoepithelial cells to secrete TGF beta 1, which subsequently contributed to activating the TGF beta/Smads pathway in DCIS cells. We noted that activation of the TGF beta signaling pathway promoted the epithelial-mesenchymal transition, basal-like phenotypes, stemness, and invasiveness of DCIS cells. Importantly, xenograft studies further demonstrated that tumor-associated myoepithelial cells enhanced the DCIS-toIDC progression in vivo. Furthermore, we found that TGF beta mediated induction of oncogenic miR-10b-5p expression and down-regulation of RB1CC1, a miR-10b-5p-targeted tumorsuppressor gene, contributed to the invasive progression of DCIS. Our findings provide the first experimental evidence to directly support the paradigm that altered DCIS-associated myoepithelial cells promote the invasive progression of DCIS into IDC via TGF beta signaling activation.	[Lo, Pang-Kuo; Zhang, Yongshu; Yao, Yuan; Wolfson, Benjamin; Yu, Justine; Han, Shu-Yan; Duru, Nadire; Zhou, Qun] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Han, Shu-Yan] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Integrat Chinese & Western Med, Beijing 100142, Peoples R China	University System of Maryland; University of Maryland Baltimore; Peking University	Zhou, Q (corresponding author), Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Greenebaum Canc Ctr,Biomed Res Facil, 108 N Greene St,Rm 337, Baltimore, MD 21201 USA.	qzhou@som.umaryland.edu		Wolfson, Benjamin/0000-0001-5074-3193	NCI, National Institutes of Health [R01 CA157779, R01 CA163820]; NATIONAL CANCER INSTITUTE [T32CA154274, R01CA157779, R01CA163820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055036] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NCI, National Institutes of Health, Grants R01 CA157779 and R01 CA163820 (to Q. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Allen MD, 2014, CANCER RES, V74, P5942, DOI 10.1158/0008-5472.CAN-14-1841; Allen MD, 2014, CLIN CANCER RES, V20, P344, DOI 10.1158/1078-0432.CCR-13-1504; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Bahena-Ocampo I, 2016, EMBO REP, V17, P1081, DOI 10.15252/embr.201642700; Barsky SH, 2005, J MAMMARY GLAND BIOL, V10, P249, DOI 10.1007/s10911-005-9585-5; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013; Blahna MT, 2013, CURR OPIN CELL BIOL, V25, P233, DOI 10.1016/j.ceb.2012.12.005; Cardenas CLL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003291; Chano T, 2002, NAT GENET, V31, P285, DOI 10.1038/ng911; Chano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011404; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Choi JD, 2013, ONCOGENE, V32, P2421, DOI 10.1038/onc.2012.262; Choi Y, 2013, HUM PATHOL, V44, P2581, DOI 10.1016/j.humpath.2013.07.003; Cowell CF, 2013, MOL ONCOL, V7, P859, DOI 10.1016/j.molonc.2013.07.005; Duru N, 2016, ONCOTARGET, V7, P47511, DOI 10.18632/oncotarget.10203; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; Esserman LJ, 2012, BREAST CANCER RES TR, V132, P1049, DOI 10.1007/s10549-011-1895-2; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gudjonsson T, 2002, J CELL SCI, V115, P39; HACKETT AJ, 1977, J NATL CANCER I, V58, P1795, DOI 10.1093/jnci/58.6.1795; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Ikebuchi K, 2009, INT J CANCER, V125, P861, DOI 10.1002/ijc.24466; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kerlikowske K, 2003, JNCI-J NATL CANCER I, V95, P1692, DOI 10.1093/jnci/djg097; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lal A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002363; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Liz J, 2016, BBA-GENE REGUL MECH, V1859, P169, DOI 10.1016/j.bbagrm.2015.06.015; Lo PK, 2016, ONCOTARGET, V7, P65067, DOI 10.18632/oncotarget.11364; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; M'hamed IF, 2015, CELL ONCOL, V38, P433, DOI 10.1007/s13402-015-0239-3; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mardekian SK, 2016, HUM PATHOL, V49, P114, DOI 10.1016/j.humpath.2015.11.003; Mayorga ME, 2012, J CELL MOL MED, V16, P1106, DOI 10.1111/j.1582-4934.2011.01385.x; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Ochi Y, 2011, ONCOL REP, V26, P805, DOI 10.3892/or.2011.1329; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sivadas VP, 2014, TUMOR BIOL, V35, P2857, DOI 10.1007/s13277-013-1481-9; Sternlicht MD, 1997, CLIN CANCER RES, V3, P1949; Tabchy A, 2010, CLIN CANCER RES, V16, P5351, DOI 10.1158/1078-0432.CCR-10-1265; Takahashi H, 2012, NAT IMMUNOL, V13, P587, DOI 10.1038/ni.2286; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Wang DY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019629, 10.1371/journal.pone.0019835]; Weinberg Robert, 2006, Cancer Res, V66, P11550, DOI 10.1158/0008-5472.CAN-06-3149; Xu H, 2014, CANCER GENE THER, V21, P60, DOI 10.1038/cgt.2013.82; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yao J, 2006, CANCER RES, V66, P4065, DOI 10.1158/0008-5472.CAN-05-4083; Yigit MV, 2013, ONCOGENE, V32, P1530, DOI 10.1038/onc.2012.173; Yue PYK, 2010, J BIOMOL SCREEN, V15, P427, DOI 10.1177/1087057110361772; Zdanov S, 2016, CANCER IMMUNOL RES, V4, P354, DOI 10.1158/2326-6066.CIR-15-0241; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064; Zhu WJ, 2001, EMBO J, V20, P5999, DOI 10.1093/emboj/20.21.5999; Zhu YB, 2015, OBESITY, V23, P1014, DOI 10.1002/oby.21062	67	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11466	11484		10.1074/jbc.M117.775080	http://dx.doi.org/10.1074/jbc.M117.775080			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28512126	Green Published, hybrid			2022-12-26	WOS:000405119600029
J	Madrid, M; Vazquez-Marin, B; Soto, T; Franco, A; Gomez-Gil, E; Vicente-Soler, J; Gacto, M; Perez, P; Cansado, J				Madrid, Marisa; Vazquez-Marin, Beatriz; Soto, Teresa; Franco, Alejandro; Gomez-Gil, Elisa; Vicente-Soler, Jero; Gacto, Mariano; Perez, Pilar; Cansado, Jose			Differential functional regulation of protein kinase C (PKC) orthologs in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL INTEGRITY PATHWAY; SCHIZOSACCHAROMYCES-POMBE; ACTIVATION; PMK1; DEGRADATION; HOMOLOG; ENCODES; STRESS; TARGET; PCK2P	The two PKC orthologs Pck1 and Pck2 in the fission yeast Schizosaccharomyces pombe operate in a redundant fashion to control essential functions, including morphogenesis and cell wall biosynthesis, as well as the activity of the cell integrity pathway and its core element, the MAPK Pmk1. We show here that, despite the strong structural similarity and functional redundancy of these two enzymes, the mechanisms regulating their maturation, activation, and stabilization have a remarkably distinct biological impact on both kinases. We found that, in contrast to Pck2, putative in vivo phosphorylation of Pck1 within the conserved activation loop, turn, and hydrophobic motifs is essential for Pck1 stability and biological functions. Constitutive Pck activation promoted dephosphorylation and destabilization of Pck2, whereas it enhanced Pck1 levels to interfere with proper downstream signaling to the cell integrity pathway via Pck2. Importantly, although catalytic activity was essential for Pck1 function, Pck2 remained partially functional independent of its catalytic activity. Our findings suggest that early divergence from a common ancestor in fission yeast involved important changes in the mechanisms regulating catalytic activation and stability of PKC family members to allow for flexible and dynamic control of downstream functions, including MAPK signaling.	[Madrid, Marisa; Vazquez-Marin, Beatriz; Soto, Teresa; Franco, Alejandro; Gomez-Gil, Elisa; Vicente-Soler, Jero; Gacto, Mariano; Cansado, Jose] Univ Murcia, Fac Biol, Dept Genet & Microbiol, Yeast Physiol Grp, E-30071 Murcia, Spain; [Perez, Pilar] Univ Salamanca, CSIC, Inst Biol Func & Genom, Salamanca 37007, Spain	University of Murcia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Madrid, M; Cansado, J (corresponding author), Univ Murcia, Fac Biol, Dept Genet & Microbiol, Yeast Physiol Grp, E-30071 Murcia, Spain.	marisa@um.es; jcansado@um.es	Madrid, Marisa/K-7755-2014; Vicente-Soler, Jerónima/ABF-6293-2020; Franco, Alejandro/ABG-6823-2020; Pino, Teresa Soto/AAC-6096-2020; Perez, Pilar/B-4948-2010; Cansado, Jose/ABC-6872-2020; Madrid, Marisa/AAV-2154-2020; Cansado, Jose/K-5212-2014	Madrid, Marisa/0000-0002-7970-2587; Vicente-Soler, Jerónima/0000-0001-8759-6545; Franco, Alejandro/0000-0001-7461-3414; Pino, Teresa Soto/0000-0003-2965-318X; Perez, Pilar/0000-0003-3557-2247; Cansado, Jose/0000-0002-2342-8152; Madrid, Marisa/0000-0002-7970-2587; Vazquez, Beatriz/0000-0001-5334-2950	Ministerio de Economia y Competitividad [BFU2014-52828-P, BIO2015-69958-P]; Fundacion Seneca [19246/PI/14]; European Regional Development Fund - European Union	Ministerio de Economia y Competitividad(Spanish Government); Fundacion Seneca(Fundacion Seneca); European Regional Development Fund - European Union	This work was supported by Ministerio de Economia y Competitividad Grants BFU2014-52828-P and BIO2015-69958-P, Fundacion Seneca Grant 19246/PI/14, and European Regional Development Fund co-funding from the European Union. The authors declare that they have no conflicts of interest with the contents of this article.	Antal CE, 2014, BIOCHEM SOC T, V42, P1477, DOI 10.1042/BST20140172; Villar-Tajadura MA, 2008, MOL MICROBIOL, V70, P867, DOI 10.1111/j.1365-2958.2008.06447.x; Arellano M, 1999, J CELL SCI, V112, P3569; Barba G, 2008, CELL SIGNAL, V20, P748, DOI 10.1016/j.cellsig.2007.12.017; Calonge TM, 2000, MOL BIOL CELL, V11, P4393, DOI 10.1091/mbc.11.12.4393; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; Carpy A, 2014, MOL CELL PROTEOMICS, V13, P1925, DOI 10.1074/mcp.M113.035824; Freeley M, 2011, CELL SIGNAL, V23, P753, DOI 10.1016/j.cellsig.2010.10.013; Gould CM, 2011, J BIOL CHEM, V286, P28922, DOI 10.1074/jbc.M111.272526; Graub R, 2003, J BASIC MICROB, V43, P473, DOI 10.1002/jobm.200310287; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Liu Y, 2006, J BIOL CHEM, V281, P12102, DOI 10.1074/jbc.M600508200; Lu ZM, 2009, ANNU REV BIOCHEM, V78, P435, DOI 10.1146/annurev.biochem.013008.092711; Ma Y, 2006, MOL BIOL CELL, V17, P5028, DOI 10.1091/mbc.E06-08-0688; Madrid M, 2006, J BIOL CHEM, V281, P2033, DOI 10.1074/jbc.M506467200; Madrid M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37515; Madrid M, 2015, J CELL SCI, V128, P266, DOI 10.1242/jcs.158295; Madrid M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-34; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mukai H, 2003, J BIOCHEM, V133, P17, DOI 10.1093/jb/mvg019; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; PEARS CJ, 1990, EUR J BIOCHEM, V194, P89, DOI 10.1111/j.1432-1033.1990.tb19431.x; Perez P, 2010, CURR PROTEIN PEPT SC, V11, P680, DOI 10.2174/138920310794557718; Roelants FM, 2004, MICROBIOL-SGM, V150, P3289, DOI 10.1099/mic.0.27286-0; Sanchez-Mir L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088020; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sugiura R, 1998, EMBO J, V17, P140, DOI 10.1093/emboj/17.1.140; Takada H, 2007, MOL BIOL CELL, V18, P4794, DOI 10.1091/mbc.E07-03-0282; Toda T, 1996, MOL CELL BIOL, V16, P6752; Viana RA, 2013, GENETICS, V195, P421, DOI 10.1534/genetics.113.154807; Wang Y, 2016, MOL BIOL CELL, V27, P410, DOI 10.1091/mbc.E15-09-0624	32	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	2017	292	27					11374	11387		10.1074/jbc.M117.786087	http://dx.doi.org/10.1074/jbc.M117.786087			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA0JN	28536259	Green Published, hybrid			2022-12-26	WOS:000405119600021
J	Azuma, Y; Zschoche, R; Hilvert, D				Azuma, Yusuke; Zschoche, Reinhard; Hilvert, Donald			The C-terminal peptide of Aquifex aeolicus riboflavin synthase directs encapsulation of native and foreign guests by a cage-forming lumazine synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biotechnology; cell compartmentalization; protein self-assembly; protein-protein interaction; synthetic biology; bacterial compartment; localization sequence; lumazine; riboflavin synthase; protein cage	CRYSTAL-STRUCTURE ANALYSIS; ENGINEERED PROTEIN CONTAINER; BACILLUS-SUBTILIS; BACTERIAL MICROCOMPARTMENTS; ANGSTROM RESOLUTION; STRUCTURAL BASIS; ENZYME ENCAPSULATION; QUATERNARY STRUCTURE; BINDING MODE; DRUG DESIGN	Encapsulation of specific enzymes in self-assembling protein cages is a hallmark of bacterial compartments that function as counterparts to eukaryotic organelles. The cage-forming enzyme lumazine synthase (LS) from Bacillus subtilis (BsLS), for example, encapsulates riboflavin synthase (BsRS), enabling channeling of lumazine from the site of its generation to the site of its conversion to vitamin B-2. Elucidating the molecular mechanisms underlying the assembly of these supramolecular complexes could help inform new approaches for metabolic engineering, nanotechnology, and drug delivery. To that end, we investigated a thermostable LS from Aquifex aeolicus (AaLS) and found that it also forms cage complexes with the cognate riboflavin synthase (AaRS) when both proteins are co-produced in the cytosol of Escherichia coli. A 12-amino acid-long peptide at the C terminus of AaRS serves as a specific localization sequence responsible for targeting the guest to the protein compartment. Sequence comparisons suggested that analogous peptide segments likely direct RS complexation by LS cages in other bacterial species. Covalent fusion of this peptide tag to heterologous guest molecules led to their internalization into AaLS assemblies both in vivo and in vitro, providing a firm foundation for creating tailored biomimetic nanocompartments for medical and biotechnological applications.	[Azuma, Yusuke; Zschoche, Reinhard; Hilvert, Donald] ETH, Lab Organ Chem, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Hilvert, D (corresponding author), ETH, Lab Organ Chem, CH-8093 Zurich, Switzerland.	hilvert@org.chem.ethz.ch	Azuma, Yusuke/D-8030-2018	Azuma, Yusuke/0000-0003-3543-3159	ETH Zurich; European Research Council (Advanced ERC Grant) [ERC-dG-2012-321295]; Uehara Memorial Foundation Research Fellowship; ETH Zurich Postdoctoral Fellowship - Marie Curie Actions program; Stipendienfonds der Schweizerischen Chemischen Industrie (SSCI)	ETH Zurich(ETH Zurich); European Research Council (Advanced ERC Grant)(European Research Council (ERC)); Uehara Memorial Foundation Research Fellowship(Uehara Memorial Foundation); ETH Zurich Postdoctoral Fellowship - Marie Curie Actions program; Stipendienfonds der Schweizerischen Chemischen Industrie (SSCI)	This work was generously supported by the ETH Zurich and the European Research Council (Advanced ERC Grant ERC-dG-2012-321295 to D. H.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of an Uehara Memorial Foundation Research Fellowship and an ETH Zurich Postdoctoral Fellowship (co-funded by the Marie Curie Actions program).; Recipient of a scholarship from the Stipendienfonds der Schweizerischen Chemischen Industrie (SSCI).	Azuma Y, 2016, ANGEW CHEM INT EDIT, V55, P1531, DOI 10.1002/anie.201508414; BACHER A, 1980, J BIOL CHEM, V255, P632; BACHER A, 1986, J MOL BIOL, V187, P75, DOI 10.1016/0022-2836(86)90407-9; Beck T, 2015, ANGEW CHEM INT EDIT, V54, P937, DOI 10.1002/anie.201408677; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; Cassidy-Amstutz C, 2016, BIOCHEMISTRY-US, V55, P3461, DOI 10.1021/acs.biochem.6b00294; Choudhary SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033210; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Fan CG, 2012, P NATL ACAD SCI USA, V109, P14995, DOI 10.1073/pnas.1207516109; Fan CG, 2010, P NATL ACAD SCI USA, V107, P7509, DOI 10.1073/pnas.0913199107; Fornasari MS, 2004, MOL BIOL EVOL, V21, P97, DOI 10.1093/molbev/msg244; Frank S, 2013, J BIOTECHNOL, V163, P273, DOI 10.1016/j.jbiotec.2012.09.002; Frey R, 2016, J AM CHEM SOC, V138, P10072, DOI 10.1021/jacs.6b04744; Frey R, 2016, CHEM COMMUN, V52, P10423, DOI 10.1039/c6cc05301g; Gerhardt S, 2002, J MOL BIOL, V318, P1317, DOI 10.1016/S0022-2836(02)00116-X; Gerhardt S, 2002, STRUCTURE, V10, P1371, DOI 10.1016/S0969-2126(02)00864-X; Haugland R P, 1995, Methods Mol Biol, V45, P205, DOI 10.1385/0-89603-308-2:205; Jakobson CM, 2015, J BIOL CHEM, V290, P24519, DOI 10.1074/jbc.M115.651919; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Kim H, 2016, RSC ADV, V6, P19208, DOI 10.1039/c6ra00233a; Kinney JN, 2012, J BIOL CHEM, V287, P17729, DOI 10.1074/jbc.M112.355305; KIS K, 1995, J BIOL CHEM, V270, P16788, DOI 10.1074/jbc.270.28.16788; Kumar P, 2011, ACTA CRYSTALLOGR D, V67, P131, DOI 10.1107/S0907444910053370; LADENSTEIN R, 1988, J MOL BIOL, V203, P1045, DOI 10.1016/0022-2836(88)90128-3; Ladenstein R, 2013, FEBS J, V280, P2537, DOI 10.1111/febs.12255; Lilavivat S, 2012, J AM CHEM SOC, V134, P13152, DOI 10.1021/ja302743g; Meining W, 2000, J MOL BIOL, V299, P181, DOI 10.1006/jmbi.2000.3742; Min J, 2014, RSC ADV, V4, P48596, DOI 10.1039/c4ra10187a; Morgunova E, 2005, BIOCHEMISTRY-US, V44, P2746, DOI 10.1021/bi047848a; Morgunova E, 2007, J BIOL CHEM, V282, P17231, DOI 10.1074/jbc.M701724200; Morgunova E, 2010, ACTA CRYSTALLOGR D, V66, P1001, DOI 10.1107/S0907444910029690; Mortl S, 1996, J BIOL CHEM, V271, P33201, DOI 10.1074/jbc.271.52.33201; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Persson K, 1999, PROTEIN SCI, V8, P2355; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; RITSERT K, 1995, J MOL BIOL, V253, P151, DOI 10.1006/jmbi.1995.0542; Rurup WF, 2014, J AM CHEM SOC, V136, P3828, DOI 10.1021/ja410891c; Sasaki E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14663; SCHOTT K, 1990, J BIOL CHEM, V265, P4204; Seebeck FP, 2006, J AM CHEM SOC, V128, P4516, DOI 10.1021/ja058363s; Shenton W, 2001, ANGEW CHEM INT EDIT, V40, P442, DOI 10.1002/1521-3773(20010119)40:2<442::AID-ANIE442>3.0.CO;2-2; Song Y, 2015, PHARM BIOL, V2015, P1, DOI DOI 10.1109/IFEEC.2015.7361560; Sutter M, 2008, NAT STRUCT MOL BIOL, V15, P939, DOI 10.1038/nsmb.1473; Tamura A, 2015, BIOTECHNOL BIOENG, V112, P13, DOI 10.1002/bit.25322; Worsdorfer B, 2012, J AM CHEM SOC, V134, P909, DOI 10.1021/ja211011k; Worsdorfer B, 2011, SCIENCE, V331, P589, DOI 10.1126/science.1199081; Worsdorfer B., 2010, THESIS; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Zhang XF, 2003, J MOL BIOL, V328, P167, DOI 10.1016/S0022-2836(03)00186-4; Zhang XF, 2001, J MOL BIOL, V306, P1099, DOI 10.1006/jmbi.2000.4435; Zschoche R, 2015, J AM CHEM SOC, V137, P16121, DOI 10.1021/jacs.5b10588; Zylberman V, 2004, J BIOL CHEM, V279, P8093, DOI 10.1074/jbc.M312035200	52	13	14	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 23	2017	292	25					10321	10327		10.1074/jbc.C117.790311	http://dx.doi.org/10.1074/jbc.C117.790311			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY6TE	28515315	Green Published, hybrid			2022-12-26	WOS:000404115400001
J	Akhtar, RS; Xie, SX; Chen, YJ; Rick, J; Gross, RG; Nasrallah, IM; Van Deerlin, VM; Trojanowski, JQ; Chen-Plotkin, AS; Hurtig, HI; Siderowf, AD; Dubroff, JG; Weintraub, D				Akhtar, Rizwan S.; Xie, Sharon X.; Chen, Yin J.; Rick, Jacqueline; Gross, Rachel G.; Nasrallah, Ilya M.; Van Deerlin, Vivianna M.; Trojanowski, John Q.; Chen-Plotkin, Alice S.; Hurtig, Howard I.; Siderowf, Andrew D.; Dubroff, Jacob G.; Weintraub, Daniel			Regional brain amyloid-beta accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; FLORBETAPIR F 18; APOLIPOPROTEIN-E EPSILON-4; VOLUME EFFECT CORRECTION; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; IN-VIVO; A-BETA; DIAGNOSTIC-CRITERIA; PET	Parkinson disease patients develop clinically significant cognitive impairment at variable times over their disease course, which is often preceded by milder deficits in memory, visuospatial, and executive domains. The significance of amyloid-beta accumulation to these problems is unclear. We hypothesized that amyloid-beta PET imaging by F-18-florbetapir, a radio-tracer that detects fibrillar amyloid-beta plaque deposits, would identify subjects with global cognitive impairment or poor performance in individual cognitive domains in non-demented Parkinson disease patients. We assessed 61 non-demented Parkinson disease patients with detailed cognitive assessments and F-18-florbetapir PET brain imaging. Scans were interpreted qualitatively (positive or negative) by two independent nuclear medicine physicians blinded to clinical data, and quantitatively by a novel volume-weighted method. The presence of mild cognitive impairment was determined through an expert consensus process using Level 1 criteria from the Movement Disorder Society. Nineteen participants (31.2%) were diagnosed with mild cognitive impairment and the remainder had normal cognition. Qualitative F-18-florbetapir PET imaging was positive in 15 participants (24.6%). Increasing age and presence of an APOE epsilon 4 allele were associated with higher composite F-18-florbetapir binding. In multivariable models, an abnormal F-18-florbetapir scan by expert rating was not associated with a diagnosis of mild cognitive impairment. However, F-18-florbetapir retention values in the posterior cingulate gyrus inversely correlated with verbal memory performance. Retention values in the frontal cortex, precuneus, and anterior cingulate gyrus retention values inversely correlated with naming performance. Regional cortical amyloid-beta amyloid, as measured by F-18-florbetapir PET, may be a biomarker of specific cognitive deficits in non-demented Parkinson disease patients.	[Akhtar, Rizwan S.; Rick, Jacqueline; Gross, Rachel G.; Chen-Plotkin, Alice S.; Hurtig, Howard I.; Siderowf, Andrew D.; Weintraub, Daniel] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Akhtar, Rizwan S.; Van Deerlin, Vivianna M.; Trojanowski, John Q.] Univ Penn, Ctr Neurodegenerat Dis Res, Perelman Sch Med, Philadelphia, PA 19104 USA; [Akhtar, Rizwan S.; Van Deerlin, Vivianna M.; Trojanowski, John Q.] Univ Penn, Inst Aging, Perelman Sch Med, Philadelphia, PA 19104 USA; [Xie, Sharon X.] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chen, Yin J.; Nasrallah, Ilya M.; Dubroff, Jacob G.] Univ Penn, Dept Radiol, Div Nucl Med & Clin Mol Imaging, Perelman Sch Med, Philadelphia, PA 19104 USA; [Van Deerlin, Vivianna M.; Trojanowski, John Q.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Siderowf, Andrew D.] AVID Radiopharmaceut, Philadelphia, PA USA; [Weintraub, Daniel] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Weintraub, Daniel] Philadelphia Vet Affairs Med Ctr, Parkinsons Dis & Mental Hlth Res Educ & Clin Ctr, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Akhtar, RS (corresponding author), Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Akhtar, RS (corresponding author), Univ Penn, Ctr Neurodegenerat Dis Res, Perelman Sch Med, Philadelphia, PA 19104 USA.; Akhtar, RS (corresponding author), Univ Penn, Inst Aging, Perelman Sch Med, Philadelphia, PA 19104 USA.	rizwan.akhtar@uphs.upenn.edu	Akhtar, Rizwan S./ABH-7946-2020; Weintraub, Daniel/AAD-8309-2020; Weintraub, Daniel/AAC-5232-2020	Akhtar, Rizwan S./0000-0001-9808-7228; Weintraub, Daniel/0000-0003-0633-7168	National Institutes of Health [P50-NS053488, P30-AG010124, R43-NS063607, K08-NS093127]; Avid Radiopharmaceuticals; Eli Lilly and Company; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R43NS063607, U01NS082134, U01NS097056, P50NS053488, K08NS093127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Avid Radiopharmaceuticals; Eli Lilly and Company(Eli Lilly); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded or supported by the National Institutes of Health: P50-NS053488 (to S.X.X., V.M.V.D., J.Q.T., A.S.C-P., H.I.H., A.D.S., and D.W.), P30-AG010124 (to V.M.V.D. and J.Q.T.), R43-NS063607 (to Daniel M. Skovronsky, Avid Radiopharmaceuticals), and K08-NS093127(to R.S.A.); and by Avid Radiopharmaceuticals, a wholly-owned subsidiary of Eli Lilly and Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2005, MOVEMENT DISORD, V20, P1255, DOI 10.1002/mds.20527; Aarsland D, 2003, ARCH NEUROL-CHICAGO, V60, P387, DOI 10.1001/archneur.60.3.387; Akhtar RS, 2016, MOVEMENT DISORDERS C; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bohnen NI, 2014, MOVEMENT DISORD, V29, P1118, DOI 10.1002/mds.25929; Brendel M, 2015, NEUROIMAGE, V108, P450, DOI 10.1016/j.neuroimage.2014.11.055; Choi SR, 2012, ALZ DIS ASSOC DIS, V26, P8, DOI 10.1097/WAD.0b013e31821300bc; Clark CM, 2012, LANCET NEUROL, V11, P669, DOI 10.1016/S1474-4422(12)70142-4; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Edison P, 2008, J NEUROL NEUROSUR PS, V79, P1331, DOI 10.1136/jnnp.2007.127878; Fleisher AS, 2013, NEUROBIOL AGING, V34, P1, DOI 10.1016/j.neurobiolaging.2012.04.017; Foster ER, 2010, MOVEMENT DISORD, V25, P2516, DOI 10.1002/mds.23393; Gomperts SN, 2013, NEUROLOGY, V80, P85, DOI 10.1212/WNL.0b013e31827b1a07; Gomperts SN, 2012, MOVEMENT DISORD, V27, P965, DOI 10.1002/mds.25048; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hurtig HI, 2000, NEUROLOGY, V54, P1916, DOI 10.1212/WNL.54.10.1916; Hutton C, 2015, EUR J NUCL MED MOL I, V42, P725, DOI 10.1007/s00259-015-2988-7; Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659; Johnson KA, 2013, ALZHEIMERS DEMENT, V9, pE1, DOI [10.1016/j.jalz.2013.01.002, 10.1016/j.jalz.2012.10.007, 10.1016/j.jalz.2013.06.001]; Joshi AD, 2015, J NUCL MED, V56, P1736, DOI 10.2967/jnumed.114.153494; Joshi A, 2012, J NUCL MED, V53, DOI 10.2967/jnumed.111.090340; Knopman DS, 2015, JAMA NEUROL, P1; Kotzbauer PT, 2012, ARCH NEUROL-CHICAGO, V69, P1326, DOI 10.1001/archneurol.2012.1608; Landau SM, 2013, J NUCL MED, V54, P70, DOI 10.2967/jnumed.112.109009; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Maetzler W, 2009, NEUROBIOL DIS, V34, P107, DOI 10.1016/j.nbd.2008.12.008; Mathis CA, 2012, SEMIN NUCL MED, V42, P423, DOI 10.1053/j.semnuclmed.2012.07.001; Mattila PM, 1998, ACTA NEUROPATHOL, V96, P417, DOI 10.1007/s004010050913; Monsell SE, 2014, PARKINSONISM RELAT D, V20, P503, DOI 10.1016/j.parkreldis.2014.02.001; Muller MLTM, 2013, MOVEMENT DISORD, V28, P296, DOI 10.1002/mds.25213; Petrou M, 2015, MOVEMENT DISORD, V30, P928, DOI 10.1002/mds.26191; Petrou M, 2012, NEUROLOGY, V79, P1161, DOI 10.1212/WNL.0b013e3182698d4a; Pfeiffer HCV, 2014, ACTA NEUROL SCAND, V129, P307, DOI 10.1111/ane.12189; Pigott K, 2015, NEUROLOGY, V85, P1276, DOI 10.1212/WNL.0000000000002001; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; Rektorova I, 2014, NEURODEGENER DIS, V13, P186, DOI 10.1159/000354237; Rullmann M, 2016, J NUCL MED, V57, P198, DOI 10.2967/jnumed.115.161893; Saint-Aubert L, 2014, EUR J NUCL MED MOL I, V41, P836, DOI 10.1007/s00259-013-2656-8; Schreiber S, 2015, JAMA NEUROL, V72, P1183, DOI 10.1001/jamaneurol.2015.1633; Siderowf A, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-79; Spetsieris PG, 2015, P NATL ACAD SCI USA, V112, P2563, DOI 10.1073/pnas.1411011112; Stebbins GT, 2013, MOVEMENT DISORD, V28, P668, DOI 10.1002/mds.25383; Toledo JB, 2012, ACTA NEUROPATHOL, V124, P23, DOI 10.1007/s00401-012-0983-7; Tsuang D, 2013, JAMA NEUROL, V70, P223, DOI 10.1001/jamaneurol.2013.600; Wong DF, 2010, J NUCL MED, V51, P913, DOI 10.2967/jnumed.109.069088	49	23	26	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177924	10.1371/journal.pone.0177924	http://dx.doi.org/10.1371/journal.pone.0177924			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542444	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800030
J	Bertoglia, MP; Gormaz, JG; Libuy, M; Sanhueza, D; Gajardo, A; Srur, A; Wallbaum, M; Erazo, M				Bertoglia, Maria P.; Gormaz, Juan G.; Libuy, Matias; Sanhueza, Dergica; Gajardo, Abraham; Srur, Andrea; Wallbaum, Magdalena; Erazo, Marcia			The population impact of obesity, sedentary lifestyle, and tobacco and alcohol consumption on the prevalence of type 2 diabetes: Analysis of a health population survey in Chile, 2010	PLOS ONE			English	Article							INSULIN-RESISTANCE; GROWTH-HORMONE; SMOKING; GLUCOSE; RISK; METABOLISM; NOREPINEPHRINE; MECHANISMS; CORTISOL; RELEASE	Aim To estimate the impact of tobacco use, sedentary lifestyle, obesity and alcohol consumption on type 2 diabetes mellitus (T2DM) prevalence in the Chilean population. Methods The study-included 5,293 subjects with fasting glycaemia levels from the nationwide cross-sectional health survey in 2010, commissioned by the Ministry of Health, Chile. Crude and Adjusted Odds Ratio to T2DM and its corresponding 95% confidence interval were estimated through logistic regressions. Attributable fractions and population attributable fractions were estimated. Results T2DM prevalence was 9.5%. Sedentary lifestyles and obesity were significant risk factors for T2DM. 52,4% of T2DM could be avoided if these individuals were not obese, and at a population level, 23% of T2DM could be preventable if obesity did not exist. A 64% of T2DM is explained by sedentariness, and if people would become active, a 62,2% of the cases of diabetes could be avoided. Interpretation About 79% of T2DM cases in Chile could be prevented with cost-effective strategies focused on preventing sedentary lifestyle and obesity. It's therefore urgent to implement evidence-based public health polices, aimed to decrease the prevalence of T2DM, by controlling its risk factors and consequently, reducing the complications from T2DM.	[Bertoglia, Maria P.; Libuy, Matias; Sanhueza, Dergica; Gajardo, Abraham; Erazo, Marcia] Univ Chile, Sch Publ Hlth, Publ Hlth Nutr Program, Santiago, Chile; [Gormaz, Juan G.] Univ Chile, Biomed Sci Inst, Mol & Clin Pharmacol Program, Santiago, Chile; [Srur, Andrea; Wallbaum, Magdalena] Minist Hlth Santiago, Noncommunicable Dis Dept, Santiago, Chile	Universidad de Chile; Universidad de Chile	Erazo, M (corresponding author), Univ Chile, Sch Publ Hlth, Publ Hlth Nutr Program, Santiago, Chile.	merazo@med.uchile.cl		Sanhueza, Dergica/0000-0003-4683-1603; Gajardo Cortez, Abraham Isaac Jacob/0000-0002-6387-3779; Erazo, Marcia/0000-0002-0766-9503				Alderete TL, 2013, J CLIN ENDOCR METAB, V98, P3748, DOI 10.1210/jc.2013-1138; ATTVALL S, 1993, J INTERN MED, V233, P327, DOI 10.1111/j.1365-2796.1993.tb00680.x; Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227; Barth E, 2007, CRIT CARE MED, V35, pS508, DOI 10.1097/01.CCM.0000278047.06965.20; Byrkjeland R, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-36; CRYER PE, 1976, NEW ENGL J MED, V295, P573, DOI 10.1056/NEJM197609092951101; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Davi G, 2005, ANTIOXID REDOX SIGN, V7, P256, DOI 10.1089/ars.2005.7.256; Duclos M, 2013, DIABETES METAB, V39, P205, DOI 10.1016/j.diabet.2013.03.005; Eckardt K, 2011, REV ENDOCR METAB DIS, V12, P163, DOI 10.1007/s11154-011-9168-2; Eliasson B, 1997, ATHEROSCLEROSIS, V129, P79, DOI 10.1016/S0021-9150(96)06028-5; Eliasson B, 1997, EUR J CLIN INVEST, V27; FACCHINI FS, 1992, LANCET, V339, P1128, DOI 10.1016/0140-6736(92)90730-Q; Gefeller O., 1990, STAT APP, V2, P323; Gunther T, 2010, MAGNESIUM RES, V23, P5, DOI 10.1684/mrh.2009.0195; Guido Di Dalmazi, 2012, J NUTR METAB; Hattori Y, 2002, HYPERTENSION, V39, P22, DOI 10.1161/hy1201.097300; He JM, 2007, HEPATOLOGY, V46, P1791, DOI 10.1002/hep.21904; Hu Frank B., 2008, OBESITY EPIDEMIOLOGY, P512; KERSHBAUM A, 1966, GERIATRICS, V21, P155; KIRSCHBAUM C, 1992, LIFE SCI, V50, P435, DOI 10.1016/0024-3205(92)90378-3; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Llorca J, 2001, Gac Sanit, V15, P61; Mancini T, 2004, CLIN ENDOCRINOL, V61, P768, DOI 10.1111/j.1365-2265.2004.02168.x; Ministerio de Salud Chile, 2003, RES ENC SAL CHIL 200; Ministerio de Salud Chile, 2009, ENC NAC SAL 2009 201; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Morgan TM, 2004, METABOLISM, V53, P578, DOI 10.1016/j.metabol.2003.12.006; Orpinas P., 1991, TEMAS SALUD MENTAL A, P185; Pietraszek A, 2010, NUTR METAB CARDIOVAS, V20, P366, DOI 10.1016/j.numecd.2010.05.001; Prospective Studies Collaboration, 2009, PREV CHRONIC DIS, V373, P1083; Seike N, 2008, ASIA PAC J CLIN NUTR, V17, P545; Shao SY, 2013, DNA CELL BIOL, V32, P41, DOI 10.1089/dna.2012.1874; Soumaya K, 2013, ADV EXP MED BIOL, V771, P240; Straub SG, 2012, AM J PHYSIOL-CELL PH, V302, pC1687, DOI 10.1152/ajpcell.00282.2011; Taksali SE, 2008, DIABETES, V57, P367, DOI 10.2337/db07-0932; Tuomi T, 2014, LANCET, V383, P1084, DOI 10.1016/S0140-6736(13)62219-9; Turner N, 2014, J ENDOCRINOL, V220, pT61, DOI 10.1530/JOE-13-0397; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO, 2011, GLOBAL STATUS REPORT; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; World Health Organization, 2011, HLTH CONS SMOK 50 YE; Ye JP, 2013, FRONT MED-PRC, V7, P14, DOI 10.1007/s11684-013-0262-6	44	19	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178092	10.1371/journal.pone.0178092	http://dx.doi.org/10.1371/journal.pone.0178092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542472	Green Published, gold, Green Submitted			2022-12-26	WOS:000402062800043
J	Portaro, S; Naro, A; Chillura, A; Billeri, L; Bramanti, A; Bramanti, P; Rodolico, C; Calabro, RS				Portaro, Simona; Naro, Antonino; Chillura, Antonino; Billeri, Luana; Bramanti, Alessia; Bramanti, Placido; Rodolico, Carmelo; Calabro, Rocco Salvatore			Toward a more personalized motor function rehabilitation in Myotonic dystrophy type 1: The role of neuroplasticity	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CORTICAL EXCITABILITY; MUSCULAR-DYSTROPHY; EVOKED-POTENTIALS; PROTEIN-KINASE; SILENT PERIOD; CORTEX; NEUROREHABILITATION; VARIABILITY; INVOLVEMENT	Myotonic dystrophy type 1 (DM1) is the most prevalent adult muscular dystrophy, often accompanied by impairments in attention, memory, visuospatial and executive functions. Given that DM1 is a multi-system disorder, it requires a multi-disciplinary approach, including effective rehabilitation programs, focusing on the central nervous system neuroplasticity, in order to develop patient-tailored rehabilitative procedures for motor function recovery. Herein, we performed a transcranial magnetic stimulation (TMS) study aimed at investigating central motor conduction time, sensory-motor plasticity, and cortical excitability in 7 genetically defined DM1 patients. As compared to healthy individuals, DM1 patients showed a delayed central motor conduction time and an abnormal sensory-motor plasticity, with no alteration of cortical excitability. These findings may be useful to define patient-tailored motor rehabilitative programs.	[Portaro, Simona; Naro, Antonino; Chillura, Antonino; Billeri, Luana; Bramanti, Placido; Calabro, Rocco Salvatore] IRCCS Ctr Neurolesi Bonino Pulejo, Ist Sci Res & Care, Messina, Italy; [Bramanti, Alessia] Univ Messina, Dept Clin & Expt Med, Messina, Italy; [Rodolico, Carmelo] Natl Res Council Italy, Inst Appl Sci & Intelligent Syst ISASI Edoardo Ca, Messina, Italy	IRCCS Bonino Pulejo; University of Messina; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Applicate e Sistemi Intelligenti "Eduardo Caianiello" (ISASI-CNR)	Calabro, RS (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, Ist Sci Res & Care, Messina, Italy.	salbro77@tiscali.it	Billeri, Luana LB/V-9702-2018; PORTARO, SIMONA/GVS-8522-2022; Calabrò, Rocco S/K-7520-2016; calabro, rocco salvatore/L-9570-2019; Bramanti, Placido/K-5117-2016	calabro, rocco salvatore/0000-0002-8566-3166; RODOLICO, Carmelo/0000-0003-2543-6356; Billeri, Luana/0000-0002-0462-6364; Portaro, Simona/0000-0002-6379-1642				Alia C, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00076; BARTEL PR, 1984, J NEUROL NEUROSUR PS, V47, P524, DOI 10.1136/jnnp.47.5.524; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Calabro RS, 2016, PM&R, V8, P971, DOI 10.1016/j.pmrj.2016.02.004; Di Constanzo A, 2001, EUR NEUROL, V46, P131, DOI 10.1159/000050786; Di Costanzo A, 2002, J NEUROL, V249, P1175, DOI 10.1007/s00415-002-0796-z; Di Lazzaro V, 1998, MUSCLE NERVE, V21, P662; Dimyan MA, 2011, NAT REV NEUROL, V7, P76, DOI 10.1038/nrneurol.2010.200; GLANTZ RH, 1988, ARCH NEUROL-CHICAGO, V45, P36, DOI 10.1001/archneur.1988.00520250042017; Golaszewski S, 2016, NEUROSCI LETT, V610, P218, DOI 10.1016/j.neulet.2015.11.008; Harmon EB, 2011, J BIOL CHEM, V286, P40296, DOI 10.1074/jbc.M111.241455; Harper P S, 2002, Neuromuscul Disord, V12, P596, DOI 10.1016/S0960-8966(02)00020-2; Khoshbakht R, 2014, J CLIN NEUROSCI, V21, P1123, DOI 10.1016/j.jocn.2013.09.016; KIERS L, 1993, ELECTROEN CLIN NEURO, V89, P415, DOI 10.1016/0168-5597(93)90115-6; Liepert J, 1998, EXP BRAIN RES, V118, P421, DOI 10.1007/s002210050296; Liepert J, 2004, CLIN NEUROPHYSIOL, V115, P85, DOI 10.1016/S1388-2457(03)00322-5; Liepert J, 2001, CLIN NEUROPHYSIOL, V112, P917, DOI 10.1016/S1388-2457(01)00521-1; MACDONELL RAL, 1991, NEUROLOGY, V41, P1441, DOI 10.1212/WNL.41.9.1441; Miaux Y, 1997, NEURORADIOLOGY, V39, P166, DOI 10.1007/s002340050385; Mitsuoka T, 2003, CLIN NEUROPHYSIOL, V114, P99, DOI 10.1016/S1388-2457(02)00325-5; Mochizuki H, 2001, CLIN NEUROPHYSIOL, V112, P793, DOI 10.1016/S1388-2457(01)00512-0; Oliveri M, 1997, ELECTROMYOGR MOTOR C, V105, P297, DOI 10.1016/S0924-980X(97)00023-4; Orth M, 2004, CLIN NEUROPHYSIOL, V115, P1076, DOI 10.1016/j.clinph.2003.12.025; PANAYIOTOPOULOS CP, 1976, J NEUROL SCI, V27, P1, DOI 10.1016/0022-510X(76)90230-6; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Portaro S, 2017, J NEUROL SCI, V375, P3, DOI 10.1016/j.jns.2017.01.038; Quartarone A, 2006, J PHYSIOL-LONDON, V575, P657, DOI 10.1113/jphysiol.2006.114025; Rae MG, 2016, J NEUROPHYSIOL, V116, P1304, DOI 10.1152/jn.00248.2016; Ridding MC, 1997, ELECTROMYOGR MOTOR C, V105, P340, DOI 10.1016/S0924-980X(97)00041-6; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Sansone V, 2000, NEUROL SCI, V21, pS971, DOI 10.1007/s100720070012; SCHUBERT M, 1994, ELECTROEN CLIN NEURO, V90, P304, DOI 10.1016/0013-4694(94)90149-X; Serra L, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2696085; Shen Y, 2017, BIOL PSYCHIAT, V81, pE49, DOI 10.1016/j.biopsych.2016.06.013; Shen Y, 2016, BIOL PSYCHIAT, V80, pE13, DOI 10.1016/j.biopsych.2016.02.006; Siebner HR, 1998, MUSCLE NERVE, V21, P1209, DOI 10.1002/(SICI)1097-4598(199809)21:9<1209::AID-MUS15>3.3.CO;2-O; Takeuchi N, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00349; Turner C, 2010, J NEUROL NEUROSUR PS, V81, P358, DOI 10.1136/jnnp.2008.158261; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x	39	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0178470	10.1371/journal.pone.0178470	http://dx.doi.org/10.1371/journal.pone.0178470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542314	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800093
J	Sakai, N; Ohno, H; Tomioka, M; Iino, Y				Sakai, Naoko; Ohno, Hayao; Tomioka, Masahiro; Iino, Yuichi			The intestinal TORC2 signaling pathway contributes to associative learning in Caenorhabditis elegans	PLOS ONE			English	Article							LOCAL PROTEIN-SYNTHESIS; LONG-TERM POTENTIATION; C. ELEGANS; LIFE-SPAN; TRANSCRIPTION FACTOR; RAPAMYCIN; MTOR; COMPLEX; KINASE; MEMORY	Several types of associative learning are dependent upon the presence or absence of food, and are crucial for the survival of most animals. Target of rapamycin (TOR), a kinase which exists as a component of two complexes, TOR complex 1 (TORC1) and TOR complex 2 (TORC2), is known to act as a nutrient sensor in numerous organisms. However, the in vivo roles of TOR signaling in the nervous system remain largely unclear, partly because its multifunctionality and requirement for survival make it difficult to investigate. Here, using pharmacological inhibitors and genetic analyses, we show that TORC1 and TORC2 contribute to associative learning between salt and food availability in the nematode Caenorhabditis elegans in a process called taste associative learning. Worms migrate to salt concentrations experienced previously during feeding, but they avoid salt concentrations experienced under starvation conditions. Administration of the TOR inhibitor rapamycin causes a behavioral defect after starvation conditioning. Worms lacking either RICT-1 or SINH-1, two TORC2 components, show defects in migration to high salt levels after learning under both fed and starved conditions. We also analyzed the behavioral phenotypes of mutants of the putative TORC1 substrate RSKS-1 (the C. elegans homolog of the mammalian S6 kinase S6K) and the putative TORC2 substrates SGK-1 and PKC-2 (homologs of the serum and glucocorticoid-induced kinase 1, SGK1, and protein kinase C-alpha, PKC-alpha, respectively) and found that neuronal RSKS-1 and PKC-2, as well as intestinal SGK-1, are involved in taste associative learning. Our findings shed light on the functions of TOR signaling in behavioral plasticity and provide insight into the mechanisms by which information sensed in the intestine affects the nervous system to modulate food-searching behaviors.	[Sakai, Naoko; Ohno, Hayao; Tomioka, Masahiro; Iino, Yuichi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan; [Tomioka, Masahiro; Iino, Yuichi] Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Tokyo, Japan	University of Tokyo; University of Tokyo	Tomioka, M; Iino, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan.; Tomioka, M; Iino, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Tokyo, Japan.	tomioka@bs.s.u-tokyo.ac.jp; iino@bs.s.u-tokyo.ac.jp	TOMIOKA, MASAHIRO/G-4890-2014	TOMIOKA, MASAHIRO/0000-0002-7537-714X; Sakai, Naoko/0000-0002-6311-5281; Ohno, Hayao/0000-0003-2635-6964	 [26291069];  [25115010];  [15K14310];  [25870172];  [10978]; Grants-in-Aid for Scientific Research [25115010] Funding Source: KAKEN	; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Y.I. was supported by a Grant-in-Aid for Scientific Research (B) 26291069, for Scientific Research on Innovative Areas 25115010, and for Challenging Exploratory Research 15K14310. M.T. was supported by a Grant-in-Aid for Japan Society for the Promotion of Science Young Scientists (B) 25870172. N.S. was supported by a Grant-in-Aid for Japan Society for the Promotion of Science Fellows 10978. The URL of Japan Society for the Promotion of Science; https://www.jsps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2010, GENETICS, V186, P1309, DOI 10.1534/genetics.110.119768; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BRENNER S, 1974, GENETICS, V77, P71; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Cai Zhiyou, 2013, J Biochem Pharmacol Res, V1, P84; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Chen ATY, 2013, AGING CELL, V12, P932, DOI 10.1111/acel.12120; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI 10.1038/NMETH.2641; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Graber TE, 2013, LEARN MEMORY, V20, P518, DOI 10.1101/lm.027664.112; Halloran J, 2012, NEUROSCIENCE, V223, P102, DOI 10.1016/j.neuroscience.2012.06.054; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Huang W, 2013, NAT NEUROSCI, V16, P441, DOI 10.1038/nn.3351; IslasTrejo A, 1997, J BIOL CHEM, V272, P6629, DOI 10.1074/jbc.272.10.6629; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Jobim PFC, 2012, NEUROBIOL LEARN MEM, V97, P105, DOI 10.1016/j.nlm.2011.10.002; Jones KT, 2009, PLOS BIOL, V7, P604, DOI 10.1371/journal.pbio.1000060; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kunitomo H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3210; Lang F, 2010, J PHYSIOL-LONDON, V588, P3349, DOI 10.1113/jphysiol.2010.190926; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Law BK, 2005, CRIT REV ONCOL HEMAT, V56, P47, DOI 10.1016/j.critrevonc.2004.09.009; Lin A-L, 2015, J CEREB BLOOD FLOW M, DOI DOI 10.1177/0271678; Majumder S, 2012, AGING CELL, V11, P326, DOI 10.1111/j.1474-9726.2011.00791.x; Mazei-Robison MS, 2011, NEURON, V72, P977, DOI 10.1016/j.neuron.2011.10.012; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mizunuma M, 2014, AGING CELL, V13, P869, DOI 10.1111/acel.12248; Nukazuka A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1495; Nuttley WM, 2002, P NATL ACAD SCI USA, V99, P12449, DOI 10.1073/pnas.192101699; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; Ohno H, 2014, SCIENCE, V345, P313, DOI 10.1126/science.1250709; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Qi SH, 2010, NEUROSCI RES, V68, P88, DOI 10.1016/j.neures.2010.06.008; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Sugi T, 2011, NAT NEUROSCI, V14, P984, DOI 10.1038/nn.2854; Suzuki H, 2008, NATURE, V454, P114, DOI 10.1038/nature06927; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Tabuse Y, 2002, J BIOCHEM, V132, P519, DOI 10.1093/oxfordjournals.jbchem.a003251; Talboom JS, 2015, NPJ AGING MECH DIS, V1, DOI 10.1038/npjamd.2015.8; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tischmeyer W, 2003, EUR J NEUROSCI, V18, P942, DOI 10.1046/j.1460-9568.2003.02820.x; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Tsokas P, 2005, J NEUROSCI, V25, P5833, DOI 10.1523/JNEUROSCI.0599-05.2005; Vukojevic V, 2012, EMBO J, V31, P1453, DOI 10.1038/emboj.2012.14; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xiao R, 2013, CELL, V152, P806, DOI 10.1016/j.cell.2013.01.020; Yamada K, 2010, SCIENCE, V329, P1647, DOI 10.1126/science.1192020; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zhu HH, 2013, ELIFE, V2, DOI 10.7554/eLife.00429	60	7	7	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177900	10.1371/journal.pone.0177900	http://dx.doi.org/10.1371/journal.pone.0177900			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542414	Green Published, Green Submitted, gold			2022-12-26	WOS:000402062800029
J	Jiang, X; Zhang, H; Quan, XW; Liu, ZD; Yin, YB				Jiang, Xue; Zhang, Han; Quan, Xiongwen; Liu, Zhandong; Yin, Yanbin			Disease-related gene module detection based on a multi-label propagation clustering algorithm	PLOS ONE			English	Article							NETWORKS	Detecting disease-related gene modules by analyzing gene expression data is of great significance. It is helpful for exploratory analysis of the interaction mechanisms of genes under complex disease phenotypes. The multi-label propagation algorithm (MLPA) has been widely used in module detection for its fast and easy implementation. The accuracy of MLPA greatly depends on the connections between nodes, and most existing research focuses on measuring the similarity between nodes. However, MLPA does not perform well with loose connections between disease-related genes. Moreover, the biological significance of modules obtained by MLPA has not been demonstrated. To solve these problems, we designed a double label propagation clustering algorithm (DLPCA) based on MLPA to study Huntington's disease. In DLPCA, in addition to category labels, we introduced pathogenic labels to supervise the process of multi-label propagation clustering. The pathogenic labels contain pathogenic information about disease genes and the hierarchical structure of gene expression data. Experimental results demonstrated the superior performance of DLPCA compared with other conventional gene-clustering algorithms.	[Jiang, Xue; Zhang, Han; Quan, Xiongwen] Nankai Univ, Coll Comp & Control Engn, Tianjin 300350, Peoples R China; [Jiang, Xue; Zhang, Han; Quan, Xiongwen] Nankai Univ, Tianjin Key Lab Intelligent Robot, Tianjin 300350, Peoples R China; [Liu, Zhandong] Baylor Coll Med, Dept Pediat Neurol, Houston, TX 77030 USA; [Yin, Yanbin] Northern Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA	Nankai University; Nankai University; Baylor College of Medicine; Northern Illinois University	Quan, XW (corresponding author), Nankai Univ, Coll Comp & Control Engn, Tianjin 300350, Peoples R China.; Quan, XW (corresponding author), Nankai Univ, Tianjin Key Lab Intelligent Robot, Tianjin 300350, Peoples R China.	quanxw@nankai.edu.cn	Yin, Yanbin/AAH-2665-2020	Yin, Yanbin/0000-0001-7667-881X; Liu, Zhandong/0000-0002-7608-0831	 [15JCYBJC18900];  [61403213]	; 	This work was supported by 15JCYBJC18900, http://www.tstc.gov.cn/zxbs/asxh/kjjh/yyjc/ (H. Z. is the receiver of the above funding), and 61403213, http://www.nsfc.gov.cn/publish/portal0/tab351/ (X. Q. is the receiver of this funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Barber MJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026129; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; [陈羽中 Chen Yuzhong], 2015, [模式识别与人工智能, Pattern Recognition and Artificial Intelligence], V28, P289; Cheng H, 2009, IEEE I CONF COMP VIS, P317, DOI 10.1109/ICCV.2009.5459267; Ding ZL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24115; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gregory S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/103018; Gwinner F, 2016, BIOINFORMATICS, V33, P1; Hong FX, 2008, BIOINFORMATICS, V24, P374, DOI 10.1093/bioinformatics/btm620; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang T., 2010, P SIAM INT C DAT MIN, P583; Ismail B, 2011, IMAGE ANNOTATION AND; Knox SS, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-11; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2016, NAT NEUROSCI, V19, P623, DOI 10.1038/nn.4256; Lee S, 2015, EXP NEUROBIOL, V24, P1, DOI 10.5607/en.2015.24.1.1; [雷琪 Lei Qi], 2015, [模式识别与人工智能, Pattern Recognition and Artificial Intelligence], V28, P961; Leung IXY, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.066107; Lim J, 2015, DEV CELL, V32, P491, DOI 10.1016/j.devcel.2015.02.002; Liu YS, 2017, IEEE ACM T COMPUT BI, V14, P905, DOI 10.1109/TCBB.2016.2550432; Moradi F, 2014, 2014 PROCEEDINGS OF THE IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2014), P1, DOI 10.1109/ASONAM.2014.6921552; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Romanoski CE, 2010, AM J HUM GENET, V86, P399, DOI 10.1016/j.ajhg.2010.02.002; Speriosu M, 2011, P 1 WORKSHOP UNSUPER, P53, DOI DOI 10.1017/CB09781107415324.004; Subelj L, 2011, EUR PHYS J B, V81, P353, DOI 10.1140/epjb/e2011-10979-2; Tang CY, 2015, MAGNETIC RESONANCE M, V3, P1; Tang JH, 2008, IEEE T MULTIMEDIA, V10, P620, DOI 10.1109/TMM.2008.921853; Tian Z., 2012, P SIAM INT C DAT MI, P863; Wang X, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-31; YANG Ling-peng, 2007, P 6 NTCIR WORKSH, P140; Zeng XX, 2017, IEEE ACM T COMPUT BI, V14, P687, DOI 10.1109/TCBB.2016.2520947; Zeng XX, 2016, BRIEF BIOINFORM, V17, P193, DOI 10.1093/bib/bbv033; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhu X, 2003, TECHNICAL REPORT CMU	39	25	26	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0178006	10.1371/journal.pone.0178006	http://dx.doi.org/10.1371/journal.pone.0178006			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542379	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672600039
J	Oostvogels, AJJM; Busschers, WB; Spierings, EJM; Roseboom, TJ; Gademan, MGJ; Vrijkotte, TGM				Oostvogels, Adriette J. J. M.; Busschers, Wim B.; Spierings, Eline J. M.; Roseboom, Tessa J.; Gademan, Maaike G. J.; Vrijkotte, Tanja G. M.			Pre-pregnancy weight status, early pregnancy lipid profile and blood pressure course during pregnancy: The ABCD study	PLOS ONE			English	Article							REACTIVE PROTEIN-LEVELS; BODY-MASS INDEX; MATERNAL OBESITY; ENDOTHELIAL DYSFUNCTION; ELASTIN PEPTIDES; RISK-FACTORS; PREECLAMPSIA; COMPLICATIONS; TRIGLYCERIDES; TRIMESTER	Objective Although pre-pregnancy weight status and early pregnancy lipid profile are known to influence blood pressure course during pregnancy, little is known about how these two factors interact. The association between pre-pregnancy weight status and blood pressure course during pregnancy was assessed in the prospective ABCD study and the role (independent/mediating/moderating) of early pregnancy lipid profile in this association was determined. Methods We included 2500 normal weight (<25 kg/m2) and 600 overweight (>= 25 kg/m2) women from the prospective ABCD-study with available measurements of non-fasting early pregnancy lipids [median (IQR): 13 (12-14) weeks of gestation] and blood pressure during pregnancy [mean (SD) = 10 (2.3)]. Lipids (triglycerides, total cholesterol, apolipoprotein A1, apolipoprotein B and free fatty acids) were divided into tertiles. Multilevel piecewise linear spline models were used to describe the course of systolic and diastolic blood pressure (SBP/DBP) in four time periods during gestation for overweight and normal weight women. Results Both SBP (5.3 mmHg) and DBP (3.9 mmHg) were higher in overweight compared to normal weight women and this difference remained the same over all four time periods. The difference in SBP and DBP was not mediated or moderated by the lipid profile. Lipid profile had an independent positive effect on both SBP (range 1.3-2.2 mmHg) and DBP (0.8-1.1 mmHg), but did not change blood pressure course. Conclusions Both pre-pregnancy weight status and early pregnancy lipid profile independently increase blood pressure during pregnancy. Improving pre-pregnancy weight status and early pregnancy lipid profile might result in a healthier blood pressure course during pregnancy.	[Oostvogels, Adriette J. J. M.; Busschers, Wim B.; Spierings, Eline J. M.; Gademan, Maaike G. J.; Vrijkotte, Tanja G. M.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands; [Roseboom, Tessa J.] Univ Amsterdam, Acad Med Ctr, Dept Gynaecol & Obstet, Amsterdam, Netherlands; [Roseboom, Tessa J.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Oostvogels, AJJM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands.	a.oostvogels@amc.nl		Roseboom, Tessa/0000-0003-0564-5994; Vrijkotte, Tanja/0000-0003-3641-4048	Netherlands Organization for Health Research and Development (ZonMw) (TOP) [40-00812-98-11010]	Netherlands Organization for Health Research and Development (ZonMw) (TOP)(Netherlands Organization for Health Research and Development)	This work was supported by the Netherlands Organization for Health Research and Development (ZonMw) Grant (TOP, 40-00812-98-11010), granted to TV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Bizbiz L, 1997, ATHEROSCLEROSIS, V131, P73, DOI 10.1016/S0021-9150(97)06076-0; Buuren van SG -O K, 2010, MICE MULTIVARIATE IM, V10, P1; Carpenter MW, 2007, DIABETES CARE, V30, pS246, DOI 10.2337/dc07-s224; CHIN JH, 1992, J CLIN INVEST, V89, P10, DOI 10.1172/JCI115549; Clausen T, 2001, BRIT J OBSTET GYNAEC, V108, P1081, DOI 10.1016/S0306-5456(01)00247-9; de Jonge LL, 2011, J HYPERTENS, V29, P2413, DOI 10.1097/HJH.0b013e32834c58e5; Enquobahrie DA, 2004, AM J HYPERTENS, V17, P574, DOI 10.1016/j.amjhyper.2004.03.666; Farias DR, 2016, BJOG-INT J OBSTET GY, V123, P570, DOI 10.1111/1471-0528.13293; FAURY G, 1995, J VASC RES, V32, P112, DOI 10.1159/000159084; Gademan MGJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094594; Gaillard R, 2011, J HYPERTENS, V29, P937, DOI 10.1097/HJH.0b013e328345500c; Gratacos E, 2000, EUR J OBSTET GYN R B, V92, P63, DOI 10.1016/S0301-2115(00)00427-9; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; Kandimalla B. H., 2011, Archives of Physiology and Biochemistry, V117, P215, DOI 10.3109/13813455.2010.543137; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Langsted A, 2008, CIRCULATION, V118, P2047, DOI 10.1161/CIRCULATIONAHA.108.804146; Macdonald-Wallis C, 2012, HYPERTENSION, V59, P1241, DOI 10.1161/HYPERTENSIONAHA.111.187039; Macdonald-Wallis C, 2011, J HYPERTENS, V29, P1703, DOI 10.1097/HJH.0b013e328349eec6; Magriples U, 2013, AM J PERINAT, V30, P415, DOI 10.1055/s-0032-1326987; Miller RS, 2007, PAEDIATR PERINAT EP, V21, P487, DOI 10.1111/j.1365-3016.2007.00871.x; Mohamed-Ali V, 1998, INT J OBESITY, V22, P1145, DOI 10.1038/sj.ijo.0800770; NORDESTGAARD BG, 1995, ARTERIOSCL THROM VAS, V15, P534, DOI 10.1161/01.ATV.15.4.534; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; Ray JG, 2006, BJOG-INT J OBSTET GY, V113, P379, DOI 10.1111/j.1471-0528.2006.00889.x; Sattar N, 1998, ATHEROSCLEROSIS, V138, P229, DOI 10.1016/S0021-9150(98)00037-9; Savvidou MD, 2003, LANCET, V361, P1511, DOI 10.1016/S0140-6736(03)13177-7; Scifres CM, 2014, OBESITY, V22, P932, DOI 10.1002/oby.20576; STEWART AW, 1987, AM J EPIDEMIOL, V125, P122, DOI 10.1093/oxfordjournals.aje.a114494; Torgersen CKL, 2006, CRIT CARE NURS Q, V29, P2, DOI 10.1097/00002727-200601000-00002; van Eijsden M, 2011, INT J EPIDEMIOL, V40, P1176, DOI 10.1093/ije/dyq128; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Vrijkotte TGM, 2012, J CLIN ENDOCR METAB, V97, P3917, DOI 10.1210/jc.2012-1295; WHO, 2014, GLOB DAT BOD MASS IN; Wolf M, 2001, OBSTET GYNECOL, V98, P757, DOI 10.1016/S0029-7844(01)01551-4; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473	37	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177554	10.1371/journal.pone.0177554	http://dx.doi.org/10.1371/journal.pone.0177554			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542294	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672600016
J	Liu, JH; Wei, XX; Li, A; Cui, YX; Xia, XY; Qin, WS; Zhang, MC; Gao, EZ; Sun, J; Gao, CL; Liu, FX; Wu, QY; Li, WW; Asan; Liu, ZH; Li, XJ				Liu, Jian-Hong; Wei, Xiu-Xiu; Li, Ang; Cui, Ying-Xia; Xia, Xin-Yi; Qin, Wei-Song; Zhang, Ming-Chao; Gao, Er-Zhi; Sun, Jun; Gao, Chun-Lin; Liu, Feng-Xia; Wu, Qiu-Yue; Li, Wei-Wei; Asan; Liu, Zhi-Hong; Li, Xiao-Jun			Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT; MOLECULAR ANALYSIS; GENE; GUIDELINES; VARIANTS; GENOME	Alport syndrome (AS) is a clinically and genetically heterogeneous, progressive nephropathy caused by mutations in COL4A3, COL4A4, and COL4A5, which encode type IV collagen. The large sizes of these genes and the absence of mutation hot spots have complicated mutational analysis by routine polymerase chain reaction (PCR)-based approaches. Here, in order to design a rapid and effective method for the genetic diagnosis of AS, we developed a strategy by utilizing targeted capture associated with next-generation sequencing (NGS) to analyze COL4A3, COL4A4, and COL4A5 simultaneously in 20 AS patients. All the coding exons and flanking sequences of COL4A3, COL4A4, and COL4A5 from the probands were captured followed by HiSeq 2500 sequencing. Candidate mutations were validated by classic Sanger sequencing and quantitative (q) PCR. Sixteen patients (16/20, 75%) showed X-linked inheritance, and four patients (4/20, 20%) showed autosomal recessive inheritance. None of the individuals had autosomal-dominant AS. Fifteen novel mutations, 6 known mutations, and 2 novel fragment deletions were detected by targeted capture and NGS. Of these novel mutations, 12, 3, and 2 mutations were detected in COL4A5, COL4A4, and COL4A3, respectively. A comparison of the clinical manifestations caused by different types of mutations in COL4A5 suggested that nonsense mutations and glycine substitution by an acidic amino acid are more severe than the other missense mutations. Pathogenic mutations were detected in 20 patients. These novel mutations can expand the genotypic spectrum of AS. Our results demonstrated that targeted capture and NGS technology are effective in the genetic diagnosis of AS.	[Liu, Jian-Hong; Li, Ang; Cui, Ying-Xia; Xia, Xin-Yi; Wu, Qiu-Yue; Li, Wei-Wei; Li, Xiao-Jun] Nanjing Univ, Inst Clin Lab Sci, Jinling Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China; [Wei, Xiu-Xiu; Sun, Jun; Liu, Feng-Xia; Asan] BGI Shenzhen, BGI Tianjin, Binhai Genom Inst, Tianjin, Peoples R China; [Qin, Wei-Song; Zhang, Ming-Chao; Gao, Er-Zhi; Liu, Zhi-Hong] Nanjing Univ, Jinling Hosp, Natl Clin Res Ctr Kidney Dis, Sch Med, Nanjing, Jiangsu, Peoples R China; [Gao, Chun-Lin] Nanjing Univ, Sch Med, Jinling Hosp, Dept Pediat Nephrol, Nanjing, Jiangsu, Peoples R China; [Li, Xiao-Jun] Nanjing Univ, Dept Chem, State Key Lab Analyt Chem Life Sci, Nanjing, Jiangsu, Peoples R China	Nanjing University; Beijing Genomics Institute (BGI); Nanjing University; Nanjing University; Nanjing University	Li, XJ (corresponding author), Nanjing Univ, Inst Clin Lab Sci, Jinling Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China.; Asan (corresponding author), BGI Shenzhen, BGI Tianjin, Binhai Genom Inst, Tianjin, Peoples R China.; Liu, ZH (corresponding author), Nanjing Univ, Jinling Hosp, Natl Clin Res Ctr Kidney Dis, Sch Med, Nanjing, Jiangsu, Peoples R China.; Li, XJ (corresponding author), Nanjing Univ, Dept Chem, State Key Lab Analyt Chem Life Sci, Nanjing, Jiangsu, Peoples R China.	asan@genomics.cn; zhliunj@vip.163.com; xiaojunli62@126.com		Li, Ang/0000-0002-7403-2705	Science and Technology Program of Jiangsu Province [BL2014072]; Science and Technology Development Project of Nanjing [201402008, 201503010]; National Key Clinical Program of China [2014ZDZKO03]	Science and Technology Program of Jiangsu Province; Science and Technology Development Project of Nanjing; National Key Clinical Program of China	This work is supported by the grants from Science and Technology Program of Jiangsu Province (BL2014072), Science and Technology Development Project of Nanjing (No. 201402008), (No. 201503010), and National Key Clinical Program of China (No. 2014ZDZKO03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the patients and their families for permitting us to do this study. This work is supported by the grants from Science and Technology Program of Jiangsu Province (BL2014072), Science and Technology Development Project of Nanjing (No. 201402008), (No. 201503010), and National Key Clinical Program of China (No. 2014ZDZKO03).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alport AC, 1927, BMJ-BRIT MED J, V1927, P504, DOI 10.1136/bmj.1.3454.504; Beirowski B, 2006, J AM SOC NEPHROL, V17, P1986, DOI 10.1681/ASN.2005101044; Bekheirnia MR, 2010, J AM SOC NEPHROL, V21, P876, DOI 10.1681/ASN.2009070784; Gong W, 2006, NEPHROL DIAL TRANSPL, V21, P3146, DOI 10.1093/ndt/gfl394; Gregory MC, 1996, CONTRIB NEPHROL, V117, P1; Gross O, 2002, NEPHROL DIAL TRANSPL, V17, P1218, DOI 10.1093/ndt/17.7.1218; Heidet L, 2001, J AM SOC NEPHROL, V12, P97, DOI 10.1681/ASN.V12197; Hudson BG, 2004, J AM SOC NEPHROL, V15, P2514, DOI 10.1097/01.ASN.0000141462.00630.76; Jais JP, 2003, J AM SOC NEPHROL, V14, P2603, DOI 10.1097/01.ASN.0000090034.71205.74; Jefferson JA, 1997, NEPHROL DIAL TRANSPL, V12, P1595, DOI 10.1093/ndt/12.8.1595; Kamiyoshi N, 2016, CLIN J AM SOC NEPHRO, V11, P1441, DOI 10.2215/CJN.01000116; Kashtan CE, 2000, PEDIATR NEPHROL, V14, P502, DOI 10.1007/s004670050804; KASHTAN CE, 1993, AM J KIDNEY DIS, V22, P627, DOI 10.1016/S0272-6386(12)80424-0; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Kruegel J, 2013, NAT REV NEPHROL, V9, P170, DOI 10.1038/nrneph.2012.259; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu G, 2014, GENE, V533, P547, DOI 10.1016/j.gene.2013.10.021; Longo I, 2006, NEPHROL DIAL TRANSPL, V21, P665, DOI 10.1093/ndt/gfi312; Longo I, 2002, KIDNEY INT, V61, P1947, DOI 10.1046/j.1523-1755.2002.00379.x; Malone AF, 2014, KIDNEY INT, V86, P1253, DOI 10.1038/ki.2014.305; Marcocci E, 2009, NEPHROL DIAL TRANSPL, V24, P1464, DOI 10.1093/ndt/gfn681; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mencarelli MA, 2015, J MED GENET, V52, P163, DOI 10.1136/jmedgenet-2014-102822; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; Nagel Mato, 2005, Hum Mutat, V26, P60, DOI 10.1002/humu.9349; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Papazachariou L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115015; Pirson Y, 1999, KIDNEY INT, V56, P760, DOI 10.1046/j.1523-1755.1999.00601.x; POCHET JM, 1989, NEPHROL DIAL TRANSPL, V4, P1016; Renkema KY, 2014, NAT REV NEPHROL, V10, P433, DOI 10.1038/nrneph.2014.95; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Savige J, 2013, J AM SOC NEPHROL, V24, P364, DOI 10.1681/ASN.2012020148; Wei XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029500; Xie JY, 2015, J MOL CELL BIOL, V7, P184, DOI 10.1093/jmcb/mjv023	35	11	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177685	10.1371/journal.pone.0177685	http://dx.doi.org/10.1371/journal.pone.0177685			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542346	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400067
J	Rao, D; Perraud, AL; Schmitz, C; Gally, F				Rao, Deviyani; Perraud, Anne-Laure; Schmitz, Carsten; Gally, Fabienne			Cigarette smoke inhibits LPS-induced FABP5 expression by preventing c-Jun binding to the FABP5 promoter	PLOS ONE			English	Article							EPITHELIAL-CELLS; INNATE IMMUNITY; INFLAMMATION; LUNG; INFECTION; ACTIVATION; AIRWAY; IMPACT	Cigarette smoking is the primary cause of chronic obstructive pulmonary disease (COPD) with repeated and sustained infections linked to disease pathogenesis and exacerbations. The airway epithelium constitutes the first line of host defense against infection and is known to be impaired in COPD. We have previously identified Fatty Acid Binding Protein 5 (FABP5) as an important anti-inflammatory player during respiratory infections and showed that overexpression of FABP5 in primary airway epithelial cells protects against bacterial infection and inflammation. While cigarette smoke down regulates FABP5 expression, its mechanism remains unknown. In this report, we have identified three putative c-Jun binding sites on the FABP5 promoter and show that cigarette smoke inhibits the binding of c-Jun to its consensus sequence and prevents LPS-induced FABP5 expression. Using chromatin immunoprecipitation, we have determined that c-Jun binds the FABP5 promoter when stimulated with LPS but the presence of cigarette smoke greatly reduces this binding. Furthermore, cigarette smoke or a mutation in the c-Jun binding site inhibits LPS-induced FABP5 promoter activity. These data demonstrate that cigarette smoke interferes with FABP5 expression in response to bacterial infection. Thus, functional activation of FABP5 may be a new therapeutic strategy when treating COPD patients suffering from exacerbations.	[Rao, Deviyani; Perraud, Anne-Laure; Schmitz, Carsten; Gally, Fabienne] Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA; [Perraud, Anne-Laure; Schmitz, Carsten] Univ Colorado Denver, Dept Immunol & Microbiol, Denver, CO USA	National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Gally, F (corresponding author), Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA.	gallyf@njhealth.org		Gally, Fabienne/0000-0003-0503-7411	American Lung Association [RG-266855-N]; Flight Attendant Medical Research Institute (FAMRI) [YCSA-103151]	American Lung Association; Flight Attendant Medical Research Institute (FAMRI)	This work was supported by the American Lung Association RG-266855-N (FG) and Flight Attendant Medical Research Institute (FAMRI) YCSA-103151 (FG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bagaitkar Juhi, 2008, Tob Induc Dis, V4, P12, DOI 10.1186/1617-9625-4-12; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Baral P, 2014, AM J RESP CRIT CARE, V190, P722, DOI 10.1164/rccm.201406-1101PP; Bleck B, 1998, GENE, V215, P123, DOI 10.1016/S0378-1119(98)00262-5; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Donaldson GC, 2005, CHEST, V128, P1995, DOI 10.1378/chest.128.4.1995; Drannik AG, 2004, AM J RESP CRIT CARE, V170, P1164, DOI 10.1164/rccm.200311-1521OC; Fabbri Leonardo, 2004, COPD, V1, P105; FOSTER WM, 1985, AM REV RESPIR DIS, V132, P633; Gally F, 2013, AM J PHYSIOL-LUNG C, V305, pL64, DOI 10.1152/ajplung.00276.2012; Gally F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051784; Green RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006860; Gualano RC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-53; Herr C, 2009, THORAX, V64, P144, DOI 10.1136/thx.2008.102681; HOEFFLER WK, 1994, NUCLEIC ACIDS RES, V22, P1305, DOI 10.1093/nar/22.7.1305; Laan M, 2004, J IMMUNOL, V173, P4164, DOI 10.4049/jimmunol.173.6.4164; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Martin Richard J, 2006, COPD, V3, P3, DOI 10.1080/15412550500493162; Martinez-Solano L, 2008, CLIN INFECT DIS, V47, P1526, DOI 10.1086/593186; Morgan E, 2010, PPAR RES, V2010, DOI 10.1155/2010/234629; Niewoehner DE, 2006, AM J MED, V119, pS38, DOI 10.1016/j.amjmed.2006.08.006; RAMAN AS, 1983, CHEST, V83, P23, DOI 10.1378/chest.83.1.23; Razani-Boroujerdi S, 2004, CELL IMMUNOL, V230, P1, DOI 10.1016/j.cellimm.2004.07.007; Rosell A, 2005, ARCH INTERN MED, V165, P891, DOI 10.1001/archinte.165.8.891; Sethi S, 2008, NEW ENGL J MED, V359, P2355, DOI 10.1056/NEJMra0800353; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Soler N, 1999, EUR RESPIR J, V14, P1015, DOI 10.1183/09031936.99.14510159; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002	32	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0178021	10.1371/journal.pone.0178021	http://dx.doi.org/10.1371/journal.pone.0178021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542209	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400130
J	Sarlabous, L; Torres, A; Fiz, JAA; Martinez-Llorens, JM; Gea, J; Jane, R				Sarlabous, Leonardo; Torres, Abel; Fiz, Jose A. A.; Martinez-Llorens, Juana M.; Gea, Joaquim; Jane, Raimon			Inspiratory muscle activation increases with COPD severity as confirmed by non-invasive mechanomyographic analysis	PLOS ONE			English	Article							NEURAL RESPIRATORY DRIVE; POWER OUTPUT; DIAPHRAGM; FATIGUE; ELECTROMYOGRAPHY; EXACERBATIONS; PHONOMYOGRAM; EFFICIENCY; SIGNALS; FORCE	There is a lack of instruments for assessing respiratory muscle activation during the breathing cycle in clinical conditions. The aim of the present study was to evaluate the usefulness of the respiratory muscle mechanomyogram (MMG) for non-invasively assessing the mechanical activation of the inspiratory muscles of the lower chest wall in both patients with chronic obstructive pulmonary disease (COPD) and healthy subjects, and to investigate the relationship between inspiratory muscle activation and pulmonary function parameters. Both inspiratory mouth pressure and respiratory muscle MMG were simultaneously recorded under two different respiratory conditions, quiet breathing and incremental ventilatory effort, in 13 COPD patients and 7 healthy subjects. The mechanical activation of the inspiratory muscles was characterised by the non-linear multistate Lempel-Ziv index (MLZ) calculated over the inspiratory time of the MMG signal. Subsequently, the efficiency of the inspiratory muscle mechanical activation was expressed as the ratio between the peak inspiratory mouth pressure to the amplitude of the mechanical activation. This activation estimated using the MLZ index correlated strongly with peak inspiratory mouth pressure throughout the respiratory protocol in both COPD patients (r = 0.80, p<0.001) and healthy (r = 0.82, p<0.001). Moreover, the greater the COPD severity in patients, the greater the level of muscle activation (r = -0.68, p = 0.001, between muscle activation at incremental ventilator effort and FEV1). Furthermore, the efficiency of the mechanical activation of inspiratory muscle was lower in COPD patients than healthy subjects (7.61 +/- 2.06 vs 20.42 +/- 10.81, respectively, p = 0.0002), and decreased with increasing COPD severity (r = 0.78, p<0.001, between efficiency of the mechanical activation at incremental ventilatory effort and FEV1). These results suggest that the respiratory muscle mechanomyogram is a good reflection of inspiratory effort and can be used to estimate the efficiency of the mechanical activation of the inspiratory muscles. Both, inspiratory muscle activation and inspiratory muscle mechanical activation efficiency are strongly correlated with the pulmonary function. Therefore, the use of the respiratory muscle mechanomyogram can improve the assessment of inspiratory muscle activation in clinical conditions, contributing to a better understanding of breathing in COPD patients.	[Sarlabous, Leonardo; Torres, Abel; Fiz, Jose A. A.; Jane, Raimon] Inst Bioengn Catalonia, Barcelona, Spain; [Sarlabous, Leonardo; Torres, Abel; Fiz, Jose A. A.; Jane, Raimon] Ctr Biomed Res Network Bioengn Biomat & Nanomed, Barcelona, Spain; [Sarlabous, Leonardo; Torres, Abel; Jane, Raimon] Univ Politecn Cataluna, BarcelonaTech UPC, Dept Automat Control, Barcelona, Spain; [Martinez-Llorens, Juana M.; Gea, Joaquim] Hosp del Mar, CIBERES, DCEXS, UPF,Dept Resp Med,ISCiii,IMIM, Barcelona, Spain	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; Universitat Politecnica de Catalunya; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Instituto de Salud Carlos III; Pompeu Fabra University	Torres, A (corresponding author), Inst Bioengn Catalonia, Barcelona, Spain.; Torres, A (corresponding author), Ctr Biomed Res Network Bioengn Biomat & Nanomed, Barcelona, Spain.; Torres, A (corresponding author), Univ Politecn Cataluna, BarcelonaTech UPC, Dept Automat Control, Barcelona, Spain.	abel.torres@upc.edu	Sarlabous, Leonardo/AAZ-7951-2020; Sarlabous, Leonardo/L-2333-2014; Cebrian, Abel Torres/I-5730-2014	Sarlabous, Leonardo/0000-0002-0495-8422; Sarlabous, Leonardo/0000-0002-0495-8422; Cebrian, Abel Torres/0000-0003-2678-1303; Jane, Raimon/0000-0002-6541-8729	Secretariat of Universities and Research of the Ministry of Economy and Knowledge of the Generalitat de Catalunya; Plan Nacional [SAF2014-54371]; Ministry of Economy and Competitiveness of the Spanish Government; European Regional Development Fund [DPI2015-68820-R]	Secretariat of Universities and Research of the Ministry of Economy and Knowledge of the Generalitat de Catalunya; Plan Nacional; Ministry of Economy and Competitiveness of the Spanish Government(Spanish Government); European Regional Development Fund(European Commission)	This work was supported in part by the Secretariat of Universities and Research of the Ministry of Economy and Knowledge of the Generalitat de Catalunya (consolidated research groups GRC 2014 SGR 1569 and 424, and CERCA Programme), the Plan Nacional (SAF2014-54371), and by the Ministry of Economy and Competitiveness of the Spanish Government and the European Regional Development Fund, DPI2015-68820-R (MINECO/FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the Secretariat of Universities and Research of the Ministry of Economy and Knowledge of the Generalitat de Catalunya (Consolidated research groups GRC 2014 SGR 1569 and 424, and CERCA Programme), the Plan Nacional (SAF2014-54371), and the Ministry of Economy and Competitiveness of the Spanish Government and the European Regional Development Fund, DPI2015-68820-R (MINECO/FEDER).	Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; Fiz JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093595; Bakke PS, 2011, EUR RESPIR J, V38, P1261, DOI 10.1183/09031936.00193809; BARRY DT, 1987, BIOPHYS J, V51, P769, DOI 10.1016/S0006-3495(87)83403-3; Ce E., 2015, SPORT SCI HLTH, V11, P1, DOI [10.1007/s11332-015-0219-z, DOI 10.1007/S11332-015-0219-Z, DOI 10.1007/s11332-015-0219-z]; Cescon C, 2006, J ELECTROMYOGR KINES, V16, P17, DOI 10.1016/j.jelekin.2005.02.005; Cramer JT, 2000, MUSCLE NERVE, V23, P1826, DOI 10.1002/1097-4598(200012)23:12<1826::AID-MUS5>3.0.CO;2-7; DAVIS JN, 1967, J NEUROL NEUROSUR PS, V30, P420, DOI 10.1136/jnnp.30.5.420; Estrada L, 2016, IEEE J BIOMED HEALTH, V20, P476, DOI 10.1109/JBHI.2015.2398934; Finucane KE, 2009, J APPL PHYSIOL, V107, P1397, DOI 10.1152/japplphysiol.91465.2008; Fiz Jose Antonio, 2004, BMC Pulm Med, V4, P8, DOI 10.1186/1471-2466-4-8; Gorman RB, 2002, AM J RESP CRIT CARE, V166, P1461, DOI 10.1164/rccm.200111-087OC; Guenette JA, 2012, EUR RESPIR J, V40, P322, DOI 10.1183/09031936.00157711; Ibitoye MO, 2014, SENSORS-BASEL, V14, P22940, DOI 10.3390/s141222940; Ibitoye MO, 2014, CLIN BIOMECH, V29, P691, DOI 10.1016/j.clinbiomech.2014.04.003; Islam MA, 2013, IEEE SENS J, V13, P2499, DOI 10.1109/JSEN.2013.2255982; Laghi F, 2003, AM J RESP CRIT CARE, V168, P10, DOI 10.1164/rccm.2206020; LAPORTA D, 1985, J APPL PHYSIOL, V58, P1469, DOI 10.1152/jappl.1985.58.5.1469; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Luo YM, 2008, CLIN SCI, V115, P233, DOI 10.1042/CS20070348; MacBean V, 2016, PHYSIOL MEAS, V37, P2050, DOI 10.1088/0967-3334/37/11/2050; Madeleine P, 2002, EUR J APPL PHYSIOL, V87, P327, DOI 10.1007/s00421-002-0655-8; Murphy PB, 2011, THORAX, V66, P602, DOI 10.1136/thx.2010.151332; NEWELL SZ, 1989, THORAX, V44, P903, DOI 10.1136/thx.44.11.903; Orizio C, 2003, EUR J APPL PHYSIOL, V90, P326, DOI 10.1007/s00421-003-0924-1; ORIZIO C, 1993, CRIT REV BIOMED ENG, V21, P201; Orizio C, 2006, MECHANOMYOGRAPHY WIL, P1; Ottenheijm CAC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-12; Petitjean M, 1997, AM J RESP CRIT CARE, V155, P1162, DOI 10.1164/ajrccm.155.3.9117004; Petitjean M, 1996, THORAX, V51, P705, DOI 10.1136/thx.51.7.705; PETITJEAN M, 1994, MUSCLE NERVE, V17, P1201, DOI 10.1002/mus.880171011; Reilly CC, 2012, EUR RESPIR J, V40, P977, DOI 10.1183/09031936.00163111; Sarlabous L, 2015, EUR RESPIR J, V46, P1808, DOI 10.1183/13993003.00434-2015; Sarlabous L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088902; Sarlabous L, 2013, J ELECTROMYOGR KINES, V23, P548, DOI 10.1016/j.jelekin.2012.12.007; Steier J, 2009, THORAX, V64, P719, DOI 10.1136/thx.2008.109728; Suh ES, 2015, THORAX, V70, P1123, DOI 10.1136/thoraxjnl-2015-207188; Torres A, 2010, EUR RESP SOC ANN C, p503s	38	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177730	10.1371/journal.pone.0177730	http://dx.doi.org/10.1371/journal.pone.0177730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542364	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400072
J	Viegas, CSB; Costa, RM; Santos, L; Videira, PA; Silva, Z; Araujo, N; Macedo, AL; Matos, AP; Vermeer, C; Simes, DC				Viegas, Carla S. B.; Costa, Ruben M.; Santos, Lucia; Videira, Paula A.; Silva, Zelia; Araujo, Nuna; Macedo, Anjos L.; Matos, Antonio P.; Vermeer, Cees; Simes, Dina C.			Gla-rich protein function as an anti-inflammatory agent in monocytes/macrophages: Implications for calcification-related chronic inflammatory diseases	PLOS ONE			English	Article							VITAMIN-K SUPPRESSES; FACTOR-KAPPA-B; VASCULAR CALCIFICATION; SYNOVIAL MACROPHAGES; ARTICULAR-CARTILAGE; MATRIX VESICLES; OSTEOARTHRITIS; EXPRESSION; INSIGHTS; ACTIVATION	Calcification-related chronic inflammatory diseases are multifactorial pathological processes, involving a complex interplay between inflammation and calcification events in a positive feed-back loop driving disease progression. Gla-rich protein (GRP) is a vitamin K dependent protein (VKDP) shown to function as a calcification inhibitor in cardiovascular and articular tissues, and proposed as an anti-inflammatory agent in chondrocytes and synoviocytes, acting as a new crosstalk factor between these two interconnected events in osteoarthritis. However, a possible function of GRP in the immune system has never been studied. Here we focused our investigation in the involvement of GRP in the cell inflammatory response mechanisms, using a combination of freshly isolated human leucocytes and undifferentiated/differentiated THP-1 cell line. Our results demonstrate that VKDPs such as GRP and matrix gla protein (MGP) are synthesized and gamma-carboxylated in the majority of human immune system cells either involved in innate or adaptive immune responses. Stimulation of THP-1 monocytes/macrophages with LPS or hydroxyapatite (HA) up-regulated GRP expression, and treatments with GRP or GRP-coated basic calcium phosphate crystals resulted in the down-regulation of mediators of inflammation and inflammatory cytokines, independently of the protein gamma-carboxylation status. Moreover, overexpression of GRP in THP-1 cells rescued the inflammation induced by LPS and HA, by down-regulation of the proinflammatory cytokines TNF alpha, IL-1 beta and NFkB. Interestingly, GRP was detected at protein and mRNA levels in extracellular vesicles released by macrophages, which may act as vehicles for extracellular trafficking and release. Our data indicate GRP as an endogenous mediator of inflammatory responses acting as an anti-inflammatory agent in monocytes/macrophages. We propose that in a context of chronic inflammation and calcification-related pathologies, GRP might act as a novel molecular mediator linking inflammation and calcification events, with potential therapeutic application.	[Viegas, Carla S. B.; Costa, Ruben M.; Santos, Lucia; Araujo, Nuna; Simes, Dina C.] Univ Algarve, Ctr Marine Sci CCMAR, Faro, Portugal; [Viegas, Carla S. B.; Simes, Dina C.] Univ Algarve, Ctr Marine Sci CCMAR, GenoGla Diagnost, Faro, Portugal; [Videira, Paula A.; Silva, Zelia] Univ Nova Lisboa, UCIBIO REQUIMTE Dept Ciencias Vida, Fac Ciencias & Tecnol, Caparica, Portugal; [Macedo, Anjos L.] Univ Nova Lisboa, Dept Quim, UCIBIO REQUIMTE, Fac Ciencias & Tecnol, Caparica, Portugal; [Matos, Antonio P.] Egas Moniz Cooperat Ensino Super CRL, Ctr Invest Interdisciplinar Egas Moniz, Caparica, Portugal; [Vermeer, Cees] Maastricht Univ, VitaK, Maastricht, Netherlands	Universidade do Algarve; Universidade do Algarve; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Instituto Superior de Ciencias da Saude Egas Moniz; Maastricht University	Simes, DC (corresponding author), Univ Algarve, Ctr Marine Sci CCMAR, Faro, Portugal.; Simes, DC (corresponding author), Univ Algarve, Ctr Marine Sci CCMAR, GenoGla Diagnost, Faro, Portugal.	dsimes@ualg.pt	silva, zélia mc/O-7243-2015; Santos, Lúcia/U-7602-2017; Videira, P A/A-5901-2013; Simes, Dina Costa/N-2789-2014; Macedo, Anjos L/D-7216-2013; Viegas, Carla/N-6314-2019; Viegas, Carla CSB/N-6695-2014; Matos, Antonio/A-4539-2013	silva, zélia mc/0000-0001-6660-426X; Santos, Lúcia/0000-0002-3748-3697; Videira, P A/0000-0001-5987-2485; Simes, Dina Costa/0000-0002-5145-4753; Macedo, Anjos L/0000-0002-2613-4838; Viegas, Carla/0000-0002-5765-3665; Viegas, Carla CSB/0000-0002-5765-3665; Matos, Antonio/0000-0001-9386-0349	Portuguese Science and Technology Foundation (FCT) [PTDC/SAU-ORG/117266/2010, PTDC/BIM-MEC/1168/2012, UID/Multi/ 04326/2013]; FCT fellowships [SFRH/BPD/70277/2010, SFRH/BD/111824/2015]	Portuguese Science and Technology Foundation (FCT)(Portuguese Foundation for Science and Technology); FCT fellowships(Portuguese Foundation for Science and Technology)	This work was funded by projects PTDC/SAU-ORG/117266/2010 and PTDC/BIM-MEC/1168/2012, and also through project UID/Multi/ 04326/2013, all from the Portuguese Science and Technology Foundation (FCT). CSB Viegas and N Araujo are the recipients of the FCT fellowships SFRH/BPD/70277/2010 and SFRH/BD/111824/2015, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CSB Viegas and N Araujo are the recipients of the Portuguese Science and Technology Foundation (FCT) fellowships SFRH/BPD/70277/2010 and SFRH/BD/111824/2015, respectively. Authors acknowledge Dr Nuno Santos (CBME, University of Algarve, Faro, Portugal) for kindly providing the THP-1 cells used in this study.	Aldo PB, 2013, AM J REPROD IMMUNOL, V70, P80, DOI 10.1111/aji.12129; Bondeson J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2099; Bondeson J, 2010, ARTHRITIS RHEUM-US, V62, P647, DOI 10.1002/art.27290; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Cavaco S, 2016, CELL MOL LIFE SCI, V73, P1051, DOI 10.1007/s00018-015-2033-9; Chanput W, 2010, FOOD FUNCT, V1, P254, DOI 10.1039/c0fo00113a; Chatrou MLL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142335; Chen NX, 2015, CURR OSTEOPOROS REP, V13, P372, DOI 10.1007/s11914-015-0293-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Ciardiello C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020175; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Ea HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057352; Ea HK, 2011, ARTHRITIS RHEUM-US, V63, P10, DOI 10.1002/art.27761; Fernandez-Pisonero I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109081; Fujii S, 2015, BIOORGAN MED CHEM, V23, P2344, DOI 10.1016/j.bmc.2015.03.070; Gomez-Hernandez A, 2006, J CARDIOVASC PHARM, V47, P60; Henaut L, 2016, EXPERT OPIN THER TAR, V20, P89, DOI 10.1517/14728222.2015.1081685; Houard X, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0375-6; Ikeda K, 2012, BIOCHEM BIOPH RES CO, V425, P39, DOI 10.1016/j.bbrc.2012.07.045; Kapustin AN, 2015, CIRC RES, V116, P1312, DOI 10.1161/CIRCRESAHA.116.305012; Kapustin AN, 2011, CIRC RES, V109, pE1, DOI 10.1161/CIRCRESAHA.110.238808; Legein B, 2013, CELL MOL LIFE SCI, V70, P3847, DOI 10.1007/s00018-013-1289-1; Lehtonen A, 2007, J LEUKOCYTE BIOL, V82, P710, DOI 10.1189/jlb.0307194; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Martel-Pelletier J, 2003, SEMIN ARTHRITIS RHEU, V33, P155, DOI 10.1016/S0049-0172(03)00134-3; Nadra I, 2005, CIRC RES, V96, P1248, DOI 10.1161/01.RES.0000171451.88616.c2; New SEP, 2013, ARTERIOSCL THROM VAS, V33, P1753, DOI 10.1161/ATVBAHA.112.300128; New SEP, 2013, CIRC RES, V113, P72, DOI 10.1161/CIRCRESAHA.113.301036; New SEP, 2011, CIRC RES, V108, P1381, DOI 10.1161/CIRCRESAHA.110.234146; Ohsaki Y, 2006, BIOSCI BIOTECH BIOCH, V70, P926, DOI 10.1271/bbb.70.926; Ohsaki Y, 2010, J NUTR BIOCHEM, V21, P1120, DOI 10.1016/j.jnutbio.2009.09.011; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Popov A, 2013, J IMMUNOTOXICOL, V10, P17, DOI 10.3109/1547691X.2012.684159; Rafael MS, 2014, MOL NUTR FOOD RES, V58, P1636, DOI 10.1002/mnfr.201300941; Rahmati M, 2016, BONE, V85, P81, DOI 10.1016/j.bone.2016.01.019; Schurgers LJ, 2005, ARTERIOSCL THROM VAS, V25, P1629, DOI 10.1161/01.ATV.0000173313.46222.43; SHANAHAN CM, 1994, J CLIN INVEST, V93, P2393, DOI 10.1172/JCI117246; Shea MK, 2008, AM J EPIDEMIOL, V167, P313, DOI 10.1093/aje/kwm306; Shirai T, 2015, AUTOIMMUNITY, V48, P139, DOI 10.3109/08916934.2015.1027815; Smith ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060904; Sokolove J, 2013, THER ADV MUSCULOSKEL, V5, P77, DOI 10.1177/1759720X12467868; Surmann-Schmitt C, 2008, J BIOL CHEM, V283, P7082, DOI 10.1074/jbc.M702792200; Tie JK, 2016, J THROMB HAEMOST, V14, P236, DOI 10.1111/jth.13217; Tintut Y, 2002, CIRCULATION, V105, P650, DOI 10.1161/hc0502.102969; Viegas CSB, 2015, ARTERIOSCL THROM VAS, V35, P399, DOI 10.1161/ATVBAHA.114.304823; Viegas CSB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/340216; Viegas CSB, 2009, AM J PATHOL, V175, P2288, DOI 10.2353/ajpath.2009.090474; Viegas CSB, 2008, J BIOL CHEM, V283, P36655, DOI 10.1074/jbc.M802761200; Viegas CS, 2016, J NUTR DISORDERS THE, V6, P3, DOI DOI 10.4172/2161-0509.1000192; Viegas CS, 2016, J CARDIOVASC DIS DIA, V4, P245; Viegas CSB, 2017, EMMUNITY IN IN PRESS; Wallin R, 2010, OSTEOARTHR CARTILAGE, V18, P1096, DOI 10.1016/j.joca.2010.05.013; Willems BAG, 2014, MOL NUTR FOOD RES, V58, P1620, DOI 10.1002/mnfr.201300743; Zhao GX, 2012, KIDNEY INT, V82, P34, DOI 10.1038/ki.2012.40	54	53	55	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177829	10.1371/journal.pone.0177829	http://dx.doi.org/10.1371/journal.pone.0177829			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542410	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400094
J	Barrientos-Gutierrez, T; Zepeda-Tello, R; Rodrigues, ER; Colchero-Aragones, A; Rojas-Martinez, R; Lazcano-Ponce, E; Hernandez-Avila, M; Rivera-Dommarco, J; Meza, R				Barrientos-Gutierrez, Tonatiuh; Zepeda-Tello, Rodrigo; Rodrigues, Eliane R.; Colchero-Aragones, Arantxa; Rojas-Martinez, Rosalba; Lazcano-Ponce, Eduardo; Hernandez-Avila, Mauricio; Rivera-Dommarco, Juan; Meza, Rafael			Expected population weight and diabetes impact of the 1-peso-per-litre tax to sugar sweetened beverages in Mexico	PLOS ONE			English	Article							NUTRITION SURVEY 2012; NATIONAL-HEALTH; ENERGY-INTAKE; EXCISE TAX; OBESITY; OVERWEIGHT; METAANALYSIS; CONSUMPTION; PREVALENCE; ADULTS	Study question What effect on body mass index, obesity and diabetes can we expect from the 1-peso-per-litre tax to sugar sweetened beverages in Mexico? Methods Using recently published estimates of the reductions in beverage purchases due to the tax, we modelled its expected long-term impacts on body mass index (BMI), obesity and diabetes. Microsimulations based on a nationally representative dataset were used to estimate the impact of the tax on BMI and obesity. A Markov population model, built upon an age-period- cohort model of diabetes incidence, was used to estimate the impact on diagnosed diabetes in Mexico. To analyse the potential of tax increases we also modelled a 2-peso-per- litre tax scenario. Study answer and limitations Ten years after the implementation of the tax, we expect an average reduction of 0.15 kg/m(2) per person, which translates into a 2.54% reduction in obesity prevalence. People in the lowest level of socioeconomic status and those between 20 and 35 years of age showed the largest reductions in BMI and overweight and obesity prevalence. Simulations show that by 2030, under the current implementation of 1-peso-per-litre, the tax would prevent 86 to 134 thousand cases of diabetes. Overall, the 2-peso-per-litre scenario is expected to produce twice as much of a reduction. These estimates assume the tax effect on consumption remains stable over time. Sensitivity analyses were conducted to assess the robustness of findings; similar results were obtained with various parameter assumptions and alternative modelling approaches. What this study adds The sugar-sweetened beverages tax in Mexico is expected to produce sizable and sustained reductions in obesity and diabetes. Increasing the tax could produce larger benefits. While encouraging, estimates will need to be updated once data on direct changes in consumption becomes available.	[Barrientos-Gutierrez, Tonatiuh; Zepeda-Tello, Rodrigo; Rojas-Martinez, Rosalba; Lazcano-Ponce, Eduardo] Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico; [Rodrigues, Eliane R.] Univ Nacl Autonoma Mexico, Inst Matemat, Mexico City, DF, Mexico; [Colchero-Aragones, Arantxa] Natl Inst Publ Hlth, Ctr Hlth Syst Res, Cuernavaca, Morelos, Mexico; [Hernandez-Avila, Mauricio] Natl Inst Publ Hlth, Gen Direct, Cuernavaca, Morelos, Mexico; [Rivera-Dommarco, Juan] Natl Inst Publ Hlth, Ctr Nutr & Hlth Res, Cuernavaca, Morelos, Mexico; [Meza, Rafael] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	Instituto Nacional de Salud Publica; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; University of Michigan System; University of Michigan	Barrientos-Gutierrez, T (corresponding author), Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico.	tbarrientos@insp.mx		Barrientos-Gutierrez, Tonatiuh/0000-0002-0826-9106; Zepeda-Tello, Rodrigo/0000-0003-4471-5270; Rojas, Rosalba/0000-0003-4474-7926	Bloomberg Philanthropies; Michigan Centre for Diabetes Translational Research [P30DK092926]; National Institute of Public Health of Mexico; Harvard University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926] Funding Source: NIH RePORTER	Bloomberg Philanthropies; Michigan Centre for Diabetes Translational Research; National Institute of Public Health of Mexico; Harvard University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from Bloomberg Philanthropies (https://www. bloomberg.org/), the Michigan Centre for Diabetes Translational Research (Grant P30DK092926 http://www.med.umich.edu/intmed/endocrinology/ research/mcdtr.htm) and the National Institute of Public Health of Mexico. In addition, Tonatiuh Barrientos-Gutierrez received support from Harvard University through the Lown Scholar's program (https://www.hsph.harvard.edu/ lownscholars/scholars/). The funders had no role in the study design or the analysis and interpretation of the data. All authors and their institutions reserve intellectual freedom from the funders .	Abdullah A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005629; Abdullah A, 2011, PUBLIC HEALTH NUTR, V14, P119, DOI 10.1017/S1368980010001813; Aburto TC, 2016, J NUTR; Aguilar S, 2012, CONCLUSIONES TOMA PO; Andreyeva T, 2011, PREV MED, V52, P413, DOI 10.1016/j.ypmed.2011.03.013; Colchero MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6704; Arredondo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068443; Cervera SB, 2010, GAC MED MEX, V146, P397; Barquera S, 2008, J NUTR, V138, P2454, DOI 10.3945/jn.108.092163; Barquera S, 2013, SALUD PUBLICA MEXICO, V55, pS151, DOI 10.21149/spm.v55s2.5111; Basu S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001582; Briggs ADM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-860; Briggs ADM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6189; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; Chen LW, 2009, AM J CLIN NUTR, V89, P1299, DOI 10.3945/ajcn.2008.27240; Chow CC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000045; Chriqui JF, 2013, J PUBLIC HEALTH POL, V34, P403, DOI 10.1057/jphp.2013.17; Colchero MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163463; Consejo Nacional de Poblacion, 2016, DAT PROYECC; Ezzati M, 2004, COMP QUANTIFICATION; Fagherazzi G, 2013, AM J CLIN NUTR, V97, P517, DOI 10.3945/ajcn.112.050997; Gibbs BB, 2012, J ACAD NUTR DIET, V112, P1347, DOI 10.1016/j.jand.2012.06.012; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Hall KD, 2010, AM J PHYSIOL-ENDOC M, V298, pE449, DOI 10.1152/ajpendo.00559.2009; Hall KD, 2008, AM J CLIN NUTR, V88, P1495, DOI 10.3945/ajcn.2008.26333; Huang TTK, 2015, LANCET, V385, P2422, DOI 10.1016/S0140-6736(14)61743-8; Imamura F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3576; Institute Metrics Evaluation for Health, 2013, GLOB BURD DIS COMP; Instituto Nacional de Salud Publica, 2012, ENCUESTA NACIONAL DE; Lin BH, 2011, ECON HUM BIOL, V9, P329, DOI 10.1016/j.ehb.2011.08.007; Long MW, 2015, AM J PREV MED, V49, P112, DOI 10.1016/j.amepre.2015.03.004; Ma Y, 2016, LANCET DIABETES ENDO, V4, P105, DOI 10.1016/S2213-8587(15)00477-5; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Manyema M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105287; Sanchez-Romero LM, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002158; Meza R, 2015, PREV MED, V81, P445, DOI 10.1016/j.ypmed.2015.10.015; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; OIE, 2015, OIE MAN DIAGN TESTS, P1; Organization W. H, 2009, 2008 2013 ACT PLAN G; Gutierrez JP, 2013, SALUD PUBLICA MEXICO, V55, pS341, DOI 10.21149/spm.v55s2.5133; R Core Team, 2018, R LANG ENV STAT COMP; Rivera-Dommarco JA, 2012, OBESIDAD MEXICO RECO; Romero-Martinez M, 2013, SALUD PUBLICA MEXICO, V55, pS332, DOI 10.21149/spm.v55s2.5132; Sanchez-Pimienta TG, 2016, J NUTR, V146, P1888, DOI 10.3945/jn.115.220301; Secretaria de Salud, 2016, BAS DAT DEF; SOETAERT K, 2010, J STAT SOFTWARE, V33, P1; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Te Morenga L, 2013, BR MED J; The NS, 2013, DIABETES CARE, V36, P865, DOI 10.2337/dc12-0536; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Veerman JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151460	55	58	58	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176336	10.1371/journal.pone.0176336	http://dx.doi.org/10.1371/journal.pone.0176336			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520716	gold, Green Submitted, Green Published			2022-12-26	WOS:000401487700015
J	Robinson, LS; Lewis, WG; Lewis, AL				Robinson, Lloyd S.; Lewis, Warren G.; Lewis, Amanda L.			The sialate O-acetylesterase EstA from gut Bacteroidetes species enables sialidase-mediated cross-species foraging of 9-O-acetylated sialoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-B STREPTOCOCCUS; COLONIC EPITHELIAL GLYCOPROTEINS; BIFIDOBACTERIUM-BIFIDUM PRL2010; INFLAMMATORY-BOWEL-DISEASE; COMPLETE GENOME SEQUENCE; DE-ORTHO-ACETYLATION; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; MICROBIAL DYSBIOSIS; INTESTINAL MUCINS	The gut harbors many symbiotic, commensal, and pathogenic microbes that break down and metabolize host carbohydrates. Sialic acids are prominent outermost carbohydrates on host glycoproteins called mucins and protect underlying glycan chains from enzymatic degradation. Sialidases produced by some members of the colonic microbiota can promote the expansion of several potential pathogens (e.g. Clostridium difficile, Salmonella, and Escherichia coli) that do not produce sialidases. O-Acetyl ester modifications of sialic acids help resist the action of many sialidases and are present at high levels in the mammalian colon. However, some gut bacteria, in turn, produce sialylate-O-acetylesterases to remove them. Here, we investigated O-acetyl ester removal and sialic acid degradation by Bacteroidetes sialate-O-acetylesterases and sialidases, respectively, and subsequent utilization of host sialic acids by both commensal and pathogenic E. coli strains. In vitro foraging studies demonstrated that sialidase-dependent E. coli growth on mucin is enabled by Bacteroides EstA, a sialate O-acetylesterase acting on glycosidically linked sialylate-O-acetylesterase substrates, particularly at neutral pH. Biochemical studies suggested that spontaneous migration of O-acetyl esters on the sialic acid side chain, which can occur at colonic pH, may serve as a switch controlling EstA-assisted sialic acid liberation. Specifically, EstA did not act on O-acetyl esters in their initial 7-position. However, following migration to the 9-position, glycans with O-acetyl esters became susceptible to the sequential actions of bacterial esterases and sialidases. We conclude that EstA specifically unlocks the nutritive potential of 9-O-acetylated mucus sialic acids for foraging by bacteria that otherwise are prevented from accessing this carbon source.	[Robinson, Lloyd S.; Lewis, Amanda L.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, Dept Mol Microbiol, St Louis, MO 63110 USA; [Lewis, Warren G.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Lewis, WG (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid Ave, St Louis, MO 63110 USA.; Lewis, AL (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, Box 8230,660 S Euclid Ave, St Louis, MO 63110 USA.	WarrenGLewisPhD@gmail.com; allewis@wustl.edu	Lewis, Warren G/W-4369-2019	Lewis, Warren G/0000-0003-1210-6403; Lewis, Amanda/0000-0001-6195-3030	Burroughs-Wellcome Fund Preterm Birth Initiative; NIAID, National Institutes of Health Grant [R01 AI114635]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114635] Funding Source: NIH RePORTER	Burroughs-Wellcome Fund Preterm Birth Initiative; NIAID, National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Burroughs-Wellcome Fund Preterm Birth Initiative (to A. L. L.) and the NIAID, National Institutes of Health Grant R01 AI114635 (to W. G. L. and A. L. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Accili D, 2008, HISTOL HISTOPATHOL, V23, P862, DOI 10.14670/HH-23.863; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Angelberger S, 2013, AM J GASTROENTEROL, V108, P1620, DOI 10.1038/ajg.2013.257; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; BARTON NW, 1973, J BIOL CHEM, V248, P7353; BAYLISS CE, 1982, MICRON, V13, P35, DOI 10.1016/0047-7206(82)90136-4; BITTERMAN W, 1969, DIS COLON RECTUM, V12, P96, DOI 10.1007/BF02629003; Comway T., 2015, METABOLISM BACTERIAL, P343; CORFIELD AP, 1992, INFECT IMMUN, V60, P3971, DOI 10.1128/IAI.60.10.3971-3978.1992; CORFIELD AP, 1993, GLYCOCONJUGATE J, V10, P72, DOI 10.1007/BF00731190; CORFIELD AP, 1988, CLIN SCI, V74, P71, DOI 10.1042/cs0740071; CROUCHER SC, 1983, APPL ENVIRON MICROB, V45, P1025, DOI 10.1128/AEM.45.3.1025-1033.1983; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; DIAZ S, 1989, J BIOL CHEM, V264, P19416; DRZENIEK R, 1973, HISTOCHEM J, V5, P271, DOI 10.1007/BF01004994; Egan M, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnu056; Egan M, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0282-7; Egan M, 2014, APPL ENVIRON MICROB, V80, P4414, DOI 10.1128/AEM.01114-14; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; FAILLARD H, 1959, H-S Z PHYSIOL CHEM, V317, P257, DOI 10.1515/bchm2.1959.317.1.257; Faillard H., 1972, BIOCH ACTA LIBS B, V5B, P1246; FRASER AG, 1981, J MED MICROBIOL, V14, P63, DOI 10.1099/00222615-14-1-63; HIGA HH, 1989, J BIOL CHEM, V264, P19435; HOSKINS LC, 1968, GASTROENTEROLOGY, V54, P210; HOSKINS LC, 1981, DIGEST DIS SCI, V26, P769, DOI 10.1007/BF01309606; HOSKINS LC, 1963, GASTROENTEROLOGY, V44, P456; Huang YL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9141; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Johansson MEV, 2013, DIGEST DIS, V31, P305, DOI 10.1159/000354683; Johansson MEV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041009; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Juge N, 2016, BIOCHEM SOC T, V44, P166, DOI 10.1042/BST20150226; KAMERLING JP, 1987, EUR J BIOCHEM, V162, P601, DOI 10.1111/j.1432-1033.1987.tb10681.x; Kiyohara M, 2011, GLYCOBIOLOGY, V21, P437, DOI 10.1093/glycob/cwq175; Lewis A. L., 2009, BIOINFORMATICS GLYCO, P69; Lewis AL, 2004, P NATL ACAD SCI USA, V101, P11123, DOI 10.1073/pnas.0403010101; Lewis AL, 2007, J BIOL CHEM, V282, P27562, DOI 10.1074/jbc.M700340200; Lewis WG, 2013, J BIOL CHEM, V288, P12067, DOI 10.1074/jbc.M113.453654; Marcobal A, 2013, GLYCOBIOLOGY, V23, P1038, DOI 10.1093/glycob/cwt040; Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007; Meyn LA, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.02.011; Milani C, 2015, SCI REP-UK, V5, DOI 10.1038/srep15782; Munyaka PM, 2016, J BASIC MICROB, V56, P986, DOI 10.1002/jobm.201500726; Nakayama-Imaohji H, 2012, J MED INVESTIG, V59, P79, DOI 10.2152/jmi.59.79; NEUBERGER A, 1972, BIOCHEM J, V129, P683, DOI 10.1042/bj1290683; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Okumura R, 2016, NATURE, V532, P117, DOI 10.1038/nature17406; Park KH, 2013, BBA-PROTEINS PROTEOM, V1834, P1510, DOI 10.1016/j.bbapap.2013.04.028; Peris-Bondia F., 2013, GENOME ANNOUNC, V1; Phansopa C, 2015, BIOCHEM J, V472, P157, DOI 10.1042/BJ20150388; POON H, 1983, CAN J BIOCHEM CELL B, V61, P868, DOI 10.1139/o83-111; Press AG, 1998, ALIMENT PHARM THER, V12, P673; Pudlo NA, 2015, MBIO, V6, DOI 10.1128/mBio.01282-15; Rakoff-Nahoum S, 2014, CURR BIOL, V24, P40, DOI 10.1016/j.cub.2013.10.077; REID PE, 1975, CAN J BIOCHEM CELL B, V53, P388, DOI 10.1139/o75-053; REID PE, 1975, CAN J BIOCHEM CELL B, V53, P1328, DOI 10.1139/o75-180; Reister M, 2014, J BIOTECHNOL, V187, P106, DOI 10.1016/j.jbiotec.2014.07.442; Robbe C, 2003, J BIOL CHEM, V278, P46337, DOI 10.1074/jbc.M302529200; Rogier EW, 2014, PATHOGENS, V3, P390, DOI 10.3390/pathogens3020390; SCHAUER R, 1968, H-S Z PHYSIOL CHEM, V349, P961, DOI 10.1515/bchm2.1968.349.2.961; Schulz EC, 2010, J MOL BIOL, V397, P341, DOI 10.1016/j.jmb.2010.01.028; Sela DA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193359; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Steenbergen SM, 2006, J BACTERIOL, V188, P6195, DOI 10.1128/JB.00466-06; Steenbergen SM, 2009, J BACTERIOL, V191, P7134, DOI 10.1128/JB.01000-09; Tailford LE, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00081; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; VARKI A, 1984, ANAL BIOCHEM, V137, P236, DOI 10.1016/0003-2697(84)90377-4; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; Weiman S, 2009, GLYCOBIOLOGY, V19, P1204, DOI 10.1093/glycob/cwp111; Yu ZT, 2013, GLYCOBIOLOGY, V23, P1281, DOI 10.1093/glycob/cwt065; Zitomersky NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063686	77	41	41	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11861	11872		10.1074/jbc.M116.769232	http://dx.doi.org/10.1074/jbc.M116.769232			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28526748	Green Published, hybrid			2022-12-26	WOS:000405485600023
J	Shao, LL; Melero, J; Zhang, N; Arulanandam, B; Baseman, J; Liu, QZ; Zhong, GM				Shao, Lili; Melero, Jose; Zhang, Nu; Arulanandam, Bernard; Baseman, Joel; Liu, Quanzhong; Zhong, Guangming			The cryptic plasmid is more important for Chlamydia muridarum to colonize the mouse gastrointestinal tract than to infect the genital tract	PLOS ONE			English	Article							TUBAL FACTOR INFERTILITY; CD8(+) T-CELLS; PROTECTIVE IMMUNITY; INTRAVAGINAL INOCULATION; IMMUNODOMINANT ANTIGEN; UROGENITAL INFECTION; RECTAL CHLAMYDIA; TRACHOMATIS; MICE; PATHOLOGY	Chlamydia has been detected in the gastrointestinal tracts of both animals and humans. However, the mechanism by which Chlamydia colonizes the gut remains unclear. Chlamydia muridarum is known to spread from the genital to the gastrointestinal tracts hematogenously. The C. muridarum plasmid is a key pathogenic determinant in the mouse upper genital tract although plasmid-deficient C. muridarum is still able to colonize the upper genital tract. We now report that plasmid-deficient C. muridarum exhibits significantly delayed/reduced spreading from the mouse genital to the gastrointestinal tracts. C. muridarum with or without plasmid maintained similar levels in the mouse circulatory system following intravenous inoculation but the hematogenous plasmid-deficient C. muridarum was significantly less efficient in colonizing the gastrointestinal tract. Consistently, plasmid-deficient C. muridarum failed to restore normal colonization in the gastrointestinal tract even after intragastric inoculation at a high dose. Thus, we have demonstrated a plasmid-dependent colonization of C. muridarum in the gastrointestinal tract, supporting the concept that C. muridarum may have acquired the plasmid for adaptation to the mouse gastrointestinal tract during oralfecal transmission. Since the plasmid is more important for C. muridarum to colonize the gastrointestinal tract than to infect the genital tract, the current study has laid a foundation for further defining the host pathways targeted by the plasmid-encoded or -regulated chlamydial effectors.	[Shao, Lili; Melero, Jose; Zhang, Nu; Baseman, Joel; Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Shao, Lili; Liu, Quanzhong] Tianjin Med Univ, Dept Dermatovenereol, Gen Hosp, Tianjin, Peoples R China; [Arulanandam, Bernard] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; Tianjin Medical University; University of Texas System; University of Texas at San Antonio (UTSA)	Zhong, GM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.; Liu, QZ (corresponding author), Tianjin Med Univ, Dept Dermatovenereol, Gen Hosp, Tianjin, Peoples R China.	Liuquanzhong@medmail.com.cn; Zhongg@UTHSCSA.EDU		Zhong, Guangming/0000-0001-7053-5009	US National Institutes of Health [US NIH R01AI121989]; Tianjin Medical University General Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI121989] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tianjin Medical University General Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants (to G. Zhong) from the US National Institutes of Health (US NIH R01AI121989). LS is supported by the Tianjin Medical University General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by grants (to G. Zhong) from the US National Institutes of Health. LS is supported by the Tianjin Medical University General Hospital.	Budrys NM, 2012, OBSTET GYNECOL, V119, P1009, DOI 10.1097/AOG.0b013e3182519326; Campbell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101634; *CDCP, 2008, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention, 2015, SEX TRANSM DIS TREAT; Chen CQ, 2015, INFECT IMMUN, V83, P1881, DOI 10.1128/IAI.03158-14; Chen D, 2010, J BACTERIOL, V192, P6017, DOI 10.1128/JB.00847-10; Chen JL, 2015, INFECT IMMUN, V83, P2583, DOI 10.1128/IAI.00353-15; Chen JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095076; Chen LL, 2013, INFECT IMMUN, V81, P2962, DOI 10.1128/IAI.00161-13; Chen LL, 2010, J IMMUNOL, V184, P2602, DOI 10.4049/jimmunol.0901593; Chen LL, 2009, INFECT IMMUN, V77, P3080, DOI 10.1128/IAI.00611-08; Cheng W, 2008, INFECT IMMUN, V76, P515, DOI 10.1128/IAI.01064-07; Conrad TA, 2016, INFECT IMMUN, V84, P467, DOI 10.1128/IAI.01171-15; Craig AP, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0939-3; Dai J, 2016, INFECT IMMUN, V84, P2382, DOI 10.1128/IAI.00432-16; Dai J, 2016, MICROBES INFECT, V18, P190, DOI 10.1016/j.micinf.2015.11.003; de la Maza Luis M, 2002, Curr Opin Investig Drugs, V3, P980; DELAMAZA LM, 1994, INFECT IMMUN, V62, P2094, DOI 10.1128/IAI.62.5.2094-2097.1994; Dlugosz A, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-24; ELLIOTT PR, 1981, GUT, V22, P25, DOI 10.1136/gut.22.1.25; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Farencena A, 1997, INFECT IMMUN, V65, P2965, DOI 10.1128/IAI.65.7.2965-2969.1997; Gong SQ, 2013, J BACTERIOL, V195, P3819, DOI 10.1128/JB.00511-13; Gratrix J, 2015, CLIN INFECT DIS, V60, P398, DOI 10.1093/cid/ciu831; Gratrix J, 2014, SEX TRANSM DIS, V41, P589, DOI 10.1097/OLQ.0000000000000176; Huang YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124840; Johnson RM, 2014, IMMUNOLOGY, V142, P248, DOI 10.1111/imm.12248; Lei L, 2014, INFECT IMMUN, V82, P983, DOI 10.1128/IAI.01543-13; Li LX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003707; Li ZY, 2008, INFECT IMMUN, V76, P3415, DOI 10.1128/IAI.01377-07; Liu Y, 2014, INFECT IMMUN, V82, P5327, DOI 10.1128/IAI.02576-14; Liu YJ, 2014, J BACTERIOL, V196, P989, DOI 10.1128/JB.01161-13; Lu CX, 2013, MICROBES INFECT, V15, P329, DOI 10.1016/j.micinf.2013.02.001; Manam S, 2013, PATHOG DIS, V67, P221, DOI 10.1111/2049-632X.12032; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; Murthy AK, 2011, INFECT IMMUN, V79, P2928, DOI 10.1128/IAI.05022-11; Musil K, 2016, INT J STD AIDS, V27, P526, DOI 10.1177/0956462415586317; Nigg C, 1944, J EXP MED, V79, P497, DOI 10.1084/jem.79.5.497; O'Connell CM, 2007, J IMMUNOL, V179, P4027, DOI 10.4049/jimmunol.179.6.4027; Perry LL, 1999, INFECT IMMUN, V67, P3686, DOI 10.1128/IAI.67.7.3686-3689.1999; Peters RPH, 2014, SEX TRANSM DIS, V41, P564, DOI 10.1097/OLQ.0000000000000175; PETERSON EM, 1990, PLASMID, V23, P144, DOI 10.1016/0147-619X(90)90033-9; Qu YY, 2015, INFECT IMMUN, V83, P4056, DOI 10.1128/IAI.00841-15; Ramsey KH, 2014, INFECT IMMUN, V82, P3341, DOI 10.1128/IAI.01795-14; Rank RG, 2014, INFECT IMMUN, V82, P1362, DOI 10.1128/IAI.01244-13; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Rockey DD, 2009, EXPERT REV VACCINES, V8, P1365, DOI 10.1586/ERV.09.98; Rodgers AK, 2011, FERTIL STERIL, V96, P715, DOI 10.1016/j.fertnstert.2011.06.021; Rodgers AK, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.005; Shah AA, 2005, SEX TRANSM DIS, V32, P49, DOI 10.1097/01.olq.0000148299.14513.11; Song LH, 2014, PATHOG DIS, V70, P189, DOI 10.1111/2049-632X.12104; Tang LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060345; Thomas NS, 1997, MICROBIOL-SGM, V143, P1847, DOI 10.1099/00221287-143-6-1847; Vlcek KR, 2016, IMMUNOL CELL BIOL, V94, P208, DOI 10.1038/icb.2015.74; Wang LY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155880; Yang X, 1998, J IMMUNOL, V161, P1439; Yang ZS, 2014, INFECT IMMUN, V82, P3154, DOI 10.1128/IAI.01833-14; Yeruva L, 2013, ANTIMICROB AGENTS CH, V57, P6290, DOI 10.1128/AAC.01405-13; Yeruva L, 2013, PATHOG DIS, V68, P88, DOI 10.1111/2049-632X.12052; Zhang HB, 2014, INFECT IMMUN, V82, P2688, DOI 10.1128/IAI.00055-14; Zhang Q, 2015, INFECT IMMUN, V83, P3568, DOI 10.1128/IAI.00673-15; Zhang XY, 2009, J IMMUNOL, V183, P1291, DOI 10.4049/jimmunol.0803075; Zhong GM, 2017, TRENDS MICROBIOL, V25, P141, DOI 10.1016/j.tim.2016.09.006	63	20	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2017	12	5							e0177691	10.1371/journal.pone.0177691	http://dx.doi.org/10.1371/journal.pone.0177691			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VR	28542376	Green Submitted, Green Published, gold			2022-12-26	WOS:000402062800022
J	Boubriak, II; Malhas, AN; Drozdz, MM; Pytowski, L; Vaux, DJ				Boubriak, Ivan I.; Malhas, Ashraf N.; Drozdz, Marek M.; Pytowski, Lior; Vaux, David J.			Stress-induced release of Oct-1 from the nuclear envelope is mediated by JNK phosphorylation of lamin B1	PLOS ONE			English	Article							DNA-DAMAGE; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; UBIQUITIN LIGASE; HEAT-SHOCK; C-FOS; BRCA1; REPAIR; INVOLVEMENT; EXPRESSION	The nuclear lamina can bind and sequester transcription factors (TFs), a function lost if the lamina is abnormal, with missing or mutant lamin proteins. We now show that TF sequestration is not all-or-nothing, but a dynamic physiological response to external signals. We show that the binding of the ubiquitous TF, Oct-1, to lamin B1 was reversed under conditions of cellular stress caused, inter alia, by the chemical methylating agent methylmethanesulfonate (MMS). A search for lamin B1 post-translational modifications that might mediate changes in Oct-1 binding using kinase inhibitors uncovered a role for c-Jun N-terminal kinase (JNK). Phosphoproteomic and site-directed mutagenesis analyses of lamin B1 isolated from control and MMS-treated nuclei identified T575 as a JNK site phosphorylated after stress. A new phospho-T575 specific anti-peptide antibody confirmed increased interphase cellular T575 phosphorylation after cell exposure to certain stress conditions, enabling us to conclude that lamin B1 acts as an interphase kinase target, releasing Oct-1 to execute a protective response to stress.	[Boubriak, Ivan I.; Malhas, Ashraf N.; Drozdz, Marek M.; Pytowski, Lior; Vaux, David J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England	University of Oxford	Vaux, DJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England.	david.vaux@path.ox.ac.uk	Boubriak, Ivan/GPX-1231-2022	Pytowski, Lior/0000-0002-8530-5123; Boubriak, Ivan/0000-0001-9845-2969; Malhas, Ashraf/0000-0001-8936-7551; Vaux, David/0000-0002-4901-9795	Medical Research Council [G0801917]; Biotechnology and Biological Science Research Council [BB/L002159/1]; MRC grant [G0801917]; BBSRC grant [BB/L002159/1]; Biotechnology and Biological Sciences Research Council [BB/L002159/1] Funding Source: researchfish; BBSRC [BB/L002159/1] Funding Source: UKRI; MRC [G0801917] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Medical Research Council (GB), www.mrc.ac.uk/, G0801917, to DJV; and Biotechnology and Biological Science Research Council (GB), http://www.bbsrc.ac.uk/, BB/L002159/1 to DJV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Svenja Hester, Ben Thomas and David Trudgian, members of the Central Proteomics Facility in the Dunn School of Pathology for mass spectrometry and proteomic analysis, and to Covalab Ltd for production of the custom anti-phosphopeptide antiserum. Human dermal fibroblasts were provided by Dr Winnok De Vos, Department of Molecular Biotechnology, Ghent University. This work was funded by MRC grant G0801917 and BBSRC grant BB/L002159/1.	Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Caron M, 2003, AIDS, V17, P2437, DOI 10.1097/00002030-200311210-00005; Chen MC, 2015, MOL PHARMACOL, V87, P996, DOI 10.1124/mol.114.094987; Coene ED, 2011, J CELL BIOL, V192, P497, DOI 10.1083/jcb.201004136; Dauer WT, 2009, DEV CELL, V17, P626, DOI 10.1016/j.devcel.2009.10.016; Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297; Drozdz M, 2016, METHODS MOL BIOL, V1411, P159, DOI 10.1007/978-1-4939-3530-7_10; Dynlacht JR, 1999, J CELL PHYSIOL, V178, P28, DOI 10.1002/(SICI)1097-4652(199901)178:1<28::AID-JCP4>3.3.CO;2-B; Fabrini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014125; Fan WH, 2002, J BIOL CHEM, V277, P8061, DOI 10.1074/jbc.M110225200; Favale NO, 2010, BBA-MOL CELL BIOL L, V1801, P1184, DOI 10.1016/j.bbalip.2010.07.003; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fiume R, 2009, FASEB J, V23, P957, DOI 10.1096/fj.08-121244; Fridlich R, 2015, DNA REPAIR, V30, P11, DOI 10.1016/j.dnarep.2015.03.002; Fritz G, 2006, MOL BIOL CELL, V17, P851, DOI 10.1091/mbc.E05-07-0606; Fukuda T, 2016, CURR CANCER DRUG TAR, V16, P101, DOI 10.2174/1568009615666151030102427; Gonzalez-Suarez I, 2009, EMBO J, V28, P2414, DOI 10.1038/emboj.2009.196; Gonzalo S, 2014, ADV EXP MED BIOL, V773, P377, DOI 10.1007/978-1-4899-8032-8_17; Haddad N, 2008, J CELL BIOCHEM, V105, P1485, DOI 10.1002/jcb.21968; Harper M, 2009, FEBS J, V276, P3137, DOI 10.1111/j.1742-4658.2009.07032.x; Hodge CD, 2016, J BIOL CHEM, V291, P9396, DOI 10.1074/jbc.M116.715698; Inamoto S, 1997, J BIOL CHEM, V272, P29852, DOI 10.1074/jbc.272.47.29852; Ivorra' C, 2006, GENE DEV, V20, P307, DOI 10.1101/gad.349506; Jin SQ, 2001, ONCOGENE, V20, P2683, DOI 10.1038/sj.onc.1204390; Kang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019063; Kang J, 2013, FASEB J, V27, P2807, DOI 10.1096/fj.12-220897; Kang JS, 2009, GENE DEV, V23, P208, DOI 10.1101/gad.1750709; Kuga T, 2010, EXP CELL RES, V316, P2301, DOI 10.1016/j.yexcr.2010.05.017; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; LIU YS, 1995, J BIOL CHEM, V270, P8377, DOI 10.1074/jbc.270.15.8377; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machowska M, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150094; Malhas A, 2007, J CELL BIOL, V176, P593, DOI 10.1083/jcb.200607054; Malhas A, 2011, TRENDS CELL BIOL, V21, P362, DOI 10.1016/j.tcb.2011.03.008; Malhas A, 2010, CELL CYCLE, V9, P531, DOI 10.4161/cc.9.3.10511; Malhas AN, 2011, BIOCHEM SOC T, V39, P1795, DOI 10.1042/BST20110719; Malhas AN, 2009, J CELL BIOL, V184, P45, DOI 10.1083/jcb.200804155; Gonzalez JM, 2008, J CELL BIOL, V183, P653, DOI 10.1083/jcb.200805049; Maske CP, 2003, J CELL BIOL, V162, P1223, DOI 10.1083/jcb.200303113; Navaraj A, 2005, CANCER BIOL THER, V4, P1409, DOI 10.4161/cbt.4.12.2378; Neuzillet C, 2012, EUR J CANCER, V48, P121, DOI 10.1016/S0959-8049(12)72196-2; Ohta T, 2011, FEBS LETT, V585, P2836, DOI 10.1016/j.febslet.2011.05.005; Pance A, 2016, BBA-GENE REGUL MECH, V1859, P820, DOI 10.1016/j.bbagrm.2016.04.003; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; SEGIL N, 1991, SCIENCE, V254, P1814, DOI 10.1126/science.1684878; Shimi T, 2014, ADV EXP MED BIOL, V773, P415, DOI 10.1007/978-1-4899-8032-8_19; Tong T, 2001, EXP CELL RES, V269, P64, DOI 10.1006/excr.2001.5312; Torvaldson E, 2015, NUCLEUS-PHILA, V6, P166, DOI 10.1080/19491034.2015.1017167; Van Meter M, 2016, CELL REP, V16, P2641, DOI 10.1016/j.celrep.2016.08.006; Vazquez-Arreguin K, 2016, BBA-GENE REGUL MECH, V1859, P792, DOI 10.1016/j.bbagrm.2016.02.007; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wei B, 2016, BIOCHEM BIOPH RES CO, V475, P301, DOI 10.1016/j.bbrc.2016.05.107; Xie W, 2016, METHODS MOL BIOL, V1411, P83, DOI 10.1007/978-1-4939-3530-7_4; Zhao HC, 2000, CANCER RES, V60, P6276	55	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2017	12	5							e0177990	10.1371/journal.pone.0177990	http://dx.doi.org/10.1371/journal.pone.0177990			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8VE	28542436	Green Published, Green Submitted, gold			2022-12-26	WOS:000402061500050
J	Valdersnes, S; Nilsen, BM; Breivik, JF; Borge, A; Maage, A				Valdersnes, Stig; Nilsen, Bente M.; Breivik, Joar F.; Borge, Asbjorn; Maage, Amund			Geographical trends of PFAS in cod livers along the Norwegian coast	PLOS ONE			English	Article							NORTHEAST ARCTIC COD; FRESH-WATER FISH; GADUS-MORHUA L; PERFLUORINATED COMPOUNDS; POLYFLUOROALKYL SUBSTANCES; TISSUE DISTRIBUTION; SPAWNING GROUNDS; FEEDING ECOLOGY; SOMATIC INDEX; BIOACCUMULATION	The level of perfluorinated alkyl substances (PFAS) was determined in North East Arctic cod (Gadus morhua) liver samples from 15 Norwegian fjords and harbors. Five harbors in the eastern part of Norway, six harbors in the western part and four harbours in the northern part. A total of 200 samples were analyzed for 16 PFAS. Determination of PFAS were carried out by LC-MS/MS following sample clean up by solid phase extraction and ultracentrifugation. The predominating PFAS was PFOS, which was found to be higher than the level of quantification (1.5 mu g kg(-1) wet weight) in 72% of the samples. The highest level of PFOS found was 21.8 mu g kg(-1) wet weight in a sample from Kragero in the eastern part of Norway. A significantly higher level of PFOS was found in the eastern fjords and harbors compared to fjords and harbors in the western and northern part of Norway. Within the northern fjords and harbors elevated PFOS levels were found in Narvik, which may indicate a local source there. Variations in PFOS of the cod livers thus reflect differences in levels of pollution between the areas.	[Valdersnes, Stig; Nilsen, Bente M.; Breivik, Joar F.; Maage, Amund] Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway; [Borge, Asbjorn] Inst Marine Res, Bergen, Norway	Institute of Marine Research - Norway	Valdersnes, S (corresponding author), Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway.	stig.valdersnes@nifes.no	Maage, Amund/AAH-6421-2021	Maage, Amund/0000-0002-2772-5752	Norwegian Food Safety Authority	Norwegian Food Safety Authority	This work was funded by the Norwegian Food Safety Authority (www.mattilsynet.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Norwegian Food Safety Authority for funding this work. We also would like to thank IMR personnel involved in the collection of samples and age determination by reading of otoliths. We thank Arne Duinker at NIFES for assistance in producing the map showing the fjords and harbors.	ADAMS SM, 1985, J FISH BIOL, V26, P111, DOI 10.1111/j.1095-8649.1985.tb04248.x; Alexander J, 2008, EFSA J, V6; Berger U, 2005, J CHROMATOGR A, V1081, P210, DOI 10.1016/j.chroma.2005.05.064; Conder JM, 2008, ENVIRON SCI TECHNOL, V42, P995, DOI 10.1021/es070895g; Cui L, 2009, ARCH ENVIRON CON TOX, V56, P338, DOI 10.1007/s00244-008-9194-6; ELIASSEN JE, 1982, J FISH BIOL, V20, P707, DOI 10.1111/j.1095-8649.1982.tb03981.x; Falandysz J, 2007, J ENVIRON SCI HEAL A, V42, P715, DOI 10.1080/10934520701304369; Green NW, 2015, CONTAMINANTS COASTAL, P222; HOP H, 1993, J FISH BIOL, V43, P1; HOP H, 1992, ICES J MAR SCI, V49, P453, DOI 10.1093/icesjms/49.4.453; Hoque MT, 1998, J FISH BIOL, V52, P23, DOI 10.1006/jfbi.1997.0555; Houde M, 2006, ENVIRON SCI TECHNOL, V40, P3463, DOI 10.1021/es052580b; Houde M, 2011, ENVIRON SCI TECHNOL, V45, P7962, DOI 10.1021/es104326w; JAKOBSEN T, 1987, FISH RES, V5, P223, DOI 10.1016/0165-7836(87)90042-7; Kelly BC, 2009, ENVIRON SCI TECHNOL, V43, P4037, DOI 10.1021/es9003894; KLEMETSEN A, 1982, J CONSEIL, V40, P101; Labadie P, 2011, ENVIRON POLLUT, V159, P391, DOI 10.1016/j.envpol.2010.10.039; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Martin JW, 2013, ENVIRON TOXICOL CHEM, V32, P2421, DOI 10.1002/etc.2376; Martin JW, 2003, ENVIRON TOXICOL CHEM, V22, P196, DOI 10.1897/1551-5028(2003)022&lt;0196:BATDOP&gt;2.0.CO;2; Michalsen K, 2008, ICES J MAR SCI, V65, P571, DOI 10.1093/icesjms/fsn019; Morgan MJ, 2004, ICES J MAR SCI, V61, P64, DOI 10.1016/j.icesjms.2003.09.001; Murakami M, 2011, ARCH ENVIRON CON TOX, V61, P631, DOI 10.1007/s00244-011-9660-4; Ng CA, 2014, ENVIRON SCI TECHNOL, V48, P4637, DOI 10.1021/es404008g; Nilsen BM, 2009, FREMMEDSTOFFER VILLF, P77; NMKL, 2009, VAL CHEM AN METH; Nordeide JT, 1998, SARSIA, V83, P373, DOI 10.1080/00364827.1998.10413696; Pan CG, 2014, ECOTOX ENVIRON SAFE, V107, P192, DOI 10.1016/j.ecoenv.2014.05.031; Prevedouros K, 2006, ENVIRON SCI TECHNOL, V40, P32, DOI 10.1021/es0512475; RICKER W E, 1975, P382; ROLLEFSEN G., 1933, FISKERIDIREK SKR SER HAVUNDERS REP NORWEGIAN FISH AND MAR INVEST, V4, P1; Shi YL, 2012, J ENVIRON MONITOR, V14, P636, DOI 10.1039/c1em10772k; Taniyasu S, 2005, J CHROMATOGR A, V1093, P89, DOI 10.1016/j.chroma.2005.07.053; Taylor Matthew D. B KC, 2017, SCI TOTAL ENVIRON, V581, P258; Yaragina NA, 2000, ICES J MAR SCI, V57, P42, DOI 10.1006/jmsc.1999.0493	35	12	12	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2017	12	5							e0177947	10.1371/journal.pone.0177947	http://dx.doi.org/10.1371/journal.pone.0177947			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV8UA	28531177	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000402058400044
J	Heim, C; Queric, NV; Lonescu, D; Schafer, N; Reitner, J				Heim, Christine; Queric, Nadia-Valerie; Lonescu, Danny; Schaefer, Nadine; Reitner, Joachim			Frutexites-like structures formed by iron oxidizing biofilms in the continental subsurface (Aspo Hard Rock Laboratory, Sweden)	PLOS ONE			English	Article							RARE-EARTH-ELEMENTS; FATTY-ACIDS; ANAEROBIC OXIDATION; RAMAN-SPECTRA; BACTERIA; REDUCTION; STEROLS; PHOTOSYNTHESIS; CALCIFICATION; STROMATOLITES	Stromatolitic iron-rich structures have been reported from many ancient environments and are often described as Frutexites, a cryptic microfossil. Although microbial formation of such structures is likely, a clear relation to a microbial precursor is lacking so far. Here we report recent iron oxidizing biofilms which resemble the ancient Frutexites structures. The living Frutexites-like biofilms were sampled at 160 m depth in the Aspo Hard Rock Laboratory in Sweden. Investigations using microscopy, 454 pyrosequencing, FISH, Raman spectros-copy, biomarker and trace element analysis allowed a detailed view of the structural components of the mineralized biofilm. The most abundant bacterial groups were involved in nitrogen and iron cycling. Furthermore, Archaea are widely distributed in the Frutexites-like biofilm, even though their functional role remains unclear. Biomarker analysis revealed abundant sterols in the biofilm most likely from algal and fungal origins. Our results indicate that the Frutexites-like biofilm was built up by a complex microbial community. The functional role of each community member in the formation of the dendritic structures, as well as their potential relation to fossil Frutexites remains under investigation.	[Heim, Christine; Queric, Nadia-Valerie; Schaefer, Nadine; Reitner, Joachim] Univ Gottingen, Dept Geobiol, Geosci Ctr, Gottingen, Germany; [Lonescu, Danny] Leibnitz Inst Freshwater Ecol & Inland Fisheries, IGB, Expt Limnol, Stechlin, Germany	University of Gottingen; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Heim, C; Reitner, J (corresponding author), Univ Gottingen, Dept Geobiol, Geosci Ctr, Gottingen, Germany.	cheim@gwdg.cle; jreitne@gwdg.de	Heim, Christine/ABH-5629-2020; Ionescu, Danny/P-3261-2017	Heim, Christine/0000-0003-4716-9316; Ionescu, Danny/0000-0002-4658-8597	German Research Foundation [FOR 571]; Open Access Publication Funds of the Gottingen University; German Research Foundation (DFG)	German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the Gottingen University; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by German Research Foundation-funded Research Unit FOR 571 Geobiology of Organo- and Biofilms; Open Access Publication Funds of the Gottingen University.; We acknowledge with gratitude the detailed and constructive comments provided by the reviewers. We are grateful to SKB and its team for technical and logistic support at the Aspo Hard Rock Laboratory. Special thanks go to our technicians Wolfgang Drose and Dorothea Hause-Reitner for optimizing embedding and sectioning procedures for samples and carrying out FEM imaging. Volker Thiel is greatly acknowledged for his constructive comments on the original manuscript. The manuscript was significantly improved by Leyla Seyfullahs linguistic advice. We acknowledge the financial support by the German Research Foundation (DFG) and the Open Access Publication Funds of the Gottingen University.	Alawi M, 2007, ISME J, V1, P256, DOI 10.1038/ismej.2007.34; Anderson CR, 2003, GEOBIOLOGY, V1, P169, DOI 10.1046/j.1472-4669.2003.00013.x; Andres MS, 2006, SEDIMENT GEOL, V185, P319, DOI 10.1016/j.sedgeo.2005.12.020; Andrews JE, 2015, GEOL MAG, V152, P1, DOI 10.1017/S0016756814000107; Arp G, 2001, SCIENCE, V292, P1701, DOI 10.1126/science.1057204; Bau M, 1996, PRECAMBRIAN RES, V79, P37, DOI 10.1016/0301-9268(95)00087-9; Bohm F., 1993, FACIES, V28, P145, DOI [10.1007/BF02539734, DOI 10.1007/BF02539734]; Cavalazzi B, 2007, SEDIMENT GEOL, V200, P73, DOI 10.1016/j.sedgeo.2007.03.002; Coby AJ, 2005, APPL ENVIRON MICROB, V71, P5267, DOI 10.1128/AEM.71.9.5267-5274.2005; Cooper DC, 2003, APPL ENVIRON MICROB, V69, P3517, DOI 10.1128/AEM.69.6.3517-3525.2003; Daims H, 2016, NATURE; deFaria DLA, 1997, J RAMAN SPECTROSC, V28, P873, DOI 10.1002/(SICI)1097-4555(199711)28:11<873::AID-JRS177>3.0.CO;2-B; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; DOWLING NJE, 1986, J GEN MICROBIOL, V132, P1815; Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005; EDLUND A, 1985, J LIPID RES, V26, P982; Elvert M, 2003, GEOMICROBIOL J, V20, P403, DOI 10.1080/01490450303894; Emerson D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000667; Frei R, 2008, PRECAMBRIAN RES, V162, P441, DOI 10.1016/j.precamres.2007.10.005; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Giner JL, 2008, PHYTOCHEMISTRY, V69, P2167, DOI 10.1016/j.phytochem.2008.05.013; Gischler E, 1996, PALAEOGEOGR PALAEOCL, V123, P297, DOI 10.1016/0031-0182(95)00125-5; GOOSSENS H, 1986, ORG GEOCHEM, V10, P683, DOI 10.1016/S0146-6380(86)80004-3; Guido A, 2016, FRUTEXITES MICROBIAL; Heim C, 2015, FRONT EARTH SC-SWITZ, V3, DOI 10.3389/feart.2015.00006; Hengsuwan M, 2015, GEOMICROBIOL J, V32, P243, DOI 10.1080/01490451.2014.962121; Ionescu D, 2015, GEOMICROBIOL J, V32, P221, DOI 10.1080/01490451.2014.887393; Ionescu D, 2015, GEOMICROBIOL J, V32, P207, DOI 10.1080/01490451.2014.884196; Ionescu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038319; Ivarsson M, 2016, FUNGAL ECOL, V20, P249, DOI 10.1016/j.funeco.2016.01.009; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Kazmierczak J, 2006, NATURWISSENSCHAFTEN, V93, P119, DOI 10.1007/s00114-005-0066-x; Konhauser K., 2007, INTRO GEOMICROBIOLOG; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Laaksoharju M, 1999, APPL GEOCHEM, V14, P835, DOI 10.1016/S0883-2927(99)00023-2; Lafuente B., 2015, HIGHLIGHTS MINERALOG, P1, DOI DOI 10.1515/9783110417104-003; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Leblond JD, 2011, PHYCOL RES, V59, P129, DOI 10.1111/j.1440-1835.2011.00610.x; Lechevalier H., 1988, MICROBIAL LIPIDS; Lucker S, 2015, ISME J, V9, P708, DOI 10.1038/ismej.2014.158; Manz W, 2000, J MICROBIOL METH, V40, P125, DOI 10.1016/S0167-7012(99)00103-7; Marshall JA, 2002, J APPL PHYCOL, V14, P255, DOI 10.1023/A:1021101203543; Maslov VP, 1960, T I GEOLOGICHESKIKH, V41, P188; Mazzetti L, 2002, J RAMAN SPECTROSC, V33, P104, DOI 10.1002/jrs.830; MCLENNAN SM, 1989, REV MINERAL, V21, P169; MEIKLEJOHN J, 1953, J GEN MICROBIOL, V8, P58, DOI 10.1099/00221287-8-1-58; MYROW P M, 1991, Palaios, V6, P572, DOI 10.2307/3514920; Nielsen PH, 1997, WATER SCI TECHNOL, V36, P11, DOI 10.1016/S0273-1223(97)00318-1; Pedersen K, 1997, FEMS MICROBIOL REV, V20, P399, DOI 10.1111/j.1574-6976.1997.tb00325.x; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Reid RP, 2000, NATURE, V406, P989, DOI 10.1038/35023158; REITNER J, 1995, FACIES, V32, P203, DOI 10.1007/BF02536869; Reitner J., 2017, PAIZ; Reitner Joachim, 1993, Facies, V29, P3, DOI 10.1007/BF02536915; Rodruiguez-Martuinez M., 2011, ENCY GEOBIOLOGY, P396, DOI DOI 10.1007/978-1-4020-9212-1_94; Romano I, 2008, INT J SYST EVOL MICR, V58, P886, DOI 10.1099/ijs.0.65457-0; Ronnback P, 2008, APPL GEOCHEM, V23, P1862, DOI 10.1016/j.apgeochem.2008.02.008; Seemann M, 1999, TETRAHEDRON LETT, V40, P1681, DOI 10.1016/S0040-4039(99)00064-7; Shiraishi F, 2008, GEOMICROBIOL J, V25, P83, DOI 10.1080/01490450801934888; TAYLOR J, 1983, J GEN MICROBIOL, V129, P3303; THIBEAU RJ, 1978, APPL SPECTROSC, V32, P532, DOI 10.1366/000370278774330739; VAINSHTEIN M, 1992, SYST APPL MICROBIOL, V15, P554, DOI 10.1016/S0723-2020(11)80115-3; van Kessel M. A. H. J., 2015, NATURE; Volkman JK, 1998, ORG GEOCHEM, V29, P1163, DOI 10.1016/S0146-6380(98)00062-X; Wahlgren C-H, 2006, R0569 SVENSK KAMBR A; Weete JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010899; Westall F, 2008, SPACE SCI REV, V135, P95, DOI 10.1007/s11214-008-9354-z; Wingender J., 1999, MICROBIAL EXTRACELLU, P1; Woods AD, 2008, SEDIMENT GEOL, V209, P1, DOI 10.1016/j.sedgeo.2008.06.002; Ziegenbalg SB, 2012, CHEM GEOL, V292, P140, DOI 10.1016/j.chemgeo.2011.11.024	70	19	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177542	10.1371/journal.pone.0177542	http://dx.doi.org/10.1371/journal.pone.0177542			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542238	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672600015
J	Marchand-Krynski, ME; Morin-Moncet, O; Belanger, AM; Beauchamp, MH; Leonard, G				Marchand-Krynski, Marie-Eve; Morin-Moncet, Olivier; Belanger, Anne-Marie; Beauchamp, Miriam H.; Leonard, Gabriel			Shared and differentiated motor skill impairments in children with dyslexia and/or attention deficit disorder: From simple to complex sequential coordination	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; DEVELOPMENTAL DYSLEXIA; HYPERACTIVITY DISORDER; BIMANUAL COORDINATION; EXECUTIVE FUNCTIONS; READING-DISABILITY; LEARNING-DEFICITS; CEREBELLAR; ADHD; COMORBIDITY	Dyslexia and Attention deficit disorder (AD) are prevalent neurodevelopmental conditions in children and adolescents. They have high comorbidity rates and have both been associated with motor difficulties. Little is known, however, about what is shared or differentiated in dyslexia and AD in terms of motor abilities. Even when motor skill problems are identified, few studies have used the same measurement tools, resulting in inconstant findings. The present study assessed increasingly complex gross motor skills in children and adolescents with dyslexia, AD, and with both Dyslexia and AD. Our results suggest normal performance on simple motor-speed tests, whereas all three groups share a common impairment on unimanual and bimanual sequential motor tasks. Children in these groups generally improve with practice to the same level as normal subjects, though they make more errors. In addition, children with AD are the most impaired on complex bimanual out-of-phase movements and with manual dexterity. These latter findings are examined in light of the Multiple Deficit Model.	[Marchand-Krynski, Marie-Eve; Morin-Moncet, Olivier; Beauchamp, Miriam H.] Univ Montreal, Res Ctr Neuropsychol & Cognit CERNEC, Montreal, PQ, Canada; [Marchand-Krynski, Marie-Eve; Beauchamp, Miriam H.] Ste Justine Hosp, Res Ctr, Montreal, PQ, Canada; [Marchand-Krynski, Marie-Eve; Morin-Moncet, Olivier; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Marchand-Krynski, Marie-Eve; Belanger, Anne-Marie; Leonard, Gabriel] Montreal Neurol Hosp & Inst, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University	Leonard, G (corresponding author), Montreal Neurol Hosp & Inst, Montreal, PQ, Canada.	gabriel.leonard@mcgill.ca			Montreal Neurological Institute (MNI); Centres of Excellence for Commercialization and Research (CECR)	Montreal Neurological Institute (MNI); Centres of Excellence for Commercialization and Research (CECR)	This study was supported by grants from the Montreal Neurological Institute (MNI-GL) and the Centres of Excellence for Commercialization and Research (CECR-GL).; This study was supported by grants from the Montreal Neurological Institute (MNI) and the Centres of Excellence for Commercialization and Research (CECR).	Association AP, 2013, DIAGN STAT MAN MENT, P59; Barkley RA, 2003, BRAIN DEV-JPN, V25, P77, DOI 10.1016/S0387-7604(02)00152-3; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barnes KA, 2010, DEV NEUROPSYCHOL, V35, P494, DOI 10.1080/87565641.2010.494750; Belanger AM, 2015, ORG HUMAN BRAIN MAPP; Biotteau M, 2015, HUM MOVEMENT SCI, V43, P78, DOI 10.1016/j.humov.2015.07.005; BOECKER H, 1994, BRAIN, V117, P1231, DOI 10.1093/brain/117.6.1231; Brookes RL, 2010, DYSLEXIA, V16, P358, DOI 10.1002/dys.420; Brookman A, 2013, PEERJ, V1, DOI 10.7717/peerj.217; Brown L., 2010, TONI 4 TEST NONVERBA; Bush G, 2005, BIOL PSYCHIAT, V57, P1273, DOI 10.1016/j.biopsych.2005.01.034; Chaix Y, 2007, EUR J PAEDIATR NEURO, V11, P368, DOI 10.1016/j.ejpn.2007.03.006; Conners C. K., 2008, CONNERS 3 EDITION CO, V3rd; Dahan A, 2016, NEUROSCIENCE; Debaere F, 2004, NEUROIMAGE, V21, P1416, DOI 10.1016/j.neuroimage.2003.12.011; Debaere F, 2003, NEUROIMAGE, V19, P764, DOI 10.1016/S1053-8119(03)00148-4; Desrochers TM, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00185; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Duda TA, 2015, HUM MOVEMENT SCI, V44, P1, DOI 10.1016/j.humov.2015.08.006; Eckert MA, 2003, BRAIN, V126, P482, DOI 10.1093/brain/awg026; Germano E, 2010, DEV NEUROPSYCHOL, V35, P475, DOI 10.1080/87565641.2010.494748; Getchell N, 2007, PERCEPT MOTOR SKILL, V105, P207, DOI 10.2466/PMS.105.1.207-214; Giedd JN, 2001, ANN NY ACAD SCI, V931, P33; Gilbert DL, 2011, NEUROLOGY, V76, P615, DOI 10.1212/WNL.0b013e31820c2ebd; Gilger JW, 2001, DEV NEUROPSYCHOL, V20, P465, DOI 10.1207/S15326942DN2002_2; Habib M, 2000, BRAIN, V123, P2373, DOI 10.1093/brain/123.12.2373; Handler SM, 2011, PEDIATRICS, V127, pE818, DOI 10.1542/peds.2010-3670; Hernandez MT, 2002, NEUROPSYCHOLOGIA, V40, P384, DOI 10.1016/S0028-3932(01)00130-0; Howard JH, 2006, NEUROPSYCHOLOGIA, V44, P1131, DOI 10.1016/j.neuropsychologia.2005.10.015; Irannejad S, 2012, ANN DYSLEXIA, V62, P22, DOI 10.1007/s11881-011-0060-2; Iversen S, 2005, DYSLEXIA, V11, P217, DOI 10.1002/dys.297; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1313, DOI 10.1152/jn.1997.77.3.1313; Kaiser ML, 2015, RES DEV DISABIL, V36, P338, DOI 10.1016/j.ridd.2014.09.023; Kaplan BJ, 2001, J LEARN DISABIL-US, V34, P555, DOI 10.1177/002221940103400608; Keren-Happuch E, 2014, HUM BRAIN MAPP, V35, P593, DOI 10.1002/hbm.22194; Kibby MY, 2008, J CHILD NEUROL, V23, P368, DOI 10.1177/0883073807309235; Klimkeit EI, 2004, J CLIN EXP NEUROPSYC, V26, P999, DOI 10.1080/13803390490515568; LEONARD G, 1988, NEUROPSYCHOLOGIA, V26, P79, DOI 10.1016/0028-3932(88)90032-2; Leonard G, 2010, THE 40TH SOCIETY FOR; Loras H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098224; Lucas BR, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0731-6; Luft AR, 2005, MOL NEUROBIOL, V32, P205, DOI 10.1385/MN:32:3:205; Lum JAG, 2013, RES DEV DISABIL, V34, P3460, DOI 10.1016/j.ridd.2013.07.017; Makris N, 2009, DEV NEUROSCI-BASEL, V31, P36, DOI 10.1159/000207492; McCandliss BD, 2003, MENT RETARD DEV D R, V9, P196, DOI 10.1002/mrdd.10080; Memarmoghaddam M, 2016, J Med Life, V9, P373; Menghini D, 2010, NEUROPSYCHOLOGIA, V48, P863, DOI 10.1016/j.neuropsychologia.2009.11.003; Menghini D, 2006, NEUROIMAGE, V33, P1218, DOI 10.1016/j.neuroimage.2006.08.024; Menghini D, 2011, DEV NEUROPSYCHOL, V36, P199, DOI 10.1080/87565641.2010.549868; Moe-Nilssen R, 2003, EXP BRAIN RES, V150, P237, DOI 10.1007/s00221-003-1450-4; Molinari M, 2008, CEREBELLUM, V7, P611, DOI 10.1007/s12311-008-0060-x; Moreira RS, 2014, J PEDIAT-BRAZIL, V90, P119, DOI 10.1016/j.jped.2013.05.010; Morton SM, 2004, NEUROSCIENTIST, V10, P247, DOI 10.1177/1073858404263517; Moura O, 2017, J CLIN EXP NEUROPSYC, V39, P296, DOI 10.1080/13803395.2016.1225007; NICOLSON RI, 1994, ANN DYSLEXIA, V44, P147, DOI 10.1007/BF02648159; Nicolson RI, 2001, TRENDS NEUROSCI, V24, P508, DOI 10.1016/S0166-2236(00)01896-8; NICOLSON RI, 1990, COGNITION, V35, P159, DOI 10.1016/0010-0277(90)90013-A; Nicolson RI, 2011, CORTEX, V47, P117, DOI 10.1016/j.cortex.2009.08.016; Nikolas MA, 2013, NEUROPSYCHOLOGY, V27, P107, DOI 10.1037/a0030685; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orban P, 2011, NEUROSCIENCE, V179, P94, DOI 10.1016/j.neuroscience.2011.01.040; Penhune VB, 2012, BEHAV BRAIN RES, V226, P579, DOI 10.1016/j.bbr.2011.09.044; Pennington BF, 2006, COGNITION, V101, P385, DOI 10.1016/j.cognition.2006.04.008; Piek JP, 2008, HUM MOVEMENT SCI, V27, P668, DOI 10.1016/j.humov.2007.11.002; Pitcher TM, 2003, DEV MED CHILD NEUROL, V45, P525, DOI 10.1111/j.1469-8749.2003.tb00952.x; Polner B., 2014, EUROPEAN ARCH PSYCHI, V265, P689, DOI [10.1007/s00702-005-0366-5, DOI 10.1007/300406-014-0531-7]; Prehn-Kristensen A, 2011, RES DEV DISABIL, V32, P2480, DOI 10.1016/j.ridd.2011.06.021; Rae C, 2002, NEUROPSYCHOLOGIA, V40, P1285, DOI 10.1016/S0028-3932(01)00216-0; Ramus F, 2003, J CHILD PSYCHOL PSYC, V44, P712, DOI 10.1111/1469-7610.00157; Ramus F, 2003, CURR OPIN NEUROBIOL, V13, P212, DOI 10.1016/S0959-4388(03)00035-7; Reiter A, 2005, DYSLEXIA, V11, P116, DOI 10.1002/dys.289; Roberts B. A, 2013, J ATTENTION DISORDER; Rochelle KSH, 2006, J CHILD PSYCHOL PSYC, V47, P1159, DOI 10.1111/j.1469-7610.2006.01641.x; Roebers CM, 2014, HUM MOVEMENT SCI, V33, P284, DOI 10.1016/j.humov.2013.08.011; Rosch KS, 2013, J ABNORM CHILD PSYCH, V41, P485, DOI 10.1007/s10802-012-9690-z; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; Rueda-Delgado LM, 2014, NEUROSCI BIOBEHAV R, V47, P614, DOI 10.1016/j.neubiorev.2014.10.003; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Scharoun SM, 2013, RES DEV DISABIL, V34, P4142, DOI 10.1016/j.ridd.2013.08.011; Seidman LJ, 2005, BIOL PSYCHIAT, V57, P1263, DOI 10.1016/j.biopsych.2004.11.019; Shanahan MA, 2006, J ABNORM CHILD PSYCH, V34, P585, DOI 10.1007/s10802-006-9037-8; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Sheikhi AR, 2013, AM J MED GENET B, V162B, P44, DOI 10.1002/ajmg.b.32119; Stoodley CJ, 2006, DYSLEXIA, V12, P276, DOI 10.1002/dys.326; Stoodley CJ, 2013, CEREBELLUM, V12, P267, DOI 10.1007/s12311-012-0407-1; Stoodley CJ, 2011, CORTEX, V47, P101, DOI 10.1016/j.cortex.2009.10.005; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Stoodley CJ, 2008, ANN NY ACAD SCI, V1145, P173, DOI 10.1196/annals.1416.003; Stoodley CJ, 2006, NEUROPSYCHOLOGIA, V44, P795, DOI 10.1016/j.neuropsychologia.2005.07.009; Swanson James M, 2012, Int J Educ Psychol Assess, V10, P51; Thurston LL, 1944, FACTORIAL STUDY PERC; Trites R, 1977, NEUROPSYCHOLOGICAL T; Tseng MH, 2004, DEV MED CHILD NEUROL, V46, P381, DOI 10.1017/S0012162204000623; Vitola ES, 2016, PSYCHOL MED, V21, P1; Wechsler D., 2002, WECHSLER INDIVIDUAL; Westendorp M, 2011, RES DEV DISABIL, V32, P2773, DOI 10.1016/j.ridd.2011.05.032; Willcutt EG, 2000, J LEARN DISABIL, V33, P179, DOI 10.1177/002221940003300206; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; Willcutt EG, 2010, CORTEX, V46, P1345, DOI 10.1016/j.cortex.2010.06.009; WOLFF PH, 1990, DEV PSYCHOL, V26, P349, DOI 10.1037/0012-1649.26.3.349; Yan JH, 2002, RES Q EXERCISE SPORT, V73, P10, DOI 10.1080/02701367.2002.10608987	102	14	15	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177490	10.1371/journal.pone.0177490	http://dx.doi.org/10.1371/journal.pone.0177490			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542319	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672600012
J	Wallace, B; Atzberger, PJ				Wallace, Bram; Atzberger, Paul J.			Forster resonance energy transfer: Role of diffusion of fluorophore orientation and separation in observed shifts of FRET efficiency	PLOS ONE			English	Article							SINGLE-MOLECULE FRET; CONFORMATIONAL DYNAMICS; SPECTROSCOPY; DEPENDENCE; SCATTERING; PROTEINS; DONOR; IONS	Forster resonance energy transfer (FRET) is a widely used single-molecule technique for measuring nanoscale distances from changes in the non-radiative transfer of energy between donor and acceptor fluorophores. For macromolecules and complexes this observed transfer efficiency is used to infer changes in molecular conformation under differing experimental conditions. However, sometimes shifts are observed in the FRET efficiency even when there is strong experimental evidence that the molecular conformational state is unchanged. We investigate ways in which such discrepancies can arise from kinetic effects. We show that significant shifts can arise from the interplay between excitation kinetics, orientation diffusion of fluorophores, separation diffusion of fluorophores, and non-emitting quenching.	[Wallace, Bram; Atzberger, Paul J.] Univ Calif Santa Barbara, Dept Math, Santa Barbara, CA 93106 USA; [Atzberger, Paul J.] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Atzberger, PJ (corresponding author), Univ Calif Santa Barbara, Dept Math, Santa Barbara, CA 93106 USA.; Atzberger, PJ (corresponding author), Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA.	atzberg@gmail.com	Atzberger, Paul/B-2799-2016	Atzberger, Paul/0000-0001-6806-8069	National Science Foundation Career [0956210]; National Science Foundation: Division of Mathematical Sciences [1616353]; Department of Energy Advanced Scientific Computing Research [CM4 DESC0009254]; NSF CAREER [0956210]; NSF [DMS-1616353]; DOE ASCR [CM4 DESC0009254]; Direct For Mathematical & Physical Scien [1616353] Funding Source: National Science Foundation	National Science Foundation Career(National Science Foundation (NSF)); National Science Foundation: Division of Mathematical Sciences(National Science Foundation (NSF)); Department of Energy Advanced Scientific Computing Research; NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF)); DOE ASCR; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Science Foundation Career Grant 0956210, National Science Foundation: Division of Mathematical Sciences 1616353 (www. nsf gov), and Department of Energy Advanced Scientific Computing Research CM4 DESC0009254 (http://science.energy.goviascr/).; The authors P.J.A and B.W acknowledge support from research grant NSF CAREER 0956210, NSF DMS-1616353, and DOE ASCR CM4 DESC0009254. The authors would also like to thank A. Simon, E. Lipman, and K. Plaxco for helpful discussions and suggestions. While recognizing those above the authors assume full responsibility for the content and commentary in the manuscript.	Agafonov RV, 2009, P NATL ACAD SCI USA, V106, P21625, DOI 10.1073/pnas.0909757106; Andrews DL, 2009, RESONANCE ENERGY TRA, P461; Badali D, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3598109; Bernstein J, 2016, J THEOR BIOL, V401, P109, DOI 10.1016/j.jtbi.2016.04.013; Brillinger DR, 1997, J THEOR PROBAB, V10, P429, DOI 10.1023/A:1022869817770; Camley BA, 2009, THE JOURNAL OF CHEMI, V131; Chung HS, 2009, BIOPHYS J, V98, P696; Clegg RM, 2006, REV FLUORESCENCE, V3, P1; Dean KM, 2012, BBA-MOL CELL RES, V1823, P1406, DOI 10.1016/j.bbamcr.2012.04.001; Deniz AA, 1999, P NATL ACAD SCI USA, V96, P3670, DOI 10.1073/pnas.96.7.3670; Edidin M, 2001, CURRENT PROTOCOLS IM; Fan CH, 2005, TRENDS BIOTECHNOL, V23, P186, DOI 10.1016/j.tibtech.2005.02.005; FORSTER T, 1959, DISCUSS FARADAY SOC, P7; Forster T, 1960, RAD RES S, V2, P326, DOI [DOI 10.2307/3583604, 10.2307/3583604]; Gardiner C.W., 1985, SERIES SYNERGETICS; Gurunathan K, 2010, J PHYS CHEM B, V114, P980, DOI 10.1021/jp907390n; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; HAAS E, 1978, BIOPOLYMERS, V17, P11, DOI 10.1002/bip.1978.360170103; Haas Elisha, 2012, Methods Mol Biol, V895, P467, DOI 10.1007/978-1-61779-927-3_28; Hofmann H, 2010, P NATL ACAD SCI USA, V107, P11793, DOI 10.1073/pnas.1002356107; Iqbal A, 2008, P NATL ACAD SCI USA, V105, P11176, DOI 10.1073/pnas.0801707105; KAWAHARA K, 1966, J BIOL CHEM, V241, P3228; Klose D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039492; Lakowicz JR, 2003, J FLUORESC, V13, P69, DOI 10.1023/A:1022306630924; Li HT, 2004, P NATL ACAD SCI USA, V101, P14425, DOI 10.1073/pnas.0404295101; Li ZG, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061204; Liu BY, 2012, ANALYST, V137, P3717, DOI 10.1039/c2an35434a; Makarov DE, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3212602; Marras SAE, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf121; Merchant KA, 2007, P NATL ACAD SCI USA, V104, P1528, DOI 10.1073/pnas.0607097104; Mori T, 2007, NATURE, V450, P750, DOI 10.1038/nature06346; Munoz-Losa A, 2009, BIOPHYS J, V96, P4779, DOI 10.1016/j.bpj.2009.03.052; Muratsugu A, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4881461; Nath A, 2012, BIOPHYS J, V103, P1940, DOI 10.1016/j.bpj.2012.09.032; Nazarov PV, 2006, BIOPHYS J, V91, P454, DOI 10.1529/biophysj.106.082867; Ni QA, 2010, ADV BIOCHEM ENG BIOT, V119, P79, DOI 10.1007/10_2008_48; Oksendal B, 2000, STOCHASTIC DIFFERENT; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Platen E., 1992, NUMERICAL SOLUTION S; Rahman MM, 2012, SCI J PHYS; Reichl L. E., 1997, MODERN COURSE STAT P; Sahoo H, 2011, J PHOTOCH PHOTOBIO C, V12, P20, DOI 10.1016/j.jphotochemrev.2011.05.001; Schuler B, 2005, P NATL ACAD SCI USA, V102, P2754, DOI 10.1073/pnas.0408164102; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Schuler Benjamin, 2012, Methods Mol Biol, V896, P21, DOI 10.1007/978-1-4614-3704-8_2; Sharma M, 2006, J PHYS CHEM B, V110, P17207, DOI 10.1021/jp064364a; Shrestha D, 2015, INT J MOL SCI, V16, P6718, DOI 10.3390/ijms16046718; Sigurdsson JK, 2016, SOFT MATTER, V12, P6685, DOI 10.1039/c6sm00194g; Song Y, 2011, ANN BIOMED ENG, V39, P1224, DOI 10.1007/s10439-010-0225-x; STEINBERG IZ, 1968, J CHEM PHYS, V48, P2404, DOI 10.1063/1.1669460; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Ueda Y, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00163; van der Meer B. Wieb, 2014, FRET FO RSTER RESONA, P23; van der Meer BW, 2014, OPTIMIZING ORIENTATI, P63; Walczewska-Szewc K, 2014, PHYS CHEM CHEM PHYS, V16, P12317, DOI 10.1039/c4cp01222d; Watkins HM, 2015, P NATL ACAD SCI USA, V112, P6631, DOI 10.1073/pnas.1418673112; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Weiss S, 2000, NAT STRUCT BIOL, V7, P724, DOI 10.1038/78941; Wickersham CE, 2010, NANO LETT, V10, P1022, DOI 10.1021/nl904192m; Yoo TY, 2012, J MOL BIOL, V418, P226, DOI 10.1016/j.jmb.2012.01.016; Zhang J, 2007, J PHYS CHEM C, V111, P50, DOI 10.1021/jp062665e	62	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2017	12	5							e0177122	10.1371/journal.pone.0177122	http://dx.doi.org/10.1371/journal.pone.0177122			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PW	28542211	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672600004
J	Nordell, CJ; Wellicome, TI; Bayne, EM				Nordell, Cameron J.; Wellicome, Troy I.; Bayne, Erin M.			Flight initiation by Ferruginous Hawks depends on disturbance type, experience, and the anthropogenic landscape	PLOS ONE			English	Article							AVIAN NEST DEFENSE; RURAL POPULATIONS; PREDATION RISK; RESPONSES; URBAN; DISTANCES; BEHAVIOR; HUMANS; HABITUATION; CONCEALMENT	The expansion of humans and their related infrastructure is increasing the likelihood that wildlife will interact with humans. When disturbed by humans, animals often change their behaviour, which can result in time and energetic costs to that animal. An animal's decision to change behaviour is likely related to the type of disturbance, the individual's past experience with disturbance, and the landscape in which the disturbance occurs. In southern Alberta and Saskatchewan, we quantified probability of flight initiation from the nest by Ferruginous Hawks (Buteo regalis) during approaches to nests by investigators. We tested if probability of flight was related to different disturbance types, previous experience, and the anthropogenic landscape in which individual Ferruginous Hawks nested. Probability of flight was related to the type of approach by the investigator, the number of previous visits by investigators, and the vehicular traffic around the nest. Approaches by humans on foot resulted in a greater probability of flight than those in a vehicle. Approaches in a vehicle via low traffic volume access roads were related to increased probability of flight relative to other road types. The number of previous investigator approaches to the nest increased the probability of flight. Overall, we found support that Ferruginous Hawks show habituation to vehicles and the positive reinforcement hypotheses as probability of flight was negatively related to an index of traffic activity near the nest. Our work emphasizes that complex, dynamic processes drive the decision to initiate flight from the nest, and contributes to the growing body of work explaining how responses to humans vary within species.	[Nordell, Cameron J.; Bayne, Erin M.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Wellicome, Troy I.] Environm Canada, Edmonton, AB, Canada	University of Alberta; Environment & Climate Change Canada	Nordell, CJ (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	nordell@ualberta.ca		Nordell, Cameron/0000-0001-5142-6827; Bayne, Erin/0000-0002-0679-4521	Environment Canada; Alberta Environment and Parks (AEP); Canadian Department of National Defence; Saskatchewan Ministry of Environment, Agriculture and Agri-food Canada (AAFC); National Science and Engineering Research Council (NSERC); Alberta Conservation Association; Queen Elizabeth II Graduate Scholarship; Alberta Sports and Recreation; Climate Change Emissions Management Corporation	Environment Canada(CGIAR); Alberta Environment and Parks (AEP); Canadian Department of National Defence; Saskatchewan Ministry of Environment, Agriculture and Agri-food Canada (AAFC); National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Conservation Association; Queen Elizabeth II Graduate Scholarship; Alberta Sports and Recreation; Climate Change Emissions Management Corporation	The authors were supported by operating grants from Environment Canada to T.I.W., Alberta Environment and Parks (AEP), Canadian Department of National Defence, and the Saskatchewan Ministry of Environment, Agriculture and Agri-food Canada (AAFC). Additional financial support was obtained from grants awarded by the National Science and Engineering Research Council (NSERC) to E.M.B., Conservation Funds from the Alberta Conservation Association to E.M.B., the Queen Elizabeth II Graduate Scholarship (University of Alberta), Alberta Sports and Recreation, and the Climate Change Emissions Management Corporation. Industrial partners included Nexen Inc., AltaLink, L.P., Cenovus Energy, Suncor Energy, and the Petroleum Technology Alliance of Canada.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Beale C. M., 2007, INT J COMP PSYCHOL, V20, P111; Beale CM, 2004, ANIM BEHAV, V68, P1065, DOI 10.1016/j.anbehav.2004.07.002; Bjorvik LM, 2015, J ORNITHOL, V156, P239, DOI 10.1007/s10336-014-1121-1; Blumstein DT, 2005, J APPL ECOL, V42, P943, DOI 10.1111/j.1365-2664.2005.01071.x; Blumstein DT, 2004, ETHOLOGY, V110, P273, DOI 10.1111/j.1439-0310.2004.00970.x; Blumstein DT, 2003, J WILDLIFE MANAGE, V67, P852, DOI 10.2307/3802692; BOUSKILA A, 1992, AM NAT, V139, P161, DOI 10.1086/285318; BURGER J, 1990, J COMP PSYCHOL, V104, P388, DOI 10.1037/0735-7036.104.4.388; Burhans DE, 2001, AUK, V118, P237, DOI 10.1642/0004-8038(2001)118[0237:ROSNCT]2.0.CO;2; Camp MJ, 2012, ETHOLOGY, V118, P1010, DOI 10.1111/eth.12000; Carrete M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03524; Cooper Jr W. E., 2015, ESCAPING PREDATORS I; Cooper WE, 2007, J HERPETOL, V41, P197, DOI 10.1670/0022-1511(2007)41[197:NSAAPO]2.0.CO;2; Cooper WE, 2007, J THEOR BIOL, V244, P59, DOI 10.1016/j.jtbi.2006.07.011; COX DR, 1972, J R STAT SOC B, V34, P187; de Jong A, 2013, BEHAV ECOL SOCIOBIOL, V67, P1089, DOI 10.1007/s00265-013-1533-6; Diaz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064634; Eason PK, 2006, J WILDLIFE MANAGE, V70, P1796, DOI 10.2193/0022-541X(2006)70[1796:FAFIDI]2.0.CO;2; ELLIOT RD, 1985, BEHAVIOUR, V92, P168, DOI 10.1163/156853985X00433; Environment Canada, 2009, PETR IND ACT GUID WI; ESRI. ArcGIS 10. 2, 2013, ENV SYST RES I; Evans J, 2010, ETHOLOGY, V116, P588, DOI 10.1111/j.1439-0310.2010.01771.x; Fernandez-Juricic E, 2005, BIOL CONSERV, V125, P225, DOI 10.1016/j.biocon.2005.03.020; Fisher AK, 1894, HAWKS OWLS RELATED F; Fisher RJ, 2004, CAN J ZOOL, V82, P707, DOI 10.1139/Z04-035; Fraker M, 2009, OECOLOGIA, V158, P765, DOI 10.1007/s00442-008-1185-9; Frid A, 2002, CONSERV ECOL, V6; Geist C., 2005, Animal Biodiversity and Conservation, V28, P69; Gravolin I, 2014, AVIAN BIOL RES, V7, P244, DOI 10.3184/175815514X14151981691872; Herrero S, 2005, WILDLIFE SOC B, V33, P362, DOI 10.2193/0091-7648(2005)33[362:FTFBBH]2.0.CO;2; HertPicciotto I, 1997, BIOMETRICS, V53, P1151, DOI 10.2307/2533573; HOLMES TL, 1993, WILDLIFE SOC B, V21, P461; Houston AI, 2012, OIKOS, V121, P597, DOI 10.1111/j.1600-0706.2011.19594.x; Jotikapukkana S, 2010, WILDLIFE RES, V37, P466, DOI 10.1071/WR09132; Keeley WH, 2011, J WILDLIFE MANAGE, V75, P1034, DOI 10.1002/jwmg.140; Kissinger M, 2009, ECOL ECON, V68, P2309, DOI 10.1016/j.ecolecon.2009.02.022; Knight R. L., 1995, WILDLIFE RECREATIONI; KNIGHT RL, 1986, AUK, V103, P318, DOI 10.1093/auk/103.2.318; Lee WY, 2011, ANIM COGN, V14, P817, DOI 10.1007/s10071-011-0415-4; Leu M, 2008, ECOL APPL, V18, P1119, DOI 10.1890/07-0480.1; Lin T, 2012, ECOL INDIC, V15, P30, DOI 10.1016/j.ecolind.2011.09.018; Mccleery RA, 2009, LANDSCAPE ECOL, V24, P483, DOI 10.1007/s10980-009-9323-2; McGiffin A, 2013, EMU, V113, P154, DOI 10.1071/MU12107; McLeod EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082008; Migaj A, 2011, FERRUGINOUS HAWK ART; Mikula P, 2014, ARDEA, V102, P53, DOI 10.5253/078.102.0105; Miller RG, 2011, SURVIVAL ANAL, V2nd; Miller V, 2013, J FIELD ORNITHOL, V84, P171, DOI 10.1111/jofo.12015; Moller AP, 2014, BEHAV ECOL, V25, P1505, DOI 10.1093/beheco/aru130; Moller AP, 2014, BEHAV ECOL, V25, P960, DOI 10.1093/beheco/aru073; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; Northrup JM, 2012, J APPL ECOL, V49, P1159, DOI 10.1111/j.1365-2664.2012.02180.x; Olendorff RR, 1994, STATUS BIOL MANAGEME; Price MV, 2014, CURR ZOOL, V60, P693, DOI 10.1093/czoolo/60.6.693; REDONDO T, 1989, BEHAVIOUR, V111, P161, DOI 10.1163/156853989X00646; REDONDO T, 1989, BEHAV ECOL SOCIOBIOL, V25, P369, DOI 10.1007/BF00302995; REGELMANN K, 1986, ANIM BEHAV, V34, P1206, DOI 10.1016/S0003-3472(86)80180-4; Richardson CT, 1997, WILDLIFE SOC B, V25, P634; Roche EA, 2013, WILSON J ORNITHOL, V125, P685, DOI 10.1676/12-196.1; Rowe JS., 1984, PRAIRIE FORUM, V9, P231; Runyan AM, 2004, J WILDLIFE MANAGE, V68, P1124, DOI 10.2193/0022-541X(2004)068[1124:DIDIFI]2.0.CO;2; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Samson FB, 2004, WILDLIFE SOC B, V32, P6, DOI 10.2193/0091-7648(2004)32[6:GPEPPA]2.0.CO;2; SCHMUTZ JK, 1984, J WILDLIFE MANAGE, V48, P1180, DOI 10.2307/3801779; SCHMUTZ JK, 1989, CAN J ZOOL, V67, P2596, DOI 10.1139/z89-366; Scobie C.A., 2015, THESIS; Stalmaster MV, 1998, WILDLIFE MONOGR, P5; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; StataCorp, 2013, STATA STAT SOFTW REL; Steidl RJ, 2000, ECOL APPL, V10, P258, DOI 10.1890/1051-0761(2000)010[0258:EEOHAB]2.0.CO;2; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; Van Horn R. C., 1993, THESIS; Vincze E, 2015, ANIM COGN, V18, P291, DOI 10.1007/s10071-014-0799-z; Wam HK, 2014, EUR J WILDLIFE RES, V60, P839, DOI 10.1007/s10344-014-0841-0; Watson JL, 2014, NW NATURALIST, V95, P150; Watson JW, 2004, J RAPTOR RES, V38, P295; Wellicome TI, 2014, AVIAN CONSERV ECOL, V9, DOI 10.5751/ACE-00624-090104; WESTON J B, 1968, Great Basin Naturalist, V28, P111; WHITE CM, 1985, CONDOR, V87, P14, DOI 10.2307/1367125; Williams Kate, 2013, THESIS; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wolf ID, 2010, APPL ANIM BEHAV SCI, V126, P75, DOI 10.1016/j.applanim.2010.06.001; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8; [No title captured]	87	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177584	10.1371/journal.pone.0177584	http://dx.doi.org/10.1371/journal.pone.0177584			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542334	Green Published, gold, Green Submitted			2022-12-26	WOS:000401672400054
J	Tsuchiya, S; Higashide, T; Sugiyama, K				Tsuchiya, Shunsuke; Higashide, Tomomi; Sugiyama, Kazuhisa			Visual field changes after vitrectomy with internal limiting membrane peeling for epiretinal membrane or macular hole in glaucomatous eyes	PLOS ONE			English	Article							NERVE-FIBER LAYER; RETINAL GANGLION-CELLS; INDOCYANINE GREEN; TRIAMCINOLONE ACETONIDE; BLOOD-FLOW; PREVALENCE; APPEARANCE; AGE; SUSCEPTIBILITY; SENSITIVITY	Purpose To investigate visual field changes after vitrectomy for macular diseases in glaucomatous eyes. Methods A retrospective review of 54 eyes from 54 patients with glaucoma, who underwent vitrectomy for epiretinal membrane (ERM; 42 eyes) or macular hole (MH; 12 eyes). Standard automated perimetry (Humphrey visual field 24-2 program) was performed and analyzed preoperatively and twice postoperatively (1(st) and 2nd sessions; 4.7 +/- 2.5, 10.3 +/- 3.7 months after surgery, respectively). Postoperative visual field sensitivity at each test point was compared with the preoperative value. Longitudinal changes in mean visual field sensitivity (MVFS) of the 12 test points within 10 degrees eccentricity (center) and the remaining test points (periphery), best-corrected visual acuity (BCVA), intraocular pressure (IOP), and ganglion cell complex (GCC) thickness, and the association of factors with changes in central or peripheral MVFS over time were analyzed using linear mixed-effects models. In addition, 45 eyes from 45 patients without glaucoma who underwent vitrectomy for epiretinal membrane (ERM; 34 eyes) or macular hole (MH; 11 eyes) were similarly examined and statistically analyzed (control group). Results In glaucomatous eyes, visual field test points changed significantly and reproducibly; two points deteriorated only at the center and twelve points improved only at the periphery. Central MVFS decreased (p = 0.03), whereas peripheral MVFS increased postoperatively (p = 0.010). In the control group, no visual field test points showed deterioration, and central MVFS did not change significantly after vitrectomy. BCVA improved, GCC thickness decreased, and IOP did not change postoperatively in both groups. The linear mixed-effects models identified older age, systemic hypertension, longer axial length, and preoperative medication scores of >= 2 as risk factors for central MVFS deterioration in glaucomatous eyes. Conclusions Visual field sensitivity within 10 degrees eccentricity may deteriorate after vitrectomy for ERM or MH in glaucomatous eyes.	[Tsuchiya, Shunsuke; Higashide, Tomomi; Sugiyama, Kazuhisa] Kanazawa Univ, Grad Sch Med Sci, Dept Ophthalmol, Kanazawa, Ishikawa, Japan	Kanazawa University	Higashide, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Ophthalmol, Kanazawa, Ishikawa, Japan.	eyetomo@med.kanazawa-u.ac.jp						Almony A, 2012, RETINA-J RET VIT DIS, V32, P877, DOI 10.1097/IAE.0b013e318227ab39; Ang GS, 2010, J GLAUCOMA, V19, P275, DOI 10.1097/IJG.0b013e3181b21fb9; Asrani S, 2014, JAMA OPHTHALMOL, V132, P396, DOI 10.1001/jamaophthalmol.2013.7974; Baba T, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/372589; Baba T, 2012, OPHTHALMOLOGY, V119, P2609, DOI 10.1016/j.ophtha.2012.06.048; Cheng J, 2010, STAT MED, V29, P504, DOI 10.1002/sim.3775; De Moraes CG, 2012, AM J OPHTHALMOL, V154, P702, DOI 10.1016/j.ajo.2012.04.015; Enaida H, RETINA, V26, P631; Gurka MJ, 2011, STAT MED, V30, P2696, DOI 10.1002/sim.4293; Haritoglou C, 2001, BRIT J OPHTHALMOL, V85, P231, DOI 10.1136/bjo.85.2.231; Harman A, 2000, ANAT REC, V260, P124; Hayashi K, 2001, AM J OPHTHALMOL, V132, P41, DOI 10.1016/S0002-9394(01)00920-5; Higashide T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147782; Hood DC, 2007, INVEST OPHTH VIS SCI, V48, P3662, DOI 10.1167/iovs.06-1401; Imai H, 2010, JPN J OPHTHALMOL, V54, P435, DOI 10.1007/s10384-010-0839-4; Iriyama A, 2004, INVEST OPHTH VIS SCI, V45, P943, DOI 10.1167/iovs.03-1026; Ito Y, 2005, OPHTHALMOLOGY, V112, P1415, DOI 10.1016/j.ophtha.2005.02.023; Kadonosono K, 2006, AM J OPHTHALMOL, V142, P513, DOI 10.1016/j.ajo.2006.03.060; Kawasaki R, 2009, EYE, V23, P1045, DOI 10.1038/eye.2008.238; Kimura H, 2004, AM J OPHTHALMOL, V137, P172, DOI 10.1016/S0002-9394(03)00782-7; Lalezary M, 2014, OPHTHALMOLOGY, V121, P1983, DOI 10.1016/j.ophtha.2014.04.008; Leung CKS, 2013, OPHTHALMOLOGY, V120, P2485, DOI 10.1016/j.ophtha.2013.07.021; Levkovitch-Verbin H, 2013, MOL VIS, V19, P2011; Mitamura Y, 2005, OPHTHALMOLOGY, V112, P1766, DOI 10.1016/j.ophtha.2005.04.026; Moroi SE, 2000, OPHTHALMIC SURG LASE; Noma H, 2009, ACTA OPHTHALMOL, V87, P638, DOI 10.1111/j.1755-3768.2008.01318.x; Nukada K, 2013, INVEST OPHTH VIS SCI, V54, P2417, DOI 10.1167/iovs.12-10838; Okamoto M, 2014, OSLI RETINA, V45, P118, DOI 10.3928/23258160-20140306-04; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P8769, DOI 10.1167/iovs.11-8388; Peyman GA, 2000, RETINA-J RET VIT DIS, V20, P554, DOI 10.1097/00006982-200005000-00024; Rao HL, 2013, J GLAUCOMA, V22, P164, DOI 10.1097/IJG.0b013e31822e8e37; Ripandelli G, 2015, RETINA-J RET VIT DIS, V35, P498, DOI 10.1097/IAE.0000000000000330; Schadlu R, 2008, RETINA-J RET VIT DIS, V28, P853, DOI 10.1097/IAE.0b013e3181631962; Siddiqui MAR, 2007, J GLAUCOMA, V16, P205, DOI 10.1097/IJG.0b013e31802dfc35; Spaide RF, 2012, RETINA-J RET VIT DIS, V32, P1719, DOI 10.1097/IAE.0b013e3182671191; Tadayoni R, 2001, OPHTHALMOLOGY, V108, P2279, DOI 10.1016/S0161-6420(01)00856-9; Tadayoni R, 2012, BRIT J OPHTHALMOL, V96, P1513, DOI 10.1136/bjophthalmol-2012-302035; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Traynis I, 2014, JAMA OPHTHALMOL, V132, P291, DOI 10.1001/jamaophthalmol.2013.7656; Ubuka M, 2014, INVEST OPHTH VIS SCI, V55, P1625, DOI 10.1167/iovs.13-13801; Wang AL, 2007, ANN NY ACAD SCI, V1097, P64, DOI 10.1196/annals.1379.027; Yamamoto T, 2005, OPHTHALMOLOGY, V112, P1661, DOI 10.1016/j.ophtha.2005.05.012; Yamashita T, 2006, OPHTHALMOLOGY, V113, P280, DOI 10.1016/j.ophtha.2005.10.046	43	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2017	12	5							e0177526	10.1371/journal.pone.0177526	http://dx.doi.org/10.1371/journal.pone.0177526			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV3PV	28542230	Green Published, Green Submitted, gold			2022-12-26	WOS:000401672400048
J	Bhagwat, T; Hess, A; Horning, N; Khaing, T; Thein, ZM; Aung, KM; Aung, KH; Phyo, P; Tun, YL; Oo, AH; Neil, A; Thu, WM; Songer, M; Connette, KL; Bernd, A; Huang, Q; Connette, G; Leimgruber, P				Bhagwat, Tejas; Hess, Andrea; Horning, Ned; Khaing, Thiri; Thein, Zaw Min; Aung, Kyaw Moe; Aung, Kyaw Htet; Phyo, Paing; Tun, Ye Lin; Oo, Aung Htat; Neil, Anthony; Thu, Win Myo; Songer, Melissa; Connette, Katherine LaJeunesse; Bernd, Asja; Huang, Qiongyu; Connette, Grant; Leimgruber, Peter			Losing a jewel-Rapid declines in Myanmar's intact forests from 2002-2014	PLOS ONE			English	Article							MAINLAND SOUTHEAST-ASIA; PROTECTED-AREA SYSTEM; PITTA PITTA-GURNEYI; COVER CHANGE; CLOUD SHADOW; HABITAT USE; CONSERVATION; DEFORESTATION; BIODIVERSITY; CLASSIFICATION	New and rapid political and economic changes in Myanmar are increasing the pressures on the country's forests. Yet, little is known about the past and current condition of these forests and how fast they are declining. We mapped forest cover in Myanmar through a consortium of international organizations and environmental non-governmental groups, using freely-available public domain data and open source software tools. We used Landsat satellite imagery to assess the condition and spatial distribution of Myanmar's intact and degraded forests with special focus on changes in intact forest between 2002 and 2014. We found that forests cover 42,365,729 ha or 63% of Myanmar, making it one of the most forested countries in the region. However, severe logging, expanding plantations, and degradation pose increasing threats. Only 38% of the country's forests can be considered intact with canopy cover >80%. Between 2002 and 2014, intact forests declined at a rate of 0.94% annually, totaling more than 2 million ha forest loss. Losses can be extremely high locally and we identified 9 townships as forest conversion hotspots. We also delineated 13 large (> 100,000 ha) and contiguous intact forest landscapes, which are dispersed across Myanmar. The Northern Forest Complex supports four of these landscapes, totaling over 6.1 million ha of intact forest, followed by the Southern Forest Complex with three landscapes, comprising 1.5 million ha. These remaining contiguous forest landscape should have high priority for protection. Our project demonstrates how open source data and software can be used to develop and share critical information on forests when such data are not readily available elsewhere. We provide all data, code, and outputs freely via the internet at (for scripts: https://bitbucket.org/rsbiodiv/; for the data: http://geonode.themimu.info/layers/geonode%3Amyan_ lvl2_ smoothed_ dec2015_ resamp)	[Bhagwat, Tejas; Songer, Melissa; Connette, Katherine LaJeunesse; Huang, Qiongyu; Connette, Grant; Leimgruber, Peter] Smithsonian Conservat Biol Inst, Conservat Ecol Ctr, Front Royal, VA 22630 USA; [Hess, Andrea] Univ Bayreuth, Dept Geosci, Bayreuth, Germany; [Horning, Ned] Amer Museum Nat Hist, New York, NY 10024 USA; [Khaing, Thiri; Thein, Zaw Min; Aung, Kyaw Htet; Phyo, Paing; Tun, Ye Lin; Oo, Aung Htat; Neil, Anthony; Thu, Win Myo; Bernd, Asja] EcoDev ALARM, Kamayut Township, Yangon, Myanmar; [Khaing, Thiri; Thein, Zaw Min; Aung, Kyaw Moe; Aung, Kyaw Htet; Phyo, Paing; Tun, Ye Lin; Oo, Aung Htat] GMAP, Hlaing Township, Yangon, Myanmar	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Bayreuth; American Museum of Natural History (AMNH)	Leimgruber, P (corresponding author), Smithsonian Conservat Biol Inst, Conservat Ecol Ctr, Front Royal, VA 22630 USA.	leimgruberp@si.edu	Leimgruber, Peter/O-1304-2015	Leimgruber, Peter/0000-0002-3682-0153; Songer, Melissa/0000-0001-5536-6315; LaJeunesse Connette, Katie/0000-0002-9011-8859; Connette, Grant/0000-0002-9424-6591; Huang, Qiongyu/0000-0002-1450-3587	European Union's Forest Law Enforcement, Governance and Trade (EU FLEGT); Myanmar CSO ALARM (previously ECODEV); Helmsley Charitable Trust; U.S. Agency for International Development (USAID); International Union for Conservation of Nature (IUCN)	European Union's Forest Law Enforcement, Governance and Trade (EU FLEGT); Myanmar CSO ALARM (previously ECODEV); Helmsley Charitable Trust; U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); International Union for Conservation of Nature (IUCN)	We thank our colleagues from local and national conservation organizations and the Ministry of Environmental Conservation and Forestry (MOECAF) for providing expert input in developing our maps and assessing their accuracy. These organizations include Myanmar Environment Rehabilitation-conservation Network (MERN), Friends of Wildlife (FOW), GMAP, Wildlife Conservation Society (WCS), Fauna and Flora International (FFI), and International Union for Conservation of Nature (IUCN). We would like to especially thank U Kyaw Htun, Patrick Oswald, U Myint Aung, U Tin Tun, Made Ferguson, Jake Brunner, and Dan Constable for their continued interest, insights, and help in developing assessment. Funding for this research was provided European Union's Forest Law Enforcement, Governance and Trade (EU FLEGT) project with the Myanmar CSO ALARM (previously ECODEV), the Helmsley Charitable Trust, U.S. Agency for International Development (USAID), and International Union for Conservation of Nature (IUCN).	Ahrends A, 2010, P NATL ACAD SCI USA, V107, P14556, DOI 10.1073/pnas.0914471107; Bodart C, 2011, ISPRS J PHOTOGRAMM, V66, P555, DOI 10.1016/j.isprsjprs.2011.03.003; Brunner J, 1998, LOGGING BURMAS FRONT; Bryant R.L., 1997, POLITICAL ECOLOGY FO; Canty MJ, 2008, REMOTE SENS ENVIRON, V112, P1025, DOI 10.1016/j.rse.2007.07.013; Canty MJ, 2007, P SOC PHOTO-OPT INS, V6748, P74808, DOI 10.1117/12.736409; Cutler DR, 2015, RANDOM FORESTS CLASS, V88, P2783; Defourny P, 2007, INT J REMOTE SENS, V28, P5123; Donald PF, 2009, BIRD CONSERV INT, V19, P353, DOI 10.1017/S0959270909008612; Eames JC, 2005, BIRD CONSERV INT, V15, P3, DOI 10.1017/S095927090500002X; FAO, 2020, GLOBAL FOREST RESOUR; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Fox J, 2014, GLOBAL ENVIRON CHANG, V29, P318, DOI 10.1016/j.gloenvcha.2013.05.011; Fox J, 2013, J PEASANT STUD, V40, P155, DOI 10.1080/03066150.2012.750605; Ghimire B, 2010, REMOTE SENS LETT, V1, P45, DOI 10.1080/01431160903252327; Gin OK, SE ASIA HIST ENCY AN; Gislason PO, 2006, PATTERN RECOGN LETT, V27, P294, DOI 10.1016/j.patrec.2005.08.011; Gong P, 2011, GEOMATICS WORLD, V9, P34; Gong P, 2013, INT J REMOTE SENS, V34, P2607, DOI 10.1080/01431161.2012.748992; Hansen MC, 2008, REMOTE SENS ENVIRON, V112, P2495, DOI 10.1016/j.rse.2007.11.012; Hansen MC, 2012, REMOTE SENS ENVIRON, V122, P66, DOI 10.1016/j.rse.2011.08.024; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Hansen MC, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034001; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hartley CWS., 1988, OIL PALM ELAEIS GUIN, V3rd; Horning N, 2010, RANDOM FORESTS ALGOR, V2010, P1; Kim DH, 2014, REMOTE SENS ENVIRON, V155, P178, DOI 10.1016/j.rse.2014.08.017; Koy K, 2005, ANIM CONSERV, V8, P289, DOI 10.1017/S1367943005002209; Kyaw WW, 2011, ENRGY PROCED, V9, DOI 10.1016/j.egypro.2011.09.038; Leimgruber P, 2011, ECOLOGY CONSERVATION, P59; Leimgruber P, 2005, ENVIRON CONSERV, V32, P356, DOI 10.1017/S0376892905002493; Li P, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8010044; Li P, 2014, REMOTE SENS-BASEL, V6, P1654, DOI 10.3390/rs6021654; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; MoECAF, 2011, NAT BIOD STRAT ACT P; Mon MS, 2012, FOREST ECOL MANAG, V267, P190, DOI 10.1016/j.foreco.2011.11.036; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ngoprasert D, 2007, ORYX, V41, P343, DOI 10.1017/S0030605307001102; Olander LP, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/2/025011; Paul A, 2005, CURR SCI INDIA, V89, P623; Perz SG, 2013, LAND USE POLICY, V34, P27, DOI 10.1016/j.landusepol.2013.01.009; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; Potapov PV, 2012, REMOTE SENS ENVIRON, V122, P106, DOI 10.1016/j.rse.2011.08.027; RAHMAN H, 1994, INT J REMOTE SENS, V15, P123, DOI 10.1080/01431169408954055; Rao M, 2002, CONSERV BIOL, V16, P360, DOI 10.1046/j.1523-1739.2002.00219.x; Rao M, 2013, AMBIO, V42, P789, DOI 10.1007/s13280-013-0423-5; Rodriguez-Galiano VF, 2012, REMOTE SENS ENVIRON, V121, P93, DOI 10.1016/j.rse.2011.12.003; Rodriguez-Galiano VF, 2012, ISPRS J PHOTOGRAMM, V67, P93, DOI 10.1016/j.isprsjprs.2011.11.002; Saxon E.C., 2014, 1 FAUN FLOR INT; Schmidt-Vogt D, 2009, HUM ECOL, V37, P269, DOI 10.1007/s10745-009-9239-0; Selmier WT, 2013, BUS HORIZONS, V56, P757, DOI 10.1016/j.bushor.2013.08.003; Simcharoen S, 2008, BIOL CONSERV, V141, P2242, DOI 10.1016/j.biocon.2008.06.015; SKOLE D, 1993, SCIENCE, V260, P1905, DOI 10.1126/science.260.5116.1905; Smith JH, 2002, PHOTOGRAMM ENG REM S, V68, P65; Songer M, 2011, ECOLOGY CONSERVATION, P305; Songer M, 2009, BIODIVERS CONSERV, V18, P1001, DOI 10.1007/s10531-008-9490-5; Sovacool BK, 2013, ENERGY SUSTAIN DEV, V17, P305, DOI 10.1016/j.esd.2013.03.010; Stibig HJ, 2014, BIOGEOSCIENCES, V11, P247, DOI 10.5194/bg-11-247-2014; Stibig H-J, 2007, JRC SCI TECH REPORTS; Tantipisanuh N, 2016, BIOL CONSERV, V195, P203, DOI 10.1016/j.biocon.2015.12.043; Telmer KM, 2009, MERCURY FATE AND TRANSPORT IN THE GLOBAL ATMOSPHERE, P131, DOI 10.1007/978-0-387-93958-2_6; Webb EL, 2014, GLOBAL ENVIRON CHANG, V24, P321, DOI 10.1016/j.gloenvcha.2013.10.007; Win NN, 2013, OSRORAS102EC IPC AS; Wohlfart C, 2014, TROP CONSERV SCI, V7, P597, DOI 10.1177/194008291400700402; Yu L, 2012, INT J REMOTE SENS, V33, P3966, DOI 10.1080/01431161.2011.636081; Zhu Z, 2015, REMOTE SENS ENVIRON, V159, P269, DOI 10.1016/j.rse.2014.12.014; Zhu Z, 2012, REMOTE SENS ENVIRON, V118, P83, DOI 10.1016/j.rse.2011.10.028	67	64	66	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2017	12	5							e0176364	10.1371/journal.pone.0176364	http://dx.doi.org/10.1371/journal.pone.0176364			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DX	28520726	Green Submitted, Green Published, gold			2022-12-26	WOS:000401487700016
J	Schuppe, ER; Pradhan, DS; Thonkulpitak, K; Drilling, C; Black, M; Grober, MS				Schuppe, Eric R.; Pradhan, Devaleena S.; Thonkulpitak, Kevin; Drilling, Cathleen; Black, Michael; Grober, Matthew S.			Sex differences in neuromuscular androgen receptor expression and sociosexual behavior in a sex changing fish	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; SPINAL-CORD; BLUEGILL SUNFISH; LIMB MUSCLES; BRAIN; MOTOR; COURTSHIP; NUCLEUS; 11-KETOTESTOSTERONE; IMMUNOREACTIVITY	Androgen signaling, via receptor binding, is critical for regulating the physiological and morphological foundations of male-typical reproductive behavior in vertebrates. Muscles essential for male courtship behavior and copulation are highly sensitive to androgens. Differences in the distribution and density of the androgen receptor (AR) are important for maintaining dimorphic musculature and thus may provide for anatomical identification of sexually selected traits. In Lythrypnus dalli, a bi-directional hermaphroditic teleost fish, both sexes produce agonistic approach displays, but reproductive behavior is sexually dimorphic. The male-specific courtship behavior is characterized by rapid jerky movements (involving dorsal fin erection) towards a female or around their nest. Activation of the supracarinalis muscle is involved in dorsal fin contributions to both agonistic and sociosexual behavior in other fishes, suggesting that differences in goby sexual behavior may be reflected in sexual dimorphism in AR signaling in this muscle. We examined sex differences in the local distribution of AR in supracarinalis muscle and spinal cord. Our results demonstrate that males do express more AR in the supracarinalis muscle relative to females, but there was no sex difference in the number of spinal motoneurons expressing AR. Interestingly, AR expression in the supracarinalis muscle was also related to rates of sociosexual behavior in males, providing evidence that sexual selection may influence muscle androgenic sensitivity to enhance display vigor. Sex differences in the distribution and number of cells expressing AR in the supracarinalis muscle may underlie the expression of dimorphic behaviors in L. dalli.	[Schuppe, Eric R.; Pradhan, Devaleena S.; Thonkulpitak, Kevin; Drilling, Cathleen; Black, Michael; Grober, Matthew S.] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Black, Michael] Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA; [Schuppe, Eric R.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Pradhan, Devaleena S.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Wake Forest University; University of California System; University of California Los Angeles	Schuppe, ER (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA.; Schuppe, ER (corresponding author), Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA.	ericschuppe@gmail.com	Pradhan, Devaleena/AAF-7296-2019	Pradhan, Devaleena/0000-0002-7755-2538	NSF [IBN-9723817]; Georgia Research Alliance; GSU-RPE	NSF(National Science Foundation (NSF)); Georgia Research Alliance; GSU-RPE	This study was supported in part by NSF IBN-9723817 to MSG. Additional support was provided by the Georgia Research Alliance and GSU-RPE program.	Aizawa K, 2010, STEROIDS, V75, P219, DOI 10.1016/j.steroids.2009.12.002; [Anonymous], 2015, SIMULTANEOUS COURTSH; Black MP, 2005, P ROY SOC B-BIOL SCI, V272, P2435, DOI 10.1098/rspb.2005.3210; BRANTLEY RK, 1993, BRAIN BEHAV EVOLUT, V42, P336, DOI 10.1159/000114170; BREEDLOVE SM, 1981, BRAIN RES, V225, P297; Chaikovskii VS, 1984, PROBLEMY ENDOKRINOLO, V31, P78; Chakraborty SB, 2011, AQUACULT INT, V19, P1119, DOI 10.1007/s10499-011-9428-x; Copp C., 1884, P CANADIAN I; Fargo KN, 2009, FRONT NEUROENDOCRIN, V30, P130, DOI 10.1016/j.yfrne.2009.04.005; Feng NY, 2010, ENDOCRINOLOGY, V151, P1042, DOI 10.1210/en.2009-0901; Fischer LM, 1991, SEMINARS NEUROSCIENC; Flammang BE, 2008, J EXP BIOL, V211, P587, DOI 10.1242/jeb.012096; Forlano PM, 2010, J COMP NEUROL, V518, P493, DOI 10.1002/cne.22233; FREEMAN LM, 1995, J NEUROBIOL, V27, P51, DOI 10.1002/neu.480270106; Fuxjager MJ, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0156-y; Fuxjager MJ, 2015, FUNCT ECOL, V29, P1197, DOI 10.1111/1365-2435.12438; Fuxjager MJ, 2013, ENDOCRINOLOGY, V154, P3168, DOI 10.1210/en.2013-1302; Fuxjager MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051482; Fuxjager MJ, 2012, ENDOCRINOLOGY, V153, P3780, DOI 10.1210/en.2012-1313; Gustavson S, 1994, SOC NEUROSCI; Herrel A, 1996, NETH J ZOOL, V46, P253; Holmes MM, 2005, J NEUROENDOCRINOL, V17, P560, DOI 10.1111/j.1365-2826.2005.01339.x; Huyghe K, 2010, J EXP ZOOL PART A, V313A, P9, DOI 10.1002/jez.569; Kadi F, 2000, HISTOCHEM CELL BIOL, V113, P25, DOI 10.1007/s004180050003; Liu XC, 2009, GEN COMP ENDOCR, V160, P93, DOI 10.1016/j.ygcen.2008.10.026; Lorenzi V, 2008, GEN COMP ENDOCR, V155, P438, DOI 10.1016/j.ygcen.2007.07.010; Lorenzi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051158; Mangiamele LA, 2016, P NATL ACAD SCI USA; Munchrath LA, 2010, J COMP NEUROL, V518, P3302, DOI 10.1002/cne.22401; Neal JK, 2007, HORM BEHAV, V52, P228, DOI 10.1016/j.yhbeh.2007.04.009; Perez J, 1996, J NEUROBIOL, V30, P556, DOI 10.1002/(SICI)1097-4695(199608)30:4<556::AID-NEU10>3.3.CO;2-3; Pouso P, 2010, HORM BEHAV, V58, P729, DOI 10.1016/j.yhbeh.2010.07.005; Pradhan DS, 2014, HORM BEHAV, V65, P47, DOI 10.1016/j.yhbeh.2013.11.006; Pradhan DS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0239; Reavis Robert H., 1999, Acta Ethologica, V2, P51, DOI 10.1007/PL00012232; Robson MA, 2000, FUNCT ECOL, V14, P338, DOI 10.1046/j.1365-2435.2000.00427.x; Rodgers CMC, 2013, HORM BEHAV, V63, P454, DOI 10.1016/j.yhbeh.2012.12.008; Rodgers EW, 2007, J FISH BIOL, V70, P1660, DOI 10.1111/j.1095-8649.2007.01427.x; Rodgers EW, 2006, HORM BEHAV, V49, P610, DOI 10.1016/j.yhbeh.2006.01.008; Rodgers EW, 2005, BIOL BULL-US, V208, P120, DOI 10.2307/3593120; SASSOON DA, 1987, J NEUROSCI, V7, P3198; Schlinger BA, 2013, FRONT NEUROENDOCRIN, V34, P143, DOI 10.1016/j.yfrne.2013.04.001; Schultz JD, 2001, J COMP PHYSIOL A, V187, P677; Schuppe ER, 2016, EVOL DEV, V18, P285, DOI 10.1111/ede.12207; Sengelaub DR, 2008, HORM BEHAV, V53, P596, DOI 10.1016/j.yhbeh.2007.11.008; St Mary C., 1994, BEHAV ECOLOGY, V5, P304, DOI DOI 10.1093/BEHEC0/5.3.304; Stewart TA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2159; Watson NV, 2001, J NEUROSCI, V21, P1062, DOI 10.1523/JNEUROSCI.21-03-01062.2001; Willoughby DS, 2004, MED SCI SPORT EXER, V36, P1499, DOI 10.1249/01.MSS.0000139795.83030.D1; Zuloaga DG, 2008, HORM BEHAV, V53, P613, DOI 10.1016/j.yhbeh.2008.01.013	50	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2017	12	5							e0177711	10.1371/journal.pone.0177711	http://dx.doi.org/10.1371/journal.pone.0177711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EV1DC	28520775	gold, Green Published, Green Submitted			2022-12-26	WOS:000401485500061
